PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	PG	WC	SC	GA	UT	PM
J	Ishikura, S; Yamasaki, S; Ando, S; Nishida, A; Tanoue, M; Niimura, J; Asukai, N; Okazaki, Y				Ishikura, Shigeko; Yamasaki, Syudo; Ando, Shuntaro; Nishida, Atsushi; Tanoue, Michika; Niimura, Junko; Asukai, Nozomu; Okazaki, Yuji			Association between parents' trust in mental health professionals and disengagement from psychiatric service within the first 6 months of initial treatment of schizophrenia	EARLY INTERVENTION IN PSYCHIATRY			English	Article						disengagement; family; initial period of treatment; schizophrenia; trust in mental health professional	EARLY INTERVENTION; 1ST-EPISODE PSYCHOSIS; EXPECTATIONS; ILLNESS; TRIAL; TEAM; CARE	AimTo investigate the association between parents' encounter with reliable mental health professionals and disengagement from initial treatment among patients with schizophrenia. MethodsThis study was a part of the Reaching People Early Tokyo Survey. Participants were recruited from groups for family members of people with mental ill-health around Tokyo. Self-report questionnaires completed by 467 parents were analysed. ResultsDisengagement rate was 16.2% among patients whose parents met reliable mental health professionals within the initial 6 months, but 33.7% among patients whose parents did not report meeting such professionals. The odds of disengagement was less than half in the first group than in the second group (OR 0.38, 95% CI 0.21-0.67). ConclusionsEstablishing trust with family members might prevent disengagement from initial treatment among patients with schizophrenia. Mental health professionals should spend time to build a trusting relationship with families within the initial period of treatment.	[Ishikura, Shigeko; Okazaki, Yuji] Tokyo Metropolitan Matsuzawa Hosp, Dept Social Work, Tokyo, Japan; [Ishikura, Shigeko; Yamasaki, Syudo; Ando, Shuntaro; Nishida, Atsushi; Tanoue, Michika; Niimura, Junko; Asukai, Nozomu] Tokyo Metropolitan Inst Med Sci, Dept Psychiat & Behav Sci, Tokyo 1568506, Japan; [Tanoue, Michika] Tokyo Med & Dent Univ, Psychiat & Mental Hlth Nursing, Tokyo, Japan	Nishida, A (reprint author), Tokyo Metropolitan Inst Med Sci, Dept Psychiat & Behav Sci, Setagaya Ku, 2-1-6 Kamikitazawa, Tokyo 1568506, Japan.	nishida-at@igakuken.or.jp			Ministry of Health, Labour, and Welfare of Japan Scientific Research Grant [H19-kokoro-ippan-012]	This study was supported by the Ministry of Health, Labour, and Welfare of Japan Scientific Research Grant (#H19-kokoro-ippan-012) to Dr Yuji Okazaki. We would like to thank the members of the Tokyo Association of Families of People with Mental Ill-Health and the Atsugi Branch of the Kanagawa Association of Families of People with Mental Ill-Health, as well as Professor Takeshi Nonaka for their cooperation on this survey.	Ando S, 2013, PSYCHIAT SERV, V64, P932, DOI 10.1176/appi.ps.005132012; Bertolote J, 2005, BRIT J PSYCHIAT, V187, pS116, DOI 10.1192/bjp.187.48.s116; Petersen L, 2005, BRIT MED J, V331, P602, DOI 10.1136/bmj.38565.415000.E01; Crumlish N, 2009, BRIT J PSYCHIAT, V194, P18, DOI 10.1192/bjp.bp.107.048942; Craig TK, 2004, BRIT MED J, V329, P1067, DOI 10.1136/bmj.38246.594873.7C; Conus P, 2010, SCHIZOPHR RES, V118, P256, DOI 10.1016/j.schres.2010.01.032; Turner M, 2007, EARLY INTERV PSYCHIA, V1, P276, DOI 10.1111/j.1751-7893.2007.00039.x; O'Brien A, 2009, SOC PSYCH PSYCH EPID, V44, P558, DOI 10.1007/s00127-008-0476-0; Kreyenbuhl J, 2009, SCHIZOPHRENIA BULL, V35, P696, DOI 10.1093/schbul/sbp046; Kazdin AE, 1997, J CONSULT CLIN PSYCH, V65, P453, DOI 10.1037/0022-006X.65.3.453; Logan DE, 2001, CLIN PSYCHOL-SCI PR, V8, P319, DOI 10.1093/clipsy/8.3.319; Priebe S, 2005, BRIT J PSYCHIAT, V187, P438, DOI 10.1192/bjp.187.5.438; Baumann PS, 2013, EARLY INTERV PSYCHIA, V7, P322, DOI 10.1111/eip.12037; BURCK C, 1978, BRIT J SOC WORK, V8, P145; DAY L, 1980, J CONSULT CLIN PSYCH, V48, P303, DOI 10.1037//0022-006X.48.2.303; Dodgson G, 2012, EARLY INTERV PSYCHIA, V6, P465, DOI 10.1111/j.1751-7893.2012.00349.x; HOLDEN DF, 1982, SCHIZOPHRENIA BULL, V8, P626; International Early Psychosis Association Writing Group, 2005, BRIT J PSYCHIAT, V187, ps120, DOI DOI 10.1192/BJP.187.48.S120; Morrissey-Kane E, 1999, Clin Child Fam Psychol Rev, V2, P183, DOI 10.1023/A:1021807106455; Orygen Youth Health Research Centre, 2010, AUSTR CLIN GUID EARL; PLUNKETT JW, 1984, J CLIN PSYCHOL, V40, P372, DOI 10.1002/1097-4679(198401)40:1<372::AID-JCLP2270400169>3.0.CO;2-Q; Richwood DJ, 2007, MED J AUSTRALIA, V187, pS35; van de Bovenkamp HM, 2010, PATIENT EDUC COUNS, V80, P120, DOI 10.1016/j.pec.2009.09.022; Winefield HR, 1996, J MENTAL HLTH, V5, P223, DOI 10.1080/09638239650036893	24	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1751-7885	1751-7893		EARLY INTERV PSYCHIA	Early Interv. Psychiatry	AUG	2015	9	4					335	338		10.1111/eip.12162		4	Psychiatry	Psychiatry	CM8YP	WOS:000357990400010		
J	Jiao, Y; Kishiki, S; Yamada, S; Ene, D; Konishi, Y; Hoashi, Y; Terashima, M				Jiao, Yu; Kishiki, Shoichi; Yamada, Satoshi; Ene, Diana; Konishi, Yoshinao; Hoashi, Yuuma; Terashima, Masao			Low cyclic fatigue and hysteretic behavior of U-shaped steel dampers for seismically isolated buildings under dynamic cyclic loadings	EARTHQUAKE ENGINEERING & STRUCTURAL DYNAMICS			English	Article						steel damper; base isolation; full-scale dynamic loading tests; low-cycle fatigue life; plastic deformation capacity; energy dissipation capacity		Energy dissipation devices are necessary for base-isolated buildings to control the deformation in the isolation system and to dissipate the earthquake-induced energy. U-shaped steel dampers (also known as U-dampers) dissipate energy through plastic deformation of specially designed U-shaped steel elements. This type of device can be installed at several locations in the isolation system. U-dampers have been widely used in Japan for different types of isolated structures, such as hospitals, plants and residential buildings, since the 1995 Kobe Earthquake. Previous research has used static tests to estimate the performance of U-dampers. However, the ultimate plastic deformation capacities and hysteretic behaviors of full-scale U-dampers under dynamic excitations still remain unclear. In addition, it is unclear whether the initial temperature has an effect on the hysteretic behavior and plastic deformation capacity of U-dampers. In this paper, two series of dynamic loading tests of U-dampers were conducted to evaluate the issues described earlier. The major findings of the study are (i) the loading speed has little effect on the plastic deformation capacity of U-dampers; (ii) method to evaluate the ultimate plastic deformation capacities of U-shaped steel dampers of different sizes is established using a Manson-Coffin relation-based equation that is based on the peak-to-peak horizontal shear angle (t), which is defined as the lateral deformation amplitude (peak-to-peak amplitude) divided by the height of the dampers; (iii) the loading rate and the initial temperature have a minimal effect on the hysteretic behavior of the U-dampers; and (iv) a bilinear model is proposed to simulate the force-deformation relationships of the U-dampers. Copyright (c) 2014 John Wiley & Sons, Ltd.	[Jiao, Yu] Tokyo Univ Sci, Tokyo 1250051, Japan; [Kishiki, Shoichi] Osaka Inst Technol, Dept Architecture, Osaka 535, Japan; [Yamada, Satoshi] Tokyo Inst Technol, Struct Engn Res Ctr, Yokohama, Kanagawa 227, Japan; [Ene, Diana] Tokyo Inst Technol, Dept Environm Sci & Technol, Yokohama, Kanagawa 227, Japan; [Konishi, Yoshinao; Hoashi, Yuuma; Terashima, Masao] Nippon Steel & Sumikin Engn, Tokyo, Japan	Jiao, Y (reprint author), Tokyo Univ Sci, Dept Architecture, Tokyo 1250051, Japan.	yjiao.sjtu.titech@gmail.com					MOKHA A, 1991, J STRUCT ENG-ASCE, V117, P1201, DOI 10.1061/(ASCE)0733-9445(1991)117:4(1201); Hwang JS, 1997, J STRUCT ENG-ASCE, V123, P1029, DOI 10.1061/(ASCE)0733-9445(1997)123:8(1029); Konishis Y, 2012, 15 WORLD C EARTHQ EN; Kouchiyamas O, 2013, P 13 WORLD C SEISM I; Lins PY, 2004, P 13WCEE CAN; Naeims F, 2007, DESIGN SEISMIC ISOLA; Ohs S-H, 2012, INT J STEEL STRUCT, V12, P285; Robisons WH, 1988, 9 WORLD C EARTHQ ENG; Suzukis K, 2000, P ARCH I JAP AIJ A B, VB-2, P659; Suzukis K, 1999, P ARCH I JAP AIJ A B, VB-2, P665; Suzukis K, 2005, 92 NIPP STEEL TECHN	11	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0098-8847	1096-9845		EARTHQ ENG STRUCT D	Earthq. Eng. Struct. Dyn.	AUG	2015	44	10					1523	1538		10.1002/eqe.2533		16	Engineering, Civil; Engineering, Geological	Engineering	CM8SV	WOS:000357973200002		
J	Shibasaki, I; Kuriyama, K; Makino, T; Hukasawa, N; Suzuki, K				Shibasaki, Ichiro; Kuriyama, Kenji; Makino, Takashi; Hukasawa, Naoya; Suzuki, Kenji			High Sensitivity InAs DQW Linear Hybrid Hall ICs with InAs Deep Quantum Well Hall Elements	ELECTRONICS AND COMMUNICATIONS IN JAPAN			English	Article						Hall element; linear hybrid Hall IC; current sensor; magnetic sensor; contactless sensor		By electrically connecting and placing an InAs deep quantum well (DQW) Hall element as a magnetic sensor chip and an Si IC linear amplifier in a small plastic package, a very small InAs DQW linear hybrid Hall IC (InAs DQW LHHIC) with a high magnetic field sensitivity has been developed. The output voltage of the hybrid Hall IC showed a very small temperature coefficient of 0.02%/degrees C and the response time was very low, less than 3 s. By using this InAs DQW LHHIC, practical current sensors with high sensitivity, high accuracy, and temperature stability have been developed.	[Shibasaki, Ichiro] Toyohashi Inst Technol, Grad Sch, Toyohashi, Aichi, Japan; [Shibasaki, Ichiro] Noguchi Inst, Tokyo, Japan; [Kuriyama, Kenji; Makino, Takashi; Hukasawa, Naoya; Suzuki, Kenji] Asahi Kasei Elect Corp, Tokyo, Japan	Shibasaki, I (reprint author), Toyohashi Inst Technol, Grad Sch, Toyohashi, Aichi, Japan.						[Anonymous], 2007, ASAHI KASEI ELECT CO; KUZE N, 1995, J CRYST GROWTH, V150, P1307, DOI 10.1016/0022-0248(95)80150-B; Nagase K, 1993, 7 INT C SOL STAT SEN, P34; Shibasaki I, 1997, J CRYST GROWTH, V175, P13, DOI 10.1016/S0022-0248(96)00924-4; Shibasaki I., 1999, Transactions of the Institute of Electrical Engineers of Japan, Part E, V119-E; Suzuki K, 2003, 20 SENS S, P167	6	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1942-9533	1942-9541		ELECTR COMMUN JPN	Electr. Commun. Jpn.	AUG	2015	98	8					1	8		10.1002/ecj.11698		8	Engineering, Electrical & Electronic	Engineering	CM9DO	WOS:000358006900001		
J	Uno, K; Naito, G; Tobisa, Y; Yoshida, L; Ogawa, Y; Kotani, K; Jimbo, Y				Uno, Kosuke; Naito, Genzo; Tobisa, Yohei; Yoshida, Lui; Ogawa, Yutaro; Kotani, Kiyoshi; Jimbo, Yasuhiko			Basic Investigation of Brain-Computer Interface Combined with Augmented Reality and Development of an Improvement Method Using the Nontarget Object	ELECTRONICS AND COMMUNICATIONS IN JAPAN			English	Article						Brain-computer interface; augmented reality; P300; support vector machine; electroencephalogram	P300	Brain-computer interfaces (BCI) have been studied to allow handicapped people to communicate and control their environments. However, conventional BCIs require a determination of what objects are displayed as targets in advance. BCI combined with augmented reality (AR) can display suitable choices with consideration of real space and can allow users to control devices intuitively. However, little is known about how AR systems affect the accuracy of BCIs; significant factors that may be affected include the background of AR-BCI derived from scenery and the change of the number of target choices. In this research, uwe confirm these two effects and develop a new method using a nontarget object when there is a small number of possible targets. The results show that the background has no effect, and that changing the target decreases the accuracy. However, the proposed method improves the accuracy of AR-BCI.	[Uno, Kosuke] Univ Tokyo, ME Program Human & Environm Studies, Grad Sch Frontier Sci, Tokyo 1138654, Japan; [Naito, Genzo; Tobisa, Yohei; Yoshida, Lui] Univ Tokyo, Grad Sch Frontier Sci, Tokyo 1138654, Japan; [Ogawa, Yutaro] Univ Tokyo, Tokyo 1138654, Japan; [Kotani, Kiyoshi] Univ Tokyo, Grad Sch Engn, Tokyo 1138654, Japan; [Jimbo, Yasuhiko] Univ Tokyo, Fac Engn, Precis Mech Engn, Tokyo 1138654, Japan	Uno, K (reprint author), Univ Tokyo, ME Program Human & Environm Studies, Grad Sch Frontier Sci, Tokyo 1138654, Japan.				"Young ICT Researcher R&D in the Strategic Information and Communication R&D Promotion Programme" (SCOPE) of the Ministry of Internal Affairs and Communications; KDDI Corporation	The present research was supported in part by the "Young ICT Researcher R&D in the Strategic Information and Communication R&D Promotion Programme" (SCOPE) of the Ministry of Internal Affairs and Communications, and also by the KDDI Corporation.	PICTON TW, 1992, J CLIN NEUROPHYSIOL, V9, P456, DOI 10.1097/00004691-199210000-00002; Krusienski DJ, 2008, J NEUROSCI METH, V167, P15, DOI 10.1016/j.jneumeth.2007.07.017; Wolpaw JR, 2000, IEEE T REHABIL ENG, V8, P164, DOI 10.1109/TRE.2000.847807; Azuma R, 2001, IEEE COMPUT GRAPH, V21, P34, DOI 10.1109/38.963459; FARWELL LA, 1988, ELECTROEN CLIN NEURO, V70, P510, DOI 10.1016/0013-4694(88)90149-6; Azuma RT, 1997, PRESENCE-TELEOP VIRT, V6, P355; Sellers EW, 2006, CLIN NEUROPHYSIOL, V117, P538, DOI 10.1016/j.clinph.2005.06.027; Cawley GC, 2003, PATTERN RECOGN, V36, P2585, DOI 10.1016/S0031-3203(03)00136-5; Kansaku K, 2010, NEUROSCI RES, V66, P219, DOI 10.1016/j.neures.2009.10.006; Chang C-C, 2011, ACM T INTEL SYST TEC, V2, P3, DOI DOI 10.1145/1961189.1961199; Kato H., 2002, TECHNICAL REPORT IEI, V101, P79; Matsushita M, 2011, INFORM PROCESSING SO; PRITCHARD WS, 1981, PSYCHOL BULL, V89, P506, DOI 10.1037//0033-2909.89.3.506	13	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1942-9533	1942-9541		ELECTR COMMUN JPN	Electr. Commun. Jpn.	AUG	2015	98	8					9	15		10.1002/ecj.11715		7	Engineering, Electrical & Electronic	Engineering	CM9DO	WOS:000358006900002		
J	Kobayashi, M; Nagasaka, Y; Itoh, Y				Kobayashi, Masaki; Nagasaka, Yasunori; Itoh, Yoshio			A Noise-Free Adaptive Transversal Notch Filter Using the SSCF Algorithm with Decorrelation Parameter	ELECTRONICS AND COMMUNICATIONS IN JAPAN			English	Article						Signal processing; automatic control; digital filter; notch filter; autocorrelation function		Adaptive notch filters composed of an adaptive transversal filter have the limitation of bias error resulting from the broadband signal included in the input signal. In this paper, we propose an adaptive notch filter with a smaller bias error using a new adaptive algorithm based on the square sum of the correlation function with decorrelation parameter (SSCF-DP). The cost function of the SSCF-DP algorithm is the square sum of the cross-correlation coefficient of the input and output error signal with the decorrelation parameter. The analytical results and the features described above are verified by computer simulation.	[Kobayashi, Masaki] Chubu Univ, Kasugai, Aichi 487, Japan; [Nagasaka, Yasunori] Chubu Univ, Dept Elect Engn, Kasugai, Aichi 487, Japan; [Itoh, Yoshio] Tottori Univ, Tottori, Japan	Kobayashi, M (reprint author), Chubu Univ, Kasugai, Aichi 487, Japan.						DeBrunner V, 2000, IEEE T SIGNAL PROCES, V48, P550, DOI 10.1109/78.823981; HUHTA JC, 1973, IEEE T BIO-MED ENG, VBM20, P91, DOI 10.1109/TBME.1973.324169; Izutsu Jun, 2011, Memoirs of College of Engineering, Chubu University, V46; Kobayashi M, 2010, T IEICE A, V193-A, P510; Kobayashi Masaki, 2008, Transactions of the Institute of Electrical Engineers of Japan, Part C, V128C, DOI 10.1541/ieejeiss.128.1265; Kobayashi M, 2012, T IEEJ C, V132-C, P1334; Kobayashi M, 2012, T IEEJ C, V132-C, P991; Kobayashi M, 2010, T IEE JAPAN, V130-C, P2001; Kobayashi M, 1999, T IEICE, VJ82-A, P325; Obite S, 2000, 2000 C IEICE FDN BOU, P4; Shiogai K, 2012, SIS201225 IEICE, P57; Wang C, 2008, P IEICE ENG SCI SOC; Yamada K, 2007, NANOSCALE SERVO CONT, P59	13	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1942-9533	1942-9541		ELECTR COMMUN JPN	Electr. Commun. Jpn.	AUG	2015	98	8					16	23		10.1002/ecj.11717		8	Engineering, Electrical & Electronic	Engineering	CM9DO	WOS:000358006900003		
J	Mizuno, T; Matsumoto, K; Mori, N				Mizuno, Tomoki; Matsumoto, Keinosuke; Mori, Naoki			Applying Component-Based Technologies to Model-Driven Software Development	ELECTRONICS AND COMMUNICATIONS IN JAPAN			English	Article						model-driven development; component-based technologies; UML; graphical model		Improving the reusability of models and increasing automatic code generation efficiency are problems in model-driven development. In order to solve these problems, we apply component-based development technologies that have mainly been developed at the software implementation level to the modeling level. In the proposed approach, functionally relevant model elements are packaged as a component, and the modeling of software is performed by associating them with the model components. The role of a model becomes clear by introducing the concept of a component, and the reusability of model components is improved by externalizing the dependencies between the components. In addition, flexible model transformation rules united with the roles of models can be designed. As a result, the proposed method is able to generate more source code automatically. The validity of the proposed approach is verified through application experiments.	[Mizuno, Tomoki] Osaka Prefecture Univ, Sakai, Osaka, Japan; [Matsumoto, Keinosuke; Mori, Naoki] Osaka Prefecture Univ, Dept Comp Sci, Sakai, Osaka, Japan; [Matsumoto, Keinosuke; Mori, Naoki] Osaka Prefecture Univ, Grad Sch Engn, Sakai, Osaka, Japan	Mizuno, T (reprint author), Osaka Prefecture Univ, Sakai, Osaka, Japan.				JSPS [24560501]	This research was supported in part by a JSPS Grant-in-Aid (24560501), and the authors express their gratitude for this support.	Alur D, 2003, CORE J2EE PATTERNS B; Mellor SJ, 2003, IEEE SOFTWARE, V20, P14, DOI 10.1109/MS.2003.1231145; Gamma E, 1995, DESIGN PATTERN ELEME; Kirikoe S, 2007, 2007IS100 IPSJ, P35; Matsumoto K, 2010, MODELING SIMULATION, P147; Mellor S., 2004, MDA DISTILLED PRINCI; Murakami M, 2010, T IEEJ C, V130-C, P615; Object Management Group, 2007, OMB UN MOD LANG OMG; Rosenburg D, 2007, USE CASE DRIVEN OBJE; Wills AC, 1998, OBJECTS COMPONENTS F; Yoshida K, 2002, J IPSJ, V43, P156	11	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1942-9533	1942-9541		ELECTR COMMUN JPN	Electr. Commun. Jpn.	AUG	2015	98	8					24	31		10.1002/ecj.11719		8	Engineering, Electrical & Electronic	Engineering	CM9DO	WOS:000358006900004		
J	Ono, Y; Ishihara, M; Yamashiro, M				Ono, Yuichi; Ishihara, Manabu; Yamashiro, Mitsuo			Construction and Evaluation of Digital Material Distribution Systems in Foreign Language Teaching	ELECTRONICS AND COMMUNICATIONS IN JAPAN			English	Article						e-learning system; podcasting; mobile device; second language acquisition		This paper is concerned with an evaluation of participants' use of two multimedia distribution systems: PC-based podcasting and mobile-based distribution. We carried out two experiments: (i) evaluation of user's impressions when using these distribution systems and (ii) the relationship between download time and resulting frustration felt by users. The results of student questionnaires revealed that there is a statistical significance between these two systems and that mobile-based podcasting was observed to have more salient factors concerning operability, such as easy to operate and friendliness, regardless of the difficulty of the content. Moreover, comparative study of the download time between the two systems showed that users did not feel less comfortable when downloading materials to mobile devices, even though mobiles took longer times to download materials than did a PC. These results lead us to the interesting idea that mobile devices have great potential to change the learning environment because they will play an important role in the so-called blended instruction classroom environment when used in a traditional classroom setting in the near future.	[Ono, Yuichi] Univ Tsukuba, Humanities & Social Studies Dept, Tsukuba, Ibaraki 305, Japan; [Ishihara, Manabu] Oyama Natl Coll Technol, Dept Elect & Elect Engn, Sendai, Miyagi, Japan; [Yamashiro, Mitsuo] Ashikaga Inst Technol, Managerial Sci Dept, Ashikaga, Tochigi, Japan; [Yamashiro, Mitsuo] Ashikaga Inst Technol, Informat Syst Design, Dept Ind Engn, Ashikaga, Tochigi, Japan	Ono, Y (reprint author), Univ Tsukuba, Humanities & Social Studies Dept, Tsukuba, Ibaraki 305, Japan.				 [22720230];  [22500954];  [25350369]	This research was supported in part by a Scientific Grant-in-Aid (Early Research (B) 22720230: representative Yasuo Ono, and Basic Research (C) 22500954, 25350369: representative Manabu Ishihara).	Keller JM, 2010, MOTIVATIONAL DESIGN FOR LEARNING AND PERFORMANCE: THE ARCS MODEL APPROACH, P43, DOI 10.1007/978-1-4419-1250-3_3; FUJISHIRO N, 2009, ED TECHNOL RES, V32, P79; Maki K., 2000, WHAT IS IMAGE ENG AN, P95; Matsuura K, 2005, ED TECHNOL RES J, V29, P251; Ono Yuichi, 2012, International Journal of Mobile Learning and Organisation, V6, DOI 10.1504/IJMLO.2012.047597; Ono Y, 2009, P AUD LANG IM PROC I, P46; Ono Y, 2009, P 5 INT CDIO C, P2; Ono Y, 2011, P 19 INT C COMP ED, P422; Ono Y, 2012, P 2012 ANN C IEEJ EL, P1689; Ono Y, 2011, STUD E LEARN LANG ED, V6, P89; Ono Y, 2012, P 1 IEEE GLOB C CONS, P90; Ono Y, 2011, P JPN E LEARN ASS, V2011, P99; Sakumoto K, 2004, ED TECHNOL RES J, V28, P249; Sakurai H, 2000, ACAD J PHILOS PSYCHO, V26, P21; Sugimura A., 2009, IEICE TECH REP ED TE, V108, P7; Yamagishi N, 2010, LESSON DESIGN LEARNI, P12; Yoshida H, 2007, FEBS J, P1	17	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1942-9533	1942-9541		ELECTR COMMUN JPN	Electr. Commun. Jpn.	AUG	2015	98	8					32	40		10.1002/ecj.11722		9	Engineering, Electrical & Electronic	Engineering	CM9DO	WOS:000358006900005		
J	Takahashi, S; Kodama, N; Kosugi, N; Takeuchi, H				Takahashi, Shingo; Kodama, Naoki; Kosugi, Naoko; Takeuchi, Hiroshi			Study of Prefrontal Blood Flow in Dementia Patients Using Near-Infrared	ELECTRONICS AND COMMUNICATIONS IN JAPAN			English	Article						category fluency task; near-infrared; dementia	SPECTROSCOPY	The category frequency task has become one of the most important tools for measuring brain function. In this investigation, we used near-infrared spectroscopy to examine the prefrontal blood flow in the brain, using a category fluency task function test to determine if this method can be used to diagnose dementia in the early stages. We examined 21 healthy volunteer students (age 21.0 +/- 1.4; 11 males and 10 females) and 50 patients with dementia (age 83.3 +/- 6.7; 12 males and 38 females; mini mental status: 0-22). The category fluency task required the subjects to produce nouns belonging to the category of vegetables. Our results showed that the healthy volunteer students had an increase in the blood flow while performing this task. On the other hand, the dementia patients did not show any relevant increase in blood flow while performing this task. The results suggest that the combination of the category fluency task and near-infrared spectroscopy could be used as one more tool for the diagnosis of dementia.	[Takahashi, Shingo] Takasaki Univ Hlth & Welf, MS Program, Grad Sch Hlth & Welf, Takasaki, Gumma, Japan; [Kodama, Naoki] Takasaki Univ Hlth & Welf, Hlth & Welf Imaging, Dept Elect Engn, Takasaki, Gumma, Japan; [Takeuchi, Hiroshi] Takasaki Univ Hlth & Welf, Dept Elect Engn, Takasaki, Gumma, Japan; [Kosugi, Naoko] NTT Commun Sci Labs, Kyoto, Japan	Takahashi, S (reprint author), Takasaki Univ Hlth & Welf, MS Program, Grad Sch Hlth & Welf, Takasaki, Gumma, Japan.				Funding Program for Next Generation World-Leading Researchers of the Cabinet Office of the Japanese Government [LR039]; Ministry of Education, Culture, Sports, Science and Technology [23700840]	This research was supported in part by the Funding Program for Next Generation World-Leading Researchers of the Cabinet Office of the Japanese Government (LR039), and by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology (B) 23700840.	Kameyama M, 2004, NEUROIMAGE, V22, P1715, DOI 10.1016/j.neuroimage.2004.03.050; Arai H, 2006, BRAIN COGNITION, V61, P189, DOI 10.1016/j.bandc.2005.12.012; Asada T, 2013, INCIDENCE DEMENTIA U; Fallatter AJ, 1967, COGNITIVE BRAIN RES, V6, P67; Matsuda H, 2012, JAPAN J GERIATR PSYC, V23, P413; Mihara Y, 2010, CLIN BRAIN WAVES, V52, P501; Mikuni M, 2006, ANN REP PHARMACOPSYC, P40; Mishima K, 2010, FUKUOKA U CENTRAL RE, V84, P49; Miura S, 2006, ANN REP PHARMACOPSYC, V17, P248; Miyakawa M, 2006, JAPAN J GERIATR PSYC, V17, P1209; Miyakawa S, 2007, JAPAN J GERIATR PSYC, V18, P861; Mizuno T, 2009, T TECH M MED BIOL EN, P1; Okada G, 2004, ANN REP PHARMACOPSYC, P248; Ozawa A, 2006, HIGHER BRAIN FUNC RE, V26, P327; Shigemori K, 2011, SHIZUOKA SCI THER J, P14; Takizawa R, 2008, BRAIN SCI MENTAL DIS, V19, P219; Tamai K, 2008, GEN PROGRAM MINUTES, V104, P155	17	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1942-9533	1942-9541		ELECTR COMMUN JPN	Electr. Commun. Jpn.	AUG	2015	98	8					41	47		10.1002/ecj.11724		7	Engineering, Electrical & Electronic	Engineering	CM9DO	WOS:000358006900006		
J	Arima, M; Sato, T; Watanabe, Y				Arima, Masahiro; Sato, Takayuki; Watanabe, Yasuaki			Experimental Compensation for Difference between Small-Particle Aggregates and Substitute Large Particles in Ultrasonic Spectroscopy	ELECTRONICS AND COMMUNICATIONS IN JAPAN			English	Article						ultrasonic; ultrasonic spectroscopy; red blood cell; aggregates; particle size	BLOOD-VISCOSITY; RETINOPATHY; FLOW	The measurement of blood viscosity in the human body is very important for preventing diabetes mellitus. The blood viscosity is strongly correlated with aggregation of red blood cells. Some noninvasive methods for estimating the blood viscosity based on ultrasonic spectroscopy have been proposed. In these studies, substitution experiments using particles with a large diameter have been performed in general because control of the aggregation size is very difficult. This study is aimed at assessing the validity of the substitution experiments and proposing a compensation technique for use in the substitution experiments.	[Arima, Masahiro; Sato, Takayuki; Watanabe, Yasuaki] Tokyo Metropolitan Univ, Tokyo, Japan	Arima, M (reprint author), Tokyo Metropolitan Univ, Tokyo, Japan.				Japan Society for the Promotion of Science [2350563]	This research was supported by a Scientific Grant-in-Aid from the Japan Society for the Promotion of Science (Basic Research (C) 2350563).	JAN KM, 1973, J GEN PHYSIOL, V61, P638, DOI 10.1085/jgp.61.5.638; Baskurt OK, 2003, SEMIN THROMB HEMOST, V29, P435; Baskurt OK, 1997, BIORHEOLOGY, V34, P235, DOI 10.1016/S0006-355X(97)00027-9; Barnett CE, 1942, J PHYS CHEM-US, V46, P69, DOI 10.1021/j150415a009; Berliner S, 2004, THROMB RES, V114, P37, DOI 10.1016/j.thromres.2004.04.009; Dukhin A. S., 2002, ULTRASOUND CHARACTER; Dukhin AS, 2010, STUD INTERF SCI, V24, P1; Franschini E, 1992, IEEE T ULTRASON FERR, V58; Fukushima T, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.07HF02; Huang CC, 2009, IEEE T ULTRASON FERR, V56, P1677, DOI 10.1109/TUFFC.2009.1232; Khokhlova MD, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.2.025001; LOWE GDO, 1980, DIABETOLOGIA, V18, P359; MACRURY SM, 1988, DIABETIC MED, V5, P830; MELLI M, 1983, RES CLIN LAB, V13, P371; Sato T, 2013, JPN J APPL PHYS, V52; Seinfeld J. H., 2006, ATMOSPHERIC CHEM PHY; Wood JH, 1987, STROKE, V18, P812	17	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1942-9533	1942-9541		ELECTR COMMUN JPN	Electr. Commun. Jpn.	AUG	2015	98	8					48	56		10.1002/ecj.11725		9	Engineering, Electrical & Electronic	Engineering	CM9DO	WOS:000358006900007		
J	Nomura, M; Suzuki, T; Kageyama, Y; Ishizawa, C; Nishida, M				Nomura, Matsunobu; Suzuki, Takuma; Kageyama, Yoichi; Ishizawa, Chikako; Nishida, Makoto			Extraction of Character Sequences from Signboards by Using Background Color Information	ELECTRONICS AND COMMUNICATIONS IN JAPAN			English	Article						signboard; scene image; color information; shape features		Smart phones, tablets, and mobile phones with built-in cameras are very popular today because they are easy to use. It is important for image processors to be able to identify a signboard in an image and extract the character sequence. Techniques for extracting a character sequence from a signboard can be combined with various other systems to realize a diverse range of services. When utilization of such a system is assumed, it is necessary to take into consideration improvements in the accuracy of extraction of character sequence regions and improvements in processing speed. Therefore, this paper proposes an algorithm for extracting a character sequence from a signboard on the basis of scene image features. In order to improve the processing speed and accuracy, information about the background color of the signboard obtained in cooperation with a car navigation system or any other source was also utilized. In an experiment conducted on 319 color signboards, the proposed method detected 313 signboards (98.12%). Among 569 black and white signboards, the proposed method detected 513 signboards (90.16%). The average processing time in the proposed method was about 0.47 s for a color signboard and about 0.95 s for a black and white signboard. The experimental results revealed that the proposed method could accurately extract various types of character strings from signboards.	[Nomura, Matsunobu] Akita Univ Art, Dept Art, Akita, Japan; [Nomura, Matsunobu; Suzuki, Takuma; Kageyama, Yoichi; Nishida, Makoto] Akita Univ, Akita 010, Japan; [Kageyama, Yoichi; Ishizawa, Chikako; Nishida, Makoto] Akita Univ, Grad Sch Engn & Resource Sci, Akita 010, Japan; [Ishizawa, Chikako] Akita Univ, Dept Informat Sci, Sch Min, Akita 010, Japan; [Nishida, Makoto] Akita Univ, Sch Min, Akita 010, Japan; [Nishida, Makoto] Akita Univ, Combined Informat Proc Ctr, Akita 010, Japan; [Nishida, Makoto] Akita Univ, Engn & Resource Sci, Akita 010, Japan	Nomura, M (reprint author), Akita Univ Art, Dept Art, Akita, Japan.						Clark P., 2002, International Journal on Document Analysis and Recognition, V4, DOI 10.1007/s10032-001-0072-2; Don HS, 2001, INT J DOC ANAL RECOG, V4, P131, DOI 10.1007/s100320100062; Fu H, 2003, J I IMAGE INFORM TEL, V57, P819; Hirayama K, 2006, T IEICE D, VJ89-D, P893; Liu Y., 1998, Transactions of the Institute of Electronics, Information and Communication Engineers D-II, VJ81D-II; Matsuda Y, 2010, T IEICE D, VJ93-D, P336; Matsuo K, 1997, T I ELECT INFORM COM, VJ80-D2, P1617; Otsu N., 1980, T I ELECT COMMUN E D, V63-D, P349; Saitoh F., 2001, IEEJ T EIS, V121, P1355; Takagi M., 2004, HDB IMAGE ANAL; Takahashi H, 2005, T IEICE D2, VJ88-D-II, P1808; The Color Science Association of Japan, 1998, COL SCI ASS JAP HDB; Yamaguchi T., 2005, Transactions of the Institute of Electronics, Information and Communication Engineers D-II, VJ88-D-II; Zhang XH, 2005, T IPSJ, V46, P2556	14	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1942-9533	1942-9541		ELECTR COMMUN JPN	Electr. Commun. Jpn.	AUG	2015	98	8					57	68		10.1002/ecj.11730		12	Engineering, Electrical & Electronic	Engineering	CM9DO	WOS:000358006900008		
J	Nakazawa, F; Konya, K; Kadota, T; Ohata, T				Nakazawa, Fumio; Konya, Keiko; Kadota, Tsutomu; Ohata, Tetsuo			Depositional and summer snow melting features in 2007-2011 on the upstream side of Potanin Glacier, Mongolian Altai, reconstructed by pollen and oxygen isotope analysis	ENVIRONMENTAL EARTH SCIENCES			English	Article						Pollen; Glacier; Altai; Ice core; Dating	LAYERS	This study analyzed pollen in snow pits dug in late summer (2008-2011) on the upstream side of Potanin Glacier, a summer accumulation-type glacier in the Mongolian Altai, to reconstruct the recent snow depositional environment, particularly melting conditions. Annual snow pit observations were performed at sites 0 and 4 (3752 and 3890 ma.s.l., respectively). Seasonal layers in the pits were identified according to the presence of pollen from three taxa (Betulaceae, Pinus, and Artemisia), which have different pollen seasons typically between May and early September. The pollen-dating method was successful in snow pits where conventional methods such as ice layer dating and use of delta O-18 records were unreliable due to significant melting. Depths of pollen concentration peaks for the three taxa differed annually at both sites. In some years, concentration peaks of the three pollen taxa were found at different depths, but in other years, peaks associated with each taxon were found at the same depth. This difference was explained by summer temperature. Snow melting during the relatively warm summers of 2007 and 2008 caused pollen grains to concentrate on the glacier surface, producing peaks at the same depth. In contrast, snow melting during the relatively cool summer of 2009 did not substantially alter pollen grain location, and each peak thus retained its original depth. The median temperatures in 2010 and 2011 corresponded to pollen concentrating on the glacier surface at site 0 but retaining their original position at site 4.	[Nakazawa, Fumio] Natl Inst Polar Res, Tachikawa, Tokyo 1908518, Japan; [Nakazawa, Fumio] Transdisciplinary Res Integrat Ctr, Minato Ku, Tokyo 1050001, Japan; [Konya, Keiko; Kadota, Tsutomu; Ohata, Tetsuo] Japan Agcy Marine Earth Sci & Technol, Dept Environm Geochem Cycle Res, Yokosuka, Kanagawa 2370061, Japan	Nakazawa, F (reprint author), Natl Inst Polar Res, 10-3 Midori Cho, Tachikawa, Tokyo 1908518, Japan.	nakazawa@nipr.ac.jp			"Systematic Analysis for Global Environmental Change and Life on Earth" research project of the Transdisciplinary Research Integration Center; Japan Society for the Promotion of Science KAKENHI [24710019]; National Institute of Polar Research	The authors thank all the individuals who assisted in conducting this study. This research was funded by the "Systematic Analysis for Global Environmental Change and Life on Earth" research project of the Transdisciplinary Research Integration Center, and by Japan Society for the Promotion of Science KAKENHI Grant Number 24710019. Production of this paper was supported by a National Institute of Polar Research publication subsidy.	Nakazawa F, 2011, ARCT ANTARCT ALP RES, V43, P66, DOI 10.1657/1938-4246-43.1.66; AGETA Y, 1984, GEOGR ANN A, V66, P249, DOI 10.2307/520698; Bourgeois JC, 2000, REV PALAEOBOT PALYNO, V108, P17, DOI 10.1016/S0034-6667(99)00031-7; Yao TD, 2004, SCI CHINA SER D, V47, P1065, DOI 10.1360/03yd0256; Yoshimura Y, 2000, J GLACIOL, V46, P335, DOI 10.3189/172756500781832918; Nakazawa F, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/3/035402; Thompson LG, 1998, SCIENCE, V282, P1858, DOI 10.1126/science.282.5395.1858; Nakazawa F, 2005, J GLACIOL, V51, P483, DOI 10.3189/172756505781829179; Pu JC, 2008, HYDROL PROCESS, V22, P2953, DOI 10.1002/hyp.6865; BOURGEOIS JC, 1990, BOREAS, V19, P313; Fujita K, 1997, J GLACIOL, V43, P583; Fujita K., 2001, B GLACIOL RES, V18, P51; Fujita K, 2004, B GLACIOL RES, V21, P57; Ganiushkin D, 2015, ENVIRON EARTH SCI, V74, P1883, DOI 10.1007/s12665-015-4301-2; Kadota Tsutomu, 2011, Bulletin of Glaciological Research, V29, DOI 10.5331/bgr.29.41; Kadota T, 2007, ANN GLACIOL, V46, P185, DOI DOI 10.3189/172756407782871675; Konya Keiko, 2010, Bulletin of Glaciological Research, V28, DOI 10.5331/bgr.28.7; Konya K, 2013, B GLACIOL RES, V31, P9; Luchik ZI, 1970, INTRO TRESS BUSHES A; Naito N, 2002, B GLACIOL RES, V19, P41; Nakazawa F, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/1/014032; Nakazawa F, 2004, J GEOPHYS RES, V109, pF4; Nakazawa F, 2008, B GLACIOL RES, V25, P1; Osipov EY, 2015, ENVIRON EARTH SCI, V74, P1969, DOI 10.1007/s12665-015-4352-4; Pyak AI, 2008, ENDEMIC PLANTS ALTAI; Segawa T, 2010, POLAR SCI, V4, P214; Smedt BD, 2004, ANN GLACIOL, V37, P143; Uetake J, 2011, J GEOPHYS RES-BIOGEO, V116, DOI 10.1029/2010JG001337; Vorobyeva SS, 2015, ENVIRON EARTH SCI, V74, P2055, DOI 10.1007/s12665-015-4164-6; Wang N, 2015, ENV EARTH S IN PRESS; WGMS, 2013, GLAC MASS BAL B, V12; Yabuki H, 2013, MONGOLIAN GLACIER IN	32	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1866-6280	1866-6299		ENVIRON EARTH SCI	Environ. Earth Sci.	AUG	2015	74	3					1851	1859		10.1007/s12665-015-4436-1		9	Environmental Sciences; Geosciences, Multidisciplinary; Water Resources	Environmental Sciences & Ecology; Geology; Water Resources	CN0AL	WOS:000358073800002		
J	Bonatti, C; Shinohara, K				Bonatti, Christian; Shinohara, Katsutoshi			Flexible periodic points	ERGODIC THEORY AND DYNAMICAL SYSTEMS			English	Article							HOMOCLINIC TANGENCIES; HETERODIMENSIONAL CYCLES; DIFFEOMORPHISMS; PERTURBATIONS; HYPERBOLICITY; STABILITY; SYSTEMS; ORBITS	We define the notion of epsilon-flexible periodic point: it is a periodic point with stable index equal to two whose dynamics restricted to the stable direction admits epsilon-perturbations both to a homothety and a saddle having an eigenvalue equal to one. We show that an epsilon-perturbation to an epsilon-flexible point allows us to change it to a stable index one periodic point whose (one-dimensional) stable manifold is an arbitrarily chosen C-1-curve. We also show that the existence of flexible points is a general phenomenon among systems with a robustly non-hyperbolic two-dimensional center-stable bundle.	[Bonatti, Christian] Univ Bourgogne, CNRS, UMR 5584, Inst Math Bourgogne, F-21000 Dijon, France; [Shinohara, Katsutoshi] Univ Tokyo, Inst Ind Sci, Collaborat Res Ctr Innovat Math Modelling, Meguro Ku, Tokyo 1538505, Japan	Bonatti, C (reprint author), Univ Bourgogne, CNRS, UMR 5584, Inst Math Bourgogne, 9 Av A Savary, F-21000 Dijon, France.	bonatti@u-bourgogne.fr; herrsinon@07.alumni.u-tokyo.ac.jp			ANR [08 BLAN-0264-01]; CNPq (Brazil); Aihara Project, the FIRST program from JSPS; CSTP (Japan)	During the preparation of this paper, the authors were supported by ANR 08 BLAN-0264-01 DynNonHyp (postdoctoral grant), CNPq (Brazil) and the Aihara Project, the FIRST program from JSPS, initiated by CSTP (Japan). The authors thank Sylvain Crovisier, Nicolas Gourmelon, Rafael Potrie and Dawei Yang for useful discussions.	Abdenur A., 2007, ERGOD THEORY DYN SYS, V27, P1; Abraham R., 1968, P S PURE MATH, VXIV, P5; FRANKS J, 1971, T AM MATH SOC, V158, P301, DOI 10.2307/1995906; Hayashi S, 1997, ANN MATH, V145, P81, DOI 10.2307/2951824; Bonatti C, 2011, ERGOD THEOR DYN SYST, V31, P959, DOI 10.1017/S0143385710000891; Bonatti C, 2008, J INST MATH JUSSIEU, V7, P469, DOI 10.1017/S1474748008000030; Bonatti C, 2003, PUBL MATH, P171; Bonatti C, 2004, INVENT MATH, V158, P33, DOI 10.1007/s00222-004-0368-1; Bonatti C, 2003, ANN MATH, V158, P355; MANE R, 1982, ANN MATH, V116, P503, DOI 10.2307/2007021; Pujals ER, 2000, ANN MATH, V151, P961, DOI 10.2307/121127; Bonatti C, 2000, ISRAEL J MATH, V115, P157, DOI 10.1007/BF02810585; Bochi J, 2012, P LOND MATH SOC, V105, P1, DOI 10.1112/plms/pdr048; Bonatti C, 2013, ERGOD THEOR DYN SYST, V33, P739, DOI 10.1017/S0143385712000028; Bonatti C., UNPUB; Bonatti C, 2012, NONLINEARITY, V25, DOI 10.1088/0951-7715/25/4/931; Bonatti C, 2006, ERGOD THEOR DYN SYST, V26, P1307, DOI 10.1017/S0413385706000253; Bonatti C, 2008, ANN SCI ECOLE NORM S, V41, P925; Crovisier S, PREPRINT; Gourmelon N, 2010, DISCRETE CONT DYN-A, V26, P1, DOI 10.3934/dcds.2009.26.1; Newhouse S., 1974, TOPOLOGY, V13, P9, DOI 10.1016/0040-9383(74)90034-2; Shinohara K, 2011, DISCRETE CONT DYN-A, V31, P913, DOI 10.3934/dcds.2011.31.913; Wen L, 2002, NONLINEARITY, V15, P1445, DOI 10.1088/0951-7715/15/5/306	23	0	0	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0143-3857	1469-4417		ERGOD THEOR DYN SYST	Ergod. Theory Dyn. Syst.	AUG	2015	35		5				1394	1422		10.1017/etds.2013.105		29	Mathematics, Applied; Mathematics	Mathematics	CM3TA	WOS:000357605900004		
J	Akima, H; Yoshiko, A; Hioki, M; Kanehira, N; Shimaoka, K; Koike, T; Sakakibara, H; Oshida, Y				Akima, Hiroshi; Yoshiko, Akito; Hioki, Maya; Kanehira, Nana; Shimaoka, Kiyoshi; Koike, Teruhiko; Sakakibara, Hisataka; Oshida, Yoshiharu			Skeletal muscle size is a major predictor of intramuscular fat content regardless of age	EUROPEAN JOURNAL OF APPLIED PHYSIOLOGY			English	Article						Skeletal muscle; Sarcopenia; Magnetic resonance imaging; Blood lipids	INTERMUSCULAR ADIPOSE-TISSUE; CROSS-SECTIONAL AREA; INSULIN SENSITIVITY; BODY-COMPOSITION; ELDERLY-MEN; NONCONTRACTILE TISSUE; LOWER-EXTREMITY; THIGH MUSCLE; RISK-FACTORS; WOMEN	Skeletal muscles of older individuals have a larger amount of intramuscular adipose tissue (IntraMAT) than those of younger individuals. It is not understood how aging affects the IntraMAT content of individual muscles of the thigh. We assessed the relationship between IntraMAT content and skeletal muscle cross-sectional area (CSA), subcutaneous adipose tissue CSA, biochemical blood profiles, and physical activity. Fifteen older (70.7 +/- A 3.8 years) and 15 younger (20.9 +/- A 0.3 years) men and women participated in this study. Magnetic resonance imaging of the right thigh was taken to measure IntraMAT content and skeletal muscle CSA for the quadriceps femoris (QF), hamstrings (HM), adductor (AD) muscle groups and subcutaneous adipose tissue CSA of the thigh. Fasting blood samples were collected to measure plasma lipids, adiponectin, and HbA1c levels. IntraMAT content in QF, HM, and AD for the Older group was significantly higher than in the Younger group. However, skeletal muscle CSA normalized by body weight (skeletal muscle CSA/bw) in the QF (P < 0.001) and total thigh (P < 0.01) were significantly lower in the Older group compared with the Younger group.There were no significant differences in HM and AD. Stepwise regression analysis with IntraMAT content as a dependent variable revealed that skeletal muscle CSA/bw of the thigh was the only predictive variable for IntraMAT content in Older and Younger groups. These results suggest that skeletal muscle size could be a major determinant of IntraMAT content regardless of age.	[Akima, Hiroshi; Koike, Teruhiko; Oshida, Yoshiharu] Nagoya Univ, Res Ctr Hlth Phys Fitness & Sports, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Akima, Hiroshi] Nagoya Univ, Grad Sch Educ & Human Dev, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Yoshiko, Akito; Hioki, Maya; Koike, Teruhiko; Oshida, Yoshiharu] Nagoya Univ, Grad Sch Med, Chikusa Ku, Nagoya, Aichi 4668550, Japan; [Sakakibara, Hisataka] Nagoya Univ, Grad Sch Med, Higashi Ku, Nagoya, Aichi 4618673, Japan; [Kanehira, Nana] Tokaigakuen Univ, Fac Human Wellness & Nutr, Miyoshi, Aichi 4700207, Japan; [Shimaoka, Kiyoshi] Tokaigakuen Univ, Fac Human Wellness, Miyoshi, Aichi 4700207, Japan	Akima, H (reprint author), Nagoya Univ, Res Ctr Hlth Phys Fitness & Sports, Chikusa Ku, Nagoya, Aichi 4648601, Japan.	akima@nagoya-u.jp			Ministry of Education, Culture, Sports and Science and Technology [23650432]	The authors gratefully thank the volunteers for participation as well as Drs Haruo Isoda and Atsushi Fukuyama and Radiologic technologist Mr. Akira Ishizuka, Graduate School of Medicine, Nagoya University. This study was supported in part by a Grant-in-Aid for challenging Exploratory Research from the Ministry of Education, Culture, Sports and Science and Technology Grant (#23650432) to HA.	Akima H, 2012, NEUROMUSCULAR DISORD, V22, P16, DOI 10.1016/j.nmd.2011.06.750; Ryan AS, 2011, NEUROREHAB NEURAL RE, V25, P865, DOI 10.1177/1545968311408920; Sezgin M, 2004, J ELECTRON IMAGING, V13, P146, DOI [10.1117/1.1631315, 10.1117/1.16313161]; Manini TM, 2007, AM J CLIN NUTR, V85, P377; Taaffe DR, 2009, GERONTOLOGY, V55, P217, DOI 10.1159/000182084; Gacesa JZP, 2011, J MAGN RESON IMAGING, V33, P1114, DOI 10.1002/jmri.22548; Kumahara H, 2004, BRIT J NUTR, V91, P235, DOI 10.1079/BJN20031033; Fukunaga T, 2001, ACTA PHYSIOL SCAND, V172, P249, DOI 10.1046/j.1365-201x.2001.00867.x; Zoico E, 2010, J GERONTOL A-BIOL, V65, P295, DOI 10.1093/gerona/glp155; Ryan AS, 2002, OBES RES, V10, P336, DOI 10.1038/oby.2002.47; Boettcher M, 2009, J MAGN RESON IMAGING, V29, P1340, DOI 10.1002/jmri.21754; Rossi A, 2010, OBESITY, V18, P2379, DOI 10.1038/oby.2010.48; Gallagher D, 2005, AM J CLIN NUTR, V81, P903; Goodpaster BH, 2000, AM J CLIN NUTR, V71, P885; Ramsay JW, 2011, J BIOMECH, V44, P2741, DOI 10.1016/j.jbiomech.2011.09.001; Janssen I, 2002, DIABETES CARE, V25, P431, DOI 10.2337/diacare.25.3.431; Schwenzer NF, 2009, J MAGN RESON IMAGING, V29, P1346, DOI 10.1002/jmri.21789; Lihn AS, 2005, OBES REV, V6, P13, DOI 10.1111/j.1467-789X.2005.00159.x; Visser M, 2002, J AM GERIATR SOC, V50, P897, DOI 10.1046/j.1532-5415.2002.50217.x; Sled JG, 1998, IEEE T MED IMAGING, V17, P87, DOI 10.1109/42.668698; Kent-Braun JA, 2000, J APPL PHYSIOL, V88, P662; Goodpaster BH, 2003, DIABETES CARE, V26, P372, DOI 10.2337/diacare.26.2.372; Akima H, 2001, MED SCI SPORT EXER, V33, P220; OVEREND TJ, 1992, J GERONTOL, V47, pM204; DeNino WF, 2001, DIABETES CARE, V24, P925, DOI 10.2337/diacare.24.5.925; Crane JD, 2010, J GERONTOL A-BIOL, V65, P119, DOI 10.1093/gerona/glp179; Song MY, 2004, AM J CLIN NUTR, V79, P874; Marcus RL, 2012, J AGING RES, V2012, P1; MAUGHAN RJ, 1983, J PHYSIOL-LONDON, V338, P37; Ryan AS, 1999, INT J OBESITY, V23, P126, DOI 10.1038/sj.ijo.0800777; Tuttle LJ, 2012, J AGING RES, V2012, P1	31	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1439-6319	1439-6327		EUR J APPL PHYSIOL	Eur. J. Appl. Physiol.	AUG	2015	115	8					1627	1635		10.1007/s00421-015-3148-2		9	Physiology; Sport Sciences	Physiology; Sport Sciences	CM9JZ	WOS:000358026000002		
J	Kubo, K; Miyazaki, D; Shimoju, S; Tsunoda, N				Kubo, Keitaro; Miyazaki, Daisuke; Shimoju, Shozo; Tsunoda, Naoya			Relationship between elastic properties of tendon structures and performance in long distance runners	EUROPEAN JOURNAL OF APPLIED PHYSIOLOGY			English	Article						Tendon stiffness; Running; Knee extensors; Plantar flexors; Ultrasonography	TRICEPS SURAE TENDON; STRUCTURES IN-VIVO; MUSCLE-TENDON; ACHILLES-TENDON; RUNNING ECONOMY; GASTROCNEMIUS-MUSCLE; PLANTAR FLEXORS; MOMENT ARM; STIFFNESS; EXERCISE	The purpose of this study was to investigate the relationship between running performance (best official record in a 5000 m race) and elastic properties of tendon structures in knee extensors and plantar flexors among a large population of long distance runners. Sixty-four highly trained male long distance runners participated in this study. Elongation of tendon structures in the knee extensors and plantar flexors was measured using ultrasonography while subjects performed ramp isometric contractions up to the voluntary maximum. The relationship between the estimated muscle force and tendon elongation was fit to a linear regression, the slope of which was defined as the stiffness of the tendon structures. Muscle and tendon thicknesses were also measured in the knee extensors and plantar flexors using ultrasonography. The best official record in a 5000 m race was negatively correlated to the stiffness of the tendon structures in the knee extensors (r = -0.341, p < 0.01), whereas it was positively correlated to the stiffness of the tendon structures in the plantar flexors (r = 0.414, p < 0.001). In both the knee extensors and plantar flexors, the other measured variables of muscle and tendon structures did not correlate with the best official record in a 5000 m race. These results suggested that better long distance runners had stiffer tendon structures in the knee extensors and more compliant ones in the plantar flexors. These results implied that tendon structures in knee extensors and plantar flexors adapted to endurance running training and contributed to running performance of long distance runners separately.	[Kubo, Keitaro] Univ Tokyo, Dept Life Sci Sports Sci, Meguro Ku, Tokyo 1538902, Japan; [Miyazaki, Daisuke; Shimoju, Shozo; Tsunoda, Naoya] Kokushikan Univ, Fac Phys Educ, Tokyo, Japan	Kubo, K (reprint author), Univ Tokyo, Dept Life Sci Sports Sci, Meguro Ku, Komaba 3-8-1, Tokyo 1538902, Japan.	kubo@idaten.c.u-tokyo.ac.jp			Japan Society for the Promotion of Science [21680047]	This study was supported by a Grant-in-Aid for Young Scientists (A) (21680047 to K. Kubo) from the Japan Society for the Promotion of Science.	Akima H, 2001, ACTA PHYSIOL SCAND, V172, P269, DOI 10.1046/j.1365-201x.2001.00869.x; Albracht K, 2013, EUR J APPL PHYSIOL, V113, P1605, DOI 10.1007/s00421-012-2585-4; Bojsen-Moller J, 2005, J APPL PHYSIOL, V99, P986, DOI 10.1152/japplphysiol.01305.2004; KER RF, 1987, NATURE, V325, P147, DOI 10.1038/325147a0; Rosager S, 2002, SCAND J MED SCI SPOR, V12, P90, DOI 10.1034/j.1600-0838.2002.120205.x; Kubo K, 2007, EUR J APPL PHYSIOL, V99, P235, DOI 10.1007/s00421-006-0338-y; ALEXANDER RM, 1977, NATURE, V265, P114, DOI 10.1038/265114a0; Arampatzis A, 2007, J BIOMECH, V40, P1946, DOI 10.1016/j.jbiomech.2006.09.005; Ishikawa M, 2007, J APPL PHYSIOL, V103, P1030, DOI 10.1152/japplphysiol.00277.2007; Arampatzis A, 2006, J EXP BIOL, V209, P3345, DOI 10.1242/jeb.02340; Kubo K, 1999, J APPL PHYSIOL, V87, P2090; Kubo K, 2001, J APPL PHYSIOL, V91, P26; Schache AG, 2011, MED SCI SPORT EXER, V43, P1260, DOI 10.1249/MSS.0b013e3182084929; Kubo K, 2000, ACTA PHYSIOL SCAND, V170, P127, DOI 10.1046/j.1365-201x.2000.00768.x; Hof AL, 2002, ACTA PHYSIOL SCAND, V174, P17, DOI 10.1046/j.1365-201x.2002.00917.x; Sasaki K, 2006, GAIT POSTURE, V23, P383, DOI 10.1016/j.gaitpost.2005.05.002; Kawakami Y, 2002, J PHYSIOL-LONDON, V540, P635, DOI 10.1113/jphysiol.2001.013459; Fukunaga T, 2001, P ROY SOC B-BIOL SCI, V268, P229; Farris DJ, 2012, P NATL ACAD SCI USA, V109, P977, DOI 10.1073/pnas.1107972109; VISSER JJ, 1990, EUR J APPL PHYSIOL O, V61, P453, DOI 10.1007/BF00236067; Maganaris CN, 1998, J PHYSIOL-LONDON, V510, P977, DOI 10.1111/j.1469-7793.1998.977bj.x; Kubo K, 2010, EUR J APPL PHYSIOL, V110, P507, DOI 10.1007/s00421-010-1528-1; Kawakami Y, 1998, J APPL PHYSIOL, V85, P398; Kubo K, 2002, SCAND J MED SCI SPOR, V12, P3, DOI 10.1034/j.1600-0838.2002.120102.x; Fukunaga T, 1996, J APPL PHYSIOL, V80, P158; Fujimoto T, 2000, EUR J APPL PHYSIOL, V83, P297, DOI 10.1007/s004210000254; Berg K, 1998, J SPORT MED PHYS FIT, V38, P253; Cavagna G A, 1977, Exerc Sport Sci Rev, V5, P89; Finni T, 2013, J APPL PHYSIOL, V114, P515, DOI 10.1152/japplphysiol.01005.2012; Finni T, 2009, J APPL PHYSIOL, V106, P1332, DOI 10.1152/japplphysiol.91439.2008; Fletcher JR, 2010, EUR J APPL PHYSIOL, V110, P1037, DOI 10.1007/s00421-010-1582-8; Greive DW, 1978, BIOMECHANICS A, VVI, P405; Kubo K, 2000, EUR J APPL PHYSIOL O, V81, P181, DOI 10.1007/s004210050028; Kubo K, 2005, INT J SPORT HLTH SCI, V3, P143, DOI 10.5432/ijshs.3.143; Kubo K, 2010, J APPL BIOMECH, V26, P316; Kyrolainen RJ, 2005, J SPORTS SCI, V23, P1101; Ohta Y, 2012, ACTA BIOENG BIOMECH, V14, P45, DOI 10.5277/abb120406; Peltonen J, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-212	38	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1439-6319	1439-6327		EUR J APPL PHYSIOL	Eur. J. Appl. Physiol.	AUG	2015	115	8					1725	1733		10.1007/s00421-015-3156-2		9	Physiology; Sport Sciences	Physiology; Sport Sciences	CM9JZ	WOS:000358026000012		
J	Deguchi, I; Hayashi, T; Fukuoka, T; Kobayashi, S; Tanahashi, N				Deguchi, I.; Hayashi, T.; Fukuoka, T.; Kobayashi, S.; Tanahashi, N.		Japan Standard Stroke Registry	Features of cardioembolic stroke with persistent and paroxysmal atrial fibrillation - a study with the Japan Stroke Registry	EUROPEAN JOURNAL OF NEUROLOGY			English	Article						atrial fibrillation; cardioembolic stroke; clinical outcomes	ACUTE ISCHEMIC-STROKE; EARLY DEATH; RISK	Background and purposeThe stroke severity on admission and clinical outcomes were compared between ischaemic stroke patients with non-valvular atrial fibrillation (NVAF) of the persistent (PeAF) and paroxysmal (PAF) types. MethodsThe study comprised 9293 patients with cardioembolic stroke and NVAF who were registered in the Japanese stroke databank: 6522 had PeAF (70.2%) and 2771 had PAF (29.8%). Stroke severity on admission and the clinical outcomes on discharge were retrospectively compared between these patient groups. ResultsThe National Institutes of Health Stroke Scale score on admission (median, interquartile range) was 10 (3-20) for PeAF patients and 7 (2-17) for PAF patients, indicating that stroke severity on admission was significantly worse in PeAF patients than PAF patients (P<0.001). Good outcomes (modified Rankin scale score 2) were achieved by 45% PeAF patients and 53% PAF patients. Thus, PeAF patients had significantly poorer clinical outcomes than PAF patients (P<0.001). In-hospital mortality was significantly higher amongst PeAF patients (11%) than PAF patients (8%) (P<0.001). Multivariate analysis of factors contributing to clinical outcomes showed that PeAF was a contributing factor for in-hospital mortality (odds ratio 1.261; 95% confidence interval 1.011-1.652; P=0.045). ConclusionsAmongst cardioembolic stroke patients with NVAF, those with PeAF have significantly higher stroke severity on admission than those with PAF, and PeAF is a factor contributing to in-hospital mortality. Thus, our study suggests that the type of atrial fibrillation affects stroke severity and clinical outcomes following cerebral infarction.	[Deguchi, I.; Hayashi, T.; Fukuoka, T.; Tanahashi, N.] Saitama Med Univ, Int Med Ctr, Dept Neurol, Hidaka, Saitama 3501298, Japan; [Kobayashi, S.] Shimane Univ, Japan Standard Stroke Registry Study Grp, Matsue, Shimane, Japan	Deguchi, I (reprint author), Saitama Med Univ, Int Med Ctr, Dept Neurol, 1397-1 Yamane, Hidaka, Saitama 3501298, Japan.	ideguchi@saitama-med.ac.jp					Saposnik G, 2013, STROKE, V44, P99, DOI 10.1161/STROKEAHA.112.676551; Saxena R, 2001, STROKE, V32, P2333, DOI 10.1161/hs1001.097093; Kobayashi S, 2006, AM J PREV MED, V31, pS240, DOI 10.1016/j.amepre.2006.08.011; Hohnloser SH, 2007, J AM COLL CARDIOL, V50, P2156, DOI 10.1016/j.jacc.2007.07.076; Friberg L, 2010, EUR HEART J, V31, P967, DOI 10.1093/eurheartj/ehn599; WOLF PA, 1991, STROKE, V22, P983; Kato T, 2004, CIRC J, V68, P568, DOI 10.1253/circj.68.568; Arboix A, 2000, INT J CARDIOL, V73, P33, DOI 10.1016/S0167-5273(99)00214-4; DESVOS CB, 2010, J AM COLL CARDIOL, V55, P725; Kimura K, 2005, J NEUROL NEUROSUR PS, V76, P679, DOI 10.1136/jnnp.2004.048827	10	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1351-5101	1468-1331		EUR J NEUROL	Eur. J. Neurol.	AUG	2015	22	8					1215	1219		10.1111/ene.12728		5	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CM5KZ	WOS:000357728000012		
J	Kitajima, K; Fukushima, K; Miyoshi, Y; Nishimukai, A; Hirota, S; Igarashi, Y; Katsuura, T; Maruyama, K; Hirota, S				Kitajima, Kazuhiro; Fukushima, Kazuhito; Miyoshi, Yasuo; Nishimukai, Arisa; Hirota, Seiichi; Igarashi, Yoko; Katsuura, Takayuki; Maruyama, Kaoru; Hirota, Shozo			Association between F-18-FDG uptake and molecular subtype of breast cancer	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Article						Breast cancer; Molecular subtype; FDG; PET/CT; SUVmax	ESTROGEN-RECEPTOR; NEOADJUVANT CHEMOTHERAPY; EXPRESSION; THERAPY; PET/CT	Purpose To determine whether F-18-FDG uptake in breast cancer correlates with immunohistochemically defined subtype and is able to predict molecular subtypes. Methods This retrospective study involved 306 patients with 308 mass-type invasive breast cancers (mean size 2.65 cm, range 1.0-15.0 cm) who underwent F-18-FDG PET/CT before therapy. The correlations between primary tumour F-18-FDG uptake on PET/CT, expressed as SUVmax, and clinicopathological findings and molecular subtype, i.e. luminal A, luminal B (HER2-negative), luminal B (HER2-positive), HER2-positive and triple-negative, were analysed. The predictors of these subtypes were investigated. Results The mean SUVmax of the 308 tumours was 5.33 +/- 3.63 (range 1.15-19.01). Among the subtypes of the 308 tumours, 87 (28.2 %) were luminal A, 111 (36.0 %) were luminal B (HER2-negative), 31 (10.1 %) were luminal B (HER2-positive), 26 (8.4 %) were HER2-positive and 53 (17.2 %) were triple-negative, and the corresponding mean SUVmax were 3.41 +/- 2.07 (range 1.18-14.30), 5.17 +/- 3.52 (range 1.35-19.01), 6.57 +/- 3.84 (range 1.42-15.58), 7.55 +/- 3.63 (range 2.30-13.60) and 6.97 +/- 4.17 (range 1.15-16.06), respectively. A cut-off value of 3.60 yielded 70.1 % sensitivity and 66.1 % specificity with an area under the receiver operating characteristics curve (AUC) of 0.734 for predicting that a tumour was of the luminal A subtype. A cut-off value of 6.75 yielded 65.4 % sensitivity and 75.2 % specificity with an AUC of 0.704 for predicting a HER2-positive subtype. Conclusion SUVmax, a metabolic semiquantitative parameter, shows a significant correlation with the molecular subtype of breast cancer, and is useful for predicting the luminal A or HER2-positive subtype.	[Kitajima, Kazuhiro; Fukushima, Kazuhito; Igarashi, Yoko; Katsuura, Takayuki; Maruyama, Kaoru] Hyogo Coll Med, Dept Nucl Med, Nishinomiya, Hyogo 6638501, Japan; [Kitajima, Kazuhiro; Fukushima, Kazuhito; Igarashi, Yoko; Katsuura, Takayuki; Maruyama, Kaoru] Hyogo Coll Med, PET Ctr, Nishinomiya, Hyogo 6638501, Japan; [Miyoshi, Yasuo; Nishimukai, Arisa] Hyogo Coll Med, Dept Breast & Endocrine Surg, Nishinomiya, Hyogo 6638501, Japan; [Hirota, Seiichi] Hyogo Coll Med, Dept Surg Pathol, Nishinomiya, Hyogo 6638501, Japan; [Hirota, Shozo] Hyogo Coll Med, Dept Radiol, Nishinomiya, Hyogo 6638501, Japan	Kitajima, K (reprint author), Hyogo Coll Med, Dept Nucl Med, 1-1 Mukogawa Cho, Nishinomiya, Hyogo 6638501, Japan.	kazu10041976@yahoo.co.jp					Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Osborne JR, 2010, J NUCL MED, V51, P543, DOI 10.2967/jnumed.108.060459; Cheang MCU, 2009, J NATL CANCER I, V101, P736, DOI 10.1093/jnci/djp082; Gianni L, 2011, LANCET ONCOL, V12, P236, DOI 10.1016/S1470-2045(11)70033-X; Vicente AMG, 2013, EUR J NUCL MED MOL I, V40, P1304, DOI 10.1007/s00259-013-2418-7; Hugh J, 2009, J CLIN ONCOL, V27, P1168, DOI 10.1200/JCO.2008.18.1024; Ueda S, 2008, JPN J CLIN ONCOL, V38, P250, DOI 10.1093/jjco/hyn019; Wang CL, 2011, AM J ROENTGENOL, V197, pW247, DOI 10.2214/AJR.11.6478; Goldhirsch A, 2011, ANN ONCOL, V22, P1736, DOI 10.1093/annonc/mdr304; Koolen BB, 2012, EUR J NUCL MED MOL I, V39, P1830, DOI 10.1007/s00259-012-2211-z; Heudel P, 2010, INT J CLIN ONCOL, V15, P588, DOI 10.1007/s10147-010-0120-3; Koo HR, 2014, EUR RADIOL, V24, P610, DOI 10.1007/s00330-013-3037-1; Dubsky P, 2013, ANN ONCOL, V24, P640, DOI 10.1093/annonc/mds334; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Niemiec J, 2013, CLIN BREAST CANCER, V13, P119, DOI 10.1016/j.clbc.2012.12.005; Caudle AS, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3198; Groheux D, 2011, EUR J NUCL MED MOL I, V38, P426, DOI 10.1007/s00259-010-1640-9; Miyake KK, 2014, AM J ROENTGENOL, V203, P272, DOI 10.2214/AJR.13.11971; Murase K, 2014, BREAST CANCER-TOKYO, V21, P52, DOI 10.1007/s12282-012-0348-z; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; van't Veer LJ, 2005, J CLIN ONCOL, V23, P1631, DOI 10.1200/JCO.2005.12.005	22	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	AUG	2015	42	9					1371	1377		10.1007/s00259-015-3070-1		7	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CM9UX	WOS:000358055700005		
J	Kaneko, N; Taniyama, N; Inatani, Y; Nagano, Y; Fujiwara, M; Torao, M; Miyakoshi, Y; Shimizu, M				Kaneko, Nobuto; Taniyama, Natsumi; Inatani, Yu; Nagano, Yuta; Fujiwara, Makoto; Torao, Mitsuru; Miyakoshi, Yasuyuki; Shimizu, Munetaka			Circulating insulin-like growth factor I in juvenile chum salmon: relationship with growth rate and changes during downstream and coastal migration in northeastern Hokkaido, Japan	FISH PHYSIOLOGY AND BIOCHEMISTRY			English	Article						Chum salmon; Juvenile; Migration; Growth rate; RNA/DNA ratio; Insulin-like growth factor I	POSTSMOLT COHO SALMON; ATLANTIC SALMON; CHINOOK SALMON; ONCORHYNCHUS-TSHAWYTSCHA; IGF-I; PERIOD HYPOTHESIS; ENDOCRINE CHANGES; MARINE SURVIVAL; FACTOR (IGF)-I; CRITICAL SIZE	Chum salmon (Oncorhynchus keta) migrate to the ocean in their first spring, and growth during early marine life is critical for survival. We examined the validity of circulating IGF-I and muscle RNA/DNA ratio as indices of growth rate using individually tagged juvenile chum salmon fed or fasted for 10 days. Serum IGF-I level was highly, positively correlated with individual growth rate. Muscle RNA/DNA ratio also showed a positive correlation, but its relation was not as high as that of IGF-I. We next measured these physiological parameters in chum salmon juveniles caught at river, estuary, port and nearshore of the northeastern Hokkaido, Japan, from May to June in 2013 and 2014, respectively. In both years, there was a trend that serum IGF-I levels were high in nearshore fish and low in river/estuarine fish in June. In contrast, muscle RNA/DNA ratio showed no clear temporal and spatial patterns. The present study shows that circulating IGF-I can be used as a growth index in juvenile chum salmon. Monitoring growth status using serum IGF-I suggests that growth of juvenile chum salmon in the survey area was activated when they left the coast.	[Kaneko, Nobuto; Taniyama, Natsumi; Inatani, Yu; Nagano, Yuta; Shimizu, Munetaka] Hokkaido Univ, Fac Fisheries Sci, Hakodate, Hokkaido 0418611, Japan; [Fujiwara, Makoto; Torao, Mitsuru; Miyakoshi, Yasuyuki] Hokkaido Res Org, Salmon & Freshwater Fisheries Res Inst, Eniwa, Hokkaido 0611433, Japan	Shimizu, M (reprint author), Hokkaido Univ, Fac Fisheries Sci, 3-1-1 Minato, Hakodate, Hokkaido 0418611, Japan.	mune@fish.hokudai.ac.jp			Japan Society for the Promotion of Science [25450289]; Hokusui Foundation	We thank Yuji Yoshida and staffs of the Abashiri Fisheries Cooperative Association, the Abashiri City Science Center and the East Branch of Fisheries Technical Guidance Office for supporting field surveys. We also thank staffs of the Kitami Salmon Enhancement Programs Association for providing juvenile chum salmon for tank experiment. This work was supported by Grant-in-Aids for Scientific Research from Japan Society for the Promotion of Science (#25450289) and Hokusui Foundation.	Shimizu M, 2000, GEN COMP ENDOCR, V119, P26, DOI 10.1006/gcen.2000.7498; Kocik JF, 2009, AM FISH S S, V69, P293; HEALEY MC, 1982, CAN J FISH AQUAT SCI, V39, P952, DOI 10.1139/f82-130; Picha ME, 2008, N AM J AQUACULT, V70, P196, DOI 10.1577/AO7-038.1; Beamish RJ, 2001, PROG OCEANOGR, V49, P423, DOI 10.1016/S0079-6611(01)00034-9; Chicharo MA, 2008, INT J MOL SCI, V9, P1453, DOI 10.3390/ijms9081453; Pierce AL, 2005, GEN COMP ENDOCR, V140, P192, DOI 10.1016/j.ygcen.2004.10.017; Dyer AR, 2004, AQUACULTURE, V236, P583, DOI 10.1016/j.aquaculture.2003.12.025; Ohlsson C, 2009, ENDOCR REV, V30, P494, DOI 10.1210/er.2009-0010; Small BC, 2005, DOMEST ANIM ENDOCRIN, V28, P202, DOI 10.1016/j.domaniend.2004.09.002; DAUGHADAY WH, 1989, ENDOCR REV, V10, P68; Beckman BR, 2004, GEN COMP ENDOCR, V135, P334, DOI 10.1016/j.ygcen.2003.10.013; Le Roith D, 2001, ENDOCR REV, V22, P53, DOI 10.1210/er.22.1.53; Magnusson A, 2003, ESTUARIES, V26, P1094, DOI 10.1007/BF02803366; Beamish RJ, 2004, T AM FISH SOC, V133, P26, DOI 10.1577/T03-028; BUCKLEY LJ, 1984, MAR BIOL, V80, P291, DOI 10.1007/BF00392824; Farley Edward V. Jr, 2007, North Pacific Anadromous Fish Commission Bulletin, V4, P311; Beckman BR, 2011, GEN COMP ENDOCR, V170, P233, DOI 10.1016/j.ygcen.2010.08.009; Arndt SKA, 1996, J FISH BIOL, V49, P257; BAX NJ, 1983, CAN J FISH AQUAT SCI, V40, P426; Beaudreau AH, 2011, MAR BIOL, V158, P439, DOI 10.1007/s00227-010-1571-9; Beckman BR, 2001, COMP BIOCHEM PHYS A, V129, P585, DOI 10.1016/S1095-6433(01)00297-5; Beckman BR, 2004, T AM FISH SOC, V133, P1057, DOI 10.1577/T03-098.1; Beckman BR, 2004, AQUACULTURE, V241, P601, DOI 10.1016/j.aquaculture.2004.08.013; Beckman BR, 1998, GEN COMP ENDOCR, V109, P325, DOI 10.1006/gcen.1997.7036; Ferriss BE, 2014, MAR ECOL PROG SER, V503, P247, DOI 10.3354/meps10726; Fukuwaka M, 2002, J FISH BIOL, V60, P3, DOI 10.1006/jfbi.2001.1803; GREMARE A, 1994, COMP BIOCHEM PHYS B, V107, P297, DOI 10.1016/0305-0491(94)90052-3; Hillgruber N, 2009, AM FISHERIES SOC S, V70, P183; Johnson MW, 2002, J EXP MAR BIOL ECOL, V274, P141, DOI 10.1016/S0022-0981(02)00203-4; Kawaguchi K, 2013, COMP BIOCHEM PHYS A, V165, P191, DOI 10.1016/j.cbpa.2013.02.029; Larsen DA, 2001, N AM J AQUACULT, V63, P1, DOI 10.1577/1548-8454(2001)063<0001:TEOLTA>2.0.CO;2; MacLean SA, 2008, T AM FISH SOC, V137, P1279, DOI 10.1577/T07-254.1; McCormick SD, 2013, CAN J FISH AQUAT SCI, V70, P105, DOI 10.1139/cjfas-2012-0151; Miyakoshi Y, 2013, REV FISH SCI, V21, P469, DOI 10.1080/10641262.2013.836446; Nagata Mitsuhiro, 2007, North Pacific Anadromous Fish Commission Bulletin, V4, P223; Salo EO, 1991, PACIFIC SALMON LIFE, P233; Stefansson SO, 2012, AQUACULTURE, V362, P127, DOI 10.1016/j.aquaculture.2011.07.002; WEDEMEYER GA, 1980, US NMFS MAR FISH REV, V42, P1; Wertheimer AC, 2007, AM FISH SOC S, V57, P1	40	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0920-1742	1573-5168		FISH PHYSIOL BIOCHEM	Fish Physiol. Biochem.	AUG	2015	41	4					991	1003		10.1007/s10695-015-0064-7		13	Biochemistry & Molecular Biology; Fisheries; Physiology	Biochemistry & Molecular Biology; Fisheries; Physiology	CM4NE	WOS:000357660700015		
J	Matsuzaki, I; Miyahara, R; Hirooka, Y; Funasaka, K; Ohno, E; Nakamura, M; Kawashima, H; Nukaga, A; Shimoyama, Y; Goto, H				Matsuzaki, Ippei; Miyahara, Ryoji; Hirooka, Yoshiki; Funasaka, Kohei; Ohno, Eizaburo; Nakamura, Masanao; Kawashima, Hiroki; Nukaga, Akiko; Shimoyama, Yoshie; Goto, Hidemi			Forward-viewing versus oblique-viewing echoendoscopes in the diagnosis of upper GI subepithelial lesions with EUS-guided FNA: a prospective, randomized, crossover study	GASTROINTESTINAL ENDOSCOPY			English	Article							FINE-NEEDLE-ASPIRATION; GASTROINTESTINAL STROMAL TUMORS; ENDOSCOPIC SUBMUCOSAL DISSECTION; TRUCUT BIOPSY; TISSUE ACQUISITION; INITIAL EVALUATION; ULTRASOUND; YIELD; RESECTION; STOMACH	Background: The role of the forward-viewing echoendoscope compared with the oblique-viewing echoendoscope for EUS-guided FNA (EUS-FNA) of upper GI subepithelial lesions has not been defined. Objective: To compare the diagnostic yield and clinical efficacy of EUS-FNA by using the 2 echoendoscopes in the same upper GI subepithelial lesion. Design: Prospective, randomized, crossover study. Setting: Tertiary-care medical center. Patients: Forty-one patients with an upper GI subepithelial lesion. Interventions: All patients first underwent EUS-FNA with a 19-gauge needle by using both echoendoscopes, based on random selection. When required, 22-gauge or 25-gauge needles were used additionally. Main Outcome Measurements: Comparison of diagnostic yield, tissue sample area, puncture success rates, procedure time, and adverse events. Results: Forty-one patients (median lesion size 22 mm, range 15-63 mm) were enrolled. Rates of histologic diagnosis were 80.5% (33/41) and 73.2% (30/41) (P = .453) by using forward-viewing and oblique-viewing echoendoscopes, respectively. Median tissue sample area in GI stromal tumors (n = 22) obtained with the forward-viewing echoendoscope was larger than with the oblique-viewing echoendoscope (2.46 mm(2) vs 1.00 mm2; P = .046). Puncture success rates were 39 of 41 (95.1%) and 35 of 41 (85.4%; P = .289) with forward-viewing and oblique-viewing echoendoscopes, respectively. Median procedure time was 21 minutes with the forward-viewing echoendoscope and 27 minutes with the oblique-viewing echoendoscope (P = .009). An infectious adverse event occurred in a patient and was treated with antibiotics. Limitations: Small sample size. Conclusion: Diagnostic yield did not differ between the 2 echoendoscopes. However, tissue sample area and procedure time were superior with the forward-viewing echoendoscope.	[Matsuzaki, Ippei; Miyahara, Ryoji; Ohno, Eizaburo; Nakamura, Masanao; Kawashima, Hiroki; Goto, Hidemi] Nagoya Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Nagoya, Aichi 4668550, Japan; [Hirooka, Yoshiki; Funasaka, Kohei; Goto, Hidemi] Nagoya Univ Hosp, Dept Endoscopy, Nagoya, Japan; [Nukaga, Akiko; Shimoyama, Yoshie] Nagoya Univ Hosp, Dept Pathol & Clin Labs, Nagoya, Aichi, Japan	Miyahara, R (reprint author), Nagoya Univ, Grad Sch Med, Dept Gastroenterol, Showa Ku, 65 Tsuruma Cho, Nagoya, Aichi 4668550, Japan.		KAWASHIMA, Hiroki/I-7285-2014				Storch I, 2006, GASTROINTEST ENDOSC, V64, P505, DOI 10.1016/j.gie.2006.02.056; Eckardt AJ, 2012, EUR J GASTROEN HEPAT, V24, P1135, DOI 10.1097/MEG.0b013e328356eae2; Polkowski M, 2009, ENDOSCOPY, V41, P329, DOI 10.1055/s-0029-1214447; Levy MJ, 2003, GASTROINTEST ENDOSC, V57, P101, DOI 10.1067/mge.2003.49; Cantor MJ, 2006, GASTROINTEST ENDOSC, V64, P29, DOI 10.1016/j.gie.2006.02.027; Mitsui T, 2014, GASTRIC CANCER, V17, P594, DOI 10.1007/s10120-013-0291-5; Buscaglia JM, 2012, GASTROINTEST ENDOSC, V75, P1147, DOI 10.1016/j.gie.2012.01.032; Fletcher CDM, 2002, HUM PATHOL, V33, P459, DOI 10.1053/hupa.2002.123545; Larghi A, 2012, GASTROINTEST ENDOSC, V76, P570, DOI 10.1016/j.gie.2012.04.477; Larghi A, 2011, GASTROINTEST ENDOSC, V74, P504, DOI 10.1016/j.gie.2011.05.014; Hoda KM, 2009, GASTROINTEST ENDOSC, V69, P1218, DOI 10.1016/j.gie.2008.09.045; Trevino JM, 2009, GASTROINTEST ENDOSC, V69, P361, DOI 10.1016/j.gie.2008.09.021; Eloubeidi MA, 2011, J GASTROEN HEPATOL, V26, P63, DOI 10.1111/j.1440-1746.2010.06409.x; Akahoshi K, 2007, WORLD J GASTROENTERO, V13, P2077; Chak A, 1997, GASTROINTEST ENDOSC, V45, P468, DOI 10.1016/S0016-5107(97)70175-5; Lee CK, 2010, GASTROINTEST ENDOSC, V71, P188, DOI 10.1016/j.gie.2009.07.029; Tanaka J, 2010, DIGEST ENDOSC, V22, P354, DOI 10.1111/j.1443-1661.2010.01032.x; Lee IL, 2006, ENDOSCOPY, V38, P1024, DOI 10.1055/s-2006-944814; DeWitt J, 2011, SURG ENDOSC, V25, P2192, DOI 10.1007/s00464-010-1522-z; Dumonceau JM, 2011, ENDOSCOPY, V43, P897, DOI 10.1055/s-0030-1256754; Okubo K, 2004, J GASTROENTEROL, V39, P747, DOI 10.1007/s00535-004-1383-0; Voermans RP, 2011, GASTROINTEST ENDOSC, V74, P1285, DOI 10.1016/j.gie.2011.07.059; Lim YL, 2010, WORLD J GASTROENTERO, V16, P439, DOI 10.3748/wjg.v16.i4.439; Voermans RP, 2007, GASTROINTEST ENDOSC, V66, P1013, DOI 10.1016/j.gie.2007.02.057; Kojima T, 1999, GASTROINTEST ENDOSC, V50, P516, DOI 10.1016/S0016-5107(99)70075-1; Philipper M, 2010, ENDOSCOPY, V42, P300, DOI 10.1055/s-0029-1244006; Kim MY, 2011, J CLIN GASTROENTEROL, V45, P330, DOI 10.1097/MCG.0b013e318206474e; Hwang JH, 2005, GASTROINTEST ENDOSC, V62, P202, DOI 10.1016/S0016-5107(05)01567-1; Hara K, 2013, ENDOSCOPY, V45, P392, DOI 10.1055/s-0032-1326076; Schlag C, 2013, ENDOSCOPY, V45, P4, DOI 10.1055/s-0032-1325760; Varadarajulu S, 2004, ENDOSCOPY, V36, P397, DOI 10.1055/s-2004-814316; Mekky MA, 2010, GASTROINTEST ENDOSC, V71, P913, DOI 10.1016/j.gie.2009.11.044; Hiki N, 2008, SURG ENDOSC, V22, P1729, DOI 10.1007/s00464-007-9696-8; Miettinen M, 2006, SEMIN DIAGN PATHOL, V23, P70, DOI 10.1053/j.semdp.2006.09.001; Inoue H, 2012, SURG ONCOL CLIN N AM, V21, P129, DOI 10.1016/j.soc.2011.09.012; Ando N, 2002, GASTROINTEST ENDOSC, V55, P37, DOI 10.1067/mge.2002.120323; Bang JY, 2013, ENDOSCOPY, V45, P445, DOI 10.1055/s-0032-1326268; BOYCE GA, 1991, GASTROINTEST ENDOSC, V37, P449, DOI 10.1016/S0016-5107(91)70778-5; Fernandez-Esparrach G, 2010, ENDOSCOPY, V42, P292, DOI 10.1055/s-0029-1244074; Hunt GC, 2003, GASTROINTEST ENDOSC, V57, P68, DOI 10.1067/mge.2003.34; Irisawa A, 2010, DIGEST ENDOSC, V22, pS128, DOI 10.1111/j.1443-1661.2010.00974.x; Iwashita T, 2012, J GASTROEN HEPATOL, V27, P362, DOI 10.1111/j.1440-1746.2011.06923.x; Ji Jeong-Seon, 2009, Korean Journal of Internal Medicine, V24, P101, DOI 10.3904/kjim.2009.24.2.101; Kataoka M, 2013, DIGEST ENDOSC, V25, P274, DOI 10.1111/j.1443-1661.2012.01384.x; Kida M, 2011, ENDOSCOPY, V43, P796, DOI 10.1055/s-0030-1256508; Larghi A, 2014, ENDOSCOPY, V46, P39, DOI 10.1055/s-0033-1344895; Larghi A, 2009, GASTROINTEST ENDOSC, V69, P356, DOI 10.1016/j.gie.2008.08.038; Matsui M, 1998, ENDOSCOPY, V30, P750, DOI 10.1055/s-2007-1001416; Sakamoto Hiroki, 2010, World J Radiol, V2, P289, DOI 10.4329/wjr.v2.i8.289; Watson RR, 2011, DIGEST DIS SCI, V56, P1757, DOI 10.1007/s10620-011-1646-6	50	2	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0016-5107	1097-6779		GASTROINTEST ENDOSC	Gastrointest. Endosc.	AUG	2015	82	2					287	295		10.1016/j.gie.2014.12.051		9	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CM7SZ	WOS:000357898100012		
J	Gotoda, T; Yang, HK				Gotoda, Takuji; Yang, Han-Kwang			The desired balance between treatment and curability in treatment planning for early gastric cancer	GASTROINTESTINAL ENDOSCOPY			English	Editorial Material							ENDOSCOPIC SUBMUCOSAL DISSECTION; RESECTION		[Gotoda, Takuji] Tokyo Med Univ, Dept Gastroenterol & Hepatol, Tokyo 1608402, Japan; [Yang, Han-Kwang] Seoul Natl Univ, Coll Med, Dept Surg, Seoul, South Korea	Gotoda, T (reprint author), Tokyo Med Univ, Dept Gastroenterol & Hepatol, Tokyo 1608402, Japan.						Fujiya M, 2015, GASTROINTEST ENDOSC, V81, P583, DOI 10.1016/j.gie.2014.07.034; Soetikno R, 2005, J CLIN ONCOL, V23, P4490, DOI 10.1200/JCO.2005.19.935; Gotoda T, 2010, BRIT J SURG, V97, P868, DOI 10.1002/bjs.7033; Choi JH, 2015, GASTROINTEST ENDOSC, V82, P299, DOI 10.1016/j.gie.2015.01.019; Chung IK, 2009, GASTROINTEST ENDOSC, V69, P1228, DOI 10.1016/j.gie.2008.09.027; Bourke MJ, 2014, ENDOSCOPY, V46, P677, DOI 10.1055/s-0034-1377449; Goto O, 2014, GASTRIC CANCER; Gotoda T, 2000, GASTRIC CANCER, V3, P219, DOI 10.1007/PL00011720; Gotoda T, 2014, GASTRIC CANCER; Nakada K, 2015, GASTRIC CANCER, V18, P147, DOI 10.1007/s10120-014-0344-4	10	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0016-5107	1097-6779		GASTROINTEST ENDOSC	Gastrointest. Endosc.	AUG	2015	82	2					308	310		10.1016/j.gie.2015.02.050		3	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CM7SZ	WOS:000357898100015		
J	Umeda, J; Itoi, T; Tsuchiya, T; Sofuni, A; Itokawa, F; Ishii, K; Tsuji, S; Ikeuchi, N; Kamada, K; Tanaka, R; Tonozuka, R; Honjo, M; Mukai, S; Fujita, M; Moriyasu, F				Umeda, Junko; Itoi, Takao; Tsuchiya, Takayoshi; Sofuni, Atsushi; Itokawa, Fumihide; Ishii, Kentaro; Tsuji, Shujiro; Ikeuchi, Nobuhito; Kamada, Kentaro; Tanaka, Reina; Tonozuka, Ryosuke; Honjo, Mitsuyoshi; Mukai, Shuntaro; Fujita, Mitsuru; Moriyasu, Fuminori			A newly designed plastic stent for EUS-guided hepaticogastrostomy: a prospective preliminary feasibility study	GASTROINTESTINAL ENDOSCOPY			English	Article							BILIARY DRAINAGE; OBSTRUCTION	Background: There are currently no dedicated plastic stents for EUS-guided hepaticogastrostomy (EUS-HGS). Objective: We prospectively evaluated the feasibility and the technical and functional success rates of our newly designed plastic stent for EUS-HGS. Design: Prospective preliminary feasibility study. Setting: A tertiary-care referral center. Patients: Twenty-three consecutive patients were treated. The reasons for requiring EUS-HGS were periampullary tumor invasion (n = 9), altered anatomy (n = 7), failed duodenal intubation (n = 3), and previous ERCP failure (n = 4). Interventions: An 8F single-pigtail plastic stent with 4 flanges was placed for EUS-HGS. Main Outcome Measurements: Technical success, clinical success, and adverse events according to the American Society for Gastrointestinal Endoscopy lexicon. Results: All stents were successfully deployed without procedural adverse events (100% technical success rate). Bleeding from the punctured gastric wall occurred in 1 patient 3 days postoperatively. We exchanged the plastic stent for a fully covered self-expandable metal stent. A mild adverse event of self-limited abdominal pain occurred in 3 patients. Treatment success was achieved in all patients. The occlusion rate was 13.7% (3/22) during the median follow-up period (5.0 months, range 0.5-12.5 months). The median duration of stent patency was 4.0 months (range 0.5-9.0 months). There was no stent migration or dislocation during the follow-up period. Limitations: Small number of patients and lack of a control group. Conclusions: This newly designed single-pigtail plastic stent dedicated for EUS-HGS was technically feasible and can possibly be used for highly selected patients with advanced malignancy or benign stricture.	[Umeda, Junko; Itoi, Takao; Tsuchiya, Takayoshi; Sofuni, Atsushi; Itokawa, Fumihide; Ishii, Kentaro; Tsuji, Shujiro; Ikeuchi, Nobuhito; Kamada, Kentaro; Tanaka, Reina; Tonozuka, Ryosuke; Honjo, Mitsuyoshi; Mukai, Shuntaro; Fujita, Mitsuru; Moriyasu, Fuminori] Tokyo Med Univ, Dept Gastroenterol & Hepatol, Tokyo 1600023, Japan	Itoi, T (reprint author), Tokyo Med Univ, Shinjuku Ku, 6-7-1 Nishishinjuku, Tokyo 1600023, Japan.						Artifon ELA, 2007, CLINICS, V62, P799, DOI 10.1590/S1807-59322007000600023; Khashab MA, 2013, GASTROINTEST ENDOSC, V78, P734, DOI 10.1016/j.gie.2013.05.013; Martins FP, 2010, ENDOSCOPY, V42, pE126, DOI 10.1055/s-0029-1243911; Giovannini M, 2003, ENDOSCOPY, V35, P1076; Bories E, 2007, ENDOSCOPY, V39, P287, DOI 10.1055/s-2007-966212; Itoi T, 2010, J HEPATO-BIL-PAN SCI, V17, P611, DOI 10.1007/s00534-009-0196-1; Burmester E, 2003, GASTROINTEST ENDOSC, V57, P246, DOI 10.1067/mge.2003.85; Kahaleh M, 2006, GASTROINTEST ENDOSC, V64, P52, DOI 10.1016/j.gie.2006.01.063; Cotton PB, 2010, GASTROINTEST ENDOSC, V71, P746; Itoi T, 2013, J HEPATO-BIL-PAN SCI, V20, P71, DOI 10.1007/s00534-012-0569-8; Iwashita Takuji, 2014, Clin J Gastroenterol, V7, P94, DOI 10.1007/s12328-014-0467-5; Park DH, 2008, WORLD J GASTROENTERO, V14, P6078; Will U, 2007, ENDOSCOPY, V39, P292, DOI 10.1055/s-2007-966215	13	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0016-5107	1097-6779		GASTROINTEST ENDOSC	Gastrointest. Endosc.	AUG	2015	82	2					390	+		10.1016/j.gie.2015.02.041		9	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CM7SZ	WOS:000357898100029		
J	Mori, H; Kobara, H; Nishiyama, N; Fujihara, S; Ayaki, M; Chiyo, T; Masaki, T				Mori, Hirohito; Kobara, Hideki; Nishiyama, Noriko; Fujihara, Shintaro; Ayaki, Maki; Chiyo, Taiga; Masaki, Tsutomu			High-resolution imaging by using 2-balloon radial EUS sonography in the esophagus	GASTROINTESTINAL ENDOSCOPY			English	Editorial Material									[Mori, Hirohito; Kobara, Hideki; Nishiyama, Noriko; Fujihara, Shintaro; Ayaki, Maki; Chiyo, Taiga; Masaki, Tsutomu] Kagawa Univ, Dept Gastroenterol & Neurol, Kita Ku, Takamatsu, Kagawa 760, Japan	Mori, H (reprint author), Kagawa Univ, Dept Gastroenterol & Neurol, Kita Ku, Takamatsu, Kagawa 760, Japan.							0	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0016-5107	1097-6779		GASTROINTEST ENDOSC	Gastrointest. Endosc.	AUG	2015	82	2					400	401		10.1016/j.gie.2015.03.1905		2	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CM7SZ	WOS:000357898100033		
J	Kin, T; Katanuma, A; Takahashi, K; Osanai, M; Yane, K; Ikarashi, S; Sen-yo, M; Minami, R; Sano, I; Yamazaki, H; Maguchi, H				Kin, Toshifumi; Katanuma, Akio; Takahashi, Kuniyuki; Osanai, Manabu; Yane, Kei; Ikarashi, Satoshi; Sen-yo, Manabu; Minami, Ryuki; Sano, Itsuki; Yamazaki, Hajime; Maguchi, Hiroyuki			Successful reintervention of biliary stent occlusion after biliary and duodenal stenting by using argon plasma coagulation	GASTROINTESTINAL ENDOSCOPY			English	Editorial Material									[Kin, Toshifumi; Katanuma, Akio; Takahashi, Kuniyuki; Osanai, Manabu; Yane, Kei; Ikarashi, Satoshi; Sen-yo, Manabu; Minami, Ryuki; Sano, Itsuki; Yamazaki, Hajime; Maguchi, Hiroyuki] Teine Keijinkai Hosp, Ctr Gastroenterol, Sapporo, Hokkaido, Japan	Kin, T (reprint author), Teine Keijinkai Hosp, Ctr Gastroenterol, Sapporo, Hokkaido, Japan.							0	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0016-5107	1097-6779		GASTROINTEST ENDOSC	Gastrointest. Endosc.	AUG	2015	82	2					407	407		10.1016/j.gie.2015.02.037		1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CM7SZ	WOS:000357898100040		
J	Namikawa, T; Kobayashi, M; Hanazaki, K				Namikawa, Tsutomu; Kobayashi, Michiya; Hanazaki, Kazuhiro			Multiple adenocarcinomas in intrathoracic upside-down stomach	GASTROINTESTINAL ENDOSCOPY			English	Editorial Material									[Namikawa, Tsutomu; Kobayashi, Michiya; Hanazaki, Kazuhiro] Kochi Med Sch, Dept Surg, Kochi, Japan	Namikawa, T (reprint author), Kochi Med Sch, Dept Surg, Kochi, Japan.							0	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0016-5107	1097-6779		GASTROINTEST ENDOSC	Gastrointest. Endosc.	AUG	2015	82	2					411	412		10.1016/j.gie.2015.02.007		3	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CM7SZ	WOS:000357898100044		
J	Ito, T; Takeuchi, Y; Hanaoka, N; Matsuura, N; Hamada, K; Uedo, N; Ishihara, R; Shingai, T; Ohue, M; Tomita, Y; Iishi, H				Ito, Takashi; Takeuchi, Yoji; Hanaoka, Noboru; Matsuura, Noriko; Hamada, Kenta; Uedo, Noriya; Ishihara, Ryu; Shingai, Tatsushi; Ohue, Masayuki; Tomita, Yasuhiko; Iishi, Hiroyasu			Ten-millimeter advanced transverse colon cancer accompanied by a sessile serrated adenoma and/or polyp	GASTROINTESTINAL ENDOSCOPY			English	Editorial Material									[Ito, Takashi; Ishihara, Ryu; Iishi, Hiroyasu] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Gastrointestinal Oncol, Osaka, Japan; [Ito, Takashi] Hokkaido PWFAC Obihiro Kosei Gen Hosp, Dept Gastrointestinal Oncol, Obihiro, Hokkaido, Japan; [Shingai, Tatsushi; Ohue, Masayuki] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Gastrointestinal Surg, Osaka, Japan; [Tomita, Yasuhiko] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Pathol, Osaka, Japan	Ito, T (reprint author), Osaka Med Ctr Canc & Cardiovasc Dis, Dept Gastrointestinal Oncol, Osaka, Japan.							0	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0016-5107	1097-6779		GASTROINTEST ENDOSC	Gastrointest. Endosc.	AUG	2015	82	2					419	420		10.1016/j.gie.2015.02.010		3	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CM7SZ	WOS:000357898100054		
J	Kim, A; Pyke, K				Kim, Allen; Pyke, Karen			Taming Tiger Dads: Hegemonic American Masculinity and South Korea's Father School	GENDER & SOCIETY			English	Article						globalization; hegemony; Korean men; masculinity; men's movement	PROMISE KEEPERS; MEN; GENDER; FAMILY; LIFE	How do non-Western men interact with and understand the form of Western masculinity associated with global dominance? Is their experience of Western hegemonic masculinity's denigration of their national/ethnic masculinity similar to what occurs among subordinated nonwhite and lower-class men in Western countries? We take up this subject in our study of the South Korean Father School movement, which trains Korean men to become more involved and loving family men. Our analysis of the discursive practices of Father School organizational leadership and participants discovers the relational construction of a problematic Korean masculinity and a remedial New Man masculinity associated with white American men. We draw on Chen (1999) to suggest the Father School men's movement is an attempt to elevate Korean masculinity on the world stage by bargaining with Western hegemonic masculinity.	[Kim, Allen] Int Christian Univ, Sociol, Tokyo, Japan; [Pyke, Karen] Univ Calif Riverside, Sociol, Riverside, CA 92521 USA	Kim, A (reprint author), Int Christian Univ, Sociol, Tokyo, Japan.	oneallenkim@gmail.com			National Science Foundation [1015701]; Korea Foundation	This research was supported by grants from the National Science Foundation (1015701) and the Korea Foundation (2012) awarded to Allen Kim. The authors thank Joya Misra and Maxine Craig as well as the anonymous reviewers for their helpful comments. Correspondence concerning this article should be addressed to Allen J. Kim; e-mail: oneallenkim@gmail.com.	Adams Michele, 2008, GENDER LENS SERIES, V2nd; Kwon YI, 2007, J COMP FAM STUD, V38, P285; Pyke K, 2000, J MARRIAGE FAM, V62, P240, DOI 10.1111/j.1741-3737.2000.00240.x; Heath M, 2003, GENDER SOC, V17, P423, DOI 10.1177/0891243203251731; Connell RW, 2005, SIGNS, V30, P1801, DOI 10.1086/427525; Schrock D, 2009, ANNU REV SOCIOL, V35, P277, DOI 10.1146/annurev-soc-070308-115933; Khang YH, 2005, INT J EPIDEMIOL, V34, P1291, DOI 10.1093/ije/dyi224; Dreby J, 2006, GENDER SOC, V20, P32, DOI 10.1177/0891243205282660; Pyke KD, 2003, GENDER SOC, V17, P33, DOI 10.1177/0891243202238977; Connell RW, 2005, GENDER SOC, V19, P829, DOI 10.1177/0891243205278639; Pyke KD, 1996, GENDER SOC, V10, P527, DOI 10.1177/089124396010005003; Bartkowski John, 2004, PROMISE KEEPERS SERV; BERNARD J, 1981, AM PSYCHOL, V36, P1; Brickner Bryan, 1999, PROMISE KEEPERS POLI; Cancian Francesca, 1987, LOVE AM INDIVIDUALIS; Chapman Gary, 1995, 5 LANGUAGES LOVE; Charmaz K., 2000, HDB QUALITATIVE RES, P509, DOI DOI 10.1177/0891241609342193; Chen AS, 1999, GENDER SOC, V13, P584, DOI 10.1177/089124399013005002; Choi Sun Young, 2012, KOREA J SOCIOLOGY, V46, P203; Chua Amy, 2011, BATTLE HYMN TIGER MO; Chung Jiyoung, 2012, DONGA NEWSPAPER 0604; Connell R. W, 1995, MASCULINITIES; Connell RW, 2005, MEN MASC, V7, P347, DOI DOI 10.1177/1097184X03260969; Donovan B, 1998, THEOR SOC, V27, P817, DOI 10.1023/A:1006909132442; Father School, 2010, DUR FATH SCH MARK BR; Father School, 2010, FATH SCH ADV MAN; Father School, 2010, 15 ANN FATH SCH BOOK; Father School, 2012, DUR FATH SCH MARK BR; Kim AJ, 2014, SOCIOL PERSPECT, V57, P321, DOI 10.1177/0731121414523734; Kim Allen J., 2013, KOREANS AM HIST CULT, P173; Kim Allen J., 2013, WILEY BLACKWELL ENCY; Kim Eunjung, 2008, NEW SHORES UNDERSTAN, P175; Kim Yu Gyung, 2009, STUDY CHANGES FAMILY; Kimmel MS, 2003, INT SOCIOL, V18, P603, DOI 10.1177/02685809030183008; Laporte Nicole, 2011, NY TIMES MAGAZINE, pMM22; Lee Yoonjung, 2010, KOREAN HOME MANAGEME, P223; Lu A, 2013, GENDER SOC, V27, P345, DOI 10.1177/0891243213479446; Magnuson E, 2008, J CONTEMP ETHNOGR, V37, P255, DOI 10.1177/0891241607303393; Magnuson Eric, 2007, J MENS STUDIES, V15, P31, DOI 10.3149/jms.1501.31; Mirande A, 2011, MEN MASC, V14, P309, DOI 10.1177/1097184X10371288; Mohanty Chandra Talpade, 1984, BOUNDARY 2, V2, P333, DOI 10.2307/302821; Montes V, 2013, GENDER SOC, V27, P469, DOI 10.1177/0891243212470491; Oh Dallan, 2009, 16 KOREAN FAMILIES G; Park Ki-Bum, 2014, MULTICULTURAL FATHER; Pierrette Hondagneu-Sotelo, 1994, THEORIZING MASCULINI; Pyke K., 2010, J INTERCULTURAL STUD, V31, P81; Said's E., 1978, ORIENTALISM; Son So Young, 2013, KOREAN SOC BASIC DES, V14, P219; Strauss A., 1988, BASICS QUALITATIVE R; Sung J., RE LOOK IDEAL FATHER; Sung S., 1998, J KOREAN FEMINISM, V18, P75; Taga Futoshi, 2005, HDB STUDIES MEN MASC; Thai Hung Cam, 2008, BETTER WORSE VIETNAM; Yoon L., 2010, WALL STREET J	54	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0891-2432	1552-3977		GENDER SOC	Gend. Soc.	AUG	2015	29	4					509	533		10.1177/0891243215584602		25	Sociology; Women's Studies	Sociology; Women's Studies	CM6KA	WOS:000357796100003		
J	Fujiki, M; Miyamoto, S; Sakuraba, M; Nagamatsu, S; Hayashi, R				Fujiki, Masahide; Miyamoto, Shimpei; Sakuraba, Minoru; Nagamatsu, Shogo; Hayashi, Ryuichi			Risk factors for tracheal necrosis after total pharyngolaryngectomy	HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK			English	Article						tracheal necrosis; total pharyngolaryngectomy; free jejunal transfer; hypopharyngeal cancer; esophageal cancer	SQUAMOUS-CELL CARCINOMA; RECONSTRUCTION; ESOPHAGECTOMY; HEAD; IRRADIATION; SURGERY; TISSUE; ARTERY	BackgroundTracheal necrosis is a severe complication of total pharyngolaryngectomy (TPL). The purpose of this retrospective study was to identify risk factors for tracheal necrosis after TPL. MethodsWe performed a retrospective chart review of 177 patients who had undergone TPL. The preoperative, operative, and postoperative variables were examined, and possible risk factors for tracheal necrosis were subjected to univariate analysis and multivariate logistic regression. ResultsTracheal necrosis occurred in 35 patients (19.8%), and tracheoesophageal fistula subsequently developed in 3 of these patients. Multivariate logistic regression analysis identified total esophagectomy and diabetes mellitus as significant risk factors for tracheal necrosis after TPL. ConclusionThe findings of this study will be useful for assessing the risk of tracheal necrosis after TPL. In patients at high risk for tracheal necrosis, efforts should be made to preserve the tracheal circulation and to prevent life-threatening sequelae if tracheal necrosis occurs. (c) 2014 Wiley Periodicals, Inc. Head Neck37: 1207-1210, 2015	[Fujiki, Masahide; Sakuraba, Minoru; Nagamatsu, Shogo] Natl Canc Ctr Hosp East, Div Plast & Reconstruct Surg, Chiba, Japan; [Miyamoto, Shimpei] Natl Canc Ctr, Div Plast & Reconstruct Surg, Tokyo, Japan; [Hayashi, Ryuichi] Natl Canc Ctr Hosp East, Div Head & Neck Surg, Chiba, Japan	Fujiki, M (reprint author), Natl Canc Ctr Hosp East, Div Plast & Reconstruct Surg, 6-5-1 Kashiwanoha, Kashiwa, Chiba 2778577, Japan.	masahide-fujiki@umin.ac.jp			National Cancer Center Research and Development Fund [20-A-26]	Contract grant sponsor: This article was supported by the National Cancer Center Research and Development Fund (grant 20-A-26).	ABBEY NC, 1989, CHEST, V95, P459, DOI 10.1378/chest.95.2.459; Allen Mark S, 2003, Chest Surg Clin N Am, V13, P191, DOI 10.1016/S1052-3359(03)00037-1; Clark RAF, 2007, J INVEST DERMATOL, V127, P1018, DOI 10.1038/sj.jid.5700715; Tam JCW, 2011, J ETHNOPHARMACOL, V134, P831, DOI 10.1016/j.jep.2011.01.032; SALASSA JR, 1977, ANN THORAC SURG, V24, P100; MARX RE, 1990, AM J SURG, V160, P519, DOI 10.1016/S0002-9610(05)81019-0; Bartels HE, 1998, BRIT J SURG, V85, P403; Tachimori Y, 2009, J THORAC CARDIOV SUR, V137, P49, DOI 10.1016/j.jtcvs.2008.05.016; Dagan R, 2010, LARYNGOSCOPE, V120, P945, DOI 10.1002/lary.20854; FUJITA H, 1988, JPN J SURG, V18, P77, DOI 10.1007/BF02470850; Ghaisas MM, 2012, INT WOUND J; Maruyama K, 2009, WORLD J SURG, V33, P778, DOI 10.1007/s00268-008-9871-7; McKee D M, 1978, Clin Plast Surg, V5, P305; Minnich DJ, 2006, THORAC SURG CLIN, V17, P571; MIURA T, 1966, SURG GYNECOL OBSTETR, V123, P99; Miyamoto S, 2011, LARYNGOSCOPE, V121, P947, DOI 10.1002/lary.21742; MORAIN WD, 1990, CLIN PLAST SURG, V17, P493; Patel RS, 2010, HEAD NECK-J SCI SPEC, V32, P109, DOI 10.1002/hed.21169; Philippe G, 2012, CRIT CARE RES PRACT, V2012; Pramesh CS, 2004, J SURG ONCOL, V85, P202, DOI 10.1002/jso.20033; REECE GP, 1994, CLIN PLAST SURG, V21, P125; SUMI Y, 1984, PLAST RECONSTR SURG, V74, P385, DOI 10.1097/00006534-198409000-00009; Sun KL, 1997, SURGERY, V122, P15, DOI 10.1016/S0039-6060(97)90258-0; YAMAMOTO Y, 1995, HEAD NECK-J SCI SPEC, V17, P213, DOI 10.1002/hed.2880170308	24	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1043-3074	1097-0347		HEAD NECK-J SCI SPEC	Head Neck-J. Sci. Spec. Head Neck	AUG	2015	37	8					1207	1210		10.1002/hed.23737		4	Otorhinolaryngology; Surgery	Otorhinolaryngology; Surgery	CM8JM	WOS:000357946400023		
J	Takahashi, KH; Blanckenhorn, WU				Takahashi, K. H.; Blanckenhorn, W. U.			Effect of genomic deficiencies on sexual size dimorphism through modification of developmental time in Drosophila melanogaster	HEREDITY			English	Article							BODY-SIZE; PHENOTYPIC PLASTICITY; REACTION NORMS; RENSCHS RULE; WING SIZE; EVOLUTION; ALLOMETRY; INSECTS; COLLECTION; RESOURCE	Sexual size dimorphism (SSD), a difference in body size between sexes, is common in many taxa. In insects, females are larger than males in > 70% of all taxa in most orders. The fruit fly, Drosophila melanogaster is one prominent model organism to investigate SSD since its clear and representative female-biased SSD and its growth regulation are well studied. Elucidating the number and nature of genetic elements that can potentially influence SSD would be helpful in understanding the evolutionary potential of SSD. Here, we investigated the SSD pattern caused by artificially introduced genetic variation in D. melanogaster, and examined whether variation in SSD was mediated by the sex-specific modification of developmental time. To map the genomic regions that had effects on sexual wing size and/or developmental time differences (SDtD), we reanalyzed previously published genome-wide deficiency mapping data to evaluate the effects of 376 isogenic deficiencies covering a total of similar to 67% of the genomic regions of the second and third chromosomes of D. melanogaster. We found genetic variation in SSD and SDtD generated by genomic deficiencies, and a negative genetic correlation between size and development time. We also found SSD and SDtD allometries that are not qualitatively congruent, which however overall at best only partly help in explaining the patterns found. We identified several genomic deficiencies with the tendency to either exaggerate or suppress SSD, in agreement with quantitative genetic null expectations of many loci with small effects. These novel findings contribute to a better understanding of the evolutionary potential of sexual dimorphism.	[Takahashi, K. H.] Okayama Univ, Grad Sch Environm Sci, Kita Ku, Okayama 7008530, Japan; [Blanckenhorn, W. U.] Univ Zurich, Inst Evolutionary Biol & Environm Studies, Zurich, Switzerland	Takahashi, KH (reprint author), Okayama Univ, Grad Sch Environm Sci, Kita Ku, Tsushima Naka 1-1-1, Okayama 7008530, Japan.	kaz_tak@cc.okayama-u.ac.jp			Special Coordination Funds for Promoting Sciences and Technology of The Ministry of Education, Sport, Culture, Science and Technology of Japan;  [KAKENHI 25440212]	This work was financially supported by Special Coordination Funds for Promoting Sciences and Technology of The Ministry of Education, Sport, Culture, Science and Technology of Japan, and a Grant-in-Aid for Scientific Research (KAKENHI 25440212) to KHT.	Stillwell RC, 2010, ANNU REV ENTOMOL, V55, P227, DOI 10.1146/annurev-ento-112408-085500; Ryder E, 2007, GENETICS, V177, P615, DOI 10.1534/genetics.107.076216; Badyaev AV, 2002, TRENDS ECOL EVOL, V17, P369, DOI 10.1016/S0169-5347(02)02569-7; Fairbairn DJ, 1997, ANNU REV ECOL SYST, V28, P659, DOI 10.1146/annurev.ecolsys.28.1.659; STEARNS SC, 1986, EVOLUTION, V40, P893, DOI 10.2307/2408752; Teder T, 2005, OIKOS, V108, P321, DOI 10.1111/j.0030-1299.2005.13609.x; Blanckenhorn WU, 1999, EVOL ECOL, V13, P395, DOI 10.1023/A:1006741222586; Ryder E, 2004, GENETICS, V167, P797, DOI 10.1534/genetics.104.026658; BENJAMINI Y, 1995, J ROY STAT SOC B MET, V57, P289; JAMES AC, 1995, GENETICS, V140, P659; Takahashi KH, 2011, EVOLUTION, V65, P3565, DOI 10.1111/j.1558-5646.2011.01400.x; BERRIGAN D, 1994, J EVOLUTION BIOL, V7, P549, DOI 10.1046/j.1420-9101.1994.7050549.x; Pelabon C, 2013, AM NAT, V181, P195, DOI 10.1086/668820; Gilchrist GW, 2004, EVOLUTION, V58, P768; Blanckenhorn WU, 2007, AM NAT, V169, P245, DOI 10.1086/510597; Blanckenhorn WU, 2007, SEX SIZE GENDER ROLE; CHEVERUD JM, 1982, AM J PHYS ANTHROPOL, V59, P139, DOI 10.1002/ajpa.1330590204; Fairbairn D J., 2007, SEX SIZE GENDER ROLE; Fairbairn DJ, 2005, AM NAT, V166, pS69, DOI 10.1086/444600; Falconer D. S., 1989, INTRO QUANTITATIVE G; Gilchrist AS, 1999, GENETICS, V153, P1775; Huey RB, 2006, ZOOLOGY, V109, P318, DOI 10.1016/j.zool.2006.04.003; LOVICH JE, 1992, GROWTH DEVELOP AGING, V56, P269; Lynch M, 1998, GENETICS ANAL QUANTI; Nunney L, 1996, EVOLUTION, V50, P1193, DOI 10.2307/2410660; Rensch B., 1960, EVOLUTION SPECIES LE; Roff DA, 1997, EVOLUTIONARY QUANTIT; Takahashi KH, 2011, J HERED, V102, P448, DOI 10.1093/jhered/esr026; Teder T, 2014, FUNCT ECOL, V28, P479; Testa ND, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058936	30	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0018-067X	1365-2540		HEREDITY	Heredity	AUG	2015	115	2			SI		140	145		10.1038/hdy.2015.1		6	Ecology; Evolutionary Biology; Genetics & Heredity	Environmental Sciences & Ecology; Evolutionary Biology; Genetics & Heredity	CM9DQ	WOS:000358007200007		
J	Hale, MD; Gotoda, T; Hayden, JD; Grabsch, HI				Hale, Matthew David; Gotoda, Takuji; Hayden, Jeremy David; Grabsch, Heike Irmgard			Endoscopic biopsies from gastrointestinal carcinomas and their suitability for molecular analysis: a review of the literature and recommendations for clinical practice and research	HISTOPATHOLOGY			English	Review						gastrointestinal carcinoma; endoscopic biopsy; molecular profiling	SQUAMOUS-CELL CARCINOMA; MESSENGER-RNA EXPRESSION; GROWTH-FACTOR RECEPTOR; IN-SITU HYBRIDIZATION; SURGICALLY RESECTED SPECIMENS; GASTRIC-CANCER; GENE-EXPRESSION; COLORECTAL-CANCER; ESOPHAGEAL CANCER; PREOPERATIVE BIOPSY	Endoscopic biopsies (EBs) are the gold standard for diagnosing gastrointestinal carcinoma yet no guidelines address EB use for prognostic and predictive molecular testing. This review summarizes the reported quantity and quality of EBs, their relationship with molecular test failure rates and the resultant concordance between EB and resection specimen. Studies reporting molecular testing on gastrointestinal carcinoma EBs published between 2002 and 2014 were identified. Details regarding EB quantity, quality, tumour content, molecular test failure rates as well as causes and concordance with resection specimens were reviewed. Seventy-five studies were identified. Eighteen (24%) reported the mean EB number per patient (median: 2.1, range: 1-6.6 EBs). Sixty-one (81%) reported the frequency of test failure (median: 0%, range: 0-100%). Twenty-two (29%) investigated EB and resection specimen concordance (range: 0-100%). EB quantity and quality affected neither concordance nor failure rate. In summary, few studies currently report EB quantity, EB quality or EB and resection specimen concordance. Reliable molecular testing in EBs appears achievable, and can be representative of resection specimens. Concordance depends upon the testing methodology and biomarker heterogeneity within the tumour. To improve patient care, EB sampling, processing and reporting requires standardization and needs optimization for each biomarker individually.	[Hale, Matthew David; Grabsch, Heike Irmgard] Univ Leeds, Leeds Inst Canc & Pathol, Leeds, W Yorkshire, England; [Gotoda, Takuji] Tokyo Med Univ, Dept Gastroenterol & Hepatol, Tokyo 1608402, Japan; [Hayden, Jeremy David] Leeds Teaching Hosp NHS Trust, St Jamess Inst Oncol, Dept Upper Gastrointestinal Surg, Leeds, W Yorkshire, England; [Grabsch, Heike Irmgard] Maastricht Univ Med Ctr, Dept Pathol, NL-6229 HX Maastricht, Netherlands	Grabsch, HI (reprint author), Maastricht Univ Med Ctr, Dept Pathol, P Debyelaan 25, NL-6229 HX Maastricht, Netherlands.	heike.grabsch@mumc.nl			Yorkshire Cancer Research; Jean Shanks Foundation; Association of Clinical Pathologists; British Division of the International Association of Pathologists	M.H. was funded by bursaries from Yorkshire Cancer Research, The Jean Shanks Foundation, The Association of Clinical Pathologists and the British Division of the International Association of Pathologists.	Suzuki T, 2013, INT J RADIAT ONCOL, V85, P1232, DOI 10.1016/j.ijrobp.2012.09.031; Kim HS, 2013, PATHOBIOLOGY, V80, P127, DOI 10.1159/000346034; Allum WH, 2011, GUT, V60, P1449, DOI 10.1136/gut.2010.228254; Kumarasinghe AP, 2010, PATHOLOGY, V42, P414, DOI 10.3109/00313025.2010.493862; Muller W, 1996, BRIT J CANCER, V74, P759, DOI 10.1038/bjc.1996.433; Galamb O, 2008, CANCER EPIDEM BIOMAR, V17, P2835, DOI 10.1158/1055-9965.EPI-08-0231; Motoori M, 2010, INT J ONCOL, V37, P1113, DOI 10.3892/ijo_00000763; Seymour MT, 2013, LANCET ONCOL, V14, P749, DOI 10.1016/S1470-2045(13)70163-3; Theisen J, 2008, DIS ESOPHAGUS, V21, P601, DOI 10.1111/j.1442-2050.2008.00820.x; Yano T, 2006, ONCOL REP, V15, P65; Kuang RG, 2013, WORLD J GASTROENTERO, V19, P6637, DOI 10.3748/wjg.v19.i39.6637; Affolter K, 2013, GENE CHROMOSOME CANC, V52, P748, DOI 10.1002/gcc.22070; Luthra R, 2006, J CLIN ONCOL, V24, P259, DOI 10.1200/JCO.2005.03.3688; Owonikoko T, 2002, AM J CLIN PATHOL, V117, P558; Yan B, 2011, J CLIN PATHOL, V64, P880, DOI 10.1136/jclinpath-2011-200009; Suceveanu AI, 2009, J GASTROINTEST LIVER, V18, P33; Zsikla V, 2004, J CLIN PATHOL, V57, P654, DOI 10.1136/jcp.2003.013961; Shia JR, 2011, AM J SURG PATHOL, V35, P447, DOI 10.1097/PAS.0b013e31820a091d; Grabsch H, 2010, CELL ONCOL, V32, P57, DOI 10.3233/CLO-2009-0497; Staal EFWC, 2010, EUR J CANCER, V46, P720, DOI 10.1016/j.ejca.2009.12.006; Ruschoff J, 2010, VIRCHOWS ARCH, V457, P299, DOI 10.1007/s00428-010-0952-2; [Anonymous], 1980, TRENDS ENZ HIST CYT, V73; Watanabe T, 2006, CANCER RES, V66, P3370, DOI 10.1158/0008-5472.CAN-05-3834; Li W, 2013, WORLD J GASTROENTERO, V19, P6894, DOI 10.3748/wjg.v19.i40.6894; Shia J, 2013, MODERN PATHOL, V26, P131, DOI 10.1038/modpathol.2012.138; Lee S, 2011, HISTOPATHOLOGY, V59, P832, DOI 10.1111/j.1365-2559.2011.04017.x; Terada T, 2013, INT J CLIN EXP PATHO, V6, P613; Hofmann M, 2008, HISTOPATHOLOGY, V52, P797, DOI 10.1111/j.1365-2559.2008.03028.x; Yoshida H, 2014, VIRCHOWS ARCH, V465, P145, DOI 10.1007/s00428-014-1597-3; Rojo F, 2006, J CLIN ONCOL, V24, P4309, DOI 10.1200/JCO.2005.04.2424; Makino T, 2009, BRIT J CANCER, V101, P1298, DOI 10.1038/sj.bjc.6605313; Smith E, 2014, BRIT J CANCER, V110, P775, DOI 10.1038/bjc.2013.783; Moehler M, 2011, Z GASTROENTEROL, V49, P461, DOI 10.1055/s-0031-1273201; Wang T, 2014, HUM PATHOL, V45, P970, DOI 10.1016/j.humpath.2013.12.010; Okines AFC, 2013, ANN ONCOL, V24, P1253, DOI 10.1093/annonc/mds622; Shah MA, 2011, CLIN CANCER RES, V17, P2693, DOI 10.1158/1078-0432.CCR-10-2203; Arista-Nasr J, 2005, ARCH PATHOL LAB MED, V129, P899; Bang YJ, 2010, LANCET, V376, P687, DOI 10.1016/S0140-6736(10)61121-X; Betts G, 2013, VIRCHOWS ARCH, V464, P145; Beyer BCM, 2006, CANCER-AM CANCER SOC, V106, P1026, DOI 10.1002/cncr.21682; Clarke PA, 2003, CANCER RES, V63, P6855; Dey Biswajit, 2014, J Clin Diagn Res, V8, pFC01, DOI 10.7860/JCDR/2014/7428.4309; Engel KB, 2011, ARCH PATHOL LAB MED, V135, P537, DOI 10.1043/2010-0702-RAIR.1; Evers DL, 2011, J MOL DIAGN, V13, P282, DOI 10.1016/j.jmoldx.2011.01.010; Fadhil W, 2012, HISTOPATHOLOGY, V61, P1117, DOI 10.1111/j.1365-2559.2012.04321.x; Galamb O, 2007, CYTOM PART B-CLIN CY, V72B, P299, DOI 10.1002/cyto.b.20189; Galamb O, 2006, WORLD J GASTROENTERO, V12, P6998; Ghadimi BM, 2005, J CLIN ONCOL, V23, P1826, DOI 10.1200/JCO.2005.00.406; Gomes TS, 2013, PATHOL RES PRACT, V209, P6, DOI 10.1016/j.prp.2012.08.011; Gulmann C, 2003, HISTOPATHOLOGY, V42, P70, DOI 10.1046/j.1365-2559.2003.01556.x; Hironaka S, 2002, CLIN CANCER RES, V8, P124; Hu Y, 2011, BRIT J NUTR, V106, P572, DOI 10.1017/S0007114511000420; Inokuchi K, 1992, GASTRIC CANCER, P88; Ishikawa M, 2005, WORLD J SURG ONCOL, V3, P2, DOI 10.1186/1477-7819-3-2; Kim HK, 2010, J PROTEOME RES, V9, P4123, DOI 10.1021/pr100302b; Kimura M, 2005, JPN J CLIN ONCOL, V35, P324, DOI 10.1093/jjco/hyi089; Komori T, 2008, INT J ONCOL, V32, P367; KOSHIBA M, 1993, PATHOL RES PRACT, V189, P66; Krol LC, 2012, EUR J CANCER, V48, P1108, DOI 10.1016/j.ejca.2012.02.054; Langer R, 2005, CLIN CANCER RES, V11, P7462, DOI 10.1158/1078-0432.CCR-05-0042; Luderer LA, 2012, INT J SURG PATHOL, V20, P355, DOI 10.1177/1066896912437412; Mi YJ, 2013, DIS ESOPHAGUS, V26, P636, DOI 10.1111/dote.12002; Miyazaki I, 2010, WORLD J GASTROENTERO, V16, P4575, DOI 10.3748/wjg.v16.i36.4575; Motoori M, 2009, INT J ONCOL, V35, P265, DOI 10.3892/ijo_00000336; National Comprehensive Cancer Network, 2013, GAST CANC VERS 2 201; National Comprehensive Cancer Network, 2014, COL CANC VERS 3 2014; National Comprehensive Cancer Network, 2013, ES ES JUNCT CANC VER; National Comprehensive Cancer Network, 2014, RECT CANC VERS 3 201; National Institute for Health and Care Excellence, 2004, DYSP MAN DYSP AD PRI; Novelli MR, 2007, DATASET HISTOPATHOLO, V2nd; Nozawa H, 2002, CANCER CHEMOTH PHARM, V49, P267, DOI 10.1007/s00280-002-0422-x; Pirrelli M., 2012, DIGEST DIS SCI, V58, P397; Scottish Intercollegiate Guidelines Network (SIGN), 2011, DIAGN MAN COL CANC; Singhal R, 2013, J PROTEOMICS, V80, P207, DOI 10.1016/j.jprot.2013.01.016; Takahashi N, 2014, ARCH MED RES, V45, P366, DOI 10.1016/j.arcmed.2014.05.004; Takahashi Y, 2002, JPN J CANCER RES, V93, P1258; Terada T, 2013, INT J CLIN EXP PATHO, V6, P630; Terada T, 2013, INT J CLIN EXP PATHO, V6, P191; Ueno T, 2003, CLIN CANCER RES, V9, P5137; van de Velde CJH, 2014, EUR J CANCER, V50, DOI 10.1016/j.ejca.2013.06.048; Vogl TJ, 2013, ROFO-FORTSCHR RONTG, V185, P699, DOI 10.1055/s-0033-1335818; Wierzbicki R, 2011, INVEST NEW DRUG, V29, P167, DOI 10.1007/s10637-009-9341-6; Yamada Y, 2008, CANCER SCI, V99, P2193, DOI 10.1111/j.1349-7006.2008.00935.x; Yang QH, 2012, J CLIN PATHOL, V65, P604, DOI 10.1136/jclinpath-2012-200746; Zauber NP, 2006, DIAGN MOL PATHOL, V15, P162, DOI 10.1097/01.pdm.0000213457.68268.83; Zhang SC, 2006, CLIN CANCER RES, V12, P1735, DOI 10.1158/1078-0432.CCR-05-1982	86	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0309-0167	1365-2559		HISTOPATHOLOGY	Histopathology	AUG	2015	67	2					147	157		10.1111/his.12626		11	Cell Biology; Pathology	Cell Biology; Pathology	CM9BQ	WOS:000358000900001		
J	Tomaru, U; Tsuji, T; Kiuchi, S; Ishizu, A; Suzuki, A; Otsuka, N; Ito, T; Ikeda, H; Fukasawa, Y; Kasahara, M				Tomaru, Utano; Tsuji, Takahiro; Kiuchi, Shizuka; Ishizu, Akihiro; Suzuki, Akira; Otsuka, Noriyuki; Ito, Tomoki; Ikeda, Hitoshi; Fukasawa, Yuichiro; Kasahara, Masanori			Decreased expression of thymus-specific proteasome subunit 5t in Down syndrome patients	HISTOPATHOLOGY			English	Article						Down syndrome; proteasome subunit 5t; thymoproteasome; thymus; trisomy	T-CELL DEVELOPMENT; EPITHELIAL TUMORS; CARDIAC-SURGERY; CHILDREN; SELECTION; THYMOPROTEASOME; SUBSETS; BETA-5T	AimsThe majority of patients with Down syndrome (DS), trisomy 21, have morphologically abnormal thymuses and present with intrinsic immunological abnormalities affecting mainly the cellular immune response. The aim of this study was to examine whether the expression of functionally important molecules is altered in thymic stromal cells in patients with DS. Methods and resultsWe analysed thymic tissues from patients with trisomy 13 (n=4), trisomy 18 (n=14) and trisomy 21 (n=13) for histological alterations, and for the expression of functionally important molecules such as 5t, a thymoproteasome subunit, and cathepsins L and S. In patients with trisomy 13 and trisomy 18, the thymus was morphologically normal or showed only mild depletion of cortical thymocytes. In contrast, the thymus showed variable histological changes in patients with trisomy 21; six of 13 cases showed severe depletion of thymocytes accompanied by the disappearance of thymic lobular architecture. In such thymuses, spindle-shaped keratin-positive cells were densely distributed, and expression of 5t, but not of cathepsin L, was markedly decreased. ConclusionsThe present study suggests that abnormal thymic architecture and decreased expression of functionally important molecules in thymic stromal cells may be involved in immunological abnormalities in DS patients.	[Tomaru, Utano; Kiuchi, Shizuka; Otsuka, Noriyuki; Ito, Tomoki; Kasahara, Masanori] Hokkaido Univ, Grad Sch Med, Dept Pathol, Sapporo, Hokkaido, Japan; [Tsuji, Takahiro; Fukasawa, Yuichiro] Sapporo City Gen Hosp, Dept Diagnost Pathol, Sapporo, Hokkaido, Japan; [Ishizu, Akihiro] Hokkaido Univ, Fac Hlth Sci, Sapporo, Hokkaido, Japan; [Suzuki, Akira] KKR Sapporo Med Ctr, Dept Diagnost Pathol, Sapporo, Hokkaido, Japan; [Ikeda, Hitoshi] Hokkaido Bunkyo Univ, Fac Human Sci, Dept Phys Therapy, Eniwa, Japan	Tomaru, U (reprint author), Kita 15,Nishi 7,Kita Ku, Sapporo, Hokkaido 0608638, Japan.	tomaruu@med.hokudai.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan	We thank Kayo Miyazaki, Junko Tamba and Ken-ichi Nakase for technical support. This work was supported in part by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Takahama Y, 2006, NAT REV IMMUNOL, V6, P127, DOI 10.1038/nri1781; Kusters MAA, 2009, CLIN EXP IMMUNOL, V156, P189, DOI 10.1111/j.1365-2249.2009.03890.x; Eysteinsdottir JH, 2004, CLIN EXP IMMUNOL, V136, P349, DOI 10.1111/j.1365-2249.2004.02437.x; Ripen AM, 2011, EUR J IMMUNOL, V41, P1278, DOI 10.1002/eji.201041375; Anderson G, 2007, NAT REV IMMUNOL, V7, P954, DOI 10.1038/nri2187; Murata S, 2007, SCIENCE, V316, P1349, DOI 10.1126/science.1141915; Nitta T, 2010, IMMUNITY, V32, P29, DOI 10.1016/j.immuni.2009.10.009; HASSOLD TJ, 1984, ANNU REV GENET, V18, P69, DOI 10.1146/annurev.genet.18.1.69; Anderson G, 2012, TRENDS IMMUNOL, V33, P256, DOI 10.1016/j.it.2012.03.005; Habermehl P, 2003, EUR J PEDIATR, V162, P15, DOI 10.1007/s00431-001-0892-6; Kuhn DE, 2008, BIOCHEM BIOPH RES CO, V370, P473, DOI 10.1016/j.bbrc.2008.03.120; LAROCCA LM, 1990, AM J MED GENET, P225; LEVIN S, 1979, PEDIATRICS, V63, P80; Lima FA, 2011, J IMMUNOL, V187, P3422, DOI 10.4049/jimmunol.1003053; Murata S, 2008, CURR OPIN IMMUNOL, V20, P192, DOI 10.1016/j.coi.2008.03.002; Murphy M., 1990, AM J MED GENETIC SS7, V37, P234, DOI 10.1002/ajmg.1320370747; Sommer CA, 2008, GENOME, V51, P19, DOI 10.1139/g07-100; Tomaru U, 2009, BLOOD, V113, P5186, DOI 10.1182/blood-2008-11-187633; Tomaru U, 2013, ARCH IMMUNOL THER EX, V61, P357, DOI 10.1007/s00005-013-0234-1; vansEwijk W, 1994, IMMUNOL TODAY, V15, P214; Yamada Y, 2011, AM J SURG PATHOL, V35, P1296, DOI 10.1097/PAS.0b013e3182237f5d; Yamaguchi T, 2000, SURG TODAY, V30, P875	22	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0309-0167	1365-2559		HISTOPATHOLOGY	Histopathology	AUG	2015	67	2					235	244		10.1111/his.12642		10	Cell Biology; Pathology	Cell Biology; Pathology	CM9BQ	WOS:000358000900010		
J	Katsuya, Y; Yoshida, A; Watanabe, S; Tsuta, K				Katsuya, Yuki; Yoshida, Akihiko; Watanabe, Shun-ichi; Tsuta, Koji			Tumour-to-tumour metastasis from papillary thyroid carcinoma with BRAF mutation to lung adenocarcinoma with EGFR mutation: the utility of mutation-specific antibodies	HISTOPATHOLOGY			English	Article						gene mutation; immunohistochemistry; lung adenocarcinoma; papillary thyroid tumour; tumour-to-tumour metastasis	ADENOID CYSTIC CARCINOMA; CANCER METASTASIS	AimsTumour-to-tumour metastasis is a rare event. The aim of this study is to demonstrate the utility of mutation-specific antibodies to prove the occurrence of metastatic papillary thyroid cancer donor into lung adenocarcinoma recipient. Methods and resultsWe report the case of an 80-year-old woman who had a papillary thyroid carcinoma with a v-raf murine sarcoma viral oncogene homologue B1 mutation that metastasized into a lungadenocarcinoma with an epidermal growth factor receptor mutation. Immunohistochemical analysis with mutation-specific antibodies not only clearly revealed two components, but also revealed their gene mutation statuses. ConclusionsAs a component of multimodal diagnostic tools, immunohistochemistry can avoid some pitfalls involved in the molecular diagnosis of complicated cases (such as our own) and can helptoensure that patients receive optimal treatments.	[Katsuya, Yuki; Yoshida, Akihiko; Tsuta, Koji] Natl Canc Ctr, Div Pathol & Clin Lab, Tokyo 1040045, Japan; [Katsuya, Yuki] Natl Canc Ctr, Dept Thorac Oncol, Tokyo 1040045, Japan; [Watanabe, Shun-ichi] Natl Canc Ctr, Div Thorac Surg, Tokyo 1040045, Japan	Tsuta, K (reprint author), Natl Canc Ctr, Div Pathol & Clin Lab, Chuo Ku, 1-1 Tsukiji 5 Chome, Tokyo 1040045, Japan.	ktsuta@ncc.go.jp			National Cancer Centre Research and Development Fund [26-A-13, 24-A-1];  [25460446]	We would like to thank Sachiko Miura and Chizu Kina for their skilful technical assistance. This work was supported in part by the National Cancer Centre Research and Development Fund (26-A-13 and 24-A-1), and by a Grant-in-Aid for Scientific Research (C) (Grant Number: 25460446).	Hashimoto K, 2011, PATHOL INT, V61, P435, DOI 10.1111/j.1440-1827.2011.02679.x; Li S, 2014, BRIT J CANCER, V110, P2812, DOI 10.1038/bjc.2014.210; Berent W, 1902, ZENTRALBL ALLG PATHO, V13, P406; Blanco M, 2012, REV PORT PNEUMOL, V18, P42, DOI 10.1016/j.rppneu.2011.06.005; Kim KM, 2012, KOREAN J PATHOL, V46, P282, DOI 10.4132/KoreanJPathol.2012.46.3.282; Lin WY, 2010, ANN THORAC SURG, V90, pE59, DOI 10.1016/j.athoracsur.2010.06.063; Matsukuma S, 2013, VIRCHOWS ARCH, V463, P525, DOI 10.1007/s00428-013-1455-8; MORIYA T, 1988, ARCH PATHOL LAB MED, V112, P286; NONOMURA A, 1994, ENDOCR PATHOL, V5, P233, DOI 10.1007/BF02921492; ONUIGBO WIB, 1963, J PATHOL BACTERIOL, V86, P541, DOI 10.1002/path.1700860232; OTTOSSON L, 1968, ACTA PATHOL MIC SC, V73, P481; Piacentini F, 2011, LUNG CANCER, V74, P145, DOI 10.1016/j.lungcan.2011.06.008; Roscoe KJ, 2006, CLIN NUCL MED, V31, P359, DOI 10.1097/01.rlu.0000219081.67943.90; Xue LY, 2013, DIAGN PATHOL, V8, DOI 10.1186/1746-1596-8-26	14	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0309-0167	1365-2559		HISTOPATHOLOGY	Histopathology	AUG	2015	67	2					262	266		10.1111/his.12643		5	Cell Biology; Pathology	Cell Biology; Pathology	CM9BQ	WOS:000358000900013		
J	Savioja, L; Ando, A; Duraiswami, R; Habets, EAP; Spors, S				Savioja, Lauri; Ando, Akio; Duraiswami, Ramani; Habets, Emanuel A. P.; Spors, Sascha			Introduction to the Issue on Spatial Audio	IEEE JOURNAL OF SELECTED TOPICS IN SIGNAL PROCESSING			English	Editorial Material									[Savioja, Lauri] Aalto Univ, Dept Comp Sci, Espoo 02150, Finland; [Ando, Akio] Toyama Univ, Toyama 9300887, Japan; [Duraiswami, Ramani] Univ Maryland, Inst Adv Comp Studies, College Pk, MD 20742 USA; [Habets, Emanuel A. P.] Int Audio Labs Erlangen, D-91058 Erlangen, Germany; [Spors, Sascha] Univ Rostock, Inst Telecommun Engn, D-18051 Rostock, Germany	Savioja, L (reprint author), Aalto Univ, Dept Comp Sci, Espoo 02150, Finland.		Savioja, Lauri/F-3854-2012	Savioja, Lauri/0000-0002-8261-4596				0	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1932-4553	1941-0484		IEEE J-STSP	IEEE J. Sel. Top. Signal Process.	AUG	2015	9	5					767	769		10.1109/JSTSP.2015.2447112		3	Engineering, Electrical & Electronic	Engineering	CM8EW	WOS:000357932100001		
J	Koyama, S; Furuya, K; Haneda, Y; Saruwatari, H				Koyama, Shoichi; Furuya, Ken'ichi; Haneda, Yoichi; Saruwatari, Hiroshi			Source-Location-Informed Sound Field Recording and Reproduction	IEEE JOURNAL OF SELECTED TOPICS IN SIGNAL PROCESSING			English	Article						Sound field reproduction; wave field synthesis; maximum a posteriori (MAP) estimation; super-resolution	FREQUENCY-DOMAIN; ROOM ACOUSTICS; REGULARIZATION	A sound field recording and reproduction method that exploits prior information on the locations of sound sources to be reproduced is proposed. Current methods do not take such prior information into consideration in the transformation from the signals received by microphones into the driving signals of loudspeakers. The proposed method for planar and linear arrays of microphones and loudspeakers optimizes spatial basis functions and their coefficients, which represent the driving signals of loudspeakers, on the basis of the maximum a posteriori (MAP) estimation approach, leading to higher reproduction accuracy above the spatial Nyquist frequency when there are fewer microphones than loudspeakers, i.e., super-resolution in sound field recording and reproduction. Numerical simulations show that the reproduction accuracy at frequencies above the spatial Nyquist frequency was maintained using the proposed method even when there was a mismatch between actual and prior locations of the sound sources to be reproduced.	[Koyama, Shoichi; Saruwatari, Hiroshi] Univ Tokyo, Grad Sch Informat Sci & Technol, Tokyo 1138656, Japan; [Furuya, Ken'ichi] Oita Univ, Fac Engn, Oita 8701192, Japan; [Haneda, Yoichi] Univ Electrocommun, Grad Sch Informat & Engn, Tokyo 1828585, Japan	Koyama, S (reprint author), Univ Tokyo, Grad Sch Informat Sci & Technol, Tokyo 1138656, Japan.	koyama.shoichi@ieee.org; furuya-kenichi@oita-u.ac.jp; haneda.yoichi@uec.ac.jp; hiroshi_saruwatari@ipc.i.u-tokyo.ac.jp					BERKHOUT AJ, 1993, J ACOUST SOC AM, V93, P2764, DOI 10.1121/1.405852; Ahrens J, 2010, IEEE T AUDIO SPEECH, V18, P2038, DOI 10.1109/TASL.2010.2041106; Antoni J, 2012, J ACOUST SOC AM, V131, P2873, DOI 10.1121/1.3685484; ALLEN JB, 1979, J ACOUST SOC AM, V65, P943, DOI 10.1121/1.382599; HANSEN PC, 1993, SIAM J SCI COMPUT, V14, P1487, DOI 10.1137/0914086; MIYOSHI M, 1988, IEEE T ACOUST SPEECH, V36, P145, DOI 10.1109/29.1509; Kirkeby O, 1996, J ACOUST SOC AM, V100, P1584, DOI 10.1121/1.416060; Fazi FM, 2012, ACTA ACUST UNITED AC, V98, P1, DOI 10.3813/AAA.918487; Blauert J., 1996, SPATIAL HEARING PSYC; de Vries D., 2009, AES MONOGRAPH; Gauthier PA, 2005, J ACOUST SOC AM, V117, P662, DOI 10.1121/1.1850032; Hastie T., 2009, ELEMENTS STAT LEARNI; Kaipio J., 2010, STAT COMPUTATIONAL I; KIRKEBY O, 1993, J ACOUST SOC AM, V94, P2992, DOI 10.1121/1.407330; Kolundzija M, 2011, J AUDIO ENG SOC, V59, P721; Koyama S., 2013, P IEEE INT WORKSH AP; Koyama S, 2013, IEEE T AUDIO SPEECH, V21, P685, DOI 10.1109/TASL.2012.2229985; Koyama S, 2012, 2012 IEEE INTERNATIONAL CONFERENCE ON ACOUSTICS, SPEECH AND SIGNAL PROCESSING (ICASSP), P381; NELSON PA, 1994, J SOUND VIB, V177, P447, DOI 10.1006/jsvi.1994.1446; Spors S., 2008, P 124 AES CONV AMST; Van Trees H. L., 2002, OPTIMUM ARRAY PROC 4; Verheijen E. N. G., 1997, THESIS DELFT U TECHN; Williams E. G., 1999, FOURIER ACOUSTICS SO; Woodward P. M., 1964, PROBABILITY INFORM T	24	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1932-4553	1941-0484		IEEE J-STSP	IEEE J. Sel. Top. Signal Process.	AUG	2015	9	5					881	894		10.1109/JSTSP.2015.2434319		14	Engineering, Electrical & Electronic	Engineering	CM8EW	WOS:000357932100011		
J	Wang, DF; Du, X; Wang, X; Ikehara, T; Maeda, R				Wang, Dong F.; Du, Xu; Wang, Xin; Ikehara, Tsuyoshi; Maeda, Ryutaro			Multiplication in Frequencies by Synchronized and Superharmonic Oscillations: Sensing Verification With Picogram Order Microspheres	IEEE SENSORS JOURNAL			English	Article						Frequency multiplication; mass sensing verification; picogram mass perturbation; polystyrene microspheres; coupled micro-cantilevers; synchronized oscillation; super-harmonic oscillation	ATTONEWTON FORCE DETECTION; SILICON CANTILEVERS; RESONATORS; NANOMECHANICS; SENSITIVITY; RESONANCE; GEOMETRY; SYSTEMS; SHIFT; NOISE	The frequency multiplication in a simplified two-cantilever system was characterized and its mass sensing capability was demonstrated. Two microcantilevers similar in cross section but different in length, with primary frequencies of 177.38 kHz [omega(1) of (long) low-frequency cantilever] and 351.66 kHz [omega(2) of (short) high-frequency cantilever], are connected micromechanically with each other by a coupling overhang. In synchronized regime, when the long cantilever is excited at its primary frequency of omega(1), the frequency response of the coupled short cantilever has a peak at double the primary frequency of 2 omega(1) of the long cantilever. While in superharmonic oscillation, the drive frequency of 0.5 omega(2) was multiplied to omega(2) with a higher vibration power along high-frequency cantilever. Mass sensing in picogram order was demonstrated by applying polystyrene microspheres as a small mass perturbation onto the tip of low-frequency cantilever. Comparing with no mass perturbation, almost no frequency shift was observed in superharmonic oscillation although the vibration power decreased slightly, while the frequency shift was multiplied by a factor of n = 2 from 6.13 to 12.26 kHz with a slightly increased vibration power due to synchronized oscillation. A mass of 8.609 pg was then derived for the applied polystyrene microspheres, corresponding to the calculated value of 8.792 pg from geometrical size and chemical density. To the best of our knowledge, this is the first experimental demonstration of synchronized oscillation used for picogram mass sensing, as well as the original comparative study of the frequency multiplication conducted by synchronized oscillation with respect to superharmonic one.	[Wang, Dong F.; Du, Xu; Wang, Xin] Jilin Univ, Sch Mech Sci & Engn, Micro Engn & Micro Syst Lab, Changchun 130025, Peoples R China; [Wang, Dong F.; Ikehara, Tsuyoshi; Maeda, Ryutaro] Natl Inst Adv Ind Sci & Technol, Res Ctr Ubiquitous MEMS & Micro Engn, Tsukuba, Ibaraki 3058564, Japan	Wang, DF (reprint author), Jilin Univ, Sch Mech Sci & Engn, Micro Engn & Micro Syst Lab, Changchun 130025, Peoples R China.	dongfwang@jlu.edu.cn; duxu1411@mails.jlu.edu.cn; wxin@jlu.edu.cn; ikehara.t@aist.go.jp; maeda-ryutaro@aist.go.jp			Japan Society for the Promotion of Science through the Program for World-Leading Innovative Research and Development on Science and Technology (FIRST Program); Council for Science and Technology Policy	This work was supported in part by the Japan Society for the Promotion of Science through the Funding Program for World-Leading Innovative Research and Development on Science and Technology (FIRST Program) and in part by the Council for Science and Technology Policy. The associate editor coordinating the review of this paper and approving it for publication was Prof. Boris Stoeber.	Ono T, 2003, APPL PHYS LETT, V83, P1950, DOI 10.1063/1.1608485; Wang DF, 2013, MICROSYST TECHNOL, V19, P503, DOI 10.1007/s00542-012-1632-8; Stowe TD, 1997, APPL PHYS LETT, V71, P288, DOI 10.1063/1.119522; Shim SB, 2007, SCIENCE, V316, P95, DOI 10.1126/science.1137307; Mamin HJ, 2001, APPL PHYS LETT, V79, P3358, DOI 10.1063/1.1418256; ALBRECHT TR, 1991, J APPL PHYS, V69, P668, DOI 10.1063/1.347347; Wang DF, 2003, APPL PHYS LETT, V83, P3189, DOI 10.1063/1.1616652; Cleland AN, 2002, J APPL PHYS, V92, P2758, DOI 10.1063/1.1499745; Requa M. V., 2006, Applied Physics Letters, V88, DOI 10.1063/1.2216033; Wang DF, 2012, MICROSYST TECHNOL, V18, P773, DOI 10.1007/s00542-012-1521-1; Naeli K, 2009, J APPL PHYS, V105, DOI 10.1063/1.3062204; Wang DF, 2004, NANOTECHNOLOGY, V15, P1851, DOI 10.1088/0957-4484/15/12/028; Zalalutdinov M, 2003, APPL PHYS LETT, V83, P3281, DOI 10.1063/1.1618363; Ekinci KL, 2004, J APPL PHYS, V95, P2682, DOI 10.1063/1.1642738; Ekinci KL, 2004, APPL PHYS LETT, V84, P4469, DOI 10.1063/.1.1755417; Lavrik NV, 2004, REV SCI INSTRUM, V75, P2229, DOI 10.1063/1.1763252; Nayfeh AH, 2005, J MICROMECH MICROENG, V15, P1840, DOI 10.1088/0960-1317/15/10/008; Wang DF, 2010, PROC IEEE MICR ELECT, P703; Becker P, 2013, SENSOR ACTUAT A-PHYS, V202, P155, DOI 10.1016/j.sna.2013.04.030; FILLER RL, 1988, IEEE T ULTRASON FERR, V35, P297, DOI 10.1109/58.20450; Ishinabe H., 2012, P IUMRS ICEM; Ishinabe H., 2012, P 7 IEEE INT C NEMS, P615; NAYFEH AH, 1983, J SOUND VIB, V89, P457, DOI 10.1016/0022-460X(83)90347-4; NAYFEH AH, 1984, J SOUND VIB, V92, P363, DOI 10.1016/0022-460X(84)90385-7; Nayfeh A.H., 1981, INTRO PERTURBATION T; Ono T, 2003, IEEE SENSOR, P825, DOI 10.1109/ICSENS.2003.1279058; Pikovsky A., 2001, SYNCHRONIZATION UNIV; Tang LH, 2011, SMART MATER STRUCT, V20, DOI 10.1088/0964-1726/20/8/085022; Wang DF, 2012, MICRO NANO LETT, V7, P188, DOI 10.1049/mnl.2011.0618; Wang DF, 2012, MICRO NANO LETT, V7, P717, DOI 10.1049/mnl.2012.0389	30	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1530-437X	1558-1748		IEEE SENS J	IEEE Sens. J.	AUG	2015	15	8					4464	4471		10.1109/JSEN.2015.2421312		8	Engineering, Electrical & Electronic; Instruments & Instrumentation; Physics, Applied	Engineering; Instruments & Instrumentation; Physics	CM6MF	WOS:000357802000039		
J	Abo-Zahhad, M; Ahmed, SM; Sabor, N; Sasaki, S				Abo-Zahhad, Mohammed; Ahmed, Sabah M.; Sabor, Nabil; Sasaki, Shigenobu			Mobile Sink-Based Adaptive Immune Energy-Efficient Clustering Protocol for Improving the Lifetime and Stability Period of Wireless Sensor Networks	IEEE SENSORS JOURNAL			English	Article						Wireless sensor networks; immune algorithm; clustering protocols; mobile sink; energy hole problem		Energy hole problem is a critical issue for data gathering in wireless sensor networks. Sensors near the static sink act as relays for far sensors and thus will deplete their energy very quickly, resulting energy holes in the sensor field. Exploiting the mobility of a sink has been widely accepted as an efficient way to alleviate this problem. However, determining an optimal moving trajectory for a mobile sink is a non-deterministic polynomial-time hard problem. Thus, this paper proposed a mobile sink-based adaptive immune energy-efficient clustering protocol (MSIEEP) to alleviate the energy holes. A MSIEEP uses the adaptive immune algorithm (AIA) to guide the mobile sink-based on minimizing the total dissipated energy in communication and overhead control packets. Moreover, AIA is used to find the optimum number of cluster heads (CHs) to improve the lifetime and stability period of the network. The performance of MSIEEP is compared with the previously published protocols; namely, low-energy adaptive clustering hierarchy (LEACH), genetic algorithm-based LEACH, amend LEACH, rendezvous, and mobile sink improved energy-efficient PEGASIS-based routing protocol using MATLAB. Simulation results show that MSIEEP is more reliable and energy efficient as compared with other protocols. Furthermore, it improves the lifetime, the stability, and the instability periods over the previous protocols, because it always selects CHs from high-energy nodes. Moreover, the mobile sink increases the ability of the proposed protocol to deliver packets to the destination.	[Abo-Zahhad, Mohammed; Ahmed, Sabah M.; Sabor, Nabil] Assiut Univ, Dept Elect & Elect Engn, Fac Engn, Asyut 71515, Egypt; [Sasaki, Shigenobu] Niigata Univ, Dept Elect & Elect Engn, Niigata 9502181, Japan	Abo-Zahhad, M (reprint author), Assiut Univ, Dept Elect & Elect Engn, Fac Engn, Asyut 71515, Egypt.	zahhad@yahoo.com; sabahma@yahoo.com; nabil_sabor@aun.edu.eg; sasakish@eng.niigata-u.ac.jp		Abo-Zahhad, M./0000-0002-7926-0037	Egyptian Ministry of Higher Education; Egyptian Cultural and Educational Bureau in Tokyo	The work of N. Sabor was supported in part by the Egyptian Ministry of Higher Education and in part by the Egyptian Cultural and Educational Bureau in Tokyo.	Abo-zahhad M., 2012, J SIGNAL INF PROCESS, V3, P86; Abo-Zahhad Mohammed, 2010, International Journal of Signal and Imaging Systems Engineering, V3, DOI 10.1504/IJSISE.2010.038018; Abbasi AA, 2007, COMPUT COMMUN, V30, P2826, DOI [10.1016/j.comcom.2007.05.024, 10.1016/j.conicom.2007.05.024]; Zhou QL, 2009, PROCEEDINGS OF THE 2009 INTERNATIONAL CONFERENCE ON WIRELESS NETWORKS AND INFORMATION SYSTEMS, P312, DOI 10.1109/WNIS.2009.103; [Anonymous], 2013, WORLD APPL SCI J, DOI DOI 10.5829/idosi.wasj.2013.21.9.175; Basagni S, 2008, WIREL NETW, V14, P831, DOI 10.1007/s11276-007-0017-x; Ahmad A, 2014, IEEE SENS J, V14, P3516, DOI 10.1109/JSEN.2014.2328613; Heinzelman WB, 2002, IEEE T WIREL COMMUN, V1, P660, DOI 10.1109/TWC.2002.804190; Chatzigiannakis L, 2008, COMPUT COMMUN, V31, P896, DOI 10.1016/j.comcom.2007.12.011; Chuang P.-J., 2014, IET WIRELESS SENS SY, V4, P97; Gupta S. K., 2013, INT J ADV RES COMPUT, V2, P3295; Hamida E.B., 2008, IEEE WIREL COMMUN, V15, P31; Kim JW, 2010, IEEE T CONSUM ELECTR, V56, P2310, DOI 10.1109/TCE.2010.5681105; Liang W., 2010, P IEEE GLOB TEL C GL, P1; Liu J. L., 2011, INT J MACHINE LEARNI, V1, P79; Lu X, 2011, INT J MODELL IDENTIF, V12, P119, DOI 10.1504/IJMIC.2011.037840; Mottaghi S., 2014, AEU-INT J ELECTRON C, V69, P507; Nazir B., 2010, P 2010 INT C COMP AP, P624; Rappaport T. S., 2002, WIRELESS COMMUNICATI; Sandhu M. M., 2014, P 9 INT C BWCCA GUAN, P155; Shinghal K., 2011, INT J COMPUTER ENG S, V1, P8; Singh S.K., 2010, Indian Journal of Scientific Research, V1, P63, DOI 10.5121/ijcses.2010.1206; Vijayvargiya K. G., 2012, INT J CURRENT ENG TE, V2, P427	23	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1530-437X	1558-1748		IEEE SENS J	IEEE Sens. J.	AUG	2015	15	8					4576	4586		10.1109/JSEN.2015.2424296		11	Engineering, Electrical & Electronic; Instruments & Instrumentation; Physics, Applied	Engineering; Instruments & Instrumentation; Physics	CM6MF	WOS:000357802000050		
J	Yang, L; Cao, JN; Cheng, H; Ji, YS				Yang, Lei; Cao, Jiannong; Cheng, Hui; Ji, Yusheng			Multi-User Computation Partitioning for Latency Sensitive Mobile Cloud Applications	IEEE TRANSACTIONS ON COMPUTERS			English	Article						Mobile cloud computing; offloading; computation partitioning; job scheduling		Elastic partitioning of computations between mobile devices and cloud is an important and challenging research topic for mobile cloud computing. Existing works focus on the single-user computation partitioning, which aims to optimize the application completion time for one particular single user. These works assume that the cloud always has enough resources to execute the computations immediately when they are offloaded to the cloud. However, this assumption does not hold for large scale mobile cloud applications. In these applications, due to the competition for cloud resources among a large number of users, the offloaded computations may be executed with certain scheduling delay on the cloud. Single user partitioning that does not take into account the scheduling delay on the cloud may yield significant performance degradation. In this paper, we study, for the first time, multi-user computation partitioning problem (MCPP), which considers the partitioning of multiple users' computations together with the scheduling of offloaded computations on the cloud resources. Instead of pursuing the minimum application completion time for every single user, we aim to achieve minimum average completion time for all the users, based on the number of provisioned resources on the cloud. We show that MCPP is different from and more difficult than the classical job scheduling problems. We design an offline heuristic algorithm, namely SearchAdjust, to solve MCPP. We demonstrate through benchmarks that SearchAdjust outperforms both the single user partitioning approaches and classical job scheduling approaches by 10 percent on average in terms of application delay. Based on SearchAdjust, we also design an online algorithm for MCPP that can be easily deployed in practical systems. We validate the effectiveness of our online algorithm using real world load traces.	[Yang, Lei; Cao, Jiannong] Hong Kong Polytech Univ, Dept Comp, Hong Kong, Hong Kong, Peoples R China; [Cheng, Hui] Liverpool John Moores Univ, Sch Comp & Math Sci, Liverpool L3 5UX, Merseyside, England; [Ji, Yusheng] Natl Inst Informat, Informat Syst Architecture Res Div, Tokyo, Japan	Yang, L (reprint author), Hong Kong Polytech Univ, Dept Comp, Hong Kong, Hong Kong, Peoples R China.	csleiyang@comp.polyu.edu.hk; csjcao@comp.polyu.edu.hk; h.cheng@ljmu.ac.uk; kei@nii.ac.jp			Hong Kong RGC under GRF Grant [510412]; Microsoft [H-ZD89]; National High-Technology Research and Development Program (863 Program) of China [2013AA01A212]	The research was partially supported by Hong Kong RGC under GRF Grant 510412, Microsoft under Grant H-ZD89, and the National High-Technology Research and Development Program (863 Program) of China under Grant 2013AA01A212.	Lee YC, 2011, IEEE T PARALL DISTR, V22, P1374, DOI 10.1109/TPDS.2010.208; Satyanarayanan M, 2009, IEEE PERVAS COMPUT, V8, P14, DOI 10.1109/MPRV.2009.82; Kumar K, 2010, COMPUTER, V43, P51, DOI 10.1109/MC.2010.98; Urdaneta G, 2009, COMPUT NETW, V53, P1830, DOI 10.1016/j.comnet.2009.02.019; Lee YC, 2008, IEEE T PARALL DISTR, V19, P1215, DOI 10.1109/TPDS.2007.70815; LAWLER EL, 1966, OPER RES, V14, P699, DOI 10.1287/opre.14.4.699; Chun BG, 2011, EUROSYS 11: PROCEEDINGS OF THE EUROSYS 2011 CONFERENCE, P301; Topcuoglu H, 2002, IEEE T PARALL DISTR, V13, P260, DOI 10.1109/71.993206; Sharma U, 2011, INT CON DISTR COMP S, P559, DOI 10.1109/ICDCS.2011.59; Lowe DG, 2004, INT J COMPUT VISION, V60, P91, DOI 10.1023/B:VISI.0000029664.99615.94; Canepa G., 2010, P 1 ACM WORKSH MOB C, P37; Cuervo E., 2010, P 8 INT C MOB SYST A, P49, DOI DOI 10.1145/1814433.1814441; Darbha S, 1998, IEEE T PARALL DISTR, V9, P87, DOI 10.1109/71.655248; Giurgiu I, 2009, LECT NOTES COMPUT SC, V5896, P83, DOI 10.1007/978-3-642-10445-9_5; Hall LA, 1996, PROCEEDINGS OF THE SEVENTH ANNUAL ACM-SIAM SYMPOSIUM ON DISCRETE ALGORITHMS, P142; KOSTA S, 2012, P IEEE INFOCOM, P945; Kwok YK, 1996, IEEE T PARALL DISTR, V7, P506, DOI 10.1109/71.503776; Li Z., 2001, P INT C COMP ARCH SY, P238; Marinelli E. E., 2009, THESIS CARNEGIE MELL; Pinedo M., 2002, SCHEDULING THEORY AL; Ra M. R., 2011, P 9 INT C MOB SYST A, P43; Yang L., 2012, P IEEE 5 INT C CLOUD, P794; Zhang X., 2009, MOBILE NETW APPL, V16, P379	23	0	0	IEEE COMPUTER SOC	LOS ALAMITOS	10662 LOS VAQUEROS CIRCLE, PO BOX 3014, LOS ALAMITOS, CA 90720-1314 USA	0018-9340	1557-9956		IEEE T COMPUT	IEEE Trans. Comput.	AUG	2015	64	8					2253	2266		10.1109/TC.2014.2366735		14	Computer Science, Hardware & Architecture; Engineering, Electrical & Electronic	Computer Science; Engineering	CM8EG	WOS:000357929500012		
J	Yu, KP; Arifuzzaman, M; Wen, Z; Zhang, D; Sato, T				Yu, Keping; Arifuzzaman, Mohammad; Wen, Zheng; Zhang, Di; Sato, Takuro			A Key Management Scheme for Secure Communications of Information Centric Advanced Metering Infrastructure in Smart Grid	IEEE TRANSACTIONS ON INSTRUMENTATION AND MEASUREMENT			English	Article						Advanced metering infrastructure (AMI); cyber security; information centric network (ICN); key management scheme (KMS); smart grid		Advanced metering infrastructure (AMI), as the totality of systems and networks to measure, collect, store, analyze, and use energy usage data, is supposed to be the core component in smart grid. In AMI, there are numerous challenges among which cyber security is a major one that needs to be addressed with priority. The information centric networking (ICN) is a promising architecture for the future Internet that disseminates content based on named data instead of named hosts. The congestion control and self-security can enable more scalable, secure, collaborative, and pervasive networking, these make the ICN a potential network architecture for smart grid. This paper aims to apply the ICN approach on AMI system, which we termed as information centric AMI (ICN-AMI). To the best of our knowledge, this is the first attempt to distribute contents (or requests for contents) based on ICN in AMI system. Moreover, a simulation-based performance evaluation is employed to evaluate the effectiveness of the proposed ICN-AMI approach in traffic control for developing AMI system in smart grid. In addition, we proposed a novel key management scheme (KMS) for a large number of smart meters in this system to ensure confidentiality, integrality, and authentication. To validate the scheme, the security analysis, comparisons are done to demonstrate that the proposed information centric KMS (ICN-KMS) is possible and a promising solution for ICN-AMI system.	[Yu, Keping; Arifuzzaman, Mohammad; Wen, Zheng; Zhang, Di; Sato, Takuro] Waseda Univ, Grad Sch Global Informat & Telecommun Studies, Tokyo 1690061, Japan	Yu, KP (reprint author), Waseda Univ, Grad Sch Global Informat & Telecommun Studies, Tokyo 1690061, Japan.	yukeping@fuji.waseda.jp			Research and Development on Fundamental and Utilization Technologies for Social Big Data, the Commissioned Research of National Institute of Information and Communications Technology (NICT), Japan	This work was supported by the Research and Development on Fundamental and Utilization Technologies for Social Big Data, the Commissioned Research of National Institute of Information and Communications Technology (NICT), Japan. The Associate Editor coordinating the review process was Dr. Lorenzo Peretto.	Afanasyev A., 2012, NDN0005 U CAL DEP CO; Kim YJ, 2010, IEEE COMMUN MAG, V48, P58, DOI 10.1109/MCOM.2010.5621968; Lee S, 2014, 2014 INTERNATIONAL CONFERENCE ON INFORMATION NETWORKING (ICOIN 2014), P592; Wong CK, 2000, IEEE ACM T NETWORK, V8, P16; Wan ZG, 2014, IEEE T IND ELECTRON, V61, P7055, DOI 10.1109/TIE.2014.2331014; Gennaro R, 1999, LECT NOTES COMPUT SC, V1592, P295; Han D, 2014, 2014 INTERNATIONAL CONFERENCE ON INFORMATION NETWORKING (ICOIN 2014), P214; Ahlgren B, 2012, IEEE COMMUN MAG, V50, P26, DOI 10.1109/MCOM.2012.6231276; Liu NA, 2013, IEEE T IND ELECTRON, V60, P4746, DOI 10.1109/TIE.2012.2216237; Butt M. R., 2012, P 25 IEEE CAN C EL C, P1; Ciancaglini V, 2013, 2013 IEEE 27TH INTERNATIONAL CONFERENCE ON ADVANCED INFORMATION NETWORKING AND APPLICATIONS WORKSHOPS (WAINA), P982, DOI 10.1109/WAINA.2013.19; Cleveland F. M., 2008, P IEEE POW EN SOC GE, P1; DongLi J, 2011, INT C ADV POW SYST A, V1, P26; Ganguly S., 2011, THESIS U COLORADO BO; Groenewald H., 2009, NRS049 ESK; Hashmi M., 2011, P 2011 IEEE PES C 20, P1; Jacobson V., 2009, P 5 INT C EM NETW EX, P1, DOI DOI 10.1145/1658939.1658941; Kamto J, 2011, 2011 IEEE GLOBECOM WORKSHOPS (GC WKSHPS), P1216, DOI 10.1109/GLOCOMW.2011.6162375; Katz R.H., 2011, SUSTAINABLE COMPUTIN, V1, P7, DOI 10.1016/j.suscom.2010.10.001; Kounev V, 2013, IEEE CONF COMPUT, P31; Lee Uichin, 2010, P 1 INT C EN EFF COM, P179, DOI DOI 10.1145/1791314.1791342; Nabeel M, 2012, 2012 IEEE THIRD INTERNATIONAL CONFERENCE ON SMART GRID COMMUNICATIONS (SMARTGRIDCOMM), P324, DOI 10.1109/SmartGridComm.2012.6486004; Ravindran R, 2013, 2013 IFIP/IEEE INTERNATIONAL SYMPOSIUM ON INTEGRATED NETWORK MANAGEMENT (IM 2013), P1102; Selvam C., 2012, P INT C REC TRENDS I, P145; Tang C.-J., 2010, P 1 INT C NETW COMP, P237; Yahgmaee M. H., 2014, P CHALL IMPL ACT DIS, P1; Yu K., 2014, INT C POW SYST TECHN, P2019; Yu K., 2014, P IEEE INT WORKSH AP, P1; Zhang JQ, 2012, 2012 IEEE THIRD INTERNATIONAL CONFERENCE ON SMART GRID COMMUNICATIONS (SMARTGRIDCOMM), P217; Zhang W., 2014, P IEEE 80 VEH TECHN, P1	30	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9456	1557-9662		IEEE T INSTRUM MEAS	IEEE Trans. Instrum. Meas.	AUG	2015	64	8					2072	2085		10.1109/TIM.2015.2444238		14	Engineering, Electrical & Electronic; Instruments & Instrumentation	Engineering; Instruments & Instrumentation	CM8KT	WOS:000357950300005		
J	Saiki, R; Gotoh, H; Toga, K; Miura, T; Maekawa, K				Saiki, R.; Gotoh, H.; Toga, K.; Miura, T.; Maekawa, K.			High juvenile hormone titre and abdominal activation of JH signalling may induce reproduction of termite neotenics	INSECT MOLECULAR BIOLOGY			English	Article						termites; caste differentiation; neotenic reproductives; juvenile hormone	RETICULITERMES-SPERATUS ISOPTERA; BEETLE TRIBOLIUM-CASTANEUM; CASTE DIFFERENTIATION; METHOPRENE-TOLERANT; GENE-EXPRESSION; NASUTITERMES-TAKASAGOENSIS; PRESOLDIER DIFFERENTIATION; SOLDIER DIFFERENTIATION; ZOOTERMOPSIS-NEVADENSIS; OVARIAN DEVELOPMENT	Termite castes are a key example of polyphenism, in which reproductive division of labour is clearly seen in colonies. The reproductive castes in termites include primary and neotenic reproductives; primary reproductives found a new colony whereas neotenics succeed them in the reproductive role when the primary reproductives die or become senescent. Neotenics usually differentiate from nymphs or workers by developing functional gonads while retaining juvenile characteristics; however, the developmental mechanism during neotenic differentiation remains poorly understood. Juvenile hormone (JH) mediates a number of aspects of developmental regulation in caste differentiation in termites. In the present study we quantified JH titres in neotenic reproductives of Reticulitermes speratus, and compared these with other developmental stages. In addition, expression changes in JH signalling gene homologues (Methoprene-tolerant [Met], Kruppel-homolog1, Broad-Complex) in the head, thorax and abdomen were investigated during neotenic differentiation. Finally, we examined the function of Met in reproduction of neotenics by RNA interference (RNAi). Our results showed that the JH titres of neotenics were significantly higher than those of nymphs and workers. JH signalling genes were highly expressed in neotenic abdomens, compared with those in workers and nymphs. Met RNAi resulted in the inhibition of vitellogenin gene expression in newly moulted neotenics. These results suggest that the fertility of neotenics might be controlled by a large increase of JH titres and body-part-specific activation of JH signalling pathways.	[Saiki, R.; Toga, K.; Maekawa, K.] Toyama Univ, Grad Sch Sci & Engn, Dept Biol, Toyama 9308555, Japan; [Gotoh, H.] Washington State Univ, Dept Entomol, Pullman, WA 99164 USA; [Gotoh, H.; Miura, T.] Hokkaido Univ, Grad Sch Environm Sci, Lab Ecol Genet, Sapporo, Hokkaido 0600810, Japan; [Gotoh, H.; Toga, K.] Nagoya Univ, Grad Sch Bioagr Sci, Lab Sericulture & Entomoresources, Nagoya, Aichi 4668550, Japan	Maekawa, K (reprint author), Toyama Univ, Grad Sch Sci & Engn, 3190 Gofuku, Toyama 9308555, Japan.	kmaekawa@sci.u-toyama.ac.jp			Japan Society for the Promotion of Science [10120, 25251041, 24570022, 25128705]	We are grateful to Nathan Lo (The University of Sydney) who corrected the English in the manuscript and gave us valuable comments. We thank Tsutomu Tsuchida, Satoshi Miyazaki, Akiko Fujiwara, Hiroaki Matsuzawa, Dai Watanabe, Hajime Yaguchi, Yutaka Hashimoto, Yudai Masuoka and Shutaro Hanmoto (University of Toyama) for their help during both field and laboratory work. This study was supported in part by Grant-in-Aids for JSPS Fellows (No. 10120 to RS) and Scientific Research (No. 25251041 to TM, Nos. 24570022 and 25128705 to KM) from the Japan Society for the Promotion of Science.	Charles JP, 2011, P NATL ACAD SCI USA, V108, P21128, DOI 10.1073/pnas.1116123109; Miura T, 2011, BIOLOGY OF TERMITES: A MODERN SYNTHESIS, P211, DOI 10.1007/978-90-481-3977-4_9; Tsuchiya M, 2008, APPL ENTOMOL ZOOL, V43, P307, DOI 10.1303/aez.2008.307; Nijhout HF, 2003, EVOL DEV, V5, P9, DOI 10.1046/j.1525-142X.2003.03003.x; Li M, 2011, P NATL ACAD SCI USA, V108, P638, DOI 10.1073/pnas.1013914108; Toga K, 2012, EVOL DEV, V14, P286, DOI 10.1111/j.1525-142X.2012.00545.x; Laine LV, 2003, B ENTOMOL RES, V93, P267, DOI 10.1079/BER2003238; Maekawa K, 2010, PHYSIOL ENTOMOL, V35, P52, DOI 10.1111/j.1365-3032.2009.00711.x; Saiki R, 2014, ZOOL SCI, V31, P573, DOI 10.2108/zs140083; Konopova B, 2008, DEVELOPMENT, V135, P559, DOI 10.1242/dev.016097; Korb J, 2009, EVOL DEV, V11, P269, DOI 10.1111/j.1525-142X.2009.00329.x; Cornette R, 2008, J INSECT PHYSIOL, V54, P922, DOI 10.1016/j.jinsphys.2008.04.017; Minakuchi C, 2009, DEV BIOL, V325, P341, DOI 10.1016/j.ydbio.2008.10.016; Smykal V, 2014, INSECT BIOCHEM MOLEC, V45, P69, DOI 10.1016/j.ibmb.2013.12.003; Matsuura K, 2009, SCIENCE, V323, P1687, DOI 10.1126/science.1169702; Maekawa K, 2014, AUSTRAL ENTOMOL, V53, P138, DOI 10.1111/aen.12060; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Elliott KL, 2007, GEN COMP ENDOCR, V152, P102, DOI 10.1016/j.ygcen.2007.03.003; Watanabe D, 2011, J INSECT PHYSIOL, V57, P791, DOI 10.1016/j.jinsphys.2011.03.005; Minakuchi C, 2008, MECH DEVELOP, V125, P91, DOI 10.1016/j.mod.2007.10.002; Shimada K, 2010, J INSECT PHYSIOL, V56, P1118, DOI 10.1016/j.jinsphys.2010.03.011; Matsuura K, 2010, P NATL ACAD SCI USA, V107, P12963, DOI 10.1073/pnas.1004675107; Toga K, 2009, ZOOL SCI, V26, P382, DOI 10.2108/zsj.26.382; Konopova B, 2007, P NATL ACAD SCI USA, V104, P10488, DOI 10.1073/pnas.0703719104; Bordereau C, 1985, CASTE DIFFERENTIATIO, P221, DOI DOI 10.1016/B978-0-08-030783-1.50021-5; Gilbert LI, 2000, INSECT BIOCHEM MOLEC, V30, P617, DOI 10.1016/S0965-1748(00)00034-5; Hayashi Y., 2013, PLOS ONE, V8, P1; Henderson Gregg, 1998, P314; Hojo M, 2011, ARCH INSECT BIOCHEM, V77, P17, DOI 10.1002/arch.20415; Howard R.W., 1979, Sociobiology, V4, P269; Huang J. H., 2012, BIOCHIM BIOPHYS ACTA, V1830, P2178; Ishitani K, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.19401; Konopova B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028728; Lozano J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103614; Maekawa K, 2008, ZOOL SCI, V25, P699, DOI 10.2108/zsj.25.699; Marchal E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106737; Matsuura K, 2004, INSECT SOC, V51, P325, DOI 10.1007/s00040-004-0746-0; Minakuchi C., 2008, DEV BIOL, V325, P341; Miura K, 2005, FEBS J, V272, P1169, DOI 10.1111/j.1742-4658.2005.04552.x; Miura T, 2003, J MORPHOL, V257, P22, DOI 10.1002/jmor.10100; Miyazaki S, 2014, BMC EVOL BIOL, V14, DOI 10.1186/s12862-014-0177-0; Nijhout HF, 1994, INSECT HORMONES; Noirot C., 1990, P5; Noirot C, 1985, CASTE DETERMINATION, P59; Okot-Korber M., 1980, MACROTERMES MICHAELS, V5, P407; Jindra M, 2013, ANNU REV ENTOMOL, V58, P181, DOI 10.1146/annurev-ento-120811-153700; Roisin Y, 2000, TERMITES: EVOLUTION, SOCIALITY, SYMBIOSES, ECOLOGY, P95; Saiki R, 2011, SOCIOBIOLOGY, V58, P499; Scharf ME, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r62; Shimizu K., 1970, MIYAZAKI U FAC AGR B, V17, P1; Takematsu Y., 1992, KONCHUU, V60, P67; Thorne BL, 1996, SOCIOBIOLOGY, V28, P253; Vandesompele J., 2002, GENOME BIOL, V18, P3, DOI DOI 10.1186/GB-2002-3-7-RESEARCH0034; Watanabe D, 2008, SOCIOBIOLOGY, V52, P437; ZIMET M, 1982, SOCIOBIOLOGY, V7, P1	55	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0962-1075	1365-2583		INSECT MOL BIOL	Insect Mol. Biol.	AUG	2015	24	4					432	441		10.1111/imb.12169		10	Biochemistry & Molecular Biology; Entomology	Biochemistry & Molecular Biology; Entomology	CM7OG	WOS:000357883500004		
J	Hoste, E; Bagshaw, S; Bellomo, R; Cely, C; Colman, R; Cruz, D; Edipidis, K; Forni, L; Gomersall, C; Govil, D; Honore, PM; Joannes-Boyau, O; Joannidis, M; Korhonen, AM; Lavrentieva, A; Mehta, R; Palevsky, P; Roessler, E; Ronco, C; Uchino, S; Vazquez, J; Vidal Andrade, E; Webb, S; Kellum, J				Hoste, Eric A. J.; Bagshaw, Sean M.; Bellomo, Rinaldo; Cely, Cynthia M.; Colman, Roos; Cruz, Dinna N.; Edipidis, Kyriakos; Forni, Lui G.; Gomersall, Charles D.; Govil, Deepak; Honore, Patrick M.; Joannes-Boyau, Olivier; Joannidis, Michael; Korhonen, Anna-Maija; Lavrentieva, Athina; Mehta, Ravindra L.; Palevsky, Paul; Roessler, Eric; Ronco, Claudio; Uchino, Shigehiko; Vazquez, Jorge A.; Vidal Andrade, Erick; Webb, Steve; Kellum, John A.			Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study	INTENSIVE CARE MEDICINE			English	Article						Acute kidney injury; Critically ill; Renal replacement therapy; Epidemiology; Kidney function; Hospital mortality	RENAL REPLACEMENT THERAPY; GLOMERULAR-FILTRATION; 90-DAY MORTALITY; RISK-FACTORS; FAILURE; ICU; CLASSIFICATION; DEFINITION; CREATININE; PROGNOSIS	Current reports on acute kidney injury (AKI) in the intensive care unit (ICU) show wide variation in occurrence rate and are limited by study biases such as use of incomplete AKI definition, selected cohorts, or retrospective design. Our aim was to prospectively investigate the occurrence and outcomes of AKI in ICU patients. The Acute Kidney Injury-Epidemiologic Prospective Investigation (AKI-EPI) study was an international cross-sectional study performed in 97 centers on patients during the first week of ICU admission. We measured AKI by Kidney Disease: Improving Global Outcomes (KDIGO) criteria, and outcomes at hospital discharge. A total of 1032 ICU patients out of 1802 [57.3 %; 95 % confidence interval (CI) 55.0-59.6] had AKI. Increasing AKI severity was associated with hospital mortality when adjusted for other variables; odds ratio of stage 1 = 1.679 (95 % CI 0.890-3.169; p = 0.109), stage 2 = 2.945 (95 % CI 1.382-6.276; p = 0.005), and stage 3 = 6.884 (95 % CI 3.876-12.228; p < 0.001). Risk-adjusted rates of AKI and mortality were similar across the world. Patients developing AKI had worse kidney function at hospital discharge with estimated glomerular filtration rate less than 60 mL/min/1.73 m(2) in 47.7 % (95 % CI 43.6-51.7) versus 14.8 % (95 % CI 11.9-18.2) in those without AKI, p < 0.001. This is the first multinational cross-sectional study on the epidemiology of AKI in ICU patients using the complete KDIGO criteria. We found that AKI occurred in more than half of ICU patients. Increasing AKI severity was associated with increased mortality, and AKI patients had worse renal function at the time of hospital discharge. Adjusted risks for AKI and mortality were similar across different continents and regions.	[Hoste, Eric A. J.] Univ Ghent, Ghent Univ Hosp, Dept Intens Care Med, B-9000 Ghent, Belgium; [Hoste, Eric A. J.] Res Fdn Flanders, Brussels, Belgium; [Hoste, Eric A. J.; Kellum, John A.] Univ Pittsburgh, Sch Med, Dept Crit Care Med, Clin Res Invest & Syst Modelling Acute Illnes CRI, Pittsburgh, PA USA; [Bagshaw, Sean M.] Univ Alberta, Fac Med & Dent, Div Crit Care Med, Edmonton, AB, Canada; [Bellomo, Rinaldo] Austin Hosp, Dept Intens Care, Melbourne, Vic 3084, Australia; [Cely, Cynthia M.] Univ Miami, Miller Sch Med, Div Pulm Crit Care & Sleep Med, Miami, FL 33136 USA; [Colman, Roos] Univ Ghent, Dept Publ Hlth, B-9000 Ghent, Belgium; [Cruz, Dinna N.] Univ Calif San Diego, Dept Med, Div Nephrol Hypertens, San Diego, CA 92103 USA; [Edipidis, Kyriakos] Hygeia Med Ctr, Athens, Greece; [Forni, Lui G.] Univ Surrey, Fac Hlth & Med Sci, Dept Intens Care Med, Guildford GU2 7TE, Surrey, England; [Forni, Lui G.] Univ Surrey, Surrey Peri Operat Anaesthesia Crit Care Res Grp, Royal Surrey Cty Hosp NHS Fdn Trust, Guildford GU2 7TE, Surrey, England; [Gomersall, Charles D.] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Anaesthesia & Intens Care, Hong Kong, Hong Kong, Peoples R China; [Govil, Deepak] Medanta, Inst Crit Care & Anesthesia, Gurgaon, India; [Honore, Patrick M.] VUB Univ, Univ Ziekenhuis Brussel, Dept Intens Care, Brussels, Belgium; [Joannes-Boyau, Olivier] CHU Bordeaux, Serv Anesthesie Reanimat 2, F-33000 Bordeaux, France; [Joannidis, Michael] Med Univ Innsbruck, Dept Internal Med, Div Intens Care & Emergency Med, A-6020 Innsbruck, Austria; [Korhonen, Anna-Maija] Meilahti Univ Hosp, Cent Hosp, Dept Surg, Intens Care Unit,Div Anaesthesia & Intens Care Me, Helsinki, Finland; [Korhonen, Anna-Maija] Univ Helsinki, Dept Clin Sci, Helsinki, Finland; [Lavrentieva, Athina] Papanikolaou Gen Hosp, Burn ICU, Thessaloniki, Greece; [Mehta, Ravindra L.] Univ Calif San Diego, Dept Med, Med Ctr, San Diego, CA 92103 USA; [Palevsky, Paul] VA Pittsburgh Healthcare Syst, Renal Sect, Pittsburgh, PA USA; [Palevsky, Paul] Univ Pittsburgh, Sch Med, Dept Med, Renal Electrolyte Div, Pittsburgh, PA 15213 USA; [Palevsky, Paul; Kellum, John A.] Univ Pittsburgh, Sch Med, Dept Crit Care Med, Ctr Crit Care Nephrol, Pittsburgh, PA 15213 USA; [Roessler, Eric] Pontificia Univ Catolica Chile, Fac Med, Dept Nephrol, Santiago, Chile; [Ronco, Claudio] San Bortolo Hosp, Int Renal Res Inst, Dept Nephrol Dialysis & Transplantat, Vicenza, Italy; [Uchino, Shigehiko] Jikei Univ, Sch Med, Dept Anesthesiol, Intens Care Unit, Tokyo, Japan; [Vazquez, Jorge A.] Clin Modelo Lanus, Dept Crit Care Med, Buenos Aires, DF, Argentina; [Vidal Andrade, Erick] Hosp Angeles Lomas, Dept Crit Care Med, Mexico City, DF, Mexico; [Webb, Steve] Univ Western Australia, Dept Crit Care Med, Perth, WA 6009, Australia; [Webb, Steve] Royal Perth Hosp, Perth, WA 6001, Australia	Hoste, E (reprint author), Univ Ghent, Ghent Univ Hosp, Dept Intens Care Med, De Pintelaan 185, B-9000 Ghent, Belgium.	eric.hoste@ugent.be		Hoste, Eric/0000-0001-9301-8055	Astute Medical; Industrial Research Fund (IOF) from Ghent University; Gambro; BBraun; Fresenius; Baxter; Alere; AM Pharma; Spectral; Grifols; Cytosorbents; Alung; Atox Bio; Bard; Kaneka; International Safety Adverse Events Consortium; Thrasos	EH received speakers fee from Astute Medical, and an Industrial Research Fund (IOF) from Ghent University for a validation study on a biomarker for AKI. SMB has consulted for and received honoraria from Gambro-Baxter. CG has received sponsorship for an academic conference from Gambro. OJB has received grants and non-financial support from Gambro, BBraun, Fresenius, and Astute Medical. MJ has consulted for and received honoraria from Baxter, Gambro, Fresenius, CLS Behring, BBraun, AM Pharma, Sanofi, Astute. JK has received grant support and/or consulting fees from Fresenius, Gambro, Baxter, Astute Medical, Alere, AM Pharma, Spectral, Grifols, Cytosorbents, Alung, Atox Bio, Bard, Kaneka. RM has received grants from the International Safety Adverse Events Consortium and Thrasos, he has options in Astute Medical and served in the scientific advisory board for trials for Abbvie, AM Pharma, and Eli Lilly, and consulted for CSL Behring, GSK, Baxter, Sova, Astellas, and Sanofi-Aventis. PP has consulted for Complexa Inc. SW is Director and Shareholder of Aalix Healthcare Services Consulting, which has provided services related to AKI.	Altman D. G., 2000, STAT CONFIDENCE CONF; Reynvoet E, 2009, CRIT CARE MED, V37, P2203, DOI 10.1097/CCM.0b013e3181a03961; Nisula S, 2013, INTENS CARE MED, V39, P420, DOI 10.1007/s00134-012-2796-5; Li X, 2009, CURR OPIN CRIT CARE, V15, P481, DOI 10.1097/MCC.0b013e328332f69e; Siew ED, 2010, KIDNEY INT, V77, P536, DOI 10.1038/ki.2009.479; Mehta RL, 2011, INTENS CARE MED, V37, P241, DOI 10.1007/s00134-010-2089-9; Udy AA, 2013, INTENS CARE MED, V39, P2070, DOI 10.1007/s00134-013-3088-4; Singbartl K, 2012, KIDNEY INT, V81, P819, DOI 10.1038/ki.2011.339; Schneider AG, 2012, NEPHROL DIAL TRANSPL, V27, P947, DOI [10.1093/ndt/gfr501, 10.1093/ndt/gfr50]; Levey AS, 2009, ANN INTERN MED, V150, P604; Bellomo R, 2012, LANCET, V380, P756, DOI 10.1016/S0140-6736(11)61454-2; De Waele JJ, 2014, INTENS CARE MED, V40, P1340, DOI 10.1007/s00134-014-3403-8; Murugan R, 2011, NAT REV NEPHROL, V7, P209, DOI 10.1038/nrneph.2011.13; Lameire NH, 2013, LANCET, V382, P170, DOI 10.1016/S0140-6736(13)60647-9; Carlier M, 2015, INTENS CARE MED, V41, P427, DOI 10.1007/s00134-014-3641-9; Mandelbaum T, 2011, CRIT CARE MED, V39, P2659, DOI 10.1097/CCM.0b013e3182281f1b; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; Uchino S, 2001, INTENS CARE MED, V27, P1037, DOI 10.1007/s001340100953; Grams ME, 2014, CLIN J AM SOC NEPHRO, V9, P682, DOI 10.2215/CJN.07650713; Zavada J, 2010, NEPHROL DIAL TRANSPL, V25, P3911, DOI 10.1093/ndt/gfp766; Chawla LS, 2014, NEW ENGL J MED, V371, P58, DOI 10.1056/NEJMra1214243; Kellum JA, 2004, CRIT CARE, V8, P331, DOI 10.1186/cc2900; Uchino S, 2005, JAMA-J AM MED ASSOC, V294, P813, DOI 10.1001/jama.294.7.813; Moreno RP, 2005, INTENS CARE MED, V31, P1345, DOI 10.1007/s00134-005-2763-5; Bellomo R, 2004, CRIT CARE, V8, pR204, DOI 10.1186/cc2872; Disease Kidney: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group, 2012, KIDNEY INT S, V2, P1; Elseviers MM, 2010, CRIT CARE, V14, DOI 10.1186/cc9355; Hoste EA, 2006, CRIT CARE, V10, pR73; Hoste EAJ, 2008, CRIT CARE MED, V36, pS146, DOI 10.1097/CCM.0b013e318168c590; Hoste EAJ, 2004, J AM SOC NEPHROL, V15, P454, DOI 10.1097/01.ASN.0000110182.14608.0C; Hoste EAJ, 2011, CONTRIB NEPHROL, V174, P56, DOI 10.1159/000329236; Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713; National Confidential Enquiry into Patient Outcome and Death, 2009, AC KIDN INJ ADD INS; Schetz M, 2014, INTENS CARE MED, V40, P1709, DOI 10.1007/s00134-014-3487-1; Siew ED, 2015, KIDNEY INT, V87, P46, DOI 10.1038/ki.2014.293; The World Bank, 2014, COUNTR EC; United Nations, 2013, COMP MACR CONT REG G; Vaara ST, 2012, CRIT CARE, V16, DOI 10.1186/cc11682; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; World Health Organisation, 2014, GLOB HLTH EXP DAT QU	40	5	5	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0342-4642	1432-1238		INTENS CARE MED	Intensive Care Med.	AUG	2015	41	8					1411	1423		10.1007/s00134-015-3934-7		13	Critical Care Medicine	General & Internal Medicine	CM9VI	WOS:000358057000003		
J	Zakaria, MN; Takeshita, T; Shibata, Y; Maeda, H; Wada, N; Akamine, A; Yamashita, Y				Zakaria, M. N.; Takeshita, T.; Shibata, Y.; Maeda, H.; Wada, N.; Akamine, A.; Yamashita, Y.			Microbial community in persistent apical periodontitis: a 16S rRNA gene clone library analysis	INTERNATIONAL ENDODONTIC JOURNAL			English	Article						16S rRNA; apical periodontitis; clone library	ROOT-FILLED TEETH; FAILED ENDODONTIC TREATMENT; PORPHYROMONAS-GINGIVALIS; FUSOBACTERIUM-NUCLEATUM; ENTEROCOCCUS-FAECALIS; EXTRARADICULAR BIOFILM; BACTERIAL-FLORA; MOLECULAR CHARACTERIZATION; PERIRADICULAR LESIONS; PERIAPICAL LESIONS	AimTo characterize the microbial composition of persistent periapical lesions of root filled teeth using a molecular genetics approach. MethodologyApical lesion samples were collected from 12 patients (23-80years old) who visited the Kyushu University Hospital for apicectomy with persistent periapical lesions associated with root filled teeth. DNA was directly extracted from each sample and the microbial composition was comprehensively analysed using clone library analysis of the 16S rRNA gene. Enterococcus faecalis, Candida albicans and specific fimA genotypes of Porphyromonas gingivalis were confirmed using polymerase chain reaction (PCR) analysis with specific primers. ResultsBacteria were detected in all samples, and the dominant findings were P.gingivalis (19.9%), Fusobacterium nucleatum (11.2%) and Propionibacterium acnes (9%). Bacterial diversity was greater in symptomatic lesions than in asymptomatic ones. In addition, the following bacteria or bacterial combinations were characteristic to symptomatic lesions: Prevotella spp., Treponema spp., Peptostreptococcaceae sp. HOT-113, Olsenella uli, Slackia exigua, Selemonas infelix, P.gingivalis with type IV fimA, and a combination of P.gingivalis, F.nucleatum, and Peptostreptococcaceae sp. HOT-113 and predominance of Streptococcus spp. On the other hand, neither Enterococcus faecalis nor C. albicans were detected in any of the samples. ConclusionWhilst a diverse bacterial species were observed in the persistent apical lesions, some characteristic patterns of bacterial community were found in the symptomatic lesions. The diverse variation of community indicates that bacterial combinations as a community may cause persistent inflammation in periapical tissues rather than specific bacterial species.	[Zakaria, M. N.; Takeshita, T.; Shibata, Y.; Yamashita, Y.] Kyushu Univ, Sect Prevent & Publ Hlth Dent, Div Oral Hlth Growth & Dev, Fac Dent Sci, Fukuoka 8128582, Japan; [Zakaria, M. N.; Maeda, H.; Wada, N.; Akamine, A.] Kyushu Univ, Div Oral Rehabil, Dept Endodontol & Operat Dent, Fac Dent Sci, Fukuoka 8128582, Japan; [Zakaria, M. N.] Jenderal Achmad Yani Univ, Fac Med, Bandung, Indonesia	Yamashita, Y (reprint author), Kyushu Univ, Sect Prevent & Publ Hlth Dent, Div Oral Hlth Growth & Dev, Fac Dent Sci,Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	yoshi@dent.kyushu-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [25463249, 25293428]; Ministry of Education and Culture, Directorate of Higher Education (DIKTI), Republic of Indonesia; Faculty of Medicine, Jenderal Achmad Yani University, Indonesia	This study was supported in part by Grants-in Aid for Scientific Research 25463249 (T. T.) and 25293428 (Y. Y.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The first author is grateful to the Ministry of Education and Culture, Directorate of Higher Education (DIKTI), Republic of Indonesia for doctoral scholarship and to the Faculty of Medicine, Jenderal Achmad Yani University, Indonesia for supporting doctoral study.	Saito A, 2008, FEMS IMMUNOL MED MIC, V54, P349, DOI 10.1111/j.1574-695X.2008.00481.x; Molander A, 1998, INT ENDOD J, V31, P1, DOI 10.1046/j.1365-2591.1998.t01-1-00111.x; Baca P, 2011, J ENDODONT, V37, P363, DOI 10.1016/j.joen.2010.11.036; Zoletti GO, 2006, J ENDODONT, V32, P722, DOI 10.1016/j.joen.2006.02.001; Brundin M, 2010, ORAL SURG ORAL MED O, V110, P789, DOI 10.1016/j.tripleo.2010.07.010; Noguchi N, 2005, APPL ENVIRON MICROB, V71, P8738, DOI 10.1128/AEM.71.12.8738-8743.2005; Nakagawa I, 2000, J CLIN MICROBIOL, V38, P1909; Amano A, 1999, J CLIN MICROBIOL, V37, P1426; Waltimo TMT, 1997, INT ENDOD J, V30, P96, DOI 10.1111/j.1365-2591.1997.tb00681.x; Luo GZ, 2002, J CLIN MICROBIOL, V40, P2860, DOI 10.1128/JCM.40.8.2860-2865.2002; Pinheiro ET, 2003, INT ENDOD J, V36, P1, DOI 10.1046/j.1365-2591.2003.00603.x; Stuart CH, 2006, J ENDODONT, V32, P93, DOI 10.1016/j.joen.2005.10.049; Takeshita T, 2009, ISME J, V3, P65, DOI 10.1038/ismej.2008.91; Peciuliene V, 2001, INT ENDOD J, V34, P429, DOI 10.1046/j.1365-2591.2001.00411.x; Zhu XF, 2010, J ENDODONT, V36, P1950, DOI 10.1016/j.joen.2010.08.053; Perry A, 2011, EXPERT REV ANTI-INFE, V9, P1149, DOI [10.1586/eri.11.137, 10.1586/ERI.11.137]; Sunde PT, 2002, J ENDODONT, V28, P304, DOI 10.1097/00004770-200204000-00011; Waltimo TMT, 2003, CRIT REV ORAL BIOL M, V14, P128; Ricucci D, 2008, J ENDODONT, V34, P1124, DOI 10.1016/j.joen.2008.06.002; Metzger Z, 2009, J ENDODONT, V35, P82, DOI 10.1016/j.joen.2008.10.011; Siqueira JF, 2004, ORAL SURG ORAL MED O, V97, P85, DOI 10.1016/S1079-2104(03)00353-6; Wang J, 2012, J ENDODONT, V38, P954, DOI 10.1016/j.joen.2012.03.004; Sundqvist G, 1998, ORAL SURG ORAL MED O, V85, P86, DOI 10.1016/S1079-2104(98)90404-8; Han YW, 2000, INFECT IMMUN, V68, P3140, DOI 10.1128/IAI.68.6.3140-3146.2000; Amano A, 2000, J DENT RES, V79, P1664; de Paz LC, 2007, J ENDODONT, V33, P652, DOI 10.1016/j.joen.2006.11.004; Siqueira JF, 2008, J ENDODONT, V34, P1291, DOI 10.1016/j.joen.2008.07.028; Nair PNR, 2004, CRIT REV ORAL BIOL M, V15, P348; Ates M, 2005, ORAL SURG ORAL MED O, V100, P626, DOI 10.1016/j.tripleo.2005.03.004; Ercan Ertuğrul, 2006, Oral Surg Oral Med Oral Pathol Oral Radiol Endod, V102, pe27, DOI 10.1016/j.tripleo.2006.02.022; Fujii R, 2009, ORAL MICROBIOL IMMUN, V24, P502, DOI 10.1111/j.1399-302X.2009.00534.x; GOMES BPFA, 1994, INT ENDOD J, V27, P291, DOI 10.1111/j.1365-2591.1994.tb00271.x; Handal T, 2009, J ORAL MICROBIOLOGY, V1, P1946; Li H, 2012, ORAL DIS, V18, P771, DOI 10.1111/j.1601-0825.2012.01944.x; Love MR, 2001, INT ENDOD J, V34, P399; Nagayama M, 2001, LETT APPL MICROBIOL, V33, P122, DOI 10.1046/j.1472-765x.2001.00964.x; Periasamy S, 2009, INFECT IMMUN, V77, P3542, DOI 10.1128/IAI.00345-09; Rocas IN, 2011, J ENDODONT, V37, P143, DOI 10.1016/j.joen.2010.11.006; Saber MH, 2012, J ENDODONT, V38, P1484, DOI 10.1016/j.joen.2012.06.037; Sassone LM, 2008, J ENDODONT, V34, P541, DOI 10.1016/j.joen.2008.02.004; Siqueira JF, 2003, ORAL SURG ORAL MED O, V96, P215, DOI 10.1016/S1079-2104(03)00158-6; Soejima T, 2008, J CLIN MICROBIOL, V46, P2305, DOI 10.1128/JCM.02171-07; Su LY, 2010, ORAL SURG ORAL MED O, V110, pE40, DOI 10.1016/j.tripleo.2009.12.051; Takeshita T, 2007, ORAL MICROBIOL IMMUN, V22, P419, DOI 10.1111/j.1399-302X.2007.00384.x; Tong ZX, 2013, J ENDODONT, V39, P674, DOI 10.1016/j.joen.2012.12.010	45	3	3	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0143-2885	1365-2591		INT ENDOD J	Int. Endod. J.	AUG	2015	48	8					717	728		10.1111/iej.12361		12	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CM7KL	WOS:000357870800001		
J	Muroga, R; Tsuruta, J; Morio, I				Muroga, R.; Tsuruta, J.; Morio, I.			Disparity in perception of the working condition of dental hygienists between dentists and dental hygiene students in Japan	INTERNATIONAL JOURNAL OF DENTAL HYGIENE			English	Article						certified dental hygienist; dental hygiene education; dental team work; four-handed dentistry; the scope of dental hygienists' practice; working environment		ObjectivesIn Japan, there continues to be a shortage of active dental hygienists. The scope of dental hygienists' practice is also considered to be unclear. One of the reasons for this is that dental hygienists find the working conditions during dental hygiene education different from those in reality. The purpose of this study was to clarify the actual working condition of dental hygienists in dental clinics, as well as evaluate the awareness of dental hygiene students and dentists regarding the working condition of dental hygienists. MethodsQuestionnaires were sent by post to 481 dentists and were distributed to 89 dental hygiene students. The awareness about the working condition of dental hygienists was compared between dentists and dental hygiene students. ResultsTwo hundred twenty-two dentists and 89 dental hygiene students responded to questionnaires. Dental hygiene students considered the team of dental hygienist, dental technician and clerk' to be more effective in providing dental care than dentists (P<0.001). Among the dentists, 37.1% did not find any clear distinction between hygienists and assistants in their clinics. However, 97.4% of dental hygiene students answered that dental team members should clearly inform patients of the distinction between hygienists and assistants. ConclusionsThis study indicated that there was disparity between dentists' and dental hygiene students' perception of dental hygienists' working conditions, and dental team work was not always effective. For training high quality dental hygienists, all educational institutions related to dentistry must educate students regarding the more realistic dental hygienists' working condition, as well as benefits.	[Muroga, R.; Morio, I.] Tokyo Med & Dent Univ, Dent Educ Dev Sect, Grad Sch Med & Dent Sci, Bunkyo Ku, Tokyo 1138549, Japan; [Tsuruta, J.] Tokyo Med & Dent Univ, Ctr Interprofess Educ, Bunkyo Ku, Tokyo 1138549, Japan	Muroga, R (reprint author), Tokyo Med & Dent Univ, Dent Educ Dev Sect, Grad Sch Med & Dent Sci, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138549, Japan.	murogarei@gmail.com					Adachi M, 2004, INT J DENT HYG, V2, P179; General Dental Council (UK), PRINC DENT TEAM WORK; General Dental Council (UK), STAND DENT PROF; Ishii T, 2012, JPN DENT SCI REV, V48, P135; Japan Dental Association, DENT CLIN BUS COND S; Japan Dental Foundation of Dental Promotion, 2013, NUMB REG DENT HYG JA; Japan Dental Hygienists' Association, 2012, ADV DENT HYG 60 YEAR; Japan Dental Hygienists' Association, 2010, REP ACT WORK COND DE; Japanese Association for Dental Science, INV COMM DENT HYG AS; Kamijo H., 2011, Journal of the National Institute of Public Health, V60, P360; Ministry of Health Labour and Welfare, 2010, REP PUBL HLTH ADM SE; Ministry of Health Labour and Welfare, SURV MED I NUMB WORK; Patricia MJ, 2009, IDJ, V59, P63; Sato N, 2009, MED BIOL, V153, P540; Sato Y, 2007, J JAPAN ASS DENT ED, V23, P111; Shiratori T, 2011, JJSDHE, V2, P1; Suzuki A, 2003, B SHIZUOKA PREFECTUR; WORLD HEALTH ORGANIZATION, FRAM ACT INT ED COLL; Yoshida N, 2004, Int J Dent Hyg, V2, P179, DOI 10.1111/j.1601-5037.2004.00097.x; Yoshiizumi K, 2010, INT J DENT HYG, V196, P196; Yoshimi M, 1987, NIPPON DENT REV, V536, P213	21	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1601-5029	1601-5037		INT J DENT HYG	Int. J. Dent. Hyg.	AUG	2015	13	3					213	221		10.1111/idh.12105		9	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CM7QC	WOS:000357889300010		
J	Kawakami, T; Okano, T; Takeuchi, S; Kimura, S; Soma, Y				Kawakami, Tamihiro; Okano, Tatsuro; Takeuchi, Sora; Kimura, Satoko; Soma, Yoshinao			Complete resolution of refractory cutaneous arteritis by intravenous cyclophosphamide pulse therapy	INTERNATIONAL JOURNAL OF DERMATOLOGY			English	Letter							RANDOMIZED-TRIAL; GRANULOMATOSIS; VASCULITIS		[Kawakami, Tamihiro; Okano, Tatsuro; Takeuchi, Sora; Kimura, Satoko; Soma, Yoshinao] St Marianna Univ, Sch Med, Dept Dermatol, Kawasaki, Kanagawa, Japan	Kawakami, T (reprint author), St Marianna Univ, Sch Med, Dept Dermatol, Kawasaki, Kanagawa, Japan.	tami@marianna-u.ac.jp					Kawakami T, 2007, ARTHRIT RHEUM-ARTHR, V57, P1507, DOI 10.1002/art.23081; Jennette JC, 2013, ARTHRITIS RHEUM-US, V65, P1, DOI 10.1002/art.37715; Takeuchi S, 2013, RHEUMATOLOGY, V52, P1592, DOI 10.1093/rheumatology/ket159; Jayne D, 2003, NEW ENGL J MED, V349, P36, DOI 10.1056/NEJMoa020286; Guillevin L, 1997, ARTHRITIS RHEUM, V40, P2187, DOI 10.1002/art.1780401213; desGroot K, 2009, ANN INTERN MED, V150, P670; HOFFMAN GS, 1992, ANN INTERN MED, V116, P488; Kawakami T, 2013, J DERMATOL, V40, P955, DOI 10.1111/1346-8138.12303; Kawakami T, 2011, MEDICINE, V90, P119, DOI 10.1097/MD.0b013e3182115508	9	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0011-9059	1365-4632		INT J DERMATOL	Int. J. Dermatol.	AUG	2015	54	8					E323	E325		10.1111/ijd.12863		3	Dermatology	Dermatology	CN0SY	WOS:000358125100011		
J	Kobayashi, T; Ito, T; Kawakami, H; Fuzishiro, K; Hirano, H; Okubo, Y; Tsuboi, R				Kobayashi, Tomoko; Ito, Tomonobu; Kawakami, Hiroshi; Fuzishiro, Kanzan; Hirano, Hirofumi; Okubo, Yukari; Tsuboi, Ryoji			Eighteen cases of wheat allergy and wheat-dependent exercise-induced urticaria/anaphylaxis sensitized by hydrolyzed wheat protein in soap	INTERNATIONAL JOURNAL OF DERMATOLOGY			English	Article							INDUCED ANAPHYLAXIS	Background Glupearl 19S, an acid-hydrolyzed wheat protein (HWP), is used widely in Japan as a moisturizing ingredient in facial soaps. Since 2010, there has been an increasing number of reports of contact urticaria and wheat allergy resulting from the use of products containing this substance. Case reports Sixty-one patients who had used HWP-containing facial soap visited our hospital. Thirty-five of these experienced urticaria or anaphylaxis after consuming wheat-containing food. Results Eighteen of the 35 patients tested positive to 0.01% Glupearl 19S solution. Wheat-specific IgE and serum gluten-specific IgE were higher in the patients with HWP allergy than in non-HWP allergy patients. Among the patients who tested positive to Glupearl 19S on the skin prick test, nine experienced HWP-wheat-dependent exercise-induced anaphylaxis, and four experienced food-dependent anaphylaxis. Moreover, four of these patients not only experienced food-dependent anaphylaxis but also a worsening of the symptoms during exercise. Discussion The clinical symptomology was so variable that the patients were classified into six groups. We found that patients with HWP allergy tended to manifest symptoms of both HWP-wheat-dependent exercise-induced anaphylaxis and contact urticaria. The etiology of hydrolyzed wheat protein allergy is unknown. Patients with a history of these symptoms need to be informed about the risk of consuming wheat-containing foods and the importance of excluding such items from their diet.	[Kobayashi, Tomoko; Ito, Tomonobu; Kawakami, Hiroshi; Fuzishiro, Kanzan; Hirano, Hirofumi; Okubo, Yukari; Tsuboi, Ryoji] Tokyo Med Univ, Dept Dermatol, Tokyo 1600023, Japan	Ito, T (reprint author), Tokyo Med Univ, Dept Dermatol, Shinjuku Ku, 6-7-1 Nishi Shinjuku, Tokyo 1600023, Japan.	tomonobu@tokyo-med.ac.jp					Ishii K, 2012, ACTA DERM-VENEREOL, V92, P490, DOI 10.2340/00015555-1321; Chinuki Y, 2011, CONTACT DERMATITIS, V65, P55, DOI 10.1111/j.1600-0536.2011.01917.x; Lauriere M, 2006, CONTACT DERMATITIS, V54, P283, DOI 10.1111/j.0105-1873.2006.00830.x; Fukutomi Y, 2011, J ALLERGY CLIN IMMUN, V127, P531, DOI 10.1016/j.jaci.2010.09.035; Dreborg S., 1989, ALLERGY S10, V44, P1	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0011-9059	1365-4632		INT J DERMATOL	Int. J. Dermatol.	AUG	2015	54	8					E302	E305		10.1111/ijd.12767		4	Dermatology	Dermatology	CN0SY	WOS:000358125100004		
J	Ukawa, S; Tamakoshi, A; Ono, K				Ukawa, Shigekazu; Tamakoshi, Akiko; Ono, Kota			A randomized controlled trial of a long-term functioning improvement tool home visit program for frail older Japanese people	INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY			English	Letter									[Ukawa, Shigekazu; Tamakoshi, Akiko] Hokkaido Univ Grad Sch Med, Dept Publ Hlth Sci, Sapporo, Hokkaido, Japan; [Ono, Kota] Hokkaido Univ Grad Sch Med, Dept Biostat, Sapporo, Hokkaido, Japan	Ukawa, S (reprint author), Hokkaido Univ Grad Sch Med, Dept Publ Hlth Sci, Sapporo, Hokkaido, Japan.	s-ukawa@med.hokudai.ac.jp			Mitsubishi Foundation [25037]; Nipponkoa Welfare Foundation [fukushi12-08]	This study was supported by a grant for social welfare activities from the Mitsubishi Foundation (No. 25037; principal investigator: Dr. Shigekazu Ukawa) and a grant from Nipponkoa Welfare Foundation (No. fukushi12-08; principal investigator: Dr. Shigekazu Ukawa). We would like to thank Naoko Watanabe, Mikako Kachi, and Rikako Aizawa of Takiawa city for their assistance and cooperation.	Dubois B, 2000, NEUROLOGY, V55, P1621; Tsutsui T, 2007, J AM GERIATR SOC, V55, P1458, DOI 10.1111/j.1532-5415.2007.01281.x; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Ukawa S, 2012, INT J GERIATR PSYCH, V27, P557, DOI 10.1002/gps.2753; Ukawa S, 2012, AUSTRALAS J AGEING, V31, P187, DOI 10.1111/j.1741-6612.2012.00589.x	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0885-6230	1099-1166		INT J GERIATR PSYCH	Int. J. Geriatr. Psychiatr.	AUG	2015	30	8					887	U5		10.1002/gps.4311		2	Geriatrics & Gerontology; Gerontology; Psychiatry	Geriatrics & Gerontology; Psychiatry	CM7OM	WOS:000357884200013		
J	Torlakovic, EE; Brynes, RK; Hyjek, E; Lee, SH; Kreipe, H; Kremer, M; McKenna, R; Sadahira, Y; Tzankov, A; Reis, M; Porwit, A				Torlakovic, E. E.; Brynes, R. K.; Hyjek, E.; Lee, S-H.; Kreipe, H.; Kremer, M.; McKenna, R.; Sadahira, Y.; Tzankov, A.; Reis, M.; Porwit, A.		Int Council Standardization	ICSH guidelines for the standardization of bone marrow immunohistochemistry	INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY			English	Review						Standardization; immunohistochemistry; bone marrow; trephine biopsy	TREPHINE BIOPSY SPECIMENS; ACUTE MYELOID-LEUKEMIA; IN-SITU HYBRIDIZATION; TYRAMIDE SIGNAL AMPLIFICATION; INVASIVE BREAST-CARCINOMA; PRE-ANALYTIC VARIABLES; HUMAN TEMPORAL BONES; PLASMA-CELL MYELOMA; COLD ISCHEMIC TIME; MYELODYSPLASTIC SYNDROMES	Bone marrow (BM) tissue biopsy evaluation, including trephine biopsy and clot section, is an integral part of BM investigation and is often followed by ancillary studies, in particular immunohistochemistry (IHC). IHC provides insitu coupling of morphological assessment and immunophenotype. The number of different IHC tests that can be applied to BM trephine biopsies and the number of indications for IHC testing is increasing concurrently with the development of flow cytometry and molecular diagnostic methods. An international Working Party for the Standardization of Bone Marrow IHC was formed by the International Council for Standardization in Hematology (ICSH) to prepare a set of guidelines for the standardization of BM IHC based on currently available published evidence and modern understanding of quality assurance principles as applied to IHC in general. The guidelines were discussed at the ICSH General Assemblies and reviewed by an international panel of experts to achieve further consensus and represent further development of the previously published ICSH guidelines for the standardization of BM specimens handling and reports.	[Torlakovic, E. E.; Porwit, A.] Univ Toronto, Univ Hlth Network, Dept Lab Hematol, Toronto, ON M5G 2C4, Canada; [Brynes, R. K.] Univ So Calif, Keck Sch Med, Dept Pathol, Los Angeles, CA 90033 USA; [Hyjek, E.] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA; [Lee, S-H.] SEALS Cent, St George Hosp, Dept Haematol, Sydney, NSW, Australia; [Kreipe, H.] Hannover Med Sch, Dept Pathol, Hannover, Germany; [Kremer, M.] Munich Municipal Hosp, Inst Pathol, Munich, Germany; [McKenna, R.] Univ Minnesota, Dept Lab Med & Pathol, Special Hematol, Minneapolis, MN 55455 USA; [Sadahira, Y.] Kawasaki Med Univ, Dept Pathol, Kurashiki, Okayama, Japan; [Tzankov, A.] Univ Basel Hosp, Inst Pathol, CH-4031 Basel, Switzerland; [Reis, M.] Sunnybrook Hlth Sci Ctr, Dept Clin Pathol, Toronto, ON M4N 3M5, Canada; [Porwit, A.] Karolinska Inst, Dept Pathol, S-10401 Stockholm, Sweden	Torlakovic, EE (reprint author), Univ Toronto, Univ Hlth Network, Dept Lab Hematol, 11th Floor R411,200 Elizabeth St, Toronto, ON M5G 2C4, Canada.	emina.torlakovic@uhn.ca		Tzankov, Alexandar/0000-0002-1100-3819	International Council for Standardization in Haematology (ICSH)	This guideline was supported and endorsed by the International Council for Standardization in Haematology (ICSH). The Working Party gratefully acknowledges the following reviewers for their expert comments: Prof. Dr. med. Falko Fend, University Hospital Tuebingen, Tuebingen, Germany; Ass. Prof. Tracy I. George, University of New Mexico HSC, Albuquerque, NM, USA; Prof. LoAnn C. Peterson, Feinberg Medical School of Northwestern University, Chicago, IL, USA; Prof. Dr. Stefano Pileri, Bologna University School of Medicine, Bologna, Italy; Prof. Clive R. Taylor, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA; and Dr. Jon Van der Walt, St. Thomas' Hospital, London, UK.	Bai YL, 2011, LAB INVEST, V91, P1253, DOI 10.1038/labinvest.2011.75; Torlakovic EE, 2009, J CLIN PATHOL, V62, P547, DOI 10.1136/jcp.2008.063446; BRUNNING RD, 1975, ANN INTERN MED, V82, P365; Zhao S, 2014, HUM PATHOL, V45, P1024, DOI 10.1016/j.humpath.2013.12.019; Kremer M, 2005, VIRCHOWS ARCH, V447, P920, DOI 10.1007/s00428-005-0070-8; McCourt CM, 2013, J CLIN PATHOL, V66, P58, DOI 10.1136/jclinpath-2012-201140; Xiao RB, 2014, AM J SURG PATHOL, V38, P776, DOI 10.1097/PAS.0000000000000213; Wang J, 2002, CANCER, V94, P1522, DOI 10.1002/cncr.10364; Erber WN, 1997, J CLIN PATHOL, V50, P389, DOI 10.1136/jcp.50.5.389; Hammond MEH, 2010, J CLIN ONCOL, V28, P2784, DOI 10.1200/JCO.2009.25.6529; Singh VM, 2013, ANN DIAGN PATHOL, V17, P322, DOI 10.1016/j.anndiagpath.2013.02.001; Bain BJ, 2011, J CLIN PATHOL, V64, P373, DOI 10.1136/jcp.2010.080820; Werner M, 2000, AM J SURG PATHOL, V24, P1016, DOI 10.1097/00000478-200007000-00014; Valent P, 2010, ONCOTARGET, V1, P483; Brown RSD, 2002, J HISTOCHEM CYTOCHEM, V50, P113; Neumeister VM, 2012, J NATL CANCER I, V104, P1815, DOI 10.1093/jnci/djs438; Bain BJ, 2001, J CLIN PATHOL, V54, P737; Reineke T, 2006, AM J SURG PATHOL, V30, P892, DOI 10.1097/01.pas.0000213282.20166.13; Cogbill CH, 2014, AM J CLIN PATHOL, V142, P88, DOI 10.1309/AJCPWF77VOGNOVZU; Gaiser T, 2007, ACTA HAEMATOL-BASEL, V117, P122, DOI 10.1159/000097458; ATHANASOU NA, 1987, J CLIN PATHOL, V40, P874, DOI 10.1136/jcp.40.8.874; Beiske K, 2009, BRIT J CANCER, V100, P1627, DOI 10.1038/sj.bjc.6605029; Bonnas C, 2012, INT J CANCER, V131, P1621, DOI 10.1002/ijc.27422; Bennett JM, 2009, HAEMATOL-HEMATOL J, V94, P264, DOI 10.3324/haematol.13755; Orazi A, 2007, PATHOBIOLOGY, V74, P97, DOI 10.1159/000101709; Conklin CMJ, 2013, J THORAC ONCOL, V8, P45, DOI 10.1097/JTO.0b013e318274a83e; Alers JC, 1999, J HISTOCHEM CYTOCHEM, V47, P703; Lee SH, 2008, INT J LAB HEMATOL, V30, P349, DOI 10.1111/j.1751-553X.2008.01100.x; Yildiz-Aktas IZ, 2012, MODERN PATHOL, V25, P1098, DOI 10.1038/modpathol.2012.59; Naresh KN, 2006, J CLIN PATHOL, V59, P903, DOI 10.1136/jcp.2004.020610; HADDY TB, 1989, MED PEDIATR ONCOL, V17, P418; Tian WL, 2014, GENE, V542, P122, DOI 10.1016/j.gene.2014.03.046; Bussolati G, 2008, J CLIN PATHOL, V61, P1184, DOI 10.1136/jcp.2007.047720; Torlakovic EE, 2014, APPL IMMUNOHISTO M M, V22, P241, DOI 10.1097/PAI.0000000000000069; Bain BJ, 2010, BONE MARROW PATHOLOG, P1; Blythe D, 1997, J CLIN PATHOL, V50, P45, DOI 10.1136/jcp.50.1.45; Bonds LA, 2005, AM J CLIN PATHOL, V124, P205, DOI 10.1309/29DACY9KBHNW4BG6; Borgen E, 2006, CYTOM PART B-CLIN CY, V70B, P400, DOI 10.1002/cyto.b.20114; Brown D, 2006, BONE MARROW DIAGNOSI, P1; Buesche G, 2006, HISTOPATHOLOGY, V48, P133, DOI 10.1111/j.1365-2559.2005.02302.x; Buhr T, 2002, BRIT J HAEMATOL, V118, P470, DOI 10.1046/j.1365-2141.2002.03605.x; Burkhardt R., 1971, COLOR ATLAS CLIN HIS, P8; Callis G, 1998, J HISTOTECHNOL, V21, P49; Torlakovic EE, 2010, AM J CLIN PATHOL, V133, P354, DOI 10.1309/AJCPDYZ1XMF4HJWK; Cheung CC, 2014, AM J CLIN PATHOL, V142, P629, DOI 10.1309/AJCP77GXYVEQXMXT; Cotelingam JD, 2003, ADV ANAT PATHOL, V10, P8; Cunningham CD, 2001, LARYNGOSCOPE, V111, P278, DOI 10.1097/00005537-200102000-00017; Das R, 2005, ANAL QUANT CYTOL, V27, P152; Dimenstein IB, 2008, ANN DIAGN PATHOL, V12, P191, DOI 10.1016/j.anndiagpath.2007.06.004; Dimenstein IB, GROSSING TECHNOLOGY; Douds JJ, 2014, J CLIN PATHOL, V67, P792, DOI 10.1136/jclinpath-2014-202421; Erber WN, 1996, PATHOLOGY, V28, P45; Fitzgibbons PL, 2014, ARCH PATHOL LAB MED, V138, P1432, DOI 10.5858/arpa.2013-0610-CP; FORNI M, 1983, AM J CLIN PATHOL, V80, P145; Frisch B, 1990, ATLAS BONE MARROW PA, P32; Gala JL, 1997, J CLIN PATHOL, V50, P521, DOI 10.1136/jcp.50.6.521; Gatta LB, 2012, EUR J HISTOCHEM, V56, pe12; GATTER KC, 1987, HISTOPATHOLOGY, V11, P1; Goldstein NS, 2003, AM J CLIN PATHOL, V120, P86, DOI 10.1309/QPHDRB00QXGMUQ9N; Gonzalez-Chavez SA, 2013, INT J CLIN EXP PATHO, V6, P1972; Goteri G, 2010, ANAL QUANT CYTOL, V32, P201; Hodges A, 1996, Clin Lab Sci, V9, P349; Howat WJ, 2014, METHODS, V70, P34, DOI 10.1016/j.ymeth.2014.01.018; Iancu D, 2007, ARCH PATHOL LAB MED, V131, P282; Jatoi A, 1999, MODERN PATHOL, V12, P29; Johnsen IK, 2010, HORM METAB RES, V42, P93, DOI 10.1055/s-0029-1241858; Joshi R, 2008, J CLIN PATHOL, V61, P213, DOI 10.1136/jcp.2007.049130; Katz BZ, 2006, LEUKEMIA LYMPHOMA, V47, P1730, DOI 10.1080/10428190600881041; Keithley EM, 2000, HEARING RES, V148, P192, DOI 10.1016/S0378-5955(00)00153-2; Korac P, 2005, J CLIN PATHOL, V58, P1336, DOI 10.1136/jcp.2005.026468; Kreft A, 2010, PATHOL RES PRACT, V206, P560, DOI 10.1016/j.prp.2010.03.002; Krenacs T, 2005, J CLIN PATHOL, V58, P897, DOI 10.1136/jcp.2004.023788; KUBIC VL, 1989, MODERN PATHOL, V2, P618; Kunze E, 2008, APPL IMMUNOHISTO M M, V16, P76; L'Abbate A, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-396; Leong AS-Y, 1989, PATHOLOGY PHILA, V21, P81; Madden VJ, 1997, HEARING RES, V111, P76, DOI 10.1016/S0378-5955(97)00107-X; Manaloor EJ, 2000, AM J CLIN PATHOL, V113, P814; MCCLUGGAGE WG, 1995, J CLIN PATHOL, V48, P840, DOI 10.1136/jcp.48.9.840; Merli M, 2010, EUR J HAEMATOL, V85, P405, DOI 10.1111/j.1600-0609.2010.01503.x; MILAN L, 1981, American Journal of Surgical Pathology, V5, P573, DOI 10.1097/00000478-198109000-00006; MIRANDA RN, 1994, AM J PATHOL, V145, P1309; Munshi NC, 2001, SEMIN ONCOL, V28, P565, DOI 10.1016/S0093-7754(01)90025-9; Nagasaka T, 2000, LEUKEMIA LYMPHOMA, V36, P347, DOI 10.3109/10428190009148856; Ng AP, 2006, HAEMATOL-HEMATOL J, V91, P972; Padhi Somanath, 2013, Indian J Med Paediatr Oncol, V34, P283, DOI 10.4103/0971-5851.125246; Page Kathleen, 1996, P309; Park JW, 2014, LUPUS, V23, P975, DOI 10.1177/0961203314531634; Peterson LC, 2001, NEOPLASTIC HEMATOPAT, V2nd, P1391; PINKUS GS, 1977, AM J PATHOL, V87, P47; PINKUS GS, 1991, MODERN PATHOL, V4, P733; Portier BP, 2013, MODERN PATHOL, V26, P1, DOI 10.1038/modpathol.2012.123; Quintanilla-Martinez L, 2012, PATHOLOGE, V33, P481, DOI 10.1007/s00292-012-1647-z; Rolls GO, 2011, DIFFICULT BLOCKS REP; Schmidt B, 2006, LEUKEMIA LYMPHOMA, V47, P1857, DOI 10.1080/10428190600709127; Shao YY, 2006, LAB INVEST, V86, P1089, DOI 10.1038/labinvest.3700459; Siddiqui S, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2782; TABILIO A, 1982, TUMORI, V68, P417; Talaulikar D, 2009, J HEMATOL ONCOL, V2, DOI 10.1186/1756-8722-2-49; Thiele J, 2005, LEUKEMIA LYMPHOMA, V46, P709, DOI 10.1080/10428190500046554; Torlakovic EE, 2015, APPL IMMUNOHISTO M M, V23, P1, DOI 10.1097/PAI.0000000000000163; Toth Z, 2011, APPL IMMUNOHISTO M M, V19, P15, DOI 10.1097/PAI.0b013e3181ec005e; True LD, 2014, VIRCHOWS ARCH, V464, P257, DOI 10.1007/s00428-013-1531-0; US Department Of Health And Human Services Food and Drug Administration Center for Devices and Radiological Health Immunology Branch Division of Clinical Laboratory Devices Office of Device Evaluation, 1998, GUID SUBM IMM APPL F; VERDENIUS HHW, 1958, J CLIN PATHOL, V11, P229, DOI 10.1136/jcp.11.3.229; WHO, 2005, 2005 MERC HLTH CAR; Wickham CL, 2000, J CLIN PATHOL-MOL PA, V53, P19; Wilkins BS, 2009, HISTOPATHOLOGY, V55, P631, DOI 10.1111/j.1365-2559.2009.03353.x; Wilkins BS, 2011, J CLIN PATHOL, V64, P380, DOI 10.1136/jcp.2010.080838; WOLF BC, 1990, AM J CLIN PATHOL, V94, P742; WOLF E, 1992, VIRCHOWS ARCH A, V420, P17, DOI 10.1007/BF01605979; Zhang QG, 2010, MICROSC RES TECHNIQ, V73, P1067, DOI 10.1002/jemt.20836	112	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1751-5521	1751-553X		INT J LAB HEMATOL	Int. J. Lab. Hematol.	AUG	2015	37	4					431	449		10.1111/ijlh.12365		19	Hematology	Hematology	CM8ME	WOS:000357954600016		
J	Nomura, N; Saito, K; Ikeda, M; Yuasa, S; Pastore, M; Chabert, C; Kono, E; Sakai, A; Tanaka, H; Ikemoto, T; Takubo, T				Nomura, N.; Saito, K.; Ikeda, M.; Yuasa, S.; Pastore, M.; Chabert, C.; Kono, E.; Sakai, A.; Tanaka, H.; Ikemoto, T.; Takubo, T.			Evaluation of the Microsemi CRP, an automated hematology analyzer for rapid 3-part WBC differential and CRP using whole blood	INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY			English	Article						Automated hematology analyzer Microsemi CRP; 3-part WBC differential (3-Diff); C-reactive protein (CRP); point of care testing (POCT); inflammatory disease	C-REACTIVE PROTEIN; COUNT	IntroductionWe evaluated the basic performance of Microsemi CRP, an unique automated hematology analyzer which can simultaneously measure CBC including 3-part WBC differential (3-Diff) and CRP using whole blood treated with EDTA-2K anticoagulant. MethodWe found that it produced generally the acceptable results for all parameters performed (repeatability, reproducibility, linearity, interference effect, carry over, and correlation) using control materials, fresh human whole bloods, and serum samples. ResultsCBC data examined using Microsemi CRP showed the good correlation with the previous model, Micros CRP200 (r0.9), and also those obtained using the routine analyzer, ADVIA 2120i (r0.989). Concerning the 3-Diff, both GRA (%) and LYM (%) showed the excellent correlation coefficient between Microsemi CRP and Micros CRP200 (r0.992) as well as ADVIA 2120i (r0.957). MON (%) showed good correlation between Microsemi CRP and Micros CRP200 (r=0.959), but lower correlation between Microsemi CRP and ADVIA 2120 i (r=0.471). CRP data showed the good correlation with HITACHI7600 (r0.997) and Micros CRP200 (r0.997). ConclusionFrom these findings, we concluded that Microsemi CRP seemed the convenient laboratory analyzer in the setting of point of care testing (POCT) especially at NICU or primary care unit.	[Nomura, N.; Ikeda, M.; Yuasa, S.] HORIBA Med, MiyanohigashiKisshoin, Minami Ku, Kyoto, Japan; [Saito, K.] HORIBA Ltd, Tokyo Off Kanda Awaji Cho, Chiyoda Ku, Tokyo, Japan; [Pastore, M.; Chabert, C.] HORIBA ABX, Parc Euromed, Montpellier 4, France; [Kono, E.; Sakai, A.; Tanaka, H.; Ikemoto, T.; Takubo, T.] Osaka Med Coll Hosp, Dept Cent Lab, Takatsuki, Osaka, Japan	Saito, K (reprint author), Horiba Ltd, Tokyo Off Kanda Awaji Cho, Chiyoda Ku, Tokyo 1010063, Japan.	kensuke.saito@horiba.com					Siekmeier R, 2001, CLIN CHEM LAB MED, V39, P432, DOI 10.1515/CCLM.2001.069; BERGER C, 1995, EUR J PEDIATR, V154, P138; Ricos C, 1999, SCAND J CLIN LAB INV, V59, P491; Pfafflin A, 2009, ANAL BIOANAL CHEM, V393, P1473, DOI 10.1007/s00216-008-2561-3; Clinical and Laboratory Standards Institute, 2005, EP7A2 CLSI; CLSI, 2004, EP05A2 CLSI; CLSI, 2002, EP9A2 CLSI; CLSI, 2010, H26A2C CLSI; ENGLAND JM, 1993, AM J CLIN PATHOL, V100, P371; Inaba Tohru, 2010, Rinsho Byori, V58, P664; NCCLS, 1984, PROC HANDL PROC BLOO; Takemura Y, 2004, CLIN CHEM, V50, P241, DOI 10.1373/clinchem.2003.021956; Takubo T, 2013, J JPN SOC LAB HEMATO, V14, P282; Tugirimana PL, 2009, CLIN CHEM LAB MED, V47, P1417, DOI 10.1515/CCLM.2009.312; Watanabe K, 1994, Rinsho Byori, V42, P764; Woolley T., 2014, POINT CARE, V13, P66	16	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1751-5521	1751-553X		INT J LAB HEMATOL	Int. J. Lab. Hematol.	AUG	2015	37	4					466	473		10.1111/ijlh.12312		8	Hematology	Hematology	CM8ME	WOS:000357954600019		
J	Inaba, T; Maruyama, K				Inaba, T.; Maruyama, K.			Polyclonal intraocular plasmacytosis in a patient with herpetic endophthalmitis	INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY			English	Letter							CEREBROSPINAL-FLUID; DIFFERENTIATION; LYMPHOMA		[Inaba, T.] Kyoto Prefectural Univ Med, Dept Infect Control & Lab Med, Kyoto, Japan; [Maruyama, K.] Tohoku Univ, Dept Ophthalmol, Grad Sch Med, Sendai, Miyagi 980, Japan	Inaba, T (reprint author), Kyoto Prefectural Univ Med, Dept Infect Control & Lab Med, Kyoto, Japan.	inaba178@koto.kpu-m.ac.jp					MURAGUCHI A, 1988, J EXP MED, V167, P332, DOI 10.1084/jem.167.2.332; Kojima K, 2012, OPHTHALMOLOGY, V119, P2386, DOI 10.1016/j.ophtha.2012.05.033; Hsia CC, 2012, BLOOD, V120, P2936, DOI 10.1182/blood-2012-03-417816; Inaba T, 2013, INT J LAB HEMATOL, V36, pe1; Inaba T, 2012, INT J HEMATOL, V96, P399, DOI 10.1007/s12185-012-1172-0; Whitcup SM, 1997, ARCH OPHTHALMOL-CHIC, V115, P1157; Yoshimura T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008158	7	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1751-5521	1751-553X		INT J LAB HEMATOL	Int. J. Lab. Hematol.	AUG	2015	37	4					e78	e80		10.1111/ijlh.12317		3	Hematology	Hematology	CM8ME	WOS:000357954600007		
J	Premachandra, C; Premachandra, HWH; Parape, CD; Kawanaka, H				Premachandra, Chinthaka; Premachandra, H. Waruna H.; Parape, Chandana Dinesh; Kawanaka, Hiroharu			Road crack detection using color variance distribution and discriminant analysis for approaching smooth vehicle movement on non-smooth roads	INTERNATIONAL JOURNAL OF MACHINE LEARNING AND CYBERNETICS			English	Article						Smooth driving; Cracks; Image sample variance; Discriminant analysis		We present an image analysis based automatic road crack detection method for conducting smooth driving on non-smooth road surfaces. In the new proposal, first the road surface areas which include cracks are extracted as crack images by analyzing the color variance on norm. Then cracks are extracted from those areas by introducing a method on discriminant analysis. According to experiments using the images of different road surfaces, the new proposal showed better performances than the conventional approaches.	[Premachandra, Chinthaka] Tokyo Univ Sci, Katsushikaku, Tokyo 1258585, Japan; [Premachandra, H. Waruna H.] Wayamba Univ Srilanka, Makadura, Sri Lanka; [Parape, Chandana Dinesh] Kyoto Univ Katsura, Kyoto Univ, Nishikyo Ku, Kyoto 6158540, Japan; [Kawanaka, Hiroharu] Mie Univ, Tsu, Mie 5148507, Japan	Premachandra, C (reprint author), Tokyo Univ Sci, 6-3-1 Niijuku, Katsushikaku, Tokyo 1258585, Japan.	chinthaka@ee.kagu.tus.ac.jp					OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62; Ge JF, 2009, IEEE T INTELL TRANSP, V10, P283, DOI 10.1109/TITS.2009.2018961; Yang CH, 2008, PROCEEDINGS OF THE 11TH INTERNATIONAL IEEE CONFERENCE ON INTELLIGENT TRANSPORTATION SYSTEMS, P151; Tsai YCJ, 2012, J TRANSP ENG-ASCE, V138, P649, DOI 10.1061/(ASCE)TE.1943-5436.0000353; Gaviln M, 2011, BASEL, V11, P9628; Gu YL, 2010, IEEE INT VEH SYM, P7, DOI 10.1109/IVS.2010.5548005; Liu B, 2009, 2 INT C INT NETW INT, P319; Nguyen TS, 2010, 11 IASTED INT C COMP; Oliveira H, 2010, EUR SIGNAL PR CONF, V18, P274; Premachandra H. Chinthaka N., 2011, Journal of the Institute of Image Information and Television Engineers, V65, DOI 10.3169/itej.65.354; Sohn M, 1987, 2 N AM PAV MAN C; Tanaka N, 1998, IAPR WORKSH MACH VIS; Wei W, 2009, 2 INT C INT NETW INT, P319, DOI 10.1109/ICINIS.2009.88	13	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1868-8071	1868-808X		INT J MACH LEARN CYB	Int. J. Mach. Learn. Cybern.	AUG	2015	6	4					545	553		10.1007/s13042-014-0240-6		9	Computer Science, Artificial Intelligence	Computer Science	CN0AR	WOS:000358074500003		
J	Parape, CD; Premachandra, C; Tamura, M				Parape, Chandana Dinesh; Premachandra, Chinthaka; Tamura, Masayuki			Optimization of structure elements for morphological hit-or-miss transform for building extraction from VHR airborne imagery in natural hazard areas	INTERNATIONAL JOURNAL OF MACHINE LEARNING AND CYBERNETICS			English	Article						Mathematical morphological profile; HMT; Natural hazard; Airborne VHR images; Building extraction	RESOLUTION SATELLITE IMAGERY; REMOTE-SENSING IMAGES; DAMAGE DETECTION; CLASSIFICATION; EARTHQUAKE; SEGMENTATION	Template matching is a very topical issue in a wide range of imagining applications. Automated detection of features such as building roof for template matching and pattern recognition is great significance in the image processing field. In this chapter, a method which is developed optimizing the shape and size of hit-or-miss morphological filtering parameters with morphological operators is presented for building roof target detection. Morphological operations of opening and closing with constructions are applied to segmented images. Hit-or-Miss Transform (HMT) has been successfully applied for template matching in binary images. The proposed approach involves several advanced morphological operators among which an adaptive HMT with varying size and shape of the structuring elements. VHR space borne images consisting of a pre and post 2011 Pacific coast of Tohoku earthquake and the tsunami site of the Ishinomaki, Miyagi area in Japan were used. Experimental results show that the identified probability of building can reach more than 81 % by this method.	[Parape, Chandana Dinesh; Tamura, Masayuki] Kyoto Univ, Grad Sch Engn, Environm Informat Lab, Nishikyo Ku, Kyoto 6158540, Japan; [Premachandra, Chinthaka] Tokyo Univ Sci, Grad Sch Engn, Katsushikaku, Tokyo 1258585, Japan	Premachandra, C (reprint author), Tokyo Univ Sci, Grad Sch Engn, 6-3-1 Niijuku, Katsushikaku, Tokyo 1258585, Japan.	dinesh.c@ky4.ecs.kyoto-u.ac.jp			Setsutaro Kobayashi memorial foundation	We would like to thank for giving access to the airborne imagery and GIS data, provided by the Geospatial Information Authority of Japan (GSI). This study was partially supported by Setsutaro Kobayashi memorial foundation.	Aguera F, 2009, COMPUT ELECTRON AGR, V66, P191, DOI 10.1016/j.compag.2009.02.001; [Anonymous], 2011, NAT DIS DAT BOOK; Benediktsson JA, 2003, IEEE T GEOSCI REMOTE, V41, P1940, DOI 10.1109/TGRS.2003.814625; Schweier C, 2004, NAT HAZARD EARTH SYS, V4, P285; Saito K, 2004, EARTHQ SPECTRA, V20, P145, DOI 10.1193/1.1650865; Schweier C, 2006, B EARTHQ ENG, V4, P177, DOI 10.1007/s10518-006-9005-2; Soille P, 2002, IEEE T GEOSCI REMOTE, V40, P2042, DOI 10.1109/TGRS.2002.804618; Chanussot J, 2006, IEEE GEOSCI REMOTE S, V3, P40, DOI [10.1109/LGRS.2005.856117, 10.1109/05.856117]; Perret B, 2009, PATTERN RECOGN, V42, P2470, DOI 10.1016/j.patcog.2009.02.013; Dong LG, 2013, ISPRS J PHOTOGRAMM, V84, P85, DOI 10.1016/j.isprsjprs.2013.06.011; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; Cha J, 2006, PATTERN RECOGN, V39, P1034, DOI 10.1016/j.patcog.2005.05.014; Jin XY, 2005, EURASIP J APPL SIG P, V2005, P2196, DOI 10.1155/ASP.2005.2196; Pesaresi M, 2001, IEEE T GEOSCI REMOTE, V39, P309, DOI 10.1109/36.905239; Aytekin O, 2009, RAST 2009: PROCEEDINGS OF THE 4TH INTERNATIONAL CONFERENCE ON RECENT ADVANCES IN SPACE TECHNOLOGIES, P376; Derivaux S, 2006, INT GEOSCI REMOTE SE, P3712, DOI 10.1109/IGARSS.2006.951; DESTIVAL I, 1986, ACTA ASTRONAUT, V13, P371, DOI 10.1016/0094-5765(86)90092-5; Gamba P, 2007, 2007 JOINT URB REM S, P1; Guindon B, 1997, CANADIAN J REMOTE SE, V23, P38; Heijmans H.J.A.M, 1998, MATH MORPHOLOGY ITS, P191; Ito Y., 2000, INT ARCH PHOTOGRAMM, VXXXIII, P156; Kerle N, 2010, INT J APPL EARTH OBS, V12, P466, DOI 10.1016/j.jag.2010.07.004; Lefevre S., 2007, IEEE ISPRS JOINT WOR; Matsuoka M., 2005, EARTHQ SPECTRA, V21, P285; Matsuoka M, 2004, EARTHQ SPECTRA, V20, P975, DOI 10.1193/1.1774182; Rathje EM, 2005, INT GEOSCI REMOTE SE, P5045; Rehor M, 2008, INT ARCH PHOTOGRAMME; Sakamoto M, 2004, INT GEOSCI REMOTE SE, P1418; Shackelford AK, 2004, INT GEOSCI REMOTE SE, P1996; Sun X, 2008, GEOSCI REMOTE SENS S, V2, P437; Vincent V, 1993, IEEE T IMAGE PROCESS, V2, P176; Yonezawa C, 2002, INT GEOSCI REMOTE SE, P2051; Yusuf Y, 2001, J INDIAN SOC REMOTE, V29, P233	33	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1868-8071	1868-808X		INT J MACH LEARN CYB	Int. J. Mach. Learn. Cybern.	AUG	2015	6	4					641	650		10.1007/s13042-014-0326-1		10	Computer Science, Artificial Intelligence	Computer Science	CN0AR	WOS:000358074500011		
J	Maniwa, Y; Kasukabe, T; Kumakura, S				Maniwa, Yasuhisa; Kasukabe, Takashi; Kumakura, Shunichi			Vitamin K2 and cotylenin A synergistically induce monocytic differentiation and growth arrest along with the suppression of c-MYC expression and induction of cyclin G2 expression in human leukemia HL-60 cells	INTERNATIONAL JOURNAL OF ONCOLOGY			English	Article						vitamin K2; cotylenin A; differentiation; growth arrest; acute myeloid leukemia cells; c-MYC; cyclin G2	ACUTE MYELOID-LEUKEMIA; TRANS-RETINOIC ACID; PROTEIN EXPRESSION; UP-REGULATION; CANCER-CELLS; APOPTOSIS; INHIBITION; REGULATOR; RECEPTOR; PROLIFERATION	Although all-trans retinoic acid (ATRA) is a standard and effective drug used for differentiation therapy in acute promyelocytic leukemia, ATRA-resistant leukemia cells ultimately emerge during this treatment. Therefore, the development of new drugs or effective combination therapy is urgently needed. We demonstrate that the combined treatment of vitamin K2 and cotylenin A synergistically induced monocytic differentiation in HL-60 cells. This combined treatment also synergistically induced NBT-reducing activity and non-specific esterase-positive cells as well as morphological changes to monocyte/macrophage-like cells. Vitamin K2 and cotylenin A cooperatively inhibited the proliferation of HL-60 cells in short-term and long-term cultures. This treatment also induced growth arrest at the G1 phase. Although 5 mu g/ml cotylenin A or 5 mu M vitamin K2 alone reduced c-MYC gene expression in HL-60 cells to approximately 45% or 80% that of control cells, respectively, the combined treatment almost completely suppressed c-MYC gene expression. We also demonstrated that the combined treatment of vitamin K2 and cotylenin A synergistically induced the expression of cyclin G2, which had a positive effect on the promotion and maintenance of cell cycle arrest. These results suggest that the combination of vitamin K2 and cotylenin A has therapeutic value in the treatment of acute myeloid leukemia.	[Maniwa, Yasuhisa] Masuda Red Cross Hosp, Masuda 6988501, Japan; [Kasukabe, Takashi; Kumakura, Shunichi] Shimane Univ, Fac Med, Dept Med Educ & Res, Izumo, Shimane 6938501, Japan	Kasukabe, T (reprint author), Shimane Univ, Fac Med, Dept Med Educ & Res, Izumo, Shimane 6938501, Japan.	kasukabe@med.shimane-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan; Shimane University 'SUIGAN' project	This study was supported partly by a grant from the Ministry of Education, Culture, Sports, Science and Technology of Japan and by a grant from Shimane University 'SUIGAN' project.	Kasukabe T, 2005, BREAST CANCER RES, V7, pR1097, DOI 10.1186/bcr1344; Zimmermann M, 2012, J BIOL CHEM, V287, P22838, DOI 10.1074/jbc.M112.376855; DeLuca HF, 2008, NUTR REV, V66, pS73, DOI 10.1111/j.1753-4887.2008.00105.x; Marzi I, 2013, CELL CYCLE, V12, P353, DOI 10.4161/cc.23200; MCCULLOCH EA, 1983, BLOOD, V62, P1; Masui K, 2013, CELL METAB, V18, P726, DOI 10.1016/j.cmet.2013.09.013; Showalter SL, 2010, J GASTROEN HEPATOL, V25, P738, DOI 10.1111/j.1440-1746.2009.06085.x; Stossi F, 2006, J BIOL CHEM, V281, P16272, DOI 10.1074/bjc.M513405200; Delgado MD, 2013, CLIN TRANSL ONCOL, V15, P87, DOI 10.1007/s12094-012-0926-8; Singh AM, 2009, CELL STEM CELL, V5, P141, DOI 10.1016/j.stem.2009.07.003; FIELD JK, 1990, ANTICANCER RES, V10, P1; Sasaki N, 2005, J BONE MINER METAB, V23, P41, DOI 10.1007/s00774-004-0539-6; Robak T, 2009, CLIN THER, V31, P2349, DOI 10.1016/j.clinthera.2009.11.017; Guerrouahen BS, 2010, CLIN CANCER RES, V16, P1149, DOI 10.1158/1078-0432.CCR-09-2416; Gomez-Casares MT, 2013, ONCOGENE, V32, P2239, DOI 10.1038/onc.2012.246; Cheng YC, 2007, LEUKEMIA RES, V31, P1403, DOI 10.1016/j.leukres.2007.03.012; Honma Y, 2003, LEUKEMIA RES, V27, P1019, DOI 10.1016/S0145-2126(03)00071-7; Kasukabe T, 2008, CANCER SCI, V99, P1693, DOI 10.1111/j.1349-7006.2008.00867.x; Asahi K, 1997, BIOCHEM BIOPH RES CO, V238, P758, DOI 10.1006/bbrc.1997.7385; Funato K, 2002, LEUKEMIA, V16, P1519, DOI 10.1038/sj.leu.2402614; Hoffman B, 2002, ONCOGENE, V21, P3414, DOI 10.1038/sj/onc/1205400; Honma Y, 2002, LEUKEMIA LYMPHOMA, V43, P1169, DOI 10.1080/1042819020026222; Horne MC, 1997, J BIOL CHEM, V272, P12650, DOI 10.1074/jbc.272.19.12650; Jiang GS, 2008, LEUKEMIA RES, V32, P297, DOI 10.1016/j.leukres.2007.06.021; KASUKABE T, 1990, JPN J CANCER RES, V81, P807; KASUKABE T, 1987, CANCER RES, V47, P567; Kitagawa J, 2011, J CANCER RES CLIN, V137, P779, DOI 10.1007/s00432-010-0938-0; KUMAKURA S, 1994, LEUKEMIA LYMPHOMA, V14, P171, DOI 10.3109/10428199409049665; Kumakura S, 1996, LEUKEMIA LYMPHOMA, V23, P383, DOI 10.3109/10428199609054843; Liang XH, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-412; Matsumoto K, 2006, INT J ONCOL, V29, P1501; Miyazawa K, 2001, LEUKEMIA, V15, P1111, DOI 10.1038/sj.leu.2402155; Mizuta T, 2008, VITAM HORM, V78, P435, DOI 10.1016/S0083-6729(07)00018-0; Pan XN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105381; Petrie K, 2009, CURR OPIN HEMATOL, V16, P84, DOI 10.1097/MOH.0b013e3283257aee; Sada E, 2010, EUR J HAEMATOL, V85, P538, DOI 10.1111/j.1600-0609.2010.01530.x; SAKAI I, 1994, BIOCHEM BIOPH RES CO, V205, P1305, DOI 10.1006/bbrc.1994.2807; SASSA T, 1970, NATURE, V227, P379, DOI 10.1038/227379a0; Sheth A, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.112; TANAKA H, 1982, BIOCHEM J, V204, P713; Vermeer Cees, 2000, Hematology-Oncology Clinics of North America, V14, P339, DOI 10.1016/S0889-8588(05)70137-4; Yaguchi M, 1997, LEUKEMIA, V11, P779, DOI 10.1038/sj.leu.2400667; Yamada K, 2001, BRIT J HAEMATOL, V114, P814, DOI 10.1046/j.1365-2141.2001.03029.x; Yamamoto-Yamaguchi Y, 2001, BRIT J HAEMATOL, V112, P697, DOI 10.1046/j.1365-2141.2001.02601.x; Yokoyama T, 2008, AUTOPHAGY, V4, P629	45	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1019-6439	1791-2423		INT J ONCOL	Int. J. Oncol.	AUG	2015	47	2					473	480		10.3892/ijo.2015.3028		8	Oncology	Oncology	CM8QC	WOS:000357965700008		
J	Zheng, B; Ohuchida, K; Cui, L; Zhao, M; Shindo, K; Fujiwara, K; Manabe, T; Torata, N; Moriyama, T; Miyasaka, Y; Ohtsuka, T; Takahata, S; Mizumoto, K; Oda, Y; Tanaka, M				Zheng, Biao; Ohuchida, Kenoki; Cui, Lin; Zhao, Ming; Shindo, Koji; Fujiwara, Kenji; Manabe, Tatsuya; Torata, Nobuhiro; Moriyama, Taiki; Miyasaka, Yoshihiro; Ohtsuka, Takao; Takahata, Shunichi; Mizumoto, Kazuhiro; Oda, Yoshinao; Tanaka, Masao			TM4SF1 as a prognostic marker of pancreatic ductal adenocarcinoma is involved in migration and invasion of cancer cells	INTERNATIONAL JOURNAL OF ONCOLOGY			English	Article						Transmembrane 4 L6 family member 1; pancreatic ductal adenocarcinoma; prognosis; migration; invasion	TUMOR-ASSOCIATED ANTIGEN-L6; GENE-EXPRESSION; E-CADHERIN; STELLATE CELLS; LUNG-CANCER; METASTASIS; L6; PROGRESSION; CARCINOMA; ANTIBODY	The cell surface protein Transmembrane 4 L6 family member 1 (TM4SF1) has been detected in various tumors, and its expression on tumor cells is implicated in cancer cell metastasis and patient prognosis. The role of TM4SF1 in malignant tumors remains poorly understood, particularly in pancreatic cancer. We performed immunohistochemical staining to analyze the expression of TM4SF1 in resected pancreatic tissues and investigated the correlation between TM4SF1 expression and prognosis. The function of TM4SF1 in the invasion and migration of pancreatic cancer cells was analyzed in vitro using an RNA interference technique. In pancreatic cancer tissues, TM4SF1 expression was detected in cancer cells, and patients with high tumor levels of TM4SF1 showed longer survival times than those with low TM4SF1 levels (P=0.0332). In vitro, reduced TM4SF1 expression enhanced the migration (P<0.05) and invasion (P<0.05) of pancreatic cancer cells partially via decreased E-cadherin expression. TM4SF1 protein levels were also reduced after TGF-beta 1-induced epithelial-mesenchymal transition (EMT). TM4SF1 expression is associated with better prognosis in pancreatic cancer. Loss of TM4SF1 contributes to the invasion and migration of pancreatic cancer cells.	[Zheng, Biao; Ohuchida, Kenoki; Cui, Lin; Zhao, Ming; Shindo, Koji; Fujiwara, Kenji; Manabe, Tatsuya; Torata, Nobuhiro; Moriyama, Taiki; Miyasaka, Yoshihiro; Ohtsuka, Takao; Takahata, Shunichi; Mizumoto, Kazuhiro; Tanaka, Masao] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Oncol, Fukuoka 8128582, Japan; [Ohuchida, Kenoki] Kyushu Univ, Grad Sch Med Sci, Adv Med Initiat, Fukuoka 8128582, Japan; [Shindo, Koji; Oda, Yoshinao] Kyushu Univ, Grad Sch Med Sci, Dept Anat Pathol, Fukuoka 8128582, Japan; [Mizumoto, Kazuhiro] Kyushu Univ Hosp, Ctr Canc, Fukuoka 812, Japan; [Shindo, Koji] Japan Soc Promot Sci, Tokyo, Japan; [Zheng, Biao] Heilongjiang Prov Hosp, Dept Gen Surg, Harbin, Peoples R China	Ohuchida, K (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Surg & Oncol, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	kenoki@surgl.med.kyushu-u.ac.jp; mizumoto@surgl.med.kyushu-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [26293305, 25293285]; China Scholarship Council	This study was supported by Grant-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan (grant nos. 26293305 and 25293285). We are grateful to Emiko Manabe and Miyuki Omori (Department of Surgery and Oncology, Kyushu University) for skillful technical assistance, and thankful for scholarships to Biao Zheng by China Scholarship Council (http://www.csc.edu.cn/).	Nakamoto T, 2009, J GASTROENTEROL, V44, P889, DOI 10.1007/s00535-009-0081-3; Abba MC, 2004, BREAST CANCER RES, V6, pR499, DOI 10.1186/bcr899; Ohuchida K, 2004, CANCER RES, V64, P3215, DOI 10.1158/0008-5472.CAN-03-2464; Adachi M, 1996, CANCER RES, V56, P1751; Kozono S, 2013, CANCER RES, V73, P2345, DOI 10.1158/0008-5472.CAN-12-3180; Zukauskas A, 2011, ANGIOGENESIS, V14, P345, DOI 10.1007/s10456-011-9218-0; Testa JE, 1999, CANCER RES, V59, P3812; Kang YB, 2004, CELL, V118, P277, DOI 10.1016/j.cell.2004.07.011; Hemler ME, 2003, ANNU REV CELL DEV BI, V19, P397, DOI 10.1146/annurev.cellbio.19.111301.153609; Moustakas A, 2012, SEMIN CANCER BIOL, V22, P446, DOI 10.1016/j.semcancer.2012.04.002; Shimamura T, 2003, J CLIN ONCOL, V21, P659, DOI 10.1200/JCO.2003.06.179; DiMagno EP, 1999, GASTROENTEROLOGY, V117, P1464, DOI 10.1016/S0016-5085(99)70298-2; Longo N, 2001, BLOOD, V98, P3717, DOI 10.1182/blood.V98.13.3717; Zoller M, 2009, NAT REV CANCER, V9, P40, DOI 10.1038/nrc2543; Allioli N, 2011, PROSTATE, V71, P1239, DOI 10.1002/pros.21340; Ruseva Z, 2009, EXP CELL RES, V315, P1759, DOI 10.1016/j.yexcr.2009.01.007; Endo K, 2000, HUM PATHOL, V31, P558, DOI 10.1053/hp.2000.6683; Ikenaga N, 2010, GASTROENTEROLOGY, V139, P1041, DOI 10.1053/j.gastro.2010.05.084; Lekishvili T, 2008, J CELL SCI, V121, P685, DOI 10.1242/jcs.020347; Sterk LMT, 2000, J CELL BIOL, V149, P969, DOI 10.1083/jcb.149.4.969; De Craene B, 2013, NAT REV CANCER, V13, P97, DOI 10.1038/nrc3447; Shih SC, 2009, CANCER RES, V69, P3272, DOI 10.1158/0008-5472.CAN-08-4886; Berditchevski F, 2001, J CELL SCI, V114, P4143; Novitskaya V, 2010, CANCER RES, V70, P4698, DOI 10.1158/0008-5472.CAN-09-4330; Boucheix C., 2001, EXPERT REV MOL MED, V2001, P1; BRINGUIER PP, 1993, CANCER RES, V53, P3241; Cui L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012121; Edge SB, 2010, AJCC CANC STAGING MA, P241; Ellenrieder V, 1999, ANN ONCOL         S4, V10, pS46; Gordon GJ, 2003, J NATL CANCER I, V95, P598; Hruban RH, 2010, WHO CLASSIFICATION T, P281; Ikenaga N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040434; IWAMOTO Y, 1994, INT ORTHOP, V18, P240; Kanetaka K, 2003, J GASTROEN HEPATOL, V18, P1309, DOI 10.1046/j.1440-1746.2003.03182.x; Kao YR, 2003, CLIN CANCER RES, V9, P2807; Lou CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050956; Maecker HT, 1997, FASEB J, V11, P428; MARKEN JS, 1992, P NATL ACAD SCI USA, V89, P3503, DOI 10.1073/pnas.89.8.3503; Moriyama T, 2010, CANCER-AM CANCER SOC, V116, P3357, DOI 10.1002/cncr.25121; Schiedeck THK, 2003, DIS COLON RECTUM, V46, P818, DOI 10.1097/01.DCR.0000069956.47576.26; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Svensson HP, 1998, J MED CHEM, V41, P1507, DOI 10.1021/jm970779w; Tu SH, 2012, J IMMUNOTHER, V35, P235, DOI 10.1097/CJI.0b013e318248f2ae	43	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1019-6439	1791-2423		INT J ONCOL	Int. J. Oncol.	AUG	2015	47	2					490	498		10.3892/ijo.2015.3022		9	Oncology	Oncology	CM8QC	WOS:000357965700010		
J	Mizukami, T; Togashi, Y; Sogabe, S; Banno, E; Terashima, M; de Velasco, MA; Sakai, K; Fujita, Y; Tomida, S; Nakajima, TE; Boku, N; Nishio, K				Mizukami, Takuro; Togashi, Yosuke; Sogabe, Shunsuke; Banno, Eri; Terashima, Masato; de Velasco, Marco A.; Sakai, Kazuko; Fujita, Yoshihiko; Tomida, Shuta; Nakajima, Takako Eguchi; Boku, Narikazu; Nishio, Kazuto			EGFR and HER2 signals play a salvage role in MEK1-mutated gastric cancer after MEK inhibition	INTERNATIONAL JOURNAL OF ONCOLOGY			English	Article						gastric cancer; MEKI mutation; MEK inhibitor; EGFR; HER2	CELL LUNG-CANCER; GENE AMPLIFICATION; THERAPEUTIC TARGET; COLORECTAL-CANCER; PANCREATIC-CANCER; DRIVER MUTATIONS; COLON-CANCER; BRAF GENE; PHASE-III; GROWTH	Since the prognosis of unresectable advanced gastric cancer remains poor, novel therapeutic strategies are needed. Somatic MEKI gene mutations have been reported as oncogenic activating mutations in gastric cancer, and MEK inhibitors can be effective against such gastric cancers. In the present study, however, activated EGFR and HER2 signals after treatment with a MEK inhibitor (trametinib) were found in a MEK1-mutated gastric cancer cell line (OCUM-1 cell line) using a phospho-receptor tyrosine kinase array. The phosphorylation of EGFR and HER2 reactivated ERK1/2, which had been inhibited by trametinib, and EGF stimulation led to resistance to trametinib in this cell line. Lapatinib, an EGFR and an HER2 inhibitor, reversed the activation of ERK1/2 by inhibiting the phosphorylation of EGFR and HER2 and cancelled the resistance. The combination of trametinib and lapatinib synergistically inhibited the cell growth of the OCUM-1 cell line and strongly induced apoptosis by inhibiting the activated EGFR and HER2 signals. These results suggest that the EGFR and HER2 signals play a salvage role and are related to resistance to MEK inhibitors in MEK1-mutated gastric cancer. Moreover, combination therapy with trametinib and lapatinib can exhibit a synergistic effect and may contribute to overcoming the resistance to MEK inhibitors.	[Mizukami, Takuro; Togashi, Yosuke; Sogabe, Shunsuke; Banno, Eri; Terashima, Masato; de Velasco, Marco A.; Sakai, Kazuko; Fujita, Yoshihiko; Tomida, Shuta; Nishio, Kazuto] Kinki Univ, Sch Med, Dept Genome Biol, Osaka 5898511, Japan; [Mizukami, Takuro; Nakajima, Takako Eguchi; Boku, Narikazu] St Marianna Univ, Sch Med, Dept Clin Oncol, Kawasaki, Kanagawa, Japan	Nishio, K (reprint author), Kinki Univ, Sch Med, Dept Genome Biol, 377-2 Ohnohigashi, Osaka 5898511, Japan.	knishio@med.kindai.ac.jp					Gravalos C, 2008, ANN ONCOL, V19, P1523, DOI 10.1093/annonc/mdn169; Koizumi W, 2008, LANCET ONCOL, V9, P215, DOI [10.1016/S1470-2045(08)70035-4, 10.1016/S1470-204S(08)70035-4]; Pao W, 2011, LANCET ONCOL, V12, P175, DOI 10.1016/S1470-2045(10)70087-5; Bollag G, 2010, NATURE, V467, P596, DOI 10.1038/nature09454; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Yano T, 2006, ONCOL REP, V15, P65; Emery CM, 2009, P NATL ACAD SCI USA, V106, P20411, DOI 10.1073/pnas.0905833106; Van Schaeybroeck S, 2005, CLIN CANCER RES, V11, P7480, DOI 10.1158/1078-0432.CCR-05-0328; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Wang K, 2014, NAT GENET, V46, P573, DOI 10.1038/ng.2983; Kawakami H, 2013, ONCOTARGET, V4, P9; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Cunningham D, 2008, NEW ENGL J MED, V358, P36, DOI 10.1056/NEJMoa073149; Sun C, 2014, CELL REP, V7, P86, DOI 10.1016/j.celrep.2014.02.045; Walters DM, 2013, NEOPLASIA, V15, P143, DOI 10.1593/neo.121712; Hingorani SR, 2003, CANCER RES, V63, P5198; Kaneda H, 2010, CANCER RES, V70, P2053, DOI 10.1158/0008-5472.CAN-09-2161; Prahallad A, 2012, NATURE, V483, P100, DOI 10.1038/nature10868; Van Cutsem E, 2006, J CLIN ONCOL, V24, P4991, DOI 10.1200/JCO.2006.06.8429; Kakiuchi M, 2014, NAT GENET, V46, P583, DOI 10.1038/ng.2984; Li TH, 2007, CLIN CANCER RES, V13, P3413, DOI 10.1158/1078-0432.CCR-06-2923; Marks JL, 2008, CANCER RES, V68, P5524, DOI 10.1158/0008-5472.CAN-08-0099; Bang YJ, 2010, LANCET, V376, P687, DOI 10.1016/S0140-6736(10)61121-X; Bentivegna S, 2008, HUM MUTAT, V29, P441, DOI 10.1002/humu.20672; Corcoran RB, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001148; Estep AL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001279; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Freeman AK, 2013, MOL MECH TUMOR CELL, P47; Little AS, 2011, SCI SIGNAL, V4, P17; Matsumoto K, 2012, BRIT J CANCER, V106, P727, DOI 10.1038/bjc.2011.603; SAKAI K, 1986, J NATL CANCER I, V77, P1047; Sogabe S, 2014, MOL CANCER THER, V13, P3098, DOI 10.1158/1535-7163.MCT-14-0429; Togashi Y, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-126	34	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1019-6439	1791-2423		INT J ONCOL	Int. J. Oncol.	AUG	2015	47	2					499	505		10.3892/ijo.2015.3050		7	Oncology	Oncology	CM8QC	WOS:000357965700011		
J	Miyata, M; Morishita, A; Sakamoto, T; Katsura, A; Kato, K; Nishioka, T; Toyota, Y; Fujita, K; Maeda, E; Nomura, T; Tani, J; Miyoshi, H; Yoneyama, H; Kobara, H; Fujiwara, S; Nishiyama, N; Iwama, H; Himoto, T; Hirashima, M; Masaki, T				Miyata, Miwa; Morishita, Asahiro; Sakamoto, Teppei; Katsura, Akiko; Kato, Kiyohito; Nishioka, Tomoko; Toyota, Yuka; Fujita, Koji; Maeda, Emiko; Nomura, Takako; Tani, Joji; Miyoshi, Hisaaki; Yoneyama, Hirohito; Kobara, Hideki; Fujiwara, Shintaro; Nishiyama, Noriko; Iwama, Hisakazu; Himoto, Taicashi; Hirashima, Mitsuomi; Masaki, Tsutomu			MicroRNA profiles in cisplatin-induced apoptosis of hepatocellular carcinoma cells	INTERNATIONAL JOURNAL OF ONCOLOGY			English	Article						microRNA; cisplatin; apoptosis; hepatocellular carcinoma; cell cycle	EXPRESSION; GROWTH; CANCER; RESISTANCE; HEPATITIS; SUBSTRATE; PATHWAYS; PROTEINS; TARGET; PTEN	Cisplatin [cis-diamminedichloroplatinum (II)], is a platinum coordination compound that is commonly used to treat hepatocellular carcinoma (HCC). It is also one of the most compelling anticancer drugs. Recent studies suggest that cisplatin may reduce cancer risk and improve prognosis. However, the antitumor mechanism of cisplatin in several types of cancers, including HCC, has not been elucidated. The goal of the present study was to evaluate the effects of cisplatin on the proliferation of HCC cells in vitro and to determine which microRNAs (miRNAs) are associated with the anticancer effects of cisplatin in vitro. We used various human HCC-derived cell lines to study the effects of cisplatin on human HCC cells. Cisplatin led to a strong dose- and time-dependent inhibition of cell proliferation in HLE, HLF, HuH7, Li-7, Hep3B and HepG2 cells in vitro. Cisplatin also blocked the progression of the cell cycle in the G0/G1 phase, which inhibited cyclin D1 and induced apoptosis. In addition, miRNA expression was markedly altered by treatment with cisplatin in vitro. Therefore, various miRNAs induced by cisplatin may also contribute to the suppression of cellular proliferation and apoptosis. Our results demonstrate that cisplatin inhibits the growth of HCC, possibly through the induction of G1 cell cycle arrest and apoptosis through the alteration of microRNA expression.	[Miyata, Miwa; Morishita, Asahiro; Sakamoto, Teppei; Katsura, Akiko; Kato, Kiyohito; Nishioka, Tomoko; Toyota, Yuka; Fujita, Koji; Maeda, Emiko; Nomura, Takako; Tani, Joji; Miyoshi, Hisaaki; Yoneyama, Hirohito; Kobara, Hideki; Fujiwara, Shintaro; Nishiyama, Noriko; Hirashima, Mitsuomi; Masaki, Tsutomu] Kagawa Univ, Fac Med, Dept Gastroenterol & Neurol, Miki, Kagawa 7610793, Japan; [Iwama, Hisakazu] Kagawa Univ, Fac Med, Life Sci Res Ctr, Miki, Kagawa 7610793, Japan; [Himoto, Taicashi] Kagawa Prefectural Univ Hlth Sci, Dept Med Technol, Takamatsu, Kagawa 7610123, Japan	Masaki, T (reprint author), Kagawa Univ, Sch Med, Dept Gastroenterol & Neurol, 1750-1 Ikenobe, Miki, Kagawa 7610793, Japan.	tmasaki@med.kagawa-u.ac.jp					Li D, 2011, J BIOL CHEM, V286, P36677, DOI 10.1074/jbc.M111.270561; Fu XY, 2012, INT J MOL SCI, V13, P8514, DOI 10.3390/ijms13078514; Fuertes MA, 2003, CURR MED CHEM, V10, P257; Yang X, 2013, HEPATOLOGY, V58, P158, DOI 10.1002/hep.26305; Wong QWL, 2008, GASTROENTEROLOGY, V135, P257, DOI 10.1053/j.gastro.2008.04.003; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee EJ, 2007, INT J CANCER, V120, P1046, DOI 10.1002/ijc.22394; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Reuveni H, 2013, CANCER RES, V73, P4383, DOI 10.1158/0008-5472.CAN-12-3385; Varnholt H, 2008, HEPATOLOGY, V47, P1223, DOI 10.1002/hep.22158; Takamizawa J, 2004, CANCER RES, V64, P3753, DOI 10.1158/0008-5472.CAN-04-0637; LEE PH, 1995, ANN SURG, V222, P670, DOI 10.1097/00000658-199511000-00010; Yang SM, 2013, TOXICOLOGY, V306, P162, DOI 10.1016/j.tox.2013.02.014; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Guo YJ, 2011, MOL CELL BIOCHEM, V354, P275, DOI 10.1007/s11010-011-0827-0; Michael MZ, 2003, MOL CANCER RES, V1, P882; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Galluzzi L, 2012, ONCOGENE, V31, P1869, DOI 10.1038/onc.2011.384; Tanaka S, 1996, CANCER RES, V56, P3391; Gramantieri L, 2007, CANCER RES, V67, P6092, DOI 10.1158/0008-5472.CAN-06-4607; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999; Masaki T, 2005, INT J ONCOL, V26, P661; Asechi H, 2010, INT J ONCOL, V37, P89, DOI 10.3892/ijo_00000656; Belghiti Jacques, 2005, HPB (Oxford), V7, P42, DOI 10.1080/13651820410024067; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Chen LZ, 2011, MOL THER, V19, P1521, DOI 10.1038/mt.2011.64; Drayton RM, 2012, BIOCHEM SOC T, V40, P821, DOI 10.1042/BST20120055; Fu XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043204; Masaki T, 2009, HEPATOL RES, V39, P751, DOI 10.1111/j.1872-034X.2009.00572.x; Matkowski P, 2006, PRZEGL EPIDEMIOL, V60, P731; ROSENBER.B, 1965, NATURE, V205, P698, DOI 10.1038/205698a0	32	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1019-6439	1791-2423		INT J ONCOL	Int. J. Oncol.	AUG	2015	47	2					535	542		10.3892/ijo.2015.3036		8	Oncology	Oncology	CM8QC	WOS:000357965700015		
J	Kato, M; Goto, Y; Matsushita, R; Kurozumi, A; Fukumoto, I; Nishikawa, R; Sakamoto, S; Enokida, H; Nakagawa, M; Ichikawa, T; Seki, N				Kato, Mayuko; Goto, Yusuke; Matsushita, Ryosuke; Kurozumi, Akira; Fukumoto, Ichiro; Nishikawa, Rika; Sakamoto, Shinichi; Enokida, Hideki; Nakagawa, Masayuki; Ichikawa, Tomohiko; Seki, Naohiko			MicroRNA-26a/b directly regulate La-related protein 1 and inhibit cancer cell invasion in prostate cancer.	INTERNATIONAL JOURNAL OF ONCOLOGY			English	Article						miR-26a; miR-26b; LARPI; prostate cancer; microRNA; tumor suppressor	BREAST-CANCER; POSTTRANSCRIPTIONAL REGULATION; DNA METHYLATION; MESSENGER-RNA; EZH2; MECHANISMS; EXPRESSION; CARCINOMA; LET-7; MIGRATION	Our past studies of microRNA (miRNA) expression signatures of cancers including prostate cancer (PCa) revealed that microRNA-26a and microRNA-26b (miR-26a and miR-26b) were significantly downregulated in cancer tissues. In the present study, we found that restoration of miR-26a or miR-26b significantly inhibited PCa cell invasion. Gene expression data and in silico analysis showed that the gene encoding La-related protein 1 (LARP1) was a putative candidate of miR-26a and miR-26b regulation. Moreover, luciferase reporter assays revealed that LARP1 was a direct target of both miR-26a and miR-26b. Overexpression of LARP1 was observed in PCa clinical specimens and knockdown of LARP1 inhibited cancer cell migration. Therefore, LARP1 acted as an oncogene in PCa cells. Moreover, 'ribosome', 'RNA transport' and 'mTOR signaling pathway' were identified as LARP1-regulated pathways. Our present data suggested that loss of tumor-suppressive miR-26a and miR-26b enhanced cancer cell invasion in PCa through direct regulation of oncogenic LARP1. Elucidation of the molecular networks regulated by tumor-suppressive miRNAs will provide insights into the molecular mechanisms of PCa oncogenesis and metastasis.	[Kato, Mayuko; Goto, Yusuke; Kurozumi, Akira; Fukumoto, Ichiro; Nishikawa, Rika; Seki, Naohiko] Chiba Univ, Grad Sch Med, Dept Funct Genom, Chiba 2608670, Japan; [Kato, Mayuko; Goto, Yusuke; Nishikawa, Rika; Sakamoto, Shinichi; Ichikawa, Tomohiko] Chiba Univ, Grad Sch Med, Dept Urol, Chiba 2608670, Japan; [Matsushita, Ryosuke; Enokida, Hideki; Nakagawa, Masayuki] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Urol, Kagoshima 890, Japan	Seki, N (reprint author), Chiba Univ, Grad Sch Med, Dept Funct Genom, 1-8-1 Inohana Chuo Ku, Chiba 2608670, Japan.	naoseki@faculty.chiba-u.jp			KAKENHI [24592590, 15K10801, 25293333]; Futaba Electronics Memorial Foundation	We are indebted to Dr Masafumi Kurosumi at Saitama Cancer Center for helpful insight and critical suggestion of pathological data. This study was supported by the KAKENHI (C), 24592590, (C), 15K10801, (B) 25293333 and Futaba Electronics Memorial Foundation.	Andersen JN, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001065; Iorio MV, 2009, J CLIN ONCOL, V27, P5848, DOI 10.1200/JCO.2009.24.0317; Kleer CG, 2003, P NATL ACAD SCI USA, V100, P11606, DOI 10.1073/pnas.1933744100; Raman JD, 2005, CLIN CANCER RES, V11, P8570, DOI 10.1158/1078-0432.CCR-05-1047; Hagan JP, 2009, NAT STRUCT MOL BIOL, V16, P1021, DOI 10.1038/nsmb.1676; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Koh CM, 2011, ONCOTARGET, V2, P669; Kojima S, 2014, J HUM GENET, V59, P78, DOI 10.1038/jhg.2013.121; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; Sparmann A, 2006, NAT REV CANCER, V6, P846, DOI 10.1038/nrcd1991; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Nishikawa R, 2014, CANCER SCI, V105, P802, DOI 10.1111/cas.12441; Nelson KM, 2008, MOL CANCER THER, V7, P3655, DOI 10.1158/1535-7163.MCT-08-0586; Fu X, 2014, ONCOGENE, V33, P4296, DOI 10.1038/onc.2013.385; Baylin SB, 2001, HUM MOL GENET, V10, P687, DOI 10.1093/hmg/10.7.687; Goto Y, 2014, ONCOTARGET, V5, P7748; Nishikawa R, 2014, INT J ONCOL, V45, P401, DOI 10.3892/ijo.2014.2437; Zhang B, 2011, CARCINOGENESIS, V32, P2, DOI 10.1093/carcin/bgq209; Zhu Y, 2012, NUCLEIC ACIDS RES, V40, P4615, DOI 10.1093/nar/gkr1278; Sturge J, 2011, NAT REV CLIN ONCOL, V8, P357, DOI 10.1038/nrclinonc.2011.67; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Liu C, 2012, CANCER RES, V72, P3393, DOI 10.1158/0008-5472.CAN-11-3864; Borno ST, 2012, CANCER DISCOV, V2, P1024, DOI 10.1158/2159-8290.CD-12-0041; Goto Y, 2014, FEBS LETT, V588, P1973, DOI 10.1016/j.febslet.2014.04.020; Tcherkezian J, 2014, GENE DEV, V28, P357, DOI 10.1101/gad.231407.113; [Anonymous], 2008, SCIENCE, DOI [DOI 10.1126/SCIENCE.1151651), 10.1126/science.1151651]; Heo I, 2008, MOL CELL, V32, P276, DOI 10.1016/j.molcel.2008.09.014; Simon JA, 2008, MUTAT RES-FUND MOL M, V647, P21, DOI 10.1016/j.mrfmmm.2008.07.010; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Lin YW, 2013, FEBS LETT, V587, P2467, DOI 10.1016/j.febslet.2013.06.021; Aoki K, 2013, FEBS LETT, V587, P2173, DOI 10.1016/j.febslet.2013.05.035; Piskounova E, 2011, CELL, V147, P1066, DOI 10.1016/j.cell.2011.10.039; Kikkawa N, 2010, BRIT J CANCER, V103, P877, DOI 10.1038/sj.bjc.6605811; Sandhu R, 2012, INT J ONCOL, V41, P721, DOI 10.3892/ijo.2012.1505; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Kojima S, 2012, BRIT J CANCER, V106, P405, DOI 10.1038/bjc.2011.462; Chi KN, 2009, EUR UROL, V56, P594, DOI 10.1016/j.eururo.2009.06.027; Fukumoto I, 2015, BRIT J CANCER, V112, P891, DOI 10.1038/bjc.2015.19; Goto Y, 2015, INT J UROL, V22, P242, DOI 10.1111/iju.12700; Meyuhas O, 2015, BBA-GENE REGUL MECH, V1849, P801, DOI 10.1016/j.bbagrm.2014.08.015; Mura M, 2014, ONCOGENE; Nadiminty N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032832; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Xie C, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-272	44	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1019-6439	1791-2423		INT J ONCOL	Int. J. Oncol.	AUG	2015	47	2					710	718		10.3892/ijo.2015.3043		9	Oncology	Oncology	CM8QC	WOS:000357965700033		
J	Seibold, P; Behrens, S; Schmezer, P; Helmbold, I; Barnett, G; Coles, C; Yarnold, J; Talbot, CJ; Imai, T; Azria, D; Koch, CA; Dunning, AM; Burnet, N; Bliss, JM; Symonds, RP; Rattay, T; Suga, T; Kerns, SL; Bourgier, C; Vallis, KA; Sautter-Bihl, ML; Classen, J; Debus, J; Schnabel, T; Rosenstein, BS; Wenz, F; West, CM; Popanda, O; Chang-Claude, J				Seibold, Petra; Behrens, Sabine; Schmezer, Peter; Helmbold, Irmgard; Barnett, Gillian; Coles, Charlotte; Yarnold, John; Talbot, Christopher J.; Imai, Takashi; Azria, David; Koch, C. Anne; Dunning, Alison M.; Burnet, Neil; Bliss, Judith M.; Symonds, R. Paul; Rattay, Tim; Suga, Tomo; Kerns, Sarah L.; Bourgier, Celine; Vallis, Katherine A.; Sautter-Bihl, Marie-Luise; Classen, Johannes; Debus, Juergen; Schnabel, Thomas; Rosenstein, Barry S.; Wenz, Frederik; West, Catharine M.; Popanda, Odilia; Chang-Claude, Jenny			XRCC1 Polymorphism Associated With Late Toxicity After Radiation Therapy in Breast Cancer Patients	INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS			English	Article							NORMAL TISSUE COMPLICATIONS; LATE RADIOTHERAPY TOXICITY; GENOME-WIDE ASSOCIATION; DNA-REPAIR; GENETIC POLYMORPHISMS; RISK; XPD; RADIOSENSITIVITY; RADIOGENOMICS; VARIANT	Purpose: To identify single-nucleotide polymorphisms (SNPs) in oxidative stresse related genes associated with risk of late toxicities in breast cancer patients receiving radiation therapy. Methods and Materials: Using a 2-stage design, 305 SNPs in 59 candidate genes were investigated in the discovery phase in 753 breast cancer patients from 2 prospective cohorts from Germany. The 10 most promising SNPs in 4 genes were evaluated in the replication phase in up to 1883 breast cancer patients from 6 cohorts identified through the Radiogenomics Consortium. Outcomes of interest were late skin toxicity and fibrosis of the breast, as well as an overall toxicity score (Standardized Total Average Toxicity). Multivariable logistic and linear regression models were used to assess associations between SNPs and late toxicity. A meta-analysis approach was used to summarize evidence. Results: The association of a genetic variant in the base excision repair gene XRCC1, rs2682585, with normal tissue late radiation toxicity was replicated in all tested studies. In the combined analysis of discovery and replication cohorts, carrying the rare allele was associated with a significantly lower risk of skin toxicities (multivariate odds ratio 0.77, 95% confidence interval 0.61-0.96, P=.02) and a decrease in Standardized Total Average Toxicity scores (-0.08, 95% confidence interval -0.15 to -0.02, P=.016). Conclusions: Using a stage design with replication, we identified a variant allele in the base excision repair gene XRCC1 that could be used in combination with additional variants for developing a test to predict late toxicities after radiation therapy in breast cancer patients. (C) 2015 Elsevier Inc. All rights reserved.	[Seibold, Petra; Behrens, Sabine; Helmbold, Irmgard; Chang-Claude, Jenny] German Canc Res Ctr, Div Canc Epidemiol, Heidelberg, Germany; [Schmezer, Peter; Popanda, Odilia] German Canc Res Ctr, Div Epigen & Canc Risk Factors, Heidelberg, Germany; [Barnett, Gillian; Coles, Charlotte] Cambridge Univ Hosp NHS Fdn Trust, Dept Oncol, Ctr Oncol, Cambridge, England; [Yarnold, John] Inst Canc Res & Royal Marsden NHS Fdn Trust, London, England; [Talbot, Christopher J.] Univ Leicester, Dept Genet, Leicester LE1 7RH, Leics, England; [Imai, Takashi; Suga, Tomo] Natl Inst Radiol Sci, Adv Radiat Biol Res Program, Chiba 260, Japan; [Azria, David; Bourgier, Celine] ICM Inst Reg Canc Montpellier, Dept Radiat Oncol & Med Phys, Montpellier, France; [Koch, C. Anne] Univ Hlth Network, Princess Margaret Canc Ctr, Radiat Med Program, Toronto, ON, Canada; [Dunning, Alison M.] Univ Cambridge, Ctr Canc Genet Epidemiol, Strangeways Res Lab, Cambridge, England; [Burnet, Neil] Univ Cambridge, Ctr Oncol, Cambridge Univ Hosp NHS Fdn Trust, Dept Oncol, Cambridge, England; [Bliss, Judith M.] Inst Canc Res, Clin Trials & Stat Unit, Sutton, Surrey, England; [Symonds, R. Paul; Rattay, Tim] Univ Leicester, Dept Canc Studies & Mol Med, Leicester, Leics, England; [Kerns, Sarah L.; Rosenstein, Barry S.] Icahn Sch Med Mt Sinai, Dept Radiat Oncol, New York, NH USA; [Vallis, Katherine A.] Univ Oxford, Oxford Inst Radiat Oncol, Canc Res UK Med Res Council, Oxford, England; [Sautter-Bihl, Marie-Luise] Staedt Klinikum Karlsruhe, Dept Radiat Oncol, Karlsruhe, Germany; [Classen, Johannes] St Vincentius Kliniken gAG, Clin Radiat Therapy & Radiat Oncol, Karlsruhe, Germany; [Debus, Juergen] Heidelberg Univ, Dept Radiat Oncol, Heidelberg, Germany; [Schnabel, Thomas] Klinikum Ludwigshafen, Clin Radiotherapy & Radiat Oncol, Ludwigshafen, Germany; [Wenz, Frederik] Heidelberg Univ, Univ Med Ctr Mannheim, Dept Radiat Oncol, Mannheim, Germany; [West, Catharine M.] Univ Manchester, Inst Canc Sci, Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England	Chang-Claude, J (reprint author), German Canc Res Ctr, Div Canc Epidemiol C020, Neuenheimer Feld 581, D-69120 Heidelberg, Germany.	j.chang-claude@dkfz.de	West, Catharine/J-4152-2012	West, Catharine/0000-0002-0839-3449	MARIE<INF>RAD</INF> cohort, Germany: Dietmar Hopp Stiftung [23017006]; MARIE<INF>RAD</INF> cohort, Germany: Deutsche Krebshilfe [108253, 108419]; ISE-2 cohort, Germany: Federal Office for Radiation Protection [St Sch. 4116, 4233]; ISE-2 cohort, Germany: US Army Medical Research and Materiel Command (USAMRMC) Breast Cancer Research Program (BCRP) [DAMD17-02-10500]; BRRG cohort, Japan: National Institute of Radiological Sciences (NIRS); CIHR cohort, Canada: Canadian Institutes of Health Research [MOP-77703]; COHORT cohort, France: Novartis Oncology France; LeND cohort, UK: Breast Cancer Campaign [2007NovPR45]; RAPPER, UK: Cancer Research UK [C1094/AA11728, C8197/S10123]; IMRT trial, UK: Breast Cancer Campaign [2001:263, 2005Nov40]; RACE cohort, UK: Cancer Research UK, National Institute for Health Research (NIHR) Biomedical Research Centre; National Health Service (NHS) [C181/A4770]; American Cancer Society [RSGT-05-200-01-CCE]; Department of Defense [PC074201]; National Institutes of Health [1R01CA134444]; RAPPER, UK: Experimental Cancer Medicine funding	Funding was provided by the following. MARIE<INF>RAD</INF> cohort, Germany: Dietmar Hopp Stiftung (#23017006) and Deutsche Krebshilfe (#108253 and #108419). ISE-2 cohort, Germany: Federal Office for Radiation Protection (projects St Sch. 4116 and 4233), and US Army Medical Research and Materiel Command (USAMRMC) Breast Cancer Research Program (BCRP) DAMD17-02-10500. BRRG cohort, Japan: National Institute of Radiological Sciences (NIRS). CIHR cohort, Canada: Canadian Institutes of Health Research (MOP-77703). COHORT cohort, France: Institutional scientific grant support from Novartis Oncology France. LeND cohort, UK: Breast Cancer Campaign 2007NovPR45. RAPPER, UK: Cancer Research UK (C1094/AA11728, C8197/S10123) and Experimental Cancer Medicine funding. IMRT trial, UK: Breast Cancer Campaign 2001:263 & 2005Nov40. RACE cohort, UK: Cancer Research UK, National Institute for Health Research (NIHR) Biomedical Research Centre. National Health Service (NHS) funding to the NIHR Biomedical Research Centre at The Royal Marsden and The Institute of Cancer Research UK, C181/A4770. Radiogenomics Consortium is acknowledged: grants RSGT-05-200-01-CCE from the American Cancer Society, PC074201 from the Department of Defense, and 1R01CA134444 from the National Institutes of Health to BSR.	Andreassen CN, 2005, ACTA ONCOL, V44, P801, DOI 10.1080/02841860500374513; Barnett GC, 2014, RADIOTHER ONCOL, V111, P178, DOI 10.1016/j.radonc.2014.02.012; Popanda O, 2009, MUTAT RES-FUND MOL M, V667, P58, DOI 10.1016/j.mrfmmm.2008.10.014; Robertson AB, 2009, CELL MOL LIFE SCI, V66, P981, DOI 10.1007/s00018-009-8736-z; Yin M, 2011, INT J RADIAT ONCOL, V81, pE67, DOI 10.1016/j.ijrobp.2010.11.079; Barnett GC, 2012, LANCET ONCOL, V13, P65, DOI 10.1016/S1470-2045(11)70302-3; Lilla C, 2007, BREAST CANCER RES TR, V106, P143, DOI 10.1007/s10549-006-9480-9; Talbot CJ, 2012, BRIT J CANCER, V107, P748, DOI 10.1038/bjc.2012.290; Barnett GC, 2012, RADIOTHER ONCOL, V105, P289, DOI 10.1016/j.radonc.2012.10.017; Mangoni M, 2011, INT J RADIAT ONCOL, V81, P52, DOI 10.1016/j.ijrobp.2010.04.023; Suga T, 2007, INT J RADIAT ONCOL, V69, P685, DOI 10.1016/j.ijrobp.2007.06.021; Chang-Claude J, 2009, BRIT J CANCER, V100, P1680, DOI 10.1038/sj.bjc.6605036; Seibold P, 2013, BREAST, V22, P817, DOI 10.1016/j.breast.2013.02.008; Zschenker O, 2010, RADIOTHER ONCOL, V97, P26, DOI 10.1016/j.radonc.2010.01.016; Fan JB, 2003, COLD SPRING HARB SYM, V68, P69, DOI 10.1101/sqb.2003.68.69; Hornhardt S, 2014, DNA REPAIR, V16, P54, DOI 10.1016/j.dnarep.2014.02.001; Stone HB, 2003, LANCET ONCOL, V4, P529, DOI 10.1016/S1470-2045(03)01191-4; Barnett GC, 2012, INT J RADIAT ONCOL, V82, P1065, DOI 10.1016/j.ijrobp.2011.03.015; West C, 2010, INT J RADIAT ONCOL, V76, P1295, DOI 10.1016/j.ijrobp.2009.12.017; Fachal L, 2014, NAT GENET, V46, P891, DOI 10.1038/ng.3020; Al-Ghazal SK, 1999, EUR J SURG ONCOL, V25, P571, DOI 10.1053/ejso.1999.0708; Horton JK, 2008, CELL RES, V18, P48, DOI 10.1038/cr.2008.7; Bentzen SM, 2006, NAT REV CANCER, V6, P702, DOI 10.1038/nrc1950; Chang-Claude J, 2005, CLIN CANCER RES, V11, P4802, DOI 10.1158/1078-0432.CCR-04-2657; Azria D, 2010, LANCET ONCOL, V11, P258, DOI 10.1016/S1470-2045(10)70013-9; Brem R, 2006, CARCINOGENESIS, V27, P2469, DOI 10.1093/carcin/bgl114; FIRTH D, 1993, BIOMETRIKA, V80, P27, DOI 10.1093/biomet/80.1.27; Flesch-Janys Dieter, 2008, Int J Cancer, V123, P933, DOI 10.1002/ijc.23655; Giotopoulos G, 2007, BRIT J CANCER, V96, P1001, DOI 10.1038/sj.bjc.6603637; Kerns SL, 2014, RADIOTHER ONCOL, V110, P182, DOI 10.1016/j.radonc.2013.07.011; LEBESQUE JV, 1991, RADIOTHER ONCOL, V22, P45, DOI 10.1016/0167-8140(91)90068-R; Martin S, 2010, RADIOTHER ONCOL, V97, P15, DOI 10.1016/j.radonc.2010.03.019; West C, 2014, CLIN ONCOL-UK, V26, P739, DOI 10.1016/j.clon.2014.09.008	33	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0360-3016	1879-355X		INT J RADIAT ONCOL	Int. J. Radiat. Oncol. Biol. Phys.	AUG 1	2015	92	5					1084	1092		10.1016/j.ijrobp.2015.04.011		9	Oncology; Radiology, Nuclear Medicine & Medical Imaging	Oncology; Radiology, Nuclear Medicine & Medical Imaging	CM7TY	WOS:000357900600029		
J	Wada, N; Saeki, M; Masubuchi, I				Wada, N.; Saeki, M.; Masubuchi, I.			A constrained tracking control algorithm for linear systems based on a spline-type parameter-dependent Lyapunov function	INTERNATIONAL JOURNAL OF ROBUST AND NONLINEAR CONTROL			English	Article						input saturation; gain-scheduling; spline-type parameter-dependent Lyapunov function; online optimization; polynomially parameter-dependent matrix inequality	SPECIAL-ISSUE; STABILIZATION	In this paper, we propose a design method of a tracking control law for discrete-time linear systems with actuator saturation. The feedback gain of the control law is actively changed online so that the control performance is improved based on the information of the state variable and the reference signal. The control law is designed with considering the rate of convergence of the tracking error. The design condition of the control law is derived as polynomially parameter-dependent matrix inequalities, and a spline-type parameter-dependent Lyapunov function and a convex polytope are used to reduce the design condition to a finite number of LMIs. Three numerical examples are provided to illustrate effectiveness of the method. Copyright (c) 2014 John Wiley & Sons, Ltd.	[Wada, N.; Saeki, M.] Hiroshima Univ, Div Mech Syst & Appl Mech, Higashihiroshima 7398527, Japan; [Masubuchi, I.] Kobe Univ, Grad Sch Syst Informat, Nada Ku, Kobe, Hyogo 6578501, Japan	Wada, N (reprint author), Hiroshima Univ, Div Mech Syst & Appl Mech, 1-4-1 Kagamiyama, Higashihiroshima 7398527, Japan.	nwada@hiroshima-u.ac.jp					Masubuchi I, 2009, SYST CONTROL LETT, V58, P592, DOI 10.1016/j.sysconle.2009.04.002; Iwasaki T, 2001, IEEE T AUTOMAT CONTR, V46, P1195, DOI 10.1109/9.940924; Sturm JF, 1999, OPTIM METHOD SOFTW, V11-2, P625, DOI 10.1080/10556789908805766; BERNSTEIN DS, 1995, INT J ROBUST NONLIN, V5, P375, DOI 10.1002/rnc.4590050502; Boyds S, 1994, LINEAR MATRIX INEQUA; Francis B. A., 1975, SIAM J CONTROL OPTIM, V15, P480; Grognard F, 2002, AUTOMATICA, V38, P1777, DOI 10.1016/S0005-1098(02)00086-9; Hus T, 2002, AUTOMATICA, V38, P351; Lins Z, 2000, INT J ROBUST NONLIN, V10, P117; Lins Z, 1998, AUTOMATICA, V34, P897; Mantri R, 1997, INT J ROBUST NONLIN, V7, P1003, DOI 10.1002/(SICI)1099-1239(199711)7:11<1003::AID-RNC252>3.0.CO;2-2; Masubuchi I, 1998, IEEE DECIS CONTR P, P1753, DOI 10.1109/CDC.1998.758549; Megretski A., 1996, P 13 TRIENN IFAC WOR, P435; Pittet C, 1997, IEEE DECIS CONTR P, P4518, DOI 10.1109/CDC.1997.649683; Saberis A, 2000, CONTROL LINEAR SYSTE; Stoorvogel A, 1999, INT J ROBUST NONLIN, V9, P583, DOI 10.1002/(SICI)1099-1239(199908)9:10<583::AID-RNC422>3.0.CO;2-L; TEEL AR, 1995, INT J ROBUST NONLIN, V5, P399, DOI 10.1002/rnc.4590050504; Turner M, 2006, INT J SYST SCI, V37, P65, DOI 10.1080/00207720612331392435; Wada N, 2013, INT J ROBUST NONLIN, V23, P945, DOI 10.1002/rnc.2806; Wada N, 2008, SYST CONTROL LETT, V57, P255, DOI 10.1016/j.sysconle.2007.09.006	20	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1049-8923	1099-1239		INT J ROBUST NONLIN	Int. J. Robust Nonlinear Control	AUG	2015	25	12					1877	1896		10.1002/rnc.3183		20	Automation & Control Systems; Engineering, Electrical & Electronic; Mathematics, Applied	Automation & Control Systems; Engineering; Mathematics	CM7RI	WOS:000357893100010		
J	Andersen, JE; Ueno, K				Andersen, Jorgen Ellegaard; Ueno, Kenji			Construction of the Witten-Reshetikhin-Turaev TQFT from conformal field theory	INVENTIONES MATHEMATICAE			English	Article							NIELSEN-THURSTON CLASSIFICATION; MAPPING CLASS-GROUPS; 3-MANIFOLD INVARIANTS; HECKE ALGEBRAS; MODULAR CATEGORIES; SU(N) INVARIANTS; KAUFFMAN BRACKET; LINK POLYNOMIALS; QUANTUM GROUPS; REPRESENTATIONS	In Andersen and Ueno (J Knot Theory Ramif 16:127-202, 2007) we constructed the vacua modular functor based on the sheaf of vacua theory developed in Tsuchiya et al. (Adv Stud Pure Math 19:459-566, 1989) and the abelian analog in Andersen and Ueno (Int J Math 18:919-993, 2007). We here provide an explicit isomorphism from the modular functor underlying the skein-theoretic model for the Witten-Reshetikhin-Turaev TQFT due to Blanchet, Habbeger, Masbaum and Vogel to the vacua modular functor. This thus provides a geometric construction of the TQFT first proposed by Witten and constructed first by Reshetikhin-Turaev from the quantum group .	[Andersen, Jorgen Ellegaard] Univ Aarhus, Ctr Quantum Geometry Moduli Spaces, DK-8000 Aarhus, Denmark; [Ueno, Kenji] Hosei Univ, Dept Ind & Syst Engn, Fac Sci & Engn, Koganei, Tokyo 1840002, Japan	Andersen, JE (reprint author), Univ Aarhus, Ctr Quantum Geometry Moduli Spaces, DK-8000 Aarhus, Denmark.	andersen@imf.au.dk; ueno@math.kyoto-u.ac.jp			center of excellence grant "Center for quantum geometry of Moduli Spaces" from the Danish National Research Foundation; JSPS (Japan Society for the Promotion of Science) [19340007]	Supported in part by the center of excellence grant "Center for quantum geometry of Moduli Spaces" from the Danish National Research Foundation and by Grant-in-Aid for Scientific Research No. 19340007 from JSPS (Japan Society for the Promotion of Science).	Aiston A.K, 1996, THESIS U LIVERPOOL L; Andersen J.E., 2012, QUANTUM TOPOL, V3, P377; Andersen JE, 2006, Q J MATH, V57, P1, DOI 10.1093/qmath/hai008; Andersen J.E., 2011, CLAY MATH P, V14, P1; Andersen J.E., 2012, QUANTUM TOPOL, V3, P255; Andersen JE, 2008, J MATH KYOTO U, V48, P323; Andersen J.E, 2010, MANY FACETS GEOMETRY; Andersen J.E., ARXIV12062785; Andersen JE, 2010, LETT MATH PHYS, V91, P205, DOI 10.1007/s11005-009-0368-6; Andersen J.E., 2011, TRAVAUX MATH, V19, P167; Andersen J.E., ARXIV12062635; Andersen J.E, ARXIV07062184; Andersen JE, 1999, MATH ANN, V314, P291, DOI 10.1007/s002080050296; Laszlo Y, 1998, J DIFFER GEOM, V49, P547; Andersen JE, 2006, MATH PROC CAMBRIDGE, V141, P477, DOI 10.1017/S0305004106009698; RESHETIKHIN N, 1991, INVENT MATH, V103, P547, DOI 10.1007/BF01239527; Blanchet C, 2000, TOPOLOGY, V39, P193, DOI 10.1016/S0040-9383(98)00066-4; WENZL H, 1993, INVENT MATH, V114, P235, DOI 10.1007/BF01232670; Andersen JE, 2007, J KNOT THEOR RAMIF, V16, P127, DOI 10.1142/S0218216507005233; VERLINDE E, 1988, NUCL PHYS B, V300, P360, DOI 10.1016/0550-3213(88)90603-7; JONES VFR, 1987, ANN MATH, V126, P335, DOI 10.2307/1971403; MOORE G, 1989, COMMUN MATH PHYS, V123, P177, DOI 10.1007/BF01238857; Blanchet C, 1995, TOPOLOGY, V34, P883, DOI 10.1016/0040-9383(94)00051-4; WENZL H, 1988, INVENT MATH, V92, P349, DOI 10.1007/BF01404457; BLANCHET C, 1992, TOPOLOGY, V31, P685, DOI 10.1016/0040-9383(92)90002-Y; [Anonymous], 1988, ADV STUDIES PURE MAT; Aiston AK, 1998, J KNOT THEOR RAMIF, V7, P463, DOI 10.1142/S0218216598000243; MOORE G, 1988, PHYS LETT B, V212, P451, DOI 10.1016/0370-2693(88)91796-0; WALL CTC, 1969, INVENT MATH, V7, P269, DOI 10.1007/BF01404310; Andersen JE, 2006, ANN MATH, V163, P347; Andersen JE, 2007, INT J MATH, V18, P919, DOI 10.1142/S0129167X07004369; Andersen JE, 2013, J REINE ANGEW MATH, V681, P1, DOI 10.1515/crelle-2012-0033; FREYD P, 1985, B AM MATH SOC, V12, P239, DOI 10.1090/S0273-0979-1985-15361-3; KNIZHNIK VG, 1984, NUCL PHYS B, V247, P83, DOI 10.1016/0550-3213(84)90374-2; ATIYAH M, 1990, TOPOLOGY, V29, P1, DOI 10.1016/0040-9383(90)90021-B; Atiyah M.F., 1990, LEZIONI LINCEE; Bakalov B., 2001, U LECT SERIES, V21; Funar L, 1999, PAC J MATH, V188, P251; Grove J, 2001, J KNOT THEOR RAMIF, V10, P1085, DOI 10.1142/S0218216501001347; GYOJA A, 1986, OSAKA J MATH, V23, P841; HITCHIN NJ, 1990, COMMUN MATH PHYS, V131, P347, DOI 10.1007/BF02161419; Kanie Y., 1989, B FACULTY ED MIE U, V40, P1; KAWAMOTO N, 1988, COMMUN MATH PHYS, V116, P247, DOI 10.1007/BF01225258; KOHNO T, 1992, INT J MOD PHYS B, V6, P1795, DOI 10.1142/S0217979292000864; Kontsevich M.:, 1988, RATIONAL CONFORMAL F; Laszlo Y, 2013, J GEOM PHYS, V64, P64, DOI 10.1016/j.geomphys.2012.11.003; Lickorish WBR, 1997, J KNOT THEOR RAMIF, V6, P45, DOI 10.1142/S0218216597000054; Lickorish WBR, 2000, COMMENT MATH HELV, V75, P45, DOI 10.1007/s000140050112; Masbaum G., 1999, CONT MATH, V233, P137; RESHETIKHIN NY, 1990, COMMUN MATH PHYS, V127, P1, DOI 10.1007/BF02096491; Segal G., 2004, LONDON MATH SOC LECT, V38, P421; Tsuchiya A., 1989, ADV STUD PURE MATH, V19, P459; Turaev V, 1997, MATH ANN, V309, P411, DOI 10.1007/s002080050120; Turaev V. G., 1993, INT J MATH, V4, P323, DOI 10.1142/S0129167X93000170; Turaev V. G., 1994, DEGRUYTER STUDIES MA, V18; Ueno K, 1997, LECT NOTES PURE APPL, V184, P603; Ueno K., 2008, ADV ALGEBRA COMBINAT, P335, DOI 10.1142/9789812790019_0021; UENO K, 1995, LOND MATH S, V208, P283, DOI 10.1017/CBO9780511569319.011; Ueno K., 2008, FIELDS I MONOGRAPHS, V24; Walker K., 1991, WITTENS 3 MANIFOLD I; WITTEN E, 1989, COMMUN MATH PHYS, V121, P351, DOI 10.1007/BF01217730; Yokota Y, 1997, MATH ANN, V307, P109, DOI 10.1007/s002080050025	62	2	2	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0020-9910	1432-1297		INVENT MATH	Invent. Math.	AUG	2015	201	2					519	559		10.1007/s00222-014-0555-7		41	Mathematics	Mathematics	CN0FJ	WOS:000358089200002		
J	Hinoda, T; Fushimi, Y; Okada, T; Fujimoto, K; Liu, CL; Yamamoto, A; Okada, T; Kido, A; Togashi, K				Hinoda, Takuya; Fushimi, Yasutaka; Okada, Tomohisa; Fujimoto, Koji; Liu, Chunlei; Yamamoto, Akira; Okada, Tsutomu; Kido, Aki; Togashi, Kaori			Quantitative Susceptibility Mapping at 3 T and 1.5 T Evaluation of Consistency and Reproducibility	INVESTIGATIVE RADIOLOGY			English	Article							HUMAN BRAIN; MAGNETIC-SUSCEPTIBILITY; IN-VIVO; PARKINSONS-DISEASE; MULTIPLE-SCLEROSIS; ALZHEIMERS-DISEASE; SUBSTANTIA-NIGRA; IRON CONTENT; PHASE DATA; MRI	Objectives The aim of this study was to assess the consistency and reproducibility of quantitative susceptibility mapping (QSM) at 3-T and 1.5-T magnetic resonance (MR) scanners. Materials and Methods This study was approved by institutional ethics committee, and written informed consent was obtained. Twenty-two healthy volunteers underwent 2 examinations on different days. Each examination consisted of MR imaging on both 3-T and 1.5-T MR scanners. The data from both scanners and examination days were obtained, and QSM was calculated with STI Suite using 2 different algorithms-harmonic phase removal using laplacian operator (HARPERELLA) and a sophisticated harmonic artifact reduction for phase data (SHARP) method with a variable radius of the spherical kernel at the brain boundary (V-SHARP). We evaluated consistency of QSM between 3 T and 1.5 T and the reproducibility between the first and second examinations using 2-phase processing methods (HARPERELLA and V-SHARP). Results Susceptibility values of regions of interests at 3 T were highly correlated with those at 1.5 T with good agreement (HARPERELLA, R-2 = 0.838; V-SHARP, R-2 = 0.898) (average difference, +/- 1.96 SD; HARPERELLA, -0.012 +/- 0.046; V-SHARP, -0.002 +/- 0.034). Reproducibility analysis demonstrated excellent correlation between the first and second examination at both 3 T and 1.5 T for both algorithms (HARPERELLA at 3 T, R-2 = 0.921; 1.5 T, R-2 = 0.891; V-SHARP at 3 T, R-2 = 0.937; 1.5 T, R-2 = 0.926). Bland-Altman analysis showed excellent reproducibility for HARPERELLA (3 T, -0.003 +/- 0.032; 1.5 T, -0.003 +/- 0.038) and V-SHARP (3 T, -0.003 +/- 0.027; 1.5 T, -0.003 +/- 0.029). Susceptibility values of these 2 algorithms were highly correlated with good agreement (3T, R-2 = 0.961; 1.5 T, R-2 = 0.931) (3 T, 0.009 +/- 0.023; 1.5 T, -0.003 +/- 0.049). Conclusions Quantitative susceptibility mapping with HARPERELLA and V-SHARP demonstrated good reproducibility at 3 T and 1.5 T, and QSM with V-SHARP demonstrated good consistency at 3 T and 1.5 T.	[Hinoda, Takuya; Fushimi, Yasutaka; Okada, Tomohisa; Fujimoto, Koji; Yamamoto, Akira; Okada, Tsutomu; Kido, Aki; Togashi, Kaori] Kyoto Univ, Grad Sch Med, Dept Diagnost Imaging & Nucl Med, Sakyo, Kyoto 6068507, Japan; [Liu, Chunlei] Duke Univ, Med Ctr, Brain Imaging & Anal Ctr, Durham, NC USA; [Liu, Chunlei] Duke Univ, Med Ctr, Dept Radiol, Durham, NC USA	Fushimi, Y (reprint author), Kyoto Univ, Grad Sch Med, Dept Diagnost Imaging & Nucl Med, 54 Shogoinkawaharacho, Sakyo, Kyoto 6068507, Japan.	yfushimi@kuhp.kyoto-u.ac.jp			Japan Society for the Promotion of Science KAKENHI [25461815]; Toshiba Medical Systems Corporation, Japan [150100700014]	Supported by the Japan Society for the Promotion of Science KAKENHI grant number 25461815 and a sponsored research program "Researches for improvement of MR visualization ( number 150100700014)" provided to 1 of the authors, Professor Kaori Togashi, by Toshiba Medical Systems Corporation, Japan.	Schweser F, 2011, NEUROIMAGE, V54, P2789, DOI 10.1016/j.neuroimage.2010.10.070; Wu B, 2012, MAGN RESON MED, V67, P137, DOI 10.1002/mrm.23000; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Bilgic B, 2012, NEUROIMAGE, V59, P2625, DOI 10.1016/j.neuroimage.2011.08.077; Chen WW, 2014, RADIOLOGY, V270, P496, DOI 10.1148/radiol.13122640; Wharton S, 2010, MAGN RESON MED, V63, P1292, DOI 10.1002/mrm.22334; Liu T, 2011, MAGN RESON MED, V66, P777, DOI 10.1002/mrm.22816; Lee J, 2010, NEUROIMAGE, V49, P193, DOI 10.1016/j.neuroimage.2009.07.017; Li W, 2012, NEUROIMAGE, V59, P2088, DOI 10.1016/j.neuroimage.2011.10.038; Lotfipour AK, 2012, J MAGN RESON IMAGING, V35, P48, DOI 10.1002/jmri.22752; Reichenbach JR, 2012, NEUROIMAGE, V62, P1311, DOI [10.1016/j.neuroimage.2012.01.004, 10.1016/j.neuroimage.2012.01.094]; Schenck JF, 1996, MED PHYS, V23, P815, DOI 10.1118/1.597854; Hammond KE, 2008, NEUROIMAGE, V39, P1682, DOI 10.1016/j.neuroimage.2007.10.037; GORELL JM, 1995, NEUROLOGY, V45, P1138; Raven EP, 2013, J ALZHEIMERS DIS, V37, P127, DOI 10.3233/JAD-130209; Liu T, 2009, MAGN RESON MED, V61, P196, DOI 10.1002/mrm.21828; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; de Rochefort L, 2010, MAGN RESON MED, V63, P194, DOI 10.1002/mrm.22187; Shmueli K, 2009, MAGN RESON MED, V62, P1510, DOI 10.1002/mrm.22135; de Rochefort L, 2008, MAGN RESON MED, V60, P1003, DOI 10.1002/mrm.21710; Liu CL, 2011, NEUROIMAGE, V56, P930, DOI 10.1016/j.neuroimage.2011.02.024; Haacke EM, 2005, MAGN RESON IMAGING, V23, P1, DOI 10.1016/j.mri.2004.10.001; Tan H, 2014, INVEST RADIOL, V49, P498, DOI 10.1097/RLI.0000000000000043; Duyn JH, 2007, P NATL ACAD SCI USA, V104, P11796, DOI 10.1073/pnas.0610821104; Li W, 2015, NEUROIMAGE, V108, P111, DOI 10.1016/j.neuroimage.2014.12.043; Liu T, 2012, RADIOLOGY, V262, P269, DOI 10.1148/radiol.11110251; Langkammer C, 2012, NEUROIMAGE, V62, P1593, DOI 10.1016/j.neuroimage.2012.05.049; Langkammer C, 2013, RADIOLOGY, V267, P551, DOI 10.1148/radiol.12120707; Chen WW, 2014, RADIOLOGY, V271, P183, DOI 10.1148/radiol.13130353; DEDMAN DJ, 1992, BIOCHEM J, V287, P509; Deistung A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057924; Fritzsch D, 2014, INVEST RADIOL, V49, P299, DOI 10.1097/RLI.0000000000000010; Khalil M, 2011, MULT SCLER INT, V2011, DOI DOI 10.1155/2011/606807; Li W, 2014, NMR BIOMED, V27, P219, DOI 10.1002/nbm.3056; Lim IAL, 2013, NEUROIMAGE, V82, P449, DOI 10.1016/j.neuroimage.2013.05.127; Lin PY, 2015, AM J NEURORADIOL, V36, P467, DOI 10.3174/ajnr.A4137	36	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0020-9996	1536-0210		INVEST RADIOL	Invest. Radiol.	AUG	2015	50	8					522	530		10.1097/RLI.0000000000000159		9	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CM9QV	WOS:000358044900008		
J	Huang, F; Liu, C; Maruoka, N; Kitamura, SY				Huang, F.; Liu, C.; Maruoka, N.; Kitamura, S. -Y.			Dissolution behaviour of MgO based refractories in CaO-Al2O3-SiO2 slag	IRONMAKING & STEELMAKING			English	Article						Dissolution; Refractory; MgO-C; MgO-Cr2O3; Slag	STAINLESS-STEEL SLAGS; DEGRADATION MECHANISMS; CARBON REFRACTORIES; CORROSION; PARTICLES; VACUUM; OXIDE	Magnesium oxide (MgO) based refractories are widely used in secondary refining processes, and their dissolution into refining slag is the primary cause of their shortened lifespan. The dissolution rate was investigated for sintered MgO and commercial MgO-C and MgO-Cr2O3 refractories in a synthesised 50CaO-45Al(2)O(3)-5SiO(2) liquid (mass-%) slag. The change in slag composition was measured after a refractory sample was placed into the molten slag that was stirred by flowing argon gas at 1773 K. The dissolution rate of the sintered MgO was above those of the MgO-C and MgO-Cr2O3 refractories under the same gas flowrate, although the dissolution rate of all samples increased as the gas flowrate was increased from 25 to 75 mL.min(-1). The slag containing 5 mass-% FeO considerably promoted the dissolution of the MgO-C refractory because of the oxidation of carbon by FeO. The dissolution of all the refractories was greatly affected by penetration of the liquid slag, with the mass transfer of MgO in the penetrating slag at lower gas flowrates likely being the rate controlling step. At high gas flowrates, Ar bubbles covered the surface and blocked the contact between the liquid slag and the solid phase, reducing the dissolution rate.	[Huang, F.; Liu, C.] Univ Sci & Technol Beijing, Sch Met & Ecol Engn, Beijing 100083, Peoples R China; [Maruoka, N.; Kitamura, S. -Y.] Tohoku Univ, Inst Multidisciplinary Res Adv Mat, Aoba Ku, Sendai, Miyagi 9808577, Japan	Huang, F (reprint author), Univ Sci & Technol Beijing, Sch Met & Ecol Engn, 30 Xueyuan Rd, Beijing 100083, Peoples R China.	huangfuxiang@ustb.edu.cn			National Natural Science Foundation of China [51204014]	This study was carried out while F. Huang was a research fellow at Tohoku University. The authors wish to thank K. Wang for assistance with the calculation by FactSage (R) software as well as the National Natural Science Foundation of China (grant no. 51204014) for providing financial support.	Amini S, 2006, ISIJ INT, V46, P1554, DOI 10.2355/isijinternational.46.1554; Liu J, 2007, J EUR CERAM SOC, V27, P1961, DOI 10.1016/j.jeurceramsoc.2006.05.107; Guo M, 2006, J EUR CERAM SOC, V26, P3831, DOI 10.1016/j.jeurceramsoc.2005.12.025; Guo M, 2007, CERAM INT, V33, P1007, DOI 10.1016/j.ceramint.2006.03.009; Hon MH, 2008, MATER TRANS, V49, P107, DOI 10.2320/matertrans.MRA2007079; Lee WE, 1999, INT MATER REV, V44, P77, DOI 10.1179/095066099101528234; Maruoka N, 2013, HIGH TEMP MAT PR-ISR, V32, P15, DOI 10.1515/htmp-2012-0049; Wang DY, 2012, J NON-CRYST SOLIDS, V358, P1196, DOI 10.1016/j.jnoncrysol.2012.02.014; BYGDEN J, 1994, IRONMAK STEELMAK, V21, P318; Huang F., 2014, J TECHNICAL ASS REFR, V34, P215; Jansson S., 2014, P 7 INT C MOLT SLAGS, V341; Li Z., 2000, ISIJ INT, V40, P101; Maruoka N., 2011, P 6 EUR OX STEELM C, V5; Monaghan BJ, 2005, IRONMAK STEELMAK, V32, P258, DOI 10.1179/174328105X28793; Taniguchi S., 2001, TRANSPORT PHENOMENA, V43; Um H, 2012, ISIJ INT, V52, P62; UMAKOSHI M, 1984, T IRON STEEL I JPN, V24, P532	17	0	0	MANEY PUBLISHING	LEEDS	STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND	0301-9233	1743-2812		IRONMAK STEELMAK	Ironmak. Steelmak.	AUG	2015	42	7					553	560		10.1179/1743281215Y.0000000003		8	Metallurgy & Metallurgical Engineering	Metallurgy & Metallurgical Engineering	CN0CF	WOS:000358079200010		
J	Uchida, K; Ushimaru, A				Uchida, Kei; Ushimaru, Atushi			Land abandonment and intensification diminish spatial and temporal -diversity of grassland plants and herbivorous insects within paddy terraces	JOURNAL OF APPLIED ECOLOGY			English	Article						additive partitioning; agricultural land; beta diversity; butterfly; landscape; orthoptera; semi-natural grassland; species pool; turnover and nestedness	BETA-DIVERSITY; SPECIES-DIVERSITY; FARMLAND BIODIVERSITY; BIOTIC HOMOGENIZATION; GRAZING INTENSITY; LANDSCAPE; COMMUNITIES; FOREST; GRASSHOPPERS; ASSEMBLAGES	Although traditional land-use and management practices are known to enhance environmental heterogeneity in agricultural lands, loss of heterogeneity resulting from recent land-use changes can lead to spatiotemporal -diversity losses (biotic homogenization). However, patterns and causes of -diversity loss, especially at a within-field scale, have remained unexplored. We examined -diversity declines in plants, butterflies and orthopterans resulting from land abandonment and intensification in semi-natural grasslands on paddy margins at a within-field scale in relation to changes in disturbance frequency and surrounding landscapes by surveying eight abandoned, thirteen traditional and ten intensive paddy terraces. Three indices, the additive partitioning of species richness ((add)) and the turnover ((tu)) and nestedness ((ne)) components of Jaccard dissimilarity of plants and herbivores, were used to evaluate different aspects of -diversity. We hypothesized that biotic homogenization due to abandonment and intensification would be expressed as low spatiotemporal (add) and (tu), low spatial (ne) and high temporal (ne). The spatial and temporal (add) of plants and herbivores were higher in traditional terraces than in others. Changes in mowing frequency caused direct declines in butterfly (add) and indirectly decreased herbivore (add) through diminished plant (add) in abandoned and intensified terraces. Neighbouring forests increased plant spatial and butterfly temporal (add) and (tu). Abandoned terraces had higher orthopteran spatial and plant temporal (tu) than traditional terraces. Mowing frequency generally did not influence spatial and temporal (tu) of plants and herbivores. In intensive terraces, temporal (ne) of plants were higher than in traditional terraces, suggesting dominance by plant species sharing similar phenologies.Synthesis and applications. These results suggest that traditional mowing practices are essential for maintaining plant and herbivore (add), and consequently, species pools within terraces. The higher spatial or temporal species turnover of plants and orthopterans in abandoned terraces and higher temporal plant nestedness in intensive than in traditional terraces were not due to increases in species pools within terraces. Because within-terrace environmental heterogeneity is thought to remain in abandoned and intensive terraces, we recommend reduction in mowing frequency in intensive terraces and reintroduction of mowing in abandoned terraces for biodiversity restoration. These results suggest that traditional mowing practices are essential for maintaining plant and herbivore (add), and consequently, species pools within terraces. The higher spatial or temporal species turnover of plants and orthopterans in abandoned terraces and higher temporal plant nestedness in intensive than in traditional terraces were not due to increases in species pools within terraces. Because within-terrace environmental heterogeneity is thought to remain in abandoned and intensive terraces, we recommend reduction in mowing frequency in intensive terraces and reintroduction of mowing in abandoned terraces for biodiversity restoration.	[Uchida, Kei; Ushimaru, Atushi] Kobe Univ, Grad Sch Human Dev & Environm, Kobe, Hyogo 6578501, Japan	Uchida, K (reprint author), Kobe Univ, Grad Sch Human Dev & Environm, 3-11 Tsurukabuto, Kobe, Hyogo 6578501, Japan.	k.uchida023@gmail.com			Japan Society for the Promotion of Science [13J03127, 23570024]	We sincerely appreciate Joseph A. Veech, M. K. Hiraiwa and anonymous reviewers for their detailed and constructive comments on a draft of the manuscript, and E. Uchida, Y. Nagata, S. Takahashi, T. Izumisawa, K. Michimoto, S. Maihara, C. Fukada, K. Nakamoto, T. Shiotani and W. Maruyama for their assistance in field surveys. This research was partly supported by grants-in-aid for K. Uchida (No. 13J03127) and A. Ushimaru (No. 23570024) from the Japan Society for the Promotion of Science.	Abadie JC, 2011, J ECOL, V99, P1134, DOI 10.1111/j.1365-2745.2011.01851.x; JOERN A, 1979, OECOLOGIA, V38, P325, DOI 10.1007/BF00345192; Benton TG, 2003, TRENDS ECOL EVOL, V18, P182, DOI 10.1016/S0169-5347(03)00011-9; Anderson MJ, 2011, ECOL LETT, V14, P19, DOI 10.1111/j.1461-0248.2010.01552.x; Rosin ZM, 2012, J INSECT CONSERV, V16, P321, DOI 10.1007/s10841-011-9416-5; Kruess A, 2002, CONSERV BIOL, V16, P1570, DOI 10.1046/j.1523-1739.2002.01334.x; Naaf T, 2010, BIOL CONSERV, V143, P848, DOI 10.1016/j.biocon.2009.12.027; Uematsu Y, 2013, ECOL APPL, V23, P1357, DOI 10.1890/12-1939.1; Poyry J, 2009, OECOLOGIA, V160, P577, DOI 10.1007/s00442-009-1328-7; CONNELL JH, 1978, SCIENCE, V199, P1302, DOI 10.1126/science.199.4335.1302; Clough Y, 2007, J APPL ECOL, V44, P804, DOI 10.1111/j.1365-2664.2007.01294.x; Chao A, 2014, ECOL MONOGR, V84, P45, DOI 10.1890/13-0133.1; Uchida K, 2014, ECOL MONOGR, V84, P637, DOI 10.1890/13-2170.1; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Baselga A, 2012, GLOBAL ECOL BIOGEOGR, V21, P1223, DOI 10.1111/j.1466-8238.2011.00756.x; Bascompte J, 2006, SCIENCE, V312, P431, DOI 10.1126/science.1123412; Koyanagi TF, 2013, BIOL CONSERV, V167, P1, DOI 10.1016/j.biocon.2013.07.012; Joern A, 2005, ECOLOGY, V86, P861, DOI 10.1890/04-0135; Tuomisto H, 2010, ECOGRAPHY, V33, P2, DOI 10.1111/j.1600-0587.2009.05880.x; Ekroos J, 2010, J APPL ECOL, V47, P459, DOI 10.1111/j.1365-2664.2009.01767.x; Dormann CF, 2007, ECOGRAPHY, V30, P609, DOI 10.1111/j.2007.0906-7590.05171.x; Bergman KO, 2004, ECOGRAPHY, V27, P619, DOI 10.1111/j.0906-7590.2004.03906.x; Uematsu Y, 2010, AGR ECOSYST ENVIRON, V135, P304, DOI 10.1016/j.agee.2009.10.010; Baur B, 2006, BIOL CONSERV, V132, P261, DOI 10.1016/j,biocon.2006.04.018; Veech JA, 2002, OIKOS, V99, P3, DOI 10.1034/j.1600-0706.2002.990101.x; Huston MA, 1999, OIKOS, V86, P393, DOI 10.2307/3546645; Kleijn D, 2011, TRENDS ECOL EVOL, V26, P474, DOI 10.1016/j.tree.2011.05.009; Smart SM, 2006, P R SOC B, V273, P2659, DOI 10.1098/rspb.2006.3630; Kleijn D, 2009, P R SOC B, V276, P903, DOI 10.1098/rspb.2008.1509; Tylianakis JM, 2005, ECOLOGY, V86, P3296, DOI 10.1890/05-0371; Tabarelli M, 2012, BIOL CONSERV, V155, P136, DOI 10.1016/j.biocon.2012.06.020; Poyry J, 2006, OIKOS, V115, P401, DOI 10.1111/j.2006.0030-1299.15126.x; Tilman D, 2001, SCIENCE, V292, P281, DOI 10.1126/science.1057544; Krauss J, 2010, ECOL LETT, V13, P597, DOI 10.1111/j.1461-0248.2010.01457.x; Lobo D, 2011, DIVERS DISTRIB, V17, P287, DOI 10.1111/j.1472-4642.2010.00739.x; Veech JA, 2010, ECOLOGY, V91, P1988, DOI 10.1890/09-1140.1; Gabriel D, 2006, ECOL APPL, V16, P2011, DOI 10.1890/1051-0761(2006)016[2011:BDADSS]2.0.CO;2; Tscharntke T, 2005, ECOL LETT, V8, P857, DOI 10.1111/j.1461-0248.2005.00782.x; Arroyo-Rodriguez V, 2013, J ECOL, V101, P1449, DOI 10.1111/1365-2745.12153; Buhler C, 2011, DIVERS DISTRIB, V17, P1089, DOI 10.1111/j.1472-4642.2011.00799.x; Flohre A., 2011, ECOLOGICAL APPL, V21, P1722; Huston MA, 1994, BIOL DIVERSITY COEXI; Lenda M, 2010, ACTA OECOL, V36, P497, DOI 10.1016/j.actao.2010.07.002; Ohara RG, 2015, APPL VEG SCI, V18, P493, DOI 10.1111/avsc.12166; Reeve JD, 2010, J ANIM ECOL, V79, P483, DOI 10.1111/j.1365-2656.2009.01640.x; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Shirouzu T., 2006, BUTTERFLIES JAPAN CO; Storkey J., 2011, P ROYAL SOC B, V273, P2659; Uchida K., 2015, DRYAD DIGITAL REPOSI; Whittaker R.H., 1975, COMMUNITIES ECOSYSTE	50	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0021-8901	1365-2664		J APPL ECOL	J. Appl. Ecol.	AUG	2015	52	4					1033	1043		10.1111/1365-2664.12443		11	Ecology	Environmental Sciences & Ecology	CM9CR	WOS:000358004300026		
J	Chattopadhyay, A; Das, K; Hayasaka, Y; Sarkar, A				Chattopadhyay, Anupam; Das, Kaushik; Hayasaka, Yasutaka; Sarkar, Arindam			Syn- and post-tectonic granite plutonism in the Sausar Fold Belt, central India: Age constraints and tectonic implications	JOURNAL OF ASIAN EARTH SCIENCES			English	Article						Sausar Fold Belt; Deformation and metamorphism; Intrusive granites; Monazite dating; Central Indian Tectonic Zone	EASTERN GHATS BELT; ZIRCON U-PB; MOBILE BELT; ISOCHRON AGES; KEMP-LAND; RB-SR; EVOLUTION; MONAZITE; ZONE; ANTARCTICA	Sausar Fold Belt (SFB) in central India forms the southern part of the Central Indian Tectonic Zone (CITZ) - a crustal scale Proterozoic mobile belt dissecting the Indian craton, whose tectonothermal history and age is important for understanding the Proterozoic crustal history of the Indian craton. SFB comprises a gneissic basement (TBG: Tirodi Biotite Gneiss) overlain by a supracrustal sequence of quartzite-pelite-carbonate (SSG: Sausar Group). SSG and TBG are deformed and metamorphosed in greenschist to amphibolite facies. Two phases of granite intrusion are observed in the SSG - a syntectonic foliated granite and a post-tectonic massive granite, with clear structural relationship with the host rocks. Monazite chemical dating (U-Th-total Pb) of the foliated and massive granites yield Neoproterozoic (ca. 945-928 Ma) ages that contradict many earlier geochronological interpretations. Foliated granites and the immediately adjacent TBG show monazite grains with ca. 945 Ma mean age, interpreted as the timing of D-2 deformation and amphibolite facies metamorphism of SSG. The post tectonic granites intruded these rocks around 928 Ma, and were largely undeformed. A terminal thermal overprint is found in some monazite grain rims at ca. 785 Ma age. The younger Sausar tectonothermal events have overprinted the adjacent high-grade granulites of Ramakona-Katangi Granulite (RKG) belt, and should not be considered as parts of the same tectonothermal event representing different depth sections only. (C) 2015 Elsevier Ltd. All rights reserved.	[Chattopadhyay, Anupam; Sarkar, Arindam] Univ Delhi, Dept Geol, Delhi 110007, India; [Das, Kaushik; Hayasaka, Yasutaka] Hiroshima Univ, Dept Earth & Planetary Syst Sci, Hiroshima 730, Japan	Chattopadhyay, A (reprint author), Univ Delhi, Dept Geol, Delhi 110007, India.	anupamchatto@gmail.com			University Grants Commission (UGC) [F.42-66/2013(SR)-HRP]; University of Delhi RD grant [Dean (R)/RD/2012/917]	This work was partly funded by the University Grants Commission (UGC) (Grant no. F.42-66/2013(SR)-HRP) and by the University of Delhi R&D grant (Grant no. Dean (R)/R&D/2012/917) to AC. Department of Geology provided the necessary microscopic facility. We are thankful to Prof. M. Santosh for his helpful comments and editorial handling. Critical comments and suggestions of two anonymous reviewers were extremely helpful for revising the manuscript.	Acharyya SK, 2000, J GEOL SOC INDIA, V55, P239; Acharyya S. K., 2001, J GEOL SURV INDIA SP, V64, P17; Stipp M, 2002, J STRUCT GEOL, V24, P1861, DOI 10.1016/S0191-8141(02)00035-4; Kelsey DE, 2008, J METAMORPH GEOL, V26, P199, DOI 10.1111/j.1525-1314.2007.00757.x; Cocherie A, 2001, GEOCHIM COSMOCHIM AC, V65, P4509, DOI 10.1016/S0016-7037(01)00753-0; MCDONOUGH WF, 1995, CHEM GEOL, V120, P223, DOI 10.1016/0009-2541(94)00140-4; Fujii M, 2008, ISL ARC, V17, P322, DOI 10.1111/j.1440-1738.2008.00623.x; RADHAKRISHNA BP, 1986, J GEOL, V94, P145; Chattopadhyay A, 2003, GONDWANA RES, V6, P107, DOI 10.1016/S1342-937X(05)70647-X; MANIAR PD, 1989, GEOL SOC AM BULL, V101, P635, DOI 10.1130/0016-7606(1989)101<0635:TDOG>2.3.CO;2; SUZUKI K, 1991, GEOCHEM J, V25, P357; Bose S, 2011, GEOL SOC AM BULL, V123, P2031, DOI 10.1130/B30336.1; Bhowmik SK, 2011, GEOL J, V46, P574, DOI 10.1002/gj.1299; Mohanty S, 2010, J ASIAN EARTH SCI, V39, P516, DOI 10.1016/j.jseaes.2010.04.025; Dasgupta S, 2013, PRECAMBRIAN RES, V227, P247, DOI 10.1016/j.precamres.2012.04.005; Chatterjee N, 2012, CONTRIB MINERAL PETR, V163, P789, DOI 10.1007/s00410-011-0699-z; Bhandari Anubha, 2011, Geological Journal, V46, DOI 10.1002/gj.1221; Bhowmik SK, 2012, GONDWANA RES, V22, P54, DOI 10.1016/j.gr.2011.09.008; Bhowmik SK, 2003, J PETROL, V44, P387, DOI 10.1093/petrology/44.3.387; Bhowmik SK, 1999, J GEOL SOC INDIA, V53, P385; Bose S., 2008, AGU FALL M SAN FRANC, V2159; Boynton WV, 1984, DEV GEOCHEMISTRY, V2, P63; Chabria T., 1998, INT SEM PREC CRUST E, P131; Chatterjee N, 2010, PRECAMBRIAN RES, V179, P99, DOI 10.1016/j.precamres.2010.02.013; Chattopadhyay A, 2008, GEOL MAG, V145, P766, DOI 10.1017/S0016756808005074; Chattopadhyay A, 2003, J GEOL SOC INDIA, V61, P75; Chattopadhyay A., 2001, GEOL SURV INDIA SPEC, V64, P251; Chattopadhyay A, 2007, J EARTH SYST SCI, V116, P423, DOI 10.1007/s12040-007-0041-3; Chattopadhyay A, 2011, PRECAMBRIAN RES, V186, P70, DOI 10.1016/j.precamres.2011.01.006; Das K, 2011, GEOL J, V46, P217, DOI 10.1002/gj.1246; Das K, 2013, ANN M ABSTR GEOL SOC; Halpin JA, 2007, J PETROL, V48, P1321, DOI 10.1093/petrology/egm020; Halpin JA, 2005, CONTRIB MINERAL PETR, V148, P689, DOI 10.1007/s00410-004-0627-6; Harley SL, 2003, GEOL SOC SPEC PUBL, P203; Hokada T., 2006, POLAR GEOSCIENCE, V19, P118; Kelly NM, 2002, PRECAMBRIAN RES, V116, P307, DOI 10.1016/S0301-9268(02)00028-1; Khan A.S., 2002, FINAL REPORT S UNPUB; Lippolt H.J., 1994, MINER DEPOSITA, V18, P195; Ludwig K.R., 2008, SPECIAL PUBLICATION, V4, P77; Narayanaswamy S., 1963, B GEOL SURV INDIA A, V22; Pal T., 1998, METAMORPHIC HI UNPUB; Roy A, 2006, J ASIAN EARTH SCI, V26, P61, DOI 10.1016/j.jseaes.2004.09.010; Roy A, 2003, J ASIAN EARTH SCI, V22, P115, DOI 10.1016/S1367-9120(02)00180-3; Roy A., 2003, GOND GEOL MAG, V5, P23; SARKAR SN, 1986, J GEOL SOC INDIA, V27, P30; West W.D., 1936, T NAT I SCI INDIA, V1, P93	46	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	1367-9120	1878-5786		J ASIAN EARTH SCI	J. Asian Earth Sci.	AUG 1	2015	107						110	121		10.1016/j.jseaes.2015.04.006		12	Geosciences, Multidisciplinary	Geology	CN0IO	WOS:000358097500010		
J	Gao, L; Imanaka, T; Fujiwara, S				Gao, Le; Imanaka, Tadayuki; Fujiwara, Shinsuke			A Mutant Chaperonin That Is Functional at Lower Temperatures Enables Hyperthermophilic Archaea To Grow under Cold-Stress Conditions	JOURNAL OF BACTERIOLOGY			English	Article							C-TERMINAL REGION; PYROCOCCUS-KODAKARAENSIS KOD1; GROUP-II CHAPERONINS; SP-NOV; THERMOCOCCUS-KODAKARENSIS; ESCHERICHIA-COLI; EXTREME THERMOPHILE; THERMAL-STABILITY; GENE DUPLICATION; CENTRAL CAVITY	Thermococcus kodakarensis grows optimally at 85 degrees C and possesses two chaperonins, cold-inducible CpkA and heat-inducible CpkB, which are involved in adaptation to low and high temperatures, respectively. The two chaperonins share a high sequence identity (77%), except in their C-terminal regions. CpkA, which contains tandem repeats of a GGM motif, shows its highest ATPase activity at 60 degrees C to 70 degrees C, whereas CpkB shows its highest activity at temperatures higher than 90 degrees C. To clarify the effects of changes in ATPase activity on chaperonin function at lower temperatures, various CpkA variants were constructed by introducing single point mutations into the C-terminal region. A CpkA variant in which Glu530 was replaced with Gly (CpkA-E530G) showed increased ATPase activity, with its highest activity at 50 degrees C. The efficacy of the CpkA variants against denatured indole-3-glycerol-phosphate synthase of T. kodakarensis (TrpC(Tk)), which is a CpkA target, was then examined in vitro. CpkA-E530G was more effective than wild-type CpkA at facilitating the refolding of chemically unfolded TrpC(Tk) at 50 degrees C. The effect of cpkA-E530G on cell growth was then examined by introducing cpkA-E530G into the genome of T. kodakarensis KU216 (pyrF). The mutant strain, DA4 (pyrF cpkA-E530G), grew as well as the parental KU216 strain at 60 degrees C. In contrast, DA4 grew more vigorously than KU216 at 50 degrees C. These results suggested that the CpkA-E530G mutation prevented cold denaturation of proteins under cold-stress conditions, thereby enabling cells to grow in cooler environments. Thus, a single base pair substitution in a chaperonin gene allows cells to grow vigorously in a new environment. IMPORTANCE Thermococcus kodakarensis possesses two group II chaperonins, cold-inducible CpkA and heat-inducible CpkB, which are involved in adaptation to low and high temperatures, respectively. CpkA might act as an "adaptive allele" to adapt to cooler environments. In this study, we compared the last 20 amino acids within the C termini of the chaperonins and found a clear correlation between the CpkA-type chaperonin gene copy number and growth temperature. Furthermore, we introduced single mutations into the CpkA C-terminal region to clarify its role in cold adaptation, and we showed that a single base substitution allowed the organism to adapt to a lower temperature. The present data suggest that hyperthermophiles have evolved by obtaining mutations in chaperonins that allow them to adapt to a colder environment.	[Gao, Le; Fujiwara, Shinsuke] Kwansei Gakuin Univ, Grad Sch Sci & Technol, Res Ctr Intelligent Biomat, Sanda, Hyogo, Japan; [Fujiwara, Shinsuke] Kwansei Gakuin Univ, Grad Sch Sci & Technol, Dept Biosci, Sanda, Hyogo, Japan; [Imanaka, Tadayuki] Ritsumeikan Univ, Res Org Sci & Technol, Kasatsu, Shiga, Japan	Fujiwara, S (reprint author), Kwansei Gakuin Univ, Grad Sch Sci & Technol, Res Ctr Intelligent Biomat, Sanda, Hyogo, Japan.	fujiwara-s@kwansei.ac.jp			Japan Society for the Promotion of Science (JSPS) (KAKENHI grant) [26292045]; Grant for Individual Special Research	This study was supported mainly by a grant from the Japan Society for the Promotion of Science (JSPS) (KAKENHI grant 26292045). Bioinformatic analysis was supported by a Grant for Individual Special Research, provided by Kwansei-Gakuin University.	JONES PG, 1987, J BACTERIOL, V169, P2092; HUBER H, 1982, ARCH MICROBIOL, V132, P47, DOI 10.1007/BF00690816; Matsuno Y, 2009, BIOSCI BIOTECH BIOCH, V73, P104, DOI 10.1271/bbb.80520; BROCK TD, 1969, J BACTERIOL, V98, P289; PIERSON BK, 1974, ARCH MICROBIOL, V100, P5, DOI 10.1007/BF00446302; Shomura Y, 2004, J MOL BIOL, V335, P1265, DOI 10.1016/j.jbm.2003.11.028; Arenas CD, 2013, FEMS MICROBIOL REV, V37, P572, DOI 10.1111/1574-6976.12008; ZEIKUS JG, 1972, J BACTERIOL, V109, P707; Luo HB, 2011, ARCH BIOCHEM BIOPHYS, V512, P111, DOI 10.1016/j.abb.2011.04.017; Fukui T, 2005, GENOME RES, V15, P352, DOI 10.1101/gr.3003105; Sato T, 2005, APPL ENVIRON MICROB, V71, P3889, DOI 10.1128/AEM.71.7.3889-3899.2005; SOWERS KR, 1984, APPL ENVIRON MICROB, V47, P971; Kerner MJ, 2005, CELL, V122, P209, DOI 10.1016/j.cell.2005.05.028; Zhang K, 2013, PROTEIN CELL, V4, P432, DOI 10.1007/s13238-013-3026-9; Frydman J, 2001, ANNU REV BIOCHEM, V70, P603, DOI 10.1146/annurev.biochem.70.1.603; SCHLEPER C, 1995, J BACTERIOL, V177, P7050; Palotai R, 2008, IUBMB LIFE, V60, P10, DOI 10.1002/iub.8; Fujiwara S, 2008, APPL ENVIRON MICROB, V74, P7306, DOI 10.1128/AEM.01245-08; LANGER T, 1992, EMBO J, V11, P4757; Bakermans C, 2006, INT J SYST EVOL MICR, V56, P1285, DOI 10.1099/ijs.0.64043-0; Gemayel R, 2010, ANNU REV GENET, V44, P445, DOI 10.1146/annurev-genet-072610-155046; Suzuki T, 2002, EXTREMOPHILES, V6, P39, DOI 10.1007/s007920100221; Suzuki M, 2008, J BIOL CHEM, V283, P23931, DOI 10.1074/jbc.M804090200; FIALA G, 1986, ARCH MICROBIOL, V145, P56, DOI 10.1007/BF00413027; Bigotti MG, 2008, ARCH BIOCHEM BIOPHYS, V474, P331, DOI 10.1016/j.abb.2008.03.015; Tang YC, 2006, CELL, V125, P903, DOI 10.1016/j.cell.2006.04.027; Archibald JM, 2001, J STRUCT BIOL, V135, P157, DOI 10.1006/jsbi.2001.4353; Arnold FH, 1998, NAT BIOTECHNOL, V16, P617, DOI 10.1038/nbt0798-617; Atomi Haruyuki, 2004, Archaea, V1, P263, DOI 10.1155/2004/204953; Auman AJ, 2006, INT J SYST EVOL MICR, V56, P1001, DOI 10.1099/ijs.0.64068-0; Acland A, 2014, NUCLEIC ACIDS RES, V42, pD7, DOI 10.1093/nar/gkt1146; Eswar N, 2006, CURR PROTOC BIOINFOR, DOI DOI 10.1002/0471250953.BI0506S15; Farr GW, 2007, P NATL ACAD SCI USA, V104, P5342, DOI 10.1073/pnas.0700820104; Fonville NC, 2011, J MOL MICROB BIOTECH, V21, P36, DOI 10.1159/000332748; Gao L, 2012, APPL ENVIRON MICROB, V78, P3806, DOI 10.1128/AEM.07996-11; Garrity G. M., 2001, BERGEYS MANUAL SYSTE, V1; Goyal K, 2006, J MOL EVOL, V63, P781, DOI 10.1007/s00239-006-0037-7; HARDER KW, 1994, BIOCHEM J, V298, P395; Hidese R, 2014, EXTREMOPHILES, V18, P573, DOI 10.1007/s00792-014-0638-9; Izumi M, 1999, APPL ENVIRON MICROB, V65, P1801; Izumi M, 2001, BIOCHEM BIOPH RES CO, V280, P581, DOI 10.1006/bbrc.2000.4154; Liu J, 2012, PLANT METHODS, V8, DOI 10.1186/1746-4811-8-34; Machida K, 2008, J BIOL CHEM, V283, P6886, DOI 10.1074/jbc.M708002200; MAH RA, 1980, CURR MICROBIOL, V3, P321, DOI 10.1007/BF02601895; MARTIN B, 1985, J BIOL CHEM, V260, P4932; MCLENNAN NF, 1994, MOL MICROBIOL, V14, P309, DOI 10.1111/j.1365-2958.1994.tb01292.x; Nagaoka E, 2013, J BACTERIOL, V195, P3442, DOI 10.1128/JB.00332-13; Sako Y, 1996, INT J SYST BACTERIOL, V46, P1070; Sambrook J, 2001, MOL CLONING LAB MANU; Tang X, 1999, MOL GEN GENET, V262, P815; Tang YC, 2008, EMBO J, V27, P1458, DOI 10.1038/emboj.2008.77	51	0	0	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0021-9193	1098-5530		J BACTERIOL	J. Bacteriol.	AUG	2015	197	16					2642	2652		10.1128/JB.00279-15		11	Microbiology	Microbiology	CM9UA	WOS:000358053300003		
J	Mori, AS; Shiono, T; Haraguchi, TF; Ota, AT; Koide, D; Ohgue, T; Kitagawa, R; Maeshiro, R; Aung, TT; Nakamori, T; Hagiwara, Y; Matsuoka, S; Ikeda, A; Hishi, T; Hobara, S; Mizumachi, E; Frisch, A; Thor, G; Fujii, S; Osono, T; Gustafsson, L				Mori, Akira S.; Shiono, Takayuki; Haraguchi, Takashi F.; Ota, Aino T.; Koide, Dai; Ohgue, Takayuki; Kitagawa, Ryo; Maeshiro, Ryo; Aung, Toe Toe; Nakamori, Taizo; Hagiwara, Yusuke; Matsuoka, Shunsuke; Ikeda, Anzu; Hishi, Takuo; Hobara, Satoru; Mizumachi, Eri; Frisch, Andreas; Thor, Goran; Fujii, Saori; Osono, Takashi; Gustafsson, Lena			Functional redundancy of multiple forest taxa along an elevational gradient: predicting the consequences of non-random species loss	JOURNAL OF BIOGEOGRAPHY			English	Article						Distance decay of similarity; functional beta diversity; functional traits; Japan; mammalian herbivory; multi-taxon approach; no-analogue community; non-random loss of biodiversity; novel community	BETA DIVERSITY; CLIMATE-CHANGE; RESPONSE DIVERSITY; ASSEMBLY PROCESSES; VASCULAR PLANTS; GLOBAL PATTERNS; DISTANCE-DECAY; NORTH-AMERICA; ECOSYSTEM; COMMUNITIES	AimsClimate change can substantially alter ecological communities. However, we hypothesized that, even if novel communities emerge, those communities may not be novel in terms of functional composition. To infer the processes associated with rising temperatures, we evaluated elevational taxonomic/functional turnover of plant and invertebrate communities. Because climate change interacts synergistically with other environmental factors, and therefore is not the sole driver of change in ecological communities, we also considered how the taxonomic/functional composition of the communities would be affected by mammalian overgrazing/browsing, which has become prominent in the study region. LocationShiretoko National Park, Shiretoko Peninsular, Hokkaido, Japan. MethodsWe investigated the diversity of eight groups of organisms (taxa) in forests of northern Japan, and calculated the distance decay of taxonomic/functional similarity (SOrensen's -diversity) along an elevational gradient. A null model was used to separate functional turnover from taxonomic turnover. We then simulated how taxonomic/functional turnover along the gradient would be changed after non-random loss of species sensitive to mammalian herbivory. ResultsWe found that each group showed elevational decay in taxonomic similarity. Along an elevational gradient, species groups structured by stronger dispersal limitation showed faster species turnover. This suggested differences in the process of climate-induced species reassembly among the groups. We also found that elevational turnover of communities based on functional traits tended to be lower than that based on taxonomic identity for the majority of the groups, supporting our hypothesis of functional redundancy across the elevational gradient. We thus speculated that climate-induced emergence of taxonomically novel communities may have limited influence on critical ecosystem processes supported by functional diversity. Furthermore, while random species loss did not change functional turnover, non-random loss of species attributable to mammalian herbivory substantially accelerated elevational functional turnover of the taxa. This suggested a possible loss of the functional redundancy of communities. Main conclusionsFuture communities may be novel not simply because climates are changing at unprecedented rates but also because of the synergetic influences of other environmental changes. Thus ecological processes may be more seriously affected in the future than is generally anticipated based on existing climate-change scenarios, with possible consequences for ecosystem functioning.	[Mori, Akira S.; Shiono, Takayuki; Ota, Aino T.; Koide, Dai; Kitagawa, Ryo; Maeshiro, Ryo; Aung, Toe Toe; Nakamori, Taizo; Fujii, Saori] Yokohama Natl Univ, Grad Sch Environm & Informat Sci, Yokohama, Kanagawa 2408501, Japan; [Haraguchi, Takashi F.; Matsuoka, Shunsuke; Ikeda, Anzu; Osono, Takashi] Kyoto Univ, Ctr Ecol Res, Otsu, Shiga 5202113, Japan; [Ohgue, Takayuki] Kyoto Univ, Sch Sci, Kyoto 6068502, Japan; [Hagiwara, Yusuke; Hishi, Takuo] Kyushu Univ Forest, Ashoro Res Forest, Ashoro Town, Hokkaido 0893705, Japan; [Hobara, Satoru] Rakuno Gakuen Univ, Fac Environm Syst, Ebetsu, Hokkaido 0698501, Japan; [Mizumachi, Eri] Kyoto Univ, Inst Integrated Cell Mat Sci, Kyoto 6068315, Japan; [Frisch, Andreas; Thor, Goran; Gustafsson, Lena] Swedish Univ Agr Sci, Dept Ecol, SE-75007 Uppsala, Sweden	Mori, AS (reprint author), Yokohama Natl Univ, Grad Sch Environm & Informat Sci, 79-7 Tokiwadai, Yokohama, Kanagawa 2408501, Japan.	akkym@kb3.so-net.ne.jp	Osono, Takashi/N-9580-2014	Osono, Takashi/0000-0001-8552-7490	Sumitomo Foundation; Japan Securities Scholarship Foundation; Japan Society for the Promotion of Science (JSPS)	This study was supported by the Sumitomo Foundation and the Japan Securities Scholarship Foundation, with additional support from the Grant-in-Aid for Young Scientists from Japan Society for the Promotion of Science (JSPS). Logistical support for the field study was provided by the Shiretoko Foundation. We thank H. Kondo, K. Koizumi, Y. Miyake, W. Azuma, H. Kamauchi, and N. Mori for their contributions to this study. We appreciate J. Sadler, K. C. Burns and the three anonymous referees for their constructive comments.	Williams JW, 2007, FRONT ECOL ENVIRON, V5, P475, DOI 10.1890/070037; Jackson ST, 2009, SCIENCE, V325, P567, DOI 10.1126/science.1172977; Mori AS, 2013, BIOL REV, V88, P349, DOI 10.1111/brv.12004; Mason NWH, 2010, J ECOL, V98, P1422, DOI 10.1111/j.1365-2745.2010.01714.x; Mori AS, 2013, GLOBAL ECOL BIOGEOGR, V22, P878, DOI 10.1111/geb.12058; Takatsuki S, 2009, BIOL CONSERV, V142, P1922, DOI 10.1016/j.biocon.2009.02.011; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Mori AS, 2015, OECOLOGIA, V177, P533, DOI 10.1007/s00442-014-3111-7; Laliberte E, 2010, ECOL LETT, V13, P76, DOI 10.1111/j.1461-0248.2009.01403.x; Walther GR, 2010, PHILOS T R SOC B, V365, P2019, DOI 10.1098/rstb.2010.0021; Gallagher RV, 2013, ECOGRAPHY, V36, P531, DOI 10.1111/j.1600-0587.2012.07514.x; Hoiss B, 2012, P ROY SOC B-BIOL SCI, V279, P4447, DOI 10.1098/rspb.2012.1581; Qian H, 2012, GLOBAL ECOL BIOGEOGR, V21, P341, DOI 10.1111/j.1466-8238.2011.00672.x; Nekola JC, 1999, J BIOGEOGR, V26, P867, DOI 10.1046/j.1365-2699.1999.00305.x; St John MG, 2012, J ECOL, V100, P1074, DOI 10.1111/j.1365-2745.2012.02000.x; Campos GEP, 2013, NATURE, V494, P349, DOI 10.1038/nature11836; Vanbergen AJ, 2007, OECOLOGIA, V153, P713, DOI 10.1007/s00442-007-0766-3; SOLLINS P, 1982, CAN J FOREST RES, V12, P18, DOI 10.1139/x82-003; Purschke O, 2013, J ECOL, V101, P857, DOI 10.1111/1365-2745.12098; Korner C, 2007, TRENDS ECOL EVOL, V22, P569, DOI 10.1016/j.tree.2007.09.006; Crimmins SM, 2011, SCIENCE, V331, P324, DOI 10.1126/science.1199040; Peres-Neto PR, 2006, ECOLOGY, V87, P2614, DOI 10.1890/0012-9658(2006)87[2614:VPOSDM]2.0.CO;2; Borcard D, 2004, ECOLOGY, V85, P1826, DOI 10.1890/03-3111; Laliberte E, 2010, ECOLOGY, V91, P299, DOI 10.1890/08-2244.1; Bracken MES, 2008, P NATL ACAD SCI USA, V105, P924, DOI 10.1073/pnas.0704103105; Mori AS, 2013, BIOL CONSERV, V165, P115, DOI 10.1016/j.biocon.2013.05.020; Bryant JA, 2008, P NATL ACAD SCI USA, V105, P11505, DOI 10.1073/pnas.0801920105; Bardgett RD, 2013, J ECOL, V101, P334, DOI 10.1111/1365-2745.12043; Gan HJ, 2013, ECOL APPL, V23, P1311, DOI 10.1890/12-1895.1; Sheldon KS, 2011, ECOL LETT, V14, P1191, DOI 10.1111/j.1461-0248.2011.01689.x; [Anonymous], 2012, GLOBAL ECOL BIOGEOGR; Malhi Y, 2010, GLOBAL CHANGE BIOL, V16, P3171, DOI 10.1111/j.1365-2486.2010.02323.x; Morlon H, 2008, ECOL LETT, V11, P904, DOI 10.1111/j.1461-0248.2008.01202.x; Bellard C, 2012, ECOL LETT, V15, P365, DOI 10.1111/j.1461-0248.2011.01736.x; Mantyka-Pringle CS, 2012, GLOBAL CHANGE BIOL, V18, P1239, DOI 10.1111/j.1365-2486.2011.02593.x; Davidar P, 2007, GLOBAL ECOL BIOGEOGR, V16, P510, DOI 10.1111/j.1466-8238.2007.00307.x; Elmqvist T, 2003, FRONT ECOL ENVIRON, V1, P488, DOI 10.2307/3868116; Qian H, 2007, ECOL LETT, V10, P737, DOI 10.1111/j.1461-0248.2007.01066.x; Velazquez E, 2010, MICROBES FOR LEGUME IMPROVEMENT, P1, DOI 10.1007/978-3-211-99753-6_1; Cardinale BJ, 2012, NATURE, V486, P59, DOI 10.1038/nature11148; Wang JJ, 2012, GLOBAL ECOL BIOGEOGR, V21, P743, DOI 10.1111/j.1466-8238.2011.00718.x; Schleuter D, 2010, ECOL MONOGR, V80, P469, DOI 10.1890/08-2225.1; Huntingford C, 2013, NAT GEOSCI, V6, P268, DOI [10.1038/ngeo1741, 10.1038/NGEO1741]; Swenson NG, 2011, P ROY SOC B-BIOL SCI, V278, P877, DOI 10.1098/rspb.2010.1369; Mouchet M, 2008, OIKOS, V117, P794, DOI 10.1111/j.2008.0030-1299.16594.x; Isbell FI, 2008, OIKOS, V117, P996, DOI 10.1111/j.2008.0030-1299.16692.x; Jansson R, 2003, P ROY SOC B-BIOL SCI, V270, P583, DOI 10.1098/rspb.2002.2283; Baselga A, 2010, GLOBAL ECOL BIOGEOGR, V19, P134, DOI 10.1111/j.1466-8238.2009.00490.x; Tsunematsu N, 2013, J GEOPHYS RES-ATMOS, V118, P4142, DOI 10.1002/jgrd.50383; Boulanger V, 2009, FOREST ECOL MANAG, V258, P1397, DOI 10.1016/j.foreco.2009.06.055; Mouillot D, 2013, TRENDS ECOL EVOL, V28, P167, DOI 10.1016/j.tree.2012.10.004; Soininen J, 2007, ECOGRAPHY, V30, P3, DOI 10.1111/j.2006.0906-7590.04817.x; Decaens T, 2010, GLOBAL ECOL BIOGEOGR, V19, P287, DOI 10.1111/j.1466-8238.2009.00517.x; DesBie T., 2012, ECOL LETT, V15, P740; Dexter KG, 2012, P NATL ACAD SCI USA, V109, P7787, DOI 10.1073/pnas.1203523109; Qian H, 2009, GLOBAL ECOL BIOGEOGR, V18, P327, DOI 10.1111/j.1466-8238.2009.00450.x; R Core Team, 2013, R LANG ENV STAT COMP; White MA, 2012, FOREST ECOL MANAG, V269, P222, DOI 10.1016/j.foreco.2011.12.043	58	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0305-0270	1365-2699		J BIOGEOGR	J. Biogeogr.	AUG	2015	42	8					1383	1396		10.1111/jbi.12514		14	Ecology; Geography, Physical	Environmental Sciences & Ecology; Physical Geography	CM7TP	WOS:000357899700003		
J	Hirao, T; Kubota, Y; Murakami, M				Hirao, Toshihide; Kubota, Yasuhiro; Murakami, Masashi			Geographical patterns of butterfly species diversity in the subtropical Ryukyu Islands: the importance of a unidirectional filter between two source islands	JOURNAL OF BIOGEOGRAPHY			English	Article						Area; continental islands; deep-sea barriers; dissimilarity; island biogeography; isolation; Japan; latitudinal diversity gradients; nestedness; species turnover	BETA-DIVERSITY; PALEOGEOGRAPHIC IMPLICATIONS; TENEBRIONID BEETLES; TUSCAN ARCHIPELAGO; FAUNAL PATTERNS; AEGEAN ISLANDS; BIOGEOGRAPHY; RICHNESS; DISPERSAL; JAPAN	AimTo examine the roles of geohistorical and ecological factors in the development of butterfly assemblages on continental islands with multiple source pools. LocationThe Ryukyu Islands, Japan. This arc of continental islands is located between two source islands, Kyushu and Taiwan, and contains two major straits, the Tokara and Kerama gaps. MethodsA total of 489 butterfly species were identified on 59 islands, including the two source islands. The influences on species richness and rarity of latitude, area, elevation, and distances from the nearest source and from the nearest larger island were analysed using generalized linear models. The relationships between differences in area, elevation, and distance and dissimilarity between island butterfly faunas were evaluated by multiple regressions on distance matrices. The relationships between area, elevation, and distance from the source and dissimilarity to the source fauna were examined using linear models. The dissimilarity was based on the SOrensen index and its nestedness and turnover components. ResultsLatitude, area and isolation determined species richness and rarity, whereas differences in elevation and distance regulated species turnover between islands. The gaps between islands were associated with nestedness between island faunas. Area consistently had a negative relationship with the total dissimilarity to source fauna. The overall dissimilarity to Kyushu decreased with the distance from Kyushu, whereas dissimilarity to Taiwan increased with distance from Taiwan. Main conclusionsBoth environmental filtering and dispersal limitation determine the geographical patterns of butterfly assemblages in the Ryukyus. The present study focuses on the unique pattern wherein migration from Kyushu is facilitated on islands farther from Kyushu, while migration from Taiwan is inhibited on islands farther from Taiwan. The two source islands have contrasting roles that affect butterfly distributions unidirectionally. This study highlights the importance of resolving dissimilarity into nestedness and turnover components to elucidate the formation of island biota.	[Hirao, Toshihide] Hokkaido Univ, Inst Low Temp Sci, Sapporo, Hokkaido 060, Japan; [Kubota, Yasuhiro] Univ Ryukyus, Fac Sci, Nishihara, Okinawa 90301, Japan; [Murakami, Masashi] Chiba Univ, Fac Sci, Inage Ku, Chiba, Japan	Hirao, T (reprint author), Univ Tokyo Chichibu Forest, 1-1-49 Hinoda Machi, Chichibu, Saitama 3680034, Japan.	hirao@uf.a.u-tokyo.ac.jp			Japan Society for the Promotion of Science [23710281, 21310025]	We thank Shin-jiro Fujii and Hikaru Shinohara for their help with data collection and Rempei Suwa and Koh Nakamura for valuable comments on the manuscript. We also thank Bradford A. Hawkins, Jose Maria Fernandez-Palacios, Leonardo Dapporto and an anonymous referee for their thoughtful comments and suggestions. We are grateful to Leah Larkin for her assistance with editing the manuscript. Financial support was provided by the Japan Society for the Promotion of Science (nos 23710281 and 21310025).	KIRA T, 1991, ECOL RES, V6, P185, DOI 10.1007/BF02347161; Tuomisto H, 2003, SCIENCE, V299, P241, DOI 10.1126/science.1078037; Heaney LR, 2007, J BIOGEOGR, V34, P753, DOI 10.1111/j.1365-2699.2007.01692.x; Baselga A, 2012, METHODS ECOL EVOL, V3, P808, DOI 10.1111/j.2041-210X.2012.00224.x; Hawkins BA, 2003, ECOLOGY, V84, P3105, DOI 10.1890/03-8006; Ricklefs RE, 1999, J ANIM ECOL, V68, P1142, DOI 10.1046/j.1365-2656.1999.00358.x; Hawkins BA, 2010, J BIOGEOGR, V37, P647, DOI 10.1111/j.1365-2699.2009.02250.x; Kimura MT, 2004, OECOLOGIA, V140, P442, DOI 10.1007/s00442-004-1605-4; Dennis RLH, 2000, J BIOGEOGR, V27, P1365, DOI 10.1046/j.1365-2699.2000.00514.x; Nekola JC, 1999, J BIOGEOGR, V26, P867, DOI 10.1046/j.1365-2699.1999.00305.x; Williams MR, 2009, J BIOGEOGR, V36, P1994, DOI 10.1111/j.1365-2699.2009.02110.x; Wiens JJ, 2005, ANNU REV ECOL EVOL S, V36, P519, DOI 10.1146/annurev.ecolsys.36.102803.095431; Miklos I, 2004, ECOLOGY, V85, P86, DOI 10.1890/03-0101; Kreft H, 2010, J BIOGEOGR, V37, P2029, DOI 10.1111/j.1365-2699.2010.02375.x; Fattorini S, 2002, J BIOGEOGR, V29, P49, DOI 10.1046/j.1365-2699.2002.00656.x; Wiens JJ, 2004, TRENDS ECOL EVOL, V19, P639, DOI 10.1016/j.tree.2004.09.011; Holt B, 2013, SCIENCE, V339, P74, DOI 10.1126/science.1228282; Sanmartin I, 2001, BIOL J LINN SOC, V73, P345, DOI 10.1006/bijl.2001.0542; Buckley LB, 2008, P NATL ACAD SCI USA, V105, P17836, DOI 10.1073/pnas.0803524105; Wright DH, 1998, OECOLOGIA, V113, P1; Olson DM, 1998, CONSERV BIOL, V12, P502, DOI 10.1046/j.1523-1739.1998.012003502.x; Hortal J, 2011, ECOL LETT, V14, P741, DOI 10.1111/j.1461-0248.2011.01634.x; Nakamura K, 2009, J BIOGEOGR, V36, P919, DOI 10.1111/j.1365-2699.2008.02057.x; Goslee SC, 2007, J STAT SOFTW, V22, P1; PREGILL GK, 1981, ANNU REV ECOL SYST, V12, P75, DOI 10.1146/annurev.es.12.110181.000451; Koleff P, 2003, J ANIM ECOL, V72, P367, DOI 10.1046/j.1365-2656.2003.00710.x; Lomolino MV, 2000, GLOBAL ECOL BIOGEOGR, V9, P1, DOI 10.1046/j.1365-2699.2000.00185.x; Condit R, 2002, SCIENCE, V295, P666, DOI 10.1126/science.1066854; Baselga A, 2010, GLOBAL ECOL BIOGEOGR, V19, P134, DOI 10.1111/j.1466-8238.2009.00490.x; Almeida-Neto M, 2008, OIKOS, V117, P1227, DOI 10.1111/j.0030-1299.2008.16644.x; Ota H, 1998, RES POPUL ECOL, V40, P189, DOI 10.1007/BF02763404; Beck J, 2006, BIOL J LINN SOC, V89, P455, DOI 10.1111/j.1095-8312.2006.00686.x; Carlquist P, 1965, ISLAND LIFE NATURAL; Crisci J. V., 2003, HIST BIOGEOGRAPHY IN; Dapporto L, 2014, J BIOGEOGR, V41, P1639, DOI 10.1111/jbi.12315; Dapporto L, 2007, EUR J ENTOMOL, V104, P497; Dapporto L, 2008, J BIOGEOGR, V35, P664, DOI 10.1111/j.1365-2699.2007.01812.x; Dapporto L, 2009, BIOL J LINN SOC, V98, P677, DOI 10.1111/j.1095-8312.2009.01311.x; Dapporto L, 2013, ECOGRAPHY, V36, P1070, DOI 10.1111/j.1600-0587.2013.00444.x; Dobrovolski R, 2012, GLOBAL ECOL BIOGEOGR, V21, P191, DOI 10.1111/j.1466-8238.2011.00671.x; Fattorini S, 2012, INSECT CONSERV DIVER, V5, P331, DOI 10.1111/j.1752-4598.2011.00164.x; Fattorini S, 2009, J ZOOL, V277, P291, DOI 10.1111/j.1469-7998.2008.00540.x; Fattorini S, 2009, EUR J ENTOMOL, V106, P415; Fernandez-Palacios J.M., 2007, ISLAND BIOGEOGRAPHY; Goslee SC, 2010, PLANT ECOL, V206, P279, DOI 10.1007/s11258-009-9641-0; Hamano E, 1986, ECOLOGICAL ENCY TAIW; Hausdorf B, 2005, BIOL J LINN SOC, V84, P785, DOI 10.1111/j.1095-8312.2005.00467.x; Hawkins BA, 2003, GLOBAL ECOL BIOGEOGR, V12, P475, DOI 10.1046/j.1466-822X.2003.00060.x; HOSOKAWA T, 1958, VEGETATIO, V8, P65, DOI 10.1007/BF00419153; Hubbell S. P., 2001, UNIFIED NEUTRAL THEO; Kimura M, 2002, FORMATION RYUKYU ARC; Kubota Y, 2011, J BIOGEOGR, V38, P1006, DOI 10.1111/j.1365-2699.2011.02491.x; Lomolino MV, 2000, GLOBAL ECOL BIOGEOGR, V9, P39, DOI 10.1046/j.1365-2699.2000.00188.x; MacArthur RH, 1967, THEORY ISLAND BIOGEO; Mouillot D, 2013, J BIOGEOGR, V40, P2228, DOI 10.1111/jbi.12194; Oksanen J., 2014, VEGAN COMMUNITY ECOL; Pietsch TW, 2003, J BIOGEOGR, V30, P1297, DOI 10.1046/j.1365-2699.2003.00956.x; R Core Team, 2014, R LANG ENV STAT COMP; Rosenzweig M. L., 1995, SPECIES DIVERSITY SP; Shirouzu T., 2006, STANDARD BUTTERFLIES; Stefanescu C, 2009, OIKOS, V118, P1109, DOI 10.1111/j.1600-0706.2009.17274.x; Takahashi A, 2008, PAC SCI, V62, P395, DOI 10.2984/1534-6188(2008)62[395:SROLPT]2.0.CO;2; Williamson M. H., 1981, ISLAND POPULATIONS; Yeakley JA, 2000, ECOLOGY, V81, P893, DOI 10.1890/0012-9658(2000)081[0893:MSPADB]2.0.CO;2	64	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0305-0270	1365-2699		J BIOGEOGR	J. Biogeogr.	AUG	2015	42	8					1418	1430		10.1111/jbi.12501		13	Ecology; Geography, Physical	Environmental Sciences & Ecology; Physical Geography	CM7TP	WOS:000357899700006		
J	Fukumura, S; Watanabe, T; Takayama, R; Minagawa, K; Tsutsumi, H				Fukumura, Shinobu; Watanabe, Toshihide; Takayama, Rumiko; Minagawa, Kimio; Tsutsumi, Hiroyuki			Everolimus Treatment for an Early Infantile Subependymal Giant Cell Astrocytoma With Tuberous Sclerosis Complex	JOURNAL OF CHILD NEUROLOGY			English	Article						early infancy; subependymal giant cell astrocytomas; tuberous sclerosis complex; everolimus; mammalian target of rapamycin	TUMORS; EFFICACY	Subependymal giant cell astrocytomas are benign tumors often observed with tuberous sclerosis complex. These tumors are rarely diagnosed during fetal life or early infancy. Until recently, the only available treatment has been surgical resection. Current clinical research has demonstrated that everolimus can induce these tumors' regression. We report a 19-month-old boy with tuberous sclerosis complex. At 2 months of age, he presented with congenital subependymal giant cell astrocytoma that was complicated by refractory epilepsy and severe mental retardation. Treatment with everolimus was started when he was 10 months old. Three months after initiating everolimus, the tumor was significantly reduced in size, and the reduction was subsequently maintained. His seizures decreased and he showed cognitive and developmental improvement. No severe adverse events have been observed to date. Everolimus has promise as an effective alternative to surgery for subependymal giant cell astrocytomas during early infancy.	[Fukumura, Shinobu; Watanabe, Toshihide; Takayama, Rumiko; Minagawa, Kimio] Hokkaido Med Ctr Child Hlth & Rehabil, Dept Child Neurol, Teine Ku, Sapporo, Hokkaido 0060041, Japan; [Fukumura, Shinobu; Watanabe, Toshihide; Takayama, Rumiko; Minagawa, Kimio; Tsutsumi, Hiroyuki] Sapporo Med Univ, Sch Med, Dept Pediat, Chuo Ku, Sapporo, Hokkaido, Japan	Fukumura, S (reprint author), Hokkaido Med Ctr Child Hlth & Rehabil, Teine Ku, Sapporo, Hokkaido 0060041, Japan.	fukumura@sapmed.ac.jp					Krueger DA, 2010, NEW ENGL J MED, V363, P1801, DOI 10.1056/NEJMoa1001671; Crino PB, 2006, NEW ENGL J MED, V355, P1345, DOI 10.1056/NEJMra055323; [Anonymous], 2009, ENJOJI METHODS DEV S; Krueger DA, 2013, NEUROLOGY, V80, P574, DOI 10.1212/WNL.0b013e3182815428; Motzer RJ, 2008, LANCET, V372, P449, DOI 10.1016/S0140-6736(08)61039-9; Goh S, 2004, NEUROLOGY, V63, P1457; Moavero R, 2011, CHILD NERV SYST, V27, P1203, DOI 10.1007/s00381-011-1406-0; Demir HA, 2012, PEDIATRICS, V130, pE243, DOI 10.1542/peds.2011-3476; Chu-Shore CJ, 2010, EPILEPSIA, V51, P1236, DOI 10.1111/j.1528-1167.2009.02474.x; Krueger DA, 2013, ANN NEUROL, V74, P679, DOI 10.1002/ana.23960; Franz DN, 2012, LANCET, V381, P125; Iik U, 2010, PEDIATR NEUROL, V42, P157; PAINTER MJ, 1984, NEUROSURGERY, V14, P570; Prabowo AS, 2013, BRAIN PATHOL, V23, P45, DOI 10.1111/j.1750-3639.2012.00616.x; Raju GP, 2007, PEDIATR NEUROL, V36, P128, DOI 10.1016/j.pediatrneurol.2006.08.009; SHEPHERD CW, 1991, NEUROSURGERY, V28, P864	16	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0883-0738	1708-8283		J CHILD NEUROL	J. Child Neurol.	AUG	2015	30	9					1192	1195		10.1177/0883073814544703		4	Clinical Neurology; Pediatrics	Neurosciences & Neurology; Pediatrics	CN0BN	WOS:000358076900011		
J	Akamine, Y; Uehara, H; Miura, M; Yasui-Furukori, N; Uno, T				Akamine, Y.; Uehara, H.; Miura, M.; Yasui-Furukori, N.; Uno, T.			Multiple inductive effects of carbamazepine on combined therapy with paliperidone and amlodipine	JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS			English	Article						carbamazepine; CYP3A; P-glycoprotein; pharmacodynamics; pharmacokinetics	P-GLYCOPROTEIN; PLASMA; PHARMACOKINETICS	What is known and objectiveCarbamazepine is a potent inducer of cytochrome P450 3A and P-glycoprotein. However, there are no reports of the effects of carbamazepine on more than one co-administered drug. Case summaryA 53-year-old female patient with schizophrenia and hypertension was on paliperidone 12mg/day and amlodipine 5mg/day. When carbamazepine was added to this prescription, the plasma concentrations of both drugs decreased dramatically in a dose-dependent manner. Although the patient's psychotic symptoms did not change, as a result, her mean blood pressure increased to 1601/1036mmHg from 1384/914mmHg at a carbamazepine dose of 600mg/day. What is new and conclusionTheses cases show the effect of carbamazepine induction on two drugs simultaneously. Care is required when carbamazepine is added to drug regimens including paliperidone or amlodipine alone or together.	[Akamine, Y.; Miura, M.] Akita Univ Hosp, Dept Pharm, Akita 0108543, Japan; [Uehara, H.] Univ Ryukyus, Fac Med, Dept Hosp Pharm, Okinawa, Japan; [Yasui-Furukori, N.] Hirosaki Univ, Sch Med, Dept Neuropsychiat, Hirosaki, Aomori 036, Japan; [Uno, T.] Zikeikai Aoimori Hosp, Dept Pharm, Aomori, Japan	Miura, M (reprint author), Akita Univ Hosp, Dept Pharm, 1-1-1 Hondo, Akita 0108543, Japan.	m-miura@hos.akita-u.ac.jp					Dongre VG, 2008, J PHARMACEUT BIOMED, V46, P583, DOI 10.1016/j.jpba.2007.11.006; Zhu YL, 2014, DRUG METAB DISPOS, V42, P245, DOI 10.1124/dmd.113.055400; Hiemke C, 2011, PHARMACOPSYCHIATRY, V44, P195, DOI 10.1055/s-0031-1286287; Giessmann T, 2004, CLIN PHARMACOL THER, V76, P192, DOI 10.1016/j.cipt.2004.04.011; Zhang CB, 2011, EPILEPSIA, V52, P1894, DOI 10.1111/j.1528-1167.2011.03140.x; [Anonymous], 2012, GUIDANCE IND DRUG IN; Akamine Y, 2012, BRIT J CLIN PHARMACO, V73, P478, DOI 10.1111/j.1365-2125.2011.04106.x; Bayes M, 2002, METHOD FIND EXP CLIN, V24, P431; EICHELBAUM M, 1985, CLIN PHARMACOKINET, V10, P80; Fortuna A, 2012, EPILEPSIA, V53, P529, DOI 10.1111/j.1528-1167.2012.03409.x; Janssen Pharmaceutical K. K, 2011, PROD INF INVEGA; Nagasaki T, 1999, J PHARMACEUT BIOMED, V19, P595, DOI 10.1016/S0731-7085(98)00261-1; NEELS HM, 1983, J CLIN CHEM CLIN BIO, V21, P295; Oscarson M, 2006, CLIN PHARMACOL THER, V80, P440, DOI 10.1016/j.clpt.2006.08.013; Perera M, 2010, EXPERT OPIN DRUG MET, V6, P17, DOI 10.1517/17425250903379546; PYNNONEN S, 1980, INT J CLIN PHARM TH, V18, P247; SCHLANZ KD, 1991, CLIN PHARMACOKINET, V21, P448, DOI 10.2165/00003088-199121060-00005; WESTENBERG HGM, 1978, CLIN PHARMACOL THER, V23, P320; Zuo XC, 2014, DRUG METAB PHARMACOK, V29, P305, DOI 10.2133/dmpk.DMPK-13-RG-127	19	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0269-4727	1365-2710		J CLIN PHARM THER	J. Clin. Pharm. Ther.	AUG	2015	40	4					480	482		10.1111/jcpt.12286		3	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CM5QH	WOS:000357742800021		
J	Sasaki, O; Aihara, M; Nishiura, A; Takeda, H; Satoh, M				Sasaki, O.; Aihara, M.; Nishiura, A.; Takeda, H.; Satoh, M.			Genetic analysis of the cumulative pseudo-survival rate during lactation of Holstein cattle in Japan by using random regression models	JOURNAL OF DAIRY SCIENCE			English	Article						dairy cattle; genetic evaluation; survivability; random regression model	PROPORTIONAL HAZARDS MODEL; CANADIAN DAIRY-CATTLE; PRODUCTIVE LIFE; HERD LIFE; FUNCTIONAL LONGEVITY; CLINICAL MASTITIS; LINEAR-MODELS; COWS; TRAITS; SELECTION	Longevity is a crucial economic trait in the dairy farming industry. In this study, our objective was to develop a random regression model for genetic evaluation of survival. For the analysis, we used test-day records obtained for the first 5 lactations of 380,252 cows from 1,296 herds in Japan between 2001 and 2010; this data set was randomly divided into 7 subsets. The cumulative pseudo-survival rate (PSR) was determined according to whether a cow was alive (1) or absent (0) in her herd on the test day within each lactation group. Each lactation number was treated as an independent trait in a random regression multiple-trait model (MTM) or as a repeated measure in a random regression single-trait repeatability model (STRM). A proportional hazard model (PHM) was also developed as a piecewise-hazards model. The average (+/- standard deviation) heritability estimates of the PSR at 365 d in milk (DIM) among the 7 data sets in the first (LG1), second (LG2), and third to fifth lactations (LG3) of the MTM were 0.042 +/- 0.007, 0.070 +/- 0.012, and 0.084 +/- 0.007, respectively. The heritability estimate of the STRM was 0.038 +/- 0.004. The genetic correlations of PSR between distinct DIM within or between lactation groups were high when the interval between DIM was short. These results indicated that whereas the genetic factors contributing to the PSR between closely associated DIM would be similar even for different lactation numbers, the genetic factors contributing to PSR would differ between distinct lactation periods. The average ( standard deviation) effective heritability estimate based on the relative risk of the PHM among the 7 data sets was 0.068 +/- 0.009. The estimated breeding values (EBV) in LG1, LG2, LG3, the STRM, and the PHM were unbiased estimates of the genetic trend. The absolute values of the Spearman's rank correlation coefficients between the EBV of the relative risk of the PHM and the EBV of PSR at 365 DIM for LG1, LG2, LG3, and the STRM were 0.75, 0.87, 0.91, and 0.93, respectively. These results indicated that the EBV of PSR could predict the genetic contribution to survival. The EBV based on the PSR of the STRM was highly correlated with that of the MTM (0.83-0.96). Furthermore, the calculation load of the STRM was lighter than that of the MTM because the rank of the matrix of the STRM was smaller than that of the MTM. These results indicated that the STRM is an appropriate model for estimating survivability by using random regression models.	[Sasaki, O.; Nishiura, A.; Takeda, H.; Satoh, M.] NARO Inst Livestock & Grassland Sci, Tsukuba, Ibaraki 3050901, Japan; [Aihara, M.] Livestock Improvement Assoc Japan Inc, Tokyo 1350041, Japan	Sasaki, O (reprint author), NARO Inst Livestock & Grassland Sci, Tsukuba, Ibaraki 3050901, Japan.	sasa1@affrc.go.jp					Vazquez AI, 2009, J DAIRY SCI, V92, P739, DOI 10.3168/jds.2008-1325; Heringstad B, 2000, LIVEST PROD SCI, V64, P95, DOI 10.1016/S0301-6226(99)00128-1; Veerkamp RF, 2001, ANIM SCI, V72, P1; Calus MPL, 2005, J DAIRY SCI, V88, P2178; BOICHARD D, 1995, J DAIRY SCI, V78, P431; Jamrozik J, 2008, J ANIM BREED GENET, V125, P75, DOI 10.1111/j.1439-0388.2007.00712.x; Yazdi MH, 2002, J DAIRY SCI, V85, P1563; Wolf J, 2010, J DAIRY SCI, V93, P1193, DOI [10.3168/jds.2009-2443, 10.3168/jds.jds.2009-2443]; Caraviello DZ, 2004, J DAIRY SCI, V87, P1469; Sewalem A, 2010, J DAIRY SCI, V93, P4359, DOI 10.3168/jds.2009-2969; Boettcher PJ, 1999, J DAIRY SCI, V82, P1034; Caccamo M, 2008, J DAIRY SCI, V91, P3268, DOI 10.3168/jds.2007-0805; Caraviello DZ, 2004, J DAIRY SCI, V87, P3518; Carlen E, 2006, J DAIRY SCI, V89, P4049; DOHOO IR, 1984, PREV VET MED, V2, P771, DOI 10.1016/0167-5877(84)90032-1; Ducrocq V., 2010, P 9 WORLD C GEN APPL; Ducrocq V., 2002, P 7 WORLD C GEN APPL, V32, P505; Ducrocq V, 2005, ANIM SCI, V80, P249, DOI 10.1079/ASC41720249; DURR JW, 1997, J ANIM SCI, V77, P601; Essl A, 1998, LIVEST PROD SCI, V57, P79, DOI 10.1016/S0301-6226(98)00160-2; GILL GS, 1976, J DAIRY SCI, V59, P1325; Holtsmark M, 2009, J DAIRY SCI, V92, P5730, DOI 10.3168/jds.2009-2132; Liu Z., 2001, INTERBULL B, V27, P159; Liu Z, 2004, J DAIRY SCI, V87, P1896; Meijering A., 1985, Z TIERZUCHTG ZUCHTGS, V120, P95; Misztal I., 2002, P 7 WORLD C GEN APPL, V33, P743; Rajala-Schultz PJ, 1999, PREV VET MED, V41, P195, DOI 10.1016/S0167-5877(99)00046-X; Roxstrom A, 2003, GENET SEL EVOL, V35, P305, DOI 10.1051/gse:2003010; SAS, 2006, BAS SAS 9 1 3 PROC G; SAS Institute Inc, 2004, SAS STAT 9 1 US GUID; Sasaki O, 2012, ANIM SCI J, V83, P95, DOI 10.1111/j.1740-0929.2011.00943.x; Sewalem A, 2005, J DAIRY SCI, V88, P368; Sewalem A, 2007, J DAIRY SCI, V90, P2025, DOI 10.3168/jds.2006-719; Tarres J, 2006, GENET SEL EVOL, V38, P65, DOI 10.1051/gse:2005027; Terawaki Y, 2009, J DAIRY SCI, V92, P2144, DOI 10.3168/jds.2008-1199; VANRADEN PM, 1995, J DAIRY SCI, V78, P631; WEIGEL DJ, 1995, J DAIRY SCI, V78, P639; Zavadilova L, 2011, J DAIRY SCI, V94, P4090, DOI 10.3168/jds.2010-3684	38	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0022-0302	1525-3198		J DAIRY SCI	J. Dairy Sci.	AUG	2015	98	8					5781	5795		10.3168/jds.2014-9152		15	Agriculture, Dairy & Animal Science; Food Science & Technology	Agriculture; Food Science & Technology	CM7AF	WOS:000357842100068		
J	Honda, M; Matsuzaki, H; Miyake, Y; Maejima, Y; Yamagata, T; Nagai, H				Honda, Maki; Matsuzaki, Hiroyuki; Miyake, Yasuto; Maejima, Yuji; Yamagata, Takeyasu; Nagai, Hisao			Depth profile and mobility of I-129 and Cs-137 in soil originating from the Fukushima Dai-ichi Nuclear Power Plant accident	JOURNAL OF ENVIRONMENTAL RADIOACTIVITY			English	Article						FDNPP accident; Iodine-129; Cesium-137; Depth profile; Downward migration	RADIOACTIVE CESIUM; MASS-SPECTROMETRY; JAPAN; DEPOSITION; CHERNOBYL; IODINE; I-131; RADIONUCLIDES; PREFECTURE; NUCLIDES	The 1291 derived from the FDNPP accident were clearly identified near the surface and showed a trend of rapid decrease with depth. The FDNPP I-129 and Cs-137 was 51.6 +/- 1.7 mBq cm(-2) and 88.2 +/- 27.1 kBq cm(-2) (average of four cores inventory) respectively. On average, 91% of the FDNPP I-129 existed within the top 5 g cm(-2) and 98% within the top 10 g cm(-2) and average of 100% of the FDNPP Cs-137 existed within the top 5 g cm(-2). From the observation of the temporal variation of depth profiles from the same upland field (Kawauchi village, 20 km away from the FDNPP to the southwest direction), downward migration rates of 0.81 +/- 0.32 g cm(-2) yr(-1) for the FDNPP I-129 and 0.19 +/- 0.17 g cm(-2) yr(-1) for the FDNPP Cs-137 were estimated. A simple diffusion model was introduced to evaluate the downward mobility of the FDNPPderived I-129 and Cs-137. The apparent diffusion coefficients D of 0.0086 +/- 0.0034 and 0.0011 +/- 0.0010 g(2) cm(-1) d were obtained for I-129 and Cs-137, respectively. These values might be representative for Haplic Gray lowland soils in near the steady state under humid temperate climate. (C) 2015 Elsevier Ltd. All rights reserved.	[Honda, Maki] Nihon Univ, Grad Sch Integrated Basic Sci, Setagaya Ku, Tokyo 1568550, Japan; [Matsuzaki, Hiroyuki; Miyake, Yasuto] Univ Tokyo, Sch Engn, Dept Nucl Engn & Management, Bunkyo Ku, Tokyo 1138656, Japan; [Maejima, Yuji] Natl Inst Agroenvironm Sci, Tsukuba, Ibaraki 3058604, Japan; [Yamagata, Takeyasu; Nagai, Hisao] Nihon Univ, Coll Humanities & Sci, Setagaya Ku, Tokyo 1568550, Japan	Honda, M (reprint author), Nihon Univ, Grad Sch Integrated Basic Sci, Setagaya Ku, 3-25-40 Sakurajosui, Tokyo 1568550, Japan.	m-honda@ied.tsukuba.ac.jp					Toyama C, 2013, ENVIRON SCI TECHNOL, V47, P8383, DOI 10.1021/es401596z; Matsuzaki H, 2007, NUCL INSTRUM METH B, V259, P721, DOI 10.1016/j.nimb.2007.01.216; Schnetger B, 1996, ANALYST, V121, P1627, DOI 10.1039/an9962101627; Ohno T, 2012, GEOCHEM J, V46, P287; Muramatsu Y, 1998, CHEM GEOL, V147, P201, DOI 10.1016/S0009-2541(98)00013-8; Muramatsu Y, 2008, QUAT GEOCHRONOL, V3, P291, DOI 10.1016/j.quageo.2007.08.002; Tanaka K, 2012, GEOCHEM J, V46, P73; Matsuda N, 2015, J ENVIRON RADIOACTIV, V139, P427, DOI 10.1016/j.jenvrad.2014.10.001; Nakanishi T, 2014, J ENVIRON RADIOACTIV, V128, P9, DOI 10.1016/j.jenvrad.2013.10.019; Tagami K, 2011, SCI TOTAL ENVIRON, V409, P4885, DOI 10.1016/j.scitotenv.2011.07.067; Sharma P, 1997, NUCL INSTRUM METH B, V123, P347, DOI 10.1016/S0168-583X(96)00675-1; Straume T, 2006, HEALTH PHYS, V91, P7, DOI 10.1097/01.HP.0000184672.67781.a3; Aomori prefecture, 2011, ANN REP ENV RAD MON; AOYAMA M, 1987, J RADIOAN NUCL CH AR, V116, P291, DOI 10.1007/BF02035773; AOYAMA M, 1986, NATURE, V321, P819, DOI 10.1038/321819a0; Bennett B., 2006, REPORT UN CHERNOBYL; Hou XL, 2003, SCI TOTAL ENVIRON, V308, P97, DOI 10.1016/S0048-9697(02)00546-6; Igarashi Y, 2003, J RADIAT RES, V44, P319, DOI 10.1269/jrr.44.319; International Atomic Energy Agency (IAEA), 2006, REP UN CHERN FOR EXP; International Commission on Radiation Units and Measurements (ICRU), 1994, 53 ICRU; Kato H, 2012, J ENVIRON RADIOACTIV, V111, P59, DOI 10.1016/j.jenvrad.2011.10.003; Maekawa A, 2015, J RADIOANAL NUCL CH, V303, P1485, DOI 10.1007/s10967-014-3575-2; MURAMATSU Y, 1986, SCI TOTAL ENVIRON, V48, P33, DOI 10.1016/0048-9697(86)90152-X; Muramatsu Y., 2015, J ENVIRON RADIOACTIV, V139, P344; National Institute for Agro-Environmental Sciences (NIAES), SOIL INF WEB VIEW; Reithmeier H, 2006, ENVIRON SCI TECHNOL, V40, P5891, DOI 10.1021/es0605725; Saito K, 2015, J ENVIRON RADIOACTIV, V139, P308, DOI 10.1016/j.jenvrad.2014.02.014; Sato H., 2013, MRS P, V1518, P277; Soderlund M., 2011, 201104 PSIV OY; Suzuki T, 2008, QUAT GEOCHRONOL, V3, P268, DOI 10.1016/j.quageo.2007.12.004; Takahashi J, 2015, J ENVIRON RADIOACTIV, V139, P351, DOI 10.1016/j.jenvrad.2014.07.004; The Federation of Electric Power Companies (FEPC) and Japan Atomic Energy Agency (JAEA), 2007, JAEA REV 2007 010, P2007; Tsuruta H, 2014, SCI REP-UK, V4, DOI 10.1038/srep06717; UNSCEAR, 2000, UNSCEAR 2000 REP, V1, P280	34	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0265-931X	1879-1700		J ENVIRON RADIOACTIV	J. Environ. Radioact.	AUG	2015	146						35	43		10.1016/j.jenvrad.2015.03.029		9	Environmental Sciences	Environmental Sciences & Ecology	CN0HP	WOS:000358095000005		
J	Tomita, J; Yamamoto, M; Nozaki, T; Tanimura, Y; Oishi, T				Tomita, Jumpei; Yamamoto, Masayoshi; Nozaki, Teo; Tanimura, Yoshihiko; Oishi, Tetsuya			Determination of low-level radiostrontium, with emphasis on in situ pre-concentration of Sr from large volume of freshwater sample using Powdex resin	JOURNAL OF ENVIRONMENTAL RADIOACTIVITY			English	Article						Radiostrontium; Large volume of freshwater sample; Powdex resin; Electric conductivity	RAPID-DETERMINATION; SR-90; STRONTIUM; SEPARATION	An improved analytical method was developed for determining of low levels of radiostrontium in environmental freshwater samples. Emphasis was placed to the in situ pre-concentration of radiostrontium with Powdex resin in large volumes (100-300 L) of freshwater samples from many locations without using of deleterious substances such as NaOH and mineral acids. Measuring electric conductivity (EC) of water samples enabled the estimation of the amount of Powdex resin required for quantitative recovery of Sr from the large water samples in the field. The Powdex resin that adsorbed Sr was brought back to the laboratory, and Sr adsorbed in the resin was eluted by 8 M HNO3 together with Sr carrier added. Strontium was radiochemically separated by the cation exchange method for beta counting after removal of most of the Ca using Ca(OH)(2) precipitation. Through the procedure the Sr chemical yield was 88% on average. This analytical method was verified by analyzing 170 L of water samples with different salinity values, to which a known amount of Sr-90 was added. The detection limits of Sr-90 activities obtained using the 170 L water samples was estimated to be approximately 0.1 mBq L-1 for a counting time of 100 min. The method was also applied to environmental samples collected from Ibaraki and Fukushima prefectures; their Sr-90 activities ranged from 0.16 to 0.93 mBq L-1. (C) 2015 Elsevier Ltd. All rights reserved.	[Tomita, Jumpei; Nozaki, Teo; Tanimura, Yoshihiko; Oishi, Tetsuya] Japan Atom Energy Agcy, Dept Radiat Protect, Nucl Sci Res Inst, Naka, Ibaraki 3191195, Japan; [Yamamoto, Masayoshi] Kanazawa Univ, Low Level Radioact Lab, Inst Nat & Environm Technol, Nomi, Ishikawa 9231224, Japan	Tomita, J (reprint author), Japan Atom Energy Agcy, Dept Radiat Protect, Nucl Sci Res Inst, Naka, Ibaraki 3191195, Japan.	tomita.jumpei@jaea.go.jp					Vajda N, 2010, APPL RADIAT ISOTOPES, V68, P2306, DOI 10.1016/j.apradiso.2010.05.013; Eliades J, 2013, NUCL INSTRUM METH B, V294, P361, DOI 10.1016/j.nimb.2011.11.030; Chen QJ, 2002, ANAL CHIM ACTA, V466, P109, DOI 10.1016/S0003-2670(02)00571-8; Froidevaux J., 2002, J RADIOANAL NUCL CHE, V254, P23; Fukushima Prefecture, 2013, MONITORING RESULTS R; Kameo Y, 2007, J RADIOANAL NUCL CH, V274, P71, DOI 10.1007/s10967-006-6905-1; Kubota T, 2015, J RADIOANAL NUCL CH, V303, P39, DOI 10.1007/s10967-014-3348-y; Lee YK, 2000, J RADIOANAL NUCL CH, V243, P525, DOI 10.1023/A:1016019307857; Ma R, 2011, APPL GEOCHEM, V26, P884, DOI 10.1016/j.apgeochem.2011.02.008; MANOS CG, 1993, CHEMOSPHERE, V26, P2031, DOI 10.1016/0045-6535(93)90029-5; Maxwell SL, 2013, J RADIOANAL NUCL CH, V295, P965, DOI 10.1007/s10967-012-1863-2; MEXT, 2003, ANAL RADIOSTRONTIUM; NRA, DATABASE ENV RADIOAC; NRA, 2011, INVESTIGATION DISTRI; Popov L, 2006, J RADIOANAL NUCL CH, V269, P161, DOI 10.1007/s10967-006-0246-y; Ruberu S.R., 2007, HEALTH PHYS, P432; Takagai M., 2014, ANAL METHODS, V6, P355; Vinson DS, 2012, CHEM GEOL, V334, P280, DOI 10.1016/j.chemgeo.2012.10.030	18	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0265-931X	1879-1700		J ENVIRON RADIOACTIV	J. Environ. Radioact.	AUG	2015	146						88	93		10.1016/j.jenvrad.2015.04.011		6	Environmental Sciences	Environmental Sciences & Ecology	CN0HP	WOS:000358095000012		
J	Ueda, S; Hasegawa, H; Kakiuchi, H; Ochiai, S; Akata, N; Hisamatsu, S				Ueda, Shinji; Hasegawa, Hidenao; Kakiuchi, Hideki; Ochiai, Shinya; Akata, Naofumi; Hisamatsu, Shun'ichi			Nuclear accident-derived H-3 in river water of Fukushima Prefecture during 2011-2014	JOURNAL OF ENVIRONMENTAL RADIOACTIVITY			English	Article						H-3 concentration; Fukushima Nuclear Power Plant accident; River water; Base flow; Flood event	SCALE ATMOSPHERIC DISPERSION; PLANT ACCIDENT; SOURCE-TERM; TRITIUM; JAPAN; RADIONUCLIDES; RADIOCESIUM; DISCHARGE	During 2011-2014, we measured H-3 concentrations in river water samples collected during base flow conditions and during several flood events from two small rivers in a mountainous area in Fukushima Prefecture, which received deposition of Cs-137 from the Fukushima Dai-ichi Nuclear Power Plant accident. H-3 concentrations above background levels were found in water samples collected during both base flow conditions and flood events in 2011. The H-3 concentrations during flood events were generally higher than those during base flow conditions. The H-3 concentrations in both rivers during base flow conditions and flood events decreased with time after the accident and reached almost background levels in 2013. We also measured H-3 concentrations in freshwater samples from 16 other rivers and one dam in eastern Fukushima Prefecture from 2012 to 2014 during base flow conditions. The measured H-3 concentrations were higher than the background level in 2012 and decreased with time. The Cs-137 inventory in the catchment area at each sampling point was estimated from air-borne monitoring results in the literature and compared with the H-3 concentrations. We found surprisingly good correlations between Cs-137 inventories in the catchment areas and H-3 concentrations in the water samples. Further studies will be necessary to clarify the reason for the good correlation. (C) 2015 Elsevier Ltd. All rights reserved.	[Ueda, Shinji; Hasegawa, Hidenao; Kakiuchi, Hideki; Ochiai, Shinya; Hisamatsu, Shun'ichi] Inst Environm Sci, Dept Radioecol, Aomori 0393212, Japan; [Akata, Naofumi] Natl Inst Nat Sci, Natl Inst Fus Sci, Dept Hel Plasma Res, Toki, Gifu 5095292, Japan	Ueda, S (reprint author), Inst Environm Sci, Dept Radioecol, 1-7 Rokkasho, Aomori 0393212, Japan.	sueda@ies.or.jp			Government of Aomori Prefecture, Japan	We are grateful to Mr. H. Kakimoto and Mrs. S. Nakamura-Takaya (Zax Co. Ltd.) for their technical help in sample pretreatment. This study was performed under a contract with the Government of Aomori Prefecture, Japan.	Kinoshita N, 2011, P NATL ACAD SCI USA, V108, P19526, DOI 10.1073/pnas.1111724108; Terada H, 2012, J ENVIRON RADIOACTIV, V112, P141, DOI 10.1016/j.jenvrad.2012.05.023; Ueda S, 2013, J ENVIRON RADIOACTIV, V118, P96, DOI 10.1016/j.jenvrad.2012.11.009; CNSC - Canadian Nuclear Safety Commission, 2009, INFO0792; Geospatial Information Authority of Japan, 2014, FUNDAMENTAL GEOSPATI; Gordon N.D., 2004, STREAM HYDROLOGY INT; Gray J., 1995, Journal of Radiological Protection, V15, P99, DOI 10.1088/0952-4746/15/2/001; ICRP - International Commission on Radiological Protection, 1996, ANN ICRP, V26; Igarashi T, 1996, THESIS HOKKAIDU U; Kakiuchi H, 2012, SCI REP-UK, V2, DOI 10.1038/srep00947; Kaneko F., 2002, Japanese Journal of Soil Science and Plant Nutrition, V73, P501; Katata G, 2012, J ENVIRON RADIOACTIV, V109, P103, DOI 10.1016/j.jenvrad.2012.02.006; LUYKX F, 1986, RADIAT PROT DOSIM, V16, P31; Matsumoto T, 2013, SCI TOTAL ENVIRON, V445, P365, DOI 10.1016/j.scitotenv.2012.12.069; MEXT - Ministry of Education Culture Sports Science and Technology, 2012, RESULTS I 5 AIRBORNE; MEXT - Ministry of Education Culture Sports Science and Technology, 2013, I RESULTS 6 AIRBORNE; MLIT - Ministry of Land Infrastructure Transport and Tourism Japan, 2014, NATL LAND NUMERICAL; Momoshima N, 2005, FUSION SCI TECHNOL, V48, P520; Nishiharai Kenji, 2012, Transactions of the Atomic Energy Society of Japan, V11, DOI 10.3327/taesj.J11.040; Nuclear Emergency Response Headquarters Government of Japan, 2011, JAP GOV IAEA MIN C N; Nuclear Regulation Authority, 2014, DATABASE ENV RADIOAC; Ochiai S, 2015, J ENVIRON RADIOACTIV, V144, P86, DOI 10.1016/j.jenvrad.2015.03.005; UNSCEAR - United Nations Scientific Committee on the Effects of Atomic Radiation, 2008, UN SCI COMMITTEE EFF, VI, P351; Yuita K., 1996, P 22 JPN C RAD RAD B, VB230	24	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0265-931X	1879-1700		J ENVIRON RADIOACTIV	J. Environ. Radioact.	AUG	2015	146						102	109		10.1016/j.jenvrad.2015.04.014		8	Environmental Sciences	Environmental Sciences & Ecology	CN0HP	WOS:000358095000014		
J	Kobayashi, Y; Yasuoka, Y; Ornori, Y; Nagahama, H; Sanada, T; Muto, J; Suzuki, T; Homma, Y; Ihara, H; Kubota, K; Mukai, T				Kobayashi, Yuka; Yasuoka, Yumi; Omori, Yasutaka; Nagahama, Hiroyuki; Sanada, Tetsuya; Muto, Jun; Suzuki, Toshiyuki; Homma, Yoshimi; Ihara, Hayato; Kubota, Kazuhito; Mukai, Takahiro			Annual variation in the atmospheric radon concentration in Japan	JOURNAL OF ENVIRONMENTAL RADIOACTIVITY			English	Article						Atmospheric radon; Seasonal variation; Sinusoidal model; Japan; Atmospheric turbulence; Asian monsoons	EARTHQUAKE	Anomalous atmospheric variations in radon related to earthquakes have been observed in hourly exhaust-monitoring data from radioisotope institutes in Japan. The extraction of seismic anomalous radon variations would be greatly aided by understanding the normal pattern of variation in radon concentrations. Using atmospheric daily minimum radon concentration data from five sampling sites, we show that a sinusoidal regression curve can be fitted to the data. In addition, we identify areas where the atmospheric radon variation is significantly affected by the variation in atmospheric turbulence and the onshore-offshore pattern of Asian monsoons. Furthermore, by comparing the sinusoidal regression curve for the normal annual (seasonal) variations at the five sites to the sinusoidal regression curve for a previously published dataset of radon values at the five Japanese prefectures, we can estimate the normal annual variation pattern. By fitting sinusoidal regression curves to the previously published dataset containing sites in all Japanese prefectures, we find that 72% of the Japanese prefectures satisfy the requirements of the sinusoidal regression curve pattern. Using the normal annual variation pattern of atmospheric daily minimum radon concentration data, these prefectures are suitable areas for obtaining anomalous radon variations related to earthquakes. (C) 2015 Elsevier Ltd. All rights reserved.	[Kobayashi, Yuka; Yasuoka, Yumi; Mukai, Takahiro] Kobe Pharmaceut Univ, Higashinada Ku, Kobe, Hyogo 6588558, Japan; [Omori, Yasutaka; Homma, Yoshimi] Fukushima Med Univ, Fukushima, Fukushima 9601295, Japan; [Nagahama, Hiroyuki; Muto, Jun] Tohoku Univ, Aoba Ku, Sendai, Miyagi 9808578, Japan; [Sanada, Tetsuya; Suzuki, Toshiyuki] Hokkaido Univ Sci, Teine Ku, Sapporo, Hokkaido 0068585, Japan; [Ihara, Hayato] Wakayama Med Univ, Wakayama 6418509, Japan; [Kubota, Kazuhito] Univ Tokyo, Inst Med Sci, Minato Ku, Tokyo 1088639, Japan	Yasuoka, Y (reprint author), Kobe Pharmaceut Univ, Higashinada Ku, 4-19-1 Motoyamakitamachi, Kobe, Hyogo 6588558, Japan.	yasuoka@kobepharma-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan [1223]	The authors thank the staff of NINS (National Institutes of National Sciences, Okazaki Research Facilities, Center for Radioisotope Facilities) and Dr. Yoichiro lwakura (Emeritus Professor of The University of Tokyo) for permission to analyze the RI monitoring data. This study was supported by the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan under its Earthquake and Volcano Hazards Observation and Research Program (1223).	IGARASHI G, 1995, SCIENCE, V269, P60, DOI 10.1126/science.269.5220.60; PORSTENDORFER J, 1994, HEALTH PHYS, V67, P283, DOI 10.1097/00004032-199409000-00011; Zhuo WH, 2006, J NUCL SCI TECHNOL, V43, P479, DOI 10.3327/jnst.43.479; WAKITA H, 1980, SCIENCE, V207, P882, DOI 10.1126/science.207.4433.882; [Anonymous], 2013, KALEIDAGRAPH GUIDE C; Chambers S, 2009, ATMOS ENVIRON, V43, P271, DOI 10.1016/j.atmosenv.2008.09.075; Frei D., 1989, HDB FOREIGN POLICY A, P350; Hatanaka H., 2013, P 14 WORKSH ENV RAD, P379; Hayashi K, 2015, J ENVIRON RADIOACTIV, V139, P149, DOI 10.1016/j.jenvrad.2014.10.007; Hayashi K., 2014, P 15 WORKSH ENV RAD, P23; Hosoda M, 2009, J RADIAT RES, V50, P333, DOI 10.1269/jrr.08121; Kawashima K., 1988, LOW TEMP SCI A, V46, P1; Maejima I., 1967, GEOGRAPHICAL REPORTS, V2, P77; Megumi K., 1987, JON J HLTH PHYS, V22, P93; Minato Susumu, 2005, Radioisotopes, V54, P509; Nakamura S., 2013, 2 G EV AS PAC REG GL, P165; Oikawa S, 2003, J ENVIRON RADIOACTIV, V65, P203, DOI 10.1016/S0265-931X(02)00097-8; Sesana L, 2003, J ENVIRON RADIOACTIV, V65, P147, DOI 10.1016/S0265-931X(02)00093-0; Tajika Y, 2013, J RADIOANAL NUCL CH, V295, P1709, DOI 10.1007/s10967-012-1999-0; TRENBERTH KE, 1983, B AM METEOROL SOC, V64, P1276, DOI 10.1175/1520-0477(1983)064<1276:WATS>2.0.CO;2; Ukai T., 1996, ANN BURNS FIRE DISAS, V9, P235; United Nations Scientific Committee on the Effects of Atomic Radiation, 2000, UNSCEAR 2000 REPORT, VI, P99; Yasuoka Yumi, 1994, Radioisotopes, V43, P688; Zhang LA, 2011, J RADIOL PROT, V31, P129, DOI 10.1088/0952-4746/31/1/009	24	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0265-931X	1879-1700		J ENVIRON RADIOACTIV	J. Environ. Radioact.	AUG	2015	146						110	118		10.1016/j.jenvrad.2015.04.007		9	Environmental Sciences	Environmental Sciences & Ecology	CN0HP	WOS:000358095000015		
J	Dohi, T; Ohmura, Y; Kashiwadani, H; Fujiwara, K; Sakamoto, Y; Iijima, K				Dohi, Terumi; Ohmura, Yoshihito; Kashiwadani, Hiroyuki; Fujiwara, Kenso; Sakamoto, Yoshiaki; Iijima, Kazuki			Radiocaesium activity concentrations in parmelioid lichens within a 60 km radius of the Fukushima Dai-ichi Nuclear Power Plant	JOURNAL OF ENVIRONMENTAL RADIOACTIVITY			English	Article						Biomonitor; Fallout; Fukushima; Radiocesium; Flavoparmelia caperata; Parmotrema clavuliferum	VERTICAL-DISTRIBUTION; RADIONUCLIDE DISTRIBUTION; CS-137 CONCENTRATIONS; LONG-TERM; ACCIDENT; FALLOUT; BIOMONITORS; CHERNOBYL; PRODUCTS; MONITORS	Radiocaesium activity concentrations (Cs-134 and Cs-137) were measured in parmelioid lichens collected within the Fukushima Prefecture approximately 2 y after the Fukushima Dai-ichi Nuclear Power Plant accident. A total of 44 samples consisting of nine species were collected at 16 points within a 60 km radius of the Fukushima Dai-ichi Nuclear Power Plant. The activity concentration of Cs-134 ranged from 4.6 to 1000 kBq kg(-1) and for Cs-137 ranged from 7.6 to 1740 kBq kg(-1). A significant positive correlation was found between the Cs-137 activity concentration in lichens and the Cs-137 deposition density on soil (n = 44), based on the calculated Spearman's rank correlation coefficients as r = 0.90 (P < 0.01). The two dominant species, Flavoparmelia caperata (n = 12) and Parmotrema clavuliferum (n = 11), showed strong positive correlations, for which the r values were calculated as 0.92 (P < 0.01) and 0.90 (P < 0.01) respectively. Therefore, Flavoparmelia caperata and Parmotrema clavuliferum are suggested as biomonitoring species for levels of radiocaesium fallout within the Fukushima Prefecture. (C) 2015 The Authors. Published by Elsevier Ltd.	[Dohi, Terumi; Kashiwadani, Hiroyuki; Fujiwara, Kenso; Sakamoto, Yoshiaki; Iijima, Kazuki] Japan Atom Energy Agcy, Sect Fukushima Res & Dev, Fukushima, Fukushima 9608031, Japan; [Ohmura, Yoshihito; Kashiwadani, Hiroyuki] Natl Museum Nat & Sci, Dept Bot, Tsukuba, Ibaraki 3050005, Japan	Dohi, T (reprint author), Japan Atom Energy Agcy, Sect Fukushima Res & Dev, 6-6 Sakae Machi, Fukushima, Fukushima 9608031, Japan.	dohi.terumi@jaea.go.jp			Japan Society for the Promotion of Science [24651043]	We would like to express our gratitude to the local governments of Fukushima City, Namie Town, Okuma Town, Tamura City and Tomioka Town for permission undertake to our field investigations. We appreciate Dr. S. M. L Hardie for her critical reading of our manuscript and valuable discussion. We also thank colleagues for their contributions to our field investigations; Ms. A. Hoshi and Mr. K. Kawauchi for their technical assistance. Thanks also to Dr. H. Sato, two anonymous reviewers and the associate editor of JER for their valuable comments and suggestions on our research and manuscript production. This study was partly supported by Grant-in-Aid of the Japan Society for the Promotion of Science (no. 24651043).	Al-Masri MS, 2006, J ENVIRON RADIOACTIV, V86, P187, DOI 10.1016/j.jenvrad.2005.08.006; CULBERSON CF, 1982, J CHROMATOGR, V238, P483, DOI 10.1016/S0021-9673(00)81336-9; Crespo A, 2010, TAXON, V59, P1735; Masson O, 2011, ENVIRON SCI TECHNOL, V45, P7670, DOI 10.1021/es2017158; WATSON DF, 1985, GEO-PROCESSING, V2, P315; Koarashi J, 2012, SCI TOTAL ENVIRON, V431, P392, DOI 10.1016/j.scitotenv.2012.05.041; BIAZROV LG, 1994, PHYTON-ANN REI BOT A, V34, P85; Cevik U, 2009, J ENVIRON RADIOACTIV, V100, P23, DOI 10.1016/j.jenvrad.2008.09.010; Chino M, 2011, J NUCL SCI TECHNOL, V48, P1129, DOI 10.3327/jnst.48.1129; CULBERSO.CF, 1970, J CHROMATOGR, V46, P85, DOI 10.1016/S0021-9673(00)83967-9; ECKL P, 1984, NORD J BOT, V4, P521, DOI 10.1111/j.1756-1051.1984.tb02058.x; Fukushima Prefecture, 2012, ENV RADIOACTIVITY LE; Geospatial Information Authority of Japan, 2013, WEBSITE SURVEYING CA; HAMET-AHTI L, 1974, Annales Botanici Fennici, V11, P59; HANSON WC, 1971, ARCTIC, V24, P269; Heinrich G, 1999, J ENVIRON RADIOACTIV, V45, P13, DOI 10.1016/S0265-931X(98)00069-1; IAEA, 2009, IAEATECDOC1616; IAEA (International Atomic Energy Agency), 2006, ENV CONSEQUENCES CHE; Iurian AR, 2011, ROM J PHYS, V56, P983; Kirchner G, 2002, ENVIRON POLLUT, V120, P145, DOI 10.1016/S0269-7491(02)00139-2; Komori M, 2013, BUNSEKI KAGAKU, V62, P475, DOI 10.2116/bunsekikagaku.62.475; Kurokawa S, 1975, ENV BIOINDICATOR I, P233; KWAPULINSKI J, 1985, SCI TOTAL ENVIRON, V41, P125, DOI 10.1016/0048-9697(85)90182-2; Mikami S., 2015, J ENVIRON RADIOACTIV, V139, P320; Mikami S., 2015, J ENVIRON RADIOACTIV, V139, P250; Nash TH, 2008, LICHEN BIOLOGY, 2ND EDITION, P1, DOI 10.1017/CBO9780511790478.002; Nimis P. L., 1996, STUD GEOBOT, V15, P3; Nuclear Emergency Response Headquarters Government of Japan, 2011, JAP GOV IAEA MIN C N; Ohmura Y, 2015, J ENVIRON RADIOACTIV, V141, P38, DOI 10.1016/j.jenvrad.2014.11.014; Ohmura Y, 2013, LICHENOLOGIST, V45, P685, DOI 10.1017/S0024282913000431; Puhakainen M, 2007, BOREAL ENVIRON RES, V12, P29; Ramzaev V, 2014, J ENVIRON RADIOACTIV, V138, P177, DOI 10.1016/j.jenvrad.2014.09.001; Saito K, 2015, J ENVIRON RADIOACTIV, V139, P308, DOI 10.1016/j.jenvrad.2014.02.014; Saito K., 2013, MAKING DISTRIBUTION; Saito K, 2014, RADIAT PROT DOSIM, V160, P283, DOI 10.1093/rpd/ncu011; SALO A, 1964, NATURE, V201, P1177, DOI 10.1038/2011177a0; Sawidis T, 1997, CAN J BOT, V75, P2216; Sawidis T, 2010, ECOTOX ENVIRON SAFE, V73, P1789, DOI 10.1016/j.ecoenv.2010.07.011; SCHIMMACK W, 1989, GEODERMA, V44, P211, DOI 10.1016/0016-7061(89)90030-X; SEAWARD MRD, 1988, J ENVIRON RADIOACTIV, V7, P123, DOI 10.1016/0265-931X(88)90003-3; Seaward MRD, 2002, NATO SCI S SS IV EAR, V7, P85; Shukla V., 2014, LICHENS TO BIOMONITO, P47; SLOOF JE, 1992, J ENVIRON RADIOACTIV, V16, P229, DOI 10.1016/0265-931X(92)90002-B; SVENSSON GK, 1965, HEALTH PHYS, V11, P1393, DOI 10.1097/00004032-196512000-00017; Takahashi J, 2015, J ENVIRON RADIOACTIV, V139, P351, DOI 10.1016/j.jenvrad.2014.07.004; Thomas P.A., 1999, HLTH PERSPECT, V107, P527; Tuominen Y., 1973, LICHENS, P185; UNSCEAR (United Nations Scientific Committee on the Effects of Atomic Radiation), 2000, EXPOSURES EFFECTS CH	48	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0265-931X	1879-1700		J ENVIRON RADIOACTIV	J. Environ. Radioact.	AUG	2015	146						125	133		10.1016/j.jenvrad.2015.04.013		9	Environmental Sciences	Environmental Sciences & Ecology	CN0HP	WOS:000358095000017		
J	Shimizu, K				Shimizu, Katsutoshi			Adjusting denominators of capital ratios: Evidence from Japanese banks	JOURNAL OF FINANCIAL STABILITY			English	Article						Capital requirements; Basel II; Basel III; Capital conservation buffer; Japanese banks; Government bond	CREDIT CRUNCH; RISK; PORTFOLIOS; ACCORD	This study examines Japanese banks' behavior of adjusting denominators of capital ratios upon the introduction of Basel II regulations. The first analysis investigates the adjustments to the size and composition of portfolios to achieve the target risk-weighted asset (RWA). The second analysis investigates how quickly banks adjust the numerator and denominator of their capital ratio. We find evidence that banks adjusted the composition of their assets faster than their asset size to achieve the RWA targets under the macroeconomic and institutional conditions in Japan. In addition, we find that banks adjusted their level of regulatory capital faster than their RWAs to achieve the capital ratio targets. Furthermore, we find that banks that had less capital surplus shifted their portfolio composition toward lower-risk assets without reducing the total assets. The analyses provide policy implications for the time-varying minimum standards of Basel III. (c) 2015 Elsevier B.V. All rights reserved.	[Shimizu, Katsutoshi] Nagoya Univ, Dept Econ, Nagoya, Aichi 4648601, Japan	Shimizu, K (reprint author), Furo Cho,Chikusa Ku, Nagoya, Aichi 4648601, Japan.	shimizu@soec.nagoya-u.ac.jp			ISHII memorial foundation	The author gratefully acknowledges the valuable comments and helpful suggestions by two anonymous referees of this journal. Although the paper owes very much to them, only the most important suggestions are noted in the footnotes. The author is responsible for any remaining errors. The author is also grateful to the managing editor of this journal. The earlier version of this paper was presented at the 26th Australasian Finance and Banking Conference and at 2013 Annual Meeting of Nippon Finance Association held at Musashi University. The author would like to thank for the comments on the earlier version by Necmi Avkiran (University of Queensland), Naoaki Minamihashi (Bank of Canada), Wataru Ohta (Osaka University), Peng Xu (Hosei University), and other seminar participants. The author also acknowledges the funding support from ISHII memorial foundation and Grant-in-Aid for Scientific Research.	Acharya V.V., 2013, 19039 NBER; ANDERSON TW, 1981, J AM STAT ASSOC, V76, P598, DOI 10.2307/2287517; Montgomery H, 2005, J JPN INT ECON, V19, P24, DOI 10.1016/j.jjie.2004.02.002; SHRIEVES RE, 1995, J FINANC SERV RES, V9, P5, DOI 10.1007/BF01051961; ARELLANO M, 1991, REV ECON STUD, V58, P277, DOI 10.2307/2297968; Hanson SG, 2011, J ECON PERSPECT, V25, P3, DOI 10.1257/jep.25.1.3; HANCOCK D, 1994, J AM REAL ESTATE URB, V22, P59; Francis WB, 2012, J BANK FINANC, V36, P803, DOI 10.1016/j.jbankfin.2011.09.011; Flannery MJ, 2008, REV FINANC, V12, P391, DOI 10.1093/rof/rfm007; SHRIEVES RE, 1992, J BANK FINANC, V16, P439, DOI 10.1016/0378-4266(92)90024-T; Flannery MJ, 2006, J FINANC ECON, V79, P469, DOI 10.1016/j.jfineco.2005.03.004; Gordy MB, 2003, J FINANC INTERMED, V12, P199, DOI 10.1016/S1042-9573(03)00040-8; Barnoff E., 2002, J BANK FINANC, V26, P1181; Basel Committee on Banking Supervision (BCBS), 2010, BAS 3 GLOB REG FRAM; BCBS, 2006, INT CONV CAP MEAS CA; Berrospide JM, 2010, INT J CENT BANK, V6, P5; Cohen B. H., 2014, BIS WORKING PAPERS, V443; Colliard J., 2014, ECB WORKING PAPERS S, V1641; Das D., 2012, RISKY ARE BANKS RISK; HALL BJ, 1993, J JPN INT ECON, V7, P408, DOI 10.1006/jjie.1993.1024; HANCOCK D, 1995, J BANK FINANC, V19, P661, DOI 10.1016/0378-4266(94)00147-U; Krishnan CNV, 2010, J FINANC INTERMED, V19, P207, DOI 10.1016/j.jfi.2009.02.002; Noss J., 2014, 494 BANK ENGL; Shimizu K., 2014, COSTS BANK EQU UNPUB	24	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1572-3089	1878-0962		J FINANC STABIL	J. Financ. Stab.	AUG	2015	19						60	68		10.1016/j.jfs.2015.05.005		9	Business, Finance; Economics	Business & Economics	CM9AH	WOS:000357996700005		
J	Nakamura, T; Ambo, Y; Noji, T; Okada, N; Takada, M; Shimizu, T; Suzuki, O; Nakamura, F; Kashimura, N; Kishida, A; Hirano, S				Nakamura, Toru; Ambo, Yoshiyasu; Noji, Takehiro; Okada, Naoya; Takada, Minoru; Shimizu, Toru; Suzuki, On; Nakamura, Fumitaka; Kashimura, Nobuichi; Kishida, Akihiro; Hirano, Satoshi			Reduction of the Incidence of Delayed Gastric Emptying in Side-to-Side Gastrojejunostomy in Subtotal Stomach-Preserving Pancreaticoduodenectomy	JOURNAL OF GASTROINTESTINAL SURGERY			English	Article						Delayed gastric emptying; Pancreaticoduodenectomy; Subtotal stomach-preserving pancreaticoduodenectomy; Gastrojejunostomy	INTERNATIONAL STUDY-GROUP; RANDOMIZED-CONTROLLED-TRIAL; PANCREATIC SURGERY; WHIPPLE PROCEDURE; RISK-FACTORS; RECONSTRUCTION; ANASTOMOSIS; DEFINITION; SSPPD; PPPD	One of the most common morbidities of pancreaticoduodenectomies is delayed gastric emptying (DGE). The recent advent of subtotal stomach-preserving pancreaticoduodenectomy (SSPPD) attempts to lessen this troublesome complication; however, the incidence of DGE still remains to be 4.5-20 %. This study aims to evaluate whether the incidence of DGE can be reduced by the side-to-side gastric greater curvature-to-jejunal anastomosis in comparison with the gastric stump-to-jejunal end-to-side anastomosis in SSPPD. Between October 2007 and September 2012, a total of 160 consecutive patients who had undergone SSPPD were analyzed retrospectively. In the first period (October 2007-March 2010), gastrojejunostomy was performed with end-to-side anastomosis in 80 patients (SSPPD-ETS group). In the second period (April 2010-September 2012), gastrojejunostomy was performed with the greater curvature side-to-jejunal side anastomosis in 80 patients (SSPPD-STS group). The postoperative data were collected prospectively in a database and reviewed retrospectively. The incidence of DGE was 21.3 % in the SSPPD-ETS group and 2.5 % in the SSPPD-STS group (P = 0.0002). According to the classification of the International Study Group of Pancreatic Surgery (ISGPS), the incidence of DGE of grades A, B, and C were 5, 5, and 7 in the SSPPD-ETS group and 0, 2, and 0 in the SSPPD-STS group, respectively. The overall morbidity and postoperative hospital stay of the two groups were not significantly different. The greater curvature side-to-side anastomosis of gastrojejunostomy is associated with a reduced incidence of DGE after SSPPD.	[Nakamura, Toru; Ambo, Yoshiyasu; Okada, Naoya; Takada, Minoru; Shimizu, Toru; Suzuki, On; Nakamura, Fumitaka; Kashimura, Nobuichi; Kishida, Akihiro] Teine Keijinkai Hosp, Dept Surg, Teine Ku, Sapporo, Hokkaido, Japan; [Nakamura, Toru; Noji, Takehiro; Hirano, Satoshi] Hokkaido Univ, Grad Sch Med, Dept Gastroenterol Surg 2, Sapporo, Hokkaido, Japan	Nakamura, T (reprint author), Teine Keijinkai Hosp, Dept Surg, Teine Ku, Sapporo, Hokkaido, Japan.	torunakamura@med.hokudai.ac.jp					Akizuki E, 2008, J GASTROINTEST SURG, V12, P1185, DOI 10.1007/s11605-008-0513-z; Kawai M, 2011, ANN SURG, V253, P495, DOI 10.1097/SLA.0b013e31820d98f1; Bassi C, 2005, SURGERY, V138, P8, DOI 10.1016/j.surg.2005.05.001; Bassi C, 2005, ANN SURG, V242, P767, DOI 10.1097/01.sla.0000189124.47589.6d; Sugiyama M, 2004, AM J SURG, V187, P743, DOI 10.1016/j.amjsurg.2003.10.013; Atema JJ, 2013, SURGERY, V154, P583, DOI 10.1016/j.surg.2013.04.006; Tani M, 2006, ANN SURG, V243, P316, DOI 10.1097/01.sla.0000201479.84934.ca; Parmar AD, 2013, HPB, V15, P763, DOI 10.1111/hpb.12129; Yeo CJ, 2002, ANN SURG, V236, P355, DOI 10.1097/01.SLA.0000027272.08464.0B; Tran KTC, 2004, ANN SURG, V240, P738, DOI 10.1097/01.sla.0000143248.71964.29; Lin PW, 1999, BRIT J SURG, V86, P603; Nikfarjam M, 2009, J GASTROINTEST SURG, V13, P1674, DOI 10.1007/s11605-009-0944-1; YEO CJ, 1993, ANN SURG, V218, P229, DOI 10.1097/00000658-199309000-00002; Hartel M, 2005, ARCH SURG-CHICAGO, V140, P1094, DOI 10.1001/archsurg.140.11.1094; Eshuis WJ, 2014, ANN SURG, V259, P45, DOI 10.1097/SLA.0b013e3182a6f529; Kurahara H, 2010, J SURG ONCOL, V102, P615, DOI 10.1002/jso.21687; Malleo G, 2010, HPB, V12, P610, DOI 10.1111/j.1477-2574.2010.00203.x; Wente MN, 2007, SURGERY, V142, P761, DOI 10.1016/j.surg.2007.05.005; Fujii T, 2012, ANN SURG ONCOL, V19, P176, DOI 10.1245/s10434-011-1901-2; Kimura W, 2014, ANN SURG, V259, P773, DOI 10.1097/SLA.0000000000000263; Hayashibe A, 2007, J SURG ONCOL, V95, P106, DOI 10.1002/jso.20608; El Nakeeb A, 2015, J GASTROINTEST SURG; Hackert T, 2013, AM J SURG, V206, P296, DOI 10.1016/j.amjsurg.2012.10.042; Imamura N, 2014, HPB, V16, P384, DOI 10.1111/hpb.12153; Kurahara H, 2011, J SURG RES, V171, P187; Manes K, 2008, HPB, V10, P472, DOI 10.1080/13651820802286928; Masui T, 2012, SURG TODAY, V42, P441, DOI 10.1007/s00595-011-0097-1; Ohwada S, 2001, ANN SURG, V234, P668, DOI 10.1097/00000658-200111000-00013; Okada N, 2014, SURG INFECT, V15, P305, DOI 10.1089/sur.2012.170; Qu H, 2013, EJSO-EUR J SURG ONC, V39, P213, DOI 10.1016/j.ejso.2012.12.010; Sato G, 2014, WORLD J SURG, V38, P968, DOI 10.1007/s00268-013-2288-y; Traverso LW, 2008, J HEPATO-BILIARY-PAN, V15, P262, DOI 10.1007/s00534-007-1304-8	32	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1091-255X	1873-4626		J GASTROINTEST SURG	J. Gastrointest. Surg.	AUG	2015	19	8					1425	1432		10.1007/s11605-015-2870-8		8	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	CM9SB	WOS:000358048200006		
J	Namikawa, T; Kobayashi, M; Hanazaki, K				Namikawa, Tsutomu; Kobayashi, Michiya; Hanazaki, Kazuhiro			Transcatheter Arterial Embolization of Ruptured Inferior Phrenic Artery Pseudoaneurysm Following Completion Gastrectomy	JOURNAL OF GASTROINTESTINAL SURGERY			English	Editorial Material						Aneurysm; Gastric cancer; Inferior phrenic artery; Transcatheter arterial embolization	ANEURYSM	A 56-year-old man underwent completion gastrectomy and regional lymphadenectomy for adenocarcinoma of the remnant stomach. Postoperatively, he developed an esophagojejunal anastomotic insufficiency associated with leakage of activated pancreatic juice, resulting in pseudoaneurysm arising from the inferior phrenic artery (IPA) with massive bleeding. Emergency angiography was performed, and the artery was successfully embolized using N-butyl cyanoacrylate. Pseudoaneurysm of the IPA is an extremely rare entity, and transcatheter arterial embolization is an effective treatment method because of its advantages over surgery.	[Namikawa, Tsutomu; Kobayashi, Michiya; Hanazaki, Kazuhiro] Kochi Med Sch, Dept Surg, Nankoku, Kochi 7838505, Japan	Namikawa, T (reprint author), Kochi Med Sch, Dept Surg, Oko Cho, Nankoku, Kochi 7838505, Japan.	tsutomun@kochi-u.ac.jp					Arora A, 2012, ANN VASC SURG, V26, p[860, e9]; Kim GM, 2013, EUR RADIOL, V23, P2344, DOI 10.1007/s00330-013-2830-1; Lee Jun Woo, 2006, Emerg Radiol, V13, P147, DOI 10.1007/s10140-006-0524-6; SHIRAI T, 1994, CHEST, V106, P1290, DOI 10.1378/chest.106.4.1290; Toyoda H, 2004, J VASC INTERV RADIOL, V15, P886, DOI 10.1097/01.RVI.0000137149.23035.B5	5	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1091-255X	1873-4626		J GASTROINTEST SURG	J. Gastrointest. Surg.	AUG	2015	19	8					1561	1562		10.1007/s11605-015-2805-4		2	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	CM9SB	WOS:000358048200022		
J	Mizuguchi, Y; Specht, S; Isse, K; Sasatomi, E; Lunz, JG; Takizawa, T; Demetris, AJ				Mizuguchi, Yoshiaki; Specht, Susan; Isse, Kumiko; Sasatomi, Eizaburo; Lunz, John G.; Takizawa, Toshihiro; Demetris, Anthony J.			Breast tumor kinase/protein tyrosine kinase 6 (Brk/PTK6) activity in normal and neoplastic biliary epithelia	JOURNAL OF HEPATOLOGY			English	Article						Cholangiocarcinoma (CC); EGFR; ErbB2; BRK; RNA interference; SAM68; Tyrosine kinases	GROWTH-FACTOR; CANCER CELLS; THERAPEUTIC TARGET; GENE FAMILY; BRK; CHOLANGIOCARCINOMA; EXPRESSION; SRC; CYCLOOXYGENASE-2; PROLIFERATION	Background & Aims: Breast tumor kinase (BRK) augments proliferation and promotes cell survival in breast cancers via interactions with SH2 and SH3 ligand-containing proteins, such as receptor tyrosine kinases (RTK; e.g. EGFR, ErbB2/neu). Since RTK contribute to cholangiocarcinoma (CC) evolution we probed BRK protein expression and function in normal and CC livers. Methods: Immunohistochemical staining of normal livers and CC (n = 93) in a tissue microarray and three CC and an immortalized human cholangiocyte cell lines (real-time PCR, Western blotting, siRNA) were used to study the functional relationships between BRK, EGFR, ErbB2, SAM68, and SPRR2a. Results: BRK protein was expressed in normal human intrahepatic bile ducts; all CC cell lines and a majority of CC showed strong BRK protein expression. Multiplex immunostaining/tissue cytometry and immunoprecipitation studies showed: 1) BRK co-localized with EGFR and ErbB2/neu; 2) BRKhigh/EGFRhigh-co-expressing CC cells had significantly higher Ki67 labeling and; 3) stronger BRK protein expression was seen in perihilar and distal CC than intrahepatic CC and directly correlated with CC differentiation. In cell lines, BRK expression augmented proliferation in response to exogenous EGF, whereas BRK siRNA significantly reduced growth. The SH3 ligand-containing, SPRR2A activated pTyr342 BRK, which in turn, phosphorylated SAM68, causing nuclear localization and increased cell proliferation similar to observations in breast cancers. Conclusion: BRK expression in a majority of CC can interact with RTK, augmenting growth and interfering with proliferation inhibitors (SAM68). Therapeutically targeting BRK function (in addition to RTK) should be of benefit for CC treatment. (C) 2015 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.	[Mizuguchi, Yoshiaki; Specht, Susan; Isse, Kumiko; Sasatomi, Eizaburo; Lunz, John G.; Demetris, Anthony J.] Univ Pittsburgh, Med Ctr, Thomas E Starzl Transplantat Inst, Pittsburgh, PA 15260 USA; [Mizuguchi, Yoshiaki; Specht, Susan; Isse, Kumiko; Sasatomi, Eizaburo; Lunz, John G.; Demetris, Anthony J.] Univ Pittsburgh, Med Ctr, Dept Pathol, Div Liver & Transplantat Pathol, Pittsburgh, PA 15260 USA; [Takizawa, Toshihiro] Nippon Med Sch, Dept Mol Anat & Med, Bunkyo Ku, Tokyo 1138602, Japan	Demetris, AJ (reprint author), UPMC Montefiore, Dept Pathol, Rm E741,3459 5th Ave, Pittsburgh, PA 15213 USA.	demetrisaj@upmc.edu			Thomas E. Starzl Professor of Pathology Endowment Fund; Ministry of Education, Science, Sports, and Culture of Japan	This work was supported by the Thomas E. Starzl Professor of Pathology Endowment Fund. And was partially supported by Toshihiro Takizawa's grant from the Ministry of Education, Science, Sports, and Culture of Japan and Grants-in-Aid for Scientific Research, Research Fellowships for young scientists and the Core Research Project for Private University: matching fund subsidy.	Andersen JB, 2012, GASTROENTEROLOGY, V142, pe1015; MITCHELL PJ, 1994, ONCOGENE, V9, P2383; Wu T, 2005, BBA-REV CANCER, V1755, P135, DOI 10.1016/j.bbcan.2005.04.002; Li XM, 2001, MAMM GENOME, V12, P52, DOI 10.1007/s003350010230; Lukong KE, 2005, J BIOL CHEM, V280, P38639, DOI 10.1074/jbc.M505802200; Derry JJ, 2003, ONCOGENE, V22, P4212, DOI 10.1038/sj.onc.1206465; Singh PK, 2006, TRENDS CELL BIOL, V16, P467, DOI 10.1016/j.tcb.2006.07.006; Kubo T, 2009, PANCREAS, V38, pE200, DOI 10.1097/MPA.0b013e3181b8feb0; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; Born M, 2005, J PATHOL, V205, P592, DOI 10.1002/path.1720; Ostrander JH, 2007, CANCER RES, V67, P4199, DOI 10.1158/0008-5472.CAN-06-3409; Demetris AJ, 2008, J HEPATOL, V48, P276, DOI 10.1016/j.jhep.2007.09.019; Han C, 2004, CANCER RES, V64, P1369, DOI 10.1158/0008-5472.CAN-03-1086; FUMAGALLI S, 1994, NATURE, V368, P871, DOI 10.1038/368871a0; Uckun FM, 2007, BIOORGAN MED CHEM, V15, P800, DOI 10.1016/j.bmc.2006.10.050; Peng MY, 2014, ONCOTARGET, V5, P6038; Bradshaw JM, 2010, CELL SIGNAL, V22, P1175, DOI 10.1016/j.cellsig.2010.03.001; Isse K, 2013, HEPATOLOGY, V57, P1632, DOI 10.1002/hep.26131; Llor X, 1999, CLIN CANCER RES, V5, P1767; Schmandt RE, 2006, CANCER BIOL THER, V5, P1136, DOI 10.4161/cbt.5.9.2953; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Kubo T, 2009, CARCINOGENESIS, V30, P1857, DOI 10.1093/carcin/bgp206; Mizuguchi Y, 2014, HEPATOLOGY, V59, P1130, DOI 10.1002/hep.26889; Shaib Y, 2004, SEMIN LIVER DIS, V24, P115, DOI 10.1055/s-2004-828889; Sirica AE, 2005, HEPATOLOGY, V41, P5, DOI 10.1002/hep.20537; Barker KT, 1997, ONCOGENE, V15, P799, DOI 10.1038/sj.onc.1201241; Xu AM, 2010, CANCER RES, V70, P3857, DOI 10.1158/0008-5472.CAN-10-0163; Ruhe JE, 2007, CANCER RES, V67, P11368, DOI 10.1158/0008-5472.CAN-07-2703; Xiang B, 2008, P NATL ACAD SCI USA, V105, P12463, DOI 10.1073/pnas.0805009105; Harvey AJ, 2003, ONCOGENE, V22, P5006, DOI 10.1038/sj.onc.1206577; Schafer M, 2008, NAT REV MOL CELL BIO, V9, P628, DOI 10.1038/nrm2455; TAYLOR SJ, 1994, NATURE, V368, P867, DOI 10.1038/368867a0; Brauer PM, 2010, BBA-REV CANCER, V1806, P66, DOI 10.1016/j.bbcan.2010.02.003; Derry JJ, 2000, MOL CELL BIOL, V20, P6114, DOI 10.1128/MCB.20.16.6114-6126.2000; Haegebarth A, 2006, MOL CELL BIOL, V26, P4949, DOI 10.1128/MCB.01901-05; Han C, 2004, J BIOL CHEM, V279, P44344, DOI 10.1074/jbc.M404852200; Harvey AJ, 2004, ANTI-CANCER DRUG, V15, P107, DOI 10.1097/01.cad.0000113339.62364.b5; Harvey AJ, 2009, AM J PATHOL, V175, P1226, DOI 10.2353/ajpath.2009.080811; Hussain Haroon A, 2014, World J Clin Oncol, V5, P299, DOI 10.5306/wjco.v5.i3.299; Kamalati T, 1996, J BIOL CHEM, V271, P30956; Kasprzycka M, 2006, AM J PATHOL, V168, P1631, DOI 10.2353/ajpath.2006.050521; Lin HS, 2004, ARCH OTOLARYNGOL, V130, P311, DOI 10.1001/archotol.130.3.311; Maruyama M, 2004, TRANSPLANTATION, V77, P446, DOI 10.1097/01.TP.0000110292.73873.25; Nozaki I, 2005, LAB INVEST, V85, P109, DOI 10.1038/labinvest.3700213; Ostrander JH, 2010, CURR OPIN PHARMACOL, V10, P662, DOI 10.1016/j.coph.2010.08.007; Qiu HQ, 2002, J BIOL CHEM, V277, P34634, DOI 10.1074/jbc.M203877200; Serfas MS, 2003, ONCOL RES, V13, P409; Specht S, 2013, CLIN EXP METASTAS, V30, P877, DOI 10.1007/s10585-013-9589-2; Yokomuro S, 2000, HEPATOLOGY, V32, P26, DOI 10.1053/jhep.2000.8535; Zhang P, 2005, J BIOL CHEM, V280, P1982, DOI 10.1074/jbc.M412038200; Zheng Y, 2012, J BIOL CHEM, V287, P148, DOI 10.1074/jbc.M111.298117	51	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0168-8278	1600-0641		J HEPATOL	J. Hepatol.	AUG	2015	63	2					399	407		10.1016/j.jhep.2015.02.047		9	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CM8YX	WOS:000357991700017		
J	Kitamoto, T; Kitamoto, A; Ogawa, Y; Honda, Y; Imajo, K; Saito, S; Yoneda, M; Nakamura, T; Nakajima, A; Hotta, K				Kitamoto, Takuya; Kitamoto, Aya; Ogawa, Yuji; Honda, Yasushi; Imajo, Kento; Saito, Satoru; Yoneda, Masato; Nakamura, Takahiro; Nakajima, Atsushi; Hotta, Kikuko			Targeted-bisulfite sequence analysis of the methylation of CpG islands in genes encoding PNPLA3, SAMM50, and PARVB of patients with non-alcoholic fatty liver disease	JOURNAL OF HEPATOLOGY			English	Article						Non-alcoholic fatty liver disease; DNA methylation; Next-generation sequencing; Fibrosis; PNPLA3; SAMM50; PARVB	STEATOHEPATITIS; ASSOCIATION; SEVERITY; JAPAN; SUSCEPTIBILITY; METHYLOME; VARIANT; SEQ	Background & Aims: The pathogenesis of non-alcoholic fatty liver disease (NAFLD) is affected by epigenetic factors as well as by genetic variation. Methods: We performed targeted-bisulfite sequencing to determine the levels of DNA methylation of 4 CpG islands (CpG99, CpG71, CpG26, and CpG101) in the regulatory regions of PNPLA3, SAMM50, PARVB variant 1, and PARVB variant 2, respectively. We compared the levels of methylation of DNA in the livers of the first and second sets of patients with mild (fibrosis stages 0 and 1) or advanced (fibrosis stages 2 to 4) NAFLD and in those of patients with mild (F0 to F2) or advanced (F3 and F4) chronic hepatitis C infection. The hepatic mRNA levels of PNPLA3, SAMM50, and PARVB were measured using qPCR. Results: CpG26, which resides in the regulatory region of PARVB variant 1, was markedly hypomethylated in the livers of patients with advanced NAFLD. Conversely, CpG99 in the regulatory region of PNPLA3 was substantially hypermethylated in these patients. These differences in DNA methylation were replicated in a second set of patients with NAFLD or chronic hepatitis C. PNPLA3 mRNA levels in the liver of the same section of a biopsy specimen used for genomic DNA preparation were lower in patients with advanced NAFLD compared with those with mild NAFLD and correlated inversely with CpG99 methylation in liver DNA. Moreover, the levels of CpG99 methylation and PNPLA3 mRNA were affected by the rs738409 genotype. Conclusions: Hypomethylation of CpG26 and hypermethylation of CpG99 may contribute to the severity of fibrosis in patients with NAFLD or chronic hepatitis C infection. (C) 2015 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.	[Kitamoto, Takuya; Kitamoto, Aya; Hotta, Kikuko] Kyoto Univ, Grad Sch Med, Pharmacogen, Kyoto 6068501, Japan; [Ogawa, Yuji; Honda, Yasushi; Imajo, Kento; Saito, Satoru; Yoneda, Masato; Nakajima, Atsushi] Yokohama City Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Yokohama, Kanagawa 232, Japan; [Nakamura, Takahiro] Natl Def Med Coll, Math Lab, Tokorozawa, Saitama 359, Japan	Hotta, K (reprint author), Kyoto Univ, Grad Sch Med, Pharmacogen, Sakyo Ku, Kyoto 6068501, Japan.	kikukoh@kuhp.kyoto-u.ac.jp		Hotta, Kikuko/0000-0003-2427-6354	Ministry of Education, Science, Sports, and Culture of Japan [25461343, 26460999, 26870290]	This work was supported by Grants-in-Aid from the Ministry of Education, Science, Sports, and Culture of Japan (25461343 to K.H., 26460999 to T.K., and 26870290 to A.K.).	Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1056/NEJMra011775; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Brunt EM, 2001, SEMIN LIVER DIS, V21, P3, DOI 10.1055/s-2001-12925; Bedossa P, 1996, HEPATOLOGY, V24, P289, DOI 10.1002/hep.510240201; Ahrens M, 2013, CELL METAB, V18, P296, DOI 10.1016/j.cmet.2013.07.004; Krueger F, 2012, NAT METHODS, V9, P145, DOI [10.1038/nmeth.1828, 10.1038/NMETH.1828]; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Chalasani N, 2010, GASTROENTEROLOGY, V139, P1567, DOI 10.1053/j.gastro.2010.07.057; Viechtbauer W, 2010, J STAT SOFTW, V36, P1; Matteoni CA, 1999, GASTROENTEROLOGY, V116, P1413, DOI 10.1016/S0016-5085(99)70506-8; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Romeo S, 2008, NAT GENET, V40, P1461, DOI 10.1038/ng.257; Kitamoto T, 2014, J HUM GENET, V59, P241, DOI 10.1038/jhg.2014.17; Teli MR, 1995, HEPATOLOGY, V22, P1714, DOI 10.1016/0270-9139(95)90196-5; Murphy SK, 2013, GASTROENTEROLOGY, V145, P1076, DOI 10.1053/j.gastro.2013.07.047; Zain SM, 2012, HUM GENET, V131, P1145, DOI 10.1007/s00439-012-1141-y; Kitamoto T, 2013, HUM GENET, V132, P783, DOI 10.1007/s00439-013-1294-3; Sookoian S, 2011, HEPATOLOGY, V53, P1883, DOI 10.1002/hep.24283; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Krueger F, 2011, BIOINFORMATICS, V27, P1571, DOI 10.1093/bioinformatics/btr167; Paul DS, 2014, EPIGENETICS-US, V9, P678, DOI 10.4161/epi.28041; Seki Y, 2012, ENDOCRINOLOGY, V153, P1031, DOI 10.1210/en.2011-1805; LUDWIG J, 1980, MAYO CLIN PROC, V55, P434; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Sun L, 2013, STEM CELLS, V31, P1454, DOI 10.1002/stem.1394; Sookoian S, 2010, HEPATOLOGY, V52, P1992, DOI 10.1002/hep.23927; Fujii H, 2012, J GASTROENTEROL, V47, P215, DOI 10.1007/s00535-012-0527-x; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Arai H, 2006, J ATHEROSCLER THROMB, V13, P202; Farrell GC, 2003, J GASTROEN HEPATOL, V18, P124, DOI 10.1046/j.1440-1746.2003.02989.x; Hotta K, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-172; Kawaguchi T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038322; Okanoue T, 2011, J GASTROEN HEPATOL, V26, P153, DOI 10.1111/j.1440-1746.2010.06547.x; Ray Katrina, 2013, Nat Rev Gastroenterol Hepatol, V10, P565, DOI 10.1038/nrgastro.2013.161; Sanyal A. J., 2002, Gastroenterology, V123, P1705, DOI 10.1053/gast.2002.36572; Speliotes EK, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001324; Matsuzawa Y, 2002, CIRC J, V66, P987; Wang J, 2013, NUCLEIC ACIDS RES, V41, pD171, DOI 10.1093/nar/gks1221; de Alwis NMW, 2008, CURR DIABETES REP, V8, P156, DOI 10.1007/s11892-008-0027-9	39	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0168-8278	1600-0641		J HEPATOL	J. Hepatol.	AUG	2015	63	2					494	502		10.1016/j.jhep.2015.02.049		9	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CM8YX	WOS:000357991700028		
J	Kajikawa, T; Sugiyama, R; Kataoka, K; Sakurai, T				Kajikawa, Takao; Sugiyama, Ryosuke; Kataoka, Kunishige; Sakurai, Takeshi			A novel resting form of the trinuclear copper center in the double mutant of a multicopper oxidase, CueO, Cys500Ser/Glu506Ala	JOURNAL OF INORGANIC BIOCHEMISTRY			English	Article						CueO; Trinuclear copper center; Resting form	BILIRUBIN OXIDASE; PROTON-TRANSFER; DIOXYGEN; REDUCTION; LACCASE; BOND	A multicopper oxidase, Cue was doubly mutated at its type I copper ligand, Cys500 and an acidic amino add residue located in the proton transfer pathway, Glu506, to Ser and Ala, respectively. Cys500Ser/Glu506Ala was mainly in a novel resting form to afford the absorption band at ca. 400 nm and an EPR signal with a highly anisotropic character derived from type III copper. However, Cys500Ser/Glu506Ala gave the same reaction intermediate (peroxide intermediate) as that from Cys500Ser and Cys500Ser/Glu506Gln. (C) 2015 Elsevier Inc. All rights reserved.	[Kajikawa, Takao; Sugiyama, Ryosuke; Kataoka, Kunishige; Sakurai, Takeshi] Kanazawa Univ, Grad Sch Nat Sci & Technol, Kanazawa, Ishikawa 9201192, Japan	Sakurai, T (reprint author), Kanazawa Univ, Grad Sch Nat Sci & Technol, Kanazawa, Ishikawa 9201192, Japan.	tsakurai@se.kanazawa-u.ac.jp	KATAOKA, Kunishige/J-8457-2015; Sakurai, Takeshi/C-3335-2015	Sakurai, Takeshi/0000-0002-7989-8882	Ministry of Education, Culture, Sports, Science and Technology of Japan (JSPS KAKENHI) [26288076]	We would like to thank the Ministry of Education, Culture, Sports, Science and Technology of Japan for financial support (JSPS KAKENHI Grant Number 26288076). We also thank Prof. Akira Odani of this university for his discussion about the role of Trp139.	Miura Y, 2009, FUEL CELLS, V9, P70, DOI 10.1002/fuce.200800027; Sakurai T, 2007, CHEM REC, V7, P220, DOI 10.1002/tcr.20125; Augustine AJ, 2007, J AM CHEM SOC, V129, P13118, DOI 10.1021/ja073905m; Solomon EI, 2014, CHEM REV, V114, P3659, DOI 10.1021/cr400327t; Polyakov KM, 2009, ACTA CRYSTALLOGR D, V65, P611, DOI 10.1107/S0907444909011950; Komori H, 2014, ACTA CRYSTALLOGR D, V70, P772, DOI 10.1107/S1399004713033051; Kataoka K, 2009, J BIOL CHEM, V284, P14405, DOI 10.1074/jbc.M808468200; Chen ZJ, 2010, DALTON T, V39, P2875, DOI 10.1039/b922734b; Osako T, 2004, CHEM-EUR J, V10, P237, DOI 10.1002/chem.200305263; Iwaki M, 2010, FEBS LETT, V584, P4027, DOI 10.1016/j.febslet.2010.08.018; Kajikawa T, 2012, BIOCHEM BIOPH RES CO, V422, P152, DOI 10.1016/j.bbrc.2012.04.127; Komori H, 2012, ANGEW CHEM INT EDIT, V51, P1861, DOI 10.1002/anie.201107739; Komori H, 2013, BIOCHEM BIOPH RES CO, V438, P686, DOI 10.1016/j.bbrc.2013.07.121; Sakurai T., 2011, COPPER OXYGEN CHEM, P131; Shimizu A, 1999, BIOCHEMISTRY-US, V38, P3034, DOI 10.1021/bi9819531	15	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0162-0134	1873-3344		J INORG BIOCHEM	J. Inorg. Biochem.	AUG	2015	149						88	90		10.1016/j.jinorgbio.2015.03.005		3	Biochemistry & Molecular Biology; Chemistry, Inorganic & Nuclear	Biochemistry & Molecular Biology; Chemistry	CM6YC	WOS:000357836600011		
J	Enomoto, M; Yoshii, H; Mita, T; Sanke, H; Yokota, A; Yamashiro, K; Inagaki, N; Gosho, M; Ohmura, C; Kudo, K; Watada, H; Onuma, T				Enomoto, Mari; Yoshii, Hidenori; Mita, Tomoya; Sanke, Haruna; Yokota, Ayako; Yamashiro, Keiko; Inagaki, Noriko; Gosho, Masahiko; Ohmura, Chie; Kudo, Kayo; Watada, Hirotaka; Onuma, Tomio			Relationship between dietary pattern and cognitive function in elderly patients with type 2 diabetes mellitus	JOURNAL OF INTERNATIONAL MEDICAL RESEARCH			English	Article						Dietary pattern; suspected mild dementia; type 2 diabetes mellitus	MODERATE ALCOHOL-CONSUMPTION; MINI-MENTAL-STATE; MEDITERRANEAN DIET; ALZHEIMER-DISEASE; FATTY-ACIDS; RISK; DEMENTIA; DECLINE; FISH; COHORT	ObjectiveTo analyse the relationships between dietary patterns and cognitive function in elderly patients with type 2 diabetes mellitus (T2DM). MethodsPatients with T2DM completed a 3-day dietary record and Mini-mental State Examination (MMSE). Dietary patterns were identified by factor analysis. ResultsThe study included 73 patients and identified five dietary patterns, one of which was characterized by high loading for vegetables and fish. A higher consumption of vegetables and fish was significantly associated with improved MMSE score (unadjusted model, model adjusted for age and sex, and model adjusted for age, sex, education, diabetic nephropathy and alcohol consumption), and decreased prevalence of suspected mild dementia (unadjusted model, model adjusted for age and sex). ConclusionsA high score in the vegetables and fish dietary pattern was associated with high MMSE score and low prevalence of suspected mild dementia in elderly patients with T2DM.	[Enomoto, Mari; Yoshii, Hidenori; Yokota, Ayako; Yamashiro, Keiko; Inagaki, Noriko; Onuma, Tomio] Juntendo Tokyo Koto Geriatr Med Ctr, Dept Med Diabetol & Endocrinol, Tokyo 1360075, Japan; [Mita, Tomoya; Sanke, Haruna; Ohmura, Chie; Watada, Hirotaka] Juntendo Univ, Grad Sch Med, Dept Endocrinol & Metab, Tokyo, Japan; [Mita, Tomoya] Juntendo Univ, Grad Sch Med, Ctr Mol Diabetol, Tokyo, Japan; [Gosho, Masahiko; Watada, Hirotaka] Univ Tsukuba, Fac Med, Dept Clin Trials & Clin Epidemiol, Tsukuba, Ibaraki, Japan; [Kudo, Kayo] Juntendo Tokyo Koto Geriatr Med Ctr, Dept Med, Nutr Management Sect, Tokyo 1360075, Japan; [Watada, Hirotaka] Ctr Therapeut Innovat Diabet, Tokyo, Japan; [Watada, Hirotaka] Juntendo Univ, Grad Sch Med, Sportol Ctr, Tokyo, Japan	Yoshii, H (reprint author), Juntendo Tokyo Koto Geriatr Med Ctr, Dept Med Diabetol & Endocrinol, Koto Ku, Shinsuna 3-3-20, Tokyo 1360075, Japan.	hdnr1967@gmail.com			Ministry of Education, Sports and Culture of Japan [23500858]	This study was funded by a grant from the Ministry of Education, Sports and Culture of Japan to Chie Ohmura (grant number 23500858).	Chen X, 2012, J NUTR HEALTH AGING, V16, P549, DOI 10.1007/s12603-012-0023-2; Devore EE, 2009, AM J CLIN NUTR, V90, P170, DOI 10.3945/ajcn.2008.27037; Loef M, 2012, J NUTR HEALTH AGING, V16, P626, DOI 10.1007/s12603-012-0097-x; Kim JW, 2012, PSYCHIAT INVEST, V9, P8, DOI 10.4306/pi.2012.9.1.8; Feart C, 2009, JAMA-J AM MED ASSOC, V302, P638, DOI 10.1001/jama.2009.1146; Anstey KJ, 2009, AM J GERIAT PSYCHIAT, V17, P542, DOI 10.1097/JGP.0b013e3181a2fd07; CRUM RM, 1993, JAMA-J AM MED ASSOC, V269, P2386, DOI 10.1001/jama.269.18.2386; Bruce DG, 2008, DIABETOLOGIA, V51, P241, DOI 10.1007/s00125-007-0894-7; Marioni RE, 2010, DIABETES, V59, P710, DOI 10.2337/db09-1163; Luchsinger JA, 2004, LANCET NEUROL, V3, P579, DOI 10.1016/S1474-4422(04)00878-6; Hu FB, 2002, CURR OPIN LIPIDOL, V13, P3, DOI 10.1097/00041433-200202000-00002; Scarmeas N, 2007, NEUROLOGY, V69, P1084, DOI 10.1212/01.wnl.0000277320.50685.7c; Roberts RO, 2010, DEMENT GERIATR COGN, V29, P413, DOI 10.1159/000305099; Kalmijn S, 2004, NEUROLOGY, V62, P275; Umegaki H, 2013, GERIATR GERONTOL INT, V13, P28, DOI 10.1111/j.1447-0594.2012.00922.x; Reynolds K, 2003, JAMA-J AM MED ASSOC, V289, P579, DOI 10.1001/jama.289.5.579; Lobo E, 2010, AM J EPIDEMIOL, V172, P708, DOI 10.1093/aje/kwq187; Tanaka S, 2013, EPIDEMIOLOGY, V24, P204, DOI 10.1097/EDE.0b013e318281725e; Umegaki H, 2012, GERIATR GERONTOL INT, V12, P103, DOI 10.1111/j.1447-0594.2011.00817.x; Barberger-Gateau P, 2007, NEUROLOGY, V69, P1921, DOI 10.1212/01.wnl.0000278116.37320.52; Sinforiani E, 2011, FUNCT NEUROL, V26, P103; Neafsey EJ, 2011, NEUROPSYCH DIS TREAT, V7, P465, DOI 10.2147/NDT.S23159; Morris MC, 2003, ARCH NEUROL-CHICAGO, V60, P940, DOI 10.1001/archneur.60.7.940; Collins MA, 2009, ALCOHOL CLIN EXP RES, V33, P206, DOI 10.1111/j.1530-0277.2008.00828.x; Biessels GJ, 2006, LANCET NEUROL, V5, P64, DOI 10.1016/S1474-4422(05)70284-2; Swanson D, 2012, ADV NUTR, V3, P1, DOI 10.3945/an.111.000893; Barberger-Gateau P, 2002, BRIT MED J, V325, P932, DOI 10.1136/bmj.325.7370.932; Beck A. T., 1996, MANUAL BECK DEPRESSI; Berr C, 2000, J AM GERIATR SOC, V48, P1285; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Haan MN, 1996, ANN EPIDEMIOL, V6, P392, DOI 10.1016/S1047-2797(96)00062-2; Ihara M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089516; Kumari M, 2014, ADDICTION, V109, P1462, DOI 10.1111/add.12568; Murray AE, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-110; Ozawa M, 2013, AM J CLIN NUTR, V97, P1076, DOI 10.3945/ajcn.112.045575; Ozawa M, 2012, J AM GERIATR SOC, V60, P1515, DOI 10.1111/j.1532-5415.2012.04061.x; Qin B, 2014, J NUTR, V144, P1579, DOI 10.3945/jn.114.193854; Ronksley PE, 2011, BMJ-BRIT MED J, V342, P671, DOI DOI 10.1136/BMJ.D671; Sanke H, 2014, DIABETES RES CLIN PR, V106, P465, DOI 10.1016/j.diabres.2014.09.039; WILLETT WC, 1995, AM J CLIN NUTR, V61, p1402S; Ye XW, 2011, BRIT J NUTR, V106, P1423, DOI 10.1017/S0007114511001760	41	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0300-0605	1473-2300		J INT MED RES	J. Int. Med. Res.	AUG	2015	43	4					506	517		10.1177/0300060515581672		12	Medicine, Research & Experimental; Pharmacology & Pharmacy	Research & Experimental Medicine; Pharmacology & Pharmacy	CM6IN	WOS:000357791900004		
J	Suzuki, K; Furuse, H; Tsuda, T; Masaki, Y; Okazawa, S; Kambara, K; Inomata, M; Miwa, T; Matsui, S; Kashii, T; Taniguchi, H; Hayashi, R; Tobe, K				Suzuki, Kensuke; Furuse, Hideaki; Tsuda, Takeshi; Masaki, Yasuaki; Okazawa, Seisuke; Kambara, Kenta; Inomata, Minehiko; Miwa, Toshiro; Matsui, Shoko; Kashii, Tatsuhiko; Taniguchi, Hirokazu; Hayashi, Ryuji; Tobe, Kazuyuki			Utility of creatinine/cystatin C ratio as a predictive marker for adverse effects of chemotherapy in lung cancer: A retrospective study	JOURNAL OF INTERNATIONAL MEDICAL RESEARCH			English	Article						Creatinine; cystatin C; chemotherapy; sarcopenia; adverse effect	GLOMERULAR-FILTRATION-RATE; SERUM CYSTATIN-C; SARCOPENIC OBESITY; ONCOLOGY-GROUP; SOLID TUMORS; TOXICITY; BODY; DETERMINANT; PREVALENCE; CLEARANCE	Objective To determine whether the creatinine/cystatin C (Cr/CysC) ratio, which is influenced by muscle mass, can be used as a predictive marker of the adverse effects of chemotherapy. Methods This single-centre, retrospective, observational study assessed patients with lung cancer. Serum Cr and CysC levels were measured once within 1 month prior the commencement of chemotherapy. Results A total of 25 patients with lung cancer were enrolled in the study: 22 received first-line therapy; three received second-line therapy. A significant difference was noted regarding the Cr/CysC ratios between patients with nonsmall-cell lung cancer (NSCLC) and those with small-cell lung cancer (0.78 versus 0.92, respectively). A significant difference was also noted in the Cr/CysC ratios of patients with NSCLC with toxicity grades <3 and 3 (0.84 versus 0.70, respectively). Similar findings were observed in patients with NSCLC who received platinum-based combination therapy (toxicity grade<3, 0.85; toxicity grade 3, 0.69). Conclusion The Cr/CysC ratio could serve as a useful predictive marker for chemotherapy-related adverse effects in patients with NSCLC.	[Suzuki, Kensuke; Furuse, Hideaki; Tsuda, Takeshi; Masaki, Yasuaki; Taniguchi, Hirokazu] Toyama Prefectural Cent Hosp, Dept Resp Med, Toyama, Japan; [Okazawa, Seisuke; Kambara, Kenta; Inomata, Minehiko; Miwa, Toshiro; Matsui, Shoko; Hayashi, Ryuji; Tobe, Kazuyuki] Toyama Univ Hosp, Dept Med 1, Toyama, Japan; [Kashii, Tatsuhiko] Toyama Univ Hosp, Dept Med Oncol, Toyama, Japan	Suzuki, K (reprint author), Toyama Prefectural Cent Hosp, Dept Resp Med, 2-2-78 Nishi Nagae, Toyama, Toyama, Japan.	khiro.tm@gmail.com					Olivier M, 2005, MUTAT RES-FUND MOL M, V573, P103, DOI 10.1016/j.mrfmmm.2004.08.016; Morley JE, 2001, J LAB CLIN MED, V137, P231, DOI 10.1067/mlc.2001.113504; PERRONE RD, 1992, CLIN CHEM, V38, P1933; LUKASKI HC, 1985, AM J CLIN NUTR, V41, P810; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Gusella M, 2002, BRIT J CLIN PHARMACO, V54, P131, DOI 10.1046/j.1365-2125.2002.01598.x; Prado CMM, 2009, CLIN CANCER RES, V15, P2920, DOI 10.1158/1078-0432.CCR-08-2242; Rule AD, 2006, KIDNEY INT, V69, P399, DOI 10.1038/sj.ki.5000073; Extermann M, 2012, CANCER-AM CANCER SOC, V118, P3377, DOI 10.1002/cncr.26646; Tan BHL, 2009, CLIN CANCER RES, V15, P6973, DOI 10.1158/1078-0432.CCR-09-1525; Kim TN, 2010, DIABETES CARE, V33, P1497, DOI 10.2337/dc09-2310; Bajorin DF, 1999, J CLIN ONCOL, V17, P3173; FEARON KCH, 1992, P NUTR SOC, V51, P251, DOI 10.1079/PNS19920036; Hurria A, 2011, J CLIN ONCOL, V29, P3457, DOI 10.1200/JCO.2011.34.7625; OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014; ALBAIN KS, 1991, J CLIN ONCOL, V9, P1618; Baxmann AC, 2008, CLIN J AM SOC NEPHRO, V3, P348, DOI 10.2215/CJN.02870707; Zamboni M, 2008, NUTR METAB CARDIOVAS, V18, P388, DOI 10.1016/j.numecd.2007.10.002; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Filler G, 2005, CLIN BIOCHEM, V38, P1, DOI 10.1016/j.clinbiochem.2004.09.025; Prado CMM, 2008, LANCET ONCOL, V9, P629, DOI [10.1016/S1470-2045(08)70153-0, 10.1016/51470-2045(08)70153-0]; Burkhardt H, 2002, GERONTOLOGY, V48, P140, DOI 10.1159/000052832; Carbart AH, 1989, J CLIN ONCOL, V7, P1748; CROCKER H, 1988, J CLIN PATHOL, V41, P576, DOI 10.1136/jcp.41.5.576; Del Ferraro C, 2012, J HOSP PALLIAT NURS, V14, P397, DOI 10.1097/NJH.0b013e31825f3470; Duffy MJ, 2014, CRIT REV CL LAB SCI, V51, P30, DOI 10.3109/10408363.2013.865700; FONG Y, 1989, AM J PHYSIOL, V256, pR659; GOLDBERG TH, 1987, ARCH INTERN MED, V147, P1430, DOI 10.1001/archinte.147.8.1430; HELLERSTEIN MK, 1989, J CLIN INVEST, V84, P228, DOI 10.1172/JCI114145; Hermida J, 2002, CLIN CHIM ACTA, V316, P165, DOI 10.1016/S0009-8981(01)00728-8; Jatoi Aminah, 2006, J Support Oncol, V4, P499; Mir O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037563; Naoki K, 2011, INT J CLIN ONCOL, V16, P335, DOI 10.1007/s10147-011-0187-5; National Cancer Institute, 2010, TERM CRIT ADV EV CTC; Osoba David, 2011, Ther Adv Med Oncol, V3, P57, DOI 10.1177/1758834010395342; Schmitt A, 2009, CLIN CANCER RES, V15, P3633, DOI 10.1158/1078-0432.CCR-09-0017; Tanaka M, 2004, CLIN BIOCHEM, V37, P27, DOI 10.1016/j.clinbiochem.2003.08.001; Tetsuka S, 2013, NEUROL CLIN NEUROSCI, V1, P32; The Japan Clinical Oncology Group, 2012, COMM TERM CRIT ADV E; The National Comprehensive Cancer Network, 2015, NCCN CLIN PRACT GUID; Tsujinaka T, 1997, J BIOCHEM-TOKYO, V122, P595	41	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0300-0605	1473-2300		J INT MED RES	J. Int. Med. Res.	AUG	2015	43	4					573	582		10.1177/0300060515579116		10	Medicine, Research & Experimental; Pharmacology & Pharmacy	Research & Experimental Medicine; Pharmacology & Pharmacy	CM6IN	WOS:000357791900011		
J	Sakamoto, D; Sakamoto, S; Kanda, T				Sakamoto, Daisuke; Sakamoto, Shigeru; Kanda, Tsugiyasu			Validation of circulating BNP level > 1000pg/ml in all-cause mortality: A retrospective study	JOURNAL OF INTERNATIONAL MEDICAL RESEARCH			English	Article						B-type natriuretic peptide; community acquired pneumonia; heart failure	COMMUNITY-ACQUIRED PNEUMONIA; NATRIURETIC PEPTIDE BNP; STABLE HEART-FAILURE; NT-PROBNP; PROGNOSTIC VALUE; ALBUMIN; PREDICTION; BIOMARKERS	AimTo determine the primary diseases and prognoses of patients with highly elevated levels of B-type natriuretic peptide (BNP; >1000pg/ml), with or without heart failure. MethodsMedical records and echocardiograms of patients with BNP levels that fell within one of three predetermined categories (>1000pg/ml, 200-1000pg/ml and <200pg/ml) were retrospectively reviewed. ResultsThere were no significant between-group differences in duration of hospitalization. Patients with BNP levels >1000pg/ml (n=103) or 200-1000pg/ml (n=100) had significantly worse 3-year survival than those with BNP levels <200pg/ml (n=100). The majority of patients (64/103) in the BNP >1000pg/ml group had heart failure. The main cause of death in patients with other causes of BNP levels >1000pg/ml (39/103) was community acquired pneumonia. ConclusionA BNP level >1000pg/ml has clinical importance in primary care medicine and hospital settings.	[Sakamoto, Daisuke; Kanda, Tsugiyasu] Kanazawa Med Univ, Dept Community Med, Uchinada, Ishikawa 920, Japan; [Sakamoto, Shigeru] Kanazawa Med Univ, Himi Municipal Hosp, Dept Cardiovasc Surg, Himi, Japan	Kanda, T (reprint author), Kanazawa Med Univ, Dept Community Med, Uchinada, Ishikawa 920, Japan.	kandat@kanazawa-med.ac.jp					Nowak A, 2013, CLIN CHIM ACTA, V419, P67, DOI 10.1016/j.cca.2013.01.014; O'Hanlon R, 2007, J CARD FAIL, V13, P50, DOI 10.1016/j.cardfail.2006.09.003; Barchel D, 2013, EUR J INTERN MED, V24, P772, DOI 10.1016/j.ejim.2013.08.004; Weber M, 2006, HEART, V92, P843, DOI 10.1136/hrt.2005.071233; Beleigoli AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075809; Budak YU, 2015, BIOCHEM MEDICA, V25, P97, DOI 10.11613/BM.2015.012; Doust JA, 2005, BRIT MED J, V330, P625, DOI 10.1136/bmj.330.7492.625; Giannakoulas G, 2014, INT J CARDIOL, V174, P618, DOI 10.1016/j.ijcard.2014.04.156; Guglin Maya, 2007, Congest Heart Fail, V13, P136, DOI 10.1111/j.1527-5299.2007.06478.x; Hodgson D, 2012, EMERG MED J, V29, P856, DOI 10.1136/emermed-2012-201872.5; Masugata H, 2014, EXP THER MED, V8, P21, DOI 10.3892/etm.2014.1692; Nowak A, 2012, CHEST, V141, P974, DOI 10.1378/chest.11-0824; Oremus M, 2014, HEART FAIL REV, V19, P471, DOI 10.1007/s10741-014-9439-6; Sanchez I, 2014, BIOMARK MED, V8, P535, DOI 10.2217/bmm.14.24; Shimizu Y, 2009, GERIATR GERONTOL INT, V9, P148, DOI 10.1111/j.1447-0594.2009.00514.x; Steurer MA, 2014, PEDIATR RES, V76, P549, DOI 10.1038/pr.2014.136; Takase H, 2014, EUR J CLIN INVEST, V44, P303, DOI 10.1111/eci.12234; Viasus D, 2013, J INFECTION, V66, P415, DOI 10.1016/j.jinf.2012.12.007; Yamamoto E, 2012, INT HEART J, V53, P234	19	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0300-0605	1473-2300		J INT MED RES	J. Int. Med. Res.	AUG	2015	43	4					583	591		10.1177/0300060515583077		9	Medicine, Research & Experimental; Pharmacology & Pharmacy	Research & Experimental Medicine; Pharmacology & Pharmacy	CM6IN	WOS:000357791900012		
J	Mayor, P; Takeshita, RSC; Coutinho, LN; Sanchez, N; Galvez, H; Ique, C; Monteiro, FOB				Mayor, Pedro; Takeshita, Rafaela S. C.; Coutinho, Leandro Nassar; Sanchez, Nofre; Galvez, Hugo; Ique, Carlos; Barros Monteiro, Frederico Ozanan			Ovarian function in captive owl monkeys (Aotus nancymaae and A.vociferans)	JOURNAL OF MEDICAL PRIMATOLOGY			English	Article						Aotus; morphology; ovaries; owl monkey; reproduction	PRIMATE CORPUS-LUTEUM; AZARAI-INFULATUS; RENAL EVALUATION; EARLY-PREGNANCY; B-MODE; ULTRASOUND; ULTRASONOGRAPHY; CONTRACEPTION; GROWTH; ORGANS	BackgroundOvarian function and morphology of owl monkeys (Aotus spp.) is inadequately known, but it is essential to describe this organ in detail to better understand reproductive patterns of the species. MethodsThis study reports the anatomical and histological features of the ovaries from 41 owl monkeys, considering their reproductive status and parity. ResultsThe corpora lutea (CL) and reproductive state had a significant effect on ovarian volume. Follicles were observed in both pregnant and non-pregnant subjects. All females in the luteal phase and pregnant females showed at least one cyclic or pregnancy CL. Mean ovulation rate was 1.89 CL/female, and the mean ovum mortality was 37.5%. There were no significant differences in ovarian volume related to parity. ConclusionsThese results contribute to the scarce information available on the reproductive biology of owl monkeys and can aid in the development of biotechnologies involved in assisted reproduction.	[Mayor, Pedro] Univ Autonoma Barcelona, Dept Anim Hlth & Anat, Fac Vet, E-08193 Barcelona, Spain; [Mayor, Pedro] YAVACUS, Yavari Conservac & Uso Sostenible, Iquitos, Peru; [Takeshita, Rafaela S. C.] Kyoto Univ, Primate Res Inst, Dept Ecol & Social Behav, Inuyama, Aichi 484, Japan; [Coutinho, Leandro Nassar; Barros Monteiro, Frederico Ozanan] Univ Fed Rural Amazonia, Postgrad Program Anim Hlth & Prod Amazonia, Belem, Para, Brazil; [Sanchez, Nofre; Galvez, Hugo; Ique, Carlos] Univ Nacl Mayor San Marcos, Inst Vet Invest Trop & Altura, San Marcos, Peru; [Barros Monteiro, Frederico Ozanan] Univ Texas MD Anderson Canc Ctr, Dept Vet Sci, Bastrop, TX USA	Mayor, P (reprint author), Univ Autonoma Barcelona, Dept Anim Hlth & Anat, E-08193 Bellaterra, Spain.	mayorpedro@hotmail.com	Mayor, Pedro/D-6359-2015	Monteiro, Frederico/0000-0002-1406-9979; Mayor, Pedro/0000-0001-5297-792X	Veterinary Faculty of the Universidad Nacional Mayor de San Marcos (CON/CON) [20]	This project was supported by the Veterinary Faculty of the Universidad Nacional Mayor de San Marcos (CON/CON 2014, no. 20). The authors have no conflict of interest to declare. We are especially thankful for the institutional support provided by the Instituto de Investigaciones de Tropico y de Altura and the Veterinary Faculty of the Universidad Nacional Mayor de San Marcos. We also thank Dr. Fred Bercovitch and Dr. Michael Huffman from the Primate Research Institute, Kyoto University, for very useful comments and technical review on the manuscript.	McNicholl JM, 2014, AM J REPROD IMMUNOL, V71, P513, DOI 10.1111/aji.12246; Stocco C, 2007, ENDOCR REV, V28, P117, DOI 10.1210/er.2006-0022; Christenson LK, 1996, ENDOCRINOLOGY, V137, P367, DOI 10.1210/en.137.1.367; Baer JF, 1994, AOTUS THE OWL MONKEY; Bourry O, 2005, J MED PRIMATOL, V34, P25, DOI 10.1111/j.1600-0684.2004.00088.x; CAMERON JL, 1982, ENDOCRINOLOGY, V110, P2059; Coutinho LN, 2011, J MED PRIMATOL, V40, P310, DOI 10.1111/j.1600-0684.2011.00476.x; Coutinho LN, 2013, THERIOGENOLOGY, V80, P99, DOI 10.1016/j.theriogenology.2013.03.018; Dixson Allen F., 1994, P113; Domingues Sheyla Farhayldes Souza, 2004, Acta Amazonica, V34, P495, DOI 10.1590/S0044-59672004000300015; Fukuda M, 2000, HUM REPROD, V15, P1921, DOI 10.1093/humrep/15.9.1921; HERTIG AT, 1976, LAB ANIM SCI, V26, P1041; International Committee on Veterinary Embriological Nomenclatura, 1994, NOM EMBR; IUCN [International Union for Conservation of Nature], RED LIST THREAT SPEC; Lins FLDLE, 2012, AM J PRIMATOL, V74, P482, DOI 10.1002/ajp.22006; Mayor P, 2013, AM J PRIMATOL, V75, P545, DOI 10.1002/ajp.22132; Mayor P, 2013, ANIM REPROD SCI, V136, P310, DOI 10.1016/j.anireprosci.2012.11.006; Monteiro FOB, 2009, INT J PRIMATOL, V30, P327, DOI 10.1007/s10764-009-9346-1; Monteiro FOB, 2006, J MED PRIMATOL, V35, P123, DOI 10.1111/j.1600-0684.2006.00155.x; NAGLE CA, 1994, AM J PRIMATOL, V34, P19, DOI 10.1002/ajp.1350340106; Oliveira KG, 2011, ANIM REPROD SCI, V123, P75, DOI 10.1016/j.anireprosci.2010.11.002; Rowe AJ, 2002, BIOL REPROD, V67, P1180, DOI 10.1095/biolreprod.101.001529; Schuler AM, 2007, J MED PRIMATOL, V36, P113, DOI 10.1111/j.1600-0684.2007.00219.x; Schwitzer C, 2014, PRIMATES PERIL WORLD; Silva GA, 2013, J MED PRIMATOL, V42, P71; Takeshita RSC, 2011, J MED PRIMATOL, V40, P104, DOI 10.1111/j.1600-0684.2010.00452.x; TARDIF SD, 1985, BIOL REPROD, V33, P993, DOI 10.1095/biolreprod33.4.993; Veras MM, 2009, AM J PRIMATOL, V71, P145, DOI 10.1002/ajp.20633; Zuckerman L, 1997, OVARY	29	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0047-2565	1600-0684		J MED PRIMATOL	J. Med. Primatol.	AUG	2015	44	4					187	193		10.1111/jmp.12181		7	Veterinary Sciences; Zoology	Veterinary Sciences; Zoology	CM8IL	WOS:000357942800003		
J	Mori, M				Mori, Masahiro			Lethal arrhythmia due to fingolimod, a S1P receptor modulator: are we overestimating or underestimating?	JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY			English	Editorial Material							RELAPSING MULTIPLE-SCLEROSIS; SAFETY		Chiba Univ, Grad Sch Med, Dept Neurol, Chuo Ku, Chiba 2608670, Japan	Mori, M (reprint author), Chiba Univ, Grad Sch Med, Dept Neurol, Chuo Ku, 1-8-1 Inohana, Chiba 2608670, Japan.	morim@faculty.chiba-u.jp					Mangrum JM, 2000, NEW ENGL J MED, V342, P703, DOI 10.1056/NEJM200003093421006; Castillo-Trivino T, 2015, J NEUROL NEUROSUR PS, V86, P931, DOI 10.1136/jnnp-2014-310013; DiMarco JP, 2014, MULT SCLER RELAT DIS, V3, P629, DOI 10.1016/j.msard.2014.05.005; Gold R, 2014, J NEUROL, V261, P267, DOI 10.1007/s00415-013-7115-8; Kappos L, 2014, MULT SCLER RELAT DIS, V3, P494, DOI 10.1016/j.msard.2014.03.002	5	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0022-3050	1468-330X		J NEUROL NEUROSUR PS	J. Neurol. Neurosurg. Psychiatry	AUG	2015	86	8					823	823		10.1136/jnnp-2015-310451		1	Clinical Neurology; Psychiatry; Surgery	Neurosciences & Neurology; Psychiatry; Surgery	CM7ON	WOS:000357884300001		
J	Tsuboi, T; Watanabe, H; Tanaka, Y; Ohdake, R; Yoneyama, N; Hara, K; Nakamura, R; Watanabe, H; Senda, J; Atsuta, N; Ito, M; Hirayama, M; Yamamoto, M; Fujimoto, Y; Kajita, Y; Wakabayashi, T; Sobue, G				Tsuboi, Takashi; Watanabe, Hirohisa; Tanaka, Yasuhiro; Ohdake, Reiko; Yoneyama, Noritaka; Hara, Kazuhiro; Nakamura, Ryoichi; Watanabe, Hazuki; Senda, Jo; Atsuta, Naoki; Ito, Mizuki; Hirayama, Masaaki; Yamamoto, Masahiko; Fujimoto, Yasushi; Kajita, Yasukazu; Wakabayashi, Toshihiko; Sobue, Gen			Distinct phenotypes of speech and voice disorders in Parkinson's disease after subthalamic nucleus deep brain stimulation	JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY			English	Article							DYSARTHRIA; METAANALYSIS; DYSFUNCTION; ELECTRODE; TRACT; DBS	Objectives To elucidate the phenotypes and pathophysiology of speech and voice disorders in Parkinson's disease (PD) with subthalamic nucleus deep brain stimulation (STN-DBS). Methods We conducted a cross-sectional study on 76 PD patients treated with bilateral STN-DBS (PD-DBS) and 33 medically treated PD patients (PD-Med). Speech and voice functions, electrode positions, motor function and cognitive function were comprehensively assessed. Moreover, speech and voice functions were compared between the on-stimulation and off-stimulation conditions in 42 PD-DBS patients. Results Speech and voice disorders in PD-DBS patients were significantly worse than those in PD-Med patients. Factor analysis and subsequent cluster analysis classified PD-DBS patients into five clusters: relatively good speech and voice function type, 25%; stuttering type, 24%; breathy voice type, 16%; strained voice type, 18%; and spastic dysarthria type, 17%. STN-DBS ameliorated voice tremor or low volume; however, it deteriorated the overall speech intelligibility in most patients. Breathy voice did not show significant changes and stuttering exhibited slight improvement after stopping stimulation. In contrast, patients with strained voice type or spastic dysarthria type showed a greater improvement after stopping stimulation. Spastic dysarthria type patients showed speech disorders similar to spastic dysarthria, which is associated with bilateral upper motor neuron involvement. Strained voice type and spastic dysarthria type appeared to be related to current diffusion to the corticobulbar fibres. Conclusions Stuttering and breathy voice can be aggravated by STN-DBS, but are mainly due to aging or PD itself. Strained voice and spastic dysarthria are considered corticobulbar side effects.	[Tsuboi, Takashi; Watanabe, Hirohisa; Tanaka, Yasuhiro; Ohdake, Reiko; Yoneyama, Noritaka; Hara, Kazuhiro; Nakamura, Ryoichi; Watanabe, Hazuki; Senda, Jo; Atsuta, Naoki; Ito, Mizuki; Hirayama, Masaaki; Sobue, Gen] Nagoya Univ, Grad Sch Med, Dept Neurol, Nagoya, Aichi 4668550, Japan; [Yamamoto, Masahiko] Aichi Gakuin Univ, Fac Psychol & Phys Sci, Nisshin, Aichi, Japan; [Fujimoto, Yasushi] Nagoya Univ, Grad Sch Med, Dept Otorhinolaryngol, Nagoya, Aichi 4668550, Japan; [Kajita, Yasukazu; Wakabayashi, Toshihiko] Nagoya Univ, Grad Sch Med, Dept Neurosurg, Nagoya, Aichi 4668550, Japan	Sobue, G (reprint author), Nagoya Univ, Grad Sch Med, Dept Neurol, Showa Ku, Nagoya, Aichi 4668550, Japan.	sobueg@med.nagoya-u.ac.jp		Tsuboi, Takashi/0000-0001-5042-3181	Ministry of Health, Labour and Welfare, Japan	Part of this study represents the results of 'Integrated Research on Neuropsychiatric Disorders' performed under the Strategic Research Programme for Brain Sciences by the Ministry of Education, Culture, Sports, Science and Technology of Japan. This study was also supported by Health and Labour Sciences Research grants for research on measures for intractable diseases and comprehensive research on aging and health from the Ministry of Health, Labour and Welfare, Japan.	Paek SH, 2011, J KOREAN MED SCI, V26, P1344, DOI 10.3346/jkms.2011.26.10.1344; Tripoliti E, 2014, MOVEMENT DISORD, V29, P532, DOI 10.1002/mds.25816; Pollo C, 2014, BRAIN, V137, P2015, DOI 10.1093/brain/awu102; Pinto S, 2003, J NEUROL, V250, P179, DOI 10.1007/s00415-003-0966-7; Tripoliti E, 2011, MOVEMENT DISORD, V26, P2434, DOI 10.1002/mds.23887; Plaha P, 2006, BRAIN, V129, P1732, DOI 10.1093/brain/awl127; Ramig LO, 1996, NEUROLOGY, V47, P1496; Speyer R, 2010, J VOICE, V24, P281, DOI 10.1016/j.jvoice.2008.10.004; SMITH ME, 1995, J VOICE, V9, P453, DOI 10.1016/S0892-1997(05)80210-3; Barbe MT, 2014, NEUROLOGY, V82, P614, DOI 10.1212/WNL.0000000000000127; Tanei T, 2009, ACTA NEUROCHIR, V151, P589, DOI 10.1007/s00701-009-0293-6; Burghaus L, 2006, J NEURAL TRANSM, V113, P625, DOI 10.1007/s00702-005-0341-1; Klostermann F, 2008, J NEUROL NEUROSUR PS, V79, P522, DOI 10.1136/jnnp.2007.123323; Midi I, 2008, ACTA NEUROL SCAND, V117, P26, DOI 10.1111/j.1600-0404.2007.00965.x; Pinto S, 2005, MOVEMENT DISORD, V20, P1507, DOI 10.1002/mds.20601; Tommasi G, 2008, J NEUROL NEUROSUR PS, V79, P813, DOI 10.1136/jnnp.2007.117507; Benke T, 2000, J NEUROL NEUROSUR PS, V69, P319, DOI 10.1136/jnnp.69.3.319; DARLEY FL, 1969, J SPEECH HEAR RES, V12, P246; Lee JY, 2010, ACTA NEUROCHIR, V152, P2029, DOI 10.1007/s00701-010-0779-2; Tripoliti E, 2011, NEUROLOGY, V76, P80, DOI 10.1212/WNL.0b013e318203e7d0; Dromey C, 2000, MOVEMENT DISORD, V15, P1132, DOI 10.1002/1531-8257(200011)15:6<1132::AID-MDS1011>3.0.CO;2-O; Alm PA, 2004, J COMMUN DISORD, V37, P325, DOI 10.1016/j.jcomdis.2004.03.001; Parsons TD, 2006, LANCET NEUROL, V5, P578, DOI 10.1016/S1474-4422(06)70475-6; Williams-Gray CH, 2007, BRAIN, V130, P1787, DOI 10.1093/brain/awm111; Boone DR, 2005, VOICE VOICE THERAPY; D'Alatri L, 2008, J VOICE, V22, P365, DOI 10.1016/j.jvoice.2006.10.010; Fasano A, BRAIN; Hirano M, 1981, CLIN EXAMINATION VOI; Hughes A, 1992, J NEUROL NEUROSUR PS, V66, P181, DOI DOI 10.1136/JNNP.55.3.181; Jacobson BH, 1997, AM J SPEECH-LANG PAT, V6, P66; Kleiner-Fisman G, 2006, MOVEMENT DISORD, V21, pS290, DOI 10.1002/mds.20962; Narayana S, 2009, AM J SPEECH-LANG PAT, V18, P146, DOI 10.1044/1058-0360(2008/08-0004); Nishio M, 2004, ASSESSMENT MOTOR SPE; Riley G. D., 1994, STUTTERING SEVERITY; Schaltenbrand G, 1977, ATLAS STEREOTAXY HUM; Skodda Sabine, 2014, Front Neurol, V4, P218, DOI 10.3389/fneur.2013.00218; Suzuki Junichiro, 2013, Rinsho Shinkeigaku, V53, P304; Thiriez C, 2013, PARKINSONISM RELAT D, V19, P383, DOI 10.1016/j.parkreldis.2012.07.011; Toft M, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-44; Yim SH, 2013, J NEUROL SCI, V334, P63, DOI 10.1016/j.jns.2013.07.015	40	2	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0022-3050	1468-330X		J NEUROL NEUROSUR PS	J. Neurol. Neurosurg. Psychiatry	AUG	2015	86	8					856	864		10.1136/jnnp-2014-308043		9	Clinical Neurology; Psychiatry; Surgery	Neurosciences & Neurology; Psychiatry; Surgery	CM7ON	WOS:000357884300007		
J	Minami, N; Morino, M; Uda, T; Komori, T; Nakata, Y; Arai, N; Kohmura, E; Nakano, I				Minami, Noriaki; Morino, Michiharu; Uda, Takehiro; Komori, Takashi; Nakata, Yasuhiro; Arai, Nobutaka; Kohmura, Eiji; Nakano, Imaharu			Surgery for amygdala enlargement with mesial temporal lobe epilepsy: pathological findings and seizure outcome	JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY			English	Article							HIPPOCAMPAL SCLEROSIS; SELECTIVE AMYGDALOHIPPOCAMPECTOMY; NORMAL MRI; FEBRILE SEIZURES; CHILDHOOD; MEMORY; TUMOR	Objective Amygdala enlargement (AE) has been suggested to be a subtype of mesial temporal lobe epilepsy (MILE). However, most reports related to AE have referred to imaging studies, and there have been few reports regarding surgical and pathological findings. The present study was performed to clarify the surgical outcomes and pathology of AE. Methods Eighty patients with drug-resistant MILE were treated surgically at the Tokyo Metropolitan Neurological Hospital between April 2010 and July 2013. Of these patients, 11 were diagnosed as AE based on presurgical MRI. Nine patients with AE underwent selective amygdalohippocampectomy, while the remaining two patients underwent selective amygdalotomy with hippocampal transection. Intraoperative EEG was routinely performed. The histopathology of the resected amygdala tissue was evaluated and compared with the amygdala tissue of patients with hippocampal sclerosis. Results Pathological findings indicated that 10 of 11 specimens had closely clustering hypertrophic neurons with vacuolisation of the background matrix. Slight gliosis was seen in nine specimens, while the remaining two showed no gliotic changes. Intraoperative EEG showed abnormal sharp waves that seemed to originate not from the amygdala but from the hippocampus in all cases. Ten patients became seizure-free during the postoperative follow-up period. Conclusions Histopathologically, clustering hypertrophic neurons and vacuolation with slight gliosis or without gliosis were considered to be pathological characteristics of AE. Amygdalohippocampectomy or hippocampal transection with amygdalotomy is effective for seizure control in patients with AE.	[Minami, Noriaki; Morino, Michiharu; Uda, Takehiro; Nakano, Imaharu] Tokyo Metropolitan Neurol Hosp, Dept Neurosurg, Tokyo, Japan; [Minami, Noriaki; Kohmura, Eiji] Kobe Univ, Grad Sch Med, Dept Neurosurg, Kobe, Hyogo 6500017, Japan; [Komori, Takashi] Tokyo Metropolitan Neurol Hosp, Dept Lab Med & Pathol Neuropathol, Tokyo, Japan; [Nakata, Yasuhiro] Tokyo Metropolitan Neurol Hosp, Dept Neuroradiol, Tokyo, Japan; [Arai, Nobutaka] Tokyo Metropolitan Inst Med Sci, Brain Pathol Res Ctr, Tokyo 113, Japan	Minami, N (reprint author), Kobe Univ, Grad Sch Med, Dept Neurosurg, Chuo Ku, 7-5-1 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	minaminoriaki@gmail.com					Aliashkevich AF, 2003, ACTA NEUROPATHOL, V106, P99, DOI 10.1007/s00401-003-0707-0; Zentner J, 1999, J NEUROSURG, V91, P59, DOI 10.3171/jns.1999.91.1.0059; Bower SPC, 2003, J NEUROL NEUROSUR PS, V74, P1245, DOI 10.1136/jnnp.74.9.1245; Keller J, 2008, AM J PSYCHIAT, V165, P872, DOI 10.1176/appi.ajp.2008.07081257; Yilmazer-Hanke DM, 2000, J NEUROPATH EXP NEUR, V59, P907; Morino M, 2009, J NEUROSURG, V110, P1164, DOI 10.3171/2008.9.JNS08247; KUKS JBM, 1993, LANCET, V342, P1391; Koelsche C, 2013, ACTA NEUROPATHOL, V125, P891, DOI 10.1007/s00401-013-1100-2; GODDARD GV, 1967, NATURE, V214, P1020, DOI 10.1038/2141020a0; WIESER HG, 1982, SURG NEUROL, V17, P445, DOI 10.1016/S0090-3019(82)80016-5; Wieser HG, 2000, EPILEPTIC DISORD, V2, P141; Uda T, 2013, J NEUROSURG, V119, P1098, DOI 10.3171/2013.6.JNS13244; Bartolomei F, 2004, EPILEPSY RES, V61, P89, DOI 10.1016/j.eplepsyres.2004.06.006; Shimizu H, 2006, J CLIN NEUROSCI, V13, P322, DOI 10.1016/j.jocn.2005.04.020; Immonen A, 2010, EPILEPSIA, V51, P2260, DOI 10.1111/j.1528-1167.2010.02720.x; Chapman K, 2005, J NEUROL NEUROSUR PS, V76, P710, DOI 10.1136/jnnp.2003.026757; Bell ML, 2009, EPILEPSIA, V50, P2053, DOI 10.1111/j.1528-1167.2009.02079.x; Alarcon G, 2006, J NEUROL NEUROSUR PS, V77, P474, DOI 10.1136/jnnp.2005.077289; ZENTNER J, 1994, J NEUROL NEUROSUR PS, V57, P1497, DOI 10.1136/jnnp.57.12.1497; Morino M, 2006, EPILEPSY BEHAV, V9, P95, DOI 10.1016/j.yebeh.2006.04.017; Siegel AM, 2001, EPILEPSIA, V42, P883, DOI 10.1046/j.1528-1157.2001.042007883.x; Coan Ana Carolina, 2013, Front Neurol, V4, P166, DOI 10.3389/fneur.2013.00166; Coan AC, 2013, EPILEPSY BEHAV, V29, P390, DOI 10.1016/j.yebeh.2013.08.022; DUONG T, 1994, ACTA NEUROPATHOL, V87, P493; Engel J, 1993, SURG TREATMENT EPILE, P609; HARVEY AS, 1995, PEDIATR NEUROL, V12, P201, DOI 10.1016/0887-8994(95)00022-8; HITOTSUMATSU T, 1994, ACTA NEUROPATHOL, V88, P501; Holmes MD, 2000, SEIZURE-EUR J EPILEP, V9, P407, DOI 10.1053/seiz.2000.0423; Kim DW, 2012, J CLIN NEUROSCI, V19, P509, DOI 10.1016/j.jocn.2011.05.042; Kimura Y, 2015, J NEUROIMAGING, V25, P175, DOI 10.1111/jon.12106; Komori T, 2013, NEUROPATHOLOGY, V33, P459, DOI 10.1111/neup.12033; MCINTYRE DC, 1986, PROG NEUROBIOL, V27, P1, DOI 10.1016/0301-0082(86)90010-9; Mitsueda-Ono T, 2011, J NEUROL NEUROSUR PS, V82, P652, DOI 10.1136/jnnp.2010.206342; Watson C, 1996, J EPILEPSY, V9, P56, DOI 10.1016/0896-6974(95)00060-7; Yaşargil M G, 1985, Adv Tech Stand Neurosurg, V12, P93	35	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0022-3050	1468-330X		J NEUROL NEUROSUR PS	J. Neurol. Neurosurg. Psychiatry	AUG	2015	86	8					887	894		10.1136/jnnp-2014-308383		8	Clinical Neurology; Psychiatry; Surgery	Neurosciences & Neurology; Psychiatry; Surgery	CM7ON	WOS:000357884300011		
J	Tada, M; Nishizawa, M; Onodera, O				Tada, Masayoshi; Nishizawa, Masatoyo; Onodera, Osamu			Redefining cerebellar ataxia in degenerative ataxias: lessons from recent research on cerebellar systems	JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY			English	Review							MOTOR CONTROL; CIRCUIT; NEURONS; PREDICTIONS; MOVEMENT; NETWORKS; LESIONS; MODELS	Recent advances in our understanding of neurophysiological functions in the cerebellar system have revealed that each region involved in degenerative ataxias contributes differently. To regulate voluntary movements, the cerebellum forms internal models within its neural circuits that mimic the behaviour of the sensorimotor system and objects in the external environment. The cerebellum forms two different internal models: forward and inverse. The forward model is formed by efference copy signals conveyed by the corticopontocerebellar system, and it derives the estimated consequences for action. The inverse model describes sequences of motor commands to accomplish an aim. During motor learning, we improve internal models by comparing the estimated consequence of an action from the forward model with the actual consequence of the action produced by the inverse model. The functions of the cerebellum encompass the formation, storage and selection of internal models. Considering the neurophysiological properties of the cerebellar system, we have classified degenerative ataxias into four types depending on which system is involved: Purkinje cells, the corticopontocerebellar system, the spinocerebellar system and the cerebellar deep nuclei. With regard to their respective contributions to the internal models, we speculate that loss of Purkinje cells leads to malformation of the internal models, whereas disturbance of the afferent system, corticopontocerebellar system or spinocerebellar system leads to mis-selection of the proper internal model. An understanding of the pathophysiological properties of ataxias in each degenerative ataxia enables the development of new methods to evaluate ataxias.	[Tada, Masayoshi; Nishizawa, Masatoyo] Niigata Univ, Brain Res Inst, Dept Neurol, Niigata, Niigata 9518155, Japan; [Onodera, Osamu] Niigata Univ, Brain Res Inst, Ctr Bioresources, Dept Mol Neurosci, Niigata, Niigata 9518155, Japan	Onodera, O (reprint author), Niigata Univ, Brain Res Inst, Ctr Bioresources, Dept Mol Neurosci,Chuo Ku, 1-757 Asahimachidori, Niigata, Niigata 9518155, Japan.	onodera@bri.niigata-u.ac.jp			Ministry of Health, Labor and Welfare, Japan	Supported by a grant-in-aid for Comprehensive Research on Disability from Health and Welfare from the Ministry of Health, Labor and Welfare, Japan.	Seidel K, 2012, ACTA NEUROPATHOL, V124, P1, DOI 10.1007/s00401-012-1000-x; Franklin DW, 2011, NEURON, V72, P425, DOI 10.1016/j.neuron.2011.10.006; De Zeeuw CI, 2011, NAT REV NEUROSCI, V12, P327, DOI 10.1038/nrn3011; Nguyen-Vu TDB, 2013, NAT NEUROSCI, V16, P1734, DOI 10.1038/nn.3576; Pivetta C, 2014, CELL, V156, P537, DOI 10.1016/j.cell.2013.12.014; Wolpert DM, 1998, NEURAL NETWORKS, V11, P1317, DOI 10.1016/S0893-6080(98)00066-5; Synofzik M, 2008, CURR BIOL, V18, P814, DOI 10.1016/j.cub.2008.04.071; Zhou KK, 2014, CURR BIOL, V24, pR269, DOI 10.1016/j.cub.2014.02.048; Graves TD, 2009, J NEUROL SCI, V285, P238, DOI 10.1016/j.jns.2009.06.011; Jorntell H, 2006, NEURON, V52, P227, DOI 10.1016/j.neuron.2006.09.032; Miyai I, 2012, NEUROREHAB NEURAL RE, V26, P515, DOI 10.1177/1545968311425918; Wolpert DM, 1998, TRENDS COGN SCI, V2, P338, DOI 10.1016/S1364-6613(98)01221-2; Arber S, 2012, NEURON, V74, P975, DOI 10.1016/j.neuron.2012.05.011; Manto M, 2012, CEREBELLUM, V11, P457, DOI 10.1007/s12311-011-0331-9; Bostan AC, 2013, TRENDS COGN SCI, V17, P241, DOI 10.1016/j.tics.2013.03.003; Blakemore SJ, 2001, NAT REV NEUROSCI, V2, P561; Kim JS, 2000, CEREBROVASC DIS, V10, P471, DOI 10.1159/000016110; Ramnani N, 2006, NAT REV NEUROSCI, V7, P511, DOI 10.1038/nrn1953; Roth MJ, 2013, CURR BIOL, V23, P930, DOI 10.1016/j.cub.2013.04.027; Grimaldi G, 2012, CEREBELLUM, V11, P336, DOI 10.1007/s12311-011-0247-4; Hantman AW, 2010, NAT NEUROSCI, V13, P1233, DOI 10.1038/nn.2637; Dean P, 2010, NAT REV NEUROSCI, V11, P30, DOI 10.1038/nrn2756; Azim E, 2014, NATURE, V508, P357, DOI 10.1038/nature13021; Brendel B, 2015, J NEUROL, V262, P21, DOI 10.1007/s00415-014-7511-8; D'Angelo E, 2013, FRONT NEURAL CIRCUIT, V6, DOI 10.3389/fncir.2012.00116; Etlin A, 2013, J NEUROSCI, V33, P734, DOI 10.1523/JNEUROSCI.4390-12.2013; FISHER CM, 1967, NEUROLOGY, V17, P614; Horn KM, 2013, J PHYSIOL-LONDON, V591, P5475, DOI 10.1113/jphysiol.2012.234898; Ito M, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00001; Kawato Mitsuo, 2003, Prog Brain Res, V142, P171; Kawato M, 2011, CURR OPIN NEUROBIOL, V21, P791, DOI 10.1016/j.conb.2011.05.014; Llinas RR, 2011, J PHYSIOL-LONDON, V589, P3423, DOI 10.1113/jphysiol.2011.207464; Okamoto T, 2011, J NEUROSCI, V31, P8958, DOI 10.1523/JNEUROSCI.1151-11.2011; Reeber Stacey L, 2013, Front Syst Neurosci, V7, P83, DOI 10.3389/fnsys.2013.00083; Schmahmann JD, 2004, BRAIN, V127, P1269, DOI 10.1093/brain/awh138; Stecina K, 2013, J PHYSIOL-LONDON, V591, P5433, DOI 10.1113/jphysiol.2012.249110; Thach WT, 2014, CEREBELLUM, V13, P139, DOI 10.1007/s12311-013-0506-7; Tokuda IT, 2013, NEURAL NETWORKS, V47, P42, DOI 10.1016/j.neunet.2012.12.006; Uusisaari M, 2011, J PHYSIOL-LONDON, V589, P3441, DOI 10.1113/jphysiol.2010.201582; Yamada M., 2013, HDB CEREBELLUM CEREB, P2327	40	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0022-3050	1468-330X		J NEUROL NEUROSUR PS	J. Neurol. Neurosurg. Psychiatry	AUG	2015	86	8					922	928		10.1136/jnnp-2013-307225		7	Clinical Neurology; Psychiatry; Surgery	Neurosciences & Neurology; Psychiatry; Surgery	CM7ON	WOS:000357884300017		
J	Mikami, T; Kurose, A; Javed, F; Takeda, Y				Mikami, Toshinari; Kurose, Akira; Javed, Fawad; Takeda, Yasunori			Detection of Rare Variant of SS18-SSX1 Fusion Gene and Mutations of Important Cancer-Related Genes in Synovial Sarcoma of the Lip: Gene Analyses of a Case and Literature Review	JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY			English	Review							MERKEL CELL-CARCINOMA; OF-THE-LITERATURE; SYT-SSX1 FUSION; PDGFR-ALPHA; SOFT PALATE; TONGUE BASE; ATM GENE; RNA-SEQ; TRANSCRIPT; SYT	Synovial sarcoma (SS) accounts for 5 to 10% of soft tissue sarcomas; however, intraoral SS is rare. Histopathologically, SS shows a biphasic pattern with epithelial and spindle cell components or a monophasic pattern with only spindle cells. The precise diagnosis of SS, especially at an unusual site, is often a challenge to pathologists and clinical oncologists, because the differential diagnosis of SS includes a broad range of tumors, such as soft tissue sarcomas and carcinomas. In the present case, the patient was a 50-year-old woman who presented with the chief complaint of swelling and a slowly enlarging mass of the lower lip in the mucolabial fold region. The mass was covered with intact mucosa and intraoral examination showed no malignant findings. The clinical diagnosis was a benign tumor and a probable salivary gland tumor. Macroscopically, the excised mass also indicated a benign tumor; however, histopathologic findings suggested the diagnosis of SS. For definitive diagnosis, genetic analyses were performed with conventional polymerase chain reaction and next-generation sequencing. As a result, a rare variant of the SS18-SSX1 fusion transcript, which could not be identified by routine procedures for genetic diagnosis, was detected. In addition, 8 missense mutations of cancer-related genes were confirmed. Detection of the fusion transcript is widely used in the diagnosis of SS; however, reported cases of transcript variants of each fusion gene type are limited. Reports of mutational analysis of cancer-related genes on SS also are rare. The accumulation of rare transcript variants and the cytogenetic characters of SS are suggested to be necessary for assuming a genetic diagnosis of SS. (C) 2015 American Association of Oral and Maxillofacial Surgeons	[Mikami, Toshinari; Takeda, Yasunori] Iwate Med Univ, Dept Pathol, Div Anat & Cellular Pathol, Yahaba, Iwate 0283694, Japan; [Kurose, Akira] Hirosaki Univ, Grad Sch Med, Dept Anat Pathol, Aomori, Japan; [Javed, Fawad] Univ Rochester, Eastman Inst Oral Hlth, Div Gen Dent, Rochester, NY USA	Mikami, T (reprint author), Iwate Med Univ, Dept Pathol, Div Anat & Cellular Pathol, 2-1-1 Nishitokuta, Yahaba, Iwate 0283694, Japan.	toshi_m@sea.plala.or.jp			Strategic Medical Science Research Center from Ministry of Education, Culture, Sports, Science and Technology of Japan [S1001001]	This study was supported in part by a Grant-in-Aid from the Strategic Medical Science Research Center (S1001001; 2010 to 2014) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Al-Daraji W, 2009, AM J SURG PATHOL, V33, P1494, DOI 10.1097/PAS.0b013e3181aa913f; Amary MFC, 2007, HISTOPATHOLOGY, V51, P559, DOI 10.1111/j.1365-2559.2007.02812.x; Ameerally PJ, 2004, BRIT J ORAL MAX SURG, V42, P261, DOI 10.1016/j.bjoms.2003.12.005; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Holtkamp N, 2006, CARCINOGENESIS, V27, P664, DOI 10.1093/carcin/bgi273; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Panagopoulos I, 2001, GENE CHROMOSOME CANC, V31, P362, DOI 10.1002/gcc.1155; KRANSDORF MJ, 1995, AM J ROENTGENOL, V164, P129; Schneider-Stock R, 1999, VIRCHOWS ARCH, V435, P407, DOI 10.1007/s004280050418; CLARK J, 1994, NAT GENET, V7, P502, DOI 10.1038/ng0894-502; SONOBE H, 1992, LAB INVEST, V67, P498; McDermott U, 2009, CANCER RES, V69, P3937, DOI 10.1158/0008-5472.CAN-08-4327; DELEEUW B, 1995, HUM MOL GENET, V4, P1097, DOI 10.1093/hmg/4.6.1097; Amary MFC, 2007, MODERN PATHOL, V20, P482, DOI 10.1038/modpathol.3800761; Lopez-Guerrero JA, 2005, DIAGN MOL PATHOL, V14, P134; Waltari M, 2011, INT J CANCER, V129, P619, DOI 10.1002/ijc.25720; CREW AJ, 1995, EMBO J, V14, P2333; Hirota S, 2003, GASTROENTEROLOGY, V125, P660, DOI 10.1016/S001-5085(03)01046-1; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Je EM, 2012, APMIS, V120, P635, DOI 10.1111/j.1600-0463.2012.02878.x; BRIDGE JA, 1988, CANCER, V62, P935, DOI 10.1002/1097-0142(19880901)62:5<935::AID-CNCR2820620514>3.0.CO;2-E; Davids M, 2009, J CLIN ONCOL, V27, pE97, DOI 10.1200/JCO.2009.21.8149; DEARAUJO VC, 1989, J ORAL MAXIL SURG, V47, P1001, DOI 10.1016/0278-2391(89)90389-3; de Almeida-Lawall M, 2009, J ORAL MAXIL SURG, V67, P914, DOI 10.1016/j.joms.2008.08.031; Dimitriadis E, 2009, CANCER GENET CYTOGEN, V195, P54, DOI 10.1016/j.cancergencyto.2009.06.012; ENGELHARDT J, 1983, SOUTHERN MED J, V76, P243; FERLITO A, 1981, J LARYNGOL OTOL, V95, P197, DOI 10.1017/S0022215100090605; Dominguez MF, 2011, J ORAL MAXIL SURG, V69, pE482, DOI 10.1016/j.joms.2011.03.018; Fisher C, 2002, WHO CLASSIFICATION T, P200; Gure AO, 2002, INT J CANCER, V101, P448, DOI 10.1002/ijc.10634; Hartmann C, 2004, INT J CANCER, V112, P1081, DOI 10.1002/ijc.20525; HOLTZ F, 1985, ARCH OTOLARYNGOL, V111, P271; Kartha RV, 2008, MODERN PATHOL, V21, P96, DOI 10.1038/modpathol.3800980; Komis C, 2008, J ORAL MAXIL SURG, V66, P154, DOI 10.1016/j.joms.2006.11.019; Krskova L, 2007, DIAGN MOL PATHOL, V16, P179, DOI 10.1097/PDM.0b013e3180340343; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Mahesh KT, 2013, CASE REP DENT, V2013; MAMELLE G, 1986, EUR J SURG ONCOL, V12, P347; MASSARELLI G, 1978, HUM PATHOL, V9, P341, DOI 10.1016/S0046-8177(78)80091-4; Meer S, 2003, ORAL SURG ORAL MED O, V96, P306, DOI 10.1016/S1079-2104(03)00209-9; Melo JV, 2001, LEUKEMIA, V15, P1448, DOI 10.1038/sj.leu.2402223; Mettman A, 2009, ENT-EAR NOSE THROAT, V88, P1150; Monzen Y, 2001, Radiat Med, V19, P47; MOUSSAVI H, 1974, J LARYNGOL OTOL, V88, P795, DOI 10.1017/S0022215100079366; Naito N, 2000, CANCER, V89, P1992, DOI 10.1002/1097-0142(20001101)89:9<1992::AID-CNCR16>3.0.CO;2-R; Ng MHL, 2003, BRIT J HAEMATOL, V123, P637, DOI 10.1046/j.1365-2141.2003.04664.x; NUNEZALONSO C, 1979, AM J SURG PATHOL, V3, P23, DOI 10.1097/00000478-197902000-00003; O'Sullivan MJ, 2002, J MOL DIAGN, V4, P178, DOI 10.1016/S1525-1578(10)60700-3; Przybyl J, 2012, TUMOR BIOL, V33, P2245, DOI 10.1007/s13277-012-0486-0; Safar A, 1998, DIAGN MOL PATHOL, V7, P283, DOI 10.1097/00019606-199810000-00008; Sanders ME, 1999, MOL DIAGN, V4, P65, DOI 10.1016/S1084-8592(99)80051-4; SHMOOKLER BM, 1982, CANCER, V50, P269, DOI 10.1002/1097-0142(19820715)50:2<269::AID-CNCR2820500217>3.0.CO;2-7; Skytting B, 1999, J NATL CANCER I, V91, P974, DOI 10.1093/jnci/91.11.974; Swick BL, 2008, J CUTAN PATHOL, V35, P197, DOI 10.1111/j.1600-0560.2007.00793.x; Takagi M, 2004, BLOOD, V103, P283, DOI 10.1182/blood-2003-01-0094; Tamborini E, 2001, BRIT J CANCER, V84, P1087, DOI 10.1054/bjoc.2000.1710; Tornkvist M, 2002, MODERN PATHOL, V15, P679, DOI 10.1038/modpathol.3880587; Tsuji S, 1998, AM J PATHOL, V153, P1807, DOI 10.1016/S0002-9440(10)65695-7; Villaroel-Salinas J, 2012, INT J SURG PATHOL, V20, P386, DOI 10.1177/1066896911424897; Wang H, 2008, J ORAL MAXIL SURG, V66, P161, DOI 10.1016/j.joms.2007.05.007	60	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0278-2391	1531-5053		J ORAL MAXIL SURG	J. Oral Maxillofac. Surg.	AUG	2015	73	8					1505	1515		10.1016/j.joms.2015.02.010		11	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CM7MT	WOS:000357878600013		
J	Okochi, M; Ueda, K; Mochizuki, Y; Okochi, H				Okochi, Masayuki; Ueda, Kazuki; Mochizuki, Yasushi; Okochi, Hiromi			How Can Paresthesia After Zygomaticomaxillary Complex Fracture Be Determined After Long-Term Follow-Up? A New and Quantitative Evaluation Method Using Current Perception Threshold Testing	JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY			English	Article							SEMMES-WEINSTEIN MONOFILAMENTS; INFRAORBITAL NERVE; SENSORY FUNCTION; BONE-FRACTURES; INJURY; SENSIBILITY; REPAIR; REEDUCATION; RELIABILITY; RECOVERY	Purpose: The aims of the present study were to analyze the effectiveness of current perception threshold (CPT) testing to determine patients' minor paresthesia of the infraorbital region after open reduction and internal fixation (ORIF) for unilateral zygomaticomaxillary bone fracture (UZF) and to clarify which nerve fiber was related to the paresthesia. Materials and Methods: We conducted a retrospective cohort study of patients who had undergone ORIF after UZF. We also performed neurosensory testing for healthy volunteers who served as the control group. The predictor variables were the period of measurement of Semmes-Weinstein monofilament (S-W) testing and CPT testing (preoperatively and 1 and 5 years postoperatively), measurement side, and disease status (UZF or control). The outcome variables were paresthesia status of the infraorbital nerve region and the results of S-W and CPT testing in both UZF and control groups. The differences in the S-W and CPT values between the affected and unaffected sides in the UZF group and between the UZF and control groups were analyzed by t test (P < .05 was considered significant). Results: The present study included 10 patients (6 males and 4 females), with an average age of 25.0 +/- 12.7 years, and 21 controls (10 males and 11 females), with an average age of 24.3 +/- 1.7 years. In the control group, the CPT and S-W test results did not show any significant differences between the left and right sides. All 10 patients had paresthesia at 1 and 5 years postoperatively. At 5 years postoperatively, the S-W values in all patients showed normalization. From the results of CPT testing, only the A-beta fiber function showed significant improvement at 5 years postoperatively. Conclusion: The CPT test was an effective sensory test for determining minor paresthesia that could not be detected using S-W testing. Paresthesia of the infraorbital nerve region was caused by the damaged A-delta and C fibers. (C) 2015 American Association of Oral and Maxillofacial Surgeons	[Okochi, Masayuki; Ueda, Kazuki; Mochizuki, Yasushi; Okochi, Hiromi] Fukushima Med Univ, Dept Plast & Reconstruct Surg, Fukushima 9601295, Japan	Okochi, M (reprint author), Fukushima Med Univ, Dept Plast & Reconstruct Surg, 1 Hikarigaoka, Fukushima 9601295, Japan.	oktms-okt@umin.ac.jp					American Association of Electrodiagnostic Medicine, 1999, MUSCLE NERVE       S, V8, pS247; DELLON AL, 1974, PLAST RECONSTR SURG, V53, P297, DOI 10.1097/00006534-197403000-00008; Collins S, 2010, DISABIL REHABIL, V32, P2019, DOI 10.3109/09638281003797406; Sakavicius D, 2008, J ORAL REHABIL, V35, P903, DOI 10.1111/j.1365-2842.2008.01888.x; Feng Yuzhe, 2009, J Vasc Surg, V50, P675, DOI 10.1016/j.jvs.2009.05.017; ZINGG M, 1991, ARCH OTOLARYNGOL, V117, P611; Voerman VF, 1999, AM J PHYS MED REHAB, V78, P24, DOI 10.1097/00002060-199901000-00007; Fogaca WC, 2004, PLAST RECONSTR SURG, V113, P834, DOI 10.1097/01.PRS.0000105335.41930.41; Schreuders TAR, 2008, J HAND THER, V21, P28, DOI 10.1197/j.jht.2007.07.020; IMAI H, 1989, MICROSURG, V10, P142, DOI 10.1002/micr.1920100216; Ziccardi VB, 2012, J ORAL MAXIL SURG, V70, P289, DOI 10.1016/j.joms.2011.08.019; Jerosch-Herold C, 2005, J HAND SURG-BRIT EUR, V30B, P252, DOI 10.1016/jshb.2004.12.006; DEMAN K, 1988, BRIT J ORAL MAX SURG, V26, P419, DOI 10.1016/0266-4356(88)90095-2; FRANZBLAU A, 1994, J OCCUP ENVIRON MED, V36, P1015; KESARWANI A, 1989, ANN PLAS SURG, V22, P416, DOI 10.1097/00000637-198905000-00006; Kobayashi H, 2003, DERMATOLOGY, V206, P204, DOI 10.1159/000068892; Menkes D L, 2000, Electromyogr Clin Neurophysiol, V40, P205; Nishimura Akiyo, 2003, J Orthop Sci, V8, P625, DOI 10.1007/s00776-003-0684-0; Oishi M, 2002, INTERNAL MED, V41, P819, DOI 10.2169/internalmedicine.41.819; RENDELL MS, 1989, DIABETES CARE, V12, P636, DOI 10.2337/diacare.12.9.636; Siemionow M, 2011, PLAST RECONSTR SURG, V127, P1875, DOI 10.1097/PRS.0b013e31820e90c3; TAICHER S, 1993, INT J ORAL MAX SURG, V22, P339, DOI 10.1016/S0901-5027(05)80662-9; TAJIMA S, 1977, J MAXILLOFAC SURG, V5, P150, DOI 10.1016/S0301-0503(77)80094-5; Vriens JPM, 1998, INT J ORAL MAX SURG, V27, P20, DOI 10.1016/S0901-5027(98)80090-8; Yamashita T, 2002, SPINE, V27, P1567, DOI 10.1097/01.BRS.0000018483.20260.6B; ZACHARIADES N, 1990, J CRANIO MAXILL SURG, V18, P315, DOI 10.1016/S1010-5182(05)80539-6	26	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0278-2391	1531-5053		J ORAL MAXIL SURG	J. Oral Maxillofac. Surg.	AUG	2015	73	8					1554	1561		10.1016/j.joms.2015.02.029		8	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CM7MT	WOS:000357878600018		
J	Yano, J; Shirahige, C; Oki, K; Oisaka, N; Kumakura, I; Tsubahara, A; Minagi, S				Yano, J.; Shirahige, C.; Oki, K.; Oisaka, N.; Kumakura, I.; Tsubahara, A.; Minagi, S.			Effect of visual biofeedback of posterior tongue movement on articulation rehabilitation in dysarthria patients	JOURNAL OF ORAL REHABILITATION			English	Article						visual biofeedback; tongue movement; articulation; rehabilitation; dysarthria	TRAUMATIC BRAIN-INJURY; CLEFT-PALATE; NERVE PALSY; ELECTROPALATOGRAPHY; ULTRASOUND; SPEECH; MOTION; ADOLESCENTS; IMAGES	Articulation is driven by various combinations of movements of the lip, tongue, soft palate, pharynx and larynx, where the tongue plays an especially important role. In patients with cerebrovascular disorder, lingual motor function is often affected, causing dysarthria. We aimed to evaluate the effect of visual biofeedback of posterior tongue movement on articulation rehabilitation in dysarthria patients with cerebrovascular disorder. Fifteen dysarthria patients (10 men and 5 women; mean age, 707 +/- 103years) agreed to participate in this study. A device for measuring the movement of the posterior part of the tongue was used for the visual biofeedback. Subjects were instructed to produce repetitive articulation of [ka] as fast and steadily as possible between a lungful with/without visual biofeedback. For both the unaffected and affected sides, the range of ascending and descending movement of the posterior tongue with visual biofeedback was significantly larger than that without visual biofeedback. The coefficient of variation for these movements with visual biofeedback was significantly smaller than that without visual biofeedback. With visual biofeedback, the range of ascent exhibited a significant and strong correlation with that of descent for both the unaffected and affected sides. The results of this study revealed that the use of visual biofeedback leads to prompt and preferable change in the movement of the posterior part of the tongue. From the standpoint of pursuing necessary rehabilitation for patients with attention and memory disorders, visualization of tongue movement would be of marked clinical benefit.	[Yano, J.; Shirahige, C.; Oki, K.; Minagi, S.] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Occlusal & Oral Funct Rehabil, Okayama 7008525, Japan; [Yano, J.] Kawasaki Med Sch Hosp, Dept Speech Language Hearing Therapy, Rehabil Ctr, Kurashiki, Okayama, Japan; [Oisaka, N.] Oisaka Elect Device Ltd, Fukuyama, Hiroshima, Japan; [Kumakura, I.] Kawasaki Univ Med Welf, Fac Hlth Sci & Technol, Dept Sensory Sci, Kurashiki, Okayama, Japan; [Tsubahara, A.] Kawasaki Univ Med Welf, Kurashiki, Okayama, Japan	Yano, J (reprint author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Occlusal & Oral Funct Rehabil, Kita Ku, 2-5-1 Shikata Cho, Okayama 7008525, Japan.	ppkt8ybg@s.okayama-u.ac.jp					DAGENAIS PA, 1995, J COMMUN DISORD, V28, P303, DOI 10.1016/0021-9924(95)00059-1; Hartelius L, 2005, J MED SPEECH-LANG PA, V13, P189; Stone M, 2005, CLIN LINGUIST PHONET, V19, P455, DOI 10.1080/02699200500113558; Goozee JV, 1999, J MED SPEECH-LANG PA, V7, P209; Umapathi T, 2000, CEREBROVASC DIS, V10, P462, DOI 10.1159/000016108; Stone M, 2001, J ACOUST SOC AM, V109, P2974, DOI 10.1121/1.1344163; Shirahige C, 2012, J ORAL REHABIL, V39, P370, DOI 10.1111/j.1365-2842.2011.02283.x; Bernhardt B, 2003, CLIN LINGUIST PHONET, V17, P199, DOI 10.1080/0269920031000071451; DAVIS JW, 1987, J PROSTHET DENT, V57, P715, DOI 10.1016/0022-3913(87)90370-2; Duffy JR, 2012, MOTOR SPEECH DISORDE, p[80, 130, 171, 223]; Gibbon F, 2000, J MED SPEECH-LANG PA, V8, P239; Hori Kazuhiro, 2005, Gerodontology, V22, P227; Lohmander A, 2010, INT J SPEECH-LANG PA, V12, P483, DOI 10.3109/17549501003782397; MICHI K, 1993, J SPEECH HEAR RES, V36, P277; Morgan AT, 2009, EUR J PHYS REHAB MED, V45, P197; NEMEC RE, 1984, ARCH PHYS MED REHAB, V65, P103; PALEY MD, 1995, BRIT J ORAL MAX SURG, V33, P239, DOI 10.1016/0266-4356(95)90008-X; Parthasarathy V, 2007, J ACOUST SOC AM, V121, P491, DOI 10.1121/1.2363926; Raphael LJ, 2007, SPEECH SCI PRIMER PH, V5th, P146; Rosenbek JC, 1985, CLIN MANAGEMENT NEUR, P97; Stone M, 1996, J ACOUST SOC AM, V99, P3728, DOI 10.1121/1.414969; STONE M, 1990, J ACOUST SOC AM, V87, P2207, DOI 10.1121/1.399188; WILSON JR, 1994, MUSCLE NERVE, V17, P931, DOI 10.1002/mus.880170813; Yano J, 2012, J ORAL REHABIL, V39, P118, DOI 10.1111/j.1365-2842.2011.02258.x; Zemlin RW, 1998, SPEECH HEARING SCI, P303	25	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0305-182X	1365-2842		J ORAL REHABIL	J. Oral Rehabil.	AUG	2015	42	8					571	579		10.1111/joor.12293		9	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CN0EQ	WOS:000358087300002		
J	Fukatsu, H; Nohara, K; Kotani, Y; Tanaka, N; Matsuno, K; Sakai, T				Fukatsu, H.; Nohara, K.; Kotani, Y.; Tanaka, N.; Matsuno, K.; Sakai, T.			Endoscopic evaluation of food bolus formation and its relationship with the number of chewing cycles	JOURNAL OF ORAL REHABILITATION			English	Article						swallowing; aspiration; mastication; endoscopy; pharynx; diagnosis; oral	RELIABILITY; GUM	It is known that solid food is transported to the pharynx actively in parallel to it being crushed by chewing and mixed with saliva in the oral cavity. Therefore, food bolus formation should be considered to take place from the oral cavity to the pharynx. In previous studies, the chewed food was evaluated after the food had been removed from the oral cavity. However, it has been pointed out that spitting food out of the oral cavity interferes with natural food bolus formation. Therefore, we observed food boluses immediately before swallowing using an endoscope to establish a method to evaluate the food bolus-forming function, and simultaneously performed endoscopic evaluation of food bolus formation and its relationship with the number of chewing cycles. The subject was inserted the endoscope nasally and instructed to eat two coloured samples of boiled rice simultaneously in two ingestion conditions (as usual' and chewing well'). The condition of the food bolus was graded into three categories for each item of grinding, mixing and aggregation and scored 2, 1 and 0. The score of aggregation was high under both ingestion conditions. The scores of grinding and mixing tended to be higher in subjects with a high number of chewing cycles, and the score of aggregation was high regardless of the number of chewing cycles. It was suggested that food has to be aggregated, even though the number of chewing cycles is low and the food is not ground or mixed for a food bolus to reach the swallowing threshold.	[Fukatsu, H.; Nohara, K.; Kotani, Y.; Tanaka, N.; Matsuno, K.] Osaka Univ, Div Oral & Facial Disorders, Dent Hosp, Suita, Osaka 5650871, Japan; [Sakai, T.] Osaka Univ, Grad Sch Dent, Div Funct Oral Neurosci, Suita, Osaka 5650871, Japan	Nohara, K (reprint author), Osaka Univ, Div Oral & Facial Disorders, Dent Hosp, 1-8 Yamada Oka, Suita, Osaka 5650871, Japan.	nohara@dent.osaka-u.ac.jp			Japanese Foundation for Research and Promotion of Endoscopy; Kakenhi [19791634]	This study was supported in part by the Special Coordination of the Japanese Foundation for Research and Promotion of Endoscopy, and Kakenhi (Project number 19791634, Grant-in-Aid for Young Scientists B).	Abe Risako, 2011, J Prosthodont Res, V55, P171, DOI 10.1016/j.jpor.2010.12.002; Anai M, 2012, J INTEGR STUD DIET H, V23, P174; Anderson GF, 2000, HEALTH AFFAIR, V19, P191, DOI 10.1377/hlthaff.19.3.191; Duijm LEM, 2004, RADIOLOGY, V231, P564, DOI 10.1148/radiol.2312030665; Sato H, 2003, J ORAL REHABIL, V30, P68, DOI 10.1046/j.1365-2842.2003.01049.x; Engelen L, 2005, ARCH ORAL BIOL, V50, P739, DOI 10.1016/j.archoralbio.2005.01.004; MANLY RS, 1950, J DENT RES, V29, P448, DOI 10.1177/00220345500290040701; Sato S, 2003, J ORAL REHABIL, V30, P146, DOI 10.1046/j.1365-2842.2003.01050.x; Kobayashi T, 2003, UROLOGY, V61, P65, DOI 10.1016/S0090-4295(02)02002-2; Tohara H, 2010, J ORAL REHABIL, V37, P884, DOI 10.1111/j.1365-2842.2010.02116.x; LEOPOLD NA, 1983, ARCH PHYS MED REHAB, V64, P371; Sugiura T, 2009, J ORAL REHABIL, V36, P159, DOI 10.1111/j.1365-2842.2008.01917.x; Honma W, 2006, J JPN PROSTHODONT SO, V50, P219; Hsu HY, 2012, J ORAL REHABIL, V39, P559, DOI 10.1111/j.1365-2842.2012.02306.x; Iida Y, 2011, DYSPHAGIA, V26, P246, DOI 10.1007/s00455-010-9295-z; Inoue M, 2005, J JPN STOMATOL SOC, V54, P410; KAWAMURA Y., 1957, MED JOUR OSAKA UNIV, V8, P241; Kikutani T, 2012, ARCH GERONTOL GERIAT, V54, pE431, DOI 10.1016/j.archger.2012.01.010; Kinuta S, 2005, DENT MATER J, V24, P661; Langmore SE, 1988, ENDOSCOPIC EVALUATIO, P61; Martin C, 2000, AM J ORTHOD DENTOFAC, V118, P541, DOI 10.1067/med.2000.109494; Michael J, 1993, DYSPHAGIA, V8, P356; Mills S, 2014, P 29 INT C IM VIS CO, P218; Mishellany A, 2006, DYSPHAGIA, V21, P87, DOI 10.1007/s00455-006-9014-y; Nohara K, 2006, CLEFT PALATE-CRAN J, V43, P103, DOI 10.1597/04-152R.1; PALMER J B, 1992, Dysphagia, V7, P187, DOI 10.1007/BF02493469; Picinato-Pirola Melissa Nara de Carvalho, 2012, J Soc Bras Fonoaudiol, V24, P130, DOI 10.1590/S2179-64912012000200007; Prinz JF, 1999, J ORAL REHABIL, V26, P243, DOI 10.1046/j.1365-2842.1999.00362.x; Rey A, 2007, FOOD QUAL PREFER, V18, P585, DOI 10.1016/j.foodqual.2006.08.002; Schimmel M, 2007, J ORAL REHABIL, V34, P671, DOI 10.1111/j.1365-2842.2007.01773.x; Shiozawa K, 2002, JPN J ORAL BIOL, V44, P114; Shiozawa K., 2003, JPN J ORAL BIOL, V45, P59; TIBBLING L, 1991, Dysphagia, V6, P200, DOI 10.1007/BF02493526; Zhihong Gao, 2013, Journal of Texture Studies, V44, P387	34	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0305-182X	1365-2842		J ORAL REHABIL	J. Oral Rehabil.	AUG	2015	42	8					580	587		10.1111/joor.12290		8	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CN0EQ	WOS:000358087300003		
J	Yoshii, T; Nyman, JS; Yuasa, M; Esparza, JM; Okawa, A; Gutierrez, GE				Yoshii, Toshitaka; Nyman, Jeffry S.; Yuasa, Masato; Esparza, Javier M.; Okawa, Atsushi; Gutierrez, Gloria E.			Local Application of a Proteasome Inhibitor Enhances Fracture Healing in Rats	JOURNAL OF ORTHOPAEDIC RESEARCH			English	Article						fracture; treatment; proteasome inhibitors; local administration	OSTEOBLAST DIFFERENTIATION; BONE-FORMATION; MULTIPLE-MYELOMA; IN-VITRO; REPAIR; BORTEZOMIB; LOVASTATIN; VIVO; REGENERATION; ACTIVATION	The ubiquitin/proteasome system plays an important role in regulating the activity of osteoblast precursor cells. Proteasome inhibitors (PSIs) have been shown to stimulate the differentiation of osteoblast precursor cells and to promote bone formation. This raises the possibility that PSIs might be useful for enhancing fracture healing. In this study, we examined the effect of the local administration of PSI on fracture repair in rats. The effects of treatment on the healing of a fractured femur were assessed based on radiographs, micro-computed tomography (mCT) analysis, biomechanical testing, and histological analysis. PSI enhanced osteogenic differentiation in bone marrow-and periosteum-derived mesenchymal progenitor cells in vitro. Moreover, the local administration of PSI in vivo promoted fracture healing in rats, as demonstrated by an increased fracture callus volume in radiographs at 2 weeks post-fracture, and improved radiographic scores. By week 4, PSI treatment had enhanced biomechanical strength and mineral density in the callus as assessed using bending tests, and mCT, respectively. Histological sections demonstrated that PSI treatment accelerated endochondral ossification during the early stages of fracture repair. Although further investigations are necessary to assess its clinical use, the local administration of PSIs might be a novel, and effective therapeutic approach for fracture repair. (C) 2015 Orthopaedic Research Society. Published by Wiley Periodicals, Inc.	[Yoshii, Toshitaka; Nyman, Jeffry S.; Yuasa, Masato; Okawa, Atsushi] Vanderbilt Univ, Med Ctr, Dept Orthopaed & Rehabil, Nashville, TN 37232 USA; [Nyman, Jeffry S.; Esparza, Javier M.; Gutierrez, Gloria E.] Vanderbilt Univ, Med Ctr, Ctr Bone Biol, Nashville, TN 37232 USA; [Yoshii, Toshitaka; Yuasa, Masato] Tokyo Med & Dent Univ, Grad Sch, Dept Orthopaed & Spinal Surg, Bunkyo Ku, Tokyo 1138519, Japan; [Gutierrez, Gloria E.] SW Res Inst, San Antonio, TX 78238 USA	Yoshii, T (reprint author), Vanderbilt Univ, Med Ctr, Dept Orthopaed & Rehabil, 1215 21st Ave South,Room 4200, Nashville, TN 37232 USA.	yoshii.orth@tmd.ac.jp					Alkhiary YM, 2005, J BONE JOINT SURG AM, V87A, P731, DOI 10.2106/JBJS.D.02115; Garrett IR, 2007, J ORTHOP RES, V25, P1351, DOI 10.1002/jor.20391; Qiang YW, 2009, BLOOD, V113, P4319, DOI 10.1182/blood-2008-08-174300; Mukherjee S, 2008, J CLIN INVEST, V118, P491, DOI [10.1172/JCI33102, 10.1172/JC133102]; Zhao M, 2003, J BIOL CHEM, V278, P27939, DOI 10.1074/jbc.M304132200; Yoshii T, 2014, J TISSUE ENG REGEN M, V8, P589, DOI 10.1002/term.1547; Garrett IR, 2003, J CLIN INVEST, V111, P1771, DOI 10.1172/JCI200316198; Seeherman H, 2006, J BONE JOINT SURG AM, V88A, P144, DOI 10.2106/JBJS.D.02453; Kwong FNK, 2009, J ORTHOP RES, V27, P752, DOI 10.1002/jor.20794; Giuliani N, 2007, BLOOD, V110, P334, DOI 10.1182/blood-2006-11-059188; Bielby R, 2007, INJURY, V38, pS26, DOI 10.1016/j.injury.2007.02.007; Oyajobi BO, 2007, BRIT J HAEMATOL, V139, P434, DOI 10.1111/j.1365-2141.2007.06829.x; Nyman JS, 2009, J BIOMECH, V42, P891, DOI 10.1016/j.jbiomech.2009.01.016; Betz OB, 2007, GENE THER, V14, P1039, DOI 10.1038/sj.gt.3302956; Marsh DR, 1999, BRIT MED BULL, V55, P856, DOI 10.1258/0007142991902673; Shimazaki C, 2005, LEUKEMIA, V19, P1102, DOI 10.1038/sj.leu.2403758; Dimitriou R, 2005, INJURY, V36, P1392, DOI 10.1016/j.injury.2005.07.019; Cohen MM, 2003, AM J MED GENET A, V123A, P5, DOI 10.1002/ajmg.a.20495; Gutierrez GE, 2008, J BONE MINER RES, V23, P1722, DOI [10.1359/jbmr.080603, 10.1359/JBMR.080603]; Zhang XP, 2005, J BONE MINER RES, V20, P2124, DOI 10.1359/JBMR.050806; Hanada K, 2001, J CELL BIOCHEM, V81, P284, DOI 10.1002/1097-4644(20010501)81:2<284::AID-JCB1043>3.0.CO;2-D; Leung KS, 2009, J ORTHOP RES, V27, P458, DOI 10.1002/jor.20753; MANIATOPOULOS C, 1988, CELL TISSUE RES, V254, P317; Tsuji K, 2006, NAT GENET, V38, P1424, DOI 10.1038/ng1916; Zangari M, 2005, BRIT J HAEMATOL, V131, P71, DOI 10.1111/j.1365-2141.2005.05733.x; Kloen P, 2003, BONE, V33, P362, DOI 10.1016/S8756-3282(03)00191-1; SANDBERG MM, 1993, CLIN ORTHOP RELAT R, P292; Garrison KR, 2007, HEALTH TECHNOL ASSES, V11, P1; Ding S, 2005, CURR TOP MED CHEM, V5, P383, DOI 10.2174/1568026053828402; Einhorn TA, 2003, J BONE JOINT SURG AM, V85A, P1425; Gutierrez GE, 2008, J BONE MINER RES, V23, pS84; Healy W L, 1990, J Orthop Trauma, V4, P424, DOI 10.1097/00005131-199004000-00011; HULTH A, 1989, CLIN ORTHOP RELAT R, P265; Ito Y, 2011, BIOCHEM BIOPH RES CO, V407, P225, DOI 10.1016/j.bbrc.2011.03.003; Kalderon D, 2005, BIOCHEM SOC T, V33, P1509; Khedgikar V, 2013, CELL DEATH DIS, V22, pe778; Praemer A, 1992, MUSCULOSKELETAL COND, V1992, P85	37	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0736-0266	1554-527X		J ORTHOP RES	J. Orthop. Res.	AUG	2015	33	8					1197	1204		10.1002/jor.22849		8	Orthopedics	Orthopedics	CM6RN	WOS:000357817400012		
J	Izaki, S; Kurinomaru, T; Handa, K; Kimoto, T; Shiraki, K				Izaki, Shunsuke; Kurinomaru, Takaaki; Handa, Kenji; Kimoto, Tomoaki; Shiraki, Kentaro			Stress Tolerance of Antibody-Poly(Amino Acid) Complexes for Improving the Stability of High Concentration Antibody Formulations	JOURNAL OF PHARMACEUTICAL SCIENCES			English	Article						complexation; dissolution; polyelectrolytes; precipitation; protein formulation; proteins; suspensions	MONOCLONAL-ANTIBODIES; PROTEIN AGGREGATION; POLYELECTROLYTE; PRECIPITATION; PURIFICATION; CANCER; PAIR	The stabilization of antibodies in aqueous solution against physical stress remains a problematic issue for pharmaceutical applications. Recently, protein-polyelectrolyte complex (PPC) formation using poly(amino acids) was proposed to prepare antibody formulation in a salt-dissociable precipitated state without protein denaturation. Here, we investigated the stabilization effect of PPC of therapeutic antibodies with poly-l-glutamic acid on agitation and thermal stress as forms of mechanical and non-mechanical stress, respectively. The precipitated state of PPC prevented the inactivation and aggregation induced by agitation. Similar results were obtained using the suspension state of PPC, but the stabilizing effects were slightly inferior to those of the PPC precipitate. PPC precipitate and PPC suspension prevented heat-induced inactivation of the antibodies, but showed little effect on heat-induced aggregation. Thus, PPC is a new candidate as a simple storage method for antibodies in aqueous solution, as an alternative state for freeze-drying. (c) 2015 Wiley Periodicals, Inc. and the American Pharmacists Association J Pharm Sci 104:2457-2463, 2015	[Izaki, Shunsuke; Handa, Kenji; Kimoto, Tomoaki] Terumo Co Ltd, Ctr Res & Dev, Nakai, Kanagawa 2590151, Japan; [Kurinomaru, Takaaki; Shiraki, Kentaro] Univ Tsukuba, Fac Pure & Appl Sci, Tsukuba, Ibaraki 3058573, Japan	Shiraki, K (reprint author), Univ Tsukuba, Fac Pure & Appl Sci, Tsukuba, Ibaraki 3058573, Japan.	shiraki@bk.tsukuba.ac.jp			University of Tsukuba; Terumo Corporation	This study was supported financially by University of Tsukuba and Terumo Corporation.	Andersson MA, 1999, J BIOTECHNOL, V72, P21, DOI 10.1016/S0168-1656(99)00050-4; Hamada H, 2009, CURR PHARM BIOTECHNO, V10, P400; Chan AC, 2010, NAT REV IMMUNOL, V10, P301, DOI 10.1038/nri2761; Tomita S, 2011, J POLYM SCI POL CHEM, V49, P3835, DOI 10.1002/pola.24822; Richard J, 2010, IDRUGS, V13, P550; Hsu YR, 1996, PROTEIN SCI, V5, P1165; Kurinomaru T, 2012, LANGMUIR, V28, P4334, DOI 10.1021/la2043312; Ganguli S, 2009, J AM CHEM SOC, V131, P6549, DOI 10.1021/ja900786z; Wang W, 2007, J PHARM SCI-US, V96, P1, DOI 10.1002/jps.20727; Peram T, 2010, BIOTECHNOL PROGR, V26, P1322, DOI 10.1002/btpr.437; Reichert JM, 2005, NAT BIOTECHNOL, V23, P1073, DOI 10.1038/nbt0905-1073; Boeris V, 2009, PROCESS BIOCHEM, V44, P1260, DOI 10.1016/j.procbio.2009.07.001; Kerwin BA, 2007, J PHARM SCI-US, V96, P1468, DOI 10.1002/jps.20815; Tomita S, 2010, SOFT MATTER, V6, P5320, DOI 10.1039/c000930j; Weiner LM, 2010, NAT REV IMMUNOL, V10, P317, DOI 10.1038/nri2744; Zhang CM, 2005, J CHROMATOGR A, V1069, P107, DOI 10.1016/j.chroma.2004.10.018; Wang YF, 1996, BIOTECHNOL PROGR, V12, P356, DOI 10.1021/bp960013+; Lazar KL, 2010, MABS-AUSTIN, V2, P42; Sliwkowski MX, 2013, SCIENCE, V341, P1192, DOI 10.1126/science.1241145; Treuheit MJ, 2002, PHARMACEUT RES, V19, P511, DOI 10.1023/A:1015108115452; McDonald P, 2009, BIOTECHNOL BIOENG, V102, P1141, DOI 10.1002/bit.22127; Kayitmazer AB, 2013, SOFT MATTER, V9, P2553, DOI 10.1039/c2sm27002a; SLUZKY V, 1992, BIOTECHNOL BIOENG, V40, P895, DOI 10.1002/bit.260400805; Luo QZ, 2011, J BIOL CHEM, V286, P25134, DOI 10.1074/jbc.M110.160440; Kurinomaru T, 2014, LANGMUIR, V30, P3826, DOI 10.1021/la500575c; Izaki S, 2015, J PHARM SCI-US, V104, P1929, DOI 10.1002/jps.24422; Kurinomaru T, 2014, J PHARM SCI-US, V103, P2248, DOI 10.1002/jps.24025; Kurinomaru T, 2015, J PHARM SCI-US, V104, P587, DOI 10.1002/jps.24217; Mazzaferro L, 2010, INT J BIOL MACROMOL, V47, P15, DOI 10.1016/j.ijbiomac.2010.04.003; Patel J, 2011, BIOPROCESS INT, V9, P20; Philo JS, 2009, CURR PHARM BIOTECHNO, V10, P348; Rosenberg Amy S, 2006, AAPS J, V8, pE501, DOI 10.1208/aapsj080359; Wang W, 2005, INT J PHARM, V289, P1, DOI 10.1016/j.ijpharm.2004.11.014	33	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3549	1520-6017		J PHARM SCI-US	J. Pharm. Sci.	AUG	2015	104	8					2457	2463		10.1002/jps.24515		7	Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology & Pharmacy	Pharmacology & Pharmacy; Chemistry	CM9EM	WOS:000358009700007		
J	Mizuno, N; Nishibori, E; Oka, M; Jomori, T; Takata, M; Kumasaka, T				Mizuno, Nobuhiro; Nishibori, Eiji; Oka, Mitsuru; Jomori, Takahito; Takata, Masaki; Kumasaka, Takashi			Structural Basis for Polymer Packing and Solvation Properties of the Organogermanium Crystalline Polymer Propagermanium and Its Derivatives	JOURNAL OF PHARMACEUTICAL SCIENCES			English	Article						X-ray powder diffractometry; stability; crystallography; crystal structure; solvation	MACROPHAGES; SPRING-8; RECEPTOR; CCR2	Of organogermanium compounds known to have an immunostimulatory action, propagermanium [PGe; 3-oxygermylpropionic acid polymer, (C3H5GeO3.5)(n)] is the only one used as a pharmaceutical agent, to treat the hepatitis B virus in Japan. However, because of lack of information about its structure, PGe has been confused with a polymeric solid, repagermanium (RGe, Ge-132, poly-trans-[(2-carboxyethyl) germasesquioxane], (C18H30Ge6O21)(n)), which has the same essential formula as PGe. To clarify this issue, the structure of PGe was analyzed using X-ray diffraction (XRD). PGe has a polymeric ladder-shaped structure of a concatenated eight-membered ring composed of GeO bonds, which is clearly distinguished from the infinite sheet structure in RGe. Moreover, we observed temperature or moisture-dependent transformations among these compounds using powder XRD. For instance, PGe was easily dissolved in water, and transformed to RGe by exposure to water vapor, but transformed into another straight-chain structure when exposed to aqueous solution. As a result of these findings, PGe was indicated to have labile polymer packing against RGe. These characteristics of PGe may affect pharmaceutical properties such as respective stability and solubility, which indicate its unique impact on physiological activity. (c) 2015 Wiley Periodicals, Inc. and the American Pharmacists Association J Pharm Sci 104:2482-2488, 2015	[Mizuno, Nobuhiro; Kumasaka, Takashi] Japan Synchrotron Radiat Res Inst, Prot Crystal Anal Div, Tatsunocho Tominaga, Hyogo, Japan; [Nishibori, Eiji] Univ Tsukuba, Tsukuba Res Ctr Interdisciplinary Mat Sci TIMS, Fac Pure & Appl Sci, Div Phys, Tsukuba, Ibaraki, Japan; [Nishibori, Eiji] Univ Tsukuba, Ctr Integrated Res Fundamental Sci & Engn CiRfSE, Tsukuba, Ibaraki, Japan; [Oka, Mitsuru] Sanwa Kagaku Kenkyusho Co Ltd, Pharmaceut Technol Labs, Inabe, Mie, Japan; [Jomori, Takahito] Sanwa Kagaku Kenkyusho Co Ltd, Drug Dev Ctr, Nagoya, Aichi, Japan; [Takata, Masaki] RIKEN SPring 8 Ctr, Struct Mat Sci Lab, Sayo, Hyogo, Japan; [Takata, Masaki] Japan Synchrotron Radiat Res Inst, Res & Utilizat Div, Tatsunocho Tominaga, Hyogo, Japan	Kumasaka, T (reprint author), Japan Synchrotron Radiat Res Inst, Prot Crystal Anal Div, Tatsunocho Tominaga, Hyogo, Japan.	kumasaka@spring8.or.jp		Kumasaka, Takashi/0000-0001-9289-1557			Akiba M, 1994, CHEM SOC JPN, V3, P286; Amtul Z, 2007, BIOCHEM BIOPH RES CO, V356, P457, DOI 10.1016/j.bbre.2007.02.158; Ito A, 2008, J BIOL CHEM, V283, P35715, DOI 10.1074/jbc.M804220200; Kato K, 2010, AIP CONF PROC, V1234, P875, DOI 10.1063/1.3463354; Namiki M, 2002, ARTERIOSCL THROM VAS, V22, P115, DOI 10.1161/hq0102.102278; Furuichi K, 2003, J AM SOC NEPHROL, V14, P2503, DOI 10.1097/01.ASN.0000089563.63641.A8; Nishibori E, 2001, NUCL INSTRUM METH A, V467, P1045, DOI 10.1016/S0168-9002(01)00639-8; Blatov VA, 2014, CRYST GROWTH DES, V14, P3576, DOI 10.1021/cg500498k; Choi S, 2010, EUR J MED CHEM, V45, P1654, DOI 10.1016/j.ejmech.2009.12.069; Hirayama C, 2003, J GASTROENTEROL, V38, P525, DOI 10.1007/s00535-003-1098-7; Ishikawa A, 1979, JAPAN PATENT KOKAI, Patent No. 1979-115324; Jiang JH, 2013, BIOORG MED CHEM LETT, V23, P5727, DOI 10.1016/j.bmcl.2013.07.073; Kluska M, 2008, CRIT REV ANAL CHEM, V38, P84, DOI 10.1080/10408340701804459; Kondo M, 2006, ANGEW CHEM INT EDIT, V45, P5461, DOI 10.1002/anie.200600933; Kurono M, 1989, IYAKUHIN KENKYU DRUG, V20, P309; Nishibori E, 2008, J APPL CRYSTALLOGR, V41, P292, DOI 10.1107/S0021889808001520; Ohshima K, 2012, J AM SOC HYPERTENS, V6, P375, DOI 10.1016/j.jash.2012.10.002; Otwinowski Z., 1997, ENZYMOLOGY, V276, P307; Sheldrick GM, 1997, METHOD ENZYMOL, V277, P319, DOI 10.1016/S0076-6879(97)77018-6; TSUTSUI M, 1976, J AM CHEM SOC, V98, P8287, DOI 10.1021/ja00441a081; Vegas A, 2011, STRUCT BOND, V138, P1, DOI 10.1007/978-3-642-20341-1; Yokochi S, 2001, J INTERF CYTOK RES, V21, P389, DOI 10.1089/107999001750277862; Yumimoto K, 2015, J CLIN INVEST, V125, P621, DOI 10.1172/JCI78782	23	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3549	1520-6017		J PHARM SCI-US	J. Pharm. Sci.	AUG	2015	104	8					2482	2488		10.1002/jps.24486		7	Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology & Pharmacy	Pharmacology & Pharmacy; Chemistry	CM9EM	WOS:000358009700010		
J	Otsuka, N; Ueda, K; Ohyagi, N; Shimizu, K; Katakawa, K; Kumamoto, T; Higashi, K; Yamamoto, K; Moribe, K				Otsuka, Naoya; Ueda, Keisuke; Ohyagi, Naoko; Shimizu, Kozue; Katakawa, Kazuaki; Kumamoto, Takuya; Higashi, Kenjirou; Yamamoto, Keiji; Moribe, Kunikazu			An Insight into Different Stabilization Mechanisms of Phenytoin Derivatives Supersaturation by HPMC and PVP	JOURNAL OF PHARMACEUTICAL SCIENCES			English	Article						supersaturation; solubilization; crystallization; polymers; drug derivative; permeability; NMR spectroscopy	AMORPHOUS SOLID DISPERSIONS; WATER-SOLUBLE DRUGS; MAGNETIC-RESONANCE MEASUREMENTS; ORAL BIOAVAILABILITY; ACETATE SUCCINATE; CRYSTAL-GROWTH; DISSOLUTION; PRECIPITATION; SOLUBILITY; TRANSPORT	In this study, we examined the stabilization mechanism of drug supersaturation by hypromellose (HPMC) and polyvinylpirrolidone (PVP). The poorly water-soluble drugs, phenytoin (diphenylhydantoin, DPH), and its synthesized derivatives monomethylphenytoin (MDPH) and dimethylphenytoin (DMDPH) were used. DPH supersaturation was efficiently maintained by both HPMC and PVP. HPMC maintained the supersaturation of MDPH and DMDPH in a similar manner to that of DPH, whereas the ability of PVP to maintain drug supersaturation increased as follows: DPH > MDPH > DMDPH. Caco-2 permeation studies and nuclear magnetic resonance measurements revealed that the permeability and molecular state of the drug in a HPMC solution barely changed. In fact, the solubilization of the drug into PVP changed its apparent permeability and molecular state. The drug solubilization efficiency by PVP was higher and followed the order: DPH > MDPH > DMDPH. The different drug solubilization efficiencies most likely result from the different strengths in the intermolecular interaction between the DPH derivatives and PVP. The difference in the stabilization mechanism of drug supersaturation by HPMC and PVP could determine whether the efficient maintenance of the drug supersaturation was dependent on the drug species. (c) 2015 Wiley Periodicals, Inc. and the American Pharmacists Association J Pharm Sci 104:2574-2582, 2015	[Otsuka, Naoya; Ueda, Keisuke; Ohyagi, Naoko; Higashi, Kenjirou; Yamamoto, Keiji; Moribe, Kunikazu] Chiba Univ, Grad Sch Pharmaceut Sci, Chuo Ku, Chiba 2608675, Japan; [Shimizu, Kozue; Katakawa, Kazuaki; Kumamoto, Takuya] Musashino Univ, Pharmaceut Sci Res Inst, Dept Synthet Organ Chem, Tokyo 2028585, Japan	Moribe, K (reprint author), Chiba Univ, Grad Sch Pharmaceut Sci, Chuo Ku, Chiba 2608675, Japan.	moribe@faculty.chiba-u.jp			Japan Society for the Promotion of Sciences [24590045, 24790041]	This study was partly supported Grants-in-Aid for Scientific Research (C) (JSPS, 24590045) and for Young Scientist (B) (JSPS, 24790041) from the Japan Society for the Promotion of Sciences. We also thank the Shin-Etsu Chemical Company (Tokyo, Japan) for gifting HPMC and BASF (Ludwigshafen, Germany) for gifting PVP.	Vo CLN, 2013, EUR J PHARM BIOPHARM, V85, P799, DOI 10.1016/j.ejpb.2013.09.007; di Cagno M, 2013, EUR J PHARM SCI, V48, P775, DOI 10.1016/j.ejps.2013.01.006; Ilevbare GA, 2013, MOL PHARMACEUT, V10, P2381, DOI 10.1021/mp400029v; Fu M, 2014, J MATER CHEM A, V2, P735, DOI 10.1039/c3ta14050d; Ilevbare GA, 2012, CRYST GROWTH DES, V12, P3133, DOI 10.1021/cg300325p; Ueda K, 2013, MOL PHARMACEUT, V10, P3801, DOI 10.1021/mp400278j; Kojima T, 2012, PHARM RES-DORDR, V29, P2777, DOI 10.1007/s11095-011-0655-7; Brouwers J, 2009, J PHARM SCI-US, V98, P2549, DOI 10.1002/jps.21650; Ueda K, 2012, MOL PHARMACEUT, V9, P3023, DOI 10.1021/mp300083e; Sarode AL, 2014, EUR J PHARM BIOPHARM, V86, P351, DOI 10.1016/j.ejpb.2013.10.005; Kogan A, 2007, J COLLOID INTERF SCI, V315, P637, DOI 10.1016/j.jcis.2007.06.087; Konno H, 2008, EUR J PHARM BIOPHARM, V70, P493, DOI 10.1016/j.ejpb.2008.05.023; Alonzo DE, 2012, CRYST GROWTH DES, V12, P1538, DOI 10.1021/cg201590J; Jung JY, 1999, INT J PHARM, V187, P209, DOI 10.1016/S0378-5173(99)00191-X; Hauss DJ, 2007, ADV DRUG DELIVER REV, V59, P667, DOI 10.1016/j.addr.2007.05.006; Jackson MJ, 2014, MOL PHARMACEUT, V11, P3027, DOI 10.1021/mp500201s; Cohen Y, 2005, ANGEW CHEM INT EDIT, V44, P520, DOI 10.1002/anie.200300637; Mamidi N, 2012, J PHYS CHEM B, V116, P10684, DOI 10.1021/jp304787j; Park SH, 2006, INT J PHARM, V321, P35, DOI 10.1016/j.ijpharm.2006.05.004; Pouton CW, 2006, EUR J PHARM SCI, V29, P278, DOI 10.1016/j.ejps.2006.04.016; Liu ZP, 2003, NEW J CHEM, V27, P1748, DOI 10.1039/b306782c; Pade V, 1997, PHARMACEUT RES, V14, P1210, DOI 10.1023/A:1012111008617; Engers D, 2010, J PHARM SCI-US, V99, P3901, DOI 10.1002/jps.22233; CHIOU WL, 1971, J PHARM SCI, V60, P1281, DOI 10.1002/jps.2600600902; Tajarobi F, 2011, EUR J PHARM BIOPHARM, V78, P125, DOI 10.1016/j.ejpb.2010.11.020; Moribe K, 2012, J PHARM SCI-US, V101, P3413, DOI 10.1002/jps.23141; Miller JM, 2012, MOL PHARMACEUT, V9, P2009, DOI 10.1021/mp300104s; Singh T, 2007, J PHYS CHEM B, V111, P7843, DOI 10.1021/jp0726889; Alonzo DE, 2010, PHARM RES-DORDR, V27, P608, DOI 10.1007/s11095-009-0021-1; Han HK, 2011, INT J PHARMACEUT, V415, P89, DOI 10.1016/j.ijpharm.2011.05.055; Xie SY, 2010, CRYST GROWTH DES, V10, P3363, DOI 10.1021/cg901270x; Won DH, 2005, INT J PHARM, V301, P199, DOI 10.1016/j.ijpharm.2005.05.017; Artursson P, 2001, ADV DRUG DELIVER REV, V46, P27, DOI 10.1016/S0169-409X(00)00128-9; Kadam Y, 2009, COLLOID SURFACE B, V72, P141, DOI 10.1016/j.colsurfb.2009.03.027; Ozaki S, 2013, J PHARM SCI-US, V102, P2273, DOI 10.1002/jps.23588; Baum B, 2010, J MOL BIOL, V397, P1042, DOI 10.1016/j.jmb.2010.02.007; Pudipeddi M, 2005, J PHARM SCI-US, V94, P929, DOI 10.1002/jps.20302; Xu S, 2013, INT J PHARMACEUT, V453, P36, DOI 10.1016/j.ijpharm.2013.05.013; Higashi K, 2010, J PHARM SCI-US, V99, P4192, DOI 10.1002/jps.22133; Sugano K, 2010, NAT REV DRUG DISCOV, V9, P597, DOI 10.1038/nrd3187; AOYAMA Y, 1990, J AM CHEM SOC, V112, P3145, DOI 10.1021/ja00164a041; Schneider HJ, 1998, CHEM REV, V98, P1755, DOI 10.1021/cr970019t; Curatolo W, 2009, PHARM RES-DORD, V26, P1419, DOI 10.1007/s11095-009-9852-z; Gordon JE, 1970, J PHYS CHEM-US, V74, P957, DOI 10.1021/j100699a053; Higashi K, 2014, CRYST GROWTH DES, V14, P2773, DOI 10.1021/cg401934v; Ilevbare G.A., 2012, CRYST GROWTH DES, V13, P740; Jha PK, 2014, MOL PHARMACEUT, V11, P1676, DOI 10.1021/mp500068w; Ma JH, 2007, J PHYS CHEM B, V111, P13371, DOI 10.1021/jp075853t; Terebetski JL, 2014, INT J PHARMACEUT, V475, P536, DOI 10.1016/j.ijpharm.2014.09.015; Ueda K, 2014, EUR J PHARM SCI, V62, P293, DOI 10.1016/j.ejps.2014.06.007; Ueda K, 2014, INT J PHARMACEUT, V464, P205, DOI 10.1016/j.ijpharm.2014.01.005; Yano K, 2010, J PHARM SCI-US, V99, P1336, DOI 10.1002/jps.21919; ZHOU NE, 1992, J AM CHEM SOC, V114, P4320, DOI 10.1021/ja00037a042	53	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3549	1520-6017		J PHARM SCI-US	J. Pharm. Sci.	AUG	2015	104	8					2574	2582		10.1002/jps.24527		9	Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology & Pharmacy	Pharmacology & Pharmacy; Chemistry	CM9EM	WOS:000358009700020		
J	Fujiki, S; Watanabe, N; Iwao, Y; Noguchi, S; Mizoguchi, M; Iwamura, T; Itai, S				Fujiki, Sadahiro; Watanabe, Narumi; Iwao, Yasunori; Noguchi, Shuji; Mizoguchi, Midori; Iwamura, Takeru; Itai, Shigeru			Suppressed Release of Clarithromycin from Tablets by Crystalline Phase Transition of Metastable Polymorph Form I	JOURNAL OF PHARMACEUTICAL SCIENCES			English	Article						polymorphism; hydration; tablet; sustained release; controlled release; transition; pseudopolymorphism	HELICOBACTER-PYLORI	The pharmaceutical properties of clarithromycin (CAM) tablets containing the metastable form I of crystalline CAM were investigated. Although the dissolution rate of form I was higher than that of stable form II, the release of CAM from form I tablet was delayed. Disintegration test and liquid penetration test showed that the disintegration of the tablet delayed because of the slow penetration of an external solution into form I tablet. Investigation by scanning electron microscopy revealed that the surface of form I tablet was covered with fine needle-shaped crystals following an exposure to the external solution. These crystals were identified as form IV crystals by powder X-ray diffraction. The phenomenon that CAM releases from tablet was inhibited by fine crystals spontaneously formed on the tablet surface could be applied to the design of sustained-release formulation systems with high CAM contents by minimizing the amount of functional excipients. (c) 2015 Wiley Periodicals, Inc. and the American Pharmacists Association J Pharm Sci 104:2641-2644, 2015	[Fujiki, Sadahiro; Watanabe, Narumi; Iwao, Yasunori; Noguchi, Shuji; Mizoguchi, Midori; Itai, Shigeru] Univ Shizuoka, Grad Div Pharmaceut Sci, Suruga Ku, Shizuoka 4228526, Japan; [Iwamura, Takeru] Tokyo City Univ, Fac Engn, Setagaya Ku, Tokyo 1588557, Japan	Itai, S (reprint author), Univ Shizuoka, Grad Div Pharmaceut Sci, Suruga Ku, Shizuoka 4228526, Japan.	s-itai@u-shizuoka-ken.ac.jp			Japan Society for the Promotion of Science KAKENHI [26460039, 26460226, 26460224]	This work was supported by Japan Society for the Promotion of Science KAKENHI (grant Nos. 26460039, 26460226, and 26460224).	Rajinikanth PS, 2008, J CONTROL RELEASE, V125, P33, DOI 10.1016/j.jconrel.2007.07.011; Rajinikanth PS, 2008, CHEM PHARM BULL, V56, P1658, DOI 10.1248/cpb.56.1658; Yajima T, 1999, CHEM PHARM BULL, V47, P220; Noguchi S, 2014, J PHARM SCI-US, V103, P580, DOI 10.1002/jps.23825; Fujiki S, 2011, CHEM PHARM BULL, V59, P553; Meulenaar J, 2013, INT J PHARMACEUT, V441, P213, DOI 10.1016/j.ijpharm.2012.11.041; Noguchi Shuji, 2012, Acta Crystallogr Sect E Struct Rep Online, V68, po667, DOI 10.1107/S1600536812005090; Noguchi S, 2012, ACTA CRYSTALLOGR C, V68, pO41, DOI 10.1107/S0108270111054230	8	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3549	1520-6017		J PHARM SCI-US	J. Pharm. Sci.	AUG	2015	104	8					2641	2644		10.1002/jps.24516		4	Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology & Pharmacy	Pharmacology & Pharmacy; Chemistry	CM9EM	WOS:000358009700028		
J	Yoshioka, R; Kita, Y; Nagahira, A; Manno, A; Makita, N; Tomita, U; Murakawa, M				Yoshioka, Ryosuke; Kita, Yasuhiro; Nagahira, Asako; Manno, Atsushi; Makita, Naoyuki; Tomita, Urara; Murakawa, Masao			Quantitative analysis of cadherin-11 and -catenin signalling during proliferation of rheumatoid arthritis-derived synovial fibroblast cells	JOURNAL OF PHARMACY AND PHARMACOLOGY			English	Article						cadherin11; interleukine-1; rheumatoid arthritis; synovial fibroblast cell; tumour necrosis factor-	NECROSIS-FACTOR-ALPHA; ADHERENS JUNCTIONS; N-CADHERIN; ADHESION; SYNOVIOCYTES; OSTEOARTHRITIS; ARCHITECTURE; INFLAMMATION; EXPRESSION; FLUID	ObjectivesCadherin-11 (CDH11) is an adhesion molecule that anchors -catenin and is involved with various functions of synovial fibroblast cells (SFCs) during the development of rheumatoid arthritis (RA). However, the mechanism of CDH11 during RA-SFC proliferation is unclear. The aim of our study was to clarify the involvement of CDH11 and -catenin signalling during proliferation. MethodsIL-1-induced and tumour necrosis factor- (TNF-)-induced cell proliferation, with CDH11 siRNAs, -catenin-specific siRNAs and a CDH11-neutralizing antibody, were assessed by 5-Bromo-2'-deoxy-uridine ELISA. Key findingsUsing CDH11 siRNAs, there were a 42% reduction in IL-1-induced proliferation and a 64% reduction in -catenin protein. When -catenin siRNAs were applied, there was a 63% reduction in IL-1-induced proliferation. The median effective concentration (EC50) values for IL-1-induced proliferation via CDH11-mediated -catenin-dependent, total -catenin-dependent and -catenin-independent signalling were 0.0015, 0.016 and 0.18ng/ml, respectively. Blocking CDH11 ligation with a CDH11-neutralizing antibody did not decrease IL-1-induced proliferation. ConclusionsCDH11-mediated -catenin signalling was 42% involved in IL-1-induced proliferation and had the highest susceptibility to IL-1 among the proliferative signallings analysed in this study. The mode of action for CDH11 during the cell proliferation was likely associated with a pool of -catenin protein. In contrast, CDH11 and -catenin were not involved in TNF--induced RA-SFC proliferation.	[Yoshioka, Ryosuke; Kita, Yasuhiro; Manno, Atsushi; Makita, Naoyuki; Tomita, Urara; Murakawa, Masao] Asubio Pharma Co Ltd, Fac Exploratory Pharmacol, Kobe, Hyogo 6500047, Japan; [Nagahira, Asako] Asubio Pharma Co Ltd, Fac Drug Discovery Technol, Kobe, Hyogo 6500047, Japan	Yoshioka, R (reprint author), Asubio Pharma Co Ltd, Fac Exploratory Pharmacol, Chuo Ku, 6-4-3 Minatojima Minamimachi, Kobe, Hyogo 6500047, Japan.	yoshioka.ryosuke.gr@asubio.co.jp			Asubio Pharma Co., Ltd.	This work was supported by Asubio Pharma Co., Ltd.	Agarwal SK, 2008, ARTHRITIS RHEUM, V58, P1044, DOI 10.1002/art.23369; Van Der Flier LG, 2007, GASTROENTEROLOGY, V132, P628, DOI 10.1053/j.gastro.2006.08.039; Kiener HP, 2009, ARTHRITIS RHEUM, V60, P1305, DOI 10.1002/art.24453; Sekine C, 2008, J IMMUNOL, V180, P1954; Kiener HP, 2006, AM J PATHOL, V168, P1486, DOI 10.2353/apath.2006.050999; Wu MH, 2014, ARTHRITIS RHEUMATOL, V66, P1010, DOI 10.1002/art.38275; Kii I, 2004, J BONE MINER RES, V19, P1840, DOI 10.1359/JBMR.040812; HATTA K, 1986, NATURE, V320, P447, DOI 10.1038/320447a0; Valencia X, 2004, J EXP MED, V200, P1673, DOI 10.1084/jem.20041545; Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9; Chang SK, 2011, P NATL ACAD SCI USA, V108, P8402, DOI 10.1073/pnas.1019437108; Firestein GS, 2003, NATURE, V423, P356, DOI 10.1038/nature01661; Taniguchi K, 1999, NAT MED, V5, P760; Oguma K, 2008, EMBO J, V27, P1671, DOI 10.1038/emboj.2008.105; Nagafuchi A, 2001, CURR OPIN CELL BIOL, V13, P600, DOI 10.1016/S0955-0674(00)00257-X; NAGAFUCHI A, 1987, NATURE, V329, P341, DOI 10.1038/329341a0; Benedetto AD, 2010, J CELL SCI, V123, P2640; GITTER BD, 1989, IMMUNOLOGY, V66, P196; Horiuchi T, 1999, ENDOCR J, V46, P643, DOI 10.1507/endocrj.46.643; Kaler Pawan, 2009, Cancer Microenviron, V2, P69, DOI 10.1007/s12307-009-0030-y; Kam Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004580; Kokebie R, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3293; MATTHEW SH, 2004, GENE DEV, V18, P2195; Noss EH, 2011, ARTHRITIS RHEUM-US, V63, P3768, DOI 10.1002/art.30630; Troyanovsky SM, 1999, CURR OPIN CELL BIOL, V11, P561, DOI 10.1016/S0955-0674(99)00021-6; Vandooren B, 2008, ARTHRITIS RHEUM, V58, P3051, DOI 10.1002/art.23886	26	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3573	2042-7158		J PHARM PHARMACOL	J. Pharm. Pharmacol.	AUG	2015	67	8					1075	1082		10.1111/jphp.12410		8	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CM8LS	WOS:000357953300005		
J	Maeda, Y; Motoyama, K; Higashi, T; Horikoshi, Y; Takeo, T; Nakagata, N; Kurauchi, Y; Katsuki, H; Ishitsuka, Y; Kondo, Y; Irie, T; Furuya, H; Era, T; Arima, H				Maeda, Yuki; Motoyama, Keiichi; Higashi, Taishi; Horikoshi, Yuka; Takeo, Toru; Nakagata, Naomi; Kurauchi, Yuki; Katsuki, Hiroshi; Ishitsuka, Yoichi; Kondo, Yuki; Irie, Tetsumi; Furuya, Hirokazu; Era, Takumi; Arima, Hidetoshi			Effects of cyclodextrins on GM1-gangliosides in fibroblasts from GM1-gangliosidosis patients	JOURNAL OF PHARMACY AND PHARMACOLOGY			English	Article						cyclodextrins; fibroblasts; GM1-gangliosidosis; lysosomes	PICK C DISEASE; GM1 GANGLIOSIDOSIS; CHEMICAL CHAPERONE; LIPID RAFTS; EVERY ORGAN; CHOLESTEROL; STORAGE; CELLS; MICE; ACCUMULATION	ObjectivesGM1-gangliosidosis is an inherited disorder characterized by the accumulation of GM1-gangliosides in many tissues and organs, particularly in the brain. Currently, there is no treatment available for patients with ganglioside storage diseases. Therefore, we investigated the effects of cyclodextrins (CyDs) on the GM1-ganglioside level in EA1 cells, fibroblasts from patients with GM1-gangliosidosis. MethodsThe concentrations of cholesterol and phospholipids in supernatants were determined by Cholesterol E-test Wako and Phospholipid C-test Wako, respectively. The effects of CyDs on GM1-ganglioside levels in EA1 cells using fluorescence-labelled cholera toxin B-subunit, which can bind to GM1-gangliosides specifically, were investigated by flow cytometry and confocal laser scanning microscopy. Key findingsThe treatment with methylated CyDs, hydroxypropylated CyDs and branched CyDs decreased GM1-ganglioside levels in EA1 cells at 1mm for 24h. Unexpectedly, there was no significant change in the efflux of cholesterol or phospholipids from the cells after treatment with CyDs under the same experimental conditions, indicating that the efflux of membrane components is not associated with down-regulation of GM1-ganglioside levels in EA1 cells upon CyDs treatment. ConclusionsCyDs may have the potential as drugs for GM1-gangliosidosis, although the mechanism should be thereafter clarified.	[Maeda, Yuki; Motoyama, Keiichi; Higashi, Taishi; Kurauchi, Yuki; Katsuki, Hiroshi; Ishitsuka, Yoichi; Kondo, Yuki; Irie, Tetsumi; Arima, Hidetoshi] Kumamoto Univ, Grad Sch Pharmaceut Sci, Kumamoto 8620973, Japan; [Maeda, Yuki; Kurauchi, Yuki; Irie, Tetsumi; Arima, Hidetoshi] Kumamoto Univ, Program Leading Grad Sch, HIGO Hlth Life Sci Interdisciplinary & Glocal Ori, Kumamoto 8620973, Japan; [Horikoshi, Yuka; Takeo, Toru; Nakagata, Naomi] Kumamoto Univ, Div Reprod Engn, Ctr Anim Resources & Dev, Kumamoto 8620973, Japan; [Era, Takumi] Kumamoto Univ, Inst Mol Embryol & Genet, Dept Cell Modulat, Kumamoto 8620973, Japan; [Furuya, Hirokazu] Kochi Univ, Kochi Med Sch, Dept Neurol, Kochi 780, Japan	Arima, H (reprint author), Kumamoto Univ, Grad Sch Pharmaceut Sci, Chuo Ku, 5-1 Oe Honmachi, Kumamoto 8620973, Japan.	arimah@gpo.kumamoto-u.ac.jp			Health and Labor Sciences Research Grant in Japan	This study was funded by Health and Labor Sciences Research Grant in Japan.	Taylor AM, 2012, J LIPID RES, V53, P2331, DOI 10.1194/jlr.M028241; Liu B, 2010, J LIPID RES, V51, P933, DOI 10.1194/jlr.M000257; Rosenbaum AI, 2011, J NEUROCHEM, V116, P789, DOI 10.1111/j.1471-4159.2010.06976.x; Loftsson T, 2007, J PHARM SCI-US, V96, P2532, DOI 10.1002/jps.20992; Ostrom Rennolds S., 2007, V400, P459; Abi-Mosleh L, 2009, P NATL ACAD SCI USA, V106, P19316, DOI 10.1073/pnas.0910916106; Danielsen EM, 2003, BBA-BIOMEMBRANES, V1617, P1, DOI 10.1016/j.bbamem.2003.09.005; Sarkar S, 2013, CELL REP, V5, P1302, DOI 10.1016/j.celrep.2013.10.042; Ramirez CM, 2010, PEDIATR RES, V68, P309, DOI 10.1203/00006450-201011001-00604; Stella VJ, 2008, TOXICOL PATHOL, V36, P30, DOI 10.1177/0192623307310945; Szente L, 1999, ADV DRUG DELIVER REV, V36, P17, DOI 10.1016/S0169-409X(98)00092-1; Higaki K, 2011, HUM MUTAT, V32, P843, DOI 10.1002/humu.21516; Rosenbaum AI, 2010, P NATL ACAD SCI USA, V107, P5477, DOI 10.1073/pnas.0914309107; Motoyama K, 2006, EUR J PHARM SCI, V29, P111, DOI 10.1016/j.ejps.2006.06.002; Sandhoff K, 2013, J NEUROSCI, V33, P10195, DOI 10.1523/JNEUROSCI.0822-13.2013; UEKAMA K, 1987, CRIT REV THER DRUG, V3, P1; Brady RO, 2004, LANCET NEUROL, V3, P752, DOI 10.1016/S1474-4422(04)00938-X; Irie T, 1997, J PHARM SCI, V86, P147, DOI 10.1021/js960213f; Davidson CD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006951; Ermolinsky B, 2013, J MED MICROBIOL, V62, P1011, DOI 10.1099/jmm.0.057232-0; Takamura A, 2011, J NEUROCHEM, V118, P399, DOI 10.1111/j.1471-4159.2011.07310.x; Takaura N, 2003, GENE THER, V10, P1487, DOI 10.1038/sj.gt.3302033; TOKUDA A, 1991, J CLIN BIOCHEM NUTR, V10, P93; Vance JE, 2014, J LIPID RES, V55, P1609, DOI 10.1194/jlr.R047837; vansGelder CM, 2012, EXPERT OPIN PHARMACO, V13, P2281; YOO YS, 1993, J CHROMATOGR A, V652, P431	26	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3573	2042-7158		J PHARM PHARMACOL	J. Pharm. Pharmacol.	AUG	2015	67	8					1133	1142		10.1111/jphp.12405		10	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CM8LS	WOS:000357953300010		
J	Swain, NR; Lim, CCW; Levinson, D; Fiestas, F; de Girolamo, G; Moskalewicz, J; Lepine, JP; Posada-Villa, J; Haro, JM; Medina-Mora, ME; Xavier, M; Lwata, N; de Jonge, P; Bruffaerts, R; O'Neill, S; Kessler, RC; Scott, KM				Swain, Nicola R.; Lim, Carmen C. W.; Levinson, Daphna; Fiestas, Fabian; de Girolamo, Giovanni; Moskalewicz, Jacek; Lepine, Jean-Pierre; Posada-Villa, Jose; Maria Haro, Josep; Elena Medina-Mora, Maria; Xavier, Miguel; Lwata, Noboru; de Jonge, Peter; Bruffaerts, Ronny; O'Neill, Siobhan; Kessler, Ron C.; Scott, Kate M.			Associations between DSM-IV mental disorders and subsequent non-fatal, self-reported stroke	JOURNAL OF PSYCHOSOMATIC RESEARCH			English	Article						Depression; Alcohol abuse; Stroke; Comorbidity	ISCHEMIC-STROKE; RISK-FACTORS; DEPRESSION; MORTALITY; ANXIETY; WORLD; COUNTRIES; DISEASES; VERSION; RECALL	Objectives: To examine the associations between a wide range of mental disorders and subsequent onset of stroke. Lifecourse timing of stroke was examined using retrospectively reconstructed data from cross-sectional surveys. Methods: Data from the World Mental Health Surveys were accessed. This data was collected from general population surveys over 17 countries of 87,250 adults. The Composite International Diagnostic Interview retrospectively assessed lifetime prevalence and age at onset of DSM-IV mental disorders. A weighted subsample (n = 45,288), was used for analysis in the present study. Survival analyses estimated associations between first onset of mental disorders and subsequent stroke onset. Results: Bivariate models showed that 12/16 mental disorders were associated with subsequent stroke onset (ORs ranging from 1.6 to 3.8). However, after adjustment for mental disorder comorbidity and smoking, only significant relationships between depression and stroke (OR 1.3) and alcohol abuse and stroke (OR 1.5) remained. Among females, having a bipolar disorder was also associated with increased stroke incidence (OR 2.1). Increasing number of mental disorders was associated with stroke onset in a dose-response fashion (OR 3.3 for 5 + disorders). Conclusions: Depression and alcohol abuse may have specific associations with incidence of non-fatal stroke. General severity of psychopathology may be a more important predictor of non-fatal stroke onset Mental health treatment should be considered as part of stroke risk prevention. Limitations of retrospectively gathered cross sectional surveys design mean further research on the links between mental health and stroke incidence is warranted. (C) 2015 Elsevier Inc. All rights reserved.	[Swain, Nicola R.; Lim, Carmen C. W.; Scott, Kate M.] Univ Otago, Dept Psychol Med, Dunedin, New Zealand; [Kessler, Ron C.] Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA USA; [Posada-Villa, Jose] Colegio Mayor Cundinamarca Univ, Bogota, Colombia; [Elena Medina-Mora, Maria] Natl Inst Psychiat Ramon Fuente, Calzada, Mexico; [Fiestas, Fabian] Peruvian Natl Inst Hlth, Unit Anal & Generat Evidence Publ Hlth, Lima, Peru; [Lwata, Noboru] Hiroshima Int Univ, Dept Clin Psychol, Hiroshima, Japan; [Bruffaerts, Ronny] Univ Leuven, Univ Psychiat Ctr, Leuven, Belgium; [Lepine, Jean-Pierre] Univ Paris 05, Paris Diderot Inserm UMRS 1144, AP HP, Paris, France; [Levinson, Daphna] Minist Hlth Israel, Mental Hlth Serv, Jerusalem, Israel; [de Girolamo, Giovanni] IRCCS Ctr S Giovanni Dio Fatebenefratelli, Brescia, Italy; [de Jonge, Peter] Univ Groningen, Univ Med Ctr Groningen, Dept Psychiat, Interdisciplinary Ctr Psychopathol & Emot Regulat, Groningen, Netherlands; [Maria Haro, Josep] Univ Barcelona, CIBERSAM, Parc Sanitari Sant Joan Deu, E-08007 Barcelona, Spain; [O'Neill, Siobhan] Univ Ulster, Sch Psychol, Coleraine BT52 1SA, Londonderry, North Ireland; [Xavier, Miguel] Univ Nova Lisboa, Fac Ciencias Med, Chron Dis Res Ctr CEDOC, Dept Mental Hlth, P-1200 Lisbon, Portugal; [Moskalewicz, Jacek] Inst Psychiat & Neurol, Warsaw, Poland	Swain, NR (reprint author), Univ Otago, Dept Psychol Med, POB 913, Dunedin, New Zealand.	Nicola.swain@otago.ac.nz			National Institute of Mental Health (NIMH) [R01 MH070884, U01-MH60220]; John D. and Catherine T. MacArthur Foundation; Pfizer Foundation; US Public Health Service [R13-MH066849, R01-MH069864, R01 DA016558]; Fogarty International Center [FIRCA R03-TW006481]; Pan American Health Organization; Eli Lilly and Company; Ortho-McNeil Pharmaceutical; GlaxoSmithKline; Bristol-Myers Squibb; Ministry of Social Protection; European Commission [QLG5-1999-01042, SANCO 2004123, EAHC 20081308]; Piedmont Region (Italy); Fondo de Investigacion Sanitaria, Instituto de Salud Carlos III, Spain [FIS 00/0028]; Ministerio de Ciencia y Tecnologia, Spain [SAF 2000-158-CE]; Departament de Salut, Generalitat de Catalunya, Spain; Instituto de Salud Carlos III [CIBER CB06/02/0046, RETICS RD06/0011 REM-TAP]; Ministry of Health; Israel National Institute for Health Policy and Health Services Research; National Insurance Institute of Israel; Grant for Research on Psychiatric and Neurological Diseases and Mental Health from the Japan Ministry of Health, Labour and Welfare [H13-SHOGAI-023, H14-TOKUBETSU-026, H16-KOKORO-013]; National Council on Science and Technology [CONACyT-G30544-H]; PanAmerican Health Organization (PAHO); New Zealand Ministry of Health; Alcohol Advisory Council; Health Research Council; Health Social Care; National Institute of Health of the Ministry of Health of Peru; Norwegian Financial Mechanism; European Economic Area Mechanism; Polish Ministry of Health; Champalimaud Foundation; Gulbenkian Foundation; Foundation for Science and Technology (FCT); National Institute of Drug Abuse (NIDA); Substance Abuse and Mental Health Services Administration (SAMHSA); Robert Wood Johnson Foundation (RWJF) [044708]; John W. Alden Trust; National Institute of Psychiatry Ramon de la Fuente [INPRFMDIES 4280]	The World Health Organization World Mental Health (WMH) Survey Initiative which is supported by the National Institute of Mental Health (NIMH; R01 MH070884), the John D. and Catherine T. MacArthur Foundation, the Pfizer Foundation, the US Public Health Service (R13-MH066849, R01-MH069864, and R01 DA016558), the Fogarty International Center (FIRCA R03-TW006481), the Pan American Health Organization, Eli Lilly and Company, Ortho-McNeil Pharmaceutical, GlaxoSmithKline, and Bristol-Myers Squibb. We thank the staff of the WMH Data Collection and Data Analysis Co-ordination Centres for assistance with instrumentation, fieldwork, and consultation on data analysis. None of the funders had any role in the design, analysis, interpretation of results, or preparation of this paper. A complete list of all within-country and cross-national WMH publications can be found at cps. The Colombian National Study of Mental Health (NSMH) is supported by the Ministry of Social Protection. The ESEMeD project is funded by the European Commission (Contracts QLG5-1999-01042; SANCO 2004123, and EAHC 20081308), the Piedmont Region (Italy), Fondo de Investigacion Sanitaria, Instituto de Salud Carlos III, Spain (FIS 00/0028), Ministerio de Ciencia y Tecnologia, Spain (SAF 2000-158-CE), Departament de Salut, Generalitat de Catalunya, Spain, Instituto de Salud Carlos III (CIBER CB06/02/0046, RETICS RD06/0011 REM-TAP), and other local agencies and by an unrestricted educational grant from GlaxoSmithKline. The Israel National Health Survey is funded by the Ministry of Health with support from the Israel National Institute for Health Policy and Health Services Research and the National Insurance Institute of Israel. The World Mental Health Japan (WMHJ) Survey is supported by the Grant for Research on Psychiatric and Neurological Diseases and Mental Health (H13-SHOGAI-023, H14-TOKUBETSU-026, H16-KOKORO-013) from the Japan Ministry of Health, Labour and Welfare. The Mexican National Comorbidity Survey (MNCS) is supported by the National Institute of Psychiatry Ramon de la Fuente (INPRFMDIES 4280) and by the National Council on Science and Technology (CONACyT-G30544-H), with supplemental support from the PanAmerican Health Organization (PAHO). Te Rau Hinengaro: The New Zealand Mental Health Survey (NZMHS) is supported by the New Zealand Ministry of Health, Alcohol Advisory Council, and the Health Research Council. The Northern Ireland Study of Mental Health was funded by the Health & Social Care. The Peruvian World Mental Health Study was funded by the National Institute of Health of the Ministry of Health of Peru. The Polish project Epidemiology of Mental Health and Access to Care - EZOP Poland was carried out by the Institute of Psychiatry and Neurology in Warsaw in consortium with Department of Psychiatry - Medical University in Wroclaw and National Institute of Public Health - National Institute of Hygiene in Warsaw and in partnership with Psykiatrist Institut Vinderen - Universitet, Oslo. The project was funded by the Norwegian Financial Mechanism and the European Economic Area Mechanism as well as Polish Ministry of Health. No support from pharmaceutical industry neither other commercial sources was received. The Portuguese Mental Health Study was carried out by the Department of Mental Health, Faculty of Medical Sciences, NOVA University of Lisbon, with collaboration of the Portuguese Catholic University, and was funded by Champalimaud Foundation, Gulbenkian Foundation, Foundation for Science and Technology (FCT) and Ministry of Health.; The US National Comorbidity Survey Replication (NCS-R) is supported by the National Institute of Mental Health (NIMH; U01-MH60220) with supplemental support from the National Institute of Drug Abuse (NIDA), the Substance Abuse and Mental Health Services Administration (SAMHSA), the Robert Wood Johnson Foundation (RWJF; Grant 044708), and the John W. Alden Trust.	Mazzaglia G, 2001, ADDICTION, V96, P1743, DOI 10.1046/j.1360-0443.2001.961217434.x; Hankey GJ, 2006, STROKE, V37, P2181, DOI 10.1161/01.STR.0000229883.72010.e4; Lambiase MJ, 2014, STROKE, V45, P438, DOI 10.1161/STROKEAHA.113.003741; Okura Y, 2004, J CLIN EPIDEMIOL, V57, P1096, DOI 10.1016/j.jclinepi.2004.04.005; SIMON GE, 1995, EPIDEMIOL REV, V17, P221; Kleindorfer DO, 2010, STROKE, V41, P1326, DOI 10.1161/STROKEAHA.109.575043; O'Donnell MJ, 2010, LANCET, V376, P112, DOI 10.1016/S0140-6736(10)60834-3; Thurston RC, 2013, PROG CARDIOVASC DIS, V55, P524, DOI 10.1016/j.pcad.2013.03.007; Haro JM, 2006, INT J METH PSYCH RES, V15, P167, DOI 10.1002/mpr.196; Pan A, 2011, JAMA-J AM MED ASSOC, V306, P1241, DOI 10.1001/jama.2011.1282; Rahman I, 2013, EUR J EPIDEMIOL, V28, P589, DOI 10.1007/s10654-013-9821-z; Feigin VL, 2007, LANCET NEUROL, V6, P94, DOI 10.1016/S1474-4422(07)70007-8; Strong K, 2007, LANCET NEUROL, V6, P182, DOI 10.1016/S1474-4422(07)70031-5; [Anonymous], SUDAAN SOFTWARE STAT; Kessler RC, 2004, INT J METH PSYCH RES, V13, P93, DOI 10.1002/mpr.168; Koton S, 2014, JAMA-J AM MED ASSOC, V312, P259, DOI 10.1001/jama.2014.7692; Wells JE, 2004, PSYCHOL MED, V34, P1001, DOI 10.1017/S0033291703001843; Jackson CA, 2013, STROKE, V44, P1555, DOI 10.1161/STROKEAHA.113.001147; Lackland DT, 2014, STROKE, V45, P315, DOI 10.1161/01.str.0000437068.30550.cf; Jauch EC, 2013, STROKE, V44, P870, DOI 10.1161/STR.0b013e318284056a; Bos MJ, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001634; Goldstein LB, 2010, STROKE, V2; Kessler RC, 2008, WHO WORLD MENTAL HLT; Lim SS, 2013, LANCET, V380, P2224, DOI DOI 10.1016/S0140-6736(12)61766-8; Mallmann AB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035680; Rehm J, 2004, COMP QUANTIFICATION, P959; Scott KM, 2009, GLOBAL PERSPECTIVES; Scott KM, 2014, CURR OPIN PSYCHIATR, V27, P289, DOI 10.1097/YCO.0000000000000067; Shah B. V., 1998, ENCY BIOSTATISTICS, P2276; SINGER JD, 1993, J EDUC STAT, V18, P155, DOI 10.3102/10769986018002155; Statistics NCfH, 1994, VITAL HLTH STAT, V120, P1	31	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0022-3999	1879-1360		J PSYCHOSOM RES	J. Psychosomat. Res.	AUG	2015	79	2					130	136		10.1016/j.jpsychores.2015.05.008		7	Psychiatry	Psychiatry	CM5ZC	WOS:000357766500008		
J	Kawada, T				Kawada, Tomoyuki			Augmentation index as an indicator of central arterial stiffness and indicators of carotid atherosclerosis by ultrasonography in relation to life stress	JOURNAL OF PSYCHOSOMATIC RESEARCH			English	Letter							INTIMA-MEDIA THICKNESS; COMPONENTS		Nippon Med Sch, Dept Hyg & Publ Hlth, Bunkyo Ku, Tokyo 1138602, Japan	Kawada, T (reprint author), Nippon Med Sch, Dept Hyg & Publ Hlth, Bunkyo Ku, 1-1-5 Sendagi, Tokyo 1138602, Japan.	kawada@nms.ac.jp					Polak JF, 2011, NEW ENGL J MED, V365, P213, DOI 10.1056/NEJMoa1012592; Bomhof-Roordink H, 2015, J PSYCHOSOM RES, V78, P332, DOI 10.1016/j.jpsychores.2015.02.009; Gopal DM, 2014, CLIN CHEM, V60, P1402, DOI 10.1373/clinchem.2014.227116; Kawada T, 2012, J OCCUP ENVIRON MED, V54, P273, DOI 10.1097/JOM.0b013e3182300424; Kawada T, 2012, AGING MALE, V15, P42, DOI 10.3109/13685538.2011.593656; Otsuka T, 2009, PREV MED, V49, P260, DOI 10.1016/j.ypmed.2009.07.005	6	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0022-3999	1879-1360		J PSYCHOSOM RES	J. Psychosomat. Res.	AUG	2015	79	2					171	171		10.1016/j.jpsychores.2015.04.013		1	Psychiatry	Psychiatry	CM5ZC	WOS:000357766500015		
J	Farhana, M; Tamura, N; Mukai, M; Ikuma, K; Koumura, Y; Furuta, N; Yaguchi, C; Uchida, T; Suzuki, K; Sugihara, K; Itoh, H; Kanayama, N				Farhana, Mustari; Tamura, Naoaki; Mukai, Mari; Ikuma, Kotomi; Koumura, Yukiko; Furuta, Naomi; Yaguchi, Chizuko; Uchida, Toshiyuki; Suzuki, Kazunao; Sugihara, Kazuhiro; Itoh, Hiroaki; Kanayama, Naohiro			Histological characteristics of the myometrium in the postpartum hemorrhage of unknown etiology: a possible involvement of local immune reactions	JOURNAL OF REPRODUCTIVE IMMUNOLOGY			English	Article						Pregnancy; Postpartum hemorrhage (PPH); Uterine atony; Myometritis; Amniotic fluid embolism	AMNIOTIC-FLUID EMBOLISM; LABOR	The aim of this study was to evaluate the histological characteristics of the myometrium obtained in postpartum hemorrhage (PPH) of unknown etiology secondary to uterine atony. These characteristics were selected from among registered cases of clinically suspected amniotic fluid embolism (AFE) and classified as PPH of unknown etiology because of no obvious cause of PPH at Hamamatsu University School of Medicine, a registration center for clinical AFE in Japan. Immunohistochemical studies were performed on myometrium using anti-mast cell tryptase, anti-neutrophil elastase, anti-CD68, anti-CD88, anti-CD3, and anti-ZnCP-1 antibodies. Massive infiltrations of inflammatory cells with mast cell degranulation within the myometrium secondary to complement activation were observed in PPH of unknown etiology (n = 34), but not in control pregnant women (n = 15) or after delivery in women without PPH (n = 18). The concomitant immunohistochemical detection of meconium in myometrium suggests that amniotic fluids or fetal materials are one of the candidates for inducing maternal local immune activation in the PPH of unknown etiology. Postpartum acute myometritis in the absence of an infective etiology may be a histological characteristic of PPH of unknown etiology. (C) 2015 Elsevier Ireland Ltd. All rights reserved.	[Farhana, Mustari; Tamura, Naoaki; Mukai, Mari; Ikuma, Kotomi; Koumura, Yukiko; Furuta, Naomi; Yaguchi, Chizuko; Uchida, Toshiyuki; Suzuki, Kazunao; Sugihara, Kazuhiro; Itoh, Hiroaki; Kanayama, Naohiro] Hamamatsu Univ Sch Med, Dept Obstet & Gynecol, Higashi Ku, Hamamatsu, Shizuoka 4313192, Japan	Tamura, N (reprint author), Hamamatsu Univ Sch Med, Dept Obstet & Gynecol, Higashi Ku, 1-20-1 Handayama, Hamamatsu, Shizuoka 4313192, Japan.	ntamura@hama-med.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology, Japan [24390379]	The authors thank Mrs. Naoko Hakamada, Mrs. Yumiko Yamamoto, and Mrs. Naoko Kondo, for secretarial assistance. This work was supported in part by Grants-in-aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology, Japan (Grant number: 24390379).	Anderson FWJ, 2009, CLIN OBSTET GYNECOL, V52, P214, DOI 10.1097/GRF.0b013e3181a4bd53; Tamura N, 2014, GYNECOL OBSTET INVES, V78, P65, DOI 10.1159/000360537; Thomson AJ, 1999, HUM REPROD, V14, P229, DOI 10.1093/humrep/14.1.229; Karoshi M, 2009, CLIN OBSTET GYNECOL, V52, P285, DOI 10.1097/GRF.0b013e3181a4f737; Benson MD, 2007, MED HYPOTHESES, V68, P1019, DOI 10.1016/j.mehy.2006.09.052; Kanayama N, 2014, J OBSTET GYNAECOL RE, V40, P1507, DOI 10.1111/jog.12428; Rouse DJ, 2006, OBSTET GYNECOL, V108, P891, DOI 10.1097/01.AOG.0000236547.35234.8c; Oyelese Y, 2010, CLIN OBSTET GYNECOL, V53, P147, DOI 10.1097/GRF.0b013e3181cc406d; Oyelese Y, 2007, OBSTET GYN CLIN N AM, V34, P421, DOI 10.1016/j.ogc.2007.06.007; Osman I, 2003, MOL HUM REPROD, V9, P41, DOI 10.1093/humrep/gag001; Tamura N, 2014, CRIT CARE MED, V42, P1392, DOI 10.1097/CCM.0000000000000217; Benson M. D., 2012, CLIN DEV IMMUNOL, V2012; Benson MD, 2001, OBSTET GYNECOL, V97, P510, DOI 10.1016/S0029-7844(00)01213-8; Cunningham F. G., 2010, WILLIAMS OBSTET, P757; Fineschi V, 2009, VIRCHOWS ARCH, V454, P283, DOI 10.1007/s00428-009-0730-1; Furuta N, 2012, PLACENTA, V33, P24, DOI 10.1016/j.placenta.2011.10.007; Ivanisevic M, 2010, AM J REPROD IMMUNOL, V64, P188, DOI 10.1111/j.1600-0897.2010.00858.x; Kanayama N, 2011, J OBSTET GYNAECOL RE, V37, P58, DOI 10.1111/j.1447-0756.2010.01319.x; Mercier Frederic J, 2008, Anesthesiol Clin, V26, P53, DOI 10.1016/j.anclin.2007.11.008; Mousa HA, 2014, COCHRANE DB SYST REV, V2	20	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0165-0378			J REPROD IMMUNOL	J. Reprod. Immunol.	AUG	2015	110						74	80		10.1016/j.jri.2015.04.004		7	Immunology; Reproductive Biology	Immunology; Reproductive Biology	CM7WG	WOS:000357906600009		
J	Makihara, T; Onishi, S; Wadano, Y; Fujii, K; Nagata, H; Sakane, M				Makihara, Takeshi; Onishi, Shinzo; Wadano, Yasuyoshi; Fujii, Kengo; Nagata, Hiroshi; Sakane, Masataka			Regrowth of the deteriorated glenoid in advanced Charcot shoulder after suboccipital decompression for syringomyelia: a case report	JOURNAL OF SHOULDER AND ELBOW SURGERY			English	Article							NEUROPATHIC ARTHROPATHY; NEUROARTHROPATHY; MARKERS		[Makihara, Takeshi; Onishi, Shinzo; Fujii, Kengo; Sakane, Masataka] Univ Tsukuba, Dept Orthopaed Surg, Fac Med, Tsukuba, Ibaraki 3058575, Japan; [Wadano, Yasuyoshi; Nagata, Hiroshi] Ibaraki Prefectural Univ Hlth Sci, Ctr Med Sci, Inashiki, Ibaraki, Japan	Sakane, M (reprint author), Univ Tsukuba, Dept Orthopaed Surg, Fac Med, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058575, Japan.	sakane-m@md.tsukuba.ac.jp					Adamopoulos IE, 2015, NAT REV RHEUMATOL, V11, P189, DOI 10.1038/nrrheum.2014.198; Gough A, 1997, DIABETIC MED, V14, P527, DOI 10.1002/(SICI)1096-9136(199707)14:7<527::AID-DIA404>3.0.CO;2-Q; PAPA J, 1993, J BONE JOINT SURG AM, V75A, P1056; Baumhauer JF, 2006, FOOT ANKLE INT, V27, P797; Kim YH, 2002, J BONE JOINT SURG BR, V84B, P216, DOI 10.1302/0301-620X.84B2.12312; Atalar AC, 2010, ACTA ORTHOP TRAUMATO, V44, P328, DOI 10.3944/AOTT.2010.2216; FLOYD W, 1959, South Med J, V52, P563; Grahovac G, 2011, WIEN KLIN WOCHENSCHR, V123, P512, DOI 10.1007/s00508-011-0010-3; Hatzis N, 1998, J BONE JOINT SURG AM, V80A, P1314; Isu T, 1991, RINSHOU SEIKEIGEKA, V26, P1203; Matsuhashi T, 2011, J SHOULDER ELB SURG, V20, pE8, DOI 10.1016/j.jse.2011.04.032; Petrova NL, 2015, DIABETIC MED, V32, P267, DOI 10.1111/dme.12590	12	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	1058-2746			J SHOULDER ELB SURG	J. Shoulder Elbow Surg.	AUG	2015	24	8					E223	E228		10.1016/j.jse.2015.04.022		6	Orthopedics; Sport Sciences; Surgery	Orthopedics; Sport Sciences; Surgery	CM9RO	WOS:000358046800004		
J	Iino, Y; Kano, T; Adachi, F; Suzuki, M; Nishikawa, R; Ishii, N; Ohata, C; Furumura, M; Hamada, T; Hashimoto, T				Iino, Y.; Kano, T.; Adachi, F.; Suzuki, M.; Nishikawa, R.; Ishii, N.; Ohata, C.; Furumura, M.; Hamada, T.; Hashimoto, T.			A case of bullous pemphigoid associated with psoriasis vulgaris showing Hailey-Hailey disease-like histopathological changes in regenerated epidermis without genomic mutation in ATP2C1 or ATP2A2 gene	JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY			English	Letter							TRANSIENT ACANTHOLYTIC DERMATOSIS; IGG ANTIBODIES; DESMOCOLLINS		[Iino, Y.; Kano, T.; Adachi, F.; Suzuki, M.] Ibaraki Cent Hosp, Dept Dermatol, Kasama, Ibaraki, Japan; [Nishikawa, R.; Ishii, N.; Ohata, C.; Furumura, M.; Hamada, T.; Hashimoto, T.] Kurume Univ, Sch Med, Dept Dermatol, Kurume, Fukuoka 830, Japan; [Nishikawa, R.; Ishii, N.; Ohata, C.; Furumura, M.; Hamada, T.; Hashimoto, T.] Kurume Univ, Inst Cutaneous Cell Biol, Kurume, Fukuoka 830, Japan	Hashimoto, T (reprint author), Kurume Univ, Sch Med, Dept Dermatol, Kurume, Fukuoka 830, Japan.	hashimot@med.kurume-u.ac.jp					Barnadas MA, 2000, J CUTAN PATHOL, V27, P96, DOI 10.1034/j.1600-0560.2000.027002096.x; Endo Y, 2010, EUR J DERMATOL, V20, P620, DOI 10.1684/ejd.2010.1020; GROVER RW, 1984, J AM ACAD DERMATOL, V11, P253, DOI 10.1016/S0190-9622(84)70160-5; GROVER RW, 1970, ARCH DERMATOL, V101, P426, DOI 10.1001/archderm.101.4.426; Hamada T, 2008, J DERMATOL SCI, V51, P31, DOI 10.1016/j.jdermsci.2008.02.003; Kiyokawa C, 1998, J INVEST DERMATOL, V111, P1236; KOERBER WA, 1978, ARCH DERMATOL, V114, P1643, DOI 10.1001/archderm.114.11.1643; MEHREGAN DA, 1989, J AM ACAD DERMATOL, V21, P1107, DOI 10.1016/S0190-9622(89)70307-8; Ohata C, 2013, BRIT J DERMATOL, V168, P879, DOI 10.1111/bjd.12019; Ruiz-Perez VL, 1999, HUM MOL GENET, V8, P1621, DOI 10.1093/hmg/8.9.1621	10	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0926-9959	1468-3083		J EUR ACAD DERMATOL	J. Eur. Acad. Dermatol. Venereol.	AUG	2015	29	8					1646	1648		10.1111/jdv.12521		3	Dermatology	Dermatology	CM9FM	WOS:000358012800029		
J	Saeki, H; Ito, T; Hayashi, M; Fukuchi, O; Umezawa, Y; Nobeyama, Y; Teruya, K; Nakagawa, H				Saeki, H.; Ito, T.; Hayashi, M.; Fukuchi, O.; Umezawa, Y.; Nobeyama, Y.; Teruya, K.; Nakagawa, H.			Successful treatment of ustekinumab in a severe psoriasis patient with human immunodeficiency virus infection	JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY			English	Letter							ETANERCEPT; ARTHRITIS; INFLIXIMAB		[Saeki, H.; Ito, T.; Hayashi, M.; Fukuchi, O.; Umezawa, Y.; Nobeyama, Y.; Nakagawa, H.] Jikei Univ, Sch Med, Dept Dermatol, Tokyo, Japan; [Teruya, K.] Natl Ctr Global Hlth & Med, AIDS Clin Ctr, Tokyo, Japan	Saeki, H (reprint author), Jikei Univ, Sch Med, Dept Dermatol, Tokyo, Japan.	saeki-der@jikei.ac.jp					Umezawa Y, 2013, J DERMATOL, V40, P1008, DOI 10.1111/1346-8138.12353; Sellam J, 2007, JOINT BONE SPINE, V74, P197, DOI 10.1016/j.jbspin.2006.05.012; Cepeda EJ, 2008, ANN RHEUM DIS, V67, P710, DOI 10.1136/ard.2007.081513; Aboulafia DM, 2000, MAYO CLIN PROC, V75, P1093; Menon K, 2010, J AM ACAD DERMATOL, V62, P291, DOI 10.1016/j.jaad.2009.03.047; Bartke U, 2004, BRIT J DERMATOL, V150, P784, DOI 10.1111/j.0007-0963.2004.05885.x; Lee ES, 2012, J DRUGS DERMATOL, V11, P413; Linardaki G, 2007, J RHEUMATOL, V34, P1353; Mikhail M, 2008, ARCH DERMATOL, V144, P453, DOI 10.1001/archderm.144.4.453; Paparizos V, 2012, J DERMATOL TREAT, V23, P398, DOI 10.3109/09546634.2011.579085	10	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0926-9959	1468-3083		J EUR ACAD DERMATOL	J. Eur. Acad. Dermatol. Venereol.	AUG	2015	29	8					1653	1655		10.1111/jdv.12531		3	Dermatology	Dermatology	CM9FM	WOS:000358012800033		
J	Homma, E; Hata, H; Aoyagi, S; Shimizu, H				Homma, E.; Hata, H.; Aoyagi, S.; Shimizu, H.			Primary mucinous carcinoma of the skin with in-transit metastasis	JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY			English	Letter							PULMONARY METASTASES; SCALP		[Homma, E.; Hata, H.; Aoyagi, S.; Shimizu, H.] Hokkaido Univ, Grad Sch Med, Dept Dermatol, Sapporo, Hokkaido, Japan	Hata, H (reprint author), Hokkaido Univ, Grad Sch Med, Dept Dermatol, Sapporo, Hokkaido, Japan.	hata07jp@yahoo.co.jp					MENDOZA S, 1971, ARCH DERMATOL, V103, P68, DOI 10.1001/archderm.103.1.68; Jih MH, 2005, J AM ACAD DERMATOL, V52, pS76, DOI 10.1016/j.jaad.2004.06.047; Breiting L, 2008, INT J DERMATOL, V47, P242, DOI 10.1111/j.1365-4632.2008.03558.x; Aoyagi S, 2010, J SURG ONCOL, V101, P175, DOI 10.1002/jso.21456; Bang RH, 2006, J AM ACAD DERMATOL, V55, P726, DOI 10.1016/j.jaad.2006.01.071; Nijhawan N, 2010, OPHTHAL PLAST RECONS, V26, P281, DOI 10.1097/IOP.0b013e3181c32e57; Weedon D., 2009, WEEDONS SKIN PATHOLO, P757	7	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0926-9959	1468-3083		J EUR ACAD DERMATOL	J. Eur. Acad. Dermatol. Venereol.	AUG	2015	29	8					1655	1657		10.1111/jdv.12533		3	Dermatology	Dermatology	CM9FM	WOS:000358012800034		
J	Asano, S; Matsushita, Y; Hirayama, Y; Naka, T				Asano, S.; Matsushita, Y.; Hirayama, Y.; Naka, T.			Simultaneous detection of Tomato spotted wilt virus, Dahlia mosaic virus and Chrysanthemum stunt viroid by multiplex RT-PCR in dahlias and their distribution in Japanese dahlias	LETTERS IN APPLIED MICROBIOLOGY			English	Article						Chrysanthemum stunt viroid; Dahlia mosaic virus; diagnosis; multiplex RT-PCR; Tomato spotted wilt virus		Tomato spotted wilt virus (TSWV), Dahlia mosaic virus (DMV) and Chrysanthemum stunt viroid (CSVd) are economically important viruses and viroid that infect cultivated dahlias. Prior to this investigation, no multiplex RT-PCR assay for the detection of dahlia virus and viroid infections existed. In this study, we report the development of a multiplex RT-PCR that simultaneously detects TSWV, DMV and CSVd infections in dahlias. In addition, a simple RT-PCR method that does not require RNA extraction, microtissue direct RT-PCR, could be used to prepare samples for analysis by this multiplex RT-PCR. A field survey validated our results, indicating that TSWV was the dominant virus found in the Kansai region, DMV in the Tohoku and Kyushu regions, and CSVd in the Hokkaido region. This method represents a rapid, sensitive and cost effective approach to diagnose viral infections in dahlias. Significance and Impact of the StudyThe multiplex RT-PCR assay described in this study is the first report of simultaneous detection of virus and viroid in dahlia. This method represents a rapid, sensitive and cost effective approach to diagnose viral infections in dahlias. A field survey validated our results, indicating that TSWV was the dominant virus found in the Kansai region, DMV in the Tohoku and Kyushu regions and CSVd in the Hokkaido region.	[Asano, S.; Hirayama, Y.; Naka, T.] Nara Prefectural Agr Res & Dev Ctr, Kashihara, Nara, Japan; [Matsushita, Y.] NARO Inst Floricultural Sci, Tsukuba, Ibaraki, Japan	Matsushita, Y (reprint author), NARO Inst Floricultural Sci, Tsukuba, Ibaraki, Japan.	yousuken@affrc.go.jp			Ministry of Agriculture, Forestry and Fisheries of Japan	We thank Mr. K. Inda and Mr. A. Kurata for preparing the experimental materials. This study was supported by a Grant-in-Aid for 'Research and development projects for application in promoting new policy of agriculture, forestry and fisheries' from the Ministry of Agriculture, Forestry and Fisheries of Japan.	Albouy J., 1995, VIRUS VIRUS LIKE DIS, P265; Hosokawa M, 2006, J VIROL METHODS, V131, P28, DOI 10.1016/j.viromet.2005.07.001; Pappu HR, 2008, PLANT DIS, V92, P1138, DOI 10.1094/PDIS-92-7-1138B; Nakashima Akiko, 2007, Journal of General Plant Pathology, V73, P225, DOI 10.1007/s10327-007-0007-y; PALUKAITIS P, 1980, J GEN VIROL, V46, P477, DOI 10.1099/0022-1317-46-2-477; Pahalawatta V, 2008, ARCH VIROL, V153, P733, DOI 10.1007/s00705-008-0043-8; Matsushita Y, 2013, JARQ-JPN AGR RES Q, V47, P237; GERMAN TL, 1992, ANNU REV PHYTOPATHOL, V30, P315, DOI 10.1146/annurev.py.30.090192.001531; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; DEHAAN P, 1991, J GEN VIROL, V72, P2207, DOI 10.1099/0022-1317-72-9-2207; Fujii Y., 2012, B NARA AGR EXP STA, V43, P71; Jacobus Th. J. V., 2013, J GEN VIROL, V94, P711; Kawai K., 2014, J JPN SOC HORTIC SCI, V83, P23; Matsushita Y., 2010, EUR J PLANT PATHOL, V182, P165; Naka T, 2007, B NARA AGR EXP STA, V38, P17; Nicolaisen M, 2003, PLANT DIS, V87, P945, DOI 10.1094/PDIS.2003.87.8.945; Pappu HR, 2005, HORTSCIENCE, V40, P697; Seo N., 2009, ANN REPT PLANT PROT, V60, P288; Suematsu T., 1977, HUSCAP, V11, P138; Tsushima T, 2011, J GEN PLANT PATHOL, V77, P253, DOI 10.1007/s10327-011-0316-z	20	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0266-8254	1472-765X		LETT APPL MICROBIOL	Lett. Appl. Microbiol.	AUG	2015	61	2					113	120		10.1111/lam.12442		8	Biotechnology & Applied Microbiology; Microbiology	Biotechnology & Applied Microbiology; Microbiology	CM8YT	WOS:000357991100002		
J	Li, M; Ishiguro, Y; Kageyama, K; Zhu, Z				Li, M.; Ishiguro, Y.; Kageyama, K.; Zhu, Z.			A simple method for normalization of DNA extraction to improve the quantitative detection of soil-borne plant pathogenic oomycetes by real-time PCR	LETTERS IN APPLIED MICROBIOLOGY			English	Article						external DNA control; extraction efficiency; oomycete; real-time PCR; soil DNA extraction	MULTIPLEX PCR; PHYTOPHTHORA-NICOTIANAE; P. CACTORUM; QUANTIFICATION; RECOVERY; GREENHOUSES; TOOLS	Most of the current research into the quantification of soil-borne pathogenic oomycetes lacks determination of DNA extraction efficiency, probably leading to an incorrect estimation of DNA quantity. In this study, we developed a convenient method by using a 100bp artificially synthesized DNA sequence derived from the mitochondrion NADH dehydrogenase subunit 2 gene of Thunnus thynnus as a control to determine the DNA extraction efficiency. The control DNA was added to soils and then co-extracted along with soil genomic DNA. DNA extraction efficiency was determined by the control DNA. Two different DNA extraction methods were compared and evaluated using different types of soils, and the commercial kit was proved to give more consistent results. We used the control DNA combined with real-time PCR to quantify the oomycete DNAs from 12 naturally infested soils. Detectable target DNA concentrations were three to five times higher after normalization. Our tests also showed that the extraction efficiencies varied on a sample-to-sample basis and were <50%. Therefore, the method introduced here is simple and useful for the accurate quantification of soil-borne pathogenic oomycetes. Significance and Impact of the StudyOomycetes include many important plant pathogens. Accurate quantification of these pathogens is essential in the management of diseases. This study reports an easy method utilizing an external DNA control for the normalization of DNA extraction by real-time PCR. By combining two different efficient soil DNA extraction methods, the developed quantification method dramatically improved the results. This study also proves that the developed normalization method is necessary and useful for the accurate quantification of soil-borne plant pathogenic oomycetes.	[Li, M.; Zhu, Z.] Shaanxi Normal Univ, Coll Life Sci, Xian 710062, Peoples R China; [Ishiguro, Y.; Kageyama, K.] Gifu Univ, River Basin Res Ctr, Gifu, Japan	Li, M (reprint author), Shaanxi Normal Univ, Coll Life Sci, Xian 710062, Peoples R China.	limz@snnu.edu.cn			River Basin Research Center of Gifu University; China Postdoctoral Science Foundation	This study was supported by the River Basin Research Center of Gifu University and the China Postdoctoral Science Foundation.	Zhou JZ, 1996, APPL ENVIRON MICROB, V62, P316; Schroeder KL, 2013, PLANT DIS, V97, P4, DOI 10.1094/PDIS-03-12-0243-FE; Miller DN, 1999, APPL ENVIRON MICROB, V65, P4715; Li MZ, 2013, MICROBES ENVIRON, V28, P195, DOI 10.1264/jsme2.ME12177; Li MZ, 2011, PLANT DIS, V95, P1270, DOI 10.1094/PDIS-01-11-0076; Kontanis EJ, 2006, J FORENSIC SCI, V51, P795, DOI 10.1111/j.1556-4029.2006.00182.x; Li MZ, 2014, EUR J PLANT PATHOL, V140, P229, DOI 10.1007/s10658-014-0456-z; Ishiguro Y, 2013, J GEN PLANT PATHOL, V79, P350, DOI 10.1007/s10327-013-0466-2; Li MZ, 2010, MICROBIOL RES, V165, P695, DOI 10.1016/j.micres.2009.11.010; Rose P, 2003, J MICROBIOL METH, V52, P29, DOI 10.1016/S0167-7012(02)00131-8; Cooke DEL, 2007, J PLANT PATHOL, V89, P13; Asano T, 2010, J PHYTOPATHOL, V158, P609, DOI 10.1111/j.1439-0434.2009.01660.x; Robe P, 2003, EUR J SOIL BIOL, V39, P183, DOI 10.1016/S1164-5563(03)00033-5; Mumy KL, 2004, J MICROBIOL METH, V57, P259, DOI 10.1016/j.mimet.2004.01.013; Schena L, 2006, J MICROBIOL METH, V67, P70, DOI 10.1016/j.mimet.2006.03.003; Frostegard A, 1999, APPL ENVIRON MICROB, V65, P5409; CHELLY J, 1988, NATURE, V333, P858, DOI 10.1038/333858a0; Hoshino Y. T., 2005, J ENV BIOTECHNOL, V5, P43; Kageyama Koji, 2003, Journal of General Plant Pathology, V69, P153; Lee SY, 1996, APPL ENVIRON MICROB, V62, P3787; Park JW, 2005, BIOTECHNIQUES, V38, P579, DOI 10.2144/05384ST04; Robert C, 2002, BIOL REPROD, V67, P1465, DOI 10.1095/biolreprod.102.006320; Schena Leonardo, 2004, Phytopathologia Mediterranea, V43, P273	23	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0266-8254	1472-765X		LETT APPL MICROBIOL	Lett. Appl. Microbiol.	AUG	2015	61	2					179	185		10.1111/lam.12441		7	Biotechnology & Applied Microbiology; Microbiology	Biotechnology & Applied Microbiology; Microbiology	CM8YT	WOS:000357991100011		
J	Takeuchi, A; Nishioka, C; Ikezoe, T; Yang, J; Yokoyama, A				Takeuchi, Asako; Nishioka, Chie; Ikezoe, Takayuki; Yang, Jing; Yokoyama, Akihito			STAT5A regulates DNMT3A in CD34(+)/CD38(-) AML cells	LEUKEMIA RESEARCH			English	Article						AML; DNMT3A; STAT5A; PTEN	HEMATOPOIETIC STEM-CELLS; ACUTE MYELOID-LEUKEMIA; CONSTITUTIVE ACTIVATION; STEM/PROGENITOR CELLS; INITIATING CELLS; SELF-RENEWAL; PTEN GENE; INHIBITOR; DIFFERENTIATION; HETEROGENEITY	Signal transducer and activator of transcription 5 (STAT5) is activated in CD34(+)/CD38(-) acute myelogenous leukemia (AML) cells. Inhibition of STAT5 induced apoptosis and sensitized these cells to the growth inhibition mediated by conventional chemotherapeutic agents. The present study attempted to identify molecules that are regulated by STAT5 in CD34(+)/CD38(-) AML cells by utilizing cDNA microarrays, comparing the gene expression profiles of control and STAT5A shRNA-transduced CD34(+)/CD38(-) AML cells. Interestingly, DNA methyltransferase (DNMT) 3A was downregulated after depletion of STAT5A in CD34(+)/CD38(-) AML cells. Reporter gene assays found that an increase in activity of DNMT3A occurredin response to activation of STAT5A in leukemia cells. On the other hand, dephosphorylation of STAT5A by AZ960 decreased this transcriptional activity. Further studies utilizing a chromatin immunoprecipitation assay identified a STAT5A-binding site on the promoter region of DNMT3A gene. Forced expression of STAT5A in leukemia cells caused hypermethylation on the promoter region of the tumor suppressor gene, PTEN, and downregulated its mRNA levels, as measured by methylation-specific and real-time polymerase chain reaction, respectively. Taken together, these data suggest that STAT5A positively regulates levels of DNMT3A, resulting ininactivation of tumor suppressor genes by epigenetic mechanisms in AML cells. (C) 2015 Elsevier Ltd. All rights reserved.	[Takeuchi, Asako; Nishioka, Chie; Ikezoe, Takayuki; Yang, Jing; Yokoyama, Akihito] Kochi Univ, Kochi Med Sch, Dept Hematol & Resp Med, Nankoku, Kochi 7838505, Japan	Ikezoe, T (reprint author), Kochi Univ, Kochi Med Sch, Dept Hematol & Resp Med, Okoh Cho, Nankoku, Kochi 7838505, Japan.	jm-asako@kochi-u.ac.jp; ikezoet@kochi-u.ac.jp			Kochi University President's Discretionary Grant; Takeda Science Foundation	This work was supported in part by the Kochi University President's Discretionary Grant (to T.I.) and Takeda Science Foundation (to C.N).	Schuringa JJ, 2004, J EXP MED, V200, P623, DOI 10.1084/jem.20041024; Grimley PM, 1999, CYTOKINE GROWTH F R, V10, P131, DOI 10.1016/S1359-6101(99)00011-8; Yoshihara H, 2007, CELL STEM CELL, V1, P685, DOI 10.1016/j.stem.2007.10.020; Sarry JE, 2011, J CLIN INVEST, V121, P384, DOI 10.1172/JCI41495; Nishioka C, 2013, INT J CANCER, V132, P2006, DOI 10.1002/ijc.27904; Ley TJ, 2010, NEW ENGL J MED, V363, P2424, DOI 10.1056/NEJMoa1005143; Chen TP, 2003, MOL CELL BIOL, V23, P5594, DOI 10.1128/MCB.23.16.5594-5605.2003; Bachman KE, 2003, CANCER CELL, V3, P89, DOI 10.1016/S1535-6108(02)00234-9; Schepers H, 2007, BLOOD, V110, P2880, DOI 10.1182/blood-2006-08-039073; Thol F, 2011, J CLIN ONCOL, V29, P2889, DOI 10.1200/JCO.2011.35.4894; Matsuo Y, 1997, LEUKEMIA, V11, P1469, DOI 10.1038/sj.leu.2400768; Taussig DC, 2008, BLOOD, V112, P568, DOI [10.1182/blood-2007-10-118331, 10.1182/blood-2008-10-118331]; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Kim I, 2012, EXP HEMATOL, V40, P84, DOI 10.1016/j.exphem.2011.10.001; Ikezoe T, 2011, INT J CANCER, V128, P2317, DOI 10.1002/ijc.25806; Mandal M, 2011, NAT IMMUNOL, V12, P1212, DOI 10.1038/ni.2136; Yilmaz OH, 2006, NATURE, V441, P475, DOI 10.1038/nature04703; Casetti L, 2013, CANCER RES, V73, P2052, DOI 10.1158/0008-5472.CAN-12-3955; Ishikawa F, 2007, NAT BIOTECHNOL, V25, P1315, DOI 10.1038/nbt1350; Fuks F, 2000, NAT GENET, V24, P88; Moore MAS, 2007, EXP HEMATOL, V35, P105, DOI 10.1016/j.exphem.2007.01.018; Wang ZQ, 2009, BLOOD, V113, P4856, DOI 10.1182/blood-2008-09-181107; Fuks F, 2001, EMBO J, V20, P2536, DOI 10.1093/emboj/20.10.2536; Qian H, 2007, CELL STEM CELL, V1, P671, DOI 10.1016/j.stem.2007.10.008; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Nishioka C, 2014, INT J CANCER, V114, P55; Nishioka C, 2010, LEUKEMIA, V24, P1631, DOI 10.1038/leu.2010.145; Nishioka C, 2007, LEUKEMIA, V21, P1044, DOI 10.1038/sj.leu.2404622; Nishioka C, 2011, BLOOD CANCER J, V1, DOI 10.1038/bcj.2011.33; Schuringa JJ, 2004, STEM CELLS, V22, P1191, DOI 10.1634/stemcells.2004-0033	30	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0145-2126	1873-5835		LEUKEMIA RES	Leuk. Res.	AUG	2015	39	8					897	905		10.1016/j.leukres.2015.05.006		9	Oncology; Hematology	Oncology; Hematology	CM9FJ	WOS:000358012500015		
J	Muniroh, M; Khan, N; Koriyama, C; Akiba, S; Vogel, CFA; Yamamoto, M				Muniroh, Muflihatul; Khan, Noureen; Koriyama, Chihaya; Akiba, Suminori; Vogel, Christoph F. A.; Yamamoto, Megumi			Suppression of methylmercury-induced IL-6 and MCP-1 expressions by N-acetylcysteine in U-87MG human astrocytoma cells	LIFE SCIENCES			English	Article						Methylmercury; MCP-1; IL-6; N-acetylcysteine; Astrocytes; Reactive oxygen species	MERCURY-INDUCED NEUROTOXICITY; KAPPA-B; OXIDATIVE STRESS; ACTIVATION; RELEASE; INFLAMMATION; EXPOSURE; BRAIN; NEUROPROTECTION; INTERLEUKIN-6	Aims: The aim of this study was to clarify the involvement of oxidative stress in methylmercury (MeHg)-induced pro-inflammatory cytokine expressions and the suppressive effects of N-acetylcysteine (NAC) in MeHg-induced cytokine expression. Materials and methods: Using U-87-MG human astrocytoma cell line, interleukin (IL)-6 and monocyte chemoattractant protein (MCP)-1 expressions induced by 4 mu M MeHg were measured at mRNA and protein levels. Hydrogen peroxide (H2O2) and superoxide anion (O-2(-)) were quantified by flow-cytometry analysis. To examine the suppressive effects of NAC on the cytokine expressions among different timing of NAC treatment, cells were treated with 0.5 or 5 mM NAC before, simultaneously, or after MeHg administration. Key findings: MeHg exposure at 4 mu M, a non-cytotoxic concentration, significantly induced MCP-1 and IL-6 expressions at both mRNA and protein levels. A significant increase of H2O2 production but not O-2(-) was observed. MeHg-induced expression of MCP-1 and IL-6 mRNA was reduced by 10-20% in the presence of 5 mM NAC (co-treatment experiment) compared to cells treated with MeHg only. Pre-treatment of cells with 0.5 or 5 mM NAC at 0.5 or 1 h and its subsequent washout before MeHg addition suppressed MCP-1 and IL-6 cytokine expressions. Post-treatment of cells with NAC after MeHg addition also suppressed the cytokine induction, but the magnitude of suppression was evidently lower than in co-treated cells even though the H2O2 generation was almost completely suppressed by NAC. Significance: NAC may effectively suppress the MeHg-induced cytokine production through both, inhibition of reactive oxygen species as well as extracellular chelation of MeHg in astrocytes. (C) 2015 Elsevier Inc. All rights reserved.	[Muniroh, Muflihatul; Khan, Noureen; Koriyama, Chihaya; Akiba, Suminori] Kagoshima Univ Grad Sch Med & Dent Sci, Dept Epidemiol & Prevent Med, Kagoshima 8908520, Japan; [Muniroh, Muflihatul] Diponegoro Univ, Fac Med, Dept Physiol, Semarang 50725, Indonesia; [Vogel, Christoph F. A.] Univ Calif Davis, Dept Environm Toxicol, Davis, CA 95616 USA; [Vogel, Christoph F. A.] Univ Calif Davis, Ctr Hlth & Environm, Davis, CA 95616 USA; [Yamamoto, Megumi] Natl Inst Minamata Dis, Dept Basic Med Sci, Integrated Physiol Sect, Kumamoto 8670008, Japan	Koriyama, C (reprint author), Kagoshima Univ Grad Sch Med & Dent Sci, Dept Epidemiol & Prevent Med, 8-35-1 Sakuragaoka, Kagoshima 8908520, Japan.	fiy@m.kufm.kagoshima-u.ac.jp					Huang CF, 2008, TOXICOL LETT, V176, P188, DOI 10.1016/j.toxlet.2007.11.004; Van Wagoner NJ, 1999, J NEUROIMMUNOL, V100, P124, DOI 10.1016/S0165-5728(99)00187-3; Dong YS, 2001, GLIA, V36, P180, DOI 10.1002/glia.1107; Samuni Y, 2013, BBA-GEN SUBJECTS, V1830, P4117, DOI 10.1016/j.bbagen.2013.04.016; Erickson MA, 2012, BRAIN BEHAV IMMUN, V26, P1085, DOI 10.1016/j.bbi.2012.07.003; Conductier G, 2010, J NEUROIMMUNOL, V224, P93, DOI 10.1016/j.jneuroim.2010.05.010; Isaac AO, 2007, NEUROCHEM RES, V32, P1906, DOI 10.1007/s11064-007-9380-3; Allen JW, 2001, BRAIN RES, V902, P92, DOI 10.1016/S0006-8993(01)02375-7; Aschner M, 2007, BRAZ J MED BIOL RES, V40, P285, DOI 10.1590/S0100-879X2007000300001; Kaur P, 2006, NEUROTOXICOLOGY, V27, P492, DOI 10.1016/j.neuro.2006.01.010; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Das S, 2008, J NEUROSCI RES, V86, P1199, DOI 10.1002/jnr.21585; Kim H, 2000, FREE RADICAL BIO MED, V29, P674, DOI 10.1016/S0891-5849(00)00368-3; Falluel-Morel A, 2012, J NEUROSCI RES, V90, P743, DOI 10.1002/jnr.22819; Widera D, 2004, EUR J CELL BIOL, V83, P381, DOI 10.1078/0171-9335-00403; Aremu DA, 2008, ENVIRON HEALTH PERSP, V116, P26, DOI 10.1289/ehp.10383; ASCHNER M, 1990, BRAIN RES, V521, P221, DOI 10.1016/0006-8993(90)91546-S; Ballatori N, 1998, ENVIRON HEALTH PERSP, V106, P267, DOI 10.1289/ehp.98106267; Bassett T., 2011, NEUROTOXICOLOGY, V33; Chang JY, 2007, NEUROSCI LETT, V416, P217, DOI 10.1016/j.neulet.2007.01.076; Chang JY, 2011, NEUROSCI LETT, V496, P152, DOI 10.1016/j.neulet.2011.04.004; Chang JY, 2009, NEUROSCI LETT, V461, P85, DOI 10.1016/j.neulet.2009.06.004; Eskes C, 2002, GLIA, V37, P43, DOI 10.1002/glia.10019; Garg TK, 2006, J NEUROIMMUNOL, V171, P17, DOI 10.1016/j.jneuroim.2005.09.007; Ghani S., 2013, MOL MED REPORTS; Godefroy D, 2012, TOXICOL SCI, V125, P209, DOI 10.1093/toxsci/kfr252; GRESSIER B, 1994, METHOD FIND EXP CLIN, V16, P9; Haddad JJ, 2002, CELL SIGNAL, V14, P799; Hwang GW, 2011, J TOXICOL SCI, V36, P389; Kim MS, 2012, J TOXICOL SCI, V37, P1275; Ni MW, 2011, GLIA, V59, P810, DOI 10.1002/glia.21153; Noguchi Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057898; Palacio JR, 2011, INFLAMM RES, V60, P695, DOI 10.1007/s00011-011-0323-8; Shanker G, 2004, MOL BRAIN RES, V128, P48, DOI 10.1016/j.molbrainres.2004.05.022; Shinozaki Y, 2014, SCI REP-UK, V4, DOI 10.1038/srep04329; Takanaga H, 2004, J BIOL CHEM, V279, P15441, DOI 10.1074/jbc.M311844200; UNEP/WHO, 2008, GUID ID POP RISK MER; Verhasselt V, 1999, J IMMUNOL, V162, P2569; Whitney NP, 2009, J NEUROCHEM, V108, P1343, DOI 10.1111/j.1471-4159.2009.05886.x; World Health Organization, 2010, CHILDR EXP MERC COMP; Yamamoto M, 2012, J TOXICOL SCI, V37, P749; Yamamoto M, 2008, J BIOCHEM MOL TOXIC, V22, P136, DOI 10.1002/jbt.20222	42	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0024-3205	1879-0631		LIFE SCI	Life Sci.	AUG 1	2015	134						16	21		10.1016/j.lfs.2015.04.024		6	Medicine, Research & Experimental; Pharmacology & Pharmacy	Research & Experimental Medicine; Pharmacology & Pharmacy	CM9JV	WOS:000358025600003		
J	Anraku, M; Shintomo, R; Taguchi, K; Kragh-Hansen, U; Kai, T; Maruyama, T; Otagiri, M				Anraku, Makoto; Shintomo, Rina; Taguchi, Kazuaki; Kragh-Hansen, Ulrich; Kai, Toshiya; Maruyama, Toru; Otagiri, Masaki			Amino acids of importance for the antioxidant activity of human serum albumin as revealed by recombinant mutants and genetic variants	LIFE SCIENCES			English	Article						Antioxidant; Human serum albumin; Cysteine-34; Methionine; Recombinant mutants; Genetic variants	METHIONINE RESIDUES; OXIDATIVE STRESS; FREE-RADICALS; IN-VITRO; PROTEINS; IDENTIFICATION; PEROXYNITRITE; CLEAVAGE; CYSTEINE; DISEASE	Aims: To determine molecular information about the antioxidant properties of human serum albumin, which is an important extracellular antioxidant. To obtain this information, we studied this function of the protein by using H2O2 as the representative reactive oxygen species and two recombinant mutants and ten genetic variants with single-residue mutations. Main methods: The antioxidant capabilities of the isoforms were registered as their ability to diminish the H2O2-induced conversion of dihydrorhodamine 123 to rhodamine 123, which can emit fluorescence at 536 nm. Structural properties were examined by circular dichroism and SOS-PAGE. Key findings: Cysteine residues are important for the antioxidant function, but their effect depends on their position in the protein, with Cys410 > Cys34 similar to Cys169 (when not involved in forming a disulfide bond). Likewise, the substitution of a glutamic acid at position 122 or 541, but not at 240 or 560, improves the antioxidant effect, perhaps by making the methionine residues in their vicinity, Met123 and Met548, respectively, more accessible for the oxidant A lysine at position 505, but not at 82 or 570, decreases the oxidative effect Finally, the mutations D269G and K276N had no effect In certain cases, albumin acts as a sacrificial antioxidant, as in the case of the mutants 04S and, in particular, R410C and E505K. Significance: The information gained is of protein chemical relevance, but it may also be helpful in understanding the function of proteins that act as antioxidants in biological systems subjected to oxidative stress in conditions such as inflammation and aging. (C) 2015 Elsevier Inc All rights reserved.	[Anraku, Makoto; Taguchi, Kazuaki; Otagiri, Masaki] Sojo Univ, Fac Pharmaceut Sci, Kumamoto 8600082, Japan; [Shintomo, Rina; Maruyama, Toru] Kumamoto Univ, Grad Sch Pharmaceut Sci, Kumamoto 8620973, Japan; [Kragh-Hansen, Ulrich] Univ Aarhus, Dept Biomed, DK-8000 Aarhus C, Denmark; [Kai, Toshiya] Tohoku Nipro Pharmaceut Corp, Fukushima, Japan; [Otagiri, Masaki] Soja Univ, DDS Res Inst, Kumamoto 8600082, Japan	Otagiri, M (reprint author), Sojo Univ, Fac Pharmaceut Sci, Nishi Ku, 4-22-1 Ikeda, Kumamoto 8600082, Japan.	otagirim@ph.sojo-u.ac.jp			JSPS KAKENHI [23790211, 26460248]	This work was partially supported by JSPS KAKENHI Grant Numbers 23790211 and 26460248.	Sugio S, 1999, PROTEIN ENG, V12, P439, DOI 10.1093/protein/12.6.439; Fujino T, 2000, J BIOCHEM-TOKYO, V127, P1087; Iwao Y, 2012, IUBMB LIFE, V64, P450, DOI 10.1002/iub.567; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; NEUZIL J, 1993, BIOCHEM J, V293, P601; FINCH JW, 1993, ARCH BIOCHEM BIOPHYS, V305, P595, DOI 10.1006/abbi.1993.1466; Jones DP, 2006, ANTIOXID REDOX SIGN, V8, P1865, DOI 10.1089/ars.2006.8.1865; CARTER DC, 1994, ADV PROTEIN CHEM, V45, P153; RADI R, 1991, J BIOL CHEM, V266, P4244; Chuang VTG, 2002, PHARMACEUT RES, V19, P569; Anraku M, 2013, BBA-GEN SUBJECTS, V1830, P5465, DOI 10.1016/j.bbagen.2013.04.036; Kragh-Hansen U, 2013, BBA-GEN SUBJECTS, V1830, P5405, DOI 10.1016/j.bbagen.2013.03.026; Roche M, 2008, FEBS LETT, V582, P1783, DOI 10.1016/j.febslet.2008.04.057; HALLIWELL B, 1986, ARCH BIOCHEM BIOPHYS, V246, P501, DOI 10.1016/0003-9861(86)90305-X; Oettl K, 2010, METHOD ENZYMOL, V474, P181, DOI 10.1016/S0076-6879(10)74011-8; Davies MJ, 2005, BBA-PROTEINS PROTEOM, V1703, P93, DOI 10.1016/j.bbapap.2004.08.007; Anraku M, 2001, PHARMACEUT RES, V18, P632, DOI 10.1023/A:1011029226072; Bourdon E, 1999, FASEB J, V13, P233; Bourdon E, 2005, FREE RADICAL RES, V39, P15, DOI 10.1080/10715760400024935; BRENNAN SO, 1993, BIOCHIM BIOPHYS ACTA, V1182, P46, DOI 10.1016/0925-4439(93)90151-P; Buxton C. V., 1988, J PHYS CHEM REF DATA, V17, P513; Chen R.F., 1967, J BIOL CHEM, V242, P173; Fujino K., 2000, J BIOCHEM-TOKYO, V127, P1081; Grippa E, 2000, BBA-GEN SUBJECTS, V1524, P171, DOI 10.1016/S0304-4165(00)00154-9; HALLIWELL B, 1987, FASEB J, V1, P358; HALLIWELL B, 1990, ARCH BIOCHEM BIOPHYS, V280, P1, DOI 10.1016/0003-9861(90)90510-6; Hondal RJ, 1999, ARCH BIOCHEM BIOPHYS, V371, P29, DOI 10.1006/abbi.1999.1435; KRAGHHANSEN U, 1993, ANAL BIOCHEM, V210, P318, DOI 10.1006/abio.1993.1202; Otagiri M., 2013, HUMAN SERUM ALBUMIN; Peters T., 1996, ALL ALBUMIN BIOCH GE; Sies H., 1991, OXIDATIVE STRESS, P3; SORIANI M, 1994, ARCH BIOCHEM BIOPHYS, V312, P180, DOI 10.1006/abbi.1994.1297; SPECTOR A, 1988, J BIOL CHEM, V263, P4984; Watanabe H, 2001, PHARMACEUT RES, V18, P1775, DOI 10.1023/A:1013391001141	34	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0024-3205	1879-0631		LIFE SCI	Life Sci.	AUG 1	2015	134						36	41		10.1016/j.lfs.2015.05.010		6	Medicine, Research & Experimental; Pharmacology & Pharmacy	Research & Experimental Medicine; Pharmacology & Pharmacy	CM9JV	WOS:000358025600006		
J	Akasaki, E; Owada, M; Kamei, A				Akasaki, Eri; Owada, Masaaki; Kamei, Atsushi			Crustal differentiation due to partial melting of granitic rocks in an active continental margin, the Ryoke Belt, Southwest Japan	LITHOS			English	Article						Active continental margin; Ryoke Belt; Southwest Japan; High-K granite; Crustal differentiation	ND ISOTOPE RATIOS; TRACE-ELEMENT; YANAI DISTRICT; GEOCHEMICAL CHARACTERISTICS; PETROGENETIC IMPLICATIONS; PARTITION-COEFFICIENTS; METAMORPHIC BELT; VOLCANIC-ROCKS; SILICIC MAGMAS; DHARWAR CRATON	The continental margin of Pacific Asia is dominated by the voluminous Cretaceous to Paleogene granitic rocks. The Ryoke granitoids that occur in the Ryoke Belt in the Southwest Japan Arc are divided into the older and younger granites. The high-K Kibe Granite represents the younger granitic intrusion and is exposed in the Yanai area in the western part of Ryoke Belt. The Kibe Granite is associated with the coeval Himurodake Quartz Diorite and their intrusive age is 91 Ma. However, the Gamano-Obatake Granodiorite, the older granite, intruded the host Ryoke gneisses at 95 Ma. The Gamano-Obatake Granodiorite is characterized by the localized development of migmatitic structure attributed to the intrusion of the Himurodake Quartz Diorite into the granodiorite. Leucocratic pools and patches occur in the granodiorite in the vicinity of the quartz diorite. The Sr and Nd isotopic compositions of the Gamano-Obatake Granodiorite corrected to 91 Ma are plotted within those of the Kibe Granite. Geochemical modeling suggests that partial melting took place in the Gamano-Obatake Granodiorite and resulted in the formation of the Kibe Granite magma. The Himurodake Quartz Diorite is believed to be a heat source for this event. This can be considered as an essential process for the formation of the evolved younger Ryoke granite and for the crustal differentiation in the active continental margin. (C) 2015 Elsevier B.V. All rights reserved.	[Akasaki, Eri; Owada, Masaaki] Yamaguchi Univ, Dept Earth Sci, Yamaguchi 7538512, Japan; [Kamei, Atsushi] Shimane Univ, Dept Geosci, Matsue, Shimane 6908504, Japan	Owada, M (reprint author), Yamaguchi Univ, Dept Earth Sci, 1677-1 Yoshida, Yamaguchi 7538512, Japan.	owada@sci.yamaguchi-u.ac.jp			Japan Society for the Promotion of Science [23540559, 23540534]	We wish to thank T. Imaoka for many supports of isotopic analysis and discussions. Thanks go to K. Tanaka, T. Abe and K. Kawamura for helpful discussion and advice. Thanks are due to T. Kawakami and an anonymous reviewer for their critical reviews and many constructive comments, and also go to S.L. Chung (Editor-in-Chief) for useful comments and editorial handling. This work was supported by the Grant-in-Aid for Scientific Research provided by Japan Society for the Promotion of Science (23540559: M. Owada, 23540534: A. Kamei).	Akasaki E., 2013, JAPANESE MAGAZINE MI, V42, P159; BEARD JS, 1991, J PETROL, V32, P365; ARTH JG, 1976, J RES US GEOL SURV, V4, P41; Jahn BM, 2004, J ASIAN EARTH SCI, V23, P629, DOI 10.1016/S1367-9120(03)00125-1; CONRAD WK, 1988, J PETROL, V29, P765; Karsli O, 2010, CONTRIB MINERAL PETR, V160, P467, DOI 10.1007/s00410-010-0489-z; PEARCE JA, 1979, CONTRIB MINERAL PETR, V69, P33, DOI 10.1007/BF00375192; Kamei A, 2004, J ASIAN EARTH SCI, V24, P43, DOI 10.1016/j.jseaes.2003.07.001; PEARCE JA, 1984, J PETROL, V25, P956; STEIGER RH, 1977, EARTH PLANET SC LETT, V36, P359, DOI 10.1016/0012-821X(77)90060-7; MARTIN H, 1987, J PETROL, V28, P921; DEPAOLO DJ, 1981, EARTH PLANET SC LETT, V53, P189, DOI 10.1016/0012-821X(81)90153-9; Nakajima T, 1996, T ROY SOC EDIN-EARTH, V87, P183; Kananian A, 2014, J ASIAN EARTH SCI, V90, P137, DOI 10.1016/j.jseaes.2014.04.026; GROMET LP, 1987, J PETROL, V28, P75; Lopez S, 2006, CURR SCI INDIA, V91, P607; Moyen JF, 2003, PRECAMBRIAN RES, V127, P103, DOI 10.1016/S0301-9268(03)00183-9; Jayananda M, 2006, PRECAMBRIAN RES, V150, P1, DOI 10.1016/j.precamres.2006.05.004; Ikeda T, 2004, CONTRIB MINERAL PETR, V146, P577, DOI 10.1007/s00410-003-0521-7; LUGMAIR GW, 1978, EARTH PLANET SC LETT, V39, P349, DOI 10.1016/0012-821X(78)90021-3; Suzuki K, 1998, J METAMORPH GEOL, V16, P23, DOI 10.1111/j.1525-1314.1998.00057.x; Borg LE, 1998, J PETROL, V39, P1197, DOI 10.1093/petrology/39.6.1197; BEA F, 1994, CHEM GEOL, V117, P291, DOI 10.1016/0009-2541(94)90133-3; KAGAMI H, 1992, CONTRIB MINERAL PETR, V112, P165, DOI 10.1007/BF00310452; PECCERILLO A, 1976, CONTRIB MINERAL PETR, V58, P63, DOI 10.1007/BF00384745; NASH WP, 1985, GEOCHIM COSMOCHIM AC, V49, P2309, DOI 10.1016/0016-7037(85)90231-5; Tanaka T, 2000, CHEM GEOL, V168, P279, DOI 10.1016/S0009-2541(00)00198-4; JAHN BM, 1990, TECTONOPHYSICS, V183, P145; Druppel K, 2009, LITHOS, V111, P203, DOI 10.1016/j.lithos.2009.04.007; Gill JB, 1981, OROGENIC ANDESITES P; HANSON GN, 1978, EARTH PLANET SC LETT, V38, P26, DOI 10.1016/0012-821X(78)90124-3; Higashimoto S., 1983, GEOLOGY IWAKUNI DIST, V79; IIZUMI S, 1996, GEOSCIENCE REPORT SH, V15, P153; Ikeda T, 2002, ISL ARC, V11, P185, DOI 10.1046/j.1440-1738.2002.00364.x; Ikeda T, 1998, J METAMORPH GEOL, V16, P39, DOI 10.1111/j.1525-1314.1998.00060.x; Ishihara S., 1971, J GEOL SOC JAPAN, V77, P441; Johannes W, 1996, PETROGENESIS EXPT PE; Kagami H., 1987, TECHNICAL REP ISEI B, V4, P1; Kagami H., 1999, MEMOIRS GEOLOGICAL S, V53, P1; Kamei A, 2002, GONDWANA RES, V5, P813, DOI 10.1016/S1342-937X(05)70915-1; Kamitomo I., 2008, J GEOLOGICAL SOC JAP, V114, P88; Koide H., 1958, DANDO GRANODIORITIC; Kutsukake T., 1997, J MINERAL PETROL EC, V92, P231, DOI 10.2465/ganko.92.231; Kutsukake T, 2002, GONDWANA RES, V5, P355, DOI 10.1016/S1342-937X(05)70728-0; Miyashiro A., 1973, METAMORPHISM METAMOR; Miyazaki T, 1998, GEOCHEM J, V32, P345; Moutte J., 1990, GEOCHEMICAL STUDY CR, P49; Moutte J., 1984, MINING GEOLOGY, V34, P425; Okamura Y., 1957, J GEOL SOC JAPAN, V63, P684; Okano O., 1983, MAGMA, V67, P123; Okudaira T., 1993, MEMOIRS GEOLOGICAL S, V42, P91; Okudaira T, 2001, ISL ARC, V10, P98, DOI 10.1046/j.1440-1738.2001.00312.x; Rollinson H., 1993, USING GEOCHEMICAL DA; SISSON TW, 1991, GEOCHIM COSMOCHIM AC, V55, P1575, DOI 10.1016/0016-7037(91)90129-S; Sun S. S., 1989, MAGMATISM OCEAN BASI, V42, P313, DOI DOI 10.1144/GSL.SP.1989.042.01.19; Suzuki K., 1996, ISL ARC, V5, P43, DOI 10.1111/j.1440-1738.1996.tb00011.x; Takahashi M., 1983, ACCRETION TECTONICS, P69; Taylor S., 1985, CONTINENTAL CRUST IT; WEDEPOHL KH, 1995, GEOCHIM COSMOCHIM AC, V59, P1217; WEDEPOHL KH, 1991, GEOL RUNDSCH, V80, P207, DOI 10.1007/BF01829361; Yamasaki T., 1999, MAJOR TRACE ELEMENT, V7, P22; Yuhara M., 1998, B GEOLOGICAL SURVEY, V49, P477; Yuhara M., 1995, J GEOLOGICAL SOC JAP, V101, P434; Yuhara M., 1994, J MINERALOGY PETROLO, V89, P269; Yuhara M., 1999, J GEOLOGICAL SOC JAP, V105, P181	65	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0024-4937	1872-6143		LITHOS	Lithos	AUG 1	2015	230						82	91		10.1016/j.lithos.2015.04.021		10	Geochemistry & Geophysics; Mineralogy	Geochemistry & Geophysics; Mineralogy	CM6ZA	WOS:000357839000006		
J	Deng, JH; Yang, XY; Zhang, ZF; Santosh, M				Deng, Jianghong; Yang, Xiaoyong; Zhang, Zhao-Feng; Santosh, M.			Early Cretaceous arc volcanic suite in Cebu Island, Central Philippines and its implications on paleo-Pacific plate subduction: Constraints from geochemistry, zircon U-Pb geochronology and Lu-Hf isotopes	LITHOS			English	Article						Geochemistry; Zircon U-Pb geochronology and Hf isotopes; Island arc volcanics; West Philippine Basin; Pacific plate subduction	SOUTHEAST BOHOL OPHIOLITE; STRENGTH ELEMENT ENRICHMENT; SEA PLATE; TECTONIC EVOLUTION; CONTINENTAL-CRUST; TRACE-ELEMENTS; EASTERN INDONESIA; NORTHERN LUZON; MANTLE SOURCES; OCEANIC-CRUST	The Philippine island arc system is a collage of amalgamated terranes of oceanic, continental and island arc affinities. Here we investigate a volcanic suite in Cebu Island of central Philippines, including basalt, diabase dike, basaltic pyroclastic rock and porphyritic andesite. LA-ICP-MS U-Pb geochronology of zircon grains from the porphyritic andesite and pyroclastic rock yielded ages of 126 +/- 3 Ma and 119 +/- 2 Ma, respectively, indicating an Early Cretaceous age. The age distribution of the detrital zircons from river sand in the area displays a peak at ca. 118 Ma, close to the age of the pyrodastic rock. The early Cretaceous volcanic rocks in the central Philippines were previously regarded as parts of ophiolite complexes by most investigators, whereas the Cebu volcanics are distinct from these, and display calc-alkaline affinity and island arc setting, characterized by high LREE/HREE ratios and low HFSE contents. These features are similar to the Early Cretaceous arc basalts in the Amami Plateau and east Halmahera in the northernmost and southernmost West Philippine Basin respectively. Zircon Hf isotopes of the pyroclastic rocks show depleted nature similar to those of the Amami Plateau basalts, implying the subducted Pacific-type MORB as probable source. Zircon Hf isotopes of the porphyritic andesite show slight enrichment relative to that of the pyroclastic rocks and MORB, indicating subducted sediments as a minor endmember in the source. The Hf isotopic compositions of the volcanic rocks are also reflected in the detrital zircons from the river sands. We propose that the volcanic rocks of Cebu Island were derived from partial melting of subarc mantle wedge which was metasomatized by dehydration of subducted oceanic crust together with minor pelagic sediments. Within the tectonic environment of Southeast Asia during Early Cretaceous, the volcanic rocks in Cebu Island can be correlated to the subduction of paleo-Pacific plate. The Early Cretaceous volcanic suites in Cebu Island along with the Early Cretaceous arc volcanic rocks, ophiolites and boninites in the southern-western-northern margin of West Philippine Basin are inferred to have formed within single subduction zone before the opening of the Philippine Sea Plate. (C) 2015 Elsevier B.V. All rights reserved.	[Deng, Jianghong; Yang, Xiaoyong] Univ Sci & Technol China, CAS Key Lab Crust Mantle Mat & Environm, Hefei 230026, Peoples R China; [Zhang, Zhao-Feng] Chinese Acad Sci, Guangzhou Inst Geochem, State Key Lab Isotope Geochem, Guangzhou 510640, Guangdong, Peoples R China; [Santosh, M.] China Univ Geosci, Sch Earth Sci & Resources, Beijing 100083, Peoples R China; [Santosh, M.] Kochi Univ, Div Interdisciplinary Sci, Fac Sci, Kochi 7808520, Japan	Yang, XY (reprint author), Univ Sci & Technol China, CAS Key Lab Crust Mantle Mat & Environm, Hefei 230026, Peoples R China.	xyyang555@163.com			National Natural Science Foundation of China [41090372, 41373007]	This study is supported by the National Natural Science Foundation of China (Nos. 41090372 and 41373007). We thank two anonymous reviewers for constructive comments and suggestions. We thank Xiaodong Lai, Xiandong Luo and Xianghua Lan for the help of field sampling in the Philippines. We also thank Abdul Shakoor Mastoi for help. Prof. Weidong Sun is acknowledged for his guidance.	Hall R, 2002, J ASIAN EARTH SCI, V20, P353, DOI 10.1016/S1367-9120(01)00069-4; Stern CR, 2011, GONDWANA RES, V20, P284, DOI 10.1016/j.gr.2011.03.006; MCCABE R, 1987, J GEOPHYS RES-SOLID, V92, P555, DOI 10.1029/JB092iB01p00555; Praveen MN, 2014, GONDWANA RES, V26, P907, DOI 10.1016/j.gr.2013.08.004; Hickey-Vargas R, 2008, EARTH PLANET SC LETT, V268, P255, DOI 10.1016/j.epsl.2008.01.003; Manikyamba C, 2014, PRECAMBRIAN RES, V252, P1, DOI 10.1016/j.precamres.2014.06.014; MCCULLOCH MT, 1991, EARTH PLANET SC LETT, V102, P358, DOI 10.1016/0012-821X(91)90029-H; DEWEY JF, 1971, J GEOPHYS RES, V76, P3179, DOI 10.1029/JB076i014p03179; Gao J, 2007, GEOCHIM COSMOCHIM AC, V71, P4974, DOI 10.1016/j.gca.2007.07.027; Hastie AR, 2007, J PETROL, V48, P2341, DOI 10.1093/petrology/egm062; Metcalfe I, 2011, GONDWANA RES, V19, P3, DOI 10.1016/j.gr.2010.02.016; Hall R, 1995, TECTONOPHYSICS, V251, P229, DOI 10.1016/0040-1951(95)00038-0; Tatsumi Y, 1997, EARTH PLANET SC LETT, V148, P207, DOI 10.1016/S0012-821X(97)00019-8; Yumul GP, 1997, OFIOLITI, V22, P47; Aurelio MA, 2013, J ASIAN EARTH SCI, V72, P102, DOI 10.1016/j.jseaes.2012.10.007; Lister G, 2009, LITHOS, V113, P274, DOI 10.1016/j.lithos.2008.10.024; MONNIER C, 1995, GEOLOGY, V23, P851, DOI 10.1130/0091-7613(1995)023<0851:BABOFT>2.3.CO;2; Wang FY, 2013, LITHOS, V156, P97, DOI 10.1016/j.lithos.2012.10.017; Sun WD, 2007, EARTH PLANET SC LETT, V262, P533, DOI 10.1016/j.epsl.2007.08.021; FAURE M, 1989, TECTONICS, V8, P963, DOI 10.1029/TC008i005p00963; Kenji Kawai, 2013, [Geoscience Frontiers, 地学前缘], V4, P1; Plank T, 1998, CHEM GEOL, V145, P325, DOI 10.1016/S0009-2541(97)00150-2; Walia M, 2012, J ASIAN EARTH SCI, V52, P134, DOI 10.1016/j.jseaes.2012.03.005; SUN SS, 1979, EARTH PLANET SC LETT, V44, P119, DOI 10.1016/0012-821X(79)90013-X; Hawkesworth CJ, 1997, SCIENCE, V276, P551, DOI 10.1126/science.276.5312.551; Hall R, 2012, TECTONOPHYSICS, V570, P1, DOI 10.1016/j.tecto.2012.04.021; Foley S, 2002, NATURE, V417, P837, DOI 10.1038/nature00799; Yumul GP, 2007, ISL ARC, V16, P306, DOI 10.1111/j.1440-1738.2007.00573.x; PERFIT MR, 1980, CHEM GEOL, V30, P227, DOI 10.1016/0009-2541(80)90107-2; Pubellier M, 2004, TECTONOPHYSICS, V392, P9, DOI 10.1016/j.tecto.2004.04.028; Ishizuka O, 2011, GEOCHEM GEOPHY GEOSY, V12, DOI 10.1029/2010GC003440; Sun WD, 2012, J GEOL, V120, P105, DOI 10.1086/662736; Maruyama S, 1997, ISL ARC, V6, P121, DOI 10.1111/j.1440-1738.1997.tb00043.x; GREEN TH, 1987, GEOCHIM COSMOCHIM AC, V51, P55, DOI 10.1016/0016-7037(87)90006-8; Scambelluri M, 2001, EARTH PLANET SC LETT, V192, P457, DOI 10.1016/S0012-821X(01)00457-5; Metcalfe I, 2006, GONDWANA RES, V9, P24, DOI 10.1016/j.gr.2005.04.002; Schmidt MW, 2004, EARTH PLANET SC LETT, V226, P415, DOI 10.1016/j.epsl.2004.08.010; KARIG DE, 1983, TECTONICS, V2, P211, DOI 10.1029/TC002i002p00211; Sajona FG, 1996, J PETROL, V37, P693, DOI 10.1093/petrology/37.3.693; Hickey-Vargas R, 2005, ISL ARC, V14, P653, DOI 10.1111/j.1440-1738.2005.00474.x; Xiao YL, 2006, GEOCHIM COSMOCHIM AC, V70, P4770, DOI 10.1016/j.gca.2006.07.010; Castillo PR, 2007, LITHOS, V97, P271, DOI 10.1016/j.lithos.2006.12.012; Ozawa A, 2004, J ASIAN EARTH SCI, V23, P105, DOI 10.1016/S1367-9120(03)00112-3; Deschamps A, 2000, EARTH PLANET SC LETT, V179, P503, DOI 10.1016/S0012-821X(00)00136-9; Castillo PR, 1999, CONTRIB MINERAL PETR, V134, P33, DOI 10.1007/s004100050467; Woodhead JD, 1998, J PETROL, V39, P1641, DOI 10.1093/petrology/39.9.1641; Tatsumi Y, 2009, J PETROL, V50, P1575, DOI 10.1093/petrology/egp044; Zhou D, 2008, ISL ARC, V17, P186, DOI 10.1111/j.1440-1738.2008.00611.x; Foley SF, 2000, GEOCHIM COSMOCHIM AC, V64, P933, DOI 10.1016/S0016-7037(99)00355-5; Deschamps A, 2002, J GEOPHYS RES-SOL EA, V107, DOI 10.1029/2001JB001706; Chauvel C, 2009, GEOCHEM GEOPHY GEOSY, V10, DOI 10.1029/2008GC002101; Yumul GP, 2008, GEOSCI J, V12, P7, DOI 10.1007/s12303-008-0002-0; PECCERILLO A, 1976, CONTRIB MINERAL PETR, V58, P63, DOI 10.1007/BF00384745; Woodhead JD, 2001, EARTH PLANET SC LETT, V192, P331, DOI 10.1016/S0012-821X(01)00453-8; Tatsumi Y, 2001, GEOLOGY, V29, P323, DOI 10.1130/0091-7613(2001)029<0323:GMOPMO>2.0.CO;2; VENTURELLI G, 1984, CONTRIB MINERAL PETR, V86, P209, DOI 10.1007/BF00373666; Xiong XL, 2005, CHEM GEOL, V218, P339, DOI 10.1016/j.chemgeo.2005.01.014; Davidson J, 2013, J PETROL, V54, P525, DOI 10.1093/petrology/egs076; Santosh M, 2010, J GEODYN, V50, P116, DOI 10.1016/j.jog.2010.04.002; Dimalanta CB, 2006, GEOSCI J, V10, P305, DOI 10.1007/BF02910372; Cawood PA, 2009, GEOL SOC SPEC PUBL, V318, P1, DOI 10.1144/SP318.1; Lagabrielle Y, 2000, TECTONOPHYSICS, V326, P255, DOI 10.1016/S0040-1951(00)00124-4; Aurelio MA, 2000, ISL ARC, V9, P584, DOI 10.1046/j.1440-1738.2000.00304.x; Aurelio M.A., 2002, GEOLOGY MINERAL RESO, V1, P391; BALLANTYNE P., 1992, GEOL SOC LOND SPEC P, V60, P179, DOI DOI 10.1144/GSL.SP.1992.060.01.11; Ballantyne P., 1991, J SE ASIAN EARTH SCI, V6, P259, DOI 10.1016/0743-9547(91)90072-6; Bence A., 1979, DEEP DRILLING RESULT; Castillo PR, 2004, J PETROL, V45, P1089, DOI 10.1093/petrology/egh005; COCHERIE A, 1986, GEOCHIM COSMOCHIM AC, V50, P2517, DOI 10.1016/0016-7037(86)90034-7; Coleman R. G., 1977, OPHIOLITES, P220; DAVIES JH, 1992, J GEOPHYS RES-SOL EA, V97, P2037, DOI 10.1029/91JB02571; Diegor W.G., 1996, J GEOL SOC PHIL, V51, P48; Dilek Y., 2003, GEOLOGICAL SOC LONDO, V218; Ding X, 2007, GEOCHIM COSMOCHIM AC, V71, pA226; Faustino DV, 2006, GEOSCI J, V10, P291, DOI 10.1007/BF02910371; GEARY EE, 1989, TECTONOPHYSICS, V168, P109, DOI 10.1016/0040-1951(89)90371-5; Hall R, 2001, FAUNAL AND FLORAL MIGRATIONS AND EVOLUTION IN SE ASIA-AUSTRALASIA, P35; Hall R., 2009, P IND PETR ASS 33 AN, P1; HAWKESWORTH C, 1989, GEOLOGY, V17, P46, DOI 10.1130/0091-7613(1989)017<0046:CFAWRR>2.3.CO;2; Jego S, 2005, RESOUR GEOL, V55, P163, DOI 10.1111/j.1751-3928.2005.tb00239.x; Kerntke M., 1991, MITTEILUNGEN GEOLOGI, V71, P93; lonov D.A., 1995, EARTH PLANET SC LETT, V131, P341; MARCHADIER Y, 1990, TECTONOPHYSICS, V183, P273, DOI 10.1016/0040-1951(90)90421-4; Maruyama S., 1989, OXFORD MONOGR GEOL G, V8, P75; Maury RC, 1998, B SOC GEOL FR, V169, P69; Middlemost EAK, 1985, MAGMAS MAGMATIC ROCK, P1; Mitchell A.G.H., 1986, J SE ASIAN EARTH SCI, V1, P2; Pearce J.A, 1982, ANDESITES, P525; Polve M, 2007, RESOUR GEOL, V57, P197, DOI 10.1111/j.1751-3928.2007.00017.x; Pubellier M, 2003, TECTONOPHYSICS, V363, P181, DOI 10.1016/S0040-1951(02)00671-6; Rangin C, 1999, GEOPHYS J INT, V139, P296, DOI 10.1046/j.1365-246x.1999.00969.x; RANGIN C, 1990, B SOC GEOL FR, V6, P889; Sajona FG, 1997, J ASIAN EARTH SCI, V15, P121; Suerte LO, 2005, RESOUR GEOL, V55, P207, DOI 10.1111/j.1751-3928.2005.tb00242.x; Sun S. S., 1989, MAGMATISM OCEAN BASI, V42, P313, DOI DOI 10.1144/GSL.SP.1989.042.01.19; Tamayo RA, 2004, B SOC GEOL FR, V175, P443, DOI 10.2113/175.5.443; Tamayo RA, 2001, RESOUR GEOL, V51, P145, DOI 10.1111/j.1751-3928.2001.tb00088.x; TATSUMI Y., 2003, GEOLOGICAL SOC LONDO, V219, P55, DOI 10.1144/GSL.SP.2003.219.01.03; Tatsumi Y., 1995, SUBDUCTION ZONE MAGM, VBlackwell; Vervoort JD, 2002, GEOCHIM COSMOCHIM AC, V66, pA806; Walia M, 2013, TECTONOPHYSICS, V582, P205, DOI 10.1016/j.tecto.2012.10.002; Walther H.W., 1981, GEOL JB D, V48, P21; Yang Q. Y., 2014, GONDWANA RES; Yumul GP, 2003, J ASIAN EARTH SCI, V21, P957, DOI 10.1016/S1367-9120(02)00086-X; Yumul GP, 2013, J ASIAN EARTH SCI, V65, P53, DOI 10.1016/j.jseaes.2012.08.017; Yumul GP, 2001, INT GEOL REV, V43, P850; Yumul GP, 2000, ISL ARC, V9, P499, DOI 10.1046/j.1440-1738.2000.00297.x; Yumul GP, 2000, ISL ARC, V9, P627, DOI 10.1046/j.1440-1738.2000.00307.x	108	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0024-4937	1872-6143		LITHOS	Lithos	AUG 1	2015	230						166	179		10.1016/j.lithos.2015.05.020		14	Geochemistry & Geophysics; Mineralogy	Geochemistry & Geophysics; Mineralogy	CM6ZA	WOS:000357839000012		
J	Bromiley, P; McShane, M; Nair, A; Rustambekov, E				Bromiley, Philip; McShane, Michael; Nair, Anil; Rustambekov, Elzotbek			Enterprise Risk Management: Review, Critique, and Research Directions	LONG RANGE PLANNING			English	Review							DECISION-MAKING; COGNITIVE PERSPECTIVE; TEMPORAL ORIENTATION; FIRM RISK; OVERCONFIDENCE; PERFORMANCE; INVESTMENTS; PERCEPTIONS; GOVERNANCE; EXECUTIVES	Many regulators, rating agencies, executives and academics have advocated a new approach to risk management: Enterprise Risk Management (ERM). ERM proposes the integrated management of all the risks an organization faces, which inherently requires alignment of risk management with corporate governance and strategy. Academic research on ERM is still in its infancy, with articles largely in accounting and finance journals but rarely in management journals. We argue that ERM offers an important new research domain for management scholars. A critical review of ERM research allows us to identify limitations and gaps that management scholars are best equipped to address. This paper not only identifies how management scholars can contribute to ERM research, but also points out why ERM research (and practice) needs management research for its development. (C) 2014 Elsevier Ltd. All rights reserved.	[McShane, Michael] Hewlett Packard Corp, Semicond Test Equipment Facility, Tokyo, Japan; [McShane, Michael] ODU, Emergent Risk Initiat, Norfolk, VA USA; [McShane, Michael] ODU, Insurance & Financial Serv Ctr, Norfolk, VA USA; [Rustambekov, Elzotbek] Bryant Univ, Smithfield, RI USA		bromiley@uci.edu; mmcshane@odu.edu; anair@odu.edu; erustambekov@bryant.edu					Adam A., 2009, J MANAGEMENT GOVERNA, V13, P281, DOI 10.1007/s10997-008-9076-3; Andersen TJ, 2008, LONG RANGE PLANN, V41, P155, DOI 10.1016/j.lrp.2008.01.002; Andersen Torben Juul, 2009, Journal of Strategy and Management, V2, DOI 10.1108/17554250911003845; REGER RK, 1993, STRATEGIC MANAGE J, V14, P103, DOI 10.1002/smj.4250140203; Carpenter MA, 2003, STRATEGIC MANAGE J, V24, P803, DOI 10.1002/smj.338; Pagach D, 2011, J RISK INSUR, V78, P185, DOI 10.1111/j.1539-6975.2010.01378.x; Wright P, 2007, STRATEGIC MANAGE J, V28, P81, DOI 10.1002/smj.548; [Anonymous], 2010, 31000 ISO; Brown I, 2009, CORP GOV, V17, P546, DOI 10.1111/j.1467-8683.2009.00763.x; Godfrey PC, 2009, STRATEG MANAGE J, V30, P425, DOI 10.1002/smj.750; Quinn JB, 1999, SLOAN MANAGE REV, V40, P9; Marginson D, 2008, STRATEG MANAGE J, V29, P273, DOI 10.1002/smj.657; RUSSO JE, 1992, SLOAN MANAGE REV, V33, P7; Plambeck N, 2010, STRATEGIC MANAGE J, V31, P689, DOI 10.1002/smj.835; MARCH JG, 1987, MANAGE SCI, V33, P1404, DOI 10.1287/mnsc.33.11.1404; Klayman J, 1999, ORGAN BEHAV HUM DEC, V79, P216, DOI 10.1006/obhd.1999.2847; LINTNER J, 1965, REV ECON STAT, V47, P13, DOI 10.2307/1924119; Mikes A, 2009, MANAGE ACCOUNT RES, V20, P18, DOI 10.1016/j.mar.2008.10.005; McNamara G, 1999, ACAD MANAGE J, V42, P330, DOI 10.2307/256923; Dickinson G, 2001, GENEVA PAP R I-ISS P, V26, P360, DOI 10.1111/1468-0440.00121; Gordon LA, 2009, J ACCOUNT PUBLIC POL, V28, P301, DOI 10.1016/j.jaccpubpol.2009.06.006; BARR PS, 1992, STRATEGIC MANAGE J, V13, P15, DOI 10.1002/smj.4250131004; Hoyt RE, 2011, J RISK INSUR, V78, P795, DOI 10.1111/j.1539-6975.2011.01413.x; Miller KD, 2003, LONG RANGE PLANN, V36, P93, DOI 10.1016/S0024-6301(02)00205-4; Westphal JD, 1999, ACAD MANAGE J, V42, P7, DOI 10.2307/256871; JACKSON SE, 1988, ADMIN SCI QUART, V33, P370, DOI 10.2307/2392714; Devers CE, 2008, ORGAN SCI, V19, P548, DOI 10.1287/orsc.1070.0317; Schrand C, 1998, J FINANC, V53, P979, DOI 10.1111/0022-1082.00041; Miller KD, 1998, STRATEGIC MANAGE J, V19, P497, DOI 10.1002/(SICI)1097-0266(199805)19:5<497::AID-SMJ958>3.0.CO;2-M; Arena M, 2010, ACCOUNT ORG SOC, V35, P659, DOI 10.1016/j.aos.2010.07.003; Argyris Chris, 1993, KNOWLEDGE ACTION GUI; AS/NZS, 1995, 4360 ASNZS; Banham R., 1999, CFO MAGAZINE     APR; Bannister J. E., 1981, PRACTICAL RISK MANAG; Barley S.R., 1995, CULTURE; Barr G. D., 1988, J BUSINESS FINANCE A, V15, P437, DOI 10.1111/j.1468-5957.1988.tb00146.x; Barrieu P., 2004, MATH FIN P AMS IMS S; Beasley M., 2005, J ACCOUNTING PUBLIC, V24, P521, DOI DOI 10.1016/J.JACCPUBPOL.2005.10.001; Beasley M.S., 2008, J ACCOUNTING AUDITIN, V23, P311; BETTIS RA, 1983, ACAD MANAGE REV, V8, P406; Bromiley P., 2001, BLACKWELL HDB STRATE, P259; Bromiley P., 2010, AM PSYCHOL ASS HDB I, P161; Brooks D. W., 2010, ROBERT W KOLB SERIES, P87; Buchanan L., 2004, HARVARD BUS REV, V2, P13; CAS, 2003, OV ENT RISK MAN; Checkley MS, 2009, LONG RANGE PLANN, V42, P341, DOI 10.1016/j.lrp.2009.06.001; Colquitt L.L., 1999, RISK MANAGEMENT INSU, V2, P43, DOI DOI 10.1111/J.1540-6296.1999.TB00003.X; COSO, 2004, ENT RISK MAN FRAM; Croddord N., 1980, INTRO RISK MANAGEMEN; CUMMINGS LL, 1971, ACAD MANAGE J, V14, P285, DOI 10.2307/255074; D'arcy S. P., 2001, J RISK MANAGEMENT KO, V12, P207; DAS TK, 1987, STRATEGIC MANAGE J, V8, P203, DOI 10.1002/smj.4250080211; Deaves R, 2010, J ECON BEHAV ORGAN, V75, P402, DOI 10.1016/j.jebo.2010.05.001; Decagon J., 2000, OLD KNOWLEDGE NEW NA; Deloach J., 2000, FINANCIAL TIMES; Doherty N. A., 2000, INTEGRATED RISK MANA; Freeman RE, 2011, STAKEHOLDER THEORY: IMPACT AND PROSPECTS, P212; Esser JK, 1998, ORGAN BEHAV HUM DEC, V73, P116, DOI 10.1006/obhd.1998.2758; Fraser J., 1987, ROBERT W KOLD SERIES; Fraser J., 2010, ROBERT W KOLD SERIES, P399; Haimes Y. Y., 1992, GENEVA PAP RISK INS, V17, P314; Harrington S. E., 2002, J APPL CORPORATE FIN, V14, P71, DOI 10.1111/j.1745-6622.2002.tb00450.x; Holton G. A., 1996, CLOSED VALUE RISK CO; IIA, 2001, RISK OPP CHOIC IS YO; Isaksson M., 2009, MOVING CLOSER ACTION, P11; Kaplan R. S., 2013, 13063 HARV BUS SCH; Kleffner A. E., 2003, RISK MANAGEMENT INSU, V6, P53, DOI 10.1111/1098-1616.00020; Kloman H. F., 1992, GENEVA PAP RISK INS, V17, P299; Kloman H. F., 1976, FORTUNE MAGAZINE JUL; Lichtenstein S., 1986, FACTS VERSUS FEARS U; Lichtenstein S., 1982, JUDGEMENT UNCERTAINT; Liebenberg A.P., 2003, RISK MANAGEMENT INSU, V6, P37, DOI DOI 10.1111/1098-1616.00019; MacCrimmon K., 1986, MANAGEMENT UNCERTAIN; March James, 1958, ORGANIZATIONS; MCEWEN N, 1988, LONG RANGE PLANN, V21, P71, DOI 10.1016/0024-6301(88)90161-6; McNamara G, 1997, ACAD MANAGE J, V40, P1063, DOI 10.2307/256927; McNamara GM, 2002, STRATEGIC MANAGE J, V23, P153, DOI 10.1002/smj.211; Mcshane M. K., 2012, J INSURANCE ISSUES, P73; McShane M. K., 2011, J ACCOUNTING AUDITIN, V26, P641; Meulbroek L. K., 2002, INTEGRATED RISK MANA; Meulbroek L.K., 2002, J APPL CORPORATE FIN, V14, P56, DOI 10.1111/j.1745-6622.2002.tb00449.x; Miccolis J., 2000, ENTERPRISE RISK MANA; Mikes A., 2005, ENTERPRISE RISK MANA; MILLER KD, 1993, J INT BUS STUD, V24, P693, DOI 10.1057/palgrave.jibs.8490251; MILLER KD, 1992, J INT BUS STUD, V23, P311, DOI 10.1057/palgrave.jibs.8490270; Perrin T.-T., 2001, CREATING VALUE ENTER; Power M, 2004, RISK MANAGEMENT EVER; Power M, 2007, ORG UNCERTAINTY DESI; Power M, 2009, ACCOUNT ORG SOC, V34, P849, DOI 10.1016/j.aos.2009.06.001; PRUITT DG, 1969, J EXP SOC PSYCHOL, V5, P115, DOI 10.1016/0022-1031(69)90041-9; Raiffa H., 1982, JUDGMENT UNCERTAINTY, P294; RIMS, 2011, FAQ SRM ERM WHY STRA; Rousseau D. M., 1985, RES ORGAN BEHAV, V7, P1; S&P, 2008, STAND POORS APPL ENT; Saffold III G. S., 1988, ACAD MANAGE REV, V13, P546, DOI DOI 10.2307/258374; Salter M., 1979, DIVERSIFICATION ACQU; SCHWENK CR, 1988, J MANAGE STUD, V25, P41, DOI 10.1111/j.1467-6486.1988.tb00021.x; Seligman M., 1998, LEARNED OPTIMISM CHA; Shapiro A. C., 1986, INTEGRATED APPROACH; SHARPE WF, 1964, J FINANC, V19, P425, DOI 10.2307/2977928; Simon HA, 1981, SCI ARTIFICIAL; Sobel P. J., 2004, MANAGEMENT ACCOUNTIN, V5, P29; Souder D, 2012, STRATEGIC MANAGE J, V33, P550, DOI 10.1002/smj.970; Stutz R. M., 1996, J APPL CORPORATE FIN, V9, P8; SUTCLIFFE KM, 1994, ACAD MANAGE J, V37, P1360, DOI 10.2307/256677; Tidd J., 2005, MANAGING INNOVATION; Van de Ven A. H., 2007, ENGAGED SCHOLARSHIP; Verbrugge J., 2003, J APPL CORPORATE FIN, V15, P8; Walker P. L., 2002, MAKING ENTERPRISE RI; Weick K., 1969, HDB SOCIAL PSYCHOL R, V357; Weick K.E., 1968, HDB SOCIAL PSYCHOL, V2, P357	111	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0024-6301	1873-1872		LONG RANGE PLANN	Long Range Plan.	AUG	2015	48	4					265	276		10.1016/j.lrp.2014.07.005		12	Business; Management; Planning & Development	Business & Economics; Public Administration	CM7WF	WOS:000357906500003		
J	Takiwatari, K; Nanao, H; Hoshi, Y; Mori, S				Takiwatari, Koji; Nanao, Hidetaka; Hoshi, Yasushi; Mori, Shigeyuki			Molecular interaction originating from polar functional group in lubricants and its relationship with their traction property under elastohydrodynamic lubrication	LUBRICATION SCIENCE			English	Article						elastohydrodynamic lubrication; in situ observation; FTIR; hydrogen bond; traction coefficient; polar functional group	HIGH-PRESSURE; IN-SITU; SPECTROSCOPY; CONTACT; OILS; TEMPERATURE; DEPENDENCE; SHEAR; RAMAN; FTIR	The correlation between molecular interaction and traction properties was investigated using a traction tester and in situ observation of elastohydrodynamic lubrication film with a micro-Fourier transform infrared spectrometer. The sample oils used were polypropylene glycols (PPGs) with the end-group of alcohol or ether and a synthetic hydrocarbon oil, poly--olefin. From the traction tests, it was found that the traction coefficient of PPG was sensitive to the end-group. PPG with alcohol as the end-group showed a higher traction coefficient than that with the ether group. In situ observation with a micro-Fourier transform infrared was performed in order to investigate the molecular interaction of the lubricant oil. It was found that the hydrogen bonding of hydroxyl groups in PPG was strengthened by high pressure in the Hertzian contact region. These results suggest that the rheological properties in the elastohydrodynamic lubrication contact region were affected by the strengthened hydrogen bonding. Copyright (c) 2014 John Wiley & Sons, Ltd.	[Takiwatari, Koji] Ichinoseki Natl Collage Technol, Dept Chem Engn, Ichinoseki, Japan; [Nanao, Hidetaka; Hoshi, Yasushi; Mori, Shigeyuki] Iwate Univ, Dept Chem & Bioengn, Morioka, Iwate 0208550, Japan	Mori, S (reprint author), Iwate Univ, Dept Chem & Bioengn, Morioka, Iwate 0208550, Japan.	mori@iwate-u.ac.jp			project of Green Tribology Innovation Network	This work was supported financially by the project of Green Tribology Innovation Network.	Alsaad M, 1978, ASME, V100, P404; Cann PM, 2005, TRIBOL LETT, V19, P289, DOI 10.1007/s11249-005-7446-4; Takiwatari K, 2010, LUBR SCI, V22, P89, DOI 10.1002/ls.107; WONG PTT, 1988, BIOCHIM BIOPHYS ACTA, V947, P139, DOI 10.1016/0304-4157(88)90023-8; Mori S, 1996, TRIBOL INT, V29, P35, DOI 10.1016/0301-679X(95)00032-Y; Takiwatari K, 2010, LUBR SCI, V22, P367, DOI 10.1002/ls.132; Vanderkooi JM, 2005, BBA-PROTEINS PROTEOM, V1749, P214, DOI 10.1016/j.bbapap.2005.03.008; YUSA H, 1994, J APPL PHYS, V75, P1463, DOI 10.1063/1.356380; Bair S, 2006, TRIBOL LETT, V22, P197, DOI 10.1007/s11249-006-9083-y; Bondi A, 1951, PHYSICAL CHEM LUBRIC, P40; Bongaerts JHH, 2008, J APPL PHYS, V104; CANN PM, 1989, TRIBOL T, V32, P414, DOI 10.1080/10402008908981908; CANN PM, 1991, TRIBOL T, V34, P248, DOI 10.1080/10402009108982033; DAREEDWARDS MP, 1985, NATURE, V316, P614, DOI 10.1038/316614a0; Dougherty RC, 1998, J CHEM PHYS, V109, P7372, DOI 10.1063/1.477343; FISHMAN E, 1956, J CHEM PHYS, V24, P548, DOI 10.1063/1.1742544; Hata H, 1998, TRIBOL LETT, V5, P69, DOI 10.1023/A:1019108800961; Hoshi Y, 1999, J JPN SOC TRIBOLOGIS, V44, P736; Jeffrey GA, 1997, INTRO HYDROGEN BONDI, P220; JOHNSTON GJ, 1991, TRIBOL T, V34, P187, DOI 10.1080/10402009108982026; LAUER JL, 1982, ASLE TRANS, V25, P329; MURAKI M, 1987, TRIBOL INT, V20, P347, DOI 10.1016/0301-679X(87)90063-6; Nakamura Y, 2010, LUBR SCI, V22, P417, DOI 10.1002/ls.110; Nakano K, 2003, LUBR SCI, V15, P233, DOI 10.1002/ls.3010150304; Ohno N, 2009, LUBR SCI, V21, P183, DOI 10.1002/ls.82; Petravic J, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1940050; Rossi A, 2004, WEAR, V256, P578, DOI 10.1016/j.wear.2003.10.001; Sikka SK, 2007, HIGH PRESSURE RES, V27, P313, DOI 10.1080/08957950701463194; Spikes HA, 2003, TRIBOL LETT, V14, P1, DOI 10.1023/A:1021790313293; Spikes HA, 2006, LUBR SCI, V18, P265, DOI DOI 10.1002/LS.23; Tamai Y, 1982, J JPN PETROL INST, V25, P127; WONG PTT, 1987, J CHEM PHYS, V87, P4487, DOI 10.1063/1.452862	32	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0954-0075	1557-6833		LUBR SCI	Lubr. Sci.	AUG	2015	27	5					265	278		10.1002/ls.1278		14	Engineering, Chemical; Engineering, Mechanical	Engineering	CM9CY	WOS:000358005200001		
J	Yusakul, G; Udomsin, O; Tanaka, H; Morimoto, S; Juengwatanatrakul, T; Putalun, W				Yusakul, Gorawit; Udomsin, Orapin; Tanaka, Hiroyuki; Morimoto, Satoshi; Juengwatanatrakul, Thaweesak; Putalun, Waraporn			Enzyme-linked immunosorbent assay by enhanced chemiluminescence detection for the standardization of estrogenic miroestrol in Pueraria candollei Graham ex Benth	LUMINESCENCE			English	Article						Pueraria candollei; miroestrol; enzyme-linked immunosorbent assay; enhanced chemiluminescence	MAJOR ISOFLAVONOID CONTENTS; PHYTOESTROGEN-RICH-HERB; LUMINOL SIGNAL ENHANCER; PERIMENOPAUSAL WOMEN; CLIMACTERIC SYMPTOMS; POTENT PHYTOESTROGEN; KWAO KEUR; MIRIFICA; DEOXYMIROESTROL; IMMUNOASSAY	Miroestrol (ME) is a potent phytoestrogen from the P. candollei tuberous root. It has been approved for use in clinical trials due to its beneficial effect on disorders associated with estrogen deficiency. To ensure medical efficacy and safety, high performance analytical methods for ME analysis are required to standardize products from the P. candollei root. An enhanced chemiluminescence enzyme-linked immunosorbent assay (ECL-ELISA) was developed and validated using a polyclonal antibody against ME and a chemiluminescent system of luminol-H2O2-horseradish peroxidase-4-(1-imidazolyl) phenol. The ECL-ELISA system exhibited linearity over a concentration range of 0.31-10.00ngmL(-1), for which the relative standard variation (%RSD) was less than 10% for both intra- and interplate determinations. The ECL-ELISA is reliable for the determination of ME as reflected by the high recovery percentage (101.22-103.06%). As a comparative analysis, the ME content in each sample determined by ECL-ELISA was correlated with high coefficients of determination with colorimetric ELISA (R-2=0.998) and high performance liquid chromatography (HPLC) (R-2=0.998) methods. The ECL-ELISA method could be applied to all of the commercial products containing P. candollei root, when the products contain between 0.706 +/- 0.046 and 13.123 +/- 0.794 mu gg(-1) dry wt. of ME. This method is useful as a high performance analytical method for the quantity control of ME in raw materials and end products at both the research and industrial levels. Copyright (c) 2014 John Wiley & Sons, Ltd.	[Yusakul, Gorawit; Udomsin, Orapin; Putalun, Waraporn] Khon Kaen Univ, Fac Pharmaceut Sci, Khon Kaen 40002, Thailand; [Yusakul, Gorawit; Udomsin, Orapin; Putalun, Waraporn] Khon Kaen Univ, Natl Res Univ, Res Grp Pharmaceut Act Nat Prod Using Pharmaceut, Khon Kaen 40002, Thailand; [Tanaka, Hiroyuki; Morimoto, Satoshi] Kyushu Univ, Grad Sch Pharmaceut Sci, Fukuoka 8128582, Japan; [Juengwatanatrakul, Thaweesak] Ubon Rachathani Univ, Fac Pharmaceut Sci, Ubon Ratchathani 34190, Thailand	Putalun, W (reprint author), Khon Kaen Univ, Fac Pharmaceut Sci, Khon Kaen 40002, Thailand.	waraporn@kku.ac.th			Faculty of Pharmaceutical Science and Graduate School, Khon Kaen University, Thailand; Graduate School of Pharmaceutical Sciences, Kyushu University, Japan	This work was supported by the Faculty of Pharmaceutical Science and Graduate School, Khon Kaen University, Thailand, and the Graduate School of Pharmaceutical Sciences, Kyushu University, Japan. The authors thank Suranaree University of Technology, Nakhon Ratchasima province, Thailand for providing the P. candollei plant samples. Finally, the authors would like to thank Dr. Chaiyo Chaichantipyuth for providing the authentic standard miroestrol.	Dotsikas Y, 2004, ANAL CHIM ACTA, V509, P103, DOI 10.1016/j.aca.2003.12.007; Yusakul G, 2011, FITOTERAPIA, V82, P203, DOI 10.1016/j.fitote.2010.09.009; Cherdshewasart W, 2007, J PHARMACEUT BIOMED, V43, P428, DOI 10.1016/j.jpba.2006.07.013; Dotsikas Y, 2007, TALANTA, V71, P906, DOI 10.1016/j.talanta.2006.05.068; Chansakaow S, 2000, J NAT PROD, V63, P173, DOI 10.1021/np990547v; Udomsuk L, 2012, FITOTERAPIA, V83, P1687, DOI 10.1016/j.fitote.2012.09.024; Chandeying Verapol, 2007, Journal of the Medical Association of Thailand, V90, P1720; Dodeigne C, 2000, TALANTA, V51, P415, DOI 10.1016/S0039-9140(99)00294-5; Kuroda N, 2000, ANAL CHIM ACTA, V403, P131, DOI 10.1016/S0003-2670(99)00649-2; Yusakul G, 2013, ANAL CHIM ACTA, V785, P104, DOI 10.1016/j.aca.2013.04.053; Zhao LX, 2009, TRAC-TREND ANAL CHEM, V28, P404, DOI 10.1016/j.trac.2008.12.006; Quan Y, 2006, ANAL CHIM ACTA, V580, P1, DOI 10.1016/j.aca.2006.07.063; IWATA R, 1995, ANAL BIOCHEM, V231, P170, DOI 10.1006/abio.1995.1517; WEILER EW, 1976, PHYTOCHEMISTRY, V15, P1537, DOI 10.1016/S0031-9422(00)88933-5; Chandeying Verapol, 2007, Journal of the Medical Association of Thailand, V90, P1274; Cherdshewasart W, 2007, BIOSCI BIOTECH BIOCH, V71, P2527, DOI 10.1271/bbb.70316; Lamlertkittikul Surachai, 2004, Journal of the Medical Association of Thailand, V87, P33; Manonai J, 2008, MENOPAUSE, V15, P530, DOI 10.1097/gme.0b013e31815c5fd8; Manonai J, 2007, MENOPAUSE, V14, P919, DOI 10.1097/gme.0b013e3180399486; Pongkitwitoon B, 2010, PLANTA MED, V76, P831, DOI 10.1055/s-0029-1240725; Udomsuk L, 2012, NUTR RES, V32, P45, DOI 10.1016/j.nutres.2011.11.003; Virojchaiwong P, 2011, ARCH GYNECOL OBSTET, V284, P411, DOI 10.1007/s00404-010-1689-5; Yan-lis L, 2012, J LUMIN, V132, P1021	23	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1522-7235	1522-7243		LUMINESCENCE	Luminescence	AUG	2015	30	5					568	575		10.1002/bio.2787		8	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CN0VG	WOS:000358131400012		
J	Kato, S; Matsuoka, D; Miwa, N				Kato, Shinya; Matsuoka, Daigo; Miwa, Nobuhiko			Antioxidant activities of nano-bubble hydrogen-dissolved water assessed by ESR and 2,2 '-bipyridyl methods	MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS			English	Article						Hydrogen water; Electron spin resonance; 2,2 '-Bipyridyl method; Antioxidant	MOLECULAR-HYDROGEN; OXIDATIVE STRESS; CONSUMPTION; PREVENTS; IRON; MICE	We prepared nano-bubble hydrogen-dissolved water (nano-H water) which contained hydrogen nano-bubbles of <717-nm diameter for 54% of total bubbles. In the DMPO-spin trap electron spin resonance (ESR) method, the DMPO-OH:MnO ratio, being attributed to amounts of hydroxyl radicals (center dot OH), was 2.78 for pure water (dissolved hydrogen [DH] <= 0.01 ppm, oxidation-reduction potential [ORP] = +324 mV), 2.73 for tap water (0.01 ppm, +286 mV), 2.93 for commercially available hydrogen water (0.075 ppm, +49 mV), and 2.66 for manufactured hydrogen water (0.788 ppm, -614 mV), whereas the nano-H water (0.678 ppm, -644 mV) exhibited 2.05, showing the superiority of nano-H water to other types of hydrogen water in terms of center dot OH-scavenging activity. Then, the reduction activity of nano-H water was assessed spectrophotometrically by the 2,2'-bipyridyl method. Differential absorbance at 530 nm was in the order: 0.018 for pure water, 0.055 for tap water, 0.079 for nano-H water, 0.085 for commercially available hydrogen water, and 0.090 for manufactured hydrogen water, indicating a prominent reduction activity of hydrogen water and nano-H water against oxidation in ascorbate-coupled ferric ion-bipyridyl reaction. Thus, nano-H water has an improved antioxidant activity as compared to hydrogen water of similar DH-level, indicating the more marked importance of nano-bubbles rather than the concentration of hydrogen in terms of center dot OH-scavenging. (C) 2015 Elsevier B.V. All rights reserved.	[Kato, Shinya; Miwa, Nobuhiko] Prefectural Univ Hiroshima, Fac Life & Environm Sci, Lab Cell Death Control BioTechnol, Shobara, Hiroshima 7270023, Japan; [Matsuoka, Daigo] 600 mV Co Ltd, Fukuyama, Hiroshima 7200802, Japan; [Kato, Shinya] Mie Univ, Life Sci Res Ctr, Radio Isotope Facil Med Sci, Tsu, Mie 5148507, Japan; [Miwa, Nobuhiko] Butsuryo Coll Osaka, Fac Hlth Sci, Dept Radiol Technol, Nishi Ku, Sakai, Osaka 5938328, Japan	Miwa, N (reprint author), Butsuryo Coll Osaka, Fac Hlth Sci, Dept Radiol Technol, Nishi Ku, Otorikitamachi 3-33, Sakai, Osaka 5938328, Japan.	miwa@butsuiyo.ac.jp			JCAAMS (Japanese Center for Anti-Aging MedSciences, Hiroshima, Japan) [07085]	The present study was in part supported by a grant-in-aid to Anti-Aging Research (#07085) by JCAAMS (Japanese Center for Anti-Aging MedSciences, Hiroshima, Japan).	Ohta S, 2012, BBA-GEN SUBJECTS, V1820, P586, DOI 10.1016/j.bbagen.2011.05.006; Fukuda KI, 2007, BIOCHEM BIOPH RES CO, V361, P670, DOI 10.1016/j.bbrc.2007.07.088; Nakao A, 2010, J CLIN BIOCHEM NUTR, V46, P140, DOI 10.3164/jcbn.09-100; Ohsawa I, 2007, NAT MED, V13, P688, DOI 10.1038/nm1577; Ohsawa I, 2008, BIOCHEM BIOPH RES CO, V377, P1195, DOI 10.1016/j.bbrc.2008.10.156; Ohta S, 2011, CURR PHARM DESIGN, V17, P2241; Nagata K, 2009, NEUROPSYCHOPHARMACOL, V34, P501, DOI 10.1038/npp.2008.95; Ushikubo FY, 2010, COLLOID SURFACE A, V361, P31, DOI 10.1016/j.colsurfa.2010.03.005; Zheng J, 2010, UNDERSEA HYPERBAR M, V37, P185; Asada R, 2010, ONCOL REP, V24, P1463, DOI 10.3892/or_00001006; Cooper LHN, 1935, PROC R SOC SER B-BIO, V118, P419, DOI 10.1098/rspb.1935.0064; HEANEY SI, 1977, LIMNOL OCEANOGR, V22, P753; Kato S, 2011, J NANOSCI NANOTECHNO, V11, P3814, DOI 10.1166/jnn.2011.4172; Kawaguchi M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100352; Li Qiang, 2013, Med Gas Res, V3, P20, DOI 10.1186/2045-9912-3-20; Nakashima-Kamimura N, 2009, CANCER CHEMOTH PHARM, V64, P753, DOI 10.1007/s00280-008-0924-2; Onari H., 2001, J HEAT TRANSFER SOC, V40, P2; Park JS, 2009, HORTTECHNOLOGY, V19, P212	18	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0928-4931	1873-0191		MAT SCI ENG C-MATER	Mater. Sci. Eng. C-Mater. Biol. Appl.	AUG 1	2015	53						7	10		10.1016/j.msec.2015.03.064		4	Materials Science, Biomaterials	Materials Science	CN0HB	WOS:000358093600002		
J	El Fray, M; Strzalkowska, D; Mandoli, C; Pagliari, F; Di Nardo, P; Traversa, E				El Fray, M.; Strzalkowska, D.; Mandoli, C.; Pagliari, F.; Di Nardo, P.; Traversa, E.			Influence of ceria nanoparticles on chemical structure and properties of segmented polyesters	MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS			English	Article						PET-DLA copolyesters; Nanocomposites; Phase structure; Biocompatibility	MULTIBLOCK THERMOPLASTIC ELASTOMERS; POLY(ALIPHATIC/AROMATIC-ESTER) COPOLYMERS; FATIGUE BEHAVIOR; CERAMIC COMPOSITES; SCAFFOLDS; NANOCOMPOSITE; BONE; BIOCOMPATIBILITY; BIOACTIVITY; FABRICATION	In this work, we present new nanocomposite materials derived from segmented copolyesters, comprising ethylene terephthalate (PET) segments and dimerized linoleic acid (DLA), and nanometric cerium oxide particles (CeO2). Nanoparticles were incorporated in situ during polycondensation in various concentrations, from 0.1 up to 0.6 wt.%. It was found that preparation of nanocomposites in situ, during polycondensation, had no significant influence on changes in segmental composition as determined from H-1 and C-13, as well as 2D NMR. Thermal analysis and calculated degree of crystallinity showed that increasing concentration of ceria nanopartides lead to an increase in mass content of PET crystallites in hard segments. The XRD investigations also showed an increased intensity of characteristic signals with increasing ceria concentration. Simultaneously, the incorporation of CeO2 led to an increase in tensile strength and elongation at break, indicating a reinforcing and plasticizing effect of ceria nanoparticles. However, the modulus at 10% strain decreased with increasing amount of nanoparticles. The in vitro culture of human cardiac progenitor cells (hCPCs) on the new materials indicated a homogenous cell displacement across the samples after 5 days with no signs of cytotoxicity, indicating good biocompatibility in vitro of CeO2-based nanocomposites and a potential for biomedical applications. (C) 2015 Elsevier B.V. All rights reserved.	[El Fray, M.; Strzalkowska, D.] West Pomeranian Univ Technol, Inst Polymer, Div Biomat & Microbiol Technol, PL-70311 Szczecin, Poland; [Mandoli, C.; Traversa, E.] Natl Inst Mat Sci, Int Res Ctr Mat Nanoarchitecton MANA, Tsukuba, Ibaraki 3050044, Japan; [Pagliari, F.; Di Nardo, P.] Univ Roma Tor Vergata, Dept Internal Med, Lab Mol & Cellular Cardiol, I-00133 Rome, Italy	El Fray, M (reprint author), West Pomeranian Univ Technol, Inst Polymer, Div Biomat & Microbiol Technol, Al Piastow 45, PL-70311 Szczecin, Poland.	mirfray@zut.edu.pl					Fan XD, 1998, J APPL POLYM SCI, V68, P305, DOI 10.1002/(SICI)1097-4628(19980411)68:2<305::AID-APP12>3.0.CO;2-W; Schiller C, 2004, BIOMATERIALS, V25, P1239, DOI 10.1016/j.biomaterials.2003.08.047; Chen JP, 2006, NAT NANOTECHNOL, V1, P142, DOI 10.1038/nnano.2006.91; Niu JL, 2007, CARDIOVASC RES, V73, P549, DOI 10.1016/j.cardiores.2006.11.031; Habraken WJEM, 2007, ADV DRUG DELIVER REV, V59, P234, DOI 10.1016/j.addr.2007.03.011; Shi XF, 2007, BIOMATERIALS, V28, P4078, DOI 10.1016/j.biomaterials.2007.05.033; Esposito V, 2008, J AM CERAM SOC, V91, P1037, DOI 10.1111/j.1551-2916.2008.02347.x; Corma A, 2004, NAT MATER, V3, P394, DOI 10.1038/nmat1129; Rezwan K, 2006, BIOMATERIALS, V27, P3413, DOI 10.1016/j.biomaterials.2006.01.039; Renke-Gluszko M, 2004, BIOMATERIALS, V25, P5191, DOI 10.1016/j.biomaterials.2003.12.021; Kidane AG, 2009, ACTA BIOMATER, V5, P2409, DOI 10.1016/j.actbio.2009.02.025; Zheng XT, 2006, BIOMATERIALS, V27, P4288, DOI 10.1016/j.biomaterials.2006.03.043; El Fray M, 2004, POLYMER, V45, P263, DOI 10.1016/j.polymer.2003.10.034; Lee KW, 2008, BIOMATERIALS, V29, P2839, DOI 10.1016/j.biomaterials.2008.03.030; Das M, 2007, BIOMATERIALS, V28, P1918, DOI 10.1016/j.biomaterials.2006.11.036; Hung HS, 2009, BIOMATERIALS, V30, P1502, DOI 10.1016/j.biomaterials.2008.12.003; Bordes P, 2009, PROG POLYM SCI, V34, P125, DOI 10.1016/j.progpolymsci.2008.10.002; Gelinsky M, 2008, CHEM ENG J, V137, P84, DOI 10.1016/j.cej.2007.09.029; Mandoli C, 2010, ADV FUNCT MATER, V20, P1617, DOI 10.1002/adfm.200902363; Chang MC, 2003, BIOMATERIALS, V24, P2853, DOI 10.1016/S0142-9612(03)00115-7; Boccaccini AR, 2005, COMPOS PART A-APPL S, V36, P721, DOI 10.1016/j.compositesa.2004.11.002; DOMB AJ, 1993, J POLYM SCI POL CHEM, V31, P1275, DOI 10.1002/pola.1993.080310523; Prowans P, 2002, BIOMATERIALS, V23, P2973, DOI 10.1016/S0142-9612(02)00026-1; El Fray M, 2009, ADV ENG MATER, V11, pB35, DOI 10.1002/adem.200800333; El Fray M, 2005, MATER LETT, V59, P2300, DOI 10.1016/j.matlet.2005.03.008; El-Fray M, 2009, ADV ENG MATER, V11, pB200, DOI 10.1002/adem.200900104; El Fray M, 2003, POLYMER, V44, P4643, DOI 10.1016/S0032-3861(03)00418-X; El Fray M, 2003, POLYMER, V44, P4635, DOI 10.1016/S0032-3861(03)00417-8; Jawad H., 2008, EUR CELLS MATER, V16, P64; Kilboum B.T., 2001, KIRK OTHMER ENCY CHE, V5, P670; Koo J.H., 2006, POLYM NANOCOMPOSITES; Li HY, 2003, MATER LETT, V57, P2848, DOI 10.1016/S0167-577X(02)01386-1; Meng J, 2005, J BIOMED MATER RES A, V74A, P208, DOI 10.1002/jbm.a.30315; Muzzarelli RAA, 2009, CARBOHYD POLYM, V76, P167, DOI 10.1016/j.carbpol.2008.11.002; Neves N.M., 2005, BIODEGRADABLE COMPOS; Piegat A, 2008, ADV APPL CERAM, V107, P287, DOI 10.1179/174367508X297777; Piegat A., 2008, P INT C, P93; Prowans P, 2005, POLIMERY-W, V50, P131; Savaiano JK, 2004, BIOMATERIALS, V25, P1205, DOI 10.1016/j.biomaterials.2003.08.012; Scislowska P., 2009, THESIS W POMERANIAN; Traversa E, 2008, J EXP NANOSCI, V3, P97, DOI 10.1080/17458080701713946; Trovarelli A, 1996, CATAL REV, V38, P439, DOI 10.1080/01614949608006464; WOLCYRZ M, 1992, J SOLID STATE CHEM, V99, P409, DOI 10.1016/0022-4596(92)90330-X; Zdebiak P, 2008, FIBRES TEXT EAST EUR, V16, P77	44	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0928-4931	1873-0191		MAT SCI ENG C-MATER	Mater. Sci. Eng. C-Mater. Biol. Appl.	AUG 1	2015	53						15	22		10.1016/j.msec.2015.04.010		8	Materials Science, Biomaterials	Materials Science	CN0HB	WOS:000358093600004		
J	Gokcekaya, O; Ueda, K; Narushima, T; Ergun, C				Gokcekaya, Ozkan; Ueda, Kyosuke; Narushima, Takayuki; Ergun, Celaletdin			Synthesis and characterization of Ag-containing calcium phosphates with various Ca/P ratios	MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS			English	Article						Calcium phosphate; Hydroxyapatite; Tricalcium phosphate; Silver; Precipitation method; Solubility	BETA-TRICALCIUM PHOSPHATE; SILVER-SUBSTITUTED HYDROXYAPATITE; METAL-IONS; ANTIMICROBIAL ACTIVITY; THERMAL-STABILITY; THIN-FILMS; ANTIBACTERIAL; BIOCOMPATIBILITY; COATINGS; APATITES	Ag-containing calcium phosphate (CaP) powders were synthesized by a precipitation method using aqueous solutions of calcium nitrate, silver nitrate, and ammonium phosphate. The powders were sintered at temperatures ranging from 1173 to 14731<. The charged atomic ratios of (Ca + Ag)/P and Ag/(Ca + Ag) in solution were varied from 133 to 1.67 and from 0 to 030, respectively. The Ag content in the as-precipitated CaP powders increased with the charged Ag/(Ca + Ag) atomic ratio in solution and was lower than the charged Ag/(Ca + Ag) value. The as-precipitated CaP powders consisted of hydroxyapatite (HA) as the main phase. Ag nanoparticles were observed on the as-precipitated HA particles under all conditions of Ag addition. After the sintering, HA,beta-TCP (tricalcium phosphate), alpha-TCP, and beta-CPP (calcium pyrophosphate) were mainly detected as CaPs on the basis of the Ca/P atomic ratio of the as-precipitated powders. The addition of Ag stabilized the beta-TCP phase, and the distribution of Ag in beta-TCP was homogeneous. A metallic Ag phase coexisted with HA. The solubility of Ag in HA was estimated to be 0.0019-0.0061 (Ag/(Ca + Ag)) atomic ratio, which was lower than that in beta-TCP (higher than 0.0536) and higher than that of beta-CPP (below the detection limit of analyses). (C) 2015 Elsevier B.V. All rights reserved.	[Gokcekaya, Ozkan; Ueda, Kyosuke; Narushima, Takayuki] Tohoku Univ, Dept Mat Proc, Aoba Ku, Sendai, Miyagi 9808579, Japan; [Ergun, Celaletdin] Istanbul Tech Univ, Fac Mech Engn, TR-34437 Istanbul, Turkey	Gokcekaya, O (reprint author), Tohoku Univ, Dept Mat Proc, Aoba Ku, 6-6-02 Aza Aoba, Sendai, Miyagi 9808579, Japan.	gokcekaya@dc.tohoku.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan [25249094]	The authors would like to thank Dr. Kobayashi of Tohoku University for TEM analyses. This study was financially supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan, under Contract No. 25249094.	Stanic V, 2010, APPL SURF SCI, V256, P6083, DOI 10.1016/j.apsusc.2010.03.124; Raynaud S, 2002, BIOMATERIALS, V23, P1073, DOI 10.1016/S0142-9612(01)00219-8; Matsumoto N, 2009, ACTA BIOMATER, V5, P3157, DOI 10.1016/j.actbio.2009.04.010; Yoshida K, 2006, J AM CERAM SOC, V89, P688, DOI 10.1111/j.1551-2916.2005.00727.x; Cremet L, 2012, J INFECTION, V64, P169, DOI 10.1016/j.jinf.2011.11.010; Singh B, 2011, MAT SCI ENG C-MATER, V31, P1320, DOI 10.1016/j.msec.2011.04.015; Weiner S, 1998, ANNU REV MATER SCI, V28, P271, DOI 10.1146/annurev.matsci.28.1.271; Rameshbabu N, 2007, J BIOMED MATER RES A, V80A, P581, DOI 10.1002/jbm.a.30958; Matsumoto N, 2009, MATER RES BULL, V44, P1889, DOI 10.1016/j.materresbull.2009.05.012; Boanini E, 2010, ACTA BIOMATER, V6, P1882, DOI 10.1016/j.actbio.2009.12.041; Liu XM, 2013, APPL SURF SCI, V273, P748, DOI 10.1016/j.apsusc.2013.02.130; Kim TN, 1998, J MATER SCI-MATER M, V9, P129, DOI 10.1023/A:1008811501734; Dorozhkin SV, 2009, MATERIALS, V2, P399, DOI 10.3390/ma2020399; Hollinger MA, 1996, CRIT REV TOXICOL, V26, P255, DOI 10.3109/10408449609012524; Kotharu V, 2012, CERAM INT, V38, P731, DOI 10.1016/j.ceramint.2011.07.065; Ren F, 2010, ACTA BIOMATER, V6, P2787, DOI 10.1016/j.actbio.2009.12.044; Mayer I, 2008, J INORG BIOCHEM, V102, P311, DOI 10.1016/j.jinorgbio.2007.09.004; Lim PN, 2013, J BIOMED MATER RES A, V101, P2456, DOI 10.1002/jbm.a.34544; Webster TJ, 2004, BIOMATERIALS, V25, P2111, DOI 10.1016/j.biomaterials.2003.09.001; Ge X, 2010, J BIOMED MATER RES A, V95A, P588, DOI 10.1002/jbm.a.32862; SHIRKHANZADEH M, 1995, MATER LETT, V24, P7, DOI 10.1016/0167-577X(95)00059-3; Badrour L, 1998, ANN CHIM-SCI MAT, V23, P61, DOI 10.1016/S0151-9107(98)80012-3; Ergun C, 2002, J BIOMED MATER RES, V59, P305, DOI 10.1002/jbm.1246; Sadat-Shojai M, 2013, ACTA BIOMATER, V9, P7591, DOI 10.1016/j.actbio.2013.04.012; Raynaud S, 2002, BIOMATERIALS, V23, P1065, DOI 10.1016/S0142-9612(01)00218-6; Blaker JJ, 2004, BIOMATERIALS, V25, P1319, DOI 10.1016/j.biomaterials.2003.08.007; Jeyachandran YL, 2007, MAT SCI ENG C-BIO S, V27, P35, DOI 10.1016/j.msec.2006.01.004; Basar B, 2009, MATER SCI TECH-LOND, V25, P794, DOI 10.1179/174328408X317255; Cacciotti I, 2011, CERAM INT, V37, P127, DOI 10.1016/j.ceramint.2010.08.023; Chiang Y. M., 1997, PHYS CERAMICS PRINCI; Ciobanu CS, 2011, NANOSCALE RES LETT, V6, P1, DOI 10.1186/1556-276X-6-613; Costescu A, 2013, J NANOMATER, DOI 10.1155/2013/194854; Diaz M, 2009, J NANOMATER, DOI 10.1155/2009/498505; Elliott J. C., 1994, STUDIES INORGANIC CH, V18; Ergun C, 2011, CERAM INT, V37, P971, DOI 10.1016/j.ceramint.2010.11.004; Feng QL, 1998, THIN SOLID FILMS, V335, P214; Hashimoto K., 2002, PHOSPHORUS RES B, V13, P123; Jansen B, 1994, J Biomater Appl, V9, P55, DOI 10.1177/088532829400900103; Kannan S, 2007, CERAM INT, V33, P637, DOI 10.1016/j.ceramint.2005.11.014; KLEIN CPAT, 1983, J BIOMED MATER RES, V17, P769, DOI 10.1002/jbm.820170505; Lucacel RC, 2009, J NON-CRYST SOLIDS, V355, P425, DOI 10.1016/j.jnoncrysol.2008.12.012; Lukic MJ, 2012, MATER LETT, V68, P331, DOI 10.1016/j.matlet.2011.10.085; Miyaji F, 2005, MATER RES BULL, V40, P209, DOI 10.1016/j.materresbull.2004.10.020; Wakamura M, 1997, POLYHEDRON, V16, P2047, DOI 10.1016/S0277-5387(96)00513-X; WILLIAMS RL, 1989, CRIT REV BIOCOMPAT, V5, P221	45	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0928-4931	1873-0191		MAT SCI ENG C-MATER	Mater. Sci. Eng. C-Mater. Biol. Appl.	AUG 1	2015	53						111	119		10.1016/j.msec.2015.04.025		9	Materials Science, Biomaterials	Materials Science	CN0HB	WOS:000358093600016		
J	Miura, K; Nakano, T				Miura, Kento; Nakano, Takato			Analysis of mercerization process based on the intensity change of deconvoluted resonances of C-13 CP/MAS NMR: Cellulose mercerized under cooling and non-cooling conditions	MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS			English	Article						Cellulose; NMR; Mercerization; Area intensity; NaOH concentration; Cooling	AQUEOUS ALKALI SOLUTION; MOLECULAR-STRUCTURE; NA-CELLULOSE; NATIVE CELLULOSES; WOOD; CRYSTALLINITY; SPECTROSCOPY; OLIGOSACCHARIDES; MICROFIBRIL; DIFFRACTION	The area intensity change of Cl, C4, and C6 in spectrum obtained by C-13 CP/MAS NMR and the mutual relationship between their changes were examined for cellulose samples treated with various concentrations of aqueous NaOH solutions under non-cooling and cooling conditions. The area intensity of Cl-up and C6-down changed cooperatively with that of C4-down which corresponds to the crystallinity of samples: "-up" and "-down" are the up- and down- field component in a splitting peak of NMR spectrum, respectively. The intensity change of Cl-up starts to decrease with decreasing in that of C4-down after that of C6-down is almost complete. These changes were more clearly observed for samples treated under cooling condition. It can be suggested that their characteristic change relates closely to the change in conformation of cellulose chains by induced decrystallization and the subsequent crystallization of cellulose II, and presumed that their changes at microscopic level relate to the macroscopic morphological changes such as contraction along the length of cellulose chains and recovery along the length. (C) 2015 Elsevier B.V. All rights reserved.	[Miura, Kento] Mitsubishi Rayon Co Ltd, Otake Res Labs, Tokyo, Japan; [Nakano, Takato] Kyoto Univ, Grad Sch Agr, Div Forest & Biomat Sci, Lab Biomat Design, Kyoto 6068501, Japan	Nakano, T (reprint author), Kyoto Univ, Grad Sch Agr, Div Forest & Biomat Sci, Lab Biomat Design, Kyoto 6068501, Japan.	tnakano@kais.kyoto-u.ac.jp					OKANO T, 1985, J APPL POLYM SCI, V30, P325, DOI 10.1002/app.1985.070300128; KOLPAK FJ, 1978, POLYMER, V19, P123, DOI 10.1016/0032-3861(78)90027-7; KAMIDE K, 1984, POLYM J, V16, P857, DOI 10.1295/polymj.16.857; TEEAAR R, 1987, POLYM BULL, V17, P231; Roy C, 2001, BIOMACROMOLECULES, V2, P687, DOI 10.1021/bm010002r; Newman RH, 1999, SOLID STATE NUCL MAG, V15, P21, DOI 10.1016/S0926-2040(99)00043-0; Langan P, 1999, J AM CHEM SOC, V121, P9940, DOI 10.1021/ja9916254; Kono H, 2002, J AM CHEM SOC, V124, P7506, DOI 10.1021/ja010704o; VANDERHART DL, 1984, MACROMOLECULES, V17, P1465, DOI 10.1021/ma00138a009; ATALLA RH, 1984, SCIENCE, V223, P283, DOI 10.1126/science.223.4633.283; ISOGAI A, 1989, MACROMOLECULES, V22, P3168, DOI 10.1021/ma00197a045; KAMIDE K, 1985, POLYM J, V17, P707, DOI 10.1295/polymj.17.707; Larsson PT, 1997, CARBOHYD RES, V302, P19, DOI 10.1016/S0008-6215(97)00130-4; Dinand E, 2002, CELLULOSE, V9, P7, DOI 10.1023/A:1015877021688; KroonBatenburg LMJ, 1996, MACROMOLECULES, V29, P5695, DOI 10.1021/ma9518058; Atalla RH, 1999, SOLID STATE NUCL MAG, V15, P1, DOI 10.1016/S0926-2040(99)00042-9; EVANS R, 1995, HOLZFORSCHUNG, V49, P498, DOI 10.1515/hfsg.1995.49.6.498; GAST JC, 1980, CARBOHYD RES, V84, P137, DOI 10.1016/S0008-6215(00)85437-3; HORII F, 1983, POLYM BULL, V10, P357, DOI 10.1007/BF00281948; HORII F, 1984, J CARBOHYD CHEM, V3, P641, DOI 10.1080/07328308408057922; HORII F, 1982, POLYM BULL, V8, P163; KAMIDE K, 1992, POLYM J, V24, P71, DOI 10.1295/polymj.24.71; Kamide K., 1985, POLYM J, V15, P701; Kono H, 2004, MACROMOLECULES, V37, P5310, DOI 10.1021/ma030465k; Larsson PT, 1995, CARBOHYD RES, V278, P339, DOI 10.1016/0008-6215(95)00248-0; MACIEL GE, 1982, MACROMOLECULES, V15, P686, DOI 10.1021/ma00230a097; Nakano S., 2014, HOLZFORSCHUNG; Nakano T, 2000, HOLZFORSCHUNG, V54, P315, DOI 10.1515/HF.2000.053; Nakano T, 2010, CELLULOSE, V17, P711, DOI 10.1007/s10570-010-9414-x; Nakano T, 2013, J MATER SCI, V48, P7510, DOI 10.1007/s10853-013-7565-5; NAKANO T, 1989, MOKUZAI GAKKAISHI, V35, P431; NEWMAN RH, 1990, HOLZFORSCHUNG, V44, P351, DOI 10.1515/hfsg.1990.44.5.351; NEWMAN RH, 1995, CELLULOSE, V2, P95, DOI 10.1007/BF00816383; NISHIMURA H, 1991, MACROMOLECULES, V24, P759, DOI 10.1021/ma00003a020; NISHIMURA H, 1991, MACROMOLECULES, V24, P771, DOI 10.1021/ma00003a021; Porro F, 2007, BIOMACROMOLECULES, V8, P2586, DOI 10.1021/bm0702657; Sobue H, 1939, Z PHYS CHEM B-CHEM E, V43, P309; SURYANARAYANAN R, 1990, PHARMACEUT RES, V7, P184, DOI 10.1023/A:1015889021145; TAKAHASHI M, 1987, POLYM J, V19, P855, DOI 10.1295/polymj.19.855; Tanimoto T, 2012, CARBOHYD POLYM, V87, P2145, DOI 10.1016/j.carbpol.2011.10.036; Tanimoto T, 2013, MAT SCI ENG C-MATER, V33, P1236, DOI 10.1016/j.msec.2012.12.017; Watanabe S., 1968, B FACUL ENG HOKKAIDO, V47, P121; WOODCOCK C, 1980, MACROMOLECULES, V13, P1183, DOI 10.1021/ma60077a030; YOKOTA H, 1990, J APPL POLYM SCI, V41, P783, DOI 10.1002/app.1990.070410325	44	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0928-4931	1873-0191		MAT SCI ENG C-MATER	Mater. Sci. Eng. C-Mater. Biol. Appl.	AUG 1	2015	53						189	195		10.1016/j.msec.2015.04.006		7	Materials Science, Biomaterials	Materials Science	CN0HB	WOS:000358093600025		
J	Mekaru, H				Mekaru, Harutaka			Removal of drawing traces of grayscale laser lithography by reflow process	MICROELECTRONIC ENGINEERING			English	Article						Laser lithography; Thermal reflow; Grayscale; Sloped sidewall; Relief printing		In a conventional method where patterned photoresist structures are in direct contact with the metal-cylindrical roller's surface employing a relief printing, the adhesion area normally does not have a sufficient strength to hold against a subsequent contact pressure and a moment of force that are encountered during the rotation of the roller. Therefore, to improve the robustness of the protuberant photoresist structures, we introduced a residual layer of photoresist (not exposed to any UV light), where the protuberant photoresist structures with sloped sidewalls were cemented onto the residual layer. And then this whole system was used to cover around the surface of the metal-cylindrical-roller. It has been well observed, and reported that a laser drawing system using grayscale lithography leaves traces on photoresist surfaces. However, these traces can now be removed by performing a reflow process under the optimal conditions. As a result of investigating the shape's transition of the protuberant photoresist structures at different reflow times, and of the durability experiment of 10 times press operations using a flat press-plate, the practicality of our technique combining the grayscale laser lithography and the reflow process was confirmed. (C) 2015 Elsevier B.V. All rights reserved.	Natl Inst Adv Ind Sci & Technol, Res Ctr Ubiquitous MEMS & Micro Engn, Tsukuba, Ibaraki 3058564, Japan	Mekaru, H (reprint author), Natl Inst Adv Ind Sci & Technol, Res Ctr Ubiquitous MEMS & Micro Engn, 1-2-1 Namiki, Tsukuba, Ibaraki 3058564, Japan.	h-mekaru@aist.go.jp					Acton Q.A., 2013, ADV RES APPL 2013 ED; [Anonymous], 1993, AZ 4000 SER PHOT THI; [Anonymous], 2006, TECHN DAT SHEET DAT; [Anonymous], 2013, THINK LABORATORYDLC; Michel B, 2001, IBM J RES DEV, V45, P697; [Anonymous], 2009, PRODUCTS GUIDE FUJIF; [Anonymous], 2013, APPL NOT REFL PHOT; [Anonymous], 2009, FACT SHEET; Budynas R.G., 2009, SHIGLEYS MECH ENG DE, Vnineth; Gagliardi M., 2013, GLOBAL MARKETS ROLL; Grogory P., 1996, CHEM TECHNOLOGY PRIN; Klar E., 2007, POWER METALLURGY STA, P128; Stevens R., 2010, IMAGING SCI J, P202; Takahashi M., 2006, P JAP SOC PREC ENG C, P737; Thomas A. L., 1990, PHTHALOCYANINE RES A; Touloulin Y.S., 1970, THERMOPHYSICAL PROPE, V2; Wong WS, 2009, ELECTRON MATER SCI T, P143, DOI 10.1007/978-0-387-74363-9_6	17	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-9317	1873-5568		MICROELECTRON ENG	Microelectron. Eng.	AUG 1	2015	143				SI		15	20		10.1016/j.mee.2015.02.048		6	Engineering, Electrical & Electronic; Nanoscience & Nanotechnology; Optics; Physics, Applied	Engineering; Science & Technology - Other Topics; Optics; Physics	CM7XB	WOS:000357908700005		
J	Sato, T; Yamada, A; Suto, T; Inanami, R; Matsuki, K; Ito, S				Sato, Takashi; Yamada, Akiko; Suto, Takeshi; Inanami, Ryoichi; Matsuki, Kazuto; Ito, Shinichi			Printability of defects in Talbot lithography	MICROELECTRONIC ENGINEERING			English	Article						Talbot effect; Lithography; Simulation; Resist; Defect; Mask	COHERENT DIFFRACTION LITHOGRAPHY; PERIODIC PATTERNS; MASK	We conduct a simulation and experiment to investigate the effect of a defect on the pattern size around the defect in ArF Talbot lithography proposed for submicron pattern transfer. We confirm that the focal depth is more than 1 micron even if a defective mask is used. Talbot lithography with a 1:1 mask is more resistant than reduction projection lithography against the effects of mask defects. (C) 2015 Elsevier B.V. All rights reserved.	[Sato, Takashi; Yamada, Akiko; Suto, Takeshi; Inanami, Ryoichi; Matsuki, Kazuto; Ito, Shinichi] Toshiba Co Ltd, Ctr Semicond Res & Dev, Saiwai Ku, Kawasaki, Kanagawa 2128583, Japan	Sato, T (reprint author), Toshiba Co Ltd, Ctr Semicond Res & Dev, Saiwai Ku, 1 Komukai Toshiba Cho, Kawasaki, Kanagawa 2128583, Japan.	ta.sato@toshiba.co.jp					Zanke C, 2004, J VAC SCI TECHNOL B, V22, P3352, DOI 10.1116/1.1813448; Solak HH, 2011, OPT EXPRESS, V19, P10686, DOI 10.1364/OE.19.010686; Isoyan A, 2009, J VAC SCI TECHNOL B, V27, P2931, DOI 10.1116/1.3258144; Stuerzebecher L, 2010, OPT EXPRESS, V18, P19485, DOI 10.1364/OE.18.019485; Brunner TA, 2003, J VAC SCI TECHNOL B, V21, P2632, DOI 10.1116/1.1619954; BRYNGDAH.O, 1973, J OPT SOC AM, V63, P416, DOI 10.1364/JOSA.63.000416; Christian Wagner, 2010, NAT PHOTONICS, V4.1, P24; Danylyuk S, 2013, J MICRO-NANOLITH MEM, V12, DOI 10.1117/1.JMM.12.3.033002; Fucetola CP, 2009, J VAC SCI TECHNOL B, V27, P2947, DOI 10.1116/1.3237093; Higashiki T, 2011, PROC SPIE, V7970, DOI 10.1117/12.882940; Hoppe Wolfgang, 2006, P SOC PHOTO-OPT INS, V6349, DOI 10.1117/12.686604; Rayleigh Lord, 1881, PHILOS MAG, V11, P196; Sato T, 2012, APPL PHYS EXPRESS, V5, DOI 10.1143/APEX.5.092501; Sato T, 2014, MICROELECTRON ENG, V123, P80, DOI 10.1016/j.mee.2014.05.019; Sato Takashi, 2012, J VAC SCI TECHNOL B, V30; Talbot H. F., 1836, PHILOS MAG, V9, P401, DOI DOI 10.1080/14786443; Urbanski L., 2012, J VAC SCI TECHNOL B, V30; de Klerk J, 2007, P SOC PHOTO-OPT INS, V6520, pY5201, DOI 10.1117/12.712094	18	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-9317	1873-5568		MICROELECTRON ENG	Microelectron. Eng.	AUG 1	2015	143				SI		21	24		10.1016/j.mee.2015.02.046		4	Engineering, Electrical & Electronic; Nanoscience & Nanotechnology; Optics; Physics, Applied	Engineering; Science & Technology - Other Topics; Optics; Physics	CM7XB	WOS:000357908700006		
J	Miyoshi, H; Taniguchi, J				Miyoshi, Hidetatsu; Taniguchi, Jun			Fabrication of a high-resolution mask by using variable-shaped electron beam lithography with a non-chemically amplified resist and a post-exposure bake	MICROELECTRONIC ENGINEERING			English	Article						Electron-beam lithography; Resists; High-resolution lithography; Proximity effect; Annealing		A high-resolution technique was developed for fabrication of photomasks for 10-nm-technology nodes and beyond. Current mask manufacturing techniques use a chemically amplified resist (CAR) photoresist material that has a complex mechanism of acid generation that obscures the criteria for selecting the polymer, quencher, and crosslinker for industrial purposes. It is therefore important to validate non-CAR materials as alternative solutions for mask fabrication. In this research, diluted ZEP520A was used as a non-CAR material in conjunction with a JBX9000 electron-beam lithography (EBL) tool. Additionally, a post-exposure bake (PEB) is normally used in mask fabrication. The PEB method was also used in this research, and we investigated its temperature dependence. Critical dimensions (CDs) of 1:1 line-and-space, isolated space, and isolated line patterns on a diluted ZEP520A resist were measured and showed CD shrinkage, an extension effect, and retention of the integrity of the shape after the PEB process. A resolution of the order of 20 nm was attained and the insights gained from optimization of the PEB process might be usefully applied in advanced methods for fabricating masks of the next generation. (C) 2015 Elsevier B.V. All rights reserved.	[Miyoshi, Hidetatsu; Taniguchi, Jun] Tokyo Univ Sci, Dept Appl Elect, Katsushika Ku, Tokyo 1250051, Japan; [Miyoshi, Hidetatsu] Intel Corp, Technol Mfg Grp Japan, Tsukuba, Ibaraki 3002635, Japan	Miyoshi, H (reprint author), Intel Corp, Technol Mfg Grp Japan, 5-6 Tokodai, Tsukuba, Ibaraki 3002635, Japan.	hidetatsu.miyoshi@intel.com			Intel Mask Operation at Santa Clara, CF	The authors thank the Intel Mask Operation at Santa Clara, CF, for their financially support of this research.	Lawson RA, 2009, MICROELECTRON ENG, V86, P741, DOI 10.1016/j.mee.2008.12.042; Platzgummer E, 2013, J MICRO-NANOLITH MEM, V12, DOI 10.1117/1.JMM.12.3.031108; Van Steenbergen JF, 2012, PROC SPIE, V8323, DOI 10.1117/12.916624; Unno N, 2008, J VAC SCI TECHNOL B, V26, P2390, DOI 10.1116/1.3010735; Wang H, 2007, J VAC SCI TECHNOL B, V25, P102, DOI 10.1116/1.2426976; Ito H., 1999, P SPIE, V3678; ITRS, 2013, TABL LITH4 OPT REQ; Klein C, 2013, PROC SPIE, V8880, DOI 10.1117/12.2030772; Komagata T., 2001, P SPIE, V4409; Komagata T., 2001, P SPIE, V4343; Long S., 2005, P SPIE, V5645; Mohammad MA, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.06FC05; Raffaele Luigi, 2005, Proceedings of the SPIE - The International Society for Optical Engineering, V5992, DOI 10.1117/12.632399; Schlueter W.B., 2004, P SPIE, V5567; ZEON Corp, 2010, ZEP520A TECHN REP VE	15	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-9317	1873-5568		MICROELECTRON ENG	Microelectron. Eng.	AUG 1	2015	143				SI		48	54		10.1016/j.mee.2015.03.026		7	Engineering, Electrical & Electronic; Nanoscience & Nanotechnology; Optics; Physics, Applied	Engineering; Science & Technology - Other Topics; Optics; Physics	CM7XB	WOS:000357908700011		
J	Santillan, JJ; Shichiri, M; Itani, T				Santillan, Julius Joseph; Shichiri, Motoharu; Itani, Toshiro			In situ characterization of nano-scale pattern roughness during resist dissolution process	MICROELECTRONIC ENGINEERING			English	Article						Resist dissolution; Line edge roughness; In situ analysis; High speed atomic force microscope	PHOTORESIST; FILMS; IMPROVEMENT	Advancements in the resist process is viewed as one effective way in meeting the challenge of obtaining high quality, narrow patterns (low line edge roughness/line width roughness or LER/LWR) for leading, edge lithographic technologies such as extreme ultraviolet (EUV) lithography, lambda = 13.5 nm. Among these processes, resist dissolution, also referred to as resist development, is considered an important process step as this is the first instance where resist patterns are formed from resist film state. This work focuses on a fundamental approach in understanding this resist pattern formation through a visual and in situ characterization of the resist dissolution process. This was done using a high speed atomic force microscope (HS-AFM). Specifically, this paper presents the first successful demonstration of the quantification of resist pattern LER during resist dissolution in the typical alkali (2.38wt% tetramethyl ammonium hydroxide or TMAH)-based developer solution. Based on these results, a number of fundamental information were understood/confirmed regarding resist pattern formation behavior during dissolution; (1) Larger pattern LER can be observed at pattern side-walls nearer the line pattern surface, in comparison to those near the line bottom. Moreover, it was also understood that (2) a reduction of LER occurs in the early stages of pattern formation during dissolution. This trend in decreasing LER was also existent even at longer dissolution times, but was in smaller variations. Lastly, it was also found that (3) at longer dissolution times, partial dissolution of pattern top surface, resulting in line-pinching occurs. This in effect increases LER, especially for measurements taken in pattern side-walls near the line surface. (C) 2015 Elsevier B.V. All rights reserved.	[Santillan, Julius Joseph; Shichiri, Motoharu; Itani, Toshiro] EUVL Infrastruct Dev Ctr Inc EIDEC, Tsukuba, Ibaraki 3058569, Japan	Santillan, JJ (reprint author), EUVL Infrastruct Dev Ctr Inc EIDEC, 16-1 Onogawa, Tsukuba, Ibaraki 3058569, Japan.	julius.santillan@eidec.co.jp			New Energy and Industrial Technology Development Organization (NEDO); EIDEC	This work is supported by New Energy and Industrial Technology Development Organization (NEDO). The authors would also like to thank the EIDEC member companies for the continued support.	[Anonymous], 1989, OXFORD ENGLISH DICT; Ando T, 2008, PFLUG ARCH EUR J PHY, V456, P211, DOI 10.1007/s00424-007-0406-0; Itani T, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.010002; Itani T, 2009, J VAC SCI TECHNOL B, V27, P2986, DOI 10.1116/1.3258151; Chandhok M, 2008, J VAC SCI TECHNOL B, V26, P2265, DOI 10.1116/1.3013860; Fonseca C, 2011, PROC SPIE, V7969, DOI 10.1117/12.879449; Hendrickx E, 2013, J PHOTOPOLYM SCI TEC, V26, P587; Hinsberg W, 2005, MACROMOLECULES, V38, P1882, DOI 10.1021/ma048772t; Itani T, 2010, APPL PHYS EXPRESS, V3, DOI 10.1143/APEX.3.061601; Itani T., 1998, Microelectronic Engineering, V41-42, DOI 10.1016/S0167-9317(98)00084-7; Kokkinis A, 2005, J PHYS CONF SER, V10, P401, DOI 10.1088/1742-6596/10/1/098; Lee SY, 2013, PROC SPIE, V8679, DOI 10.1117/12.2011076; Neisser M, 2012, J PHOTOPOLYM SCI TEC, V25, P87, DOI 10.2494/photopolymer.25.87; Petrillo K., 2013, P SOC PHOTO-OPT INS, V867911; Santillan JJ, 2012, PROC SPIE, V8325, DOI 10.1117/12.916342; Santillan JJ, 2013, J PHOTOPOLYM SCI TEC, V26, P611; Santillan JJ, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.06GC01; Santillan JJ, 2012, PROC SPIE, V8325, DOI 10.1117/12.916343; Singh L, 2004, P SOC PHOTO-OPT INS, V5376, P1007, DOI 10.1117/12.536205; Sugie N, 2014, PROC SPIE, V9048, DOI 10.1117/12.2046229; Wood O, 2012, PROC SPIE, V8322, DOI 10.1117/12.916292	21	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-9317	1873-5568		MICROELECTRON ENG	Microelectron. Eng.	AUG 1	2015	143				SI		64	68		10.1016/j.mee.2015.03.060		5	Engineering, Electrical & Electronic; Nanoscience & Nanotechnology; Optics; Physics, Applied	Engineering; Science & Technology - Other Topics; Optics; Physics	CM7XB	WOS:000357908700013		
J	Masuda, A; Xu, J; Mitsudome, T; Nagata, Y; Morokuma, D; Mon, H; Banno, Y; Kusakabe, T; Lee, J				Masuda, Atsushi; Xu, Jian; Mitsudome, Takumi; Nagata, Yudai; Morokuma, Daisuke; Mon, Hiroaki; Banno, Yutaka; Kusakabe, Takahiro; Lee, Jae Man			Mass Production of an Active Peptide-N-Glycosidase F Using Silkworm-Baculovirus Expression System	MOLECULAR BIOTECHNOLOGY			English	Article						Baculovirus expression system; N-Linked glycosylation; PNGase F; Recombinant protein; Silkworm	PEPTIDE-N-4-(N-ACETYL-BETA-D-GLUCOSAMINYL)ASPARAGINE AMIDASE-F; BOMBYX-MORI NUCLEOPOLYHEDROVIRUS; FLAVOBACTERIUM-MENINGOSEPTICUM; ACETYLGLUCOSAMINIDASE-F; H-1-NMR SPECTROSCOPY; PROTEIN EXPRESSION; MOLECULAR-CLONING; ESCHERICHIA-COLI; BACMID SYSTEM; HIGH-MANNOSE	The peptide-N (4)-(N-acetyl-beta-d-glucosaminyl) asparagine amidase F (PNGase F) catalyzes the cleavage of N-linked oligosaccharides between the innermost GlcNAc and asparagine residues of high mannose, hybrid and complex oligosaccharides from glycoproteins. The PNGase F has broad substrate specificity and thus is extensively used for the structural and functional studies of the glycoproteins. In this study, we tried to produce active recombinant PNGase F as secreted and intracellular-expressed forms using baculovirus expression vector system (BEVS) through silkworm larvae or cultured cells. PNGase F itself contains potential N-linked glycosylation sites and we found that it was N-glycosylated when PNGase F secreted from silkworm cells. Intriguingly, the secreted recombinant PNGase F has the lower catalytic activity and self-digests its N-linked glycans and therefore this secreted form of this enzyme produced from BEVS is not appropriate for carbohydrate chain analysis. Instead, we successfully mass-produced (2.1 mg/20 silkworm larvae) and purified active recombinant PNGase F as an intracellular protein without N-glycosylations. Besides, we confirmed by directed mutagenesis that several amino acid residues are crucial for the function of PNGase F. Our results provide an alternative method for the mass production of active enzymes involved in the study of glycoproteins.	[Masuda, Atsushi; Xu, Jian; Mitsudome, Takumi; Nagata, Yudai; Morokuma, Daisuke; Mon, Hiroaki; Kusakabe, Takahiro; Lee, Jae Man] Kyushu Univ, Grad Sch Bioresource & Bioenvironm Sci, Lab Silkworm Sci, Higashi Ku, Fukuoka 8128581, Japan; [Banno, Yutaka] Kyushu Univ, Inst Genet Resources, Grad Sch Bio Resources & Bioenvironm Sci, Lab Silkworm Genet Resources,Higashi Ku, Fukuoka 8128581, Japan	Lee, J (reprint author), Kyushu Univ, Grad Sch Bioresource & Bioenvironm Sci, Lab Silkworm Sci, Higashi Ku, Hakozaki 6-10-1, Fukuoka 8128581, Japan.	jaemanle@agr.kyushu-u.ac.jp	Xu, Jian/G-6684-2015				CHU FK, 1986, J BIOL CHEM, V261, P172; Kato T, 2010, APPL MICROBIOL BIOT, V85, P459, DOI 10.1007/s00253-009-2267-2; FU DT, 1994, CARBOHYD RES, V261, P173, DOI 10.1016/0008-6215(94)84015-6; GREEN ED, 1988, J BIOL CHEM, V263, P18253; Motohashi T, 2005, BIOCHEM BIOPH RES CO, V326, P564, DOI 10.1016/j.bbrc.2004.11.060; ELDER JH, 1982, P NATL ACAD SCI-BIOL, V79, P4540, DOI 10.1073/pnas.79.15.4540; Imperiali B, 1999, CURR OPIN CHEM BIOL, V3, P643, DOI 10.1016/S1367-5931(99)00021-6; TRETTER V, 1991, EUR J BIOCHEM, V199, P647, DOI 10.1111/j.1432-1033.1991.tb16166.x; Lee JM, 2012, BIOTECHNOL LETT, V34, P1773, DOI 10.1007/s10529-012-0971-y; Harvey DJ, 2000, J AM SOC MASS SPECTR, V11, P564, DOI 10.1016/S1044-0305(00)00122-7; Mitsudome T, 2014, APPL BIOCHEM BIOTECH, V172, P3978, DOI 10.1007/s12010-014-0814-5; Apweiler R, 1999, BBA-GEN SUBJECTS, V1473, P4, DOI 10.1016/S0304-4165(99)00165-8; BARSOMIAN GD, 1990, J BIOL CHEM, V265, P6967; DASILVA MLC, 1995, ARCH BIOCHEM BIOPHYS, V318, P465, DOI 10.1006/abbi.1995.1255; Hua L, 2014, PROTEIN EXPRES PURIF, V97, P17, DOI 10.1016/j.pep.2014.02.004; Kawakami N, 2008, MOL BIOTECHNOL, V40, P180, DOI 10.1007/s12033-008-9074-3; KUHN P, 1994, BIOCHEMISTRY-US, V33, P11699, DOI 10.1021/bi00205a005; KUHN P, 1995, J BIOL CHEM, V270, P29493; LEMP D, 1990, J BIOL CHEM, V265, P15606; Loo T, 2002, PROTEIN EXPRES PURIF, V24, P90, DOI 10.1006/prep.2001.1555; Mon H, 2013, APPL MICROBIOL BIOT, V97, P6813, DOI 10.1007/s00253-012-4583-1; MUSSAR KJ, 1989, J BIOCHEM BIOPH METH, V20, P53, DOI 10.1016/0165-022X(89)90081-X; NORRIS GE, 1994, STRUCTURE, V2, P1049, DOI 10.1016/S0969-2126(94)00108-1; O'Reilly D.R., 1992, BACULOVIRUS EXPRESSI, P216; Ono Chikako, 2007, Journal of Insect Biotechnology and Sericology, V76, P161; PLUMMER TH, 1984, J BIOL CHEM, V259, P700; Soejima Y, 2013, CENT EUR J BIOL, V8, P1, DOI 10.2478/s11535-012-0112-6; TARENTINO AL, 1990, J BIOL CHEM, V265, P6961	28	0	0	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1073-6085	1559-0305		MOL BIOTECHNOL	Mol. Biotechnol.	AUG	2015	57	8					735	745		10.1007/s12033-015-9866-1		11	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology	CM9SL	WOS:000358049200007		
J	Nakamura, M; Suzuki, A; Akada, J; Yarimizu, T; Iwakiri, R; Hoshida, H; Akada, R				Nakamura, Mikiko; Suzuki, Ayako; Akada, Junko; Yarimizu, Tohru; Iwakiri, Ryo; Hoshida, Hisashi; Akada, Rinji			A Novel Terminator Primer and Enhancer Reagents for Direct Expression of PCR-Amplified Genes in Mammalian Cells	MOLECULAR BIOTECHNOLOGY			English	Article						Transfection enhancer; Terminator primer; Linear DNA; Polyethylene glycol; Transfer RNA (tRNA); PCR; Oligonucleotide primer; Expression construct	DNA TOPOLOGY; TRANSFECTION PROPERTIES; SYSTEMATIC MUTAGENESIS; HIGH-THROUGHPUT; CMV PROMOTER; HOST-CELLS; VECTOR; CONSTRUCTION; EFFICIENCY; TRANSCRIPTION	Escherichia coli plasmids are commonly used for gene expression experiments in mammalian cells, while PCR-amplified DNAs are rarely used even though PCR is a much faster and easier method to construct recombinant DNAs. One difficulty may be the limited amount of DNA produced by PCR. For direct utilization of PCR-amplified DNA in transfection experiments, efficient transfection with a smaller amount of DNA should be attained. For this purpose, we investigated two enhancer reagents, polyethylene glycol and tRNA, for a chemical transfection method. The addition of the enhancers to a commercial transfection reagent individually and synergistically exhibited higher transfection efficiency applicable for several mammalian cell culture lines in a 96-well plate. By taking advantage of a simple transfection procedure using PCR-amplified DNA, SV40 and rabbit beta-globin terminator lengths were minimized. The terminator length is short enough to design in oligonucleotides; thus, terminator primers can be used for the construction and analysis of numerous mutations, deletions, insertions, and tag-fusions at the 3'-terminus of any gene. The PCR-mediated gene manipulation with the terminator primers will transform gene expression by allowing for extremely simple and high-throughput experiments with small-scale, multi-well, and mammalian cell cultures.	[Nakamura, Mikiko; Akada, Junko] Yamaguchi Univ, Innovat Ctr, Ube, Yamaguchi 7558611, Japan; [Suzuki, Ayako; Yarimizu, Tohru; Hoshida, Hisashi; Akada, Rinji] Yamaguchi Univ, Dept Appl Mol Biosci, Grad Sch Med, Ube, Yamaguchi 7558611, Japan; [Nakamura, Mikiko; Hoshida, Hisashi; Akada, Rinji] Yamaguchi Univ, Ctr Biomed Engn, Ube, Yamaguchi 7558611, Japan; [Iwakiri, Ryo] KOHJIN Life Sci Co Ltd, Saiki 8768580, Japan	Nakamura, M (reprint author), Yamaguchi Univ, Innovat Ctr, Ube, Yamaguchi 7558611, Japan.	nakamura@crc.yamaguchi-u.ac.jp			JSPS KAKENHI [25660080, 24658096]; Adaptable and Seamless Technology Transfer Program through Target-Driven RD (JST, Japan)	We would like to thank Yukie Misumi for technical assistance. This study was supported in part by the JSPS KAKENHI (Grant Nos. 25660080, 24658096) and the Adaptable and Seamless Technology Transfer Program through Target-Driven R&D (JST, Japan), and the YU "Pump-Priming Program" for fostering Research activities.	Welsh DK, 2005, CURR OPIN BIOTECH, V16, P73, DOI 10.1016/j.copbio.2004.12.006; Shen H, 2006, BIOPHYS J, V91, P639, DOI 10.1529/biophysj.105.077404; Teschendorf C, 2002, ANTICANCER RES, V22, P3325; Grabenhorst E, 1999, GLYCOCONJUGATE J, V16, P81, DOI 10.1023/A:1026466408042; NIWA H, 1991, GENE, V108, P193; Remaut K, 2006, J CONTROL RELEASE, V115, P335, DOI 10.1016/j.jconrel.2006.08.009; CHEN SU, 1993, J STEROID BIOCHEM, V44, P347, DOI 10.1016/0960-0760(93)90238-R; Bell MR, 2013, PROTEIN SCI, V22, P1466, DOI 10.1002/pro.2356; Nakamura M, 2014, METHODS MOL BIOL, V1116, P165, DOI 10.1007/978-1-62703-764-8_12; Matsumoto A, 2011, BIOTECHNIQUES, V51, P55, DOI 10.2144/000113705; Burre J, 2012, J NEUROSCI, V32, P15227, DOI 10.1523/JNEUROSCI.3545-12.2012; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Li WJ, 2007, PHARM RES, V24, P438, DOI 10.1007/s11095-006-9180-5; Qureshi SA, 2007, BIOTECHNIQUES, V42, P91, DOI 10.2144/000112292; Cherng JY, 1999, J CONTROL RELEASE, V60, P343, DOI 10.1016/S0168-3659(99)00089-9; Palmer LR, 2003, BBA-BIOMEMBRANES, V1611, P204, DOI 10.1016/S0005-2736(03)00058-0; SCHIESTL RH, 1989, CURR GENET, V16, P339, DOI 10.1007/BF00340712; Naylor LH, 1999, BIOCHEM PHARMACOL, V58, P749, DOI 10.1016/S0006-2952(99)00096-9; KAWAI S, 1984, MOL CELL BIOL, V4, P1172; Prescher JA, 2010, CURR OPIN CHEM BIOL, V14, P80, DOI 10.1016/j.cbpa.2009.11.001; Fischer W, 2001, MOL MICROBIOL, V42, P1337, DOI 10.1046/j.1365-2958.2001.02714.x; Jiang TT, 2008, BIOTECHNOL GENET ENG, V25, P41; Dai JW, 2012, J BIOTECHNOL, V158, P91, DOI 10.1016/j.jbiotec.2011.11.019; Kamiya H, 2002, GENE THER, V9, P1500, DOI 10.1038/sj.gt.3301831; Safinya CR, 2001, CURR OPIN STRUC BIOL, V11, P440, DOI 10.1016/S0959-440X(00)00230-X; CABBARRERA EL, 1988, GENE, V70, P411, DOI 10.1016/0378-1119(88)90214-4; CHALFIE M, 1995, PHOTOCHEM PHOTOBIOL, V62, P651, DOI 10.1111/j.1751-1097.1995.tb08712.x; Dhanoya A, 2011, J BIOTECHNOL, V155, P377, DOI 10.1016/j.jbiotec.2011.07.023; Elmileik H, 2001, J BIOCHEM-TOKYO, V129, P671; FALCKPEDERSEN E, 1985, CELL, V40, P897, DOI 10.1016/0092-8674(85)90349-6; Fritze CE, 2000, METHOD ENZYMOL, V327, P3; Gopalakrishnan Bagavathi, 2009, V480, P31, DOI 10.1007/978-1-59745-429-2_3; Hoat TX, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-69; Hsu CYM, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-23; Iakhiaeva E, 2009, PROTEIN SCI, V18, P2183, DOI 10.1002/pro.232; Kim D, 2003, BIOTECHNOL PROGR, V19, P1620, DOI 10.1021/bp0341186; Lejard V, 2014, PLASMID, V74, P1, DOI 10.1016/j.plasmid.2014.05.001; PETITCLERC D, 1995, J BIOTECHNOL, V40, P169, DOI 10.1016/0168-1656(95)00047-T; Pradhan K, 2012, CYTOTECHNOLOGY, V64, P613, DOI 10.1007/s10616-012-9435-4; PRASHER DC, 1995, TRENDS GENET, V11, P320, DOI 10.1016/S0168-9525(00)89090-3; Ross PC, 1999, BBA-BIOMEMBRANES, V1421, P273, DOI 10.1016/S0005-2736(99)00132-7; Roure A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000916; Seng KC, 2008, EUR J HUM GENET, V16, P554, DOI 10.1038/ejhg.2008.12; SUGIYAMA H, 1988, GENE, V65, P135; Susa T, 2008, MOL BIOL REP, V35, P313, DOI 10.1007/s11033-007-9088-0; Suzuki H, 2001, GENOME RES, V11, P1758, DOI 10.1101/gr.180101; Sykes KF, 1999, NAT BIOTECHNOL, V17, P355; Tan R, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl449; WEINTRAUB H, 1986, CELL, V46, P115, DOI 10.1016/0092-8674(86)90865-2; WILKINSON GWG, 1992, NUCLEIC ACIDS RES, V20, P2233, DOI 10.1093/nar/20.9.2233; WITZGALL R, 1994, ANAL BIOCHEM, V223, P291, DOI 10.1006/abio.1994.1587; Xiao JH, 2007, MOL BIOTECHNOL, V35, P15, DOI 10.1385/MB:35:1:15; Xin W, 2003, BIOTECHNOL LETT, V25, P1913, DOI 10.1023/B:BILE.0000003981.60247.48; You LM, 2010, MOL BIOL REP, V37, P2757, DOI 10.1007/s11033-009-9814-x; Zhao X, 2013, J ANAL METHODS CHEM, V2013	55	1	1	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1073-6085	1559-0305		MOL BIOTECHNOL	Mol. Biotechnol.	AUG	2015	57	8					767	780		10.1007/s12033-015-9870-5		14	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology	CM9SL	WOS:000358049200010		
J	Baba, T; Sakamoto, Y; Kasamatsu, A; Minakawa, Y; Yokota, S; Higo, M; Yokoe, H; Ogawara, K; Shiiba, M; Tanzawa, H; Uzawa, K				Baba, Takao; Sakamoto, Yosuke; Kasamatsu, Atsushi; Minakawa, Yasuyuki; Yokota, Satoshi; Higo, Morihiro; Yokoe, Hidetaka; Ogawara, Katsunori; Shiiba, Masashi; Tanzawa, Hideki; Uzawa, Katsuhiro			Persephin: A potential key component in human oral cancer progression through the RET receptor tyrosine kinase-mitogen-activated protein kinase signaling pathway	MOLECULAR CARCINOGENESIS			English	Article						persephin; oral squamous cell carcinoma; proliferation; cell-cycle arrest; cyclin-dependent kinase inhibitors	SQUAMOUS-CELL CARCINOMA; NEUROTROPHIC FACTOR; GDNF-FAMILY; CYCLIN D1; DOPAMINERGIC-NEURONS; THYROID-CANCER; MAPK PATHWAYS; EXPRESSION; NEURTURIN; REGULATOR	Persephin (PSPN) is a neurotrophic factor of the glial cell line-derived neurotrophic factor (GDNF) family that promotes survival of multiple populations of neurons. Little is known about the relevance of PSPN in human malignancy including oral squamous cell carcinoma (OSCC). This study was undertaken to evaluate PSPN mRNA and protein expression by analyzing cellular proliferation and the cell cycle in PSPN knockdown cells in vitro. PSPN mRNA and protein were significantly (P<0.05) up-regulated in OSCC-derived cells compared with human normal oral keratinocytes (n=7). Cellular proliferation decreased significantly (P<0.05) in PSPN knockdown cells with reduced receptor tyrosine kinase (RTK) signaling, and cell-cycle arrest at the G1 phase resulted from up-regulation of the cyclin-dependent kinase inhibitors (p21(Cip1), p27(Kip1), p15(INK4B), and p16(INK4A)). Furthermore, the PSPN protein expression in 101 primary OSCCs was significantly (P<0.05) higher than in normal counterparts. Among the clinical variables analyzed, overexpression of PSPN also was related closely (P<0.05) to tumoral size. Our results suggested that PSPN is a possible key regulator of OSCC progression via PSPN-RET-mitogen-activated protein kinase activation and that PSPN overexpression may have diagnostic potential for OSCC. (c) 2013 Wiley Periodicals, Inc.	[Baba, Takao; Minakawa, Yasuyuki; Yokota, Satoshi; Tanzawa, Hideki; Uzawa, Katsuhiro] Chiba Univ, Grad Sch Med, Dept Clin Mol Biol, Chuo Ku, Chiba 2608670, Japan; [Sakamoto, Yosuke; Kasamatsu, Atsushi; Higo, Morihiro; Ogawara, Katsunori; Shiiba, Masashi; Tanzawa, Hideki; Uzawa, Katsuhiro] Chiba Univ Hosp, Dept Dent Oral & Maxillofacial Surg, Chiba, Japan; [Yokoe, Hidetaka] Natl Def Med Coll Hosp, Dept Oral & Maxillofacial Surg, Res Inst, Tokorozawa, Saitama, Japan	Uzawa, K (reprint author), Chiba Univ, Grad Sch Med, Dept Clin Mol Biol, Chuo Ku, 1-8-1 Inohana, Chiba 2608670, Japan.						Akerud P, 2002, MOL CELL NEUROSCI, V21, P205, DOI 10.1006/mvne.2002.1171; Allmendinger A, 2003, MECH DEVELOP, V120, P299, DOI 10.1016/S0925-4773(02)00455-0; Mitrea DM, 2012, BIOL CHEM, V393, P259, DOI 10.1515/hsz-2011-0254; LIN LFH, 1993, SCIENCE, V260, P1130, DOI 10.1126/science.8493557; Meloche S, 2007, ONCOGENE, V26, P3227, DOI 10.1038/sj.onc.1210414; Malumbres M, 2001, NAT REV CANCER, V1, P222, DOI 10.1038/35106065; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; Kasamatsu A, 2005, INT J MOL MED, V16, P269; Wada T, 2004, ONCOGENE, V23, P2838, DOI 10.1038/sj.onc.1207556; TAM SW, 1994, ONCOGENE, V9, P2663; Durbec P, 1996, NATURE, V381, P789, DOI 10.1038/381789a0; Friday BB, 2008, CLIN CANCER RES, V14, P342, DOI 10.1158/1078-0432.CCR-07-4790; Koike H, 2005, CONNECT TISSUE RES, V46, P117, DOI 10.1080/03008200591008437; Verburg FA, 2010, HORM METAB RES, V42, P736, DOI 10.1055/s-0030-1254132; Yamano Y, 2008, INT J ONCOL, V32, P1001; Todd R, 2002, CRIT REV ORAL BIOL M, V13, P51; Airaksinen MS, 2002, NAT REV NEUROSCI, V3, P383, DOI 10.1038/nrn812; Yamatoji M, 2012, INT J CANCER, V130, P2903, DOI 10.1002/ijc.26328; Ogoshi K, 2011, INT J ONCOL, V39, P329, DOI 10.3892/ijo.2011.1046; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Jing SQ, 1996, CELL, V85, P1113, DOI 10.1016/S0092-8674(00)81311-2; Mebratu Y, 2009, CELL CYCLE, V8, P1168; Zarubin T, 2005, CELL RES, V15, P11, DOI 10.1038/sj.cr.7290257; Takahashi M, 2001, CYTOKINE GROWTH F R, V12, P361, DOI 10.1016/S1359-6101(01)00012-0; Baloh RH, 1998, NEURON, V21, P1291, DOI 10.1016/S0896-6273(00)80649-2; Endo Y, 2004, INT J CANCER, V110, P225, DOI 10.1002/ijc.20118; Liu Y, 2010, J ATHEROSCLER THROMB, V17, P901; Wells SA, 2009, CLIN CANCER RES, V15, P7119, DOI 10.1158/1078-0432.CCR-08-2742; Ishiwata J, 2012, INT J ONCOL, V40, P47, DOI 10.3892/ijo.2011.1178; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Zihlmann KB, 2005, BRAIN RES BULL, V68, P42, DOI 10.1016/j.brainresbull.2004.10.012; Kotzbauer PT, 1996, NATURE, V384, P467, DOI 10.1038/384467a0; MUSGROVE EA, 1994, P NATL ACAD SCI USA, V91, P8022, DOI 10.1073/pnas.91.17.8022; Sakuma K, 2010, J CANCER RES CLIN, V136, P553, DOI 10.1007/s00432-009-0689-y; Lombardi DP, 1999, CANCER RES, V59, P5724; Robinson MJ, 1997, CURR OPIN CELL BIOL, V9, P180, DOI 10.1016/S0955-0674(97)80061-0; Bhatt KV, 2005, ONCOGENE, V24, P3459, DOI 10.1038/sj.onc.1208544; Chapnick DA, 2011, CELL BIOSCI, V1, DOI 10.1186/2045-3701-1-42; Diaz-Rodriguez E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027583; Ferrero M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028602; Golden JP, 2003, EXP NEUROL, V184, P447, DOI 10.1016/j.expneurol.2003.07.999; Iyoda M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014082; Izzo JG, 1998, ONCOGENE, V17, P2313, DOI 10.1038/sj.onc.1202153; Jing SQ, 1997, J BIOL CHEM, V272, P33111, DOI 10.1074/jbc.272.52.33111; Kisielewska J, 2009, DEV BIOL, V334, P383, DOI 10.1016/j.ydbio.2009.07.043; Lee DCW, 2002, ONCOGENE, V21, P5582, DOI 10.1038/sj.onc.1205741; Lindahl M, 2001, J BIOL CHEM, V276, P9344, DOI 10.1074/jbc.M008279200; Milbrandt J, 1998, NEURON, V20, P245, DOI 10.1016/S0896-6273(00)80453-5; Mountzios G, 2008, CLIN CANCER RES, V14, P4096, DOI 10.1158/1078-0432.CCR-07-4150; Naveilhan P, 1998, P NATL ACAD SCI USA, V95, P1295, DOI 10.1073/pnas.95.3.1295; Rosenblad C, 2000, MOL CELL NEUROSCI, V15, P199, DOI 10.1006/mcne.1999.0817; Shrestha Y, 2012, ONCOGENE, V31, P3397, DOI 10.1038/onc.2011.515; Thompson J, 1998, MOL CELL NEUROSCI, V11, P117, DOI 10.1006/mcne.1998.0682; Uchida F, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-321; Veit C, 2004, CANCER RES, V64, P5291, DOI 10.1158/0008-5472.CAN-04-1112; Worby CA, 1996, J BIOL CHEM, V271, P23619	56	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0899-1987	1098-2744		MOL CARCINOGEN	Mol. Carcinog.	AUG	2015	54	8					608	617		10.1002/mc.22127		10	Biochemistry & Molecular Biology; Oncology	Biochemistry & Molecular Biology; Oncology	CM8OF	WOS:000357960800003		
J	Liu, YN; Xin, X				Liu, Yannian; Xin, Xin			Set-point control for folded configuration of 3-link underactuated gymnastic planar robot: new results beyond the swing-up control	MULTIBODY SYSTEM DYNAMICS			English	Article						Underactuated multibody systems; 3-link gymnastic robot; Set-point control; Folded configuration; Global motion analysis; Lyapunov stability theory	GLOBAL TRACKING CONTROL; MECHANICAL SYSTEMS; STABILIZATION; AIRCRAFT; PENDUBOT; DYNAMICS; ACROBOT; JOINT	This paper concerns a set-point control for a folded configuration of a 3-link gymnastic planar robot moving in the vertical plane with the first joint being passive and the others being active. To realize the goal configuration of the kip motion of a human gymnast on the high bar, the control objective is to drive the robot from any initial state to any small neighborhood of the up-down-down equilibrium point and then balance the 3-link robot about that point, where link 1 is in the upright position and links 2 and 3 are in the downward position. This paper uses the energy-based control approach and the notion of virtual composite link to design a controller and provides a global motion analysis of the 3-link robot. Different from the swing-up control problem for which three links are fully stretched out in the upright position at the goal configuration, a new result of this paper is that in addition to some conditions on control parameters, a constraint on the mechanical parameters of the 3-link robot is needed for achieving the set-point control of the folded configuration (links 1 and 2 are folded). The proposed constraint guarantees the linear controllability at the up-down equilibrium point of the Acrobot (degenerated from the 3-link robot) whose actuated second link is the merge of links 2 and 3 of 3-link robot with all possible relative angles. The simulation results for two 3-link robots are presented to validate the obtained theoretical results.	[Liu, Yannian] Okayama Univ, Grad Sch Nat Sci & Technol, Okayama 7008530, Japan; [Xin, Xin] Okayama Prefectural Univ, Fac Comp Sci & Syst Engn, Okayama 7191197, Japan	Xin, X (reprint author), Okayama Prefectural Univ, Fac Comp Sci & Syst Engn, 111 Kuboki, Okayama 7191197, Japan.	ynliujp@yahoo.co.jp; xxin@cse.oka-pu.ac.jp			JSPS KAKENHI [22560452, 26420425]	The authors wish to thank the anonymous reviewers for their valuable and constructive comments and suggestions for improving the quality and readability of this paper. The authors wish to thank prof. M. Yamakita for helpful discussion on this paper. This work was supported in part by JSPS KAKENHI Grant Numbers 22560452, 26420425.	Sun N, 2012, IEEE T IND ELECTRON, V59, P4723, DOI 10.1109/TIE.2012.2183837; Jankovic M, 1996, IEEE T CONTR SYST T, V4, P292, DOI 10.1109/87.491203; Lynch KM, 2000, INT J ROBOT RES, V19, P1171, DOI 10.1177/02783640022068011; Xin X, 2007, INT J ROBUST NONLIN, V17, P1503, DOI 10.1002/rnc.1184; Zilic T, 2013, MULTIBODY SYST DYN, V29, P1, DOI 10.1007/s11044-012-9303-1; Ma XQ, 2002, P AMER CONTR CONF, P1001; Jiang ZP, 2002, AUTOMATICA, V38, P301, DOI 10.1016/S0005-1098(01)00199-6; Xin X, 2007, IEEE T ROBOT, V23, P1277, DOI 10.1109/TRO.2007.909805; Fang YC, 2012, IEEE T CONTR SYST T, V20, P241, DOI 10.1109/TCST.2011.2107910; Reyhanoglu M, 1999, IEEE T AUTOMAT CONTR, V44, P1663, DOI 10.1109/9.788533; Chemori A, 2008, INT J ROBUST NONLIN, V18, P876, DOI 10.1002/rnc.1248; De Luca A, 2001, IEEE ASME INT C ADV, P855, DOI 10.1109/AIM.2001.936778; Do K.D., 2005, IEEE T AUTOM CONTROL, V48, P2212; Fantoni I, 2000, IEEE T AUTOMAT CONTR, V45, P725, DOI 10.1109/9.847110; Furuta K., 1991, IND ELECT CONTROL IN, V3, P2193; Khalil H.K., 2002, NONLINEAR SYSTEMS; Kolesnichenko O, 2002, SYST CONTROL LETT, V45, P121, DOI 10.1016/S0167-6911(01)00170-0; Ortega R, 2002, IEEE T AUTOMAT CONTR, V47, P1218, DOI 10.1109/TAC.2002.800770; Ovalle DM, 2011, NONLINEAR ANAL-REAL, V12, P1654, DOI 10.1016/j.nonrwa.2010.11.001; Qian CJ, 2000, IEEE DECIS CONTR P, P2090; Sastry S., 1999, NONLINEAR SYSTEMS AN; Seifried R, 2012, MULTIBODY SYST DYN, V27, P75, DOI 10.1007/s11044-011-9261-z; SPONG MW, 1995, IEEE CONTR SYST MAG, V15, P49, DOI 10.1109/37.341864; Spong M. W., 1996, P IFAC WORLD C SAN F, P431; Suzuki K., 1996, T JPN SOC MECH ENG-C, V62, P241; Ulbrich H, 2002, MULTIBODY SYST DYN, V7, P229, DOI 10.1023/A:1014448907708; Yannick A., 2011, MULTIBODY SYST DYN, V25, P65	27	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1384-5640	1573-272X		MULTIBODY SYST DYN	Multibody Syst. Dyn.	AUG	2015	34	4					349	372		10.1007/s11044-014-9432-9		24	Mechanics	Mechanics	CN1FS	WOS:000358164200003		
J	Chen, HL; Ito, Y; Sawamukai, M; Tokunaga, T				Chen, Huali; Ito, Yuka; Sawamukai, Marie; Tokunaga, Tomochika			Flood hazard assessment in the Kujukuri Plain of Chiba Prefecture, Japan, based on GIS and multicriteria decision analysis	NATURAL HAZARDS			English	Article						Flood hazard; GIS; Multicriteria analysis; Analytic hierarchy process; Sensitivity analysis	SENSITIVITY-ANALYSIS; MODEL; MANAGEMENT; DESIGN; STORMS; RIVER; AHP	A simple flood hazard assessment based on GIS and multicriteria decision analysis was presented, and the sensitivity analysis was applied to evaluate the uncertainty of input factors. The location chosen for the study is the Kujukuri Plain, Chiba Prefecture, Japan. The model incorporates six factors: river system, elevation, depression area, ratio of impermeable area, detention ponds, and precipitation. A hazard map for the year 2004, as an example, was obtained. The method of analytic hierarchy process was applied to calculate the weighting values of each factor. The hazard map was compared with the actual flood area, and good coincidence was found between them. The relative importance and uncertainty of the six input factors and weights were evaluated by using the global sensitivity analysis, i.e., extended FAST method, and the results showed a robust behavior of the model. The flood hazard assessment method presented here is meaningful for the flood management and environment protection in the area under the similar condition as this study.	[Chen, Huali; Ito, Yuka; Tokunaga, Tomochika] Univ Tokyo, Sch Frontier Sci, Dept Environm Syst, Tokyo 2778563, Japan; [Sawamukai, Marie] VisionTech Inc, Tsukuba, Ibaraki 3050045, Japan	Chen, HL (reprint author), Zhejiang Gongshang Univ, Sch Environm Sci & Engn, Hangzhou 310018, Zhejiang, Peoples R China.	hualichen57@126.com			Keiyo Natural Gas Association	We would like to express our sincere gratitude to the Keiyo Natural Gas Association for supporting this study and Center for Spatial Information Science (CSIS), The University of Tokyo, for providing the residential maps (the CSIS Joint Research, No. 524). Special thanks go to the anonymous reviewers and editor for their critical comments that improved the quality of the manuscript.	Dewan AM, 2007, WATER RESOUR MANAG, V21, P1601, DOI 10.1007/s11269-006-9116-1; Bates PD, 2000, J HYDROL, V236, P54, DOI 10.1016/S0022-1694(00)00278-X; COTTER SC, 1979, BIOMETRIKA, V66, P317; Saltelli A, 1999, TECHNOMETRICS, V41, P39, DOI 10.2307/1270993; Chang NB, 2008, J ENVIRON MANAGE, V87, P139, DOI 10.1016/j.jenvman.2007.01.011; MORRIS MD, 1991, TECHNOMETRICS, V33, P161, DOI 10.2307/1269043; Gamper CD, 2006, NAT HAZARD EARTH SYS, V6, P293; Lee G, 2013, NAT HAZARD EARTH SYS, V13, P1293, DOI 10.5194/nhess-13-1293-2013; Zou Q, 2013, STOCH ENV RES RISK A, V27, P525, DOI 10.1007/s00477-012-0598-5; Doornkamp JC, 1998, J ENVIRON MANAGE, V52, P327, DOI 10.1006/jema.1998.0188; Crosetto M, 2001, INT J GEOGR INF SCI, V15, P415, DOI 10.1080/13658810110053125; Meyer V, 2009, NAT HAZARDS, V48, P17, DOI 10.1007/s11069-008-9244-4; HUFF FA, 1967, WATER RESOUR RES, V3, P1007, DOI 10.1029/WR003i004p01007; Sinha R, 2008, PHOTONIRVACHAK-J IND, V36, P335; Chan FTS, 2000, J MATER PROCESS TECH, V107, P330, DOI 10.1016/S0924-0136(00)00679-8; Ayalew L, 2005, GEOMORPHOLOGY, V65, P15, DOI 10.1016/j.geomorph.2004.06.010; Malczewski J, 2006, INT J GEOGR INF SCI, V20, P703, DOI 10.1080/13658810600661508; Arnold JG, 1998, J AM WATER RESOUR AS, V34, P73, DOI 10.1111/j.1752-1688.1998.tb05961.x; Anselmo V, 1996, J HYDROL, V175, P533, DOI 10.1016/S0022-1694(96)80023-0; Ballesteros-Canovas JA, 2013, WATER RESOUR MANAG, V27, P3051, DOI 10.1007/s11269-013-0332-1; Banai-Kashami AR, 1989, ENVIRON MANAGE, V13, P685; Bettonvil B, 1990, DETECTION IMP FACTOR; Cheng CH, 1997, EUR J OPER RES, V96, P343, DOI 10.1016/S0377-2217(96)00026-4; Chiba Prefecture, 2005, FLOOD REP CHIB PREF; Chiba Prefecture Chosei Civil Engineering Office, 2004, SEC GRAD RIV NAB RIV; Chiba Prefecture Chosei Regional Development Center, 2005, SEC GRAD RIV ICH RIV; COWEN DJ, 1988, PHOTOGRAMM ENG REM S, V54, P1551; Downs PW, 2000, J ENVIRON MANAGE, V58, P249, DOI 10.1006/jema.2000.0327; Environmental and Community Affairs Department Chiba Prefecture, 2007, LEV RES CHIB PREF; Furdada G, 2008, NAT HAZARDS, V45, P183, DOI 10.1007/s11069-007-9156-8; Hunt A, 2011, CLIMATIC CHANGE, V104, P13, DOI 10.1007/s10584-010-9975-6; Japan Meteorological Agency, 2004, RAD ANEDAS PREC 2004; Japan Meteorological Agency, 2014, JAP MET AG MET STAT; Malczewski J., 1999, GIS MULTICRITERIA DE; Moriwaki H, 1979, QUATERNARY RES, V18, P1; Obanawa H, 2010, IAHS PUBL, V339, P17; Saaty TL, 1980, ANAL HIERARCHY PROCE; Saltelli A., 2004, SENSITIVITY ANAL PRA; Silverman BW, 1986, DENSITY ESTIMATION S; Sobol I. M., 1993, MATH MODEL COMPUT EX, V1, P407, DOI DOI 10.2514/1.28511; Sugimoto S, 2003, IAHS PUBL, V282, P51; Takagi Y, 2001, C JAP SOC CIV ENG, P500; Tamura T, 2007, SEDIMENTOLOGY, V54, P1149, DOI 10.1111/j.1365-3091.2007.00876.x; WANG JQ, 1987, J HYDROL, V96, P279, DOI 10.1016/0022-1694(87)90159-4; Whalen TM, 2002, J HYDROL, V268, P177, DOI 10.1016/S0022-1694(02)00174-9	45	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0921-030X	1573-0840		NAT HAZARDS	Nat. Hazards	AUG	2015	78	1					105	120		10.1007/s11069-015-1699-5		16	Geosciences, Multidisciplinary; Meteorology & Atmospheric Sciences; Water Resources	Geology; Meteorology & Atmospheric Sciences; Water Resources	CM2KE	WOS:000357507900007		
J	Custer, R; Nishijima, K				Custer, Rocco; Nishijima, Kazuyoshi			Flood vulnerability assessment of residential buildings by explicit damage process modelling	NATURAL HAZARDS			English	Article						Flood; Vulnerability; Residential building; Damage process modelling; Engineering vulnerability model	AUGUST 2002	The present paper introduces a vulnerability modelling approach for residential buildings in flood. The modelling approach explicitly considers relevant damage processes, i.e. water infiltration into the building, mechanical failure of components in the building envelope and damage from water contact. Damage processes are modelled at a building component level, utilising engineering models where possible. The modelling approach is presented in general terms, which should be applicable to a large variety of building types. The paper illustrates the implementation of the approach for a 2-storey masonry building. Results are presented in terms of a parameter study for several building parameters and hazard characteristics, as well as, in terms of a comparison with damage data and literature vulnerability models. The parameter study indicates that hazard characteristics and building characteristics impact damage ratios as expected. Furthermore, the results are comparable to vulnerability models in literature. Strengths and shortcomings of the model are discussed. The modelling approach is considered as a step towards the establishment of vulnerability models that can serve as a basis for engineering decision-making for flood risk management for residential buildings.	[Custer, Rocco] Tech Univ Denmark, Civil Engn, DK-2800 Lyngby, Denmark; [Nishijima, Kazuyoshi] Kyoto Univ, DPRI, Uji, Kyoto 6110011, Japan	Custer, R (reprint author), Tech Univ Denmark, Civil Engn, Brovej 118, DK-2800 Lyngby, Denmark.	rocu@byg.dtu.dk					Aitchison J, 1986, STAT ANAL COMPOSITIO; Kreibich H, 2005, NAT HAZARD EARTH SYS, V5, P117; Kreibich H, 2009, NAT HAZARD EARTH SYS, V9, P1679; Cammerer H, 2013, NAT HAZARD EARTH SYS, V13, P3063, DOI 10.5194/nhess-13-3063-2013; Kelman I, 2004, ENG GEOL, V73, P297, DOI 10.1016/j.enggeo.2004.01.010; Jongman B, 2012, NAT HAZARD EARTH SYS, V12, P3733, DOI 10.5194/nhess-12-3733-2012; Merz B, 2010, NAT HAZARD EARTH SYS, V10, P1697, DOI 10.5194/nhess-10-1697-2010; Buchele B, 2006, NAT HAZARD EARTH SYS, V6, P485; Nadal NC, 2010, J WATER RES PL-ASCE, V136, P327, DOI 10.1061/(ASCE)WR.1943-5452.0000036; Pistrika AK, 2010, NAT HAZARDS, V54, P413, DOI 10.1007/s11069-009-9476-y; De Risi R, 2013, NAT HAZARDS, V69, P1003, DOI 10.1007/s11069-013-0749-0; Black RD, 1975, FLOOD PROOFING RURAL; BMVBW, 2005, BMVBW BUND VERK BAU; Clarke LV, 1997, INT J PRES VES PIP, V71, P71, DOI 10.1016/S0308-0161(96)00056-7; Clausen L, 1989, THESIS SCH GEOGRAPHY; Custer R, 2012, 15 AS PAC S STRUCT R; Elliott C, 2002, FRIP45 CIRIA; ETHERIDGE DW, 1977, BUILD ENVIRON, V12, P181, DOI 10.1016/0360-1323(77)90016-6; HOWAS, 2012, HOWAS 21 WEBB INF HO; JCSS, 2001, PROB MOD COD; JCSS, 2008, RISK ASS ENG; Jha AK, 2012, CITIES AND FLOODING: A GUIDE TO INTEGRATED URBAN FLOOD RISK MANAGEMENT FOR THE 21ST CENTURY, P1, DOI 10.1596/978-0-8213-8866-2; Joseph R, 2014, DEV COMPREHENSIVE SY; Kelman I, 2002, THESIS U CAMBRIDGE C; Kelman I., 2003, MASONRY INT, V16, P51; Kelman I, 2003, P I CIVIL ENG-MUNIC, V156, P207; Maiwald H, 2011, ERMITTLUNG HOCHWASSE; Mazzorana B, 2014, HYDROL EARTH SYST SC, V18, P3817, DOI 10.5194/hess-18-3817-2014; Messner F., 2007, EVALUATING FLOOD DAM; Narasimhan H, 2012, THESIS ETH ZURICH ZU; Nishijima K, 2009, STRUCT SAF, V31, P168, DOI 10.1016/j.strusafe.2008.06.016; Penning-Rowsell E., 2010, BENEFITS FLOOD COAST; Penning-Rowsell E. C., 1977, BENEFITS FLOOD ALLEV; Penning-Rowsell EC, 1981, P INT C FLOOD DIS NE; Roos W, 2003, DELFT CLUSTER PUBLIC; Scawthorn C, 2006, NAT HAZARDS REV, P7; Schroter K, 2014, WATER RESOUR RES, V50, P3378, DOI 10.1002/2013WR014396; Smith JA, 1994, WATER SA, V20, P231; Soetanto R, 2004, FLOOD DAMAGED PROPER; Thieken AH, 2005, WATER RESOUR RES, V41, DOI 10.1029/2005WR004177; USACE, 1988, FLOOD PROOF TESTS TE; USACE, 1998, FLOOD PROOF PERF SUC; USACE, 1992, CAT RES DEPTH DAM FU; USACE, 2003, EGM0401 USACE; USACE, 2000, EGM0103 USACE, P1; Vogel K, 2012, P 6 EUR WORKSH PROB; Wingfield J, 2005, WP2C CIRIA	47	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0921-030X	1573-0840		NAT HAZARDS	Nat. Hazards	AUG	2015	78	1					461	496		10.1007/s11069-015-1725-7		36	Geosciences, Multidisciplinary; Meteorology & Atmospheric Sciences; Water Resources	Geology; Meteorology & Atmospheric Sciences; Water Resources	CM2KE	WOS:000357507900025		
J	Baborie, A; Griffiths, TD; Jaros, E; Perry, R; McKeith, IG; Burn, DJ; Masuda-Suzukake, M; Hasegawa, M; Rollinson, S; Pickering-Brown, S; Robinson, AC; Davidson, YS; Mann, DMA				Baborie, A.; Griffiths, T. D.; Jaros, E.; Perry, R.; McKeith, I. G.; Burn, D. J.; Masuda-Suzukake, M.; Hasegawa, M.; Rollinson, S.; Pickering-Brown, S.; Robinson, A. C.; Davidson, Y. S.; Mann, D. M. A.			Accumulation of dipeptide repeat proteins predates that of TDP-43 in frontotemporal lobar degeneration associated with hexanucleotide repeat expansions in C9ORF72 gene	NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY			English	Article						C9ORF72; dipeptide repeat proteins; frontotemporal lobar degeneration; hexanucleotide repeat expansion	AMYOTROPHIC-LATERAL-SCLEROSIS; DEMENTIA; PATHOLOGY; CRITERIA; MUTATIONS; C9FTD/ALS; TAU; ALS; FTD	AimsFrontotemporal lobar degeneration (FTLD) and motor neurone disease are linked by the possession of a hexanucleotide repeat expansion in C9ORF72, and both show neuronal cytoplasmic inclusions within cerebellar and hippocampal neurones which are TDP-43 negative but immunoreactive for p62 and dipeptide repeat proteins (DPR), these being generated by a non-ATG RAN translation of the expanded region of the gene. MethodsTwenty-two cases of FTLD from Newcastle were analysed for an expansion in C9ORF72 by repeat primed PCR and Southern blot. Detailed case note analysis was performed, and blinded retrospective clinical impressions were achieved by review of clinical histories. Sections from all major brain regions were immunostained for TDP-43, p62 and DPR. The extent of TDP-43 and DPR pathology in expansion bearers was compared with that in 13 other previously identified cases from the Manchester Brain Bank with established disease. ResultsThree Newcastle patients bearing an expansion in C9ORF72 were identified. These three patients died prematurely, two from bronchopneumonia within 10 months and 3 years of onset, and one from myocardial infarction 3 years after onset. In all three, DPR were plentiful throughout all cerebral cortical regions, hippocampus and cerebellum, but TDP-43 pathological changes were sparse. The severity of DPR pathological changes in these three patients was similar to that in the Manchester series, although the extent of TDP-43 pathology was significantly less. ConclusionWidespread accumulation of DPR within nerve cells may occur much earlier than that of TDP-43 in patients with FTLD bearing expansion in C9ORF72.	[Baborie, A.] Walton Ctr Neurol & Neurosurg, Dept Neuropathol, Liverpool, Merseyside, England; [Griffiths, T. D.] Newcastle Univ, Sch Med, Inst Neurosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Jaros, E.; Perry, R.] Royal Victoria Infirm, Neuropathol Cellular Pathol, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England; [Jaros, E.; Perry, R.; McKeith, I. G.; Burn, D. J.] Newcastle Univ, Inst Ageing & Hlth, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Rollinson, S.; Pickering-Brown, S.] Univ Manchester, Inst Brain Behav & Mental Hlth, Manchester, Lancs, England; [Robinson, A. C.; Davidson, Y. S.; Mann, D. M. A.] Univ Manchester, Salford Royal Hosp, Inst Brain Behav & Mental Hlth, Salford, Lancs, England; [Masuda-Suzukake, M.; Hasegawa, M.] Tokyo Metropolitan Inst Med Sci, Dept Neuropathol & Cell Biol, Tokyo 113, Japan	Mann, DMA (reprint author), Univ Manchester, Salford Royal Fdn NHS Trust, Inst Brain Behav & Mental Hlth, Clin & Cognit Neurosci Res Grp, Salford M6 8HD, Lancs, England.	david.mann@manchester.ac.uk		Pickering-Brown, Stuart/0000-0003-1561-6054	UK NIHR Biomedical Research Centre for Ageing and Age-Related Disease; MRC; Wellcome Trust; UK Medical Research Council [G0400074, G1100540]; Newcastle NIHR Biomedical Research Centre in Ageing and Age Related Diseases award; Alzheimer's Society; Alzheimer's Research UK, as part of the Brains for Dementia Research Project	Dr E. Jaros has been supported by the UK NIHR Biomedical Research Centre for Ageing and Age-Related Disease award to the Newcastle upon Tyne Hospitals NHS Foundation Trust. D.M.A.M. and S.P.-B. also receive funding from MRC and Wellcome Trust which supported this study in part. Tissue for this study was provided partly by the Newcastle Brain Tissue Resource (NBTR) which is funded in part by a grant from the UK Medical Research Council (G0400074, G1100540), by the Newcastle NIHR Biomedical Research Centre in Ageing and Age Related Diseases award to the Newcastle upon Tyne Hospitals NHS Foundation Trust, and by a grant from the Alzheimer's Society and Alzheimer's Research UK, as part of the Brains for Dementia Research Project. Other tissues were provided by the Manchester Brain Bank which is also supported by a grant from the Alzheimer's Society and Alzheimer's Research UK, as part of the Brains for Dementia Research Project.	Josephs KA, 2013, BRAIN, V136, P455, DOI 10.1093/brain/aws324; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; Hodges JR, 2004, ANN NEUROL, V56, P399, DOI 10.1002/ana.20230; BROOKS BR, 1994, J NEUROL SCI, V124, P96, DOI 10.1016/0022-510X(94)90191-0; Mackenzie IR, 2013, ACTA NEUROPATHOL, V126, P859, DOI 10.1007/s00401-013-1181-y; Al-Sarraj S, 2011, ACTA NEUROPATHOL, V122, P691, DOI 10.1007/s00401-011-0911-2; Ash PEA, 2013, NEURON, V77, P639, DOI 10.1016/j.neuron.2013.02.004; King A, 2013, ACTA NEUROPATHOL, V125, P303, DOI 10.1007/s00401-012-1050-0; Neary D, 1998, NEUROLOGY, V51, P1546; Mahoney CJ, 2012, BRAIN, V135, P736, DOI 10.1093/brain/awr361; Whitwell JL, 2012, BRAIN, V135, P794, DOI 10.1093/brain/aws001; Boxer AL, 2011, J NEUROL NEUROSUR PS, V82, P196, DOI 10.1136/jnnp.2009.204081; Mackenzie IRA, 2011, ACTA NEUROPATHOL, V122, P111, DOI 10.1007/s00401-011-0845-8; Mackenzie IRA, 2010, ACTA NEUROPATHOL, V119, P1, DOI 10.1007/s00401-009-0612-2; Proudfoot M, 2014, ACTA NEUROPATHOL, V127, P451, DOI 10.1007/s00401-014-1245-7; Baborie A, 2011, ACTA NEUROPATHOL, V121, P365, DOI 10.1007/s00401-010-0765-z; Murray ME, 2011, ACTA NEUROPATHOL, V122, P673, DOI 10.1007/s00401-011-0907-y; van Blitterswijk M, 2013, NEUROLOGY, V81, P1332, DOI 10.1212/WNL.0b013e3182a8250c; Gijselinck I, 2012, LANCET NEUROL, V11, P54, DOI 10.1016/S1474-4422(11)70261-7; Snowden JS, 2013, AMYOTROPH LAT SCL FR, V14, P172, DOI 10.3109/21678421.2013.765485; Baborie A, 2012, ARCH NEUROL-CHICAGO, V69, P1052, DOI 10.1001/archneurol.2011.3323; Mori K, 2013, SCIENCE, V339, P1335, DOI 10.1126/science.1232927; Snowden JS, 2012, BRAIN, V135, P693, DOI 10.1093/brain/awr355; Davidson Yvonne S, 2014, Acta Neuropathol Commun, V2, P70, DOI 10.1186/2051-5960-2-70; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; Mann David M A, 2013, Acta Neuropathol Commun, V1, P68, DOI 10.1186/2051-5960-1-68; BRUN A, 1994, J NEUROL NEUROSUR PS, V57, P416; THOMPSON P, 1987, BRIT J PSYCHIAT, V151, P206, DOI 10.1192/bjp.151.2.206	28	4	4	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0305-1846	1365-2990		NEUROPATH APPL NEURO	Neuropathol. Appl. Neurobiol.	AUG	2015	41	5					601	612		10.1111/nan.12178		12	Clinical Neurology; Neurosciences; Pathology	Neurosciences & Neurology; Pathology	CM8II	WOS:000357942500003		
J	Noda, M; Hiyama, TY				Noda, Masaharu; Hiyama, Takeshi Y.			The Na-x Channel: What It Is and What It Does	NEUROSCIENTIST			English	Review						Na-x channel; Na-level sensor; body-fluid homeostasis; endothelin; essential hypernatremia; autoimmune channelopathy; paraneoplastic neurologic disorder	GATED SODIUM-CHANNEL; SALT-INTAKE BEHAVIOR; IDIOPATHIC HYPOTHALAMIC DYSFUNCTION; SENSORY CIRCUMVENTRICULAR ORGANS; TRAUMATIC BRAIN-INJURY; SUBFORNICAL ORGAN; AUTOIMMUNE CHANNELOPATHIES; ESSENTIAL HYPERNATREMIA; ADIPSIC HYPERNATREMIA; ENDOTHELIN RECEPTOR	Na-x, which is preferentially expressed in the glial cells of sensory circumventricular organs in the brain, is a sodium channel that is poorly homologous to voltage-gated sodium channels. We previously reported that Na-x is a sodium concentration ([Na+])-sensitive, but not a voltage-sensitive channel that is critically involved in body-fluid homeostasis. Na-x-knockout mice do not stop ingesting salt even when dehydrated and transiently develop hypernatremia. [Na+] in body fluids is strictly controlled at 135 to 145 mM in mammals. Although the set point must be within this range, Na-x was shown to have a threshold value of similar to 150 mM for extracellular [Na+] ([Na+](o)) for activation in vitro. Therefore, the [Na+](o) dependency of Na-x in vivo is presumably modified by an as yet unidentified mechanism. We recently demonstrated that the [Na+](o) dependency of Na-x in the subfornical organ was adjusted to the physiological range by endothelin-3. Pharmacological experiments revealed that endothelin receptor B signaling was involved in this modulation of Na-x gating through protein kinase C and ERK1/2 activation. In addition, we identified a case of essential hypernatremia caused by autoimmunity to Na-x. Occurrence of a ganglioneuroma composed of Schwann-like cells that robustly expressed Na-x was likely to induce the autoimmune response in this patient. An intravenous injection of the immunoglobulin fraction of the patient's serum, which contained anti-Na-x antibodies, into mice reproduced the patient's symptoms. This review provides an overview of the physiological functions of Na-x by summarizing our recent studies.	[Noda, Masaharu; Hiyama, Takeshi Y.] Natl Inst Basic Biol, Div Mol Neurobiol, Okazaki, Aichi 4448787, Japan; [Noda, Masaharu; Hiyama, Takeshi Y.] Grad Univ Adv Studies, Sch Life Sci, Okazaki, Aichi, Japan	Noda, M (reprint author), Natl Inst Basic Biol, 5-1 Higashiyama,Myodaiji Cho, Okazaki, Aichi 4448787, Japan.	madon@nibb.ac.jp			Okazaki ORION project;  [24220010]	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: Grant-in-Aid for Scientific Research (S) (24220010) of Education, Culture, Sports, Science and Technology of Japan, and the Okazaki ORION project.	Greaves DR, 2002, INT J HEMATOL, V76, P6, DOI 10.1007/BF02982713; Kedzierski RM, 2001, ANNU REV PHARMACOL, V41, P851, DOI 10.1146/annurev.pharmtox.41.1.851; Matsumoto M, 2012, FEBS LETT, V586, P3805, DOI 10.1016/j.febslet.2012.09.018; Hiyama TY, 2002, NAT NEUROSCI, V5, P511, DOI 10.1038/nn856; DAMOISEAUX JGMC, 1994, IMMUNOLOGY, V83, P140; Noda M, 2013, TRENDS NEUROSCI, V36, P661, DOI 10.1016/j.tins.2013.08.004; SAKURAI T, 1990, NATURE, V348, P732, DOI 10.1038/348732a0; FELIPE A, 1994, J BIOL CHEM, V269, P30125; Akopian AN, 1997, FEBS LETT, V400, P183, DOI 10.1016/S0014-5793(96)01389-0; ARAI H, 1990, NATURE, V348, P730, DOI 10.1038/348730a0; Watanabe E, 2000, J NEUROSCI, V20, P7743; Darnell RB, 2006, SEMIN ONCOL, V33, P270, DOI 10.1053/j.seminoncol.2006.03.008; Shimizu H, 2007, NEURON, V54, P59, DOI 10.1016/j.neuron.2007.03.014; McKinley MJ, 2003, ADV ANAT EMBRYOL CEL, V172, P1; Sasaki Y, 2003, GLIA, V44, P242, DOI 10.1002/glia.10293; Smith PM, 2010, AM J PHYSIOL-REG I, V299, pR405, DOI [10.1152/ajpregu.00103.2010, 10.1152/ajpregu.00103.2010.]; Watanabe E, 2002, NEUROSCI LETT, V330, P109, DOI 10.1016/S0304-3940(02)00708-5; BROADWELL RD, 1993, EXP NEUROL, V120, P245, DOI 10.1006/exnr.1993.1059; Hiyama TY, 2013, CELL METAB, V17, P507, DOI 10.1016/j.cmet.2013.02.018; Petrov T, 2002, NEUROSCIENCE, V115, P275, DOI 10.1016/S0306-4522(02)00345-7; THRASHER TN, 1982, ENDOCRINOLOGY, V110, P1837; Hiyama TY, 2010, NEURON, V66, P508, DOI 10.1016/j.neuron.2010.04.017; Noda M, 2006, NEUROSCIENTIST, V12, P80, DOI 10.1177/1073858405279683; Goldin AL, 2000, NEURON, V28, P365, DOI 10.1016/S0896-6273(00)00116-1; Watanabe E, 2006, AM J PHYSIOL-REG I, V290, pR568, DOI 10.1152/ajpregu.00618.2005; Hiyama TY, 2004, J NEUROSCI, V24, P9276, DOI 10.1523/JNEUROSCI.2795-04.2004; AVIOLI LV, 1962, ANN INTERN MED, V56, P131; Bappal B, 2006, SAUDI MED J, V27, P727; Buckley C, 2005, NAT CLIN PRACT NEURO, V1, P22, DOI 10.1038/ncpneuro0033; Cauble MS, 2001, J PEDIATR ENDOCR MET, V14, P1163; Chen T, 2000, BRAIN RES, V861, P281, DOI 10.1016/S0006-8993(00)01992-2; CONLEY SB, 1976, J PEDIATR-US, V89, P898, DOI 10.1016/S0022-3476(76)80593-8; DERUBERTIS FR, 1974, ARCH INTERN MED, V134, P889, DOI 10.1001/archinte.134.5.889; DURIVAGE SK, 1985, PEDIATRICS, V75, P896; GAUTRON S, 1992, P NATL ACAD SCI USA, V89, P7272, DOI 10.1073/pnas.89.15.7272; GEORGE AL, 1992, P NATL ACAD SCI USA, V89, P4893, DOI 10.1073/pnas.89.11.4893; HAYEK A, 1982, PEDIATRICS, V70, P275; Hindmarch C, 2008, AM J PHYSIOL-REG I, V295, pR1914, DOI 10.1152/ajpregu.90560.2008; MANGIAPANE ML, 1984, BRAIN RES BULL, V13, P43, DOI 10.1016/0361-9230(84)90006-6; Mendelowitsch A, 2001, BRAIN RES, V901, P230, DOI 10.1016/S0006-8993(01)02359-9; Mix Eilhard, 2006, J Neurol, V253 Suppl 5, pV9, DOI 10.1007/s00415-006-5002-2; Nauta AJ, 2002, EUR J IMMUNOL, V32, P783, DOI 10.1002/1521-4141(200203)32:3<783::AID-IMMU783>3.0.CO;2-Q; Noda M, 2007, EXP PHYSIOL, V92, P513, DOI 10.1113/expphysiol.2006.035659; Noda M, 2005, CHEM SENSES, V30, pI44, DOI 10.1093/chemse/bjh105; Peruzzo M, 2010, ITAL J PEDIATR, V36, DOI 10.1186/1824-7288-36-78; SCHAAD U, 1979, HELV PAEDIATR ACTA, V34, P63; Siren AL, 2000, NEUROCHEM RES, V25, P957, DOI 10.1023/A:1007552408463; Tsokos GC, 2003, COMPLEMENT AUTOIMMUN; Unal Cevik I, 2003, Cell Death Differ, V10, P928, DOI 10.1038/sj.cdd.4401250; Unezaki S, 2014, EUR J NEUROSCI, V39, P720, DOI 10.1111/ejn.12436; Vernino S, 2007, NEUROTHERAPEUTICS, V4, P305, DOI 10.1016/j.nurt.2007.01.007; Vincent A, 2006, NEURON, V52, P123, DOI 10.1016/j.neuron.2006.09.024; WELT LG, 1962, ANN INTERN MED, V56, P161	53	1	1	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1073-8584	1089-4098		NEUROSCIENTIST	Neuroscientist	AUG	2015	21	4					399	412		10.1177/1073858414541009		14	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CN0CD	WOS:000358078800011		
J	Aizawa, N; Ito, H; Sugiyama, R; Kamei, J; Akiyama, Y; Ichihara, K; Homma, Y; Igawa, Y				Aizawa, N.; Ito, H.; Sugiyama, R.; Kamei, J.; Akiyama, Y.; Ichihara, K.; Homma, Y.; Igawa, Y.			INHIBITORY EFFECTS OF INTRAVESICAL ADMINISTRATION OF SILODOSIN, A SELECTIVE ALPHA1A-ADRENOCEPTOR ANTAGONIST, ON SINGLE-UNIT PRIMARY BLADDER AFFERENT ACTIVITIES OF THE RAT	NEUROUROLOGY AND URODYNAMICS			English	Meeting Abstract	45th Annual Meeting of the International-Continence-Society (ICS)	OCT 06-09, 2015	Montreal, CANADA	Int Continence Soc					[Aizawa, N.; Ito, H.; Sugiyama, R.; Kamei, J.; Akiyama, Y.; Ichihara, K.; Igawa, Y.] Univ Tokyo, Grad Sch Med, Dept Continence Med, Tokyo 1138654, Japan; [Homma, Y.] Univ Tokyo, Grad Sch Med, Dept Urol, Tokyo 1138654, Japan							Goi Y, 2013, J UROLOGY, V190, P1116, DOI 10.1016/j.juro.2013.03.110; Novara G, 2014, BJU INT, V114, P427, DOI 10.1111/bju.12712; Yanase H, 2008, BIOMED RES-TOKYO, V29, P239, DOI 10.2220/biomedres.29.239	3	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0733-2467	1520-6777		NEUROUROL URODYNAM	Neurourol. Urodyn.	AUG	2015	34			3		61	S101	S102				2	Urology & Nephrology	Urology & Nephrology	CM2QY	WOS:000357528000062		
J	Aizawa, N; Ito, H; Sugiyama, R; Kamei, J; Akiyama, Y; Ichihara, K; Homma, Y; Igawa, Y				Aizawa, N.; Ito, H.; Sugiyama, R.; Kamei, J.; Akiyama, Y.; Ichihara, K.; Homma, Y.; Igawa, Y.			DIRECT INFLUENCE OF SYSTEMIC DESENSITIZATION BY RESINIFERATOXIN ON THE ACTIVITIES OF A-DELTA- AND C-FIBERS IN THE RAT PRIMARY MECHANOSENSITIVE AFFERENTS	NEUROUROLOGY AND URODYNAMICS			English	Meeting Abstract	45th Annual Meeting of the International-Continence-Society (ICS)	OCT 06-09, 2015	Montreal, CANADA	Int Continence Soc			CAPSAICIN-SENSITIVITY; BLADDER		[Aizawa, N.; Ito, H.; Sugiyama, R.; Kamei, J.; Akiyama, Y.; Ichihara, K.; Igawa, Y.] Univ Tokyo, Grad Sch Med, Dept Continence Med, Tokyo 1138654, Japan; [Homma, Y.] Univ Tokyo, Grad Sch Med, Dept Urol, Tokyo 1138654, Japan							Aizawa N, 2011, NEUROUROL URODYNAM, V30, P163, DOI 10.1002/nau.20940; Yoshimura N, 1998, NEUROSCIENCE, V83, P633; LYNN B, 1990, PAIN, V41, P61, DOI 10.1016/0304-3959(90)91110-5	3	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0733-2467	1520-6777		NEUROUROL URODYNAM	Neurourol. Urodyn.	AUG	2015	34			3		230	S194	S196				3	Urology & Nephrology	Urology & Nephrology	CM2QY	WOS:000357528000132		
J	Akino, H; Nagase, K; Ito, H; Yokokawa, R; Matsuta, Y; Aoki, Y; Yokoyama, O				Akino, H.; Nagase, K.; Ito, H.; Yokokawa, R.; Matsuta, Y.; Aoki, Y.; Yokoyama, O.			THE INHIBITION OF NON-VOIDING CONTRACTIONS DUE TO BLADDER OUTLET OBSTRUCTION BY ALPHA1-ADRENOCEPTOR BLOCKER: WHAT IS THE MECHANISM UNDERLYING THIS EFFECT?	NEUROUROLOGY AND URODYNAMICS			English	Meeting Abstract	45th Annual Meeting of the International-Continence-Society (ICS)	OCT 06-09, 2015	Montreal, CANADA	Int Continence Soc					[Akino, H.; Nagase, K.; Ito, H.; Yokokawa, R.; Matsuta, Y.; Aoki, Y.; Yokoyama, O.] Univ Fukui, Dept Urol, Fukui, Fukui, Japan							Yokoyama O, 2006, NEUROUROL URODYNAM, V25, P461, DOI 10.1002/nau.20253	1	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0733-2467	1520-6777		NEUROUROL URODYNAM	Neurourol. Urodyn.	AUG	2015	34			3		309	S294	S295				2	Urology & Nephrology	Urology & Nephrology	CM2QY	WOS:000357528000211		
J	Akiyama, Y; Maeda, D; Morikawa, T; Niimi, A; Nomiya, A; Sugiyama, R; Kamei, J; Ichihara, K; Aizawa, N; Igawa, Y; Fukayama, M; Homma, Y				Akiyama, Y.; Maeda, D.; Morikawa, T.; Niimi, A.; Nomiya, A.; Sugiyama, R.; Kamei, J.; Ichihara, K.; Aizawa, N.; Igawa, Y.; Fukayama, M.; Homma, Y.			HUNNER TYPE INTERSTITIAL CYSTITIS IS A DISTINCT INFLAMMATORY DISORDER CHARACTERIZED BY EPITHELIAL DENUDATION AND FREQUENT PRESENCE OF LIGHT CHAIN-RESTRICTED B-CELLS, IMPLYING INVOLVEMENT OF IMMUNE RESPONSES IN THE PATHOGENESIS	NEUROUROLOGY AND URODYNAMICS			English	Meeting Abstract	45th Annual Meeting of the International-Continence-Society (ICS)	OCT 06-09, 2015	Montreal, CANADA	Int Continence Soc					[Akiyama, Y.; Niimi, A.; Kamei, J.; Homma, Y.] Univ Tokyo, Grad Sch Med, Dept Urol, Tokyo 1138654, Japan; [Maeda, D.] Akita Univ, Grad Sch Med, Dept Cellular & Organ Pathol, Akita 010, Japan; [Morikawa, T.; Fukayama, M.] Univ Tokyo, Grad Sch Med, Dept Pathol, Tokyo 1138654, Japan; [Nomiya, A.] Mitsui Mem Hosp, Dept Urol, Tokyo 101, Japan; [Sugiyama, R.; Ichihara, K.; Aizawa, N.; Igawa, Y.] Univ Tokyo, Grad Sch Med, Dept Continence Med, Tokyo 1138654, Japan							Homma Y, 2009, INT J UROL, V16, P597, DOI 10.1111/j.1442-2042.2009.02326.x; Ferraccioli G, 2007, AUTOIMMUN REV, V7, P109, DOI 10.1016/j.autrev.2007.02.013; SAMOSZUK MK, 1985, DIAGN CLIN IMMUNOL, V3, P133	3	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0733-2467	1520-6777		NEUROUROL URODYNAM	Neurourol. Urodyn.	AUG	2015	34			3		20	S46	S47				2	Urology & Nephrology	Urology & Nephrology	CM2QY	WOS:000357528000021		
J	Aoki, K; Fukui, S; Morizawa, Y; Miyake, M; Torimoto, K; Fujimoto, K				Aoki, K.; Fukui, S.; Morizawa, Y.; Miyake, M.; Torimoto, K.; Fujimoto, K.			URINARY NERVE GROWTH FACTOR MAY PREDICT THERAPEUTIC SUCCESS IN MONOSYMPTOMATIC NOCTURNAL ENURESIS	NEUROUROLOGY AND URODYNAMICS			English	Meeting Abstract	45th Annual Meeting of the International-Continence-Society (ICS)	OCT 06-09, 2015	Montreal, CANADA	Int Continence Soc					[Aoki, K.; Fukui, S.; Morizawa, Y.; Miyake, M.; Torimoto, K.; Fujimoto, K.] Nara Med Univ, Dept Urol, Nara, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0733-2467	1520-6777		NEUROUROL URODYNAM	Neurourol. Urodyn.	AUG	2015	34			3		194	S143	S144				2	Urology & Nephrology	Urology & Nephrology	CM2QY	WOS:000357528000096		
J	Aoki, Y; Tsutsumiuchi, M; Yokoi, S; Matsuta, Y; Matsumoto, C; Kusaka, Y; Yokoyama, O				Aoki, Y.; Tsutsumiuchi, M.; Yokoi, S.; Matsuta, Y.; Matsumoto, C.; Kusaka, Y.; Yokoyama, O.			STRAINING TO VOID IS ASSOCIATED WITH FEMALE DYSPAREUNIA	NEUROUROLOGY AND URODYNAMICS			English	Meeting Abstract	45th Annual Meeting of the International-Continence-Society (ICS)	OCT 06-09, 2015	Montreal, CANADA	Int Continence Soc					[Aoki, Y.; Tsutsumiuchi, M.; Yokoi, S.; Matsuta, Y.; Kusaka, Y.; Yokoyama, O.] Univ Fukui, Fac Med Sci, Fukui, Japan; [Matsumoto, C.] Univ Fukui, Fac Educ & Reg Studies, Fukui, Japan							Kim, 2005, INT J IMPOT RES, V17, P158; Laumann, 1999, JAMA-J AM MED ASSOC, V281, P537; ROSEN, 2000, J SEX MARITAL THER, V26, P191	3	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0733-2467	1520-6777		NEUROUROL URODYNAM	Neurourol. Urodyn.	AUG	2015	34			3		28	S55	S56				2	Urology & Nephrology	Urology & Nephrology	CM2QY	WOS:000357528000029		
J	Ashikari, A; Miyazato, M; Oshiro, T; Saito, S				Ashikari, A.; Miyazato, M.; Oshiro, T.; Saito, S.			TRAMADOL ENHANCES URETHRAL CONTINENCE REFLEX DURING SNEEZING THROUGH M-OPIOID RECEPTORS IN THE SPINAL CORD IN RATS	NEUROUROLOGY AND URODYNAMICS			English	Meeting Abstract	45th Annual Meeting of the International-Continence-Society (ICS)	OCT 06-09, 2015	Montreal, CANADA	Int Continence Soc					[Ashikari, A.; Miyazato, M.; Oshiro, T.; Saito, S.] Univ Ryukyus, Grad Sch Med, Dept Urol, Nishihara, Okinawa 90301, Japan							[Anonymous], 2003, AM J PHYSL REGUL INT, V285, pR356; [Anonymous], 2004, CLIN PHARMACOKINET, V43, P879; [Anonymous], 2005, INT UROGYNECOL J PEL, V16, P359	3	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0733-2467	1520-6777		NEUROUROL URODYNAM	Neurourol. Urodyn.	AUG	2015	34			3		508	S425	S426				2	Urology & Nephrology	Urology & Nephrology	CM2QY	WOS:000357528000310		
J	Chiba, H; Mitsui, T; Kitta, T; Ohmura, Y; Moriya, K; Kanno, Y; Yoshioka, M; Shinohara, N				Chiba, H.; Mitsui, T.; Kitta, T.; Ohmura, Y.; Moriya, K.; Kanno, Y.; Yoshioka, M.; Shinohara, N.			THE ROLE OF SEROTONERGIC MECHANISM IN THE RAT PREFRONTAL CORTEX FOR CONTROLLING THE MICTURITION REFLEX: AN IN VIVO MICRODIALYSIS STUDY	NEUROUROLOGY AND URODYNAMICS			English	Meeting Abstract	45th Annual Meeting of the International-Continence-Society (ICS)	OCT 06-09, 2015	Montreal, CANADA	Int Continence Soc					[Chiba, H.; Mitsui, T.; Kitta, T.; Ohmura, Y.; Moriya, K.; Kanno, Y.; Yoshioka, M.; Shinohara, N.] Hokkaido Univ, Sapporo, Hokkaido 060, Japan							Fowler CJ, 2010, NEUROUROL URODYNAM, V29, P49, DOI 10.1002/nau.20740; Puig MV, 2011, MOL NEUROBIOL, V44, P449, DOI 10.1007/s12035-011-8214-0; Kesner RP, 2011, NEUROBIOL LEARN MEM, V96, P417, DOI 10.1016/j.nlm.2011.07.002	3	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0733-2467	1520-6777		NEUROUROL URODYNAM	Neurourol. Urodyn.	AUG	2015	34			3		514	S432	S433				2	Urology & Nephrology	Urology & Nephrology	CM2QY	WOS:000357528000316		
J	Fukui, S; Aoki, K; Morizawa, Y; Miyake, M; Fujimoto, K				Fukui, S.; Aoki, K.; Morizawa, Y.; Miyake, M.; Fujimoto, K.			URINARY NERVE GROWTH FACTOR MAY PREDICT THERAPEUTIC EFFICACY IN CHILDREN WITH OVERACTIVE BLADDER	NEUROUROLOGY AND URODYNAMICS			English	Meeting Abstract	45th Annual Meeting of the International-Continence-Society (ICS)	OCT 06-09, 2015	Montreal, CANADA	Int Continence Soc					[Fukui, S.] Nara Prefecture Gen Med Ctr, Dept Urol, Nara, Japan; [Aoki, K.; Morizawa, Y.; Miyake, M.; Fujimoto, K.] Nara Med Univ, Dept Urol, Nara, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0733-2467	1520-6777		NEUROUROL URODYNAM	Neurourol. Urodyn.	AUG	2015	34			3		193	S142	S143				2	Urology & Nephrology	Urology & Nephrology	CM2QY	WOS:000357528000095		
J	Funahashi, Y; Yoshida, M; Yamamoto, T; Matsukawa, Y; Majima, T; Gotoh, M				Funahashi, Y.; Yoshida, M.; Yamamoto, T.; Matsukawa, Y.; Majima, T.; Gotoh, M.			THE EFFECT OF SILODOSIN ON THE PROSTATIC MICROCIRCULATION IN A PROSTATITIS RAT MODEL INDUCED BY URINE REFLUX	NEUROUROLOGY AND URODYNAMICS			English	Meeting Abstract	45th Annual Meeting of the International-Continence-Society (ICS)	OCT 06-09, 2015	Montreal, CANADA	Int Continence Soc					[Funahashi, Y.; Yamamoto, T.; Matsukawa, Y.; Majima, T.; Gotoh, M.] Nagoya Univ, Dept Urol, Nagoya, Aichi 4648601, Japan; [Yoshida, M.] Natl Ctr Geriatr & Gerontol, Dept Urol, Obu City, Aichi, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0733-2467	1520-6777		NEUROUROL URODYNAM	Neurourol. Urodyn.	AUG	2015	34			3		55	S92	S94				3	Urology & Nephrology	Urology & Nephrology	CM2QY	WOS:000357528000056		
J	Hideaki, I; Kaiho, Y; Eriguchi, T; Kamiyama, Y; Kawamorita, N; Yamashita, S; Nakagawa, H; Arai, Y				Hideaki, I; Kaiho, Y.; Eriguchi, T.; Kamiyama, Y.; Kawamorita, N.; Yamashita, S.; Nakagawa, H.; Arai, Y.			EFFECTS OF PHOSPHODIESTERASE TYPE 5 INHIBITOR, TADALAFIL, ON CONTINENCE REFLEX IN RATS	NEUROUROLOGY AND URODYNAMICS			English	Meeting Abstract	45th Annual Meeting of the International-Continence-Society (ICS)	OCT 06-09, 2015	Montreal, CANADA	Int Continence Soc					[Hideaki, I; Kaiho, Y.; Eriguchi, T.; Kamiyama, Y.; Kawamorita, N.; Yamashita, S.; Nakagawa, H.; Arai, Y.] Tohoku Univ, Grad Sch Med, Dept Urol, Sendai, Miyagi 980, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0733-2467	1520-6777		NEUROUROL URODYNAM	Neurourol. Urodyn.	AUG	2015	34			3		60	S100	S100				1	Urology & Nephrology	Urology & Nephrology	CM2QY	WOS:000357528000061		
J	Hikita, K; Honda, M; Kawamoto, B; Panagiota, T; Muraoka, K; Shimizu, S; Saito, M; Sejima, T; Takenaka, A				Hikita, K.; Honda, M.; Kawamoto, B.; Panagiota, T.; Muraoka, K.; Shimizu, S.; Saito, M.; Sejima, T.; Takenaka, A.			ADHERENCE TO ANTICHOLINERGIC AGENTS BY JAPANESE FEMALE OAB PATIENTS: PATIENTS OF OAB WET AND OAB DRY	NEUROUROLOGY AND URODYNAMICS			English	Meeting Abstract	45th Annual Meeting of the International-Continence-Society (ICS)	OCT 06-09, 2015	Montreal, CANADA	Int Continence Soc					[Hikita, K.; Honda, M.; Kawamoto, B.] Tottori Univ, Fac Med, Dept Urol, Div Urol, Tottori, Japan; [Panagiota, T.; Muraoka, K.; Sejima, T.; Takenaka, A.] Tottori Univ, Fac Med, Dept Urol, Tottori, Japan; [Shimizu, S.; Saito, M.] Kochi Med Sch, Dept Pharmacol, Kochi, Japan							Yeaw J, 2009, J MANAGE CARE PHARM, V15, P728; Basra Ramandeep K., 2008, BJU INT, V102, P774	2	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0733-2467	1520-6777		NEUROUROL URODYNAM	Neurourol. Urodyn.	AUG	2015	34			3		496	S409	S410				2	Urology & Nephrology	Urology & Nephrology	CM2QY	WOS:000357528000298		
J	Honda, M; Kawamoto, B; Tsounapi, P; Hikita, K; Muraoka, K; Shimizu, S; Satio, M; Sejima, T; Takenaka, A				Honda, M.; Kawamoto, B.; Tsounapi, P.; Hikita, K.; Muraoka, K.; Shimizu, S.; Satio, M.; Sejima, T.; Takenaka, A.			PREDICTION OF URINARY INCONTINENCE AFTER ROBOT-ASSISTED RADICAL PROSTATECTOMY	NEUROUROLOGY AND URODYNAMICS			English	Meeting Abstract	45th Annual Meeting of the International-Continence-Society (ICS)	OCT 06-09, 2015	Montreal, CANADA	Int Continence Soc					[Honda, M.; Kawamoto, B.; Tsounapi, P.; Hikita, K.; Muraoka, K.; Sejima, T.; Takenaka, A.] Tottori Univ, Fac Med, Dept Urol, Tottori, Japan; [Shimizu, S.; Satio, M.] Kochi Med Sch, Dept Pharmacol, Nankoku, Kochi, Japan							Ficarra V, 2012, EUR UROL, V62, P405, DOI 10.1016/j.eururo.2012.05.045; Abdollah F, 2013, BJU INT, V111, P905, DOI 10.1111/j.1464-410X.2012.11560.x; Burnett AL, 1998, J UROLOGY, V160, P1301, DOI 10.1016/S0022-5347(01)62521-7	3	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0733-2467	1520-6777		NEUROUROL URODYNAM	Neurourol. Urodyn.	AUG	2015	34			3		201	S151	S152				2	Urology & Nephrology	Urology & Nephrology	CM2QY	WOS:000357528000103		
J	Ichihara, K; Aizawa, N; Sugiyama, R; Ito, H; Kamei, J; Akiyama, Y; Masumori, N; Homma, Y; Igawa, Y				Ichihara, K.; Aizawa, N.; Sugiyama, R.; Ito, H.; Kamei, J.; Akiyama, Y.; Masumori, N.; Homma, Y.; Igawa, Y.			ACTIVATION OF TOLL LIKE RECEPTOR 7 INDUCES CYSTITIS AND FACILITATION OF BLADDER PAIN AND MECHANO-SENSATION IN MICE	NEUROUROLOGY AND URODYNAMICS			English	Meeting Abstract	45th Annual Meeting of the International-Continence-Society (ICS)	OCT 06-09, 2015	Montreal, CANADA	Int Continence Soc					[Ichihara, K.; Aizawa, N.; Sugiyama, R.; Ito, H.; Kamei, J.; Akiyama, Y.; Igawa, Y.] Univ Tokyo Grad Sch Med, Dept Continence Med, Tokyo, Japan; [Masumori, N.] Sapporo Med Univ Sch Med, Dept Urol, Sapporo, Hokkaido, Japan; [Homma, Y.] Univ Tokyo Grad Sch Med, Dept Urol, Tokyo, Japan							Liu T, 2012, NEUROSCI BULL, V28, P131, DOI 10.1007/s12264-012-1219-5; Li J, 2013, PHARMACOL THERAPEUT, V138, P441, DOI 10.1016/j.pharmthera.2013.03.003; Smith EB, 2007, J UROLOGY, V177, P2347, DOI 10.1016/j.juro.2007.01.112	3	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0733-2467	1520-6777		NEUROUROL URODYNAM	Neurourol. Urodyn.	AUG	2015	34			3		442	S337	S339				3	Urology & Nephrology	Urology & Nephrology	CM2QY	WOS:000357528000244		
J	Ihara, T; Kira, S; Yamagishi, T; Miyamoto, T; Sawada, N; Yoshiyama, M; Takeda, M; Nakamura, Y; Nakao, A				Ihara, T.; Kira, S.; Yamagishi, T.; Miyamoto, T.; Sawada, N.; Yoshiyama, M.; Takeda, M.; Nakamura, Y.; Nakao, A.			CLOCK MUTANT MOUSE IS A NOVEL EXPERIMENTAL MODEL FOR NOCTURIA/NOCTURNAL POLYURIA	NEUROUROLOGY AND URODYNAMICS			English	Meeting Abstract	45th Annual Meeting of the International-Continence-Society (ICS)	OCT 06-09, 2015	Montreal, CANADA	Int Continence Soc					[Ihara, T.; Kira, S.; Yamagishi, T.; Miyamoto, T.; Sawada, N.; Yoshiyama, M.; Takeda, M.] Univ Yamanashi, Dept Urol, Kofu, Yamanashi, Japan; [Nakamura, Y.; Nakao, A.] Univ Yamanashi, Dept Immunol, Kofu, Yamanashi, Japan							Yeung CK, 2002, BJU INT, V90, P302, DOI 10.1046/j.1464-410X.2002.02884.x; Negoro H, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1812; Yoshiyama M., 2015, AM J PHYSL IN PRESS	3	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0733-2467	1520-6777		NEUROUROL URODYNAM	Neurourol. Urodyn.	AUG	2015	34			3		31	S59	S61				3	Urology & Nephrology	Urology & Nephrology	CM2QY	WOS:000357528000032		
J	Imanishi, R; Matsumoto, K; Ishihara, M; Masegi, S; Inagaki, C; Nakagawa, H; Ueki, S				Imanishi, R.; Matsumoto, K.; Ishihara, M.; Masegi, S.; Inagaki, C.; Nakagawa, H.; Ueki, S.			ASSOCIATION BETWEEN NOCTURNAL VOIDING, AROUSAL DURING SLEEP AND THE INCIDENCE RATE OF FALLS: A COMMUNITY-BASED STUDY WITH HOME-VISIT INTERVIEW	NEUROUROLOGY AND URODYNAMICS			English	Meeting Abstract	45th Annual Meeting of the International-Continence-Society (ICS)	OCT 06-09, 2015	Montreal, CANADA	Int Continence Soc					[Imanishi, R.] Niigata Univ Hlth & Welf, Dept Occupat Therapy, Niigata, Japan; [Matsumoto, K.] Niigata Univ Hlth & Welf, Dept Phys therapy, Niigata, Japan; [Ishihara, M.] Niigata Univ Hlth & Welf, Dept Nursing, Niigata, Japan; [Masegi, S.] Niigata Univ Hlth & Welf, Dept Hlth & Sports, Niigata, Japan; [Inagaki, C.] Niigata Univ Hlth & Welf, Dept Nursing, Niigata, Japan; [Nakagawa, H.] Izumi Cent Hosp, Dept Urol, Izumi, Japan; [Ueki, S.] Tohoku Bunke Gakuen Univ, Sendai, Miyagi, Japan							STEWART RB, 1992, J AM GERIATR SOC, V40, P1217; Hill EL, 2007, J GERONTOL A-BIOL, V62, P62; Zeitzer JM, 2013, J CLIN SLEEP MED, V9, P259, DOI 10.5664/jcsm.2492	3	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0733-2467	1520-6777		NEUROUROL URODYNAM	Neurourol. Urodyn.	AUG	2015	34			3		12	S35	S36				2	Urology & Nephrology	Urology & Nephrology	CM2QY	WOS:000357528000013		
J	Kadekawa, K; Yoshiyama, M; Majima, T; Wada, N; Shimizu, T; Tyagi, P; Sugaya, K; Yoshimura, N				Kadekawa, K.; Yoshiyama, M.; Majima, T.; Wada, N.; Shimizu, T.; Tyagi, P.; Sugaya, K.; Yoshimura, N.			CHARACTERIZATION OF BLADDER AND EXTERNAL URETHRAL SPHINCTER ACTIVITY IN MICE WITH OR WITHOUT SPINAL CORD INJURY- A COMPARISON STUDY WITH RATS	NEUROUROLOGY AND URODYNAMICS			English	Meeting Abstract	45th Annual Meeting of the International-Continence-Society (ICS)	OCT 06-09, 2015	Montreal, CANADA	Int Continence Soc					[Kadekawa, K.; Majima, T.; Wada, N.; Shimizu, T.; Tyagi, P.; Yoshimura, N.] Univ Pittsburgh, Sch Med, Pittsburgh, PA 15260 USA; [Yoshiyama, M.] Univ Yamanashi, Grad Sch Med Sci, Kofu, Yamanashi, Japan; [Sugaya, K.] Southern Knights Lab LLP, Okinawa, Japan							Peng CW, 2008, AM J PHYSIOL-REG I, V294, P660	1	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0733-2467	1520-6777		NEUROUROL URODYNAM	Neurourol. Urodyn.	AUG	2015	34			3		49	S85	S86				2	Urology & Nephrology	Urology & Nephrology	CM2QY	WOS:000357528000050		
J	Kajioka, S; Hayashi, M; Takahashi, R; Maki, T; Namitome, R; Naito, S				Kajioka, S.; Hayashi, M.; Takahashi, R.; Maki, T.; Namitome, R.; Naito, S.			A NOVEL EXTRACELLULAR CALCIUM-SENSING SYSTEM IN PIG URETHRAL SMOOTH MUSCLE CELLS	NEUROUROLOGY AND URODYNAMICS			English	Meeting Abstract	45th Annual Meeting of the International-Continence-Society (ICS)	OCT 06-09, 2015	Montreal, CANADA	Int Continence Soc					[Kajioka, S.; Hayashi, M.; Takahashi, R.; Maki, T.; Namitome, R.] Kyushu Univ, Dept Urol, Fukuoka 812, Japan; [Naito, S.] Hara Sanshin Hosp, Fukuoka, Fukuoka, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0733-2467	1520-6777		NEUROUROL URODYNAM	Neurourol. Urodyn.	AUG	2015	34			3		313	S300	S301				2	Urology & Nephrology	Urology & Nephrology	CM2QY	WOS:000357528000215		
J	Kamei, J; Ito, H; Aizawa, N; Sugiyama, R; Akiyama, Y; Ichihara, K; Fujita, Y; Ito, M; Andersson, K; Homma, Y; Igawa, Y				Kamei, J.; Ito, H.; Aizawa, N.; Sugiyama, R.; Akiyama, Y.; Ichihara, K.; Fujita, Y.; Ito, M.; Andersson, K.; Homma, Y.; Igawa, Y.			LONG-TERM CALORIC RESTRICTION MAY PREVENT IN VIVO LOWER URINARY TRACT DYSFUNCTION ASSOCIATED WITH AGEING IN MALE RATS	NEUROUROLOGY AND URODYNAMICS			English	Meeting Abstract	45th Annual Meeting of the International-Continence-Society (ICS)	OCT 06-09, 2015	Montreal, CANADA	Int Continence Soc					[Kamei, J.; Akiyama, Y.] Univ Tokyo, Gradual Sch Med, Dept Continence Med & Urol, Tokyo 1138654, Japan; [Ito, H.; Aizawa, N.; Sugiyama, R.; Ichihara, K.; Igawa, Y.] Univ Tokyo, Grad Sch Med, Dept Continence Med, Tokyo 1138654, Japan; [Fujita, Y.; Ito, M.] Tokyo Metropolitan Inst Gerontol, Res Team Mech Aging, Mol Gerontol, Tokyo, Japan; [Andersson, K.] Aarhus Univ, Aarhus Inst Adv Studies, Aarhus, Denmark; [Homma, Y.] Univ Tokyo, Dept Urol, Grad Sch Med, Tokyo 1138654, Japan							Lluel P, 2003, AM J PHYSIOL-REG I, V284, pR1287, DOI 10.1152/ajpregu.00499.2001; Zhao WX, 2010, J UROLOGY, V184, P378, DOI 10.1016/j.juro.2010.03.004; Ito H, J UROL IN PRESS	3	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0733-2467	1520-6777		NEUROUROL URODYNAM	Neurourol. Urodyn.	AUG	2015	34			3		312	S298	S300				3	Urology & Nephrology	Urology & Nephrology	CM2QY	WOS:000357528000214		
J	Kamibeppu, T; Katayama, Y; Wakeda, H; Muraoka, K; Kamoto, T				Kamibeppu, T.; Katayama, Y.; Wakeda, H.; Muraoka, K.; Kamoto, T.			DIFFERENCE IN UROFLOWMETRY MEASUREMENTS BETWEEN NIGHT AND DAY WITH AGING.	NEUROUROLOGY AND URODYNAMICS			English	Meeting Abstract	45th Annual Meeting of the International-Continence-Society (ICS)	OCT 06-09, 2015	Montreal, CANADA	Int Continence Soc					[Kamibeppu, T.; Katayama, Y.; Wakeda, H.; Kamoto, T.] Miyazaki Univ, Fac Med, Dept Urol, Miyazaki, Japan; [Muraoka, K.] Muraoka Clin Urol & Internal Med, Miyazaki, Japan							ISHIDORI N, 2001, SHOWA U J MED SCI, V13, P111; O ZTU RK M, 2012, J ANDROL, V6, P1165	2	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0733-2467	1520-6777		NEUROUROL URODYNAM	Neurourol. Urodyn.	AUG	2015	34			3		37	S68	S69				2	Urology & Nephrology	Urology & Nephrology	CM2QY	WOS:000357528000038		
J	Kawamorita, N; Kaiho, Y; Kamiyama, Y; Satake, Y; Izumi, H; Arai, Y				Kawamorita, N.; Kaiho, Y.; Kamiyama, Y.; Satake, Y.; Izumi, H.; Arai, Y.			URODYNAMIC STUDY: THE MOST POWERFUL TOOL TO DIAGNOSE TETHERED CORD SYNDROME EARLY IN PATIENTS WITH SPINA BIFIDA	NEUROUROLOGY AND URODYNAMICS			English	Meeting Abstract	45th Annual Meeting of the International-Continence-Society (ICS)	OCT 06-09, 2015	Montreal, CANADA	Int Continence Soc					[Kawamorita, N.; Kaiho, Y.; Kamiyama, Y.; Satake, Y.; Izumi, H.; Arai, Y.] Tohoku Univ, Grad Sch Med, Dept Urol, Sendai, Miyagi 980, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0733-2467	1520-6777		NEUROUROL URODYNAM	Neurourol. Urodyn.	AUG	2015	34			3		198	S146	S147				2	Urology & Nephrology	Urology & Nephrology	CM2QY	WOS:000357528000100		
J	Kawamoto, B; Shimizu, S; Hikita, K; Muraoka, K; Honda, M; Sejima, T; Higashi, Y; Shimizu, T; Takenaka, A; Saito, M				Kawamoto, B.; Shimizu, S.; Hikita, K.; Muraoka, K.; Honda, M.; Sejima, T.; Higashi, Y.; Shimizu, T.; Takenaka, A.; Saito, M.			VESICOVASCULAR REFLEX IN THE SPONTANEOUSLY HYPERTENSIVE RAT	NEUROUROLOGY AND URODYNAMICS			English	Meeting Abstract	45th Annual Meeting of the International-Continence-Society (ICS)	OCT 06-09, 2015	Montreal, CANADA	Int Continence Soc					[Kawamoto, B.; Hikita, K.; Muraoka, K.; Honda, M.; Sejima, T.; Takenaka, A.] Tottori Univ, Fac Med, Dept Surg, Div Urol, Tottori, Japan; [Shimizu, S.; Higashi, Y.; Shimizu, T.; Saito, M.] Kochi Univ, Kochi Med Sch, Dept Pharmacol, Kochi, Japan							Chien CT, 2000, J PHYSIOL-LONDON, V526, P397, DOI 10.1111/j.1469-7793.2000.t01-1-00397.x; Doumas M, 2012, CURR HYPERTENS REP, V14, P238, DOI 10.1007/s11906-012-0258-7; Cecelja M, 2009, HYPERTENSION, V54, P1328, DOI 10.1161/HYPERTENSIONAHA.109.137653	3	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0733-2467	1520-6777		NEUROUROL URODYNAM	Neurourol. Urodyn.	AUG	2015	34			3		53	S89	S90				2	Urology & Nephrology	Urology & Nephrology	CM2QY	WOS:000357528000054		
J	Kawamoto, B; Shimizu, S; Hikita, K; Muraoka, K; Honda, M; Sejima, T; Higashi, Y; Shimizu, T; Saito, M; Takenaka, A				Kawamoto, B.; Shimizu, S.; Hikita, K.; Muraoka, K.; Honda, M.; Sejima, T.; Higashi, Y.; Shimizu, T.; Saito, M.; Takenaka, A.			CENTRAL ANGIOTENSIN II INCREASES URINARY FREQUENCY BY ACTING ON BRAIN AT1 RECEPTORS IN RATS	NEUROUROLOGY AND URODYNAMICS			English	Meeting Abstract	45th Annual Meeting of the International-Continence-Society (ICS)	OCT 06-09, 2015	Montreal, CANADA	Int Continence Soc					[Kawamoto, B.; Hikita, K.; Muraoka, K.; Honda, M.; Sejima, T.; Takenaka, A.] Tottori Univ, Fac Med, Dept Surg, Div Urol, Tottori, Japan; [Shimizu, S.; Higashi, Y.; Shimizu, T.; Saito, M.] Kochi Univ, Kochi Med Sch, Dept Pharmacol, Kochi, Japan							ANDERSON KM, 1993, AM J PHYSIOL, V264, pC179; Nakamura K, 2014, SCI REP-UK, V4, DOI 10.1038/srep07248; Smith AL, 2011, UROLOGY, V78	3	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0733-2467	1520-6777		NEUROUROL URODYNAM	Neurourol. Urodyn.	AUG	2015	34			3		62	S102	S103				2	Urology & Nephrology	Urology & Nephrology	CM2QY	WOS:000357528000063		
J	Kitta, T; Mitsui, T; Kanno, Y; Chiba, H; Moriya, K; Shinohara, N				Kitta, T.; Mitsui, T.; Kanno, Y.; Chiba, H.; Moriya, K.; Shinohara, N.			DETRUSOR CONTRACTION "SUSTAINABILITY" RESTORE AFTER PELVIC ORGAN PROLAPSE SURGERY	NEUROUROLOGY AND URODYNAMICS			English	Meeting Abstract	45th Annual Meeting of the International-Continence-Society (ICS)	OCT 06-09, 2015	Montreal, CANADA	Int Continence Soc					[Kitta, T.; Mitsui, T.; Kanno, Y.; Chiba, H.; Moriya, K.; Shinohara, N.] Hokkaido Univ, Sapporo, Hokkaido 060, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0733-2467	1520-6777		NEUROUROL URODYNAM	Neurourol. Urodyn.	AUG	2015	34			3		250	S220	S221				2	Urology & Nephrology	Urology & Nephrology	CM2QY	WOS:000357528000152		
J	Kitta, T; Mitsui, T; Kanno, Y; Chiba, H; Moriya, K; Abe, T; Maruyama, S; Shinohara, N				Kitta, T.; Mitsui, T.; Kanno, Y.; Chiba, H.; Moriya, K.; Abe, T.; Maruyama, S.; Shinohara, N.			RADICAL PROSTATECTOMY RESTORE THE DETRUSOR CONTRACTION SUSTAINABILITY: USING A NEW PRESSURE FLOW STUDY PARAMETER	NEUROUROLOGY AND URODYNAMICS			English	Meeting Abstract	45th Annual Meeting of the International-Continence-Society (ICS)	OCT 06-09, 2015	Montreal, CANADA	Int Continence Soc					[Kitta, T.; Mitsui, T.; Kanno, Y.; Chiba, H.; Moriya, K.; Abe, T.; Maruyama, S.; Shinohara, N.] Hokkaido Univ, Sapporo, Hokkaido 060, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0733-2467	1520-6777		NEUROUROL URODYNAM	Neurourol. Urodyn.	AUG	2015	34			3		42	S75	S76				2	Urology & Nephrology	Urology & Nephrology	CM2QY	WOS:000357528000043		
J	Kurokawa, T; Zha, X; Yamauti, H; Aoki, Y; Ito, H; Yokoyama, O				Kurokawa, T.; Zha, X.; Yamauti, H.; Aoki, Y.; Ito, H.; Yokoyama, O.			URINE STORAGE DYSFUNCTION IN RATS WITH SALT-LOADING HYPERTENSION DEPENDS ON BLADDER BLOOD FLOW	NEUROUROLOGY AND URODYNAMICS			English	Meeting Abstract	45th Annual Meeting of the International-Continence-Society (ICS)	OCT 06-09, 2015	Montreal, CANADA	Int Continence Soc					[Kurokawa, T.; Zha, X.; Yamauti, H.; Aoki, Y.; Ito, H.; Yokoyama, O.] Univ Fukui, Fukui, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0733-2467	1520-6777		NEUROUROL URODYNAM	Neurourol. Urodyn.	AUG	2015	34			3		51	S87	S87				1	Urology & Nephrology	Urology & Nephrology	CM2QY	WOS:000357528000052		
J	Magari, T; Shibata, Y; Arai, S; Kashiwagi, B; Saruki, K; Suzuki, K; Suzuki, K				Magari, T.; Shibata, Y.; Arai, S.; Kashiwagi, B.; Saruki, K.; Suzuki, K.; Suzuki, K.			IN MALE RATS, CASTRATION LED TO HISTOLOGICAL CHANGES IN THE BLADDER AND BLOOD VESSELS, FURTHER, THE AGE AT WHICH CASTRATION WAS PERFORMED AFFECTED THE DEGREE OF THE HISTOLOGICAL CHANGES.	NEUROUROLOGY AND URODYNAMICS			English	Meeting Abstract	45th Annual Meeting of the International-Continence-Society (ICS)	OCT 06-09, 2015	Montreal, CANADA	Int Continence Soc					[Magari, T.] Kurosawa Hosp, Dept Urol, Takasaki, Gumma, Japan; [Shibata, Y.; Arai, S.; Kashiwagi, B.; Saruki, K.; Suzuki, K.] Gunma Univ Grad Sch Med, Dept Urol, Maebashi, Gumma, Japan; [Suzuki, K.] Gunma Univ Grad Sch Hlth Sci, Dept Pathol, Maebashi, Gumma, Japan							Salmi S, 2001, J UROLOGY, V166, P674, DOI 10.1016/S0022-5347(05)66041-7; Hak AE, 2002, J CLIN ENDOCR METAB, V87, P3632, DOI 10.1210/jc.87.8.3632; Magari T, 2012, SCAND J UROL	3	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0733-2467	1520-6777		NEUROUROL URODYNAM	Neurourol. Urodyn.	AUG	2015	34			3		469	S372	S374				3	Urology & Nephrology	Urology & Nephrology	CM2QY	WOS:000357528000271		
J	Majima, T; Tyagi, P; Dogishi, K; Kadekawa, K; Kashyap, M; Wada, N; Takai, S; Shimizu, T; Gotoh, M; Chancellor, M; Yoshimura, N				Majima, T.; Tyagi, P.; Dogishi, K.; Kadekawa, K.; Kashyap, M.; Wada, N.; Takai, S.; Shimizu, T.; Gotoh, M.; Chancellor, M.; Yoshimura, N.			THE EFFECT OF INTRAVESICAL LIPOSOME-BASED NGF ANTISENSE THERAPY ON BLADDER OVERACTIVITY AND NOCICEPTION IN A RAT MODEL OF CYSTITIS INDUCED BY HYDROGEN PEROXIDE	NEUROUROLOGY AND URODYNAMICS			English	Meeting Abstract	45th Annual Meeting of the International-Continence-Society (ICS)	OCT 06-09, 2015	Montreal, CANADA	Int Continence Soc					[Majima, T.; Tyagi, P.; Kashyap, M.; Wada, N.; Takai, S.; Shimizu, T.; Yoshimura, N.] Univ Pittsburgh, Pittsburgh, PA 15260 USA; [Majima, T.; Takai, S.; Gotoh, M.] Nagoya Univ, Grad Sch Med, Nagoya, Aichi 4648601, Japan; [Dogishi, K.] Kyoto Univ, Grad Sch Pharmaceut Sci, Kyoto 6068501, Japan; [Kadekawa, K.] Univ Pittsburgh, Southern Knights Lab LLP, Pittsburgh, PA 15260 USA; [Shimizu, T.] Kochi Univ, Kochi Med Sch, Nankoku, Kochi, Japan; [Chancellor, M.] William Beaumont Oakland Univ Sch Med, Rochester, MI USA							Kashyap M, 2013, J UROLOGY, V190, P757, DOI 10.1016/j.juro.2013.02.090; Evans RJ, 2011, J UROLOGY, V185, P1716, DOI 10.1016/j.juro.2010.12.088	2	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0733-2467	1520-6777		NEUROUROL URODYNAM	Neurourol. Urodyn.	AUG	2015	34			3		234	S201	S203				3	Urology & Nephrology	Urology & Nephrology	CM2QY	WOS:000357528000136		
J	Matos, R; Cordeiro, JM; Igawa, Y; Cruz, F; Charrua, A				Matos, R.; Cordeiro, J. M.; Igawa, Y.; Cruz, F.; Charrua, A.			BLADDER PAIN IN BPS/IC MAY RESULT FROM AN EXAGGERATED RESPONSE OF TRPV1 AND ENHANCED UROTHELIAL ATP RELEASE INDUCED BY CHRONIC ADRENERGIC OVERACTIVITY	NEUROUROLOGY AND URODYNAMICS			English	Meeting Abstract	45th Annual Meeting of the International-Continence-Society (ICS)	OCT 06-09, 2015	Montreal, CANADA	Int Continence Soc					[Matos, R.; Cruz, F.; Charrua, A.] Univ Porto, IBMC, P-4100 Oporto, Portugal; [Cordeiro, J. M.] Univ Porto, CIIMAR, Grp Anim Genet Evolut, P-4100 Oporto, Portugal; [Igawa, Y.] Univ Tokyo, Dept Continence Med, Tokyo, Japan; [Cruz, F.] Hosp Sao Joao, Dept Urol, Oporto, Portugal; [Cruz, F.; Charrua, A.] Univ Porto, Fac Med, Dept Renal Urol & Infect Dis, P-4100 Oporto, Portugal							[Anonymous], 2014, BIOMED RES INT, V2014, DOI [10.1155/2014/865463, DOI 10.1155/2014/865463]; [Anonymous], 2013, NEUROUROL URODYNAM, DOI [10.1002/nau.22542, DOI 10.1002/NAU.22542]	2	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0733-2467	1520-6777		NEUROUROL URODYNAM	Neurourol. Urodyn.	AUG	2015	34			3		444	S341	S342				2	Urology & Nephrology	Urology & Nephrology	CM2QY	WOS:000357528000246		
J	Matsukawa, Y; Takai, S; Funahashi, Y; Kato, M; Matsuo, K; Yamamoto, T; Gotoh, M				Matsukawa, Y.; Takai, S.; Funahashi, Y.; Kato, M.; Matsuo, K.; Yamamoto, T.; Gotoh, M.			THE EFFECTS OF WITHDRAWING THE ALPHA-1 BLOCKER FROM ALPHA-1 BLOCKER PLUS 5-ALPHA-REDUCTASE INHIBITOR COMBINATION THERAPY ON PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA FROM THE PERSPECTIVE OF URODYNAMICS STUDY	NEUROUROLOGY AND URODYNAMICS			English	Meeting Abstract	45th Annual Meeting of the International-Continence-Society (ICS)	OCT 06-09, 2015	Montreal, CANADA	Int Continence Soc					[Matsukawa, Y.; Takai, S.; Funahashi, Y.; Kato, M.; Matsuo, K.; Yamamoto, T.; Gotoh, M.] Nagoya Univ, Grad Sch Med, Dept Urol, Nagoya, Aichi 4648601, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0733-2467	1520-6777		NEUROUROL URODYNAM	Neurourol. Urodyn.	AUG	2015	34			3		253	S224	S224				1	Urology & Nephrology	Urology & Nephrology	CM2QY	WOS:000357528000155		
J	Matsukawa, Y; Takai, S; Matsuo, K; Funahashi, Y; Yoshino, Y; Yamamoto, T; Gotoh, M				Matsukawa, Y.; Takai, S.; Matsuo, K.; Funahashi, Y.; Yoshino, Y.; Yamamoto, T.; Gotoh, M.			OBJECTIVE EFFICACY OF MIRABEGRON ON STORAGE AND VOIDING FUNCTION IN PATIENTS WITH OVERACTIVE BLADDER THAT IS UNRESPONSIVE TO ANTIMUSCARINIC TREATMENT, BASED ON A URODYNAMIC STUDY	NEUROUROLOGY AND URODYNAMICS			English	Meeting Abstract	45th Annual Meeting of the International-Continence-Society (ICS)	OCT 06-09, 2015	Montreal, CANADA	Int Continence Soc					[Matsukawa, Y.; Takai, S.; Matsuo, K.; Funahashi, Y.; Yoshino, Y.; Yamamoto, T.; Gotoh, M.] Nagoya Univ, Dept Urol, Grad Sch Med, Nagoya, Aichi 4648601, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0733-2467	1520-6777		NEUROUROL URODYNAM	Neurourol. Urodyn.	AUG	2015	34			3		489	S400	S400				1	Urology & Nephrology	Urology & Nephrology	CM2QY	WOS:000357528000291		
J	Matsumoto, S; Takeuchi, Y; Kakizaki, H				Matsumoto, S.; Takeuchi, Y.; Kakizaki, H.			NEW UROFLOWMETRY MEASUREMENT BY WEARABLE AIRBORNE ULTRASOUND CONTINUOUS WAVE DOPPLER SYSTEM	NEUROUROLOGY AND URODYNAMICS			English	Meeting Abstract	45th Annual Meeting of the International-Continence-Society (ICS)	OCT 06-09, 2015	Montreal, CANADA	Int Continence Soc					[Matsumoto, S.; Takeuchi, Y.; Kakizaki, H.] Asahikawa Med Univ, Dept Renal & Urol Surg, Asahikawa, Hokkaido, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0733-2467	1520-6777		NEUROUROL URODYNAM	Neurourol. Urodyn.	AUG	2015	34			3		287	S263	S264				2	Urology & Nephrology	Urology & Nephrology	CM2QY	WOS:000357528000189		
J	Matsumoto, S; Abe, T; Kunimoto, M; Furukawa, H; Kakizaki, H				Matsumoto, S.; Abe, T.; Kunimoto, M.; Furukawa, H.; Kakizaki, H.			A PREVALENCE STUDY OF LOWER URINARY TRACT SYMPTOMS IN FEMALE PATIENTS WITH FECAL INCONTINENCE	NEUROUROLOGY AND URODYNAMICS			English	Meeting Abstract	45th Annual Meeting of the International-Continence-Society (ICS)	OCT 06-09, 2015	Montreal, CANADA	Int Continence Soc			JAPAN		[Matsumoto, S.; Kakizaki, H.] Asahikawa Med Univ, Dept Renal & Urol Surg, Asahikawa, Hokkaido, Japan; [Abe, T.; Kunimoto, M.] Kunimoto Hosp, Dept Surg, Asahikawa, Hokkaido, Japan; [Furukawa, H.] Asahikawa Med Univ, Dept Surg, Div Gastroenterol & Gen Surg, Asahikawa, Hokkaido, Japan							Nakanishi N, 1997, J AM GERIATR SOC, V45, P215; Matsumoto S, 2013, BJU INT, V111, P647, DOI 10.1111/j.1464-410X.2012.11591.x	2	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0733-2467	1520-6777		NEUROUROL URODYNAM	Neurourol. Urodyn.	AUG	2015	34			3		295	S274	S275				2	Urology & Nephrology	Urology & Nephrology	CM2QY	WOS:000357528000197		
J	Matsuo, T; Miyata, Y; Asai, A; Mitsunari, K; Yuzuriha, M; Kakoki, K; Ohba, K; Sakai, H				Matsuo, T.; Miyata, Y.; Asai, A.; Mitsunari, K.; Yuzuriha, M.; Kakoki, K.; Ohba, K.; Sakai, H.			EFFECTS OF DAILY SALT INTAKE ON URINARY SYMPTOMS: A COMPARISON BETWEEN PATIENTS WITH HYPERTENSION AND NORMAL BLOOD PRESSURE	NEUROUROLOGY AND URODYNAMICS			English	Meeting Abstract	45th Annual Meeting of the International-Continence-Society (ICS)	OCT 06-09, 2015	Montreal, CANADA	Int Continence Soc					[Matsuo, T.; Miyata, Y.; Asai, A.; Mitsunari, K.; Yuzuriha, M.; Kakoki, K.; Ohba, K.; Sakai, H.] Nagasaki Univ Hosp, Dept Urol & Renal Transplantat, Nagasaki, Japan							[Anonymous], 2009, LUTS, V1, P16; [Anonymous], 2002, J HUM HYPERTENS, V16, P97	2	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0733-2467	1520-6777		NEUROUROL URODYNAM	Neurourol. Urodyn.	AUG	2015	34			3		9	S31	S32				2	Urology & Nephrology	Urology & Nephrology	CM2QY	WOS:000357528000010		
J	Matsushita, C; Torimoto, K; Hirayama, A; Fujimoto, K				Matsushita, C.; Torimoto, K.; Hirayama, A.; Fujimoto, K.			THE EXAMINATION OF NOCTURNAL URINATION AND SYMPATHETIC NERVE ACTIVITY IN THE ELDERLY PEOPLE BY USING 24HR UROFLOWMETER, SLEEP EEG MEASUREMENT AND URINE CATHECHOLAMINE.	NEUROUROLOGY AND URODYNAMICS			English	Meeting Abstract	45th Annual Meeting of the International-Continence-Society (ICS)	OCT 06-09, 2015	Montreal, CANADA	Int Continence Soc					[Matsushita, C.] Tane Gen Hosp, Osaka, Japan; [Torimoto, K.; Fujimoto, K.] Nara Med Univ, Nara, Japan; [Hirayama, A.] Kinki Univ, Fac Med, Nara Hosp, Higashiosaka, Osaka 577, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0733-2467	1520-6777		NEUROUROL URODYNAM	Neurourol. Urodyn.	AUG	2015	34			3		36	S67	S68				2	Urology & Nephrology	Urology & Nephrology	CM2QY	WOS:000357528000037		
J	Matsuta, Y; Yokoi, S; Hashimoto, N; Aoki, Y; Akino, H; Yokoyama, O				Matsuta, Y.; Yokoi, S.; Hashimoto, N.; Aoki, Y.; Akino, H.; Yokoyama, O.			LOW-FREQUENCY TRANSCUTANEOUS ELECTRICAL STIMULATION OF FOOT AMELIORATES INTRACTABLE OAB SYMPTOMS	NEUROUROLOGY AND URODYNAMICS			English	Meeting Abstract	45th Annual Meeting of the International-Continence-Society (ICS)	OCT 06-09, 2015	Montreal, CANADA	Int Continence Soc			SOMATIC AFFERENT NERVES		[Matsuta, Y.; Yokoi, S.; Aoki, Y.; Akino, H.; Yokoyama, O.] Univ Fukui, Fac Med Sci, Dept Urol, Fukui, Fukui, Japan; [Hashimoto, N.] Univ Fukui, Fac Med Sci, Dept Clin Lab, Fukui, Fukui, Japan							Chen G, 2012, J UROL; Chen ML, 2014, J UROLOGY, V191, P1009, DOI 10.1016/j.juro.2013.10.024; Tai CF, 2011, BJU INT, V107, P303, DOI 10.1111/j.1464-410X.2010.09358.x	3	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0733-2467	1520-6777		NEUROUROL URODYNAM	Neurourol. Urodyn.	AUG	2015	34			3		258	S230	S231				2	Urology & Nephrology	Urology & Nephrology	CM2QY	WOS:000357528000160		
J	Minagawa, T; Goto, M; Domen, T; Yokoyama, H; Ishikawa, M; Hiragata, S; Nagai, T; Nakazawa, M; Ogawa, T; Ishizuka, O				Minagawa, T.; Goto, M.; Domen, T.; Yokoyama, H.; Ishikawa, M.; Hiragata, S.; Nagai, T.; Nakazawa, M.; Ogawa, T.; Ishizuka, O.			MORPHOLOGICAL AND FUNCTIONAL EVALUATION OF PROSTATIC URETHRA USING SONOURETHROGRAPHY WITH RETROGRADE JELLY INJECTION	NEUROUROLOGY AND URODYNAMICS			English	Meeting Abstract	45th Annual Meeting of the International-Continence-Society (ICS)	OCT 06-09, 2015	Montreal, CANADA	Int Continence Soc					[Minagawa, T.; Goto, M.; Domen, T.; Yokoyama, H.; Ishikawa, M.; Hiragata, S.; Nagai, T.; Nakazawa, M.; Ogawa, T.; Ishizuka, O.] Shinshu Univ, Matsumoto, Nagano, Japan							Cho KS, 2008, UROLOGY, V71, P858, DOI 10.1016/j.urology.2008.01.019; RIFKIN MD, 1984, RADIOLOGY, V153, P791; Seibold J, 2011, UROLOGY, V78, P696, DOI 10.1016/j.urology.2011.04.051	3	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0733-2467	1520-6777		NEUROUROL URODYNAM	Neurourol. Urodyn.	AUG	2015	34			3		208	S160	S162				3	Urology & Nephrology	Urology & Nephrology	CM2QY	WOS:000357528000110		
J	Miyazato, M; Oshiro, T; Ashikari, A; Saito, S				Miyazato, M.; Oshiro, T.; Ashikari, A.; Saito, S.			EFFECT OF THE CONTINUOUS POSITIVE AIRWAY PRESSURE ON THE NOCTURNAL URINE VOLUME IN PATIENTS WITH OBSTRUCTIVE SLEEP APNEA SYNDROME	NEUROUROLOGY AND URODYNAMICS			English	Meeting Abstract	45th Annual Meeting of the International-Continence-Society (ICS)	OCT 06-09, 2015	Montreal, CANADA	Int Continence Soc					[Miyazato, M.; Oshiro, T.; Ashikari, A.; Saito, S.] Univ Ryukyus, Grad Sch Med, Dept Urol, Nishihara, Okinawa 90301, Japan							[Anonymous], 2013, SLEEP BREATH, V17, P679; [Anonymous], 2015, UROLOGY, V85, P333; [Anonymous], 2010, J UROL, V184, P1413	3	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0733-2467	1520-6777		NEUROUROL URODYNAM	Neurourol. Urodyn.	AUG	2015	34			3		10	S33	S34				2	Urology & Nephrology	Urology & Nephrology	CM2QY	WOS:000357528000011		
J	Mizoguchi, S; Mori, K; Sato, F; Yoshimura, N; Mimata, H				Mizoguchi, S.; Mori, K.; Sato, F.; Yoshimura, N.; Mimata, H.			EFFECTS OF ESTROGEN RECEPTOR ACTIVATION ON PROSTATIC INFLAMMATION AND BLADDER OVERACTIVITY IN A RAT MODEL OF CHRONIC NONBACTERIAL PROSTATITIS	NEUROUROLOGY AND URODYNAMICS			English	Meeting Abstract	45th Annual Meeting of the International-Continence-Society (ICS)	OCT 06-09, 2015	Montreal, CANADA	Int Continence Soc					[Mizoguchi, S.; Mori, K.; Sato, F.; Mimata, H.] Oita Univ, Fac Med, Dept Urol, Oita, Japan; [Yoshimura, N.] Univ Pittsburgh, Dept Urol, Pittsburgh, PA 15260 USA							Campbell L, 2010, J EXP MED, V207, P1825, DOI 10.1084/jem.20100500; Zuloaga KL, 2012, ENDOCRINOLOGY, V153, P5949, DOI 10.1210/en.2012-1316	2	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0733-2467	1520-6777		NEUROUROL URODYNAM	Neurourol. Urodyn.	AUG	2015	34			3		227	S189	S191				3	Urology & Nephrology	Urology & Nephrology	CM2QY	WOS:000357528000129		
J	Mizuno, H; Yamamoto, T; Matsukawa, Y; Muramatsu, T; Soeda, Y; Okamoto, N; Kimura, K; Aota, Y; Gotoh, M				Mizuno, H.; Yamamoto, T.; Matsukawa, Y.; Muramatsu, T.; Soeda, Y.; Okamoto, N.; Kimura, K.; Aota, Y.; Gotoh, M.			THE IMAGING OF LEAKAGE OF RED BLOOD CELLS FROM SUBMUCOSAL CAPILLARY AFTER BLADDER OVERDISTENTION -EFFECT OF A1 BLOCKER FOR HEMATURIA AFTER ACUTE URINARY RETENTION-	NEUROUROLOGY AND URODYNAMICS			English	Meeting Abstract	45th Annual Meeting of the International-Continence-Society (ICS)	OCT 06-09, 2015	Montreal, CANADA	Int Continence Soc					[Mizuno, H.; Muramatsu, T.; Soeda, Y.; Okamoto, N.; Kimura, K.; Aota, Y.] Nagoya Med Ctr, Natl Hosp Org, Nagoya, Aichi, Japan; [Yamamoto, T.; Matsukawa, Y.; Gotoh, M.] Nagoya Univ, Grad Sch Med, Dept Urol, Nagoya, Aichi 4648601, Japan							Mine S, 2013, UROLOGY, V81, P155, DOI 10.1016/j.urology.2012.09.008; Mizuno H, 2010, UROLOGY, V76	2	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0733-2467	1520-6777		NEUROUROL URODYNAM	Neurourol. Urodyn.	AUG	2015	34			3		57	S96	S97				2	Urology & Nephrology	Urology & Nephrology	CM2QY	WOS:000357528000058		
J	Nakata, M; Nakayama, H; Kojima, T; Marumoto, Y				Nakata, M.; Nakayama, H.; Kojima, T.; Marumoto, Y.			IMPROVEMENT OF THE LOWER URINARY TRACT SYMPTOMS IN PATIENTS WITH UTERINE FIBROIDS BY SURGICAL TREATMENT	NEUROUROLOGY AND URODYNAMICS			English	Meeting Abstract	45th Annual Meeting of the International-Continence-Society (ICS)	OCT 06-09, 2015	Montreal, CANADA	Int Continence Soc					[Nakata, M.; Nakayama, H.; Kojima, T.; Marumoto, Y.] Mitsui Mem Hosp, Tokyo, Japan							Parker-Autry C, 2011, FEMALE PELVIC MED RE, V17, P91, DOI 10.1097/SPV.0b013e31820c99a9	1	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0733-2467	1520-6777		NEUROUROL URODYNAM	Neurourol. Urodyn.	AUG	2015	34			3		296	S275	S276				2	Urology & Nephrology	Urology & Nephrology	CM2QY	WOS:000357528000198		
J	Nomiya, M; Miyazaki, N; Ikegami, K; Yamaguchi, O				Nomiya, M.; Miyazaki, N.; Ikegami, K.; Yamaguchi, O.			BLADDER OVERACTIVITY MAY PROGRESS TO BLADDER UNDERACTIVITY IN A RAT MODEL OF CHRONIC BLADDER ISCHEMIA	NEUROUROLOGY AND URODYNAMICS			English	Meeting Abstract	45th Annual Meeting of the International-Continence-Society (ICS)	OCT 06-09, 2015	Montreal, CANADA	Int Continence Soc					[Nomiya, M.; Miyazaki, N.; Ikegami, K.; Yamaguchi, O.] Nihon Univ, Sch Engn, Div Bioengn & LUTS Res, Tokyo 102, Japan							Yamaguchi O, 2014, NEUROUROL URODYNAM, V33, P54, DOI 10.1002/nau.22517; Nomiya M, 2012, NEUROUROL URODYNAM, V31, P195, DOI 10.1002/nau.21073; RESNICK NM, 1987, JAMA-J AM MED ASSOC, V257, P3076, DOI 10.1001/jama.257.22.3076	3	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0733-2467	1520-6777		NEUROUROL URODYNAM	Neurourol. Urodyn.	AUG	2015	34			3		54	S91	S92				2	Urology & Nephrology	Urology & Nephrology	CM2QY	WOS:000357528000055		
J	Sakakibara, R; Doi, H; Shiina, S; Tateno, F; Tateno, H; Kishi, M; Tsuyusaki, Y; Aiba, Y; Yamamoto, T; Yamanishi, T; Uchiyama, T; Shibata, C				Sakakibara, R.; Doi, H.; Shiina, S.; Tateno, F.; Tateno, H.; Kishi, M.; Tsuyusaki, Y.; Aiba, Y.; Yamamoto, T.; Yamanishi, T.; Uchiyama, T.; Shibata, C.			TRANSDERMAL DOPAMINE AGONIST AMELIORATES GASTRIC EMPTYING IN PARKINSON'S DISEASE	NEUROUROLOGY AND URODYNAMICS			English	Meeting Abstract	45th Annual Meeting of the International-Continence-Society (ICS)	OCT 06-09, 2015	Montreal, CANADA	Int Continence Soc					[Sakakibara, R.; Tateno, F.; Tateno, H.; Kishi, M.; Tsuyusaki, Y.; Aiba, Y.] Toho Univ, Sakura Med Ctr, Neurol, Internal Med, Tokyo, Japan; [Doi, H.; Shiina, S.] Toho Univ, Sakura Med Ctr, Pharmaceut Unit, Tokyo, Japan; [Yamamoto, T.] Chiba Univ, Neurol, Chiba, Japan; [Yamanishi, T.; Uchiyama, T.; Shibata, C.] Dokkyo Med Coll, Continence Ctr, Tokyo, Japan							Arai E, 2012, BRAIN, V135, P1478, DOI 10.1093/brain/aws086; Woitalla D, 2015, PARKINSONISM RELAT D, V21, P199, DOI 10.1016/j.parkreldis.2014.11.024; RAMSBOTT.N, 1970, GUT, V11, P989, DOI 10.1136/gut.11.12.989	3	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0733-2467	1520-6777		NEUROUROL URODYNAM	Neurourol. Urodyn.	AUG	2015	34			3		436	S329	S330				2	Urology & Nephrology	Urology & Nephrology	CM2QY	WOS:000357528000238		
J	Sakakibara, R; Tateno, F; Tateno, H; Kishi, M; Tsuyusaki, Y; Aiba, Y; Yamamoto, T; Yamanishi, T; Uchiyama, T; Shibata, C				Sakakibara, R.; Tateno, F.; Tateno, H.; Kishi, M.; Tsuyusaki, Y.; Aiba, Y.; Yamamoto, T.; Yamanishi, T.; Uchiyama, T.; Shibata, C.			FESOTERODINE MODULATES THE BRAIN FUNCTION IN OAB PATIENTS: A REAL-TIME MEASURE OF OXYHEMOGLOBIN CONCENTRATION CHANGES DURING URODYNAMICS	NEUROUROLOGY AND URODYNAMICS			English	Meeting Abstract	45th Annual Meeting of the International-Continence-Society (ICS)	OCT 06-09, 2015	Montreal, CANADA	Int Continence Soc			OVERACTIVE BLADDER		[Sakakibara, R.; Tateno, F.; Tateno, H.; Kishi, M.; Tsuyusaki, Y.; Aiba, Y.] Toho Univ, Sakura Med Ctr, Neurol, Internal Med, Funabashi, Chiba, Japan; [Yamamoto, T.] Chiba Univ, Neurol, Chiba, Japan; [Yamanishi, T.; Uchiyama, T.; Shibata, C.] Dokkyo Med Coll, Continence Ctr, Mibu, Tochigi, Japan							Banakhar MA, 2012, INT UROGYNECOL J, V23, P975, DOI 10.1007/s00192-012-1682-6; Tadic SD, 2012, NEUROUROL URODYNAM, V31, P652, DOI 10.1002/nau.21240; Sakakibara R, 2013, CLIN AUTON RES, V23, P189, DOI 10.1007/s10286-013-0200-3	3	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0733-2467	1520-6777		NEUROUROL URODYNAM	Neurourol. Urodyn.	AUG	2015	34			3		495	S408	S409				2	Urology & Nephrology	Urology & Nephrology	CM2QY	WOS:000357528000297		
J	Sekido, N; Kida, J; Wakamatsu, D; Okada, H; Matsuya, H				Sekido, N.; Kida, J.; Wakamatsu, D.; Okada, H.; Matsuya, H.			THE EFFECT OF A NOVEL EP2 AND EP3 RECEPTOR DUAL AGONIST, ONO-8055, ON A NEUROGENIC UNDERACTIVE BLADDER IN A RAT LUMBAR CANAL STENOSIS MODEL	NEUROUROLOGY AND URODYNAMICS			English	Meeting Abstract	45th Annual Meeting of the International-Continence-Society (ICS)	OCT 06-09, 2015	Montreal, CANADA	Int Continence Soc					[Sekido, N.] Toho Univ, Med Ctr, Ohashi Hosp, Dept Urol, Funabashi, Chiba, Japan; [Kida, J.; Wakamatsu, D.; Okada, H.; Matsuya, H.] ONO Pharmaceut Co Ltd, Dept Biol & Pharmacol, Discovery Res Labs 4, Tokyo, Japan							[Anonymous], 2007, BJU INT, V99, P749; [Anonymous], 2014, UROLOGY, V85	2	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0733-2467	1520-6777		NEUROUROL URODYNAM	Neurourol. Urodyn.	AUG	2015	34			3		189	S136	S137				2	Urology & Nephrology	Urology & Nephrology	CM2QY	WOS:000357528000091		
J	Shimizu, S; Martin, D; Trejo, J; Wheeler, M; Liu, J; Saito, M; Weiss, R; Hittelman, A				Shimizu, S.; Martin, D.; Trejo, J.; Wheeler, M.; Liu, J.; Saito, M.; Weiss, R.; Hittelman, A.			THE INTRAVESICAL DELIVERY OF BOTULINUM TOXIN A/DIMETHYL SULFOXIDE IN A NORMAL RAT AND IN AN ACETIC ACID INDUCED BLADDER INFLAMMATORY MODEL	NEUROUROLOGY AND URODYNAMICS			English	Meeting Abstract	45th Annual Meeting of the International-Continence-Society (ICS)	OCT 06-09, 2015	Montreal, CANADA	Int Continence Soc					[Shimizu, S.; Saito, M.] Kochi Univ, Kochi Med Sch, Dept Pharmacol, Nankoku, Kochi, Japan; [Martin, D.; Trejo, J.; Wheeler, M.; Liu, J.; Weiss, R.; Hittelman, A.] Yale Univ, Sch Med, Dept Urol, New Haven, CT 06520 USA							GuhaSarkar S, 2010, J CONTROL RELEASE, V148, P147, DOI 10.1016/j.jconrel.2010.08.031; Nitti Victor W, 2006, Rev Urol, V8, P198; Smith CP, 2009, TOXICON, V54, P639, DOI 10.1016/j.toxicon.2009.02.021	3	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0733-2467	1520-6777		NEUROUROL URODYNAM	Neurourol. Urodyn.	AUG	2015	34			3		440	S334	S336				3	Urology & Nephrology	Urology & Nephrology	CM2QY	WOS:000357528000242		
J	Shimizu, T; Shimizu, S; Higashi, Y; Nakamura, K; Kadekawa, K; Wada, N; Majima, T; Honda, M; Yoshimura, N; Saito, M				Shimizu, T.; Shimizu, S.; Higashi, Y.; Nakamura, K.; Kadekawa, K.; Wada, N.; Majima, T.; Honda, M.; Yoshimura, N.; Saito, M.			BOMBESIN, A STRESS-RELATED NEUROPEPTIDE, CENTRALLY INDUCES FREQUENT URINATION IN THE RAT	NEUROUROLOGY AND URODYNAMICS			English	Meeting Abstract	45th Annual Meeting of the International-Continence-Society (ICS)	OCT 06-09, 2015	Montreal, CANADA	Int Continence Soc					[Shimizu, T.] Kochi Univ, Kochi Med Sch, Dept Pharmacol, Kochi, Japan; [Shimizu, T.; Kadekawa, K.; Wada, N.; Majima, T.; Yoshimura, N.] Univ Pittsburgh, Sch Med, Dept Urol, Pittsburgh, PA 15260 USA; [Shimizu, S.; Higashi, Y.; Nakamura, K.; Saito, M.] Kochi Univ, Kochi Med Sch, Dept Pharmacol, Kochi, Japan; [Honda, M.] Tottori Univ, Sch Med, Div Urol, Tottori, Japan							Bedard T, 2007, BEHAV BRAIN RES, V179, P133, DOI 10.1016/j.bbr.2007.01.021; Merali Z, 2002, CELL MOL LIFE SCI, V59, P272, DOI 10.1007/s00018-002-8422-x; Yokotani K, 2005, EUR J PHARMACOL, V512, P29, DOI 10.1016/j.ejphar.2005.02.027	3	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0733-2467	1520-6777		NEUROUROL URODYNAM	Neurourol. Urodyn.	AUG	2015	34			3		56	S94	S96				3	Urology & Nephrology	Urology & Nephrology	CM2QY	WOS:000357528000057		
J	Soh, S; Nishio, K; Suzuki, K; Iwahata, Y; Shimomura, M; Sadaoka, Y; Sato, R; Ashizawa, Y; Shin, T; Yagi, H; Arai, G; Okada, H				Soh, S.; Nishio, K.; Suzuki, K.; Iwahata, Y.; Shimomura, M.; Sadaoka, Y.; Sato, R.; Ashizawa, Y.; Shin, T.; Yagi, H.; Arai, G.; Okada, H.			A ROLE OF THE PELVIC FLOOR AND PROSTATE IN MALE VOIDING: A MAGNETIC RESONANCE IMAGING STUDY	NEUROUROLOGY AND URODYNAMICS			English	Meeting Abstract	45th Annual Meeting of the International-Continence-Society (ICS)	OCT 06-09, 2015	Montreal, CANADA	Int Continence Soc					[Soh, S.; Nishio, K.; Suzuki, K.; Iwahata, Y.; Shimomura, M.; Sadaoka, Y.; Sato, R.; Ashizawa, Y.; Shin, T.; Yagi, H.; Arai, G.; Okada, H.] Dokkyo Med Univ, Koshigaya Hosp, Soka, Saitama, Japan							Hocaoglu Y, 2013, BJU INT, V111, P1117, DOI 10.1111/j.1464-410X.2012.11698.x; Nishio K, 2014, INT J UROL, V21, P724, DOI 10.1111/iju.12413; Ukimura O., 1998, Neurourology and Urodynamics, V17, P377	3	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0733-2467	1520-6777		NEUROUROL URODYNAM	Neurourol. Urodyn.	AUG	2015	34			3		280	S258	S259				2	Urology & Nephrology	Urology & Nephrology	CM2QY	WOS:000357528000182		
J	Sugiyama, R; Aizawa, N; Ito, H; Kamei, J; Akiyama, Y; Ichihara, K; Fukuhara, H; Homma, Y; Igawa, Y				Sugiyama, R.; Aizawa, N.; Ito, H.; Kamei, J.; Akiyama, Y.; Ichihara, K.; Fukuhara, H.; Homma, Y.; Igawa, Y.			CHARACTERIZATION OF THE MECHANOSENSITIVE BLADDER AFFERENT ACTIVITIES IN RELATION WITH MICROCONTRACTIONS IN MALE RATS WITH BLADDER OUTLET OBSTRUCTION	NEUROUROLOGY AND URODYNAMICS			English	Meeting Abstract	45th Annual Meeting of the International-Continence-Society (ICS)	OCT 06-09, 2015	Montreal, CANADA	Int Continence Soc					[Sugiyama, R.; Aizawa, N.; Ito, H.; Kamei, J.; Akiyama, Y.; Ichihara, K.; Igawa, Y.] Univ Tokyo, Grad Sch Med, Dept Continence Med, Tokyo 1138654, Japan; [Fukuhara, H.; Homma, Y.] Univ Tokyo, Grad Sch Med, Dept Urol, Tokyo 1138654, Japan							Drake MJ, 2005, BJU INT, V95, P1002, DOI 10.1111/j.1464-410X.2005.05455.x; Drake MJ, 2003, J UROLOGY, V170, P276, DOI 10.1097/01.ju.0000069722.35137.e0; Aizawa N, 2012, EUR UROL, V62, P1165, DOI 10.1016/j.eururo.2012.08.056	3	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0733-2467	1520-6777		NEUROUROL URODYNAM	Neurourol. Urodyn.	AUG	2015	34			3		516	S435	S437				3	Urology & Nephrology	Urology & Nephrology	CM2QY	WOS:000357528000318		
J	Suzuki, T; Otsuka, A; Furuse, H; Ozono, S				Suzuki, T.; Otsuka, A.; Furuse, H.; Ozono, S.			DUTASTERIDE ADD-ON THERAPY IMPROVES BLADDER OUTLET OBSTRUCTION IN PATIENTS WITH BENIGN PROSTATIC ENLARGEMENT: ONE-YEAR FOLLOW UP WITH URODYNAMIC STUDY	NEUROUROLOGY AND URODYNAMICS			English	Meeting Abstract	45th Annual Meeting of the International-Continence-Society (ICS)	OCT 06-09, 2015	Montreal, CANADA	Int Continence Soc					[Suzuki, T.; Otsuka, A.; Furuse, H.; Ozono, S.] Hamamatsu Univ Sch Med, Hamamatsu, Shizuoka, Japan							Wada N, 2013, NEUROUROL URODYNAM, V32, P1123, DOI 10.1002/nau.22349	1	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0733-2467	1520-6777		NEUROUROL URODYNAM	Neurourol. Urodyn.	AUG	2015	34			3		40	S72	S73				2	Urology & Nephrology	Urology & Nephrology	CM2QY	WOS:000357528000041		
J	Suzuki, T; Otsuka, A; Furuse, H; Ozono, S				Suzuki, T.; Otsuka, A.; Furuse, H.; Ozono, S.			A TEMPORAL DIFFERENCE OBSERVED IN THE EFFECT OF DUTASTERIDE ON REDUCING PROSTATE VOLUME DEPENDS ON THE DEGREE OF INTRAVESICAL PROSTATIC PROTRUSION IN MALE PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA	NEUROUROLOGY AND URODYNAMICS			English	Meeting Abstract	45th Annual Meeting of the International-Continence-Society (ICS)	OCT 06-09, 2015	Montreal, CANADA	Int Continence Soc			OBSTRUCTION		[Suzuki, T.; Otsuka, A.; Furuse, H.; Ozono, S.] Hamamatsu Univ Sch Med, Hamamatsu, Shizuoka, Japan							Cumpanas AA, 2013, UROLOGY, V81, P859, DOI 10.1016/j.urology.2012.12.007; Lee LS, 2010, INT J UROL, V17, P69, DOI 10.1111/j.1442-2042.2009.02409.x; Chia SJ, 2003, BJU INT, V91, P371, DOI 10.1046/j.1464-4096.2003.04088.x	3	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0733-2467	1520-6777		NEUROUROL URODYNAM	Neurourol. Urodyn.	AUG	2015	34			3		39	S70	S72				3	Urology & Nephrology	Urology & Nephrology	CM2QY	WOS:000357528000040		
J	Tahtinen, RM; Cartwright, R; Tsui, JF; Aaltonen, RL; Aoki, Y; Joronen, KM; Mirza, E; Oksjoki, SM; Pesonen, JS; Heels-Ansdell, D; Guyatt, GH; Tikkinen, KAO				Tahtinen, R. M.; Cartwright, R.; Tsui, J. F.; Aaltonen, R. L.; Aoki, Y.; Joronen, K. M.; Mirza, E.; Oksjoki, S. M.; Pesonen, J. S.; Heels-Ansdell, D.; Guyatt, G. H.; Tikkinen, K. A. O.			LONG-TERM IMPACT OF MODE OF DELIVERY ON STRESS AND URGENCY URINARY INCONTINENCE: A SYSTEMATIC REVIEW AND META-ANALYSIS	NEUROUROLOGY AND URODYNAMICS			English	Meeting Abstract	45th Annual Meeting of the International-Continence-Society (ICS)	OCT 06-09, 2015	Montreal, CANADA	Int Continence Soc					[Tahtinen, R. M.] Kuopio Univ Hosp, Dept Obstet & Gynecol, SF-70210 Kuopio, Finland; [Cartwright, R.] Imperial Coll London, Dept Epidemiol & Biostat, London, England; [Cartwright, R.] Imperial Coll London, Dept Urogynaecol, London, England; [Tsui, J. F.] North Shore LIJ Lenox Hill Hosp, Dept Urol, New York, NY USA; [Aaltonen, R. L.; Joronen, K. M.; Oksjoki, S. M.] Univ Turku, Dept Obstet & Gynecol, Turku, Finland; [Aaltonen, R. L.; Joronen, K. M.; Oksjoki, S. M.] Turku Univ Hosp, FIN-20520 Turku, Finland; [Aoki, Y.] Univ Fukui, Dept Urol, Fac Med Sci, Fukui 910, Japan; [Mirza, E.] St Marys Hosp, Dept Obstet & Gynaecol, London, England; [Heels-Ansdell, D.; Guyatt, G. H.] Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada; [Tikkinen, K. A. O.] Univ Helsinki, Dept Urol, Helsinki, Finland; [Tikkinen, K. A. O.] Univ Helsinki, Dept Publ Hlth, Helsinki, Finland; [Tikkinen, K. A. O.] Helsinki Univ Hosp, Helsinki, Finland							Lukacz ES, 2006, OBSTET GYNECOL, V107, P1253, DOI 10.1097/01.AOG.0000218096.54169.34; Gyhagen M, 2013, BJOG-INT J OBSTET GY, V120, P1548, DOI 10.1111/1471-0528.12367; Rochwerg B, 2014, USERS GUIDES MED LIT, V3nd	3	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0733-2467	1520-6777		NEUROUROL URODYNAM	Neurourol. Urodyn.	AUG	2015	34			3		217	S174	S175				2	Urology & Nephrology	Urology & Nephrology	CM2QY	WOS:000357528000119		
J	Tateno, F; Sakakibara, R; Tateno, H; Kishi, M; Tsuyusaki, Y; Aiba, Y; Yamamoto, T; Yamanishi, T; Uchiyama, T; Awa, Y; Shibata, C; Yano, M				Tateno, F.; Sakakibara, R.; Tateno, H.; Kishi, M.; Tsuyusaki, Y.; Aiba, Y.; Yamamoto, T.; Yamanishi, T.; Uchiyama, T.; Awa, Y.; Shibata, C.; Yano, M.			LOWER URINARY TRACT DYSFUNCTION IN PROGRESSIVE SUPRANUCLEAR PALSY	NEUROUROLOGY AND URODYNAMICS			English	Meeting Abstract	45th Annual Meeting of the International-Continence-Society (ICS)	OCT 06-09, 2015	Montreal, CANADA	Int Continence Soc					[Tateno, F.; Sakakibara, R.; Tateno, H.; Kishi, M.; Tsuyusaki, Y.; Aiba, Y.] Toho Univ, Sakura Med Ctr, Neurol, Internal Med, Tokyo, Japan; [Yamamoto, T.] Chiba Univ, Neurol, Chiba, Japan; [Yamanishi, T.; Uchiyama, T.; Shibata, C.] Dokkyo Med Coll, Continence Ctr, Kobayashi, Tochigi, Japan; [Awa, Y.] Chiba Univ, Urol, Chiba, Japan; [Yano, M.] Toho Univ, Sakura Med Ctr, Urol, Tokyo, Japan							Kato N, 2003, J NEUROL SCI, V210, P57, DOI 10.1016/S0022-510X(03)00014-5; SAKAKIBARA R, 1993, J AUTONOM NERV SYST, V45, P101, DOI 10.1016/0165-1838(93)90122-B	2	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0733-2467	1520-6777		NEUROUROL URODYNAM	Neurourol. Urodyn.	AUG	2015	34			3		429	S320	S321				2	Urology & Nephrology	Urology & Nephrology	CM2QY	WOS:000357528000231		
J	Torimoto, K; Matsushita, C; Yamada, A; Goto, D; Matsumoto, Y; Hosokawa, Y; Hirayama, A; Fujimoto, K				Torimoto, K.; Matsushita, C.; Yamada, A.; Goto, D.; Matsumoto, Y.; Hosokawa, Y.; Hirayama, A.; Fujimoto, K.			CLINICAL EFFICACY AND SAFETY OF A BETA3-ADRENOCEPTOR AGONIST (MIRABEGRON) AND AN ANTIMUSCARINIC AGENT (IMIDAFENACIN) IN FEMALE PATIENTS WITH OVERACTIVE BLADDER: A RANDOMIZED CROSSOVER STUDY	NEUROUROLOGY AND URODYNAMICS			English	Meeting Abstract	45th Annual Meeting of the International-Continence-Society (ICS)	OCT 06-09, 2015	Montreal, CANADA	Int Continence Soc					[Torimoto, K.; Fujimoto, K.] Nara Med Univ, Nara, Japan; [Matsushita, C.; Hosokawa, Y.] Tane Gen Hosp, Osaka, Japan; [Yamada, A.; Goto, D.] Hirao Hosp, Kashihara, Nara, Japan; [Matsumoto, Y.] Hoshigaoka Med Ctr, Hirakata, Osaka, Japan; [Hirayama, A.] Kinki Univ, Nara Hosp, Fac Med, Higashiosaka, Osaka 577, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0733-2467	1520-6777		NEUROUROL URODYNAM	Neurourol. Urodyn.	AUG	2015	34			3		487	S396	S397				2	Urology & Nephrology	Urology & Nephrology	CM2QY	WOS:000357528000289		
J	Uchiyama, H; Takeda, M; Mitsui, T; Ihara, T; Kobayashi, H; Zakoji, H; Taniguchi, T				Uchiyama, H.; Takeda, M.; Mitsui, T.; Ihara, T.; Kobayashi, H.; Zakoji, H.; Taniguchi, T.			3 YEARS' EXPERIENCE OF HIGH ADHERENCE RATE OF MIRABEGRON IN PATIENTS WITH OVERACTIVE BLADDER IN JAPAN: COMPARISON BETWEEN GENDER, AND BETWEEN SINGLE AND COMBINED PHARMACOTHERAPIES	NEUROUROLOGY AND URODYNAMICS			English	Meeting Abstract	45th Annual Meeting of the International-Continence-Society (ICS)	OCT 06-09, 2015	Montreal, CANADA	Int Continence Soc					[Takeda, M.; Mitsui, T.; Ihara, T.; Kobayashi, H.; Zakoji, H.] Univ Yamanashi, Dept Urol, Kofu, Yamanashi, Japan; [Taniguchi, T.] Univ Yamanashi, Dept Nursing, Kofu, Yamanashi, Japan							Basra RK, 2008, BJU INT, V102, P774, DOI 10.1111/j.1464-410X.2008.07769.x; Shara F.T, 2005, AM J MANAG CARE S, V11, pS121; Yamaguchi O., 2015, BJUI IN PRESS	3	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0733-2467	1520-6777		NEUROUROL URODYNAM	Neurourol. Urodyn.	AUG	2015	34			3		488	S398	S399				2	Urology & Nephrology	Urology & Nephrology	CM2QY	WOS:000357528000290		
J	Wada, N; Kadekawa, K; Majima, T; Shimizu, T; Okada, H; Tyagi, P; Kakizaki, H; Yoshimura, N				Wada, N.; Kadekawa, K.; Majima, T.; Shimizu, T.; Okada, H.; Tyagi, P.; Kakizaki, H.; Yoshimura, N.			URODYNAMIC EFFECT OF INTRAVESICAL AND INTRATHECAL ADMINISTRATION OF SELECTIVE E-SERIES PROSTAGLANDIN 4 RECEPTOR ANTAGONIST, ONO-AE3-208, ON CYCLOPHOSPHAMIDE INDUCED CYSTITIS RATS	NEUROUROLOGY AND URODYNAMICS			English	Meeting Abstract	45th Annual Meeting of the International-Continence-Society (ICS)	OCT 06-09, 2015	Montreal, CANADA	Int Continence Soc					[Wada, N.] Asahikawa Med Univ, Dept Urol, Univ Pittsburgh, Sch Med,Dept Renal & Urol Surg, Asahikawa, Hokkaido, Japan; [Kadekawa, K.; Majima, T.; Shimizu, T.; Okada, H.; Tyagi, P.; Yoshimura, N.] Univ Pittsburgh, Dept Urol, Sch Med, Pittsburgh, PA 15260 USA; [Kakizaki, H.] Asahikawa Med Univ, Dept Renal & Urol Surg, Asahikawa, Hokkaido, Japan							Wada N, 2013, INT J UROL, V20, P235, DOI 10.1111/j.1442-2042.2012.03126.x; Chuang YC, 2012, BJU INT, V110, P1558, DOI 10.1111/j.1464-410X.2012.11096.x	2	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0733-2467	1520-6777		NEUROUROL URODYNAM	Neurourol. Urodyn.	AUG	2015	34			3		188	S134	S135				2	Urology & Nephrology	Urology & Nephrology	CM2QY	WOS:000357528000090		
J	Wada, N; Kadekawa, K; Majima, T; Shimizu, T; Tyagi, P; Kakizaki, H; Yoshimura, N				Wada, N.; Kadekawa, K.; Majima, T.; Shimizu, T.; Tyagi, P.; Kakizaki, H.; Yoshimura, N.			URODYNAMIC EFFECTS OF INTRAVENOUS AND INTRATHECAL ADMINISTRATION OF E-SERIES PROSTAGLANDIN 1 RECEPTOR ANTAGONIST ON DETRUSOR OVERACTIVITY IN RATS WITH SPINAL CORD INJURY	NEUROUROLOGY AND URODYNAMICS			English	Meeting Abstract	45th Annual Meeting of the International-Continence-Society (ICS)	OCT 06-09, 2015	Montreal, CANADA	Int Continence Soc					[Wada, N.; Kadekawa, K.; Majima, T.; Shimizu, T.; Tyagi, P.; Yoshimura, N.] Univ Pittsburgh, Sch Med, Dept Urol, Pittsburgh, PA USA; [Wada, N.; Kakizaki, H.] Asahikawa Med Univ, Dept Renal & Urol Surg, Asahikawa, Hokkaido, Japan							Wada N, 2013, INT J UROL, V20, P235, DOI 10.1111/j.1442-2042.2012.03126.x; de Groat WC, 2012, EXP NEUROL, V235, P123, DOI 10.1016/j.expneurol.2011.05.003	2	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0733-2467	1520-6777		NEUROUROL URODYNAM	Neurourol. Urodyn.	AUG	2015	34			3		311	S296	S298				3	Urology & Nephrology	Urology & Nephrology	CM2QY	WOS:000357528000213		
J	Watanabe, M; Suzuki, Y; Uchida, K; Miyazaki, N; Murata, K; Matsumoto, S; Kakizaki, H; Tominaga, M				Watanabe, M.; Suzuki, Y.; Uchida, K.; Miyazaki, N.; Murata, K.; Matsumoto, S.; Kakizaki, H.; Tominaga, M.			TRPM7 CONTRIBUTES TO INTERCELLULAR JUNCTION FORMATION IN THE UROTHELIUM - POSSIBLE LINK TO THE PATHOPHYSIOLOGY OF INTERSTITIAL CYSTITIS	NEUROUROLOGY AND URODYNAMICS			English	Meeting Abstract	45th Annual Meeting of the International-Continence-Society (ICS)	OCT 06-09, 2015	Montreal, CANADA	Int Continence Soc					[Watanabe, M.; Matsumoto, S.; Kakizaki, H.] Asahikawa Med Univ, Asahikawa, Hokkaido, Japan; [Suzuki, Y.; Uchida, K.; Tominaga, M.] Natl Inst Nat Sci, Okazaki Inst Integrat Biosci, Div Cell Signaling, Okazaki, Aichi 4448787, Japan; [Miyazaki, N.; Murata, K.] Natl Inst Nat Sci, Natl Inst Physiol Sci, Elecron Microscopy Grp, Okazaki, Aichi 4448585, Japan							[Anonymous], 2012, CANC RES, V72, P4250; [Anonymous], 2014, HDB EXP PHARM, V223, P521; [Anonymous], 2010, AM J PHYSL RENAL PHY, V298, pF682	3	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0733-2467	1520-6777		NEUROUROL URODYNAM	Neurourol. Urodyn.	AUG	2015	34			3		226	S188	S189				2	Urology & Nephrology	Urology & Nephrology	CM2QY	WOS:000357528000128		
J	Yamanishi, T; Kaga, K; Uchiyama, T; Shibata, C				Yamanishi, T.; Kaga, K.; Uchiyama, T.; Shibata, C.			A PROSPECTIVE, SIX-YEAR FOLLOWUP OF SILODOSIN MONOTHERAPY FOR THE TREATMENT OF LUTS/BPH: WHAT ARE THE FACTORS FOR CONTINUATION OR WITHDRAWAL?	NEUROUROLOGY AND URODYNAMICS			English	Meeting Abstract	45th Annual Meeting of the International-Continence-Society (ICS)	OCT 06-09, 2015	Montreal, CANADA	Int Continence Soc					[Yamanishi, T.; Kaga, K.; Uchiyama, T.; Shibata, C.] Dokkyo Med Univ, Continence Ctr, Mibu, Tochigi, Japan							[Anonymous], 2013, J UROL S, V189, pS122; [Anonymous], 2006, BJU INT, V98, P1019; [Anonymous], 2008, INT J UROL, V15, P193	3	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0733-2467	1520-6777		NEUROUROL URODYNAM	Neurourol. Urodyn.	AUG	2015	34			3		209	S162	S163				2	Urology & Nephrology	Urology & Nephrology	CM2QY	WOS:000357528000111		
J	Yanagiuchi, A; Sengoku, A; Nomi, M				Yanagiuchi, A.; Sengoku, A.; Nomi, M.			LOWER URINARY TRACT DYSFUNCTION IN PATIENTS WITH PARKINSON'S DISEASE AND ITS CORRELATION WITH AUTONOMIC NERVOUS SYSTEM FUNCTION	NEUROUROLOGY AND URODYNAMICS			English	Meeting Abstract	45th Annual Meeting of the International-Continence-Society (ICS)	OCT 06-09, 2015	Montreal, CANADA	Int Continence Soc					[Yanagiuchi, A.] Nishi Harima Rehabil Ctr, Tatsuno, Japan; [Sengoku, A.; Nomi, M.] Hyogo Rehabil Ctr, Kobe, Hyogo, Japan							Uchiyama T, 2011, J NEUROL NEUROSUR PS, V82, P1382, DOI 10.1136/jnnp.2011.241075; Terayama K, 2012, MOVEMENT DISORD, V27, P1775, DOI 10.1002/mds.25225	2	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0733-2467	1520-6777		NEUROUROL URODYNAM	Neurourol. Urodyn.	AUG	2015	34			3		439	S333	S334				2	Urology & Nephrology	Urology & Nephrology	CM2QY	WOS:000357528000241		
J	Yokokawa, R; Akino, H; Nagase, K; Yokoyama, O				Yokokawa, R.; Akino, H.; Nagase, K.; Yokoyama, O.			ALTERATIONS OF BLADDER FUNCTIONS IN A RAT MODEL OF CEREBRAL INFARCTION: EFFECT OF THE B3-AGONISTS, MIRABEGRON AND BRL37344	NEUROUROLOGY AND URODYNAMICS			English	Meeting Abstract	45th Annual Meeting of the International-Continence-Society (ICS)	OCT 06-09, 2015	Montreal, CANADA	Int Continence Soc					[Yokokawa, R.; Akino, H.; Nagase, K.; Yokoyama, O.] Univ Fukui, Fukui, Japan							Hatanaka T, 2013, N-S ARCH PHARMACOL, V386, P247, DOI 10.1007/s00210-012-0821-4	1	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0733-2467	1520-6777		NEUROUROL URODYNAM	Neurourol. Urodyn.	AUG	2015	34			3		52	S88	S88				1	Urology & Nephrology	Urology & Nephrology	CM2QY	WOS:000357528000053		
J	Yoshida, M; Ogama, N; Nakai, T; Niida, S; Toba, K; Sakurai, T				Yoshida, M.; Ogama, N.; Nakai, T.; Niida, S.; Toba, K.; Sakurai, T.			FRONTAL WHITE MATTER HYPERINTENSITY PREDICTS LOWER URINARY TRACT DYSFUNCTION IN ELDERLY WITH AMNESTIC MILD COGNITIVE IMPAIRMENT AND ALZHEIMER DISEASE	NEUROUROLOGY AND URODYNAMICS			English	Meeting Abstract	45th Annual Meeting of the International-Continence-Society (ICS)	OCT 06-09, 2015	Montreal, CANADA	Int Continence Soc					[Yoshida, M.] Natl Ctr Geriatr & Gerontol, Dept Urol, Obu City, Aichi, Japan; [Ogama, N.; Toba, K.; Sakurai, T.] Natl Ctr Geriatr & Gerontol, Ctr Comprehens Care & Res Memory Disorders, Obu City, Aichi, Japan; [Nakai, T.] Natl Ctr Geriatr & Gerontol, NeuroImaging & Informat, Obu City, Aichi, Japan; [Niida, S.] Natl Ctr Geriatr & Gerontol, Biobank, Obu City, Aichi, Japan							[Anonymous], 2008, J AM GERIATR SOC, V56, P1638; [Anonymous], 2008, GERIATR GERONTOL INT, V8, P93; [Anonymous], 2011, ACTA NEUROPATHOL, V122, P171	3	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0733-2467	1520-6777		NEUROUROL URODYNAM	Neurourol. Urodyn.	AUG	2015	34			3		243	S211	S212				2	Urology & Nephrology	Urology & Nephrology	CM2QY	WOS:000357528000145		
J	Yoshiyama, M; Mochizuki, T; Takeda, M				Yoshiyama, M.; Mochizuki, T.; Takeda, M.			ROLES OF METABOTROPIC GLUTAMATE RECEPTOR SUBTYPE 1A IN LOWER URINARY TRACT FUNCTION OF MICE	NEUROUROLOGY AND URODYNAMICS			English	Meeting Abstract	45th Annual Meeting of the International-Continence-Society (ICS)	OCT 06-09, 2015	Montreal, CANADA	Int Continence Soc					[Yoshiyama, M.; Mochizuki, T.; Takeda, M.] Univ Yamanashi, Grad Sch Med Sci, Kofu, Yamanashi, Japan							Yoshiyama M, 2009, LUTS, V1, pS101, DOI 10.1111/j.1757-5672.2009.00043.x; Yoshiyama M, 2007, NEUROSCI LETT, V420, P18, DOI 10.1016/j.neulet.2007.04.002; Yoshiyama M, 2006, INT CONT SOC 36 ANN	3	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0733-2467	1520-6777		NEUROUROL URODYNAM	Neurourol. Urodyn.	AUG	2015	34			3		59	S99	S100				2	Urology & Nephrology	Urology & Nephrology	CM2QY	WOS:000357528000060		
J	Zhang, X; Yao, J; Ihara, T; Sawada, N; Mitsui, T; Takeda, M				Zhang, X.; Yao, J.; Ihara, T.; Sawada, N.; Mitsui, T.; Takeda, M.			AMP-ACTIVATED PROTEIN KINASE SUPPRESSES CONNEXIN43 IN BLADDER SMOOTH MUSCLE CELLS AND AMELIORATES VOIDING DYSFUNCTION IN CYCLOPHOSPHAMIDE-INDUCED MOUSE CYSTITIS	NEUROUROLOGY AND URODYNAMICS			English	Meeting Abstract	45th Annual Meeting of the International-Continence-Society (ICS)	OCT 06-09, 2015	Montreal, CANADA	Int Continence Soc					[Zhang, X.] Univ Yamanashi, Dept Mol Signaling & Urol, Yamanashi, Japan; [Yao, J.] Univ Yamanashi, Dept Mol Signaling, Yamanashi, Japan; [Ihara, T.; Sawada, N.; Mitsui, T.; Takeda, M.] Univ Yamanashi, Dept Urol, Yamanashi, Japan							Gao K, 2014, MOL PHARMACOL, V85, P460, DOI 10.1124/mol.113.089458; Li K, 2011, J BIOL CHEM, V286, P41552, DOI 10.1074/jbc.M111.274449; Li K, 2012, J UROLOGY, V188, P307, DOI 10.1016/j.juro.2012.02.2556	3	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0733-2467	1520-6777		NEUROUROL URODYNAM	Neurourol. Urodyn.	AUG	2015	34			3		466	S368	S369				2	Urology & Nephrology	Urology & Nephrology	CM2QY	WOS:000357528000268		
J	Shinya, T; Sato, S; Kunisada, T; Inai, R; Yanai, H; Ozaki, T; Kanazawa, S				Shinya, Takayoshi; Sato, Shuhei; Kunisada, Toshiyuki; Inai, Ryota; Yanai, Hiroyuki; Ozaki, Toshifumi; Kanazawa, Susumu			Both a visual and a semiquantitative analysis for differentiating benign from malignant chondrogenic bone tumors using Tc-99m (V) DMSA scintigraphy: a prospective study	NUCLEAR MEDICINE COMMUNICATIONS			English	Article						bone tumor; cartilaginous; chondrogenic; chondrosarcoma; Tc-99m (V) DMSA scintigraphy	SOFT-TISSUE TUMORS; DIMERCAPTOSUCCINIC ACID; AGENT	ObjectiveThe aims of this prospective study were to assess the relationship between tumor aggressiveness and Tc-99m (V) dimercaptosuccinic acid (DMSA) uptake in chondrogenic bone tumors and the value of Tc-99m (V) DMSA scintigraphy for differentiating benign from malignant tumors.MethodsTwenty-four patients with chondrogenic tumors (19 benign and five malignant) underwent Tc-99m DMSA (V) scintigraphy. Radiopharmaceutical uptake was classified using a three-point scale to allow a visual-only analysis, and a tumor-to-background contrast (TBC) was computed using regions of interest to provide a semiquantitative analysis. Spearman's correlation coefficient was used to assess the correlation between tumor aggressiveness and TBC. The difference in TBC between benign and malignant tumors was analyzed with the Mann-Whitney U-test. An appropriate cutoff value of TBC was chosen for the diagnosis of malignancy of a tumor using receiver operating characteristic analysis.ResultsSix benign tumors showed negative uptake (uptake score 0), whereas 13 benign tumors showed positive uptake (n=10 uptake score 1; n=3 uptake score 2). All chondrosarcomas showed positive uptake (n=2 uptake score 1; n=3 uptake score 2). A significant correlation was found between tumor aggressiveness and TBC. A significant difference was seen in TBC between benign and malignant tumors. With the chosen cutoff value of TBC equal to 0.611, the sensitivity was 80.0%, specificity was 78.9%, the positive predictive value was 50.0%, and the negative predictive value was 93.8%.ConclusionTc-99m (V) DMSA scintigraphy may have the potential to improve diagnostic methods for detecting chondrosarcomas using visual and/or semiquantitative analyses.	[Shinya, Takayoshi; Sato, Shuhei; Inai, Ryota; Kanazawa, Susumu] Okayama Univ Hosp, Dept Radiol, Okayama, Okayama 7008558, Japan; [Yanai, Hiroyuki] Okayama Univ Hosp, Dept Pathol, Okayama, Okayama 7008558, Japan; [Kunisada, Toshiyuki] Okayama Univ, Grad Sch Med, Dept Med Mat Musculoskeletal Reconstruct, Okayama, Japan; [Ozaki, Toshifumi] Okayama Univ, Grad Sch Med, Dept Orthopaed Surg, Okayama, Japan	Shinya, T (reprint author), Okayama Univ Hosp, Dept Radiol, Kita Ku, 2-5-1 Shikatacho, Okayama, Okayama 7008558, Japan.	midnight-2005@nifty.com			Daiichi Radioisotopes Laboratories Ltd, Tokyo, Japan	This work was supported by Daiichi Radioisotopes Laboratories Ltd, Tokyo, Japan.	Kawakami N, 2011, CLIN NUCL MED, V36, P982, DOI 10.1097/RLU.0b013e3182177407; KOBAYASHI H, 1993, J NUCL MED, V34, P1745; Kunisada T, 1999, CANCER, V86, P949, DOI 10.1002/(SICI)1097-0142(19990915)86:6<949::AID-CNCR9>3.0.CO;2-H; Bertoni F, 1998, EUR J RADIOL, V27, P74; Choong PF, 2004, INT SEMIN SURG ONCOL, V1, P10, DOI 10.1186/1477-7800-1-10; COUGHLAN B, 1995, HUM PATHOL, V26, P620, DOI 10.1016/0046-8177(95)90166-3; Dahlin DC, 1986, BONE TUMORS GEN ASPE, V4th; DIRIX L Y, 1991, Current Opinion in Oncology, V3, P694; Greenfield GB, 1990, SOLITARY LESION RADI, V5th; HASEGAWA T, 1995, HUM PATHOL, V26, P838, DOI 10.1016/0046-8177(95)90004-7; Jaffe HL, 1943, ARCH PATHOL, V36, P335; Kayo GC, 2010, ANN NUCL MED, V24, P279; KOBAYASHI H, 1995, CLIN NUCL MED, V20, P361, DOI 10.1097/00003072-199504000-00015; KOBAYASHI H, 1993, J NUCL MED, V34, P815; KOBAYASHI H, 1994, RADIOLOGY, V190, P277; Lucas DR, 2013, WHO CLASSIFICATION T, P252; OHTA H, 1988, NUCL MED COMMUN, V9, P105; Springfield DS, 1996, AAOS INSTR COURS LEC, V45, P417; WATKINSON JC, 1989, J NUCL MED, V30, P174; YOKOYAMA A, 1985, INT J NUCL MED BIOL, V12, P273, DOI 10.1016/0047-0740(85)90180-9	20	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0143-3636	1473-5628		NUCL MED COMMUN	Nucl. Med. Commun.	AUG	2015	36	8					802	807		10.1097/MNM.0000000000000328		6	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CM4GV	WOS:000357643600007		
J	Matsutomo, N; Nagaki, A; Sasaki, M				Matsutomo, Norikazu; Nagaki, Akio; Sasaki, Masayuki			Validation of the CT iterative reconstruction technique for low-dose CT attenuation correction for improving the quality of PET images in an obesity-simulating body phantom and clinical study	NUCLEAR MEDICINE COMMUNICATIONS			English	Article						attenuation correction; CT iterative reconstruction; F-18-FDG PET/CT; low-dose CT; obesity patient	FILTERED BACK-PROJECTION; RADIATION-EXPOSURE; TUBE CURRENT; TOMOGRAPHY; REDUCTION; SYSTEM; DETECTABILITY; GERMANIUM; PROTOCOL; SAFIRE	ObjectiveThe aim of this study was to validate the efficacy of computed tomography (CT) iterative reconstruction (CT-IR) for low-dose CT attenuation correction in terms of the estimation of attenuation coefficient and quality of PET images.Materials and methodsWe used normal and obesity-simulating body phantoms. PET images were reconstructed using two attenuation correction maps obtained using filtered back projection (CT-FBP) and CT-IR. The CT numbers, attenuation coefficients, contrast-to-noise ratio (CNR10mm), and coefficient of variation were evaluated. Fifty-two consecutive patients who underwent F-18-FDG PET/CT with low-dose CT scans were selected for the clinical study. Clinical PET images were reconstructed using CT-FBP and CT-IR, and the effects of CT-IR were examined according to the maximum standardized uptake value (SUVmax), contrast-to-noise ratio in the tumor (CNRtumor), and signal-to-noise ratio in the liver (SNRliver).ResultsThe CT number on the CT-IR was significantly lower than that of CT-FBP in the obesity-simulating body phantom. The decrease in attenuation coefficients obtained using CT-IR was smaller than that obtained using CT-FBP. The CNR10mm and coefficient of variation obtained using CT-IR were superior to those obtained using CT-FBP. The SUVmax was not significantly different between the CT-FBP and CT-IR. Although the difference in the SNRliver between the CT-FBP and CT-IR was not significant, the CNRtumor of the CT-IR was significantly higher than that obtained using CT-FBP in obese patients.ConclusionWe demonstrated that CT-IR improved the estimation of the attenuation coefficient and provided significant improvement in the CNR of the clinical PET images.	[Matsutomo, Norikazu; Nagaki, Akio] Kurashiki Cent Hosp, Dept Radiol Technol, Kurashiki, Okayama 7108602, Japan; [Matsutomo, Norikazu; Sasaki, Masayuki] Kyushu Univ, Grad Sch Med Sci, Dept Hlth Sci, Fukuoka 812, Japan	Matsutomo, N (reprint author), Kurashiki Cent Hosp, Dept Radiol Technol, 1-1-1 Miwa, Kurashiki, Okayama 7108602, Japan.	nm7074@kchnet.or.jp					Kamel E, 2002, EUR J NUCL MED MOL I, V29, P346, DOI 10.1007/s00259-001-0698-9; Halpern BS, 2004, J NUCL MED, V45, P797; Moscariello A, 2011, EUR RADIOL, V21, P2130, DOI 10.1007/s00330-011-2164-9; Hara AK, 2009, AM J ROENTGENOL, V193, P764, DOI 10.2214/AJR.09.2397; Tong S, 2010, PHYS MED BIOL, V55, P1453, DOI 10.1088/0031-9155/55/5/013; Nakamoto Y, 2002, J NUCL MED, V43, P1137; Visvikis D, 2003, EUR J NUCL MED MOL I, V30, P344, DOI 10.1007/s00259-002-1070-4; Brix G, 2005, J NUCL MED, V46, P608; Akamatsu G, 2012, J NUCL MED, V53, P1716, DOI 10.2967/jnumed.112.103861; Ghetti C, 2012, PHYS MEDICA, V28, P161, DOI 10.1016/j.ejmp.2011.03.003; Alessio AM, 2010, IEEE T MED IMAGING, V29, P938, DOI 10.1109/TMI.2010.2040188; Funama Y, 2005, RADIOLOGY, V237, P905, DOI 10.1148/radiol.2373041643; Hicks RJ, 2001, J NUCL MED, V42, P1605; Han BK, 2012, J CARDIOVASC COMPUT, V6, P200, DOI 10.1016/j.jcct.2012.04.008; Xia T, 2012, PHYS MED BIOL, V57, P309, DOI 10.1088/0031-9155/57/2/309; Schulz B, 2013, AM J NEURORADIOL, V34, P1072, DOI 10.3174/ajnr.A3339; Baker ME, 2012, AM J ROENTGENOL, V199, P8, DOI 10.2214/AJR.11.7421; Cohade C, 2003, SEMIN NUCL MED, V33, P228, DOI 10.1053/snuc.2003.127312; Delbeke D, 1999, J NUCL MED, V40, P591; KAMEL IR, 1994, RADIOLOGY, V190, P683; Lee IS, 2007, J COMPUT ASSIST TOMO, V31, P635, DOI 10.1097/01.rct.0000250117.18080.d8; Nagaki A, 2012, ANN NUCL MED, V26, P359, DOI 10.1007/s12149-012-0584-5; Peter MJ, 1982, MED PHYS, V9, P464; Popilock Robert, 2008, J Nucl Med Technol, V36, P79, DOI 10.2967/jnmt.107.047431; Schoder H, 2005, J NUCL MED, V46, P1249; Townsend DW, 2008, J NUCL MED, V49, P938, DOI 10.2967/jnumed.108.051276; Wang R, 2012, EUR J RADIOL, V81, P3141, DOI 10.1016/j.ejrad.2012.04.012; Wu TH, 2004, EUR J NUCL MED MOL I, V31, P38, DOI 10.1007/s00259-003-1327-6; Wu TH, 2005, NUCL MED COMMUN, V26, P323, DOI 10.1097/00006231-200504000-00004	29	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0143-3636	1473-5628		NUCL MED COMMUN	Nucl. Med. Commun.	AUG	2015	36	8					839	847		10.1097/MNM.0000000000000326		9	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CM4GV	WOS:000357643600013		
J	Costa, ZJ; Kishida, O				Costa, Zacharia J.; Kishida, Osamu			Nonadditive impacts of temperature and basal resource availability on predator-prey interactions and phenotypes	OECOLOGIA			English	Article						Bottom-up effects; Climate change; Food webs; Phenotypic plasticity; Top-down effects	SALAMANDER HYNOBIUS-RETARDATUS; FOOD-WEB STRUCTURE; RISK TRADE-OFF; INDUCIBLE DEFENSE; TOP-DOWN; INTERACTION STRENGTH; LARVAL AMPHIBIANS; ANURAN LARVAE; PLASTICITY; SIZE	Predicting the impacts of climate change on communities requires understanding how temperature affects predator-prey interactions under different biotic conditions. In cases of size-specific predation, environmental influences on the growth rate of one or both species can determine predation rates. For example, warming increases top-down control of food webs, although this depends on resource availability for prey, as increased resources may allow prey to reach a size refuge. Moreover, because the magnitude of inducible defenses depends on predation rates and resource availability for prey, temperature and resource levels also affect phenotypic plasticity. To examine these issues, we manipulated the presence/absence of predatory Hynobius retardatus salamander larvae and herbivorous Rana pirica tadpoles at two temperatures and three basal resource levels. and measured their morphology, behavior, growth and survival. Prior work has shown that both species express antagonistic plasticity against one another in which salamanders enlarge their gape width and tadpoles increase their body width to reach a size-refuge. We found that increased temperatures increased predation rates, although this was counteracted by high basal resource availability, which further decreased salamander growth. Surprisingly, salamanders caused tadpoles to grow larger and express more extreme defensive phenotypes as resource levels decreased under warming, most likely due to their increased risk of predation. Thus, temperature and resources influenced defensive phenotype expression and its impacts on predator and prey growth by affecting their interaction strength. Our results indicate that basal resource levels can modify the impacts of increased temperatures on predator-prey interactions and its consequences for food webs.	[Costa, Zacharia J.] Virginia Commonwealth Univ, Dept Biol, Richmond, VA 23284 USA; [Kishida, Osamu] Hokkaido Univ, Field Ctr Northern Biosphere, Teshio Expt Forest, Horonobe, Hokkaido 0982943, Japan	Costa, ZJ (reprint author), Rice Univ, Dept Ecol & Evolutionary Biol, 6100 Main St, Houston, TX 77005 USA.	zachariacosta@gmail.com; bulgy_tadpoles@hotmail.com			JSPS KAKENHI [24370004]	We thank Kunio Takatsu, Ayumi Tezuka, Tomoko Sato, Emiko Taniguchi, Shiho Chiba and all of members of Teshio Experimental forest for their very helpful assistance. Nick Rasmussen provided statistical advice and Steve Kohler and several anonymous reviewers provided valuable comments that improved the manuscript. This work was supported by JSPS KAKENHI Grant Number 24370004 to O. Kishida.	Warton DI, 2011, ECOLOGY, V92, P3, DOI 10.1890/10-0340.1; Shurin JB, 2012, PHILOS T R SOC B, V367, P3008, DOI 10.1098/rstb.2012.0243; Urban MC, 2007, ECOLOGY, V88, P2587, DOI 10.1890/06-1946.1; Stoks R, 2012, J ANIM ECOL, V81, P1034, DOI 10.1111/j.1365-2656.2012.01987.x; Riessen HP, 2009, ECOLOGY, V90, P3455, DOI 10.1890/08-1652.1; Twomey M, 2012, PHILOS T R SOC B, V367, P2971, DOI 10.1098/rstb.2012.0244; Laurila A, 2008, ECOLOGY, V89, P1399, DOI 10.1890/07-1521.1; Rall BC, 2010, GLOBAL CHANGE BIOL, V16, P2145, DOI 10.1111/j.1365-2486.2009.02124.x; Bourdeau PE, 2012, OIKOS, V121, P1175, DOI 10.1111/j.1600-0706.2012.20235.x; Relyea RA, 2002, ECOLOGY, V83, P1953, DOI 10.2307/3071778; Hoekman D, 2010, ECOLOGY, V91, P2819, DOI 10.1890/10-0260.1; Baldridge AK, 2008, MAR ECOL PROG SER, V365, P25, DOI 10.3354/meps07485; Liess A, 2013, J ANIM ECOL, V82, P1316, DOI 10.1111/1365-2656.12107; Thaler JS, 2012, P NATL ACAD SCI USA, V109, P12075, DOI 10.1073/pnas.1208070109; Steiner UK, 2007, AM NAT, V169, P118, DOI 10.1086/509939; Johansson F, 2009, J ANIM ECOL, V78, P772, DOI 10.1111/j.1365-2656.2009.01530.x; Schiesari L, 2006, FRESHWATER BIOL, V51, P412, DOI 10.1111/j.1365-2427.2005.01497.x; Beckerman AP, 2010, J ANIM ECOL, V79, P1069, DOI 10.1111/j.1365-2656.2010.01703.x; Van Buskirk J, 2000, ECOLOGY, V81, P2813, DOI 10.1890/0012-9658(2000)081[2813:TCOAID]2.0.CO;2; Vucic-Pestic O, 2011, GLOBAL CHANGE BIOL, V17, P1301, DOI 10.1111/j.1365-2486.2010.02329.x; Kratina P, 2012, ECOLOGY, V93, P1421, DOI 10.1890/11-1595.1; Edgell TC, 2008, EVOLUTION, V62, P1216, DOI 10.1111/j.1558-5646.2008.00350.x; Englund G, 2011, ECOL LETT, V14, P914, DOI 10.1111/j.1461-0248.2011.01661.x; Kishida O, 2004, OECOLOGIA, V140, P414, DOI 10.1007/s00442-004-1609-0; Cahill AE, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.1890; COLEY PD, 1985, SCIENCE, V230, P895, DOI 10.1126/science.230.4728.895; Kishida O, 2006, ECOLOGY, V87, P1599, DOI 10.1890/0012-9658(2006)87[1599:RPPIAP]2.0.CO;2; Skelly DK, 2002, ECOLOGY, V83, P983, DOI 10.2307/3071907; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Kopp M, 2003, ECOL LETT, V6, P742, DOI 10.1046/j.1461-0248.2003.00485.x; Tylianakis JM, 2008, ECOL LETT, V11, P1351, DOI 10.1111/j.1461-0248.2008.01250.x; WERNER EE, 1993, AM NAT, V142, P242, DOI 10.1086/285537; Benard MF, 2004, ANNU REV ECOL EVOL S, V35, P651, DOI 10.1146/annurev.ecolsys.35.021004.112426; TOLLRIAN R, 1995, OECOLOGIA, V101, P151, DOI 10.1007/BF00317278; Woods HA, 2003, FUNCT ECOL, V17, P237, DOI 10.1046/j.1365-2435.2003.00724.x; Sentis A, 2014, ECOL LETT, V17, P785, DOI 10.1111/ele.12281; McPeek MA, 2004, AM NAT, V163, pE88, DOI 10.1086/382755; Urban MC, 2008, OIKOS, V117, P1037, DOI 10.1111/j.2008.0030-1299.16334.x; Kishida O, 2010, POPUL ECOL, V52, P37, DOI 10.1007/s10144-009-0182-0; Anderson MT, 2001, CAN J ZOOL, V79, P1834, DOI 10.1139/cjz-79-10-1834; Bennett AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082344; Chaves-Campos J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044374; COHEN JE, 1993, J ANIM ECOL, V62, P67, DOI 10.2307/5483; Harvell C. D., 1999, ECOLOGY EVOLUTION IN; Kishida O, 2014, J ANIM ECOL, V83, P899, DOI 10.1111/1365-2656.12186; Kishida O, 2009, ECOLOGY, V90, P1217, DOI 10.1890/08-0238.1; Kishida O, 2006, J ANIM ECOL, V75, P705, DOI 10.1111/j.1365-2656.01091.x; Kopp M, 2003, ECOLOGY, V84, P641, DOI 10.1890/0012-9658(2003)084[0641:TSPILB]2.0.CO;2; Michimae H, 2002, EVOLUTION, V56, P2029; Michimae H, 2006, BEHAV ECOL SOCIOBIOL, V60, P205, DOI 10.1007/s00265-005-0157-x; O'Connor MI, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000178; Padilla DK, 2001, EVOL ECOL RES, V3, P15; Pauwels K, 2010, FUNCT ECOL, V24, P322, DOI 10.1111/j.1365-2435.2009.01641.x; Rabus M, 2011, FUNCT ECOL, V25, P1137, DOI 10.1111/j.1365-2435.2011.01840.x; Rasband W.S, 1997, IMAGEJ VERSION 1 45S; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Steiner UK, 2007, ANIM BEHAV, V74, P1473, DOI 10.1016/j.anbehav.2007.02.016; Takatsu K, 2013, EVOL ECOL, V27, P1, DOI 10.1007/s10682-012-9572-4; Uitregt VO, 2013, EVOL ECOL, V27, P13	59	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0029-8549	1432-1939		OECOLOGIA	Oecologia	AUG	2015	178	4					1215	1225		10.1007/s00442-015-3302-x		11	Ecology	Environmental Sciences & Ecology	CN0FL	WOS:000358089400021		
J	Kammori, M; Sugishita, Y; Okamoto, T; Kobayashi, M; Yamazaki, K; Yamada, E; Yamada, T				Kammori, Makoto; Sugishita, Yoshiyuki; Okamoto, Takahiro; Kobayashi, Makio; Yamazaki, Kazuko; Yamada, Emiko; Yamada, Tetsu			Telomere shortening in breast cancer correlates with the pathological features of tumor progression	ONCOLOGY REPORTS			English	Article						tissue quantitative fluorescence in situ hybridization; telomere; breast cancer	IN-SITU HYBRIDIZATION; LYMPH-NODE STATUS; DNA-CONTENT; LUMINAL B; LENGTH; EXPRESSION; SUBTYPES; PROGNOSIS; FIBROBLASTS; INSTABILITY	Telomeres are involved in the maintenance of genomic stability. Telomere alteration has been observed in most human cancer types, and is known to be a feature of malignancy. The aim of the present study was to evaluate whether the telomere length of breast cancer cells correlates with TNM stage and several pathological features. We investigated a total of 44 breast cancers, including 17 scirrhous, 15 papillotubular and 12 solid-tubular carcinomas. Telomere lengths were determined by tissue quantitative fluorescence in situ hybridization (Q-FISH), and compared according to the TNM stage, histological tumor size, lymph node metastases, vascular invasion and immunohistochemical status (ER, PR, HER2 status and Ki67 labeling index). In all histological types, telomeres of cancer cells were significantly shorter than those of normal epithelial cells. Mean telomere length was significantly less in patients with TNM stage III, and in those with large tumors, lymph node metastases and vascular invasion. Our results suggest that the telomere length of cancer cells is strongly correlated with the degree of cancer progression.	[Kammori, Makoto; Yamada, Tetsu] Kanaji Thyroid Hosp, Dept Surg, Kita Ku, Tokyo 1140015, Japan; [Kammori, Makoto; Sugishita, Yoshiyuki; Yamazaki, Kazuko; Yamada, Tetsu] Kanaji Thyroid Hosp, Dept Lab, Kita Ku, Tokyo 1140015, Japan; [Yamada, Emiko] Kanaji Thyroid Hosp, Dept Med, Kita Ku, Tokyo 1140015, Japan; [Kammori, Makoto; Okamoto, Takahiro] Tokyo Womens Med Univ, Dept Surg, Div Surg Endocrinol, Shinjuku Ku, Tokyo 1620054, Japan; [Kobayashi, Makio] Tokyo Womens Med Univ, Dept Pathol 1, Shinjuku Ku, Tokyo 1620054, Japan	Kammori, M (reprint author), Kanaji Thyroid Hosp, Dept Surg, Kita Ku, 1-5-6 Nakazato, Tokyo 1140015, Japan.	kammori@kanaji.jp			Japanese Ministry of Education, Culture, Sports, Science and Technology [20591555]	This study was partly supported by a Grant-in-Aid for Scientific Research from the Japanese Ministry of Education, Culture, Sports, Science and Technology (#20591555). We would like to thank Dr Steven S.S. Poon (Terry Fox Laboratory, British Columbia Cancer Research Center) for preparation of the software for measurement of telomere length. We would also like to thank Miyoko Matsumoto (Kanaji Thyroid Hospital) for assistance with the manuscript preparation.	Ahlin C, 2007, HISTOPATHOLOGY, V51, P491, DOI 10.1111/j.1365-2559.2007.02798.x; Meeker AK, 2004, CLIN CANCER RES, V10, P3317, DOI 10.1158/1078-0432.CCR-0984-03; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Heaphy CM, 2007, CLIN CANCER RES, V13, P7037, DOI 10.1158/1078-0432.CCR-07-0432; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; Cheang MCU, 2009, J NATL CANCER I, V101, P736, DOI 10.1093/jnci/djp082; Radpour R, 2010, MODERN PATHOL, V23, P763, DOI 10.1038/modpathol.2009.195; DePinho RA, 2000, NATURE, V408, P248, DOI 10.1038/35041694; Jemal A, 2011, CA-CANCER J CLIN, V61, P69, DOI 10.3322/caac.20107; Voduc KD, 2010, J CLIN ONCOL, V28, P1684, DOI 10.1200/JCO.2009.24.9284; Meeker AK, 2004, J MAMMARY GLAND BIOL, V9, P285, DOI 10.1023/B:JOMG.0000048775.04140.92; Artandi SE, 2010, CARCINOGENESIS, V31, P9, DOI 10.1093/carcin/bgp268; Goldhirsch A, 2011, ANN ONCOL, V22, P1736, DOI 10.1093/annonc/mdr304; Kurabayashi R, 2008, HUM PATHOL, V39, P1647, DOI 10.1016/j.humpath.2008.04.005; ODAGIRI E, 1994, CANCER, V73, P2978, DOI 10.1002/1097-0142(19940615)73:12<2978::AID-CNCR2820731215>3.0.CO;2-5; Palm W, 2008, ANNU REV GENET, V42, P301, DOI 10.1146/annurev.genet.41.110306.130350; Frias C, 2008, LUNG CANCER, V60, P416, DOI 10.1016/j.lungcan.2007.11.001; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; von Zglinicki T, 2002, TRENDS BIOCHEM SCI, V27, P339, DOI 10.1016/S0968-0004(02)02110-2; de Lange T, 1998, SCIENCE, V279, P334, DOI 10.1126/science.279.5349.334; Aida J, 2007, HUM PATHOL, V38, P1192, DOI 10.1016/j.humpath.2006.11.023; Meeker AK, 2004, AM J PATHOL, V164, P925, DOI 10.1016/S0002-9440(10)63180-X; Blasco MA, 2005, NAT REV GENET, V6, P611, DOI 10.1038/nrg1656; Stewart SA, 2006, ANNU REV CELL DEV BI, V22, P531, DOI 10.1146/annurev.cellbio.22.010305.104518; Prescott J, 2012, MUTAT RES-FUND MOL M, V730, P75, DOI 10.1016/j.mrfmmm.2011.06.009; Harley Calvin B., 1995, Current Opinion in Genetics and Development, V5, P249, DOI 10.1016/0959-437X(95)80016-6; Heaphy CM, 2011, MODERN PATHOL, V24, P194, DOI 10.1038/modpathol.2010.198; Svenson U, 2009, BBA-MOL BASIS DIS, V1792, P317, DOI 10.1016/j.bbadis.2009.01.017; Deng YB, 2008, NAT REV CANCER, V8, P450, DOI 10.1038/nrc2393; Diehl MC, 2011, BREAST CANCER RES TR, V127, P623, DOI 10.1007/s10549-010-0988-7; Griffith JK, 1999, BREAST CANCER RES TR, V54, P59, DOI 10.1023/A:1006128228761; Chin K, 2004, NAT GENET, V36, P984, DOI 10.1038/ng1409; Bisoffi M, 2006, INT J CANCER, V119, P2255, DOI 10.1002/ijc.22120; CARTER CL, 1989, CANCER, V63, P181, DOI 10.1002/1097-0142(19890101)63:1<181::AID-CNCR2820630129>3.0.CO;2-H; Donaldson L, 1999, J UROLOGY, V162, P1788, DOI 10.1016/S0022-5347(05)68239-0; Fordyce CA, 2006, BREAST CANCER RES TR, V99, P193, DOI 10.1007/s10549-006-9204-1; Gebauer G, 2002, BREAST CANCER RES TR, V75, P167, DOI 10.1023/A:1019601928290; Kammori M, 2006, ONCOLOGY-BASEL, V71, P430, DOI 10.1159/000108612; Knutsvik G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112121; LEITNER SP, 1995, CANCER, V76, P2266, DOI 10.1002/1097-0142(19951201)76:11<2266::AID-CNCR2820761114>3.0.CO;2-T; Martinez-Delgado B, 2013, BREAST CANCER RES TR, V141, P231, DOI 10.1007/s10549-013-2696-6; Rogalla P, 1996, CANCER LETT, V106, P155, DOI 10.1016/0304-3835(96)04304-2; Sotiriou C, 2009, NEW ENGL J MED, V360, P790, DOI 10.1056/NEJMra0801289; Sugishita Y, 2014, ANN SURG ONCOL, V21, P2318, DOI 10.1245/s10434-014-3552-6	45	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1021-335X	1791-2431		ONCOL REP	Oncol. Rep.	AUG	2015	34	2					627	632		10.3892/or.2015.4063		6	Oncology	Oncology	CM8QB	WOS:000357965600011		
J	Kubo, S; Takagi-Kimura, M; Kasahara, N				Kubo, Shuji; Takagi-Kimura, Misato; Kasahara, Noriyuki			Combinatorial anti-angiogenic gene therapy in a human malignant mesothelioma model	ONCOLOGY REPORTS			English	Article						anti-angiogenesis; angiostatin; endostatin; sFlk1; mesothelioma	ENDOTHELIAL-GROWTH-FACTOR; PLEURAL MESOTHELIOMA; FACTOR RECEPTOR-2; TUMOR-GROWTH; FACTOR VEGF; PHASE-II; BEVACIZUMAB; CELLS; ANGIOSTATIN; INHIBITION	Anti-angiogenic gene therapy represents a promising strategy for cancer; however, it has rarely been tested in malignant mesothelioma, a highly aggressive tumor associated with asbestos with poor prognosis. In the present study, we investigated whether anti-angiogenic factors such as angiostatin, endostatin and the soluble form of vascular endothelial growth factor receptor 2 (sFlk1) were able to inhibit endothelial cell proliferation via lentivirus-mediated gene transfer into malignant mesothelioma cells in culture. We also assessed whether a dual-agent strategy had greater therapeutic benefit. Human malignant pleural mesothelioma MSTO-211H cells were transduced using lentiviral vectors that individually expressed angiostatin, endostatin and sFlk1 and linked to enhanced green fluorescent protein (EGFP) marker gene expression via an internal ribosome entry site. The lentivirus expressing EGFP alone was used as a control. The resultant cells designated as MSTO-A, MSTO-E, MSTO-F and MSTO-C were confirmed by western blot analysis and fluorescence microscopy to stably express the corresponding proteins. No differences were observed in the in vitro growth rates between any of these cells. However, co-culture of MSTO-A, MSTO-E and MSTO-F showed significant suppression of human umbilical endothelial cell growth in vitro compared with that of MSTO-C. Furthermore, a combination of any two among MSTO-A, MSTO-E and MSTO-F significantly enhanced efficacy. These results suggest that combinatorial anti-angiogenic gene therapy targeting different pathways of endothelial growth factor signaling has the potential for greater therapeutic efficacy than that of a single-agent regimen.	[Kubo, Shuji; Takagi-Kimura, Misato] Hyogo Coll Med, Dept Genet, Nishinomiya, Hyogo 6638501, Japan; [Kasahara, Noriyuki] Univ Miami, Dept Cell Biol, Miami, FL USA; [Kasahara, Noriyuki] Univ Miami, Dept Pathol, Miami, FL USA	Kubo, S (reprint author), Hyogo Coll Med, Dept Genet, 1-1 Mukogawa Cho, Nishinomiya, Hyogo 6638501, Japan.	s-kubo@hyo-med.ac.jp			Hyogo College of Medicine; Ministry of Education, Culture, Sports, Science and Technology of Japan [25460484]	We thank Atsuko Tamamoto, Nobutaka Okamura and members of the Joint-Use Research Facilities of the Hyogo College of Medicine for their technical assistance; Toshiaki Shichinohe for a part of the lentiviral constructs and Judah Folkman for sFlk1 plasmid. The present study was supported by a Grant-in-Aid for Researchers, Hyogo College of Medicine and a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (25460484).	Shichinohe T, 2001, CANCER GENE THER, V8, P879, DOI 10.1038/sj.cgt.7700388; OREILLY MS, 1994, CELL, V79, P315, DOI 10.1016/0092-8674(94)90200-3; Jenab-Wolcott J, 2009, EXPERT OPIN BIOL TH, V9, P507, DOI [10.1517/14712590902817817 , 10.1517/14712590902817817]; Takagi-Kimura M, 2013, CANCER SCI, V104, P1433, DOI 10.1111/cas.12267; Takahashi S, 2011, BIOL PHARM BULL, V34, P1785; OReilly MS, 1997, CELL, V88, P277, DOI 10.1016/S0092-8674(00)81848-6; Dowell JE, 2012, LUNG CANCER, V77, P567, DOI 10.1016/j.lungcan.2012.05.111; Remon J, 2013, CANCER TREAT REV, V39, P584, DOI 10.1016/j.ctrv.2012.12.005; Ceresoli GL, 2013, BRIT J CANCER, V109, P552, DOI 10.1038/bjc.2013.368; Lee S, 2007, CELL, V130, P691, DOI 10.1016/j.cell.2007.06.054; Yasumitsu A, 2010, J THORAC ONCOL, V5, P479, DOI 10.1097/JTO.0b013e3181d2f008; Li Q, 2007, CLIN CANCER RES, V13, P5918, DOI 10.1158/1078-0432.CCR-07-0501; Zucali PA, 2011, CANCER TREAT REV, V37, P543, DOI 10.1016/j.ctrv.2011.01.001; Kumar-Singh S, 1999, J PATHOL, V189, P72, DOI 10.1002/(SICI)1096-9896(199909)189:1<72::AID-PATH401>3.0.CO;2-0; Strizzi L, 2001, J PATHOL, V193, P468, DOI 10.1002/path.824; Bougatef F, 2009, BLOOD, V114, P5547, DOI 10.1182/blood-2009-04-217380; Robinson CJ, 2001, J CELL SCI, V114, P853; Tsao AS, 2009, J CLIN ONCOL, V27, P2081, DOI 10.1200/JCO.2008.19.8523; Weis SM, 2011, NAT MED, V17, P1359, DOI 10.1038/nm.2537; Redlitz A, 1999, J VASC RES, V36, P28, DOI 10.1159/000025623; Ismail-Khan Roohi, 2006, Cancer Control, V13, P255; Kawasaki Y, 2011, CANCER GENE THER, V18, P571, DOI 10.1038/cgt.2011.25; Kotova Svetlana, 2015, Cancer Manag Res, V7, P51, DOI 10.2147/CMAR.S72814; Kourlas H, 2007, CLIN THER, V29, P1850, DOI 10.1016/j.clinthera.2007.09.008; Kubo S, 2010, J GENE MED, V12, P681, DOI 10.1002/jgm.1486; Kubo S, 2013, CANCER GENE THER, V20, P671, DOI 10.1038/cgt.2013.67; Kubo S, 2006, P NATL ACAD SCI USA, V103, P8036, DOI 10.1073/pnas.0601954103; Kubo S, 2003, J VIROL, V77, P2964, DOI 10.1128/JVI.77.5.2964-2971.2003; Kuo CJ, 2001, P NATL ACAD SCI USA, V98, P4605, DOI 10.1073/pnas.081615298; Langer C, 2010, CLIN LUNG CANCER, V11, P82, DOI 10.3816/CLC.2010.n.011; Szentirmai O, 2008, J NEUROSURG, V108, P979, DOI 10.3171/JNS/2008/108/5/0979; Takagi-Kimura M, 2014, CANCER GENE THER, V21, P126, DOI 10.1038/cgt.2014.7; van der Most RG, 2006, CANCER GENE THER, V13, P897, DOI 10.1038/sj.cgt.7700935; Wu Y, 2006, HUM GENE THER, V17, P941, DOI 10.1089/hum.2006.17.941	34	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1021-335X	1791-2431		ONCOL REP	Oncol. Rep.	AUG	2015	34	2					633	638		10.3892/or.2015.4058		6	Oncology	Oncology	CM8QB	WOS:000357965600012		
J	Okita, Y; Ohira, M; Tanaka, H; Tokumoto, M; Go, Y; Sakurai, K; Toyokawa, T; Kubo, N; Muguruma, K; Sawada, T; Maeda, K; Hirakawa, K				Okita, Yoshihiro; Ohira, Masaichi; Tanaka, Hiroaki; Tokumoto, Mao; Go, Yukie; Sakurai, Katsunobu; Toyokawa, Takahiro; Kubo, Naoshi; Muguruma, Kazuya; Sawada, Tetsuji; Maeda, Kiyoshi; Hirakawa, Kosei			Alteration of CD4 T cell subsets in metastatic lymph nodes of human gastric cancer	ONCOLOGY REPORTS			English	Article						CD4 T cells; gastric cancer; lymph node metastasis; effector T cell subsets; T cell subsets; flow cytometry; immunology	COLORECTAL-CANCER; MEMORY; NEUTROPHILS; SURVIVAL; ANGIOGENESIS; SUPPRESSION; PROGRESSION; PHENOTYPE; MECHANISM; CARCINOMA	Studies of tumor-infiltrating immune cells have revealed that immune escape plays an important role in tumor growth. The aim of the present study was to investigate the impact of metastasis affecting CD4(+) T cell subsets in human clinical samples. Single-cell suspensions derived from tumor-draining lymph node (TDLN) and primary cancer specimens were assessed by flow cytometry, qRT-PCR and immunohistochemistry. In the CD4(+) T cell subsets detected in TDLN, effector T cells (TO in metastatic TDLN (mTDLN). was significantly lower than that in metastatic-free TDLN (mfTDLN). T-E in mfTDLN were increased compared with normal controls. Similarly, effector memory T cells (T) in mTDLN was significantly lower than in control and mfTDLN. There was a significantly positive correlation between the proportion of T-EM in TDLN and number of tumor-infiltrating CD4(+) and CD8(+) T cells. Thl to Th2 ratio was lower in mTDLN, and Treg in mTDLN was significantly higher than in mfTDLN. CD4(+) T cell and T-E subsets in TDLN were significantly affected by metastasis. Immunosuppressive cells exhibit increased migration to TDLN, in which a subset of CD4(+) T-E is skewed towards immune tolerance in the tumor microenvironment.	[Okita, Yoshihiro; Ohira, Masaichi; Tanaka, Hiroaki; Tokumoto, Mao; Go, Yukie; Sakurai, Katsunobu; Toyokawa, Takahiro; Kubo, Naoshi; Muguruma, Kazuya; Sawada, Tetsuji; Maeda, Kiyoshi; Hirakawa, Kosei] Osaka City Univ, Grad Sch Med, Dept Surg Oncol, Abeno Ku, Osaka 5458585, Japan	Tanaka, H (reprint author), Osaka City Univ, Grad Sch Med, Dept Surg Oncol, Abeno Ku, 1-4-3 Asahimachi, Osaka 5458585, Japan.	hiroakitan@med.osaka-cu.ac.jp					Bekes EM, 2011, AM J PATHOL, V179, P1455, DOI 10.1016/j.ajpath.2011.05.031; Nakamura R, 2009, EUR J CANCER, V45, P2123, DOI 10.1016/j.ejca.2009.03.024; Palmer DC, 2009, TRENDS IMMUNOL, V30, P592, DOI 10.1016/j.it.2009.09.009; Mueller SN, 2013, ANNU REV IMMUNOL, V31, P137, DOI 10.1146/annurev-immunol-032712-095954; Mlecnik B, 2011, J CLIN ONCOL, V29, P610, DOI 10.1200/JCO.2010.30.5425; Bradley LM, 2005, TRENDS IMMUNOL, V26, P172, DOI 10.1016/j.it.2005.01.004; Kristensen VN, 2012, P NATL ACAD SCI USA, V109, P2802, DOI 10.1073/pnas.1108781108; Sano T, 2011, GASTRIC CANCER, V14, P97, DOI 10.1007/s10120-011-0040-6; Shamamian P, 2001, J CELL PHYSIOL, V189, P197, DOI 10.1002/jcp.10014; Sallusto F, 2009, EUR J IMMUNOL, V39, P2076, DOI 10.1002/eji.200939722; Dong HD, 2002, NAT MED, V8, P793, DOI 10.1038/nm730; Deng LF, 2010, CLIN CANCER RES, V16, P4105, DOI 10.1158/1078-0432.CCR-10-1073; Mougiakakos D, 2010, CANCER-AM CANCER SOC, V116, P2224, DOI 10.1002/cncr.24999; Enomoto K, 2012, CLIN EXP IMMUNOL, V168, P186, DOI 10.1111/j.1365-2249.2012.04565.x; Tosolini M, 2011, CANCER RES, V71, P1263, DOI 10.1158/0008-5472.CAN-10-2907; Zhou L, 2009, IMMUNITY, V30, P646, DOI 10.1016/j.immuni.2009.05.001; Zhu JF, 2010, CELL RES, V20, P4, DOI 10.1038/cr.2009.138; Schmielau J, 2001, CANCER RES, V61, P4756; Brody JR, 2009, CELL CYCLE, V8, P1930, DOI 10.4161/cc.8.12.8745; Bates GJ, 2006, J CLIN ONCOL, V24, P5373, DOI 10.1200/JCO.2006.05.9584; Poschke I, 2012, INT J CANCER, V131, P1611, DOI 10.1002/ijc.27410; Lee HE, 2011, BRIT J CANCER, V105, P413, DOI 10.1038/bjc.2011.248; Battaglia A, 2009, CANCER IMMUNOL IMMUN, V58, P1363, DOI 10.1007/s00262-008-0646-7; Houghton AM, 2010, CELL CYCLE, V9, P1732; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Ito N, 2005, ANTICANCER RES, V25, P2027; Waugh DJJ, 2008, CLIN CANCER RES, V14, P6735, DOI 10.1158/1078-0432.CCR-07-4843; Pages F, 2009, J CLIN ONCOL, V27, P5944, DOI 10.1200/JCO.2008.19.6147; Gnerlich JL, 2010, J IMMUNOL, V185, P4063, DOI 10.4049/jimmunol.0902609; Schuster S, 2013, J LEUKOCYTE BIOL, V94, P671, DOI 10.1189/jlb.1012540; Fridlender ZG, 2009, CANCER CELL, V16, P183, DOI 10.1016/j.ccr.2009.06.017; Carus A, 2013, BRIT J CANCER, V108, P2116, DOI 10.1038/bjc.2013.167; Japanese Gastric Canc Assoc, 2011, GASTRIC CANCER, V14, P101, DOI 10.1007/s10120-011-0041-5; Kedzierska K, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00357; Kim M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053630; Okita Y, 2014, J SURG RES, V186, P192, DOI 10.1016/j.jss.2013.08.024; Ostrand-Rosenberg S, 2009, J IMMUNOL, V182, P4499, DOI 10.4049/jimmunol.0802740; Shurin Galina V, 2013, Cancer Microenviron, V6, P159, DOI 10.1007/s12307-013-0133-3; Wu FL, 2013, CANCER LETT, V339, P195, DOI 10.1016/j.canlet.2013.06.009; Zhao JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033655	40	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1021-335X	1791-2431		ONCOL REP	Oncol. Rep.	AUG	2015	34	2					639	647		10.3892/or.2015.4064		9	Oncology	Oncology	CM8QB	WOS:000357965600013		
J	Hotta, K; Sho, M; Fujimoto, K; Shimada, K; Yamato, I; Anai, S; Harada, H; Tsujikawa, K; Konishi, N; Shinohara, N; Nakajima, Y				Hotta, Kiyohiko; Sho, Masayuki; Fujimoto, Kiyohide; Shimada, Keiji; Yamato, Ichiro; Anai, Satoshi; Harada, Hiroshi; Tsujikawa, Kazutake; Konishi, Noboru; Shinohara, Nobuo; Nakajima, Yoshiyuki			Clinical significance and therapeutic potential of prostate cancer antigen-1/ALKBH3 in human renal cell carcinoma	ONCOLOGY REPORTS			English	Article						renal cell carcinoma; ALKBH3; PCA-1; apoptosis; prognosis	C-REACTIVE PROTEIN; PHASE-III TRIAL; REPAIR ENZYME ALKB; INTERFERON-ALPHA; OXIDATIVE DEMETHYLATION; DOWN-REGULATION; STRANDED-DNA; DOUBLE-BLIND; LUNG-CANCER; SURVIVAL	Prostate cancer antigen-1 (PCA-1)/ALKBH3 has been recently identified in human prostate cancer and its expression is correlated with disease progression and prognosis. However, the precise role and function of PCA-1/ALKBH3 in human malignancies are largely unknown. In the present study, we investigated the clinical significance and therapeutic potential of PCA-1/ALKBH3 in renal cell carcinoma (RCC). PCA-1/ALKBH3 expression was examined by immunohistochemistry in 101 RCC patients who underwent radical or partial nephrectomy. Its expression was positively correlated with advanced pathological T- and M-factors and TNM stage (T, P<0.05; M, P<0.01; TNM, P<0.01, respectively). In the prognostic analysis, PCA-1/ALKBH3-negative patients with RCC had a significantly better prognosis than PCA-1/ALKBH3-positive patients (5-year survival rate, 92.9 vs. 75.9%, respectively; P<0.05). Next, the therapeutic potential of targeting PCA-1/ALKBH3 was further evaluated by small interfering RNA method using a human RCC cell line (CAKI-1). We found that PCA-1/ALKBH3 knockdown significantly inhibited the growth of CAKI-1 cells compared with the control (P<0.001). Furthermore, knockdown of PCA-1 induced apoptosis in CAKI-1 cells, as assessed by poly(ADP-ribose) polymerase-cleavage assays. We demonstrated for the first time that PCA-1/ALKBH3 expression has a significant prognostic impact on patient prognosis in RCC. Furthermore, its knockdown has a therapeutic efficacy on RCC. Taken together, both our clinical and experimental data strongly suggest that PCA-1/ALKBH3 may be functionally important and a novel molecular target for human RCC.	[Hotta, Kiyohiko; Sho, Masayuki; Yamato, Ichiro; Nakajima, Yoshiyuki] Nara Med Univ, Dept Surg, Kashihara, Nara 6348522, Japan; [Fujimoto, Kiyohide; Anai, Satoshi] Nara Med Univ, Dept Urol, Kashihara, Nara 6348522, Japan; [Shimada, Keiji; Konishi, Noboru] Nara Med Univ, Dept Pathol, Kashihara, Nara 6348522, Japan; [Harada, Hiroshi] Sapporo City Gen Hosp, Kidney Transplant Surg, Sapporo, Hokkaido, Japan; [Tsujikawa, Kazutake] Osaka Univ, Grad Sch Pharmaceut Sci, Lab Mol & Cellular Physiol, Osaka, Japan; [Hotta, Kiyohiko; Shinohara, Nobuo] Hokkaido Univ, Grad Sch Med, Dept Renal & Genitourinary Surg, Sapporo, Hokkaido, Japan	Sho, M (reprint author), Nara Med Univ, Dept Surg, 840 Shijo Cho, Kashihara, Nara 6348522, Japan.	m-sho@naramed-u.ac.jp					Albiges L, 2015, EUR UROL, V67, P100, DOI 10.1016/j.eururo.2014.04.006; Sternberg CN, 2010, J CLIN ONCOL, V28, P1061, DOI 10.1200/JCO.2009.23.9764; Casamassima A, 2005, J UROLOGY, V173, P52, DOI 10.1097/01.ju.0000146713.50673.e5; Yang JC, 2003, J CLIN ONCOL, V21, P3127, DOI 10.1200/JCO.2003.02.122; Secchiero P, 2013, CLIN CANCER RES, V19, P1949, DOI 10.1158/1078-0432.CCR-12-3027; Aas PA, 2003, NATURE, V421, P859, DOI 10.1038/nature01363; Calvo JA, 2012, J CLIN INVEST, V122, P2680, DOI 10.1172/JCI63338; Hudes G, 2007, NEW ENGL J MED, V356, P2271, DOI 10.1056/NEJMoa066838; Tasaki M, 2011, BRIT J CANCER, V104, P700, DOI 10.1038/sj.bjc.6606012; Motzer RJ, 2008, LANCET, V372, P449, DOI 10.1016/S0140-6736(08)61039-9; Sundheim O, 2006, EMBO J, V25, P3389, DOI 10.1038/sj.emboj.7601219; Motzer RJ, 2009, J CLIN ONCOL, V27, P3584, DOI 10.1200/JCO.2008.20.1293; Yu B, 2006, NATURE, V439, P879, DOI 10.1038/nature04561; Falnes PO, 2002, NATURE, V419, P178, DOI 10.1038/nature01048; Yang J, 2007, CANCER CELL, V12, P252, DOI 10.1016/j.ccr.2007.08.008; Lamb GWA, 2006, BRIT J CANCER, V94, P781, DOI 10.1038/sj.bjc.6603034; Motzer RJ, 1999, J CLIN ONCOL, V17, P2530; Dinglay S, 2000, GENE DEV, V14, P2097; Rini BI, 2011, LANCET, V378, P1931, DOI 10.1016/S0140-6736(11)61613-9; Escudier B, 2007, LANCET, V370, P2103, DOI 10.1016/S0140-6736(07)61904-7; Gerken T, 2007, SCIENCE, V318, P1469, DOI 10.1126/science.1151710; Motzer RJ, 2002, J CLIN ONCOL, V20, P289, DOI 10.1200/JCO.20.1.289; Karakiewicz PI, 2007, CANCER, V110, P1241, DOI 10.1002/cncr.22896; Chen BE, 2010, MOL BIOSYST, V6, P2143, DOI 10.1039/c005148a; Shimada K, 2009, CANCER RES, V69, P3157, DOI 10.1158/0008-5472.CAN-08-3530; Shimada K, 2012, CLIN CANCER RES, V18, P5247, DOI 10.1158/1078-0432.CCR-12-0955; Escudier B, 2009, J CLIN ONCOL, V27, P3312, DOI 10.1200/JCO.2008.19.5511; Hausinger RP, 2004, CRIT REV BIOCHEM MOL, V39, P21, DOI 10.1080/10409230490440541; FUHRMAN SA, 1982, AM J SURG PATHOL, V6, P655, DOI 10.1097/00000478-198210000-00007; Gao W, 2011, J GASTROEN HEPATOL, V26, P577, DOI 10.1111/j.1440-1746.2010.06531.x; Guinan P, 1997, CANCER, V80, P992, DOI 10.1002/(SICI)1097-0142(19970901)80:5<992::AID-CNCR26>3.0.CO;2-Q; Cohen HT, 2005, NEW ENGL J MED, V353, P2477, DOI 10.1056/NEJMra043172; Konishi N, 2005, CLIN CANCER RES, V11, P5090, DOI 10.1158/1078-0432.CCR-05-0195; Kurowski MA, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-48; Neta G, 2011, CARCINOGENESIS, V32, P1231, DOI 10.1093/carcin/bgr100; Ougland R, 2004, MOL CELL, V16, P107, DOI 10.1016/j.molcel.2004.09.002; Shimada K, 2008, CANCER SCI, V99, P39, DOI 10.1111/j.1349-7006.2007.00655.x; Tsujikawa K, 2007, J CELL MOL MED, V11, P1105, DOI 10.1111/j.1582-4934.2007.00094.x; Wu SS, 2011, ACTA PHARMACOL SIN, V32, P393, DOI 10.1038/aps.2010.216; Yamato I, 2012, CANCER RES, V72, P4829, DOI 10.1158/0008-5472.CAN-12-0328	40	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1021-335X	1791-2431		ONCOL REP	Oncol. Rep.	AUG	2015	34	2					648	654		10.3892/or.2015.4017		7	Oncology	Oncology	CM8QB	WOS:000357965600014		
J	Shinmura, K; Kato, H; Kawanishi, Y; Nagura, K; Kamo, T; Okubo, Y; Inoue, Y; Kurabe, N; Du, CP; Iwaizumi, M; Kurachi, K; Nakamura, T; Sugimura, H				Shinmura, Kazuya; Kato, Hisami; Kawanishi, Yuichi; Nagura, Kiyoko; Kamo, Takaharu; Okubo, Yusuke; Inoue, Yusuke; Kurabe, Nobuya; Du, Chunping; Iwaizumi, Moriya; Kurachi, Kiyotaka; Nakamura, Toshio; Sugimura, Haruhiko			SASS6 overexpression is associated with mitotic chromosomal abnormalities and a poor prognosis in patients with colorectal cancer	ONCOLOGY REPORTS			English	Article						SASS6; centrosome amplification; colorectal cancer; overexpression; prognosis	CENTROSOME AMPLIFICATION; HUMAN-CELLS; GASTRIC-CANCER; COLON-CANCER; INSTABILITY; CENTRIOLE; EXPRESSION; DUPLICATION; CYCLE; MECHANISMS	Spindle assembly abnormal protein 6 homolog (SASS6) plays an important role in the regulation of centriole duplication. To date, the genetic alteration of SASS6 has not been reported in human cancers. In the present study, we examined whether SASS6 expression is abnormally regulated in colorectal cancers (CRCs). Increased SASS6 mRNA and protein expression levels were observed in 49 (60.5%) of the 81 primary CRCs and 11(57.9%) of the 19 primary CRCs, respectively. Moreover, the upregulation of SASS6 mRNA expression was statistically significant (P=0.0410). Next, using DLD-1 colon cancer cells inducibly expressing SASS6, SASS6 overexpression was shown to induce centrosome amplification, mitotic abnormalities such as chromosomal misalignment and lagging chromosome, and chromosomal numerical changes. Furthermore, SASS6 overexpression was associated with anaphase bridge formation, a type of mitotic structural abnormality, in primary CRCs (P<0.01). SASS6 upregulation in colon cancer was also revealed in the Cancer Genome Atlas (TCGA) data and was shown to be an independent predictor of poor survival (multivariate analysis: hazard ratio, 2.805; 95% confidence interval, 1.244-7.512; P=0.0112). Finally, further analysis of the TCGA data demonstrated SASS6 upregulation in a modest manner in 8 of 11 cancer types other than colon cancer, and SASS6 upregulation was found to be associated with a poor survival outcome in patients with kidney renal cell carcinoma and lung adenocarcinoma. Our present findings revealed that the upregulation of SASS6 expression is involved in the pathogenesis of CRC and is associated with a poor prognosis among patients with colon cancer. They also suggest that SASS6 upregulation is a genetic abnormality relatively common in human cancer.	[Shinmura, Kazuya; Kato, Hisami; Nagura, Kiyoko; Kamo, Takaharu; Okubo, Yusuke; Inoue, Yusuke; Kurabe, Nobuya; Du, Chunping; Iwaizumi, Moriya; Sugimura, Haruhiko] Hamamatsu Univ Sch Med, Dept Tumor Pathol, Hamamatsu, Shizuoka 4313192, Japan; [Kawanishi, Yuichi] Hamamatsu Univ Sch Med, Res Equipment Ctr, Hamamatsu, Shizuoka 4313192, Japan; [Kurachi, Kiyotaka] Hamamatsu Univ Sch Med, Dept Surg, Hamamatsu, Shizuoka 4313192, Japan; [Nakamura, Toshio] Fujieda Municipal Gen Hosp, Dept Surg, Fujieda, Shizuoka, Japan	Shinmura, K (reprint author), Hamamatsu Univ Sch Med, Dept Tumor Pathol, Hamamatsu, Shizuoka 4313192, Japan.	kzshinmu@hama-med.ac.jp	Shinmura, Kazuya /K-8940-2012	Shinmura, Kazuya /0000-0003-4963-746X	Ministry of Health, Labour and Welfare [21-1, 10103838]; Japan Society for the Promotion of Science [25460476]; Ministry of Education, Culture, Sports, Science and Technology [221S0001]; Takeda Science Foundation; Smoking Research Foundation	We would like to thank Professor T.K. Tang (Institute of Biomedical Sciences, Academia Sinica, Taiwan, ROC) for providing us with the GFP-SASS6 vector. The present study was supported in part by a Grant-in-Aid from the Ministry of Health, Labour and Welfare (21-1, 10103838), the Japan Society for the Promotion of Science (25460476), the Ministry of Education, Culture, Sports, Science and Technology (221S0001), the Takeda Science Foundation and the Smoking Research Foundation.	Strnad P, 2007, DEV CELL, V13, P203, DOI 10.1016/j.devcel.2007.07.004; Dykhuizen EC, 2013, NATURE, V497, P624, DOI 10.1038/nature12146; Kramer A, 2011, MOL ONCOL, V5, P324, DOI 10.1016/j.molonc.2011.05.003; Leidel S, 2005, NAT CELL BIOL, V7, P115, DOI 10.1038/ncb1220; Pfau SJ, 2012, EMBO REP, V13, P515, DOI 10.1038/embor.2012.65; Nam HJ, 2010, CARCINOGENESIS, V31, P1531, DOI 10.1093/carcin/bgq133; Lin YC, 2013, EMBO J, V32, P1141, DOI 10.1038/emboj.2013.56; Ganan-Gomez I, 2013, FREE RADICAL BIO MED, V65, P750, DOI 10.1016/j.freeradbiomed.2013.06.041; Ding S, 2005, CELL, V122, P473, DOI 10.1016/j.cell.2005.07.013; Comartin D, 2013, CURR BIOL, V23, P1360, DOI 10.1016/j.cub.2013.06.002; Chan JY, 2011, INT J BIOL SCI, V7, P1122; Smith JJ, 2010, GASTROENTEROLOGY, V138, P958, DOI 10.1053/j.gastro.2009.11.005; Nigg EA, 2011, NAT CELL BIOL, V13, P1154, DOI 10.1038/ncb2345; Zhou HY, 1998, NAT GENET, V20, P189, DOI 10.1038/2496; Fukasawa K, 2007, NAT REV CANCER, V7, P911, DOI 10.1038/nrc2249; Thompson SL, 2010, CURR BIOL, V20, pR285, DOI 10.1016/j.cub.2010.01.034; Nigg EA, 2009, CELL, V139, P663, DOI 10.1016/j.cell.2009.10.036; Liu J, 2013, ONCOGENE, V32, P713, DOI 10.1038/onc.2012.94; Watanabe T, 2012, J CLIN ONCOL, V30, P2256, DOI 10.1200/JCO.2011.38.6490; Stewenius Y, 2005, P NATL ACAD SCI USA, V102, P5541, DOI 10.1073/pnas.0408454102; Arquint C, 2012, J CELL SCI, V125, P1342, DOI 10.1242/jcs.099887; Duensing S, 2002, CANCER RES, V62, P7075; Burrell RA, 2013, NATURE, V494, P492, DOI 10.1038/nature11935; Thompson SL, 2011, P NATL ACAD SCI USA, V108, P17974, DOI 10.1073/pnas.1109720108; Ganem NJ, 2009, NATURE, V460, P278, DOI 10.1038/nature08136; Gisselsson D, 2000, P NATL ACAD SCI USA, V97, P5357, DOI 10.1073/pnas.090013497; Izumi H, 2009, ONCOGENE, V28, P2806, DOI 10.1038/onc.2009.141; Godinho SA, 2014, NATURE, V510, P167, DOI 10.1038/nature13277; Macmillan JC, 2001, ANN SURG ONCOL, V8, P729, DOI 10.1245/aso.2001.8.9.729; Keller D, 2014, J CELL BIOL, V204, P697, DOI 10.1083/jcb.201307049; Yang SB, 2007, ONCOL REP, V17, P1083; Hveem TS, 2014, BRIT J CANCER, V110, P2159, DOI 10.1038/bjc.2014.133; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Joshi H C, 1994, Curr Opin Cell Biol, V6, P54; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li J, 2014, J PATHOL, V234, P178, DOI 10.1002/path.4374; Liu L, 2012, PLOS ONE, V7; Oakley BR, 2000, CURR TOP DEV BIOL, V49, P27; Shinmura K, 2012, LUNG DIS SELECTED ST, P171; Shinmura K, 2008, J PATHOL, V216, P365, DOI 10.1002/path.2422; Shinmura K, 2011, J PATHOL, V225, P414, DOI 10.1002/path.2953; Tsai KW, 2015, ONCOL REP, V33, P485, DOI 10.3892/or.2014.3598; Vincent-Salomon A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076496	43	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1021-335X	1791-2431		ONCOL REP	Oncol. Rep.	AUG	2015	34	2					727	738		10.3892/or.2015.4014		12	Oncology	Oncology	CM8QB	WOS:000357965600023		
J	Kurihara, K; Isobe, T; Yamamoto, G; Tanaka, Y; Katakura, A; Tachikawa, T				Kurihara, Kinue; Isobe, Tomohide; Yamamoto, Gou; Tanaka, Yoichi; Katakura, Akira; Tachikawa, Tetsuhiko			Expression of BMI1 and ZEB1 in epithelial-mesenchymal transition of tongue squamous cell carcinoma	ONCOLOGY REPORTS			English	Article						tongue squamous cell carcinoma; BMI1; ZEB1; epithelial-mesenchymal transition	POLYCOMB GROUP PROTEINS; CANCER STEM-CELLS; NECK-CANCER; POOR-PROGNOSIS; PREDICTS PROGNOSIS; COLORECTAL-CANCER; BREAST-CANCER; HEAD; METASTASIS; DISEASE	Epithelial-mesenchymal transition (EMT) is a crucial event required for the invasion and progression of carcinogenesis, inducing stem-like properties in epithelial cells. In the present study, the expression of BMI1, which controls self-renewal in stem cells, as well as that of ZEB1, a transcription factor that regulates EMT, was evaluated for its role in EMT and the carcinogenic processes of tongue squamous cell carcinoma (TSCC). Collagen invasion assays using two TSCC cells and 64 tongue specimens (32 carcinomas and 32 dysplasias) were employed and analyzed in the present study. We assessed the protein and mRNA expression levels of BMI1, ZEB1, vimentin and E-cadherin in the two cell lines and tumor tissues. The protein and mRNA expression of BMI1 and ZEB1 occurred at the invasion of TSCC. The elevated levels of BMI1 and ZEB1 were accompanied by the downregulation of E-cadherin and upregulation of vimentin at the invasive front, indicative of EMT in vitro and in vivo. The results showed that BMI1 and ZEB1 are important factors in association with the promotion of EMT and invasion of TSCC.	[Kurihara, Kinue; Katakura, Akira] Tokyo Dent Coll, Dept Oral Med Oral & Maxillofacial Surg, Ichikawa, Chiba 2728513, Japan; [Isobe, Tomohide; Yamamoto, Gou] Showa Univ, Sch Dent, Dept Oral Diagnost Sci, Div Pathol,Shinagawa Ku, Tokyo 1428555, Japan; [Tanaka, Yoichi] Ichikawa Gen Hosp, Clin Lab, Div Surg Pathol, Ichikawa, Chiba 2728513, Japan; [Tachikawa, Tetsuhiko] Showa Univ, Innovat Res Ctr Oral Canc, Shinagawa Ku, Tokyo 1428555, Japan	Kurihara, K (reprint author), Tokyo Dent Coll, Dept Oral Med Oral & Maxillofacial Surg, 5-11-13 Sugano, Ichikawa, Chiba 2728513, Japan.	kuriharak@tdc.ac.jp					Yokobori T, 2013, CANCER SCI, V104, P48, DOI 10.1111/cas.12030; Raimondi C, 2010, CURR CANCER DRUG TAR, V10, P496; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Gil J, 2005, DNA CELL BIOL, V24, P117, DOI 10.1089/dna.2005.24.117; Lo WL, 2011, J PATHOL, V223, P482, DOI 10.1002/path.2826; Gheldof A, 2012, CELL MOL LIFE SCI, V69, P2527, DOI 10.1007/s00018-012-0935-3; Chen ML, 2012, CLIN EXP METASTAS, V29, P457, DOI 10.1007/s10585-012-9463-7; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Yang MH, 2010, NAT CELL BIOL, V12, P982, DOI 10.1038/ncb2099; Kim JH, 2004, CANCER LETT, V203, P217, DOI 10.1016/j.canlet.2003.07.009; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Chen YJ, 2008, CANCER SCI, V99, P1507, DOI 10.1111/j.1349-7006.2008.00863.x; Gemmill RM, 2011, CANCER LETT, V300, P66, DOI 10.1016/j.canlet.2010.09.007; Liu JH, 2008, J SURG ONCOL, V97, P267, DOI 10.1002/jso.20934; Pasini D, 2004, CELL CYCLE, V3, P396; Zhang ZC, 2012, ORAL ONCOL, V48, P1, DOI 10.1016/j.oraloncology.2011.10.004; Vonlanthen S, 2001, BRIT J CANCER, V84, P1372, DOI 10.1054/bjoc.2001.1791; Rosen JM, 2009, SCIENCE, V324, P1670, DOI 10.1126/science.1171837; Siddique HR, 2012, STEM CELLS, V30, P372, DOI 10.1002/stem.1035; Chen C, 2013, CANCER LETT, V338, P47, DOI 10.1016/j.canlet.2012.06.013; Song LB, 2009, J CLIN INVEST, V119, P3626, DOI 10.1172/JCI39374; Nieto MA, 2011, ANNU REV CELL DEV BI, V27, P347, DOI 10.1146/annurev-cellbio-092910-154036; Gibson MK, 2006, LANCET ONCOL, V7, P565, DOI 10.1016/S1470-2045(06)70757-4; Chu PY, 2013, ORAL ONCOL, V49, P34, DOI 10.1016/j.oraloncology.2012.07.012; Kang MK, 2007, BRIT J CANCER, V96, P126, DOI 10.1038/sj.bjc.6603529; Nakamura E, 2008, CANCER SCI, V99, P1390, DOI 10.1111/j.1349-7006.2008.00838.x; Zhang GJ, 2013, ONCOL LETT, V5, P564, DOI 10.3892/ol.2012.1026; Crea F, 2011, INT J CANCER, V128, P1946, DOI 10.1002/ijc.25522; Balasubramanian S, 2008, NUTR REV, V66, pS65, DOI 10.1111/j.1753-4887.2008.00071.x; Guo BH, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-10; Haddad RI, 2008, NEW ENGL J MED, V359, P1143, DOI 10.1056/NEJMra0707975; Hayry V, 2010, BRIT J CANCER, V102, P892, DOI 10.1038/sj.bjc.6605544; He XT, 2009, WORLD J GASTROENTERO, V15, P2389, DOI 10.3748/wjg.15.2389; Major AG, 2013, STEM CELLS INT, V2013, DOI DOI 10.1155/2013/319489; REMMELE W, 1987, PATHOLOGE, V8, P138; Soini Y, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-73; Tong YQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027804; Wang EF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017918	39	1	1	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1021-335X	1791-2431		ONCOL REP	Oncol. Rep.	AUG	2015	34	2					771	778		10.3892/or.2015.4032		8	Oncology	Oncology	CM8QB	WOS:000357965600028		
J	Osanai, M; Lee, GH				Osanai, Makoto; Lee, Gang-Hong			The retinoic acid-metabolizing enzyme CYP26A1 upregulates fascin and promotes the malignant behavior of breast carcinoma cells	ONCOLOGY REPORTS			English	Article						retinoic acid; retinoic acid-metabolizing enzyme CYP26A1; oncogene; fascin; breast cancer	ACTIN-BUNDLING PROTEIN; CELLULAR SENESCENCE; TUMOR-CELLS; IN-VITRO; DIFFERENTIATION; EXPRESSION; MOTILITY; CANCER; ROLES; MECHANISM	The retinoic acid (RA)-metabolizing enzyme CYP26A1 has been shown to efficiently enhance the oncogenic potential of breast cancer, suggesting a potential oncogenic function. We previously demonstrated that CYP26A1 confers unique cell survival properties by modulating the expression of a variety of genes and identified a number of genes that drive the cells into the oncogenic state. Accumulating evidence suggested that fascin is overexpressed in various types of cancer, primarily leading to increased cell motility. Therefore, in the present study, we examined fascin, an actin-bundling protein, using immunohistochemical and SA-P-gal staining as well as TUNEL and colony forming assays. The results of the present study showed that the expression levels of fascin increased significantly in response to CYP26A1 overexpression and, conversely, treatment with all-trans RA downregulated the expression of fascin. In addition, primary breast carcinoma samples, particularly hormone receptor-negative carcinomas and CYP26A1-overexpressing cancers, expressed elevated levels of fascin. Notably, fascin contributed to the ability of breast carcinoma cells to escape premature senescence and exhibit enhanced cell apoptotic resistance, promoting anchorage-independent growth properties. Fascin also promoted cell motility and the invasiveness of CYP26A1-expressing breast carcinoma cells. These data suggest that fascin expression is modulated by the intracellular RA status regulated by the expression of CYP26A1 and plays a significant role in the malignant behavior of CYP26A1-expressing breast carcinoma cells. CYP26A1 exerts oncogenic functions during breast carcinogenesis. Therefore, CYP26A1-mediated oncogenic characteristics may be partially responsible for the elevated expression of fascin.	[Osanai, Makoto; Lee, Gang-Hong] Kochi Univ, Sch Med, Dept Pathol, Nanko Ku, Kochi 7838505, Japan	Osanai, M (reprint author), Kochi Univ, Sch Med, Dept Pathol, Nanko Ku, Oko Cho, Kochi 7838505, Japan.	osanaim@kochi-u.ac.jp			Japan Society for the Promotion of Science; Smoking Research Foundation of Japan	The present study was supported in part by grants from the Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science and the Smoking Research Foundation of Japan.	te Poele RH, 2002, CANCER RES, V62, P1876; Hayashi Y, 2011, CANCER SCI, V102, P1228, DOI 10.1111/j.1349-7006.2011.01910.x; Grothey A, 2000, ONCOGENE, V19, P4864, DOI 10.1038/sj.onc.1203838; Ben-Porath I, 2004, J CLIN INVEST, V113, P8, DOI 10.1172/JCI200420663; Jawhari AU, 2003, AM J PATHOL, V162, P69, DOI 10.1016/S0002-9440(10)63799-6; Adams JC, 2004, CURR OPIN CELL BIOL, V16, P590, DOI 10.1016/j.ceb.2004.07.009; McConnell BB, 1998, CURR BIOL, V8, P351, DOI 10.1016/S0960-9822(98)70137-X; Sherr CJ, 2000, CELL, V102, P407, DOI 10.1016/S0092-8674(00)00046-5; Megiorni F, 2005, NEUROSCI LETT, V381, P169, DOI 10.1016/j.neulet.2005.02.027; Hashimoto Y, 2005, CLIN CANCER RES, V11, P2597, DOI 10.1158/1078-0432.CCR-04-1378; Chang BD, 1999, CANCER RES, V59, P3761; Kureishy N, 2002, BIOESSAYS, V24, P350, DOI 10.1002/bies.10070; Brown GT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090776; Chang CL, 2008, ONCOGENE, V27, P2951, DOI 10.1038/sj.onc.1210969; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; EDWARDS RA, 1995, CELL MOTIL CYTOSKEL, V32, P1, DOI 10.1002/cm.970320102; ELLIOTT BE, 1988, CANCER RES, V48, P7237; Grothey A, 2000, BRIT J CANCER, V83, P870, DOI 10.1054/bjoc.2000.1395; Hwang Jeong Hyun, 2008, Neoplasia, V10, P149, DOI 10.1593/neo.07909; Kawasaki H, 1998, NATURE, V393, P284; Murray GI, 2010, HISTOPATHOLOGY, V57, P202, DOI 10.1111/j.1365-2559.2010.03606.x; Osanai M, 2010, ONCOGENE, V29, P1135, DOI 10.1038/onc.2009.414; Shelton DN, 2006, CANCER RES, V66, P7571, DOI 10.1158/0008-5472.CAN-06-1067; Trost TM, 2005, CANCER RES, V65, P840	24	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1021-335X	1791-2431		ONCOL REP	Oncol. Rep.	AUG	2015	34	2					850	858		10.3892/or.2015.4042		9	Oncology	Oncology	CM8QB	WOS:000357965600037		
J	Kagiya, G; Ogawa, R; Choudhuri, R; Cook, JA; Hatashita, M; Tanaka, Y; Koda, K; Yamashita, K; Kubo, M; Kawakami, F; Mitchell, JB				Kagiya, Go; Ogawa, Ryohei; Choudhuri, Rajani; Cook, John A.; Hatashita, Masanori; Tanaka, Yoshikazu; Koda, Kana; Yamashita, Kei; Kubo, Makoto; Kawakami, Fumitaka; Mitchell, James B.			Selective enhancement of hypoxic cell killing by tempol-regulated suicide gene expression	ONCOLOGY REPORTS			English	Article						tempol; hypoxia; HIF-1 alpha; hypoxic cell killing; suicide gene; gene therapy	INDUCIBLE FACTOR-1; STEM-CELLS; CARCINOMA; HIF-1-ALPHA; RESISTANCE; ALOPECIA; THERAPY; HIF-1	The presence of hypoxic regions within solid tumors is caused by an imbalance between cell proliferation and angiogenesis. Such regions may facilitate the onset of recurrence after radiation therapy and chemotherapy, as hypoxic cells show resistance to these treatments. We found that tempol, a nitroxide, strongly induces the accumulation of hypoxia-inducible factor (HIF)-1 alpha, particularly under conditions of hypoxia. We, therefore, evaluated whether tempol enhances the gene expression via HIF-1 alpha, potentially leading to various applications for cancer gene therapy targeting hypoxic cells. Consequently, following treatment with tempol under hypoxia, the luciferase (Luc) activity in the cells transfected with the plasmid containing the luc gene with the oxygen-dependent degradation domain and a promoter composed of hypoxia-responsive elements increased up to approximately 10-fold compared to that observed in cells treated identically with the exception of tempol. The plasmid constructed by replacing the luc gene with the fcy:.:fur fusion gene as a suicide gene, strongly induced the accumulation of the Fcy::Fur fusion protein, only when incubated in the presence of the hypoxic mimic CoCl2 and tempol. The transfected cells were successfully killed with the addition of 5-fluorocytosine to the cell culture according to the fcy::fur fusion gene expression. As similar but lesser enhancement of the Luc activity was also observed in solid tumor tissues in nude mice, this strategy may be applied for hypoxic cancer eradication.	[Kagiya, Go; Kubo, Makoto; Kawakami, Fumitaka] Kitasato Univ, Sch Allied Hlth Sci, Minami Ku, Sagamihara, Kanagawa 2288555, Japan; [Ogawa, Ryohei] Univ Toyama, Grad Sch Med & Pharmaceut Sci, Dept Radiol Sci, Toyama 9300194, Japan; [Choudhuri, Rajani; Cook, John A.; Mitchell, James B.] NCI, Radiat Biol Branch, Natl Inst Hlth, Bethesda, MD 20892 USA; [Hatashita, Masanori; Tanaka, Yoshikazu] Wakasa Wan Energy Res Ctr, Biol Grp, Tsuruga, Fukui 9140192, Japan; [Koda, Kana] Japanese Fdn Canc Res, Canc Inst Hosp, Radiat Oncol, Tokyo 1358550, Japan; [Yamashita, Kei] Chiba Univ, Grad Sch Med & Pharmaceut Sci, Inage Ku, Chiba 2368555, Japan	Ogawa, R (reprint author), Univ Toyama, Grad Sch Med & Pharmaceut Sci, Dept Radiol Sci, Toyama 9300194, Japan.	ogawa@med.u-toyama.ac.jp			National Institutes of Health, National Cancer Institute; Japan Society for the Promotion of Science [21591618, 24591849]; Kitasato University School of Allied Health Sciences [2012-1018]	This research was supported in part by the Intramural Research Program of the National Institutes of Health, National Cancer Institute. In addition, this research was also supported in part by Grants-in-Aid for Scientific Research (C) (nos. 21591618 and 24591849) from the Japan Society for the Promotion of Science and by a grant from the Kitasato University School of Allied Health Sciences (Grants-in-Aid for Research Project, no. 2012-1018).	Hu CJ, 2003, MOL CELL BIOL, V23, P9361, DOI 10.1128/MCB.23.24.9361-9374.2003; Feldser D, 1999, CANCER RES, V59, P3915; Wykoff CC, 2000, CANCER RES, V60, P7075; Li QF, 2006, CELL RES, V16, P548, DOI 10.1038/sj.cr.7310072; Krishnamachary B, 2003, CANCER RES, V63, P1138; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Rich JN, 2007, CANCER RES, V67, P8980, DOI 10.1158/0008-5472.CAN-07-0895; GOFFMAN T, 1992, INT J RADIAT ONCOL, V22, P803; Jiang BH, 1996, AM J PHYSIOL-CELL PH, V271, pC1172; Kaluz S, 2008, BIOCHEM BIOPH RES CO, V370, P613, DOI 10.1016/j.bbrc.2008.03.147; Semenza GL, 2010, CURR OPIN GENET DEV, V20, P51, DOI 10.1016/j.gde.2009.10.009; Vaupel P, 2007, ANTIOXID REDOX SIGN, V9, P1221, DOI 10.1089/ars.2007.1628; Metz JM, 2004, CLIN CANCER RES, V10, P6411, DOI 10.1158/1078-0432.CCR-04-0658; Harada H, 2002, CANCER RES, V62, P2013; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Maynard MA, 2005, FASEB J, V19, P1396, DOI 10.1096/fj.05-3788com; Hall EJ, 1994, RADIOBIOLOGY RADIOBI, V4th; Hyodo F, 2006, CANCER RES, V66, P9921, DOI 10.1158/0008-5472.CAN-06-0879; Ido A, 2001, CANCER RES, V61, P3016; Lee JW, 2004, EXP MOL MED, V36, P1; Prasad KN, 1995, HDB RADIOBIOLOGY, V2nd; Sabharwal SS, 2014, NAT REV CANCER, V14, P709, DOI 10.1038/nrc3803; Sambrook J, 2001, MOL CLONING LAB MANU	23	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1021-335X	1791-2431		ONCOL REP	Oncol. Rep.	AUG	2015	34	2					1065	1073		10.3892/or.2015.4020		9	Oncology	Oncology	CM8QB	WOS:000357965600063		
J	Okada, S; Igarashi, K; Inoue, K				Okada, Shohei; Igarashi, Koji; Inoue, Kyo			Bit-error-rate improvement of binary phase-shift keying signals with an optoelectronic regenerator based on the feed-forward control of a LiNbO3 intensity modulator	OPTICAL FIBER TECHNOLOGY			English	Article						Regenerator; Optoelectronic signal processing; Phase-modulated signal	ELECTROABSORPTION MODULATOR; CONTROL-CIRCUIT; TRANSMISSION; AMPLIFIERS	This study evaluates the performance of an optoelectronic regenerator based on feed-forward control of a LiNbO3 intensity modulator for optical binary phase-shift keying (BPSK) signals. First, in order to confirm the operation principle, we measure the transfer function of the regenerator in terms of the optical power, and observe the power limiting effect. Next, we numerically and experimentally evaluate the performance of the regenerator for 10-Gbit/s optical BPSK signals where BER is measured for various receiver OSNR. We obtain a received power improvement of approximately 1 dB at a bit error rate of 10(-4). Finally, we compare the regenerator performance for BPSK signals with that for differential phase-shift keying (DPSK) signals by calculating the BERs with offline digital signal processor for identical experimental data. It is shown that the regenerator is more effective for BPSK signals than for DPSK signals because DPSK signals are more fragile against phase fluctuation that cannot be suppressed by our regenerator. (C) 2015 Elsevier Inc. All rights reserved.	[Okada, Shohei; Igarashi, Koji; Inoue, Kyo] Osaka Univ, Suita, Osaka 5650871, Japan	Inoue, K (reprint author), Osaka Univ, 2-1 Yamadaoka, Suita, Osaka 5650871, Japan.	kyo@comm.eng.osaka-u.ac.jp					Kunigita N, 2013, OPT FIBER TECHNOL, V19, P52, DOI 10.1016/j.yofte.2012.10.003; Savory SJ, 2008, OPT EXPRESS, V16, P804, DOI 10.1364/OE.16.000804; Winzer PJ, 2010, J LIGHTWAVE TECHNOL, V28, P547, DOI 10.1109/JLT.2009.2031922; Ibrahim SK, 2011, OPT EXPRESS, V19, P9445, DOI 10.1364/OE.19.009445; Chou HF, 2005, OPT EXPRESS, V13, P2742, DOI 10.1364/OPEX.13.002742; Fragkos A, 2013, IEEE PHOTONIC TECH L, V25, P667, DOI 10.1109/LPT.2013.2246834; Hu Z., 2005, OPT FIB COMM C OFC20; Inoue K, 1997, IEEE PHOTONIC TECH L, V9, P109, DOI 10.1109/68.554518; Inoue K, 2014, IEEE J QUANTUM ELECT, V50, P563, DOI 10.1109/JQE.2014.2325906; Kunigita N, 2013, OPT FIBER TECHNOL, V19, P185, DOI 10.1016/j.yofte.2012.12.008; Kunigita N, 2012, J LIGHTWAVE TECHNOL, V30, P2839, DOI 10.1109/JLT.2012.2206559; Matsumoto M., 2013, C LAS EL CLEO2013 SA; Pincemin E, 2013, IEEE PHOTONIC TECH L, V25, P1835, DOI 10.1109/LPT.2013.2277604; Rochette M, 2006, OPT EXPRESS, V14, P6414, DOI 10.1364/OE.14.006414; Roethlingshoefer T., 2012, EUR C EXH OPT COMM E; Roethlingshoefer T., 2013, C LAS EL CLEO2013 SA; Slavik R., 2011, OPT FIB COMM OFC2011; Xu C, 2002, OPT LETT, V27, P1619, DOI 10.1364/OL.27.001619; Yoshikane N., 2013, OPT FIB COMM C OFC20	19	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1068-5200	1095-9912		OPT FIBER TECHNOL	Opt. Fiber Technol.	AUG	2015	24						49	55		10.1016/j.yofte.2015.04.009		7	Engineering, Electrical & Electronic; Optics; Telecommunications	Engineering; Optics; Telecommunications	CM4XA	WOS:000357687900009		
J	Shimizu, Y; Kim, H; Yoshida, H; Shimada, H; Suzuki, T				Shimizu, Y.; Kim, H.; Yoshida, H.; Shimada, H.; Suzuki, T.			Serum 25-hydroxyvitamin D level and risk of falls in Japanese community-dwelling elderly women: a 1-year follow-up study	OSTEOPOROSIS INTERNATIONAL			English	Article						Elderly; Fall; Follow-up; Serum 25-hydroxyvitamin D; Women	VITAMIN-D STATUS; POSTMENOPAUSAL WOMEN; PHYSICAL PERFORMANCE; D DEFICIENCY; MUSCLE STRENGTH; OLDER-PEOPLE; D INADEQUACY; HEALTH; MASS; OSTEOPOROSIS	A Summary The present prospective follow-up study among 1,393 community-dwelling elderly women aged 75 years or older was conducted to clarify the association between serum 25-hydroxyvitamin D (25(OH)D) level and risk of falls. Lower serum 25(OH)D, particularly level < 20 ng/mL, was significantly associated with an increased risk of falls. Introduction Serum 25(OH)D level has been revealed to be important factor not only for skeletal health but also for fall prevention among the elderly. Our previous cross-sectional study indicated that low serum 25(OH)D level is associated with inferior physical performance and falls among elderly Japanese women. The present prospective study was designed to clarify the association between serum 25(OH)D level and risk of falls before and after 1 year of follow-up. Methods The community-dwelling elderly women aged 75 years or older (N = 1,393) who participated in a mass health examination were followed 1 year later by a mailed self-administered questionnaire. Results Responses were obtained from 1,285 subjects (response rate = 92.2 %). The incidence of falls at baseline and at 1-year follow-up was 18.8 and 24.4 %, respectively. The baseline prevalence of serum 25(OH)D < 20 ng/mL was 35.2 %. Odds ratios (95 % confidence intervals) in the lowest tertile of serum 25(OH)D (< 20 ng/mL) compared with those in the highest tertile (a parts per thousand yen25 ng/mL) were 1.40 (1.01-1.94) for any falls and 1.47 (0.93-2.32) for recurrent falls vs. no falls adjusted for potential risk factors. Conclusions Among elderly Japanese women, the lower serum 25(OH)D, particularly level < 20 ng/mL, was significantly associated with an increased risk of falls.	[Shimizu, Y.; Kim, H.; Yoshida, H.] Tokyo Metropolitan Inst Gerontol, Res Team Promoting Independence Elderly, Itabashi Ku, Tokyo 1730015, Japan; [Shimada, H.] Natl Ctr Geriatr & Gerontol, Ctr Gerontol & Social Sci, Dept Functioning Activat, Obu City, Aichi 4748511, Japan; [Suzuki, T.] Natl Ctr Geriatr & Gerontol, Res Inst, Obu City, Aichi 4748511, Japan	Shimizu, Y (reprint author), Tokyo Metropolitan Inst Gerontol, Res Team Promoting Independence Elderly, Itabashi Ku, 35-2 Sakae Cho, Tokyo 1730015, Japan.	yshimizu@tmig.or.jp			Ministry of Education, Culture, Sports, Science and Technology in Japan [20390189]; Ministry of Health, Labour and Welfare in Japan [H20-Choujyu-009]	This study was supported by a Grant-in Aid for Scientific research 20390189 (Director, Takao Suzuki) from the Ministry of Education, Culture, Sports, Science and Technology in Japan and by a Grant-in-Aid for Scientific Research H20-Choujyu-009 (Director, Noriko Yoshimura) from the Ministry of Health, Labour and Welfare in Japan.	Suzuki T, 2008, J BONE MINER RES, V23, P1309, DOI [10.1359/jbmr.080328, 10.1359/JBMR.080328]; Visser M, 2003, J CLIN ENDOCR METAB, V88, P5766, DOI 10.1210/jc.2003-030604; Menant JC, 2012, OSTEOPOROSIS INT, V23, P981, DOI 10.1007/s00198-011-1637-7; Broe KE, 2007, J AM GERIATR SOC, V55, P234, DOI 10.1111/j.1532-5415.2007.01048.x; Lips P, 2001, ENDOCR REV, V22, P477, DOI 10.1210/er.22.4.477; Lips P, 2001, J CLIN ENDOCR METAB, V86, P1212, DOI 10.1210/jc.86.3.1212; Bischoff-Ferrari HA, 2004, AM J CLIN NUTR, V80, P752; Faulkner KA, 2006, OSTEOPOROSIS INT, V17, P1318, DOI 10.1007/s00198-006-0071-8; Dawson-Hughes B, 2005, OSTEOPOROSIS INT, V16, P713, DOI 10.1007/s00198-005-1867-7; Kwon J, 2007, GERONTOLOGY, V53, P322, DOI 10.1159/000103257; Wicherts IS, 2007, J CLIN ENDOCR METAB, V92, P2058, DOI 10.1210/jc.2006-1525; Snijder MB, 2006, J CLIN ENDOCR METAB, V91, P2980, DOI 10.1210/jc.2006-0510; Holick MF, 2006, MAYO CLIN PROC, V81, P353; Kulie T, 2009, J AM BOARD FAM MED, V22, P698, DOI 10.3122/jabfm.2009.06.090037; Holick MF, 2011, J CLIN ENDOCR METAB, V96, P1911, DOI 10.1210/jc.2011-0385; Rothenbacher D, 2014, OSTEOPOROSIS INT, V25, P923, DOI 10.1007/s00198-013-2565-5; Visser M, 2005, AM J CLIN NUTR, V82, P531; Nakamura K, 2008, BONE, V42, P271, DOI 10.1016/j.bone.2007.09.056; Chu LW, 2005, ANN ACAD MED SINGAP, V34, P60; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Houston DK, 2007, J GERONTOL A-BIOL, V62, P440; Dam TTL, 2009, OSTEOPOROSIS INT, V20, P751, DOI 10.1007/s00198-008-0749-1; Shimada H, 2009, GERONTOLOGY, V55, P532, DOI 10.1159/000236364; Wortsman J, 2000, AM J CLIN NUTR, V72, P690; Barrett-Connor E, 2009, OSTEOPOROSIS INT, V20, P715, DOI 10.1007/s00198-008-0748-2; Campbell PMF, 2006, GERONTOLOGY, V52, P335, DOI 10.1159/000094881; Dawson-Hughes B, 2008, AM J CLIN NUTR, V88, p537S; Dukas LC, 2005, OSTEOPOROSIS INT, V16, P332, DOI 10.1007/s00198-004-1690-6; Freedman DM, 2013, AM J EPIDEMIOL, V177, P180, DOI 10.1093/aje/kws223; Gaugris S, 2005, QJM-INT J MED, V98, P667, DOI 10.1093/qjmed/hci096; Haga H, 1996, JAPANESE J PUBLIC HL, V43, P983; IOM (Institute of Medicine), 2011, DIET REF INT CALC VI; Iwasa H, 2007, AGING CLIN EXP RES, V19, P240; Iwasa H, 2009, J PSYCHOSOM RES, V66, P155, DOI 10.1016/j.jpsychores.2008.07.006; Ministry of Health Labour and Welfare, 2009, COMPR SURV LIV COND; Nakamura Kazutoshi, 2006, Environmental Health and Preventive Medicine, V11, P271, DOI 10.1007/BF02898016; Stewart JW, 2009, MENOPAUSE, V16, P1093, DOI 10.1097/gme.0b013e3181a8f7ed; Suzuki T, 2003, JPN J PUBLIC HLTH, V50, P39	38	0	0	SPRINGER LONDON LTD	LONDON	236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND	0937-941X	1433-2965		OSTEOPOROSIS INT	Osteoporosis Int.	AUG	2015	26	8					2185	2192		10.1007/s00198-015-3130-1		8	Endocrinology & Metabolism	Endocrinology & Metabolism	CM9PI	WOS:000358040800015		
J	Niimi, R; Kono, T; Nishihara, A; Hasegawa, M; Matsumine, A; Kono, T; Sudo, A				Niimi, R.; Kono, T.; Nishihara, A.; Hasegawa, M.; Matsumine, A.; Kono, T.; Sudo, A.			Analysis of daily teriparatide treatment for osteoporosis in men (vol 26, pg 1303, 2015)	OSTEOPOROSIS INTERNATIONAL			English	Correction									[Niimi, R.; Kono, T.; Nishihara, A.; Kono, T.] Tomidahama Hosp, Dept Orthopaed Surg, Yokaichi, Mie 5108008, Japan; [Hasegawa, M.; Matsumine, A.; Sudo, A.] Mie Univ, Grad Sch Med, Dept Orthopaed Surg, Tsu, Mie 514, Japan	Niimi, R (reprint author), Tomidahama Hosp, Dept Orthopaed Surg, 26-14 Tomidahamacho, Yokaichi, Mie 5108008, Japan.	furikakefuri@hotmail.co.jp					Niimi R, 2015, OSTEOPOROSIS INT, V26, P1303, DOI 10.1007/s00198-014-3001-1	1	0	0	SPRINGER LONDON LTD	LONDON	236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND	0937-941X	1433-2965		OSTEOPOROSIS INT	Osteoporosis Int.	AUG	2015	26	8					2221	2221		10.1007/s00198-015-3204-0		1	Endocrinology & Metabolism	Endocrinology & Metabolism	CM9PI	WOS:000358040800023		
J	Calzada, JE; Saldana, A; Gonzalez, K; Rigg, C; Pineda, V; Santamaria, AM; Rodriguez, I; Gottdenker, NL; Laurenti, MD; Chaves, LF				Calzada, Jose E.; Saldana, Azael; Gonzalez, Kadir; Rigg, Chystrie; Pineda, Vanessa; Maria Santamaria, Ana; Rodriguez, Indra; Gottdenker, Nicole L.; Laurenti, Marcia D.; Chaves, Luis F.			Cutaneous Leishmaniasis in dogs: is high seroprevalence indicative of a reservoir role?	PARASITOLOGY			English	Article						Canis familiaris; Leishmania panamensis; reservoirs; endemicity; force of infection; catalytic models	SAND FLIES DIPTERA; AMERICAN TEGUMENTARY LEISHMANIASIS; CANINE VISCERAL LEISHMANIASIS; VIANNIA BRAZILIENSIS; IDENTIFYING RESERVOIRS; DIAGNOSTIC-TESTS; PANAMA; INFECTION; PSYCHODIDAE; TRANSMISSION	American cutaneous leishmaniasis (ACL) is a complex disease with a rich diversity of animal host species. This diversity imposes a challenge, since understanding ACL transmission requires the adequate identification of reservoir hosts, those species able to be a source of additional infections. In this study we present results from an ACL cross-sectional serological survey of 51 dogs (Canis familiaris), where we used diagnostic tests that measure dog's exposure to Leishmania spp. parasites. We did our research in Panama, at a village that has undergone significant ecosystem level transformations. We found an ACL seroprevalence of 47% among dogs, and their exposure was positively associated with dog age and abundance of sand fly vectors in the houses of dog owners. Using mathematical models, which were fitted to data on the proportion of positive tests as function of dog age, we estimated a basic reproductive number (R-0 +/- S.E.) of 1.22 +/- 0.09 that indicates the disease is endemically established in the dogs. Nevertheless, this information by itself is insufficient to incriminate dogs as ACL reservoirs, given the inability to find parasites (or their DNA) in seropositive dogs and previously reported failures to experimentally infect vectors feeding on dogs with ACL parasites.	[Calzada, Jose E.; Saldana, Azael; Gonzalez, Kadir; Rigg, Chystrie; Pineda, Vanessa; Maria Santamaria, Ana] ICGES, Dept Parasitol, Panama City, Panama; [Calzada, Jose E.; Rodriguez, Indra] Univ Panama, Fac Med Vet, Panama City, Panama; [Gottdenker, Nicole L.] Univ Georgia, Coll Vet Med, Dept Vet Pathol, Athens, GA USA; [Laurenti, Marcia D.] Univ Sao Paulo, Fac Med, Dept Patol, Sao Paulo, Brazil; [Chaves, Luis F.] Nagasaki Univ, Inst Trop Med NEKKEN, Nagasaki, Japan; [Chaves, Luis F.] Univ Nacl, Escuela Med Vet, PIET, Heredia, Costa Rica	Chaves, LF (reprint author), Nagasaki Univ, Inst Trop Med NEKKEN, 852-8523 Sakamoto 1-12-4, Nagasaki, Japan.	lchaves@nagasaki-u.ac.jp	Chaves, Luis Fernando/F-3448-2010	Chaves, Luis Fernando/0000-0002-5301-2764	Gorgas Memorial Research Award of the American Society of Tropical Medicine and Hygiene; NETROPICA grant [04-N-2010]; SENACYT grant [CCP06-040]; Nagasaki University (Program for Nurturing Global Leaders in Tropical and Emerging Communicable Diseases)	This study was funded by a Gorgas Memorial Research Award of the American Society of Tropical Medicine and Hygiene to LFC, NETROPICA grant 04-N-2010 to JEC and LFC, SENACYT grant CCP06-040 to JEC and AS, and Nagasaki University (Program for Nurturing Global Leaders in Tropical and Emerging Communicable Diseases) to LFC.	AGUILAR CM, 1989, MEM I OSWALDO CRUZ, V84, P19; Alexander B, 2001, MED VET ENTOMOL, V15, P364, DOI 10.1046/j.0269-283x.2001.00322.x; ALEXANDER JB, 1987, J MED ENTOMOL, V24, P552; Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671; PIRMEZ C, 1988, AM J TROP MED HYG, V38, P52; Pineda V, 2011, VET PARASITOL, V178, P360, DOI 10.1016/j.vetpar.2010.12.043; Saldana A, 2013, AM J TROP MED HYG, V88, P572, DOI 10.4269/ajtmh.12-0579; Garcia L, 2004, J CLIN MICROBIOL, V42, P2294, DOI 10.1128/JCM.42.5.2294-2297.2004; THATCHER VE, 1966, ANN ENTOMOL SOC AM, V59, P46; CHRISTENSEN HA, 1982, AM J TROP MED HYG, V31, P243; Marco JD, 2001, MEM I OSWALDO CRUZ, V96, P649, DOI 10.1590/S0074-02762001000500009; Levins R, 2006, BIOL PHILOS, V21, P741, DOI 10.1007/s10539-006-9052-8; Dantas-Torres F, 2007, VET PARASITOL, V149, P139, DOI 10.1016/j.vetpar.2007.07.007; Chaves LF, 2007, TRENDS PARASITOL, V23, P311, DOI 10.1016/j.pt.2007.05.003; Lemos EM, 2008, ACTA TROP, V107, P205, DOI 10.1016/j.actatropica.2008.04.023; Dendukuri N, 2001, BIOMETRICS, V57, P158, DOI 10.1111/j.0006-341X.2001.00158.x; CHRISTENSEN HA, 1983, J MED ENTOMOL, V20, P463; Boggild AK, 2010, AM J TROP MED HYG, V83, P345, DOI 10.4269/ajtmh.2010.09-0414; Fung HL, 2014, ACTA TROP, V135, P67, DOI 10.1016/j.actatropica.2014.03.010; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Quinnell RJ, 1997, PARASITOLOGY, V115, P143, DOI 10.1017/S0031182097001200; Carey JR, 2001, ANNU REV ENTOMOL, V46, P79, DOI 10.1146/annurev.ento.46.1.79; Pan W, 2001, BIOMETRICS, V57, P120, DOI 10.1111/j.0006-341X.2001.00120.x; Padilla AM, 2002, VET PARASITOL, V110, P1, DOI 10.1016/S0304-4017(02)00330-8; Reithinger R, 1999, AM J TROP MED HYG, V61, P530; Vergel C, 2005, AM J TROP MED HYG, V72, P423; Miranda A, 2012, T ROY SOC TROP MED H, V106, P544, DOI 10.1016/j.trstmh.2012.05.005; MORRISON AC, 1993, J MED ENTOMOL, V30, P427; Branscum AJ, 2005, PREV VET MED, V68, P145, DOI 10.1016/j.prevetmed.2004.12.005; Chaves LF, 2004, ACTA TROP, V92, P245, DOI 10.1016/j.actatropica.2004.08.004; Chaves LF, 2010, J MED ENTOMOL, V47, P291, DOI 10.1603/ME09250; Viana M, 2014, TRENDS ECOL EVOL, V29, P270, DOI 10.1016/j.tree.2014.03.002; FALQUETO A, 1991, MEM I OSWALDO CRUZ, V86, P499; Reithinger R, 2003, T ROY SOC TROP MED H, V97, P141, DOI 10.1016/S0035-9203(03)90101-5; Aragao H. de B., 1927, Memorias do Instituto Oswaldo Cruz, V20, P177; Ashford RW, 1997, ANN TROP MED PARASIT, V91, P693; Bolker B. M, 2008, ECOLOGICAL MODELS DA; Bretscher MT, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-21; Calzada JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053289; Carey J.R., 2003, LONGEVITY BIOL DEMOG; Castro EA, 2007, EXP PARASITOL, V117, P13, DOI 10.1016/j.exppara.2007.03.003; Chaves LF, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003210; Chaves L. F., 2008, DIVULGACIONES MATEMA, V16, P125; HERRER A, 1980, AM J TROP MED HYG, V29, P1196; HERRER A, 1976, AM J TROP MED HYG, V25, P54; CHRISTEN.HA, 1973, AM J TROP MED HYG, V22, P578; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Colombo FA, 2011, PARASITOL RES, V109, P267, DOI 10.1007/s00436-010-2247-6; Davies C. R., 2002, T ROY SOC TROP MED H, V96; DEREURE J, 1994, ANN SOC BELG MED TR, V74, P29; Dutari LC, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-218; DYE C, 1993, EPIDEMIOL INFECT, V110, P647; Faraway J. J., 2006, EXTENDING LINEAR MOD; Faraway J. J., 2004, LINEAR MODELS R; GARNHAM PCC, 1965, AM ZOOL, V5, P141; Gil JF, 2011, MEDICINA-BUENOS AIRE, V71, P420; Gonzalez Kadir, 2015, Tropical Medicine and Health, V43, P75, DOI 10.2149/tmh.2014-30; Hern&aacute;ndez D., 2006, BIOMEDICA, V26, ps242; CHRISTEN.HA, 1972, T ROY SOC TROP MED H, V66, P798, DOI 10.1016/0035-9203(72)90098-3; HERRER A, 1976, AM J TROP MED HYG, V25, P59; CHRISTENSEN HA, 1980, J MED ENTOMOL, V17, P522; CHRISTENSEN HA, 1979, J MED ENTOMOL, V16, P424; Krebs CJ, 1998, ECOLOGICAL METHODOLO; Levins R, 1968, EVOLUTION CHANGING E; Marco JD, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-191; May RM, 1991, INFECT DIS HUMANS DY; OIE, 2008, MAN DIAGN TESTS VACC; Pedroso A. M., 1913, ANN PAULISTAS MED CI, V1, P33; Quinnell RJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0001992; Quintana MG, 2010, J MED ENTOMOL, V47, P1003, DOI 10.1603/ME09072; Reithinger R, 2002, T ROY SOC TROP MED H, V96, P76, DOI 10.1016/S0035-9203(02)90249-X; Reithinger R, 2010, J CLIN MICROBIOL, V48, P3003, DOI 10.1128/JCM.02474-09; Reithinger R, 2000, J CLIN MICROBIOL, V38, P748; Rohlf F. J., 1994, ECOLOGICAL METHODS; Scorza J. V., 1990, MEM I OSWALDO CRUZ, V84, P29; Stewart L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006083; TELFORD SR, 1972, ANN TROP MED PARASIT, V66, P173; Travi B. L., 2006, BIOMEDICA, V26, ps249; Venables W.N., 2002, MODERN APPLIED STATI	79	1	1	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0031-1820	1469-8161		PARASITOLOGY	Parasitology	AUG	2015	142	9					1202	1214		10.1017/S0031182015000475		13	Parasitology	Parasitology	CM5PF	WOS:000357739700008		
J	Tajima, M; Shiozawa, Y; Kagawa, J				Tajima, Miyu; Shiozawa, Yusuke; Kagawa, Jiro			Early Appearance of Principal Symptoms of Kawasaki Disease is a Risk Factor for Intravenous Immunoglobulin Resistance	PEDIATRIC CARDIOLOGY			English	Article						Kawasaki disease; IVIG; Coronary artery aneurysm; Non-responder; Principal symptom; Risk score	CORONARY-ARTERY ABNORMALITIES; OPEN-LABEL; THERAPY; PREDICTION; MANAGEMENT; INFLIXIMAB; DIAGNOSIS; EFFICACY; LESIONS; UPDATE	It is difficult to accurately predict treatment resistance in Kawasaki disease (KD). Patients considered to be low-risk cases often develop resistance to intravenous immunoglobulin (IVIG). We herein examined whether information from the clinical course of KD could improve the prediction accuracy of a previously reported risk score. We retrospectively reviewed the clinical records of 100 KD patients. The clinical characteristics and laboratory data were compared between IVIG-sensitive and IVIG-resistant patients and also between patients with and without coronary artery aneurysm (CAA). The total incidence of IVIG resistance and CAA development was 34 and 13 %, respectively. Multiple regression analysis identified the early appearance of principal symptoms (a parts per thousand currency signday 2 of the illness) as a risk factor for IVIG resistance (OR 2.88, 95 % CI 1.11-7.44, p = 0.0041), whereas delayed IVIG administration (a parts per thousand yenday 6) (OR 2.23, 95 % CI 0.66-7.64, p = 0.018) and IVIG resistance (OR 9.05, 95 % CI 2.27-36.10, p = 0.015) were independent predictors for CAA development. The addition of the first appearance day of principal symptoms into a previously reported scoring system improved its prediction accuracy for IVIG resistance. KD patients who had presented with any principal symptoms within 2 days of fever onset were at a high risk for IVIG resistance regardless of previously reported risk score. A careful medical history-taking that is focused on the clinical course enables a better prediction of IVIG resistance.	[Tajima, Miyu] Univ Tokyo, Dept Cardiol, Tokyo, Japan; [Tajima, Miyu; Shiozawa, Yusuke; Kagawa, Jiro] Fujieda Municipal Gen Hosp, Dept Pediat, Fujieda, Shizuoka 4268677, Japan; [Shiozawa, Yusuke] Univ Tokyo, Dept Pediat, Tokyo, Japan	Tajima, M (reprint author), Univ Tokyo, Dept Cardiol, Tokyo, Japan.	mtajima-tky@umin.ac.jp					Newburger JW, 2004, CIRCULATION, V110, P2747, DOI 10.1161/01.CIR.0000145143.19711.78; Luca NJC, 2012, DRUGS, V72, P1029, DOI 10.2165/11631440-000000000-00000; Kuo HC, 2012, PEDIATR NEONATOL, V53, P4, DOI 10.1016/j.pedneo.2011.11.003; Sano T, 2007, EUR J PEDIATR, V166, P131, DOI 10.1007/s00431-006-0223-z; Tremoulet AH, 2014, LANCET, V383, P1731, DOI 10.1016/S0140-6736(13)62298-9; Ayusawa M, 2005, PEDIATR INT, V47, P232, DOI 10.1111/j.1442-200x.2005.02033.x; Kobayashi T, 2006, CIRCULATION, V113, P2606, DOI 10.1161/CIRCULATIONAHA.105.592865; Senzaki H, 2008, CIRCULATION, V118, P2763, DOI 10.1161/CIRCULATIONAHA.107.749515; Sato S, 2013, INT J RHEUM DIS, V16, P168, DOI 10.1111/1756-185X.12082; Wang YJ, 2013, ARTHRITIS RHEUM-US, V65, P805, DOI 10.1002/art.37815; Kobayashi T, 2012, LANCET, V379, P1613, DOI 10.1016/S0140-6736(11)61930-2; Takahashi K, 2014, CURR OPIN RHEUMATOL, V26, P31, DOI 10.1097/BOR.0000000000000010; Daniels LB, 2012, CURR OPIN CARDIOL, V27, P572, DOI 10.1097/HCO.0b013e3283588f06; Callinan LS, 2012, PEDIATR INFECT DIS J, V31, P894, DOI 10.1097/INF.0b013e31825c4d7c; Egami K, 2006, J PEDIATR-US, V149, P237, DOI 10.1016/j.jpeds.2006.03.050; Durongpisitkul K, 2003, PEDIATR CARDIOL, V24, P145, DOI 10.1007/s00246-002-0216-2; Jamieson N, 2013, INT J PEDIAT, V2013, DOI 10.1155/2013/645391; Moore A, 2014, BRIT J GEN PRACT, V64, pE477, DOI 10.3399/bjgp14X680953; Mori M, 2012, J RHEUMATOL, V39, P864, DOI 10.3899/jrheum.110877; Nakamura Y, 2013, J EPIDEMIOL, V23, P429, DOI 10.2188/jea.JE20130048; Ruan Y, 2013, PEDIATR INFECT DIS J, V32, pE397, DOI 10.1097/INF.0b013e31829dd45e; Shiozawa Y, 2013, PEDIATR INFECT DIS J, V32, pE365, DOI 10.1097/INF.0b013e3182952027; Sudo D, 2010, PEDIATR INT, V52, P790, DOI 10.1111/j.1442-200X.2010.03161.x; Takahashi Kei, 2010, Ann Vasc Dis, V3, P173, DOI 10.3400/avd.sasvp01003	24	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0172-0643	1432-1971		PEDIATR CARDIOL	Pediatr. Cardiol.	AUG	2015	36	6					1159	1165		10.1007/s00246-015-1136-2		7	Cardiac & Cardiovascular Systems; Pediatrics	Cardiovascular System & Cardiology; Pediatrics	CM4VS	WOS:000357683800008		
J	Nakamura, Y; Hagino, I; Aoki, M; Higashi, K; Nakajima, H				Nakamura, Yuki; Hagino, Ikuo; Aoki, Mitsuru; Higashi, Kouji; Nakajima, Hiromichi			Changes in Plasma Atrial and Brain Natriuretic Peptide Levels in Children Undergoing Surgical Isolated Atrial Septal Defect Closure	PEDIATRIC CARDIOLOGY			English	Article						Atrial natriuretic peptide; Brain natriuretic peptide; Atrial septal defect; Pediatric heart surgery	CONGENITAL HEART-DISEASE; TOTAL CAVOPULMONARY CONNECTION; CARDIOPULMONARY BYPASS; CARDIAC-SURGERY; FAILURE; SECRETION; REPAIR; ADULTS; VOLUME	Plasma atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP) levels increase after cardiopulmonary bypass (CPB) in pediatric patients. However, the exact reason for the postoperative increase remains unclear. This study elucidated the perioperative changes in plasma natriuretic peptide levels in children undergoing surgical isolated atrial septal defect (ASD) closure. Between 2010 and 2012, 24 pediatric patients (median 7.1, range 2.7-15.7 years) underwent surgery for simple ASD using CPB under ventricular fibrillation (Group A, 16 patients) or under cardiac arrest (Group B, 8 patients). Natriuretic peptide levels were measured before surgery, on postoperative day 0, 1, 3, and at the first outpatient visit. The pulmonary to systemic blood flow ratio (Qp/Qs) was estimated by echocardiography using an index of right ventricle end-diastolic area. Preoperative natriuretic peptide levels positively correlated with the Qp/Qs. Plasma ANP levels peaked on postoperative day 0, and its values were higher in Group A than in Group B patients (p < 0.001). Plasma BNP levels increased significantly in both Groups on postoperative day 1, and its values were significantly greater in Group A than in Group B patients (p = 0.007). There was a weak negative correlation between the amount of postoperative increase in natriuretic peptide levels and the Qp/Qs. There was no appreciable difference in the acute postoperative clinical course and echocardiographic parameter on postoperative day 3 between Group A and B patients. In conclusion, acute postoperative natriuretic peptide levels after isolated ASD closure were multifactorial, and they might be unreliable for predicting clinical outcomes.	[Nakamura, Yuki; Hagino, Ikuo; Aoki, Mitsuru] Chiba Children Hosp, Div Cardiovasc Surg, Midori, Chiba 2660007, Japan; [Higashi, Kouji; Nakajima, Hiromichi] Chiba Children Hosp, Div Pediat Cardiol, Midori, Chiba 2660007, Japan	Nakamura, Y (reprint author), Chiba Children Hosp, Div Cardiovasc Surg, 579-1 Heta, Midori, Chiba 2660007, Japan.	yukicvs@gmail.com					Niedner MF, 2010, CONGENIT HEART DIS, V5, P243, DOI 10.1111/j.1747-0803.2010.00396.x; Shih CY, 2006, J THORAC CARDIOV SUR, V131, P632, DOI 10.1016/j.jtcvs.2005.10.052; Hsu JH, 2007, J THORAC CARDIOV SUR, V134, P939, DOI 10.1016/j.jtcvs.2007.04.017; Kunii Y, 2003, ACTA MED OKAYAMA, V57, P191; Das BB, 2010, PEDIATR CARDIOL, V31, P1135, DOI 10.1007/s00246-010-9758-x; Santoro G, 2004, AM J CARDIOL, V93, P876, DOI 10.1016/j.amjcard.2003.12.027; Globits S, 1998, AM HEART J, V135, P592, DOI 10.1016/S0002-8703(98)70272-8; Ozhan H, 2007, PEDIATR CARDIOL, V28, P272, DOI 10.1007/s00246-006-0014-3; Walsh R, 2008, J THORAC CARDIOV SUR, V135, P98, DOI 10.1016/j.jtcvs.2007.08.012; Hsu JH, 2008, J THORAC CARDIOV SUR, V135, P746, DOI 10.1016/j.jtcvs.2007.10.040; Aotsuka H, 1995, ACTA PAEDIATR JAPON, V99, P1756; ATIONU A, 1993, CARDIOVASC RES, V27, P1538, DOI 10.1093/cvr/27.8.1538; BURCH M, 1992, BRIT HEART J, V68, P309; Cantinotti M, 2014, HEART FAIL REV, V19, P727, DOI 10.1007/s10741-014-9422-2; Costello JM, 2005, J THORAC CARDIOV SUR, V130, P822, DOI 10.1016/j.jtcvs.2005.03.008; Ikeda H, 2004, ACTA CARDIOL PAEDIAT, V20, P423; Koch A, 2007, INT J CARDIOL, V114, P339, DOI 10.1016/j.ijcard.2006.01.022; Mainwaring RD, 2007, ANN THORAC SURG, V84, P2066, DOI 10.1016/j.athoracsur.2007.07.021; Masutani S, 2009, AM J CARDIOL, V104, P1732, DOI 10.1016/j.amjcard.2009.07.058; Ootaki Y, 2003, J THORAC CARDIOV SUR, V126, P1411, DOI 10.1016/S0022-5223(03)01020-1; Uz O, 2011, ECHOCARDIOGR-J CARD, V28, P243, DOI 10.1111/j.1540-8175.2010.01285.x; Wu ET, 2007, CATHETER CARDIO INTE, V69, P866, DOI 10.1002/ccd.21075; Yap Lok Bin, 2004, Chest, V126, P1330, DOI 10.1378/chest.126.4.1330; Yoshimura N, 2000, J THORAC CARDIOV SUR, V120, P764, DOI 10.1067/mtc.2000.108595	24	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0172-0643	1432-1971		PEDIATR CARDIOL	Pediatr. Cardiol.	AUG	2015	36	6					1219	1224		10.1007/s00246-015-1148-y		6	Cardiac & Cardiovascular Systems; Pediatrics	Cardiovascular System & Cardiology; Pediatrics	CM4VS	WOS:000357683800016		
J	Yamamoto, M; Takahashi, M				Yamamoto, Masaru; Takahashi, Masaaki			Dynamics of polar vortices at cloud top and base on Venus inferred from a general circulation model: Case of a strong diurnal thermal tide	PLANETARY AND SPACE SCIENCE			English	Article						Venus; Atmospheric dynamics; Polar vortex	MIDDLE ATMOSPHERE; BAROTROPIC INSTABILITY; WINDS; SUPERROTATION; TEMPERATURE; STABILITY; GALILEO; VORTEX	Polar vortices in the presence of a thermal tide are investigated using a Venusian middle atmosphere general circulation model. Around the cloud top, where the warm polar region is maintained by the thermal wind associated with a high latitude jet, the temperature contrast forms the polar vortex pattern. The cold collar and hot oval (monopole) near the pole are enhanced by the polar diurnal tide, and unstable vortices form the hot dipole and tripole. The centroid of the hot oval is displaced from the pole to around 80 degrees by the diurnal tide. The hot dipole appears and breaks up into a tripole when transient vortical and divergent eddies with zonal wavenumbers 2 and higher are predominant within the polar hot oval region. Because the divergence and temperature are a quarter cycle out of phase with the eddy vorticity, the vortical eddies transport heat toward the cold region. Thus, the cloud-top polar vortices are mainly formed by a combination of the diurnal tide and transient baroclinic wave. At the cloud base, isotherms are almost zonally uniform and the eddy temperature structure is not apparent. In contrast, divergence and vorticity have large amplitudes within this region. The vortical eddies have a comma-shaped pattern, which is stably maintained and rotates with a period of about 5 days. The divergence and vorticity might be important in controlling cloud morphology at the cloud base via material transport. (C) 2015 Elsevier Ltd. All rights reserved.	[Yamamoto, Masaru] Kyushu Univ, Appl Mech Res Inst, Kasuga, Fukuoka 8168580, Japan; [Takahashi, Masaaki] Univ Tokyo, Atmosphere & Ocean Res Inst, Kashiwa, Chiba 2778568, Japan	Yamamoto, M (reprint author), Kyushu Univ, Appl Mech Res Inst, 6-1 Kasuga Kouen, Kasuga, Fukuoka 8168580, Japan.	yamakatu@kyudai.jp; masaaki@aori.u-tokyo.ac.jp	Kyushu, RIAM/F-4018-2015		Cooperative Research Project of the Atmosphere and Ocean Research Institute; University of Tokyo; Japan Society for the Promotion of Science/Ministry of Education, Culture, Sports, Science and Technology (KAKENHI) [23540514, 26400467]	We would like to thank editors and reviewers for their constructive comments and valuable suggestions. This study was supported by the Cooperative Research Project of the Atmosphere and Ocean Research Institute, the University of Tokyo, and by a Japan Society for the Promotion of Science/Ministry of Education, Culture, Sports, Science and Technology Grant-in-Aid (KAKENHI Grant nos. 23540514 and 26400467). Numerical experiments in this study were conducted using supercomputing resources at the Information Synergy Center, The University of Tokyo, Japan, and the Research Institute for Information Technology of Kyushu University, Japan.	Grassi D, 2014, J GEOPHYS RES-PLANET, V119, P837, DOI 10.1002/2013JE004586; Ignatiev NI, 2009, J GEOPHYS RES-PLANET, V114, DOI 10.1029/2008JE003320; SCHOFIELD JT, 1983, Q J ROY METEOR SOC, V109, P57, DOI 10.1002/qj.49710945904; Peralta J, 2012, ICARUS, V220, P958, DOI 10.1016/j.icarus.2012.06.015; NEWMAN M, 1984, J ATMOS SCI, V41, P1901, DOI 10.1175/1520-0469(1984)041<1901:ZWITMA>2.0.CO;2; BELTON MJS, 1991, SCIENCE, V253, P1531, DOI 10.1126/science.253.5027.1531; Yamamoto M, 2006, J ATMOS SCI, V63, P3296, DOI 10.1175/JAS3859.1; Luz D, 2011, SCIENCE, V332, P577, DOI 10.1126/science.1201629; Smith MD, 1996, ICARUS, V123, P313, DOI 10.1006/icar.1996.0160; Sanchez-Lavega A, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL033817; Iga S, 2005, J ATMOS SCI, V62, P2514, DOI 10.1175/JAS3484.1; CHARNEY JG, 1962, J ATMOS SCI, V19, P159, DOI 10.1175/1520-0469(1962)019<0159:OTSOIB>2.0.CO;2; Piccioni G, 2007, NATURE, V450, P637, DOI 10.1038/nature06209; Limaye SS, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL036093; Yamamoto M, 2009, J GEOPHYS RES-PLANET, V114, DOI 10.1029/2009JE003381; NEWMAN M, 1992, SCIENCE, V257, P647, DOI 10.1126/science.257.5070.647; Titov DV, 2008, NATURE, V456, P620, DOI 10.1038/nature07466; Piccialli A, 2012, ICARUS, V217, P669, DOI 10.1016/j.icarus.2011.07.016; YOUNG RE, 1984, J ATMOS SCI, V41, P2310, DOI 10.1175/1520-0469(1984)041<2310:BIITVA>2.0.CO;2; CRISP D, 1991, SCIENCE, V253, P1538, DOI 10.1126/science.253.5027.1538; Yamamoto M, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL019518; Moissl R, 2009, J GEOPHYS RES-PLANET, V114, DOI 10.1029/2008JE003117; DOBROVOLSKIS AR, 1990, J ATMOS SCI, V47, P1578, DOI 10.1175/1520-0469(1990)047<1578:BIWDTA>2.0.CO;2; ELSON LS, 1978, GEOPHYS RES LETT, V5, P603, DOI 10.1029/GL005i007p00603; Garate-Lopez I, 2013, NAT GEOSCI, V6, P254, DOI [10.1038/ngeo1764, 10.1038/NGEO1764]; Lebonnois S., 2013, UNDERSTANDING CLIMAT, V11, P129; Lee C, 2010, ICARUS, V206, P662, DOI 10.1016/j.icarus.2009.09.017; Lewis SR, 2013, ISSI SCI REP SER, V11, P111, DOI 10.1007/978-1-4614-5064-1_7; Numaguti A., 1997, CGERS SUPERCOMPUTER, V3, P91; PECHMANN JB, 1984, J ATMOS SCI, V41, P3290; Satomura T., 1981, J MET SOC JAPAN, V59, P148; Takagi M, 2005, GEOPHYS RES LETT, V32, DOI [10.1029/2005GL023700, 10.1029/2004GL022060]; TAYLOR FW, 1979, SCIENCE, V205, P65, DOI 10.1126/science.205.4401.65; Tomasko M. G., 1985, Advances in Space Research, V5, DOI 10.1016/0273-1177(85)90272-8; Yamamoto M, 2012, ICARUS, V217, P702, DOI 10.1016/j.icarus.2011.06.017; Yamamoto M, 2006, GEOPHYS ASTRO FLUID, V100, P185, DOI 10.1080/03091920600748266	36	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0032-0633			PLANET SPACE SCI	Planet Space Sci.	AUG	2015	113				SI		109	119		10.1016/j.pss.2015.01.017		11	Astronomy & Astrophysics	Astronomy & Astrophysics	CM5UX	WOS:000357755600009		
J	Iwagami, N; Hashimoto, GL; Ohtsuki, S; Takagi, S; Robert, S				Iwagami, N.; Hashimoto, G. L.; Ohtsuki, S.; Takagi, S.; Robert, S.			Ground-based IR observation of oxygen isotope ratios in Venus's atmosphere	PLANETARY AND SPACE SCIENCE			English	Article						Oxygen isotope; Venus atmosphere; Ground-based; IR spectroscopy	SPECTROSCOPY	The oxygen isotope ratios O-17/O-16 and O-18/O-16 in Venus's atmosphere were measured simultaneously by ground-based IR spectroscopy. The CO2 absorption lines in the 2648 cm(-1) (for O-17/O-18) and 4582 cm(-1) (for O-18/O-16) regions were observed using the IRTF/CSHELL spectrometer. The deviations of the isotope fractions are found to be delta O-17 = +92 +/- 158 parts per thousand, and delta O-18 = -42 +/- 85 parts per thousand as compared to the terrestrial standard (HITRAN 2012) where the uncertainties include both random and systematic errors. Such combination agrees with the Earth-Moon fractionation line within the errors. This is consistent to the fact that the proto-Venus matter was also well mixed with the proto-Earth-Moon matter. (C) 2014 Elsevier Ltd. All rights reserved.	[Iwagami, N.; Takagi, S.] Univ Tokyo, Dept Earth & Planetary Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Hashimoto, G. L.] Okayama Univ, Dept Earth Sci, Okayama 7008530, Japan; [Ohtsuki, S.] Senshu Univ, Sch Commerce, Tama Ku, Kawasaki, Kanagawa 2148580, Japan; [Robert, S.] Belgian Inst Space Aeron, B-1180 Brussels, Belgium	Iwagami, N (reprint author), Univ Tokyo, Dept Earth & Planetary Sci, Bunkyo Ku, Tokyo 1130033, Japan.	iwagami@eps.s.u-tokyo.ac.jp			National Aeronautics and Space Administration, Science Mission Directorate, Planetary Aeronomy Program [NCC 5-538]; Ministry of Education, Culture, Sports, Science and Technology, Japan [21540460]; Belgian Federal Science Policy Office [1-MO/35/030]; IUAP PlanetTOPERS; EuroVenus [GA 606798]	The authors would like to thank the staff at the IRTF for their support during the observations. The Infrared Telescope Facility is operated by the University of Hawaii under Co-operative agreement no. NCC 5-538 with the National Aeronautics and Space Administration, Science Mission Directorate, Planetary Aeronomy Program. The authors are also grateful to the Open CLASTER project for the use of the RSTAR (a system for the transfer of atmospheric radiation) package in this research. This research is partly supported by Grant-in-aid for scientific research (C) no. 21540460 from the Ministry of Education, Culture, Sports, Science and Technology, Japan. SR acknowledges funding from by the Belgian Federal Science Policy Office (Action 1-MO/35/030) and would like to thank the IUAP PlanetTOPERS and EuroVenus (GA 606798) projects for their support	Coplen TB, 2002, PURE APPL CHEM, V74, P1987, DOI 10.1351/pac200274101987; GREENE TP, 1993, P SOC PHOTO-OPT INS, V1946, P313, DOI 10.1117/12.158684; Rothman LS, 2013, J QUANT SPECTROSC RA, V130, P4, DOI 10.1016/j.jqsrt.2013.07.002; Thiemens MH, 1999, SCIENCE, V283, P341, DOI 10.1126/science.283.5400.341; POLLACK JB, 1993, ICARUS, V103, P1, DOI 10.1006/icar.1993.1055; NAKAJIMA T, 1988, J QUANT SPECTROSC RA, V40, P51, DOI 10.1016/0022-4073(88)90031-3; NAKAJIMA T, 1986, J QUANT SPECTROSC RA, V35, P13, DOI 10.1016/0022-4073(86)90088-9; BEZARD B, 1987, ICARUS, V72, P623, DOI 10.1016/0019-1035(87)90057-1; Borkov YG, 2014, J QUANT SPECTROSC RA, V137, P57, DOI 10.1016/j.jqsrt.2013.11.008; Donahue TM, 1997, SPACE SCI S, P385; Hoffman J. H., 1980, J GEOPHYS RES, V85, P7882, DOI 10.1029/JA085iA13p07882; HUMLICEK J, 1982, J QUANT SPECTROSC RA, V27, P437, DOI 10.1016/0022-4073(82)90078-4; Livingston W., 1991, 91001 NSO NAT OPT AS, P67; McKeegan, 2011, SCIENCE, V332, P1528; Picone JM, 2002, J GEOPHYS RES-SPACE, V107, DOI 10.1029/2002JA009430; Scott E.R.D., 2001, PLANET SCI DISCOV; Seiff A., 1985, ADV SPACE RES, V5, P3, DOI DOI 10.1016/0273-1177(85)90197-8; Takagi S, 2011, EARTH PLANETS SPACE, V63, P435, DOI 10.5047/eps.2011.01.007	18	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0032-0633			PLANET SPACE SCI	Planet Space Sci.	AUG	2015	113				SI		292	297		10.1016/j.pss.2014.10.004		6	Astronomy & Astrophysics	Astronomy & Astrophysics	CM5UX	WOS:000357755600023		
J	Lee, YJ; Titov, DV; Ignatiev, NI; Tellmann, S; Patzold, M; Piccioni, G				Lee, Y. J.; Titov, D. V.; Ignatiev, N. I.; Tellmann, S.; Paetzold, M.; Piccioni, G.			The radiative forcing variability caused by the changes of the upper cloud vertical structure in the Venus mesosphere	PLANETARY AND SPACE SCIENCE			English	Article						Venus; Mesosphere; Clouds; Radiative energy balance	PLANETARY-ATMOSPHERES; MIDDLE ATMOSPHERE; THERMAL STRUCTURE; EXPRESS; CO2; TEMPERATURE; ABSORPTION; SCATTERING; NIGHTSIDE; CIRCULATION	The upper cloud layer of Venus is a key factor affecting radiative energy balance of the mesosphere. Observations of the temperature and the cloud top structure by Venus Express revealed their strong variability with latitude. We used the 1-D radiative transfer model to study the dependence of the radiative forcing on the cloud top structure. The cloud top altitude effectively controls outgoing thermal fluxes. Sharp cloud top boundary can produce a pronounced peak of both solar heating and thermal cooling that suggests a radiative origin of temperature inversions in the cold collar. Strong diurnal variation of net forcing at low latitudes can be responsible for the origin of convective cells observed in UV images. Latitudinal contrasts in the radiative forcing in the mesosphere can drive meridional Hadley-type circulation with meridional winds of few m/s and vertical motions with speed of few cm/s. (C) 2014 Elsevier Ltd. All rights reserved.	[Lee, Y. J.] Japan Aerosp Explorat Agcy JAXA, ISAS, Sagamihara, Kanagawa, Japan; [Lee, Y. J.] Max Planck Inst Solar Syst Res, Gottingen, Germany; [Titov, D. V.] ESA ESTEC, Noordwijk, Netherlands; [Ignatiev, N. I.] Space Res Inst IKI, Moscow, Russia; [Tellmann, S.; Paetzold, M.] Univ Cologne, Rheinish Inst Environm Res, Cologne, Germany; [Piccioni, G.] INAF IAPS, Rome, Italy	Lee, YJ (reprint author), Japan Aerosp Explorat Agcy JAXA, ISAS, Sagamihara, Kanagawa, Japan.	leeyj@ac.jaxa.jp		Piccioni, Giuseppe/0000-0002-7893-6808			Patzold M, 2007, NATURE, V450, P657, DOI 10.1038/nature06239; TOIGO A, 1994, ICARUS, V109, P318, DOI 10.1006/icar.1994.1097; Crisp D, 1997, SPACE SCI S, P353; MOROZ VI, 1983, ICARUS, V53, P509, DOI 10.1016/0019-1035(83)90213-0; Taylor FW, 2006, PLANET SPACE SCI, V54, P1249, DOI 10.1016/j.pss.2006.04.031; Wu CYR, 2000, ICARUS, V145, P289, DOI 10.1006/icar.1999.6322; Evans KF, 1998, J ATMOS SCI, V55, P429, DOI 10.1175/1520-0469(1998)055<0429:TSHDOM>2.0.CO;2; Sanchez-Lavega A, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL033817; BARKER ES, 1975, J ATMOS SCI, V32, P1205, DOI 10.1175/1520-0469(1975)032<1205:RSOVFT>2.0.CO;2; PALMER KF, 1975, APPL OPTICS, V14, P208, DOI 10.1364/AO.14.000208; Grassi D, 2010, J GEOPHYS RES-PLANET, V115, DOI 10.1029/2009JE003553; Tonkov MV, 1996, APPL OPTICS, V35, P4863, DOI 10.1364/AO.35.004863; Migliorini A, 2012, ICARUS, V217, P640, DOI 10.1016/j.icarus.2011.07.013; Levoni C, 1997, APPL OPTICS, V36, P8031, DOI 10.1364/AO.36.008031; CRISP D, 1989, ICARUS, V77, P391, DOI 10.1016/0019-1035(89)90096-1; Haus R, 2014, ICARUS, V232, P232, DOI 10.1016/j.icarus.2014.01.020; Gierasch PJ, 1997, SPACE SCI S, P459; Rothman LS, 2009, J QUANT SPECTROSC RA, V110, P533, DOI 10.1016/j.jqsrt.2009.02.013; Zasova LV, 2007, PLANET SPACE SCI, V55, P1712, DOI 10.1016/j.pss.2007.01.011; Hausler B, 2006, PLANET SPACE SCI, V54, P1315, DOI 10.1016/j.pss.2006.04.032; HANSEN JE, 1974, SPACE SCI REV, V16, P527, DOI 10.1007/BF00168069; WINTERS BH, 1964, J QUANT SPECTROSC RA, V4, P527, DOI 10.1016/0022-4073(64)90014-7; BURCH DE, 1969, J OPT SOC AM, V59, P267, DOI 10.1364/JOSA.59.000267; Lee YJ, 2012, ICARUS, V217, P599, DOI 10.1016/j.icarus.2011.07.001; POLLACK JB, 1993, ICARUS, V103, P1, DOI 10.1006/icar.1993.1055; Meadows VS, 1996, J GEOPHYS RES-PLANET, V101, P4595, DOI 10.1029/95JE03567; Khatuntsev IV, 2013, ICARUS, V226, P140, DOI 10.1016/j.icarus.2013.05.018; WISCOMBE WJ, 1980, APPL OPTICS, V19, P1505, DOI 10.1364/AO.19.001505; Lee C, 2011, J ATMOS SCI, V68, P1323, DOI 10.1175/2011JAS3703.1; Bullock M.A., 1997, THESIS U COLORADO BO; Chapman S., 2007, FORTRAN 95 2003 SCI, V3rd; CRISP D, 1986, ICARUS, V67, P484, DOI 10.1016/0019-1035(86)90126-0; Esposito L.W., 1980, J GEOPHYS RES, V85, P8151, DOI 10.1029/JA085iA13p08151; Fedorova A., 2008, J GEOPHYS RES PLANET, V113; Goody R. M., 1989, ATMOSPHERIC RAD THEO; Holton J. R., 1992, INTRO DYNAMIC METEOR; Ignatiev NI, 1999, PLANET SPACE SCI, V47, P1061, DOI 10.1016/S0032-0633(99)00030-6; Ignatiev N.I., 2009, J GEOPHYS RES PLANET, V114; Imamura T, 2014, ICARUS, V228, P181, DOI 10.1016/j.icarus.2013.10.012; Knollenberg R.G., 1980, J GEOPHYS RES, V85, P8039, DOI 10.1029/JA085iA13p08039; Kouyama T, 2013, J GEOPHYS RES-PLANET, V118, DOI 10.1029/2011JE004013; Lebonnois S, 2010, J GEOPHYS RES-PLANET, V115, DOI 10.1029/2009JE003458; Limaye S.S., 2007, J GEOPHYS RES, V112, P4; Moroz V. I., 1985, ADV SPACE RES, V5, P197, DOI 10.1016/0273-1177(85)90202-9; Moskalenko N.I., 1981, P 6 ALL UN S PROP LA, P110; Pollack J.B., 1980, J GEOPHYS RES, V85, P8141, DOI DOI 10.1029/JA085IA13P08141; POLLACK JB, 1979, SCIENCE, V205, P76, DOI 10.1126/science.205.4401.76; POLLACK JB, 1967, ICARUS, V7, P42, DOI 10.1016/0019-1035(67)90045-0; Ragent B, 1985, ADV SPACE RES, V5, P85, DOI DOI 10.1016/0273-1177(85)90199-1; SANTEE ML, 1995, J GEOPHYS RES-PLANET, V100, P5465, DOI 10.1029/94JE03207; Seiff A., 1985, ADV SPACE RES, V5, P3, DOI DOI 10.1016/0273-1177(85)90197-8; Takagi M., 2007, JGRD, V112, P9112; TANAKA M, 1977, J QUANT SPECTROSC RA, V17, P421, DOI 10.1016/0022-4073(77)90121-2; Taylor F. W., 1983, Venus; Tellmann S., 2009, J GEOPHYS RES PLANET, V114; Titov DV, 1997, PLANET SPACE SCI, V45, P369, DOI 10.1016/S0032-0633(96)00129-8; Titov D.V., 2007, GEOPHYS MONOGRAPH SE; Tomasko M. G., 1980, J GEOPHYS RES, V85, P8167, DOI 10.1029/JA085iA13p08167; Tomasko M. G., 1985, Advances in Space Research, V5, DOI 10.1016/0273-1177(85)90272-8; Tomasko M.G., 1980, J GEOPHYS RES, V85, P8187, DOI 10.1029/JA085iA13p08187	60	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0032-0633			PLANET SPACE SCI	Planet Space Sci.	AUG	2015	113				SI		298	308		10.1016/j.pss.2014.12.006		11	Astronomy & Astrophysics	Astronomy & Astrophysics	CM5UX	WOS:000357755600024		
J	Chaki, S; Shimazaki, T; Karasawa, J; Aoki, T; Kaku, A; Iijima, M; Kambe, D; Yamamoto, S; Kawakita, Y; Shibata, T; Abe, K; Okubo, T; Sekiguchi, Y; Okuyama, S				Chaki, Shigeyuki; Shimazaki, Toshiharu; Karasawa, Jun-ichi; Aoki, Takeshi; Kaku, Ayaka; Iijima, Michihiko; Kambe, Daiji; Yamamoto, Shuji; Kawakita, Yasunori; Shibata, Tsuyoshi; Abe, Kumi; Okubo, Taketoshi; Sekiguchi, Yoshinori; Okuyama, Shigeru			Efficacy of a glycine transporter 1 inhibitor TASP0315003 in animal models of cognitive dysfunction and negative symptoms of schizophrenia	PSYCHOPHARMACOLOGY			English	Article						Glycine transporter 1 inhibitor; Schizophrenia; Negative symptoms; Cognitive dysfunction; TASP0315003	5-HT6 RECEPTOR ANTAGONISTS; OBJECT RECOGNITION TEST; ADD-ON TREATMENT; D-SERINE; SELECTIVE INHIBITOR; SOCIAL RECOGNITION; ACUTE EXACERBATION; N-METHYLGLYCINE; DOUBLE-BLIND; RATS	Since the hypofunction of the N-methyl-D-aspartate (NMDA) receptor is known to be involved in the pathophysiology of schizophrenia, the enhancement of NMDA receptor function through glycine modulatory sites is expected to be a useful approach for the treatment of schizophrenia. We investigated the efficacy of a glycine transporter 1 (GlyT1) inhibitor that potentiates NMDA receptor function by increasing synaptic glycine levels in animal models for cognitive dysfunction and negative symptoms, both of which are poorly managed by current antipsychotics. A newly synthesized GlyT1 inhibitor, 3-chloro-N-{(S)-[3-(1-ethyl-1H-pyrazol-4-yl)phenyl][(2S)-piperidin-2-yl]methyl}-4-(trifluoromethyl)pyridine-2-carboxamide (TASP0315003) significantly improved cognitive deficit induced by MK-801 in the object recognition test in rats. Likewise, TASP0315003 significantly improved MK-801 impaired cognition in the social recognition test in rats and also enhanced social memory in treatment-na < ve rats. In addition, repeated phencyclidine (PCP) treatment reduced the social interaction of paired mice, which may reflect negative symptoms such as social withdrawal, and both acute and sub-chronic treatment with TASP0315003 reversed the reduction in social interaction induced by PCP. Moreover, TASP0315003 additionally exhibited an antidepressant effect in the forced swimming test in rats. In contrast, TASP0315003 did not affect spontaneous locomotor activity or rotarod performance and did not induce catalepsy, indicating that TASP0315003 does not cause sedation or motor dysfunction, which is sometimes observed with the use of current antipsychotics. These results suggest that GlyT1 inhibitors including TASP0315003 may be useful for the treatment of cognitive dysfunction and the negative symptoms of schizophrenia without having undesirable central nervous system side effects.	[Chaki, Shigeyuki; Shimazaki, Toshiharu; Karasawa, Jun-ichi; Aoki, Takeshi; Kaku, Ayaka; Iijima, Michihiko; Kambe, Daiji] Taisho Pharmaceut Co Ltd, Pharmacol Labs, Saitama, Saitama 3319530, Japan; [Yamamoto, Shuji; Shibata, Tsuyoshi; Abe, Kumi; Okubo, Taketoshi; Sekiguchi, Yoshinori] Taisho Pharmaceut Co Ltd, Chem Labs, Saitama, Saitama 3319530, Japan; [Kawakita, Yasunori] Taisho Pharmaceut Co Ltd, Drug Safety & Pharmacokinet Labs, Saitama, Saitama 3319530, Japan; [Okuyama, Shigeru] Taisho Pharmaceut Co Ltd, Res Headquarters, Saitama, Saitama 3319530, Japan	Chaki, S (reprint author), Taisho Pharmaceut Co Ltd, Pharmacol Labs, 1-403 Yoshino Cho, Saitama, Saitama 3319530, Japan.	s-chaki@so.taisho.co.jp					van Kampen M, 2004, PSYCHOPHARMACOLOGY, V172, P375, DOI 10.1007/s00213-003-1668-7; Alberati D, 2012, NEUROPHARMACOLOGY, V62, P1152, DOI 10.1016/j.neuropharm.2011.11.008; Lane HY, 2010, INT J NEUROPSYCHOPH, V13, P451, DOI 10.1017/S1461145709990939; Krystal JH, 2003, PSYCHOPHARMACOLOGY, V169, P215, DOI 10.1007/s00213-003-1582-z; Green MF, 2004, BIOL PSYCHIAT, V56, P301, DOI 10.1016/j.biopsych.2004.06.023; Lane HY, 2005, ARCH GEN PSYCHIAT, V62, P1196, DOI 10.1001/archpsyc.62.11.1196; Bugarski-Kirola D, 2014, EUR NEUROPSYCHOPHARM, V24, P1024, DOI 10.1016/j.euroneuro.2014.03.007; Schoemaker JH, 2014, J CLIN PSYCHOPHARM, V34, P190, DOI 10.1097/JCP.0000000000000073; Lipska BK, 2000, NEUROPSYCHOPHARMACOL, V23, P223, DOI 10.1016/S0893-133X(00)00137-8; Horiguchi M, 2011, J PHARMACOL EXP THER, V338, P605, DOI 10.1124/jpet.111.180638; Rajagopal L, 2014, CURR PHARM DESIGN, V20, P5104; Green MF, 2000, SCHIZOPHRENIA BULL, V26, P119; Watson DJG, 2012, NEUROPSYCHOPHARMACOL, V37, P770, DOI 10.1038/npp.2011.254; Gururajan A, 2010, BEHAV PHARMACOL, V21, P690, DOI 10.1097/FBP.0b013e32833fa7df; Tsai GC, 2004, BIOL PSYCHIAT, V55, P452, DOI 10.1016/j.biopsych.2003.09.012; King MV, 2004, NEUROPHARMACOLOGY, V47, P195, DOI 10.1016/j.neuropharm.2004.03.012; Huang CC, 2013, BIOL PSYCHIAT, V74, P734, DOI 10.1016/j.biopsych.2013.02.020; KRYSTAL JH, 1994, ARCH GEN PSYCHIAT, V51, P199; YOUNG AB, 1973, P NATL ACAD SCI USA, V70, P2832, DOI 10.1073/pnas.70.10.2832; Karasawa JI, 2008, BEHAV BRAIN RES, V186, P78, DOI 10.1016/j.bbr.2007.07.033; Umbricht D, 2014, JAMA PSYCHIAT, V71, P637, DOI 10.1001/jamapsychiatry.2014.163; Krystal JH, 2013, BIOL PSYCHIAT, V73, P1133, DOI 10.1016/j.biopsych.2013.03.026; Coyle JT, 2004, PSYCHOPHARMACOLOGY, V174, P32, DOI 10.1007/s00213-003-1709-2; Boulay D, 2008, PHARMACOL BIOCHEM BE, V91, P47, DOI 10.1016/j.pbb.2008.06.009; Loiseau F, 2008, PSYCHOPHARMACOLOGY, V196, P93, DOI 10.1007/s00213-007-0934-5; Harada K, 2012, EUR J PHARMACOL, V685, P59, DOI 10.1016/j.ejphar.2012.04.013; Depoortere R, 2005, NEUROPSYCHOPHARMACOL, V30, P1963, DOI 10.1038/sj.npp.1300772; Chaki S, 2003, J PHARMACOL EXP THER, V304, P818, DOI 10.1124/jpet.102.044826; Enomoto T, 2007, METHOD FIND EXP CLIN, V29, P291, DOI 10.1358/mf.2007.29.4.1075358; Fox GB, 2005, J PHARMACOL EXP THER, V313, P176, DOI 10.1124/jpet.104.078402; GRIMWOOD S, 1992, MOL PHARMACOL, V41, P923; Hanson E, 2010, CURR PSYCHIAT REP, V12, P563, DOI 10.1007/s11920-010-0148-0; Qiao H, 2001, NEUROREPORT, V12, P11, DOI 10.1097/00001756-200101220-00010; Shimazaki T, 2010, PSYCHOPHARMACOLOGY, V209, P263, DOI 10.1007/s00213-010-1794-y; Singer P, 2007, BEHAV NEUROSCI, V121, P815, DOI 10.1037/0735-7044.121.5.815; Wang DY, 2007, NEUROPHARMACOLOGY, V52, P1179, DOI 10.1016/j.neuropharm.2006.12.007	36	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0033-3158	1432-2072		PSYCHOPHARMACOLOGY	Psychopharmacology	AUG	2015	232	15					2849	2861		10.1007/s00213-015-3920-3		13	Neurosciences; Pharmacology & Pharmacy; Psychiatry	Neurosciences & Neurology; Pharmacology & Pharmacy; Psychiatry	CM9WH	WOS:000358059700018		
J	Hashimoto, K				Hashimoto, Kenji			Role of EphA4 signaling in the pathogenesis of amyotrophic lateral sclerosis and therapeutic potential of traditional Chinese medicine rhynchophylline	PSYCHOPHARMACOLOGY			English	Letter									Chiba Univ, Ctr Forens Mental Hlth, Div Clin Neurosci, Chiba 2608670, Japan	Hashimoto, K (reprint author), Chiba Univ, Ctr Forens Mental Hlth, Div Clin Neurosci, 1-8-1 Inohana, Chiba 2608670, Japan.	hashimoto@faculty.chiba-u.jp					Zhou JY, 2010, J ETHNOPHARMACOL, V132, P15, DOI 10.1016/j.jep.2010.08.041; Fu AKY, 2014, P NATL ACAD SCI USA, V111, P9959, DOI 10.1073/pnas.1405803111; Boyd AW, 2014, NAT REV DRUG DISCOV, V13, P39, DOI 10.1038/nrd4175; Miller R.G., 2012, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD001447.PUB3; Miyaoka T, 2015, PSYCHOPHARMACOLOGY, V232, P155, DOI 10.1007/s00213-014-3645-8; Okamoto H, 2014, NEUROPSYCH DIS TREAT, V10, P1727, DOI 10.2147/NDT.S65257	6	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0033-3158	1432-2072		PSYCHOPHARMACOLOGY	Psychopharmacology	AUG	2015	232	15					2873	2875		10.1007/s00213-015-4013-z		3	Neurosciences; Pharmacology & Pharmacy; Psychiatry	Neurosciences & Neurology; Pharmacology & Pharmacy; Psychiatry	CM9WH	WOS:000358059700020		
J	Nakamoto, M; Uemura, H; Sakai, T; Katsuura-Kamano, S; Yamaguchi, M; Hiyoshi, M; Arisawa, K				Nakamoto, Mariko; Uemura, Hirokazu; Sakai, Tohru; Katsuura-Kamano, Sakurako; Yamaguchi, Miwa; Hiyoshi, Mineyoshi; Arisawa, Kokichi			Inverse association between soya food consumption and insulin resistance in Japanese adults	PUBLIC HEALTH NUTRITION			English	Article						HOMA-IR; Soya product intake; Soya isoflavone; Cross-sectional study	TYPE-2 DIABETES-MELLITUS; SHANGHAI WOMENS HEALTH; POSTMENOPAUSAL WOMEN; FREQUENCY QUESTIONNAIRE; GLUCOSE-METABOLISM; GLYCEMIC CONTROL; CONTROLLED-TRIAL; DOUBLE-BLIND; PROTEIN; ISOFLAVONES	Objective: The purpose of the present study was to examine the association between soya food consumption and insulin resistance using baseline data of the Japan Multi-Institutional Collaborative Cohort (J-MICC) Study in Tokushima, Japan. Design: This cross-sectional study included 1274 subjects, aged 34-70 years at baseline, living in Tokushima Prefecture between 2008 and 2013. Fasting blood samples were collected and information on lifestyle characteristics including soya food intake and medical history were obtained using a structured self-administered questionnaire. The homeostasis model assessment of insulin resistance (HOMA-IR) was measured and those with HOMA-IR >= 2.5 were defined as having insulin resistance. Multiple logistic regression models were used to analyse the association between soya product intake and the prevalence of insulin resistance. Setting: Rural communities located in Tokushima Prefecture, Japan, between 2008 and 2013. Subjects: A total of 1148 adults (565 men and 583 women), aged 34-70 years. Results: The frequency of intake of miso soup, total non-fried soya products and total soya products showed significant inverse dose-response relationships with insulin resistance, after adjustments for potential confounders. When soya product intake was calculated as soya protein and isoflavone, the odds ratios of insulin resistance decreased significantly as the estimated intake of soya protein increased. Furthermore, significant inverse dose-response relationships were observed for total non-fried soya products and total soya products, after adjustment for total vegetable or total fibre consumption. Conclusions: The present results indicate that the intake of soya products and non-fried soya products is associated with reduced insulin resistance in the Japanese population.	[Nakamoto, Mariko; Uemura, Hirokazu; Katsuura-Kamano, Sakurako; Yamaguchi, Miwa; Hiyoshi, Mineyoshi; Arisawa, Kokichi] Univ Tokushima, Grad Sch, Dept Prevent Med, Inst Hlth Biosci, Tokushima 7708503, Japan; [Nakamoto, Mariko; Sakai, Tohru] Univ Tokushima, Grad Sch, Dept Publ Hlth & Appl Nutr, Inst Hlth Biosci, Tokushima 7708503, Japan; [Nakamoto, Mariko] Japan Soc Promot Sci, Tokyo, Japan	Arisawa, K (reprint author), Univ Tokushima, Grad Sch, Dept Prevent Med, Inst Hlth Biosci, 3-18-15 Kuramoto Cho, Tokushima 7708503, Japan.	karisawa@basic.med.tokushima-u.ac.jp			Japanese Ministry of Education, Culture, Sports, Science and Technology [17015018, 221S0001]	Financial support: This study was supported in part by Grants-in-Aid for Scientific Research on Priority Areas of Cancer (number 17015018) and on Innovative Areas (number 221S0001) from the Japanese Ministry of Education, Culture, Sports, Science and Technology. The Japanese Ministry of Education, Culture, Sports, Science and Technology had no role in the design, analysis or writing of this article.	Liu DM, 2006, DIABETES, V55, P1043, DOI 10.2337/diabetes.55.04.06.db05-1089; Sites CK, 2007, FERTIL STERIL, V88, P1609, DOI 10.1016/j.fertnstert.2007.01.061; Li Z, 2005, EUR J CLIN NUTR, V59, P411, DOI 10.1038/sj.ejcn.1602089; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Tokudome Y, 2005, J EPIDEMIOL, V15, P135, DOI 10.2188/jea.15.135; Hishida A, 2012, ENDOCR J, V59, P589, DOI 10.1507/endocrj.EJ11-0310; Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI20042162S, 10.1172/JCI200421625]; Lampe JW, 1998, P SOC EXP BIOL MED, V217, P335; Nikander E, 2004, J CLIN ENDOCR METAB, V89, P3567, DOI 10.1210/jc.2003-032229; Neville SE, 2009, DIABETES-METAB RES, V25, P705, DOI 10.1002/dmrr.1012; Ascencio C, 2004, J NUTR, V134, P522; Lu MP, 2008, NUTR RES, V28, P464, DOI 10.1016/j.nutres.2008.03.009; Liu ZM, 2011, AM J CLIN NUTR, V93, P1092, DOI 10.3945/ajcn.110.007187; Nanri A, 2010, J NUTR, V140, P580, DOI 10.3945/jn.109.116020; Azadbakht L, 2007, AM J CLIN NUTR, V85, P735; Morimoto Y, 2011, EUR J CLIN NUTR, V65, P279, DOI 10.1038/ejcn.2010.228; Bhathena SJ, 2002, AM J CLIN NUTR, V76, P1191; Pinhas-Hamiel O, 2005, J PEDIATR-US, V146, P693, DOI 10.1016/j.jpeds.2004.12.042; Gobert CP, 2010, BRIT J NUTR, V103, P412, DOI 10.1017/S0007114509991802; Wu J, 2007, MENOPAUSE, V14, P866, DOI 10.1097/gme.0b013e3180305299; Naaz A, 2003, ENDOCRINOLOGY, V144, P3315, DOI 10.1210/en.2003-0076; Ricci E, 2010, MENOPAUSE, V17, P1080, DOI 10.1097/gme.0b013e3181dd05a9; Orgaard A, 2008, EXP BIOL MED, V233, P1066, DOI 10.3181/0712-MR-347; Hamajima N, 2007, ASIAN PAC J CANCER P, V8, P317; Vedavanam K, 1999, PHYTOTHER RES, V13, P601, DOI 10.1002/(SICI)1099-1573(199911)13:7<601::AID-PTR550>3.3.CO;2-F; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Villegas R, 2008, AM J CLIN NUTR, V87, P162; Imaeda N, 2007, J EPIDEMIOL, V17, P100, DOI 10.2188/jea.17.100; Mueller NT, 2012, EUR J NUTR, V51, P1033, DOI 10.1007/s00394-011-0276-2; Arai Y, 2000, J Epidemiol, V10, P127; Goto C., 2006, Scandinavian Journal of Food & Nutrition, V50, P77, DOI 10.1080/11026480600568720; Hall WL, 2006, AM J CLIN NUTR, V83, P592; HAMOSH M, 1975, J CLIN INVEST, V55, P1132, DOI 10.1172/JCI108015; Jayagopal V, 2002, DIABETES CARE, V25, P1709, DOI 10.2337/diacare.25.10.1709; Liu ZM, 2010, AM J CLIN NUTR, V91, P1394, DOI 10.3945/ajcn.2009.28813; Molavi Behzad, 2007, Vasc Health Risk Manag, V3, P967; Ren MQ, 2001, EUR J NUTR, V40, P135, DOI 10.1007/PL00007388; SAS Institute, 1997, SAS STAT SOFTW CHANG; Tokudome Shinkan, 2004, Asian Pac J Cancer Prev, V5, P40; Yang G, 2004, EUR J CLIN NUTR, V58, P615, DOI 10.1038/sj.ejcn.1601855	40	0	0	CAMBRIDGE UNIV PRESS	CAMBRIDGE	EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND	1368-9800	1475-2727		PUBLIC HEALTH NUTR	Public Health Nutr.	AUG	2015	18	11					2031	2040		10.1017/S136898001400247X		10	Public, Environmental & Occupational Health; Nutrition & Dietetics	Public, Environmental & Occupational Health; Nutrition & Dietetics	CM4RY	WOS:000357673600014		
J	SaiToh, A				SaiToh, Akira			Quantum digital-to-analog conversion algorithm using decoherence	QUANTUM INFORMATION PROCESSING			English	Article						Digital-to-analog conversion; Quantum algorithm; Bulk-ensemble computation	SPIN LIOUVILLE SPACE; SELECTIVE EXCITATION; RESOLUTION NMR; ENTANGLEMENT; COMPUTER; CIRCUITS; ENSEMBLE; QUBITS; LOGIC; STATE	We consider the problem of mapping digital data encoded on a quantum register to analog amplitudes in parallel. It is shown to be unlikely that a fully unitary polynomial-time quantum algorithm exists for this problem; NP becomes a subset of BQP if it exists. In the practical point of view, we propose a nonunitary linear-time algorithm using quantum decoherence. It tacitly uses an exponentially large physical resource, which is typically a huge number of identical molecules. Quantumness of correlation appearing in the process of the algorithm is also discussed.	Toyohashi Univ Technol, Dept Comp Sci & Engn, Toyohashi, Aichi 4418580, Japan	SaiToh, A (reprint author), Toyohashi Univ Technol, Dept Comp Sci & Engn, 1-1 Hibarigaoka, Toyohashi, Aichi 4418580, Japan.	saitoh@sqcs.org			JSPS [25871052]	This work was supported by the Grant-in-Aid for Scientific Research from JSPS (Grant No. 25871052).	Aiello A, 2007, PHYS REV A, V76, DOI 10.1103/PhysRevA.76.032323; Ali M, 2010, PHYS REV A, V81, DOI 10.1103/PhysRevA.81.042105; MORRIS GA, 1978, J MAGN RESON, V29, P433, DOI 10.1016/0022-2364(78)90003-3; Shende VV, 2006, IEEE T COMPUT AID D, V25, P1000, DOI 10.1109/TCAD.2005.855930; Long GL, 2003, J CHEM PHYS, V119, P8473, DOI 10.1063/1.1611177; Lanyon BP, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.200501; Boykin PO, 2002, P NATL ACAD SCI USA, V99, P3388, DOI 10.1073/pnas.241641898; Henderson L, 2001, J PHYS A-MATH GEN, V34, P6899, DOI 10.1088/0305-4470/34/35/315; Xiao L, 2006, PHYS LETT A, V359, P424, DOI 10.1016/j.physleta.2006.06.086; Hamieh S, 2004, PHYS REV A, V70, DOI 10.1103/PhysRevA.70.052325; Plenio MB, 2007, QUANTUM INF COMPUT, V7, P1; Ventura D, 1999, FOUND PHYS LETT, V12, P547, DOI 10.1023/A:1021695125245; Almeida MP, 2007, SCIENCE, V316, P579, DOI 10.1126/science.1139892; Vartiainen JJ, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.177902; Jones JA, 2011, PROG NUCL MAG RES SP, V59, P91, DOI 10.1016/j.pnmrs.2010.11.001; Ramelow S, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.253601; FREEMAN R, 1991, CHEM REV, V91, P1397, DOI 10.1021/cr00007a006; Foroozandeh M, 2014, ANGEW CHEM INT EDIT, V53, P6990, DOI 10.1002/anie.201404111; Horodecki R, 2009, REV MOD PHYS, V81, P865, DOI 10.1103/RevModPhys.81.865; Arora S, 2009, COMPUTATIONAL COMPLEXITY: A MODERN APPROACH, P1, DOI 10.1017/CBO9780511804090; Bardhan B. R., 2013, PHYS REV A, V88; Becker E. D., 1980, HIGH RESOLUTION NMR, V2nd; Bengtsson I, 2006, GEOMETRY QUANTUM STA; Berglund A. J., 2000, ARXIVQUANTPH0010001; Brodutch A., 2011, J PHYS C SER, V306; Bruschweiler R, 2000, PHYS REV LETT, V85, P4815, DOI 10.1103/PhysRevLett.85.4815; Gruska J., 1999, QUANTUM COMPUTING; Holevo A., 2012, REP PROG PHYS, V75; Jeong YC, 2013, PHYS REV A, V87, DOI 10.1103/PhysRevA.87.014301; Khitrin AK, 2011, QUANTUM INF PROCESS, V10, P557, DOI 10.1007/s11128-010-0219-5; Kitagawa M., 2003, P 6 INT C QUANT COMM, P275; Klenke A., 2008, PROBABILITY THEORY C; Kondo Y., 2007, J PHYS SOC JPN, V76; Li C. K., 2013, INT J QUANTUM INF, V11; Luo SL, 2008, PHYS REV A, V77, DOI 10.1103/PhysRevA.77.042303; Mehring M., 2001, OBJECT ORIENTED MAGN; Microchip Technology Inc, 2007, COMPUTATIONAL COMPLE; Microchip Technology Inc, 2010, COMPUTATIONAL COMPLE; Milburn G. J., 2012, COMPUT COMPLEX, P2437; Nakajima Y, 2006, QUANTUM INFORM COMPU, V6, P67; Nielsen M, 2000, QUANTUM COMPUTATION; Ollivier H, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.017901; Ortigosa-Blanch A, 2006, PHYS REV A, V73, DOI 10.1103/PhysRevA.73.024305; Peters N, 2003, QUANTUM INFORM COMPU, V3, P503; Radulov G, 2011, ANALOG CIRC SIG PROC, P3, DOI 10.1007/978-94-007-0347-6; SaiToh A, 2005, PHYS REV A, V71, DOI 10.1103/PhysRevA.71.022303; Saitoh A, 2012, QUANTUM INF COMPUT, V12, P944; SaiToh A, 2006, PHYS REV A, V73, DOI 10.1103/PhysRevA.73.062332; Schmuser F, 2005, PHYS REV A, V72, DOI 10.1103/PhysRevA.72.042324; Schulman L. J., 1999, Proceedings of the Thirty-First Annual ACM Symposium on Theory of Computing, DOI 10.1145/301250.301332; Shiryaev A. L., 1996, PROBABILITY; Tarasov VE, 2002, J PHYS A-MATH GEN, V35, P5207, DOI 10.1088/0305-4470/35/25/305; Tucci R. R., 1999, ARXIVQUANTPH9902062; Usmani I, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1010; Watrous J., 2009, ENCY COMPLEXITY SYST, P1; Xiao L, 2002, PHYS REV A, V66, DOI 10.1103/PhysRevA.66.052320; Zhang T, 2008, OPT COMMUN, V281, P4800, DOI 10.1016/j.optcom.2008.06.009	57	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1570-0755	1573-1332		QUANTUM INF PROCESS	Quantum Inf. Process.	AUG	2015	14	8					2729	2748		10.1007/s11128-015-1033-x		20	Physics, Multidisciplinary; Physics, Mathematical	Physics	CM9ZB	WOS:000358068600002		
J	Choi, BS				Choi, Byung-Soo			Dual-code quantum computation model	QUANTUM INFORMATION PROCESSING			English	Article						Fault-tolerant quantum computation; Steane code; Bacon-Shor code; Reed-Muller code; Code conversion; Teleportation	ERROR-CORRECTION; THRESHOLD; UNIVERSALITY; COMPUTERS	In this work, we propose the dual-code quantum computation model-a fault-tolerant quantum computation scheme which alternates between two different quantum error-correction codes. Since the chosen two codes have different sets of transversal gates, we can implement a universal set of gates transversally, thereby reducing the overall cost. We use code teleportation to convert between quantum states in different codes. The overall cost is decreased if code teleportation requires fewer resources than the fault-tolerant implementation of the non-transversal gate in a specific code. To analyze the cost reduction, we investigate two cases with different base codes, namely the Steane and Bacon-Shor codes. For the Steane code, neither the proposed dual-code model nor another variation of it achieves any cost reduction since the conventional approach is simple. For the Bacon-Shor code, the three proposed variations of the dual-code model reduce the overall cost. However, as the encoding level increases, the cost reduction decreases and becomes negative. Therefore, the proposed dual-code model is advantageous only when the encoding level is low and the cost of the non-transversal gate is relatively high.	Univ Tokyo, Dept Appl Phys, Tokyo 113, Japan	Choi, BS (reprint author), Univ Tokyo, Dept Appl Phys, 7-3-1 Hongo, Tokyo 113, Japan.	bschoi3@gmail.com					Aliferis P., QUANT INF COMPUT, V6, P97; Buchbinder SD, 2013, QUANTUM INF PROCESS, V12, P699, DOI 10.1007/s11128-012-0414-7; Bravyi S, 2012, PHYS REV A, V86, DOI 10.1103/PhysRevA.86.052329; Steane A, 1996, P ROY SOC A-MATH PHY, V452, P2551, DOI 10.1098/rspa.1996.0136; Dennis E, 2002, J MATH PHYS, V43, P4452, DOI 10.1063/1.1499754; Bombin H, 2009, J PHYS A-MATH THEOR, V42, DOI 10.1088/1751-8113/42/9/095302; Anderson JT, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.080501; Steane AM, 2003, PHYS REV A, V68, DOI 10.1103/PhysRevA.68.042322; Wang DS, 2011, PHYS REV A, V83, DOI 10.1103/PhysRevA.83.020302; Fowler AG, 2009, PHYS REV A, V80, DOI 10.1103/PhysRevA.80.052312; Knill E, 1998, P ROY SOC A-MATH PHY, V454, P365; Calderbank AR, 1996, PHYS REV A, V54, P1098, DOI 10.1103/PhysRevA.54.1098; Paetznick A, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.090505; Aharonov D, 2008, SIAM J COMPUT, V38, P1207, DOI 10.1137/S0097539799359385; Choi BS, 2013, 2013 INTERNATIONAL CONFERENCE ON ICT CONVERGENCE (ICTC 2013): FUTURE CREATIVE CONVERGENCE TECHNOLOGIES FOR NEW ICT ECOSYSTEMS, P1083; Cleve R, 1997, PHYS REV A, V56, P76, DOI 10.1103/PhysRevA.56.76; Unger F, 2008, IEEE T INFORM THEORY, V54, P3693, DOI 10.1109/TIT.2008.926459; Eastin B, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.110502; Gottesman D, 1998, PHYS REV A, V57, P127, DOI 10.1103/PhysRevA.57.127; Gottesman D, 1999, NATURE, V402, P390; Bacon D, 2006, PHYS REV A, V73, DOI 10.1103/PhysRevA.73.012340; Bravyi S, 2005, PHYS REV A, V71, DOI 10.1103/PhysRevA.71.022316; Jochym-O'Connor T, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.010505; Bombin H., 2013, ARXIV E PRINTS; Bombin H, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/4/043005; Brun T., 2013, APS M MARCH, P27007; Campbell ET, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.030503; Dumer I., 2014, ARXIV E PRINTS; Fowler AG, 2013, SCI REP-UK, V3, DOI 10.1038/srep01939; Gottesman D., 2013, ARXIV E PRINTS; Gottesman D., 1998, ARXIVQUANTPH9807006; Jochym-O'Connor T., 2012, ARXIV E PRINTS; Jones C., 2012, ARXIV E PRINTS; Jones C, 2013, PHYS REV A, V87, DOI 10.1103/PhysRevA.87.022328; Julia K., 2008, P 35 INT C AUT LAN 1, P845; Knill E, 1996, ARXIVQUANTPH9610011; Knill E., 2004, ARXIVQUANTPH0404104; Knill E., 2004, ARXIVQUANTPH0402171; Knill E., 1996, ARXIVQUANTPH9608012; Metodi T. S., 2011, SYNTHESIS LECT COMPU; Nielsen M, 2000, QUANTUM COMPUTATION; Oskin M, 2002, COMPUTER, V35, P79, DOI 10.1109/2.976922; Preskill J, 1998, P ROY SOC A-MATH PHY, V454, P385, DOI 10.1098/rspa.1998.0167; Reichardt B. W., 2011, QUANTUM INF COMPUT, V9, P1030; Shor PW, 1996, AN S FDN CO, P56, DOI 10.1109/SFCS.1996.548464; Steane A., 1996, ARXIVQUANTPH9608026; Stephens A. M., 2014, ARXIV E PRINTS; Thaker D. D., 2006, ISCA 06, P378; Van den Nest M, 2010, QUANTUM INF COMPUT, V10, P258; Wang DS, 2010, QUANTUM INF COMPUT, V10, P780; Weinstein YS, 2011, PHYS REV A, V84, DOI 10.1103/PhysRevA.84.012323; Zeng B, 2011, IEEE T INFORM THEORY, V57, P6272, DOI 10.1109/TIT.2011.2161917	52	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1570-0755	1573-1332		QUANTUM INF PROCESS	Quantum Inf. Process.	AUG	2015	14	8					2775	2818		10.1007/s11128-015-1022-0		44	Physics, Multidisciplinary; Physics, Mathematical	Physics	CM9ZB	WOS:000358068600005		
J	Inoue, Y; Takine, T				Inoue, Yoshiaki; Takine, Tetsuya			Analysis of the loss probability in the M/G/1+G queue	QUEUEING SYSTEMS			English	Article						M/G/1 queue; General impatient customers; Loss probability; Virtual waiting time	SINGLE-SERVER QUEUES; VIRTUAL WAITING TIME; BUSY PERIOD ANALYSIS; IMPATIENT CUSTOMERS; RESTRICTED ACCESSIBILITY; WORKLOAD	We consider the loss probability in the stationary M/G/1+G queue, i.e., the stationary M/G/1 queue with impatient customers whose impatience times are generally distributed. It is known that the loss probability is given in terms of the probability density function v(x) of the virtual waiting time and that v(x) is given by a formal series solution of a Volterra integral equation. In this paper, we show that the series solution of v(x) can be interpreted as the probability density function of a random sum of dependent random variables and we reveal its dependency structure through the analysis of a last-come first-served, preemptive-resume M/G/1 queue with workload-dependent loss. Furthermore, based on this observation, we show some properties of the loss probability.	[Inoue, Yoshiaki; Takine, Tetsuya] Osaka Univ, Grad Sch Engn, Dept Informat & Commun Technol, Suita, Osaka 5650871, Japan; [Inoue, Yoshiaki] Japan Soc Promot Sci, Tokyo, Japan	Inoue, Y (reprint author), Osaka Univ, Grad Sch Engn, Dept Informat & Commun Technol, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	y-inoue@post.comm.eng.osaka-u.ac.jp; takine@comm.eng.osaka-u.ac.jp			Japan Society for the Promotion of Science [25330027, 26-670]	This research was supported in part by Grant-in-Aid for Japan Society for the Promotion of Science Fellows Grant No. 26-670 and Grant-in-Aid for Scientific Research (C) of Japan Society for the Promotion of Science under Grant No. 25330027.	Ancker C. J., 1962, J IND ENG, V13, P84; BACCELLI F, 1984, ADV APPL PROBAB, V16, P887, DOI 10.2307/1427345; BARRER DY, 1957, OPER RES, V5, P650, DOI 10.1287/opre.5.5.650; Baccelli F., 1981, Performance '81. Proceedings of the 8th International Symposium on Computer Performance Modelling, Measurement and Evaluation; Bae J, 2013, J KOREAN STAT SOC, V42, P375, DOI 10.1016/j.jkss.2013.01.001; Bae J, 2001, QUEUEING SYST, V38, P485, DOI 10.1023/A:1010956213680; Bartoszewicz J, 2006, STAT PROBABIL LETT, V76, P587, DOI 10.1016/j.spl.2005.09.003; Boxma O, 2011, QUEUEING SYST, V67, P207, DOI 10.1007/s11134-010-9205-y; Boxma O, 2010, J APPL PROBAB, V47, P130; Brandt A, 2013, QUEUEING SYST, V75, P189, DOI 10.1007/s11134-013-9373-7; Brandt A, 1999, PERFORM EVALUATION, V35, P1, DOI 10.1016/S0166-5316(98)00042-X; BRILL PH, 1977, OPER RES, V25, P662, DOI 10.1287/opre.25.4.662; COHEN JW, 1977, J APPL PROBAB, V14, P405, DOI 10.2307/3213014; COHEN JW, 1969, J ENG MATH, V3, P265, DOI 10.1007/BF01535299; Daley D.J., 1965, J APPL PROBAB, V2, P186, DOI 10.2307/3211884; HEYMAN DP, 1980, OPER RES, V28, P983, DOI 10.1287/opre.28.4.983; Inoue Y., COMPUTATIONAL UNPUB; Kelly F. P., 1979, REVERSIBILITY STOCHA; Kim J., 2013, COMMUN KOREAN MATH S, V28, P383; Kim S, 2001, QUEUEING SYST, V39, P201, DOI 10.1023/A:1012700718302; Liu LQ, 2008, QUEUEING SYST, V59, P37, DOI 10.1007/s11134-008-9074-9; PERRY D, 1995, QUEUEING SYST, V19, P105, DOI 10.1007/BF01148942; Perry D, 2000, OPER RES LETT, V27, P163, DOI 10.1016/S0167-6377(00)00043-2; Rao S.S., 1967, METRIKA, V12, P173; Shaked M, 2007, SPRINGER SER STAT, P3; Stanford R. E., 1979, Mathematics of Operations Research, V4, DOI 10.1287/moor.4.2.162; VANDOORN EA, 1988, OPER RES LETT, V7, P229, DOI 10.1016/0167-6377(88)90036-3	27	1	1	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0257-0130	1572-9443		QUEUEING SYST	Queueing Syst.	AUG	2015	80	4					363	386		10.1007/s11134-015-9449-7		24	Computer Science, Interdisciplinary Applications; Operations Research & Management Science	Computer Science; Operations Research & Management Science	CM5KP	WOS:000357727000003		
J	Osogami, T; Raymond, R				Osogami, Takayuki; Raymond, Rudy			Analysis of transient queues with semidefinite optimization (vol 73, pg 195, 2013)	QUEUEING SYSTEMS			English	Correction									[Osogami, Takayuki; Raymond, Rudy] IBM Corp, Yamato, Kanagawa 2428502, Japan	Osogami, T (reprint author), IBM Corp, 1623-14 Shimotsuruma, Yamato, Kanagawa 2428502, Japan.	osogami@jp.ibm.com; raymond@jp.ibm.com					Osogami T, 2013, QUEUEING SYST, V73, P195, DOI 10.1007/s11134-012-9309-7	1	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0257-0130	1572-9443		QUEUEING SYST	Queueing Syst.	AUG	2015	80	4					387	388		10.1007/s11134-015-9452-z		2	Computer Science, Interdisciplinary Applications; Operations Research & Management Science	Computer Science; Operations Research & Management Science	CM5KP	WOS:000357727000004		
J	Sakai, Y				Sakai, Yuichi			On modular solutions of fractional weights for the Kaneko-Zagier equation for Gamma(0)*(2) and Gamma(0)*(3)	RAMANUJAN JOURNAL			English	Article						Modular form; Differential equations; The Heun series; Supersingular j(N)-polynomial	DIFFERENTIAL-EQUATION; HYPERGEOMETRIC TYPE; FORMS	For the full modular group, Kaneko gave a modular form solution of fractional weights for a holomorphic modular differential equation of second order. In this paper, we give modular form solutions of fractional weights for a modular differential equation on the Fricke group of levels 2 and 3.	Kyushu Univ, Fac Math, Nishi Ku, Fukuoka 8190395, Japan	Sakai, Y (reprint author), Kyushu Univ, Fac Math, Nishi Ku, 744 Motooka, Fukuoka 8190395, Japan.	dynamixaxs@gmail.com					Conway J. H., 1979, B LOND MATH SOC, V11, P308, DOI DOI 10.1112/BLMS/11.3.308; Ihara Y., 1974, J FS U TOKYO IA, V21, P97; Kaneko M, 2006, DEV MATH, V15, P97; Kaneko M, 2003, RAMANUJAN J, V7, P145, DOI 10.1023/A:1026291027692; Kaneko M, 2004, DEV MATH, V11, P329; Kaneko M., 1998, AMS IP STUDIES ADV M, V7, P97; Kohler G, 2011, SPRINGER MONOGR MATH, pXIII, DOI 10.1007/978-3-642-16152-0; KOIKE M, 1973, J FAC SCI U TOKYO 1, V20, P129; Koike M., 2009, PREPRINT; Ronveaux A., 1995, HEUNS DIFFERENTIAL E; Sakai Y, 2011, INT J NUMBER THEORY, V7, P1637, DOI 10.1142/S1793042111004460	11	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1382-4090	1572-9303		RAMANUJAN J	Ramanujan J.	AUG	2015	37	3					461	467		10.1007/s11139-014-9563-x		7	Mathematics	Mathematics	CM9ZH	WOS:000358069400001		
J	Taira, K; Nakao, K; Suzuki, K				Taira, Kenji; Nakao, Kenji; Suzuki, Kimihito			CO2 capture in humid gas using ZnO/activated carbon and ZnO reactivity with CO2	REACTION KINETICS MECHANISMS AND CATALYSIS			English	Article						Carbon dioxide; Zinc carbonate hydroxide; Basic zinc carbonate; Activated carbon; Humid gas	TEMPERATURE H2S REMOVAL; ZINC-OXIDE; THERMAL-DECOMPOSITION; ACTIVATED CARBON; ROOM-TEMPERATURE; FINE PARTICLES; ROCK-SALT; X-RAYS; ADSORPTION; DIOXIDE	Carbon dioxide capture with ZnO/activated carbon adsorbates and reactivity of ZnO particle with CO2 are discussed for the effective CO2 capture in humid exhaust gas. Coarse ZnO particles (d = 670 nm), and small diameters, d < 20 nm, of zinc oxide particles on activated carbon supports were prepared. The amounts of CO2 adsorbed on ZnO particles and activated carbon supports were measured and calculated. The calculated value and thermal gravimetric analysis results indicate that only the surface layer (< 0.5 nm) of ZnO particles reacts with CO2 and H2O for all sizes of ZnO particles. These results lead to the conclusion that ZnO reactivity with CO2 is still independent of the particle size even in the small diameters in this study. The results quantitatively present the gas-phase carbonation rate of ZnO and its independency on the particle diameter for the first time. This research sheds light on the difficulty in using ZnO as CO2 adsorbent. Some possible solutions for the difficulty are also discussed in view of enhancing of its reactivity.	[Taira, Kenji; Nakao, Kenji; Suzuki, Kimihito] Nippon Steel & Sumitomo Met Corp, Adv Technol Res Labs, Futtsu, Chiba 2938511, Japan	Taira, K (reprint author), Nippon Steel & Sumitomo Met Corp, Adv Technol Res Labs, 20-1 Shintomi, Futtsu, Chiba 2938511, Japan.	taira.e84.kenji@jp.nssmc.com					PIRES J, 1993, J MOL CATAL, V85, P295, DOI 10.1016/0304-5102(93)80057-2; Millward AR, 2005, J AM CHEM SOC, V127, P17998, DOI 10.1021/ja0570032; BISHOP DM, 1993, J CHEM PHYS, V98, P8024, DOI 10.1063/1.464556; Goj A, 2002, J PHYS CHEM B, V106, P8367, DOI 10.1021/jp025895b; Zhang J, 2008, MICROPOR MESOPOR MAT, V111, P478, DOI 10.1016/j.micromeso.2007.08.022; Valenzano L, 2010, J PHYS CHEM C, V114, P11185, DOI 10.1021/jp102574f; Jaramillo E, 2004, J PHYS CHEM B, V108, P20155, DOI 10.1021/jp048078f; Grasa GS, 2006, IND ENG CHEM RES, V45, P8846, DOI 10.1021/ie0606946; Yin CY, 2007, SEP PURIF TECHNOL, V52, P403, DOI 10.1016/j.seppur.2006.06.009; Luna-delRisco M, 2011, J HAZARD MATER, V189, P603, DOI 10.1016/j.jhazmat.2011.02.085; [Anonymous], 2008, BUILD LOW CARB EC UK; Yang ST, 2010, MICROPOR MESOPOR MAT, V135, P90, DOI 10.1016/j.micromeso.2010.06.015; Chernavskii PA, 2007, RUSS J PHYS CHEM B+, V1, P394, DOI 10.1134/S1990793107040082; Pulido A, 2009, J PHYS CHEM C, V113, P2928, DOI 10.1021/jp810038b; Delgado JA, 2006, SEP PURIF TECHNOL, V48, P223, DOI 10.1016/j.seppur.2005.07.027; Li G, 2008, ADSORPTION, V14, P415, DOI 10.1007/s10450-007-9100-y; Lee SC, 2006, CATAL TODAY, V111, P385, DOI 10.1016/j.cattod.2005.10.051; van Setten BAAL, 2001, CATAL REV, V43, P489, DOI 10.1081/CR-120001810; YANAGISAWA Y, 1995, J PHYS CHEM-US, V99, P3704, DOI 10.1021/j100011a043; Olsson COA, 2003, ELECTROCHIM ACTA, V48, P1093, DOI 10.1016/S0013-4686(02)00841-1; Kizzie AC, 2011, LANGMUIR, V27, P6368, DOI 10.1021/la200547k; KWAK BS, 1992, PHYS REV LETT, V68, P3733, DOI 10.1103/PhysRevLett.68.3733; SING KSW, 1985, PURE APPL CHEM, V57, P603, DOI 10.1351/pac198557040603; [Anonymous], 2013, REDRAWING ENERGY CLI; Coloma F, 1996, APPL CATAL A-GEN, V148, P63, DOI 10.1016/S0926-860X(96)00218-9; Sobana N, 2007, SOL ENERG MAT SOL C, V91, P727, DOI 10.1016/j.solmat.2006.12.013; Talesh SSA, 2010, IRAN J CHEM CHEM ENG, V29, P37; AUMANN CE, 1995, J VAC SCI TECHNOL B, V13, P1178, DOI 10.1116/1.588232; Baniecki JD, 2009, J APPL PHYS, V106, DOI 10.1063/1.3169654; Bearat H, 2002, J AM CERAM SOC, V85, P742; Bi HJ, 2002, J APPL PHYS, V92, P7491, DOI 10.1063/1.1518147; Bonenfant D, 2008, SCI TECHNOL ADV MAT, V9, DOI 10.1088/1468-6996/9/1/013007; Bragg WL, 1921, PHILOS MAG, V42, P1; Bragg WL, 1921, PHILOS MAG, V41, P309; Breck DW, 1973, MOL SIEVES; Carnes CL, 2000, LANGMUIR, V16, P3764, DOI 10.1021/la991498p; Castellano M, 1989, CHEM MATER, V1, P78, DOI 10.1021/cm00001a018; Charnock JM, 1996, MINERAL MAG, V60, P887, DOI 10.1180/minmag.1996.060.403.04; Choudhary VR, 1996, LANGMUIR, V12, P980, DOI 10.1021/la950333n; CRIADO JM, 1982, J THERM ANAL, V24, P59, DOI 10.1007/BF01914800; Didenko OZ, 2011, J MOL CATAL A-CHEM, V335, P14, DOI 10.1016/j.molcata.2010.12.005; GOLDEN TC, 1994, J COLLOID INTERF SCI, V162, P182, DOI 10.1006/jcis.1994.1023; Hernandez-Maldonado AJ, 2003, LANGMUIR, V19, P2193, DOI 10.1021/la026424j; Hu SW, 2001, J COLLOID INTERF SCI, V243, P306; Jambor JL, 1964, CAN MINERAL, V8, P92; Kanari N, 2004, THERMOCHIM ACTA, V410, P93, DOI 10.1016/S0040-6031(03)00396-4; Katoh M, 2000, J COLLOID INTERF SCI, V226, P145, DOI 10.1006/jcis.2000.6795; Khassin AA, 2006, CATAL TODAY, V112, P143, DOI 10.1016/j.cattod.2005.11.047; KHVOSHCHEV SS, 1990, THERMOCHIM ACTA, V164, P315, DOI 10.1016/0040-6031(90)80447-7; Koga N, 2005, J THERM ANAL CALORIM, V82, P725, DOI 10.1007/s10973-005-0956-3; Kubota Y, 2007, J VAC SOC JPN, V49, P205; Kyaw K, 1996, J CHEM ENG JPN, V29, P119, DOI 10.1252/jcej.29.119; Lee SC, 2004, STUD SURF SCI CATAL, V153, P527; LEW S, 1989, IND ENG CHEM RES, V28, P535, DOI 10.1021/ie00089a006; Liu QL, 2011, CHEMSUSCHEM, V4, P91, DOI 10.1002/cssc.201000256; Millar GJ, 1998, J CHEM SOC FARADAY T, V94, P593, DOI 10.1039/a703954i; Music A, 1997, APPL CATAL A-GEN, V165, P115, DOI 10.1016/S0926-860X(97)00195-6; OHKUMA N, 1987, NIPPON KAGAKU KAISHI, P802; Ohkuma N, 1988, HYOMEN KAGAKU, V9, P42; Ohkuma N, 1988, HYOMEN KAGAKU, V9, P452; Melian EP, 2009, APPL CATAL A-GEN, V364, P174, DOI 10.1016/j.apcata.2009.05.042; Saito Y, 2005, J FUEL CELL TECHNOLO, V5, P68; Sawada Y, 1996, THERMOCHIM ACTA, V273, P95, DOI 10.1016/0040-6031(95)02631-2; Shirouzu K, 2010, JPN J APPL PHYS, V49, DOI 10.1143/JJAP.49.010201; Skrzypski J, 2011, IND ENG CHEM RES, V50, P5714, DOI 10.1021/ie200240e; SolerIllia GJDA, 1997, CHEM MATER, V9, P184, DOI 10.1021/cm9602813; Wu CM, 2011, J PHYS CHEM C, V115, P10164, DOI 10.1021/jp201986j; Wu WW, 2006, MATER LETT, V60, P2791, DOI 10.1016/j.matlet.2006.01.090; Zhao CW, 2010, IND ENG CHEM RES, V49, P12212, DOI 10.1021/ie1018035; Zheng JS, 2007, ELECTROCHEM COMMUN, V9, P895, DOI 10.1016/j.elecom.2006.12.006	70	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1878-5190	1878-5204		REACT KINET MECH CAT	React. Kinet. Mech. Catal.	AUG	2015	115	2					563	579		10.1007/s11144-015-0855-y		17	Chemistry, Physical	Chemistry	CN1HT	WOS:000358170200011		
J	Gopiraman, M; Babu, SG; Khatri, Z; Kim, BS; Wei, K; Karvembu, R; Kim, IS				Gopiraman, Mayakrishnan; Babu, Sundaram Ganesh; Khatri, Zeeshan; Kim, Byoung-Suhk; Wei, Kai; Karvembu, Ramasamy; Kim, Ick Soo			Photodegradation of dyes by a novel TiO2/u-RuO2/GNS nanocatalyst derived from Ru/GNS after its use as a catalyst in the aerial oxidation of primary alcohols (GNS = graphene nanosheets)	REACTION KINETICS MECHANISMS AND CATALYSIS			English	Article						Graphene nanosheets; Ruthenium oxide nanoparticles; Aerial oxidation; Recycling; Titania; Photocatalytic degradation	PHOTOCATALYTIC DEGRADATION; ACRIDINE-ORANGE; TRANSFER HYDROGENATION; AQUEOUS SUSPENSIONS; TITANIUM-DIOXIDE; IRRADIATION; EFFICIENT; NANOCOMPOSITES; NANOPLATELETS; NANOPARTICLES	Ruthenium nanoparticles (RuNPs) supported on graphene nanosheets (GNS), a composite (Ru/GNS), were prepared by a dry synthesis method and were used as nanocatalysts for the aerial oxidation of various primary alcohols. Ru/GNS was highly efficient, selective, stable and heterogeneous in nature. Owing to the high stability of the used catalyst (u-Ru/GNS), it was further applied in a different catalytic system viz photocatalytic degradation, after suitable modifications. We have obtained a novel TiO2/u-RuO2/GNS catalyst from u-Ru/GNS by the sol-gel method. The catalytic activity of TiO2/u-RuO2/GNS toward the photodegradation of methyl orange (MO) and acridine orange (AO) was found to be excellent. Overall, the sustainable use of these recyclable materials (Ru/GNS and TiO2/u-RuO2/GNS) could lead to economic and environmental benefits.	[Gopiraman, Mayakrishnan; Babu, Sundaram Ganesh; Khatri, Zeeshan; Kim, Ick Soo] Shinshu Univ, Nano Fusion Technol Res Lab, Inst Fiber Engn IFES, Div Frontier Fibers,ICCER,Natl Univ Corp, Ueda, Nagano 603203, Japan; [Babu, Sundaram Ganesh] SRM Univ, SRM Res Inst, Kattankulathur 603203, India; [Kim, Byoung-Suhk] Chonbuk Natl Univ, Dept Organ Mat & Fiber Engn, Jeonju 561756, Jeollabuk Do, South Korea; [Wei, Kai] Soochow Univ, Coll Text Clothing Engn, Suzhou 215021, Peoples R China; [Karvembu, Ramasamy] Natl Inst Technol, Dept Chem, Tiruchchirappalli 620015, Tamil Nadu, India	Kim, IS (reprint author), Shinshu Univ, Nano Fusion Technol Res Lab, Inst Fiber Engn IFES, Div Frontier Fibers,ICCER,Natl Univ Corp, Ueda, Nagano 603203, Japan.	kim@shinshu-u.ac.jp	Kim, Byoung-Suhk/K-1573-2015; Khatri, Zeeshan/J-3977-2014	Khatri, Zeeshan/0000-0001-8779-3805	Ministry of Education, Culture, Sports, Science, and Technology, Japan	This work was supported by the Grant-in-Aid for Global COE program by the Ministry of Education, Culture, Sports, Science, and Technology, Japan.	Adschiri T, 2011, GREEN CHEM, V13, P1380, DOI 10.1039/c1gc15158d; Xie YD, 2000, J PHOTOCH PHOTOBIO A, V136, P235, DOI 10.1016/S1010-6030(00)00341-5; Perera SD, 2012, ACS CATAL, V2, P949, DOI 10.1021/cs200621c; MANCUSO AJ, 1978, J ORG CHEM, V43, P2480, DOI 10.1021/jo00406a041; Princaud M, 2014, ACS SUSTAIN CHEM ENG, V2, P1498, DOI 10.1021/sc500174m; Nagaveni K, 2004, LANGMUIR, V20, P2900, DOI 10.1021/la035777v; He DP, 2014, CARBON, V66, P312, DOI 10.1016/j.carbon.2013.09.005; Pimenta S, 2011, WASTE MANAGE, V31, P378, DOI 10.1016/j.wasman.2010.09.019; Jiang YY, 2013, ACS CATAL, V3, P1263, DOI 10.1021/cs4001927; Faisal M, 2007, DYES PIGMENTS, V72, P233, DOI 10.1016/j.dyepig.2005.08.020; Fotiou T, 2013, IND ENG CHEM RES, V52, P13991, DOI 10.1021/ie400382r; Gopiraman M, 2013, CATAL SCI TECHNOL, V3, P1485, DOI 10.1039/c3cy20735h; Gopiraman M, 2014, ACS CATAL, V4, P2118, DOI 10.1021/cs500460m; Goto M, 2009, J SUPERCRIT FLUID, V47, P500, DOI 10.1016/j.supflu.2008.10.011; Kamimura A, 2013, RSC ADV, V3, P468, DOI 10.1039/c2ra22117a; Gopiraman M, 2013, J PHYS CHEM C, V117, P23582, DOI 10.1021/jp402978q; Xiong ZG, 2010, CHEM COMMUN, V46, P6099, DOI 10.1039/c0cc01259a; Mondal A, 2014, ACS CATAL, V4, P593, DOI 10.1021/cs401032p; Gopiraman M, 2013, CARBON, V62, P135, DOI 10.1016/j.carbon.2013.06.005; Sakthivel S, 2003, ANGEW CHEM INT EDIT, V42, P4908, DOI 10.1002/anie.200351577; Gopiraman M, 2014, CATAL SCI TECHNOL, V4, P2099, DOI 10.1039/c3cy00963g; Ibhadon AO, 2008, CATAL COMMUN, V9, P153, DOI 10.1016/j.catcom.2007.05.038; Ruan SP, 2001, MATER CHEM PHYS, V69, P7, DOI 10.1016/S0254-0584(00)00301-1; Stengl V, 2011, J PHYS CHEM C, V115, P25209, DOI 10.1021/jp207515z; Xiang QJ, 2012, CHEM SOC REV, V41, P782, DOI 10.1039/c1cs15172j; Chen CC, 2009, J CHIN CHEM SOC-TAIP, V56, P1147; Chen H, 2002, WATER RES, V36, P4106, DOI 10.1016/S0043-1354(02)00116-1; Emayavaramban P, 2014, ADV SCI ENG MED, V6, P659; Faria J. L., 2009, CARBON MAT CATALYSIS, P481; Babu SG, 2014, CATAL LETT, V144, P1245, DOI 10.1007/s10562-014-1262-0; Jiaguo Y, 2001, MATER CHEM PHYS, V69, P25; Li G, 2008, J CATAL, V25, P105; Liang W, 2010, CHINESE J CATAL, V31, P943; Lu CS, 2008, DYES PIGMENTS, V76, P706, DOI 10.1016/j.dyepig.2007.01.009; Luo LJ, 2015, REACT KINET MECH CAT, V114, P311, DOI 10.1007/s11144-014-0761-8; Peining Zhu, 2012, ACS Appl Mater Interfaces, V4, P581, DOI 10.1021/am201448p; Rodriguez-Reinoso F, 1998, CARBON, V36, P159, DOI 10.1016/S0008-6223(97)00173-5; Serp P., 2009, CARBON MAT CATALYSIS; Yasunobu I, 1992, J CHEM SOC CHEM COMM, V7, P579	39	1	1	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1878-5190	1878-5204		REACT KINET MECH CAT	React. Kinet. Mech. Catal.	AUG	2015	115	2					759	772		10.1007/s11144-015-0861-0		14	Chemistry, Physical	Chemistry	CN1HT	WOS:000358170200024		
J	Ali, HES; Kitahara, G; Torisu, S; Nibe, K; Kaneko, Y; Hidaka, Y; Osawa, T				Ali, H. El-Sheikh; Kitahara, G.; Torisu, S.; Nibe, K.; Kaneko, Y.; Hidaka, Y.; Osawa, T.			Evidence of Spontaneous Recovery of Granulosa-Theca Cell Tumour in a Heifer: A Retrospective Report	REPRODUCTION IN DOMESTIC ANIMALS			English	Article							ANTI-MULLERIAN HORMONE; LAPAROSCOPIC OVARIECTOMY; BIOMARKER; CATTLE; AMH; PROFILES; MARES; COWS	Contents A 14-month-old Japanese Black heifer was evaluated on Day 0 (D 0) for enlargement of the right ovary (RO). Transrectal ultrasonography (TRUS) revealed that the RO was markedly enlarged and multicystic, while the left ovary (LO) was small and inactive. The presumptive diagnosis was granulosa-theca cell tumour (GTCT), which was confirmed by markedly elevated plasma anti-Mullerian hormone (AMH) of 4.42ng/ml. Therefore, ovariectomy of the RO was the treatment of choice. The heifer was checked by TRUS and blood sampling on D 42, D 63 and immediately before ovariectomy on D 85. On D 42, TRUS did not show marked changes in either ovary in comparison with D 0. However, on D 63, the RO had transformed into a single cyst, and on D 85, the LO had resumed cyclic activity. The RO was extracted on D 85 by hand-assisted laparoscopic ovariectomy to allow better control. Unexpectedly, histopathology revealed the lesion to be a fluid-filled cystic structure, with no neoplastic proliferation of follicular epithelium that would indicate GTCT. The wall of the cystic structure consisted of collagen fibres and a few degenerated granulosa cells. The retrospective hormonal analysis revealed that the AMH concentrations had markedly dropped on D 63 and 85, which coincided with resumption of cyclicity in the LO. These findings suggest that the GTCT had self-cured and transformed into a cyst-like structure. The heifer then received an oestrous synchronization regime on D 105, was artificially inseminated on D 115 and became pregnant.	[Ali, H. El-Sheikh; Kitahara, G.; Osawa, T.] Miyazaki Univ, Dept Vet Sci, Lab Theriogenol, Fac Agr, Miyazaki 8892192, Japan; [Ali, H. El-Sheikh] Univ Mansoura, Dept Theriogenol, Fac Vet Med, Mansoura, Egypt; [Torisu, S.; Kaneko, Y.] Miyazaki Univ, Vet Teaching Hosp, Fac Agr, Miyazaki 8892192, Japan; [Nibe, K.] Japan Anim Referral Med Ctr, Takatsu Ku, Kawasaki, Kanagawa, Japan; [Hidaka, Y.] Miyazaki Univ, Lab Vet Surg, Dept Vet Sci, Fac Agr, Miyazaki 8892192, Japan	Osawa, T (reprint author), Miyazaki Univ, Dept Vet Sci, Lab Theriogenol, Fac Agr, Gakuen Kibanadai Nishi 1-1, Miyazaki 8892192, Japan.	osawa@cc.miyazaki-u.ac.jp			Ministry of Higher Education, Egypt	Hossam El-Sheikh Ali was supported by a postdoctoral scholarship from the Ministry of Higher Education, Egypt. The authors thank all of the members of the Laboratory of Theriogenology, University of Miyazaki, Japan, for their assistance during clinical and laboratory protocols. This article is dedicated to the memory of Prof. Shunichi Kamimura.	Ali HE, 2013, THERIOGENOLOGY, V80, P940, DOI 10.1016/j.theriogenology.2013.07.022; Ireland JLH, 2008, BIOL REPROD, V79, P1219, DOI 10.1095/biolreprod.108.071670; Peter AT, 2009, THERIOGENOLOGY, V71, P1343, DOI 10.1016/j.theriogenology.2008.12.026; Rodgerson DH, 2002, J AM VET MED ASSOC, V220, P1503, DOI 10.2460/javma.2002.220.1503; Campbell BK, 2012, ENDOCRINOLOGY, V153, P4533, DOI 10.1210/en.2012-1158; Monniaux D, 2008, BIOL REPROD, V79, P387, DOI 10.1095/biolreprod.107.065847; Bleul U, 2005, ANIM REPROD SCI, V90, P193, DOI 10.1016/j.anireprosci.2005.01.022; Anttonen M, 2011, LAB INVEST, V91, P1605, DOI 10.1038/labinvest.2011.116; Blowey RW, 1992, FARM ANIMAL PRACTICE; Delling U, 2004, VET SURG, V33, P487, DOI 10.1111/1.1532-950X.2004.04063.X; DROST M, 1992, J AM VET MED ASSOC, V200, P337; DUCHENS M, 1995, ANIM REPROD SCI, V37, P95, DOI 10.1016/0378-4320(94)01334-I; Goodin JT, 2011, VET SURG, V40, P90, DOI 10.1111/j.1532-950X.2010.00771.x; Hoque S, 2003, J VET MED SCI, V65, P749; HULL BL, 1995, VET CLIN N AM-FOOD A, V11, P37; Inokuma M., 2006, Journal of the Japan Veterinary Medical Association, V59, P746; Kitahara G, 2012, J REPROD DEVELOP, V58, P98, DOI 10.1262/jrd.11-101T; Kitahara G, 2012, J REPROD DEVELOP, V58, P310, DOI 10.1262/jrd.11-072T; LasMarca A, 2007, HUM REPROD UPDATE, V13, P265; Meganck V, 2011, REPROD DOMEST ANIM, V46, P746, DOI 10.1111/j.1439-0531.2010.01717.x; Nagata S, 1996, J REPROD DEVELOP, V42, P43; Peter AT, 1997, CURRENT THERAPY LARG, P349	22	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0936-6768	1439-0531		REPROD DOMEST ANIM	Reprod. Domest. Anim.	AUG	2015	50	4					696	703		10.1111/rda.12555		8	Agriculture, Dairy & Animal Science; Reproductive Biology; Veterinary Sciences	Agriculture; Reproductive Biology; Veterinary Sciences	CM8TY	WOS:000357976200025		
J	Yamauchi, Y; Yasunaga, H; Matsui, H; Hasegawa, W; Jo, T; Takami, K; Fushimi, K; Nagase, T				Yamauchi, Yasuhiro; Yasunaga, Hideo; Matsui, Hiroki; Hasegawa, Wakae; Jo, Taisuke; Takami, Kazutaka; Fushimi, Kiyohide; Nagase, Takahide			Comparison of in-hospital mortality in patients with COPD, asthma and asthma-COPD overlap exacerbations	RESPIROLOGY			English	Article						asthma; asthma-chronic obstructive pulmonary disease overlap syndrome; chronic obstructive pulmonary disease; in-hospital mortality; obstructive airway disease	OBSTRUCTIVE PULMONARY-DISEASE; FEATURES; HEALTH	Background and objectiveObstructive airway diseases, such as asthma and chronic obstructive pulmonary disease (COPD), have airflow limitation associated with chronic inflammation. Using a national inpatient database in Japan, we aimed to evaluate factors affecting in-hospital mortality in patients with asthma, COPD or asthma-COPD overlap (ACO). MethodsWe retrospectively collected data for inpatients (age >40 years) with exacerbation of COPD and/or asthma in 1073 hospitals across Japan between July 2010 and May 2013. We performed multivariable logistic regression analysis to examine the association of various factors with all-cause in-hospital mortality, including diagnosis of ACO, asthma alone and COPD alone. ResultsOf 30405 eligible patients, in-hospital mortality in patients with ACO, asthma alone and COPD alone was 2.3%, 1.2% and 9.7%, respectively. COPD patients had a significantly higher mortality than ACO patients (odds ratio 1.96; 95% confidence interval: 1.38-2.79); patients with asthma alone showed lower mortality (0.70; 0.50-0.97). Higher mortality was also significantly associated with older age, male gender, lower body mass index, more severe dyspnoea, lower level of consciousness, worse activities of daily life and higher daily dose of corticosteroids. ConclusionAsthma alone was associated with lower mortality, but COPD alone was associated with higher mortality than ACO. We evaluated all-cause in-hospital mortality in patients with asthma, COPD and asthma-COPD overlap (ACO), who were admitted for exacerbation. The in-hospital mortality in patients with ACO was lower than that in patients with COPD alone, but worse than that in patients with asthma alone.	[Yamauchi, Yasuhiro; Hasegawa, Wakae; Jo, Taisuke; Takami, Kazutaka; Nagase, Takahide] Univ Tokyo, Grad Sch Med, Dept Resp Med, Tokyo 1138655, Japan; [Yamauchi, Yasuhiro; Jo, Taisuke] Univ Tokyo, Div Hlth Serv Promot, Tokyo 1138655, Japan; [Yasunaga, Hideo; Matsui, Hiroki] Univ Tokyo, Sch Publ Hlth, Dept Clin Epidemiol & Hlth Econ, Tokyo 1138655, Japan; [Fushimi, Kiyohide] Tokyo Med & Dent Univ, Grad Sch Med, Dept Hlth Policy & Informat, Tokyo, Japan	Yamauchi, Y (reprint author), Univ Tokyo, Grad Sch Med, Dept Resp Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	yamauchiy-int@h.u-tokyo.ac.jp			Ministry of Health, Labour and Welfare, Japan; Ministry of Education, Culture, Sports, Science and Technology of Japan	This work was supported by grants from the Ministry of Health, Labour and Welfare, Japan (grant to the Respiratory Failure Research Group) and grants-in-aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Gibson PG, 2009, THORAX, V64, P728, DOI 10.1136/thx.2008.108027; Menezes AMB, 2014, CHEST, V145, P297, DOI 10.1378/chest.13-0622; Hubbard AE, 2010, EPIDEMIOLOGY, V21, P467, DOI 10.1097/EDE.0b013e3181caeb90; Hardin M, 2014, EUR RESPIR J, V44, P341, DOI 10.1183/09031936.00216013; Soriano JB, 2003, CHEST, V124, P474, DOI 10.1378/chest.124.2.474; Guerra S, 2005, CURR OPIN PULM MED, V11, P7; Papaiwannou A, 2014, J THORAC DIS, V6, pS146, DOI 10.3978/j.issn.2072-1439.2014.03.04; Chung JW, 2014, INT J CHRONIC OBSTR, V9, P795, DOI 10.2147/COPD.S61093; Fu JJ, 2014, RESPIRATION, V87, P63, DOI 10.1159/000352053; Global Initiative for Asthma, 2014, GINA REP GLOB STRAT; Global Initiative for Chronic Obstructive Lung Disease, 2014, GOLD GLOB STRAT DIAG; Hardin Megan, 2011, Respir Res, V12, P127, DOI 10.1186/1465-9921-12-127; HUGHJONES P, 1952, BRIT MED J, V1, P65; Louie S, 2013, EXPERT REV CLIN PHAR, V6, P197, DOI [10.1586/ecp.13.2, 10.1586/ECP.13.2]; MAHONEY F I, 1965, Md State Med J, V14, P61; Ohta T, 1974, No Shinkei Geka, V2, P623; Pleasants RA, 2014, COPD, V11, P256, DOI 10.3109/15412555.2013.840571; TODO T, 1991, J NEUROSURG, V74, P81, DOI 10.3171/jns.1991.74.1.0081; Wildman MJ, 2009, QJM-INT J MED, V102, P389, DOI 10.1093/qjmed/hcp036	19	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-7799	1440-1843		RESPIROLOGY	Respirology	AUG	2015	20	6					940	946		10.1111/resp.12556		7	Respiratory System	Respiratory System	CM7MY	WOS:000357879100014		
J	Yoshino, N; Kaji, S; Asonuma, T				Yoshino, Naoyuki; Kaji, Sahoko; Asonuma, Tamon			Dynamic Analysis of the Exchange Rate Regime: Policy Implications for Emerging Countries in East Asia	REVIEW OF DEVELOPMENT ECONOMICS			English	Article							DOLLAR-PEG	This paper discusses exchange rate policies in East Asia. In particular, we explore whether actual policies that have been implemented by East Asian countries after the Asian Financial Crisis follow or deviate from theoretically desirable policies over the medium and long terms. On theoretical analysis, we show the relative superiority of a basket-peg regime with the basket weight rule when compared with a floating regime implementing the interest rate rule or money supply rule. For countries that currently adopt a fixed exchange rate regime, they would be better off shifting toward either a basket-peg or a floating regime over the medium term. A shift to a basket peg is more preferred when compared with a shift to a floating regime when the exchange rate fluctuations are large.	[Yoshino, Naoyuki] Asian Dev Bank Inst, Chiyoda Ku, Tokyo 1006008, Japan; [Kaji, Sahoko] Keio Univ, Dept Econ, Tokyo 108, Japan; [Asonuma, Tamon] Int Monetary Fund, Washington, DC 20431 USA	Asonuma, T (reprint author), Int Monetary Fund, 700 19th St NW, Washington, DC 20431 USA.	nyoshino@adbi.org; tasonuma@imf.org					Adams Charles, 2004, EXCHANGE RATE REGIME, P417; Yoshino N, 2012, SINGAP ECON REV, V57, DOI 10.1142/S0217590812500245; Yoshino N, 2004, J JPN INT ECON, V18, P183, DOI 10.1016/S0889-1583(03)00051-0; McCallum BT, 1999, J MONETARY ECON, V43, P553, DOI 10.1016/S0304-3932(99)00005-7; Yoshino N, 2014, CHINA WORLD ECON, V22, P36, DOI 10.1111/j.1749-124X.2014.12067.x; Ito T, 1998, J JPN INT ECON, V12, P256, DOI 10.1006/jjie.1998.0415; Ogawa E, 2002, J JPN INT ECON, V16, P317, DOI 10.1006/jjie.2002.0499; Clarida Richard, 2002, J MONETARY ECON, V49, P877; Ilzetzki Ethan O., 2010, EXCHANGE RATE UNPUB; International Monetary Fund, 2011, ANN REP EXCH RAT ARR; International Monetary Fund, 2007, INT FIN STAT; Ito Takatoshi, 2003, MONETARY FINANCIAL I, V1, P143; Kawai Masahiro, 2004, EC LINKAGES IMPLICAT, P360; McKibbin Warwick J., 2004, EXCHANGE RATE REGIME, P385; Taylor J. B., 1993, CARNEGIE-ROCHESTER C, V39, P195, DOI DOI 10.1016/0167-2231(93)90009-L; Yoshino Naoyuki, 2015, ADBI WORKING PAPERS; Yoshino Naoyuki, J INT COMME IN PRESS; Yoshino Naoyuki, 2004, KEIO EC STUDIES, V41, P25	18	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1363-6669	1467-9361		REV DEV ECON	Rev. Dev. Econ.	AUG	2015	19	3					624	637		10.1111/rode.12163		14	Economics; Planning & Development	Business & Economics; Public Administration	CM9QK	WOS:000358043700013		
J	Forero, MDB; Ida, T; Kuroda, T				Forero, Maria del Pilar Baquero; Ida, Takanori; Kuroda, Toshifumi			Institutions and Cultural Heterogeneity as Determinants of National Income: A Random-coefficients Stochastic Frontier Model	REVIEW OF DEVELOPMENT ECONOMICS			English	Article							PRODUCTIVITY GROWTH; EAST-ASIA; GOVERNANCE; ECONOMIES; DIVERSITY; COUNTRIES; OUTPUT; RULE	Previous research on total factor productivity (TFP) shows that cross-country differences in income cannot be fully explained by stocks of capital (K), labor (L) and human capital (E). In addition, the omission of major production inputs or the use of proxies to estimate unobservable inputs leads to biased estimation results. This study addresses the above issues by employing a novel econometric approach and provides empirical evidence that a fixed production input, and therefore a country's income, is positively correlated with the existence of British-style institutions and negatively correlated with cultural heterogeneity and Spanish-style institutions. Our methodology is twofold. First, using data for 62 countries from 1980 to 2004, we regressed a random-coefficients stochastic production frontier that allows estimating a fixed unobservable production input without using proxies. Second, the estimated fixed production input is shown to be related to colonial institutions and cultural heterogeneity by means of ordinary least squares and feasible generalized least squares regressions.	[Kuroda, Toshifumi] Michigan State Univ, E Lansing, MI 48824 USA; [Kuroda, Toshifumi] Tokyo Keizai Univ, Fac Econ, Kokubunji, Tokyo 1858502, Japan; [Forero, Maria del Pilar Baquero; Ida, Takanori] Kyoto Univ, Sakyo Ku, Kyoto 6068501, Japan	Kuroda, T (reprint author), Michigan State Univ, Commun Arts & Sci Bldg,Room 538,404 Wilson Rd, E Lansing, MI 48824 USA.	kuroda@tku.ac.jp			Monbukagakusho scholarship from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of the Government of Japan	This study was supported by the Monbukagakusho scholarship from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of the Government of Japan.	Acemoglu Daron, 2002, Q J ECON, V117, P1231; Alvarez Antonio, 2004, ECONOMETRIC SOC, P1; Klenow PJ, 1997, NBER MACROECON ANN, V12, P73, DOI 10.2307/3585220; Alesina A, 2005, J ECON LIT, V43, P762, DOI 10.1257/002205105774431243; Bhattacharyya S, 2009, J COMP ECON, V37, P106, DOI 10.1016/j.jce.2008.08.001; Alvarez A, 2003, AM J AGR ECON, V85, P134, DOI 10.1111/1467-8276.00108; Fearon JD, 2003, J ECON GROWTH, V8, P195, DOI 10.1023/A:1024419522867; Licht AN, 2007, J COMP ECON, V35, P659, DOI 10.1016/j.jce.2007.09.001; Huynh KP, 2009, J COMP ECON, V37, P121, DOI 10.1016/j.jce.2008.08.003; Acemoglu D, 2001, AM ECON REV, V91, P1369, DOI 10.1257/aer.91.5.1369; Tsionas EG, 2002, J APPL ECONOM, V17, P127, DOI 10.1002/jae.637; Dehejia RH, 2005, ECON DEV CULT CHANGE, V53, P913, DOI 10.1086/428714; Woodberry RD, 2012, AM POLIT SCI REV, V106, P244, DOI 10.1017/S0003055412000093; Deliktas E, 2005, EMERG MARK FINANC TR, V41, P6; Marques RC, 2010, APPL ECON LETT, V18, P29, DOI 10.1080/13504850903409763; Chung Jae, 1994, UTILITY PRODUCTION F; CIA, 2011, THE WORLD FACTB; Easterly William, 2001, NBER WORKING PAPER S, V59; Felipe J, 1999, J DEV STUD, V35, P1, DOI 10.1080/00220389908422579; Fukuyama Francis, 2001, INT ENCY SOCIAL BEHA; Greene W, 2005, J ECONOMETRICS, V126, P269, DOI 10.1016/j.jeconom.2004.05.003; International Union for Conservation of Nature, 1988, TROP COUNTR; JONDROW J, 1982, J ECONOMETRICS, V19, P233, DOI 10.1016/0304-4076(82)90004-5; Hall RE, 1999, Q J ECON, V114, P83, DOI 10.1162/003355399555954; Kim S, 2006, APPL ECON, V38, P1697, DOI 10.1080/00036840500426884; Koop G, 2000, ECON PLANN, V33, P185, DOI 10.1023/A:1003919013358; Barro RJ, 2001, OXFORD ECON PAP, V53, P541, DOI 10.1093/oep/53.3.541; Lovell C. A. K., 2000, STOCHASTIC FRONTIER; Maudos J., 2003, International Review of Applied Economics, V17, DOI 10.1080/0269217032000118756; Mefford Robert, 1986, REV ECON STAT, P96; Rodrik D, 2004, J ECON GROWTH, V9, P131, DOI 10.1023/B:JOEG.0000031425.72248.85; Wijeweera A, 2010, J DEV AREAS, V43, P143; World Bank Development Data Group, 2007, WORLD DEV IND	33	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1363-6669	1467-9361		REV DEV ECON	Rev. Dev. Econ.	AUG	2015	19	3					710	724		10.1111/rode.12153		15	Economics; Planning & Development	Business & Economics; Public Administration	CM9QK	WOS:000358043700019		
J	Morita, T; Ueda, M; Kubo, K; Aiba, H				Morita, Teppei; Ueda, Masaki; Kubo, Kento; Aiba, Hiroji			Insights into transcription termination of Hfq-binding sRNAs of Escherichia coli and characterization of readthrough products	RNA			English	Article						Hfq; bacterial sRNA; Rho-independent terminator; transcriptional readthrough; termination and stress	BACTERIAL SMALL RNA; MESSENGER-RNA; POSTTRANSCRIPTIONAL REGULATION; TRANSLATIONAL REPRESSION; GLUCOSEPHOSPHATE STRESS; NONCODING RNAS; GENE; TRANSPORTER; POLYMERASE; EXPRESSION	The genes encoding Hfq-dependent sRNAs possess a typical Rho-independent transcription terminator. Here, we have studied the molecular events occurring at Rho-independent terminators of sRNA genes, focusing on two well-characterized Hfq-binding sRNAs, SgrS and RyhB. We constructed several hybrid genes in which the DNA sequence corresponding to a strong Rho-independent terminator was placed just downstream from the Rho-independent terminators of sRNA genes. By using this system, we demonstrate that transcripts frequently read through the Rho-independent terminators of sgrS and ryhB in normally growing cells. We show that Hfq does not affect the transcriptional readthrough event itself. We also find that the readthrough products no longer bind to Hfq in vivo. We have developed a competition assay based on a biotin-streptavidin system to analyze the interaction of Hfq and a particular RNA molecule in vitro. By using this method, we verify that the 3'-extended form of SgrS does not bind to Hfq in vitro. Finally, we demonstrate that transcription termination is significantly enhanced under stress conditions where transcription initiation of sRNA genes on the chromosome is induced. We conclude that the production of sRNAs is regulated not only at the step of transcription initiation but also at the step of transcription termination. The mechanism by which transcription termination is enhanced under stress conditions remains to be understood.	[Morita, Teppei; Ueda, Masaki; Kubo, Kento; Aiba, Hiroji] Suzuka Univ Med Sci, Fac Pharmaceut Sci, Suzuka, Mie 5130816, Japan	Morita, T (reprint author), Suzuka Univ Med Sci, Fac Pharmaceut Sci, Suzuka, Mie 5130816, Japan.	morita-t@suzuka-u.ac.jp; aiba@suzuka-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan; Takeda Science Foundation	We thank Susan Gottesman and Donald Court for critical reading of the manuscript and helpful comments. This work was supported by Grants-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to H.A. and T.M.) and Takeda Science Foundation (T.M.).	Abe H, 1999, GENES CELLS, V4, P87, DOI 10.1046/j.1365-2443.1999.00246.x; AIBA H, 1981, J BIOL CHEM, V256, P1905; AIBA H, 1982, NUCLEIC ACIDS RES, V10, P1345, DOI 10.1093/nar/10.4.1345; Sauer E, 2011, P NATL ACAD SCI USA, V108, P13065, DOI 10.1073/pnas.1103420108; Kawamoto H, 2006, MOL MICROBIOL, V61, P1013, DOI 10.1111/j.1365-2958.2006.05288.x; Sun Y, 2011, J BACTERIOL, V193, P143, DOI 10.1128/JB.01008-10; Vanderpool CK, 2004, MOL MICROBIOL, V54, P1076, DOI 10.1111/j.1365-2958.2004.04348.x; Otaka H, 2011, P NATL ACAD SCI USA, V108, P13059, DOI 10.1073/pnas.1107050108; Morita T, 2005, GENE DEV, V19, P2176, DOI 10.1101/gad.1330405; Ishikawa H, 2012, RNA, V18, P1062, DOI 10.1261/rna.031575.111; Papenfort K, 2013, CELL, V153, P426, DOI 10.1016/j.cell.2013.03.003; Kawamoto H, 2005, GENE DEV, V19, P328, DOI 10.1101/gad.1270605; Vogel J, 2011, NAT REV MICROBIOL, V9, P578, DOI 10.1038/nrmicro2615; Chao YJ, 2012, EMBO J, V31, P4005, DOI 10.1038/emboj.2012.229; SLEDJESKI D, 1995, P NATL ACAD SCI USA, V92, P2003, DOI 10.1073/pnas.92.6.2003; BROSIUS J, 1981, J MOL BIOL, V148, P107, DOI 10.1016/0022-2836(81)90508-8; Waters LS, 2009, CELL, V136, P615, DOI 10.1016/j.cell.2009.01.043; Vogel J, 2003, NUCLEIC ACIDS RES, V31, P6435, DOI 10.1093/nar/gkg867; Maki K, 2010, MOL MICROBIOL, V76, P782, DOI 10.1111/j.1365-2958.2010.07141.x; Masse E, 2002, P NATL ACAD SCI USA, V99, P4620, DOI 10.1073/pnas.032066599; Masse E, 2003, GENE DEV, V17, P2374, DOI 10.1101/gad.1127103; Morita T, 2006, P NATL ACAD SCI USA, V103, P4858, DOI 10.1073/pnas.0509638103; Guo MS, 2014, GENE DEV, V28, P1620, DOI 10.1101/gad.243485.114; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595; Vassinova N, 2000, MICROBIOL-UK, V146, P3171; Vanderpool CK, 2007, J BACTERIOL, V189, P2238, DOI 10.1128/JB.01689-06; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; CARAFA YD, 1990, J MOL BIOL, V216, P835, DOI 10.1016/S0022-2836(99)80005-9; Gottesman S, 2010, COLD SPRING HARB PER, V1, P1; PLATT T, 1986, ANNU REV BIOCHEM, V55, P339, DOI 10.1146/annurev.biochem.55.1.339; POST LE, 1979, P NATL ACAD SCI USA, V76, P1697, DOI 10.1073/pnas.76.4.1697; Rabhi M, 2011, EMBO J, V30, P2805, DOI 10.1038/emboj.2011.192; REYNOLDS R, 1992, J MOL BIOL, V224, P31, DOI 10.1016/0022-2836(92)90574-4; ROSENBERG M, 1979, ANNU REV GENET, V13, P319, DOI 10.1146/annurev.ge.13.120179.001535; Said N, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp719; Storz G, 2006, VERSATILE ROLES SMAL; Vincent HA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079142; YAGER TD, 1991, BIOCHEMISTRY-US, V30, P1097, DOI 10.1021/bi00218a032	38	0	0	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	1355-8382	1469-9001		RNA	RNA	AUG	2015	21	8					1490	1501		10.1261/rna.051870.115		12	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CM9GQ	WOS:000358016000010		
J	Wakabayashi, C; Furusako, S; Miyazaki, Y				Wakabayashi, C.; Furusako, S.; Miyazaki, Y.			Strengthening spot weld joint by autotempering acceleration at heat affected zone	SCIENCE AND TECHNOLOGY OF WELDING AND JOINING			English	Article						Spot weld; Joint-strength; High tensile strength sheet; Auto-tempering; Post-heating; Auto-tempering acceleration; Heat affected zone; Cross-tension strength	MARTENSITE-START TEMPERATURE; AUSTENITE GRAIN-SIZE	High tensile strength steel sheets in automotive body are composed of high weight fraction carbon and other additional elements. Therefore, securing the joint strength is difficult in spot welding. This study proposes a new technique for improving the spot weld joint strength. Typically, high joint strength can be obtained by prolonging the post-heating duration. This post-heating is expected to prevent propagation of crack into the nugget and improve the toughness of the heat affected zone. Compared to the conventional spot welding and other methods, the heat input is higher, thereby increasing the highest reaching temperature of heat affected zone. Hence, the austenite grain size becomes larger and martensite start temperature increases. Consequently, autotempering is promoted, resulting in stronger joint strength.	[Wakabayashi, C.; Furusako, S.; Miyazaki, Y.] Nippon Steel & Sumitomo Met Corp, Tech Res & Deveropment Bur, Futtsu, Chiba 2938511, Japan	Wakabayashi, C (reprint author), Nippon Steel & Sumitomo Met Corp, Tech Res & Deveropment Bur, 20-1 Shintomi, Futtsu, Chiba 2938511, Japan.	wakabayashi.e93.chisato@jp.nssmc.com					Yang HS, 2009, SCRIPTA MATER, V60, P493, DOI 10.1016/j.scriptamat.2008.11.043; Pouranvari M, 2007, SCI TECHNOL WELD JOI, V12, P217, DOI 10.1179/174329307X164409; Beshiyo K., 1974, SUMITOMO MET, V26, P182; Clare G., 2008, PENTONS WELD MAG, V81, P14; Deqrden J., 1940, T INT WELD, V1940, P203; Garcia-Junceda A, 2008, SCRIPTA MATER, V58, P134, DOI 10.1016/j.scriptamat.2007.09.017; Oikawa H., 2006, 385 NIPP STEEL, P36; Sawanishi C, 2014, SCI TECHNOL WELD JOI, V19, P52, DOI 10.1179/1362171813Y.0000000165; Takahashi M., 2003, 88 NIPP STEEL; Watanabe F., 2013, MATH MODELL WELD PHE, V10, P653	10	1	1	MANEY PUBLISHING	LEEDS	STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND	1362-1718			SCI TECHNOL WELD JOI	Sci. Technol. Weld. Join.	AUG	2015	20	6					468	472		10.1179/1362171815Y.0000000023		5	Materials Science, Multidisciplinary; Metallurgy & Metallurgical Engineering	Materials Science; Metallurgy & Metallurgical Engineering	CN0BQ	WOS:000358077200004		
J	Egawa, M; Sato, Y				Egawa, M.; Sato, Y.			In vivo evaluation of two forms of urea in the skin by Raman spectroscopy after application of urea-containing cream	SKIN RESEARCH AND TECHNOLOGY			English	Article						depth profile; urea; Raman spectroscopy; skin; stratum corneum	WATER CONCENTRATION PROFILES; HUMAN STRATUM-CORNEUM; MOISTURIZERS; HYDRATION; MICROSPECTROSCOPY; CONSTITUENTS	Background/purposeAs urea is one of the natural moisturizing factor (NMF) components in the stratum corneum, it has been used in topical products to improve skin conditions. However, the penetration behavior of urea in the skin after application of urea-containing cream has not been determined as there has been no technique with which to measure the urea content in the skin in vivo non-invasively. We therefore applied Raman spectroscopy to evaluate the depth profile of urea content in the skin. We investigated changes in depth profiles of two forms of urea to evaluate the penetration behavior of urea after application of urea-containing cream. MethodsCommercially available moisturizing creams F and R in quantities of 2.2-mg/cm(2) and containing 20% (w/w) urea were applied to volar forearm skin of six Japanese subjects. Raman spectra of the skin were measured at 2-m intervals from the skin surface toward the interior using a confocal Raman spectrometer (model 3510 SCA) before and 15, 60, and 120min after the application of the creams. The amounts of the two forms of urea, urea in water solution and urea in a solid state, were calculated by adding the spectra of solid urea and the cream base to a previously reported algorithm including the spectrum of urea in water solution. ResultsThe characteristic band of urea in water solution was observed at approximately 1004/cm and that of the solid state at approximately 1010/cm in the Raman spectra of the skin after application of either cream. There was more urea in water solution form in the area where cream F was applied than in the area where cream R was applied. There was more urea in a solid state in the area where cream R was applied than in the area where cream F was applied at all depths and measurement times. In particular, there was significantly more urea in a solid state below a depth of 2m in the area where cream R was applied than in the area where cream F was applied 15min after application. ConclusionThe present study demonstrated that we can measure both urea forms in the skin after the application of urea-containing creams. The proposed technique would be useful in the evaluation of characteristics of the penetration behavior of urea in the skin after the application of various urea-containing moisturizers.	[Egawa, M.; Sato, Y.] Shiseido Res Ctr, Yokohama, Kanagawa 2248558, Japan	Egawa, M (reprint author), Shiseido Res Ctr, Tsuzuki Ku, 2-2-1 Hayabuchi, Yokohama, Kanagawa 2248558, Japan.	mariko.egawa@to.shiseido.co.jp					Loden M, 2001, SKIN RES TECHNOL, V7, P209, DOI 10.1034/j.1600-0846.2001.70401.x; Egawa M, 2009, SKIN RES TECHNOL, V15, P242, DOI 10.1111/j.1600-0846.2009.00362.x; Egawa M, 2009, SKIN RES TECHNOL, V15, P195, DOI 10.1111/j.1600-0846.2009.00353.x; Caspers PJ, 2001, J INVEST DERMATOL, V116, P434, DOI 10.1046/j.1523-1747.2001.01258.x; Caspers PJ, 1998, BIOSPECTROSCOPY, V4, pS31, DOI 10.1002/(SICI)1520-6343(1998)4:5+<S31::AID-BSPY4>3.0.CO;2-M; STEWART JE, 1957, J CHEM PHYS, V26, P248, DOI 10.1063/1.1743279; Egawa M, 2008, SKIN RES TECHNOL, V14, P410, DOI 10.1111/j.1600-0846.2008.00318.x; Egawa M, 2007, ACTA DERM-VENEREOL, V87, P4, DOI 10.2340/00015555-0183; Stamatas GN, 2008, J DERMATOL SCI, V50, P135, DOI 10.1016/j.jdermsci.2007.11.006; Egawa M, 2010, PHOTOCH PHOTOBIO SCI, V9, P730, DOI 10.1039/b9pp00143c; Caspers PJ, 2002, PHARMACEUT RES, V19, P1577, DOI 10.1023/A:1020481305420; Rousseau B, 1998, J PHYS CHEM A, V102, P6540, DOI 10.1021/jp981008m; Egawa M, 2010, J DERMATOL SCI, V57, P66, DOI 10.1016/j.jdermsci.2009.10.006; Egawa M, 2008, BRIT J DERMATOL, V158, P251, DOI 10.1111/j.1365-2133.2007.08311.x; Caspers PJ, 2000, J RAMAN SPECTROSC, V31, P813, DOI 10.1002/1097-4555(200008/09)31:8/9<813::AID-JRS573>3.0.CO;2-7; Budavari S., 1996, MERCK INDEX; Fern NS, 2010, AAPS PHARMSCITECH, V11, P1432; Fluhr J. W., 1999, SKIN RES TECHNOL, V5, P171, DOI 10.1111/j.1600-0846.1999.tb00127.x; Jacobi OK, 1959, DRUG COSMET IND, V88, P732; Keuleers R, 1999, J PHYS CHEM A, V103, P4321; Kuzmina N, 2002, SKIN PHARMACOL APPL, V15, P166, DOI 10.1159/000063545; LODEN M, 1991, ACTA DERM-VENEREOL, V71, P79; Loden M, 2009, SKIN MOISTURIZATION, V2nd, P335; Miettinen H, 1999, SKIN PHARMACOL APPL, V12, P344, DOI 10.1159/000029896; Pudney PDA, 2007, APPL SPECTROSC, V61, P804, DOI 10.1366/000370207781540042; SERUP J, 1992, ACTA DERM-VENEREOL, P29; TAGAMI H, 1980, J INVEST DERMATOL, V75, P500, DOI 10.1111/1523-1747.ep12524316; Wascotte V, 2007, PHARM RES, V24, P1897, DOI 10.1007/s11095-007-9314-4	28	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0909-752X	1600-0846		SKIN RES TECHNOL	Skin Res. Technol.	AUG	2015	21	3					259	264		10.1111/srt.12184		6	Dermatology	Dermatology	CM8JI	WOS:000357945700001		
J	Nagaoka, T; Kiyohara, Y; Koga, H; Nakamura, A; Saida, T; Sota, T				Nagaoka, T.; Kiyohara, Y.; Koga, H.; Nakamura, A.; Saida, T.; Sota, T.			Modification of a melanoma discrimination index derived from hyperspectral data: a clinical trial conducted in 2 centers between March 2011 and December 2013	SKIN RESEARCH AND TECHNOLOGY			English	Article						spectrum analysis; computer-assisted diagnosis; early detection of melanoma; melanoma	MELANOCYTIC SKIN-LESIONS; ABCD RULE; MALIGNANT-MELANOMA; SURFACE MICROSCOPY; DIAGNOSIS; DERMATOSCOPY; FEATURES; SYSTEM	BackgroundThe morphology of pigmented skin lesions (PSLs) is predominantly a result of varying concentrations and distributions of pigmented molecules such as melanin and hemoglobin. Based on these differences and the fact that their information is contained in cutaneous spectra, a hyperspectral imager (HSI) for pigmented melanoma and a single discrimination index derived from the resultant hyperspectral data are proposed. ObjectiveTo develop and evaluate a new discrimination index for melanomas, compared to the previous index. MethodsA HSI, which is convenient for both patients and clinicians, was newly developed and used in a clinical trial conducted in 2 centers with 80 patients with primary lesions and 17 volunteers between March 2011 and December 2013. There were 24 melanomas and 110 other PSLs. A previously proposed discrimination index was used without modifications. A new index, which emphasized the essential features of melanoma, was proposed, and its performance was examined. For each index, a threshold value was set to minimize the average value of the false positive and false negative fractions. The performances of both indices were compared. ResultsThe sensitivity and specificity of the old index were 75% and 97%, respectively, while those of the new index were 96% and 87%. ConclusionThe new index had a higher sensitivity and adequate specificity, indicating that it is more useful than the old index.	[Nagaoka, T.; Nakamura, A.; Sota, T.] Waseda Univ, Waseda Res Inst Sci & Engn, Shinjuku Ku, Tokyo 1698555, Japan; [Kiyohara, Y.] Shizuoka Canc Ctr Hosp, Div Dermatol, Nagaizumi, Shizuoka, Japan; [Koga, H.; Saida, T.] Shinshu Univ Hosp, Dept Dermatol, Matsumoto, Nagano, Japan; [Sota, T.] Waseda Univ, Dept Elect Engn & Biosci, Shinjuku Ku, Tokyo 1698555, Japan	Nagaoka, T (reprint author), Waseda Univ, Waseda Res Inst Sci & Engn, Shinjuku Ku, Tokyo 1698555, Japan.	nagaoka@aoni.waseda.jp			Ministry of Economy, Trade and Industry, Development of Systems and Technology for Advanced Measurement and Analysis; Japan Science and Technology Agency; Japan Society for the Promotion of Science [23700584]	This work was partially supported by program to support development of medical equipment and devices to solve unmet medical needs, Ministry of Economy, Trade and Industry, Development of Systems and Technology for Advanced Measurement and Analysis, Japan Science and Technology Agency, and KAKENHI (23700584) of the Japan Society for the Promotion of Science.	SOYER HP, 1987, LANCET, V2, P803; STOLZ W, 1994, EUR J DERMATOL, V4, P521; NACHBAR F, 1994, J AM ACAD DERMATOL, V30, P551; Argenziano G, 1998, ARCH DERMATOL, V134, P1563, DOI 10.1001/archderm.134.12.1563; Khoobehi B, 2004, INVEST OPHTH VIS SCI, V45, P1464, DOI 10.1167/iovs.03-1069; Vo-Dinh T, 2004, IEEE ENG MED BIOL, V23, P40; Menzies SW, 1996, ARCH DERMATOL, V132, P1178, DOI 10.1001/archderm.132.10.1178; Emerson JD, 2000, UNDERSTANDING ROBUST, P66; KRUSE FA, 1993, REMOTE SENS ENVIRON, V44, P145, DOI 10.1016/0034-4257(93)90013-N; Menzies SW, 1996, MELANOMA RES, V6, P55, DOI 10.1097/00008390-199602000-00008; Nagaoka T, 2012, SKIN RES TECHNOL, V18, P301, DOI 10.1111/j.1600-0846.2011.00571.x; Nagaoka T, 2013, SKIN RES TECHNOL, V19, pE290, DOI 10.1111/j.1600-0846.2012.00642.x	12	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0909-752X	1600-0846		SKIN RES TECHNOL	Skin Res. Technol.	AUG	2015	21	3					278	283		10.1111/srt.12188		6	Dermatology	Dermatology	CM8JI	WOS:000357945700004		
J	Kojima, T; Yamada, H; Saito, Y; Nawa, T; Isobe, M; Yamamoto, T; Aoki, D; Matsushita, Y; Fukushima, K				Kojima, T.; Yamada, H.; Saito, Y.; Nawa, T.; Isobe, M.; Yamamoto, T.; Aoki, D.; Matsushita, Y.; Fukushima, K.			Investigation of dyeing behavior of oxidative dye in fine structures of the human hair cuticle by nanoscale secondary ion mass spectrometry	SKIN RESEARCH AND TECHNOLOGY			English	Article						dyeing behavior; oxidative dye; human hair; cuticle; NanoSIMS	TOF-SIMS	Background/purposeIn oxidative coloring, the hair cuticle layers are not only the penetration pathway for active ingredients but also one of the most important dyeing regions. The dyeing mechanism of oxidative dyes in fine structures of the cuticle remains unclear. To investigate the dyeing behavior of oxidative dyes in fine structures of the cuticle, hair cross-sections were analyzed by nanoscale secondary ion mass spectrometry (NanoSIMS). MethodsThe preparation method of hair cross-section for NanoSIMS measurement was improved. Improved hair cross-sections were analyzed using NanoSIMS. ResultsThe cuticle layer thickness of the hair cross-section could be widened. It was confirmed that C-12(-) ions were more strongly detected from endocuticle than from other fine structures of cuticle. The NanoSIMS C-12(-) image and hue saturation intensity (HSI) D-/H-1(-) ratio image of the hair, dyed with deuterium-labeled oxidative dye, indicated that the endocuticle had a higher D-/H-1(-) ratio than the other fine structures of the cuticle. It was substantiated that more colored chromophores were fixated in the endocuticle than in other fine structures of the cuticle. ConclusionThe dyeing behavior of oxidative dyes in fine structures of hair cuticle was substantiated by NanoSIMS analysis using the improved hair cross-section preparation method.	[Kojima, T.; Yamada, H.; Saito, Y.; Nawa, T.; Isobe, M.; Yamamoto, T.] Hoyu Co Ltd, Gen Res & Dev Inst, Nagakute, Aichi 4801136, Japan; [Aoki, D.; Matsushita, Y.; Fukushima, K.] Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan	Kojima, T (reprint author), Hoyu Co Ltd, Gen Res & Dev Inst, 1-12 Roboku, Nagakute, Aichi 4801136, Japan.	tooru_kojima@hoyu.co.jp					Saito K, 2012, PLANT J, V69, P542, DOI 10.1111/j.1365-313X.2011.04811.x; Morel OJX, 2011, CHEM REV, V111, P2537, DOI 10.1021/cr1000145; Clode PL, 2009, PLANT PHYSIOL, V151, P1751, DOI 10.1104/pp.109.141499; Clode PL, 2007, MICROSC RES TECHNIQ, V70, P220, DOI 10.1002/jemt.20409; Boxer SG, 2009, ANNU REV BIOPHYS, V38, P53, DOI 10.1146/annurev.biophys.050708.133634; Saito K, 2008, ANAL CHEM, V80, P1552, DOI 10.1021/ac7021162; Herrmann AM, 2007, SOIL BIOL BIOCHEM, V39, P1835, DOI 10.1016/j.soilbio.2007.03.011; Kojima T, 2013, COLLOID SURFACE B, V106, P140, DOI 10.1016/j.colsurfb.2013.01.028; Audinot JN, 2004, APPL SURF SCI, V231, P490, DOI 10.1016/j.apsusc.2004.03.192; Bhushan B, 2010, BIOPHYSICS HUMAN HAI, P1; Brown KC, 1997, HAIR HAIR CARE, P191; Chen N, 2005, J MICROSC-OXFORD, V220, P96, DOI 10.1111/j.1365-2818.2005.01517.x; CORBETT JF, 1973, J SOC COSMET CHEM, V24, P103; Gummer GL, 2001, J COSMET SCI, V52, P265; Hallegot P, 2004, J INVEST DERMATOL, V122, P381, DOI 10.1046/j.0022-202X.2004.22217.x; HALLEGOT P, 1993, J MICROSC-OXFORD, V172, P131; Imai T, 2008, J SOC COSMET CHEM JP, V42, P305; Imai T, 2010, J SOC COSMET CHEM JP, V44, P208; Kempson IM, 2005, SCI TOTAL ENVIRON, V338, P213, DOI 10.1016/j.scitotenv.2004.07.017; Kitano H, 2009, COMPOS INTERFACE, V16, P1, DOI 10.1163/156855408X379397; Kojima T, 2012, INT J POLYM ANAL CH, V17, P21, DOI 10.1080/1023666X.2012.638435; Kojima T, 2011, SURF INTERFACE ANAL, V43, P562, DOI 10.1002/sia.3635; Lechene Claude, 2006, J Biol, V5, P20, DOI 10.1186/jbiol42; Marsh JM, 2012, PRACTICAL MODERN HAI, P117; McMahon G, 2006, APPL SURF SCI, V252, P6895, DOI 10.1016/j.apsusc.2006.02.170; Naito S, 1992, SEN-I GAKKAISHI, V48, P420; Pillai ZS, 2005, RES CHEM INTERMEDIAT, V31, P103, DOI 10.1163/1568567053146977; Popescu C, 2007, CHEM SOC REV, V36, P1282, DOI 10.1039/b604537p; Robins CR, 2012, CHEM PHYS BEHAV HUMA; Smart KE, 2009, J COSMET SCI, V60, P337; Swift JA, 1992, P 8 INT HAIR SCI S D; Swift JA, 1999, J COSMET SCI, V50, P23; Swift JA, 1997, FORMATION STRUCTURE, P149; Wilmsman H, 1961, J SOC COSMET CHEM, V12, P490; Wortmann FJ, 1997, TEXT RES J, V67, P720; Zvaik C, 1986, SCI HAIR CARE, P263	36	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0909-752X	1600-0846		SKIN RES TECHNOL	Skin Res. Technol.	AUG	2015	21	3					295	301		10.1111/srt.12192		7	Dermatology	Dermatology	CM8JI	WOS:000357945700007		
J	Yamaguchi, A				Yamaguchi, Ayano			Influences of Quality of Life on Health and Well-Being	SOCIAL INDICATORS RESEARCH			English	Article						Quality of life; Health; Well-being; Social indicators	POLICY	The quality of life (QOL) indicators surrounding health, including worry and well-being, the way in which they function as multi-dimensional constructs and the potential stability of relationships were examined across universities in Hawaii and Japan. Maintaining or strengthening QOL indicators of collective and individual health and well-being is a core factor of social indicators, including social capital, and is instrumental in reducing individuals' stress and worry and increasing their trust. Qualitative in-depth interviews with 64 male and female college students (32 college students at the University of Hawaii at Manoa; 32 college students at Reitaku University in Japan) were used to collect information on QOL indicators related to health and well-being and its associated concepts. The students' perceptions were grouped under 11 themes. The data indicate that QOL indicators have an impact on college students' health and well-being. They also suggest that differences in health status and well-being can be plausibly attributed to processes associated with socioenvironmental circumstances and situations.	Reitaku Univ, Coll Foreign Studies, Kashiwa, Chiba 2778686, Japan	Yamaguchi, A (reprint author), Reitaku Univ, Coll Foreign Studies, 2-1-1 Hikarigaoka, Kashiwa, Chiba 2778686, Japan.	ayamag13@reitaku-u.ac.jp					Poortinga W, 2006, SOC SCI MED, V62, P292, DOI 10.1016/j.socscimed.2005.06.008; Fujisawa Y, 2009, SOC SCI MED, V69, P500, DOI 10.1016/j.socscimed.2009.05.046; BERGNER M, 1989, MED CARE, V27, pS148, DOI 10.1097/00005650-198903001-00012; Brinton MC, 2000, POLICY SCI, V33, P289, DOI 10.1023/A:1004893624263; Hagerty MR, 2001, SOC INDIC RES, V55, P1, DOI 10.1023/A:1010811312332; Felce D, 1997, J INTELL DISABIL RES, V41, P126, DOI 10.1111/j.1365-2788.1997.tb00689.x; [Anonymous], 2009, JAPAN TIMES     1008; Haas BK, 1999, WESTERN J NURS RES, V21, P728, DOI 10.1177/01939459922044153; Blum H. L., 1981, PLANNING HLTH, V2nd; Centers for Disease Control and Prevention, 2000, MEAS HLTH DAYS POP A; Cummins R. A., 1997, QUALITY LIFE PEOPLE, V2nd; Diener E, 1997, SOC INDIC RES, V40, P189, DOI 10.1023/A:1006859511756; Felce D., 1995, RES DEV DISABIL, V1, P51, DOI DOI 10.1016/0891-4222(94)00028-8; Keith K. D., 2001, INT REV RES MENTAL R, V24; MARWICK C, 1995, JAMA-J AM MED ASSOC, V273, P1561, DOI 10.1001/jama.273.20.1561; MEEBERG GA, 1993, J ADV NURS, V18, P32, DOI 10.1046/j.1365-2648.1993.18010032.x; Portes A., 1996, AM PROSPECT, V7, P18; Putnam R., 1993, AM PROSPECT, V13, P35; Putnam Robert, 2000, BOWLING ALONE; Raphael D., 1996, QUALITY LIFE HLTH PR; ROSS L, 1995, INT J NURS STUD, V32, P457, DOI 10.1016/0020-7489(95)00007-K; Schalock R. L, 1996, QUALITY OF LIFE, V1; Schalock R. L., 2004, J DISABIL POLICY STU, V14, P204, DOI DOI 10.1177/10442073040140040201; Swanson C S, 1995, Issues Compr Pediatr Nurs, V18, P267, DOI 10.3109/01460869509087275; KUYKEN W, 1995, SOC SCI MED, V41, P1403; Vitterso J, 2004, SOC INDIC RES, V65, P299, DOI 10.1023/B:SOCI.0000003910.26194.ef; World Health Organization [WHO], 1948, OFF REC WHO; Yamagishi T., 1999, SOC RELIEF SOC TRUST	28	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0303-8300	1573-0921		SOC INDIC RES	Soc. Indic. Res.	AUG	2015	123	1					77	102		10.1007/s11205-014-0738-z		26	Social Sciences, Interdisciplinary; Sociology	Social Sciences - Other Topics; Sociology	CM4YC	WOS:000357691500005		
J	Tedor, MF; Sharp, SF; Kobayashi, E				Tedor, Miyuki Fukushima; Sharp, Susan F.; Kobayashi, Emiko			A Cross-Cultural Examination of the Disjuncture Between Aspirations and Expectations/Perceived Outcomes: Strain and Academic Deviance in the United States and Japan	SOCIOLOGICAL INQUIRY			English	Article							GENERAL-THEORY; SELF-CONTROL; EMPIRICAL-TEST; DISHONESTY; STUDENTS; CRIME; DELINQUENCY; DETERRENCE; PERSONALITY; FOUNDATION	Using comparable self-reported survey data collected among college students in the United States (n=502) and Japan (n=441), this study examines a paradox of higher academic deviance among otherwise more conforming Japanese youth while revisiting the debate concerning the disjuncture between aspirations and expectations/perceived outcomes in Agnew's general strain theory (GST). Confirming the paradox, our results indicate that Japanese students are significantly more deviant academically than American students. However, contrary to the expectation of GST, but in support of past empirical studies, the higher academic deviance among the Japanese, as compared to Americans, is explained by their lower aspirations, irrespective of the levels of expectations/perceived outcomes	[Tedor, Miyuki Fukushima] Cleveland State Univ, Dept Sociol & Criminol, Cleveland, OH 44115 USA; [Sharp, Susan F.] Univ Oklahoma, Dept Sociol, Norman, OK 73019 USA; [Kobayashi, Emiko] Kanazawa Univ, Foreign Language Inst, Kanazawa, Ishikawa 9201192, Japan	Tedor, MF (reprint author), Cleveland State Univ, Dept Sociol & Criminol, Rhodes Tower 1733,2121 Euclid Ave, Cleveland, OH 44115 USA.	m.fukushima@csuohio.edu					Adler Freda, 1983, NATIONS NOT OBSESSED; Agnew R., 2007, PRESSURED CRIME OVER; Agnew R., 1996, JUSTICE Q, V13, P681, DOI 10.1080/07418829600093151; Agnew R, 2002, CRIMINOLOGY, V40, P43, DOI 10.1111/j.1745-9125.2002.tb00949.x; AGNEW R, 1992, CRIMINOLOGY, V30, P47, DOI 10.1111/j.1745-9125.1992.tb01093.x; Vandehey MA, 2007, J COLL STUDENT DEV, V48, P468, DOI 10.1353/csd.2007.0043; Paternoster R, 1998, CRIMINOLOGY, V36, P859, DOI 10.1111/j.1745-9125.1998.tb01268.x; WARD DA, 1993, DEVIANT BEHAV, V14, P43; Nagin DS, 2003, CRIMINOLOGY, V41, P167, DOI 10.1111/j.1745-9125.2003.tb00985.x; Muraven M, 2006, J QUANT CRIMINOL, V22, P263, DOI 10.1007/s10940-006-9011-1; McCabe DL, 2006, ACAD MANAG LEARN EDU, V5, P294; Bolin AU, 2004, J PSYCHOL, V138, P101, DOI 10.3200/JRLP.138.2.101-114; AGNEW R, 1992, CRIMINOLOGY, V30, P475, DOI 10.1111/j.1745-9125.1992.tb01113.x; Newstead SE, 1996, J EDUC PSYCHOL, V88, P229; FRANKLYNSTOKES A, 1995, STUD HIGH EDUC, V20, P159, DOI 10.1080/03075079512331381673; MICHAELS JW, 1989, SOC SCI QUART, V70, P870; Agnew R, 2001, J RES CRIME DELINQ, V38, P319, DOI 10.1177/0022427801038004001; AGNEW R, 1985, SOC FORCES, V64, P151, DOI 10.2307/2578977; Cochran JK, 1999, SOCIOL INQ, V69, P91, DOI 10.1111/j.1475-682X.1999.tb00491.x; Agnew R, 2012, SOC FORCES, V91, P33, DOI 10.1093/sf/sos117; Broidy L, 1997, J RES CRIME DELINQ, V34, P275, DOI 10.1177/0022427897034003001; Li YY, 2012, J SECOND LANG WRIT, V21, P165, DOI 10.1016/j.jslw.2012.03.002; Cochran JK, 1998, DEVIANT BEHAV, V19, P227; HAINES VJ, 1986, RES HIGH EDUC, V25, P342, DOI 10.1007/BF00992130; SCHAB F, 1991, ADOLESCENCE, V26, P839; Asli Yazici, 2011, ED STUDIES, V37, P221; Bichler-Robertson Gisela, 2003, J CRIME JUSTICE, V26, P23; Burns Susan R, 1998, COLL STUDENT J, V32, P590; Burton Susan, 2013, TIMES HIGHER ED, V2106, P19; Hoffmann JP, 1999, CRIMINOLOGY, V37, P343, DOI 10.1111/j.1745-9125.1999.tb00489.x; Cheung HY, 2012, ASIA-PAC EDUC RES, V21, P454; Cizek Gregory J., 1999, CHEATING TESTS DO IT, P74; Davis S. F., 1994, COLL STUDENT J, V28, P353; Desruisseaux Paul, 1999, CHRON HIGHER EDUC, V45, P1; Diekhoff GM, 1999, RES HIGH EDUC, V40, P343, DOI 10.1023/A:1018703217828; Elliott D. A., 1974, DELINQUENCY DROPOUT; Eve Raymond, 1981, YOUTH SOC, V13, P20; Fackler Martin, 2011, NY TIMES; Fujimoto Takayuki, 2009, IPSJ SIG TECHNICAL R, V32, P17; Grimes Paul W., 2005, INT REV EC ED, V4, P23; Hirschi T., 1969, CAUSES DELINQUENCY; HOUSTON JP, 1977, CONTEMP EDUC PSYCHOL, V2, P275, DOI 10.1016/0361-476X(77)90030-3; Hrabak M, 2004, MED EDUC, V38, P276, DOI 10.1046/j.1365-2923.2004.01766.x; Iberahim H, 2013, PROCD SOC BEHV, V90, P152, DOI 10.1016/j.sbspro.2013.07.076; Jones S, 2004, DEVIANT BEHAV, V25, P401, DOI 10.1080/01639620490467508; Kerbo Harold R., 1998, MODERN JAPAN; Kerbo Harold R., 1994, SOCIOLOGICAL VIEW PO, V10, P66; Koljatic M, 2002, PSYCHOL REP, V90, P883, DOI 10.2466/PR0.90.3.883-888; LANZAKADUCE L, 1986, DEVIANT BEHAV, V7, P243; Lim VKG, 2001, ETHICS BEHAV, V11, P261, DOI 10.1207/S15327019EB1103_5; McCabe D., 1996, CHANGE, V28, P28; McCabe DL, 2008, RES HIGH EDUC, V49, P451, DOI 10.1007/s11162-008-9092-9; McKinstry John A., 2011, JAPANESE SOC HIST; MILLHAM J, 1974, J RES PERS, V8, P378, DOI 10.1016/0092-6566(74)90028-2; Minamikata Satoshi, 1994, INT J LAW FAMILY, V8, P281; Mok K. H., 2006, ED REFORM ED POLICY; Nakane Chie, 1970, JAPANESE SOC; Norifumi Mizoue, 2005, NEO SCH RECORD SOC; Payan J., 2010, J MARKETING ED, V32, P275, DOI [10.1177/0273475310377781, DOI 10.1177/0273475310377781]; Pupovac Vanja, 2008, DIGITHUMN, V10, P14; Rawwas M., 2004, J MARKETING ED, V26, P89, DOI [10.1177/0273475303262354, DOI 10.1177/0273475303262354]; Reischauer Edwin O., 1988, THE JAPANESE; Rohlen Thomas P., 1983, JAPANS HIGH SCH; Sims R. L., 1993, J ED BUSINESS, V68, P207; Smith Tony R., 2013, INT J CRIMINAL JUSTI, V8, P88; Stogner J. M., 2013, J CRIMINAL JUSTICE E, V24, P175, DOI [10.1080/10511253.2012.693516, DOI 10.1080/10511253.2012.693516]; Teferra D, 2001, INT J EDUC DEV, V21, P163, DOI 10.1016/S0738-0593(00)00037-7; Teixeira Aurora A. C., 2010, J ACAD ETHICS, V8, P21; Tibbetts S. G., 1999, AM J CRIMINAL JUSTIC, V23, P179, DOI 10.1007/BF02887271; Tibbetts SG, 1997, DEVIANT BEHAV, V18, P393; TITTLE CR, 1973, SOC PROBL, V20, P488, DOI 10.1525/sp.1973.20.4.03a00080; Vowell PR, 2004, SOCIOL INQ, V74, P226, DOI 10.1111/j.1475-682X.2004.00088.x	72	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0038-0245	1475-682X		SOCIOL INQ	Sociol. Inq.	AUG	2015	85	3					462	491		10.1111/soin.12087		30	Sociology	Sociology	CN0EA	WOS:000358085200005		
J	Takaishi, R; Hiraoka, K; Wada, H; Morita, S; Nakashima, T; Nonami, H				Takaishi, R.; Hiraoka, K.; Wada, H.; Morita, S.; Nakashima, T.; Nonami, H.			Electrospray droplet impact/secondary ion mass spectrometry (EDI/SIMS) using NaF and AgF as cationization matrices	SURFACE AND INTERFACE ANALYSIS			English	Article						EDI; SIMS; cyclodextrin; cationization matrix; NaF; AgF; magic number	CHARGED WATER DROPLETS; CLUSTER-IMPACT; LARGE BIOMOLECULES; DEPTH ANALYSIS; DESORPTION; HALIDES	In our previous paper, it was suggested that metal fluorides may be useful as cationization matrices in Electrospray droplet impact/SIMS. In this work, NaF and AgF were used as the cationization matrices for cyclodextrin (CD), polyethylene glycol (PEG), polystyrene (PS), garlic juice, and sliced raw rice. EDI mass spectra were measured without and with the use of matrices. Enhancement of ion abundances of [M+Na](+) for CD and PEG with NaF matrix and that of [M+Ag](+) for PS with AgF matrix were observed. However, the addition of matrices was not effective for the cationization of garlic juice and sliced raw rice samples. This may be due to the Coulombic repulsion of the reagent ions of Na+ or Ag+ with the preformed K+ adducts of oligosaccharides already present in the samples. Copyright (c) 2015 John Wiley & Sons, Ltd.	[Takaishi, R.; Hiraoka, K.] Univ Yamanashi, Clean Energy Res Ctr, Kofu, Yamanashi 4008511, Japan; [Wada, H.; Morita, S.] Natl Agr & Food Res Org, Kyushu Okinawa Agr Res Ctr, Fukuoka 8330041, Japan; [Nakashima, T.; Nonami, H.] Ehime Univ, Dept Biomech Syst, Fac Agr, Matsuyama, Ehime 7908566, Japan	Hiraoka, K (reprint author), Univ Yamanashi, Clean Energy Res Ctr, Kofu, Yamanashi 4008511, Japan.	hiraoka@yamanashi.ac.jp			Japanese Science and Technology Agency	The financial support from the Japanese Science and Technology Agency is gratefully acknowledged. The authors are also thankful to Drs Y. Sakai and S. Ninomiya of the University of Yamanashi for their valuable discussions.	MAHONEY JF, 1992, J AM SOC MASS SPECTR, V3, P311, DOI 10.1016/1044-0305(92)87058-7; CORNETT DS, 1994, RAPID COMMUN MASS SP, V8, P996; Zhang JT, 2014, RAPID COMMUN MASS SP, V28, P2211, DOI 10.1002/rcm.7006; Mori K, 2008, INT J MASS SPECTROM, V269, P95, DOI 10.1016/j.ijms.2007.09.013; MAHONEY JF, 1991, RAPID COMMUN MASS SP, V5, P441, DOI 10.1002/rcm.1290051004; Aksyonov SA, 2001, RAPID COMMUN MASS SP, V15, P2001, DOI 10.1002/rcm.470; Hiraoka K, 2006, EUR PHYS J D, V38, P225, DOI 10.1140/epjd/e2005-00282-6; Hiraoka K, 2011, SURF INTERFACE ANAL, V43, P236, DOI 10.1002/sia.3486; Hiraoka K, 2009, APPL SURF SCI, V255, P8947, DOI 10.1016/j.apsusc.2009.06.101; Hiraoka K, 2010, J VAC SCI TECHNOL A, V28, P510, DOI 10.1116/1.3420465; Hiraoka K, 2013, SURF INTERFACE ANAL, V45, P968, DOI 10.1002/sia.5191; Hiraoka K, 2009, J VAC SCI TECHNOL A, V27, P748, DOI 10.1116/1.3100219; Hiraoka K., 2013, FUNDAMENTALS MASS SP; MAHONEY JF, 1994, RAPID COMMUN MASS SP, V8, P403, DOI 10.1002/rcm.1290080513; Sakai Y, 2011, SURF INTERFACE ANAL, V43, P1605, DOI 10.1002/sia.3754; Sakai Y, 2010, SURF INTERFACE ANAL, V42, P658, DOI 10.1002/sia.3254; Sakai Y., 2010, SURF INTERFACE ANAL, V43, P167; Sakai Y, 2008, SURF INTERFACE ANAL, V40, P1716, DOI 10.1002/sia.2946; Sakai Y, 2012, SURF INTERFACE ANAL, V44, P938, DOI 10.1002/sia.4843; Sakai Y, 2009, J VAC SCI TECHNOL A, V27, P743, DOI 10.1116/1.3077283; Takaishi R, 2014, SURF INTERFACE ANAL, V46, P134, DOI 10.1002/sia.5360	21	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0142-2421	1096-9918		SURF INTERFACE ANAL	Surf. Interface Anal.	AUG	2015	47	8					832	837		10.1002/sia.5782		6	Chemistry, Physical	Chemistry	CM8RO	WOS:000357969900005		
J	Arkenbosch, J; Miyagaki, H; Kumara, HMCS; Yan, XH; Cekic, V; Whelan, RL				Arkenbosch, Jeanine; Miyagaki, Hiromichi; Kumara, H. M. C. Shantha; Yan, Xiaohong; Cekic, Vesna; Whelan, Richard L.			Efficacy of laparoscopic-assisted approach for reversal of Hartmann's procedure: results from the American College of Surgeons National Surgical Quality Improvement Program (ACS-NSQIP) database	SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES			English	Article; Proceedings Paper	Annual Meeting of the Society-of-American-Gastrointestinal-and-Endoscopic-Surgeons (SAGES) / 17th World Congress of Endoscopic Surgery	APR 02-05, 2014	Salt Lake City, UT	Soc Amer Gastrointestinal & Endoscop Surg		Open and Laparoscopic-assisted Hartmann's reversal procedure ACS-NSQIP database; Post-operative clinical outcomes	DIVERTICULITIS	Morbidity after reversal of Hartmann's procedure remains high. The laparoscopic approach (LAP) may be associated with lower morbidity versus open Hartmann's closure. This study's aim is to compare results after LAP and OPEN colostomy takedown and Hartmann's reversal. The American College of Surgeons National Surgical Quality Improvement Program database was queried from 2005 to 2012 for CPT procedure codes 44227 (LAP) and 44626 (OPEN). Exclusion criteria included: ventilator dependence, ASA class 4 or 5, SIRS, sepsis, emergency case, and advanced malignancy. Demographic parameters were assessed as well as comorbidities and short-term outcomes. Statistical methods used include Fisher's exact test for categorical variables and Student's t test for continuous variables. In total, 4,148 patients underwent stoma closure and Hartmann's reversal (LAP 732 [17.6 %], OPEN 3,416 [82.3 %]). The mean BMI was lower in the LAP (mean +/- A SD 27.6 +/- A 6.6) versus OPEN group (28.3 +/- A 6.8, p = 0.012). The groups were similar as regards comorbidities except for dyspnea (LAP 5.6 %, OPEN 7.8 %, p = 0.043). The mean surgery times were similar and the median LOS shorter in the LAP versus OPEN groups (5 vs 6 days, p < 0.0001). A lower overall morbidity rate was noted for the LAP group (18.4 % vs OPEN 27 %, p < 0.0001) but mortality was statistically similar. Lower rates were noted in the LAP group for the following complications: incisional SSI (10.4 vs 14.1 %, p = 0.033), organ space SSI (3.1 vs 5.0 %, p = 0.033), UTI (1.6 vs 3.3 %, p = 0.005), sepsis (3.4 vs 6.0 %, p = 0.038), and reoperation (3.1 vs 5.4 %, p = 0.011). Only 18 % of Hartmann's reversal's were done using LAP methods. The LAP and OPEN groups were similar except for gender, BMI, and dyspnea history. LAP methods were associated with a 1 day LOS benefit and significantly lower overall morbidity and lower rates of incisional and deep SSI, UTI, sepsis, and reoperations. Operative length was similar. The short-term results of the LAP approach are superior to the OPEN results.	[Arkenbosch, Jeanine; Miyagaki, Hiromichi; Kumara, H. M. C. Shantha; Yan, Xiaohong; Cekic, Vesna; Whelan, Richard L.] Mt Sinai Roosevelt Hosp, Dept Surg, Div Colon & Rectal Surg, New York, NY 10019 USA; [Miyagaki, Hiromichi] Saiseika Senri Hosp, Dept Surg, Suita, Osaka 5650862, Japan; [Whelan, Richard L.] Icahn Sch Med Mt Sinai, New York, NY 10029 USA	Whelan, RL (reprint author), Mt Sinai Roosevelt Hosp, Dept Surg, Div Colon & Rectal Surg, Suite 7B,425 West,59th St, New York, NY 10019 USA.	hmsach_6@yahoo.com; rwhelan@chpnet.org					American College of Surgeons National Surgical Quality Improvement Program, 2008, US GUID 2007 PART US; BRUUSGAARD C, 1947, SURGERY, V22, P466; GOREY TF, 1993, BRIT J SURG, V80, P109, DOI 10.1002/bjs.1800800135; BOYDEN AM, 1950, ANN SURG, V132, P94; van de Wall BJM, 2010, J GASTROINTEST SURG, V14, P743, DOI 10.1007/s11605-009-1084-3; Mazeh H, 2009, SURG ENDOSC, V23, P496, DOI 10.1007/s00464-008-0052-4; Haughn C, 2008, DIS COLON RECTUM, V51, P1232, DOI 10.1007/s10350-008-9264-x; Antolovic D, 2011, LANGENBECK ARCH SURG, V396, P989, DOI 10.1007/s00423-011-0763-1; Gooszen AW, 2001, BRIT J SURG, V88, P693, DOI 10.1046/j.1365-2168.2001.01748.x; Vermeulen J, 2010, J GASTROINTEST SURG, V14, P651, DOI 10.1007/s11605-010-1155-5; Banerjee S, 2005, COLORECTAL DIS, V7, P454, DOI 10.1111/j.1463-1318.2005.00862.x; Cellini C, 2013, BRIT J SURG, V100, P1094, DOI 10.1002/bjs.9153; Golash Vishwanath, 2006, J Minim Access Surg, V2, P211, DOI 10.4103/0972-9941.28182; Holland JC, 2002, SURG LAPARO ENDO PER, V12, P291, DOI 10.1097/01.SLE.0000025147.21417.45; Parkin E, 2013, SURG LAPARO ENDO PER, V23, P41, DOI 10.1097/SLE.0b013e3182803163; Riansuwan W, 2009, DIS COLON RECTUM, V52, P1400, DOI 10.1007/DCR.0b013e3181a79575	16	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0930-2794	1432-2218		SURG ENDOSC	Surg. Endosc.	AUG	2015	29	8					2109	2114		10.1007/s00464-014-3926-7		6	Surgery	Surgery	CM9QF	WOS:000358043100006		
J	Kinoshita, H; Nakagawa, K; Usui, Y; Iwamura, M; Ito, A; Miyajima, A; Hoshi, A; Arai, Y; Baba, S; Matsuda, T				Kinoshita, Hidefumi; Nakagawa, Ken; Usui, Yukio; Iwamura, Masatsugu; Ito, Akihiro; Miyajima, Akira; Hoshi, Akio; Arai, Yoichi; Baba, Shiro; Matsuda, Tadashi			High-definition resolution three-dimensional imaging systems in laparoscopic radical prostatectomy: randomized comparative study with high-definition resolution two-dimensional systems	SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES			English	Article						Three-dimensional (3D) imaging; High-definition (HD) resolution; Suturing feasibility; Randomized comparative study; Laparoscopic radical prostatectomy	PARTIAL NEPHRECTOMY; AUGMENTED REALITY; LEARNING-CURVE; PERFORMANCE; SURGERY; VISION	Three-dimensional (3D) imaging systems have been introduced worldwide for surgical instrumentation. A difficulty of laparoscopic surgery involves converting two-dimensional (2D) images into 3D images and depth perception rearrangement. 3D imaging may remove the need for depth perception rearrangement and therefore have clinical benefits. We conducted a multicenter, open-label, randomized trial to compare the surgical outcome of 3D-high-definition (HD) resolution and 2D-HD imaging in laparoscopic radical prostatectomy (LRP), in order to determine whether an LRP under HD resolution 3D imaging is superior to that under HD resolution 2D imaging in perioperative outcome, feasibility, and fatigue. One-hundred twenty-two patients were randomly assigned to a 2D or 3D group. The primary outcome was time to perform vesicourethral anastomosis (VUA), which is technically demanding and may include a number of technical difficulties considered in laparoscopic surgeries. VUA time was not significantly shorter in the 3D group (26.7 min, mean) compared with the 2D group (30.1 min, mean) (p = 0.11, Student's t test). However, experienced surgeons and 3D-HD imaging were independent predictors for shorter VUA times (p = 0.000, p = 0.014, multivariate logistic regression analysis). Total pneumoperitoneum time was not different. No conversion case from 3D to 2D or LRP to open RP was observed. Fatigue was evaluated by a simulation sickness questionnaire and critical flicker frequency. Results were not different between the two groups. Subjective feasibility and satisfaction scores were significantly higher in the 3D group. Using a 3D imaging system in LRP may have only limited advantages in decreasing operation times over 2D imaging systems. However, the 3D system increased surgical feasibility and decreased surgeons' effort levels without inducing significant fatigue.	[Kinoshita, Hidefumi; Matsuda, Tadashi] Kansai Med Univ, Dept Urol & Androl, Hirakata, Osaka 5731010, Japan; [Nakagawa, Ken; Miyajima, Akira] Keio Univ, Sch Med, Dept Urol, Tokyo, Japan; [Usui, Yukio; Hoshi, Akio] Tokai Univ Hosp, Dept Urol, Isehara, Kanagawa, Japan; [Iwamura, Masatsugu; Baba, Shiro] Kitasato Univ, Sch Med, Dept Urol, Sagamihara, Kanagawa 228, Japan; [Ito, Akihiro; Arai, Yoichi] Tohoku Univ, Grad Sch Med, Dept Urol, Sendai, Miyagi 980, Japan	Matsuda, T (reprint author), Kansai Med Univ, Dept Urol & Androl, 2-5-1 Shin Machi, Hirakata, Osaka 5731010, Japan.	matsudat@hirakata.kmu.ac.jp			Olympus Medical Systems Corp.	Drs. Hidefumi Kinoshita, Ken Nakagawa, Yukio Usui, Masatsugu Iwamura, Akihiro Ito, Yoichi Arai, Shiro Baba, and Tadashi Matsuda have received honoraria and research funding from Olympus Medical Systems Corp. Drs. Akira Miyajima and Akio Hoshi have received research funding from Olympus Medical Systems Corp.	Beller S, 2007, ANN SURG, V246, P288, DOI 10.1097/01.sla.0000264233.48306.99; Wagner OJ, 2012, SURG ENDOSC, V26, P2961, DOI 10.1007/s00464-012-2295-3; Secin FP, 2010, J UROLOGY, V184, P2291, DOI 10.1016/j.juro.2010.08.003; Vickers AJ, 2009, LANCET ONCOL, V10, P475, DOI 10.1016/S1470-2045(09)70079-8; Ukimura O, 2012, EUR UROL, V61, P211, DOI 10.1016/j.eururo.2011.07.068; Mueller MD, 1999, SURG ENDOSC-ULTRAS, V13, P469; Su LM, 2009, UROLOGY, V73, P896, DOI 10.1016/j.urology.2008.11.040; Herron DM, 1999, SURG ENDOSC, V13, P751, DOI 10.1007/s004649901092; Badani KK, 2005, J ENDOUROL, V19, P1212, DOI 10.1089/end.2005.19.1212; Ficarra V, 2009, EUR UROL, V55, P1037, DOI 10.1016/j.eururo.2009.01.036; Storz P, 2012, SURG ENDOSC, V26, P1454, DOI 10.1007/s00464-011-2055-9; Hanna GB, 1998, LANCET, V351, P248, DOI 10.1016/S0140-6736(97)08005-7; Taffinder N, 1999, SURG ENDOSC-ULTRAS, V13, P1087, DOI 10.1007/s004649901179; SIMONSON E, 1959, AM J OPHTHALMOL, V47, P556; Teber D, 2009, EUR UROL, V56, P332, DOI 10.1016/j.eururo.2009.05.017; Radtke A, 2010, ANN SURG, V252, P876, DOI 10.1097/SLA.0b013e3181fdd012; Hara AK, 1997, RADIOLOGY, V205, P59; Kong SH, 2010, SURG ENDOSC, V24, P1132, DOI 10.1007/s00464-009-0740-8; Blavier A, 2006, ACTA CHIR BELG, V106, P662; Good DW, 2013, WORLD J UROL, V32, P1225; Hagiike M, 2007, SURG ENDOSC, V21, P1849, DOI 10.1007/s00464-007-9541-0; Hanna GB, 2000, WORLD J SURG, V24, P444; Kennedy RS, 1993, INT J AVIAT PSYCHOL, V3, P203, DOI DOI 10.1207/S15327108IJAP0303_; Lagrange CA, 2008, J ENDOUROL, V22, P511, DOI 10.1089/end.2007.0241; Solimini AG, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-779; Ukimura O, 2010, CURR OPIN UROL, V20, P136, DOI 10.1097/MOU.0b013e3283362610; van Bergen P, 2000, SURG ENDOSC-ULTRAS, V14, P71, DOI 10.1007/s004649900015; Voorhorst FA, 1996, MED PROG TECHNOL, V21, P211, DOI 10.1023/A:1016980226787	28	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0930-2794	1432-2218		SURG ENDOSC	Surg. Endosc.	AUG	2015	29	8					2203	2209		10.1007/s00464-014-3925-8		7	Surgery	Surgery	CM9QF	WOS:000358043100018		
J	Shirobe, T; Maruyama, S				Shirobe, Takashi; Maruyama, Shotaro			Laparoscopic radical cholecystectomy with lymph node dissection for gallbladder carcinoma	SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES			English	Article						Laparoscopic radical cholecystectomy; Gallbladder carcinoma; Lymph node dissection	SUBSEROSAL LAYER; CANCER	Laparoscopic surgery has been widely employed in the field of digestive surgery, since the minimally invasive procedure provides a significant benefit to patients. However, laparoscopic curative surgery for gallbladder cancer has been rarely described. The aim of this study was to evaluate the effectiveness and validity of laparoscopic radical cholecystectomy with lymph node dissection (Lap-RC) to treat with T1b/T2 gallbladder carcinoma. A total of 11 patients underwent Lap-RC for gallbladder carcinoma from November 2001 until June 2013. While 4 patients were preoperatively diagnosed with T1b/T2 gallbladder carcinoma, 7 patients were diagnosed with incidental T1b/T2 gallbladder carcinoma by postoperative pathological examination after laparoscopic cholecystectomy. Common bile duct resection and biliary tract reconstruction were performed in 2 cases. End points in this clinical study were tumor recurrence and survival of patients. Mean operative time was 196 min, and average hospital stay after surgery was 6.4 days, excluding 2 cases with biliary tract reconstruction. One patient died of recurrence of cancer 89 months after surgery, and another patient died of other reason with local recurrence 39 months after the operation. The other 9 patients were all alive without recurrence at this writing. The 5-year survival rate was 100 % for T1b patients and 83.3 % for T2. These results indicate that almost equivalent outcomes compared with open surgery in terms of curability were achieved. We conclude that pure laparoscopic radical cholecystectomy with lymph node dissection is safe and beneficial for the patients with T1b/T2 gallbladder carcinoma.	[Shirobe, Takashi] Chiba Tokushukai Hosp, Dept Surg, Funabashi, Chiba 2748503, Japan; [Maruyama, Shotaro] Tamakyuryo Hosp, Dept Surg, Tokyo, Japan	Shirobe, T (reprint author), Chiba Tokushukai Hosp, Dept Surg, 2-11-1 Takanedai, Funabashi, Chiba 2748503, Japan.	takashishirobe@gmail.com					Sun CD, 2005, J SURG ONCOL, V91, P253, DOI 10.1002/jso.20318; Jin KT, 2011, CLIN TRANSL ONCOL, V13, P25, DOI 10.1007/s12094-011-0613-1; SHIRAI Y, 1992, ANN SURG, V215, P326, DOI 10.1097/00000658-199204000-00004; Chijiiwa K, 2001, J AM COLL SURGEONS, V192, P600, DOI 10.1016/S1072-7515(01)00814-6; Cavallaro A, 2012, WORLD J GASTROENTERO, V18, P4019, DOI 10.3748/wjg.v18.i30.4019; Varshney S, 2002, EUR J SURG ONCOL, V28, P4, DOI 10.1053/ejso.2001.1175; Cangemi V, 2006, TUMORI, V92, P487; Chan KM, 2006, SURG ENDOSC, V20, P1867, DOI 10.1007/s00464-005-0195-5; Toyonaga T, 2003, WORLD J SURG, V27, P266, DOI 10.1007/s00268-002-6609-9; de Aretxabala X, 2006, J GASTROINTEST SURG, V10, P186, DOI 10.1016/j.gassur.2005.11.003; Evrard S, 1997, WORLD J SURG, V21, P353; Gumbs AA, 2010, SURG ENDOSC, V24, P1766, DOI 10.1007/s00464-009-0840-5; Hu JB, 2008, WORLD J GASTROENTERO, V14, P6428, DOI 10.3748/wjg.14.6428; Koshenkov VP, 2013, J SURG ONCOL, V107, P118, DOI 10.1002/jso.23239; Lai Eric C H, 2013, Asian J Endosc Surg, V6, P158, DOI 10.1111/ases.12040; Lee JM, 2011, AM SURGEON, V77, P697; Misra MC, 2006, J SURG ONCOL, V93, P690, DOI 10.1002/jso.20537; Morise Z, 2011, Asian J Endosc Surg, V4, P143, DOI 10.1111/j.1758-5910.2011.00081.x; Shirai Y, 2012, WORLD J GASTROENTERO, V18, P2775, DOI 10.3748/wjg.v18.i22.2775; Suzuki K, 2000, SURG ENDOSC, V14, P712, DOI 10.1007/s004640000145; Wakai T, 2002, WORLD J SURG, V26, P867, DOI 10.1007/s00268-002-6274-z; WIBBENMEYER LA, 1995, J AM COLL SURGEONS, V181, P504; Yamaguchi K, 1996, ARCH SURG-CHICAGO, V131, P981; Yamamoto H, 2005, J HEPATO-BILIARY-PAN, V12, P391, DOI 10.1007/s00534-005-0996-x	24	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0930-2794	1432-2218		SURG ENDOSC	Surg. Endosc.	AUG	2015	29	8					2244	2250		10.1007/s00464-014-3932-9		7	Surgery	Surgery	CM9QF	WOS:000358043100023		
J	Yoshida, M; Kakushima, N; Tokunaga, M; Tanaka, M; Takizawa, K; Imai, K; Hotta, K; Matsubayashi, H; Tanizawa, Y; Bando, E; Kawamura, T; Terashima, M; Ono, H				Yoshida, Masao; Kakushima, Naomi; Tokunaga, Masanori; Tanaka, Masaki; Takizawa, Kohei; Imai, Kenichiro; Hotta, Kinichi; Matsubayashi, Hiroyuki; Tanizawa, Yutaka; Bando, Etsuro; Kawamura, Taiichi; Terashima, Masanori; Ono, Hiroyuki			Efficacy and long-term outcome of pre-emptive endoscopic resection and surgery for multiple synchronous gastric cancers	SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES			English	Article						Gastric cancer; Endoscopic resection; Gastrectomy; Minimally invasive surgery; Quality of life	QUALITY-OF-LIFE; SUBMUCOSAL DISSECTION; MUCOSAL RESECTION; REMNANT STOMACH; GASTRECTOMY; COHORT; NEOPLASMS	In cases of synchronous gastric cancers (SGC) that include one for surgical indication and another for endoscopic resection (ER) in two different regions of the stomach, patients can avoid total gastrectomy and undergo subtotal gastrectomy following successful pre-emptive ER. The aim of this study was to evaluate the feasibility and efficacy of pre-emptive endoscopic resection and surgery (PRES) with curative intent for such SGCs. Between September 2002 and December 2012, 34 patients with SGCs (72 lesions) underwent PRES. Our institutional principals of PRES ensure the following: (1) treatment with curative intent, (2) multiple lesions indicated for ER and surgery, (3) evasion of TG following successful pre-emptive ER, (4) exclusion of type 4 and large type 3 (> 80 mm) tumors, and (5) nonemergent cases such as hemorrhage, perforation, and obstruction. Clinicopathological characteristics and technical data were evaluated for all patients, and long-term outcomes were analyzed in patients who obtained curative ER and underwent subtotal gastrectomy. Curative ER was obtained in 31 patients (91.1 %), and subtotal gastrectomy was performed a median of 44 days after ER. Final stages were as follows: stage I, 25 patients (80.6 %); stage II, four patients (12.9 %); stage III, one patient (3.2 %); and stage IV, one patient (3.2 %). The 5-year overall and cause-specific survival rates were 96.3 % (95 % confidence interval 89.4-100 %) and 100 %, respectively. PRES was feasible and effective as the first treatment of choice for multiple SGCs. PRES enables minimally invasive surgery with promising oncological outcomes.	[Yoshida, Masao; Kakushima, Naomi; Tanaka, Masaki; Takizawa, Kohei; Imai, Kenichiro; Hotta, Kinichi; Matsubayashi, Hiroyuki; Ono, Hiroyuki] Shizuoka Canc Ctr, Div Endoscopy, Nagaizumi, Shizuoka 4118777, Japan; [Tokunaga, Masanori; Tanizawa, Yutaka; Bando, Etsuro; Kawamura, Taiichi; Terashima, Masanori] Shizuoka Canc Ctr, Div Gastr Surg, Nagaizumi, Shizuoka 4118777, Japan	Kakushima, N (reprint author), Shizuoka Canc Ctr, Div Endoscopy, 1007 Shimonagakubo, Nagaizumi, Shizuoka 4118777, Japan.	ma.yoshida@scchr.jp; kakushin-tky@umin.ac.jp		Imai, Kenichiro/0000-0002-9257-5842			Nashimoto A, 2013, GASTRIC CANCER, V16, P1, DOI 10.1007/s10120-012-0163-4; Gotoda T, 2007, GASTRIC CANCER, V10, P1, DOI 10.1007/s10120-006-0408-1; Soetikno R, 2005, J CLIN ONCOL, V23, P4490, DOI 10.1200/JCO.2005.19.935; Hirasawa T, 2009, GASTRIC CANCER, V12, P148, DOI 10.1007/s10120-009-0515-x; Rembacken BJ, 2001, ENDOSCOPY, V33, P709, DOI 10.1055/s-2001-16224; Tanaka M, 2008, DIGESTION, V77, P23, DOI 10.1159/000111484; Kim AR, 2012, ANN SURG, V256, P1008, DOI 10.1097/SLA.0b013e31827661c9; Kiyama T, 2005, J GASTROINTEST SURG, V9, P313, DOI 10.1016/j.gasseur.2004.11.008; Minami S, 2006, GASTROINTEST ENDOSC, V63, P596, DOI 10.1016/j.gie.2005.07.029; Jentschura D, 1997, HEPATO-GASTROENTEROL, V44, P1137; Choi KS, 2011, GASTROINTEST ENDOSC, V73, P942, DOI 10.1016/j.gie.2010.12.032; Chiu PWY, 2012, SURG ENDOSC, V26, P3584, DOI 10.1007/s00464-012-2371-8; Fujishiro M, 2006, ENDOSCOPY, V38, P1001, DOI 10.1055/s-2006-944775; Karanicolas PJ, 2013, ANN SURG, V257, P1039, DOI 10.1097/SLA.0b013e31828c4a19; Iwasaki Y, 2013, J SURG ONCOL, V107, P741, DOI 10.1002/jso.23301; Ichikawa D, 2014, GASTRIC CANCER, V17, P141, DOI 10.1007/s10120-013-0257-7; Ono H, 2001, GUT, V48, P225, DOI 10.1136/gut.48.2.225; Everett SM, 1997, GUT, V41, P142; Jang MY, 2013, KOREAN J INTERN MED, V28, P687, DOI 10.3904/kjim.2013.28.6.687; Gotoda T, 2000, GASTRIC CANCER, V3, P219, DOI 10.1007/PL00011720; Hosokawa O, 2002, ENDOSCOPY, V34, P469, DOI 10.1055/s-2002-32007; Japanese Gastric Canc Assoc, 2011, GASTRIC CANCER, V14, P113, DOI 10.1007/s10120-011-0042-4; Martin RCG, 2002, J AM COLL SURGEONS, V194, P568, DOI 10.1016/S1072-7515(02)01116-X; Nishide N, 2012, ENDOSCOPY, V44, P577, DOI 10.1055/s-0031-1291712; Nonaka S, 2013, GASTROINTEST ENDOSC, V78, P63, DOI 10.1016/j.gie.2013.02.006; Oda Ichiro, 2006, Gastric Cancer, V9, P262, DOI 10.1007/s10120-006-0389-0	26	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0930-2794	1432-2218		SURG ENDOSC	Surg. Endosc.	AUG	2015	29	8					2352	2358		10.1007/s00464-014-3959-y		7	Surgery	Surgery	CM9QF	WOS:000358043100038		
J	Takeyama, H; Yamamoto, H; Hata, T; Takahashi, Y; Ohtsuka, M; Nonaka, R; Inoue, A; Naito, A; Matsumura, T; Uemura, M; Nishimura, J; Takemasa, I; Mizushima, T; Doki, Y; Mori, M				Takeyama, Hiroshi; Yamamoto, Hirofumi; Hata, Taishi; Takahashi, Yusuke; Ohtsuka, Masahisa; Nonaka, Ryoji; Inoue, Akira; Naito, Atsushi; Matsumura, Tae; Uemura, Mamoru; Nishimura, Junichi; Takemasa, Ichiro; Mizushima, Tsunekazu; Doki, Yuichiro; Mori, Masaki			A novel single-stapling technique for colorectal anastomosis: a pre-ligation single-stapling technique (L-SST) in a porcine model	SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES			English	Article						Single-stapling anastomosis (SSA); Single-stapled technique (SST); Double-stapling anastomosis (DSA); Double-stapling technique (DST); Laparoscopy; Laparoscopic surgery; Colorectal neoplasm; SurgiTie (TM)	LOW ANTERIOR RESECTION; INTESTINAL ANASTOMOSIS; RECTAL-CANCER; SMALL-BOWEL; FEASIBILITY; OUTCOMES; SURGERY; DEVICE	In low anterior resections, anastomosis continues to present major problems. Although the single-stapling technique (SST) is considered to be superior to the double-staple technique (DST) in terms of leakage and stenosis, SST requires suturing, which is particularly difficult during laparoscopic surgery. A simpler and safer method of anastomosis is needed. In this study, we developed a pre-ligation SST (L-SST) that does not require suturing and evaluated the usefulness of L-SST in an ex vivo and an in vivo porcine model. Porcine rectums were ligated using SurgiTie (TM) and sharply resected instead of using a linear stapler. The burst pressures of the closed rectums after using a linear stapler and SurgiTie (TM) (each group; n = 5) and the burst pressures of the anastomoses performed with L-SST and DST (each group; n = 4) were measured. During in vivo porcine laparoscopic surgery, we performed and evaluated the feasibility of L-SST. After completing the anastomosis with L-SST, the ligated portion using SurgiTie (TM) was completely removed. The stump closed using SurgiTie (TM) was much stronger than that closed using a stapler (131.2 and 25.6 mmHg, respectively; P = 0.01). The average burst pressure of the anastomoses performed with L-SST was 33.8 mmHg, whereas that performed with DST was 30.5 mmHg. We did not find significant difference between these two groups (P = 0.88). We also confirmed the feasibility of L-SST in an in vivo porcine laparoscopic surgery model. We developed a novel SST, the L-SST. We were able to perform L-SST successfully using an ex vivo porcine rectum and during in vivo porcine laparoscopic surgery.	[Takeyama, Hiroshi; Yamamoto, Hirofumi; Hata, Taishi; Takahashi, Yusuke; Ohtsuka, Masahisa; Nonaka, Ryoji; Inoue, Akira; Naito, Atsushi; Matsumura, Tae; Uemura, Mamoru; Nishimura, Junichi; Takemasa, Ichiro; Mizushima, Tsunekazu; Doki, Yuichiro; Mori, Masaki] Osaka Univ, Grad Sch Med, Dept Surg, Gastroenterol Surg, Suita, Osaka 5650871, Japan	Yamamoto, H (reprint author), Osaka Univ, Grad Sch Med, Dept Surg, Gastroenterol Surg, 2-2 Yamada Oka, Suita, Osaka 5650871, Japan.	hyamamoto@gesurg.med.osaka-u.ac.jp	Nishimura, Junichi/K-8390-2015	Nishimura, Junichi/0000-0001-8220-3423	Japan Surgical Society	This study was supported by a Grant for young surgeon awards from the Japan Surgical Society (to H. Takeyama).	Kawasaki K, 2007, SURG ENDOSC, V21, P1796, DOI 10.1007/s00464-007-9265-1; Leroy J, 2004, SURG ENDOSC, V18, P281, DOI 10.1007/s00464-002-8877-8; Cheung YM, 2009, SURG ENDOSC, V23, P2796, DOI 10.1007/s00464-009-0566-4; GRIFFEN FD, 1990, ANN SURG, V211, P745, DOI 10.1097/00000658-199006000-00014; Ito M, 2008, INT J COLORECTAL DIS, V23, P703, DOI 10.1007/s00384-008-0470-8; Myers SR, 2011, SURG ENDOSC, V25, P3043, DOI 10.1007/s00464-011-1667-4; Stefanidis D, 2010, SURG ENDOSC, V24, P377, DOI 10.1007/s00464-009-0578-0; Poon JTC, 2009, ANN SURG ONCOL, V16, P3038, DOI 10.1245/s10434-009-0603-5; Mirnezami A, 2011, ANN SURG, V253, P890, DOI 10.1097/SLA.0b013e3182128929; COHEN Z, 1983, DIS COLON RECTUM, V26, P231, DOI 10.1007/BF02562484; Kang J, 2013, J GASTROINTEST SURG, V17, P771, DOI 10.1007/s11605-012-2122-0; BLUETT MK, 1986, SOUTHERN MED J, V79, P712, DOI 10.1097/00007611-198606000-00016; Brisinda G, 2009, J SURG ONCOL, V99, P75, DOI 10.1002/jso.21182; Demura Y, 2013, SURG ENDOSC, V27, P4693, DOI 10.1007/s00464-013-3117-y; Fujii S, 2010, SURG ENDOSC, V24, P476, DOI 10.1007/s00464-009-0564-6; KNIGHT CD, 1980, SURGERY, V88, P710; Marecik SJ, 2007, AM J SURG, V193, P395, DOI 10.1016/j.amjsurg.2006.12.008; Ruurda JP, 2003, SURG ENDOSC, V17, P236, DOI 10.1007/s00464-002-9016-2; Salameh JR, 2006, AM J SURG, V191, P791, DOI 10.1016/j.amjsurg.2005.05.045; Sanchez-De Pedro F, 2014, SURG ENDOSC, V28, P508, DOI 10.1007/s00464-013-3194-y; Sodergren M, 2011, SURG ENDOSC, V25, P3266, DOI 10.1007/s00464-011-1703-4	21	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0930-2794	1432-2218		SURG ENDOSC	Surg. Endosc.	AUG	2015	29	8					2371	2376		10.1007/s00464-014-3960-5		6	Surgery	Surgery	CM9QF	WOS:000358043100041		
J	Jung, YH; Lee, J; Gromski, MA; Kato, M; Rodriguez, S; Chuttani, R; Matthes, K				Jung, Yunho; Lee, Jongchan; Gromski, Mark A.; Kato, Masayuki; Rodriguez, Sam; Chuttani, Ram; Matthes, Kai			Assessment of the length of myotomy in peroral endoscopic pyloromyotomy (G-POEM) using a submucosal tunnel technique (video)	SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES			English	Article						Stomach; Pylorus; Myotomy	PYLORIC-STENOSIS; BOTULINUM-TOXIN; LAPAROSCOPIC PYLOROMYOTOMY; REFRACTORY GASTROPARESIS; DIABETES-MELLITUS; INJECTION; ACHALASIA; SYMPTOMS	Peroral endoscopic pyloromyotomy is a novel technique that has recently been described in the literature. There is little data to guide the length of myotomy created. The aim of study was to evaluate the proper incision length of the muscular layer during peroral endoscopic pyloromyotomy using a submucosal tunnel technique. The study was designed as a prospective ex vivo study. Fresh ex vivo porcine stomachs from animals weighing 80-100 kg and porcine stomachs from animals weighing 15-25 kg were used for pyloromyotomy. Four different myotomy lengths (1, 2, 3, and 4) were compared in the large animal series and three different myotomy lengths (1, 2, and 3) were compared in the small series. A total of 23 cases of the submucosal tunnel technique were performed by two endoscopists using 12 large stomachs and 11 small stomachs. The mean overall procedure time (+/- SD) of pyloromyotomy was 65.7 (+/- 14.3) min. In the large stomach series, the mean pyloric diameter (+/- SD) and change from baseline (as percentage) following a 1, 2, 3, and 4 pyloromyotomy were 13.3 +/- A 9.5 mm (7.1 %), 20.7 +/- A 11.7 mm (10.6 %), 31.1 +/- A 15.0 mm (15.2 %), and 33.0 +/- A 15.0 mm (16.0 %), respectively. In the small stomach series, the changes of mean pyloric diameter following a 1, 2, and 3 cm pyloromyotomy were 12.2 +/- A 5.6 mm (7.5 %), 23.1 +/- A 7.6 mm (13.1 %), and 28.0 +/- A 10.4 mm (15.5 %), respectively. A 3 cm pyloromyotomy for a large animal series and 2 cm for the small animal series appeared to be most appropriate for enlargement of the pylorus.	[Jung, Yunho; Lee, Jongchan; Gromski, Mark A.; Kato, Masayuki; Chuttani, Ram; Matthes, Kai] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Gastroenterol,Dept Med, Boston, MA 02215 USA; [Jung, Yunho] Soonchunhyang Univ, Coll Med, Dept Med, Div Gastroenterol, Cheonan, South Korea; [Kato, Masayuki] Jikei Univ, Sch Med, Dept Endoscopy, Tokyo, Japan; [Rodriguez, Sam; Matthes, Kai] Harvard Univ, Childrens Hosp Boston, Sch Med, Dept Anesthesiol Perioperat & Pain Med, Boston, MA 02115 USA	Jung, YH (reprint author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Gastroenterol,Dept Med, Boston, MA 02215 USA.	yoonho7575@naver.com; kmatthes@bidmc.harvard.edu					Bromer MQ, 2005, GASTROINTEST ENDOSC, V61, P833, DOI 10.1016/S0016-5107(05)00328-7; von Renteln D, 2012, AM J GASTROENTEROL, V107, P411, DOI 10.1038/ajg.2011.388; Khashab MA, 2013, GASTROINTEST ENDOSC, V78, P764, DOI 10.1016/j.gie.2013.07.019; Jones MP, 2003, AM J GASTROENTEROL, V98, P2122, DOI 10.1016/S0002-9270(03)00754-8; Hibbard ML, 2011, J GASTROINTEST SURG, V15, P1513, DOI 10.1007/s11605-011-1607-6; Maleki D, 2000, ARCH INTERN MED, V160, P2808, DOI 10.1001/archinte.160.18.2808; Miller LS, 2002, AM J GASTROENTEROL, V97, P1653; Fukami N, 2011, GASTROINTEST ENDOSC, V74, P13, DOI 10.1016/j.gie.2010.12.003; Ezzeddine D, 2002, GASTROINTEST ENDOSC, V55, P920, DOI 10.1067/mge.2002.124739; Kawai M, 2012, ENDOSCOPY, V44, P169, DOI 10.1055/s-0031-1291475; MEARIN F, 1986, GASTROENTEROLOGY, V90, P1919; Lee CK, 2010, GASTROINTEST ENDOSC, V72, P889, DOI 10.1016/j.gie.2010.01.035; Bytzer P, 2001, ARCH INTERN MED, V161, P1989, DOI 10.1001/archinte.161.16.1989; Eleftheriadis N, 2012, THER CLIN RISK MANAG, V8, P329, DOI 10.2147/TCRM.S32666; Ibarguen-Secchia E, 2005, GASTROINTEST ENDOSC, V61, P598, DOI 10.1016/S0016-5107(05)00075-1; Costamagna G, 2012, DIGEST LIVER DIS, V44, P827, DOI 10.1016/j.dld.2012.04.003; To T, 2005, ARCH PEDIAT ADOL MED, V159, P520, DOI 10.1001/archpedi.159.6.520; Coleski R, 2009, DIGEST DIS SCI, V54, P2634, DOI 10.1007/s10620-008-0660-9; Dinkevich E, 2000, Pediatr Rev, V21, P249; Haricharan RN, 2008, J PEDIATR SURG, V43, P92, DOI 10.1016/j.jpedsurg.2007.09.026; HOUGHTON LA, 1988, GASTROENTEROLOGY, V94, P1285; Ostlie DJ, 2004, SURGERY, V136, P827, DOI 10.1016/j.surg.2004.06.020	22	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0930-2794	1432-2218		SURG ENDOSC	Surg. Endosc.	AUG	2015	29	8					2377	2384		10.1007/s00464-014-3948-1		8	Surgery	Surgery	CM9QF	WOS:000358043100042		
J	Conrad, C; Ogiso, S; Inoue, Y; Shivathirthan, N; Gayet, B				Conrad, Claudius; Ogiso, Satoshi; Inoue, Yosuke; Shivathirthan, Nairuthya; Gayet, Brice			Laparoscopic parenchymal-sparing liver resection of lesions in the central segments: feasible, safe, and effective	SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES			English	Article						Laparoscopic liver resection; Laparoscopic hepatectomy; Mesohepatectomy; Colorectal metastasis; Central liver resection; Synchronous liver resection	LOCATED HEPATOCELLULAR-CARCINOMA; OPEN HEPATIC RESECTION; CENTRAL HEPATECTOMY; MESOHEPATECTOMY; TUMORS; APPRAISAL; IMPACT	Here we report the first systematic evaluation of laparoscopic parenchymal-sparing segmentectomies for the resection of lesions in the central liver segments and the first series of laparoscopic mesohepatectomies. From 1995 to 2012, 482 laparoscopic hepatectomies were performed. Thirty-two patients underwent isolated resection of IVa and VIII, bisegmentectomies of IVa/IVb and V/VIII, or mesohepatectomy. Sixteen isolated resections of IVb or V were excluded. Data was extracted from a retrolective database and chart review. Complications were classified (Clavien-Dindo) by three independent surgeons. Seventeen patients had colorectal liver metastasis, four had neuroendocrine tumors, five had hepatocellular carcinoma, two had GIST, and one each had esophageal cancer, breast cancer, and melanoma. Fifteen patients underwent anatomic- and 17 non-anatomic wedge resection. Average blood loss was 403 cc (SD 475), and overall operative time was 183 (SD 106) for hepatectomy and 253 min (SD 94) for mesohepatectomies. Major complications were mainly attributable to synchronous procedures. Mortality, transfusion, and morbidity rates were 0, 12, and 37 %, respectively. Parenchymal-sparing laparoscopic central liver resections and mesohepatectomies are feasible, safe, and effective if specific technical details we have learned over time are considered. Concomitant procedures should be an exception. This approach exhibits an alternative to open surgery while avoiding unnecessary sacrifice of functional parenchyma.	[Conrad, Claudius; Ogiso, Satoshi; Shivathirthan, Nairuthya; Gayet, Brice] Paris Descartes Univ, Inst Mutulatiste Montsouris, Dept Digest Pathol, Paris, France; [Conrad, Claudius] Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Unit 1484, Houston, TX 77030 USA; [Inoue, Yosuke] Univ Tokyo, Canc Inst Hosp, Tokyo, Japan	Conrad, C (reprint author), Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Unit 1484, 1515 Holcombe Blvd, Houston, TX 77030 USA.	cconrad1@mdanderson.org					Machado MA, 2011, SURG ENDOSC, V25, P2020, DOI 10.1007/s00464-010-1483-2; Nguyen KT, 2011, ARCH SURG-CHICAGO, V146, P348, DOI 10.1001/archsurg.2010.248; Stratopoulos C, 2007, SURG ONCOL, V16, P99, DOI 10.1016/j.suronc.2007.05.002; Chouillard E, 2003, ANN SURG, V238, P29, DOI 10.1097/01.sla.0000075058.37052.49; Scudamore CH, 2000, AM J SURG, V179, P356, DOI 10.1016/S0002-9610(00)00374-3; Eguchi S, 2008, SURGERY, V143, P469, DOI 10.1016/j.surg.2007.12.003; Croome KP, 2010, ARCH SURG-CHICAGO, V145, P1109, DOI 10.1001/archsurg.2010.227; Wu CC, 1999, J AM COLL SURGEONS, V188, P508, DOI 10.1016/S1072-7515(99)00026-5; Hasegawa K, 2005, ANN SURG, V242, P252, DOI 10.1097/01.sla.0000171307.37401.db; [Anonymous], COMM CANC TYP; Hu R, 2003, SURGERY, V133, P251, DOI 10.1067/msy.2003.102; Buell JF, 2009, ANN SURG, V250, P825, DOI 10.1097/SLA.0b013e3181b3b2d8; Chen XP, 2008, INT J COLORECTAL DIS, V23, P543, DOI 10.1007/s00384-007-0411-y; Eltawil KM, 2010, WORLD J SURG ONCOL, V8, DOI 10.1186/1477-7819-8-43; Jacobs M, 2003, AM SURGEON, V69, P186; Jarnagin William R, 2002, Ann Surg, V236, P397; MCBRIDE CM, 1972, ARCH SURG-CHICAGO, V105, P289; Mehrabi A, 2008, J AM COLL SURGEONS, V207, P499, DOI 10.1016/j.jamcollsurg.2008.05.024; Miwa S, 2007, J HEPATO-BILIARY-PAN, V14, P136, DOI 10.1007/s00534-006-1107-3; Strasberg SM, 2000, HPB, V2, P33; Yoon YS, 2009, J LAPAROENDOSC ADV S, V19, P653, DOI 10.1089/lap.2009.0012	21	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0930-2794	1432-2218		SURG ENDOSC	Surg. Endosc.	AUG	2015	29	8					2410	2417		10.1007/s00464-014-3924-9		8	Surgery	Surgery	CM9QF	WOS:000358043100048		
J	Oshikiri, T; Yasuda, T; Harada, H; Goto, H; Oyama, M; Hasegawa, H; Ohara, T; Sendo, H; Nakamura, T; Fujino, Y; Tominaga, M; Kakeji, Y				Oshikiri, Taro; Yasuda, Takashi; Harada, Hitoshi; Goto, Hironobu; Oyama, Masato; Hasegawa, Hiroshi; Ohara, Tadayuki; Sendo, Hiroyoshi; Nakamura, Tetsu; Fujino, Yasuhiro; Tominaga, Masahiro; Kakeji, Yoshihiro			A new method (the "Bascule method") for lymphadenectomy along the left recurrent laryngeal nerve during prone esophagectomy for esophageal cancer	SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES			English	Article						Prone esophagectomy; Lymphadenectomy; Left recurrent laryngeal nerve; Esophageal cancer; Lateral pedicle; Bascule method	LYMPH-NODE DISSECTION; THORACIC ESOPHAGUS; CARCINOMA	In esophageal cancer, lymph nodes along the recurrent laryngeal nerves (RLNs) are thought to be highly involved. Complete dissection of these lymph nodes is recommended but there is limited working space in the left upper mediastinum and advanced dissection skills are required. We present herein a new method for lymphadenectomy along the left RLN, called the Bascule method during prone esophagectomy. The fundamental concept of this new method is to draw the proximal portion of the divided esophagus and tissue that includes the left RLN and lymph nodes through a gap between the vertebral body and the right scapula. Using this technique, a two-dimensional membrane, similar to the "esophageal mesenteriolum" (lateral pedicle), will be easily recognizable. Identification and reliable cutting of the tracheoesophageal artery and distinguishing the left RLN from the lymph nodes should be easy. This technique was evaluated in 39 consecutive cases of prone esophagectomy for squamous cell cancer. There were 18 patients who underwent the new method (Bascule method; Bm) and 21 patients who underwent the conventional method (Cm). The duration of the thoracic procedure and dissection along the left RLN was significantly shorter in Bm group than in Cm group (258 +/- A 30 vs. 291 +/- A 39 min; p = 0.007 and 66 +/- A 9 vs. 75 +/- A 14 min; p = 0.036, respectively). Estimated blood loss in Bm group was 20 +/- A 11 g compared to 38 +/- A 32 g in Cm group (p = 0.028). No intraoperative morbidity related to the left RLN was observed in either group. The hoarseness rate in Bm group was 28 %, which was lower than that in the Cm group (48 %). The Bascule method for lymphadenectomy along the left RLN during prone esophagectomy is technically safe and feasible and reduces operative time and blood loss.	[Oshikiri, Taro; Yasuda, Takashi; Harada, Hitoshi; Goto, Hironobu; Oyama, Masato; Hasegawa, Hiroshi; Ohara, Tadayuki; Sendo, Hiroyoshi; Fujino, Yasuhiro; Tominaga, Masahiro] Hyogo Canc Ctr, Dept Gastroenterol Surg, Akashi, Hyogo 6738558, Japan; [Nakamura, Tetsu; Kakeji, Yoshihiro] Kobe Univ, Grad Sch Med, Dept Surg, Div Gastrointestinal Surg,Chuo Ku, Kobe, Hyogo 6500017, Japan	Oshikiri, T (reprint author), Hyogo Canc Ctr, Dept Gastroenterol Surg, 13-70 Kitaoji Cho, Akashi, Hyogo 6738558, Japan.	taro_oshikiri@hp.pref.hyogo.jp					Noshiro H, 2010, SURG ENDOSC, V24, P2965, DOI 10.1007/s00464-010-1072-4; Palanivelu C, 2006, J AM COLL SURGEONS, V203, P7, DOI 10.1016/j.jamcollsurg.2006.03.016; AKIYAMA H, 1994, ANN SURG, V220, P364, DOI 10.1097/00000658-199409000-00012; Watanabe H, 2000, Recent Results Cancer Res, V155, P123; Rice TW, 2010, ANN SURG ONCOL, V17, P1721, DOI 10.1245/s10434-010-1024-1; SALASSA JR, 1977, ANN THORAC SURG, V24, P100; Shiozaki H, 2001, DIS ESOPHAGUS, V14, P191, DOI 10.1046/j.1442-2050.2001.00206.x; Cuschieri A, 1992, J R Coll Surg Edinb, V37, P7; Jianyuan Chai M, 2012, WORLD J GASTROENTERO, V18, P6521; Nishimaki T, 1997, SURG TODAY, V27, P3; Osugi H, 2003, BRIT J SURG, V90, P108, DOI 10.1002/bjs.4022; Tsurumaru M, 2001, Ann Thorac Cardiovasc Surg, V7, P325; WATSON A, 1994, WORLD J SURG, V18, P361	13	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0930-2794	1432-2218		SURG ENDOSC	Surg. Endosc.	AUG	2015	29	8					2442	2450		10.1007/s00464-014-3919-6		9	Surgery	Surgery	CM9QF	WOS:000358043100053		
J	Tanaka, R; Gitelis, M; Meiselman, D; Abar, B; Zapf, M; Carbray, J; Vigneswaran, Y; Zhao, JC; Ujiki, M				Tanaka, Ryota; Gitelis, Matthew; Meiselman, Danny; Abar, Bijan; Zapf, Matthew; Carbray, JoAnn; Vigneswaran, Yalini; Zhao, Jin-Cheng; Ujiki, Michael			Evaluation of Vessel Sealing Performance Among Ultrasonic Devices in a Porcine Model	SURGICAL INNOVATION			English	Article						vessel sealing; burst pressure; ultrasonic device	ELECTROSURGERY; THUNDERBEAT; ENERGY	Background. As new technologies emerge, it is imperative to define which new devices are most likely to provide a reproducible, effective result for the patient and surgeon. The purpose of our study was to analyze 3 commercially available ultrasonic energy devices; the Sonicision (SC), the Harmonic ACE (HA), and the THUNDERBEAT (TB). Material and Methods. Eight female Yorkshire pigs were used for data collection and vessel harvest. Three devices were evaluated and compared with each other with respect to seal failure and cutting speed in vivo. After vessel harvest, one end of the fragment was sent for histological evaluation, and the other was used for burst pressure measurement testing in a blinded fashion. The coagulation and cut levels of all the generators were set up at a similar and constant level. Results. Eighty-four vessels (47 arteries and 37 veins) were tested. Mean vessel diameter was equal among the groups. Cutting speed was significantly faster with TB (3.4 +/- 0.7 seconds) than SC or HA (5.8 +/- 2.4 and 6.1 +/- 3.1 seconds; P < .0001). Burst pressure trended higher after ligation with TB (505.4 +/- 349.4 mm Hg) than SC and HA (435.8 +/- 403.0 and 437.6 +/- 291.3 mm Hg). There were 2 seal failures in the SC group and HA group and none in the TB group. Histologically, the perpendicular width of tissue seal with TB (1.250 +/- 0.55 mm) was significantly longer than that of the SC and the HA (0.772 +/- 0.23 and 0.686 +/- 0.23 mm; P < .0001). Conclusions. TB has proven to provide the most rapid and reliable seal. Therefore, TB may be safer and may decrease time during surgical procedures.	[Tanaka, Ryota; Gitelis, Matthew; Meiselman, Danny; Abar, Bijan; Zapf, Matthew; Carbray, JoAnn; Vigneswaran, Yalini; Zhao, Jin-Cheng; Ujiki, Michael] NorthShore Univ HealthSyst, Evanston, IL 60201 USA; [Tanaka, Ryota; Gitelis, Matthew; Meiselman, Danny; Abar, Bijan; Zapf, Matthew; Carbray, JoAnn; Vigneswaran, Yalini; Zhao, Jin-Cheng; Ujiki, Michael] Univ Chicago, Pritzker Sch Med, Chicago, IL 60637 USA; [Tanaka, Ryota] Kyorin Univ, Sch Med, Tokyo, Japan	Ujiki, M (reprint author), NorthShore Univ HealthSyst, Sect Minimally Invas Surg, Dept Surg, 2650 Ridge Ave, Evanston, IL 60201 USA.	mujiki@northshore.org					Kinoshita T, 1999, SURG ENDOSC-ULTRAS, V13, P621, DOI 10.1007/s004649901055; Seehofer D, 2012, SURG ENDOSC, V26, P2541, DOI 10.1007/s00464-012-2229-0; Newcomb WL, 2009, SURG ENDOSC, V23, P90, DOI 10.1007/s00464-008-9932-x; Landman J, 2003, J UROLOGY, V169, P697, DOI 10.1097/01.ju.0000045160.87700.32; Milsom J, 2012, J LAPAROENDOSC ADV S, V22, P378, DOI 10.1089/lap.2011.0420; Fagotti A, 2014, J MINIM INVAS GYN, V21, P447, DOI 10.1016/j.jmig.2013.12.001; Foschi D, 2002, SURG ENDOSC, V16, P814, DOI 10.1007/s00464-001-9074-x	7	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1553-3506	1553-3514		SURG INNOV	Surg. Innov.	AUG	2015	22	4					338	343		10.1177/1553350615579730		6	Surgery	Surgery	CM8OW	WOS:000357962500002		
J	Marubashi, S; Gotoh, K; Akita, H; Takahashi, H; Sugimura, K; Miyoshi, N; Motoori, M; Kishi, K; Noura, S; Fujiwara, Y; Ohue, M; Yano, M; Ishikawa, O; Sakon, M				Marubashi, Shigeru; Gotoh, Kunihito; Akita, Hirofumi; Takahashi, Hidenori; Sugimura, Keijiro; Miyoshi, Norikatsu; Motoori, Masaaki; Kishi, Kentaro; Noura, Shingo; Fujiwara, Yoshiyuki; Ohue, Masayuki; Yano, Masahiko; Ishikawa, Osamu; Sakon, Masato			Navigation Guidance Using Polyglycolic Acid Felt in Pure Laparoscopic Partial Hepatectomy	SURGICAL INNOVATION			English	Article						image guided surgery; simulation; surgical oncology	HEPATOCELLULAR-CARCINOMA; LIVER RESECTION; TUMOR HEMODYNAMICS; HEPATIC RESECTION; CLINICAL-EXPERIENCE; FIBRIN SEALANT; SUBSEGMENTECTOMY; OUTCOMES; SURGERY; PGA	Background. Appropriate determination of the dissecting plane for removing the tumor blood flow drainage area (TBF-D area) around a hepatocellular carcinoma as well as the tumor itself is essential in pure laparoscopic hepatectomy, but it is often difficult with the usual devices. Navigation technologies have been developed in an attempt to improve the technical accuracy, but they are still under development and cannot be easily applied yet in current clinical practice. To resolve this problem, we created a novel method of using absorbable polyglycolic acid felt (PGA felt) as a navigation guide in pure laparoscopic partial hepatectomy (PLH). Methods. We used a PGA felt cut into the appropriate shape in accordance with the shape determined preoperatively by simulation computed tomography in each case. We applied the felt on the surface of the liver intraoperatively as a guide for PLH. Results. The PGA felt was placed on the surface of the liver, with the central portion of the felt aligned to the central portion of the tumor. The resection line was marked around the felt using monopolar electrocautery. Then, after removing the PGA felt, PLH was successfully performed along the marked line. The surgical margin was confirmed to be adequate in the resected specimen, which showed complete resection of the TBF-D area as well as of the tumor in a comparison with the preoperative computed tomography angiography images. Conclusion. This new technique is easy and safe and enables resection of both the tumor(s) and the TBF-D area appropriately and accurately in PLH.	[Marubashi, Shigeru; Gotoh, Kunihito; Akita, Hirofumi; Takahashi, Hidenori; Sugimura, Keijiro; Miyoshi, Norikatsu; Motoori, Masaaki; Kishi, Kentaro; Noura, Shingo; Fujiwara, Yoshiyuki; Ohue, Masayuki; Yano, Masahiko; Ishikawa, Osamu; Sakon, Masato] Osaka Med Ctr Canc & Cardiovasc Dis, Osaka 5378511, Japan	Marubashi, S (reprint author), Osaka Med Ctr Canc & Cardiovasc Dis, Dept Surg, 1-3-3 Higashinariku, Osaka 5378511, Japan.	s-marubashi@umin.ac.jp					Kenngott HG, 2014, SURG ENDOSC, V28, P933, DOI 10.1007/s00464-013-3249-0; Ho CM, 2013, SURG ENDOSC, V27, P732, DOI 10.1007/s00464-012-2547-2; Kazaryan AM, 2011, SURG ENDOSC, V25, P3881, DOI 10.1007/s00464-011-1815-x; MAKUUCHI M, 1985, SURG GYNECOL OBSTET, V161, P346; Zijlmans M, 2012, MINIM INVASIV THER, V21, P241, DOI 10.3109/13645706.2012.665805; Eguchi S, 2008, SURGERY, V143, P469, DOI 10.1016/j.surg.2007.12.003; Tranchart H, 2010, SURG ENDOSC, V24, P1170, DOI 10.1007/s00464-009-0745-3; Slakey DP, 2013, JSLS-J SOC LAPAROEND, V17, P46, DOI 10.4293/108680812X13517013317716; Hasegawa K, 2005, ANN SURG, V242, P252, DOI 10.1097/01.sla.0000171307.37401.db; Cai XJ, 2008, SURG ENDOSC, V22, P2350, DOI 10.1007/s00464-008-9789-z; Nguyen KT, 2009, ANN SURG, V250, P831, DOI 10.1097/SLA.0b013e3181b0c4df; Polignano FM, 2008, SURG ENDOSC, V22, P2564, DOI 10.1007/s00464-008-0110-y; Lin NC, 2013, ANN SURG, V257, P205, DOI 10.1097/SLA.0b013e31827da7fe; Inoue Y, 2013, AM SURGEON, V79, P495; Kobayashi S, 2011, SURG ENDOSC, V25, P3590, DOI 10.1007/s00464-011-1764-4; Cheung TT, 2013, ANN SURG, V257, P506, DOI 10.1097/SLA.0b013e31827b947a; Volonte F, 2011, J HEPATO-BIL-PAN SCI, V18, P506, DOI 10.1007/s00534-011-0385-6; [Anonymous], 2010, HEPATOL RES S1, V40, P2; Kobayashi S, 2012, HEPATO-GASTROENTEROL, V59, P2564, DOI 10.5754/hge10315; Morino M, 2003, SURG ENDOSC, V17, P1914, DOI 10.1007/s00464-003-9070-4; Imamurai H, 1999, BRIT J SURG, V86, P1032, DOI 10.1046/j.1365-2168.1999.01185.x; Kleemann M, 2012, CASE REP SURG, V2012; Mise Yoshihiro, 2013, Liver Cancer, V2, P55, DOI 10.1159/000346225; NAKAMURA T, 1990, THORAC CARDIOV SURG, V38, P81, DOI 10.1055/s-2007-1013999; Sakon M, 2013, HEPATOL RES, V43, P155, DOI 10.1111/hepr.12001; Sakon M, 2002, ARCH SURG-CHICAGO, V137, P94, DOI 10.1001/archsurg.137.1.94; Sakon M, 2000, J SURG ONCOL, V73, P179, DOI 10.1002/(SICI)1096-9098(200003)73:3<179::AID-JSO13>3.0.CO;2-M; Tsinberg M, 2009, SURG ENDOSC, V23, P847, DOI 10.1007/s00464-008-0262-9; Yamamoto M, 2001, SURGERY, V130, P443, DOI 10.1067/msy.2001.116406	29	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1553-3506	1553-3514		SURG INNOV	Surg. Innov.	AUG	2015	22	4					355	359		10.1177/1553350614547772		5	Surgery	Surgery	CM8OW	WOS:000357962500005		
J	Imai, K; Kawaharada, Y; Ogawa, J; Saito, H; Kudo, S; Takashima, S; Saito, Y; Atari, M; Ito, A; Terata, K; Yoshino, K; Sato, Y; Motoyama, S; Minamiya, Y				Imai, Kazuhiro; Kawaharada, Yasushi; Ogawa, Jun-ichi; Saito, Hajime; Kudo, Satoshi; Takashima, Shinogu; Saito, Yoshitaro; Atari, Maiko; Ito, Aki; Terata, Kaori; Yoshino, Kei; Sato, Yusuke; Motoyama, Satoru; Minamiya, Yoshihiro			Development of a New Magnetometer for Sentinel Lymph Node Mapping Designed for Video-Assisted Thoracic Surgery in Non-Small Cell Lung Cancer	SURGICAL INNOVATION			English	Article						lung cancer; video-assisted thoracic surgery; sentinel lymph node; magnetometer	BREAST-CARCINOMA; SEGMENTECTOMY; LOBECTOMY; BIOPSY; RESECTION; VATS	Background. We previously developed a method for sentinel lymph node (SLN) mapping in non-small cell lung cancer (NSCLC), based on the magnetic force produced by a magnetite tracer already approved for use as a contrast material for magnetic resonance imaging. However, it is difficult to use that technique with video-assisted thoracic surgery (VATS) because the sensing element of the magnetometer is large and thick. The purpose of the present study was to develop a smaller, thinner VATS-compatible magnetometer. Methods. The tracer employed was Ferucarbotran, a colloidal solution of superparamagnetic iron oxide coated with carbodextran. Fifteen patients with clinical stage I NSCLC were enrolled, and each received 1.6 mL of Ferucarbotran, injected intraoperatively at 5 points around the tumor. The magnetic force within the sampling lymph nodes was measured using the new VATS-compatible magnetometer. Results. SLNs were detected in 11 (73.3%) of the 15 patients using the VATS-compatible magnetometer. The average number of SLNs identified per patient was 1.8 (range 0-4). No complications related to the SLN detection method were observed. Conclusions. The new VATS-compatible magnetometer appears to have substantial advantages over techniques using a radioisotope and our earlier magnetometer, as it can be inserted through the small VATS port site.	[Imai, Kazuhiro; Kawaharada, Yasushi; Ogawa, Jun-ichi; Saito, Hajime; Kudo, Satoshi; Takashima, Shinogu; Saito, Yoshitaro; Atari, Maiko; Ito, Aki; Terata, Kaori; Yoshino, Kei; Sato, Yusuke; Motoyama, Satoru; Minamiya, Yoshihiro] Akita Univ, Grad Sch Med, Akita 0108543, Japan	Imai, K (reprint author), Akita Univ, Grad Sch Med, Dept Gen Thorac Surg & Breast & Endocrine Surg, 1-1-1 Hondo, Akita 0108543, Japan.	i-karo@mui.biglobe.ne.jp			Japan Science and Technology Agency [H24 Mori II-1]	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported in part by a Grant-in-Aid for Revitalization Promotion Program (H24 Mori II-1) from the Japan Science and Technology Agency.	Albo D, 2001, AM J SURG, V182, P393, DOI 10.1016/S0002-9610(01)00734-6; Turner RR, 1997, ANN SURG, V226, P271, DOI 10.1097/00000658-199709000-00006; Nakamura K, 2010, JPN J CLIN ONCOL, V40, P271, DOI 10.1093/jjco/hyp156; Nakagawa T, 2003, J THORAC CARDIOV SUR, V126, P563, DOI 10.1016/S0022-5223(03)00216-2; Flores RM, 2009, J THORAC CARDIOV SUR, V138, P11, DOI 10.1016/j.jtcvs.2009.03.030; Petrek JA, 2001, CANCER, V92, P1368, DOI 10.1002/1097-0142(20010915)92:6<1368::AID-CNCR1459>3.0.CO;2-9; Schuchert MJ, 2007, ANN THORAC SURG, V84, P926, DOI 10.1016/j.athoracsur.2007.05.007; Toda H, 2011, ACTA HISTOCHEM CYTOC, V44, P133, DOI 10.1267/ahc.11006; Okada M, 2006, J THORAC CARDIOV SUR, V132, P769, DOI 10.1016/j.jtcvs.2006.02.063; Rueth NM, 2010, ANN THORAC SURG, V89, pS2107, DOI 10.1016/j.athoracsur.2010.03.020; Flores RM, 2007, ANN THORAC SURG, V85, pS710; Haegele J, 2014, INT J NANOMED, V9, P4203, DOI 10.2147/IJN.S49976; Ikeda Norihiko, 2013, Asian J Endosc Surg, V6, P9, DOI 10.1111/ases.12013; Jones DR, 2003, ANN THORAC SURG, V76, P343, DOI 10.1016/S0003-4975(03)00437-5; Koizumi Kiyoshi, 2007, Ann Thorac Cardiovasc Surg, V13, P228; Liptay MJ, 2000, ANN THORAC SURG, V70, P383; Minamiya Y, 2006, ANN THORAC SURG, V81, P327, DOI 10.1016/j.athoracsur.2005.06.005; Nomori H, 2007, J THORAC CARDIOV SUR, V133, P780, DOI 10.1016/j.jtcvs.2006.10.027; Ono Takashi, 2009, Interact Cardiovasc Thorac Surg, V9, P659, DOI 10.1510/icvts.2009.214197; Rubio IT, 2015, EJSO-EUR J SURG ONC, V41, P46, DOI 10.1016/j.ejso.2014.11.006; Shen J, 2002, SEMIN ONCOL, V29, P341, DOI 10.1053/sonc.2002.34112; Sobin LH, 2009, TNM CLASSIFICATION M; Sugi K, 2003, LUNG CANCER-J IASLC, V39, P37, DOI 10.1016/S0169-5002(02)00385-9; Ueda K, 2004, ANN THORAC SURG, V77, P426, DOI 10.1016/S0003-4975(03)01351-1; Waddington W A, 2000, Eur J Nucl Med, V27, P377, DOI 10.1007/s002590050520	25	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1553-3506	1553-3514		SURG INNOV	Surg. Innov.	AUG	2015	22	4					401	405		10.1177/1553350615585421		5	Surgery	Surgery	CM8OW	WOS:000357962500013		
J	Igarashi, Y; Okada, M				Igarashi, Yoichiro; Okada, Makoto			Social innovation through a dementia project using innovation architecture	TECHNOLOGICAL FORECASTING AND SOCIAL CHANGE			English	Article						Technology roadmapping; Innovation architecture; Dementia; Social innovation	SUPPORT TECHNOLOGY IST; ROADMAPPING METHODS; EVOLUTION	This paper discusses a methodology for companies to use in conducting a mid-long term project to find unknown markets or customers emerging in the future. The motivation for doing this study was to establish a practical way to handle emerging market requirements for research and development in turbulent markets with a smaller impact requiring few changes or additions to existing business processes. Many companies understand the significance of having a mid-long term marketing strategy. However, adding different types of workflows could be a burden for companies that are concentrating on their daily business operations. The applied methodology uses technology roadmapping (TRM) tools, which are used in organizations as common and visual languages for discussing strategies. This paper proposes an extended application of a TRM tool and demonstrates that companies can handle the challenges of social innovation with a smaller impact. In the authors' project called "Society Living with Dementia," the company formed a "virtual team" with new stakeholders that a conventional business process would not be able to manage and created shared knowledge. The contribution is a practical example of a private-sector company that establishes relationships in a step-by-step fashion with potential stakeholders including non-profit organizations, policy makers, and people with dementia to address a social issue. (C) 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).	[Igarashi, Yoichiro] Fujitsu Labs Ltd, Fujitsu Res Inst, Kawasaki, Kanagawa 211, Japan; [Okada, Makoto] Int Univ Japan, Fujitsu Labs Ltd, Fujitsu Res Inst, Minamiuonuma, Niigata, Japan	Igarashi, Y (reprint author), Fujitsu Labs Ltd, Fujitsu Res Inst, Kawasaki, Kanagawa 211, Japan.						Abe H., 2006, P PICMET 06 PORTL IN, P66; Abe H, 2013, P PICMET 13 TECHN MA, P2219; ABE H, 2008, P PICMET 08 PORTL IN, P2141; Abe H., 2004, P PICMET 04 PORTL IN; Abe H, 2009, TECHNOL FORECAST SOC, V76, P80, DOI 10.1016/j.techfore.2008.03.027; Abe H, 2007, PORTL INT CONF MANAG, P584, DOI 10.1109/PICMET.2007.4349373; [Anonymous], 2014, WHAT ARE FUTURE CTR; [Anonymous], 2012, ESTIMATION NUMBER OL; [Anonymous], 2012, DEMENTIA CASES SET T; [Anonymous], 2012, RESTORING JAPAN 3 11; Rinne M, 2004, TECHNOL FORECAST SOC, V71, P67, DOI 10.1016/j.techfore.2003.10.002; [Anonymous], 2013, GUIDE SOCIAL RETURN; [Anonymous], 2012, PFIZER J J ALZHEIMER; Di Stefano G, 2012, RES POLICY, V41, P1283, DOI 10.1016/j.respol.2012.03.021; Phaal R, 2004, TECHNOL FORECAST SOC, V71, P5, DOI 10.1016/S0040-1625(03)00072-6; Chujo K, 2013, FUJITSU SCI TECH J, V49, P153; [Anonymous], 2012, DEMENTIA FRIENDSHIP; [Anonymous], 2014, FUJITSU AT A GLANCE; Blair Andrew J, 2009, PICMET '09 - 2009 Portland International Conference on Management of Engineering & Technology, DOI 10.1109/PICMET.2009.5261812; Bryden C., 2012, WHO WILL I BE I DIE; Chesbrough H. W., 2006, OPEN INNOVATION NEW; Dvir R., 2007, IASP C BARC; Hall Samuel Roland, 1924, HDB SALES MANAGEMENT; Hart S. L., 2010, CAPITALISM CROSSROAD; Igarashi Yoichiro, 2009, PICMET '09 - 2009 Portland International Conference on Management of Engineering & Technology, DOI 10.1109/PICMET.2009.5261811; Kida T, 2011, FUJITSU SCI TECH J, V47, P3; Mauboussin Michael J, 2012, HARVARD BUSINESS REV; Mulgan G., 2006, INNOVATIONS, V1, P145, DOI DOI 10.1162/ITGG.2006.1.2.145; Mulgan G., 2007, SOCIAL INNOVATION WH; Nonaka I, 2014, JISSEN SOCIAL INNOVA; Nonaka Ikujiro, 1998, CALIF MANAGE REV, V30; Okada M, 2013, FUJITSU SCI TECH J, V49, P448; Pantano E., 2014, J RETAIL CONSUM SERV, V21, P43; Phaal R., 2001, TECHNOLOGY ROADMAPPI; Phaal R., 2001, T PLAN FAST START TE; Sauber T., 2006, STRUCTURED CREATIVIT; Tschirky H., 2008, DESIGN INTRO EXECUTI, P106; Tschirky H., 2003, TECHNOLOGY INNOVATIO; Uniliever, 2011, UN SUST LIV PLAN PRO, P35	39	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0040-1625	1873-5509		TECHNOL FORECAST SOC	Technol. Forecast. Soc. Chang.	AUG	2015	97						193	204		10.1016/j.techfore.2015.01.001		12	Business; Planning & Development	Business & Economics; Public Administration	CM7VU	WOS:000357905400017		
J	Oguma, T; Hirai, T; Fukui, M; Tanabe, N; Marumo, S; Nakamura, H; Ito, H; Sato, S; Niimi, A; Ito, I; Matsumoto, H; Muro, S; Mishima, M				Oguma, Tsuyoshi; Hirai, Toyohiro; Fukui, Motonari; Tanabe, Naoya; Marumo, Satoshi; Nakamura, Hajime; Ito, Hisao; Sato, Susumu; Niimi, Akio; Ito, Isao; Matsumoto, Hisako; Muro, Shigeo; Mishima, Michiaki			Longitudinal shape irregularity of airway lumen assessed by CT in patients with bronchial asthma and COPD	THORAX			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; COMPUTED-TOMOGRAPHY; WALL THICKNESS; CHEST CT; DIMENSIONS; EMPHYSEMA; SCANS	Background Airway remodelling in bronchial asthma (BA) and COPD has been quantitatively assessed by analysing the airway wall area and the luminal area on cross-sectional CT images. To date, there have been no reports on assessment of the longitudinal structure of the airway lumen. Methods Quantitative airway analysis using CT was performed on three groups consisting of 29 patients with BA, 58 patients with COPD and 59 healthy controls. To assess the longitudinal shape irregularity of the airway lumen, new quantitative CT parameters, validated by a phantom study, were established. The internal radii of imaginary inscribed spheres in the airway lumen were measured as a function of distance from the level of the carina to the fifth-order branches of the right posterior basal bronchus. The gaps of these radii from the regression line were calculated as parameters to reflect the longitudinal airway lumen shape irregularity. These new parameters were compared among the study groups as well as with the conventional parameters of airway wall thickening and luminal area. Results Longitudinal airway lumen shape irregularity was significantly greater in patients with COPD than in those with BA and healthy controls. Wall thickening was significantly greater, and luminal area smaller, in patients with BA than in those with COPD and healthy controls. These results were consistent even among the BA and COPD subgroups with similar airflow limitation. Conclusions The combination of cross-sectional and longitudinal airway structure analyses using CT images may suggest differences in the characteristics of airway remodelling between COPD and asthma.	[Oguma, Tsuyoshi; Hirai, Toyohiro; Tanabe, Naoya; Sato, Susumu; Ito, Isao; Matsumoto, Hisako; Muro, Shigeo; Mishima, Michiaki] Kyoto Univ, Grad Sch Med, Dept Resp Med, Kyoto 6068507, Japan; [Fukui, Motonari; Marumo, Satoshi] Kitano Hosp, Tazuke Kofukai Med Res Inst, Resp Dis Ctr, Osaka, Japan; [Nakamura, Hajime] Kitano Hosp, Tazuke Kofukai Med Res Inst, Dept Prevent Med, Osaka, Japan; [Ito, Hisao] Kitano Hosp, Tazuke Kofukai Med Res Inst, Dept Radiol, Osaka, Japan; [Niimi, Akio] Nagoya City Univ, Grad Sch Med Sci, Dept Med Oncol & Immunol, Nagoya, Aichi, Japan	Hirai, T (reprint author), Kyoto Univ, Grad Sch Med, Dept Resp Med, Sakyo Ku, Kawahara 54, Kyoto 6068507, Japan.	t_hirai@kuhp.kyoto-u.ac.jp			Ministry of Health, Labour and Welfare, Japan [25461156]	This study was partly supported by Grants-in-Aid for scientific research (No 25461156) and a grant to the Respiratory Failure Research Group from the Ministry of Health, Labour and Welfare, Japan.	Nakano Y, 2000, AM J RESP CRIT CARE, V162, P1102; DUNNILL MS, 1969, THORAX, V24, P176, DOI 10.1136/thx.24.2.176; Hasegawa M, 2006, AM J RESP CRIT CARE, V173, P1309, DOI 10.1164/rccm.200601-037OC; MULLER NL, 1988, CHEST, V94, P782, DOI 10.1378/chest.94.4.782; Shimizu K, 2011, RESP MED, V105, P1275, DOI 10.1016/j.rmed.2011.04.007; Niimi A, 2000, AM J RESP CRIT CARE, V162, P1518; [Anonymous], 2004, PUBL NIH, V#02-3659; Mishima M, 1999, P NATL ACAD SCI USA, V96, P8829, DOI 10.1073/pnas.96.16.8829; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Committee of Pulmonary Physiology the Japanese Respiratory Society, 2004, GUID PULM FUNCT TEST; Global Initiative for Obstructive Lung Disease (GOLD), 2011, GLOB STRAT DIAGN MAN; Gupta S, 2010, THORAX, V65, P775, DOI 10.1136/thx.2010.136374; Jeffery PK, 2001, AM J RESP CRIT CARE, V164, P528; Niimi A, 2003, AM J RESP CRIT CARE, V168, P983, DOI 10.1164/rccm.200211.1268OC; Oguma T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076381; Ohara T, 2008, RESPIROLOGY, V13, P372, DOI 10.1111/j.1440-1843.2008.01269.x; Ohara T, 2006, RESPIROLOGY, V11, P579, DOI 10.1111/j.1400-1843.2006.00899.x; SAKAI N, 1994, CHEST, V106, P1319, DOI 10.1378/chest.106.5.1319; Takahashi M, 2011, EUR J RADIOL, V80, pE524, DOI 10.1016/j.ejrad.2010.12.035	19	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0040-6376	1468-3296		THORAX	Thorax	AUG	2015	70	8					719	724		10.1136/thoraxjnl-2014-206651		6	Respiratory System	Respiratory System	CM7UA	WOS:000357900800005		
J	Yoshimura, Y; Nakamura, K; Endo, T; Kajitani, N; Kazuki, K; Kazuki, Y; Kugoh, H; Oshimura, M; Ohbayashi, T				Yoshimura, Yuki; Nakamura, Kazuomi; Endo, Takeshi; Kajitani, Naoyo; Kazuki, Kanako; Kazuki, Yasuhiro; Kugoh, Hiroyuki; Oshimura, Mitsuo; Ohbayashi, Tetsuya			Mouse embryonic stem cells with a multi-integrase mouse artificial chromosome for transchromosomic mouse generation	TRANSGENIC RESEARCH			English	Article						Transchromosomic mice; Mouse artificial chromosome; Gene delivery	SINGLE-COPY; MICE; EXPRESSION; GENES	The mouse artificial chromosome (MAC) has several advantages as a gene delivery vector, including stable episomal maintenance of the exogenous genetic material and the ability to carry large and/or multiple gene inserts including their regulatory elements. Previously, a MAC containing multi-integration site (MI-MAC) was generated to facilitate transfer of multiple genes into desired cells. To generate transchromosomic (Tc) mice containing a MI-MAC with genes of interest, the desired genes were inserted into MI-MAC in CHO cells, and then the MI-MAC was transferred to mouse embryonic stem (mES) cells via microcell-mediated chromosome transfer (MMCT). However, the efficiency of MMCT from CHO to mES cells is very low (< 10(-6)). In this study, we constructed mES cell lines containing a MI-MAC vector to directly insert a gene of interest into the MI-MAC in mES cells via a simple transfection method for Tc mouse generation. The recombination rate of the GFP gene at each attachment site (FRT, PhiC31attP, R4attP, TP901-1attP and Bxb1attP) on MI-MAC was greater than 50 % in MI-MAC mES cells. Chimeric mice with high coat colour chimerism were generated from the MI-MAC mES cell lines and germline transmission from the chimera was observed. As an example for the generation of Tc mice with a desired gene by the MI-MAC mES approach, a Tc mouse strain ubiquitously expressing Emerald luciferase was efficiently established. Thus, the findings suggest that this new Tc strategy employing mES cells and a MI-MAC vector is efficient and useful for animal transgenesis.	[Yoshimura, Yuki; Nakamura, Kazuomi; Ohbayashi, Tetsuya] Tottori Univ, Res Ctr Biosci & Technol, Div Lab Anim Sci, Yonago, Tottori 6838503, Japan; [Yoshimura, Yuki; Kazuki, Yasuhiro; Kugoh, Hiroyuki] Tottori Univ, Inst Regenerat Med & Biofunct, Grad Sch Med Sci, Dept Biomed Sci, Yonago, Tottori 6838503, Japan; [Endo, Takeshi] Org Tottori Ind Promot, Tottori, Tottori 6891112, Japan; [Kajitani, Naoyo; Kazuki, Kanako; Kazuki, Yasuhiro; Kugoh, Hiroyuki; Oshimura, Mitsuo] Tottori Univ, Chromosome Engn Res Ctr CERC, Yonago, Tottori 6838503, Japan	Ohbayashi, T (reprint author), Tottori Univ, Res Ctr Biosci & Technol, Div Lab Anim Sci, 86 Nishi Cho, Yonago, Tottori 6838503, Japan.	oshimura@grape.med.tottori-u.ac.jp; ohbayashi@grape.med.tottori-u.ac.jp			Ministry of Economy, Trade and Industry (METI); JST, CREST; Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT); Human Frontier Science Program	We thank Drs. Kosuke Tomimatsu, Natsumi Noda, Soichi Ozaki and Mr. Yasushi Kuromi for valuable discussion; Ms. Kaoru Shima, Ms. Kayoko Morimoto, Ms. Sanae Okuda, Mr. Naohiro Sunamura and Dr. Yuji Nakayama for technical assistance. This study was supported in part by Ministry of Economy, Trade and Industry (METI) (T.O. and M.O.), JST, CREST (M.O.), Regional Innovation Strategy Support Program from the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT) (T.O. and M.O.), and the Human Frontier Science Program (T.O.).	Kazuki Y, 2013, HUM MOL GENET, V22, P578, DOI 10.1093/hmg/dds468; Geurts AM, 2009, SCIENCE, V325, P433, DOI 10.1126/science.1172447; Kuroiwa Y, 2009, NAT BIOTECHNOL, V27, P173, DOI 10.1038/nbt.1521; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Ren XY, 2006, STEM CELL REV, V2, P43, DOI 10.1385/SCR:2:1:43; Rodriguez CI, 2000, NAT GENET, V25, P139; Tomizuka K, 1997, NAT GENET, V16, P133, DOI 10.1038/ng0697-133; Masliah E, 2000, SCIENCE, V287, P1265, DOI 10.1126/science.287.5456.1265; Olive KP, 2004, CELL, V119, P847, DOI 10.1016/j.cell.2004.11.004; Yang GS, 2009, GENOMICS, V93, P196, DOI 10.1016/j.ygeno.2008.09.014; Sung YH, 2013, NAT BIOTECHNOL, V31, P23, DOI 10.1038/nbt.2477; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Tasic B, 2011, P NATL ACAD SCI USA, V108, P7902, DOI 10.1073/pnas.1019507108; Shi QZ, 2014, BLOOD, V123, P395, DOI 10.1182/blood-2013-08-520478; Christiansen B, 1996, J BACTERIOL, V178, P5164; Katoh M, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-37; Kazuki K, 2013, BIOCHEM BIOPH RES CO, V442, P44, DOI 10.1016/j.bbrc.2013.10.171; Kazuki Y, 2008, GENE THER, V15, P617, DOI 10.1038/sj.gt.3303091; KUHSTOSS S, 1991, J MOL BIOL, V222, P897, DOI 10.1016/0022-2836(91)90584-S; Matssura Manabu, 1996, Journal of Bacteriology, V178, P3374; Mediavilla J, 2000, MOL MICROBIOL, V38, P955, DOI 10.1046/j.1365-2958.2000.02183.x; Mee PJ, 2003, CHROMOSOMA, V112, P183, DOI 10.1007/s00412-003-0260-6; Miyamoto K, 2014, TRANSGENIC RES, V23, P317, DOI 10.1007/s11248-013-9772-x; Nakajima Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010011; Oshimura M, 2013, NEW VECTORS GENE DEL, DOI [10.1002/9780470015902.a0024474, DOI 10.1002/9780470015902.A0024474]; Suzuki T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110404; Takiguchi M, 2014, ACS SYNTH BIOL, V3, P903, DOI 10.1021/sb3000723; Yamaguchi S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017267	28	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0962-8819	1573-9368		TRANSGENIC RES	Transgenic Res.	AUG	2015	24	4					717	727		10.1007/s11248-015-9884-6		11	Biochemical Research Methods; Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology	CM9ZQ	WOS:000358070900010		
J	Kasuga, A				Kasuga, Ayuka			The introduction of the steam press: a court case on smoke and noise nuisances in a London mansion, 1824	URBAN HISTORY			English	Article								It has recently been revealed that English common law played a certain role in dealing with the pollution problems that accompanied industrialization. This article explores the role of legal actions in solving environmental problems, not within a legal theory but in a larger framework of environmental politics. By focusing on legal actions, it is shown that the Act on Smoke Abatement of 1821 triggered smoke and noise nuisance lawsuits in London, especially against printers. The introduction of the steam press not only contributed to the production of cheap prints but also transformed the printing business into a polluting industry. Legal actions could sometimes remove a polluting business from a plaintiff's neighbourhood, though it also raised the problem of environmental inequality.	Kyoto Univ, Grad Sch Global Environm Studies, Sakyo Ku, Kyoto 6068501, Japan	Kasuga, A (reprint author), Kyoto Univ, Grad Sch Global Environm Studies, Sakyo Ku, Yoshida Honmachi, Kyoto 6068501, Japan.						[Anonymous], 1828, MP              1219; [Anonymous], 1828, TIMES; [Anonymous], 1828, MC              0415; [Anonymous], 1824, MC              0429; [Anonymous], 1827, STANDARD        1214; [Anonymous], 1822, LEEDS MERCURY   0427; [Anonymous], 1827, MC              1214; [Anonymous], 1823, MC              1118; [Anonymous], 1824, TIMES; [Anonymous], 1825, MC              0531; [Anonymous], 1784, OXFORD DICT NATL BIO; [Anonymous], 1823, MC              0718; [Anonymous], 1828, MC              0612; [Anonymous], 1820, MORNING CHRONIC 0524; [Anonymous], 1824, EXAMINER        0613, P375; [Anonymous], 1822, LEEDS MERCURY   0921; [Anonymous], 1821, STATUTES UK GREAT BR, P93; [Anonymous], 1825, MC              0121; [Anonymous], 1825, TIMES; [Anonymous], 1822, LEEDS MERCURY   0202; [Anonymous], 1822, LEEDS MERCURY   0302; [Anonymous], 1814, TIMES; [Anonymous], 1820, MORNING POST MP 0525; Ashby E., 1981, POLITICS CLEAN AIR; Bowler C., 2000, ENV HIST, V6, P71, DOI 10.3197/096734000129342226; Brenner J. F., 1974, J LEGAL STUD, V3, P421; Brimblecombe P., 1987, BIG SMOKE HIST AIR P, P101; Cavendish M., 1667, LIFE W CAVENDISHE DU, P85; Clark J., 2007, URBAN HIST, V34, P255, DOI 10.1017/S0963926807004634; Clowes W. B., 1953, FAMILY BUSINESS 1803, P6; Cockayne E., 2007, HUBBUB FILTH NOISE S; Cooper T, 2008, HIST RES, V81, P710; Curtis S., 1941, W CURTIS 1746 1799 F, P84; de Fonblanque E. B., 1887, ANN HOUSE PERCY CONQ, VII, P569; Earwaker J. P., 1889, COURT LEET RECORDS M; Evelyn J., 1661, FUMIFUGIUM; Fox C., 1988, GRAPHIC JOURNALISM E, P143; Goddard N, 1996, J HIST GEOGR, V22, P274, DOI 10.1006/jhge.1996.0017; Graham-Leigh J., 2000, LONDONS WATER WARS C, p[16, 19]; Guerci M., 2008, PERSISTENCE CLASSICA, P136; Gugliotta A, 2000, ENVIRON HIST, V5, P165, DOI 10.2307/3985634; Hamlin C., 1998, PUBLIC HLTH SOCIAL J; Hansard T. C., 1820, PARLIAMENTARY DEBATE, VI, P51; Harling P, 1996, ENGL HIST REV, V111, P1159; Hills R. L., 2006, J WATT, P48; Joyce Patrick, 2003, RULE FREEDOM LIBERAL; Kasuga A., 2013, THESIS U NOTTINGHAM, P125; Lee D., 1994, LORD LYNDHURST FLEXI; Longstaffe-Gowan T., 2001, LONDON TOWN GARDEN 1, P17; Martin V. M., 1985, COPING ABUNDANCE ENE; Massard-Guilbaud G, 2011, ENVIRONMENTAL AND SOCIAL JUSTICE IN THE CITY: HISTORICAL PERSPECTIVES, P1; McLaren J., 1983, OJLS, V3, P160; Merritt J. F., 2005, SOCIAL WORLD EARLY M, P184; Miller P., 1764, GARDENERS DICT; Moran J., 1973, PRINTING PRESSES HIS, P123; Mosley S., 2001, CHIMNEY WORLD HIST S; Otter C., 2008, VICTORIAN EYE POLITI; Payer P, 2007, J URBAN HIST, V33, P773, DOI 10.1177/0096144207301420; Place F., 1972, AUTOBIOGRAPHY F PLAC, p[213, 228]; Pontin B., 2007, ENV LAW MANAGEMENT, V19, P7; Pontin Ben, 2007, ELM, V19, P271; Sheppard F., 1971, LONDON 1808 1870 INF, P29; Shoemaker Robert, 2004, LONDON MOB VIOLENCE; Strasser S., 1999, WASTE WANT SOCIAL HI; Thorsheim Peter, 2006, INVENTING POLLUTION; Tomory L, 2012, ENVIRON HIST-US, V17, P29, DOI 10.1093/envhis/emr093; Vickery Amanda, 2009, CLOSED DOORS HOME GE	67	0	0	CAMBRIDGE UNIV PRESS	CAMBRIDGE	EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND	0963-9268	1469-8706		URBAN HIST	Urban Hist.	AUG	2015	42	3					405	423		10.1017/S0963926814000728		19	History	History	CM2PS	WOS:000357524300003		
J	Hasegawa, J				Hasegawa, Junichi			Urban planning by obliteration of both waterways and opponents: the infilling of canals during the 1950s reconstruction of central Tokyo	URBAN HISTORY			English	Article							BRITAIN	This article examines the infilling of canals constructed in early modern times and subsequent development on newly created land in central Tokyo in the 1950s, following the curtailment of official war-damage reconstruction after World War II. New developments included a high-rise central station building, a four-storey amusement complex, an underground entertainment street and an elevated motorway. The Tokyo Metropolitan Government and Japanese National Railways were driving forces in infilling and development, which resulted in enormous political and social reactions in the local communities, newspapers and the National Diet (Parliament).	Keio Univ, Fac Econ, Minato Ku, Tokyo 1088345, Japan	Hasegawa, J (reprint author), Keio Univ, Fac Econ, Minato Ku, 2-15-45 Mita, Tokyo 1088345, Japan.						Amin A., 2002, CITIES; [Anonymous], 1951, TOKYO SHIMBUN   0918; [Anonymous], 1953, CHOGI, V18; [Anonymous], 1954, MARUNOUCHI TIME 0818; [Anonymous], 1949, METR ASS M 10 MAR, P374; [Anonymous], 1949, METR ASS M 10 MAR, P369; [Anonymous], 1954, YOMIURI         0514; [Anonymous], 1946, ASAHI           1115; [Anonymous], 1954, MARUNOUCHI TIME 0714; [Anonymous], 1953, TOSEI SHINPO    1127; [Anonymous], 1953, CHOGI, V18; [Anonymous], 1953, ASAHI           1120; [Anonymous], 1954, ASAHI           0303; [Anonymous], 1954, YOMIURI         0109; [Anonymous], 1954, MARUNOUCHI TIME 0804; [Anonymous], 1947, ASAHI           0206; [Anonymous], 1954, ASAHI           0404; [Anonymous], 1951, YOMIURI         1102; [Anonymous], 1953, ASAHI           1128; [Anonymous], 1954, METR ASS M 25 MAY, P135; [Anonymous], 1957, YOMIURI         0121; [Anonymous], 1949, YOMIURI         0409; [Anonymous], 1954, ASAHI           1002; [Anonymous], 1953, ASAHI           0331; [Anonymous], 1949, YOMIURI SHIMBUN 0319; [Anonymous], 1948, TOKYO SHIMBUN   0517; [Anonymous], 1948, TOKYO SHIMBUN   0830; [Anonymous], 1951, YOMIURI        1201; [Anonymous], 1952, ASAHI           0818; [Anonymous], 1954, ASAHI           0401; [Anonymous], 1953, TOSEI SHINPO    1009; [Anonymous], 1951, CHOGI, V4; [Anonymous], 1951, SHINSO          0105, P28; [Anonymous], 1959, ASAHI           0111; [Anonymous], 1951, YOMIURI         1108; [Anonymous], 1954, YOMIURI         0907; [Anonymous], 1954, YOMIURI         1021; [Anonymous], 1955, METR ASS M 8 OCT, P190; [Anonymous], 1948, ASAHI           0402; [Anonymous], 1945, ASAHI           1014; [Anonymous], 1954, ASAHI           0410; [Anonymous], 1951, SHINSO          0105, P29; [Anonymous], 1949, ASAHI           1022; [Anonymous], 1959, SHUKAN SHINCHO  0202, P26; [Anonymous], 1954, METR ASS M 30 JUN, P341; [Anonymous], 1946, ASAHI           1128; [Anonymous], 1954, MARUNOUCHI TIME 1020; [Anonymous], 1953, COMMUNICATION, P1; [Anonymous], 1954, YOMIURI         1022; [Anonymous], 1951, ASAHI           1230; [Anonymous], 1954, ASAHI           0320; [Anonymous], 1954, METR ASS M 30 JUN, P334; [Anonymous], 1954, MAINICHI SHIMBU 0208; [Anonymous], 1954, YOMIURI         1030; [Anonymous], 1954, ASAHI           0330; [Anonymous], 1968, ASAHI           1209; [Anonymous], 1952, ASAHI           0528; [Anonymous], 1955, TOSEI SHINPO    0325; [Anonymous], 1954, YOMIURI         0806; [Anonymous], 1951, HOUS COUNC BUDG COMM, P12; [Anonymous], 1948, METR ASS M 30 MAR, P974; [Anonymous], 1954, TOSEI SHINPO    0702; [Anonymous], 1954, METR ASS M 27 JUL, P38; [Anonymous], 1954, YOMIURI         1002; [Anonymous], 1954, YOMIURI         0501; [Anonymous], 1948, TOKYO SHIMBUN   0323; [Anonymous], 1956, ASAHI           0801; Bognar B., 1997, TOKYO; Brayshay M., 2008, URBAN HIST, V35, P437; Diefendorf J. M., 1993, IN THE WAKE OF WAR; Diefendorf J. M., 1990, EUROPES BOMBED CITIE; Ginmekai, 1975, GINZA WAGAMACHI, P184; Gunn S, 2013, SOC HIST, V38, P220, DOI 10.1080/03071022.2013.790139; Hasegawa J., 1992, REPLANNING BLIZED CI; Hasegawa J, 2014, PLAN PERSPECT, V29, P231, DOI 10.1080/02665433.2014.899921; Hasegawa J, 2013, PLAN PERSPECT, V28, P271, DOI 10.1080/02665433.2013.737712; Ishikawa H., 1940, DORO, V2, P9; Ishikawa H., 1940, DORO ROAD, V2, P36; Jackson N., 2013, BLITZ ITS LEGACY; Kensetsusho (Ministry of Construction), 1959, SENSAIFUKKOSHI, VI; Larkham P. J., 2013, PLANNING PERSPECTIVE; Larkham P. J., 2001, PLANNING CITY TOMORR; Maki H., 2010, TOKUMUKIKANCHO KONOM; Minerbi L., 1986, LAND READJUSTMENT JA; Seidensticker E., 1990, TOKYO RISING CITY GR, P147; Sensaifukkoshihenshuiinkai, 1984, SENSAIFUKKOSHI, P36; Sensaifukkoshihenshuiinkai, 1984, SENSAIFUKKOSHI, P40; Smith H. D., 1978, J JAPANESE STUDIES, V4, P45, DOI 10.2307/132072; Sorensen A., 2002, MAKING URBAN JAPAN C; Suzuki M., 1989, EDO NO KAWA TOKYO NO, P239; Tabuchi J., 1961, BUNGEI SHUNJU, P144; Tabuchi J., 1961, BUNGEI SHUNJU, P147; Tiratsoo, 2003, REBUILDING URBAN JAP; Tiratsoo N., 2002, URBAN RECONSTRUCTION; Tiratsoo N., 1990, RECONSTRUCTION AFFLU; Tokyoto, 1953, TOKYO SENSAISHI, P533; Yasui S., 1961, TOKYOSHIKI, P50	97	1	1	CAMBRIDGE UNIV PRESS	CAMBRIDGE	EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND	0963-9268	1469-8706		URBAN HIST	Urban Hist.	AUG	2015	42	3					483	506		10.1017/S0963926814000741		24	History	History	CM2PS	WOS:000357524300007		
J	Kadosawa, T; Watabe, A				Kadosawa, Tsuyoshi; Watabe, Ai			The effects of surgery-induced immunosuppression and angiogenesis on tumour growth	VETERINARY JOURNAL			English	Article						Angiogenesis; Dormancy; Micrometastases; Immunosuppression; Oncology; Surgical stress	LOW-DOSE CYCLOPHOSPHAMIDE; KILLER-CELL ACTIVITY; COLORECTAL-CANCER; BREAST-CANCER; CYCLOOXYGENASE-2 INHIBITOR; PROPHYLACTIC MEASURES; PERIPHERAL-BLOOD; LUNG-CANCER; METASTASIS; SUPPRESSION	Surgical removal of primary tumours can help in the treatment of cancer but carries the risk of triggering the proliferation of dormant micrometastases. Many experimental and clinical studies have demonstrated that anti-angiogenic mechanisms and immune surveillance are essential to inhibit metastatic tumour cells from growing. As surgical stress often induces a reduction in anti-angiogenic factors in parallel with increases in angiogenic factors and suppression of immune surveillance during the post-operative period, new strategies for pen-operative immunostimulation and chemotherapy are required. This review summarises the factors and proposed mechanisms underlying the effects of surgery on immunosuppression and angiogenesis. (C) 2015 Elsevier Ltd. All rights reserved.	[Kadosawa, Tsuyoshi; Watabe, Ai] Rakuno Gakuen Univ, Sch Vet Med, Dept Small Anim Clin Sci, Ebetsu, Hokkaido 0698501, Japan	Kadosawa, T (reprint author), Rakuno Gakuen Univ, Sch Vet Med, Dept Small Anim Clin Sci, 582 Bunkyodai Midorimachi, Ebetsu, Hokkaido 0698501, Japan.	kado@rakuno.ac.jp					Condeelis J, 2006, CELL, V124, P263, DOI 10.1016/j.cell.2006.01.007; Wei DY, 2004, CANCER RES, V64, P2030, DOI 10.1158/0008-5472.CAN-03-1945; UCHIDA A, 1990, J NATL CANCER I, V82, P1697, DOI 10.1093/jnci/82.21.1697; OREILLY MS, 1994, CELL, V79, P315, DOI 10.1016/0092-8674(94)90200-3; Atzil S, 2008, ANESTHESIOLOGY, V109, P989, DOI 10.1097/ALN.0b013e31818ddb72; HOLMGREN L, 1995, NAT MED, V1, P149, DOI 10.1038/nm0295-149; Rabelink TJ, 2004, ARTERIOSCL THROM VAS, V24, P834, DOI 10.1161/01.ATV.0000124891.57581.9f; Lawler PR, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006627; Glasner A, 2010, J IMMUNOL, V184, P2449, DOI 10.4049/jimmunol.0903301; Melamed R, 2003, ANESTH ANALG, V97, P1331, DOI 10.1213/01.ANE.0000082995.44040.07; Goldfarb Y, 2009, J IMMUNOTHER, V32, P280, DOI 10.1097/CJI.0b013e31819a2982; London C, 2012, VET COMP ONCOL, V10, P194, DOI 10.1111/j.1476-5829.2011.00275.x; Schadler KL, 2014, CANCER RES, V74, P2171, DOI 10.1158/0008-5472.CAN-13-0094; Li TS, 2001, EUR J CANCER, V37, P2283, DOI 10.1016/S0959-8049(01)00281-7; Greenfeld K, 2007, BRAIN BEHAV IMMUN, V21, P503, DOI 10.1016/j.bbi.2006.12.006; Tagliabue E, 2003, LANCET, V362, P527, DOI 10.1016/S0140-6736(03)14112-8; Ma L, 2002, P NATL ACAD SCI USA, V99, P13243, DOI 10.1073/pnas.202392199; Hofer SOP, 1999, EUR J SURG ONCOL, V25, P231, DOI 10.1053/ejso.1998.0634; Benish M, 2008, ANN SURG ONCOL, V15, P2042, DOI 10.1245/s10434-008-9890-5; Hormbrey E, 2003, CLIN CANCER RES, V9, P4332; Lacy AM, 2002, LANCET, V359, P2224, DOI 10.1016/S0140-6736(02)09290-5; Shakhar G, 2003, ANN SURG ONCOL, V10, P972, DOI 10.1245/ASO.2003.02.007; Postow M, 2011, CANCER J, V17, P372, DOI 10.1097/PPO.0b013e31823261db; Rosenberger PH, 2009, J BONE JOINT SURG AM, V91A, P2783, DOI 10.2106/JBJS.H.00989; MACEWEN EG, 1984, J AM VET MED ASSOC, V185, P201; Burton JH, 2011, J VET INTERN MED, V25, P920, DOI 10.1111/j.1939-1676.2011.0753.x; Roche-Nagle G, 2004, BRIT J CANCER, V91, P359, DOI 10.1038/sj.bjc.6601967; Shavit Y, 2004, NEUROIMMUNOMODULAT, V11, P255, DOI 10.1159/000078444; Cornell KK, 2000, PROSTATE, V45, P173; Yamaguchi K, 2000, ANN SURG, V232, P58, DOI 10.1097/00000658-200007000-00009; Decaens T, 2006, WORLD J GASTROENTERO, V12, P7319; Folkman J, 2006, EXP CELL RES, V312, P594, DOI 10.1016/j.yexcr.2005.11.015; PENN I, 1993, TRANSPLANTATION, V55, P742, DOI 10.1097/00007890-199304000-00011; BURNET FM, 1967, LANCET, V1, P1171; Miyata Y, 2013, INT J MOL SCI, V14, P12249, DOI 10.3390/ijms140612249; Damber JE, 2006, CANCER CHEMOTH PHARM, V58, P354, DOI 10.1007/s00280-005-0163-8; Sinicrope FA, 2004, CANCER METAST REV, V23, P63, DOI 10.1023/A:1025863029529; Detry O, 2000, TRANSPLANT P, V32, P127, DOI 10.1016/S0041-1345(99)00908-2; Bartal I, 2010, BRAIN BEHAV IMMUN, V24, P376, DOI 10.1016/j.bbi.2009.02.010; Brivio F, 1996, ONCOLOGY, V53, P263; Demicheli R, 2001, BRIT J CANCER, V85, P490, DOI 10.1054/bjoc.2001.1969; Ehrlich P., 1905, BERL KLIN WSCHR, V42, P871; FISHER B, 1959, SCIENCE, V130, P918, DOI 10.1126/science.130.3380.918; FOLKMAN J, 1985, ADV CANCER RES, V43, P175; GERSHON RK, 1968, SCIENCE, V159, P646, DOI 10.1126/science.159.3815.646; HADFIELD G, 1954, BRIT MED J, V2, P607; Ikeda Masataka, 2002, Gastric Cancer, V5, P137, DOI 10.1007/s101200200024; Inbar S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019246; Iversen P, 1995, Scand J Urol Nephrol Suppl, V172, P65; Javidnia H, 2014, J SURG ONCOL, V109, P151, DOI 10.1002/jso.23468; Kadosawa T., 2012, P 2 WORLD VET CANC C, P30; Kerbel RS, 2001, J CLIN ONCOL, V19, p45S; LEE YTN, 1977, J SURG ONCOL, V9, P425, DOI 10.1002/jso.2930090503; Maniwa Y, 1998, CHEST, V114, P1668, DOI 10.1378/chest.114.6.1668; Marie P., 1910, B ASS FRANC ETUDE CA, V3, P19; McCoy JL, 2000, BREAST CANCER RES TR, V60, P227, DOI 10.1023/A:1006405504158; MEDLEAU L, 1983, AM J VET RES, V44, P859; Mitchell L, 2012, J VET INTERN MED, V26, P355, DOI 10.1111/j.1939-1676.2011.00883.x; Momosaki Kazuya, 2014, Kurume Med J, V60, P79; POLLOCK RE, 1989, SEMIN SURG ONCOL, V5, P414, DOI 10.1002/ssu.2980050607; Saito Y, 2013, SURG TODAY, V43, P608, DOI 10.1007/s00595-013-0517-5; Sun RC, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-225; Tai LH, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.26618; van der Bilt JDW, 2004, BBA-REV CANCER, V1654, P95, DOI 10.1016/j.bbcan.2004.01.003; Watabe A., 2012, P 2 WORLD VET CANC C, P46; Wu F. P. K., 2003, Angiogenesis, V6, P255, DOI 10.1023/B:AGEN.0000029410.32264.b0; YUHAS JM, 1974, CANCER RES, V34, P2005	67	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1090-0233	1532-2971		VET J	Vet. J.	AUG	2015	205	2			SI		175	179		10.1016/j.tvjl.2015.04.009		5	Veterinary Sciences	Veterinary Sciences	CN0JB	WOS:000358098800011		
J	Bonkobara, M				Bonkobara, Makoto			Dysregulation of tyrosine kinases and use of imatinib in small animal practice	VETERINARY JOURNAL			English	Article						Canine; Feline; Imatinib; KIT mutations; Mast cell tumours	MAST-CELL TUMORS; GASTROINTESTINAL STROMAL TUMORS; KIT EXON 11; CHRONIC MYELOID-LEUKEMIA; RECEPTOR C-KIT; PULMONARY ARTERIAL-HYPERTENSION; INTERNAL TANDEM DUPLICATIONS; CHRONIC MONOCYTIC LEUKEMIA; CANINE MALIGNANT-MELANOMA; BCR-ABL TRANSLOCATION	Imatinib inhibits the activity of several tyrosine kinases, including BCR-ABL, KIT and platelet-derived growth factor receptor (PDGFR). Dysregulation of KIT is found in mast cell tumours (MCTs) and KIT is mutated in approximately 30% and 70% of canine and feline MCTs, respectively. KIT mutations have also been reported in canine and feline gastrointestinal stromal tumours (GISTs), canine acute myeloid leukaemia and canine melanoma. In addition, BCR-ABL and PDGFR mutations have been found in canine leukaemia and haemangiosarcoma, respectively. Imatinib has anti-tumour activity with tolerable toxicity towards a certain subset of MCTs in dogs and cats. Favourable clinical responses are likely to be associated with the presence of KIT mutation. Anti-tumour activity of imatinib has also been demonstrated in canine GISTs with a KIT mutation and in feline hypereosinophilic syndrome; however, to date only one of each of these cases has been reported. In conclusion, analysis of KIT mutations appears to provide valuable data for individual treatment with imatinib in dogs and cats. (C) 2014 The Author. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).	Nippon Vet & Life Sci Univ, Dept Vet Clin Pathol, Musashino, Tokyo 1808602, Japan	Bonkobara, M (reprint author), Nippon Vet & Life Sci Univ, Dept Vet Clin Pathol, 1-7-1 Kyonan Cho, Musashino, Tokyo 1808602, Japan.	bonkobara@nvlu.ac.jp					Amagai Y, 2013, J SMALL ANIM PRACT, V54, P377, DOI 10.1111/jsap.12069; Maniscalco L, 2013, VET J, V195, P41, DOI 10.1016/j.tvjl.2012.05.003; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; Druker BJ, 1996, NAT MED, V2, P561, DOI 10.1038/nm0596-561; Pardanani A, 2003, BLOOD, V102, P3093, DOI 10.1182/blood-2003-05-1627; London CA, 2009, CLIN CANCER RES, V15, P3856, DOI 10.1158/1078-0432.CCR-08-1860; Garcia-Montero AC, 2006, BLOOD, V108, P2366, DOI 10.1182/blood-2006-04-015545; Morini M, 2004, J HISTOCHEM CYTOCHEM, V52, P705; Peng B, 2004, J CLIN ONCOL, V22, P935, DOI 10.1200/JCO.2004.03.050; Katayama R, 2004, CANCER CHEMOTH PHARM, V54, P25, DOI 10.1007/s00280-004-0780-7; Hahn KA, 2008, J VET INTERN MED, V22, P1301, DOI 10.1111/j.1939-1676.2008.0190.x; Isotani M, 2010, BRIT J HAEMATOL, V148, P144, DOI 10.1111/j.1365-2141.2009.07926.x; Hodi FS, 2013, J CLIN ONCOL, V31, P3182, DOI 10.1200/JCO.2012.47.7836; Morini M, 2011, J COMP PATHOL, V145, P152, DOI 10.1016/j.jcpa.2010.12.010; Webster JD, 2006, NEOPLASIA, V8, P104, DOI 10.1593/neo.05622; Druker BJ, 2000, J CLIN INVEST, V105, P3, DOI 10.1172/JCI9083; Zemke D, 2002, VET PATHOL, V39, P529, DOI 10.1354/vp.39-5-529; London CA, 1999, EXP HEMATOL, V27, P689, DOI 10.1016/S0301-472X(98)00075-7; Takeuchi Y, 2013, VET J, V196, P492, DOI 10.1016/j.tvjl.2012.11.018; Heinrich MC, 2008, J CLIN ONCOL, V26, P5352, DOI 10.1200/JCO.2007.15.7461; Giantin M, 2013, VET IMMUNOL IMMUNOP, V152, P325, DOI 10.1016/j.vetimm.2013.01.003; Figueiredo JF, 2012, VET CLIN PATH, V41, P362, DOI 10.1111/j.1939-165X.2012.00450.x; Higgins RJ, 2010, J NEURO-ONCOL, V98, P49, DOI 10.1007/s11060-009-0072-5; Cools J, 2003, NEW ENGL J MED, V348, P1201, DOI 10.1056/NEJMoa025217; Isotani M, 2006, VET IMMUNOL IMMUNOP, V114, P168, DOI 10.1016/j.vetimm.2006.07.004; Isotani M, 2008, J VET INTERN MED, V22, P985, DOI 10.1111/j.1939-1676.2008.00132.x; Heinrich MC, 2003, J CLIN ONCOL, V21, P4342, DOI 10.1200/JCO.2003.04.190; Nguyen SM, 2015, VET COMP ONCOL, V13, P176, DOI 10.1111/vco.12032; Nakano Y, 2014, J VET MED SCI, V76, P545, DOI 10.1292/jvms.13-0156; Sabattini S, 2013, VET PATHOL, V50, P797, DOI 10.1177/0300985813476064; Backlund B, 2011, J FELINE MED SURG, V13, P291, DOI 10.1016/j.jfms.2010.12.011; Culver S, 2013, VET CLIN PATH, V42, P314, DOI 10.1111/vcp.12055; Sabattini S, 2010, VET PATHOL, V47, P643, DOI 10.1177/0300985810364509; Zwick E, 2002, TRENDS MOL MED, V8, P17, DOI 10.1016/S1471-4914(01)02217-1; Ma YS, 2002, BLOOD, V99, P1741, DOI 10.1182/blood.V99.5.1741; Lachowicz JL, 2005, J VET INTERN MED, V19, P860, DOI 10.1892/0891-6640(2005)19[860:APICTE]2.0.CO;2; Deininger M, 2005, BLOOD, V105, P2640, DOI 10.1182/blood-2004-08-3097; Perez ML, 2013, ANTI-CANCER DRUG, V24, P1098, DOI 10.1097/CAD.0000000000000018; Rabinovitch M, 2008, J CLIN INVEST, V118, P2372, DOI 10.1172/JCI33452; Kobayashi M, 2013, VET J, V198, P271, DOI 10.1016/j.tvjl.2013.05.035; Bedard PL, 2013, NATURE, V501, P355, DOI 10.1038/nature12627; Manley PW, 2010, BIOORGAN MED CHEM, V18, P6977, DOI 10.1016/j.bmc.2010.08.026; Usher SG, 2009, EXP HEMATOL, V37, P65, DOI 10.1016/j.exphem.2008.09.005; Breen M, 2008, CHROMOSOME RES, V16, P145, DOI 10.1007/s10577-007-1212-4; Ma YS, 1999, J INVEST DERMATOL, V112, P165, DOI 10.1046/j.1523-1747.1999.00488.x; Beadling C, 2008, CLIN CANCER RES, V14, P6821, DOI 10.1158/1078-0432.CCR-08-0575; Letard S, 2008, MOL CANCER RES, V6, P1137, DOI 10.1158/1541-7786.MCR-08-0067; Downing S, 2002, AM J VET RES, V63, P1718, DOI 10.2460/ajvr.2002.63.1718; Dank G, 2002, AM J VET RES, V63, P1129, DOI 10.2460/ajvr.2002.63.1129; Debiec-Rychter M, 2004, EUR J CANCER, V40, P689, DOI 10.1016/j.ejca.2003.11.025; Corless CL, 2011, NAT REV CANCER, V11, P865, DOI 10.1038/nrc3143; Foster R, 2004, J MOL GRAPH MODEL, V23, P139, DOI 10.1016/j.jmgm.2004.04.003; Rodriguez-Carino C, 2009, VET PATHOL, V46, P878, DOI 10.1354/vp.08-VP-0084-R-FL; Dewar AL, 2005, BLOOD, V105, P3127, DOI 10.1182/blood-2004-10-3967; Arico A, 2014, J COMP PATHOL, V151, P322, DOI 10.1016/j.jcpa.2014.07.001; Arita S, 2013, CAN VET J, V54, P255; Asa S Abou, 2012, Histol Histopathol, V27, P601; Brown RJ, 2012, VET COMP ONCOL, V10, P74, DOI 10.1111/j.1476-5829.2011.00286.x; Brunetti B, 2014, J COMP PATHOL, V151, P202, DOI 10.1016/j.jcpa.2014.04.018; Cardona JAC, 2011, VET CLIN PATH, V40, P40, DOI 10.1111/j.1939-165X.2010.00277.x; Chu PY, 2013, VET J, V196, P226, DOI 10.1016/j.tvjl.2012.09.005; Dickerson EB, 2013, TRANSL ONCOL, V6, P158, DOI 10.1593/tlo.12307; Frost D, 2003, VET PATHOL, V40, P42, DOI 10.1354/vp.40-1-42; Giantin M, 2013, VET IMMUNOL IMMUNOP, V154, P153, DOI 10.1016/j.vetimm.2013.05.014; Gregory-Bryson E, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-559; Hara S, 2014, J COMP PATHOL, V151, P10, DOI 10.1016/j.jcpa.2014.02.003; Ito K, 2013, VET J, V198, P577, DOI 10.1016/j.tvjl.2013.08.003; Kobayashi M, 2012, VET J, V193, P264, DOI 10.1016/j.tvjl.2011.10.027; Kubo K, 1998, J VET MED SCI, V60, P1335, DOI 10.1292/jvms.60.1335; Lahortiga I, 2008, HAEMATOL-HEMATOL J, V93, P49, DOI 10.3324/haematol.11836; Lasota J, 1999, AM J PATHOL, V154, P53, DOI 10.1016/S0002-9440(10)65250-9; Liao AT, 2002, BLOOD, V100, P585, DOI 10.1182/blood-2001-12-0350; London CA, 1996, J COMP PATHOL, V115, P399, DOI 10.1016/S0021-9975(96)80074-0; Marconato L, 2008, J VET INTERN MED, V22, P1001, DOI 10.1111/j.1939-1676.2008.0128.x; Marconato L, 2014, J VET INTERN MED, V28, P547, DOI 10.1111/jvim.12266; Gil da Costa Rui M, 2007, BMC Vet Res, V3, P19, DOI 10.1186/1746-6148-3-19; Murakami A, 2011, VET COMP ONCOL, V9, P219, DOI 10.1111/j.1476-5829.2010.00253.x; Newman SJ, 2012, VET PATHOL, V49, P760, DOI 10.1177/0300985811414032; Pardanani A, 2013, AM J HEMATOL, V88, P612, DOI 10.1002/ajh.23459; Sabattini S, 2009, J COMP PATHOL, V140, P158, DOI 10.1016/j.jcpa.2008.10.006; Smith AJ, 2009, VET PATHOL, V46, P934, DOI 10.1354/vp.08-VP-0219-L-FL; Urie BK, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-67; Verstovsek S., 2007, US ONCOLOGICAL DIS, V1, P36; Veterinary Co-operative Oncology Group, 2011, VET COMP ONCOL, DOI [10.1111/j.1476-5829.2011.00283.x, DOI 10.1111/J.1476-5829.2011.00283.X]; Yamada O, 2011, VET IMMUNOL IMMUNOP, V142, P101, DOI 10.1016/j.vetimm.2011.04.002; Abou Asa S, 2015, VET COMP ONCOL, V13, P237, DOI 10.1111/vco.12035; Zavodovskaya R, 2006, AM J VET RES, V67, P633, DOI 10.2460/ajvr.67.4.633	87	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1090-0233	1532-2971		VET J	Vet. J.	AUG	2015	205	2			SI		180	188		10.1016/j.tvjl.2014.12.015		9	Veterinary Sciences	Veterinary Sciences	CN0JB	WOS:000358098800012		
J	Saeki, K; Watanabe, M; Michishita, M; Tsuboi, M; Sugano, S; Yoshitake, R; Murai, K; Tanaka, Y; Ong, SM; Saito, T; Matsumoto, K; Fujita, N; Nishimura, R; Nakagawa, T				Saeki, K.; Watanabe, M.; Michishita, M.; Tsuboi, M.; Sugano, S.; Yoshitake, R.; Murai, K.; Tanaka, Y.; Ong, S. M.; Saito, T.; Matsumoto, K.; Fujita, N.; Nishimura, R.; Nakagawa, T.			Phenotypic screening of a library of compounds against metastatic and non-metastatic clones of a canine mammary gland tumour cell line	VETERINARY JOURNAL			English	Article						Canine; Mammary gland tumour cell lines; Metastases; Mitochondrial respiratory chain complex inhibitors; Chemotherapy; Compound screening	CANCER CALU-6 CELLS; MESENCHYMAL TRANSITION; BREAST-CANCER; LUNG-CANCER; E-CADHERIN; MATRIX METALLOPROTEINASES; PARKINSONS-DISEASE; PROGNOSTIC-FACTORS; DRUG-RESISTANCE; BETA-CATENIN	Metastases are associated with a poor prognosis for canine mammary gland tumours (CMGTs). Metastatic and non-metastatic clones were isolated previously from a single malignant CMGT cell line. The difference in metastatic potential between the two cell lines was hypothesised to be associated with distinct cellular signalling. The aim of this study was to screen for compounds that specifically target metastatic cells in order to improve CMGT therapeutic outcomes. The two clonal cell lines were characterised by transcriptome analysis and their sensitivity to a library of 291 different compounds was compared. The metastatic clone exhibited elevated expression of molecules associated with degradation of the extracellular matrix, epithelial-mesenchymal transition and cancer stem cell phenotype. This was confirmed using a matrigel invasion assay and by assessment of aldehyde dehydrogenase activity. The mitochondrial respiratory chain complex inhibitors (MRCIs; rotenone, antimycin and oligomycin) significantly inhibited the growth of the metastatic clone. Although MRCIs similarly depleted mitochondrial ATP in both clones, the subsequent cellular response was different, with toxicity to the metastatic clone being independent of AMP-activated protein kinase activity. The results of this study suggest a potential utility of MRCIs as anti-tumour agents against metastatic CMGTs. Further studies are needed to investigate the clinical utility of MRCIs and to determine the association between MRCI sensitivity and malignancy. (C) 2015 Elsevier Ltd. All rights reserved.	[Saeki, K.; Yoshitake, R.; Murai, K.; Tanaka, Y.; Ong, S. M.; Saito, T.; Matsumoto, K.; Fujita, N.; Nishimura, R.; Nakagawa, T.] Univ Tokyo, Lab Vet Surg, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo 1138657, Japan; [Watanabe, M.; Sugano, S.] Univ Tokyo, Dept Med Genome Sci, Grad Sch Frontier Sci, Kashiwa, Chiba 2778561, Japan; [Michishita, M.] Nippon Vet & Life Sci Univ, Dept Vet Pathol, Musashino, Tokyo 1808602, Japan; [Tsuboi, M.] Univ Tokyo, Lab Vet Pathol, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo 1138657, Japan	Nakagawa, T (reprint author), Univ Tokyo, Lab Vet Surg, Grad Sch Agr & Life Sci, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	anakaga@mail.ecc.u-tokyo.ac.jp			JSPS KAKENHI Grant [25450442]; Ministry of Education, Culture, Sports, Science and Technology, Japan	This work was supported by JSPS KAKENHI Grant Number 25450442. The funding source played no role in the study design, in the collection, analysis and interpretation of data, or in the manuscript writing or submission for publication. None of the authors has any financial or personal relationships that could inappropriately influence or bias the content of the paper. Screening kits were provided by the SCADS supported by a Grant-in-Aid for Scientific Research on Innovative Areas, Scientific Support Programmes for Cancer Research, from the Ministry of Education, Culture, Sports, Science and Technology, Japan. Preliminary results were presented as an Abstract at the Veterinary Cancer Society Annual Conference 2012, Las Vegas, NV, 18-21 October 2012.	Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Maryanovich M, 2013, TRENDS CELL BIOL, V23, P129, DOI 10.1016/j.tcb.2012.09.007; Boichuk S, 2014, CANCER RES, V74, P1200, DOI 10.1158/0008-5472.CAN-13-1955; Kominsky SL, 2003, ONCOGENE, V22, P2021, DOI 10.1038/sj.onc.1206199; Coulom H, 2004, J NEUROSCI, V24, P10993, DOI 10.1523/JNEUROSCI.2993-04.2004; Han YH, 2009, LUNG CANCER, V65, P150, DOI 10.1016/j.lungcan.2008.11.005; Restucci B, 2007, ANTICANCER RES, V27, P3083; Rizos CV, 2013, EUR J PHARMACOL, V705, P96, DOI 10.1016/j.ejphar.2013.02.038; Riedmaier AE, 2013, TRENDS PHARMACOL SCI, V34, P126, DOI 10.1016/j.tips.2012.11.005; Shao MM, 2012, VIRCHOWS ARCH, V461, P313, DOI 10.1007/s00428-012-1289-9; Seipke RF, 2013, BEILSTEIN J ORG CHEM, V9, P2556, DOI 10.3762/bjoc.9.290; Han YH, 2009, ONCOL REP, V21, P253, DOI 10.3892/or_00000216; Garraway LA, 2013, CELL, V153, P17, DOI 10.1016/j.cell.2013.03.002; Liu XN, 2014, P NATL ACAD SCI USA, V111, pE435, DOI 10.1073/pnas.1311121111; Gusterson BA, 2012, SEMIN CELL DEV BIOL, V23, P567, DOI 10.1016/j.semcdb.2012.03.013; Gama A, 2008, VET J, V177, P45, DOI 10.1016/j.tvjl.2007.05.024; Xiong N, 2012, CRIT REV TOXICOL, V42, P613, DOI 10.3109/10408444.2012.680431; DORN CR, 1968, J NATL CANCER I, V40, P307; Ishikawa K, 2008, SCIENCE, V320, P661, DOI 10.1126/science.1156906; Di Stefano M, 2013, FEBS J, V280, P4711, DOI 10.1111/febs.12433; McCormack N, 2013, CELL SIGNAL, V25, P2856, DOI 10.1016/j.cellsig.2013.09.012; Lonardo E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076518; Liang JY, 2013, CANCER RES, V73, P2929, DOI 10.1158/0008-5472.CAN-12-3876; Tomiyasu H, 2010, J VET MED SCI, V72, P1165, DOI 10.1292/jvms.09-0575; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Gupta PB, 2009, CELL, V138, P645, DOI 10.1016/j.cell.2009.06.034; Dieter SM, 2011, CELL STEM CELL, V9, P357, DOI 10.1016/j.stem.2011.08.010; Chang SC, 2005, JAVMA-J AM VET MED A, V227, P1625, DOI 10.2460/javma.2005.227.1625; Holohan C, 2013, NAT REV CANCER, V13, P714, DOI 10.1038/nrc3599; FIDLER IJ, 1977, SCIENCE, V197, P893, DOI 10.1126/science.887927; Overall CM, 2006, NAT REV CANCER, V6, P227, DOI 10.1038/nrc1821; Mamane Y, 2006, ONCOGENE, V25, P6416, DOI 10.1038/sj.onc.1209888; Kreso A, 2014, CELL STEM CELL, V14, P275, DOI 10.1016/j.stem.2014.02.006; Cheng S, 2008, J SURG RES, V146, P104, DOI 10.1016/j.jss.2007.05.032; Clemente M, 2010, J COMP PATHOL, V143, P157, DOI 10.1016/j.jcpa.2010.02.002; Drasin DJ, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3037; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Hong YY, 2014, NEUROSCI LETT, V560, P46, DOI 10.1016/j.neulet.2013.11.039; Kashiwagi S, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3068; Kitambi SS, 2014, CELL, V157, P313, DOI 10.1016/j.cell.2014.02.021; Michishita M, 2012, VET J, V193, P508, DOI 10.1016/j.tvjl.2012.01.006; Murai K, 2012, RES VET SCI, V93, P468, DOI 10.1016/j.rvsc.2011.06.012; Oguri T, 2006, MOL CANCER THER, V5, P1800, DOI 10.1158/1535-7163.MCT-06-0025; Pagliarani A, 2013, MITOCHONDRION, V13, P312, DOI 10.1016/j.mito.2013.04.005; R Development Core Team, 2013, R LANG ENV STAT COMP; Remacle AG, 1998, BRIT J CANCER, V77, P926, DOI 10.1038/bjc.1998.153; ROSTAMI M, 1994, J VET MED SCI, V56, P403; Santos AA, 2012, AM J VET RES, V73, P689, DOI 10.2460/ajvr.73.5.689; Song CW, 2012, SCI REP-UK, V2, DOI 10.1038/srep00362; Sugimachi K, 2014, ANN SURG ONCOL, V21, P3680, DOI 10.1245/s10434-013-3366-y; Szczubial M, 2011, VET COMP ONCOL, V9, P296, DOI 10.1111/j.1476-5829.2011.00268.x; Tomiyasu H, 2013, LEUKEMIA LYMPHOMA, V54, P1309, DOI 10.3109/10428194.2012.751529; Verdin E, 2014, NAT MED, V20, P25, DOI 10.1038/nm.3447; Withrow S.J., 2012, WITHROW MACEWENS SMA, P538; Yeh C.-T., 2013, EVID-BASED COMPL ALT, V2013; Yoshida K, 2014, J VET MED SCI, V76, P1321, DOI 10.1292/jvms.14-0104	57	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1090-0233	1532-2971		VET J	Vet. J.	AUG	2015	205	2			SI		288	296		10.1016/j.tvjl.2015.04.025		9	Veterinary Sciences	Veterinary Sciences	CN0JB	WOS:000358098800025		
J	Saeki, K; Watanabe, M; Tsuboi, M; Sugano, S; Yoshitake, R; Tanaka, Y; Ong, SM; Saito, T; Matsumoto, K; Fujita, N; Nishimura, R; Nakagawa, T				Saeki, K.; Watanabe, M.; Tsuboi, M.; Sugano, S.; Yoshitake, R.; Tanaka, Y.; Ong, S. M.; Saito, T.; Matsumoto, K.; Fujita, N.; Nishimura, R.; Nakagawa, T.			Anti-tumour effect of metformin in canine mammary gland tumour cells	VETERINARY JOURNAL			English	Article						Canine; Mammary gland tumour; Metastasis; Metformin; AMP-activated protein kinase (AMPK); Mitochondria	MESENCHYMAL TRANSITION EMT; ACTIVATED PROTEIN-KINASE; BREAST-CANCER CELLS; TRANSLATION INITIATION; AMPK; MODELS; PHOSPHORYLATION; PROGRESSION; INHIBITION; REVERSES	Metformin is an oral hypoglycaemic drug used in type 2 diabetes. Its pharmacological activity reportedly involves mitochondrial respiratory complex I, and mitochondrial respiratory complex inhibitors have a strong inhibitory effect on the growth of metastatic canine mammary gland tumour (CMGT) cell lines. It is hypothesised that metformin has selective anti-tumour effects on metastatic CMGT cells. The aim of this study was to investigate the in vitro effect of metformin on cell growth, production of ATP and reactive oxygen species (ROS), and the AMP-activated protein kinase (AMPK) mammalian target of rapamycin (mTOR) pathway in two CMGT clonal cell lines with different metastatic potential. In addition, transcriptome analysis was used to determine cellular processes disrupted by metformin and in vivo anti-tumour effects were examined in a mouse xenograft model. Metformin inhibited CMGT cell growth in vitro, with the metastatic clone (CHMp-5b) displaying greater sensitivity. ATP depletion and ROS elevation were observed to a similar extent in the metastatic and non-metastatic (CHMp-13a) cell lines after metformin exposure. However, subsequent AMPK activation and mTOR pathway inhibition were prominent only in metformin-insensitive non-metastatic cells. Microarray analysis revealed inhibition of cell cycle progression by metformin treatment in CHMp-5b cells, which was further confirmed by Western blotting and cell cycle analysis. Additionally, metformin significantly suppressed tumour growth in xenografted metastatic CMGT cells. In conclusion, metformin exhibited an anti-tumour effect in metastatic CMGT cells through AMPK-independent cell cycle arrest. Its mechanism of action differed in the non-metastatic clone, where AMPK activation and mTOR inhibition were observed. (C) 2015 Elsevier Ltd. All rights reserved.	[Saeki, K.; Yoshitake, R.; Tanaka, Y.; Ong, S. M.; Saito, T.; Matsumoto, K.; Fujita, N.; Nishimura, R.; Nakagawa, T.] Univ Tokyo, Lab Vet Surg, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo 1138657, Japan; [Watanabe, M.; Sugano, S.] Univ Tokyo, Dept Med Genome Sci, Grad Sch Frontier Sci, Kashiwa, Chiba 2778561, Japan; [Tsuboi, M.] Univ Tokyo, Lab Vet Pathol, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo 1138657, Japan	Nakagawa, T (reprint author), Univ Tokyo, Lab Vet Surg, Grad Sch Agr & Life Sci, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	anakaga@mail.ecc.u-tokyo.ac.jp			JSPS KAKENHI Grant [25450442]	This work was supported by JSPS KAKENHI Grant Number 25450442. The funding source played no role in the study design, in the collection, analysis and interpretation of data, or in the manuscript writing or submission for publication. None of the authors has any financial or personal relationships that could inappropriately influence or bias the content of the paper. Preliminary results describing the in vitro anti-tumour effects of metformin on canine mammary gland tumour cells were presented as an abstract at the Veterinary Cancer Society Annual Conference, Minneapolis, USA, 17-20 October 2013. Furthermore, preliminary results describing the mechanism of anti-tumour effects of metformin on canine mammary gland tumour cells and the involvement of the mTOR pathway were presented as an abstract at The Veterinary Cancer Society Annual Conference, St. Louis, USA, 9-11 October 2014.	Sasaki H, 2009, CIRCULATION, V119, P2568, DOI 10.1161/CIRCULATIONAHA.108.798561; Cazzaniga M, 2013, BRIT J CANCER, V109, P2792, DOI 10.1038/bjc.2013.657; Zhu P, 2014, CANCER PREV RES, V7, P199, DOI 10.1158/1940-6207.CAPR-13-0181; Dowling RJO, 2007, CANCER RES, V67, P10804, DOI 10.1158/0008-5472.CAN-07-2310; Ashinuma H, 2012, ONCOL REP, V28, P8, DOI 10.3892/or.2012.1763; Seo-Mayer PW, 2011, AM J PHYSIOL-RENAL, V301, pF1346, DOI 10.1152/ajprenal.00420.2010; DeCensi A, 2010, CANCER PREV RES, V3, P1451, DOI 10.1158/1940-6207.CAPR-10-0157; Riedmaier AE, 2013, TRENDS PHARMACOL SCI, V34, P126, DOI 10.1016/j.tips.2012.11.005; Seipke RF, 2013, BEILSTEIN J ORG CHEM, V9, P2556, DOI 10.3762/bjoc.9.290; Rubin SM, 2013, TRENDS BIOCHEM SCI, V38, P12, DOI 10.1016/j.tibs.2012.10.007; Xiong N, 2012, CRIT REV TOXICOL, V42, P613, DOI 10.3109/10408444.2012.680431; Hadad S, 2011, BREAST CANCER RES TR, V128, P783, DOI 10.1007/s10549-011-1612-1; Chou CC, 2014, CANCER RES, V74, P4783, DOI 10.1158/0008-5472.CAN-14-0135; Musgrove EA, 2011, NAT REV CANCER, V11, P558, DOI 10.1038/nrc3090; Lonardo E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076518; Wurth R, 2013, CELL CYCLE, V12, P145, DOI 10.4161/cc.23050; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Quinn BJ, 2013, TRENDS ENDOCRIN MET, V24, P469, DOI 10.1016/j.tem.2013.05.004; Vazquez-Martin A, 2010, CELL CYCLE, V9, P3807, DOI 10.4161/cc.9.18.13131; Ben Sahra I, 2008, ONCOGENE, V27, P3576, DOI 10.1038/sj.onc.1211024; Klopfleisch R, 2009, RES VET SCI, V87, P91, DOI 10.1016/j.rvsc.2008.12.010; Giacinti C, 2006, ONCOGENE, V25, P5220, DOI 10.1038/sj.onc.1209615; Mamane Y, 2006, ONCOGENE, V25, P6416, DOI 10.1038/sj.onc.1209888; Cuyas E, 2014, ONCOTARGET, V5, P3970; Kreso A, 2014, CELL STEM CELL, V14, P275, DOI 10.1016/j.stem.2014.02.006; Ansieau S, 2013, CANCER LETT, V338, P63, DOI 10.1016/j.canlet.2012.05.014; Chiarini F, 2015, TRENDS PHARMACOL SCI, V36, P124, DOI 10.1016/j.tips.2014.11.004; Choi MK, 2010, XENOBIOTICA, V40, P817, DOI 10.3109/00498254.2010.520349; Clemente M, 2010, J COMP PATHOL, V143, P157, DOI 10.1016/j.jcpa.2010.02.002; Ekstrom N, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001076; Franciosi M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071583; Klopfleisch R, 2010, RES VET SCI, V88, P300, DOI 10.1016/j.rvsc.2009.08.007; Murai K, 2012, RES VET SCI, V93, P468, DOI 10.1016/j.rvsc.2011.06.012; Nelson RW, 2000, J SMALL ANIM PRACT, V41, P486, DOI 10.1111/j.1748-5827.2000.tb03969.x; Nieto MA, 2013, SCIENCE, V342, P708, DOI 10.1126/science.1234850; Noto H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033411; Pagliarani A, 2013, MITOCHONDRION, V13, P312, DOI 10.1016/j.mito.2013.04.005; Qu C, 2014, MOL CELL BIOCHEM, V386, P63, DOI 10.1007/s11010-013-1845-x; R Development Core Team, 2013, R LANG ENV STAT COMP; Saeki K., 2015, VET J, DOI [10.1016/j.tvjl.2015.04.025, DOI 10.1016/J.TVJ1.2015.04.025]; Saito T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070010; Song CW, 2012, SCI REP-UK, V2, DOI 10.1038/srep00362; Szczubial M, 2011, VET COMP ONCOL, V9, P296, DOI 10.1111/j.1476-5829.2011.00268.x; Withrow S.J., 2012, WITHROW MACEWENS SMA, P538	44	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1090-0233	1532-2971		VET J	Vet. J.	AUG	2015	205	2			SI		297	304		10.1016/j.tvjl.2015.04.026		8	Veterinary Sciences	Veterinary Sciences	CN0JB	WOS:000358098800026		
J	Fujiwara-Igarashi, A; Igarashi, H; Mizutani, N; Goto-Koshino, Y; Takahashi, M; Ohno, K; Tsujimoto, H				Fujiwara-Igarashi, Aki; Igarashi, Hirotaka; Mizutani, Noriyuki; Goto-Koshino, Yuko; Takahashi, Masashi; Ohno, Koichi; Tsujimoto, Hajime			Expression profile of circulating serum microRNAs in dogs with lymphoma	VETERINARY JOURNAL			English	Article						Biomarker; Dog; Lymphoma; miRNA; Serum	TUMOR-SUPPRESSOR GENE; CANINE LYMPHOMA; HUMAN-DISEASES; CELL LINES; BIOMARKERS; CANCER; IDENTIFICATION; POPULATION; NEOPLASIA; CARCINOMA	Serum microRNAs (miRNAs) are mediators of cell-to-cell communication and alter the cellular microenvironment; they are stable for hours under certain conditions in body fluids despite the presence of RNases. Certain miRNAs have been found to be altered in the serum or plasma of humans with various cancers and may represent promising, non-invasive biomarkers for various diseases in humans and animals. The objective of this study was to determine the expression profile of circulating miRNAs in the serum of dogs with lymphoma. Serum samples were obtained from 61 dogs with lymphoma and 40 control dogs, and real-time reverse transcription-polymerase chain reaction was used for miRNA measurement. In order to select candidate genes, a comprehensive expression analysis was undertaken prior to validation of several candidate miRNAs. Of 277 miRNAs, five (let-7b, miR-223, miR-25, miR-92a, and miR-423a) were selected as candidates. The expression levels of four miRNAs (let-7b, miR-223, miR-25, miR-92a) were significantly reduced in the lymphoma group, whereas miR-423a levels were significantly increased compared to the controls. When the lymphoma cases were categorized into high- or low-grade as well as into their anatomic form, miR-25 levels were lower in the serum samples from the lymphoma group compared to those from the control group. Although the biological function of serum miRNAs still remains unclear, determining their functional roles in serum and tissues will contribute not only to the identification of potential biomarkers but also to the elucidation of the pathogenesis of canine lymphoma. (C) 2015 Elsevier Ltd. All rights reserved.	[Fujiwara-Igarashi, Aki; Igarashi, Hirotaka; Mizutani, Noriyuki; Goto-Koshino, Yuko; Takahashi, Masashi; Ohno, Koichi; Tsujimoto, Hajime] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Vet Internal Med, Bunkyo Ku, Tokyo 1138657, Japan; [Fujiwara-Igarashi, Aki] Nippon Vet & Life Sci Univ, Dept Clin Vet Med, Div Therapeut Sci 1, Musashino, Tokyo 1830023, Japan	Fujiwara-Igarashi, A (reprint author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Vet Internal Med, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	afjig@nvlu.ac.jp			Japan Society for the Promotion of Science, KAKENHI [24658265]	The authors would like to acknowledge Dr. Noriyasu Sasaki, Laboratory of Veterinary Biochemistry, Nippon Veterinary and Life Science University, for providing technical advice. This study was supported by the Japan Society for the Promotion of Science, KAKENHI 24658265.	Deng DJ, 2010, ADV GENET, V71, P125, DOI [10.1016/B978-0-12-380864-6.00005-5, 10.1016/S0065-2660(10)71005-1]; Mellanby RJ, 2003, J SMALL ANIM PRACT, V44, P100, DOI 10.1111/j.1748-5827.2003.tb00127.x; Cortez MA, 2009, EXPERT OPIN BIOL TH, V9, P703, DOI [10.1517/14712590902932889 , 10.1517/14712590902932889]; Dobson JM, 2002, J SMALL ANIM PRACT, V43, P240, DOI 10.1111/j.1748-5827.2002.tb00066.x; Burnett RC, 2003, VET PATHOL, V40, P32, DOI 10.1354/vp.40-1-32; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Mortarino M, 2010, LEUKEMIA RES, V34, P1070, DOI 10.1016/j.leukres.2009.10.023; Haluskova J, 2010, FOLIA BIOL-PRAGUE, V56, P83; Lawrie CH, 2008, BRIT J HAEMATOL, V141, P672, DOI 10.1111/j.1365-2141.2008.07077.x; Veldhoen N, 1998, ONCOGENE, V16, P249, DOI 10.1038/sj.onc.1201489; Tomiyasu H, 2014, VET J, V199, P103, DOI 10.1016/j.tvjl.2013.10.022; Chen X, 2012, PROTEIN CELL, V3, P28, DOI 10.1007/s13238-012-2003-z; Xu XH, 2012, BIOCHEM BIOPH RES CO, V421, P640, DOI 10.1016/j.bbrc.2012.03.048; DORN CR, 1968, J NATL CANCER I, V40, P307; Suh SS, 2012, P NATL ACAD SCI USA, V109, P5316, DOI 10.1073/pnas.1202465109; Kanwal R, 2010, J APPL PHYSIOL, V109, P598, DOI 10.1152/japplphysiol.00066.2010; Weiland M, 2012, RNA BIOL, V9, P850, DOI 10.4161/rna.20378; Breen M, 2008, CHROMOSOME RES, V16, P145, DOI 10.1007/s10577-007-1212-4; Li Y, 2009, CANCER SCI, V100, P1234, DOI 10.1111/j.1349-7006.2009.01164.x; Etheridge A, 2011, MUTAT RES-FUND MOL M, V717, P85, DOI 10.1016/j.mrfmmm.2011.03.004; Wang K, 2009, P NATL ACAD SCI USA, V106, P4402, DOI 10.1073/pnas.0813371106; Arroyo JD, 2011, P NATL ACAD SCI USA, V108, P5003, DOI 10.1073/pnas.1019055108; Boggs RM, 2008, MAMM GENOME, V19, P561, DOI 10.1007/s00335-008-9128-7; Cortez M.A., 2012, NAT REV CLIN ONCOL, V8, P467; Ettinger SN, 2003, CLIN TECH SMALL AN P, V18, P92, DOI 10.1053/svms.2003.36622; Fujiwara-Igarashi A, 2014, VET J, V199, P236, DOI 10.1016/j.tvjl.2013.11.004; Fujiwara-Igarashi A, 2014, RES VET SCI, V97, P60, DOI 10.1016/j.rvsc.2014.04.008; Gioia G, 2011, VET IMMUNOL IMMUNOP, V142, P228, DOI 10.1016/j.vetimm.2011.05.020; Kaiser H.E., 1981, NEOPLASMS COMP PATHO, P747; Nielsen LB, 2012, EXP DIABETES RES, V2012, DOI 10.1155/2012/896362; Noguchi S., 2011, J VET MED SCI, V74, P1; Ohyashiki K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016408; Poliseno L, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000594; Setoguchi A, 2001, AM J VET RES, V62, P433, DOI 10.2460/ajvr.2001.62.433; Sokolowska J, 2005, J VET MED A, V52, P172, DOI 10.1111/j.1439-0442.2005.00707.x; Steudemann C, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-12; Uhl E, 2011, GENE CHROMOSOME CANC, V50, P950, DOI 10.1002/gcc.20917; Valli V. E., 2006, VET PATHOL, V48, P198; Vezzali E., 2009, VET COMP ONCOL, V8, P38	39	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1090-0233	1532-2971		VET J	Vet. J.	AUG	2015	205	2			SI		317	321		10.1016/j.tvjl.2015.04.029		5	Veterinary Sciences	Veterinary Sciences	CN0JB	WOS:000358098800029		
J	Oda, T; Hashimoto, S; Miyamoto, R; Shimomura, O; Fukunaga, K; Kohno, K; Ohshiro, Y; Akashi, Y; Enomoto, T; Ohkohchi, N				Oda, Tatsuya; Hashimoto, Shinji; Miyamoto, Ryoichi; Shimomura, Osamu; Fukunaga, Kiyoshi; Kohno, Keisuke; Ohshiro, Yukio; Akashi, Yoshimasa; Enomoto, Tsuyoshi; Ohkohchi, Nobuhiro			The Tight Adaptation at Pancreatic Anastomosis Without Parenchymal Laceration: An Institutional Experience in Introducing and Modifying the New Procedure	WORLD JOURNAL OF SURGERY			English	Article; Proceedings Paper	26th Meeting of Japanese-Society-of-Hepato-Biliary-Pancreatic-Surgery	JUN, 2014	Wakayama Culture & Arts Fdn, Wakayama, JAPAN	Japanese Soc Hepato Biliary Pancreat Surg	Wakayama Culture & Arts Fdn		DUCT-TO-MUCOSA; PANCREATICODUODENECTOMY DECREASE RATE; UNDERSTANDING HOSPITAL READMISSIONS; PROSPECTIVE RANDOMIZED-TRIAL; BLUMGART ANASTOMOSIS; UNITED-STATES; PANCREATICOJEJUNOSTOMY; COMPLICATIONS; FISTULA; RECONSTRUCTION	Among the types of pancreatic anastomosis used after pancreatoduodenectomy (PD), Blumgart type reconstruction has rapidly been distributed for its theoretical reasonableness, including secure tight adaptation of jejunal wall and pancreatic parenchyma without cause of parenchymal laceration. The clinical appropriateness of our modified Blumgart method was demonstrated by comparing to that of Kakita method. Retrospective analysis of 156 patients underwent elective open PD, reconstructed former 78 patients with the Kakita method, utilizing a full-thickness penetrating suture for tight stump adhesion. The later 78 patients were treated with the modified Blumgart method, which involved clamping the pancreatic parenchymal stump by the jejunal seromuscular layers with horizontal mattress-type penetration sutures. Evaluated variables were the rate of pancreatic fistula (PF) and the length of postoperative hospital stay (POHS). The rate of ISGPF grade B + C PF was 29/78 (37.2 %) in the Kakita group and 16/78 (20.5 %) in the Blumgart group (P = 0.033). The median POHS for the Kakita group was 23 days, whereas that for the Blumgart group was 16 days (P < 0.001), one of the shortest value among Japanese high-volume centers. There was no perioperative intensive hemorrhage or deaths in either group. A unique concept of Blumgart pancreatic anastomosis, i.e., utilizing the jejunum as an interstitial cushion to prevent pancreatic laceration at the knot site, has become realistic through a simple "one step" modification. This technique, also providing flexible handling space at main pancreatic duct anastomosis, should contribute to the improved PF prevention and shortening the POHS.	[Oda, Tatsuya; Hashimoto, Shinji; Miyamoto, Ryoichi; Shimomura, Osamu; Fukunaga, Kiyoshi; Kohno, Keisuke; Ohshiro, Yukio; Akashi, Yoshimasa; Enomoto, Tsuyoshi; Ohkohchi, Nobuhiro] Univ Tsukuba, Dept Surg, Clin Sci, Fac Med, Tsukuba, Ibaraki 3058575, Japan	Oda, T (reprint author), Univ Tsukuba, Dept Surg, Clin Sci, Fac Med, Tsukuba, Ibaraki 3058575, Japan.	tatoda@md.tsukuba.ac.jp	Akashi, Yoshihiro/E-5227-2011	Akashi, Yoshihiro/0000-0001-7670-7326			Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Buchler MW, 2003, ARCH SURG-CHICAGO, V138, P1310, DOI 10.1001/archsurg.138.12.1310; Kennedy EP, 2011, J HEPATO-BIL-PAN SCI, V18, P769, DOI 10.1007/s00534-011-0429-y; Bassi C, 2005, SURGERY, V138, P8, DOI 10.1016/j.surg.2005.05.001; Berger AC, 2009, J AM COLL SURGEONS, V208, P738, DOI 10.1016/j.jamcollsurg.2008.12.031; Teh SH, 2009, ARCH SURG-CHICAGO, V144, P713, DOI 10.1001/archsurg.2009.67; Poon RTP, 2002, AM J SURG, V183, P42, DOI 10.1016/S0002-9610(01)00829-7; Peng SY, 2007, ANN SURG, V245, P692, DOI 10.1097/01.sla.0000255588.50964.5d; Grobmyer SR, 2010, J AM COLL SURGEONS, V210, P54, DOI 10.1016/j.jamcollsurg.2009.09.020; Duffas JP, 2005, AM J SURG, V189, P720, DOI 10.1016/j.amjsurg.2005.03.015; Kazaure HS, 2012, ARCH SURG-CHICAGO, V147, P1000, DOI 10.1001/2013.jamasurg.114; Hyder O, 2013, JAMA SURG, V148, P1095, DOI 10.1001/jamasurg.2013.2509; Fujii T, 2014, J GASTROINTEST SURG, V18, P1108, DOI 10.1007/s11605-014-2523-3; Bassi C, 2003, SURGERY, V134, P766, DOI 10.1016/S0039-6060(03)00345-3; Topal B, 2013, LANCET ONCOL, V14, P655, DOI 10.1016/S1470-2045(13)70126-8; Harnoss JC, 2014, SURGERY, V155, P47, DOI 10.1016/j.surg.2013.05.035; Kleespies A, 2009, BRIT J SURG, V96, P741, DOI 10.1002/bjs.6634; Kimura W, 2014, ANN SURG, V259, P773, DOI 10.1097/SLA.0000000000000263; Tani M, 2010, AM J SURG, V199, P759, DOI 10.1016/j.amjsurg.2009.04.017; Cameron JL, 2009, J AM COLL SURGEONS, V208, P747; Brennan M, 2000, SURG LIVER BILIARY T, P1073; Fong ZV, 2014, J GASTROINTEST SURG, V18, P137, DOI 10.1007/s11605-013-2336-9; Vollmer C, 2014, J GASTROINTEST SURG, V18, P144; Haane C, 2013, LANGENBECK ARCH SURG, V398, P1097, DOI 10.1007/s00423-013-1130-1; Kakita A, 1996, SURG TODAY, V26, P532; Kakita A, 2001, J Hepatobiliary Pancreat Surg, V8, P230, DOI 10.1007/s005340170022; Sakamoto Y, 2009, SURG TODAY, V39, P32, DOI 10.1007/s00595-008-3814-7; Satoi S, 2010, PANCREAS, V39, P165, DOI 10.1097/MPA.0b013e3181bd672c; Sugimoto M, 2013, J GASTROINTEST SURG, V17, P1744, DOI 10.1007/s11605-013-2320-4; Yeo CJ, 1997, ANN SURG, V226, P248, DOI 10.1097/00000658-199709000-00004	30	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-2313	1432-2323		WORLD J SURG	World J.Surg.	AUG	2015	39	8					2014	2022		10.1007/s00268-015-3075-8		9	Surgery	Surgery	CM4XW	WOS:000357690700024		
J	Nakayama, Y; Ishizaki, Y; Yoshimoto, J; Sugo, H; Imamura, H; Kawasaki, S				Nakayama, Yoshimi; Ishizaki, Yoichi; Yoshimoto, Jiro; Sugo, Hiroyuki; Imamura, Hiroshi; Kawasaki, Seiji			Hypertrophy of the Left Liver in Patients with Large Tumors in the Right Liver	WORLD JOURNAL OF SURGERY			English	Article							PORTAL-VEIN EMBOLIZATION; INTERMITTENT PRINGLE MANEUVER; BILE-DUCT CANCER; VOLUMETRIC-ANALYSIS; HEPATIC RESECTION; RIGHT-HEPATECTOMY; TOMOGRAPHY; CARCINOMA; LIGATION; REMNANT	It has been speculated that, when right-sided major hepatectomy (RSMH) is planned for patients with large tumors in the right liver, it may not lead to a marked decrease in normally functional hepatic mass. We collected data for patients who had undergone RSMH for tumors more than 8 cm in diameter (n = 50) and compared them with control patients who had undergone RSMH for tumors less than 5 cm in diameter (n = 21). The ratio of the remnant left liver volume to the nontumorous liver volume (left liver ratio) in the patients with large tumors was significantly greater than that in the control group (50.0 +/- A 12.8 % vs. 40.2 +/- A 8.3 %, p = 0.002). Left liver ratio was significantly correlated with tumor volume (p < 0.001). Preoperative portal vein embolization was performed in only four of the 50 patients with large tumors. None of the patients with large tumors developed postoperative liver failure. Left liver volume in patients with large tumors in the right liver was larger than usual, perhaps reducing the risk of postoperative liver insufficiency after RSMH.	[Nakayama, Yoshimi; Ishizaki, Yoichi; Yoshimoto, Jiro; Sugo, Hiroyuki; Imamura, Hiroshi; Kawasaki, Seiji] Juntendo Univ, Sch Med, Dept Hepatobiliary Pancreat Surg, Bunkyo Ku, Tokyo 1138421, Japan	Ishizaki, Y (reprint author), Juntendo Univ, Sch Med, Dept Hepatobiliary Pancreat Surg, Bunkyo Ku, 2-1-1 Hongo, Tokyo 1138421, Japan.	ishizaki@juntendo.ac.jp					Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Bedossa P, 1996, HEPATOLOGY, V24, P289, DOI 10.1002/hep.510240201; Akamatsu N, 2010, J GASTROEN HEPATOL, V25, P731, DOI 10.1111/j.1440-1746.2009.06113.x; Kubota K, 1997, HEPATOLOGY, V26, P1176; Imamura H, 1999, HEPATOLOGY, V29, P1099, DOI 10.1002/hep.510290415; van der Vorst JR, 2010, WORLD J SURG, V34, P2426, DOI 10.1007/s00268-010-0663-5; Kawasaki S, 2003, ANN SURG, V238, P84, DOI 10.1097/01.SLA.0000074984.83031.02; Aussilhou B, 2008, J GASTROINTEST SURG, V12, P297, DOI 10.1007/s11605-007-0410-x; HEYMSFIELD SB, 1979, ANN INTERN MED, V90, P185; Kishi Y, 2009, ANN SURG, V250, P540, DOI 10.1097/SLA.0b013e3181b674df; OKAMOTO E, 1984, SURGERY, V95, P586; Farges O, 2003, ANN SURG, V237, P208, DOI 10.1097/00000658-200302000-00010; Belghiti J, 2012, ANN SURG, V255, P528, DOI 10.1097/SLA.0b013e3182472152; MAKUUCHI M, 1990, SURGERY, V107, P521; Yokoyama Y, 2007, WORLD J SURG, V31, P367, DOI 10.1007/s00268-006-0526-2; Shoup M, 2003, J GASTROINTEST SURG, V7, P325, DOI 10.1016/S1091-255X(02)00370-0; BOERMA EJ, 1990, SURGERY, V108, P572; Chik BH, 2007, ARCH SURG-CHICAGO, V142, P63, DOI 10.1001/archsurg.142.1.63; Ishizaki Y, 2006, ARCH SURG-CHICAGO, V141, P649, DOI 10.1001/archsurg.141.7.649; Ishizaki Y, 2008, AM J SURG, V196, P353, DOI 10.1016/j.amjsurg.2007.09.046; Jakab F, 1996, HPB Surg, V9, P245, DOI 10.1155/1996/62057; Ju MK, 2012, TRANSPL P, V44, P338, DOI 10.1016/j.transproceed.2012.01.063; KAWASAKI S, 1994, SURGERY, V115, P674; KAWASAKI S, 1993, HEPATOLOGY, V18, P1115; Liu H, 2009, AM J SURG, V197, P686, DOI 10.1016/j.amjsurg.2008.04.022; MATHIE RT, 1988, SURG GYNECOL OBSTET, V166, P125; Reichman TW, 2011, LIVER TRANSPLANT, V17, P1404, DOI 10.1002/lt.22420; Vetelainen R, 2006, J VASC INTERV RADIOL, V17, P1181, DOI 10.1097/01.RVI.0000228460.48294.2E	28	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-2313	1432-2323		WORLD J SURG	World J.Surg.	AUG	2015	39	8					2031	2036		10.1007/s00268-015-3033-5		6	Surgery	Surgery	CM4XW	WOS:000357690700026		
J	Takahashi, H; Okabayashi, K; Tsuruta, M; Hasegawa, H; Yahagi, M; Kitagawa, Y				Takahashi, Hidena; Okabayashi, Koji; Tsuruta, Masashi; Hasegawa, Hirotoshi; Yahagi, Masashi; Kitagawa, Yuko			Self-Expanding Metallic Stents Versus Surgical Intervention as Palliative Therapy for Obstructive Colorectal Cancer: A Meta-analysis	WORLD JOURNAL OF SURGERY			English	Article							QUALITY-OF-LIFE; LARGE-BOWEL OBSTRUCTION; RECURRENT GYNECOLOGIC CANCER; COLON-CANCER; SURGERY; MANAGEMENT; PLACEMENT; CARCINOMA; OUTCOMES; MULTICENTER	Although self-expanding metallic stents (SEMS) are useful tools for relieving large bowel obstructions in patients with colorectal cancer (CRC), their efficacy in a palliative setting has not been validated. This meta-analysis aimed to evaluate the feasibility of SEMS as a palliation for unresectable CRC patients with bowel obstructions and to determine their contribution to the prognosis of CRC, compared with surgical intervention. We conducted a literature search of the PubMed and Cochrane Library databases. We selected all controlled trials that compared SEMS with surgical interventions as palliative treatments in unresectable obstructive CRC patients. The primary outcome was early complications, and the secondary outcomes were mortality, other morbidities, and long-term survival rates. Ten studies met our inclusion criteria. SEMS significantly reduced the risk of early complications (odds ratio [OR] 0.34; 95 % confidence interval [CI] 0.20-0.58 %; P < 0.01), mortality (OR 0.31; 95 % CI 0.15 %-0.64 %; P < 0.01), and stoma creation (OR 0.19; 95 % CI 0.12-0.28 %; P < 0.01). Although SEMS placement was significantly associated with a higher risk of perforation of the large bowel (OR 5.25 95 % CI 2.00-13.78 %; P < 0.01) and late complications (OR 1.94; 95 % CI 0.90-4.19 %; P = 0.03), it also contributed significantly to better long-term survival (hazard ratio 0.46; 95 % CI 0.31-0.68 %; P < 0.01). Compared with surgical intervention, SEMS could provide feasible palliation for patients with bowel obstructions and unresectable CRC, because of their acceptable morbidity rates and better patient prognoses.	[Takahashi, Hidena; Okabayashi, Koji; Tsuruta, Masashi; Hasegawa, Hirotoshi; Yahagi, Masashi; Kitagawa, Yuko] Keio Univ, Sch Med, Dept Surg, Shinjuku Ku, Tokyo 160, Japan	Takahashi, H (reprint author), Keio Univ, Sch Med, Dept Surg, Shinjuku Ku, 35 Shinanotmachi, Tokyo 160, Japan.	hidenayo@yahoo.co.jp; okabayashikoji@gmail.com; masashitsuruta@z2.keio.jp; hasegawa@z8.keio.jp; dct_masa@hotmail.com; kitagawa@a3.keio.jp					Zhang Y, 2012, SURG ENDOSC, V26, P110, DOI 10.1007/s00464-011-1835-6; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Faragher IG, 2008, COLORECTAL DIS, V10, P668, DOI 10.1111/j.1463-1318.2007.01446.x; Khot UP, 2002, BRIT J SURG, V89, P1096, DOI 10.1046/j.1365-2168.2002.02148.x; Sterne JAC, 2001, J CLIN EPIDEMIOL, V54, P1046, DOI 10.1016/S0895-4356(01)00377-8; Camunez F, 2000, RADIOLOGY, V216, P492; Krouse R, 2007, J SURG RES, V138, P79, DOI 10.1016/j.jss.2006.04.033; van Hooft JE, 2008, ENDOSCOPY, V40, P184, DOI 10.1055/s-2007-995426; Sterne JAC, 2000, J CLIN EPIDEMIOL, V53, P1119, DOI 10.1016/S0895-4356(00)00242-0; Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z; Nugent KP, 1999, DIS COLON RECTUM, V42, P1569, DOI 10.1007/BF02236209; Sideris L, 2005, DIS COLON RECTUM, V48, P2180, DOI 10.1007/s10350-005-0155-0; Vemulapalli R, 2010, DIGEST DIS SCI, V55, P1732, DOI 10.1007/s10620-009-0945-7; Aviv RI, 2002, CLIN RADIOL, V57, P347, DOI 10.1053/crad.2001.0844; Bhardwaj R, 2003, Colorectal Dis, V5, P518, DOI 10.1046/j.1463-1318.2003.00519.x; Caceres A, 2008, GYNECOL ONCOL, V108, P482, DOI 10.1016/j.ygyno.2007.11.035; Carne PWG, 2004, DIS COLON RECTUM, V47, P1455, DOI 10.1007/s10350-004-0624-x; Castillo JJ, 2010, BLOOD, V116, P2897, DOI 10.1182/blood-2010-03-276683; Cole SJ, 2000, COLORECTAL DIS, V2, P282; DEANS GT, 1994, BRIT J SURG, V81, P1270, DOI 10.1002/bjs.1800810905; De Gregorio MA, 1998, RADIOLOGY, V209, P117; Lobato RF, 1999, INT SURG, V84, P159; Fiori E, 2012, AM J SURG, V204, P321, DOI 10.1016/j.amjsurg.2011.11.013; Green S, 2011, COCHRANE HDB SYSTEMA, DOI [10.1002/9780470712184, DOI 10.1002/9780470712184.FMATTER]; Johnson R, 2004, ANN ROY COLL SURG, V86, P99, DOI 10.1308/003588404322827473; Karoui M, 2007, ARCH SURG-CHICAGO, V142, P619, DOI 10.1001/archsurg.142.7.619; Law WL, 2004, DIS COLON RECTUM, V47, P39, DOI 10.1007/s10350-003-0005-x; Lee HJ, 2011, GASTROINTEST ENDOSC, V73, P535, DOI 10.1016/j.gie.2010.10.052; Lee WS, 2012, AM J SURG, V203, P715, DOI 10.1016/j.amjsurg.2011.05.015; Marudiachalam K, 2007, BRIT J SURG, V94, P1151, DOI 10.1002/bjs.5790; Meisner S, 2004, DIS COLON RECTUM, V47, P444, DOI 10.1007/s10350-003-0081-y; Nagula S, 2010, J AM COLL SURGEONS, V210, P45, DOI 10.1016/j.jamcollsurg.2009.09.039; OHMAN U, 1982, AM J SURG, V144, P344, DOI 10.1016/0002-9610(82)90017-4; Pothuri B, 2004, GYNECOL ONCOL, V95, P513, DOI 10.1016/j.ygyno.2004.07.064; Ptok H, 2006, WORLD J SURG, V30, P1481, DOI 10.1007/s00268-005-0513-z; Shin SJ, 2008, DIS COLON RECTUM, V51, P578, DOI 10.1007/s10350-008-9207-6; Small Aaron J, 2008, Gastrointest Endosc, V67, P478, DOI 10.1016/j.gie.2007.08.043; Suarez J, 2010, INT J COLORECTAL DIS, V25, P91, DOI 10.1007/s00384-009-0814-z; Suzuki N, 2004, DIS COLON RECTUM, V47, P1201, DOI 10.1007/s10350-004-0556-5; Tack J, 1998, GASTROINTEST ENDOSC, V48, P267, DOI 10.1016/S0016-5107(98)70189-0; Tierney JF, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-16; White SI, 2011, ANZ J SURG, V81, P257, DOI 10.1111/j.1445-2197.2010.05477.x; Xinopoulos D, 2004, SURG ENDOSC, V18, P421, DOI 10.1007/s00464-003-8109-x	43	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-2313	1432-2323		WORLD J SURG	World J.Surg.	AUG	2015	39	8					2037	2044		10.1007/s00268-015-3068-7		8	Surgery	Surgery	CM4XW	WOS:000357690700027		
J	Ferretti, S; Tranchart, H; Buell, JF; Eretta, C; Patriti, A; Spampinato, MG; Huh, JW; Vigano, L; Han, HS; Ettorre, GM; Jovine, E; Gamblin, TC; Belli, G; Wakabayashi, G; Gayet, B; Dagher, I				Ferretti, Stefano; Tranchart, Hadrien; Buell, Joseph F.; Eretta, Constantino; Patriti, Alberto; Spampinato, Marcello Giuseppe; Huh, Jung Wook; Vigano, Luca; Han, Ho Seong; Ettorre, Giuseppe Maria; Jovine, Elio; Gamblin, Thomas Clark; Belli, Giulio; Wakabayashi, Go; Gayet, Brice; Dagher, Ibrahim			Laparoscopic Simultaneous Resection of Colorectal Primary Tumor and Liver Metastases: Results of a Multicenter International Study	WORLD JOURNAL OF SURGERY			English	Article							RANDOMIZED CLINICAL-TRIAL; SHORT-TERM OUTCOMES; MRC CLASICC TRIAL; HEPATIC METASTASES; COLON-CANCER; OPEN SURGERY; HEPATOCELLULAR-CARCINOMA; NEOADJUVANT CHEMOTHERAPY; SELECTION CRITERIA; ASSISTED SURGERY	With the advance of modern laparoscopic technology, laparoscopic colorectal surgery and laparoscopic liver surgery are both worldwide accepted. Preliminary brief series have shown the feasibility of combined laparoscopic resection of colorectal cancer (CRC) and synchronous colorectal liver metastases (SCRLM). We aim to report a large International multicenter series of laparoscopic simultaneous resection of CRC and SCRLM. Between 1997 and 2013, 142 laparoscopic liver resections were performed with simultaneous colorectal surgery for SCRLM. The surgical and postoperative variables evaluated were the duration of the intervention, blood loss, transfusion rate, conversion rate, resection margin, specific and overall morbidity, perioperative mortality, length of hospital stay, and survival. Univariate and multivariate analyses were performed examining postoperative morbidity in the all cohort of patients. The median number of liver lesions was 1 (1-9) and the median larger diameter at diagnosis was 28 (2-100) mm. The median operative time was 360 (120-690) min. Seven patients (4.9 %) required conversion. The global morbidity was 31.0 % and the mortality was 2.1 %. After a median follow-up of 29 (1-108) months, 40 patients (28.2 %) developed tumor recurrence. Curative treatment of recurrence was possible in 17 patients (12.0 %), including a second liver resection in 13 patients (9.1 %), which was performed by laparoscopy in 7 patients (4.9 %). Overall 1-, 3-, and 5-year survivals were 98.8, 82.1, and 71.9 %, respectively. By multivariate analysis, ASA score a parts per thousand yen3 [OR 13.6 (1.8-99.6); P = 0.01] and operative time [OR 1.008 (1.001-1.016); P = 0.03] were independent predictors of postoperative morbidity. Our combined data show that in experienced centers, simultaneous laparoscopic approach is technically feasible, safe, and associated with good oncological outcomes.	[Ferretti, Stefano; Tranchart, Hadrien; Dagher, Ibrahim] Univ Paris 11, Antoine Beclere Hosp, AP HP, Dept Minimally Invas Digest Surg, F-92141 Clamart, France; [Buell, Joseph F.] Tulane Abdominal Transplant Inst, Dept Surg, New Orleans, LA 70112 USA; [Eretta, Constantino] St Andreas Hosp, Div Gen Surg, I-19100 La Spezia, Italy; [Patriti, Alberto] San Matteo Infermi Hosp, Div Gen Minimally Invas & Robot Surg, I-06049 Perugia, Italy; [Spampinato, Marcello Giuseppe] Policlin Abano Terme, HPB & Adv Laparoscop Surg Unit, I-35031 Abano Terme, Italy; [Huh, Jung Wook] Chonnam Natl Univ, Dept Surg, Hwasun Hosp & Med Sch, Seoul 135710, South Korea; [Vigano, Luca] Osped Mauriziano Umberto 1, Dept HPB & Digest Surg, I-10100 Turin, Italy; [Han, Ho Seong] Seoul Natl Univ, Dept Surg, Bundang Hosp, Seoul 135710, South Korea; [Ettorre, Giuseppe Maria] San Camillo Forlanini Hosp, Gen Surg & Liver Transplantat Unit, I-00152 Rome, Italy; [Jovine, Elio] Maggiore Hosp, Dept Surg, I-40133 Bologna, Italy; [Gamblin, Thomas Clark] Med Coll Wisconsin, Div Surg Oncol, Milwaukee, WI 53226 USA; [Belli, Giulio] S Maria di Loreto Nuevo Hosp, Div Gen Surg, I-80142 Naples, Italy; [Wakabayashi, Go] Iwate Med Univ, Dept Surg, Sch Med, Morioka, Iwate 0208505, Japan; [Gayet, Brice] Inst Mutualiste Montsouris, Dept Digest Dis, F-75014 Paris, France	Tranchart, H (reprint author), Univ Paris 11, Antoine Beclere Hosp, AP HP, Dept Minimally Invas Digest Surg, 157 Rue Porte Trivaux, F-92141 Clamart, France.	hadrien.tranchart@abc.aphp.fr					Akiyoshi T, 2009, DIGEST SURG, V26, P471, DOI 10.1159/000237109; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Martin R, 2003, J AM COLL SURGEONS, V197, P233, DOI 10.1016/S1072-7515(03)00390-9; Lacy AM, 2008, ANN SURG, V248, P1, DOI 10.1097/SLA.0b013e31816a9d65; Mentha G, 2006, BRIT J SURG, V93, P872, DOI 10.1002/bjs.5346; Brouquet A, 2010, J AM COLL SURGEONS, V210, P934, DOI 10.1016/j.jamcollsurg.2010.02.039; Huh JW, 2011, SURG ENDOSC, V25, P193, DOI 10.1007/s00464-010-1158-z; Hillingso JG, 2009, COLORECTAL DIS, V11, P3, DOI 10.1111/j.1463-1318.2008.01625.x; Gutt CN, 2004, SURG ENDOSC, V18, P898, DOI 10.1007/s00464-003-9233-3; Choti MA, 2002, ANN SURG, V235, P759, DOI 10.1097/00000658-200206000-00002; STEELE G, 1989, ANN SURG, V210, P127, DOI 10.1097/00000658-198908000-00001; STANGL R, 1994, LANCET, V343, P1405, DOI 10.1016/S0140-6736(94)92529-1; Minagawa M, 2006, ARCH SURG-CHICAGO, V141, P1006, DOI 10.1001/archsurg.141.10.1006; Belli G, 2013, SURG ENDOSC, V27, P2721, DOI 10.1007/s00464-013-2840-8; Capussotti L, 2007, ANN SURG ONCOL, V14, P1143, DOI 10.1245/s10434-006-9284-5; van der Pas MHGM, 2013, LANCET ONCOL, V14, P210, DOI 10.1016/S1470-2045(13)70016-0; Correa-Gallego C, 2013, ANN SURG ONCOL, V20, P2477, DOI 10.1245/s10434-013-2975-9; Fleshman J, 2007, ANN SURG, V246, P655, DOI 10.1097/SLA.0b013e318155a762; Weber JC, 2003, BRIT J SURG, V90, P956, DOI 10.1002/bjs.4132; Allen PJ, 2003, J GASTROINTEST SURG, V7, P109, DOI 10.1016/S1091-255X(02)00121-X; Bretagnol F, 2008, SURGERY, V144, P436, DOI 10.1016/j.surg.2008.04.014; Fong Y, 1999, ANN SURG, V230, P309, DOI 10.1097/00000658-199909000-00004; Tranchart H, 2011, HPB, V13, P46, DOI 10.1111/j.1477-2574.2010.00238.x; Mayo SC, 2013, J AM COLL SURGEONS, V216, P707, DOI 10.1016/j.jamcollsurg.2012.12.029; Cannon RM, 2012, SURGERY, V152, P567, DOI 10.1016/j.surg.2012.07.013; Lacy AM, 2002, LANCET, V359, P2224, DOI 10.1016/S0140-6736(02)09290-5; Jayne DG, 2007, J CLIN ONCOL, V25, P3061, DOI 10.1200/JCO.2006.09.7758; Reddy SK, 2007, ANN SURG ONCOL, V14, P3481, DOI 10.1245/s10434-007-9522-5; Polignano FM, 2012, SURG ENDOSC, V26, P2571, DOI 10.1007/s00464-012-2235-2; Leporrier J, 2006, BRIT J SURG, V93, P465, DOI 10.1002/bjs.5278; Bolton JS, 2000, ANN SURG, V231, P743, DOI 10.1097/00000658-200005000-00015; Guillou PJ, 2005, LANCET, V365, P1718, DOI 10.1016/S0140-6736(05)66545-2; Capussotti L, 2007, ANN SURG ONCOL, V14, P195, DOI 10.1245/s10434-006-9055-3; Nguyen KT, 2009, ANN SURG, V250, P842, DOI 10.1097/SLA.0b013e3181bc789c; [Anonymous], 2003, WHO WORLD CANC REP; Casciola L, 2011, SURG ENDOSC, V25, P3815, DOI 10.1007/s00464-011-1796-9; Nordlinger B, 1996, CANCER, V77, P1254, DOI 10.1002/(SICI)1097-0142(19960401)77:7<1254::AID-CNCR5>3.3.CO;2-R; Garden OJ, 2006, GUT, V55, P1, DOI 10.1136/gut.2006.098053; Bagshaw PF, 2012, ANN SURG, V256, P915, DOI 10.1097/SLA.0b013e3182765ff8; Castaing D, 2009, ANN SURG, V250, P849, DOI 10.1097/SLA.0b013e3181bcaf63; Fong YM, 1997, J CLIN ONCOL, V15, P938; Minagawa M, 2003, ANN SURG, V238, P703, DOI 10.1097/01.sla.0000094549.11754.e6; Krarup PM, 2014, ANN SURG, V259, P930, DOI 10.1097/SLA.0b013e3182a6f2fc; Chen JG, 2011, INT J COLORECTAL DIS, V26, P191, DOI 10.1007/s00384-010-1018-2; BELGHITI J, 1990, ANN CHIR, V44, P427; Belli G, 2007, SURG ENDOSC, V21, P2004, DOI 10.1007/s00464-007-9503-6; Buell JF, 2008, ANN SURG, V250, P825, DOI [10.1097/SLA.0b013e3181b3b2d8, DOI 10.1097/SLA.0B013E3181B3B2D8]; Cheung TT, 2012, ANZ J SURG, V83, P847; de Santibanes E, 2010, WORLD J SURG, V34, P2133, DOI 10.1007/s00268-010-0654-6; ELIAS D, 1995, AM J SURG, V169, P254, DOI 10.1016/S0002-9610(99)80146-9; Fong Y, 1998, ONCOLOGY-NY, V12, P1489; Hatwell C, 2013, COLOR DIS, V15, P21; Hu MG, 2011, WORLD J SURG, V35, P648, DOI 10.1007/s00268-010-0919-0; Jaeck D, 1997, BRIT J SURG, V84, P977, DOI 10.1002/bjs.1800840719; Kang SB, 2010, DIS COLON RECTUM, V53, P1400, DOI 10.1007/DCR.0b013e3181e5e0b1; Kimura F, 1996, BRIT J SURG, V83, P1002, DOI 10.1002/bjs.1800830738; Lin Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105747; Luna-Perez P, 1998, ARCH MED RES, V29, P319; Luo YX, 2010, J GASTROINTEST SURG, V14, P1974, DOI 10.1007/s11605-010-1284-x; Nadig DE, 1997, ARCH SURG-CHICAGO, V132, P115; Schiffman SC, 2014, SURGERY, V157, P211; Soubrane O, 2013, HPB OXFORD, V16, P357; Spampinato MG, 2012, SURGERY, V153, P861; Tuttle TM, 1997, ANN SURG ONCOL, V4, P125, DOI 10.1007/BF02303794; Bonjer HJ, 2005, LANCET ONCOL, V6, P477, DOI 10.1016/S1470-2045(05)70221-7; Vigano L, 2013, BRIT J SURG, V100, P535, DOI 10.1002/bjs.9025; Yoshioka R, 2014, SURGERY, V155, P478, DOI 10.1016/j.surg.2013.10.015	67	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-2313	1432-2323		WORLD J SURG	World J.Surg.	AUG	2015	39	8					2052	2060		10.1007/s00268-015-3034-4		9	Surgery	Surgery	CM4XW	WOS:000357690700029		
J	Ichikawa, M; Nakahara, S; Taniguchi, A				Ichikawa, Masao; Nakahara, Shinji; Taniguchi, Ayako			Older drivers' risks of at-fault motor vehicle collisions	ACCIDENT ANALYSIS AND PREVENTION			English	Article						Older drivers; At-fault collision risk; Drivers' relative risk	AGE; INVOLVEMENT; FRAGILITY; GENDER; RATES	In aging societies, increasing numbers of older drivers are involved in motor vehicle collisions (MVCs), and preserving their safety is a growing concern. In this study, we focused on whether older drivers were more likely to cause MVCs and injuries than drivers in other age groups. To do so we compared at-fault MVC incidence and resulting injury risks by drivers' ages, using data from Japan, a country with a rapidly aging population. The at-fault MVC incidence was calculated based on distance traveled made for non-commercial purposes, and the injury risks posed to at-fault drivers and other road users per at-fault MVCs. We used MVC data for 2010 from the National Police Agency of Japan and driving exposure data from the Nationwide Person Trip Survey conducted by a Japanese governmental ministry in 2010. The at-fault MVC incidence showed a U-shaped curve across the drivers' ages, where teenage and the oldest drivers appeared to be the highest risk groups in terms of causing MVCs, and the incidence was higher for female drivers after age 25. The injury risk older drivers posed to other vehicle occupants because of their at-fault MVCs was lower than for drivers in other age groups, while their own injury risk appeared much higher. As the number of older drivers is increasing, efforts to reduce their at-fault MVCs appear justified. (C) 2015 Elsevier Ltd. All rights reserved.	[Ichikawa, Masao] Univ Tsukuba, Fac Med, Tsukuba, Ibaraki 3058577, Japan; [Nakahara, Shinji] Kanagawa Univ Human Serv, Yokosuka, Kanagawa 2388522, Japan; [Taniguchi, Ayako] Univ Tsukuba, Fac Engn Informat & Syst, Tsukuba, Ibaraki 3058573, Japan	Ichikawa, M (reprint author), Univ Tsukuba, Fac Med, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058577, Japan.	masao@md.tsukuba.ac.jp; nakahara-sry@kuhs.ac.jp; taniguchi@risk.tsukuba.ac.jp			University of Tsukuba	This work was supported by the University of Tsukuba.	Langford J, 2006, ACCIDENT ANAL PREV, V38, P574, DOI 10.1016/j.aap.2005.12.002; MASSIE DL, 1995, ACCIDENT ANAL PREV, V27, P73, DOI 10.1016/0001-4575(94)00050-V; Li GH, 2003, ACCIDENT ANAL PREV, V35, P227, DOI 10.1016/S0001-4575(01)00107-5; Meuleners LB, 2006, ACCIDENT ANAL PREV, V38, P1006, DOI 10.1016/j.aap.2006.04.005; Mitchell CGB, 2013, ACCIDENT ANAL PREV, V50, P732, DOI 10.1016/j.aap.2012.06.027; Cabinet Office Government of Japan, 2011, SURV RES LIV ENV ELD; Doi Y., 2014, RITSUMEI KEIEIGAKU, V52, P195; Evans L., 2004, TRAFFIC SAFETY; Ichikawa M, 2015, ACCIDENT ANAL PREV, V75, P55, DOI 10.1016/j.aap.2014.11.015; Kahvedzic A., 2013, INT RELICENSING MODE; Kohata S., 2011, IATSS REV, V35, P161; Korner-Bitensky N, 2009, J SAFETY RES, V40, P105, DOI 10.1016/j.jsr.2009.02.002; Langford J, 2008, TRAFFIC INJ PREV, V9, P181, DOI 10.1080/15389580801975632; Lardelli-Claret P, 2011, ACCIDENT ANAL PREV, V43, P1555, DOI 10.1016/j.aap.2011.03.011; National Police Agency, 2010, DRIV LIC STAT; Organization for Economic Co-Operation and Development, 2001, AG TRANSP MOB NEEDS; Russell KF, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003300.pub3; Taniguchi A., 2006, EMPIRICAL STUDY PSYC; Tefft BC, 2008, J SAFETY RES, V39, P577, DOI 10.1016/j.jsr.2008.10.002; Williams AF, 2003, J SAFETY RES, V34, P527, DOI 10.1016/j.jsr.2003.03.001	20	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0001-4575	1879-2057		ACCIDENT ANAL PREV	Accid. Anal. Prev.	AUG	2015	81						120	123		10.1016/j.aap.2015.05.004		4	Ergonomics; Public, Environmental & Occupational Health; Social Sciences, Interdisciplinary; Transportation	Engineering; Public, Environmental & Occupational Health; Social Sciences - Other Topics; Transportation	CM2YR	WOS:000357548800012		
J	Asano, Y; Yamada, K; Jikuya, I				Asano, Yuta; Yamada, Katsuhiko; Jikuya, Ichiro			Approximating elliptic halo orbits based on the variation of constants	ACTA ASTRONAUTICA			English	Article						Halo orbit; Periodic orbit; Elliptic restricted three body problem; Variation of constants	RESTRICTED 3-BODY PROBLEM; COLLINEAR POINTS; PERIODIC-ORBITS; FORMULATION	A computational procedure is presented for approximating elliptic halo orbits about the collinear equilibrium points based on the variation of constants in the sense of the second-order approximation. Simulation results show that the approximate solutions agree well with the results of two-point boundary-value problems. The existence conditions of the elliptic halo orbits are also determined with respect to the mass ratio of the primaries and the eccentricity. (C) 2015 IAA. Published by Elsevier Ltd. All rights reserved.	[Asano, Yuta] Mitsubishi Electr Corp, Adv Technol R&D Ctr, Amagasaki, Hyogo 6618661, Japan; [Yamada, Katsuhiko] Osaka Univ, Dept Mech Engn, Osaka 5650871, Japan; [Jikuya, Ichiro] Nagoya Univ, Dept Aerosp Engn, Nagoya, Aichi 4648603, Japan	Jikuya, I (reprint author), Nagoya Univ, Dept Aerosp Engn, Nagoya, Aichi 4648603, Japan.	jikuya@nuae.nagoya-u.ac.jp					BREAKWELL JV, 1979, CELESTIAL MECH, V20, P389, DOI 10.1007/BF01230405; RICHARDSON DL, 1980, CELESTIAL MECH, V22, P241, DOI 10.1007/BF01229511; Mingotti G, 2011, J GUID CONTROL DYNAM, V34, P1644, DOI 10.2514/1.52493; Hou XY, 2011, MON NOT R ASTRON SOC, V415, P3552, DOI 10.1111/j.1365-2966.2011.18970.x; Campagnola S., 2008, AIAA SPAC FLIGHT MEC; Duffy B., 2012, THESIS G WASHINGTON; Duffy B., 2012, P 22 AIAA AAS SPAC F; Dunham D.W., 2002, P LIBR ORB APPL AIG, P45; Eapen RT, 2014, ASTROPHYS SPACE SCI, V352, P437, DOI 10.1007/s10509-014-1951-6; Eapen RT, 2014, ASTROPHYS SPACE SCI, V353, P65, DOI 10.1007/s10509-014-2012-x; Farquhar R.W., 1968, THESIS STANFORD U ST; Farquhar R.W., 1966, AAS SCI TECHNOLOGY S, P519; Farquhar R. W., 1973, Celestial Mechanics, V7, DOI 10.1007/BF01227511; HOWELL KC, 1984, CELESTIAL MECH, V32, P53; Ikenaga T., 2012, T JPN SOC AERONAUT S, V10; McKay RJ, 2011, J GUID CONTROL DYNAM, V34, P645, DOI 10.2514/1.52133; Nakamiya M, 2012, J GUID CONTROL DYNAM, V35, P1224, DOI 10.2514/1.55305; RICHARDSON DL, 1980, J GUID CONTROL, V3, P543, DOI 10.2514/3.56033; RICHARDSON DL, 1980, CELESTIAL MECH, V22, P231, DOI 10.1007/BF01229509; Schaub H., 2003, AIAA ED SERIES, P492; Szebehely V. G, 1967, THEORY ORBITS RESTRI	21	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0094-5765	1879-2030		ACTA ASTRONAUT	Acta Astronaut.	AUG-SEP	2015	113						169	179		10.1016/j.actaastro.2015.04.005		11	Engineering, Aerospace	Engineering	CL8RA	WOS:000357240600016		
J	Hagiuda, J; Ishikawa, H; Marumo, K				Hagiuda, J.; Ishikawa, H.; Marumo, K.			Serum oestradiol levels in male partners of infertile couples	ANDROLOGIA			English	Article						Body mass index; oestradiol; semen quality; testosterone	HUMAN EJACULATED SPERMATOZOA; BODY-MASS INDEX; ERECTILE DYSFUNCTION; ESTROGEN-RECEPTORS; METABOLIC SYNDROME; MALE REPRODUCTION; SPERM QUALITY; OBESE MEN; AROMATASE; DEFICIENCY	A prospective clinical study was performed in the reproduction centre of Ichikawa General Hospital (Chiba, Japan) to investigate the relationship between sperm quality and serum oestradiol (E2) level in male partners of infertile couples. The semen parameters and blood samples were assessed in relation to several variables, including body mass index (BMI) and serum oestradiol (E2) levels. Four hundred and nine male partners of infertile couples aged 22-55years (mean: 36.5years) were referred to the reproduction centre. In total, 143 patients (35.0%) were included in the low E2 level group (18pgml(-1)E2). Serum E2 levels were slightly correlated with testosterone levels, BMI and serum FSH levels. Total motile sperm count and morphology were decreased in low E2 level group. In multivariate analysis, serum testosterone, E2 levels, existence of varicocele and age were risk factors for decreased semen quality. Serum E2 might be associated with BMI, serum testosterone level and spermatogenesis.	[Hagiuda, J.; Ishikawa, H.; Marumo, K.] Ichikawa Gen Hosp, Tokyo Dent Coll, Dept Urol, Ichikawa, Chiba 2728513, Japan	Hagiuda, J (reprint author), Ichikawa Gen Hosp, Tokyo Dent Coll, Dept Urol, Sugano 5-11-13, Ichikawa, Chiba 2728513, Japan.	junhagi@hotmail.com					Zohdy W, 2007, J SEX MED, V4, P797, DOI 10.1111/j.1743-6109.2007.00499.x; Aquila S, 2002, J CLIN ENDOCR METAB, V87, P3385, DOI 10.1210/jc.87.7.3385; Carreau S, 2010, PHILOS T R SOC B, V365, P1517, DOI 10.1098/rstb.2009.0235; Lambard S, 2004, J MOL ENDOCRINOL, V32, P279, DOI 10.1677/jme.0.0320279; Carreau S, 2006, MOL CELL ENDOCRINOL, V246, P65, DOI 10.1016/j.mce.2005.11.021; Sinkevicius KW, 2009, ENDOCRINOLOGY, V150, P2898, DOI 10.1210/en.2008-1016; Derby CA, 2006, CLIN ENDOCRINOL, V65, P125, DOI 10.1111/j.1365-2265.2006.02560.x; Carreau S, 2009, MICROSC RES TECHNIQ, V72, P552, DOI 10.1002/jemt.20703; Aquila S, 2004, J CLIN ENDOCR METAB, V89, P1443, DOI 10.1210/jc.2003-031681; Mohr BA, 2006, EUR J ENDOCRINOL, V155, P443, DOI 10.1530/eje.1.02241; Carreau S, 2010, PHILOS T R SOC B, V365, P1571, DOI 10.1098/rstb.2009.0113; Kaplan SA, 2006, J UROLOGY, V176, P1524, DOI 10.1016/j.juro.2006.06.003; Pauli EM, 2008, FERTIL STERIL, V90, P346, DOI 10.1016/j.fertnstert.2007.06.046; Mazumdar M, 2000, STAT MED, V19, P113, DOI 10.1002/(SICI)1097-0258(20000115)19:1<113::AID-SIM245>3.3.CO;2-F; Laaksonen DE, 2005, J CLIN ENDOCR METAB, V90, P712, DOI 10.1210/jc.2004-0970; Flegal KM, 2012, JAMA-J AM MED ASSOC, V307, P491, DOI 10.1001/jama.2012.39; Carreau S, 1999, INT J ANDROL, V22, P211, DOI 10.1046/j.1365-2605.1999.00172.x; Carreau Serge, 2003, Reprod Biol Endocrinol, V1, P35, DOI 10.1186/1477-7827-1-35; FOUCAULT P, 1992, J ANDROL, V13, P361; Irvine S, 1996, BRIT MED J, V312, P467; Iwasa T, 2006, OBSTET GYNECOL, V1, P133; Lambard S, 2003, MOL HUM REPROD, V9, P117, DOI 10.1093/molehr/gag020; Ministry of Health Labor and Welfare, 2006, OB JAP PEOPL; PAYNE AH, 1976, J CLIN ENDOCR METAB, V42, P1081; Rochira V, 2009, NAT REV ENDOCRINOL, V5, P559, DOI 10.1038/nrendo.2009.176; Toppari J, 1996, ENVIRON HEALTH PERSP, V104, P741, DOI 10.2307/3432709; VanWaeleghem K, 1996, HUM REPROD, V11, P325; World Health Organisation, OB OV; World Health Organization, 2010, WHO LAB MAN EX PROC; World Health Organization, 2000, WHO MAN STAND INV DI	30	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0303-4569	1439-0272		ANDROLOGIA	Andrologia	AUG	2015	47	6					669	673		10.1111/and.12315		5	Andrology	Endocrinology & Metabolism	CM1HH	WOS:000357431400009		
J	Ogawa, S; Yokoyama, Y; Suzukawa, K; Nanmoku, T; Kurita, N; Seki, M; Maie, K; Suyama, T; Takaiwa, N; Sakata-Yanagimoto, M; Obara, N; Hasegawa, Y; Chiba, S				Ogawa, Shinichi; Yokoyama, Yasuhisa; Suzukawa, Kazumi; Nanmoku, Toru; Kurita, Naoki; Seki, Masanori; Maie, Koichiro; Suyama, Takuya; Takaiwa, Naoko; Sakata-Yanagimoto, Mamiko; Obara, Naoshi; Hasegawa, Yuichi; Chiba, Shigeru			Identification of a fusion gene composed of a Hippo pathway gene MST2 and a common translocation partner ETV6 in a recurrent translocation t(8;12)(q22;p13) in acute myeloid leukemia	ANNALS OF HEMATOLOGY			English	Letter							MALIGNANCIES; TEL		[Ogawa, Shinichi; Yokoyama, Yasuhisa; Suzukawa, Kazumi; Kurita, Naoki; Seki, Masanori; Maie, Koichiro; Suyama, Takuya; Takaiwa, Naoko; Sakata-Yanagimoto, Mamiko; Obara, Naoshi; Hasegawa, Yuichi; Chiba, Shigeru] Univ Tsukuba Hosp, Dept Hematol, Tsukuba, Ibaraki, Japan; [Yokoyama, Yasuhisa; Suzukawa, Kazumi; Kurita, Naoki; Seki, Masanori; Sakata-Yanagimoto, Mamiko; Obara, Naoshi; Hasegawa, Yuichi; Chiba, Shigeru] Univ Tsukuba, Dept Hematol, Fac Med, Tsukuba, Ibaraki, Japan; [Nanmoku, Toru] Univ Tsukuba Hosp, Dept Clin Lab, Tsukuba, Ibaraki, Japan	Chiba, S (reprint author), Univ Tsukuba Hosp, Dept Hematol, 1-1-1 Tennodai, Tsukuba, Ibaraki, Japan.	schiba-t@md.tsukuba.ac.jp		Suzukawa, Kazumi/0000-0001-9904-3905			Errani C, 2011, GENE CHROMOSOME CANC, V50, P644, DOI 10.1002/gcc.20886; De Braekeleer E, 2012, LEUKEMIA RES, V36, P945, DOI 10.1016/j.leukres.2012.04.010; van Dongen JJM, 1999, LEUKEMIA, V13, P1901, DOI 10.1038/sj.leu.2401592; Harvey KF, 2013, NAT REV CANCER, V13, P246, DOI 10.1038/nrc3458; Haferlach C, 2012, GENE CHROMOSOME CANC, V51, P328, DOI 10.1002/gcc.21918; van Doorn-Khosrovani SBV, 2005, ONCOGENE, V24, P4129, DOI 10.1038/sj.onc.1208588; Fenrick R, 2000, MOL CELL BIOL, V20, P5828, DOI 10.1128/MCB.20.16.5828-5839.2000; Pan D, 2010, NAT REV CANCER, V19, P491, DOI [10.1016/ j. devcel. 2010.09.011, DOI 10.1016/J.DEVCEL.2010.09.011]	8	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0939-5555	1432-0584		ANN HEMATOL	Ann. Hematol.	AUG	2015	94	8					1431	1433		10.1007/s00277-015-2391-2		3	Hematology	Hematology	CL9EU	WOS:000357279200029		
J	Ishii, H; Konuma, T; Kato, S; Ota, Y; Tojo, A; Takahashi, S				Ishii, Hiroto; Konuma, Takaaki; Kato, Seiko; Ota, Yasunori; Tojo, Arinobu; Takahashi, Satoshi			Eosinophilic gastroenteritis after allogeneic bone marrow transplantation	ANNALS OF HEMATOLOGY			English	Letter							MYELOID-LEUKEMIA; COLITIS; PATIENT; DISEASE		[Ishii, Hiroto; Konuma, Takaaki; Kato, Seiko; Tojo, Arinobu; Takahashi, Satoshi] Univ Tokyo, Inst Med Sci, Dept Hematol Oncol, Minato Ku, Tokyo 1088639, Japan; [Ota, Yasunori] Univ Tokyo, Inst Med Sci, Dept Pathol & Lab Med, Tokyo 1088639, Japan	Konuma, T (reprint author), Univ Tokyo, Inst Med Sci, Dept Hematol Oncol, Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.	tkonuma@ims.u-tokyo.ac.jp					Chen M, 2013, BLOOD, V121, P4020, DOI 10.1182/blood-2012-12-471003; Bischoff SC, 2010, CURR OPIN ALLERGY CL, V10, P238, DOI 10.1097/ACI.0b013e32833982c3; TALLEY NJ, 1990, GUT, V31, P54, DOI 10.1136/gut.31.1.54; Ashida T, 2003, INT J HEMATOL, V78, P76, DOI 10.1007/BF02983245; Shindano A, 2009, ACTA GASTRO-ENT BELG, V72, P267	5	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0939-5555	1432-0584		ANN HEMATOL	Ann. Hematol.	AUG	2015	94	8					1435	1436		10.1007/s00277-015-2388-x		2	Hematology	Hematology	CL9EU	WOS:000357279200030		
J	Yoon, J; Adachi, K; Kasai, H				Yoon, Jaewoo; Adachi, Kyoko; Kasai, Hiroaki			Isolation and characterization of a novel marine Bacteroidetes as Algitalea ulvae gen. nov., sp nov., isolated from the green alga Ulva pertusa	ANTONIE VAN LEEUWENHOEK INTERNATIONAL JOURNAL OF GENERAL AND MOLECULAR MICROBIOLOGY			English	Article						Bacteroidetes; Algitalea ulvae gen. nov., sp nov.; Chlorophyta; 16S rRNA gene; Polyphasic taxonomy	PERFORMANCE LIQUID-CHROMATOGRAPHY; IN-SITU HYBRIDIZATION; LATERCULA LEWIN 1969; FAMILY FLAVOBACTERIACEAE; EMENDED DESCRIPTION; COMB. NOV; PHYLOGENETIC DIVERSITY; DEOXYRIBONUCLEIC-ACID; BACTERIUM; SEA	A polyphasic taxonomic investigation was performed on a bacterial strain, 38-Ka-2(T), which was isolated from the green alga Ulva pertusa Kjellman (Chlorophyta) in Hokkaido, Japan. The bacterial cells were observed to be golden-yellow coloured, Gram-negative, strictly aerobic, non-spore-forming, non-motile and rod-shaped. Phylogenetic analyses based on the 16S rRNA gene sequence indicated that the new strain is a member of the family Flavobacteriaceae within the phylum Bacteroidetes and that it shows high sequence similarity (94.8 %) to Aquimarina addita JC2680(T). The genomic DNA G+C content of strain 38-Ka-2(T) was determined to be 36 mol%; MK-6 was identified as the major menaquinone; and the presence of iso-C15:0, C18:0 and iso-C17:0 3-OH as the major (> 10 %) cellular fatty acids. The polar lipid profile was found to consist of phosphatidylethanolamine, an unidentified glycolipid and two unidentified lipids. From the distinct phylogenetic position and combination of genotypic and phenotypic characteristics, strain 38-Ka-2(T) is considered to represent a novel genus for which the name Algitalea ulvae gen. nov., sp. nov. is proposed. The type strain of A. ulvae is 38-Ka-2(T) (=KCTC 32994(T) = NBRC 110017(T)).	[Yoon, Jaewoo] Keimyung Univ, Coll Pharm, ZA-704701 Daegu, South Africa; [Adachi, Kyoko] Marine Biotechnol Inst, Kamaishi, Iwate 0260001, Japan; [Kasai, Hiroaki] Kitasato Univ, Marine Biosci Kamaishi Res Lab, Ofunato, Iwate 0220101, Japan	Yoon, J (reprint author), Keimyung Univ, Coll Pharm, 1095 Dalgubeoldaero, ZA-704701 Daegu, South Africa.	jwyoon@kmu.ac.kr			Bisa Research Grant of Keimyung University	This research was supported by the Bisa Research Grant of Keimyung University in 2015.	FITCH WM, 1971, SYST ZOOL, V20, P406, DOI 10.2307/2412116; Bowman JP, 1997, INT J SYST BACTERIOL, V47, P670; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Nedashkovskaya OI, 2005, INT J SYST EVOL MICR, V55, P225, DOI 10.1099/ijs.0.63349-0; Kim OS, 2012, INT J SYST EVOL MICR, V62, P716, DOI 10.1099/ijs.0.038075-0; O'Sullivan LA, 2006, INT J SYST EVOL MICR, V56, P169, DOI 10.1099/ijs.0.63941-0; Srinivas TNR, 2013, INT J SYST EVOL MICR, V63, P729, DOI 10.1099/ijs.0.040907-0; Kirchman DL, 2002, FEMS MICROBIOL ECOL, V39, P91, DOI 10.1111/j.1574-6941.2002.tb00910.x; MARMUR J, 1961, J MOL BIOL, V3, P208; Brettar I, 2004, INT J SYST EVOL MICR, V54, P2335, DOI 10.1099/ijs.0.63255-0; Cottrell MT, 2000, APPL ENVIRON MICROB, V66, P5116, DOI 10.1128/AEM.66.12.5116-5122.2000; Glockner FO, 1999, APPL ENVIRON MICROB, V65, P3721; Bernardet JF, 2002, INT J SYST EVOL MICR, V52, P1049, DOI 10.1099/ijs.0.02136-0; Zhang ZH, 2014, INT J SYST EVOL MICR, V64, P1991, DOI 10.1099/ijs.0.062695-0; DITTMER JC, 1964, J LIPID RES, V5, P126; COLLINS MD, 1981, J APPL BACTERIOL, V51, P129, DOI 10.1111/j.1365-2672.1981.tb00916.x; WEISBURG WG, 1991, J BACTERIOL, V173, P697; Burke C, 2011, ISME J, V5, P590, DOI 10.1038/ismej.2010.164; Matsuo Y, 2003, ENVIRON MICROBIOL, V5, P25, DOI 10.1046/j.1462-2920.2003.00382.x; Bowman JP, 2005, INT J SYST EVOL MICR, V55, P1471, DOI 10.1099/ijs.0.63527-0; PERRY LB, 1973, J APPL BACTERIOL, V36, P227, DOI 10.1111/j.1365-2672.1973.tb04095.x; KOMAGATA K, 1987, METHOD MICROBIOL, V19, P161; Choi JH, 2007, INT J SYST EVOL MICR, V57, P2645, DOI 10.1099/ijs.0.65036-0; Park S, 2013, ANTON LEEUW INT J G, V104, P253, DOI 10.1007/s10482-013-9944-y; Nedashkovskaya OI, 2008, INT J SYST EVOL MICR, V58, P2694, DOI 10.1099/ijs.0.65799-0; DELONG EF, 1993, LIMNOL OCEANOGR, V38, P924; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Baek K, 2014, INT J SYST EVOL MICR, V65, P183; Barbeyron T, 2011, INT J SYST EVOL MICR, V61, P1899, DOI 10.1099/ijs.0.024489-0; Bernardet JF, 2006, PROKARYOTES EVOLVING; Bernardet J.-F., 2011, BERGEYS MANUAL SYSTE, V4, P106; BIANCHI A, 1995, MICROBIAL DIVERSITY AND ECOSYSTEM FUNCTION, P185; Collins C. H., 1984, MICROBIOLOGICAL METH; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.2307/2408678; Garrity G. M., 2001, BERGEYS MANUAL SYSTE, P119; HANSEN GH, 1991, J MICROBIOL METH, V13, P231; Jooste PJ, 1985, THESIS U ORANGE FREE; Kimura M., 1983, NEUTRAL THEORY MOL E; Kwon KK, 2006, INT J SYST EVOL MICR, V56, P1055, DOI 10.1099/ijs.0.64171-0; Ludwig W, 2001, BERGEYS MANUAL SYSTE, V1, P49; MESBAH M, 1989, INT J SYST BACTERIOL, V39, P159; MINNIKIN DE, 1984, J MICROBIOL METH, V2, P233, DOI 10.1016/0167-7012(84)90018-6; Nedashkovskaya OI, 2006, INT J SYST EVOL MICR, V56, P2037, DOI 10.1099/ijs.0.64155-0; Nedashkovskaya OI, 2004, INT J SYST EVOL MICR, V54, P1257, DOI 10.1099/ijs.0.02949-0; Nedashkovskaya OI, 2007, INT J SYST EVOL MICR, V57, P2147, DOI 10.1099/ijs.0.65165-0; Pinhassi J, 2003, APPL ENVIRON MICROB, V69, P199, DOI 10.1128/AEM.69.1.199-211.2003; SAITOU N, 1987, MOL BIOL EVOL, V4, P406; Sasser M., 1990, 101 MIDI; Worliczek HL, 2007, SYST APPL MICROBIOL, V30, P355, DOI 10.1016/j.syapm.2007.03.004; Yi H, 2011, INT J SYST EVOL MICR, V61, P2445, DOI 10.1099/ijs.0.027433-0; Yoon J, 2015, CURR MICROBIOL, V70, P51, DOI 10.1007/s00284-014-0682-9; Yoon JH, 2013, INT J SYST EVOL MICR, V63, P4771, DOI 10.1099/ijs.0.053983-0; Yoon JH, 2005, INT J SYST EVOL MICR, V55, P2323, DOI 10.1099/ijs.0.63817-0; Yoon JH, 2012, INT J SYST EVOL MICR, V62, P1896, DOI 10.1099/ijs.0.035253-0	54	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0003-6072	1572-9699		ANTON LEEUW INT J G	Antonie Van Leeuwenhoek	AUG	2015	108	2					505	513		10.1007/s10482-015-0504-5		9	Microbiology	Microbiology	CM1RP	WOS:000357458300024		
J	Kobayashi, S; Asakura, K; Suga, H; Sasaki, S				Kobayashi, Satomi; Asakura, Keiko; Suga, Hitomi; Sasaki, Satoshi			Cohabitational effect of grandparents on dietary intake among young Japanese women and their mothers living together. A multicenter cross-sectional study	APPETITE			English	Article						Cohabitation; Three-generation families; Self-administered diet history questionnaire; Japanese women	FAMILY RESEMBLANCE; FAT INTAKE; HISTORY QUESTIONNAIRES; 3-GENERATION FAMILIES; CHILD; OVERWEIGHT; OBESITY; PARENT; ENERGY; ADULTS	We examined the cohabitational effect of the grandparents on dietary intakes among young Japanese women and their mothers, using data from a cross-sectional multicenter study conducted in 35 of 47 prefectures in Japan. Among a total of 2032 three-generation families, 1336 female dietetic students (18-20 years), 1336 of their mothers (36-59 years), and 1560 of their paternal or maternal grandmothers (59-94 years) were included. Intake of foods and nutrients was assessed with self-administered diet history questionnaires. The prevalence of students and their mothers living with the grandparents (GP) was 36%. Students living with GP had a higher intake of fruits, vegetables, total dietary fiber, beta-carotene, vitamin C and potassium and lower intake of meats than those living without GP. For mothers, fish and shellfish and vitamin C intakes were higher and meat intake was lower among participants living with GP. The median correlation coefficients of food and nutrient intakes in the students-grandmothers living together was higher than in those living apart for both paternal grandmothers (PGM) and maternal grandmothers (MGM) (all P <0.01). The median values of mothers-PGM living together were also significantly higher than in those living apart (P <0.01). However, the values of mothers-MGM did not significantly differ between those living with and without MGM. These results may suggest that family members who live together tend to share similar dietary habits. Further, the mother's dietary habits might affect those of their children even after they live apart. (C) 2015 Elsevier Ltd. All rights reserved.	[Kobayashi, Satomi] Natl Inst Environm Studies, Ctr Environm Hlth Sci, Integrated Hlth Risk Assessment Sect, Tsukuba, Ibaraki 3058506, Japan; [Kobayashi, Satomi; Suga, Hitomi; Sasaki, Satoshi] Univ Tokyo, Grad Sch Med, Dept Social & Prevent Epidemiol, Bunkyo Ku, Tokyo 1130033, Japan; [Asakura, Keiko; Sasaki, Satoshi] Univ Tokyo, Sch Publ Hlth, Dept Social & Prevent Epidemiol, Bunkyo Ku, Tokyo 1130033, Japan; [Asakura, Keiko] Univ Tokyo, Interfac Initiat Informat Studies, Bunkyo Ku, Tokyo 1130033, Japan	Kobayashi, S (reprint author), Natl Inst Environm Studies, Ctr Environm Hlth Sci, Integrated Hlth Risk Assessment Sect, Tsukuba, Ibaraki 3058506, Japan.	satomikoba@m.u-tokyo.ac.jp					Pearce A, 2010, INT J OBESITY, V34, P1160, DOI 10.1038/ijo.2010.15; OLIVERIA SA, 1992, AM J CLIN NUTR, V56, P593; Raynor HA, 2011, J AM DIET ASSOC, V111, P425, DOI 10.1016/j.jada.2010.12.013; Popkin BM, 2006, AM J CLIN NUTR, V84, P289; Kobayashi S, 2011, PUBLIC HEALTH NUTR, V14, P1200, DOI 10.1017/S1368980011000504; Jiang JX, 2007, APPETITE, V48, P377, DOI 10.1016/j.appet.2006.10.004; Wroten KC, 2012, APPETITE, V59, P316, DOI 10.1016/j.appet.2012.05.014; Pearson N, 2009, PUBLIC HEALTH NUTR, V12, P267, DOI 10.1017/S1368980008002589; Ainsworth BE, 2011, MED SCI SPORT EXER, V43, P1575, DOI 10.1249/MSS.0b013e31821ece12; Wang Y, 2011, J EPIDEMIOL COMMUN H, V65, P177, DOI 10.1136/jech.2009.095901; Watanabe E, 2011, INT J OBESITY, V35, P945, DOI 10.1038/ijo.2011.82; Feunekes GIJ, 1998, PREV MED, V27, P645, DOI 10.1006/pmed.1998.0341; Kobayashi S, 2012, J EPIDEMIOL, V22, P151, DOI [10.2188/jeaJE20110075, 10.2188/jea.JE20110075]; Beydoun MA, 2009, SOC SCI MED, V68, P2137, DOI 10.1016/j.socscimed.2009.03.029; Dim K., 1982, GEIGY SCI TABLES INT, V2, P215; Feunekes GIJ, 1997, EUR J CLIN NUTR, V51, P793, DOI 10.1038/sj.ejcn.1600494; Formisano A., 2013, PUBLIC HEALTH NUTR, V17, P2307; GARN SM, 1979, HUM BIOL, V51, P565; Kasamatsu Takahiro, 1995, Japanese Journal of Nutrition, V53, P175; Kobayashi S, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-164; Kobayashi S, 2014, J NUTR HEALTH AGING, V18, P827, DOI [10.1007/s12603-014-0478-4, 10.1007/s12603-014-0556-7]; Laroche HH, 2007, J AM BOARD FAM MED, V20, P9, DOI 10.3122/jabfm.2007.01.060085; Ministry of Education Culture Sports Science and Technology, 2014, GEN SURV SCH 2014; Ministry of Health Labour and Welfare, 2014, NAT HLTH NUTR SURV J; Ministry of Health Labour and Welfare, 2014, DIET REF INT JAP 201; Ministry of Health Labour and Welfare, 2014, NAT LIV SURV 2013; Ministry of Internal Affairs and Communications, 2012, GEN SURV SOC LIF 201; Park HS, 2004, ANN EPIDEMIOL, V14, P486, DOI 10.1016/j.annepidem.2003.10.007; PERUSSE L, 1988, AM J CLIN NUTR, V47, P629; Sasaki S., 2003, Journal of Community Nutrition, V5, P93; Sasaki S, 1998, J Epidemiol, V8, P203; Science and Technology Agency, 2010, STAND TABL FOOD COMP; Shrivastava A, 2013, PUBLIC HEALTH NUTR, V16, P1476, DOI 10.1017/S1368980012003667; STAFLEU A, 1994, PREV MED, V23, P474, DOI 10.1006/pmed.1994.1065; Tanskanen AO, 2013, EVOL PSYCHOL-US, V11, P417; Vagstrand K, 2010, BRIT J NUTR, V103, P1205, DOI 10.1017/S0007114509992972; Vauthier JM, 1996, INT J EPIDEMIOL, V25, P1030, DOI 10.1093/ije/25.5.1030	37	0	0	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	0195-6663	1095-8304		APPETITE	Appetite	AUG 1	2015	91						287	297		10.1016/j.appet.2015.04.059		11	Behavioral Sciences; Nutrition & Dietetics	Behavioral Sciences; Nutrition & Dietetics	CM2XW	WOS:000357546600038		
J	Tsuge, T; Hyakutake, M; Mizuno, K				Tsuge, Takeharu; Hyakutake, Manami; Mizuno, Kouhei			Class IV polyhydroxyalkanoate (PHA) synthases and PHA-producing Bacillus	APPLIED MICROBIOLOGY AND BIOTECHNOLOGY			English	Review						Alcoholysis; Bacillus; Class IV; PhaC box; Polyhydroxyalkanoate; Terminal modification; Two-component synthase	POLY-BETA-HYDROXYBUTYRATE; RECOMBINANT ESCHERICHIA-COLI; MOLECULAR-WEIGHT; RALSTONIA-EUTROPHA; CEREUS YB-4; COENZYME-A; POLYHYDROXYBUTYRATE PRODUCTION; RHODOSPIRILLUM-RUBRUM; THURINGIENSIS R-510; MEGATERIUM STRAIN	This review highlights the recent investigations of class IV polyhydroxyalkanoate (PHA) synthases, the newest classification of PHA synthases. Class IV synthases are prevalent in organisms of the Bacillus genus and are composed of a catalytic subunit PhaC (approximately 40 kDa), which has a PhaC box sequence ([GS]-X-C-X-[GA]-G) at the active site, and a second subunit PhaR (approximately 20 kDa). The representative PHA-producing Bacillus strains are Bacillus megaterium and Bacillus cereus; the nucleotide sequence of phaC and the genetic organization of the PHA biosynthesis gene locus are somewhat different between these two strains. It is generally considered that class IV synthases favor short-chain-length monomers such as 3-hydroxybutyrate (C4) and 3-hydroxyvalerate (C5) for polymerization, but can polymerize some unusual monomers as minor components. In Escherichia coli expressing PhaRC from B. cereus YB-4, the biosynthesized PHA undergoes synthase-catalyzed alcoholytic cleavage using endogenous and exogenous alcohols. This alcoholysis is thought to be shared among class IV synthases, and this reaction is useful not only for the regulation of PHA molecular weight but also for the modification of the PHA carboxy terminus. The novel properties of class IV synthases will open up the possibility for the design of new PHA materials.	[Tsuge, Takeharu] Tokyo Inst Technol, Dept Innovat & Engn Mat, Midori Ku, Yokohama, Kanagawa 2268502, Japan; [Hyakutake, Manami] RIKEN Ctr Sustainable Resource Sci, Biomass Engn Res Div, Wako, Saitama 3510198, Japan; [Mizuno, Kouhei] Kitakyushu Natl Coll Technol, Dept Mat Sci & Chem Engn, Kokuraminami Ku, Kitakyushu, Fukuoka 8020985, Japan	Tsuge, T (reprint author), Tokyo Inst Technol, Dept Innovat & Engn Mat, Midori Ku, 4259 Nagatsuta, Yokohama, Kanagawa 2268502, Japan.	tsuge.t.aa@m.titech.ac.jp	Tsuge, Takeharu/F-6618-2011	Tsuge, Takeharu/0000-0002-6296-6500	 [KAKENHI 23310060];  [KAKENHI 15K16147]	This work was supported by Grant-in-Aid for Scientific Research KAKENHI 23310060 to T. Tsuge and KAKENHI 15K16147 to M. Hyakutake.	Agus J, 2010, POLYM DEGRAD STABIL, V95, P2250, DOI 10.1016/j.polymdegradstab.2010.09.009; Masood F, 2012, J POLYM ENVIRON, V20, P865, DOI 10.1007/s10924-012-0457-y; Kulpreecha S, 2009, J BIOSCI BIOENG, V107, P240, DOI 10.1016/j.jbiosc.2008.10.006; Tsuge T, 2002, J BIOSCI BIOENG, V94, P579, DOI 10.1016/S1389-1723(02)80198-0; Lu JN, 2009, POLYM REV, V49, P226, DOI 10.1080/15583720903048243; Sato S, 2011, APPL MICROBIOL BIOT, V90, P951, DOI 10.1007/s00253-011-3150-5; SLEPECKY RA, 1961, J BACTERIOL, V82, P37; GRIEBEL R, 1968, BIOCHEMISTRY-US, V7, P3676, DOI 10.1021/bi00850a047; Full TD, 2006, LETT APPL MICROBIOL, V43, P377, DOI 10.1111/j.1472-765X.2006.01981.x; Sangkharak K, 2013, BIOTECHNOL BIOPROC E, V18, P272, DOI 10.1007/s12257-012-0615-z; Agus J, 2006, POLYM DEGRAD STABIL, V91, P1138, DOI 10.1016/j.polymdegradstab.2005.07.006; Sato S, 2007, J BIOSCI BIOENG, V103, P38, DOI 10.1263/jbb.103.38; Wang JP, 2013, MOL CELL PROTEOMICS, V12, P1363, DOI 10.1074/mcp.M112.023986; Matsusaki H, 1998, J BACTERIOL, V180, P6459; CHEN GQ, 1991, FEMS MICROBIOL LETT, V84, P173; Halami PM, 2008, WORLD J MICROB BIOT, V24, P805, DOI 10.1007/s11274-007-9543-z; Tseng CL, 2006, J BACTERIOL, V188, P7592, DOI 10.1128/JB.00729-06; Fukui T, 1998, J BACTERIOL, V180, P667; Tajima K, 2003, J BIOSCI BIOENG, V95, P77, DOI 10.1016/S1389-1723(03)80152-4; Sangkharak K, 2012, J GEN APPL MICROBIOL, V58, P173; Han J, 2010, APPL ENVIRON MICROB, V76, P7811, DOI 10.1128/AEM.01117-10; Tsuge T, 2003, INT J BIOL MACROMOL, V31, P195, DOI 10.1016/S0141-8130(02)00082-X; Shamala TR, 2003, J APPL MICROBIOL, V94, P369, DOI 10.1046/j.1365-2672.2003.01838.x; Hori K, 2002, APPL MICROBIOL BIOT, V59, P211, DOI 10.1007/s00253-002-0986-8; Singh M, 2013, INDIAN J MICROBIOL, V53, P77, DOI 10.1007/s12088-012-0294-7; Cai SF, 2012, APPL ENVIRON MICROB, V78, P1946, DOI 10.1128/AEM.07114-11; McCool GJ, 2001, J BACTERIOL, V183, P4235, DOI 10.1128/JB.183.14.4235-4243.2001; Tomizawa S, 2011, BIOMACROMOLECULES, V12, P2660, DOI 10.1021/bm2004687; Mizuno K, 2010, POLYM DEGRAD STABIL, V95, P1335, DOI 10.1016/j.polymdegradstab.2010.01.033; Madden LA, 1999, INT J BIOL MACROMOL, V25, P43, DOI 10.1016/S0141-8130(99)00014-8; Rehm BHA, 2003, BIOCHEM J, V376, P15, DOI 10.1042/BJ20031254; Gouda MK, 2001, MICROBIOL RES, V156, P201, DOI 10.1078/0944-5013-00104; Zhang YH, 2013, BIORESOURCE TECHNOL, V147, P307, DOI 10.1016/j.biortech.2013.08.029; Valappil SP, 2007, J BIOTECHNOL, V132, P251, DOI 10.1016/j.jbiotec.2007.03.013; Hiroe A, 2013, ACS CHEM BIOL, V8, P2568, DOI 10.1021/cb400465p; Tomizawa S, 2010, APPL MICROBIOL BIOT, V87, P1427, DOI 10.1007/s00253-010-2601-8; Zribi-Maaloul E, 2013, INT J BIOL MACROMOL, V61, P82, DOI 10.1016/j.ijbiomac.2013.06.043; Yang TH, 2010, BIOTECHNOL BIOENG, V105, P150, DOI 10.1002/bit.22547; Steinbuchel A, 2001, MACROMOL BIOSCI, V1, P1; Jendrossek D, 2009, J BACTERIOL, V191, P3195, DOI 10.1128/JB.01723-08; McCool GJ, 1999, J BACTERIOL, V181, P585; Shahid S, 2013, J BIOSCI BIOENG, V116, P302, DOI 10.1016/j.jbiosc.2013.02.017; Valappil SP, 2007, ANTON LEEUW INT J G, V91, P1, DOI 10.1007/s10482-006-9095-5; Wu Q, 2001, ANTON LEEUW INT J G, V80, P111, DOI 10.1023/A:1012222625201; Lenz RW, 2005, BIOMACROMOLECULES, V6, P1, DOI 10.1021/bm049700c; Kawashima Y, 2012, APPL ENVIRON MICROB, V78, P493, DOI 10.1128/AEM.06937-11; Hyakutake M, 2015, APPL MICROBIOL BIOT, V99, P4701, DOI 10.1007/s00253-014-6276-4; Kumar P, 2013, BIOTECHNOL ADV, V31, P1543, DOI 10.1016/j.biotechadv.2013.08.007; Hyakutake M, 2011, BIOSCI BIOTECH BIOCH, V75, P1615, DOI 10.1271/bbb.110229; Chen DJ, 2012, J PROTEOMICS, V75, P5176, DOI 10.1016/j.jprot.2012.06.002; CABALLERO KP, 1995, INT J BIOL MACROMOL, V17, P86, DOI 10.1016/0141-8130(95)93522-Y; Chen HJ, 2010, FEMS MICROBIOL LETT, V304, P74, DOI 10.1111/j.1574-6968.2010.01888.x; Desetty RD, 2008, WORLD J MICROB BIOT, V24, P1769, DOI 10.1007/s11274-008-9669-7; Han Jing, 2010, Saline Systems, V6, P9, DOI 10.1186/1746-1448-6-9; Heylen K, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00371; Hyakutake M, 2015, POLYM DEGRAD STABIL, V117, P90, DOI 10.1016/j.polymdegradstab.2015.04.002; Hyakutake M, 2014, APPL ENVIRON MICROB, V80, P1421, DOI 10.1128/AEM.03576-13; Ilham M, 2014, POLYM DEGRAD STABIL, V109, P416, DOI 10.1016/j.polymdegradstab.2014.04.024; Janto B, 2011, ENVIRON MICROBIOL, V13, P3289, DOI 10.1111/j.1462-2920.2011.02591.x; Jina H, 2012, J BACTERIOL, V194, P5522; Kalia VC, 2007, GENE, V389, P19, DOI 10.1016/j.gene.2006.09.010; KAWAGUCHI Y, 1992, MACROMOLECULES, V25, P2324, DOI 10.1021/ma00035a007; Kaynar P, 2009, FISHERIES SCI, V75, P439, DOI 10.1007/s12562-008-0047-z; Labuzek S, 2001, J APPL MICROBIOL, V90, P353; Lee KT, 1995, J MICROBIOL, V33, P59; Lee TR, 2004, J BACTERIOL, V186, P3015, DOI 10.1128/JB.186.10.3015-3021.2004; Masood F, 2013, J MATER SCI-MATER M, V24, P1927, DOI 10.1007/s10856-013-4946-x; MOSKOWIT.GJ, 1969, BIOCHEMISTRY-US, V8, P2748, DOI 10.1021/bi00835a009; Nayak P. K., 2013, ISRN BACTERIOLOGY, V2013, DOI DOI 10.1155/2013/562014; Omar S, 2001, BIOTECHNOL LETT, V23, P1119, DOI 10.1023/A:1010559800535; Park SK, 1997, J MICROBIOL, V35, P127; Peplinski K, 2010, MICROBIOL-SGM, V156, P2136, DOI 10.1099/mic.0.038380-0; Philip S, 2009, BIOMACROMOLECULES, V10, P691, DOI 10.1021/bm801395p; Prabhu NN, 2010, ANTON LEEUW INT J G, V97, P41, DOI 10.1007/s10482-009-9386-8; Reiser SE, 2000, APPL MICROBIOL BIOT, V53, P209; Rodriguez-Contreras A, 2013, J APPL MICROBIOL, V114, P1378, DOI 10.1111/jam.12151; Satoh Y, 2002, J BIOSCI BIOENG, V94, P343, DOI 10.1263/jbb.94.343; Silva LF, 2004, J IND MICROBIOL BIOT, V31, P245; Singh M, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-38; Solaiman DKY, 2005, BIOMACROMOLECULES, V6, P532, DOI 10.1021/bm0493640; Stubbe J, 2003, NAT PROD REP, V20, P445, DOI 10.1039/b209687k; Tariq A, 2015, J BIOMOL STRUCT DYN, V33, P1225, DOI 10.1080/07391102.2014.941401; Tay BY, 2010, WORLD J MICROB BIOT, V26, P1015, DOI 10.1007/s11274-009-0264-3; Tomizawa S, 2013, APPL MICROBIOL BIOT, V97, P4821, DOI 10.1007/s00253-013-4798-9; Ueda S, 1996, J BACTERIOL, V178, P774; Ushimaru K, 2013, APPL MICROBIOL BIOT, V97, P1175, DOI 10.1007/s00253-012-4089-x; Valappil SP, 2007, J BIOTECHNOL, V127, P475, DOI 10.1016/j.jbiotec.2006.07.015; Reddy SV, 2009, J IND MICROBIOL BIOT, V36, P837, DOI 10.1007/s10295-009-0561-8; Yilmaz M, 2005, WORLD J MICROB BIOT, V21, P565, DOI 10.1007/s11274-004-3274-1	89	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0175-7598	1432-0614		APPL MICROBIOL BIOT	Appl. Microbiol. Biotechnol.	AUG	2015	99	15					6231	6240		10.1007/s00253-015-6777-9		10	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	CM4IX	WOS:000357649200005		
J	Terami, Y; Yoshida, H; Uechi, K; Morimoto, K; Takata, G; Kamitori, S				Terami, Yuji; Yoshida, Hiromi; Uechi, Keiko; Morimoto, Kenji; Takata, Goro; Kamitori, Shigehiro			Essentiality of tetramer formation of Cellulomonas parahominis L-ribose isomerase involved in novel L-ribose metabolic pathway	APPLIED MICROBIOLOGY AND BIOTECHNOLOGY			English	Article						Crystal structure; Cupin-type beta-barrel; Rare sugar; L-Ribose isomerase	D-LYXOSE ISOMERASE; SP STRAIN DL-28; ESCHERICHIA-COLI; SUBSTRATE-SPECIFICITY; XYLOSE ISOMERASE; RHAMNOSE ISOMERASE; D-PSICOSE; METAL; ISOMERIZATION; REPLACEMENT	L-Ribose isomerase from Cellulomonas parahominis MB426 (CpL-RI) can catalyze the isomerization between L-ribose and L-ribulose, which are non-abundant in nature and called rare sugars. CpL-RI has a broad substrate specificity and can catalyze the isomerization between D-lyxose and D-xylulose, D-talose and D-tagatose, L-allose and L-psicose, L-gulose and L-sorbose, and D-mannose and D-fructose. To elucidate the molecular basis underlying the substrate recognition mechanism of CpL-RI, the crystal structures of CpL-RI alone and in complexes with L-ribose, L-allose, and L-psicose were determined. The structure of CpL-RI was very similar to that of L-ribose isomerase from Acinetobacter sp. strain DL-28, previously determined by us. CpL-RI had a cupin-type beta-barrel structure, and the catalytic site was detected between two large beta-sheets with a bound metal ion. The bound substrates coordinated to the metal ion, and Glu113 and Glu204 were shown to act as acid/base catalysts in the catalytic reaction via a cis-enediol intermediate. Glu211 and Arg243 were found to be responsible for the recognition of substrates with various configurations at 4- and 5-positions of sugar. CpL-RI formed a homo-tetramer in crystals, and the catalytic site independently consisted of residues within a subunit, suggesting that the catalytic site acted independently. Crystal structure and site-direct mutagenesis analyses showed that the tetramer structure is essential for the enzyme activity and that each subunit of CpL-RI could be structurally stabilized by intermolecular contacts with other subunits. The results of growth complementation assays suggest that CpL-RI is involved in a novel metabolic pathway using L-ribose as a carbon source.	[Terami, Yuji; Uechi, Keiko; Morimoto, Kenji; Takata, Goro] Kagawa Univ, Rare Sugar Res Ctr, Miki, Kagawa 7610795, Japan; [Terami, Yuji; Uechi, Keiko; Morimoto, Kenji; Takata, Goro] Kagawa Univ, Fac Agr, Miki, Kagawa 7610795, Japan; [Yoshida, Hiromi; Kamitori, Shigehiro] Kagawa Univ, Life Sci Res Ctr, Miki, Kagawa 7610793, Japan; [Yoshida, Hiromi; Kamitori, Shigehiro] Kagawa Univ, Fac Med, Miki, Kagawa 7610793, Japan	Kamitori, S (reprint author), Kagawa Univ, Life Sci Res Ctr, 1750-1 Ikenobe, Miki, Kagawa 7610793, Japan.	kamitori@med.kagawa-u.ac.jp			Japan Society for the Promotion of Science (JSPS) [25440028, 23770122, 22780068, 26450097, 22580088]; Kagawa University New Research Areas and Collaborative Research Organization	We thank Dr. A. Itoh and Mr. K. Yube for their technical assistant with DNA sequencing. Y. Terami is supported by a Grant-in-Aid from the Japan Society for the Promotion of Science (JSPS) Research Fellows. This study was supported in part by Grants-in-Aid for Scientific Research (25440028, 23770122, 22780068, 26450097, 22580088) from JSPS, and by the funds from the Kagawa University New Research Areas and Collaborative Research Organization. This research was performed with the approval of the Photon Factory Advisory Committee and National Laboratory for High Energy Physics (2012G550 and 2013G506) Japan.	ALLEN KN, 1994, BIOCHEMISTRY-US, V33, P1488, DOI 10.1021/bi00172a027; ANDERSON RL, 1965, J BIOL CHEM, V240, P2367; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kim K, 2006, J MOL BIOL, V361, P920, DOI 10.1016/j.jmb.2006.06.069; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Hayashi N, 2010, BIOSCI BIOTECH BIOCH, V74, P510, DOI 10.1271/bbb.90707; Morimoto K, 2013, J BIOSCI BIOENG, V115, P377, DOI 10.1016/j.jbiosc.2012.10.021; Yoshida H, 2011, ACTA CRYSTALLOGR F, V67, P1281, DOI 10.1107/S1744309111030351; Gumina G, 2001, FEMS MICROBIOL LETT, V202, P9, DOI 10.1016/S0378-1097(01)00285-3; Mizanur RM, 2001, BBA-GENE STRUCT EXPR, V1521, P141, DOI 10.1016/S0167-4781(01)00290-1; WHITLOW M, 1991, PROTEINS, V9, P153, DOI 10.1002/prot.340090302; Shimonishi T, 1996, J FERMENT BIOENG, V81, P493, DOI 10.1016/0922-338X(96)81468-1; DAVENPORT RC, 1991, BIOCHEMISTRY-US, V30, P5821, DOI 10.1021/bi00238a002; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Brunger AT, 1993, X PLOR 3 1 SYSTEM XR; Cheng Yung-Chi, 2001, Cancer Letters, V162, pS33, DOI 10.1016/S0304-3835(00)00650-9; Cho EA, 2007, J BACTERIOL, V189, P1655, DOI 10.1128/JB.01568-06; Choi JG, 2012, BIOTECHNOL LETT, V34, P1079, DOI 10.1007/s10529-012-0874-y; COLLINS P.M., 1995, MONOSACCHARIDES THEI; DeLano W. L., 2002, PYMOL MOL GRAPHICS S; GUNSALUS IC, 1955, BACTERIOL REV, V19, P79; Hayashi N, 2014, J FUNCT FOODS, V11, P152, DOI 10.1016/j.jff.2014.09.020; HEATH EC, 1958, J BIOL CHEM, V231, P1009; IZUMORI K, 1976, J BACTERIOL, V128, P587; Korndorfer IP, 2000, J MOL BIOL, V300, P917, DOI 10.1006/jmbi.2000.3896; Kwon HJ, 2010, J BIOSCI BIOENG, V110, P26, DOI 10.1016/j.jbiosc.2009.12.011; Laskowski RA, 1992, PROCHECK V 2 PROGRAM; LEE N, 1986, GENE, V47, P231, DOI 10.1016/0378-1119(86)90067-3; Levin Gilbert V., 2002, Journal of Medicinal Food, V5, P23, DOI 10.1089/109662002753723197; Marles-Wright J, 2011, PROTEINS, V79, P2015, DOI 10.1002/prot.23028; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park CS, 2010, BIOTECHNOL LETT, V32, P1305, DOI 10.1007/s10529-010-0300-2; Patel DH, 2011, APPL ENVIRON MICROB, V77, P3343, DOI 10.1128/AEM.02693-10; Ramachandran G N, 1968, Adv Protein Chem, V23, P283, DOI 10.1016/S0065-3233(08)60402-7; Schleif R, 2000, TRENDS GENET, V16, P559, DOI 10.1016/S0168-9525(00)02153-3; Staalduinen LM, 2010, J MOL BIOL, V401, P866, DOI [10.1016/j.jmb.2010.06.063, DOI 10.1016/J.JMB.2010.06.063]; STEVENS FJ, 1976, J GEN MICROBIOL, V97, P257; Takeda K, 2010, BBA-PROTEINS PROTEOM, V1804, P1359, DOI 10.1016/j.bbapap.2010.01.018; Yoshida H, 2007, J MOL BIOL, V365, P1505, DOI 10.1016/j.jmb.2006.11.004; Yoshida H, 2014, FEBS J, V281, P3150, DOI 10.1111/febs.12850	43	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0175-7598	1432-0614		APPL MICROBIOL BIOT	Appl. Microbiol. Biotechnol.	AUG	2015	99	15					6303	6313		10.1007/s00253-015-6417-4		11	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	CM4IX	WOS:000357649200011		
J	Ueda, H; Mitsuhara, I; Tabata, J; Kugimiya, S; Watanabe, T; Suzuki, K; Yoshida, S; Kitamoto, H				Ueda, Hirokazu; Mitsuhara, Ichiro; Tabata, Jun; Kugimiya, Soichi; Watanabe, Takashi; Suzuki, Ken; Yoshida, Shigenobu; Kitamoto, Hiroko			Extracellular esterases of phylloplane yeast Pseudozyma antarctica induce defect on cuticle layer structure and water-holding ability of plant leaves	APPLIED MICROBIOLOGY AND BIOTECHNOLOGY			English	Article						Pseudozyma antarctica; Plant surface; Cuticle layer; Biodegradable plastic-degrading enzyme; Drought stress response	ABSCISIC-ACID; KEY ENZYME; ARABIDOPSIS; TOMATO; PHYLLOSPHERE; MEMBRANES; SUBERIN; CLONING	Aerial plant surface (phylloplane) is a primary key habitat for many microorganisms but is generally recognized as limited in nutrient resources. Pseudozyma antarctica, a nonpathogenic yeast, is commonly isolated from plant surfaces and characterized as an esterase producer with fatty acid assimilation ability. In order to elucidate the biological functions of these esterases, culture filtrate with high esterase activity (crude enzyme) of P. antarctica was applied onto leaves of tomato and Arabidopsis. These leaves showed a wilty phenotype, which is typically associated with water deficiency. Furthermore, we confirmed that crude enzyme-treated detached leaves clearly lost their water-holding ability. In treated leaves of both plants, genes associated to abscisic acid (ABA; a plant stress hormone responding osmotic stress) were activated and accumulation of ABA was confirmed in tomato plants. Microscopic observation of treated leaf surfaces revealed that cuticle layer covering the aerial epidermis of leaves became thinner. A gas chromatography-mass spectrometry (GC-MS) analysis exhibited that fatty acids with 16 and 18 carbon chains were released in larger amounts from treated leaf surfaces, indicating that the crude enzyme has ability to degrade lipid components of cuticle layer. Among the three esterases detected in the crude enzyme, lipase A, lipase B, and P. antarctica esterase (PaE), an in vitro enzyme assay using para-nitrophenyl palmitate as substrate demonstrated that PaE was the most responsible for the degradation. These results suggest that PaE has a potential role in the extraction of fatty acids from plant surfaces, making them available for the growth of phylloplane yeasts.	[Ueda, Hirokazu; Tabata, Jun; Kugimiya, Soichi; Watanabe, Takashi; Suzuki, Ken; Yoshida, Shigenobu; Kitamoto, Hiroko] Natl Inst Agroenvironm Sci NIAES, Tsukuba, Ibaraki 3058604, Japan; [Mitsuhara, Ichiro] Natl Inst Agrobiol Sci, Tsukuba, Ibaraki 3058602, Japan	Kitamoto, H (reprint author), Natl Inst Agroenvironm Sci NIAES, 3-1-3 Kannondai, Tsukuba, Ibaraki 3058604, Japan.	kitamoto@affrc.go.jp			National Institute for Agro-Environmental Sciences, Japan; Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry	We thank D. H. Kaku for technical advise, Dr. E. Suto for the valuable comments, and Ms. X. Cao for technical assistance in this research. This research was financially supported by the National Institute for Agro-Environmental Sciences, Japan, and Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry.	Abo M, 1992, Patent No. [WO1992013130, 1992013130]; Lindow SE, 2003, APPL ENVIRON MICROB, V69, P1875, DOI 10.1128/AEM.69.4.1875-1883.2003; SCHONHERR J, 1976, PLANTA, V128, P113, DOI 10.1007/BF00390312; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Iuchi S, 2001, PLANT J, V27, P325, DOI 10.1046/j.1365-313x.2001.01096.x; Saito S, 2004, PLANT PHYSIOL, V134, P1439, DOI 10.1104/pp.103.037614; Isaacson T, 2009, PLANT J, V60, P363, DOI 10.1111/j.1365-313X.2009.03969.x; Bessire M, 2007, EMBO J, V26, P2158, DOI 10.1038/sj.emboj.7601658; Shinozaki Y, 2013, APPL MICROBIOL BIOT, V97, P2951, DOI 10.1007/s00253-012-4188-8; Buschhaus C, 2012, PLANT PHYSIOL, V160, P1120, DOI 10.1104/pp.112.198473; AbuQamar S, 2009, PLANT J, V58, P347, DOI 10.1111/j.1365-313X.2008.03783.x; Franke R, 2005, PHYTOCHEMISTRY, V66, P2643, DOI 10.1016/j.phytochem.2005.09.027; SEO S, 1995, SCIENCE, V270, P1988, DOI 10.1126/science.270.5244.1988; Sieber P, 2000, PLANT CELL, V12, P721, DOI 10.1105/tpc.12.5.721; Buda GJ, 2009, PLANT J, V60, P378, DOI 10.1111/j.1365-313X.2009.03960.x; Yeats TH, 2013, PLANT PHYSIOL, V163, P5, DOI 10.1104/pp.113.222737; KOLATTUKUDY PE, 1980, SCIENCE, V208, P990, DOI 10.1126/science.208.4447.990; Nadakuduti SS, 2012, PLANT PHYSIOL, V159, P945, DOI 10.1104/pp.112.198374; Watanabe T, 2014, J BIOSCI BIOENG, V117, P325, DOI 10.1016/j.jbiosc.2013.09.002; Chen S, 2013, BIOTECHNOL ADV, V31, P1754, DOI 10.1016/j.biotechadv.2013.09.005; Park JJ, 2010, PLANT MOL BIOL, V74, P91, DOI 10.1007/s11103-010-9656-x; Baldwin IT, 1997, PLANTA, V201, P397, DOI 10.1007/s004250050082; BASHI E, 1977, T BRIT MYCOL SOC, V68, P17; Chassot C, 2005, PLANT BIOSYST, V139, P28, DOI 10.1080/112635000500056344; Cominelli Eleonora, 2008, Plant Signal Behav, V3, P556; Finkelstein Ruth, 2013, Arabidopsis Book, V11, pe0166, DOI 10.1199/tab.0166; Fonseca AI, 2006, BIODIVERSITY ECOPHYS, P264; Holm HC, 2012, Patent No. [WO2012130961, 2012130961]; Ichihara K, 2009, J LIPID RES, V51, P635, DOI 10.1194/jlr.D001065; Ishii M, 1988, Positionally non-specific lipase from Candida sp., a method for producing it, its use and a recombinant DNA process for produce it, Patent No. [WO 88/02775, 8802775]; Karpushova A, 2005, APPL MICROBIOL BIOT, V67, P59, DOI 10.1007/s00253-004-1780-6; Kitamoto HK, 2011, AMB EXPRESS, V1, DOI 10.1186/2191-0855-1-44; Kmieciak M, 2002, GENE, V283, P171, DOI 10.1016/S0378-1119(02)00855-7; Kurtzman CP, 2011, YEASTS: A TAXONOMIC STUDY, VOLS 1-3, 5TH EDITION, P1; L'Haridon F, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002148; Nielsen TB, 1999, BIOTECHNOLOGICAL APPLICATIONS OF COLD-ADAPTED ORGANISMS, P49; Nitsch LMC, 2009, PLANTA, V229, P1335, DOI 10.1007/s00425-009-0913-7; PATKAR SA, 1993, INDIAN J CHEM B, V32, P76; RIEDERER M, 1986, PLANTA, V169, P69, DOI 10.1007/BF01369777; Tabata J, 2012, NATURWISSENSCHAFTEN, V99, P567, DOI 10.1007/s00114-012-0935-z	40	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0175-7598	1432-0614		APPL MICROBIOL BIOT	Appl. Microbiol. Biotechnol.	AUG	2015	99	15					6405	6415		10.1007/s00253-015-6523-3		11	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	CM4IX	WOS:000357649200019		
J	Bashiruddin, NK; Nagano, M; Suga, H				Bashiruddin, Nasir Kato; Nagano, Masanobu; Suga, Hiroaki			Synthesis of fused tricyclic peptides using a reprogrammed translation system and chemical modification	BIOORGANIC CHEMISTRY			English	Article						Peptides; Translation; Cyclic peptides	GENETIC-CODE; DRUG DESIGN; CYCLIZATION; CYCLOTIDES; INHIBITORS; DISCOVERY; LIBRARIES; CYSTEINE	Here we report a unique method of ribosomally synthesizing fused tricyclic peptides. Flexizyme-assisted in vitro translation of a linear peptide with the N-terminal chloroacetyl group and four downstream cysteines followed by the addition of 1,3,5-tris(bromomethyl) benzene results in selective production of the fused tricyclic peptide. This technology can be used for the ribosomal synthesis of fused tricyclic peptide libraries for the in vitro selection of bioactive peptides with tricyclic topology. (C) 2015 The Authors. Published by Elsevier Inc.	[Bashiruddin, Nasir Kato; Nagano, Masanobu; Suga, Hiroaki] Univ Tokyo, Grad Sch Sci, Dept Chem, Bunkyo Ku, Tokyo 1130033, Japan	Suga, H (reprint author), Univ Tokyo, Grad Sch Sci, Dept Chem, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	hsuga@chem.s.u-tokyo.ac.jp			Japan Society for the Promotion of Science (JSPS); Platform for Drug Discovery, Informatics, and Structural Life Science from MEXT, Japan; JSPS [253534];  [23220204]	We thank Dr. Yuki Goto, Dr. Nikita D. Loik and other members of the Suga group for invaluable discussions. This work was supported by a Grant-in-Aid for Scientific Research S (23220204), Japan Society for the Promotion of Science (JSPS), and Platform for Drug Discovery, Informatics, and Structural Life Science from MEXT, Japan, and JSPS Grants-in-Aid for Fellows to M.N. (253534).	Henriques ST, 2010, DRUG DISCOV TODAY, V15, P57, DOI 10.1016/j.drudis.2009.10.007; Liu WT, 2009, ANAL CHEM, V81, P4200, DOI 10.1021/ac900114t; KEMP DS, 1985, J ORG CHEM, V50, P5834, DOI 10.1021/jo00350a077; Davies JS, 2003, J PEPT SCI, V9, P471, DOI 10.1002/psc.491; Schlippe YVG, 2012, J AM CHEM SOC, V134, P10469, DOI 10.1021/ja301017y; Iwasaki K, 2012, ORG BIOMOL CHEM, V10, P5783, DOI 10.1039/c2ob25306b; Yamagishi Y, 2011, CHEM BIOL, V18, P1562, DOI 10.1016/j.chembiol.2011.09.013; Touati J, 2011, CHEMBIOCHEM, V12, P38, DOI 10.1002/cbic.201000451; Kodan A, 2014, P NATL ACAD SCI USA, V111, P4049, DOI 10.1073/pnas.1321562111; Goto Y, 2011, NAT PROTOC, V6, P779, DOI 10.1038/nprot.2011.331; Heinis C, 2009, NAT CHEM BIOL, V5, P502, DOI 10.1038/nchembio.184; Timmerman P, 2005, CHEMBIOCHEM, V6, P821, DOI 10.1002/cbic.200400374; Craik DJ, 2012, EXPERT OPIN DRUG DIS, V7, P179, DOI 10.1517/17460441.2012.661554; Olivera BM, 2006, J BIOL CHEM, V281, P31173, DOI 10.1074/jbc.R600020200; Morimoto J, 2012, ANGEW CHEM INT EDIT, V51, P3423, DOI 10.1002/anie.201108118; Bashiruddin N.K., 2014, CURR OPIN CHEM BIO C, V24C, P131; Cole AM, 2003, EXPERT OPIN THER TAR, V7, P329, DOI 10.1517/eott.7.3.329.22436; Goto Y, 2013, ACS CHEM BIOL, V8, P2630, DOI 10.1021/cb400549p; Hayashi Y., 2012, ACS CHEM BIOL; Hipolito CJ, 2013, MOLECULES, V18, P10514, DOI 10.3390/molecules180910514; Kawakami T., 2013, ACS CHEM; Millward SW, 2005, J AM CHEM SOC, V127, P14142, DOI 10.1021/ja054373h; Ohta A, 2007, CHEM BIOL, V14, P1315, DOI 10.1016/j.chembiol.2007.10.015; Sako Y, 2008, ACS CHEM BIOL, V3, P241, DOI 10.1021/cb800010p	24	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0045-2068	1090-2120		BIOORG CHEM	Bioorganic Chem.	AUG	2015	61						45	50		10.1016/j.bioorg.2015.06.002		6	Biochemistry & Molecular Biology; Chemistry, Organic	Biochemistry & Molecular Biology; Chemistry	CM4OO	WOS:000357664500007		
J	Kang, CX; Kuba, T; Hao, AM; Iseri, Y				Kang, Caixia; Kuba, Takahiro; Hao, Aimin; Iseri, Yasushi			Antioxidant Responses of Vallisneria asiatica to Eutrophic Sediments in Lake Taihu, China	BULLETIN OF ENVIRONMENTAL CONTAMINATION AND TOXICOLOGY			English	Article						Polluted sediment; Oxidative stress; Lake Taihu; Submerged macrophyte	MACROPHYTE CERATOPHYLLUM-DEMERSUM; OXIDATIVE STRESS; SUBMERSED MACROPHYTES; SUPEROXIDE-DISMUTASE; MICROCYSTIN-LR; HEAVY-METAL; GROWTH; L.	Three kinds of representative sediments were obtained from a macrophyte-dominated bay (East Lake Taihu) and two algae-dominated regions (Western Lake Taihu and Meiliang Bay). Physiological responses of Vallisneria asiatica to these sediments were compared. Results from 20 days exposures showed no obvious differences in malondialdehyde (MDA) in roots, while the MDA content in leaves of plants exposed to Western Lake Taihu sediment was significantly (p < 0.05) higher than those exposed to the other two sediments. In comparison to the other two sediments, plants exposed to Western Lake Taihu sediment showed significantly lower (p < 0.05) superoxide dismutase in roots and leaves on the 10th and 40th day. On the 40th day, root catalase (CAT) activities in V. asiatica from Western Lake Taihu and Meiliang Bay sediments were lower than that from East Lake Taihu sediment, while leaf CAT activity in V. asiatica from Western Lake Taihu sediment was higher than that from East Lake Taihu sediment (p < 0.05). Western Lake Taihu sediment caused more serious oxidative stress in V. asiatica than East Lake Taihu sediment. Results indicated eutrophic sediment was a contributing factor in the disappearance of V. asiatica in Western Lake Taihu.	[Kang, Caixia; Kuba, Takahiro] Kyushu Univ, Grad Sch Engn, Nishi Ku, Fukuoka 8190395, Japan; [Hao, Aimin] Kyushu Univ, Res Inst East Asia Environm, Nishi Ku, Fukuoka 8190395, Japan; [Iseri, Yasushi] West Japan Engn Consultants Inc, Chuo Ku, Fukuoka 8100004, Japan	Kang, CX (reprint author), Kyushu Univ, Grad Sch Engn, Nishi Ku, 744 Motooka, Fukuoka 8190395, Japan.	kangcaixia123@163.com			Research Institute for East Asia Environments, Kyushu University; Mitsubishi Corporation in Japan	This research was supported by the Research Institute for East Asia Environments, Kyushu University, and financed by Mitsubishi Corporation in Japan.	Xing W, 2010, ENVIRON TOXICOL, V25, P103, DOI 10.1002/tox.20480; Madsen JD, 2001, HYDROBIOLOGIA, V444, P71, DOI 10.1023/A:1017520800568; Nakai S, 2000, WATER RES, V34, P3026, DOI 10.1016/S0043-1354(00)00039-7; Codd GA, 1995, WATER SCI TECHNOL, V32, P149, DOI 10.1016/0273-1223(95)00692-3; Blokhina O, 2003, ANN BOT-LONDON, V91, P179, DOI 10.1093/aob/mcf118; Jayakumar AR, 2006, J NEUROSCI, V26, P4774, DOI 10.1523/JNEUROSCI.0120-06.2006; Kleeberg A, 2010, LIMNOLOGICA, V40, P102, DOI 10.1016/j.limno.2009.11.001; Kabala K, 2008, J PLANT PHYSIOL, V165, P278, DOI 10.1016/j.jplph.2007.03.007; Yu HC, 2010, ECOL ENG, V36, P1285, DOI 10.1016/j.ecoleng.2010.06.004; Peuthert A, 2010, TOXICON, V56, P411, DOI 10.1016/j.toxicon.2010.04.004; HEATH RL, 1968, ARCH BIOCHEM BIOPHYS, V125, P189, DOI 10.1016/0003-9861(68)90654-1; Pflugmacher S, 2004, AQUAT TOXICOL, V70, P169, DOI 10.1016/j.aquatox.2004.06.010; Lesage E, 2007, ECOL ENG, V30, P320, DOI 10.1016/j.ecoleng.2007.04.007; Zhang M, 2011, CHEMOSPHERE, V82, P329, DOI 10.1016/j.chemosphere.2010.10.038; Qu WC, 2001, HYDROBIOLOGIA, V450, P83, DOI 10.1023/A:1017551701587; Ye C, 2009, ECOL ENG, V35, P1656, DOI 10.1016/j.ecoleng.2008.05.008; BEAUCHAM.C, 1971, ANAL BIOCHEM, V44, P276, DOI 10.1016/0003-2697(71)90370-8; BOWLER C, 1992, ANNU REV PLANT PHYS, V43, P83, DOI 10.1146/annurev.pp.43.060192.000503; Ducic Tanja, 2005, Brazilian Journal of Plant Physiology, V17, P103, DOI 10.1590/S1677-04202005000100009; ENGEL S, 1988, J FRESHWATER ECOL, V4, P329, DOI 10.1080/02705060.1988.9665182; Foyer CH, 1999, SCIENCE, V284, P599, DOI 10.1126/science.284.5414.599; GREENFIELD RE, 1954, J BIOL CHEM, V209, P355; Hach, 2002, WATER ANALYSIS HANDB; Li JinCai, 2002, Horticultural Research (Japan), V1, P279, DOI 10.2503/hrj.1.279; Wang C, 2009, CHEMOSPHERE, V76, P938, DOI 10.1016/j.chemosphere.2009.04.038; Yin Y, 2008, ENVIRON TOXICOL, V23, P328, DOI 10.1002/tox.20330; Zhang ZH, 2008, AQUAT BOT, V89, P317, DOI 10.1016/j.aquabot.2008.03.007; Zhu GW, 2008, J LAKE SCI, V20, P21	28	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0007-4861	1432-0800		B ENVIRON CONTAM TOX	Bull. Environ. Contam. Toxicol.	AUG	2015	95	2					194	199		10.1007/s00128-015-1579-4		6	Environmental Sciences; Toxicology	Environmental Sciences & Ecology; Toxicology	CM2AE	WOS:000357481100010		
J	Niida, Y; Ozaki, M; Inoue, M; Takase, E; Kuroda, M; Mitani, Y; Okumura, A; Yokoi, A; Fujita, S; Yamada, K				Niida, Y.; Ozaki, M.; Inoue, M.; Takase, E.; Kuroda, M.; Mitani, Y.; Okumura, A.; Yokoi, A.; Fujita, S.; Yamada, K.			CHIPS for genetic testing to improve a regional clinical genetic service	CLINICAL GENETICS			English	Article						clinical genetics; enzyme mismatch cleavage; genetic testing; multiple congenital anomalies syndrome; skeletal dysplasia	TUBEROUS SCLEROSIS COMPLEX; ENZYME MISMATCH CLEAVAGE; MUTATIONS; STANDARD	In current practice of clinical genetics, molecular diagnosis has become more widely used than ever before. DNA diagnosis is important for appropriate medical care of the patient, and proper genetic counseling to the family. However, genetic testing of orphan disease cannot always be performed easily. In multiple congenital anomalies (MCA) syndromes by monogenic cause, the broad mutational spectrum and large size of responsible genes often make molecular diagnosis expensive and cumbersome. We solve this problem with on-demand genetic testing by CHIPS (CEL nuclease mediated heteroduplex incision with polyacrylamide gel electrophoresis and silver staining) technology, which is the ultimately conventional and economical mutation screening system. In this article, we show eight patients with MCA syndromes who were recently treated at our hospital, and demonstrate that CHIPS successfully offers efficient and inexpensive genetic testing and facilitates clinical genetic service in our local region.	[Niida, Y.; Ozaki, M.] Kanazawa Med Univ, Med Res Inst, Div Genom Med, Dept Adv Med, Uchinada, Ishikawa 9200293, Japan; [Niida, Y.; Ozaki, M.; Takase, E.] Kanazawa Med Univ Hosp, Ctr Med Genet, Uchinada, Ishikawa, Japan; [Inoue, M.; Kuroda, M.; Mitani, Y.; Okumura, A.; Yokoi, A.] Kanazawa Univ, Grad Sch Med Sci, Dept Pediat, Kanazawa, Ishikawa, Japan; [Fujita, S.] Toyama Prefectural Cent Hosp, Dept Pediat, Toyama, Japan; [Yamada, K.] Tonami Gen Hosp, Dept Pediat, Toyama, Japan	Niida, Y (reprint author), Kanazawa Med Univ, Med Res Inst, Div Genom Med, Dept Adv Med, 1-1 Daigaku, Uchinada, Ishikawa 9200293, Japan.	niida@kanazawa-med.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan; Ministry of Health, Labor, and Welfare of Japan, Tokyo	This work was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and a grant from the Ministry of Health, Labor, and Welfare of Japan, Tokyo.	Boycott KM, 2013, NAT REV GENET, V14, P681, DOI 10.1038/nrg3555; Tsuji T, 2008, ELECTROPHORESIS, V29, P1473, DOI 10.1002/elps.200700729; van der Heiden IP, 2004, CLIN CHEM, V50, P248, DOI 10.1373/clinchem.2003.024604; Gupta PA, 2002, HUM MUTAT, V19, P39, DOI 10.1002/humu.10017; Razzaque MA, 2007, NAT GENET, V39, P1013, DOI 10.1038/ng2078; Ibarreta D, 2004, NAT BIOTECHNOL, V22, P1230, DOI 10.1038/nbt1004-1230; Johansson S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038050; Niida Y, 2013, J HUM GENET, V58, P216, DOI 10.1038/jhg.2013.3; Niida Y, 2012, MOL GENET METAB, V107, P580, DOI 10.1016/j.ymgme.2012.09.008; Williams CJ, 1996, AM J MED GENET, V63, P461, DOI 10.1002/(SICI)1096-8628(19960614)63:3<461::AID-AJMG9>3.0.CO;2-U; Yamada H, 2014, BRAIN DEV-JPN, V36, P254, DOI 10.1016/j.braindev.2013.04.002; Yen HC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092817	12	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0009-9163	1399-0004		CLIN GENET	Clin. Genet.	AUG	2015	88	2					155	160		10.1111/cge.12463		6	Genetics & Heredity	Genetics & Heredity	CM4YG	WOS:000357692000010		
J	Machida, J; Nishiyama, T; Kishino, H; Yamaguchi, S; Kimura, M; Shibata, A; Tatematsu, T; Kamamoto, M; Yamamoto, K; Makino, S; Miyachi, H; Shimozato, K; Tokita, Y				Machida, J.; Nishiyama, T.; Kishino, H.; Yamaguchi, S.; Kimura, M.; Shibata, A.; Tatematsu, T.; Kamamoto, M.; Yamamoto, K.; Makino, S.; Miyachi, H.; Shimozato, K.; Tokita, Y.			Genetic epidemiology of tooth agenesis in Japan: a population- and family-based study	CLINICAL GENETICS			English	Article						hypodontia; oligodontia; prevalence; sibling recurrence risk; tooth agenesis	PERMANENT TEETH; SCHOOLCHILDREN; HYPODONTIA; PREVALENCE	Tooth agenesis is one of the most common congenital anomalies in humans. However, the etiology of tooth agenesis remains largely unclear, as well as evidence base useful for genetic counseling. Therefore, we estimated the prevalence and sibling recurrence risk, and investigated agenetic patterns systematically. Tooth agenesis was classified into two subtypes: hypodontia (one to five missing teeth) and oligodontia (six or more missing teeth). The prevalence of these two subtypes were 6.8% [95% confidence interval (CI): 6.1-7.7%] and 0.1% (95% CI: 0.04-0.3%), respectively, and sibling recurrence risk of these were 24.5% (95% CI: 13.8-38.3%) and 43.8% (95% CI: 26.4-62.3%), respectively. This result suggests that the severe phenotype, oligodontia, might be mostly transmitted in a dominant fashion. Using a simple statistical modeling approach, our data were found to be consistent with a bilateral symmetry model, meaning that there was equal probability of missing teeth from the right and left sides.	[Machida, J.] Toyota Mem Hosp, Dept Oral & Maxillofacial Surg, Toyota, Japan; [Nishiyama, T.] Aichi Med Univ, Dept Publ Hlth, Sch Med, Nagakute, Aichi 4801195, Japan; [Kishino, H.] Univ Tokyo, Grad Sch Agr & Life Sci, Lab Biometry & Bioinformat, Tokyo, Japan; [Yamaguchi, S.; Kimura, M.; Shibata, A.; Tatematsu, T.; Yamamoto, K.; Makino, S.; Miyachi, H.; Shimozato, K.] Aichi Gakuin Univ, Dept Maxillofacial Surg, Nagoya, Aichi 464, Japan; [Kamamoto, M.] Himeji Red Cross Hosp, Dept Oral & Maxillofacial Surg, Himeji, Hyogo, Japan; [Tokita, Y.] Aichi Human Serv Ctr, Inst Dev Res, Dept Perinatol, Kasugai, Aichi, Japan	Nishiyama, T (reprint author), Aichi Med Univ, Dept Publ Hlth, Sch Med, 1-1 Yazako, Nagakute, Aichi 4801195, Japan.	nishiyama@minos.ocn.ne.jp					AASHEIM B, 1993, SCAND J DENT RES, V101, P257; DAVIS PJ, 1987, COMMUNITY DENT ORAL, V15, P218, DOI 10.1111/j.1600-0528.1987.tb00524.x; Nieminen P, 2009, J EXP ZOOL PART B, V312B, P320, DOI 10.1002/jez.b.21277; Polder BJ, 2004, COMMUNITY DENT ORAL, V32, P217, DOI 10.1111/j.1600-0528.2004.00158.x; Levin M, 2005, MECH DEVELOP, V122, P3, DOI 10.1016/j.mod.2004.08.006; Peck S, 1996, ANGLE ORTHOD, V66, P83; Bergendal B, 2011, AM J MED GENET A, V155A, P1616, DOI 10.1002/ajmg.a.34045; Rolling S, 2009, INT J PAEDIATR DENT, V19, P172, DOI 10.1111/j.1365-263X.2008.00958.x; Bäckman B, 2001, Int J Paediatr Dent, V11, P11, DOI 10.1046/j.1365-263x.2001.00205.x; Bergström K, 1977, Swed Dent J, V1, P145; Fleiss JL, 1981, STAT METHODS RATES P; Japanese Ministry of Education Culture Sports Science and Technology Ministry of Health Labor and Welfare, 2013, ETH GUID EP RES; Langland OE, 1989, PANORAMIC RADIOLOGY, V2nd; R Development Core Team, 2012, R LANG ENV STAT COMP; Sham P., 1998, STAT HUMAN GENETICS	15	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0009-9163	1399-0004		CLIN GENET	Clin. Genet.	AUG	2015	88	2					167	171		10.1111/cge.12456		5	Genetics & Heredity	Genetics & Heredity	CM4YG	WOS:000357692000012		
J	Tomii, M; Mizuno, J; Itoh, Y; Watanabe, K				Tomii, Masato; Mizuno, Junichi; Itoh, Yasunobu; Watanabe, Kazuo			Clinical study of C3-C4 level surgical cases of cervical spondylosis	CLINICAL NEUROLOGY AND NEUROSURGERY			English	Article						C3-C4 level; Cervical spondylotic myelopathy; Anterior cervical discectomy and fusion; Instability	ELDERLY-PATIENTS; MYELOPATHY; SPINE; PATHOGENESIS	Objective: The purpose of this study was to elucidate the pathological characteristics of C3-C4 cervical spondylotic myelopathy (CSM). Methods: Single-level anterior cervical discectomy and fusion (ACDF) was performed at C3-C4 in 53 patients (38 men, 15 women). The mean duration of preoperative symptoms was 6.0 months. Fifty-three non C3-C4 ACDF patients of our random sample of ACDF patients were compared to the C3-C4 ACDF patients. Clinical outcomes were assessed according to the Japanese Orthopedic Association score (JOA score), the Neurosurgical Cervical Spine Scale (NCSS), and the Nurick scale. And radiological findings including C2-C7 lordosis, C3-C4 range of intervertebral motion (ROM), C2-C7 ROM, and C3-C4%ROM in the cervical spine were evaluated in both groups. Results: The recovery rates of JOA score and the NCSS in C3-C4 ACDF patients were 62.5% and 62.1%, respectively. The radiological study of C3-C4 ACDF patients showed that they had significant cervical lordosis, and cervical motion was dependent on the C3-C4 segment, which accounted for 39.8% of C2-C7 ROM (total motion). Conclusion: In C3-C4 ACDF patients, not only static factors, but dynamic factors (instability) at the C3-C4 level contributed to the major causes of CSM. (C) 2015 Elsevier B.V. All rights reserved.	[Tomii, Masato; Mizuno, Junichi; Watanabe, Kazuo] Southern TOHOKU Gen Hosp, Dept Neurosurg, Iwanuma, Miyagi 9892483, Japan; [Itoh, Yasunobu; Watanabe, Kazuo] Southern TOHOKU Gen Hosp, Dept Neurosurg, Southern TOHOKU Res Inst Neurosci, Koriyama, Fukushima, Japan	Tomii, M (reprint author), Southern TOHOKU Gen Hosp, Dept Neurosurg, 1-2-5 Satonomori, Iwanuma, Miyagi 9892483, Japan.	masatotomii@ybb.ne.jp					Yukawa Y, 2012, EUR SPINE J, V21, P1492, DOI 10.1007/s00586-012-2167-5; NURICK S, 1972, BRAIN, V95, P87; Morishita Y, 2009, EUR SPINE J, V18, P877, DOI 10.1007/s00586-009-0968-y; HAYASHI H, 1988, SPINE, V13, P618; BOIJSEN E, 1954, ACTA RADIOL, V42, P101; Ikegami H, 2004, SURG TECH SPINE SPIN, V6, P103; Jacson R, 1958, CERVICAL SYNDROME, V2nd; Japanese Orthopaedic Association, 1975, J JPN ORTHOP ASS, V99; KADOYA S, 1992, Neurologia Medico-Chirurgica, V32, P40, DOI 10.2176/nmc.32.40; Kawasaki M, 2007, J ORTHOP SCI, V12, P207, DOI 10.1007/s00776-007-1122-5; Mihara H, 2000, SPINE, V25, P796, DOI 10.1097/00007632-200004010-00006; Nishizawa S, 1999, ACTA NEUROCHIR, V141, P119, DOI 10.1007/s007010050275; Okamoto A, 1990, E JAPAN RINSYO SEIKE, V2, P229; Soo M Y, 1997, Australas Radiol, V41, P351; Tsunoda K, 2009, SPINAL SURG, V23, P24	15	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0303-8467	1872-6968		CLIN NEUROL NEUROSUR	Clin. Neurol. Neurosurg.	AUG	2015	135						11	14		10.1016/j.clineuro.2015.04.024		4	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CL8LS	WOS:000357226800003		
J	Akutsu, H; Yamamoto, T; Masuda, Y; Ishikawa, E; Masumoto, T; Matsuda, M; Matsumura, A				Akutsu, Hiroyoshi; Yamamoto, Tetsuya; Masuda, Yosuke; Ishikawa, Eiichi; Masumoto, Tomohiko; Matsuda, Masahide; Matsumura, Akira			Movable intraoperative magnetic resonance imaging incorporating a seismic system	CLINICAL NEUROLOGY AND NEUROSURGERY			English	Article						Movable intraoperative MRI; Seismic event; Safety; Image quality	GLIOMA; RESECTION; GUIDANCE; EXTENT; MRI	Introduction: A high-field ceiling-mounted and movable intraoperative MR imaging (iMRI) can minimize additional risks for MRI and enhance safety by not moving the patient. In this system, hanging the heavy magnet from the ceiling requires structural stability; this stability was confirmed in earlier studies, but not proved during a seismic event. Objective: We have installed a 1.5 T movable iMRI system with an incorporated seismic system in our hospital in Japan, a seismic event-prone region. This arrangement is the first in the world, to our knowledge. The objective of this study was to describe the mechanism of this seismic system and the first clinical experience using this system. Methods: The seismic system consists of a stabilizer pad that is mounted directly under the magnet, in addition to the structural stability. The seismic system was tested with using a shaker table testing at a test laboratory. Results: Ninety-one patients underwent neurosurgical intervention using this iMRI and seismic system at our hospital. In all patients, intra-, pre, and/or postoperative MR images were successfully obtained, and image quality was excellent. The workflow of moving the magnet and scanning were smooth and unproblematic. We had 169 seismic events in our city during this time period, but had no incidental or accidental events related to the seismic events. Conclusion: With the use of the seismic system, a ceiling-mounted, movable iMRI system can be more safely used. This seismic system may contribute to the spread of movable iMRI systems in countries where seismic events occur. (C) 2015 Elsevier B.V. All rights reserved.	[Akutsu, Hiroyoshi; Yamamoto, Tetsuya; Masuda, Yosuke; Ishikawa, Eiichi; Matsuda, Masahide; Matsumura, Akira] Univ Tsukuba, Fac Med, Dept Neurosurg, Tsukuba, Ibaraki 3058575, Japan; [Masumoto, Tomohiko] Univ Tsukuba, Fac Med, Dept Radiol, Tsukuba, Ibaraki 3058575, Japan	Akutsu, H (reprint author), Univ Tsukuba, Fac Med, Dept Neurosurg, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058575, Japan.	akutsuh@md.tsukuba.ac.jp					Bohinski RJ, 2001, NEUROSURGERY, V49, P1133; Senft C, 2011, LANCET ONCOL, V12, P997, DOI 10.1016/S1470-2045(11)70196-6; Claus EB, 2005, CANCER, V103, P1227, DOI 10.1002/cncr.20867; Levy R, 2009, J NEUROSURG-PEDIATR, V4, P467, DOI 10.3171/2009.4.PEDS08464; Bohinski RJ, 2001, NEUROSURGERY, V49, P1143; Buchfelder M, 2012, ENDOCRINE, V42, P483, DOI 10.1007/s12020-012-9752-6; Choudhri AF, 2014, AM J NEURORADIOL, V35, P2382, DOI 10.3174/ajnr.A4040; Kuhnt D, 2011, NEUROSURGERY, V69, P862; Kuhnt D, 2011, NEUROSURGERY, V69, P852, DOI 10.1227/NEU.0b013e318225ea6b; Lang MJ, 2011, NEUROSURGERY, V68, P168, DOI 10.1227/NEU.0b013e3182045803	10	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0303-8467	1872-6968		CLIN NEUROL NEUROSUR	Clin. Neurol. Neurosurg.	AUG	2015	135						57	61		10.1016/j.clineuro.2015.05.003		5	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CL8LS	WOS:000357226800012		
J	Hiraga, A; Yatomi, M; Ozaki, D; Kamitsukasa, I; Kuwabara, S				Hiraga, Akiyuki; Yatomi, Mari; Ozaki, Daisuke; Kamitsukasa, Ikuo; Kuwabara, Satoshi			Cryptococcosis mimicking lung cancer with brain metastasis	CLINICAL NEUROLOGY AND NEUROSURGERY			English	Article						Cryptococcosis; Brain tumour; Lung cancer	PULMONARY CRYPTOCOCCOSIS; MRI FINDINGS; IMMUNOCOMPETENT		[Hiraga, Akiyuki; Kamitsukasa, Ikuo] Chiba Rosai Hosp, Dept Neurol, Ichihara, Chiba 2900003, Japan; [Yatomi, Mari] Chiba Rosai Hosp, Dept Internal Med, Ichihara, Chiba 2900003, Japan; [Ozaki, Daisuke] Chiba Rosai Hosp, Dept Pathol, Ichihara, Chiba 2900003, Japan; [Kuwabara, Satoshi] Chiba Univ, Grad Sch Med, Dept Neurol, Chiba, Japan	Hiraga, A (reprint author), Chiba Rosai Hosp, Dept Neurol, 2-16 Tatsumidai Higashi, Ichihara, Chiba 2900003, Japan.	hiragaa@yahoo.co.jp					Chang WC, 2006, CHEST, V129, P333, DOI 10.1378/chest.129.2.333; Miszkiel KA, 1996, CLIN RADIOL, V51, P842, DOI 10.1016/S0009-9260(96)80080-8; Chen SQ, 2011, J MED IMAG RADIAT ON, V55, P52, DOI 10.1111/j.1754-9485.2010.02229.x; Choe YH, 2009, SCAND J INFECT DIS, V41, P602, DOI 10.1080/00365540903036212; Saigal G, 2005, AM J NEURORADIOL, V26, P2522	5	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0303-8467	1872-6968		CLIN NEUROL NEUROSUR	Clin. Neurol. Neurosurg.	AUG	2015	135						93	95		10.1016/j.clineuro.2015.05.014		3	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CL8LS	WOS:000357226800018		
J	Mori, A; Nodera, H; Takamatsu, N; Shimatani, Y; Maruyama, K; Oda, M; Izumi, Y; Kaji, R				Mori, Atsuko; Nodera, Hiroyuki; Takamatsu, Naoko; Shimatani, Yoshimitsu; Maruyama, Keiko; Oda, Masaya; Izumi, Yuishin; Kaji, Ryuji			Focal nerve enlargement is not the cause for increased distal motor latency in ALS: Sonographic evaluation	CLINICAL NEUROPHYSIOLOGY			English	Article						ALS; Median nerve; Sonography; Carpal tunnel syndrome; Distal latency	AMYOTROPHIC-LATERAL-SCLEROSIS; CARPAL-TUNNEL-SYNDROME; GUILLAIN-BARRE-SYNDROME; ENTRAPMENT NEUROPATHIES; ULNAR NERVES; CONDUCTION; DIAGNOSIS; CRITERIA; DISEASE; ROOTS	Objective: To elucidate the mechanism of focal conduction slowing in the median nerve in ALS. Methods: The patients with ALS and CTS and normal control subjects were tested with sonography of the median and ulnar nerves. The cross-sectional areas (CSAs) and the wrist-forearm CSA ratios were compared with the parameters of nerve conduction study. Results: The median motor distal latency was frequently prolonged in ALS and CTS. CSA and the wrist-forearm ratio of the median nerve were smaller in ALS than in CTS. The ulnar nerve sonography was similar in all the groups. Conclusions: Selective conduction slowing of the median nerve at the wrist in ALS is unlikely due to secondary compressive neuropathy, as seen in carpal tunnel syndrome. Significance: Unique vulnerability of the median nerve in ALS may explain the selective conduction slowing. (c) 2014 International Federation of Clinical Neurophysiology. Published by Elsevier Ireland Ltd. All rights reserved.	[Mori, Atsuko; Nodera, Hiroyuki; Takamatsu, Naoko; Shimatani, Yoshimitsu; Maruyama, Keiko; Izumi, Yuishin; Kaji, Ryuji] Univ Tokushima, Dept Neurol, Tokushima 770, Japan; [Takamatsu, Naoko; Oda, Masaya; Izumi, Yuishin] Vihara Hananosato Hosp, Dept Neurol, Hiroshima, Japan	Nodera, H (reprint author), Dept Neurol, 3-18-15 Kuramotocho, Tokushima 7708503, Japan.	hnodera@tokushima-u.ac.jp; yizumi@clin.med.tokushima-u.ac.jp		Nodera, Hiroyuki/0000-0002-5357-5081	Research Committee of CNS Degenerative Diseases, the Ministry of Health, Labour and Welfare of Japan	This work was supported by Grants-in-Aid from the Research Committee of CNS Degenerative Diseases, the Ministry of Health, Labour and Welfare of Japan.	Kaji R, 2003, MUSCLE NERVE, V27, P285, DOI 10.1002/mus.10273; Tai TW, 2012, ULTRASOUND MED BIOL, V38, P1121, DOI 10.1016/j.ultrasmedbio.2012.02.026; Murata K, 2004, J HAND SURG-AM, V29A, P500, DOI 10.1016/j.jhsa.2004.01.006; Braak H, 2013, NAT REV NEUROL, V9, P708, DOI 10.1038/nrneurol.2013.221; Dadon-Nachum M, 2011, J MOL NEUROSCI, V43, P470, DOI 10.1007/s12031-010-9467-1; Keith MW, 2009, J AM ACAD ORTHOP SUR, V17, P389; Nutini M, 2011, MOL CELL NEUROSCI, V47, P108, DOI 10.1016/j.mcn.2011.03.005; Nodera H, 2014, CLIN NEUROPHYSIOL, V125, P1906, DOI 10.1016/j.clinph.2014.01.033; de Carvalho M, 2000, MUSCLE NERVE, V23, P344, DOI 10.1002/(SICI)1097-4598(200003)23:3<344::AID-MUS5>3.0.CO;2-N; Mills KR, 1998, J NEUROL SCI, V159, P82, DOI 10.1016/S0022-510X(98)00148-8; Brooks BR, 2000, AMYOTROPH LATERAL SC, V1, P293, DOI 10.1080/146608200300079536; Eisen A, 2001, MUSCLE NERVE, V24, P564, DOI 10.1002/mus.1042; Cartwright MS, 2013, MUSCLE NERVE, V48, P696, DOI 10.1002/mus.23900; Kuwabara S, 2013, LANCET NEUROL, V12, P1180, DOI 10.1016/S1474-4422(13)70215-1; de Carvalho M, 2008, CLIN NEUROPHYSIOL, V119, P497, DOI 10.1016/j.clinph.2007.09.143; Zaidman CM, 2013, NEUROLOGY, V80, P1634, DOI 10.1212/WNL.0b013e3182904f3f; Sugimoto T, 2013, ULTRASOUND MED BIOL, V39, P1560, DOI 10.1016/j.ultrasmedbio.2013.03.031; Wilbourn AJ, 2000, MUSCLE NERVE, V23, P138, DOI 10.1002/(SICI)1097-4598(200001)23:1<138::AID-MUS22>3.0.CO;2-7; Cartwright MS, 2011, MUSCLE NERVE, V44, P346, DOI 10.1002/mus.22035; ARGYROPOULOS CJ, 1978, MUSCLE NERVE, V1, P479, DOI 10.1002/mus.880010607; Cocito D, 2001, MUSCLE NERVE, V24, P1278, DOI 10.1002/mus.1145; Felice KJ, 1998, MUSCLE NERVE, V21, P756, DOI 10.1002/(SICI)1097-4598(199806)21:6<756::AID-MUS7>3.3.CO;2-G; Gunasekaran R, 2009, BRAIN RES, V1255, P170, DOI 10.1016/j.brainres.2008.11.099; HANSEN S, 1978, J NEUROL NEUROSUR PS, V41, P773, DOI 10.1136/jnnp.41.9.773; Kimura J, 2013, ELECTRODIAGNOSIS DIS, V4th; Kokubun N, 2013, CLIN NEUROPHYSIOL, V124, P1671, DOI 10.1016/j.clinph.2013.02.010; Kollewe K, 2011, AMYOTROPH LATERAL SC, V12, P349, DOI 10.3109/17482968.2011.572980; Kothari MJ, 1996, ARCH PHYS MED REHAB, V77, P1186, DOI 10.1016/S0003-9993(96)90146-X; Mills KR, 1997, J NEUROL NEUROSUR PS, V62, P541, DOI 10.1136/jnnp.62.5.541-a; Mohammadi B, 2007, NEUROL RES, V29, P425, DOI 10.1179/016164107X159261; Moloney EB, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00252; Noto Y, 2011, J NEUROL SCI, V302, P58, DOI 10.1016/j.jns.2010.11.025; Shibuta Y, 2013, CLIN NEUROPHYSIOL, V124, P2046, DOI 10.1016/j.clinph.2013.02.117; Simovic D, 1997, MUSCLE NERVE, V20, P1178, DOI 10.1002/(SICI)1097-4598(199709)20:9<1178::AID-MUS14>3.0.CO;2-P; Stalberg E, 1992, NEUROPHYSIOLOGICAL S; Sugimoto T, 2013, J NEUROL, V260, P2580, DOI 10.1007/s00415-013-7021-0; Swash M, 2004, AMYOTROPH LATERAL SC, V5, P108, DOI 10.1080/17434470410020067	37	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	1388-2457	1872-8952		CLIN NEUROPHYSIOL	Clin. Neurophysiol.	AUG	2015	126	8					1632	1637		10.1016/j.clinph.2014.10.152		6	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CM2DA	WOS:000357488800025		
J	Osaki, Y; Takamatsu, N; Shimatani, Y; Mori, A; Maruyama, K; Miyazaki, Y; Nodera, H; Kaji, R				Osaki, Yusuke; Takamatsu, Naoko; Shimatani, Yoshimitsu; Mori, Atsuko; Maruyama, Keiko; Miyazaki, Yoshimichi; Nodera, Hiroyuki; Kaji, Ryuji			Ultrasonographic evaluation of myokymic discharges	CLINICAL NEUROPHYSIOLOGY			English	Letter							FASCICULATIONS; SYNKINESIS		[Osaki, Yusuke; Takamatsu, Naoko; Shimatani, Yoshimitsu; Mori, Atsuko; Maruyama, Keiko; Miyazaki, Yoshimichi; Nodera, Hiroyuki; Kaji, Ryuji] Univ Tokushima, Inst Hlth Biosci, Dept Clin Neurosci, Tokushima 7708503, Japan	Nodera, H (reprint author), Univ Tokushima, Inst Hlth Biosci, Dept Clin Neurosci, 3-18-15 Kuramoto Cho, Tokushima 7708503, Japan.	hnodera@tokushima-u.ac.jp		Nodera, Hiroyuki/0000-0002-5357-5081			ALBERS JW, 1981, MUSCLE NERVE, V4, P494, DOI 10.1002/mus.880040606; Kimura J, 2013, ELECTRODIAGNOSIS DIS, V4th; Lam L, 2010, NEUROLOGY, V74, pE69, DOI 10.1212/WNL.0b013e3181d9ed1e; Pillen S, 2009, CLIN NEUROPHYSIOL, V120, P932, DOI 10.1016/j.clinph.2009.01.016; Reimers CD, 1996, J NEUROL, V243, P579, DOI 10.1007/BF00900945; SWIFT TR, 1980, NEUROLOGY, V30, P339; WALKER FO, 1990, MUSCLE NERVE, V13, P33, DOI 10.1002/mus.880130108	7	1	1	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	1388-2457	1872-8952		CLIN NEUROPHYSIOL	Clin. Neurophysiol.	AUG	2015	126	8					1638	1639		10.1016/j.clinph.2014.10.154		2	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CM2DA	WOS:000357488800026		
J	Fujiwara, K; Machihara, S; Ozawa, T				Fujiwara, Kazumasa; Machihara, Shuji; Ozawa, Tohru			Well-Posedness for the Cauchy Problem for a System of Semirelativistic Equations	COMMUNICATIONS IN MATHEMATICAL PHYSICS			English	Article							NONLINEAR SCHRODINGER-EQUATIONS; MIXED PROBLEM; ONE-DIMENSION; REGULARITY	The local well-posedness for the Cauchy problem of a system of semirelativistic equations in one space dimension is shown in the Sobolev space H-s of order s >= 0. We apply the standard contraction mapping theorem by using Bourgain type spaces X-s,X-b. We also use an auxiliary space for the solution in L-2 = H-0. We give the global well-posedness by this conservation law and the argument of the persistence of regularity.	[Fujiwara, Kazumasa] Waseda Univ, Dept Pure & Appl Phys, Shinjuku Ku, Tokyo 1698555, Japan; [Machihara, Shuji] Saitama Univ, Fac Sci, Saitama 3388570, Japan; [Ozawa, Tohru] Waseda Univ, Dept Appl Phys, Shinjuku Ku, Tokyo 1698555, Japan	Fujiwara, K (reprint author), Waseda Univ, Dept Pure & Appl Phys, Shinjuku Ku, 3-4-1 Okubo, Tokyo 1698555, Japan.	k-fujiwara@asagi.waseda.jp; machihar@rimath.saitama-u.ac.jp; txozawa@waseda.jp					D'Ancona P, 2007, J EUR MATH SOC, V9, P877; Hayashi N, 2011, DIFFER INTEGRAL EQU, V24, P417; Lenzmann E, 2007, MATH PHYS ANAL GEOM, V10, P43, DOI 10.1007/s11040-007-9020-9; Machihara S, 2010, KYOTO J MATH, V50, P403, DOI 10.1215/0023608X-2009-018; Krieger J, 2013, ARCH RATION MECH AN, V209, P61, DOI 10.1007/s00205-013-0620-1; Ginibre J, 1997, J FUNCT ANAL, V151, P384, DOI 10.1006/jfan.1997.3148; Hayashi N, 2013, ANN I H POINCARE-AN, V30, P661, DOI 10.1016/j.anihpc.2012.10.007; Borgna JP, 2012, J MATH PHYS, V53, DOI 10.1063/1.4726198; Bournaveas N, 2012, DIFFER INTEGRAL EQU, V25, P699; Bournaveas N, 2008, DISCRETE CONT DYN S, V20, P605; Cho Y, 2006, SIAM J MATH ANAL, V38, P1060, DOI 10.1137/060653688; Frohlich J., 2007, COMMUN PURE APPL MAT, V60, P1691, DOI 10.1002/cpa.20186; Hayashi N., 2011, DIFFER EQU APPL, V3, P415; Hoshino G., 2013, DIFFER EQU APPL, V5, P395; OGAWA T, 1990, NONLINEAR ANAL-THEOR, V14, P765, DOI 10.1016/0362-546X(90)90104-O; OGAWA T, 1991, J MATH ANAL APPL, V155, P531, DOI 10.1016/0022-247X(91)90017-T; Ozawa T, 2006, CALC VAR PARTIAL DIF, V25, P403, DOI 10.1007/s00526-005-0349-2; Selberg S, 2008, COMMUN CONTEMP MATH, V10, P181, DOI 10.1142/S0219199708002740; VLADIMIROV MV, 1984, DOKL AKAD NAUK SSSR+, V275, P780	19	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0010-3616	1432-0916		COMMUN MATH PHYS	Commun. Math. Phys.	AUG	2015	338	1					367	391		10.1007/s00220-015-2347-3		25	Physics, Mathematical	Physics	CM3JM	WOS:000357578100012		
J	Kato, A; Terashima, Y				Kato, Akishi; Terashima, Yuji			Quantum Dilogarithms and Partition q-Series	COMMUNICATIONS IN MATHEMATICAL PHYSICS			English	Article							CLUSTER ALGEBRAS	In our previous work (Kato and Terashima, Commun Math Phys. arXiv:1403.6569, 2014), we introduced the partition q-series for mutation loop gamma-a loop in exchange quiver. In this paper, we show that for a certain class of mutation sequences, called reddening sequences, the graded version of partition q-series essentially coincides with the ordered product of quantum dilogarithm associated with each mutation; the partition q-series provides a state-sum description of combinatorial Donaldson-Thomas invariants introduced by Keller.	[Kato, Akishi] Univ Tokyo, Grad Sch Math Sci, Meguro Ku, Tokyo 1538914, Japan; [Terashima, Yuji] Tokyo Inst Technol, Grad Sch Informat Sci & Engn, Meguro Ku, Tokyo 1528550, Japan	Kato, A (reprint author), Univ Tokyo, Grad Sch Math Sci, Meguro Ku, 3-8-1 Komaba, Tokyo 1538914, Japan.	akishi@ms.u-tokyo.ac.jp; tera@is.titech.ac.jp			Japan Society for the Promotion of Science (JSPS) [23654079, 25400083]	We would like to thank H. Fuji, K. Hikami, A. Kuniba, R. Inoue, J. Suzuki, S. Terashima, O. Warnaar and M. Yamazaki for helpful discussions. We would also like to thank the anonymous referee for his/her valuable comments and suggestions to improve the quality of the paper. This work was partially supported by Japan Society for the Promotion of Science (JSPS), Grants-in-Aid for Scientific Research Grant (KAKENHI) Number 23654079 and 25400083. This paper is dedicated to the memory of Kentaro Nagao.	Fomin S, 2002, J AM MATH SOC, V15, P497, DOI 10.1090/S0894-0347-01-00385-X; Reineke M, 2011, COMPOS MATH, V147, P943, DOI 10.1112/S0010437X1000521X; Fomin S, 2007, COMPOS MATH, V143, P112, DOI 10.1112/S0010437X06002521; Nagao K, 2013, DUKE MATH J, V162, P1313, DOI 10.1215/00127094-2142753; Kontsevich M, 2011, COMMUN NUMBER THEORY, V5, P231; Keller B, 2011, EMS SER CONGR REP, P85; FADDEEV L, 1993, PHYS LETT B, V315, P311, DOI 10.1016/0370-2693(93)91618-W; FADDEEV LD, 1994, MOD PHYS LETT A, V9, P427, DOI 10.1142/S0217732394000447; Nakanishi T, 2012, CONTEMP MATH, V565, P217, DOI 10.1090/conm/565/11159; Plamondon PG, 2011, ADV MATH, V227, P1, DOI 10.1016/j.aim.2010.12.010; Derksen H, 2010, J AM MATH SOC, V23, P749; Keller B, 2012, EMS SER CONGR REP, P123; Brustle T, 2014, INT MATH RES NOTICES, P4547, DOI 10.1093/imrn/rnt075; Cecotti S., 2010, PREPRINT; Ginzburg V., 2006, PREPRINT; Kato A., 2014, COMMUN MATH IN PRESS; Keller B., 2013, FPSAC 13 25 INT C FO; Kontsevich M., 2008, PREPRINT; Nagao K, 2011, RIMS KOKYUROKU BES B, V28, P165; Reineke M, 2010, J INST MATH JUSSIEU, V9, P653, DOI 10.1017/S1474748009000176; SCHUTZENBERGER MP, 1953, CR HEBD ACAD SCI, V236, P352	21	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0010-3616	1432-0916		COMMUN MATH PHYS	Commun. Math. Phys.	AUG	2015	338	1					457	481		10.1007/s00220-015-2323-y		25	Physics, Mathematical	Physics	CM3JM	WOS:000357578100014		
J	Rezansoff, AM; Crispo, E; Blair, C; Cruz, E; Kitano, J; Vamosi, SM; Rogers, SM				Rezansoff, Andrew M.; Crispo, Erika; Blair, Christopher; Cruz, Edward; Kitano, Jun; Vamosi, Steven M.; Rogers, Sean M.			Toward the genetic origins of a potentially non-native population of threespine stickleback (Gasterosteus aculeatus) in Alberta	CONSERVATION GENETICS			English	Article						Stickleback; Invasion genetics; Invasive species; Introduced species; Pleistocene glaciations; Refugial population	GUPPIES POECILIA-RETICULATA; MULTILOCUS GENOTYPE DATA; NORTH-AMERICA; ADAPTIVE EVOLUTION; PUNGITIUS-PUNGITIUS; MAXIMUM-LIKELIHOOD; LARGE PHYLOGENIES; HISTORY; FISH; DIVERGENCE	Disentangling the origin of putatively introduced/invasive species is of increasing priority in conservation biology. The presence of a previously undocumented species may be due to an undetected recent population or range expansion associated with environmental change, or due to an introduction by humans. We used molecular tools to address the origin of a population of threespine stickleback (Gasterosteus aculeatus) first identified in central Alberta, Canada in 1980 from a single lake. We characterized this inland, high elevation Alberta population in comparison to samples from five representative geographic regions worldwide, using mtDNA and nine microsatellite loci to elucidate genetic structure and estimate divergence times. We found significantly lower levels of genetic variation in the Alberta population, which could reflect either a recent colonization or periodic bottlenecks associated with winterkills. While we did find that the Alberta samples were most closely related to the North American West Coast populations, we did not uncover a putative source population. Alberta samples formed a clade in phylogenetic analyses, with divergence time estimates between the Alberta and British Columbia samples ca. 250-750 kya. The hypothesis that the Alberta population represents a natural colonization during North America's last glacial recession could not be rejected. Collectively, these data suggest that the genetic signature of colonizing populations following introductions may be similar to populations at their range limit, contributing to difficulties establishing population origins.	[Rezansoff, Andrew M.] Univ Calgary, Fac Vet Med, Dept Comparat Biol & Expt Med, Calgary, AB T2N 4N1, Canada; [Crispo, Erika; Cruz, Edward] Pace Univ, Dept Biol & Hlth Sci, New York, NY 10038 USA; [Blair, Christopher] CUNY, Dept Biol Sci, New York City Coll Technol, Brooklyn, NY 11201 USA; [Kitano, Jun] Natl Inst Genet, Ecol Genet Lab, Mishima, Shizuoka 4118540, Japan; [Vamosi, Steven M.; Rogers, Sean M.] Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada	Rogers, SM (reprint author), Univ Calgary, Dept Biol Sci, 2500 Univ Dr NW, Calgary, AB T2N 1N4, Canada.	amrezans@ucalgary.ca; ecrispo@pace.edu; cblair@citytech.cuny.edu; ec29541n@pace.edu; jkitano@lab.nig.ac.jp; smvamosi@ucalgary.ca; srogers@ucalgary.ca			Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant program; Alberta Innovates Technology Futures New Faculty Award; NSERC Postdoctoral Fellowship; Alberta Conservation Association	We would like to thank Dr. Stephen Spencer of Environment and Sustainable Resource Development Alberta, and Stevi Vanderzwan for help collecting the Alberta samples. Thanks to Jacquelin DeFaveri of the Ecological Genetics Research Unit at the University of Helsinki, Finland, Scott McCairns of Universite Laval, Canada, and Ella Bowles of the University of Calgary, Canada, for providing the Norwegian, East Coast, and Alaskan fish samples, respectively. The authors thank Matthew Morris for providing comments on a draft of the manuscript. SMR and SMV are supported by the Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant program. SMR was supported by an Alberta Innovates Technology Futures New Faculty Award. EC was supported by an NSERC Postdoctoral Fellowship. SMR and EC were supported by the Alberta Conservation Association. SMR would like to thank the late Dr. Joseph Nelson (1937-2011) who graciously provided many key reprints and advice in 2010 during the inception of this research.	Alberta Environment Sustainable Resource and Development, 2014, FOC FISH MAN; Taylor BW, 2014, BIOSCIENCE, V64, P531, DOI 10.1093/biosci/biu060; Stamford MD, 2004, MOL ECOL, V13, P1533, DOI 10.1111/j.1365-294X.2004.02174.x; Cornuet JM, 1996, GENETICS, V144, P2001; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Wilson CC, 1998, CAN J FISH AQUAT SCI, V55, P1010, DOI 10.1139/cjfas-55-4-1010; Hey J, 2005, PLOS BIOL, V3, P965, DOI 10.1371/journal.pbio.0030193; Mee JA, 2015, EVOL APPL, V8, P423, DOI 10.1111/eva.12247; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Baker JA, 2008, BEHAVIOUR, V145, P579, DOI 10.1163/156853908792451539; KIMURA M, 1964, GENETICS, V49, P725; Prentis PJ, 2008, TRENDS PLANT SCI, V13, P288, DOI 10.1016/j.tplants.2008.03.004; Peichel CL, 2001, NATURE, V414, P901, DOI 10.1038/414901a; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Grover A, 2011, CURR SCI INDIA, V100, P859; Pritchard JK, 2000, GENETICS, V155, P945; Pejchar L, 2009, TRENDS ECOL EVOL, V24, P497, DOI 10.1016/j.tree.2009.03.016; Crispo E, 2005, CONSERV GENET, V6, P665, DOI 10.1007/s10592-005-9026-4; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; [Anonymous], 2012, CONSERV GENET RESOUR, DOI DOI 10.1007/S12686-011-9548-7; McCairns RJS, 2008, MOL ECOL, V17, P3901, DOI 10.1111/j.1365-294X.2008.03884.x; Morris MRJ, 2014, MOL ECOL, V23, P3226, DOI 10.1111/mec.12820; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Bernatchez L, 1998, MOL ECOL, V7, P431, DOI 10.1046/j.1365-294x.1998.00319.x; Ascunce MS, 2011, SCIENCE, V331, P1066, DOI 10.1126/science.1198734; Shikano T, 2010, MOL ECOL, V19, P1147, DOI 10.1111/j.1365-294X.2010.04553.x; Davy CM, 2011, J BIOGEOGR, V38, P272, DOI 10.1111/j.1365-2699.2010.02422.x; Lee CE, 2002, TRENDS ECOL EVOL, V17, P386, DOI 10.1016/S0169-5347(02)02554-5; Eckert CG, 2008, MOL ECOL, V17, P1170, DOI 10.1111/j.1365-294X.2007.03659.x; MUNZING J, 1963, EVOLUTION, V17, P320, DOI 10.2307/2406161; Rogers SM, 2012, EVOLUTION, V66, P2439, DOI 10.1111/j.1558-5646.2012.01622.x; LEBERG PL, 1992, EVOLUTION, V46, P477, DOI 10.2307/2409866; Mee JA, 2014, J BIOGEOGR, V41, P837, DOI 10.1111/jbi.12254; Dieringer D, 2003, MOL ECOL NOTES, V3, P167, DOI 10.1046/j.1471-8286.2003.00351.x; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Herborg LM, 2007, CAN J FISH AQUAT SCI, V64, P1723, DOI 10.1139/F07-130; MEYER A, 1990, NATURE, V347, P550, DOI 10.1038/347550a0; MENOTTIRAYMOND M, 1993, P NATL ACAD SCI USA, V90, P3172, DOI 10.1073/pnas.90.8.3172; Drinan DP, 2011, CONSERV GENET, V12, P1513, DOI 10.1007/s10592-011-0249-2; Jones FC, 2012, NATURE, V484, P55, DOI 10.1038/nature10944; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; DIRIENZO A, 1994, P NATL ACAD SCI USA, V91, P3166; McKinnon JS, 2002, TRENDS ECOL EVOL, V17, P480, DOI 10.1016/S0169-5347(02)02579-X; Bryan MB, 2005, MOL ECOL, V14, P3757, DOI 10.1111/j.1365-294X.2005.02716.x; Falush D, 2003, GENETICS, V164, P1567; KOCHER TD, 1989, P NATL ACAD SCI USA, V86, P6196, DOI 10.1073/pnas.86.16.6196; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Dlugosch KM, 2008, MOL ECOL, V17, P431, DOI 10.1111/j.1365-294X.2007.03538.x; Aldenhoven JT, 2010, MOL ECOL, V19, P4061, DOI 10.1111/j.1365-294X.2010.04801.x; Austin JD, 2004, GENETICS, V168, P1491, DOI 10.1534/genetics.104.027987; Barrett R. D. H., 2010, P ROYAL SOC B, V278, P233, DOI DOI 10.1098/RSPB.2010.0923; Barson NJ, 2009, J EVOLUTION BIOL, V22, P485, DOI 10.1111/j.1420-9101.2008.01675.x; Bell Michael A., 1994, P1; Bell MA, 2009, COPEIA, P256, DOI 10.1643/CG-08-059; CHAKRABORTY R, 1977, EVOLUTION, V31, P347, DOI 10.2307/2407757; Chapman RW, 1986, GENETICS, V123, P399; Costello AB, 2003, EVOLUTION, V57, P328; Crispo E, 2008, MOL ECOL, V17, P2134, DOI 10.1111/j.1365-294X.2008.03729.x; DeFaveri J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080866; DeHaan PW, 2014, CONSERV GENET, P1; Dennenmoser S, 2013, CONSERV GENET, V14, P735, DOI 10.1007/s10592-013-0465-z; Hall T. A., 1999, NUCL ACIDS S SER, V4, P95, DOI DOI 10.1111/J.1469-8137.2009.02874.X; Houston DD, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-111; Hubert N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002490; Huey JA, 2011, J FISH BIOL, V79, P1047, DOI 10.1111/j.1095-8649.2011.03088.x; Jackson LJ, 2007, FRESHWATER BIOL, V52, P1782, DOI 10.1111/j.1365-2427.2007.01809.x; Kinnison MT, 2002, MOL ECOL, V11, P739, DOI 10.1046/j.1365-294X.2002.01477.x; Kolar C. S., 2005, ASIAN CARPS GENUS HY; Lindholm AK, 2005, MOL ECOL, V14, P3671, DOI 10.1111/j.1365-294X.2005.02697.x; McPhail J.D., 1994, P399; Neff BD, 1999, CAN J FISH AQUAT SCI, V56, P1198, DOI 10.1139/cjfas-56-7-1198; Nei M., 1987, MOL EVOLUTIONARY GEN; NELSON JS, 1987, ENVIRON BIOL FISH, V18, P173, DOI 10.1007/BF00000357; Rafinski J, 1989, J ZOOLOGICAL SYSTEMA, V27, P33; Rambaut A., 2007, TRACER V1 4, V4; RAWLINSON SE, 1982, J PALEONTOL, V56, P583; Richmond JQ, 2014, BIOL INVASIONS, V17, P1; Seyfert AL, 2008, GENETICS, V178, P2113, DOI 10.1534/genetics.107.081927; Shafer BA, 2010, MOL ECOL, V19, P4589; Smith TW, 1989, THESIS U ALBERTA EDM; Vamosi SM, 2003, EVOL ECOL RES, V5, P717; Wang YQ, 2005, CONSERV GENET, V6, P575, DOI 10.1007/s10592-005-9015-7; Yoshida K, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004223	88	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1566-0621	1572-9737		CONSERV GENET	Conserv. Genet.	AUG	2015	16	4					859	873		10.1007/s10592-015-0706-4		15	Biodiversity Conservation; Genetics & Heredity	Biodiversity & Conservation; Genetics & Heredity	CL9GP	WOS:000357285500009		
J	Takeuchi, T; Takahashi, J; Kiyoshi, T; Nomura, T; Tsubaki, Y				Takeuchi, Tsuyoshi; Takahashi, Junichi; Kiyoshi, Takuya; Nomura, Tetsuro; Tsubaki, Yoshitaka			Genetic differentiation in the endangered myrmecophilous butterfly Niphanda fusca: a comparison of natural and secondary habitats	CONSERVATION GENETICS			English	Article						Ant; Genetic structure; Mitochondrial DNA; Nuclear DNA; Parasite	LEPIDOPTERA LYCAENIDAE; MITOCHONDRIAL-DNA; CONSERVATION; DIVERSITY; EVOLUTION; SEQUENCES; FRAGMENTATION; NYMPHALIDAE; PHYLOGENY; WOLBACHIA	Niphanda fusca is an endangered myrmecophilous butterfly inhabiting environments at early stages of succession. Most of its habitats are places where succession is prevented by human activity. In some places, however, N. fusca lives in natural semi-bare areas, such as cliffs in mountains or grasslands around volcanos. We investigate the genetic structure of N. fusca in Japan and South Korea to address two questions. (1) Are populations in natural environments genetically different from those in secondary environments? and (2) Do populations in natural environments possess greater genetic diversity than those in secondary environments? The AMOVA results indicated that the populations in natural environments and those in secondary environments were differentiated to some extent; however, more than 80 % of genetic variation was found to occur within the same habitat type and within each population. We found no differences in genetic diversity between populations in the two environments. At present, we have not found a strong reason to consider populations in the two environments as different evolutionarily significant units. We think it is practical to conserve populations in natural environments at first, because in this case we need not manage habitats to protect N. fusca. We have only to inhibit habitat destruction. In contrast, in order to conserve populations in secondary environments, we would have to continue managing the habitats. This is far more difficult than inhibiting habitat destruction.	[Takeuchi, Tsuyoshi; Tsubaki, Yoshitaka] Kyoto Univ, Ctr Ecol Res, Otsu, Shiga 5202113, Japan; [Takahashi, Junichi; Nomura, Tetsuro] Kyoto Sangyo Univ, Dept Bioresource & Environm Sci, Fac Life Sci, Kyoto 6038555, Japan; [Kiyoshi, Takuya] Natl Museum Nat & Sci, Dept Zool, Tsukuba, Ibaraki 3050005, Japan	Takeuchi, T (reprint author), Kyoto Univ, Ctr Ecol Res, Hirano 2-509-3, Otsu, Shiga 5202113, Japan.	takeuchiozephyrus@yahoo.co.jp			Fujiwara Natural History Foundation; Kyoto University; MEXT	We are grateful to S. Asano, H. Fukuda, T. Ichikawa, H. Inoue, K. Kamata, T. Kobayashi, C. Kudo, T. Kumon, Y. Matsuoka, H. Nagayama, T. Nishiguchi, H. Oh, T. Tani, and O. Yamamoto for collecting samples. We are also grateful to T. Okamoto for valuable comments on the manuscript. This work was supported by a grant from the Fujiwara Natural History Foundation, a grant for start up for young scientists of Kyoto University, Global COE program A06 of Kyoto University, and MEXT Grants for Excellent Graduate Schools.	Monteiro A, 2001, MOL PHYLOGENET EVOL, V18, P264, DOI 10.1006/mpev.2000.0872; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Nakamura Y, 2011, J INSECT CONSERV, V15, P5, DOI 10.1007/s10841-010-9299-x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Pimm SL, 2014, SCIENCE, V344, P987, DOI 10.1126/science.1246752; Sielezniew M, 2011, EUR J ENTOMOL, V108, P537; Crandall KA, 2000, TRENDS ECOL EVOL, V15, P290, DOI 10.1016/S0169-5347(00)01876-0; Thomas JA, 2009, SCIENCE, V325, P80, DOI 10.1126/science.1175726; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651; Als TD, 2004, NATURE, V432, P386, DOI 10.1038/nature03020; DeChaine EG, 2004, EVOLUTION, V58, P113, DOI 10.1111/j.0014-3820.2004.tb01578.x; Laurance WF, 2000, NATURE, V404, P836, DOI 10.1038/35009032; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Dupanloup I, 2002, MOL ECOL, V11, P2571, DOI 10.1046/j.1365-294X.2002.01650.x; Sielezniew M, 2012, INSECT CONSERV DIVER, V5, P223, DOI 10.1111/j.1752-4598.2011.00163.x; Pierce NE, 2002, ANNU REV ENTOMOL, V47, P733, DOI 10.1146/annurev.ento.47.091201.145257; Nash DR, 2008, SCIENCE, V319, P88, DOI 10.1126/science.1149180; Bossart JL, 2013, CONSERV GENET, V14, P511, DOI 10.1007/s10592-012-0436-9; BRISCOE D. A., 2002, INTRO CONSERVATION G; de Jong MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021385; Downey MH, 2013, EVOL ECOL, V27, P565, DOI 10.1007/s10682-012-9626-7; Eastwood R, 2006, EVOLUTION, V60, P315; EXCOFFIER L, 1992, GENETICS, V131, P479; Fukuda H, 1984, PICTORIAL GUIDE ECOL, V4; Graham RI, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-204; Hojo MK, 2009, P R SOC B, V276, P551, DOI 10.1098/rspb.2008.1064; Imai H, 2004, ANTS OF JAPAN; Kira T, 1971, NATURE SEEN ECOLOGIC; Mano T, 2009, DECLINE CONSERVATION, VVI; Ministry of Environment of Japan, 2012, RED LIST, V4th; Narita S, 2006, MOL ECOL, V15, P1095, DOI 10.1111/j.1365-294X.2006.02857.x; Nei M., 1987, MOL EVOLUTIONARY GEN; Neve G, 2009, EUR J ENTOMOL, V106, P11; Sakamoto Y, 2015, B ENTOMOL RES, V105, P152, DOI 10.1017/S0007485314000819; Ugelvig LV, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-201; Washitani I., 2001, GLOBAL ENV RES, V5, P119; Wu LW, 2010, BIOL INVASIONS, V12, P2649, DOI 10.1007/s10530-009-9672-4; Yagi T, 1999, J MOL EVOL, V48, P42, DOI 10.1007/PL00006443	38	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1566-0621	1572-9737		CONSERV GENET	Conserv. Genet.	AUG	2015	16	4					979	986		10.1007/s10592-015-0717-1		8	Biodiversity Conservation; Genetics & Heredity	Biodiversity & Conservation; Genetics & Heredity	CL9GP	WOS:000357285500018		
J	Kakehashi, R; Igawa, T; Sumida, M				Kakehashi, Ryosuke; Igawa, Takeshi; Sumida, Masayuki			Genetic population structure and demographic history of an endangered frog, Babina holsti	CONSERVATION GENETICS			English	Article						Conservation genetics; Demographic history; Microsatellite DNA; Mitochondrial DNA; Babina holsti	ALLELE FREQUENCY DATA; MITOCHONDRIAL GENOMES; MICROSATELLITE LOCI; ISLAND POPULATIONS; DNA POLYMORPHISM; COMPUTER-PROGRAM; GENUS RANA; DIFFERENTIATION; SOFTWARE; EXTINCTION	Babina holsti is a ranid frog that occurs on northern Okinawa (Yanbaru) and Tokashiki Islands of southwest Japan. Because of its narrow distribution and recent habitat destruction, its population size is believed to have decreased, and the species has been listed as an endangered species on the IUCN Red List. To promote effective conservation management, we examined the population structure, gene flow, and demographic history of B. holsti using a mitochondrial gene and 12 microsatellite loci. The population structure analyses first distinguished the Tokashiki Island population from the Yanbaru ones. The Yanbaru populations were further divided into main and southernmost populations. Large genetic differences were detected between the Tokashiki and Yanbaru populations, and their divergence time was estimated as 0.38 Mya. Based on demographic analyses on Yanbaru, population expansion generally occurred after the last glacial period and then decreased rapidly. Specifically, only the southern Yanbaru populations have experienced a population decline within the past 5000 years. These results suggested that prehistoric geographic events may have affected the historical population decline on Yanbaru. On Tokashiki, the lowest genetic diversity and a significant population bottleneck were detected, both probably caused by scarcer environmental resources. These results are beneficial to sustainable conservation management of B. holsti, especially the conservation priority of the populations in Tokashiki and southern Yanbaru.	[Kakehashi, Ryosuke; Sumida, Masayuki] Hiroshima Univ, Grad Sch Sci, Inst Amphibian Biol, Hiroshima 7398529, Japan; [Igawa, Takeshi] Hiroshima Univ, Grad Sch Int Dev & Cooperat, Hiroshima 7398529, Japan	Igawa, T (reprint author), Hiroshima Univ, Grad Sch Sci, Inst Amphibian Biol, Hiroshima 7398529, Japan.	tigawa@hiroshima-u.ac.jp	Igawa, Takeshi/E-2881-2014	Igawa, Takeshi/0000-0001-6880-6180	Ministry of Education, Culture, Sports, Science and Technology, Japan [24310173, 20510216, 23710282]	We are grateful to the Boards of Education of Okinawa Prefecture, Japan, for allowing us to collect the materials of Babina holsti protected by law. This work was supported by a Grants-in-Aid for Scientific Research (B and C; Nos. 24310173 and 20510216) to MS and a Grant-in-Aid for Young Scientists (B; No. 23710282) to TI from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Crochet PA, 2000, MOL ECOL, V9, P1463, DOI 10.1046/j.1365-294x.2000.01026.x; Kakehashi R, 2013, GENES GENET SYST, V88, P59; Matsui M, 2005, MOL PHYLOGENET EVOL, V37, P733, DOI 10.1016/j.ympev.2005.04.030; Cornuet JM, 1996, GENETICS, V144, P2001; Takezaki N, 2014, MOL BIOL EVOL, V31, P1622, DOI 10.1093/molbev/msu093; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Chen XH, 2013, MOL PHYLOGENET EVOL, V69, P1196, DOI 10.1016/j.ympev.2013.07.023; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Pritchard JK, 2000, GENETICS, V155, P945; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; [Anonymous], 2012, CONSERV GENET RESOUR, DOI DOI 10.1007/S12686-011-9548-7; Galtier N, 2009, MOL ECOL, V18, P4541, DOI 10.1111/j.1365-294X.2009.04380.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Raymond M, 1995, EVOLUTION, V49, P1280, DOI 10.2307/2410454; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Hoegg S, 2004, MOL BIOL EVOL, V21, P1188, DOI 10.1093/molbev/msh081; OHTA T, 1973, GENET RES, V22, P201; Wilson GA, 2003, GENETICS, V163, P1177; Fu YX, 1997, GENETICS, V147, P915; Jarne P, 1996, TRENDS ECOL EVOL, V11, P424, DOI 10.1016/0169-5347(96)10049-5; Funk WC, 2005, MOL ECOL, V14, P483, DOI 10.1111/j.1365-294X.2005.02426.x; Igawa T, 2008, GENE, V407, P116, DOI 10.1016/j.gene.2007.10.001; TEMPLETON AR, 1992, GENETICS, V132, P619; TAJIMA F, 1989, GENETICS, V123, P585; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Newman D, 1997, EVOLUTION, V51, P354, DOI 10.2307/2411107; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Vences M, 2013, MOL PHYLOGENET EVOL, V68, P657, DOI 10.1016/j.ympev.2013.04.014; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197; Rousset F, 1997, GENETICS, V145, P1219; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; NEI M, 1975, EVOLUTION, V29, P1, DOI 10.2307/2407137; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; BIRKY CW, 1983, GENETICS, V103, P513; Wake DB, 2012, SCIENCE, V335, P1052, DOI 10.1126/science.1218364; Igawa T, 2013, HEREDITY, V110, P46, DOI 10.1038/hdy.2012.59; Manni F, 2004, HUM BIOL, V76, P173, DOI 10.1353/hub.2004.0034; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Lisiecki LE, 2005, PALEOCEANOGRAPHY, V20, DOI 10.1029/2004PA001071; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI 10.1093/molbev/msi103; Vences M, 2002, MOL ECOL, V11, P1453, DOI 10.1046/j.1365-294X.2002.01543.x; Donoghue PCJ, 2007, TRENDS ECOL EVOL, V22, P424, DOI 10.1016/j.tree.2007.05.005; Garza JC, 2001, MOL ECOL, V10, P305, DOI 10.1046/j.1365-294x.2001.01190.x; Excoffier L, 1998, AM J HUM GENET, V62, P171, DOI 10.1086/301674; Frankham R, 1998, CONSERV BIOL, V12, P665, DOI 10.1046/j.1523-1739.1998.96456.x; Wright S, 1943, GENETICS, V28, P114; BRISCOE D. A., 2002, INTRO CONSERVATION G; Bryant EH, 1999, CONSERV BIOL, V13, P1487, DOI 10.1046/j.1523-1739.1999.98440.x; Drummond AJ, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-114; Environment Agency of Japan, 2000, THREAT WILDL JAP RED, V3; Hewitt Godfrey M., 2004, Frontiers in Zoology, V1, P1, DOI 10.1186/1742-9994-1-4; Honda M, 2012, MOL PHYLOGENET EVOL, V65, P642, DOI 10.1016/j.ympev.2012.07.019; Hongo C, 2010, PALAEOGEOGR PALAEOCL, V287, P143, DOI 10.1016/j.palaeo.2010.01.033; Iha K, 1966, OKINAWA AGR, V5, P39; Ihaka R., 1996, J COMPUTATIONAL GRAP, V5, P299, DOI DOI 10.2307/1390807; International Union for Conservation of Nature (IUCN), 2013, IUCN RED LIST THREAT; Kakehashi R, 2013, CONSERV GENET RESOUR, V5, P1071, DOI 10.1007/s12686-013-9981-x; Kan H, 2014, EMPIRICAL STUDIES EN, V2; Knopp T, 2007, CONSERV GENET, V8, P45, DOI 10.1007/s10592-006-9147-4; Kuroda T., 1996, J GEOGR, V105, P328; Maeda N, 1999, FROGS TOADS JAPAN; MONMONIER MS, 1973, GEOGR ANAL, V3, P245; NEI M, 1983, J MOL EVOL, V19, P153, DOI 10.1007/BF02300753; Ogura G, 2002, MAMM SCI, V41, P53; Omoto K, 2004, RADIOCARBON, V46, P539; PULLIAM HR, 1988, AM NAT, V132, P652, DOI 10.1086/284880; Rambaut A., 2007, TRACER V1 4, V4; Simoes PI, 2008, BIOTROPICA, V40, P607, DOI 10.1111/j.1744-7429.2008.00416.x; SOKAL ROBERT R., 1958, UNIV KANSAS SCI BULL, V38, P1409; Tominaga A, 2014, ZOOL SCI, V31, P64, DOI 10.2108/zsj.31.64; Toyama M, 1996, BASIC DATA RARE WILD; Williamson-Natesan EG, 2005, CONSERV GENET, V6, P551, DOI 10.1007/s10592-005-9009-5; Wilson J. P., 2000, TERRAIN ANAL PRINCIP; Wright S, 1969, THEORY GENE FREQUENC; Yokoyama Y, 2000, NATURE, V406, P1998	81	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1566-0621	1572-9737		CONSERV GENET	Conserv. Genet.	AUG	2015	16	4					987	1000		10.1007/s10592-015-0718-0		14	Biodiversity Conservation; Genetics & Heredity	Biodiversity & Conservation; Genetics & Heredity	CL9GP	WOS:000357285500019		
J	Xu, J; Shoji, T; Jang, C				Xu, Jian; Shoji, Tetsuo; Jang, Changheui			The effects of dissolved hydrogen on the corrosion behavior of Alloy 182 Cross Mark in simulated primary water	CORROSION SCIENCE			English	Article						A. Alloy; B. XPS; B. Raman spectroscopy; B. SEM; C. High temperature corrosion	HIGH-TEMPERATURE WATER; OXIDE-FILMS; ELECTROCHEMICAL-BEHAVIOR; NICKEL-ALLOYS; CRACK-GROWTH; METAL; SURFACE; OXYGEN; 690TT; STEEL	The effects of dissolved hydrogen (DH) on the corrosion behavior of Alloy 182 in high temperature (320 degrees C) water were studied using in situ electrochemical measurements and ex situ surface analyses. The film resistance and thickness increased with decreasing DH. Under conditions of DH = 50 cm(3)/kg and 30 cm(3)/kg, the oxide film was very thin and predominantly consisted of Cr3+. At DH = 5 cm(3)/kg, the oxide film grew thicker, and the outer part consisted of NiO and spinel, with Cr3+ primarily located in the inner part. The underlying mechanism of stress corrosion cracking (SCC) susceptibility was considered. (C) 2015 Elsevier Ltd. All rights reserved.	[Xu, Jian; Shoji, Tetsuo] Tohoku Univ, New Ind Creat Hatchery Ctr, Frontier Res Initiat, Aoba Ku, Sendai, Miyagi 9808579, Japan; [Jang, Changheui] Korea Adv Inst Sci & Technol, Dept Nucl & Quantum Engn, Taejon 305701, South Korea	Xu, J (reprint author), Tohoku Univ, New Ind Creat Hatchery Ctr, Frontier Res Initiat, Aoba Ku, 6-6-10 Aramaki Aoba, Sendai, Miyagi 9808579, Japan.	xujian@fri.niche.tohoku.ac.jp	Jang, Changheui/C-1633-2011	Jang, Changheui/0000-0002-8970-704X	KETEP-International Collaborative Energy Technology R&D Program of MOTIE of Rep. of Korea [20128540010010]	This work is supported by the KETEP-International Collaborative Energy Technology R&D Program (No. 20128540010010) of MOTIE of Rep. of Korea.	Peng QJ, 2013, CORROS SCI, V67, P91, DOI 10.1016/j.corsci.2012.10.012; MCINTYRE NS, 1975, ANAL CHEM, V47, P2208, DOI 10.1021/ac60363a034; Huang F, 2013, CORROS SCI, V76, P52, DOI 10.1016/j.corsci.2013.06.023; Terachi T, 2003, J NUCL SCI TECHNOL, V40, P509, DOI 10.3327/jnst.40.509; Sun H, 2009, CORROS SCI, V51, P2565, DOI 10.1016/j.corsci.2009.06.043; Kim J, 2014, CORROS SCI, V86, P295, DOI 10.1016/j.corsci.2014.06.006; Xu J, 2012, ELECTROCHIM ACTA, V71, P219, DOI 10.1016/j.electacta.2012.03.148; Lu ZP, 2012, CORROS SCI, V58, P211, DOI 10.1016/j.corsci.2012.01.029; Stellwag B, 1998, CORROS SCI, V40, P337, DOI 10.1016/S0010-938X(97)00140-6; Machet A, 2004, ELECTROCHIM ACTA, V49, P3957, DOI 10.1016/j.electacta.2004.04.032; Andresen PL, 2008, CORROSION, V64, P707; Zhang ZM, 2011, CORROS SCI, V53, P3623, DOI 10.1016/j.corsci.2011.07.012; Wang JQ, 2014, CORROSION, V70, P598, DOI 10.5006/1167; Machet A, 2002, SURF INTERFACE ANAL, V34, P197, DOI 10.1002/sia.1282; Nakagawa T, 2003, J NUCL SCI TECHNOL, V40, P39, DOI 10.3327/jnst.40.39; Huang JB, 2010, CORROS SCI, V52, P3444, DOI 10.1016/j.corsci.2010.06.016; Qiu YB, 2011, CORROS SCI, V53, P1983, DOI 10.1016/j.corsci.2011.02.020; Kim JH, 2005, NUCL ENG DES, V235, P1029, DOI 10.1016/j.nucengdes.2004.12.002; Thomas LE, 2000, CORROSION, V56, P572; Liu JH, 2009, J NUCL MATER, V393, P242, DOI 10.1016/j.jnucmat.2009.06.012; Peng QJ, 2012, CORROS SCI, V57, P81, DOI 10.1016/j.corsci.2011.12.031; Attanasio S.A., 2003, P 11 INT C ENV DEGR, P143; Bosch RW, 2007, ELECTROCHIM ACTA, V52, P7538, DOI 10.1016/j.electacta.2007.02.013; Figueiredo CD, 2011, ELECTROCHIM ACTA, V56, P7871, DOI 10.1016/j.electacta.2011.05.077; Kuang W.J., 2013, CORROS SCI, P197; Lima L.I. L., 2011, CORROSION, V67; Marichev VA, 1996, CORROS SCI, V38, P531, DOI 10.1016/0010-938X(96)00152-7; Maslar JE, 2002, CORROSION, V58, P225; Orazem M. E., 2008, ELECTROCHEMICAL IMPE; Peng Q, 2007, CORROS SCI, V49, P2767, DOI 10.1016/j.corsci.2006.12.022; Peng QJ, 2011, ELECTROCHIM ACTA, V56, P8375, DOI 10.1016/j.electacta.2011.07.032; Scott P., 2007, 20071015427 EPRI; Sun H, 2012, CORROS SCI, V59, P334, DOI 10.1016/j.corsci.2012.03.022; Wang F., 2012, IN SITU SURFACE ENHA; White G. A., 2005, 12 INT C ENV DEGR MA, P511; Ziemniak SE, 2008, CORROS SCI, V50, P449, DOI 10.1016/j.corsci.2007.07.013	36	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0010-938X	1879-0496		CORROS SCI	Corrosion Sci.	AUG	2015	97						115	125		10.1016/j.corsci.2015.04.021		11	Materials Science, Multidisciplinary; Metallurgy & Metallurgical Engineering	Materials Science; Metallurgy & Metallurgical Engineering	CM2YJ	WOS:000357548000012		
J	Fujii, T; Tohgo, K; Kenmochi, A; Shimamura, Y				Fujii, Tomoyuki; Tohgo, Keiichiro; Kenmochi, Akihiro; Shimamura, Yoshinobu			Experimental and numerical investigation of stress corrosion cracking of sensitized type 304 stainless steel under high-temperature and high-purity water	CORROSION SCIENCE			English	Article						A. Stainless steel; B. Modelling studies; C. Stress corrosion	MONTE-CARLO-SIMULATION; STRUCTURAL METAL MATERIALS; STAINLESS-STEELS; PITTING CORROSION; LIFE PREDICTION; ALLOYS; INITIATION; EVOLUTION; BEHAVIOR; SURFACE	This paper deals with experimental and numerical investigation of stress corrosion cracking of stainless steel under simulated environment of boiling water reactors. Constant tensile load tests were conducted in high-temperature and high-purity water. The number and maximum length of cracks increase with increasing applied stress and testing time. The length of micro-cracks is normally-distributed with the mean of 54 mu m and standard deviation of 20 mu m, which are close to the grain diameter, irrespective of applied stress and testing time. The Monte Carlo simulation was conducted on the basis of the experimental results. The applicability of the simulation is discussed. (C) 2015 Elsevier Ltd. All rights reserved.	[Fujii, Tomoyuki; Tohgo, Keiichiro; Kenmochi, Akihiro; Shimamura, Yoshinobu] Shizuoka Univ, Dept Mech Engn, Naka Ku, Hamamatsu, Shizuoka 4328561, Japan	Fujii, T (reprint author), Shizuoka Univ, Dept Mech Engn, Naka Ku, 3-5-1 Johoku, Hamamatsu, Shizuoka 4328561, Japan.	fujii.tomoyuki@shizuoka.ac.jp					Akashi M., 1983, BOSHOKU GIJUTSU, V32, P9; Akashi M., 1997, ASTM STP, P150; Akashi M., 1997, P INT S PLANT AG LIF, P99; ANDRESEN PL, 1988, MAT SCI ENG A-STRUCT, V103, P167, DOI 10.1016/0025-5416(88)90564-2; Kamaya M, 2009, ENG FRACT MECH, V76, P386, DOI 10.1016/j.engfracmech.2008.11.004; Trethewey KR, 2008, MATER DESIGN, V29, P501, DOI 10.1016/j.matdes.2007.02.001; Shoji T, 2010, CORROS SCI, V52, P769, DOI 10.1016/j.corsci.2009.10.041; Andresen PL, 2008, J NUCL MATER, V383, P97, DOI 10.1016/j.jnucmat.2008.08.005; Frankel GS, 1998, J ELECTROCHEM SOC, V145, P2186, DOI 10.1149/1.1838615; Shipilov SA, 2007, ENG FAIL ANAL, V14, P1550, DOI 10.1016/j.engfailanal.2006.12.003; ABRAMSON G, 1985, METALL TRANS A, V16, P101, DOI 10.1007/BF02656717; Lu ZP, 2012, J NUCL MATER, V423, P28, DOI 10.1016/j.jnucmat.2011.12.030; Turnbull A, 2006, CORROS SCI, V48, P2084, DOI 10.1016/j.corsci.2005.08.010; Kamaya M, 2007, INT J SOLIDS STRUCT, V44, P3267, DOI 10.1016/j.ijsolstr.2006.09.020; Kamaya M, 2006, CORROS SCI, V48, P2442, DOI 10.1016/j.corsci.2005.09.015; Hall MM, 2008, CORROS SCI, V50, P2902, DOI [10.1016/j.corsci.2008.07.011, 10.1016/j.corsci.2008.07.01]; ASME, 2003, BOIL PRESS VESS COD; Fujii T., 2013, J SOL MECH MAT ENG, V7, P341; Fujii T., 2012, CORROS ENG, V61, P30; Gangloff RP, 1990, ENV INDUCED CRACKING, P55; Gertsman VY, 2001, ACTA MATER, V49, P1589, DOI 10.1016/S1359-6454(01)00064-7; Hu J, 2011, NUCL ENG DES, V241, P4289, DOI 10.1016/j.nucengdes.2011.08.016; Japan Society of Corrosion Engineering, 1984, LIF PRED MAT COMP, P172; JSME, 2004, FITN FOR SERV COD S; Kaji Y, 2008, J NUCL SCI TECHNOL, V45, P725, DOI 10.3327/jnst.45.725; Kamaya M., 2001, ZAIRYO TO KANKYO, V50, P57; Kamaya M., 2007, P ZAIRYO TO KANKYO, P149; Karlsen W, 2010, J NUCL MATER, V406, P138, DOI 10.1016/j.jnucmat.2010.01.029; Khatak HS, 1996, METALL MATER TRANS A, V27, P1313, DOI 10.1007/BF02649868; Kitagawa H., 1978, ASTM STP, P98; Markgraf J. F. W., 1998, P FONT 4 INT S CONTR, P147; Murakami Y., 1981, T JAPAN SOC MECH E A, V47, P295; Nakanishi K., 1997, P INT S PLANT AG LIF, P691; Novotny R., 2006, P FONT 6 INT S CONTR, P887; PARKINS RN, 1992, JOM-J MIN MET MAT S, V44, P12; Siato K., 2001, CORROS SCI, V43, P1751; Speidel M. O., 1984, Corrosion in Power Generating Equipment. Proceedings of the Eighth International Brown Boveri Symposium; Szklaska-Smialowska Z., 1986, PITTING CORROSION ME, P218; Tahon C., 1990, CORROSION PREVENTION, P153; Takegawa T., 1982, BOSHOKU GIJYUTSU, V31, P537; Tohgo K, 2009, CORROS SCI, V51, P2208, DOI 10.1016/j.corsci.2009.06.013; Tohgo K, 2007, KEY ENG MAT, V353-358, P1068; Tohgo K, 2006, KEY ENG MAT, V306-308, P447; Turnbull A, 2006, SCRIPTA MATER, V54, P575, DOI 10.1016/j.scriptamat.2005.10.053	44	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0010-938X	1879-0496		CORROS SCI	Corrosion Sci.	AUG	2015	97						139	149		10.1016/j.corsci.2015.05.001		11	Materials Science, Multidisciplinary; Metallurgy & Metallurgical Engineering	Materials Science; Metallurgy & Metallurgical Engineering	CM2YJ	WOS:000357548000014		
J	Arumugam, S; Sreedhar, R; Thandavarayan, RA; Giridharan, VV; Karuppagounder, V; Pitchaimani, V; Afrin, MR; Miyashita, S; Nomoto, M; Harima, M; Suzuki, H; Nakamura, T; Nakamura, M; Suzuki, K; Watanabe, K				Arumugam, Somasundaram; Sreedhar, Remya; Thandavarayan, Rajarajan A.; Giridharan, Vijayasree V.; Karuppagounder, Vengadeshprabhu; Pitchaimani, Vigneshwaran; Afrin, Mst. Rejina; Miyashita, Shizuka; Nomoto, Mayumi; Harima, Meilei; Suzuki, Hiroshi; Nakamura, Takashi; Nakamura, Masahiko; Suzuki, Kenji; Watanabe, Kenichi			Telmisartan treatment targets inflammatory cytokines to suppress the pathogenesis of acute colitis induced by dextran sulphate sodium	CYTOKINE			English	Article						Telmisartan; Renin angiotensin system; Acute colitis; Apoptosis; Inflammatory cytokines	EXPERIMENTAL AUTOIMMUNE MYOCARDITIS; OXIDATIVE STRESS; ULCERATIVE-COLITIS; SIGNALING PATHWAYS; MICE; RATS; ANTIOXIDANT; MODULATION; ACTIVATION; GENOTOXICITY	The renin angiotensin system (RAS) is essential for the regulation of cardiovascular and renal functions to maintain the fluid and electrolyte homeostasis. Recent studies have demonstrated a locally expressed RAS in various tissues of mammals, which is having pathophysiological roles in those organ system. Interestingly, local RAS has important role during the inflammatory bowel disease pathogenesis. Further to delineate its role and also to identify the potential effects of telmisartan, an angiotensin receptor blocker, we have used a mouse model of acute colitis induced by dextran sulphate sodium. We have used 0.01 and 5 mg/kg body weight doses of telmisartan and administered as enema to facilitate the onsite action and to reduce the systemic adverse effects. Telmisartan high dose treatment significantly reduced the disease activity index score when compared with the colitis control mice. In addition, oxidative stress and endoplasmic reticulum stress markers expression were also significantly reduced when compared with the colitis control mice. Subsequent experiments were carried out to investigate some of the mechanisms underlying its anti-inflammatory effects and identified that the mRNA levels of pro-inflammatory cytokines such as tumour necrosis factor alpha, interleukin 1 beta, interleukin 6 and monocyte chemoattractant protein I as well as cellular DNA damage were significantly suppressed when compared with the colitis control mice. Similarly the apoptosis marker proteins such as cleaved caspase 3 and 7 levels were down-regulated and anti-apoptotic protein Bcl2 level was significantly upregulated by telmisartan treatment. These results indicate that blockade of RAS by telmisartan can be an effective therapeutic option against acute colitis. (C) 2015 Elsevier Ltd. All rights reserved.	[Arumugam, Somasundaram; Sreedhar, Remya; Thandavarayan, Rajarajan A.; Karuppagounder, Vengadeshprabhu; Pitchaimani, Vigneshwaran; Afrin, Mst. Rejina; Miyashita, Shizuka; Nomoto, Mayumi; Harima, Meilei; Suzuki, Hiroshi; Nakamura, Takashi; Watanabe, Kenichi] Niigata Univ Pharm & Appl Life Sci, Dept Clin Pharmacol, Niigata 9568603, Japan; [Thandavarayan, Rajarajan A.] Houston Methodist Res Inst, Dept Cardiovasc Sci, Houston, TX 77030 USA; [Giridharan, Vijayasree V.] JKK Nattraja Coll Pharm, Namakkal 638183, Tamil Nadu, India; [Nakamura, Masahiko] Yamanashi Prefectural Cent Hosp, Dept Cardiol, Kofu, Yamanashi, Japan; [Suzuki, Kenji] Niigata Univ, Grad Sch Med & Dent Sci, Dept Gastroenterol & Hepatol, Niigata 9518510, Japan	Watanabe, K (reprint author), Niigata Univ Pharm & Appl Life Sci, Dept Clin Pharmacol, Akiha Ku, 265-1 Higashijima, Niigata 9568603, Japan.	watanabe@nupals.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [23602012]; Promotion and Mutual Aid Corporation for Private Schools, Japan [26460239]	We acknowledge both The Ministry of Education, Culture, Sports, Science and Technology of Japan and the Promotion and Mutual Aid Corporation for Private Schools, Japan for their grant support (23602012 and 26460239 respectively).	Sekiguchi K, 2004, CARDIOVASC RES, V63, P433, DOI 10.1016/j.cardiores.2004.02.005; Tun X, 2014, FREE RADICAL BIO MED, V74, P108, DOI 10.1016/j.freeradbiomed.2014.06.020; Ueda M, 2014, BIOCHEM BIOPH RES CO, V443, P1232, DOI 10.1016/j.bbrc.2013.12.114; Giridharan VV, 2012, FREE RADICAL RES, V46, P50, DOI 10.3109/10715762.2011.638291; Celinski K, 2011, J PHYSIOL PHARMACOL, V62, P347; Arumugam S, 2013, CARDIOVASC THER, V31, P352, DOI 10.1111/1755-5922.12029; Zhang LY, 2014, J BIOL CHEM, V289, P26847, DOI 10.1074/jbc.M114.590554; Arumugam S, 2012, EXP MOL PATHOL, V93, P183, DOI 10.1016/j.yexmp.2012.04.012; Rana SV, 2014, INDIAN J MED RES, V139, P568; Yao J, 2010, ARCH MED RES, V41, P288, DOI 10.1016/j.arcmed.2010.05.002; Jung KH, 2007, J PHARMACOL EXP THER, V322, P1051, DOI 10.1124/jpet.107.120097; Thandavarayan RA, 2011, CELL PHYSIOL BIOCHEM, V28, P911, DOI 10.1159/000335805; Arab HH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097193; Arumugam S, 2014, PHARMANUTRITION, V2, P129; Christian P, 2014, AM J PHYSIOL-ENDOC M, V307, pE729, DOI 10.1152/ajpendo.00194.2014; Hartman KG, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt366; Jeong J. J., 2014, EVID-BASED COMPL ALT, V2014; Katada K, 2008, INFLAMM RES, V57, P84, DOI 10.1007/s00011-007-7098-y; Kurihara T., 2012, INT J INFLAM, V2012, DOI DOI 10.1155/2012/581695; Lee C, 2014, LIFE SCI, V95, P29, DOI 10.1016/j.lfs.2013.11.005; Luis A, 2014, FREE RADICAL BIO MED, V77, P217, DOI 10.1016/j.freeradbiomed.2014.09.008; Mu YP, 2010, LAB INVEST, V90, P245, DOI 10.1038/labinvest.2009.123; Narayan BH, 2010, FOOD FUNCT, V1, P174, DOI 10.1039/c0fo00102c; Okawada M, 2011, DIGEST DIS SCI, V56, P2553, DOI 10.1007/s10620-011-1651-9; Piechota-Polanczyk A, 2014, N-S ARCH PHARMACOL, V387, P605, DOI 10.1007/s00210-014-0985-1; Shao J, 2007, J HYPERTENS, V25, P1643, DOI 10.1097/HJH.0b013e328165d159; Shizuma T, 2013, TURK J GASTROENTEROL, V24, P30, DOI 10.4318/tjg.2013.0558; Xiao X, 2015, FOOD CHEM, V167, P438, DOI 10.1016/j.foodchem.2014.07.006; Zarepoor L, 2014, AM J PHYSIOL-GASTR L, V306, pC1042, DOI 10.1152/ajpgi.00253.2013	29	2	2	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	1043-4666	1096-0023		CYTOKINE	Cytokine	AUG	2015	74	2					305	312		10.1016/j.cyto.2015.03.017		8	Biochemistry & Molecular Biology; Cell Biology; Immunology	Biochemistry & Molecular Biology; Cell Biology; Immunology	CM5CM	WOS:000357704400019		
J	Matsui, M; Okuma, Y; Yamanaka, J; Uryu, H; Sato, N; Shichino, H; Matsushita, T				Matsui, Motohiro; Okuma, Yoshiaki; Yamanaka, Junko; Uryu, Hideko; Sato, Noriko; Shichino, Hiroyuki; Matsushita, Takeji			Kawasaki disease refractory to standard treatments that responds to a combination of pulsed methylprednisolone and plasma exchange: Cytokine profiling and literature review	CYTOKINE			English	Review						Kawasaki disease; Cytokine; Plasma exchange; Methylprednisolone; Refractory	ADDITIONAL IMMUNE GLOBULIN; INTRAVENOUS IMMUNOGLOBULIN; GAMMA-GLOBULIN; THERAPY	We present a case of Kawasaki Disease (KD) that was refractory to plasma exchange (PE), but which finally responded to concurrent intravenous methylprednisolone pulse (IVMP) and PE treatment. To determine direct and indirect evidence for the efficacy of this combination therapy, we analyzed data of patients with refractory KD by review of the literature using medical databases and cytokine profiling. For literature searches, we used the Pubmed (TM) and Ichushi (TM) databases. Search terms used included "Kawasaki disease" and "plasma exchange" to extract articles that described KD cases treated with PE. For cytokine profiling, we measured interleukin (IL)-6, soluble tumor necrosis factor-alpha receptor (sTNF-alpha R) type 1 and type 2 before and after PE and PE with IVMP. Our search revealed 201 KD patients treated with PE, of which PE treatment was effective in 188 patients (93.5%), but not in 13 cases (6.5%). All 13 cases were treated successfully with additional treatment. Of the 13 cases, only six (2.5%) had recurrence during the PE treatment period. In our case, cytokine profiling showed PE treatment decreased IL6, while sTNF-alpha R type1 and type2 remained at high levels. PE and IVMP decreased IL-6 and sTNF alpha-R type 1 and type 2 levels. Conclusion: PE concurrent with additional anti-inflammatory treatment such as IVMP might be a very promising treatment option for PE refractory patients. (C) 2015 Elsevier Ltd. All rights reserved.	[Matsui, Motohiro; Okuma, Yoshiaki; Yamanaka, Junko; Uryu, Hideko; Sato, Noriko; Shichino, Hiroyuki; Matsushita, Takeji] Natl Ctr Global Hlth & Med, Div Pediat, Shinjyuku Ku, Tokyo, Japan; [Okuma, Yoshiaki; Uryu, Hideko] Juntendo Univ, Grad Sch Med, Adv & Specialized Med, Tokyo, Japan	Matsui, M (reprint author), Natl Ctr Global Hlth & Med, Div Pediat, Shinjyuku Ku, 1-21-1 Toyama, Tokyo, Japan.	motohiro612@yahoo.co.jp			National Center for Global Health and Medicine [23D114]	This work was supported by the grant of National Center for Global Health and Medicine (23D114)	Kobayashi T, 2006, CIRCULATION, V113, P2606, DOI 10.1161/CIRCULATIONAHA.105.592865; Burns JC, 2008, J PEDIATR, V153, P833, DOI 10.1016/j.jpeds.2008.06.011; Fukui R, 2010, PROG MED, V30, P1843; Furukawa T, 2008, ARCH DIS CHILD, V93, P142, DOI 10.1136/adc.2007.126144; Ishii M, 2001, PEDIATR INT, V43, P211; Imagawa T, 2004, EUR J PEDIATR, V163, P263, DOI 10.1007/s00431-003-1267-y; Kashiwagi Y, 2012, THER APHER DIAL, V16, P281, DOI 10.1111/j.1744-9987.2012.01065.x; Kawasaki T., 1967, JAP J ALLERG, V16, P178; Miura M, 2008, EUR J PEDIATR, V167, P1119, DOI 10.1007/s00431-007-0642-5; Mori Masaaki, 2004, Mod Rheumatol, V14, P43, DOI 10.1007/s10165-003-0264-3; NEWBURGER JW, 1991, NEW ENGL J MED, V324, P1633, DOI 10.1056/NEJM199106063242305; Ogata S, 2009, J CARDIOL, V53, P15, DOI 10.1016/j.jjcc.2008.08.002; Sato N, 1999, PEDIATR INT, V41, P1; Takahara T, 2012, PROG MED, V32, P1474	14	0	0	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	1043-4666	1096-0023		CYTOKINE	Cytokine	AUG	2015	74	2					339	342		10.1016/j.cyto.2015.02.014		4	Biochemistry & Molecular Biology; Cell Biology; Immunology	Biochemistry & Molecular Biology; Cell Biology; Immunology	CM5CM	WOS:000357704400025		
J	Wakayama, H; Hashimoto, N; Matsushita, Y; Matsubara, K; Yamamoto, N; Hasegawa, Y; Ueda, M; Yamamoto, A				Wakayama, Hirotaka; Hashimoto, Naozumi; Matsushita, Yoshihiro; Matsubara, Kohki; Yamamoto, Noriyuki; Hasegawa, Yoshinori; Ueda, Minoru; Yamamoto, Akihito			Factors secreted from dental pulp stem cells show multifaceted benefits for treating acute lung injury in mice	CYTOTHERAPY			English	Article						conditioned medium; dental pulp stem cells; inflammation; macrophages; respiratory distress syndrome	RESPIRATORY-DISTRESS-SYNDROME; EXFOLIATED DECIDUOUS TEETH; SPINAL-CORD-INJURY; CONDITIONED MEDIUM; PULMONARY-FIBROSIS; REGENERATIVE MECHANISMS; GROWTH-FACTOR; IN-VIVO; RECOVERY; REPAIR	Background aims. Acute respiratory distress syndrome (ARDS) is a severe inflammatory disorder characterized by acute respiratory failure, resulting from severe, destructive lung inflammation and irreversible lung fibrosis. We evaluated the use of stem cells derived from human exfoliated deciduous teeth (SHEDs) or SHED-derived serum-free conditioned medium (SHED-CM) as treatments for bleomycin (BLM)-induced mice acute lung injury (ALI), exhibiting several pathogenic features associated with the human disease ARDS. Methods. Mice with BLM-induced ALI with or without SHED or SHED-CM treatment were examined for weight loss and survival. The lung tissue was characterized by histological and real-time quantitative polymerase chain reaction analysis. The effects of SHED-CM on macrophage differentiation in vitro were also assessed. Results. A single intravenous administration of either SHEDs or SHED-CM attenuated the lung injury and weight loss in BLM-treated mice and improved their survival rate. Similar recovery levels were seen in the SHEDs and SHED-CM treatment groups, suggesting that SHED improves ALI by paracrine mechanisms. SHED-CM contained multiple therapeutic factors involved in lung-regenerative mechanisms. Importantly, SHED-CM attenuated the BLM-induced pro-inflammatory response and generated an anti-inflammatory/tissue-regenerating environment, accompanied by the induction of anti-inflammatory M2-like lung macrophages. Furthermore, SHED-CM promoted the in vitro differentiation of bone marrow derived macrophages into M2-like cells, which expressed high levels of Arginasel, CD206 and Ym-1. Discussion. Our results suggest that SHED-secreted factors provide multifaceted therapeutic effects, including a strong M2-inducing activity, for treating BLM-induced ALI. This work may open new avenues for research on stem cell-based ARDS therapies.	[Wakayama, Hirotaka; Matsushita, Yoshihiro; Matsubara, Kohki; Yamamoto, Noriyuki; Ueda, Minoru; Yamamoto, Akihito] Nagoya Univ, Grad Sch Med, Dept Oral & Maxillofacial Surg, Nagoya, Aichi 4668550, Japan; [Hashimoto, Naozumi; Hasegawa, Yoshinori] Nagoya Univ, Grad Sch Med, Dept Resp Med, Nagoya, Aichi 4668550, Japan	Yamamoto, A (reprint author), Nagoya Univ, Grad Sch Med, Dept Oral & Maxillofacial Surg, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.	akihito@med.nagoya-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan	We are grateful to K. Furukawa (Nagoya University) and S. Toyokuni (Nagoya University) for critical comments on the minuscript. We thank the Division of Experimental Animals and Medical Research Engineering, Nagoya University Graduate School of Medicine, for housing the animals and for microscope maintenance. This work was supported by Grants-in-Aid for Scientific Research on Priority Areas from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Akhmetshina A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1734; Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008; Chen F, 2012, NAT MED, V18, P260, DOI 10.1038/nm.2628; Sakamoto K, 2012, AM J PHYSIOL-LUNG C, V303, pL43, DOI 10.1152/ajplung.00061.2012; Saito S, 2011, AM J PATHOL, V179, P1088, DOI 10.1016/j.ajpath.2011.05.027; Nakashima M, 2009, CYTOKINE GROWTH F R, V20, P435, DOI 10.1016/j.cytogfr.2009.10.012; Yamagata M, 2013, STROKE, V44, P551, DOI 10.1161/STROKEAHA.112.676759; Wheeler AP, 2007, LANCET, V369, P1553, DOI 10.1016/S0140-6736(07)60604-7; Murphy S, 2011, CELL TRANSPLANT, V20, P909, DOI 10.3727/096368910X543385; Ware LB, 2002, AM J PHYSIOL-LUNG C, V282, pL924, DOI 10.1152/ajplung.00439.2001; Gandia C, 2008, STEM CELLS, V26, P638, DOI 10.1634/stemcells.2007-0484; Herold S, 2013, AM J PHYSIOL-LUNG C, V305, pL665, DOI 10.1152/ajplung.00232.2013; Ranganath SH, 2012, CELL STEM CELL, V10, P244, DOI 10.1016/j.stem.2012.02.005; Rojas M, 2005, AM J RESP CELL MOL, V33, P145, DOI 10.1165/rcmb.2004-0330OC; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Cargnoni A, 2009, CELL TRANSPLANT, V18, P405, DOI 10.3727/096368909788809857; Roca H, 2009, J BIOL CHEM, V284, P34342, DOI 10.1074/jbc.M109.042671; Wynn TA, 2012, NAT MED, V18, P1028, DOI 10.1038/nm.2807; Ortiz LA, 2003, P NATL ACAD SCI USA, V100, P8407, DOI 10.1073/pnas.1432929100; Moodley Y, 2010, AM J RESP CRIT CARE, V182, P643, DOI 10.1164/rccm.201001-0014OC; McWhorter FY, 2013, P NATL ACAD SCI USA, V110, P17253, DOI 10.1073/pnas.1308887110; Sueblinvong V, 2010, TRANSL RES, V156, P188, DOI 10.1016/j.trsl.2010.06.007; Inoue T, 2013, TISSUE ENG PT A, V19, P24, DOI [10.1089/ten.TEA.2011.0385, 10.1089/ten.tea.2011.0385]; Ortiz LA, 2007, P NATL ACAD SCI USA, V104, P11002, DOI 10.1073/pnas.0704421104; Yamamoto A, 2014, NEUROSCI RES, V78, P16, DOI 10.1016/j.neures.2013.10.010; Sakai K, 2012, J CLIN INVEST, V122, P80, DOI 10.1172/JCI59251; Mantovani A, 2013, J PATHOL, V229, P176, DOI 10.1002/path.4133; Ando Y, 2014, BONE, V61, P82, DOI 10.1016/j.bone.2013.12.029; Martinez-Pomares L, 2012, J LEUKOCYTE BIOL, V92, P1177, DOI 10.1189/jlb.0512231; Crestani Bruno, 2012, Proc Am Thorac Soc, V9, P158, DOI 10.1513/pats.201202-018AW; Matthay MA, 2012, J CLIN INVEST, V122, P2731, DOI 10.1172/JCI60331; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Aoki F, 2005, AM J RESP CRIT CARE, V172, P713, DOI 10.1164/rccm.200412-1620OC; Hashimoto N, 2004, J CLIN INVEST, V113, P243, DOI 10.1172/JCI200418847; Moodley Y, 2009, AM J PATHOL, V175, P303, DOI 10.2353/ajpath.2009.080629; Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653; ASHCROFT T, 1988, J CLIN PATHOL, V41, P467, DOI 10.1136/jcp.41.4.467; Cargnoni A, 2012, CYTOTHERAPY, V14, P153, DOI 10.3109/14653249.2011.613930; Gronthos S, 2000, P NATL ACAD SCI USA, V97, P13625, DOI 10.1073/pnas.240309797; Ionescu L, 2012, AM J PHYSIOL-LUNG C, V303, pL967, DOI 10.1152/ajplung.00144.2011; Matsubara K, 2015, J NEUROSCI, V35, P2452, DOI 10.1523/JNEUROSCI.4088-14.2015; Miura M, 2003, P NATL ACAD SCI USA, V100, P5807, DOI 10.1073/pnas.0937635100; Mizuno S, 2005, FASEB J, V19, P580, DOI 10.1096/fj.04-1535fje; Sugahara K, 1998, J PATHOL, V186, P90; Yamaza T, 2010, STEM CELL RES THER, V1, DOI 10.1186/scrt5	45	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1465-3249	1477-2566		CYTOTHERAPY	Cytotherapy	AUG	2015	17	8					1119	1129		10.1016/j.jcyt.2015.04.009		11	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology; Hematology; Medicine, Research & Experimental	Cell Biology; Biotechnology & Applied Microbiology; Hematology; Research & Experimental Medicine	CM7AN	WOS:000357842900010		
J	Mukuno, J				Mukuno, Jun-ichi			On the fundamental group of a complete globally hyperbolic Lorentzian manifold with a lower bound for the curvature tensor	DIFFERENTIAL GEOMETRY AND ITS APPLICATIONS			English	Article						Lorentzian geometry; Fundamental group; Myers theorem; Comparison theorem; Global hyperbolicity	SPACE-FORMS; CAUCHY HYPERSURFACES; TIME FUNCTIONS	In this paper, we study the fundamental group of a certain class of globally hyperbolic Lorentzian manifolds with a positive curvature tensor. We prove that the fundamental group of lightlike geodesically complete parametrized Lorentzian products is finite under the conditions of a positive curvature tensor and the fiber compact. (C) 2015 Elsevier B.V. All rights reserved.	Nagoya Univ, Grad Sch Math, Chikusa Ku, Nagoya, Aichi 4648602, Japan	Mukuno, J (reprint author), Nagoya Univ, Grad Sch Math, Chikusa Ku, Nagoya, Aichi 4648602, Japan.	m08043e@math.nagoya-u.ac.jp			 [24-205]	This work is partially supported by the Grant-in-Aid for JSPS Fellows No. 24-205.	Andersson L, 1998, COMMUN ANAL GEOM, V6, P819; Bernal AN, 2006, LETT MATH PHYS, V77, P183, DOI 10.1007/s11005-006-0091-5; PENROSE R, 1965, PHYS REV LETT, V14, P57, DOI 10.1103/PhysRevLett.14.57; Bernal AN, 2003, COMMUN MATH PHYS, V243, P461, DOI 10.1007/s00220-003-0982-6; BEEM JK, 1987, MATH PROC CAMBRIDGE, V102, P319, DOI 10.1017/S0305004100067347; Bernal AN, 2005, COMMUN MATH PHYS, V257, P43, DOI 10.1007/s00220-005-1346-1; CALABI E, 1962, ANN MATH, V75, P63, DOI 10.2307/1970419; Cheeger Jeff, 1971, J DIFFER GEOM, V6, P119; KOBAYASHI T, 1989, MATH ANN, V285, P249, DOI 10.1007/BF01443517; Kobayashi T., 1993, J GEOM PHYS, V12, P133, DOI 10.1016/0393-0440(93)90011-3; Kobayashi T., 2001, MATH UNLIMITED 2001, P723; KULKARNI RS, 1981, ADV MATH, V40, P10, DOI 10.1016/0001-8708(81)90031-1; KULKARNI RS, 1979, COMMENT MATH HELV, V54, P173, DOI 10.1007/BF02566265; TOPONOGOV VA, 1959, DOKL AKAD NAUK SSSR+, V127, P977; WOLF JA, 1962, ANN MATH, V75, P77, DOI 10.2307/1970420	15	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0926-2245	1872-6984		DIFFER GEOM APPL	Differ. Geom. Appl.	AUG	2015	41						33	38		10.1016/j.difgeo.2015.04.002		6	Mathematics, Applied; Mathematics	Mathematics	CL8KE	WOS:000357222800003		
J	Yamashita, S; Ando, K; Hoshina, H; Ito, N; Katayama, Y; Kawanabe, M; Maruyama, M; Itioka, T				Yamashita, Satoshi; Ando, Kiyoshi; Hoshina, Hideto; Ito, Noboru; Katayama, Yuji; Kawanabe, Makoto; Maruyama, Munetoshi; Itioka, Takao			Food web structure of the fungivorous insect community on bracket fungi in a Bornean tropical rain forest	ECOLOGICAL ENTOMOLOGY			English	Article						Host specificity; host-associated community; insect diversity; macrofungi; network analysis; polypore specialisation; Staphylinidae; Tenebrionidae	APHYLLOPHORACEOUS FUNGI; HOST-SPECIFICITY; NICHE BREADTH; DIVERSITY; POLYPORES; MALAYSIA; COLEOPTERA; PATTERNS; SARAWAK; PREDICTABILITY	1. If fungivorous insect diversity is maintained by host specialisation on particular fungi, it should be higher in the tropics than in temperate or boreal regions owing to high macrofungus species diversity. 2. To reveal the community and food web structure of fungivorous insects on bracket fungi, fungivorous insects were collected from 427 fruiting bodies belonging to 22 genera throughout the development and deterioration process in a 3-ha plot of lowland dipterocarp tropical rain forest on Borneo Island. 3. Eight hundred and twenty-nine individuals of 82 coleopteran species in 13 families from 111 fruiting bodies of 15 fungal genera were collected. Tenebrionidae and Staphylinidae were most common. Fifty-three and 19 insect species were observed on Ganoderma and Phellinus, respectively. The numbers of insect species and individuals on a particular fungal genus were positively correlated with the abundance of that fungal genus. 4. Quantitative food web analysis revealed a high degree of specialisation at the whole-community level. At least 65% of insect individuals were observed on Ganoderma at every stage of development and deterioration. Diverse insects coexist on one dominant fungal genus, Ganoderma, in contrast to our hypothesis. 5. The high abundance of Ganoderma fruiting bodies, which lack obvious defences against insect feeding, probably influences the bracket fungus-insect food web in this tropical rainforest.	[Yamashita, Satoshi] Forestry & Forest Prod Res Inst, Dept Forest Entomol, Tsukuba, Ibaraki 305, Japan; [Yamashita, Satoshi] Kyoto Univ, Grad Sch Global Environm Studies, Kyoto, Japan; [Ando, Kiyoshi] Ehime Univ, Fac Agr, Matsuyama, Ehime 790, Japan; [Hoshina, Hideto] Univ Fukui, Fac Educ & Reg Studies, Fukui 910, Japan; [Ito, Noboru] Trend Tone Imaging Inc, Hsinchu, Taiwan; [Kawanabe, Makoto] Res Inst Nat & Soc Co Ltd, Hachioji, Tokyo, Japan; [Maruyama, Munetoshi] Kyushu Univ Museum, Fukuoka, Japan; [Itioka, Takao] Kyoto Univ, Grad Sch Human & Environm Studies, Kyoto, Japan	Yamashita, S (reprint author), Univ Tokushima, Fac Biosci & Bioind, Minami Josanjima 2-1, Tokushima 7708506, Japan.	symsht@tokushima-u.ac.jp			Japanese Ministry of Education, Science and Culture; Environment Research and Technology Development Fund (S9) of the Ministry of the Environment, Japan	This study was conducted in accordance with the Memorandum of Understanding signed between the Sarawak Forestry Corporation and the Japan Research Consortium for Tropical Forests in Sarawak in November 2005. We are grateful to Joseph Jawa Kendawang (Sarawak Forest Department) and Lucy Chong (Sarawak Forestry Corporation) for permission to conduct this study. We thank Tsutomu Hattori for teaching S.Y. bracket fungus identification. This study was funded in part by a Grant-in-Aid for JSPS Fellows (to S.Y.) from the Japanese Ministry of Education, Science and Culture and the Environment Research and Technology Development Fund (S9) of the Ministry of the Environment, Japan.	Novotny V, 2005, P ROY SOC B-BIOL SCI, V272, P1083, DOI 10.1098/rspb.2004.3023; Berglund H, 2005, ECOL APPL, V15, P970, DOI 10.1890/04-0628; Kadowaki K, 2011, FUNGAL BIOL-UK, V115, P768, DOI 10.1016/j.funbio.2011.06.001; COLWELL RK, 1994, PHILOS T ROY SOC B, V345, P101, DOI 10.1098/rstb.1994.0091; Norros V, 2012, OIKOS, V121, P961, DOI 10.1111/j.1600-0706.2012.20052.x; Jonsell M, 2004, ECOL ENTOMOL, V29, P697, DOI 10.1111/j.0307-6946.2004.00654.x; Bluthgen N, 2007, CURR BIOL, V17, P341, DOI 10.1016/j.cub.2006.12.039; Nikitsky NB, 2004, ENTOMOL FENNICA, V15, P6; Dyer LA, 2007, NATURE, V448, P696, DOI 10.1038/nature05884; Sotome K, 2008, MYCOLOGIA, V100, P603, DOI 10.3852/07-191R; Halme P, 2012, BIODIVERS CONSERV, V21, P205, DOI 10.1007/s10531-011-0176-z; Bersier LF, 2002, ECOLOGY, V83, P2394, DOI 10.2307/3071801; LACY RC, 1984, ECOL ENTOMOL, V9, P43, DOI 10.1111/j.1365-2311.1984.tb00697.x; Basset Y, 2003, ARTHROPODS TROPICAL; Bluethgen Nico, 2006, BMC Ecology, V6, P9, DOI 10.1186/1472-6785-6-9; Bruns T.D., 1984, P91; CHAO A, 1984, SCAND J STAT, V11, P265; Colwell R K, 2006, ESTIMATES STAT ESTIM; DORMANN C. F., 2008, R NEWS, V8, P8; ERWIN T L, 1982, Coleopterists Bulletin, V36, P74; GRAVES ROBERT C., 1960, ANN ENT SOC AMER, V53, P61; Hagvar Sigmund, 1999, Norwegian Journal of Entomology, V46, P25; Hammond P.M., 1989, P275; Hanski I., 1989, Insect-fungus interactions. 14th Symposium of the Royal Entomological Society of London in collaboration with the British Mycological Society., P25; Hattori T, 2012, BIODIVERS CONSERV, V21, P2375, DOI 10.1007/s10531-012-0238-x; JAENIKE J, 1978, EVOLUTION, V32, P676, DOI 10.2307/2407734; Johansen I, 1980, PRELIMINARY POLYPORE; KLOPFENSTEIN PC, 1989, ENTOMOL NEWS, V100, P157; Krasutskii B.V., 2007, ENTOMOLOGICAL REV, V87, P512, DOI 10.1134/S0013873807050028; Kula E., 1999, Miscellania Zoologica (Barcelona), V22, P75; Lawrence J.F., 1989, P1; LAWRENCE J F, 1977, Coleopterists Bulletin, V31, P25; LESCHEN R A B, 1990, University of Kansas Science Bulletin, V54, P165; Leschen RAB, 2005, COLEOPTS BULL, V59, P3; Leschen RAB, 2001, J ZOOL SYST EVOL RES, V39, P25; MATTHEWM.WG, 1971, CAN ENTOMOL, V103, P775; Newton A. F., 1984, FUNGUS INSECT RELATI, P1; Novotny V, 2006, SCIENCE, V313, P1115, DOI 10.1126/science.1129237; Nunez M, 2001, E ASIAN POLYPORES, V2; Nunez M, 2000, SYNOPSIS FUNGORUM, V13, P1; Orledge GM, 2005, ECOL ENTOMOL, V30, P620, DOI 10.1111/j.0307-6946.2005.00727.x; PAVIOUR-SMITH KITTY, 1960, OIKOS, V11, P43, DOI 10.2307/3564883; PIELOU DP, 1968, CAN ENTOMOL, V100, P1179; Pimm S. L., 1982, FOOD WEBS; R Core Team, 2013, R LANG ENV STAT COMP; Reagan DP, 1996, FOOD WEB TROPICAL RA; Schigel D. S., 2012, Mycology - An International Journal on Fungal Biology, V3, P258; Schigel Dmitry S., 2011, Russian Entomological Journal, V20, P141; Setsuda K, 1993, AKITSU S1, P1; Stenlid J., 2001, ECOLOGICAL B, V49, P85; STORK NE, 1988, BIOL J LINN SOC, V35, P321, DOI 10.1111/j.1095-8312.1988.tb00474.x; Thunes KH, 2000, BIODIVERS CONSERV, V9, P833, DOI 10.1023/A:1008927410513; Toda MJ, 1997, J ANIM ECOL, V66, P154, DOI 10.2307/6018; Wright David H., 1993, P66; Yamashita S, 2010, MYCOLOGIA, V102, P11, DOI 10.3852/09-008; Yamashita S, 2009, MYCOL RES, V113, P1200, DOI 10.1016/j.mycres.2009.08.004; Yamashita S, 2007, EUR J ENTOMOL, V104, P225; Yamashita Satoshi, 2009, Contributions from the Biological Laboratory Kyoto University, V30, P1; Yamashita S, 2008, BIOTROPICA, V40, P354, DOI 10.1111/j.1744-7429.2007.00366.x; Yamashita S, 2003, ECOL RES, V18, P131, DOI 10.1046/j.1440-1703.2003.00541.x; Yamashita S, 2015, BIODIVERS CONSERV, V24, P393, DOI 10.1007/s10531-014-0815-2; Yumoto T, 2005, ECOL STU AN, V174, P13	62	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0307-6946	1365-2311		ECOL ENTOMOL	Ecol. Entomol.	AUG	2015	40	4					390	400		10.1111/een.12200		11	Entomology	Entomology	CM1ZR	WOS:000357479700008		
J	Kojima, W				Kojima, Wataru			Variation in body size in the giant rhinoceros beetle Trypoxylus dichotomus is mediated by maternal effects on egg size	ECOLOGICAL ENTOMOLOGY			English	Article						Dynastinae; growth rate; horn beetle; maternal effect; scarab beetle; sexual size dimorphism	CALLOSOBRUCHUS-MACULATUS COLEOPTERA; JAPANESE HORNED BEETLE; ALLOMYRINA-DICHOTOMA; SEED BEETLE; OFFSPRING PERFORMANCE; LARVAL PERFORMANCE; L. COLEOPTERA; COWPEA WEEVIL; CLUTCH SIZE; SCARABAEIDAE	1. The egg size of insects can vary depending on maternal body size or resource status, and it may influence offspring body size by determining initial resource level. 2. The giant rhinoceros beetle Trypoxylus dichotomus exhibits considerable variation in body size, some of which is attributed to the variation in larval food (humus) quality, although a substantial amount of variation in body size remains unexplained. In the present study, changes in the egg size and offspring body size in response to several maternal variables were examined (i.e. body size, age, and, nutritional status). 3. Nutritional intake of the females during the adult stage did not affect the egg size. Larvae hatched from small eggs partially recovered from the initial disadvantage during their ontogenetic processes by increasing growth rate (i.e. compensatory growth); however, there was still a positive relationship between egg size and pupal body size. 4. Older females produced small eggs, but because of compensatory growth, the pupae were no longer small. By contrast, due to a lack of compensatory growth, small females produced small eggs as well as small pupae. 5. These results suggest that maternal body size affects offspring body size through effects on egg size. This transgenerational effect may account for some of the variation in adult body size of T. dichotomus.	Univ Tokyo, Grad Sch Arts & Sci, Dept Gen Syst Studies, Meguro Ku, Tokyo 1538902, Japan	Kojima, W (reprint author), Univ Tokyo, Grad Sch Arts & Sci, Dept Gen Syst Studies, Meguro Ku, 3-8-1 Komaba, Tokyo 1538902, Japan.	koj.wataru@gmail.com			Japan Society for the Promotion of Science [13J08975]	I thank S. Hoshizaki and M. Shimada for discussion and feedback on this study, and am grateful to the two anonymous reviewers and the associate editor for their helpful comments on the manuscript. The Research Fellowship for Young Scientists (13J08975) provided by the Japan Society for the Promotion of Science is greatly appreciated.	Emlen DJ, 1997, BEHAV ECOL SOCIOBIOL, V41, P335, DOI 10.1007/s002650050393; FOX CW, 1994, FUNCT ECOL, V8, P600, DOI 10.2307/2389921; Karino K, 2005, J INSECT BEHAV, V18, P805, DOI 10.1007/s10905-005-8741-5; BERRIGAN D, 1991, OIKOS, V60, P313, DOI 10.2307/3545073; Torres-Vila LM, 2002, OIKOS, V99, P272, DOI 10.1034/j.1600-0706.2002.990207.x; Kyneb A, 2006, ECOL ENTOMOL, V31, P322, DOI 10.1111/j.1365-2311.2006.00775.x; Marshall DJ, 2007, OIKOS, V116, P1957, DOI 10.1111/j.2007.0030-1299.16203.x; McCullough EL, 2012, BEHAV ECOL, V23, P1042, DOI 10.1093/beheco/ars069; FOX CW, 1993, FUNCT ECOL, V7, P203, DOI 10.2307/2389888; Hongo Y, 2007, BEHAV ECOL SOCIOBIOL, V62, P245, DOI 10.1007/s00265-007-0459-2; Fox CW, 2000, ANNU REV ENTOMOL, V45, P341, DOI 10.1146/annurev.ento.45.1.341; Johns A, 2014, INTEGR COMP BIOL, V54, P614, DOI 10.1093/icb/icu041; Emlen DJ, 2012, SCIENCE, V337, P860, DOI 10.1126/science.1224286; Bernardo J, 1996, AM ZOOL, V36, P216; FOX CW, 1994, OIKOS, V71, P321, DOI 10.2307/3546280; WIKLUND C, 1983, OIKOS, V40, P53, DOI 10.2307/3544198; Kudo S, 2001, OIKOS, V92, P208, DOI 10.1034/j.1600-0706.2001.920202.x; FOX CW, 1993, OECOLOGIA, V96, P139, DOI 10.1007/BF00318042; SMITH CC, 1974, AM NAT, V108, P499, DOI 10.1086/282929; Rollinson N, 2013, ECOLOGY, V94, P315; BEGON M, 1986, OIKOS, V47, P293, DOI 10.2307/3565440; SIVAJOTHY MT, 1987, J ETHOL, V5, P165, DOI 10.1007/BF02349949; Azevedo RBR, 1997, AM NAT, V150, P250, DOI 10.1086/286065; Bauerfeind SS, 2007, J INSECT PHYSIOL, V53, P964, DOI 10.1016/j.jinsphys.2007.01.013; BRABY MF, 1994, OIKOS, V71, P119, DOI 10.2307/3546179; Esperk T, 2010, PHYSIOL ENTOMOL, V35, P222, DOI 10.1111/j.1365-3032.2010.00739.x; Fischer K, 2002, OECOLOGIA, V131, P375, DOI 10.1007/s00442-002-0913-9; Fox CW, 1996, OECOLOGIA, V107, P541, DOI 10.1007/BF00333946; Fox CW, 1998, EVOLUTION, V52, P172, DOI 10.2307/2410932; FOX CW, 1994, HEREDITY, V73, P509, DOI 10.1038/hdy.1994.149; Fujiyama S., 1999, INSECTS NATURE, V34, P30; Guntrip J, 1997, ECOL ENTOMOL, V22, P264, DOI 10.1046/j.1365-2311.1997.00076.x; Hinton H. E., 1981, BIOL INSECT EGGS, VI-III; Iguchi Y, 1998, ANN ENTOMOL SOC AM, V91, P845; Karino K, 2004, ECOL RES, V19, P663, DOI 10.1111/j.1440-1703.2004.00681.x; KAWECKI TJ, 1995, OECOLOGIA, V102, P81; Kishi S, 2014, ECOL ENTOMOL, V39, P355, DOI 10.1111/een.12102; Kojima W, 2014, ZOOL SCI, V31, P109, DOI 10.2108/zsj.31.109; Plaistow SJ, 2005, ECOL ENTOMOL, V30, P692, DOI 10.1111/j.0307-6946.2005.00740.x; R Development Core Team, 2014, R LANG ENV STAT COMP; REAVEY D, 1992, J ZOOL, V227, P277; Setsuda K, 1999, J ETHOL, V17, P73, DOI 10.1007/BF02769300; Stearns S. C., 1992, EVOLUTION LIFE HIST; WASSERMAN SS, 1985, OIKOS, V45, P191, DOI 10.2307/3565705; WIKLUND C, 1987, AM NAT, V130, P828, DOI 10.1086/284750; Yanagi S, 2012, J INSECT PHYSIOL, V58, P1432, DOI 10.1016/j.jinsphys.2012.08.007	46	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0307-6946	1365-2311		ECOL ENTOMOL	Ecol. Entomol.	AUG	2015	40	4					420	427		10.1111/een.12205		8	Entomology	Entomology	CM1ZR	WOS:000357479700011		
J	Cisse, S; Ghaout, S; Mazih, A; Jourdan-Pineau, H; Maeno, KO; Piou, C				Cisse, Sory; Ghaout, Said; Mazih, Ahmed; Jourdan-Pineau, Helene; Maeno, Koutaro Ould; Piou, Cyril			Characterizing phase-related differences in behaviour of Schistocerca gregaria with spatial distribution analysis	ENTOMOLOGIA EXPERIMENTALIS ET APPLICATA			English	Article						desert locust; phase polyphenism; attraction; repulsion; activity; point pattern analysis; Orthoptera; Acrididae	DESERT LOCUST GREGARIZATION; VEGETATION PATTERNS; POINT PATTERNS; NYMPHS; POLYPHENISM; CONSPECIFICS; HATCHLINGS; STIMULI; STATE	The behaviour of locusts has been studied extensively using two approaches: (1) analysing a single individual's response to a group stimulus or (2) using group conditions to look at aggregation patterns. The second approach has, in contrast with the first one, not been improved in terms of statistical analyses since the 1960s. In the present study, we propose a spatial statistics approach of point-pattern analysis to improve the group-based assessment of behavioural phase characterization. This diagnostic tool was developed and tested in the laboratory with comparative analysis of solitarious (isolation-reared) and gregarious (crowd-reared) desert locusts, Schistocerca gregaria (Forskal) (Orthoptera: Acrididae). The spatial distribution patterns of 10 either solitarious or gregarious third-instar hoppers were characterized with nearest neighbour distance measurements in a circular arena. The temporal sequence of spatial disposition of locusts was recorded with a digital camera taking photographs at regular intervals. The approach of point-pattern analysis focused on the spatial distribution of observed events and allowed us to make inferences about the underlying process that generated them. The results confirmed that our diagnostic tool could identify that crowd-reared hoppers tended to aggregate more to conspecifics than isolation-reared ones. We could also verify that isolation-reared hoppers were less active than crowd-reared ones, but this was only true at the beginning of the experiments. The spatial statistics approach proposed in the present study could help with observations of phase-related differences in the behaviour of locusts.	[Cisse, Sory; Jourdan-Pineau, Helene; Piou, Cyril] CIRAD, UMR CBGP, F-34398 Montpellier, France; [Cisse, Sory] Ctr Natl Lutte Criquet Pelerin, Bamako, Mali; [Cisse, Sory; Ghaout, Said; Piou, Cyril] Ctr Natl Lutte Antiacridienne, Inezgane, Agadir, Morocco; [Cisse, Sory; Mazih, Ahmed; Piou, Cyril] Inst Agron & Vet Hassan II, Dept Phytiatrie, Agadir 80000, Morocco; [Cisse, Sory; Maeno, Koutaro Ould] CNLA, Nouakchott, Mauritania; [Maeno, Koutaro Ould] Kyoto Univ, Grad Sch Agr, Hakubi Ctr Adv Res, Kyoto 6068502, Japan; [Maeno, Koutaro Ould] Kyoto Univ, Grad Sch Agr, Lab Insect Ecol, Kyoto 6068502, Japan	Piou, C (reprint author), CIRAD, UMR CBGP, F-34398 Montpellier, France.	cyril.piou@cirad.fr			FAO Commission for Controlling the Desert Locust in the Western Region (CLCPRO)	We thank the staff members of CIRAD laboratory research in Montpellier for their kind help in different ways. We are very grateful to Gregory Sword and an anonymous reviewer for their constructive comments on a previous version of this manuscript. This work was supported by funds from the FAO Commission for Controlling the Desert Locust in the Western Region (CLCPRO).	Baddeley A, 2005, J STAT SOFTW, V12, P1; Sword GA, 2000, P ROY SOC B-BIOL SCI, V267, P63, DOI 10.1098/rspb.2000.0967; CLARK PJ, 1954, ECOLOGY, V35, P445, DOI 10.2307/1931034; Simpson SJ, 1999, BIOL REV, V74, P461, DOI 10.1017/S000632319900540X; Shaddick G, 2002, J ROY STAT SOC C-APP, V51, P351, DOI 10.1111/1467-9876.00273; Buhl J, 2006, SCIENCE, V312, P1402, DOI 10.1126/science.1125142; ROFFEY J, 1968, NATURE, V219, P446, DOI 10.1038/219446a0; Maeno K, 2011, J INSECT PHYSIOL, V57, P74, DOI 10.1016/j.jinsphys.2010.09.009; Pener MP, 2009, ADV INSECT PHYSIOL, V36, P1, DOI 10.1016/S0065-2806(08)36001-9; Sword GA, 2010, J INSECT PHYSIOL, V56, P949, DOI 10.1016/j.jinsphys.2010.05.005; Bivand RS, 2008, USE R, P1; BOUAICHI A, 1995, PHYSIOL ENTOMOL, V20, P199, DOI 10.1111/j.1365-3032.1995.tb00002.x; Cisse S, 2013, ENTOMOL EXP APPL, V149, P159, DOI 10.1111/eea.12121; Cisse S, 2015, ENTOMOLOGIA IN PRESS; Collett M, 1998, P NATL ACAD SCI USA, V95, P13052, DOI 10.1073/pnas.95.22.13052; Cressman K, 2013, J APPL REMOTE SENS, V7, DOI 10.1117/1.JRS.7.075098; Cullen DA, 2012, ANIM BEHAV, V84, P771, DOI 10.1016/j.anbehav.2012.06.031; Despland E, 2001, J INSECT BEHAV, V14, P35, DOI 10.1023/A:1007845528500; Despland E, 2000, OIKOS, V88, P652, DOI 10.1034/j.1600-0706.2000.880322.x; Despland E, 2000, ANIM BEHAV, V59, P643, DOI 10.1006/anbe.1999.1335; Despland E, 2004, ECOGRAPHY, V27, P381, DOI 10.1111/j.0906-7590.2004.03779.x; Despland E, 2000, PHYSIOL ENTOMOL, V25, P74, DOI 10.1046/j.1365-3032.2000.00166.x; DIGGLE PJ, 1976, BIOMETRICS, V32, P659, DOI 10.2307/2529754; Edney E. B., 1937, Bulletin of Entomological Research London, V28, P243; Ellis P. E., 1957, ANTILOCUST B, V25, P1; Ellis P. E., 1959, Animal Behaviour London, V7, P91, DOI 10.1016/0003-3472(59)90037-5; ELLIS P. E., 1953, BEHAVIOUR, V5, P225, DOI 10.1163/156853953X00122; ELLIS PEGGY E., 1962, ANIMAL BEHAVIOUR, V10, P305, DOI 10.1016/0003-3472(62)90054-4; Gray LJ, 2009, BIOL LETTERS, V5, P306, DOI 10.1098/rsbl.2008.0764; Harano K, 2011, J INSECT PHYSIOL, V57, P27, DOI 10.1016/j.jinsphys.2010.09.001; Hunter-Jones P., 1958, Anti-Locust Bulletin, Vno. 29, P1; LECOQ M, 1991, UNIV FRA S, P71; Lester BL, 2005, J INSECT PHYSL, V51, P737; Loecher M, 2012, READIMAGES IMAGE REA; Louveaux A, 1994, ELEVAGE ACRIDIENS; Maeno KO, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00345; PENER MP, 1991, ADV INSECT PHYSIOL, V23, P1, DOI 10.1016/S0065-2806(08)60091-0; Piou C, 2013, BASIC APPL ECOL, V14, P593, DOI 10.1016/j.baae.2013.08.007; R Development Core Team, 2012, R LANG ENV STAT COMP; ROESSINGH P, 1993, P ROY SOC B-BIOL SCI, V252, P43, DOI 10.1098/rspb.1993.0044; ROESSINGH P, 1994, PHYSIOL ENTOMOL, V19, P191, DOI 10.1111/j.1365-3032.1994.tb01042.x; Roessingh P, 1998, J INSECT PHYSIOL, V44, P883, DOI 10.1016/S0022-1910(98)00070-5; Rogers SM, 2003, J EXP BIOL, V206, P3991, DOI 10.1242/jeb.00648; Rogers SM, 2014, J INSECT PHYSIOL, V65, P9, DOI 10.1016/j.jinsphys.2014.04.004; Simpson Stephen J., 2005, Journal of Orthoptera Research, V14, P213, DOI 10.1665/1082-6467(2005)14[213:ACACIL]2.0.CO;2; Simpson SJ, 2001, P NATL ACAD SCI USA, V98, P3895, DOI 10.1073/pnas.071527998; Sword GA, 1999, NATURE, V397, P217, DOI 10.1038/16609; Sword GA, 2003, J INSECT PHYSIOL, V49, P709, DOI 10.1016/S0022-1910(03)00092-1; Tanaka S, 2013, J INSECT PHYSIOL, V59, P101, DOI 10.1016/j.jinsphys.2012.10.018; Thomas A., 2006, R NEWS, V6, P12; Uvarov B, 1966, GRASSHOPPERS LOCUSTS; Uvarov B, 1977, GRASSHOPPERS LOCUSTS, V2	52	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0013-8703	1570-7458		ENTOMOL EXP APPL	Entomol. Exp. Appl.	AUG	2015	156	2					128	135		10.1111/eea.12318		8	Entomology	Entomology	CM5MQ	WOS:000357732600003		
J	Ueda, Y; Egawa, K; Ito, T; Takeuchi, F; Nakajima, M; Otsuka, K; Asahina, N; Takahashi, K; Nakane, S; Kohsaka, S; Shiraishi, H				Ueda, Yuki; Egawa, Kiyoshi; Ito, Tomoshiro; Takeuchi, Fumiya; Nakajima, Midori; Otsuka, Kosuke; Asahina, Naoko; Takahashi, Kayoko; Nakane, Shingo; Kohsaka, Shinobu; Shiraishi, Hideaki			The presence of short and sharp MEG spikes implies focal cortical dysplasia	EPILEPSY RESEARCH			English	Article						Focal cortical dysplasia; Epilepsy; Magnetoencephalography; Spike morphology; Waveform analysis	TEMPORAL-LOBE EPILEPSY; INTRINSIC EPILEPTOGENICITY; EXTRATEMPORAL EPILEPSY; INTERICTAL SPIKES; ROLANDIC SPIKES; SURGERY; MAGNETOENCEPHALOGRAPHY; ELECTROCORTICOGRAPHY; EEG; LOCALIZATION	Purpose: This study focused on the characteristic needle-like epileptic spikes of short duration and steep shape seen on magnetoencephalography (MEG) in patients diagnosed with focal cortical dysplasia (FCD) morphologically. We aimed to validate the analysis of MEG spike morphology as a noninvasive method of identifying the presence and location of FCD. Methods: MEG was collected by 204-channel helmet-shaped gradiometers. We analyzed MEG spike sources for 282 patients with symptomatic localization-related epilepsy. MEG showed clustered equivalent current dipoles when superimposed on their three-dimensional-magnetic resonance images (MRI) in 85 patients. Fifty-seven patients were excluded from our study, because they had destructive brain lesions or an insufficient number of spikes for statistical analysis. Twenty-eight patients (18 males, 10 females; aged 1-34 years) were finally matched to our inclusion criteria, and were categorized into three groups: FCD (7 patients), non-FCD (10 patients), and non-lesion (11 patients), based on the MRI findings. We measured the duration, amplitude, and tilt manually for at least 15 spikes per patient, and compared the three groups using a one-way analysis of variance, followed by the Tukey test when statistically significant (p <0.05). In 17 patients with visible MRI lesions, we investigated the correlation between the depth of the lesion and the tilt using the Pearson product moment correlation. Results: The average spike duration was significantly shorter in the FCD and non-lesion groups than in the non-FCD group (p <0.05). The average amplitude was not significantly different between the three groups. The average spike tilt was significantly steeper in the FCD group than in the non-FCD group (p = 0.0058). There was no significant difference between FCD and non-lesion patients in both duration and tilt. Our additional study revealed a significant negative correlation between the depth of the lesion and the average tilt (p = 0.0009). Significance: MEG epileptiform discharges of short duration and steep tilt characterize FCD, especially when located at the superficial neocortical gyrus. We speculate that this particular spike morphology results from the intrinsic epileptogenicity of FCD. Morphological analysis of MEG spikes can evaluate the etiology of epileptogenic lesions and detect a strong, localized epileptogenic focus such as that typically observed in FCD. (C) 2015 Elsevier B.V. All rights reserved.	[Ueda, Yuki; Egawa, Kiyoshi; Ito, Tomoshiro; Nakajima, Midori; Otsuka, Kosuke; Asahina, Naoko; Kohsaka, Shinobu; Shiraishi, Hideaki] Hokkaido Univ, Grad Sch Med, Dept Pediat, Kita Ku, Sapporo, Hokkaido, Japan; [Takeuchi, Fumiya] Hokkaido Univ, Grad Sch Med, Dept Hlth Sci, Kita Ku, Sapporo, Hokkaido, Japan; [Takahashi, Kayoko; Nakane, Shingo] Hokkaido Univ Hosp, Div Magnetoencephalog, Kita Ku, Sapporo, Hokkaido 060, Japan	Ueda, Y (reprint author), Hokkaido Univ, Grad Sch Med, Dept Pediat, Kita Ku, North 15 West 7, Sapporo, Hokkaido, Japan.	yuki_ueda@med.hokudai.ac.jp; egakiyo@huhp.hokudai.ac.jp; itou_tomoshiro@kitami.jrc.or.jp; take@hs.hokudai.ac.jp; midori.nakajima@yahoo.com; kounet@med.hokudai.ac.jp; asahi-na@med.hokudai.ac.jp; tk5623@med.hokudai.ac.jp; sinakane@med.hokudai.ac.jp; shinobu-masako@ac.auone-net.jp; siraisi@med.hokudai.ac.jp					Alexandre V, 2006, SEIZURE-EUR J EPILEP, V15, P420, DOI 10.1016/j.seizure.2006.05.005; Ishibashi H, 2002, NEUROL RES, V24, P525, DOI 10.1179/016164102101200483; Ebersole JS, 1996, EPILEPSIA, V37, P386, DOI 10.1111/j.1528-1157.1996.tb00577.x; Palmini A, 2004, NEUROLOGY, V62, pS2; TAYLOR DC, 1971, J NEUROL NEUROSUR PS, V34, P369, DOI 10.1136/jnnp.34.4.369; Cukiert A, 2001, EPILEPSIA, V42, P889, DOI 10.1046/j.1528-1157.2001.00201.x; Fauser S, 2004, BRAIN, V127, P2406, DOI 10.1093/brain/awh277; Mikuni N, 1997, NEUROIMAGE, V5, P298, DOI 10.1006/nimg.1997.0272; Krsek P, 2009, EPILEPSIA, V50, P125, DOI 10.1111/j.1528-1167.2008.01682.x; Chapman K, 2005, J NEUROL NEUROSUR PS, V76, P710, DOI 10.1136/jnnp.2003.026757; de Jongh A, 2005, J CLIN NEUROPHYSIOL, V22, P153, DOI 10.1097/01.WNP.0000158947.68733.51; PALMINI A, 1995, ANN NEUROL, V37, P476, DOI 10.1002/ana.410370410; Bast T, 2004, EPILEPSIA, V45, P621, DOI 10.1111/j.0013-9580.2004.56503.x; Alarcon G, 2006, J NEUROL NEUROSUR PS, V77, P474, DOI 10.1136/jnnp.2005.077289; Barkley GL, 2003, J CLIN NEUROPHYSIOL, V20, P163, DOI 10.1097/00004691-200305000-00002; Cohen-Gadol AA, 2004, J NEUROSURG, V101, P55, DOI 10.3171/jns.2004.101.1.0055; Stefan H, 2003, BRAIN, V126, P2396, DOI 10.1093/brain/awg239; Fukao K, 2010, EPILEPSIA, V51, P1846, DOI 10.1111/j.1528-1167.2010.02655.x; Hong SC, 2000, J NEUROSURG, V93, P766, DOI 10.3171/jns.2000.93.5.0766; Ishii R, 2008, EPILEPSY RES, V81, P228, DOI 10.1016/j.eplepsyres.2008.06.006; Ishitobi M, 2005, NEUROIMAGE, V25, P417, DOI 10.1016/j.neuroimage.2004.11.040; Ito T., 2014, BRAIN DEV; Kakisaka Y, 2009, EPILEPSY RES, V84, P153, DOI 10.1016/j.eplepsyres.2009.01.012; Kirsch HE, 2006, CLIN NEUROPHYSIOL, V117, P2264, DOI 10.1016/j.clinph.2006.06.708; Kloss S, 2002, NEUROPEDIATRICS, V33, P21, DOI 10.1055/s-2002-23595; Kral T, 2003, J NEUROL NEUROSUR PS, V74, P183, DOI 10.1136/jnnp.74.2.183; Iida K, 2005, J NEUROSURG, V102, P187, DOI 10.3171/jns.2005.102.2.0187; Morioka T, 1999, EPILEPSY RES, V33, P177, DOI 10.1016/S0920-1211(98)00096-5; Oishi M, 2002, EPILEPSIA, V43, P1390, DOI 10.1046/j.1528-1157.2002.10702.x; Oishi M, 2006, EPILEPSIA, V47, P355, DOI 10.1111/j.1528-1167.2006.00428.x; Otsubo H, 2001, EPILEPSIA, V42, P1523, DOI 10.1046/j.1528-1157.2001.16701.x; Park HM, 2004, TOHOKU J EXP MED, V203, P165, DOI 10.1620/tjem.203.165; Santiuste M, 2008, J CLIN NEUROPHYSIOL, V25, P331, DOI 10.1097/WNP.0b013e31818e7913; Stefan H, 2000, J CLIN NEUROPHYSIOL, V17, P190, DOI 10.1097/00004691-200003000-00008; Widjajaa E, 2008, EPILEPSY RES, V82, P147, DOI 10.1016/j.eplepsyres.2008.07.013	35	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0920-1211	1872-6844		EPILEPSY RES	Epilepsy Res.	AUG	2015	114						141	146		10.1016/j.eplepsyres.2015.04.020		6	Clinical Neurology	Neurosciences & Neurology	CM1JY	WOS:000357438400019		
J	Joensuu, H; Martin-Broto, J; Nishida, T; Reichardt, P; Schoffski, P; Maki, RG				Joensuu, H.; Martin-Broto, J.; Nishida, T.; Reichardt, P.; Schoffski, P.; Maki, R. G.			Follow-up strategies for patients with gastrointestinal stromal tumour treated with or without adjuvant imatinib after surgery	EUROPEAN JOURNAL OF CANCER			English	Review						Gastrointestinal stromal tumour; GIST; Risk stratification; Computerised tomography; Magnetic resonance imaging; Positron emission tomography; Imatinib; Adjuvant treatment; Treatment guidelines	RECURRENCE; KIT; MUTATIONS; TRIAL; RISK; GIST; RESECTION; MESYLATE; SURVIVAL; KINASE	Background: Patients with gastrointestinal stromal tumour (GIST) are often followed up after surgery with longitudinally repeated imaging examinations to detect recurrence early. Studies on follow-up of GIST patients are few, the optimal follow-up methods are unknown and the recommendations for follow-up vary in guidelines. Methods: We reviewed the current evidence for follow-up of patients treated with surgery alone and of patients who were treated with adjuvant or neoadjuvant imatinib. Results: Imaging of the abdomen and the pelvis with computerised tomography (CT) or magnetic resonance imaging (MRI) usually suffices, since metastases are uncommon at other sites. The frequency of imaging may be adjusted with the risk of recurrence with time. Very low risk GISTs are very frequently cured with surgery and usually require no regular follow-up after complete surgery, and annual CT of the abdomen and the pelvis for 5 years suffices for most patients with a low to intermediate risk for recurrence. Most high-risk patients are treated with imatinib for at least 3 years after surgery. CT or MRI may be carried out 6-monthly during adjuvant imatinib, 3 to 4-monthly during the 2 years that follow discontinuation of imatinib when the risk of recurrence is high, and then at 6-12 month intervals to complete 10 years of follow-up. Recurrence after the first 10 years of follow-up is infrequent. Conclusions: The follow-up schedules are best tailored with the risk of recurrence. The risk of recurrence should be estimated with the prognostic tools that consider the most relevant prognostic factors. (C) 2015 The Authors. Published by Elsevier Ltd.	[Joensuu, H.] Comprehens Canc Ctr Helsinki, Helsinki 00029, Finland; [Joensuu, H.] Univ Helsinki, Helsinki, Finland; [Martin-Broto, J.] Virgen del Roci Univ Hosp, Inst Biomed Sevilla IBIS, Seville, Spain; [Nishida, T.] Hosp East, Natl Canc Ctr, Chiba, Japan; [Reichardt, P.] HELIOS Klin, Canc Ctr Berlin Buch, Berlin, Germany; [Schoffski, P.] Univ Hosp Leuven, Leuven Canc Inst, Leuven, Belgium; [Maki, R. G.] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA	Joensuu, H (reprint author), Comprehens Canc Ctr Helsinki, Dept Oncol, Haartmaninkatu 4, Helsinki 00029, Finland.	heikki.joensuu@hus.fi; jmartin@mustbesevilla.org; tnishida@east.ncc.go.jp; peter.reichardt@helios-kliniken.de; patrick.schoffski@uzleuven.be; robert.maki@mssm.edu			Academy of Finland; Cancer Society of Finland; Sigrid Juselius Foundation; Jane and Aatos Erkko Foundation	Academy of Finland, Cancer Society of Finland, Sigrid Juselius Foundation, Jane and Aatos Erkko Foundation. No writing assistance was involved.	Agaimy A, 2009, LANGENBECK ARCH SURG, V394, P375, DOI 10.1007/s00423-008-0449-5; Miettinen M, 2005, AM J SURG PATHOL, V29, P52, DOI 10.1097/01.pas.0000146010.92933.de; Woodall CE, 2009, ARCH SURG-CHICAGO, V144, P670, DOI 10.1001/archsurg.2009.108; DeMatteo RP, 2009, LANCET, V373, P1097, DOI 10.1016/S0140-6736(09)60500-6; Joensuu H, 2008, HUM PATHOL, V39, P1411, DOI 10.1016/j.humpath.2008.06.025; DeMatteo RP, 2000, ANN SURG, V231, P51, DOI 10.1097/00000658-200001000-00008; Joensuu H, 2014, CANCER-AM CANCER SOC, V120, P2325, DOI 10.1002/cncr.28669; Wardelmann E, 2003, INT J CANCER, V106, P887, DOI 10.1002/ijc.11323; Joensuu H, 2012, LANCET ONCOL, V13, P265, DOI 10.1016/S1470-2045(11)70299-6; Rege TA, 2011, AM J SURG PATHOL, V35, P495, DOI 10.1097/PAS.0b013e31820e5f7d; Blanke CD, 2008, J CLIN ONCOL, V26, P626, DOI 10.1200/JCO.2007.13.4452; Miettinen M, 2006, AM J SURG PATHOL, V30, P477, DOI 10.1097/00000478-200604000-00008; Corless CL, 2014, J CLIN ONCOL, V32, P1563, DOI 10.1200/JCO.2013.51.2046; Choi H, 2008, ONCOLOGIST, V13, P4, DOI 10.1634/theoncologist.13-S2-4; Heinrich MC, 2003, J CLIN ONCOL, V21, P4342, DOI 10.1200/JCO.2003.04.190; Wozniak A, 2012, ANN ONCOL, V23, P353, DOI 10.1093/annonc/mdr127; Lagarde P, 2012, CLIN CANCER RES, V18, P826, DOI 10.1158/1078-0432.CCR-11-1610; Joensuu H, 2012, JAMA-J AM MED ASSOC, V307, P1265, DOI 10.1001/jama.2012.347; DeMatteo RP, 2008, CANCER, V112, P608, DOI 10.1002/cncr23199; Martin-Broto J, 2010, ANN ONCOL, V21, P1552, DOI 10.1093/annonc/mdq047; Joensuu H, 2013, LANCET, V382, P973, DOI 10.1016/S0140-6736(13)60106-3; Miettinen M, 2006, SEMIN DIAGN PATHOL, V23, P70, DOI 10.1053/j.semdp.2006.09.001; Corless CL, 2011, NAT REV CANCER, V11, P865, DOI 10.1038/nrc3143; Casali PG, 2013, J CLIN ONCOL S, V31, p632s; Davies HE, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d947; Ducimetiere F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020294; ESMO/European Sarcoma Network Working Group, 2014, ANN ONCOL, V25, piii21, DOI 10.1093/annonc/mdu255; Hohenberger P, 2009, J CLIN ONCOL S, V27, P548; Joensuu H, 2014, RADIOLOGY, V271, P96, DOI 10.1148/radiol.13131040; Joensuu H, 2015, J CLIN ONCOL, V33, P634, DOI 10.1200/JCO.2014.57.4970; Kunstlinger H, 2013, AM J SURG PATHOL, V37, P1648, DOI 10.1097/PAS.0b013e3182986b88; Rutkowski P, 2014, MEMO, V7, P92	32	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0959-8049	1879-0852		EUR J CANCER	Eur. J. Cancer	AUG	2015	51	12					1611	1617		10.1016/j.ejca.2015.05.009		7	Oncology	Oncology	CM4MN	WOS:000357658900014		
J	Baba, M; Maeda, I; Morita, T; Inoue, S; Ikenaga, M; Matsumoto, Y; Sekine, R; Yamaguchi, T; Hirohashi, T; Tajima, T; Tatara, R; Watanabe, H; Otani, H; Takigawa, C; Matsuda, Y; Nagaoka, H; Mori, M; Tei, Y; Hiramoto, S; Suga, A; Kinoshita, H				Baba, Mika; Maeda, Isseki; Morita, Tatsuya; Inoue, Satoshi; Ikenaga, Masayuki; Matsumoto, Yoshihisa; Sekine, Ryuichi; Yamaguchi, Takashi; Hirohashi, Takeshi; Tajima, Tsukasa; Tatara, Ryohei; Watanabe, Hiroaki; Otani, Hiroyuki; Takigawa, Chizuko; Matsuda, Yoshinobu; Nagaoka, Hiroka; Mori, Masanori; Tei, Yo; Hiramoto, Shuji; Suga, Akihiko; Kinoshita, Hiroya			Survival prediction for advanced cancer patients in the real world: A comparison of the Palliative Prognostic Score, Delirium-Palliative Prognostic Score, Palliative Prognostic Index and modified Prognosis in Palliative Care Study predictor model	EUROPEAN JOURNAL OF CANCER			English	Article						Prognosis; Predication; Palliative Prognostic Score; Palliative Prognostic Index; PiPS model; Palliative care; Accuracy	PROSPECTIVE VALIDATION; CONSULTATION SERVICE; AGGRESSIVENESS; SYSTEM; TRENDS; LIFE; PAP; END	Purpose: The aim of this study was to investigate the feasibility and accuracy of the Palliative Prognostic Score (PaP score), Delirium-Palliative Prognostic Score (D-PaP score), Palliative Prognostic Index (PPI) and modified Prognosis in Palliative Care Study predictor model (PiPS model). Patients and methods: This multicentre prospective cohort study involved 58 palliative care services, including 19 hospital palliative care teams, 16 palliative care units and 23 home palliative care services, in Japan from September 2012 to April 2014. Analyses were performed involving four patient groups: those treated by palliative care teams, those in palliative care units, those at home and those receiving chemotherapy. Results: We recruited 2426 participants, and 2361 patients were finally analysed. Risk groups based on these instruments successfully identified patients with different survival profiles in all groups. The feasibility of PPI and modified PiPS-A was more than 90% in all groups, followed by PaP and D-PaP scores; modified PiPS-B had the lowest feasibility. The accuracy of prognostic scores was >= 69% in all groups and the difference was within 13%, while c-statistics were significantly lower with the PPI than PaP and D-PaP scores. Conclusion: The PaP score, D-PaP score, PPI and modified PiPS model provided distinct survival groups for patients in the three palliative care settings and those receiving chemotherapy. The PPI seems to be suitable for routine clinical use for situations where rough estimates of prognosis are sufficient and/or patients do not want invasive procedure. If clinicians can address more items, the modified PiPS-A would be a non-invasive alternative. In cases where blood samples are available or those requiring more accurate prediction, the PaP and D-PaP scores and modified PiPS-B would be more appropriate. (C) 2015 Elsevier Ltd. All rights reserved.	[Baba, Mika] Saito Yukoukai Hosp, Palliat Care Div, Ibaraki, Osaka 5670085, Japan; [Maeda, Isseki] Osaka Univ, Grad Sch Med, Dept Palliat Med, Suita, Osaka 5650871, Japan; [Morita, Tatsuya] Seirei Mikatahara Gen Hosp, Palliat & Support Care Div, Kita Ku, Hamamatsu, Shizuoka 4338558, Japan; [Inoue, Satoshi; Tei, Yo] Seirei Mikatahara Gen Hosp, Seirei Hosp, Kita Ku, Hamamatsu, Shizuoka 4338558, Japan; [Ikenaga, Masayuki] Yodogawa Christians Hosp, Childrens Hosp Hosp, Higashiyodogawa Ku, Osaka 5330033, Japan; [Matsumoto, Yoshihisa; Kinoshita, Hiroya] Natl Canc Ctr Hosp East, Dept Palliat Med, Kashiwa, Chiba 2778577, Japan; [Sekine, Ryuichi] Kameda Med Ctr, Dept Pain & Palliat Care, Kamogawa City, Chiba 2968602, Japan; [Yamaguchi, Takashi] Kobe Univ, Grad Sch Med, Dept Palliat Med, Chuo Ku, Kobe, Hyogo 6500017, Japan; [Hirohashi, Takeshi] Mitui Mem Hosp, Dept Palliat Care, Chiyoda Ku, Tokyo 1018643, Japan; [Tajima, Tsukasa] Tohoku Univ Hosp, Dept Palliat Med, Aoba Ku, Sendai, Miyagi 9808574, Japan; [Tatara, Ryohei] Osaka City Gen Hosp, Dept Palliat Med, Miyakojima Ku, Osaka 5340021, Japan; [Watanabe, Hiroaki] Komaki City Hosp, Komaki, Aichi 4858520, Japan; [Otani, Hiroyuki] Kyushu Natl Canc Ctr, Dept Palliat Care Team, Minami Ku, Fukuoka 8111395, Japan; [Otani, Hiroyuki] Kyushu Natl Canc Ctr, Dept Palliat & Support Care, Minami Ku, Fukuoka 8111395, Japan; [Takigawa, Chizuko] KKR Sapporo Med Ctr, Dept Palliat Care, Toyohira Ku, Sapporo, Hokkaido 0620931, Japan; [Matsuda, Yoshinobu] Natl Hosp Org, Kinki Chuo Chest Med Ctr, Dept Psychosomat Med, Sakai, Osaka 5918555, Japan; [Nagaoka, Hiroka] Univ Tsukuba, Dept Med Social Serv, Ctr Palliat, Tsukuba, Ibaraki 3058576, Japan; [Mori, Masanori] Seirei Hamamatsu Gen Hosp, Naka Ku, Hamamatsu, Shizuoka 4308558, Japan; [Hiramoto, Shuji] Mitsubishi Kyoto Hosp, Dept Oncol, Nishikyo Ku, Kyoto 6158087, Japan; [Suga, Akihiko] Shizuoka Saiseikai Gen Hosp, Dept Palliat Med, Suruga, Shizuoka 4228527, Japan	Baba, M (reprint author), Saito Yukoukai Hosp, Palliat Care Div, 7-2-18 Saito Asagi, Ibaraki, Osaka 5670085, Japan.	baba@saito-yukoukai-hp.jp; maeda@pm.med.osaka-u.ac.jp; tmorita@sis.seirei.or.jp; inosa@sis.seirei.or.jp; a190185@ych.or.jp; yosmatsu@east.ncc.go.jp; sekiner@kameda.jp; ikagoro@pop06.odn.ne.jp; hirohashi.med@gmail.com; ttajima@med.tohoku.ac.jp; r-tatara@hotmail.co.jp; hi.watanabe@komakihp.gr.jp; cas60020@pop21.odn.ne.jp; takki236@gmail.com; ymatsuda@kch.hosp.go.jp; nagaoka3taro@gmail.com; Masanori.Mori@sis.seirei.or.jp; y-jeong680909@ktb.biglobe.ne.jp; otomari1rx.8@gmail.com; akihikosuga@gmail.com; hikinosh@east.ncc.go.jp			National Cancer Center Research and Development Fund [25-A-22]	This work was supported in part by The National Cancer Center Research and Development Fund (25-A-22).	Maltoni M, 2005, J CLIN ONCOL, V23, P6240, DOI 10.1200/JCO.2005.06.866; Naylor C, 2010, J PAIN SYMPTOM MANAG, V39, P69, DOI 10.1016/j.jpainsymman.2009.05.020; Hyodo I, 2010, JPN J CLIN ONCOL, V40, P442, DOI 10.1093/jjco/hyp182; Glare P, 2001, J PAIN SYMPTOM MANAG, V22, P891, DOI 10.1016/S0885-3924(01)00341-4; Morita T, 1999, SUPPORT CARE CANCER, V7, P128, DOI 10.1007/s005200050242; Stone PC, 2007, ANN ONCOL, V18, P971, DOI 10.1093/annonc/md1343; Alshemmari S, 2012, J PALLIAT MED, V15, P200, DOI 10.1089/jpm.2011.0253; Temel JS, 2010, NEW ENGL J MED, V363, P733, DOI 10.1056/NEJMoa1000678; Zimmermann C, 2010, SUPPORT CARE CANCER, V18, P609, DOI 10.1007/s00520-009-0700-9; Baba M, 2015, J PAIN SYMPTOM MANAG, V49, P853, DOI 10.1016/j.jpainsymman.2014.10.010; Feliu J, 2011, J NATL CANCER I, V103, P1613, DOI 10.1093/jnci/djr388; Maltoni M, 2012, ONCOLOGIST, V17, P446, DOI 10.1634/theoncologist.2011-0397; Earle CC, 2004, J CLIN ONCOL, V22, P315, DOI 10.1200/JCO.2004.08.036; Tassinari D, 2008, SUPPORT CARE CANCER, V16, P359, DOI 10.1007/s00520-007-0302-3; Morita T, 1999, JPN J CLIN ONCOL, V29, P156, DOI 10.1093/jjco/29.3.156; Glare P, 2003, BRIT MED J, V327, P195, DOI 10.1136/bmj.327.7408.195; Pirovano M, 1999, J PAIN SYMPTOM MANAG, V17, P231, DOI 10.1016/S0885-3924(98)00145-6; Maltoni M, 1999, J PAIN SYMPTOM MANAG, V17, P240, DOI 10.1016/S0885-3924(98)00146-8; Smith TJ, 2012, J CLIN ONCOL, V30, P880, DOI 10.1200/JCO.2011.38.5161; Stone CA, 2008, J PAIN SYMPTOM MANAG, V35, P617, DOI 10.1016/j.jpainsymman.2007.07.006; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Lau F, 2007, J PALLIAT CARE, V23, P93; Glare PA, 2004, J CLIN ONCOL, V22, P4823, DOI 10.1200/JCO.2004.12.056; Ho TH, 2011, J CLIN ONCOL, V29, P1587, DOI 10.1200/JCO.2010.31.9897; Gwilliam B, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d4920; Kim Eun-Shin, 2014, Korean J Fam Med, V35, P283, DOI 10.4082/kjfm.2014.35.6.283; Kurashima AY, 2010, PEDIATR BLOOD CANCER, V55, P1167, DOI 10.1002/pbc.22644; Numico G, 2011, SUPPORT CARE CANCER, V19, P1823, DOI 10.1007/s00520-010-1024-5; Scarpi E, 2011, ONCOLOGIST, V16, P1793, DOI 10.1634/theoncologist.2011-0130; Tarumi Y, 2011, J PAIN SYMPTOM MANAG, V42, P419, DOI 10.1016/j.jpainsymman.2010.12.013; Yoong Jaclyn, 2010, J Pain Symptom Manage, V39, pe2, DOI 10.1016/j.jpainsymman.2009.08.001	31	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0959-8049	1879-0852		EUR J CANCER	Eur. J. Cancer	AUG	2015	51	12					1618	1629		10.1016/j.ejca.2015.04.025		12	Oncology	Oncology	CM4MN	WOS:000357658900015		
J	Romero, MJRH; Nakashima, S; Nikaido, T; Ichinose, S; Sadr, A; Tagami, J				Romero, Maria J. R. H.; Nakashima, Syozi; Nikaido, Toru; Ichinose, Shizuko; Sadr, Alireza; Tagami, Junji			Inhibition of hydroxyapatite growth by casein, a potential salivary phosphoprotein homologue	EUROPEAN JOURNAL OF ORAL SCIENCES			English	Article						apatite; casein; mineral regulation; pellicle; salivary phosphoproteins	CALCIUM-PHOSPHATE PRECIPITATION; PROLINE-RICH PROTEINS; ACQUIRED ENAMEL PELLICLE; IN-VITRO; BOVINE ENAMEL; ARTIFICIAL SALIVAS; REMINERALIZATION; EROSION; STATHERIN; DEMINERALIZATION	Salivary phosphoproteins are essential in tooth mineral regulation but are often overlooked invitro. This study aimed to evaluate the effect of casein, as a salivary phosphoprotein homologue, on the deposition and growth of hydroxyapatite (HA) on tooth surfaces. Hydroxyapatite growth was quantified using seeded crystal systems. Artificial saliva (AS) containing HA powder and 0, 10, 20, 50, or 100gml(-1) of casein, or 100gml(-1) of dephosphorylated casein (Dcasein), was incubated for 0-8h at 37 degrees C, pH 7.2. Calcium concentrations were measured using atomic absorption spectroscopy (AAS). Surface precipitation of HA on bovine enamel and dentine blocks, incubated in similar conditions for 7d, was examined using field emission scanning electron microscopy (FE-SEM) and transmission electron microscopy (TEM) with selected area electron diffraction (SAED). Casein adsorption was assessed using modified Lowry assays and zeta-potential measurements. The AAS results revealed a concentration-dependent inhibition of calcium consumption. Hydroxyapatite precipitation occurred when no casein was present, whereas precipitation of HA was apparently completely inhibited in casein-containing groups. Adsorption data demonstrated increasingly negative zeta-potential with increased casein concentration and an affinity constant similar to proline-rich proteins with Langmuir modelling. Casein inhibited the deposition and growth of HA primarily through the binding of esterized phosphate to HA active sites, indicating its potential as a mineral-regulating salivary phosphoprotein homologue invitro.	[Romero, Maria J. R. H.; Nakashima, Syozi; Nikaido, Toru; Tagami, Junji] Tokyo Med & Dent Univ, Dept Cariol & Operat Dent, Div Oral Hlth Sci, Grad Sch Med & Dent Sci, Tokyo 1138549, Japan; [Ichinose, Shizuko] Tokyo Med & Dent Univ, Instrumental Anal Res Ctr, Tokyo 1138549, Japan; [Sadr, Alireza] Tokyo Med & Dent Univ, Int Exchange Ctr, Tokyo 1138549, Japan; [Sadr, Alireza] Univ Washington, Sch Dent, Dept Restorat Dent, Seattle, WA 98195 USA	Nakashima, S (reprint author), Tokyo Med & Dent Univ, Dept Cariol & Operat Dent, Div Oral Hlth Sci, Grad Sch Med & Dent Sci,Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138549, Japan.	s-nakashima.ope@tmd.ac.jp			Japanese Ministry of Education; Global Center of Excellence (GCOE) Program, International Research Center for Molecular Science in Tooth and Bone Diseases; Japan Society for the Promotion of Science [25462949]	This work was supported by a grant from the Japanese Ministry of Education and Global Center of Excellence (GCOE) Program, International Research Center for Molecular Science in Tooth and Bone Diseases, and by Grant-in-Aid for Scientific Research no. 25462949 from the Japan Society for the Promotion of Science. The authors are grateful to Professor Akihisa Tsurumoto, from the Department of Community Dentistry, Tsurumi University, for allowing us to use their Atomic Absorption Spectrometer, and to Professor Hideki Sakai of the Department of Pure and Applied Chemistry, Tokyo University of Science, for much-needed help with the zeta-potential measurements.	SCHWARTZ SS, 1992, CALCIFIED TISSUE INT, V50, P511, DOI 10.1007/BF00582164; LAMKIN MS, 1993, CRIT REV ORAL BIOL M, V4, P251; Tercinier L, 2013, J COLLOID INTERF SCI, V394, P458, DOI 10.1016/j.jcis.2012.11.058; Amaechi BT, 2013, CARIES RES, V47, P399, DOI 10.1159/000348589; Holt C, 1996, BIOCHEM J, V314, P1035; Barbour ME, 2008, EUR J ORAL SCI, V116, P473, DOI 10.1111/j.1600-0722.2008.00565.x; Huq NL, 2000, J MOL MODEL, V6, P35; HAY DI, 1987, CALCIFIED TISSUE INT, V40, P126, DOI 10.1007/BF02555696; Cheaib Z, 2011, CARIES RES, V45, P107, DOI 10.1159/000324803; Siqueira WL, 2012, J DENT RES, V91, P1110, DOI 10.1177/0022034512462578; KUMOSINSKI TF, 1993, J DAIRY SCI, V76, P931, DOI 10.3168/jds.S0022-0302(93)77420-2; Margolis HC, 2006, J DENT RES, V85, P775; REYNOLDS EC, 1982, CALCIFIED TISSUE INT, V34, pS52; Cochrane NJ, 2010, J DENT RES, V89, P1187, DOI 10.1177/0022034510376046; Leung VWH, 1997, J DENT, V25, P475, DOI 10.1016/S0300-5712(96)00068-1; Meyer-Lueckel H, 2006, ARCH ORAL BIOL, V51, P541, DOI 10.1016/j.archoralbio.2006.01.006; Zhang K, 2010, J ENDODONT, V36, P105, DOI 10.1016/j.joen.2009.10.020; Hemingway CA, 2010, CARIES RES, V44, P525, DOI 10.1159/000320984; Carpio-Perochena AE, 2011, J ENDODONT, V8, P1134; Fujikawa H, 2008, CARIES RES, V42, P37, DOI 10.1159/000111748; Gaffar A, 1989, RECENT ADV STUDY DEN, P155; Hara AT, 2008, EUR J ORAL SCI, V116, P552, DOI 10.1111/j.1600-0722.2008.00575.x; HAY DI, 1982, CALCIFIED TISSUE INT, V34, P531, DOI 10.1007/BF02411299; Ichinose S, 2013, MED MOL MORPHOL, V46, P24, DOI 10.1007/s00795-012-0005-9; Jager DHJ, 2013, CARIES RES, V47, P135, DOI 10.1159/000344016; JOHNSSON M, 1993, CRIT REV ORAL BIOL M, V4, P371; Kielbassa AM, 2005, J ORAL REHABIL, V32, P90, DOI 10.1111/j.1365-2842.2004.01392.x; KUMOSINSKI TF, 1991, J DAIRY SCI, V74, P2879; LEVINE MJ, 1993, CRIT REV ORAL BIOL M, V4, P279; Lindh L, 2007, J COLLOID INTERF SCI, V310, P74, DOI 10.1016/j.jcis.2007.01.086; Martins C, 2013, CARIES RES, V47, P56, DOI 10.1159/000343574; Mekmene O, 2011, FOOD CHEM, V127, P676, DOI 10.1016/j.foodchem.2010.12.121; Moreno EC, 1989, RECENT ADV STUDY DEN, P129; MORENO EC, 1979, CALCIFIED TISSUE INT, V28, P7, DOI 10.1007/BF02441212; MORENO EC, 1982, J BIOL CHEM, V257, P2981; Nongonierma AB, 2012, CARIES RES, V46, P243; Schupbach P, 2001, EUR J ORAL SCI, V109, P60, DOI 10.1034/j.1600-0722.2001.00925.x; Sotres J, 2014, CARIES RES, V48, P98, DOI 10.1159/000351871; Tamaki N, 2002, CALCIFIED TISSUE INT, V71, P59, DOI 10.1007/s00223-001-1084-0; Tschoppe P, 2011, QUINTESSENCE INT, V42, P501; VANKEMENADE MJJM, 1989, J COLLOID INTERF SCI, V129, P1, DOI 10.1016/0021-9797(89)90411-6; Whelton H., 2004, SALIVA ORAL HLTH, P1; ZAHRADNIK RT, 1979, J DENT RES, V58, P2066, DOI 10.1177/00220345790580110501	43	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0909-8836	1600-0722		EUR J ORAL SCI	Eur. J. Oral Sci.	AUG	2015	123	4					288	296		10.1111/eos.12196		9	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CM4ZU	WOS:000357696500011		
J	Shimauchi, A; Abe, H; Schacht, DV; Jian, YL; Pineda, FD; Jansen, SA; Ganesh, R; Newstead, GM				Shimauchi, Akiko; Abe, Hiroyuki; Schacht, David V.; Jian Yulei; Pineda, Federico D.; Jansen, Sanaz A.; Ganesh, Rajiv; Newstead, Gillian M.			Evaluation of Kinetic Entropy of Breast Masses Initially Found on MRI using Whole-lesion Curve Distribution Data: Comparison with the Standard Kinetic Analysis	EUROPEAN RADIOLOGY			English	Article						Breast; Magnetic resonance imaging; Cancer; Diagnosis; Computer-Assisted; Imaging	CONTRAST-ENHANCED MRI; DIFFERENTIAL-DIAGNOSIS; COMPUTERIZED ASSESSMENT; FIELD INHOMOGENEITY; CLINICAL-VALUE; DCE-MRI; MAMMOGRAPHY; CRITERIA; FEATURES; SYSTEMS	To quantify kinetic heterogeneity of breast masses that were initially detected with dynamic contrast-enhanced MRI, using whole-lesion kinetic distribution data obtained from computer-aided evaluation (CAE), and to compare that with standard kinetic curve analysis. Clinical MR images from 2006 to 2011 with breast masses initially detected with MRI were evaluated with CAE. The relative frequencies of six kinetic patterns (medium-persistent, medium-plateau, medium-washout, rapid-persistent, rapid-plateau, rapid-washout) within the entire lesion were used to calculate kinetic entropy (KE), a quantitative measure of enhancement pattern heterogeneity. Initial uptake (IU) and signal enhancement ratio (SER) were obtained from the most-suspicious kinetic curve. Mann-Whitney U test and ROC analysis were conducted for differentiation of malignant and benign masses. Forty benign and 37 malignant masses comprised the case set. IU and SER were not significantly different between malignant and benign masses, whereas KE was significantly greater for malignant than benign masses (p = 0.748, p = 0.083, and p < 0.0001, respectively). Areas under ROC curve for IU, SER, and KE were 0.479, 0.615, and 0.662, respectively. Quantification of kinetic heterogeneity of whole-lesion time-curve data with KE has the potential to improve differentiation of malignant from benign breast masses on breast MRI. aEuro cent Kinetic heterogeneity can be quantified by computer-aided evaluation of breast MRI aEuro cent Kinetic entropy was greater in malignant masses than benign masses aEuro cent Kinetic entropy has the potential to improve differentiation of breast masses.	[Shimauchi, Akiko; Abe, Hiroyuki; Schacht, David V.; Jian Yulei; Pineda, Federico D.; Jansen, Sanaz A.; Ganesh, Rajiv; Newstead, Gillian M.] Univ Chicago, Dept Radiol, Chicago, IL 60637 USA	Shimauchi, A (reprint author), Tohoku Univ, Grad Sch Med, Dept Diagnost Radiol, Aoba Ku, 1-1 Seiryo, Sendai, Miyagi 9800872, Japan.	akikoshima@gmail.com; habe@radiology.bsd.uchicago.edu; dschacht@radiology.bsd.uchicago.edu; y-jiang@uchicago.edu; pineda.fd@gmail.com; jansensa0@gmail.com; rajiv.ganesh@gmail.com; gnewstead@aol.com			National Cancer Institute (NCI) of the National Institutes of Health [CA092361]	The authors are grateful to Keiko Tsuchiya, MD, PhD, for data collection of our study. The scientific guarantor of this publication is Hiroyuki Abe, M.D., Ph.D. The authors of this manuscript declare relationships with the following companies: Seno Medical Instruments, Inc., Bayer AG and Three Palm Software LLC. This study has received funding by National Cancer Institute (NCI) of the National Institutes of Health through grant CA092361. No complex statistical methods were necessary for this paper. Institutional review board approval was obtained. Written informed consent was waived by the institutional review board. Methodology: retrospective, observational, performed at one institution.	Wang LC, 2009, AM J ROENTGENOL, V193, P826, DOI 10.2214/AJR.08.1335; Marini C, 2007, EUR RADIOL, V17, P2646, DOI 10.1007/s00330-007-0621-2; Guo Y, 2002, J MAGN RESON IMAGING, V16, P172, DOI 10.1002/jmri.10140; Karahaliou A, 2010, BRIT J RADIOL, V83, P296, DOI 10.1259/bjr/50743919; [Anonymous], 2013, ACR BREAST IMAGING R, V5th; Buadu LD, 1996, RADIOLOGY, V200, P639; Schnall MD, 2006, RADIOLOGY, V238, P42, DOI 10.1148/radiol.2381042117; Partridge SC, 2010, J MAGN RESON IMAGING, V31, P562, DOI 10.1002/jmri.22078; Kinkel K, 2000, AM J ROENTGENOL, V175, P35; KAISER WA, 1989, RADIOLOGY, V170, P681; Newell D, 2010, EUR RADIOL, V20, P771, DOI 10.1007/s00330-009-1616-y; Rahbar H, 2012, J MAGN RESON IMAGING, V35, P1222, DOI 10.1002/jmri.23571; Kuhl CK, 1999, RADIOLOGY, V211, P101; Szabo BK, 2003, ACTA RADIOL, V44, P379, DOI 10.1034/j.1600-0455.2003.00084.x; Jansen SA, 2009, AM J ROENTGENOL, V193, P832, DOI 10.2214/AJR.08.2025; Chen WJ, 2004, MED PHYS, V31, P1076, DOI 10.1118/1.1695652; Kierans AS, 2013, J MAGN RESON IMAGING, V37, P164, DOI 10.1002/jmri.23794; Preim U, 2012, EUR J RADIOL, V81, P1532, DOI 10.1016/j.ejrad.2011.04.045; Hauth EAM, 2008, EUR J RADIOL, V66, P300, DOI 10.1016/j.ejrad.2007.05.026; Azlan CA, 2010, J MAGN RESON IMAGING, V31, P234, DOI 10.1002/jmri.22018; Baltzer PAT, 2010, EUR RADIOL, V20, P1101, DOI 10.1007/s00330-009-1654-5; Baltzer PAT, 2009, ACAD RADIOL, V16, P435, DOI 10.1016/j.acra.2008.10.007; Banik S, 2013, INT J COMPUT ASS RAD, V8, P121, DOI 10.1007/s11548-012-0681-x; Chen WJ, 2010, ACAD RADIOL, V17, P822, DOI 10.1016/j.acra.2010.03.007; Gilhuijs KGA, 2002, RADIOLOGY, V225, P907, DOI 10.1148/radiol.2253011582; Hatakenaka Masamitsu, 2008, Magn Reson Med Sci, V7, P23, DOI 10.2463/mrms.7.23; Jansen SA, 2008, MED PHYS, V35, P3102, DOI 10.1118/1.2936220; Kuhl CK, 2000, EUR RADIOL, V10, P46, DOI 10.1007/s003300050006; Lehman CD, 2013, AM J ROENTGENOL, V200, pW683, DOI 10.2214/AJR.11.8394; Lehman CD, 2006, AM J ROENTGENOL, V187, P51, DOI 10.2214/AJR.05.0269; Liu YH, 2014, J CANCER, V5, P585, DOI 10.7150/jca.9785; Mussurakis S, 1996, BRIT J RADIOL, V69, P1009; Mussurakis S, 1998, J COMPUT ASSIST TOMO, V22, P35, DOI 10.1097/00004728-199801000-00007; Pan J, 2013, J DIGIT IMAGING, V26, P971, DOI 10.1007/s10278-013-9602-y; Renz DM, 2008, ROFO-FORTSCHR RONTG, V180, P968, DOI 10.1055/s-2008-1027772; Schmidt MA, 2013, EUR RADIOL, V23, P1537, DOI 10.1007/s00330-012-2735-4; Schnall MD, 2001, ACAD RADIOL, V8, P591, DOI 10.1016/S1076-6332(03)80683-9; Shimauchi A, 2010, AM J ROENTGENOL, V194, P1674, DOI 10.2214/AJR.09.3568; Spick C, 2014, EUR RADIOL, V24, P1204, DOI 10.1007/s00330-014-3153-6; STOMPER PC, 1995, RADIOLOGY, V197, P387; Tozaki Mitsuhiro, 2004, Magn Reson Med Sci, V3, P189, DOI 10.2463/mrms.3.189; Wang TC, 2014, MAGN RESON IMAGING, V32, P197, DOI 10.1016/j.mri.2013.12.002; Wedegartner U, 2001, EUR RADIOL, V11, P1645; Woodhams Reiko, 2005, Magn Reson Med Sci, V4, P35, DOI 10.2463/mrms.4.35	44	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0938-7994	1432-1084		EUR RADIOL	Eur. Radiol.	AUG	2015	25	8					2470	2478		10.1007/s00330-015-3635-1		9	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CM4MZ	WOS:000357660100034		
J	Hiramitsu, A; Funakoshi, M				Hiramitsu, Ai; Funakoshi, Mitsuaki			Surface waves in a square container due to its resonant horizontal elliptic motion	FLUID DYNAMICS RESEARCH			English	Article						surface wave; sloshing; elliptic motion; rotating wave	BASE	Surface waves in a square container due to its resonant horizontal elliptic or linear motion are investigated theoretically. The motion of the container is characterized by the ratio, expressed as tan phi, of the length of the minor axis to the length of the major axis of its elliptic orbit, and by the angle theta between the directions of the major axis and one of its sidewalls. Using the reductive perturbation method, non-linear time evolution equations for the complex amplitudes of two degenerate modes excited by this motion are derived with the inclusion of linear damping. When tan phi is small, for any theta these equations have two kinds of stable stationary solutions corresponding to regular co-rotating waves whose direction of rotation is the same as that of the container and regular counter-rotating waves of the opposite direction of rotation. As tan phi increases to one, the region of forcing frequency in which stable regular counter-rotating waves are observed shrinks and then disappears for any theta. Solutions with chaotic or periodic slow variations in amplitude and phase of excited surface waves are also obtained for forcing frequencies where no stable stationary solutions exist. Non-stationary solutions are either uni-directionally or bidirectionally rotating waves. For theta = 0 degrees, chaotic waves and bidirectionally rotating waves are observed more frequently for smaller tan phi. For theta = phi = 0 degrees, for sufficiently small fluid depth, regular non-rotating waves are expected to occur for any forcing frequency. Moreover, stable stationary and non-stationary solutions obtained for phi = 0 degrees are found to agree fairly well with the experimental results in a preceding study.	[Hiramitsu, Ai; Funakoshi, Mitsuaki] Kyoto Univ, Grad Sch Informat, Dept Appl Anal & Complex Dynam Syst, Kyoto 6068501, Japan	Funakoshi, M (reprint author), Kyoto Univ, Grad Sch Informat, Dept Appl Anal & Complex Dynam Syst, Kyoto 6068501, Japan.	ai_hiramitsu@acs.i.kyoto-u.ac.jp; mitsu@acs.i.kyoto-u.ac.jp			JSPS KAKENHI [25390154]	This work was supported by JSPS KAKENHI Grant Number 25390154.	Yoshimatsu K, 2001, J PHYS SOC JPN, V70, P394, DOI 10.1143/JPSJ.70.394; MILES J, 1990, ANNU REV FLUID MECH, V22, P143; NAGATA M, 1989, J FLUID MECH, V209, P265, DOI 10.1017/S0022112089003101; Ikeda T, 2012, J FLUID MECH, V700, P304, DOI 10.1017/jfm.2012.133; Faltinsen O.M., 2009, SLOSHING; FUNAKOSHI M, 1990, FLUID DYN RES, V5, P255, DOI 10.1016/0169-5983(90)90022-Q; FUNAKOSHI M, 1988, J FLUID MECH, V192, P219, DOI 10.1017/S0022112088001843; Hutton R E, 1963, NASA TECH NOTE D, V1870, P1; Ibrahim RA, 2005, LIQUID SLOSHING DYNAMICS: THEORY AND APPLICATIONS, P1, DOI 10.1017/CBO9780511536656; MILES JW, 1984, J FLUID MECH, V149, P15, DOI 10.1017/S0022112084002512; NOBILI M, 1988, EUROPHYS LETT, V7, P587, DOI 10.1209/0295-5075/7/7/003; Royon-Lebeaud A, 2007, J FLUID MECH, V577, P467, DOI 10.1017/S0022112007004764	12	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0169-5983	1873-7005		FLUID DYN RES	Fluid Dyn. Res.	AUG	2015	47	4							045504	10.1088/0169-5983/47/4/045504		25	Mechanics; Physics, Fluids & Plasmas	Mechanics; Physics	CM4VV	WOS:000357684100005		
J	Kobayashi, F; Odake, S				Kobayashi, Fumiyuki; Odake, Sachiko			Quality Evaluation of Unfiltered Beer as Affected by Inactivated Yeast Using Two-Stage System of Low Pressure Carbon Dioxide Microbubbles	FOOD AND BIOPROCESS TECHNOLOGY			English	Article						Low pressure carbon dioxide microbubbles; Taste and flavour; Unfiltered beer; Yeast	CO2 MICROBUBBLES; LACTOBACILLUS FRUCTIVORANS; ENZYME INACTIVATION; AMBIENT-TEMPERATURE; UNPASTEURIZED SAKE; ORGANIC-ACIDS; MICROORGANISMS; PASTEURIZATION; SHOCHU	Yeast in unfiltered beer (UFB) was inactivated by a two-stage system that was additionally pressurised at an ambient temperature after carbon dioxide microbubbles (MB-CO2) were mixed with UFB at a low temperature and pressure (two-stage MB-CO2). The quality of the treated beer was compared with UFB and heat-treated beer (HTB). Five-log reductions could be achieved by two-stage MB-CO2 treatment with a heating coil at 50 A degrees C for 5 min, while yeast in UFB was not completely inactivated by heat treatment at 80 A degrees C for 5 min. In sensory evaluation of these beers, there were no significant differences on the score of flavour, although bitterness of two-stage MB-CO2-treated beer (MBB) was significantly low on the score of taste. In analysis of volatile compounds, dimethyl sulphide, dimethyl disulphide, beta-myrcene and styrene in MBB were less than those in UFB and HTB. Glucose and maltose contents in MBB and UFB were almost the same, although those in HTB significantly decreased. Organic acids, except for acetic acid in MBB, were nearly identical with those in UFB and HTB. Most of the free amino acids in MBB were lower than those in UFB and HTB. Bitter units of beer increased in the order of MBB, HTB and UFB. These results suggested that two-stage MB-CO2 shows promise as a practical technique for inactivating yeast in UFB. The inactivation efficiency of two-stage MB-CO2 had less influence of materials in beer than that of heat treatment, and two-stage MB-CO2 has little negative impact on the beer quality.	[Kobayashi, Fumiyuki; Odake, Sachiko] Nippon Vet & Life Sci Univ, Fac Appl Life Sci, Tokyo 1808602, Japan	Kobayashi, F (reprint author), Nippon Vet & Life Sci Univ, Fac Appl Life Sci, 1-7-1 Kyonan, Tokyo 1808602, Japan.	fkoba@nvlu.ac.jp; odake@nvlu.ac.jp			Ryoushokukenkyukai	We thank Dr. Yumiko Yoshizaki of Laboratory of Shochu Fermentation Technology, Faculty of Agriculture, Kagoshima University (Kagoshima, Japan), and Masaki Sugiura of School of Agriculture, Meiji University (Kawasaki, Japan), for technical assistance. The research was financially supported by the Ryoushokukenkyukai.	Kobayashi F, 2009, T ASABE, V52, P1621; KLOPPER WJ, 1986, J I BREWING, V92, P225; Damar S, 2006, J FOOD SCI, V71, pR1; Kobayashi F, 2012, INT J FOOD SCI TECH, V47, P1151, DOI 10.1111/j.1365-2621.2012.02954.x; Yoshizaki Y, 2010, J I BREWING, V116, P49; Kobayashi F, 2013, INNOV FOOD SCI EMERG, V18, P108, DOI 10.1016/j.ifset.2013.01.003; Dagan GE, 2006, J FOOD SCI, V71, pE164; Kobayashi F, 2010, T ASABE, V53, P1217; Garcia-Gonzalez L, 2007, INT J FOOD MICROBIOL, V117, P1, DOI 10.1016/j.ijfoodmicro.2007.02.018; Guo MM, 2011, EUR FOOD RES TECHNOL, V232, P803, DOI 10.1007/s00217-011-1447-3; Chen JL, 2009, J AGR FOOD CHEM, V57, P5805, DOI 10.1021/jf900752b; Descoins C, 2006, FOOD CHEM, V95, P541, DOI 10.1016/j.foodchem.2004.11.031; Garcia-Gonzalez L, 2009, INT J FOOD MICROBIOL, V129, P253, DOI 10.1016/j.ijfoodmicro.2008.12.005; Kobayashi F, 2012, LWT-FOOD SCI TECHNOL, V48, P330, DOI 10.1016/j.lwt.2012.04.011; Kobayashi F, 2014, FOOD CONTROL, V46, P35, DOI 10.1016/j.foodcont.2014.04.034; Arimura H., 2000, J BREWING SOC JAPAN, V95, P791; Brewery Convention of Japan, 1997, J BREWING SOC JAPAN, V92, P364; Brewing Society of Japan, 1999, JOUZ; COOTE N, 1974, J I BREWING, V80, P474; Hashimoto N., 1980, KAGAKUTOSEIBUTSU, V18, P626; Inui M., 2001, J BREWING SOC JAPAN, V96, P151; ISHIKAWA H, 1995, BIOSCI BIOTECH BIOCH, V59, P1027; Kashiwada S., 2001, J BREWING SOC JAPAN, V96, P298; Kazazi H, 2007, FOOD CHEM, V105, P805, DOI 10.1016/j.foodchem.2007.01.059; Kirin Holdings Company Limited, 2012, KIR DAT BOOK 2012; Kunitake N., 1976, Journal of the Society of Brewing, Japan, V71, P682; Miyamoto Y., 2001, J BREWING SOC JAPAN, V96, P455; Ohata K., 1983, J BREWING SOC JAPAN, V78, P508; Okumura J., 1991, DENPUN KAGAKU, V38, P81; Sogawa H., 1990, J BREWING SOC JAPAN, V85, P588; Spilimbergo S, 2003, BIOTECHNOL BIOENG, V84, P627, DOI 10.1002/bit.10783; Tanimoto S, 2008, BIOSCI BIOTECH BIOCH, V72, P22, DOI 10.1271/bbb.70297; Yoshizaki Y, 2011, J I BREWING, V117, P217	33	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1935-5130	1935-5149		FOOD BIOPROCESS TECH	Food Bioprocess Technol.	AUG	2015	8	8					1690	1698		10.1007/s11947-015-1530-z		9	Food Science & Technology	Food Science & Technology	CM1ND	WOS:000357446700008		
J	Sormacheva, I; Golovnina, K; Vavilova, V; Kosuge, K; Watanabe, N; Blinov, A; Goncharov, NP				Sormacheva, Irina; Golovnina, Kseniya; Vavilova, Valeriya; Kosuge, Kazumasa; Watanabe, Nobuyoshi; Blinov, Alexandr; Goncharov, Nikolay P.			Q gene variability in wheat species with different spike morphology	GENETIC RESOURCES AND CROP EVOLUTION			English	Article						Aegilops; Domestication; Genetic variability; Spelt factor gene; Spike morphology; Triticum	TRITICUM-AESTIVUM L.; FREE-THRESHING HABIT; NEAR-ISOGENIC LINES; HEXAPLOID WHEAT; COMMON WHEAT; DOMESTICATION; ALIGNMENT; LOCI; WILD; IDENTIFICATION	Q gene is the major domestication gene of wheat and many questions concerning Q gene genetics, including Q gene variability and its functional influence on phenotype, remain unanswered for the majority of wheat species. Here we crossed wheat species with dominant (Q) and recessive (q) alleles and confirmed that Q gene controls threshability, rachis fragility and spike shape traits. In the present study 18 new Q gene sequences were obtained and the Q gene sequences from 42 di- and polyploid wheat species with variable spike morphology were analyzed. We identified correlation between Q gene variability (coding mutation 329Val/Ile, promoter variability, microRNA172 binding site substitution) and threshability, rachis fragility and spike shape traits in polyploid wheat species. The analysis of 3D structures of q and Q proteins indicated that 329Val/Ile mutation does not affect overall protein structure and likely protein activity. We conclude that alterations in all three regions are essential for the formation of free-threshing non fragile normal phenotype in polyploid wheat.	[Sormacheva, Irina; Golovnina, Kseniya; Vavilova, Valeriya; Blinov, Alexandr; Goncharov, Nikolay P.] Russian Acad Sci, Inst Cytol & Genet SB, Novosibirsk 630090, Russia; [Kosuge, Kazumasa; Watanabe, Nobuyoshi] Ibaraki Univ, Coll Agr, Inashiki, Ibaraki 3000393, Japan; [Goncharov, Nikolay P.] Novosibirsk State Agrarian Univ, Novosibirsk 630039, Russia	Sormacheva, I (reprint author), Russian Acad Sci, Inst Cytol & Genet SB, Prospekt Lavrentyeva 10, Novosibirsk 630090, Russia.	sormacheva@bionet.nsc.ru	Konopatskaya, Irina/N-5882-2015; Blinov, Alexandr/N-6117-2015		Russian Foundation for Basic Research [12-04-01099-a]; RAS [VI.53.1.1]	We thank Dr. Julie Hayes, Australian Centre for Plant Functional Genomics, the University of Adelaide, Australia, for helpful comments on our manuscript. Partial financial support of this investigation was provided by the Russian Foundation for Basic Research (Grant No. 12-04-01099-a) and Basis Project of RAS No. VI.53.1.1.	C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Jantasuriyarat C, 2004, THEOR APPL GENET, V108, P261, DOI 10.1007/s00122-003-1432-8; Nalam VJ, 2007, THEOR APPL GENET, V116, P135, DOI 10.1007/s00122-007-0653-7; Chen XM, 2004, SCIENCE, V303, P2022, DOI 10.1126/science.1088060; Zhang ZC, 2011, P NATL ACAD SCI USA, V108, P18737, DOI 10.1073/pnas.1110552108; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Sood S, 2009, THEOR APPL GENET, V119, P341, DOI 10.1007/s00122-009-1043-0; Okonechnikov K, 2012, BIOINFORMATICS, V28, P1166, DOI 10.1093/bioinformatics/bts091; Kato K, 1999, THEOR APPL GENET, V98, P472, DOI 10.1007/s001220051094; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Dvorak J, 2012, J HERED, V103, P426, DOI 10.1093/jhered/esr152; Hammer K, 2011, GENET RESOUR CROP EV, V58, P3, DOI 10.1007/s10722-010-9590-4; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Salamini F, 2002, NAT REV GENET, V3, P429, DOI 10.1038/nrg817; Tsujimoto H, 2001, J HERED, V92, P254, DOI 10.1093/jhered/92.3.254; Higo K, 1999, NUCLEIC ACIDS RES, V27, P297, DOI 10.1093/nar/27.1.297; Sang T, 2009, PLANT PHYSIOL, V149, P63, DOI 10.1104/pp.108.128827; Lescot M, 2002, NUCLEIC ACIDS RES, V30, P325, DOI 10.1093/nar/30.1.325; Chuck G, 2007, NAT GENET, V39, P1517, DOI 10.1038/ng.2007.20; Simons KJ, 2006, GENETICS, V172, P547, DOI 10.1534/genetics.105.044727; Faris JD, 2003, GENETICS, V164, P311; MURAMATSU M, 1963, GENETICS, V48, P469; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Matsuoka Y, 2011, PLANT CELL PHYSIOL, V52, P750, DOI 10.1093/pcp/pcr018; Dorofeev VF, 1979, CULTIVATED FLORA USS, V1, P348; Dror O, 2003, PROTEIN SCI, V12, P2492, DOI 10.1110/ps.03200603; ENDO TR, 1988, JPN J GENET, V63, P501, DOI 10.1266/jjg.63.501; Faris JD, 2002, GENOME, V45, P706, DOI 10.1139/G02-036; Feldman MF, 2001, WHEAT BOOK, P1; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.2307/2408678; Flaksberger KA, 1935, CULTIVATED FLORA USS, P19; Golovnina KA, 2009, RUSS J GENET+, V45, P1360, DOI 10.1134/S1022795409110106; Goncharov NP, 2011, PLANT SYST EVOL, V295, P1, DOI 10.1007/s00606-011-0480-9; Goncharov NP, 2005, RUSS J GENET+, V41, P1262, DOI 10.1007/s11177-005-0227-1; Goncharov N. P., 2008, P407, DOI 10.1007/978-0-387-68656-1_29; HAMMER K, 1984, Kulturpflanze, V32, P11; KERBER ER, 1974, CAN J GENET CYTOL, V16, P145; Kimber G, 1983, P 6 INT WHEAT GEN S, P1195; Kosuge K, 2012, GENET RESOUR CROP EV, V59, P1115, DOI 10.1007/s10722-011-9747-9; Koval SF, 1997, GENETIKA+, V33, P1168; LEIGHTY CE, 1921, J AGR RES, V7, P335; Lu Guoqing, 2004, Brief Bioinform, V5, P378, DOI 10.1093/bib/5.4.378; MACKEY J, 1954, HEREDITAS, V40, P65; Mac Key J., 1966, Hereditas, V2, P237; Miller TE, 1982, WHEAT INFORM SERV, V55, P10; MURAMATSU M, 1986, CAN J GENET CYTOL, V28, P30; Nilsson-Ehle H, 1920, HEREDITAS, V1, P277; Nilsson-Ehle H, 1917, UNTERSUCHUNGEN SPELT, P305; Papoglou Ch, 1981, BERICHTE DTSCH BOT G, V93, P689; Peng JH, 2011, AUST J CROP SCI, V5, P1127; Sears E, 1954, MO EXP STA RES B, V572, P1; Swaminathan MS, 1961, WHEAT INFORM SERV, V13, P9; Winge O, 1924, HEREDITAS, V5, P241	53	1	1	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0925-9864	1573-5109		GENET RESOUR CROP EV	Genet. Resour. Crop Evol.	AUG	2015	62	6					837	852		10.1007/s10722-014-0195-1		16	Agronomy; Plant Sciences	Agriculture; Plant Sciences	CM0AT	WOS:000357341300005		
J	Li, ML; Qi, X; Yuyama, N; Wang, YW; Sun, Y; Mao, PS; Cai, HW				Li, Manli; Qi, Xiao; Yuyama, Nana; Wang, Yunwen; Sun, Yan; Mao, Peisheng; Cai, Hongwei			Synteny between Zoysia japonica Steud. and Oryza sativa L. based on RFLP, CISP and PLUG markers	GENETIC RESOURCES AND CROP EVOLUTION			English	Article						Linkage map; Molecular marker; Oryza sativa; Synteny; Zoysia japonica	LINKAGE MAP; GENETIC-MAP; CHROMOSOMAL REARRANGEMENTS; FESTUCA-PRATENSIS; LOLIUM-PERENNE; RICE GENOMES; WHEAT; GRASSES; REVEAL; PROBES	In order to study the synteny between Zoysia japonica and Oryza sativa, we added three types of markers including Restriction fragment length polymorphism, Conserved intron scanning primers and PCR-based landmark unique gene in our previous high-density SSR-based linkage map. A total of 100 loci showed homology to the rice genome were merged into our previously constructed SSR-based linkage map of zoysiagrass. The new map was longer than all zoysiagrass genetic maps reported previously, and contains the number of linkage groups 20, which is equal to the haploid number of chromosomes of zoysiagrass. The new mapped 100 homologous loci were mapped to 19 linkage groups (LGs) except of LG 20, of them, the LGs 2, 8 and 13 of zoysiagrass showed colinearity with chromosomes 3, 6 and 1 of rice respectively, and other LGs of zoysiagrass contained variable numbers of markers that showed homology with the rice genome. These results suggested a syntenic relationship between zoysiagrass and rice. The improved genetic linkage map and the new markers developed in this study will serve as reference genetic linkage maps for zoysiagrass species and will be useful for mapping QTLs associated with various traits, and for improving zoysiagrass breeding programs.	[Li, Manli; Wang, Yunwen; Sun, Yan; Mao, Peisheng] China Agr Univ, Dept Grassland Sci, Coll Anim Sci & Technol, Beijing 100193, Peoples R China; [Qi, Xiao] Chinese Acad Agr Sci, Inst Grassland Res, Hohhot 010010, Inner Mongolia, Peoples R China; [Qi, Xiao] Natl Anim Husb Serv, Beijing 100125, Peoples R China; [Yuyama, Nana; Cai, Hongwei] Japan Grassland Agr & Forage Seed Assoc, Forage Crop Res Inst, Nasushiobara, Tochigi 3292742, Japan; [Cai, Hongwei] China Agr Univ, Coll Agron & Biotechnol, Dept Plant Genet & Breeding, Beijing 100193, Peoples R China	Cai, HW (reprint author), China Agr Univ, Coll Agron & Biotechnol, Dept Plant Genet & Breeding, 2 Yuanmingyuan West Rd, Beijing 100193, Peoples R China.	caihw@cau.edu.cn			National Natural Science Foundation of China [31101757, 31271784]; Science and Technology Support Program of China [2011BAD17B01-02]	This study was partially financially supported by a Grant from the National Natural Science Foundation of China (No. 31101757, No. 31271784) and Science and Technology Support Program of China (No. 2011BAD17B01-02). We thank two anonymous reviewers for their valuable comments on this manuscript.	AHN S, 1993, MOL GEN GENET, V241, P483, DOI 10.1007/BF00279889; Alm V, 2003, THEOR APPL GENET, V108, P25, DOI 10.1007/s00122-003-1399-5; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Ishikawa G, 2009, THEOR APPL GENET, V118, P499, DOI 10.1007/s00122-008-0916-y; Sorrells ME, 2003, GENOME RES, V13, P1818, DOI 10.1101/gr.1113003; MOORE G, 1995, CURR BIOL, V5, P737, DOI 10.1016/S0960-9822(95)00148-5; STAM P, 1993, PLANT J, V3, P739, DOI 10.1111/j.1365-313X.1993.00739.x; Panaud O, 1996, MOL GEN GENET, V252, P597, DOI 10.1007/s004380050267; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Jones ES, 2002, GENOME, V45, P282, DOI 10.1139/G01-144; Cai H, 2004, PLANT BREEDING, V123, P543, DOI 10.1111/j.1439-0523.2004.01022.x; Keller B, 2000, TRENDS PLANT SCI, V5, P246, DOI 10.1016/S1360-1385(00)01629-0; Devos KM, 2000, PLANT CELL, V12, P637, DOI 10.1105/tpc.12.5.637; Wu JZ, 2002, PLANT CELL, V14, P525, DOI 10.1105/tpc.010274; Paterson AH, 2005, GENOME RES, V15, P1643, DOI 10.1101/gr.3725905; Li ML, 2009, EUPHYTICA, V170, P327, DOI 10.1007/s10681-009-9990-8; King J, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-437; Gale MD, 1998, P NATL ACAD SCI USA, V95, P1971, DOI 10.1073/pnas.95.5.1971; Zhu HY, 2003, PLANT PHYSIOL, V131, P1018, DOI 10.1104/pp.102.016436; Bartos J, 2011, THEOR APPL GENET, V122, P1133, DOI 10.1007/s00122-010-1518-z; Cai HW, 2005, THEOR APPL GENET, V112, P158, DOI 10.1007/s00122-005-0118-9; Chen M, 1997, P NATL ACAD SCI USA, V94, P3431, DOI 10.1073/pnas.94.7.3431; Ebina M, 1999, PLANT ANIMAL GENOME, P278; Feltus FA, 2006, PLANT PHYSIOL, V140, P1183, DOI 10.1104/pp.105.074203; Guan XL, 2014, GRASSL SCI, V60, P142, DOI 10.1111/grs.12055; Herrmann D, 2006, THEOR APPL GENET, V112, P536, DOI 10.1007/s00122-005-0158-1; Ishikawa G, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-135; Li ML, 2010, MOL BREEDING, V26, P467, DOI 10.1007/s11032-009-9386-4; Patton AJ, 2010, GOLF COURSE MGMT, V78, P90; Sim S, 2005, THEOR APPL GENET, V110, P1011, DOI 10.1007/s00122-004-1916-1; Timms L, 2006, GENETICS, V173, P2227, DOI 10.1534/genetics.105.049205; Van Deynze AE, 1998, THEOR APPL GENET, V97, P356, DOI 10.1007/s001220050906; VIRUEL MA, 1995, THEOR APPL GENET, V91, P964, DOI 10.1007/BF00223907; Yaneshita M, 1999, THEOR APPL GENET, V98, P751, DOI 10.1007/s001220051131	34	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0925-9864	1573-5109		GENET RESOUR CROP EV	Genet. Resour. Crop Evol.	AUG	2015	62	6					853	862		10.1007/s10722-014-0196-0		10	Agronomy; Plant Sciences	Agriculture; Plant Sciences	CM0AT	WOS:000357341300006		
J	Yoshikawa, S; Kanamatsu, T; Goto, K; Sakamoto, I; Yagi, M; Fujimaki, M; Imura, R; Nemoto, K; Sakaguchi, H				Yoshikawa, Shuro; Kanamatsu, Toshiya; Goto, Kazuhisa; Sakamoto, Izumi; Yagi, Masatoshi; Fujimaki, Mikio; Imura, Riichirou; Nemoto, Kenji; Sakaguchi, Hide			Evidence for erosion and deposition by the 2011 Tohoku-oki tsunami on the nearshore shelf of Sendai Bay, Japan	GEO-MARINE LETTERS			English	Article							INNER CONTINENTAL-SHELF; INDIAN-OCEAN TSUNAMI; KHAO LAK; EARTHQUAKE; SEDIMENT; OFFSHORE; COAST; TRANSPORT; THAILAND; PLAIN	Ongoing geological research into processes operating on the nearshore continental shelf and beyond is vital to our understanding of modern tsunami-generated sediment transport and deposition. This paper investigates the southern part of Sendai Bay, Japan, by means of high-resolution seismic surveys, vibracoring, bathymetric data assimilation, and radioisotope analysis of a core. For the first time, it was possible to identify an erosional surface in the shallow subsurface, formed by both seafloor erosion and associated offshore-directed sediment transport caused by the 2011 Tohoku-oki tsunami. The area of erosion and deposition extends at least 1,100 m offshore from the shoreline down to water depths of 16.7 m. The tsunami-generated sedimentological signature reaches up to 1.2 m below the present seafloor, whereas bathymetric changes due to storm-related reworking over a period of 3 years following the tsunami event have been limited to the upper similar to 0.3 m, despite the fact that the study area is located on an open shelf facing the Pacific Ocean. Tsunami-generated erosion surfaces may thus be preserved for extended periods of time, and may even enter the rock record, because the depth of tsunami erosion can exceed the depth of storm erosion. This finding is also important for interpretation of modern submarine strata, since erosion surfaces in shallow (depths less than similar to 1 m) seismic records from open coast shelves have generally been interpreted as storm-generated surfaces or transgressive ravinement surfaces.	[Yoshikawa, Shuro; Sakaguchi, Hide] Japan Agcy Marine Earth Sci & Technol, Dept Math Sci & Adv Technol, Kanazawa Ku, Yokohama, Kanagawa 2360001, Japan; [Kanamatsu, Toshiya] Japan Agcy Marine Earth Sci & Technol, Res & Dev Ctr Earthquake & Tsunami, Yokosuka, Kanagawa 2370061, Japan; [Goto, Kazuhisa] Tohoku Univ, Int Res Inst Disaster Sci IRIDeS, Aoba Ku, Sendai, Miyagi 9800845, Japan; [Sakamoto, Izumi; Nemoto, Kenji] Tokai Univ, Sch Marine Sci & Technol, Shimizu Ku, Shizuoka 4248610, Japan; [Yagi, Masatoshi] Tokai Univ, Grad Sch Sci & Engn, Shimizu Ku, Shizuoka 4248610, Japan; [Fujimaki, Mikio] Coastal Ocean Res Co Ltd, Taitou Ku, Tokyo 1100016, Japan; [Imura, Riichirou] Fuyo Ocean Dev Engn Co Ltd, Taitou Ku, Tokyo 1110051, Japan	Yoshikawa, S (reprint author), Japan Agcy Marine Earth Sci & Technol, Dept Math Sci & Adv Technol, Kanazawa Ku, 3173-25 Showa Machi, Yokohama, Kanagawa 2360001, Japan.	s-yoshikawa@jamstec.go.jp	Yoshikawa, Shuro/P-3286-2015				Sakuna D, 2012, EARTH PLANETS SPACE, V64, P931, DOI 10.5047/eps.2011.08.010; Goto K, 2012, EARTH PLANETS SPACE, V64, P1247, DOI 10.5047/eps.2012.02.007; Feldens P, 2012, EARTH PLANETS SPACE, V64, P875, DOI 10.5047/eps.2011.09.001; Goff JA, 2010, GEOLOGY, V38, P351, DOI 10.1130/G30632.1; Goff JA, 2005, CONT SHELF RES, V25, P461, DOI 10.1016/j.csr.2004.09.019; Goto K, 2011, MAR GEOL, V290, P46, DOI 10.1016/j.margeo.2011.10.004; Tappin DR, 2012, SEDIMENT GEOL, V282, P151, DOI 10.1016/j.sedgeo.2012.09.011; Arai K, 2013, GEOLOGY, V41, P1195, DOI 10.1130/G34777.1; Flemming BW, 2005, ENCY COASTAL SCI, P954, DOI 10.1007/1-4020-3880-1_315; Goto K, 2014, ANN M SED SOC JAP, P85; Goto K, 2014, MAR GEOL, V358, P38; GSI, 2011, 2011 PAC COAST TOH E; Haraguchi T, 2013, MAR GEOL, V335, P200, DOI 10.1016/j.margeo.2012.11.005; Hayes MO, 1979, BARRIER ISLANDS GULF, P1; Hosoi H, 2009, J JPN SOC CIV ENG B, VB2, P696; Ikehara K, 2013, PLANNING OFFICER RES, P253; Ikehara K, 2014, MAR GEOL, V358, P120, DOI 10.1016/j.margeo.2014.11.004; Noda A, 2007, SEDIMENT GEOL, V200, P314, DOI 10.1016/j.sedgeo.2007.01.010; Nomura K, 1986, ANN J COAST ENG COMM, V33, P267; Oguri K, 2013, SCI REP-UK, V3, DOI 10.1038/srep01915; Saito Y, 1989, SEDIMENTARY FACIES A, P331; Sugawara D, 2012, SEDIMENT GEOL, V282, P110, DOI 10.1016/j.sedgeo.2012.08.002; Sugawara D, 2014, MAR GEOL, V358, P18, DOI 10.1016/j.margeo.2014.05.005; Takeuchi T, 1989, ANN J COAST ENG COMM, V36, P364; TTJS, 2012, FIELD SURV RES; Udo K., 2013, J JAPAN SOC CIVIL EN, V69; Udo K, 2015, POSTTSUNAMI HAZARD R, V44, P225; Yoshikawa S, 2014, MAR GEOL, V353, P84, DOI 10.1016/j.margeo.2014.03.018	28	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0276-0460	1432-1157		GEO-MAR LETT	Geo-Mar. Lett.	AUG	2015	35	4					315	328		10.1007/s00367-015-0409-3		14	Geosciences, Multidisciplinary; Oceanography	Geology; Oceanography	CM4NV	WOS:000357662500006		
J	Masterson, JC; McNamee, EN; Fillon, SA; Hosford, L; Harris, R; Fernando, SD; Jedlicka, P; Iwamoto, R; Jacobsen, E; Protheroe, C; Eltzschig, HK; Colgan, SP; Arita, M; Lee, JJ; Furuta, GT				Masterson, Joanne C.; McNamee, Eoin N.; Fillon, Sophie A.; Hosford, Lindsay; Harris, Rachel; Fernando, Shahan D.; Jedlicka, Paul; Iwamoto, Ryo; Jacobsen, Elizabeth; Protheroe, Cheryl; Eltzschig, Holger K.; Colgan, Sean P.; Arita, Makoto; Lee, James J.; Furuta, Glenn T.			Eosinophil-mediated signalling attenuates inflammatory responses in experimental colitis	GUT			English	Article							POLYUNSATURATED FATTY-ACIDS; MAJOR BASIC-PROTEIN; BOWEL-DISEASE; ULCERATIVE-COLITIS; GASTROINTESTINAL-DISEASES; TRANSGENIC MICE; DEFICIENT MICE; ANIMAL-MODEL; ASTHMA; RESOLUTION	Objective Eosinophils reside in the colonic mucosa and increase significantly during disease. Although a number of studies have suggested that eosinophils contribute to the pathogenesis of GI inflammation, the expanding scope of eosinophil-mediated activities indicate that they also regulate local immune responses and modulate tissue inflammation. We sought to define the impact of eosinophils that respond to acute phases of colitis in mice. Design Acute colitis was induced in mice by administration of dextran sulfate sodium, 2,4,6-trinitrobenzenesulfonic acid or oxazolone to C57BL/6J (control) or eosinophil deficient (PHIL) mice. Eosinophils were also depleted from mice using antibodies against interleukin (IL)-5 or by grafting bone marrow from PHIL mice into control mice. Colon tissues were collected and analysed by immunohistochemistry, flow cytometry and reverse transcription PCR; lipids were analysed by mass spectroscopy. Results Eosinophil-deficient mice developed significantly more severe colitis, and their colon tissues contained a greater number of neutrophils, than controls. This compensatory increase in neutrophils was accompanied by increased levels of the chemokines CXCL1 and CXCL2, which attract neutrophils. Lipidomic analyses of colonic tissue from eosinophil-deficient mice identified a deficiency in the docosahexaenoic acidderived anti-inflammatory mediator 10, 17-dihydroxydocosahexaenoic acid (diHDoHE), namely protectin D1 (PD1). Administration of an exogenous PD1-isomer (10S, 17S-DiHDoHE) reduced the severity of colitis in eosinophil-deficient mice. The PD1-isomer also attenuated neutrophil infiltration and reduced levels of tumour necrosis factor-a, IL-1 beta, IL-6 and inducible NO-synthase in colons of mice. Finally, in vitro assays identified a direct inhibitory effect of PD1-isomer on neutrophil transepithelial migration. Conclusions Eosinophils exert a protective effect in acute mouse colitis, via production of anti-inflammatory lipid mediators.	[Masterson, Joanne C.; Fillon, Sophie A.; Hosford, Lindsay; Harris, Rachel; Fernando, Shahan D.; Furuta, Glenn T.] Univ Colorado, Sch Med, Childrens Hosp Colorado,Sec Pediat Gastroenterol, Digest Hlth Inst,Dept Pediat,Gastrointestinal Eos, Aurora, CO 80045 USA; [Masterson, Joanne C.; McNamee, Eoin N.; Fillon, Sophie A.; Hosford, Lindsay; Harris, Rachel; Fernando, Shahan D.; Eltzschig, Holger K.; Colgan, Sean P.; Furuta, Glenn T.] Univ Colorado, Sch Med, Mucosal Inflammat Program, Aurora, CO USA; [Masterson, Joanne C.; McNamee, Eoin N.; Fillon, Sophie A.; Hosford, Lindsay; Harris, Rachel; Fernando, Shahan D.; Jedlicka, Paul; Eltzschig, Holger K.; Colgan, Sean P.; Furuta, Glenn T.] Univ Colorado, Sch Med, Aurora, CO USA; [McNamee, Eoin N.; Eltzschig, Holger K.] Univ Colorado, Sch Med, Dept Anesthesiol, Aurora, CO USA; [Jedlicka, Paul] Univ Colorado, Sch Med, Dept Pathol, Aurora, CO USA; [Iwamoto, Ryo; Arita, Makoto] Univ Tokyo, Grad Sch Pharmaceut Sci, Dept Hlth Chem, Tokyo, Japan; [Jacobsen, Elizabeth; Protheroe, Cheryl; Arita, Makoto] RIKEN Ctr Integrat Med Sci IMS, Lab Metabol, Yokohama, Kanagawa, Japan; [Jacobsen, Elizabeth; Protheroe, Cheryl; Lee, James J.] Mayo Clin Scottsdale, Dept Biochem & Mol Biol, Scottsdale, AZ USA; [Colgan, Sean P.] Univ Colorado, Sch Med, Dept Med, Aurora, CO USA	Furuta, GT (reprint author), Univ Colorado, Sch Med, Dept Pediat, Sect Pediat Gastroenterol Hepatol & Nutr, 13123 East 16th Ave B290, Aurora, CO 80045 USA.	glenn.furuta@childrenscolorado.org			USA National Institutes of Health [R01-DK62245, K24-DK 100303, R01-HL065228, K26-RR0109709, DK097075, R01-HL0921, R01-DK083385, R01-HL098294, POIHL114457-01]; Crohn's and Colitis Foundation of America; North American Society for Pediatric Gastroenterology Hepatology and Nutrition; Mayo Foundation for Medical Education and Research; Japan Science and Technology Agency Precursory Research for Embryonic Science and Technology; Ministry of Education, Culture, Sports, Science, and Technology of Japan	Grants from the USA National Institutes of Health (R01-DK62245 and K24-DK 100303) (GTF), (R01-HL065228 and K26-RR0109709) (JJL), and (DK097075, R01-HL0921, R01-DK083385, R01-HL098294 and POIHL114457-01) (HKE), Crohn's and Colitis Foundation of America (JCM, HKE), the North American Society for Pediatric Gastroenterology Hepatology and Nutrition (JCM, GTF), the Mayo Foundation for Medical Education and Research (JJL), a Grant-in-aid from the Japan Science and Technology Agency Precursory Research for Embryonic Science and Technology (MA) and a Grant-in-aid from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (MA) were the sources of funding used in the performance of studies including data analysis and manuscript preparation.	Kuhl AA, 2007, GASTROENTEROLOGY, V133, P1882, DOI 10.1053/j.gastro.2007.08.073; Furuta GT, 2005, AM J PHYSIOL-GASTR L, V289, pG890, DOI 10.1152/ajpgi.00015.2005; Arita M, 2012, J BIOCHEM, V152, P313, DOI 10.1093/jb/mvs092; Smith P, 2007, J IMMUNOL, V178, P4557; Masterson JC, 2014, GUT, V63, P43, DOI 10.1136/gutjnl-2012-303631; Ajuebor MN, 2000, AM J PHYSIOL-GASTR L, V279, pG238; Yamada T, 2011, FASEB J, V25, P561, DOI 10.1096/fj.10-170027; Wedemeyer J, 2008, BEST PRACT RES CL GA, V22, P537, DOI 10.1016/j.bpg.2007.12.001; Ahrens R, 2008, J IMMUNOL, V181, P7390; Nei Y, 2013, P NATL ACAD SCI USA, V110, P18620, DOI 10.1073/pnas.1311668110; Masterson JC, 2011, AM J PATHOL, V179, P2302, DOI 10.1016/j.ajpath.2011.07.039; Serhan CN, 2006, J IMMUNOL, V176, P1848; Forbes E, 2004, J IMMUNOL, V172, P5664; Protheroe C, 2009, CLIN GASTROENTEROL H, V7, P749, DOI 10.1016/j.cgh.2009.03.022; Kuhn H, 2006, PROG LIPID RES, V45, P334, DOI 10.1016/j.plipres.2006.02.003; Aherne CM, 2012, GUT, V61, P695, DOI 10.1136/gutjnl-2011-300012; Marcheselli VL, 2003, J BIOL CHEM, V278, P43807, DOI 10.1074/jbc.M305841200; Campbell EL, 2014, IMMUNITY, V40, P66, DOI 10.1016/j.immuni.2013.11.020; Ibrahim A, 2011, CLIN NUTR, V30, P678, DOI 10.1016/j.clnu.2011.05.002; Lee JJ, 2004, SCIENCE, V305, P1773, DOI 10.1126/science.1099472; Lampinen M, 2005, GUT, V54, P1714, DOI 10.1136/gut.2005.066423; Hogan SP, 2009, IMMUNOL ALLERGY CLIN, V29, P129, DOI 10.1016/j.iac.2008.10.004; Schwab JM, 2007, NATURE, V447, P869, DOI 10.1038/nature05877; Jacobsen EA, 2007, CURR ALLERGY ASTHM R, V7, P18, DOI 10.1007/s11882-007-0026-y; Rothenberg ME, 2006, ANNU REV IMMUNOL, V24, P147, DOI 10.1146/annurev.immunol.24.021605.090720; Hogan SP, 2008, CLIN EXP ALLERGY, V38, P709, DOI 10.1111/j.1365-2222.2008.02958.x; Bannenberg G, 2010, BBA-MOL CELL BIOL L, V1801, P1260, DOI 10.1016/j.bbalip.2010.08.002; Shoda R, 1996, AM J CLIN NUTR, V63, P741; Hudert CA, 2006, P NATL ACAD SCI USA, V103, P11276, DOI 10.1073/pnas/0601280103; Jacobsen EA, 2014, ALLERGY, V69, P315, DOI 10.1111/all.12321; Marcheselli VL, 2010, PROSTAG LEUKOTR ESS, V82, P27, DOI 10.1016/j.plefa.2009.10.010; Levy BD, 2007, J IMMUNOL, V178, P496; McNamee EN, 2011, P NATL ACAD SCI USA, V108, P16711, DOI 10.1073/pnas.1111982108; Vieira AT, 2009, AM J PATHOL, V175, P2382, DOI 10.2353/ajpath.2009.090093; KROMANN N, 1980, ACTA MED SCAND, V208, P401; Sakamoto N, 2005, INFLAMM BOWEL DIS, V11, P154, DOI 10.1097/00054725-200502000-00009; Colgan SP, 1996, J EXP MED, V184, P1003, DOI 10.1084/jem.184.3.1003; Bento AF, 2011, J IMMUNOL, V187, P1957, DOI 10.4049/jimmunol.1101305; Chu VT, 2014, IMMUNITY, V40, P582, DOI 10.1016/j.immuni.2014.02.014; Furuta GT, 1998, BLOOD, V92, P1055; Boyce JA, 2012, J ALLERGY CLIN IMMUN, V129, P335, DOI 10.1016/j.jaci.2011.12.968; Chen P, 2009, FEBS LETT, V583, P3478, DOI 10.1016/j.febslet.2009.10.004; Chu Van Trung, 2011, Nat Immunol, V12, P151, DOI 10.1038/ni.1981; Forbes E, 2006, J LEUKOCYTE BIOL, V80, P330, DOI 10.1189/jlb.1105643; HILLIER K, 1991, GUT, V32, P1151, DOI 10.1136/gut.32.10.1151; Hogan SP, 2013, CURR OPIN GASTROEN, V29, P7, DOI 10.1097/MOG.0b013e32835ab29a; Isobe Y, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00270; Katz MS, 2012, J PEDIATR SURG, V47, P194, DOI 10.1016/j.jpedsurg.2011.10.043; Ma BW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047416; Masterson JC, 2011, CURR OPIN GASTROEN, V27, P515, DOI 10.1097/MOG.0b013e32834b314c; Matsunaga H, 2009, CLIN EXP IMMUNOL, V158, P325, DOI 10.1111/j.1365-2249.2009.04020.x; Miyata J, 2013, J ALLERGY CLIN IMMUN, V131, P353, DOI 10.1016/j.jaci.2012.07.048; OFLAHERTY JT, 1985, PROSTA LEUKOTR MED, V17, P199, DOI 10.1016/0262-1746(85)90107-6; Specht S, 2006, MICROBES INFECT, V8, P694, DOI 10.1016/j.micinf.2005.09.006; Stasikowska-Kanicka O, 2012, ADV MED SCI-POLAND, V57, P230, DOI 10.2478/v10039-012-0029-3; Stevceva L, 2000, GENES IMMUN, V1, P213, DOI 10.1038/sj.gene.6363654; Varma S, 2010, LIPIDS, V45, P843, DOI 10.1007/s11745-010-3455-7; Woodruff SA, 2011, J PEDIATR GASTR NUTR, V52, P650, DOI 10.1097/MPG.0b013e3182128512	58	2	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0017-5749	1468-3288		GUT	Gut	AUG	2015	64	8					1236	1247		10.1136/gutjnl-2014-306998		12	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CM4ZZ	WOS:000357697000009		
J	King, LY; Canasto-Chibuque, C; Johnson, KB; Yip, S; Chen, XT; Kojima, K; Deshmukh, M; Venkatesh, A; Tan, PS; Sun, XC; Villanueva, A; Sangiovanni, A; Nair, V; Mahajan, M; Kobayashi, M; Kumada, H; Iavarone, M; Colombo, M; Fiel, MI; Friedman, SL; Llovet, JM; Chung, RT; Hoshida, Y				King, Lindsay Y.; Canasto-Chibuque, Claudia; Johnson, Kara B.; Yip, Shun; Chen, Xintong; Kojima, Kensuke; Deshmukh, Manjeet; Venkatesh, Anu; Tan, Poh Seng; Sun, Xiaochen; Villanueva, Augusto; Sangiovanni, Angelo; Nair, Venugopalan; Mahajan, Milind; Kobayashi, Masahiro; Kumada, Hiromitsu; Iavarone, Massimo; Colombo, Massimo; Fiel, Maria Isabel; Friedman, Scott L.; Llovet, Josep M.; Chung, Raymond T.; Hoshida, Yujin			A genomic and clinical prognostic index for hepatitis C-related early-stage cirrhosis that predicts clinical deterioration	GUT			English	Article							HEPATOCELLULAR-CARCINOMA; VIRUS-INFECTION; GENE-EXPRESSION; UNITED-STATES; FIBROSIS; CHALLENGES; MORTALITY; DISEASE; BURDEN; SURVEILLANCE	Objective The number of patients with HCV-related cirrhosis is increasing, leading to a rising risk of complications and death. Prognostic stratification in patients with early-stage cirrhosis is still challenging. We aimed to develop and validate a clinically useful prognostic index based on genomic and clinical variables to identify patients at high risk of disease progression. Design We developed a prognostic index, comprised of a 186-gene signature validated in our previous genome-wide profiling study, bilirubin (>1 mg/dL) and platelet count (<100 000/mm(3)), in an Italian HCV cirrhosis cohort (training cohort, n=216, median follow-up 10 years). The gene signature test was implemented using a digital transcript counting (nCounter) assay specifically developed for clinical use and the prognostic index was evaluated using archived specimens from an independent cohort of HCV-related cirrhosis in the USA (validation cohort, n=145, median follow-up 8 years). Results In the training cohort, the prognostic index was associated with hepatic decompensation (HR=2.71, p=0.003), overall death (HR=6.00, p<0.001), hepatocellular carcinoma (HR=3.31, p=0.001) and progression of Child-Turcotte-Pugh class (HR=6.70, p<0.001). The patients in the validation cohort were stratified into high-risk (16%), intermediate-risk (42%) or low-risk (42%) groups by the prognostic index. The high-risk group had a significantly increased risk of hepatic decompensation (HR=7.36, p<0.001), overall death (HR=3.57, p=0.002), liver-related death (HR=6.49, p<0.001) and all liver-related adverse events (HR=4.98, p<0.001). Conclusions A genomic and clinical prognostic index readily available for clinical use was successfully validated, warranting further clinical evaluation for prognostic prediction and clinical trial stratification and enrichment for preventive interventions.	[King, Lindsay Y.; Johnson, Kara B.; Chung, Raymond T.] Harvard Univ, Sch Publ Hlth, Massachusetts Gen Hosp, Dept Med,Liver Ctr & Gastrointestinal Div, Boston, MA 02115 USA; [Canasto-Chibuque, Claudia; Yip, Shun; Chen, Xintong; Kojima, Kensuke; Deshmukh, Manjeet; Venkatesh, Anu; Tan, Poh Seng; Sun, Xiaochen; Friedman, Scott L.; Llovet, Josep M.; Hoshida, Yujin] Icahn Sch Med Mt Sinai, Hess Ctr Sci & Med, Dept Med, Div Liver Dis,Tisch Canc Inst,Liver Canc Program, New York, NY 10029 USA; [Tan, Poh Seng] Natl Univ Hlth Syst, Univ Med Cluster, Div Gastroenterol & Hepatol, Singapore, Singapore; [Villanueva, Augusto] Kings Coll London, Inst Liver Sci, London, England; [Sangiovanni, Angelo; Iavarone, Massimo; Colombo, Massimo] Univ Milan, M&A Migliavacca Ctr Liver Dis, Milan, Italy; [Sangiovanni, Angelo; Iavarone, Massimo; Colombo, Massimo] Univ Milan, Div Gastroenterol 1, Fdn IRCCS Granda Osped Maggiore Policlin, Milan, Italy; [Nair, Venugopalan] Icahn Sch Med Mt Sinai, Dept Neurol, New York, NY 10029 USA; [Mahajan, Milind] Icahn Sch Med Mt Sinai, Inst Genom & Multiscale Biol, New York, NY 10029 USA; [Kobayashi, Masahiro; Kumada, Hiromitsu] Toranomon Gen Hosp, Dept Hepatol, Tokyo, Japan; [Fiel, Maria Isabel] Icahn Sch Med Mt Sinai, Dept Pathol, New York, NY 10029 USA; [Llovet, Josep M.] Hosp Clin Barcelona, Inst Invest Biomed August & Sunyer Ctr Invest Red, Barcelona Clin Liver Canc Grp, HCC Translat Res Lab, Barcelona, Catalonia, Spain; [Llovet, Josep M.] ICREA, Barcelona, Catalonia, Spain	Hoshida, Y (reprint author), Icahn Sch Med Mt Sinai, Hess Ctr Sci & Med, Dept Med, Div Liver Dis,Tisch Canc Inst,Liver Canc Program, 1470 Madison Ave,Box 1123, New York, NY 10029 USA.	yujin.hoshida@mssm.edu		Llovet, Josep M/0000-0003-0547-2667	National Institute of Health [DK099558, DA033541, DK098079, DK078772, DK56621, AA020709, DK076986, DK007191]; European Commission; Samuel Waxman Cancer Research Foundation; Spanish National Health Institute [SAF-2010-16055]; Asociacion Espanola para el Estudio del Cancer (AECC)	This research was supported by the National Institute of Health (DK099558 to YH; DA033541, DK098079, DK078772 to RTC; DK56621 and AA020709 to SLF; DK076986 to JML; DK007191 to LYK and KBJ); the European Commission Framework Programme 7 (Heptromic, proposal number 259744 to YH, JML); the Samuel Waxman Cancer Research Foundation, the Spanish National Health Institute (SAF-2010-16055) and the Asociacion Espanola para el Estudio del Cancer (AECC) to JML.	Lippman SM, 2009, JAMA-J AM MED ASSOC, V301, P39, DOI 10.1001/jama.2008.864; Simon R, 2008, CLIN CANCER RES, V14, P5984, DOI 10.1158/1078-0432.CCR-07-4531; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Singh S, 2014, NAT REV GASTRO HEPAT, V11, P45, DOI 10.1038/nrgastro.2013.143; Hoshida Y, 2013, GASTROENTEROLOGY, V144, P1024, DOI 10.1053/j.gastro.2013.01.021; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Chou R, 2013, ANN INTERN MED, V158, P807, DOI 10.7326/0003-4819-158-11-201306040-00005; Villanueva A, 2011, GASTROENTEROLOGY, V140, P1501, DOI 10.1053/j.gastro.2011.02.006; El-Serag HB, 2014, GASTROENTEROLOGY, V146, P1249, DOI 10.1053/j.gastro.2014.01.045; Ly KN, 2012, ANN INTERN MED, V156, P271, DOI 10.7326/0003-4819-156-4-201202210-00004; Kamath PS, 2007, HEPATOLOGY, V45, P797, DOI 10.1002/hep.21563; Chung RT, 2014, NEW ENGL J MED, V370, P1576, DOI 10.1056/NEJMp1400986; Smith JO, 2009, ALIMENT PHARM THER, V30, P557, DOI 10.1111/j.1365-2036.2009.04062.x; ISHAK K, 1995, J HEPATOL, V22, P696, DOI 10.1016/0168-8278(95)80226-6; Lok AS, 2011, GASTROENTEROLOGY, V140, P840, DOI 10.1053/j.gastro.2010.11.050; Fuchs BC, 2014, HEPATOLOGY, V59, P1577, DOI 10.1002/hep.26898; Davila JA, 2011, ANN INTERN MED, V154, P85, DOI [10.7326/0003-4819-154-2-201101180-00006, 10.1059/0003-4819-154-2-201101180-00006]; Nault JC, 2013, GASTROENTEROLOGY, V145, P176, DOI 10.1053/j.gastro.2013.03.051; van der Meer AJ, 2012, JAMA-J AM MED ASSOC, V308, P2584, DOI 10.1001/jama.2012.144878; Forner A, 2012, LANCET, V379, P1245, DOI 10.1016/S0140-6736(11)61347-0; Garraway LA, 2013, J CLIN ONCOL, V31, P1806, DOI 10.1200/JCO.2012.46.8934; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Singal AG, 2013, AM J GASTROENTEROL, V108, P1723, DOI 10.1038/ajg.2013.332; Friedman SL, 2010, NAT REV GASTRO HEPAT, V7, P425, DOI 10.1038/nrgastro.2010.97; Northcott PA, 2012, ACTA NEUROPATHOL, V123, P615, DOI 10.1007/s00401-011-0899-7; Dufour JF, 2013, GASTROENTEROLOGY, V144, P876, DOI 10.1053/j.gastro.2013.03.015; Sangiovanni A, 2004, GASTROENTEROLOGY, V126, P1005, DOI 10.1053/j.gastro.2003.12.049; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Hoshida Y, 2008, NEW ENGL J MED, V359, P1995, DOI 10.1056/NEJMoa0804525; Jacobson IM, 2010, CLIN GASTROENTEROL H, V8, P924, DOI 10.1016/j.cgh.2010.06.032; BECK JR, 1982, AM J MED, V73, P889, DOI 10.1016/0002-9343(82)90787-2; Bruix J, 2011, GASTROENTEROLOGY, V140, P1990, DOI 10.1053/j.gastro.2011.03.010; COLOMBO M, 1991, NEW ENGL J MED, V325, P675, DOI 10.1056/NEJM199109053251002; El-Serag HB, 2011, NEW ENGL J MED, V365, P1118, DOI 10.1056/NEJMra1001683; Llovet JM, 2012, J HEPATOL, V56, P908; Hoshida Y, 2012, CURR CANCER DRUG TAR, V12, P1129; Hoshida Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015543; Kojima K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086961; Koscielny S, 2010, SCI TRANSL MED, V2, p14ps2; Myers RP, 2014, CAN J GASTROENTEROL, V28, P243; Okita K, 2014, J GASTROENTEROL; Reis PP, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-46; The French METAVIR Cooperative Study Group, 1994, HEPATOLOGY, V20, P15, DOI DOI 10.1002/HEP.1840200104.PUBMED:8020885; van der Meer AJ, 2015, GUT, V64, P322, DOI 10.1136/gutjnl-2013-305357; Wong Kwong-Fai, 2013, Expert Opin Med Diagn, V7, P319, DOI 10.1517/17530059.2013.795146; Zalesak M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063959	46	2	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0017-5749	1468-3288		GUT	Gut	AUG	2015	64	8					1296	1302		10.1136/gutjnl-2014-307862		7	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CM4ZZ	WOS:000357697000017		
J	Masamune, A; Nakano, E; Hamada, S; Kakuta, Y; Kume, K; Shimosegawa, T				Masamune, Atsushi; Nakano, Eriko; Hamada, Shin; Kakuta, Yoichi; Kume, Kiyoshi; Shimosegawa, Tooru			Common variants at PRSS1-PRSS2 and CLDN2-MORC4 loci associate with chronic pancreatitis in Japan	GUT			English	Letter							RISK		[Masamune, Atsushi; Nakano, Eriko; Hamada, Shin; Kakuta, Yoichi; Kume, Kiyoshi; Shimosegawa, Tooru] Tohoku Univ, Grad Sch Med, Div Gastroenterol, Sendai, Miyagi 9808574, Japan	Masamune, A (reprint author), Tohoku Univ, Grad Sch Med, Div Gastroenterol, Aoba Ku, 1-1 Seiryo Machi, Sendai, Miyagi 9808574, Japan.	amasamune@med.tohoku.ac.jp					Whitcomb DC, 2012, NAT GENET, V44, P1349, DOI 10.1038/ng.2466; Derikx MH, 2014, GUT, DOI [10.1136/gutjnl-2014-307453., DOI 10.1136/GUTJNL-2014-307453]; Kume K, 2015, PANCREAS, V44, P53, DOI 10.1097/MPA.0000000000000256; Masamune A, 2014, TOHOKU J EXP MED, V232, P69, DOI 10.1620/tjem.232.69	4	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0017-5749	1468-3288		GUT	Gut	AUG	2015	64	8					1345	1346		10.1136/gutjnl-2015-309802		2	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CM4ZZ	WOS:000357697000027		
J	Takahashi, F; Sato, K; Endo, A; Ono, K; Ban, N; Hasegawa, T; Katsunuma, Y; Yoshitake, T; Kai, M				Takahashi, Fumiaki; Sato, Kaoru; Endo, Akira; Ono, Koji; Ban, Nobuhiko; Hasegawa, Takayuki; Katsunuma, Yasushi; Yoshitake, Takayasu; Kai, Michiaki			Numerical Analysis of Organ Doses Delivered During Computed Tomography Examinations Using Japanese Adult Phantoms with the WAZA-ARI Dosimetry System	HEALTH PHYSICS			English	Article							MONTE-CARLO SIMULATIONS; CT EXAMINATIONS; ANTHROPOMORPHIC PHANTOMS; PATIENT; FEASIBILITY; PARTICLE; MODELS; FEMALE; SCANS	A dosimetry system for computed tomography (CT) examinations, named WAZA-ARI, is being developed to accurately assess radiation doses to patients in Japan. For dose calculations in WAZA-ARI, organ doses were numerically analyzed using average adult Japanese male (JM) and female (JF) phantoms with the Particle and Heavy Ion Transport code System (PHITS). Experimental studies clarified the photon energy distribution of emitted photons and dose profiles on the table for some multi-detector row CT (MDCT) devices. Numerical analyses using a source model in PHITS could specifically take into account emissions of x rays from the tube to the table with attenuation of photons through a beam-shaping filter for each MDCT device based on the experiment results. The source model was validated by measuring the CT dose index (CTDI). Numerical analyses with PHITS revealed a concordance of organ doses with body sizes of the JM and JF phantoms. The organ doses in the JM phantoms were compared with data obtained using previously developed systems. In addition, the dose calculations in WAZA-ARI were verified with previously reported results by realistic NUBAS phantoms and radiation dose measurement using a physical Japanese model (THRA1 phantom). The results imply that numerical analyses using the Japanese phantoms and specified source models can give reasonable estimates of dose for MDCT devices for typical Japanese adults.	[Takahashi, Fumiaki; Sato, Kaoru; Endo, Akira] Japan Atom Energy Agcy, Tokai, Ibaraki 3191195, Japan; [Ono, Koji; Ban, Nobuhiko] Tokyo Healthcare Univ, Tokyo, Japan; [Hasegawa, Takayuki] Tokai Univ, Oiso Hosp, Hiratsuka, Kanagawa 25912, Japan; [Katsunuma, Yasushi] Tokai Univ Hosp, Tokai, Ibaraki, Japan; [Yoshitake, Takayasu] Shin Beppu Hosp, Beppu, Oita, Japan; [Kai, Michiaki] Oita Univ Nursing & Hlth Sci, Oita, Japan	Takahashi, F (reprint author), Japan Atom Energy Agcy, 2-4 Shirakata, Tokai, Ibaraki 3191195, Japan.	takahashi.fumiaki@jaea.go.jp			Ministry of Education, Science, Sports and Culture (MEXT)	The authors wish to thank Siemens Healthcare Japan (Siemens Asahi Medics Corporation) and GE Healthcare Japan for their important help with our work. This work has been supported by the Ministry of Education, Science, Sports and Culture (MEXT), Grant-in-Aid for Scientific Research.	Lee C, 2010, PHYS MED BIOL, V55, P339, DOI 10.1088/0031-9155/55/2/002; Ban N, 2011, RADIAT PROT DOSIM, V147, P333, DOI 10.1093/rpd/ncr333; Turner AC, 2009, MED PHYS, V36, P2154, DOI 10.1118/1.3117683; Liu HK, 2010, PHYS MED BIOL, V55, P1441, DOI 10.1088/0031-9155/55/5/012; Zhang D, 2009, MED PHYS, V36, P1025, DOI 10.1118/1.3078053; Lee C, 2007, PHYS MED BIOL, V52, P3309, DOI 10.1088/0031-9155/52/12/001; Fujii K, 2009, BRIT J RADIOL, V82, P1010, DOI 10.1259/bjr/13320880; Turner AC, 2010, MED PHYS, V37, P1816, DOI 10.1118/1.3368596; Lee C, 2011, MED PHYS, V38, P1196, DOI 10.1118/1.3544658; Sato T, 2013, J NUCL SCI TECHNOL, V50, P913, DOI 10.1080/00223131.2013.814553; Gu J, 2009, PHYS MED BIOL, V54, P2699, DOI 10.1088/0031-9155/54/9/007; Turner AC, 2011, MED PHYS, V38, P820, DOI 10.1118/1.3533897; Ban N, 2011, RADIAT PROT DOSIM, V146, P244, DOI 10.1093/rpd/ncr161; Hubbell J.H., 1995, 5632 NISTIR; International Commission on Radiation Units and Measurements, 1989, 44 INT COMM RAD UN M; International Commission on Radiological Protection, 2002, ICRP PUBL, V89; International Commission on Radiological Protection, 2007, ANN ICRP, V102, P1; International Commission on Radiological Protection, 2007, ICRP PUBL, V103; Jansen JT, 2011, PROG NUCLEAR SCI TEC, V2, P165; Jansen JTM, 1996, BRIT J RADIOL, V69, P33; Jones DG, 1991, NRPBR250; Kim KP, 2012, RADIAT PROT DOSIM, V150, P415, DOI 10.1093/rpd/ncr429; Li X, 2010, MED PHYS, V38, P397; Nowotny R, 1985, Rofo, V142, P685, DOI 10.1055/s-2008-1052738; Sato K, 2011, CONSTRUCTION AVERAGE; Satoh D, 2010, J NUCL SCI TECHNOL, V47, P62, DOI 10.3327/jnst.47.62; Schlattl H, 2010, PHYS MED BIOL, V55, P6243, DOI 10.1088/0031-9155/55/20/013; Shimomura K, 2005, P 12 EGS UNS M JAP T, p[2005, 99]; Shrimpton PC, 1991, NRPBR249; Stamm D, 2002, ROFO FORTSCHR RONTG, V174, P1570; Takahashi F, 2011, RADIAT PROT DOSIM, V146, P241, DOI 10.1093/rpd/ncr160; Takahashi F, 2011, PROGR NUC SCI TECH, V2, P153; Takahashi F, 2011, PROG NUCL SCI TECHNO, V1, P517; Tanaka G, 1996, NIRSM115; United Nations Scientific Committee on the Effects of Atomic Radiation, 2010, 2008 REP GEN ASS ANN; Veit R, 1991, TOMOGRAPHIC ANTHROPO; Zankl M, 1991, CALCULATION DOSE EXT	37	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0017-9078	1538-5159		HEALTH PHYS	Health Phys.	AUG	2015	109	2					104	112		10.1097/HP.0000000000000299		9	Environmental Sciences; Public, Environmental & Occupational Health; Nuclear Science & Technology; Radiology, Nuclear Medicine & Medical Imaging	Environmental Sciences & Ecology; Public, Environmental & Occupational Health; Nuclear Science & Technology; Radiology, Nuclear Medicine & Medical Imaging	CM2GV	WOS:000357498800002		
J	Yajima, K; Kurihara, O; Ohmachi, Y; Takada, M; Omori, Y; Akahane, K; Kim, E; Torikoshi, M; Yonehara, H; Yoshida, S; Sakai, K; Akashi, M				Yajima, Kazuaki; Kurihara, Osamu; Ohmachi, Yasushi; Takada, Masashi; Omori, Yasutaka; Akahane, Keiichi; Kim, Eunjoo; Torikoshi, Masami; Yonehara, Hidenori; Yoshida, Satoshi; Sakai, Kazuo; Akashi, Makoto			Estimating Annual Individual Doses for Evacuees Returning Home to Areas Affected by the Fukushima Nuclear Accident	HEALTH PHYSICS			English	Article							POWER-PLANT	To contribute to the reconstruction and revitalization of Fukushima Prefecture following the 2011 nuclear power disaster, annual individual doses were estimated for evacuees who will return home to Tamura City, Kawauchi Village, and Iitate Village in Fukushima. Ambient external dose rates and individual doses obtained with personal dosimeters were measured at many residential and occupational sites throughout the study areas to obtain fundamental data needed for the estimation. The measurement results indicated that the ratio of individual dose based on a personal dosimeter to the ambient external dose measurement was 0.7 with 10% uncertainty. Multiplying the ambient external dose by 0.7 may be an appropriate measure of the effective dose to an individual in the investigated area. Annual individual doses were estimated for representative lifestyles and occupations based on the ambient external dose rates at the measurement sites, taking into account the relationship between the ambient external dose and individual dose. The results were as follows: 0.6-2.3 mSv y(-1) in Tamura, 1.1-5.5 mSv y(-1) in Kawauchi, and 3.8-17 mSv y(-1) in Iitate. For all areas investigated, the estimated dose to outdoor workers was higher than that to indoor workers. Identifying ways to reduce the amount of time that an outdoor worker spends outdoors would provide an effective measure to reduce dose.	[Yajima, Kazuaki; Kurihara, Osamu; Ohmachi, Yasushi; Akahane, Keiichi; Kim, Eunjoo; Yonehara, Hidenori; Yoshida, Satoshi; Sakai, Kazuo; Akashi, Makoto] Natl Inst Radiol Sci, Inage Ku, Chiba 2638555, Japan; [Takada, Masashi] Natl Def Acad Japan, Dept Appl Phys, Yokosuka, Kanagawa 2398686, Japan; [Omori, Yasutaka] Fukushima Med Univ, Sch Med, Dept Radiat Phys & Chem, Fukushima 9601295, Japan; [Torikoshi, Masami] Tohto Coll Hlth Sci, Dept Human Care, Nishi Ku, Fukaya City, Saitama 3660052, Japan	Yajima, K (reprint author), Natl Inst Radiol Sci, Inage Ku, 4-9-1 Anagawa, Chiba 2638555, Japan.	k_yajima@nirs.go.jp					Andoh M, 2015, J ENVIRON RADIOACTIV, V139, P266, DOI 10.1016/j.jenvrad.2014.05.014; [Anonymous], 2014, INT EXP M RAD PROT F; Hirayama Hideo, 2013, Radioisotopes, V62, P335; International Atomic Energy Agency, 1979, IAEATECDOC225, V225; International Commission on Radiological Protection, 2007, ANN ICRP, V103, P37; International Commission on Radiological Protection, 1996, ANN ICRP, V74; Mikami S, 2015, J ENVIRON RADIOACTIV, V139, P250, DOI 10.1016/j.jenvrad.2014.08.020; Ministry of Economy Trade and Industry, 2014, RAD DOS EV DIR AR E; Ministry of Economy Trade and Industry, 2012, PRACT OP DES AR WHIC; Ministry of the Environment, 2013, REC GREAT E JAP EART; Miyaushiro N, 2013, DEV INNOVATIVE RAD M, P132; NHK Broadcasting Culture Research Institute, 2011, NHK DAT BOOK 2010 NA; Nuclear Emergency Response Headquarters Government of Japan, 2011, JAP GOV IAEA MIN C N; Nuclear Regulation Authority of Japan, 2013, PRACT MEAS EV RET TH; Nuclear Regulation Authority of Japan, 2014, MON INF ENV RAD LEV; Saito K, 2014, RADIAT PROT DOSIM, V160, P283, DOI 10.1093/rpd/ncu011; Takada M, 2014, PROG NUCL SCI TECHNO, V4, P43; Tominaga T, 2012, RAD EMERGENCY MED, V1, P56	18	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0017-9078	1538-5159		HEALTH PHYS	Health Phys.	AUG	2015	109	2					122	133		10.1097/HP.0000000000000308		12	Environmental Sciences; Public, Environmental & Occupational Health; Nuclear Science & Technology; Radiology, Nuclear Medicine & Medical Imaging	Environmental Sciences & Ecology; Public, Environmental & Occupational Health; Nuclear Science & Technology; Radiology, Nuclear Medicine & Medical Imaging	CM2GV	WOS:000357498800005		
J	Watanabe, H; Maehara, Y; Fujibuchi, T; Koizumi, M; Yamaguchi, I; Kida, T; Ooyama, M; Horitsugi, G; Hiraki, H; Tsukamoto, A; Itami, J				Watanabe, Hiroshi; Maehara, Yoshiaki; Fujibuchi, Toshioh; Koizumi, Mitsue; Yamaguchi, Ichiro; Kida, Tetsuo; Ooyama, Masaya; Horitsugi, Genki; Hiraki, Hitoshi; Tsukamoto, Atsuko; Itami, Jyun			Assessing the Effectiveness of Risk Communication for Maintenance Workers Who Deal With Induced Radioactivity Management of Medical Linear Accelerators	HEALTH PHYSICS			English	Article							RADIATION-THERAPY; ACTIVATION	In Japan, an amended law that mandates levels of unintended induced radioactivity has been in effect since 1 April 2012. According to the new regulation, if the concentration of induced radioactivity in affected parts is above the clearance level, the parts must be regarded as radioactive even if they weigh less than 1 kg. This regulation reform raises several new issues concerning medical linear accelerators, including how to determine the decay period for induced radioactivity before maintenance can be performed and how to identify what parts should be considered radioactive waste. The authors performed several risk communication (RC) activities aimed at improving the understanding of maintenance workers at medical accelerator manufacturers and establishing good guidelines by involving stakeholders. For this purpose, a working group was established and conducted RC activities, such as holding opinion exchange meetings between medical staff and maintenance workers and creating a booklet to answer questions from maintenance workers. To evaluate these activities, three questionnaire surveys were conducted between 2011 and 2014. According to the results of this study, the ratio of maintenance workers who accepted "The decay period is within one week" was approximately 60% at the third survey and significantly increased (P < 0.0001) during the survey period. Approximately 25% of the maintenance workers felt that not enough information was provided about the decay period, and approximately 63% thought that the information provided on the health effects of radiation was sufficient. These results suggest that the present RC was successful.	[Watanabe, Hiroshi] Yokohama Rosai Hosp, Japan Labour Hlth & Welf Org, Dept Radiol Technol, Kohoku Ku, Yokohama, Kanagawa 2220036, Japan; [Watanabe, Hiroshi] Suzuka Univ Med Sci, Grad Sch Hlth Sci, Suzuka, Mie 5100293, Japan; [Maehara, Yoshiaki] St Marianna Univ, Sch Med Hosp, Imaging Ctr, Miyamae Ku, Kawasaki, Kanagawa 2168511, Japan; [Fujibuchi, Toshioh] Kyushu Univ, Grad Sch Med Sci, Fac Med Sci, Med Quantum Sci,Dept Hlth Sci,Higashi Ku, Fukuoka 812, Japan; [Koizumi, Mitsue] Kawasaki Municipal Tama Hosp, Diagnost Imaging, Tama Ku, Kawasak Cityi, Kanagawa 2148525, Japan; [Yamaguchi, Ichiro] Natl Inst Publ Hlth, Dept Environm Hlth, Minami Ku, Wako, Saitama 3510197, Japan; [Kida, Tetsuo] Shiga Univ Med Sci Hosp, Dept Radiol Serv, Ootsu City, Shiga 5202192, Japan; [Ooyama, Masaya] Natl Hosp Org Chiba East Hosp, Dept Radiol, Cyuou Ku, Chiba 2608712, Japan; [Horitsugi, Genki] Osaka Univ, Grad Sch Med, Dept Nucl Med & Tracer Kinet, Suita, Osaka, Japan; [Hiraki, Hitoshi] Teikyo Univ, Sch Med, Univ Hosp, Dept Radiol Technol,Takatsu Ku, Kawasaki, Kanagawa 2138507, Japan; [Tsukamoto, Atsuko] NTT Med Ctr Tokyo, Dept Radiol, Shinagawa Ku, Tokyo 1418625, Japan; [Itami, Jyun] Natl Canc Ctr, Dept Radiat Oncol, Chuo Ku, Tokyo, Japan	Watanabe, H (reprint author), Yokohama Rosai Hosp, Japan Labour Hlth & Welf Org, Dept Radiol Technol, Kohoku Ku, 3211 Kozukue Chou, Yokohama, Kanagawa 2220036, Japan.	hiwatanabe-jsnmt@umin.ac.jp			Japanese Society of Radiological Technologists; Health and Labour Sciences Research Grants, Research on Region Medical [H26-medicine-general-019]	We appreciate the maintenance staff of the radiation therapy equipment manufacturers who cooperated with the study and the help received from Hitoshi Tsuchiya, Ryohei Nakayama, Kozo Fujisawa, and Yasuo Chinzei (Suzuka University of Medical Science, Graduate School). Some of the present study was supported with research funding from the Japanese Society of Radiological Technologists in 2010 and 2011 and Health and Labour Sciences Research Grants, Research on Region Medical (H26-medicine-general-019).	ALMEN A, 1991, PHYS MED BIOL, V36, P815, DOI 10.1088/0031-9155/36/6/009; Fischer HW, 2008, HEALTH PHYS, V94, P272, DOI 10.1097/01.HP.0000291945.15684.a7; BECKHAM WA, 1990, BRIT J RADIOL, V63, P298; Fujibuchi T, 2011, RADIAT PROT DOSIM, V148, P168; Fukuma H, 2010, JAPANESE J RADIOLOGI, V66, P495; IEC, 2009, 6060121 IEC; National Research Council, 1989, IMPR RISK COMM; Okoshi Minoru, 2007, Transactions of the Atomic Energy Society of Japan, V6; Perrin B, 2003, PHYS MED BIOL, V48, pN75, DOI 10.1088/0031-9155/48/5/402; R Development Core Team, 2011, R LANG ENV STAT COMP; Rawlinson JA, 2002, MED PHYS, V29, P598, DOI 10.1118/1.1463063; Suzuki Y, 2010, JAPANESE J RADIOLOGI, V66, P599; U. S. Environmental Protection Agency, 1988, RISK DEC MAK, P87; Watanabe H, 2013, JAPANESE J RADIOLOGI, V69, P1353; Yamaguchi I, 2010, RADIOL PHYS TECHNOL, V2, P98	15	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0017-9078	1538-5159		HEALTH PHYS	Health Phys.	AUG	2015	109	2					145	156		10.1097/HP.0000000000000306		12	Environmental Sciences; Public, Environmental & Occupational Health; Nuclear Science & Technology; Radiology, Nuclear Medicine & Medical Imaging	Environmental Sciences & Ecology; Public, Environmental & Occupational Health; Nuclear Science & Technology; Radiology, Nuclear Medicine & Medical Imaging	CM2GV	WOS:000357498800007		
J	Guo, Y; Deng, BQ; Ge, DQ; Shen, XZ				Guo, Yuan; Deng, Baoqing; Ge, Daqiang; Shen, Xiuzhong			CFD simulation on hydrodynamics in fluidized beds: assessment of gradient approximations and turbulence models	HEAT AND MASS TRANSFER			English	Article							EXPERIMENTAL VALIDATION; KINETIC-THEORY; GRANULAR FLOW; SOLIDS; RISER; DISPERSION; REACTORS	CFD simulations of gas-solid fluidized beds have been performed in Euler-Euler framework. Green-Gauss Cell Based gradient approximation can predict the solid velocity well among gradient approximations. The dispersed choice in the turbulence model can reproduce the solid velocity correctly while the mixture and per phase choices cannot. The standard k-epsilon model, RNG k-epsilon model and SST k-omega model with the dispersed choice can predict the solid velocity well.	[Guo, Yuan; Deng, Baoqing; Ge, Daqiang] Univ Shanghai Sci & Technol, Dept Environm Sci & Engn, Shanghai 200093, Peoples R China; [Shen, Xiuzhong] Kyoto Univ, Inst Res Reactor, Kyoto, Japan	Deng, BQ (reprint author), Univ Shanghai Sci & Technol, Dept Environm Sci & Engn, Shanghai 200093, Peoples R China.	bqdeng@usst.edu.cn			Innovation Program of Shanghai Municipal Education Commission [14ZZ136]; Shanghai Committee of Science and Technology [13ZR1427600]	This study was supported by Innovation Program of Shanghai Municipal Education Commission (No. 14ZZ136) and the Shanghai Committee of Science and Technology (No. 13ZR1427600).	Almuttahar A, 2008, POWDER TECHNOL, V185, P11, DOI 10.1016/j.powtec.2007.09.010; Xue Q, 2011, CHEM ENG SCI, V66, P2440, DOI 10.1016/j.ces.2011.03.010; DING J, 1990, AICHE J, V36, P523, DOI 10.1002/aic.690360404; Armstrong LM, 2010, INT J MULTIPHAS FLOW, V36, P916, DOI 10.1016/j.ijmultiphaseflow.2010.07.004; Armstrong LM, 2010, INT J HEAT MASS TRAN, V53, P4949, DOI 10.1016/j.ijheatmasstransfer.2010.05.047; Patil DJ, 2005, CHEM ENG SCI, V60, P57, DOI 10.1016/j.ces.2004.07.059; Panneerselvam R, 2009, CHEM ENG SCI, V64, P1119, DOI 10.1016/j.ces.2008.10.052; Chen XZ, 2011, POWDER TECHNOL, V205, P276, DOI 10.1016/j.powtec.2010.09.039; Hartge EU, 2009, PARTICUOLOGY, V7, P283, DOI 10.1016/j.partic.2009.04.005; Min J, 2010, AICHE J, V56, P1434, DOI 10.1002/aic.12077; Bastos JCSC, 2008, CATAL TODAY, V130, P462, DOI 10.1016/j.cattod.2007.10.075; Rafique M, 2004, REV CHEM ENG, V20, P225; Grabner M, 2007, FUEL PROCESS TECHNOL, V88, P948, DOI 10.1016/j.fuproc.2007.05.006; Hosseini SH, 2010, POWDER TECHNOL, V200, P202, DOI 10.1016/j.powtec.2010.02.024; van Wachem BGM, 2001, AICHE J, V47, P1035, DOI 10.1002/aic.690470510; Cooper S, 2005, POWDER TECHNOL, V151, P27, DOI 10.1016/j.powtec.2004.11.041; Sokolichin A, 2004, AICHE J, V50, P24, DOI 10.1002/aic.10003; Jung J, 2005, IND ENG CHEM RES, V44, P1329, DOI 10.1021/ie0496838; Mazzei L, 2010, CHEM ENG J, V156, P432, DOI 10.1016/j.cej.2009.11.003; Chen R, 2004, AICHE J, V40, P1093; Fluent Inc, 2006, FLUENT 6 3 US GUID; Gidaspow D., 1994, MULTIPHASE FLOW FLUI; Johansson K, 2006, CHEM ENG SCI, V61, P1705, DOI 10.1016/j.ces.2005.09.014; Larachi F, 1996, AICHE J, V42, P2439, DOI 10.1002/aic.690420905; Li TW, 2009, CHEM ENG SCI, V64, P4884, DOI 10.1016/j.ces.2009.07.024; Pei P., 2011, POWDER TECHNOL, V221, P114; Sun J, 2006, CHEM ENG SCI, V61, P1470, DOI 10.1016/j.ces.2005.09.003; Yunhau Z, 2006, CHEM ENG J, V118, P1	28	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0947-7411	1432-1181		HEAT MASS TRANSFER	Heat Mass Transf.	AUG	2015	51	8					1067	1074		10.1007/s00231-014-1478-y		8	Thermodynamics; Mechanics	Thermodynamics; Mechanics	CM4OS	WOS:000357664900003		
J	Postiglione, GA; Arimoto, A				Postiglione, Gerard A.; Arimoto, Akira			Building research universities in East Asia	HIGHER EDUCATION			English	Editorial Material									[Postiglione, Gerard A.] Univ Hong Kong, Pokfulam, Hong Kong, Peoples R China; [Arimoto, Akira] Kurashiki Sakuyo Univ, Kurashiki, Okayama, Japan	Postiglione, GA (reprint author), Univ Hong Kong, Pokfulam, Hong Kong, Peoples R China.	gerry.hku@gmail.com						0	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0018-1560	1573-174X		HIGH EDUC	High. Educ.	AUG	2015	70	2			SI		151	153		10.1007/s10734-015-9873-y		3	Education & Educational Research	Education & Educational Research	CM4OX	WOS:000357665400001		
J	Arimoto, A				Arimoto, Akira			Declining symptom of academic productivity in the Japanese research university sector	HIGHER EDUCATION			English	Article						Academic productivity; Research universities; Market mechanism; Tate-shakai; Inbreeding; R-T-S nexus		From a framework of this study, modern society may be explained by a paradigm transformation from ascription to achievement and also from particularism to universalism. According to this hypothesis, Japanese university society has not developed successfully for more than the closed society to the opened society. This paper intends to deal with the Japanese differentiated university stratification, which has been formed among these value orientations by connection of particularism and ascription, with a focus on its effects on the academic productivity including both research and teaching productivity. For example, a closed academic structure with an inbreeding mechanism in tate-shakai (vertical society) has brought about a great deal of effect either positively or negatively on academic system throughout the country. We intend to discuss the reasons behind the declining symptom of academic productivity of the university on the basis of the given framework.	Kurashi Sakuyo Univ, Kurashiki, Okayama, Japan	Arimoto, A (reprint author), Kurashi Sakuyo Univ, Kurashiki, Okayama, Japan.	arimotoakira@gmail.com					Altbach P. G., 1996, INT ACAD PROFESSION; [Anonymous], 2001, TOH PLAN; [Anonymous], 1951, GEN THEORY ACTION; Arimoto A., 1996, DAIGAKU KYOJUSHOKU N; Arimoto A., 2005, DAIGAKU KYOJUSHOKU F; Arimoto A., 2013, JAHER 16 ANN C HELD; Arimoto A., 1987, MERTON KAGAKU SHAKAI; Arimoto A., 1981, DAIGAKUJIN NO SHAKAI; Arimoto A., 2009, RIHE INT SEMINAR REP, V13; Arimoto A., 2011, HENBOUSURU SEKAI NO; Arimoto A., 2013, INT C AC PROF RUSS H, P1; Arimoto A., 2008, HENBOUSURU NIPPON NO; Asahi-Shinbunsha, 2013, DAIG RANK 2014 BAN; Ben-David Joseph, 1977, CTR LEARNING BRITAIN; Clark B., 1983, HIGHER ED SYSTEM ACA; Clark BR, 1997, J HIGH EDUC, V68, P241, DOI 10.2307/2960040; Konaka Y., 1978, TODAI HOGAKU BU; Leuters Thomson, 2010, WORLD U RANKINGS 201; Merton RK, 1973, SOCIOLOGY SCI THEORE; MEXT, 2002, 21 CENT COE PROGR; Nakane C., 1967, TATA SHAKAI NO NINGE; Parsons T., 1951, SOCIAL SYSTEM; Pierson G. W., 1952, YALE COLL ED HIST 18; Saka A., 2012, BENCHMARKING SCI RES; Shin J., 2011, U RANKINGS THEORETIC; Shin JC, 2014, TEACHING RES CONT HI; Shinbori M., 1984, DAIGAKU KYOJUSHOKU N; Shinbori M., 1965, NIPPON NO DAIGAKU KY; Teihchler U., 2013, CHANGING ACAD PROFES; Times Higher Education, 2013, WORLD U RANK 2013 20; Ushiogi M., 2009, SHOKUGYOU TOSHITENO; Von Humboldt W., 1910, MINELVA, V8, P242; Yamanoi A., 1990, DAIGAKU KYOJU NO IDO; Yamanoi A., 2007, NIPPON NO DAIGAKU KY; Yamanoi A., 2008, CHANGING ACAD PROFES, P62	35	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0018-1560	1573-174X		HIGH EDUC	High. Educ.	AUG	2015	70	2			SI		155	172		10.1007/s10734-014-9848-4		18	Education & Educational Research	Education & Educational Research	CM4OX	WOS:000357665400002		
J	Yonezawa, A; Shimmi, Y				Yonezawa, Akiyoshi; Shimmi, Yukiko			Transformation of university governance through internationalization: challenges for top universities and government policies in Japan	HIGHER EDUCATION			English	Article						University governance; Internationalization; World-class universities; Japan	HIGHER-EDUCATION	In order to strengthen their international presence, universities pursuing a world-class status are striving to increase their internationalization. Internationalization implies a transformation of university governance, especially for universities in a non-English-speaking system such as Japan's. This paper examines the challenges of internationalization for Japan's top universities as a transformation process of these universities' governance. First, the historical background of Japanese higher education as an early front-runner in Asia is discussed, along with the dynamics of national identity and global trends. Second, a series of government-funded programs for research and internationalization are examined from the viewpoint of governance reform. The construction of "world-class" universities not only implies concentrated financial investment but also a comprehensive transformation of university governance in a global context. The major challenges for top Japanese research universities in terms of maintaining and improving their international presence are also highlighted. This article suggests the importance of examining the historical and current context of university governance in East Asian higher education.	[Yonezawa, Akiyoshi] Nagoya Univ, Grad Sch Int Dev, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Shimmi, Yukiko] Hitotsubashi Univ, Grad Sch Law, Tokyo 1868601, Japan	Yonezawa, A (reprint author), Nagoya Univ, Grad Sch Int Dev, Chikusa Ku, Furocho, Nagoya, Aichi 4648601, Japan.	yonezawa@gsid.nagoya-u.ac.jp; y.shimmi@r.hit-u.ac.jp					Adams J., 2010, GLOBAL RES REPORT; Altbach P. G., 2007, WORLD CLASS WORLDWID; Altbach P. G., 2011, ROAD ACAD EXCELLENCE; Amano I., 1998, ED SCH JAPAN 1945, P152; Huang FT, 2009, J STUD INT EDUC, V13, P143, DOI 10.1177/1028315308331101; Willmott H, 2003, STUD HIGH EDUC, V28, P129, DOI 10.1080/0307507032000058127; Douglass John Aubrey, 2000, CALIFORNIA IDEA AM H; Education Rebuilding Council, 2013, U ED GLOB HUM RES DE; Hazelkorn E, 2011, RANKINGS AND THE RESHAPING OF HIGHER EDUCATION: THE BATTLE FOR WORLD-CLASS EXCELLENCE, P1, DOI 10.1057/9780230306394; Huang F., 2005, HIGH EDUC POLICY, V18, P117, DOI DOI 10.1057/PALGRAVE.HEP.8300076; Huang F., 2014, INT ACAD CHANGES REA; Hur JY, 2013, ASIA PAC EDUC REV, V14, P113, DOI 10.1007/s12564-012-9238-5; Institute for International Cooperation Japan International Cooperation Agency, 2003, HIST JAP ED DEV WHAT; Kaneko M., 2004, ASIAN U HIST PERSPEC, P115; Kaneko M, 2009, ASIA PAC EDUC REV, V10, P59, DOI 10.1007/s12564-009-9004-5; Kehm B.M., 2013, I WORLD CLASS U GLOB; Kyvik S., 2004, HIGHER ED EUROPE, V24, P393, DOI DOI 10.1080/0379772042000331679; Marginson S., 2011, HIGHER ED ASIA PACIF; MEXT, 2014, NIH JIN NO RYUG JOK; Mohrman K., 2014, WORLD CLASS U AFFECT, P177; Moon Mugyeong, 2001, ASIA PACIFIC ED REV, V2, P96; Newby H., 2009, OECD REV TERTIARY ED; Ota H., 2014, EMERGING INT DIMENSI, P227; Prime Minister of Japan and His Cabinet, 2010, NEW GROWTH STRAT; Prime Minister of Japan and His Cabinet, 2013, JAP REV STRAT JAP IS; Saka A., 2013, KAGAKU KENKYU NO BEN; Salmi J, 2009, DIR DEV, P1, DOI 10.1596/978-0-8213-7865-6; Teichler U., 1999, TERTIARY ED MANAGEME, V5, P5, DOI 10.1023/A:1018736718422; Tokunaga T., 2011, GLOBAL JINZAI IKUSEI; Yonezawa A., 2014, WORLD CLASS U AFFECT, P85; Yonezawa A., 2013, INT HIGHER ED E ASIA, P179; Yonezawa A., 2014, ED STUDIES JAPAN, V8, P19; Yonezawa A., 2003, HIGHER ED MANAGEMENT, V15, P9, DOI 10.1787/hemp-v15-art10-en; Yonezawa A., 2013, RANKINGS ACCOUNTABIL, P171	34	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0018-1560	1573-174X		HIGH EDUC	High. Educ.	AUG	2015	70	2			SI		173	186		10.1007/s10734-015-9863-0		14	Education & Educational Research	Education & Educational Research	CM4OX	WOS:000357665400003		
J	Huang, FT				Huang, Futao			Building the world-class research universities: a case study of China	HIGHER EDUCATION			English	Article						China; Research university; World-class university; University ranking systems		The purpose of this study is to analyze how China has strived to develop its world-class research universities and what are distinguishing characteristics of China's efforts to form these universities for the last decades. This study begins with a review of literature and research questions. It then touches on the background and rationale of creating China's world-class university. In the third section, it examines national policies and strategies of building China's world-class research university since the mid-1990s. In the fourth section, based on national documentation and institutional strategies as well as major findings from the international survey of the Changing Academic Profession which was exercised in China in 2007, the study presents what has been achieved in the effort launched to create Chinese world-class research university and challenges facing China in this regard. The study concludes by arguing the following aspects: firstly, China has made an impressive progress of forming its world-class research university and national policies and strategies are effective; secondly, differing from the world-class research universities in the USA and the UK, the Chinese path to building a world-class research university is characterized with a top-down policy, accompanied by the growth in intensive funding from both national government and especially local authorities on few selected elite universities; and finally, the Chinese way is still receptive to Western influence and external international ranking systems or organizations; therefore, there is still a long way for China to become an internationally influential part of the higher education landscape.	Hiroshima Univ, Res Inst Higher Educ, Higashihiroshima, Hiroshima 7398512, Japan	Huang, FT (reprint author), Hiroshima Univ, Res Inst Higher Educ, Kagamiyama 1-2-2, Higashihiroshima, Hiroshima 7398512, Japan.	futao@hiroshima-u.ac.jp					Altbach, 2007, WORLD CLASS WORLDWID; Altbach P., 2013, INT IMPERATIVE HIGHE, V27, P95; Altbach P., 1989, DEPENDENCE AUTONOMY, pxii; Altbach P. G., 2011, ROAD ACAD EXCELLENCE; Byun K, 2013, HIGH EDUC, V65, P645, DOI 10.1007/s10734-012-9568-6; Yang R, 2012, HIGH EDUC, V63, P645, DOI 10.1007/s10734-011-9465-4; Huang F., 2006, COE PUBLICATION SERI, V21, P13; Jiang Z., 1998, COMMUNICATION; Lamon M., 2014, CHRONICAL HIGHER ED; Leon C., 2014, HIGH EDUC POLICY, V27, P341, DOI [10.1057/hep.2013.33, DOI 10.1057/HEP.2013.33]; Luo Y., 2013, I WORLD CLASS U GLOB, P165; MOE (Ministry of Education), 2013, STAT NAT ED DEV 2013; MOE (Ministry of Education), 1991, YB CHIN ED, P22; Pepper S., 1996, RADICALISM ED REFORM, P157, DOI 10.1017/CBO9780511584725.007; Rhoads Robert A., 2014, CHINAS RISING RES U; Sadlak J., 2009, WORLD CLASS U PART N; Salmi J, 2009, DIR DEV, P1, DOI 10.1596/978-0-8213-7865-6; Shin J. C., 2013, IND ELECT IEEE T, P1; Wang Q., 2011, WCU 4 SHANGH NOV 3 4; Wang Q., 2009, GUANGMING DAILY 1015; Wang Q., 2009, WCU 3 SHANGH NOV 7 8; Wang Q. H., 2011, ROAD ACAD EXCELLENCE; Yang CP, 2014, J FORESTRY RES, V25, P1, DOI 10.1007/s11676-014-0428-3; Zhang J., 2009, CHINA ED DAILY  0920	24	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0018-1560	1573-174X		HIGH EDUC	High. Educ.	AUG	2015	70	2			SI		203	215		10.1007/s10734-015-9876-8		13	Education & Educational Research	Education & Educational Research	CM4OX	WOS:000357665400005		
J	Neugebauer, I; Brauer, A; Schwab, MJ; Dulski, P; Frank, U; Hadzhiivanova, E; Kitagawa, H; Litt, T; Schiebel, V; Taha, N; Waldmann, ND				Neugebauer, Ina; Brauer, Achim; Schwab, Markus J.; Dulski, Peter; Frank, Ute; Hadzhiivanova, Elitsa; Kitagawa, Hiroyuki; Litt, Thomas; Schiebel, Vera; Taha, Nimer; Waldmann, Nicolas D.		DSDDP Sci Party	Evidences for centennial dry periods at similar to 3300 and similar to 2800 cal. yr BP from micro-facies analyses of the Dead Sea sediments	HOLOCENE			English	Article						ICDP Dead Sea drilling; Levant palaeoclimate; varve chronology; micro-facies; dry periods; extreme events	HOLOCENE CLIMATE VARIABILITY; EASTERN MEDITERRANEAN REGION; GREIGITE BEARING SEDIMENTS; LAKE LISAN; ATMOSPHERIC CIRCULATION; NORTH-ATLANTIC; NEAR-EAST; VARVED SEDIMENTS; LEVEL VARIATIONS; SOLAR INFLUENCE	Laminated lake sediments from the Dead Sea basin provide high-resolution records of climatic variability in the eastern Mediterranean region, which is especially sensitive to changing climatic conditions. In this study, we aim on detailed reconstruction of climatic fluctuations and related changes in the frequency of flood and dust deposition events at ca. 3300 and especially at 2800cal. yr BP from high-resolution sediment records of the Dead Sea basin. A ca. 4-m-thick, mostly varved sediment section from the western margin of the Dead Sea (DSEn - Ein Gedi profile) was analysed and correlated to the new International Continental Scientific Drilling Program (ICDP) Dead Sea Deep Drilling Project core 5017-1 from the deep basin. To detect even single event layers, we applied a multi-proxy approach of high-resolution microscopic thin section analyses, micro-X-ray fluorescence (mu-XRF) element scanning and magnetic susceptibility measurements, supported by grain size data and palynological analyses. Based on radiocarbon and varve dating, two pronounced dry periods were detected at similar to 3500-3300 and similar to 3000-2400 cal. yr BP which are differently expressed in the sediment records. In the shallow-water core (DSEn), the older dry period is characterised by a thick sand deposit, whereas the sedimentological change at 2800 cal. yr BP is less pronounced and characterised mainly by an enhanced frequency of coarse detrital layers interpreted as erosion events. In the 5017-1 deep-basin core, both dry periods are depicted by halite deposits. The onset of the younger dry period coincides with the Homeric Grand Solar Minimum at ca. 2800 cal. yr BP. Our results suggest that during this period, the Dead Sea region experienced an overall dry climate, superimposed by an increased occurrence of flash floods caused by a change in synoptic weather patterns.	[Neugebauer, Ina; Brauer, Achim; Schwab, Markus J.; Dulski, Peter; Frank, Ute] GFZ German Res Ctr Geosci Potsdam, Sect Climate Dynam & Landscape Evolut 5 2, D-14473 Potsdam, Germany; [Hadzhiivanova, Elitsa; Taha, Nimer; Waldmann, Nicolas D.] Univ Haifa, Leon H Charney Sch Marine Sci, Dr Strauss Dept Marine Geosci, IL-31999 Haifa, Israel; [Kitagawa, Hiroyuki] Nagoya Univ, Grad Sch Environm Studies, Nagoya, Aichi 4648601, Japan; [Litt, Thomas; Schiebel, Vera] Univ Bonn, Steinmann Inst Geol Mineral & Paleontol, Bonn, Germany	Neugebauer, I (reprint author), GFZ German Res Ctr Geosci Potsdam, Sect Climate Dynam & Landscape Evolut 5 2, D-14473 Potsdam, Germany.	inaneu@gfz-potsdam.de			International Continental Scientific Drilling Program (ICDP); German Science Foundation (DFG) [FR 1672/2-1, BR 2208/10-1]; Helmholtz Centre Potsdam, GFZ (Germany)	This study was supported by the International Continental Scientific Drilling Program (ICDP), the German Science Foundation (DFG Grants FR 1672/2-1 and BR 2208/10-1) and the Helmholtz Centre Potsdam, GFZ (Germany). This study is a contribution to the Helmholtz Association (HGF) climate initiative REKLIM Topic 8 'Rapid climate change derived from proxy data'.	Agnon A, 2006, GEOL SOC AM SPEC PAP, V401, P195, DOI 10.1130/2006.2401(13); Meeker LD, 2002, HOLOCENE, V12, P257, DOI 10.1191/0959683602hl542ft; Brauer A, 2001, J PALEOLIMNOL, V25, P163, DOI 10.1023/A:1008136029735; Torfstein A, 2008, GEOCHIM COSMOCHIM AC, V72, P2491, DOI 10.1016/j.gca.2008.02.015; Litt T, 2012, QUATERNARY SCI REV, V49, P95, DOI 10.1016/j.quascirev.2012.06.012; Herzschuh U, 2007, J BIOGEOGR, V34, P1265, DOI 10.1111/j.1365-2699.2006.01680.x; Ojala AEK, 2012, QUATERNARY SCI REV, V43, P45, DOI 10.1016/j.quascirev.2012.04.006; Bond G, 2001, SCIENCE, V294, P2130, DOI 10.1126/science.1065680; de Vries AJ, 2013, J GEOPHYS RES-ATMOS, V118, P7087, DOI 10.1002/jgrd.50569; Roberts N, 2011, HOLOCENE, V21, P147, DOI 10.1177/0959683610386819; Kushnir Y, 2010, QUATERNARY SCI REV, V29, P3843, DOI 10.1016/j.quascirev.2010.09.004; Mayewski PA, 1997, J GEOPHYS RES-OCEANS, V102, P26345, DOI 10.1029/96JC03365; Robinson SA, 2006, QUATERNARY SCI REV, V25, P1517, DOI 10.1016/j.quascirev.2006.02.006; Neumann FH, 2010, J ARID ENVIRON, V74, P756, DOI 10.1016/j.jaridenv.2009.04.015; Brauer A, 1999, QUATERN INT, V61, P17, DOI 10.1016/S1040-6182(99)00014-2; Neugebauer I, 2014, QUATERNARY SCI REV, V102, P149, DOI 10.1016/j.quascirev.2014.08.013; Holzhauser H, 2005, HOLOCENE, V15, P789, DOI 10.1191/0959683605hl853ra; Rohling EJ, 2002, CLIM DYNAM, V18, P587, DOI 10.1007/s00382-001-0194-8; Martin-Puertas C, 2012, NAT GEOSCI, V5, P397, DOI [10.1038/ngeo1460, 10.1038/NGEO1460]; Langgut D, 2014, PALYNOLOGY, V38, P280, DOI 10.1080/01916122.2014.906001; Enzel Y, 2008, GLOBAL PLANET CHANGE, V60, P165, DOI 10.1016/j.gloplacha.2007.02.003; Mayewski PA, 2004, QUATERNARY RES, V62, P243, DOI 10.1016/j.yqres.2004.07.001; Dayan U, 2006, GEOL SOC AM SPEC PAP, V401, P53, DOI 10.1130/2006.2401(04); Waldmann N, 2010, GEOLOGY, V38, P567, DOI 10.1130/G30654.1; Bar-Matthews M, 2003, GEOCHIM COSMOCHIM AC, V67, P3181, DOI 10.1016/S0016-7037(02)01031-1; Alpert P, 2004, INT J CLIMATOL, V24, P1001, DOI 10.1002/joc.1036; Lazar B, 2014, EARTH PLANET SC LETT, V400, P94, DOI 10.1016/j.epsl.2014.03.019; Ineson S, 2011, NAT GEOSCI, V4, P753, DOI [10.1038/ngeo1282, 10.1038/NGEO1282]; Reimer PJ, 2013, RADIOCARBON, V55, P1869; ELMOSLIMANY AP, 1990, REV PALAEOBOT PALYNO, V64, P343, DOI 10.1016/0034-6667(90)90150-H; Sirocko F, 2005, NATURE, V436, P833, DOI 10.1038/nature03905; Magny M, 2004, QUATERN INT, V113, P65, DOI 10.1016/S1040-6182(03)00080-6; Haliva-Cohen A, 2012, QUATERNARY SCI REV, V50, P55, DOI 10.1016/j.quascirev.2012.06.014; Bartov Y, 2003, GEOLOGY, V31, P439, DOI 10.1130/0091-7613(2003)031<0439:CAEITE>2.0.CO;2; Stein M, 1997, GEOCHIM COSMOCHIM AC, V61, P3975, DOI 10.1016/S0016-7037(97)00191-9; Enzel Y, 2003, QUATERNARY RES, V60, P263, DOI 10.1016/j.yqres.2003.07.011; Migowski C, 2004, EARTH PLANET SC LETT, V222, P301, DOI 10.1016/j.epsl.2004.02.015; Bartov Y, 2002, QUATERNARY RES, V57, P9, DOI 10.1006/qres.2001.2284; van Geel B, 1999, QUATERNARY SCI REV, V18, P331, DOI 10.1016/S0277-3791(98)00088-2; Ron H, 2007, GEOPHYS J INT, V170, P117, DOI 10.1111/j.1365-246X.2007.03425.x; Neumann FH, 2007, QUATERNARY SCI REV, V26, P1476, DOI 10.1016/j.quascirev.2007.03.004; Bookman R, 2004, GEOL SOC AM BULL, V116, P555, DOI 10.1130/B25286.1; Torfstein A, 2013, QUATERNARY SCI REV, V69, P1, DOI 10.1016/j.quascirev.2013.02.015; Migowski C, 2006, QUATERNARY RES, V66, P421, DOI 10.1016/j.yqres.2006.06.010; Kahana R, 2002, INT J CLIMATOL, V22, P867, DOI 10.1002/joc.766; Mauquoy D, 2004, HOLOCENE, V14, P45, DOI 10.1191/0959683604hl688rp; Saaroni H, 2010, INT J CLIMATOL, V30, P1014, DOI 10.1002/joc.1912; Finne M, 2011, J ARCHAEOL SCI, V38, P3153, DOI 10.1016/j.jas.2011.05.007; Czymzik M, 2013, QUATERNARY SCI REV, V61, P96, DOI 10.1016/j.quascirev.2012.11.010; Swierczynski T, 2013, QUATERNARY SCI REV, V80, P78, DOI 10.1016/j.quascirev.2013.08.018; Ariztegui D, 2010, GLOBAL PLANET CHANGE, V71, P183, DOI 10.1016/j.gloplacha.2009.11.016; Bar-Matthews M, 2004, DEV PALEOENVIRON RES, V6, P363; Begin ZB, 1974, GEOLOGICAL SURVEY IS, V63; BENTOR YK, 1961, GEOCHIM COSMOCHIM AC, V25, P239, DOI 10.1016/0016-7037(61)90061-8; Bookman R, 2006, GEOL SOC AM SPEC PAP, V401, P155, DOI 10.1130/2006.2401(10); Brauer A., 2009, PAGES (Past Global Changes) News, V17, P96; Brauer A, 2008, PALAEOGEOGR PALAEOCL, V259, P121, DOI 10.1016/j.palaeo.2007.10.003; Bronk R. C., 2009, RADIOCARBON, V51, P337, DOI DOI 10.2458/RC.V51I1.3494; Bronk Ramsey C, 2008, QUATERNARY SCI REV, V27, P42, DOI DOI 10.1016/J.QUASCIREV2007.1001.1019; Brown SL, 2000, GEOLOGY, V28, P335, DOI 10.1130/0091-7613(2000)028<0335:YROEHE>2.3.CO;2; Croudace IW, 2006, GEOL SOC SPEC PUBL, V267, P51, DOI 10.1144/GSL.SP.2006.267.01.04; Danin A., 1988, The zoogeography of Israel. The distribution and abundance at a zoogeographical crossroad, P129; Dayan U, 2008, INT J CLIMATOL, V28, P915, DOI 10.1002/joc.1587; Faegri K., 1989, TXB POLLEN ANAL; Frank U, 2007, GEOPHYS J INT, V168, P904, DOI 10.1111/j.1365-246X.2006.03263.x; Frank U, 2007, GEOPHYS J INT, V168, P921, DOI [10.1111/j.1365-246X.2006.03273.x, 10.1111/j.1365-246X.2003.03273.x]; Garber R.A., 1987, CARBONATE EVAPORITE, V2, P43; Heim C, 1997, NATURWISSENSCHAFTEN, V84, P398, DOI 10.1007/s001140050416; Kagan EJ, 2015, RADIOCARBON, V57, P237, DOI 10.2458/azu_rc.57.18560; Kaniewski D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071004; KATZ A, 1977, GEOCHIM COSMOCHIM AC, V41, P1609, DOI 10.1016/0016-7037(77)90172-7; Koutsodendris A, 2015, J PALEOLIMNOL, V53, P255, DOI 10.1007/s10933-014-9823-1; Kroonenberg SB, 2007, QUATERN INT, V173, P137, DOI 10.1016/j.quaint.2007.03.010; Lamy F, 2006, PALEOCEANOGRAPHY, V21, DOI 10.1029/2005PA001184; Leroy SAG, 2010, QUATERNARY RES, V73, P191, DOI 10.1016/j.yqres.2009.10.003; Leroy SAG, 2010, J ARCHAEOL SCI, V37, P306, DOI 10.1016/j.jas.2009.09.042; Martin-Puertas C, 2009, QUATERNARY RES, V71, P108, DOI 10.1016/j.yqres.2008.10.004; Migowski C, 2001, THESIS U POTSDAM; Neev D, 1967, GEOLOGICAL SURVEY IS, V147; Nowaczyk N.R., 2001, TRACKING ENV CHANGE, V1, P155; Prasad S, 2004, GEOLOGY, V32, P581, DOI 10.1130/G20553.1; Schlolaut G, 2014, QUATERNARY SCI REV, V83, P157, DOI 10.1016/j.quascirev.2013.10.026; Solanki SK, 2007, SOLAR VARIABILITY PL, P25; Stein M, 2014, MOD APPR SOL EARTH S, V6, P279, DOI 10.1007/978-94-017-8872-4_10; Stein M, 2011, EOS, V92, P453; Stein M, 2010, QUATERNARY SCI REV, V29, P567, DOI 10.1016/j.quascirev.2009.10.015; Steinhilber F, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL040142; VanGeel B, 1996, J QUATERNARY SCI, V11, P451, DOI 10.1002/(SICI)1099-1417(199611/12)11:6<451::AID-JQS275>3.0.CO;2-9; van Geel B, 2004, J ARCHAEOL SCI, V31, P1735, DOI 10.1016/j.jas.2004.05.004; YECHIELI Y, 1993, QUATERNARY RES, V39, P59, DOI 10.1006/qres.1993.1007; Zangvil A, 2003, INT J CLIMATOL, V23, P1567, DOI 10.1002/joc.955; Zhao Y, 2012, HOLOCENE, V22, P1385, DOI 10.1177/0959683612449762	92	1	1	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0959-6836	1477-0911		HOLOCENE	Holocene	AUG	2015	25	8					1358	1371		10.1177/0959683615584208		14	Geography, Physical; Geosciences, Multidisciplinary	Physical Geography; Geology	CM2PT	WOS:000357524500013		
J	Tanizawa, K; Matsuura, H; Ogawa, K; Kaneko, T; Banno, E; Uesaka, K; Takasaka, S; Iwai, H; Ota, K; Kuwatsuka, H; Oikawa, Y; Yagi, T; Shoji, H; Namiki, S				Tanizawa, Ken; Matsuura, Hiroyuki; Ogawa, Kensuke; Kaneko, Toshimitsu; Banno, Eiichi; Uesaka, Katsumi; Takasaka, Shigehiro; Iwai, Hidenori; Ota, Kazuya; Kuwatsuka, Haruhiko; Oikawa, Yoichi; Yagi, Takeshi; Shoji, Hajime; Namiki, Shu			Autonomous Parametric Tunable Dispersion Compensation for Dynamic Optical Switching	IEEE PHOTONICS TECHNOLOGY LETTERS			English	Article						Chromatic dispersion; dispersion compensation; four-wave mixing; optical fiber communication		We demonstrate dynamic parametric optical dispersion compensation in dynamic optical path networks (DOPNs). A fully automatic parametric tunable dispersion compensator (P-TDC) based on four-wave mixing process is developed with a fast tunable distributed amplification chirped sampled grating distributed reflector laser, a field-programmable gate array (FPGA) pump controller, and a fast dispersion monitor based on spectral shearing interferometer. The dispersion monitor detects a change in the dispersion of a path, and the monitoring signal is fed forward to the FPGA controller. The fast tunable laser sets its wavelength accordingly for the dispersion compensation through parametric process. A response time of <17 ms is demonstrated in a testbed of DOPN. The autonomous P-TDC has a potential response of submillisecond.	[Tanizawa, Ken; Matsuura, Hiroyuki; Kuwatsuka, Haruhiko; Namiki, Shu] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058569, Japan; [Ogawa, Kensuke] Fujikura Ltd, Chiba 2858550, Japan; [Kaneko, Toshimitsu; Banno, Eiichi; Uesaka, Katsumi; Shoji, Hajime] Sumitomo Elect Ind Ltd, Yokohama, Kanagawa 2448588, Japan; [Takasaka, Shigehiro; Yagi, Takeshi] Furukawa Elect Corp Ltd, Chiba 2908555, Japan; [Iwai, Hidenori; Ota, Kazuya; Oikawa, Yoichi] Trimatiz Ltd, Chiba 2720023, Japan	Tanizawa, K (reprint author), Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058569, Japan.	ken.tanizawa@aist.go.jp; hiroyuki.matsuura@aist.go.jp; kensuke.ogawa@jp.fujikura.com; kaneko-toshimitsu@sei.co.jp; banno-eiichi@sei.co.jp; uesaka-katsumi@sei.co.jp; shigehiro@ch.furukawa.co.jp; iwai@trimatiz.com; ota@trimatiz.com; haruhiko.kuwatsuka@aist.go.jp; yoikawa@trimatiz.com; tyagi@ch.furukawa.co.jp; shoji-hajime@sei.co.jp; shu.namiki@aist.go.jp			Project for Developing Innovation Systems through the Ministry of Education, Culture, Sports, Science and Technology, Japan	This work was supported by the Project for Developing Innovation Systems through the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Yamazaki E, 2011, OPT EXPRESS, V19, P13179, DOI 10.1364/OE.19.013179; Devaux F., 1993, J LIGHTWAVE TECHNOL, V11, P1937; Kaneishi T., 2011, Proceedings of the 2011 IEEE 17th Pacific Rim International Symposium on Dependable Computing (PRDC 2011), DOI 10.1109/PRDC.2011.10; Kurumida J., 2014, P ECOC SEP, P1; Matsuura H., 2013, P ECOC SEP, P1; Matsuura H, 2014, 2014 OPTOELECTRONICS AND COMMUNICATIONS CONFERENCE AND AUSTRALIAN CONFERENCE ON OPTICAL FIBRE TECHNOLOGY (OECC/ACOFT 2014), P296; Namiki S, 2008, J LIGHTWAVE TECHNOL, V26, P28, DOI 10.1109/JLT.2007.912113; Sano A., 1996, P EUR C OPT COMM OSL, V2, P207; Takasaka S., 2010, P ECOC SEP, P1; Tanizawa K, 2013, OPT EXPRESS, V21, P27169, DOI 10.1364/OE.21.027169; Tanizawa K., 2015, P OFC; Van Erps J, 2010, OPT EXPRESS, V18, P25415, DOI 10.1364/OE.18.025415; WONG V, 1994, OPT LETT, V19, P287, DOI 10.1364/OL.19.000287	13	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1041-1135	1941-0174		IEEE PHOTONIC TECH L	IEEE Photonics Technol. Lett.	AUG 1	2015	27	15					1589	1592		10.1109/LPT.2015.2432112		4	Engineering, Electrical & Electronic; Optics; Physics, Applied	Engineering; Optics; Physics	CM6VU	WOS:000357830000004		
J	Feng, JJ; Akimoto, R				Feng, Jijun; Akimoto, Ryoichi			T-Shape Suspended Silicon Nitride Ring Resonator for Optical Sensing Applications	IEEE PHOTONICS TECHNOLOGY LETTERS			English	Article						Optical resonance; silicon nitride; suspended; integrated optics; sensitivity	WAVE-GUIDES; LABEL-FREE; MICROCAVITIES; FABRICATION	A T-shape suspended silicon nitride racetrack ring resonator sitting on a silicon dioxide pedestal is experimentally demonstrated. Compared with unsuspended device, it allows an enhanced interaction with the surrounded environment while maintaining a high quality factor. The resonator consists of a directional coupler with a waveguide width of 1.3 mu m and a ring structure with curve radius of 20 mu m. More than 1.6 x 10(4) quality factor at a wavelength of 1550.4 nm can be obtained, with a moderate extinction ratio of similar to 9.2 dB and a free-spectral range of 5.48 nm. The measured device sensitivity is similar to 247 nm/RIU. The device	[Feng, Jijun; Akimoto, Ryoichi] Natl Inst Adv Ind Sci & Technol, Elect & Photon Res Inst, Tsukuba, Ibaraki 3058568, Japan	Feng, JJ (reprint author), Natl Inst Adv Ind Sci & Technol, Elect & Photon Res Inst, Tsukuba, Ibaraki 3058568, Japan.	fjijun@siom.ac.cn; r-akimoto@aist.go.jp			Japan Society for the Promotion of Science	The work of J. Feng was supported by the Japan Society for the Promotion of Science.	Li Q, 2013, OPT EXPRESS, V21, P18236, DOI 10.1364/OE.21.018236; Wang XK, 2013, OPT LETT, V38, P5405, DOI 10.1364/OL.38.005405; Xia Y, 2013, OPT LETT, V38, P1122, DOI 10.1364/OL.38.001122; Bermudez VM, 2004, APPL SURF SCI, V235, P406, DOI 10.1016/j.apsusc.2004.02.065; Feng JJ, 2014, IEEE PHOTONIC TECH L, V26, P706, DOI 10.1109/LPT.2014.2303484; Roeloffzen CGH, 2013, OPT EXPRESS, V21, P22937, DOI 10.1364/OE.21.022937; Donzella V, 2015, OPT EXPRESS, V23, P4791, DOI 10.1364/OE.23.004791; Bauters JF, 2011, OPT EXPRESS, V19, P24090, DOI 10.1364/OE.19.024090; Robinson JT, 2008, OPT EXPRESS, V16, P4296, DOI 10.1364/OE.16.004296; Armani AM, 2007, SCIENCE, V317, P783, DOI 10.1126/science.1145002; Sekaric L, 2002, SENSOR ACTUAT A-PHYS, V101, P215, DOI 10.1016/S0924-4247(02)00149-8; Zhang Y, 2014, OPT LETT, V39, P1282, DOI 10.1364/OL.39.001282; Vollmer F, 2012, NANOPHOTONICS-BERLIN, V1, P267, DOI 10.1515/nanoph-2012-0021; Claes T, 2010, OPT EXPRESS, V18, P22747, DOI 10.1364/OE.18.022747; Luke K, 2013, OPT EXPRESS, V21, P22829, DOI 10.1364/OE.21.022829; Hosseini ES, 2009, OPT EXPRESS, V17, P14543, DOI 10.1364/OE.17.014543; Doolin C., 2015, APPL PHYS LETT, V106; Feng JJ, 2014, IEEE PHOTONIC TECH L, V26, P2391, DOI 10.1109/LPT.2014.2358216; Goykhman I., 2010, APPL PHYS LETT, V97; Huang QZ, 2014, OPT LETT, V39, P6553, DOI 10.1364/OL.39.006553; Kokubun Y, 2001, ELECTRON LETT, V37, P90, DOI 10.1049/el:20010085; Liu L, 2014, MOL IMAGING, V13, P1, DOI DOI 10.1016/S0140-6736(14)61698-6; Lutti J., 2008, APPL PHYS LETT, V93	23	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1041-1135	1941-0174		IEEE PHOTONIC TECH L	IEEE Photonics Technol. Lett.	AUG 1	2015	27	15					1601	1604		10.1109/LPT.2015.2432124		4	Engineering, Electrical & Electronic; Optics; Physics, Applied	Engineering; Optics; Physics	CM6VU	WOS:000357830000007		
J	Okazaki, M; Yoshimoto, S; Chichibu, T; Suhara, T				Okazaki, Masahide; Yoshimoto, Syuhei; Chichibu, Takao; Suhara, Toshiaki			Electro-Optic Spatial Light Modulator Using Periodically-Poled MgO:s-LiTaO3 Waveguide	IEEE PHOTONICS TECHNOLOGY LETTERS			English	Article						Electro-optic modulator; Bragg diffraction; proton-exchanged waveguide; periodically-poled structure; lithium tantalate; spatial light modulator; ultraviolet laser	LITHIUM TANTALATE; DEVICES	We propose and demonstrate an electro-optic spatial light modulator using a deep-proton-exchanged waveguide in periodically-poled MgO:s-LiTaO3 thin crystal for UV laser light. The fine pixel profile, the good contrast, and the low driving voltage of 10 V were accomplished at 355-nm wavelength. The waveguide showed stable performances in the mode size and the transmittance at a life test over 1000 h under a light intensity as high as 2.7 kW/cm(2).	[Okazaki, Masahide; Yoshimoto, Syuhei; Chichibu, Takao] SCREEN Holdings Co Ltd, Kyoto 6128486, Japan; [Suhara, Toshiaki] Osaka Univ, Grad Sch Engn, Dept Elect Elect & Informat Engn, Osaka 5650871, Japan	Okazaki, M (reprint author), SCREEN Holdings Co Ltd, Kyoto 6128486, Japan.	m.okazaki@screen.co.jp; yoshimoto@screen.co.jp; chichibu@screen.co.jp; suhara@eei.eng.osaka-u.ac.jp					Juvalta F, 2006, J OPT SOC AM B, V23, P276, DOI 10.1364/JOSAB.23.000276; Yamada M, 2000, REV SCI INSTRUM, V71, P4010, DOI 10.1063/1.1319341; Collings N, 2011, J DISP TECHNOL, V7, P112, DOI 10.1109/JDT.2010.2049337; Furukawa Y., 2001, ADV SOLID STATE LASE, V15; Gnewuch H, 1998, IEEE PHOTONIC TECH L, V10, P1730, DOI 10.1109/68.730484; Inoue T, 2011, IEEE PHOTONIC TECH L, V23, P1252, DOI 10.1109/LPT.2011.2159198; Lobino M, 2006, OPT LETT, V31, P83, DOI 10.1364/OL.31.000083; Nishihara H., 1989, OPTICAL INTEGRATED C, P73; Okazaki M., 2015, JPN J APPL IN PRESS, V54; Okazaki M, 2011, IEEE PHOTONIC TECH L, V23, P1709, DOI 10.1109/LPT.2011.2167745; Okazaki M, 2014, IEEE PHOTONIC TECH L, V26, P2334, DOI 10.1109/LPT.2014.2355913; Schmidt JU, 2014, PROC SPIE, V8977, DOI 10.1117/12.2036533	12	1	1	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1041-1135	1941-0174		IEEE PHOTONIC TECH L	IEEE Photonics Technol. Lett.	AUG 1	2015	27	15					1646	1648		10.1109/LPT.2015.2433313		3	Engineering, Electrical & Electronic; Optics; Physics, Applied	Engineering; Optics; Physics	CM6VU	WOS:000357830000019		
J	Naito, H; Nagakura, T; Torii, K; Takauji, M; Aoshima, H; Morita, T; Maeda, J; Yoshida, H				Naito, Hideyuki; Nagakura, Takehito; Torii, Kousuke; Takauji, Motoki; Aoshima, Hiroki; Morita, Takenori; Maeda, Junya; Yoshida, Harumasa			Long-Term Reliability of 915-nm Broad-Area Laser Diodes Under 20-W CW Operation	IEEE PHOTONICS TECHNOLOGY LETTERS			English	Article						Power lasers; fiber lasers; pump lasers; semiconductor lasers; reliability	HIGH-POWER; ION-IMPLANTATION; DIFFUSION; GAAS	We report on the long-term reliable continuous wave (CW) operation of high-power and high-efficiency 915-nm broad-area laser diodes (BA-LDs). An output power of over 20 W and a maximum power-conversion efficiency of over 65% have been marked at a heat-sink temperature of 20 degrees C. Stable operations of over 5000 h have also been achieved for the 915-nm and 976-nm BA-LDs with CW output powers of 20 W, respectively. The window structure with a bandgap difference of 100 meV provides the reliable operation at the high-output power range.	[Naito, Hideyuki; Nagakura, Takehito; Torii, Kousuke; Takauji, Motoki; Aoshima, Hiroki; Morita, Takenori; Maeda, Junya; Yoshida, Harumasa] Hamamatsu Photon KK, Hamamatsu, Shizuoka 4348601, Japan	Naito, H (reprint author), Hamamatsu Photon KK, Hamamatsu, Shizuoka 4348601, Japan.	hideyuki-naito@crl.hpk.co.jp; takehito@crl.hpk.co.jp; torii-k@crl.hpk.co.jp; takauji@lsr.hpk.co.jp; hiroki.aoshima@lsr.hpk.co.jp; take-m@crl.hpk.co.jp; junmaeda@crl.hpk.co.jp; harumasa@crl.hpk.co.jp			New Energy and Industrial Technology Development Organization of Japan	This work was supported in part by the New Energy and Industrial Technology Development Organization of Japan.	Lin T, 2007, J CRYST GROWTH, V309, P140, DOI 10.1016/j.jcrysgro.2007.09.029; Bao L., 2011, P SOC PHOTO-OPT INS; Ooi BS, 1997, IEEE J QUANTUM ELECT, V33, P1784; Crump P., 2009, P SOC PHOTO-OPT INS; Crump P., 2015, P SOC PHOTO-OPT INS; ELMAN B, 1989, J APPL PHYS, V66, P2104, DOI 10.1063/1.344488; FUKUDA M, 1994, IEEE J QUANTUM ELECT, V30, P471, DOI 10.1109/3.283796; Hiramoto K, 1999, IEEE J SEL TOP QUANT, V5, P817, DOI 10.1109/2944.788455; Kageyama N, 2012, IEEE J QUANTUM ELECT, V48, P991, DOI 10.1109/JQE.2012.2199084; KUZUHARA M, 1989, J APPL PHYS, V66, P5833, DOI 10.1063/1.343603; Morita T, 2013, IEEE J SEL TOP QUANT, V19, DOI 10.1109/JSTQE.2013.2245103; TANG WC, 1991, APPL PHYS LETT, V59, P1005, DOI 10.1063/1.106326; Taniguchi H, 2007, IEEE J SEL TOP QUANT, V13, P1176, DOI 10.1109/JSTQE.2007.903373; Walker CL, 2002, IEEE PHOTONIC TECH L, V14, P1394, DOI 10.1109/LPT.2002.802080; YONEZU HO, 1979, IEEE J QUANTUM ELECT, V15, P775, DOI 10.1109/JQE.1979.1070102; Zucker E., 2014, P SOC PHOTO-OPT INS	16	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1041-1135	1941-0174		IEEE PHOTONIC TECH L	IEEE Photonics Technol. Lett.	AUG 1	2015	27	15					1660	1662		10.1109/LPT.2015.2433927		3	Engineering, Electrical & Electronic; Optics; Physics, Applied	Engineering; Optics; Physics	CM6VU	WOS:000357830000023		
J	Aeron, S; Bose, S; Valero, HP				Aeron, Shuchin; Bose, Sandip; Valero, Henri-Pierre			Joint Multi-Mode Dispersion Extraction in Frequency-Wavenumber and Space-Time Domains	IEEE TRANSACTIONS ON SIGNAL PROCESSING			English	Article						Continuous wavelet transform; dispersion extraction; space-time methods; sparsity	SIGNALS; MODES	In this paper, we present a novel broadband approach for the extraction of dispersion curves of multiple time frequency overlapped dispersive modes from borehole acoustic data. The new approach works jointly in the frequency-wavenumber and space-time domains and, in contrast to existing methods it efficiently handles multiple signals with significant time frequency overlap. The proposed method begins by exploiting the slowness (phase and group) and time location estimates obtained by a broadband dispersion extraction method based on frequency- wavenumber (f - k) domain sparsity penalization proposed in [A. Aeron, S. Bose, H.-P. Valero, and V. Saligrama, "Broadband dispersion extraction using simultaneous sparse penalization," IEEE Trans. Signal Process., vol. 50, no. 10, pp. 4821-4837, 2011]. In this context, we first present a Cramer-Rao Bound (CRB) analysis for slowness estimation and show that for the f - k domain broadband processing, group slowness estimates have more variance than the phase slowness and time location estimates. In order to improve the group slowness estimates, we exploit the time compactness property of the modes to effectively represent the data as a linear superposition of time compact space-time propagators parameterized by the phase and group slowness. A linear least squares estimation algorithm in the space-time domain is then used to obtain improved group slowness estimates. The performance of the method is demonstrated on real borehole acoustic data sets.	[Aeron, Shuchin] Tufts Univ, Dept Elect & Comp Engn ECE, Medford, MA 02155 USA; [Bose, Sandip] SDR, Math & Modeling Dept, Cambridge, MA 02139 USA; [Valero, Henri-Pierre] SKK, Sagamihara, Kanagawa 2520206, Japan	Aeron, S (reprint author), Tufts Univ, Dept Elect & Comp Engn ECE, Medford, MA 02155 USA.	shuchin@ece.tufts.edu; bose1@slb.com; hvalero@slb.com					Acton F. S., 1966, ANAL STRATIGHT LINE; Aeron S., 2014, U. S. Patent App., Patent No. [13/712 971, 13712]; Aeron S., 2008, IEEE INT C AC SPEECH; Aeron S, 2011, IEEE T SIGNAL PROCES, V59, P4821, DOI 10.1109/TSP.2011.2160632; Tropp JA, 2006, IEEE T INFORM THEORY, V52, P1030, DOI 10.1109/TIT.2005.864420; AUGER F, 1995, IEEE T SIGNAL PROCES, V43, P1068, DOI 10.1109/78.382394; RISSANEN J, 1978, AUTOMATICA, V14, P465, DOI 10.1016/0005-1098(78)90005-5; ROY R, 1989, IEEE T ACOUST SPEECH, V37, P984, DOI 10.1109/29.32276; SINHA BK, 1994, GEOPHYSICS, V59, P1037, DOI 10.1190/1.1443660; Ekstrom M., 1995, 1995 C REC 29 AS C S, V1, P449; Franco J., 2006, OILFIELD REV, V18, P14; Grossmann A., 1984, J MATH ANAL, V5, P723, DOI DOI 10.1137/0515056; Grossmann A., 1989, WAVELET TIME FREQUEN; Hsu K., 1990, P ANN INT GEOSC REM, P367; Kimball C., 1984, GEOPHYSICS, V49, P264, DOI DOI 10.1190/1.1441659; LANG SW, 1987, GEOPHYSICS, V52, P530, DOI 10.1190/1.1442322; Nolte B., 1997, DISPERSION ANAL SPLI; Paillet F. L., 1991, ACOUSTIC WAVES BOREH; Prosser W H, 1999, J Acoust Soc Am, V105, P2669, DOI 10.1121/1.426883; Rao V. N. R., 2005, DISPERSIVE WAVE ANAL; Roueff A, 2005, IEEE T SIGNAL PROCES, V53, P3738, DOI 10.1109/TSP.2005.855430; Sinha BK, 2009, GEOPHYSICS, V74, pE111, DOI 10.1190/1.3085644; Sinha B.K., 1999, GEOPHYS PROSPECTING; Tang X., 2004, QUANTITATIVE BOREHOL; Viberg M., 1989, THESIS LINKOPING U L; Wang C., 2004, U. S. Patent, Patent No. [7 120 541 B2, 7]; WAX M, 1985, IEEE T ACOUST SPEECH, V33, P387, DOI 10.1109/TASSP.1985.1164557	27	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1053-587X	1941-0476		IEEE T SIGNAL PROCES	IEEE Trans. Signal Process.	AUG 1	2015	63	15					4115	4128		10.1109/TSP.2015.2436367		14	Engineering, Electrical & Electronic	Engineering	CL6XN	WOS:000357112300021		
J	Brandes, U; Hagen, H; Takahashi, S; Yuan, XR				Brandes, Ulrik; Hagen, Hans; Takahashi, Shigeo; Yuan, Xiaoru			Guest Editors' Introduction: Special Section on the IEEE Pacific Visualization Symposium 2014	IEEE TRANSACTIONS ON VISUALIZATION AND COMPUTER GRAPHICS			English	Editorial Material									[Brandes, Ulrik] Univ Konstanz, Algorithm, Constance, Germany; [Brandes, Ulrik] Univ Passau, Passau, Germany; [Takahashi, Shigeo] PacificVis 2014, Program cochair, Yokohama, Kanagawa, Japan; [Takahashi, Shigeo] PacificVis 2015, Yokohama, Kanagawa, Japan; [Takahashi, Shigeo] VINCI, Alexandre Giros, France; [Yuan, Xiaoru] Peking Univ, Informat Sci Ctr, Beijing, Peoples R China	Brandes, U (reprint author), Univ Konstanz, Algorithm, Constance, Germany.							0	0	0	IEEE COMPUTER SOC	LOS ALAMITOS	10662 LOS VAQUEROS CIRCLE, PO BOX 3014, LOS ALAMITOS, CA 90720-1314 USA	1077-2626	1941-0506		IEEE T VIS COMPUT GR	IEEE Trans. Vis. Comput. Graph.	AUG	2015	21	8					887	888		10.1109/TVCG.2015.2442351		2	Computer Science, Software Engineering	Computer Science	CM3QU	WOS:000357599100001		
J	Bujack, R; Hotz, I; Scheuermann, G; Hitzer, E				Bujack, Roxana; Hotz, Ingrid; Scheuermann, Gerik; Hitzer, Eckhard			Moment Invariants for 2D Flow Fields via Normalization in Detail	IEEE TRANSACTIONS ON VISUALIZATION AND COMPUTER GRAPHICS			English	Article						Moments; moment invariants; pattern recognition; flow visualization; normalization	IMAGE-ANALYSIS; VORTEX; IDENTIFICATION; VISUALIZATION	The analysis of 2D flow data is often guided by the search for characteristic structures with semantic meaning. One way to approach this question is to identify structures of interest by a human observer, with the goal of finding similar structures in the same or other datasets. The major challenges related to this task are to specify the notion of similarity and define respective pattern descriptors. While the descriptors should be invariant to certain transformations, such as rotation and scaling, they should provide a similarity measure with respect to other transformations, such as deformations. In this paper, we propose to use moment invariants as pattern descriptors for flow fields. Moment invariants are one of the most popular techniques for the description of objects in the field of image recognition. They have recently also been applied to identify 2D vector patterns limited to the directional properties of flow fields. Moreover, we discuss which transformations should be considered for the application to flow analysis. In contrast to previous work, we follow the intuitive approach of moment normalization, which results in a complete and independent set of translation, rotation, and scaling invariant flow field descriptors. They also allow to distinguish flow features with different velocity profiles. We apply the moment invariants in a pattern recognition algorithm to a real world dataset and show that the theoretical results can be extended to discrete functions in a robust way.	[Bujack, Roxana; Scheuermann, Gerik] Univ Leipzig, Dept Comp Sci, D-04109 Leipzig, Germany; [Hotz, Ingrid] German Aerosp Ctr, Dept Simulat & Software Technol, Braunschweig, Germany; [Hitzer, Eckhard] Int Christian Univ, Dept Mat Sci, Tokyo, Japan	Bujack, R (reprint author), Univ Leipzig, Dept Comp Sci, D-04109 Leipzig, Germany.	bujack@informatik.uni-leipzig.de; hotz@gzib.de; scheuermann@informatik.uni-leipzig.de; hitzer@icu.ac.jp			European Social Fund [100098251]	The authors thank Gerd Mutschke from the TU Dresden for providing the von Karmann vortex street dataset and Prof. Kollmann from the University of California at Davis for producing the swirling jet dataset. The would further like to thank the FAnToM development group from the Leipzig University for providing the environment for the visualization of the presented work, especially Jens Kasten and Stefan Koch. This work was partially supported by the European Social Fund (Application No. 100098251).	ABUMOSTAFA YS, 1984, IEEE T PATTERN ANAL, V6, P698; Kasten J, 2011, IEEE T VIS COMPUT GR, V17, P2080, DOI 10.1109/TVCG.2011.249; Sahner J, 2007, IEEE T VIS COMPUT GR, V13, P980, DOI 10.1109/TVCG.2007.1053; JEONG J, 1995, J FLUID MECH, V285, P69, DOI 10.1017/S0022112095000462; Laramee RS, 2007, MATH VIS, P1, DOI 10.1007/978-3-540-70823-0_1; Schneider D, 2008, IEEE T VIS COMPUT GR, V14, P1475, DOI 10.1109/TVCG.2008.143; TEH CH, 1988, IEEE T PATTERN ANAL, V10, P496, DOI 10.1109/34.3913; Flusser J, 2000, PATTERN RECOGN, V33, P1405, DOI 10.1016/S0031-3203(99)00127-2; HU M, 1962, IRE T INFORM THEOR, V8, P179; TEAGUE MR, 1980, J OPT SOC AM, V70, P920, DOI 10.1364/JOSA.70.000920; Brambilla A., 2012, P EUR STAT OF THE AR, P75; Bujack R., 2014, P IEEE PAC VIS S, P41; Cabral B., 1993, COMPUT GRAPH, P263; Daniels J, 2010, IEEE T VIS COMPUT GR, V16, P1560, DOI 10.1109/TVCG.2010.170; DIRILTEN H, 1977, IEEE T COMPUT, V26, P314; Ebling J, 2004, PROCEEDINGS OF THE FOURTH IASTED INTERNATIONAL CONFERENCE ON VISUALIZATION, IMAGING, AND IMAGE PROCESSING, P825; Ebling J., 2006, THESIS U LEIPZIG LEI; Erlebacher G., 2006, P IEEE VIS TUTS; Flusser J., 2009, MOMENTS MOMENT INVAR; Heiberg E, 2003, IEEE T VIS COMPUT GR, V9, P313, DOI 10.1109/TVCG.2003.1207439; Kasten J., 2012, P TOP METH DAT AN VI, P207; Liu W, 2010, LECT NOTES COMPUT SC, V6218, P522; McLoughlin T., 2009, P EUROGRAPHICS 09, P73; Moxey CE, 2003, IEEE T SIGNAL PROCES, V51, P1941, DOI 10.1109/TSP.2003.812734; Sadlo F., 2004, P IEEE VIS, P179; Salzbrunn T, 2008, P SIM VIS, P75; Schlemmer M., 2009, P VIS MOD VIS VMV 09, V1, P255; Schlemmer M., 2011, THESIS TU KAISERSLAU; Schlemmer M, 2007, IEEE T VIS COMPUT GR, V13, P1743, DOI 10.1109/TVCG.2007.70579	29	0	0	IEEE COMPUTER SOC	LOS ALAMITOS	10662 LOS VAQUEROS CIRCLE, PO BOX 3014, LOS ALAMITOS, CA 90720-1314 USA	1077-2626	1941-0506		IEEE T VIS COMPUT GR	IEEE Trans. Vis. Comput. Graph.	AUG	2015	21	8					916	929		10.1109/TVCG.2014.2369036		14	Computer Science, Software Engineering	Computer Science	CM3QU	WOS:000357599100004		
J	Wang, B; Lu, F; Cheng, Y; Chen, JH; Jeon, HY; Ha, KS; Cao, J; Nyunt, MH; Han, JH; Lee, SK; Kyaw, MP; Sattabongkot, J; Takashima, E; Tsuboi, T; Han, ET				Wang, Bo; Lu, Feng; Cheng, Yang; Chen, Jun-Hu; Jeon, Hye-Yoon; Ha, Kwon-Soo; Cao, Jun; Nyunt, Myat Htut; Han, Jin-Hee; Lee, Seong-Kyun; Kyaw, Myat Phone; Sattabongkot, Jetsumon; Takashima, Eizo; Tsuboi, Takafumi; Han, Eun-Taek			Immunoprofiling of the Tryptophan-Rich Antigen Family in Plasmodium vivax	INFECTION AND IMMUNITY			English	Article							MEROZOITE SURFACE PROTEIN-1; CAVEOLA-VESICLE COMPLEXES; HUMORAL IMMUNE-RESPONSES; INFECTED ERYTHROCYTES; ANTIBODY-RESPONSES; SCHUFFNERS DOTS; MALARIA; FALCIPARUM; VACCINE; IDENTIFICATION	Tryptophan-rich antigens (TRAgs) are an antigen family that has been identified in human and rodent malaria parasites. TRAgs have been proposed as candidate antigens for potential vaccines. The Plasmodium vivax TRAg (PvTRAg) family includes 36 members. Each PvTRAg contains a tryptophan-rich (TR) domain in the C-terminal region. In this study, we recombinantly expressed all 36 PvTRAgs using a cell-free expression system, and, for the first time, profiled the IgG antibody responses against all PvTRAgs in the sera from 96 vivax malaria patients and 40 healthy individuals using protein microarray technology. The mean seropositive rate for all PvTRAgs was 60.3%. Among them, nine PvTRAgs were newly identified in this study and showed a seropositive rate of >50%. Five of them, PvTRAg_13, PvTRAg_15, PvTRAg_16, PvTRAg_26, and PvTRAg_29, produced higher levels of IgG antibody, even in low-endemicity countries. In addition, the results of an immunofluorescence analysis suggest that PvTRAgs are, at least in part, associated with caveola-vesicle complexes, a unique structure of P. vivax-infected erythrocytes. The mechanism of formation and the function of these abundant membrane structures are not known. Further investigation aimed at determining the functions of these proteins would lead to a better understanding of the blood-stage biology of P. vivax.	[Wang, Bo; Lu, Feng; Cheng, Yang; Chen, Jun-Hu; Nyunt, Myat Htut; Han, Jin-Hee; Lee, Seong-Kyun; Han, Eun-Taek] Kangwon Natl Univ, Sch Med, Dept Med Environm Biol & Trop Med, Chunchon, Gangwon Do, South Korea; [Wang, Bo] Anhui Med Univ, Affiliated Hosp 1, Dept Clin Lab, Hefei, Anhui, Peoples R China; [Lu, Feng; Cao, Jun] Jiangsu Inst Parasit Dis, Minist Hlth, Key Lab Parasit Dis Control & Prevent, Wuxi, Jiangsu, Peoples R China; [Lu, Feng; Cao, Jun] Jiangsu Inst Parasit Dis, Jiangsu Prov Key Lab Parasite Mol Biol, Wuxi, Jiangsu, Peoples R China; [Cheng, Yang] NIAID, Lab Malaria & Vector Res, NIH, Rockville, MD USA; [Jeon, Hye-Yoon; Ha, Kwon-Soo] Kangwon Natl Univ, Sch Med, Dept Mol & Cellular Biochem, Chunchon, Gangwon Do, South Korea; [Nyunt, Myat Htut; Kyaw, Myat Phone] Dept Med Res, Yangon, Myanmar; [Sattabongkot, Jetsumon] Mahidol Univ, Fac Trop Med, Mahidol Vivax Res Unit, Bangkok, Thailand; [Takashima, Eizo; Tsuboi, Takafumi] Ehime Univ, Proteosci Ctr, Div Malaria Res, Matsuyama, Ehime, Japan	Tsuboi, T (reprint author), Ehime Univ, Proteosci Ctr, Div Malaria Res, Matsuyama, Ehime, Japan.	tsuboi.takafumi.mb@ehime-u.ac.jp; ethan@kangwon.ac.kr			Korea Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea [A121180]; MEXT [23117008]; JSPS, Japan [26670202, 26253026]	This work was supported by a grant from the Korea Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea (A121180). This work was also supported in part by MEXT KAKENHI (23117008) and JSPS KAKENHI (26670202, 26253026), Japan.	AIKAWA M, 1975, AM J PATHOL, V79, P285; Beeson JG, 2008, TRENDS PARASITOL, V24, P578, DOI 10.1016/j.pt.2008.08.008; Udhayakumar V, 2001, AM J TROP MED HYG, V65, P100; Arevalo-Herrera M, 2010, HUM VACCINES, V6, P124; Langhorne J, 2008, NAT IMMUNOL, V9, P725, DOI 10.1038/ni.f.205; Salzwedel K, 1999, J VIROL, V73, P2469; Wipasa J, 2002, IMMUNOL CELL BIOL, V80, P401, DOI 10.1046/j.1440-1711.2002.01107.x; Zeeshan M, 2013, J INFECT DIS, V207, P175, DOI 10.1093/infdis/jis650; Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; Ntumngia FB, 2004, MOL BIOCHEM PARASIT, V137, P349, DOI 10.1016/j.molbiopara.2004.06.008; Tsuboi T, 2008, INFECT IMMUN, V76, P1702, DOI 10.1128/IAI.01539-07; Ndungu FM, 2013, EUR J IMMUNOL, V43, P2919, DOI 10.1002/eji.201343630; Akpogheneta OJ, 2008, INFECT IMMUN, V76, P1748, DOI 10.1128/IAI.01333-07; Cheng Y, 2014, PARASITOL RES, V113, P2559, DOI 10.1007/s00436-014-3907-8; Dorfman JR, 2005, J INFECT DIS, V191, P1623, DOI 10.1086/429671; Carlton JM, 2008, NATURE, V455, P757, DOI 10.1038/nature07327; Cooke BM, 2001, ADV PARASIT, V50, P1, DOI 10.1016/S0065-308X(01)50029-9; Cavanagh DR, 1998, J IMMUNOL, V161, P347; Taylor RR, 1996, INT IMMUNOL, V8, P905, DOI 10.1093/intimm/8.6.905; Zeeshan M, 2015, J INFECT DIS, V211, P1111, DOI 10.1093/infdis/jiu558; Burns JM, 2000, MOL BIOCHEM PARASIT, V110, P11, DOI 10.1016/S0166-6851(00)00252-8; Mendis K, 2001, AM J TROP MED HYG, V64, P97; Drakeley CJ, 2005, P NATL ACAD SCI USA, V102, P5108, DOI 10.1073/pnas.0408725102; Uhlemann AC, 2001, MOL BIOCHEM PARASIT, V118, P41, DOI 10.1016/S0166-6851(01)00370-X; Akinyi S, 2012, MOL MICROBIOL, V84, P816, DOI 10.1111/j.1365-2958.2012.08060.x; Bozdech Z, 2008, P NATL ACAD SCI USA, V105, P16290, DOI 10.1073/pnas.0807404105; Curtidor H, 2006, BIOCHEM BIOPH RES CO, V339, P888, DOI 10.1016/j.bbrc.2005.11.089; Saeed AI, 2003, BIOTECHNIQUES, V34, P374; Cheng Y, 2013, INFECT IMMUN, V81, P1585, DOI 10.1128/IAI.01117-12; WHO, 2013, WORLD MALARIA REPORT 2013, P1; Jalah R, 2005, MOL BIOCHEM PARASIT, V142, P158, DOI 10.1016/j.molbiopara.2005.01.020; Lu F, 2014, J PROTEOMICS, V102, P66, DOI 10.1016/j.jprot.2014.02.029; Arevalo-Herrera M, 2001, MOL IMMUNOL, V38, P443, DOI 10.1016/S0161-5890(01)00080-3; Chen JH, 2011, PARASITOL RES, V109, P1259, DOI 10.1007/s00436-011-2370-z; Chen JH, 2010, J PROTEOME RES, V9, P6479, DOI 10.1021/pr100705g; Gething PW, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001814; Hopkins RJ, 2004, CLIN INFECT DIS, V39, P759, DOI 10.1086/422998; Tyagi RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050754; Wang B, 2013, PARASITOL RES, V112, P585, DOI 10.1007/s00436-012-3170-9; Wipasa J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000770	40	0	0	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0019-9567	1098-5522		INFECT IMMUN	Infect. Immun.	AUG	2015	83	8					3083	3095		10.1128/IAI.03067-14		13	Immunology; Infectious Diseases	Immunology; Infectious Diseases	CM3XI	WOS:000357618300008		
J	Zhou, Y; Sztukowska, M; Wang, Q; Inaba, H; Potempa, J; Scott, DA; Wang, HZ; Lamont, RJ				Zhou, Yun; Sztukowska, Maryta; Wang, Qian; Inaba, Hiroaki; Potempa, Jan; Scott, David A.; Wang, Huizhi; Lamont, Richard J.			Noncanonical Activation of beta-Catenin by Porphyromonas gingivalis	INFECTION AND IMMUNITY			English	Article							SQUAMOUS-CELL CARCINOMA; EPITHELIAL-CELLS; WNT/BETA-CATENIN; POLYMICROBIAL SYNERGY; SIGNALING PATHWAY; MEMBRANE VESICLES; OUTER-MEMBRANE; ORAL PATHOGEN; ARG-GINGIPAIN; E-CADHERIN	Porphyromonas gingivalis is an established pathogen in periodontal disease and an emerging pathogen in serious systemic conditions, including some forms of cancer. We investigated the effect of P. gingivalis on beta-catenin signaling, a major pathway in the control of cell proliferation and tumorigenesis. Infection of gingival epithelial cells with P. gingivalis did not influence the phosphorylation status of beta-catenin but resulted in proteolytic processing. The use of mutants deficient in gingipain production, along with gingipain-specific inhibitors, revealed that gingipain proteolytic activity was required for beta-catenin processing. The beta-catenin destruction complex components Axin1, adenomatous polyposis coli (APC), and GSK3 beta were also proteolytically processed by P. gingivalis gingipains. Cell fractionation and Western blotting demonstrated that beta-catenin fragments were translocated to the nucleus. The accumulation of beta-catenin in the nucleus following P. gingivalis infection was confirmed by immunofluorescence microscopy. A luciferase reporter assay showed that P. gingivalis increased the activity of the beta-catenin-dependent TCF/LEF promoter. P. gingivalis did not increase Wnt3a mRNA levels, a finding consistent with P. gingivalis-induced proteolytic processing causing the increase in TCF/LEF promoter activity. Thus, our data indicate that P. gingivalis can induce the non-canonical activation of beta-catenin and disassociation of the beta-catenin destruction complex by gingipain-dependent proteolytic processing. beta-Catenin activation in epithelial cells by P. gingivalis may contribute to a proliferative phenotype.	[Zhou, Yun; Sztukowska, Maryta; Wang, Qian; Potempa, Jan; Scott, David A.; Wang, Huizhi; Lamont, Richard J.] Univ Louisville, Sch Dent, Dept Oral Immunol & Infect Dis, Louisville, KY 40292 USA; [Inaba, Hiroaki] Asahi Univ, Sch Dent, Dept Oral Microbiol, Mizuho Ku, Gifu, Japan; [Potempa, Jan] Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Dept Microbiol, Krakow, Poland; [Potempa, Jan] Jagiellonian Univ, Malopolska Ctr Biotechnol, Krakow, Poland	Lamont, RJ (reprint author), Univ Louisville, Sch Dent, Dept Oral Immunol & Infect Dis, Louisville, KY 40292 USA.	rich.lamont@louisville.edu	Wang, Huizhi/M-8229-2015		National Institutes of Health [DE01111, DE017921, DE023207, DE023633, DE017680, DE022597]	The support of the National Institutes of Health through grants DE01111 and DE017921 (R.J.L.), DE022597 and DE023207 (J.P.), DE023633 (H.W.), and DE017680 (D.A.S.) is gratefully acknowledged.	Aduse-Opoku J, 2006, INFECT IMMUN, V74, P449, DOI 10.1128/IAI.74.1.449-460.2006; Hirano T, 2013, MOL ORAL MICROBIOL, V28, P70, DOI 10.1111/omi.12007; Bostanci N, 2012, FEMS MICROBIOL LETT, V333, P1, DOI 10.1111/j.1574-6968.2012.02579.x; Atanasova KR, 2014, MOL ORAL MICROBIOL, V29, P55, DOI 10.1111/omi.12047; Scragg MA, 2002, INFECT IMMUN, V70, P5740, DOI 10.1128/IAI.70.10.5740-5750.2002; Tribble GD, 2010, PERIODONTOL 2000, V52, P68, DOI 10.1111/j.1600-0757.2009.00323.x; Rubinstein MR, 2013, CELL HOST MICROBE, V14, P195, DOI 10.1016/j.chom.2013.07.012; Veillard F, 2013, BBA-GEN SUBJECTS, V1830, P4218, DOI 10.1016/j.bbagen.2013.04.005; Fang DX, 2007, J BIOL CHEM, V282, P11221, DOI 10.1074/jbc.M611871200; Chaw SY, 2012, ORAL ONCOL, V48, P997, DOI 10.1016/j.oraloncology.2012.05.011; Yilmaz O, 2006, INFECT IMMUN, V74, P703, DOI 10.1128/IAI.74.1.703-710.2006; Nagy KN, 1998, ORAL ONCOL, V34, P304, DOI 10.1016/S1368-8375(98)00008-6; Kandasamy AD, 2010, CARDIOVASC RES, V85, P413, DOI 10.1093/cvr/cvp268; Furuta N, 2009, INFECT IMMUN, V77, P4761, DOI 10.1128/IAI.00841-09; Darveau RP, 2012, J DENT RES, V91, P816, DOI 10.1177/0022034512453589; Lamont RJ, 1998, MICROBIOL MOL BIOL R, V62, P1244; Veith PD, 2014, J PROTEOME RES, V13, P2420, DOI 10.1021/pr401227e; Huang H, 2008, CURR OPIN CELL BIOL, V20, P119, DOI 10.1016/j.ceb.2008.01.009; Haurat MF, 2011, J BIOL CHEM, V286, P1269, DOI 10.1074/jbc.M110.185744; Kuboniwa M, 2008, MICROBES INFECT, V10, P122, DOI 10.1016/j.micinf.2007.10.011; Hajishengallis G, 2012, MOL ORAL MICROBIOL, V27, P409, DOI 10.1111/j.2041-1014.2012.00663.x; Tribble GD, 2013, FUTURE MICROBIOL, V8, P607, DOI [10.2217/fmb.13.30, 10.2217/FMB.13.30]; Wang HZ, 2014, TRENDS MICROBIOL, V22, P208, DOI 10.1016/j.tim.2014.01.009; Yilmaz O, 2002, CELL MICROBIOL, V4, P305, DOI 10.1046/j.1462-5822.2002.00192.x; Tanaka N, 2003, BRIT J CANCER, V89, P557, DOI 10.1038/sj.bjc.6601124; Kinane JA, 2012, CELL MICROBIOL, V14, P1085, DOI 10.1111/j.1462-5822.2012.01780.x; Duan YL, 2007, LAB INVEST, V87, P613, DOI 10.1038/labinvest.3700545; Shi Y, 1999, J BIOL CHEM, V274, P17955, DOI 10.1074/jbc.274.25.17955; Inaba H, 2014, CELL MICROBIOL, V16, P131, DOI 10.1111/cmi.12211; Moffatt CE, 2012, CELL MICROBIOL, V14, P577, DOI 10.1111/j.1462-5822.2011.01743.x; Brembeck FH, 2006, CURR OPIN GENET DEV, V16, P51, DOI 10.1016/j.gde.2005.12.007; Mantri CK, 2015, MICROBIOLOGYOPEN, V4, P53, DOI 10.1002/mbo3.221; Mao S, 2007, CELL MICROBIOL, V9, P1997, DOI 10.1111/j.1462-5822.2007.00931.x; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Peng Y, 2013, BIOCHEM BIOPH RES CO, V441, P751, DOI 10.1016/j.bbrc.2013.10.127; Handfield M, 2005, CELL MICROBIOL, V7, P811, DOI 10.1111/j.1462-5822.2005.00513.x; Stafford P, 2013, MOL ORAL MICROBIOL, V28, P366, DOI 10.1111/omi.12030; Kikuchi A, 2006, EXP MOL MED, V38, P1; NAKAYAMA K, 1995, J BIOL CHEM, V270, P23619; Curtis MA, 2001, CRIT REV ORAL BIOL M, V12, P192; Yao L, 2010, MOL ORAL MICROBIOL, V25, P89, DOI 10.1111/j.2041-1014.2010.00569.x; Fracalossi ACC, 2010, EXP MOL PATHOL, V88, P176, DOI 10.1016/j.yexmp.2009.11.004; Glew MD, 2012, J BIOL CHEM, V287, P24605, DOI 10.1074/jbc.M112.369223; Moffatt CE, 2011, INFECT IMMUN, V79, P2632, DOI 10.1128/IAI.00082-11; Chen JS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120390; Debelec-Butuner B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109868; Dierick H, 1999, CURR TOP DEV BIOL, V43, P153, DOI 10.1016/S0070-2153(08)60381-6; Hajishengallis G, 2014, MOL ORAL MICROBIOL, V29, P248, DOI 10.1111/omi.12065; Herbst A, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-74; Inaba H, MED MICROBI IN PRESS; Inaba H, 2012, INFECT IMMUN, V80, P2847, DOI 10.1128/IAI.00258-12; Jauregui CE, 2013, INFECT IMMUN, V81, P2288, DOI 10.1128/IAI.00264-13; Katz J, 2011, INT J ORAL SCI, V3, P209, DOI 10.4248/IJOS11075; Keerthivasan S, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007607; Lamont RJ, 2015, TRENDS MOL MED, V21, P172, DOI 10.1016/j.molmed.2014.11.004; Lang M, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-41; Larabee JL, 2008, INFECT IMMUN, V76, P4895, DOI 10.1128/IAI.00889-08; Lima BB, 2014, INFECT IMMUN, V82, P2680, DOI 10.1128/IAI.00567-13; Lo Muzio L, 2001, CRIT REV ORAL BIOL M, V12, P152; Lu R, 2014, ONCOGENESIS, V3, DOI 10.1038/oncsis.2014.20; Nakayama K, 2015, J PERIODONTAL RES, V50, P1, DOI 10.1111/jre.12255; Nakayama M, 2015, J BIOL CHEM, V290, P5190, DOI 10.1074/jbc.M114.591610; Nishikawa K, 2010, J BACTERIOL, V192, P1975, DOI 10.1128/JB.01474-09; Palm E, 2015, MOL ORAL MICROBIOL, V30, P74, DOI 10.1111/omi.12073; Rims CR, 2014, EXP LUNG RES, V40, P126, DOI 10.3109/01902148.2014.890681; Silva-Garcia O, 2014, MEDIAT INFLAMM, DOI 10.1155/2014/310183; Takeuchi H, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003326; Tancharoen S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117775; Tang Y, 2014, J DENT RES, V93, P175, DOI 10.1177/0022034513512507; Tokuda M, 1998, INFECT IMMUN, V66, P1159; Uraguchi M, 2004, J DENT RES, V83, P327; Wang J, 2013, INFLAMMATION, V36, P1393, DOI 10.1007/s10753-013-9679-y; Whitmore SE, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003933; Xing QA, 2010, J CELL PHYSIOL, V225, P106, DOI [10.1002/jcp.22201, 10.1002/jcp.2220]	74	1	1	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0019-9567	1098-5522		INFECT IMMUN	Infect. Immun.	AUG	2015	83	8					3195	3203		10.1128/IAI.00302-15		9	Immunology; Infectious Diseases	Immunology; Infectious Diseases	CM3XI	WOS:000357618300019		
J	Yoshiyama, T; Harada, N; Higuchi, K; Saitou, M; Kato, S				Yoshiyama, Takashi; Harada, Nobuyuki; Higuchi, Kazue; Saitou, Masami; Kato, Seiya			Use of the QuantiFERON (R)-TB Gold in Tube test for screening TB contacts and predictive value for active TB	INFECTIOUS DISEASES			English	Article						Tuberculosis; interferon-gamma release test; infection; diseases; QFT-GIT	LATENT TUBERCULOSIS INFECTION; BLOOD INTERFERON-GAMMA; RELEASE ASSAYS; DIAGNOSIS; RISK	Background: This study estimated the incidence of progression to active tuberculosis (TB) among contacts categorized by QuantiFERON (R)-TB Gold in Tube (QFT-GIT) test results and investigated other risk factors related to progression to TB. Methods: Contacts of patients with TB were tested using QFT-GIT and were followed up every 6 months at public health centers to detect clinical progression to TB. Results: Analysis of a retrospective cohort revealed that, of the 625 contacts, 168 were QFT-GIT positive and 457 were negative. Of these, 10 (6%) QFT-GIT-positive and two (0.4%) QFT-GIT-negative contacts progressed to TB during the follow-up period (p < 0.01, statistically significant). Multivariable logistic regression analysis revealed that QFT-GIT positivity (p < 0.01), contact of index patients with many other positive contacts (p < 0.01), household contact (p = 0.014), and untreated latent TB infection (p = 0.047) were independent risk factors for progression to TB during an average follow-up period of 637 days. Conclusions: Progression to TB among QFT-GIT-positive contacts was higher than among QFT-GIT-negative contacts. Other independent risk factors for progression to TB were index cases with more QFT-GIT-positive contacts as well as household contacts.	[Yoshiyama, Takashi; Saitou, Masami] Fukujuji Hosp, Resp Dis Ctr, Kiyose, Japan; [Harada, Nobuyuki; Higuchi, Kazue] Res Inst Immunol Diag, Tachikawa, Tokyo, Japan; [Kato, Seiya] Res Inst TB, Kiyose, Japan	Yoshiyama, T (reprint author), 3-1-24 Matsuyama Kiyose, Tokyo 2048522, Japan.	yoshiyama1962@yahoo.co.jp			Japanese Ministry of Health, Labor and Welfare [H24 Shinko Ippan 011]	This study was supported by a grant for a 'study for effective TB control, including a cost-benefit analysis of periodic health examination and BCG' from the Japanese Ministry of Health, Labor and Welfare (grant no. H24 Shinko Ippan 011). The authors report no conflicts of interest.	Ahiko T., 2014, GUIDELINES CONTACT I, P23; Harada N, 2006, INFECT CONT HOSP EP, V27, P442, DOI 10.1086/504358; Diel R, 2011, AM J RESP CRIT CARE, V183, P88, DOI 10.1164/rccm.201006-0974OC; Herrera V, 2011, CLIN INFECT DIS, V52, P1031, DOI 10.1093/cid/cir068; Diel R, 2012, CHEST, V142, P63, DOI 10.1378/chest.11-3157; Rangaka MX, 2012, LANCET INFECT DIS, V12, P45, DOI 10.1016/S1473-3099(11)70210-9; Yoshiyama T, 2010, INT J TUBERC LUNG D, V14, P819; Farebee SH, 1970, ADV TUBERC RES, V17, P28; Kruczak K, 2014, SCAND J INFECT DIS, V46, P649, DOI 10.3109/00365548.2014.927955; Qiagen, QUANTIFERON TB GOLD; Sloot R, 2014, AM J RESP CRIT CARE, V190, P1044, DOI 10.1164/rccm.201406-1159OC; WHO Guidelines Development Group, 2015, GUID MAN LAT TUB INF; Yoshiyama T., 2009, KEKKAKU, V84, P31	13	0	0	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	2374-4235	2374-4243		INFECT DIS-NOR	Infect. Dis.	AUG	2015	47	8					542	549		10.3109/23744235.2015.1026935		8	Infectious Diseases	Infectious Diseases	CM5OS	WOS:000357738200005		
J	Kuribayashi, T; Seita, T; Momotani, E; Yamazaki, S; Hagimori, K; Yamamoto, S				Kuribayashi, Takashi; Seita, Tetsuro; Momotani, Eiichi; Yamazaki, Shunsuke; Hagimori, Kohei; Yamamoto, Shizuo			Elimination Half-Lives of Acute Phase Proteins in Rats and Beagle Dogs During Acute Inflammation	INFLAMMATION			English	Article						CRP; AAG; alpha 2M; half-life; beagle dogs; rats	C-REACTIVE PROTEIN; ALPHA-1-ACID GLYCOPROTEIN; ADULT DOGS; SERUM; ALPHA(2)-MACROGLOBULIN; HEALTHY; SURGERY; YOUNG; STIMULATION; DISEASES	The half-lives of typical acute phase proteins in rats and beagle dogs during acute inflammation were investigated. Acute inflammation was induced by injection of turpentine oil in rats and administration of indomethacin in beagle dogs. Serum concentrations of alpha(2)-macroglobulin (alpha 2M) and C-reactive protein (CRP) were measured by enzyme-linked immunosorbent assay and alpha(1)-acid glycoprotein (AAG) was measured by single radial immunodiffusion. Half-life was calculated as 0.693/elimination rate constant (K). The mean half-lives in the terminal elimination phase of alpha 2M and AAG were 68.1 and 164.8 h, respectively. The half-life of AAG was significantly longer than that of alpha 2M. Mean half-lives in the terminal elimination phase of CRP and AAG were 161.9 and 304.4 h, respectively. The half-life of AAG was significantly longer than that of CRP in beagle dogs. No significant differences in the half-life of AAG were observed between rats and beagle dogs. Furthermore, serum concentrations in the terminal elimination phase could be simulated with the K data acquired in this study.	[Kuribayashi, Takashi; Seita, Tetsuro; Yamamoto, Shizuo] Azabu Univ, Grad Sch Environm & Hlth Sci, Chou Ku, Sagamihara, Kanagawa 2525201, Japan; [Momotani, Eiichi] Tohto Coll Hlth Sci, Dept Human Hlth Care, Fukaya, Saitama 3660052, Japan; [Yamazaki, Shunsuke] Kamakura Womens Univ, Dept Food & Nutr, Physiol Lab, Kamakura, Kanagawa 2478512, Japan; [Hagimori, Kohei] Azabu Univ, Fac Life & Environm Sci, Immunol Lab, Chou Ku, Sagamihara, Kanagawa 2525201, Japan	Yamamoto, S (reprint author), Azabu Univ, Grad Sch Environm & Hlth Sci, Chou Ku, 1-17-71 Fuchinobe, Sagamihara, Kanagawa 2525201, Japan.	yamamoto@azabu-u.ac.jp			Azabu University	This research was partially supported by a research project grant awarded by Azabu University.	Anderson N, 2002, BIOMED CHROMATOGR, V16, P365, DOI 10.1002/bmc.167; Ceron JJ, 2005, VET CLIN PATH, V34, P85; YAMAMOTO S, 1994, VET QUART, V16, P74; Jinbo T, 2001, COMPARATIVE MED, V51, P332; BURTON SA, 1994, AM J VET RES, V55, P613; Otabe K, 2000, LAB ANIM, V34, P434, DOI 10.1258/002367700780387679; Kjelgaard-Hansen M, 2013, VET CLIN PATH, V42, P342, DOI 10.1111/vcp.12063; YAMAMOTO S, 1994, VET RES COMMUN, V18, P347, DOI 10.1007/BF01839285; Kuribayashi T, 2003, EXP ANIM TOKYO, V52, P377, DOI 10.1538/expanim.52.377; Ram R, 2013, J INFECTION, V67, P194, DOI 10.1016/j.jinf.2013.05.005; Veilleux-Lemieux D, 2013, J AM ASSOC LAB ANIM, V52, P567; Jinbo T, 2002, LAB ANIM-UK, V36, P153, DOI 10.1258/0023677021912433; Fournier T, 2000, BBA-PROTEIN STRUCT M, V1482, P157, DOI 10.1016/S0167-4838(00)00153-9; Sheikh N, 2007, LAB INVEST, V87, P713, DOI 10.1038/labinvest.3700553; Chase D, 2012, VET REC, V170, P648, DOI 10.1136/vr.100401; Clinch D., IRISH MED J, V82, P172; Davidson J, 2013, PEDIATR RES, V74, P413, DOI 10.1038/pr.2013.124; DOMSCHKE S, 1984, CLIN GASTROENTEROL, V13, P405; Eckersall P.D., 2000, IRISH VET J, V53, P3007; Hayashi S, 2001, VET RES COMMUN, V25, P117, DOI 10.1023/A:1006404902214; Honjo T, 2010, EXP ANIM TOKYO, V59, P589; Hudig D, 1978, Inflammation, V3, P137, DOI 10.1007/BF00910735; Kuribayashi T, 2011, LAB ANIM-UK, V45, P215, DOI 10.1258/la.2011.010112; Kuribayashi T, 2013, INFLAMMATION, V36, P1448, DOI 10.1007/s10753-013-9685-0; Nakou ES, 2010, OPEN CLIN CHEM J, V3, P10; Nivy R, 2014, VET PARASITOL, V203, P153, DOI 10.1016/j.vetpar.2014.02.001; Spiridonov VK, 2008, B EXP BIOL MED+, V146, P375; Um SY, 2012, ANAL CHIM ACTA, V722, P87, DOI 10.1016/j.aca.2012.01.062; YAMASHITA K, 1994, J VET MED SCI, V56, P487; Yuki M, 2010, VET CLIN PATH, V39, P65, DOI 10.1111/j.1939-165X.2009.00181.x; Yuki M, 2011, VET RES COMMUN, V35, P1, DOI 10.1007/s11259-010-9445-7	31	0	0	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0360-3997	1573-2576		INFLAMMATION	Inflammation	AUG	2015	38	4					1401	1405		10.1007/s10753-015-0114-4		5	Cell Biology; Immunology	Cell Biology; Immunology	CM4PD	WOS:000357666000003		
J	Miyake, Y; Hitsumoto, S; Tanaka, K; Arakawa, M				Miyake, Yoshihiro; Hitsumoto, Shinichi; Tanaka, Keiko; Arakawa, Masashi			Association Between TSLP Polymorphisms and Eczema in Japanese Women: the Kyushu Okinawa Maternal and Child Health Study	INFLAMMATION			English	Article						eczema; Japanese women; polymorphism; TSLP	GENOME-WIDE ASSOCIATION; THYMIC STROMAL LYMPHOPOIETIN; WORLDWIDE VARIATIONS; ASTHMA; PREVALENCE; SYMPTOMS; ALLERGIES	We examined the association between thymic stromal lymphopoietin (TSLP) single nucleotide polymorphisms (SNPs) and eczema in young adult Japanese women. Cases were 188 women who met the criteria of the International Study of Asthma and Allergies in Childhood (ISAAC) for eczema. Controls were 565 women without eczema according to the ISAAC criteria, who had not been diagnosed with asthma, atopic eczema, and/or allergic rhinitis by a doctor and who had no asthma as defined by the European Community Respiratory Health Survey criteria and no rhinoconjunctivitis according to the ISAAC criteria. Compared with women with the TT genotype of SNP rs1837253, those with the TC or CC genotype had a significantly increased risk of eczema after adjustment for age and smoking, although this association was not significant in crude analysis. There were no relationships between SNP rs3806933 or rs2289276 and eczema. The TC and CC genotypes combined of SNP rs1837253 may be significantly positively associated with eczema.	[Miyake, Yoshihiro; Tanaka, Keiko] Ehime Univ, Grad Sch Med, Dept Publ Hlth, Matsuyama, Ehime 7910295, Japan; [Hitsumoto, Shinichi] Ehime Univ Hosp, Total Med Support Ctr, Matsuyama, Ehime, Japan; [Arakawa, Masashi] Univ Ryukyus, Grad Sch Tourism Sci, Hlth Tourism Res Ctr, Okinawa, Japan	Miyake, Y (reprint author), Ehime Univ, Grad Sch Med, Dept Publ Hlth, Matsuyama, Ehime 7910295, Japan.	miyake.yoshihiro.ls@ehime-u.ac.jp			JSPS KAKENHI [19590606, 20791654, 21590673, 22592355, 22119507, 24390158, 25463275, 25670305]; Ministry of Health, Labour, and Welfare of Japan; Takeda Science Foundation	The authors would like to thank the Kyushu Branch of the Japan Allergy Foundation, the Fukuoka Association of Obstetricians and Gynecologists, the Okinawa Association of Obstetricians and Gynecologists, the Miyazaki Association of Obstetricians and Gynecologists, the Oita Association of Obstetricians and Gynecologists, the Kumamoto Association of Obstetricians and Gynecologists, the Nagasaki Association of Obstetricians and Gynecologists, the Kagoshima Association of Obstetricians and Gynecologists, the Saga Association of Obstetricians and Gynecologists, the Fukuoka Society of Obstetrics and Gynecology, the Okinawa Society of Obstetrics and Gynecology, the Fukuoka City government, and the Fukuoka City Medical Association for their valuable support, as well as Mrs. Yukari Hayashi for her technical assistance. This study was supported by JSPS KAKENHI Grant Numbers 19590606, 20791654, 21590673, 22592355, 22119507, 24390158, 25463275, and 25670305, by Health and Labour Sciences Research Grants for Research on Allergic Disease and Immunology and Health Research on Children, Youth and Families from the Ministry of Health, Labour, and Welfare of Japan and by the Takeda Science Foundation.	Harada M, 2009, AM J RESP CELL MOL, V40, P368, DOI 10.1165/rcmb.2008-0041OC; Hunninghake GM, 2010, ALLERGY, V65, P1566, DOI 10.1111/j.1398-9995.2010.02415.x; Knol MJ, 2011, EUR J EPIDEMIOL, V26, P433, DOI 10.1007/s10654-011-9554-9; Torgerson DG, 2011, NAT GENET, V43, P887, DOI 10.1038/ng.888; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Ferreira MAR, 2014, J ALLERGY CLIN IMMUN, V133, P1564, DOI 10.1016/j.jaci.2013.10.030; He JQ, 2009, J ALLERGY CLIN IMMUN, V124, P222, DOI 10.1016/j.jaci.2009.04.018; Strachan DP, 1997, PEDIATR ALLERGY IMMU, V8, P161, DOI 10.1111/j.1399-3038.1997.tb00156.x; Gao PS, 2010, J ALLERGY CLIN IMMUN, V125, P1403, DOI 10.1016/j.jaci.2010.03.016; Hirota T, 2011, NAT GENET, V43, P893, DOI 10.1038/ng.887; Ziegler SF, 2010, NAT IMMUNOL, V11, P289, DOI 10.1038/ni.1852; Williams H, 1999, J ALLERGY CLIN IMMUN, V103, P125, DOI 10.1016/S0091-6749(99)70536-1; Gauderman WJ, 2002, STAT MED, V21, P35, DOI 10.1002/sim.973; Andersson T, 2005, EUR J EPIDEMIOL, V20, P575, DOI 10.1007/s10654-005-7835-x; Soumelis V, 2002, NAT IMMUNOL, V3, P673, DOI 10.1038/ni805; Ying S, 2005, J IMMUNOL, V174, P8183; Harada M, 2011, AM J RESP CELL MOL, V44, P787, DOI 10.1165/rcmb.2009-0418OC; European Community Respiratory Health Survey, 1996, EUR RESPIR J, V9, P687; He R, 2010, ANN NY ACAD SCI, V1183, P13, DOI 10.1111/j.1749-6632.2009.05128.x; Liu ML, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025099; Miyake Y, 2013, J PSYCHIATR RES, V47, P572, DOI 10.1016/j.jpsychires.2013.01.012; Statistics Bureau Ministry of Public Management Home Affairs Posts and Telecommunications, 2002, 2000 POP CENS JAP	22	0	0	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0360-3997	1573-2576		INFLAMMATION	Inflammation	AUG	2015	38	4					1663	1668		10.1007/s10753-015-0143-z		6	Cell Biology; Immunology	Cell Biology; Immunology	CM4PD	WOS:000357666000033		
J	Chalmers, JD; Matsushita, M; Kilpatrick, DC; Hill, AT				Chalmers, James D.; Matsushita, Misao; Kilpatrick, David C.; Hill, Adam T.			No Strong Relationship Between Components of the Lectin Pathway of Complement and Susceptibility to Pulmonary Tuberculosis	INFLAMMATION			English	Article						tuberculosis; innate immunity; mannose-binding lectin; ficolin; complement; phagocytosis; case-control study	MANNOSE-BINDING LECTIN; MYCOBACTERIUM-TUBERCULOSIS; GENETIC SUSCEPTIBILITY; CONFERS PROTECTION; PROTEIN; POLYMORPHISMS; PHAGOCYTOSIS; ASSOCIATION; VARIANTS; RISK	Mycobacterium tuberculosis (TB) may utilise the lectin complement pathway to facilitate entry into its niche within macrophages. Previous studies examining mannose-binding lectin (MBL) in patients with TB have been limited by failure to correlate genotype/phenotype relationships. This study investigated serum levels and genotypes of MBL, Ficolin-2, Ficolin-3 and MASP-2 in 168 patients with pulmonary tuberculosis and 168 age/sex-matched controls. Low serum levels of MBL and Ficolin-2 were defined using cut-offs previously identified in the literature. Median MBL serum levels were higher in TB patients than controls-1400 ng/ml (IQR 435-2520) vs 1030 ng/ml (350-2050), p = 0.02-but this was not mirrored by a difference in MBL haplotype frequencies (MBL deficient haplotypes were observed in 11.9 % of TB patients and 11.3 % of controls). Severe Ficolin-2 deficiency (< 1200 ng/ml) was more frequent in TB than controls (7.1 vs 3.0 %, odds ratio 2.51 95 % CI 0.86-7.28, p = 0.1) but the difference was not statistically significant. No relationship between Ficolin-2, Ficolin-3 or MASP-2 genotypes or serum levels and TB were observed. No strong relationship between the lectin complement pathway and pulmonary tuberculosis was observed. Previous data linking high MBL serum levels with TB were likely due to an acute phase response rather than a true effect on disease susceptibility.	[Chalmers, James D.] Univ Dundee, Tayside Resp Res Grp, Dundee DD1 9SY, Scotland; [Matsushita, Misao] Tokai Univ, Dept Appl Biochem, Hiratsuka, Kanagawa 25912, Japan; [Kilpatrick, David C.] Scottish Natl Blood Transfus Serv, Edinburgh EH17 7QT, Midlothian, Scotland; [Hill, Adam T.] Univ Edinburgh, Royal Infirm Edinburgh, Dept Resp Med, Edinburgh EH16 4SA, Midlothian, Scotland	Chalmers, JD (reprint author), Univ Dundee, Tayside Resp Res Grp, Dundee DD1 9SY, Scotland.	jchalmers@dundee.ac.uk					Tosh K, 2006, P NATL ACAD SCI USA, V103, P10364, DOI 10.1073/pnas.0603340103; Kilpatrick DC, 1999, IMMUNOL LETT, V67, P109, DOI 10.1016/S0165-2478(98)00147-3; Selvaraj P, 2006, FEMS IMMUNOL MED MIC, V46, P433, DOI 10.1111/j.1574-695X.2006.00053.x; Capparelli R, 2009, J INFECT DIS, V199, P666, DOI 10.1086/596658; Neth O, 2000, INFECT IMMUN, V68, P688, DOI 10.1128/IAI.68.2.688-693.2000; Herpers BL, 2009, CLIN EXP IMMUNOL, V156, P488, DOI 10.1111/j.1365-2249.2009.03929.x; Honore C, 2008, MOL IMMUNOL, V45, P2782, DOI 10.1016/j.molimm.2008.02.005; Garred P, 1997, SCAND J IMMUNOL, V46, P204, DOI 10.1046/j.1365-3083.1997.d01-111.x; Soborg C, 2003, J INFECT DIS, V188, P777; Carroll MV, 2009, MOL IMMUNOL, V46, P3367, DOI 10.1016/j.molimm.2009.07.015; Kang PB, 2005, J EXP MED, V202, P987, DOI 10.1084/jem.20051239; Bellamy R, 2005, CLIN CHEST MED, V26, P233, DOI 10.1016/j.ccm.2005.02.006; Hummelshoj T, 2005, HUM MOL GENET, V14, P1651, DOI 10.1093/hmg/ddi173; Eisen DP, 2008, CLIN INFECT DIS, V47, P510, DOI 10.1086/590006; Gagneux S, 2006, P NATL ACAD SCI USA, V103, P2869, DOI 10.1073/pnas.0511240103; Hoal-van Helden EG, 1999, PEDIATR RES, V45, P459, DOI 10.1203/00006450-199904010-00002; Roth DE, 2004, J INFECT DIS, V190, P920, DOI 10.1086/423212; Kilpatrick DC, 2009, CLIN RESPIR J, V3, P29, DOI 10.1111/j.1752-699X.2008.00105.x; Denholm JT, 2010, CLIN EXP IMMUNOL, V162, P84, DOI 10.1111/j.1365-2249.2010.04221.x; SCHLESINGER LS, 1990, J IMMUNOL, V144, P2771; Chalmers JD, 2013, LANCET RESP MED, V1, P175; Cosar H, 2008, EUR J CLIN MICROBIOL, V27, P1165, DOI 10.1007/s10096-008-0573-8; EZEKOWITZ RAB, 1988, J EXP MED, V167, P1034, DOI 10.1084/jem.167.3.1034; Flores-Villanueva PO, 2005, J EXP MED, V202, P1649, DOI 10.1084/jem20050216; Fortune A., 2004, J IMMUNOL, V172, P6272; Houben ENG, 2006, CURR OPIN MICROBIOL, V9, P76, DOI 10.1016/j.mib.2005.12.014; Kilpatrick DC, 2012, J BIOMED BIOTECHNOL, V2012, DOI [10.1155/2012/138797, DOI 10.1155/2012/138797]; Kilpatrick DC, 2003, BIOCHEM SOC T, V31, P745, DOI 10.1042/BST0310745; Kilpatrick DC, 1995, MOL HUM REPROD, V1, P2501; Lambourne J, 2009, CLIN INFECT DIS, V49, P1486, DOI 10.1086/644619; Muhlebach MS, 2006, CLIN EXP IMMUNOL, V145, P302, DOI 10.1111/j.1365-2249.2006.03151.x; Sallakci N, 2007, TUBERCULOSIS, V87, P225, DOI 10.1016/j.tube.2006.10.002; Schlapbach LJ, 2007, PEDIATR INFECT DIS J, V26, P989, DOI 10.1097/INF.0b013e31811ffe6a; Stop TB Partnership and World Health Organization, 2006, WHOHTMSTB200635	34	1	1	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0360-3997	1573-2576		INFLAMMATION	Inflammation	AUG	2015	38	4					1731	1737		10.1007/s10753-015-0150-0		7	Cell Biology; Immunology	Cell Biology; Immunology	CM4PD	WOS:000357666000040		
J	Ogai, K; Matsumoto, M; Minematsu, T; Kitamura, K; Kobayashi, M; Sugama, J; Sanada, H				Ogai, K.; Matsumoto, M.; Minematsu, T.; Kitamura, K.; Kobayashi, M.; Sugama, J.; Sanada, H.			Development of an improved method for quantitative analysis of skin blotting: increasing reliability and applicability for skin assessment	INTERNATIONAL JOURNAL OF COSMETIC SCIENCE			English	Article						biotechnology; fermentation; normalization; safety testing; skin blotting; skin physiology; structure	QUALITY-OF-LIFE; NECROSIS-FACTOR-ALPHA; BARRIER FUNCTION; MATRIX METALLOPROTEINASES; INSULIN-RESISTANCE; NONINVASIVE ASSESSMENT; OXIDATIVE STRESS; BODY-MASS; IN-VITRO; PROTEINS	ObjectiveA novel skin assessment tool named skin blotting' has been recently developed, which can easily predict the skin status to avoid its deterioration. The aim of this study was to propose a normalization method for skin blotting to compensate for individual differences that can hamper the quantitative comparisons and clinical applications. MethodsTo normalize individual differences, we utilized a total protein as a normalizer' with calibration curves. For evaluation, we performed a simple simulation experiment, in which the same concentration of a protein of interest [tumour necrosis factor (TNF)-] was applied at different volumes as a virtual individual difference. Moreover, to demonstrate the applicability of this normalization, male volunteers were recruited for skin blotting followed by the estimation of TNF- with normalization. ResultsWe obtained good calibration curves for total protein (R-2=0.995) and TNF- (R-2=0.997), both of which were necessary for an exact quantification. In the simulation experiment, we estimated the exact concentration of TNF- regardless of the applied volume, demonstrating the applicability of this normalization method in skin blotting. Further, skin blotting on human subjects showed a wide range of variation in the total protein content, although the normalization was thought to reduce such individual variations. ConclusionThis study has proposed total protein normalization for skin blotting with calibration curves. This method may strengthen the quantitative performance of skin blotting, which may expand the applicability of this method as a skin assessment tool in broader fields, such as nursing and cosmetology. Resume ObjectifUn nouvel outil d'evaluation de la peau nomme skin blotting a ete recemment mis au point, qui peut facilement predire l'etat de la peau pour eviter sa deterioration. Le but de cette etude est de proposer une methode de normalisation pour la peau buvard pour compenser les differences individuelles qui peuvent entraver les comparaisons quantitatives et applications cliniques. MethodesPour normaliser les differences individuelles, nous avons utilise le parametre proteine totale comme << normalisateur >> avec des courbes d'etalonnage. Pour l'evaluation, nous avons realise une experience de simulation simple, dans lequel la meme concentration d'une proteine d'interet [facteur de necrose tumorale (TNF) -] a ete applique a des volumes differents en tant que difference individuelle virtuel. En outre, pour demontrer l'applicabilite de cette normalisation, les volontaires masculins ont ete recrutes pour le skin blotting suivi par l'estimation de TNF- avec la normalisation. ResultatsNous avons obtenu de bonnes courbes d'etalonnage pour les proteines totales (R-2=0.995) et le TNF- (R-2=0.997), qui etaient tous deux necessaires pour une quantification exacte. Dans l'experience de simulation, nous avons estime la concentration exacte de TNF- quel que soit le volume applique, ce qui demontre l'applicabilite de cette methode de normalisation de la peau buvard. En outre, le skin blotting sur sujets humains a montre une large gamme de variation de la teneur totale en proteines, bien que la normalisation ait du reduire ces variations individuelles. ConclusionCette etude a propose une normalisation de proteines pour le skin blotting avec des courbes d'etalonnage. Cette methode peut augmenter la performance quantitative de la technique, ce qui peut elargir l'applicabilite de cette methode comme un outil d'evaluation de la peau dans des domaines plus larges, comme les soins infirmiers et de la cosmetologie.	[Ogai, K.; Kobayashi, M.; Sugama, J.] Kanazawa Univ, Inst Med Pharmaceut & Hlth Sci, Wellness Promot Sci Ctr, Kanazawa, Ishikawa 9200942, Japan; [Matsumoto, M.; Sugama, J.] Kanazawa Univ, Grad Sch Med, Div Hlth Sci, Dept Clin Nursing, Kanazawa, Ishikawa 9200942, Japan; [Minematsu, T.; Sanada, H.] Univ Tokyo, Grad Sch Med, Dept Gerontol Nursing Wound Care Management, Bunkyo Ku, Tokyo, Japan; [Kitamura, K.] Kanazawa Univ, Grad Sch Med Sci, Dept Clin Lab Sci, Kanazawa, Ishikawa 9200942, Japan	Ogai, K (reprint author), Kanazawa Univ, Inst Med Pharmaceut & Hlth Sci, Wellness Promot Sci Ctr, 5-11-80 Kodatsuno, Kanazawa, Ishikawa 9200942, Japan.	kazuhiro@staff.kanazawa-u.ac.jp			MEXT/JST Tenure Track Promotion Programme	This study was funded in part by the MEXT/JST Tenure Track Promotion Programme.	Akase T, 2012, BIOL RES NURS, V14, P180, DOI 10.1177/1099800411401013; Akiba S, 1999, J Epidemiol, V9, pS136; Ibuki A, 2012, EXP DERMATOL, V21, P178, DOI 10.1111/j.1600-0625.2011.01409.x; Prasai MJ, 2013, DIABETES, V62, P1981, DOI 10.2337/db11-1740; Tzanavari T, 2010, CURR DIR AUTOIMMUN, V11, P145, DOI 10.1159/000289203; ROSKOS KV, 1989, PHARMACEUT RES, V6, P949, DOI 10.1023/A:1015941412620; Omori-Miyake M, 2014, J INVEST DERMATOL, V134, P1342, DOI 10.1038/jid.2013.503; Perkins MA, 2001, SKIN RES TECHNOL, V7, P227, DOI 10.1034/j.1600-0846.2001.70405.x; ODonnell BF, 1997, BRIT J DERMATOL, V136, P197; Iizaka S, 2010, NUTRITION, V26, P890, DOI 10.1016/j.nut.2009.09.008; Chuong CM, 2002, EXP DERMATOL, V11, P159; Madison KC, 2003, J INVEST DERMATOL, V121, P231, DOI 10.1046/j.1523-1747.2003.12359.x; Meerwaldt R, 2004, DIABETOLOGIA, V47, P1324, DOI 10.1007/s00125-004-1451-2; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; Hillebrand GG, 2001, J DERMATOL SCI, V27, pS42; VanGilder C, 2009, J NURS CARE QUAL, V24, P127, DOI 10.1097/01.NCQ.0000347449.83052.1a; Frank S, 2000, J CLIN INVEST, V106, P501, DOI 10.1172/JCI9148; MOTTA S, 1994, ARCH DERMATOL, V130, P452, DOI 10.1001/archderm.130.4.452; Minematsu T, 2012, BIOL RES NURS, V14, P242, DOI 10.1177/1099800411410870; Stalder JF, 2014, J EUR ACAD DERMATOL, V28, P1, DOI 10.1111/jdv.12509; Yonan CR, 2005, ANAL BIOCHEM, V338, P159, DOI 10.1016/j.ab.2004.11.010; Wolkenstein P, 2007, J AM ACAD DERMATOL, V56, P621, DOI 10.1016/j.jaad.2006.08.061; Coon D, 2009, ANN SURG, V249, P397, DOI 10.1097/SLA.0b013e318196d0c6; Lasek RJ, 1998, ARCH DERMATOL, V134, P454, DOI 10.1001/archderm.134.4.454; HOTAMISLIGIL GS, 1995, J CLIN INVEST, V95, P2409, DOI 10.1172/JCI117936; Bremmer S, 2010, J AM ACAD DERMATOL, V63, P1058, DOI 10.1016/j.jaad.2009.09.053; Bargo PR, 2013, EXP DERMATOL, V22, P18, DOI 10.1111/exd.12053; Berggren K, 1999, ANAL BIOCHEM, V276, P129, DOI 10.1006/abio.1999.4364; de Jongh CM, 2007, SKIN RES TECHNOL, V13, P390, DOI 10.1111/j.1600-0846.2007.00242.x; FINLAY AY, 1995, BRIT J DERMATOL, V132, P236; Holmes Regina F, 2013, Home Healthc Nurse, V31, P90, DOI 10.1097/NHH.0b013e31827f458a; Horii M., 2013, J JPN WOCM, V17, P23; Kishi C, 2015, BIOL RES NURS, V17, P135, DOI 10.1177/1099800414532827; Koyano Y., 2014, INT WOUND J, DOI [10.1111/iwj.12251, DOI 10.1111/IWJ.12251]; Matsumoto M, 2014, INT J COSMETIC SCI, V36, P477, DOI 10.1111/ics.12145; Minematsu T, 2014, ADV SKIN WOUND CARE, V27, P272, DOI 10.1097/01.ASW.0000448461.25542.36; MOEREMANS M, 1985, ANAL BIOCHEM, V145, P315, DOI 10.1016/0003-2697(85)90368-9; Mugita Y., 2013, J JPN SOC WOUND OSTO, V17, P201; NAKAMURA K, 1985, ANAL BIOCHEM, V148, P311, DOI 10.1016/0003-2697(85)90234-9; Otranto M, 2013, WOUND REPAIR REGEN, V21, P464, DOI 10.1111/wrr.12042; Pence BD, 2014, ADV WOUND CARE NEW R, V3, P71; Pierpont YN, 2014, ISRN OBES, V2014, DOI [DOI 10.1155/2014/638936, 10.1155/2014/638936PMID:24701367]; Puissant C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061320; SO T, 1992, BIOL REPROD, V46, P772, DOI 10.1095/biolreprod46.5.772; Stojadinovic O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069223	45	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0142-5463	1468-2494		INT J COSMETIC SCI	Int. J. Cosmetic Sci.	AUG	2015	37	4					425	432		10.1111/ics.12217		8	Chemistry, Applied; Dermatology	Chemistry; Dermatology	CM2BB	WOS:000357483500010		
J	Martinez-Blanco, J; Inaba, A; Quiros, A; Valdivia, S; Mila-i-Canals, L; Finkbeiner, M				Martinez-Blanco, Julia; Inaba, Atsushi; Quiros, Ana; Valdivia, Sonia; Mila-i-Canals, Llorenc; Finkbeiner, Matthias			Organizational LCA: the new member of the LCA family-introducing the UNEP/SETAC Life Cycle Initiative guidance document	INTERNATIONAL JOURNAL OF LIFE CYCLE ASSESSMENT			English	Editorial Material									[Martinez-Blanco, Julia; Finkbeiner, Matthias] Tech Univ Berlin, Dept Environm Technol, SEE, D-10623 Berlin, Germany; [Inaba, Atsushi] Kogakuin Univ, Dept Environm & Energy Chem, Tokyo 1638677, Japan; [Quiros, Ana] ECOGLOBAL, San Jose, Costa Rica; [Valdivia, Sonia] World Resources Forum, CH-9014 St Gallen, Switzerland; [Mila-i-Canals, Llorenc] UNEP SETAC Life Cycle Initiat, F-75009 Paris, France	Martinez-Blanco, J (reprint author), Tech Univ Berlin, Dept Environm Technol, SEE, D-10623 Berlin, Germany.	julia.martinezblanco@tu-berlin.de					Martinez-Blanco J, 2015, INT J LIFE CYCLE ASS, V20, P829, DOI 10.1007/s11367-015-0883-x; Clift R, 2000, TECHNOL FORECAST SOC, V65, P281, DOI 10.1016/S0040-1625(99)00055-4; European Commission, 2013, ORG ENV FOOTPR GUID; Finkbeiner M, 2013, J ENV ACCOUNT MANAG, V1, P55; Finkbeiner M, 1998, INT J LIFE CYCLE ASS, V3, P169, DOI 10.1007/BF02978825; International Organization for Standardization (ISO), 2006, 14044 ISO; ISO, 2014, 14072 ISO ISOTS; Klopffer W, 1995, SEM OK PROD EU OK AU; Martinez-Blanco J, 2015, J LIFE CYCLE ASSESSM, V11, P1; Taylor AP, 1996, P 4 LCA CAS STUD S S, P181; UNEP, 2015, GUID ORG LIF CYCL AS; UNEP/SETAC, 2009, GUID SOC LIF ASS PRO; WRI and WBCSD, 2011, CORP VAL CHAIN SCOP; WRI and WBCSD, 2004, GHG PROT CORP ACC RE	14	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0948-3349	1614-7502		INT J LIFE CYCLE ASS	Int. J. Life Cycle Assess.	AUG	2015	20	8					1045	1047		10.1007/s11367-015-0912-9		3	Engineering, Environmental; Environmental Sciences	Engineering; Environmental Sciences & Ecology	CM2MF	WOS:000357513700001		
J	Hokazono, S; Hayashi, K				Hokazono, Shingo; Hayashi, Kiyotada			Life cycle assessment of organic paddy rotation systems using land- and product-based indicators: a case study in Japan	INTERNATIONAL JOURNAL OF LIFE CYCLE ASSESSMENT			English	Article						Crop rotations; Land-oriented expression; Organic conversion; Paddy fields; Product-oriented expression; Tradeoffs; Win-win	CROP-ROTATION; ENVIRONMENTAL IMPACTS; WEED MANAGEMENT; ECO-EFFICIENCY; SOIL; SUSTAINABILITY; CONVERSION; NITROGEN; TILLAGE; FIELD	This study aims to compare crop rotation systems used in organic farming (organic rotation systems) with those of both conventional farming (conventional rotation systems) and continuous rice cropping systems. Life cycle assessment (LCA) is performed based on land- and product-based indicators. Seven crop rotation systems for rice, barley, and soybeans and continuous rice production systems were evaluated in this study. These systems are practiced by farmers in the study region and were constructed using production records, statistics, and guidelines. Comparisons were then made between organic and conventional crop rotation systems and between these crop rotation systems and a continuous rice production system. We used land-oriented expression to analyze tradeoffs between physical and monetary productivity and the environmental impact per area unit and product-oriented expression to analyze efficiency as measured by the environmental impact per product unit. Results are summarized as follows: (1) The product-oriented expression, which is equivalent to conducting product LCA, revealed that organic conversion tended to be efficient, irrespective of using physical productivity (the functional unit of product mass measured as averaged annual energy yield) or using monetary productivity (the functional unit of product mass measured as averaged annual income). (2) However, the land-oriented expression revealed that there were tradeoffs between physical productivity and environmental impacts, although these tradeoffs were converted to win-win relationships if monetary productivity was used instead of physical productivity, and (3) the alteration of a continuous rice production system into crop rotations tended to be efficient and enables a win-win relationship. Organic rotation systems have the potential of being recommended as sustainable agricultural practices in comparison with conventional rotation systems and continuous (organic and conventional) rice production systems. However, it was not clarified which productivity concepts should be used as evaluation criteria. It is considered that further studies using mechanistic modeling of crop rotations are required to improve LCA practices.	[Hokazono, Shingo; Hayashi, Kiyotada] Natl Agr & Food Res Org, Agr Res Ctr, Tsukuba, Ibaraki 3058666, Japan	Hayashi, K (reprint author), Natl Agr & Food Res Org, Agr Res Ctr, 3-1-1 Kannondai, Tsukuba, Ibaraki 3058666, Japan.	hayashi@affrc.go.jp					Acs S, 2007, AGR SYST, V94, P405, DOI 10.1016/j.agsy.2006.11.002; Mouron P, 2006, ECOL ECON, V58, P561, DOI 10.1016/j.ecolecon.2005.08.007; BULLOCK DG, 1992, CRIT REV PLANT SCI, V11, P309, DOI 10.1080/07352689209382349; KARLEN DL, 1994, ADV AGRON, V53, P1, DOI 10.1016/S0065-2113(08)60611-2; Glendining MJ, 2009, AGR SYST, V99, P117, DOI 10.1016/j.agsy.2008.11.001; Huppes G, 2005, J IND ECOL, V9, P43, DOI 10.1162/108819805775247891; Krupinsky JM, 2002, AGRON J, V94, P198; LIEBMAN M, 1993, ECOL APPL, V3, P92, DOI 10.2307/1941795; Kicherer A, 2007, INT J LIFE CYCLE ASS, V12, P537, DOI 10.1065/lca2007.01.305; HAVLIN JL, 1990, SOIL SCI SOC AM J, V54, P448; Reganold JP, 2001, NATURE, V410, P926, DOI 10.1038/35073574; Kuminoff NV, 2010, J AGR ECON, V61, P240, DOI 10.1111/j.1477-9552.2009.00235.x; Uematsu H, 2012, ECOL ECON, V78, P55, DOI 10.1016/j.ecolecon.2012.03.013; Nemecek T, 2008, EUR J AGRON, V28, P380, DOI 10.1016/j.eja.2007.11.004; Watson CA, 2002, SOIL USE MANAGE, V18, P239, DOI 10.1079/SUM2002131; Hokazono S, 2012, J CLEAN PROD, V28, P101, DOI 10.1016/j.jclepro.2011.12.005; Bulson HA, 1996, ASPECTS APPL BIOL, V47, P277; Cooper W.W., 2011, HDB DATA ENVELOPMENT; CROOKSTON RK, 1991, AGRON J, V83, P108; Department of Agriculture, 2008, DIAGN IND FARM MAN; Fare R., 2004, NEW DIRECTIONS EFFIC; Gentry LE, 2001, PLANT SOIL, V236, P175, DOI 10.1023/A:1012707617126; Hayashi K, 2012, P 10 INT C ECOBALANC, P2; Hayashi K, 2013, INT J LIFE CYCLE ASS, V18, P331, DOI 10.1007/s11367-012-0493-9; Hayashi K, 2014, J INT DEV, V17, P9; Hayer F, 2010, 9 EUR IFSA S VIENN, P903; Heijungs R., 1992, ENV LIFE CYCLE ASSES; Hokazono S, 2012, J LIFE CYCLE ASSESS, V8, P2; IPCC, 2007, 4 IPCC, P212; Jan P, 2012, INT J LIFE CYCLE ASS, V17, P706, DOI 10.1007/s11367-012-0405-z; JSAPA, 2007, RES BITS DOM SOYB; Jungbluth N, 2009, IMPLEMENTATION LIFE, P33; Knudsen MT, 2012, P 8 INT C LIF CYCL A, P368; KUNDU DK, 1995, SOIL BIOL BIOCHEM, V27, P431, DOI 10.1016/0038-0717(95)98615-U; Lampkin N, 1990, ORGANIC FARMING, P125; Lupwayi NZ, 1998, SOIL BIOL BIOCHEM, V30, P1733, DOI 10.1016/S0038-0717(98)00025-X; MAFF, 2006, STAT AGR PROD COST F; MAFF, 2006, STAT YB CER FY2006 2; MAFF, 2012, STAT ACR AGR LAND CU; MAFF, 2014, FOOD BAL SHEET FY201; MEXT, 2005, STAND TABL FOOD COMP, VFifth; Meyer-Aurich A, 2006, AGRON J, V98, P1204, DOI 10.2134/agronj2005.0262; Nemecek T, 2001, P INT C LCA FOODS GO, P65; Nishimura S, 2011, SOIL SCI PLANT NUTR, V57, P167, DOI 10.1080/00380768.2010.551346; Omay AB, 1997, SOIL SCI SOC AM J, V61, P1672; Owa N, 1996, 6 KANT TOK AGR STUD, P1; Pacini C, 2004, AGR SYST, V80, P171, DOI 10.1016/j.agsy.2003.07.002; Robson MC, 2002, ADV AGRON, V77, P369, DOI 10.1016/S0065-2113(02)77018-1; Smith PD, 2007, MITIGATION CONTRIBUT, P497; Sumida H, 2005, B NATL AGR RES CENT, V103, P39; Takakai F, 2010, SOIL SCI PLANT NUTR, V56, P760, DOI 10.1111/j.1747-0765.2010.00503.x; Tochigi Prefectural Agricultural Experiment Station, 2011, FARM MAN DAT ORG RIC, VIII; Watanabe H, 2011, WEED BIOL MANAG, V11, P175, DOI 10.1111/j.1445-6664.2011.00419.x; Witt C, 2000, PLANT SOIL, V225, P263, DOI 10.1023/A:1026594118145; Zimmermann A, 2011, INT J LIFE CYCLE ASS, V16, P548, DOI 10.1007/s11367-011-0286-6	55	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0948-3349	1614-7502		INT J LIFE CYCLE ASS	Int. J. Life Cycle Assess.	AUG	2015	20	8					1061	1075		10.1007/s11367-015-0906-7		15	Engineering, Environmental; Environmental Sciences	Engineering; Environmental Sciences & Ecology	CM2MF	WOS:000357513700003		
J	Sano, H; Ichioka, S				Sano, Hitomi; Ichioka, Shigeru			Involvement of nitric oxide in the wound bed microcirculatory change during negative pressure wound therapy	INTERNATIONAL WOUND JOURNAL			English	Article						Blood flow; Intravital microscope; L-NAME; Mechanical stress	VACUUM-ASSISTED CLOSURE; ENDOTHELIAL-CELLS; RELAXING FACTOR; SHEAR-STRESS; FLOW; SYNTHASE; PHOSPHORYLATION; ACETYLCHOLINE; ARTERY	This study investigated the role of nitric oxide (NO) in the mechanism of blood flow increase in the wound bed during negative pressure wound therapy (NPWT). We developed an improved experimental model that allowed visualisation of the wound bed microcirculation under NPWT. Wounds were created on the mouse ear, taking care to preserve the subdermal vascular plexus, because the wound bed microcirculation was visualised using an intravital microscope system. We investigated whether application of a NO synthase inhibitor (N-G-nitro-l-arginine methyl ester: L-NAME) might diminish the effect of the NPWT in increasing the wound blood flow. The experimental animals were divided into a negative pressure group (negative pressure of -125 mmHg applied to the wound for 5 minutes; n = 8), and a negative pressure plus L-NAME group (administration of L-NAME prior to application of the negative pressure; n = 8). In the negative pressure group, significant increase of blood flow was observed at 1 minute after the negative pressure application, which was sustained until 5 minutes. On the contrary, in the negative pressure plus L-NAME group, no significant changes were observed throughout the period of observation. These findings suggest that NO synthesis is involved in the wound bed microcirculatory change induced by NPWT.	[Sano, Hitomi] Univ Tokyo, Grad Sch Med, Dept Surg Sci, Tokyo, Japan; [Ichioka, Shigeru] Saitama Med Univ, Dept Plast & Reconstruct Surg, Moroyama, Saitama 3500495, Japan	Ichioka, S (reprint author), Saitama Med Univ, Dept Plast & Reconstruct Surg, 38 Morohongo, Moroyama, Saitama 3500495, Japan.	ichioka2006@yahoo.co.jp					AWOLESI MA, 1994, SURGERY, V116, P439; FURCHGOTT RF, 1980, NATURE, V288, P373, DOI 10.1038/288373a0; DAVIES PF, 1995, PHYSIOL REV, V75, P519; Satake N, 1997, GEN PHARMACOL, V28, P453, DOI 10.1016/S0306-3623(96)00238-8; Yamamoto K, 2006, NAT MED, V12, P133, DOI 10.1038/nm1338; Lundberg JO, 2008, NAT REV DRUG DISCOV, V7, P156, DOI 10.1038/nrd2466; Ichioka S, 2008, WOUND REPAIR REGEN, V16, P460, DOI 10.1111/j.1524-475X.2008.00390.x; Boo YC, 2003, AM J PHYSIOL-CELL PH, V285, pC499, DOI 10.1152/ajpcell.00122.2003; PALMER RMJ, 1987, NATURE, V327, P524, DOI 10.1038/327524a0; Corson MA, 1996, CIRC RES, V79, P984; Ayajiki K, 1996, CIRC RES, V78, P750; Morykwas MJ, 1997, ANN PLAS SURG, V38, P553, DOI 10.1097/00000637-199706000-00001; IGNARRO LJ, 1987, P NATL ACAD SCI USA, V84, P9265, DOI 10.1073/pnas.84.24.9265; Argenta LC, 1997, ANN PLAS SURG, V38, P563, DOI 10.1097/00000637-199706000-00002; Koss MC, 1999, EUR J PHARMACOL, V374, P161, DOI 10.1016/S0014-2999(99)00242-3; HAMPL V, 1995, EUR RESPIR J, V8, P515; Ichioka S, 2011, OSTOMY WOUND MANAG, V57, P40; Morykwas MJ, 2006, PLAST RECONSTR SURG, V117, p121S; Orgill DP, 2009, SURGERY, V146, P40, DOI 10.1016/j.surg.2009.02.002; Sano H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050212; Shibata M, 2005, AM J PHYSIOL-HEART C, V289, P2673; Wilkes R, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.2947358	22	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1742-4801	1742-481X		INT WOUND J	Int. Wound J.	AUG	2015	12	4					397	401		10.1111/iwj.12121		5	Dermatology; Surgery	Dermatology; Surgery	CM2OI	WOS:000357520400004		
J	Horinouchi, H; Yamamoto, N; Fujiwara, Y; Sekine, I; Nokihara, H; Kubota, K; Kanda, S; Yagishita, S; Wakui, H; Kitazono, S; Mizugaki, H; Tokudome, T; Tamura, T				Horinouchi, Hidehito; Yamamoto, Noboru; Fujiwara, Yutaka; Sekine, Ikuo; Nokihara, Hiroshi; Kubota, Kaoru; Kanda, Shintaro; Yagishita, Shigehiro; Wakui, Hiroshi; Kitazono, Satoru; Mizugaki, Hidenori; Tokudome, Takuto; Tamura, Tomohide			Phase I study of ipilimumab in phased combination with paclitaxel and carboplatin in Japanese patients with non-small-cell lung cancer	INVESTIGATIONAL NEW DRUGS			English	Article						Ipilimumab; Paclitaxel; Carboplatin; Non-small-cell lung cancer; Phase I study; Japanese patients	METASTATIC MELANOMA; IMMUNOTHERAPY; CRITERIA; SAFETY	Background Ipilimumab is an antibody that targets the cytotoxic T-lymphocyte antigen-4 to potentiate an antitumor response. Adding ipilimumab 10 mg/kg to paclitaxel (PTX) and carboplatin (CBDCA) in a phased schedule improved progression-free survival in a phase II non-small-cell lung cancer (NSCLC) study. Methods This dose-escalating, phase I study was designed to identify the recommended dose of ipilimumab (3 or 10 mg/kg) by evaluating dose-limiting toxicity (DLT; Cycles 3 and 4) in phased combination with PTX (175 mg/m(2)) and CBDCA (area under the curve = 6) in Japanese patients with advanced NSCLC. Treatment was administered intravenously every 3 weeks initially, followed by some eligible patients receiving maintenance ipilimumab once every 12 weeks. Additional endpoints included safety, tumor response, pharmacokinetics, and immunogenicity. Results Fifteen patients were enrolled and 12 received ipilimumab (n = 6, 3 mg/kg; n = 6, 10 mg/kg) in combination with PTX and CBDCA. DLTs occurred in 2 patients (ipilimumab 3 mg/kg) and 1 patient (ipilimumab 10 mg/kg). The most common grade 3/4 adverse events (AEs) were decreased hemoglobin, leukopenia, and neutropenia. The most common immune-related AEs affected the skin, gastrointestinal, and nervous system. The safety profile was similar in both cohorts. Three patients in each cohort achieved a partial response. The pharmacokinetic (PK) profile of ipilimumab in Japanese patients was similar to that observed in previous studies in non-Japanese patients. Conclusions The recommended dose of ipilimumab in phased combination with PTX and CBDCA in Japanese patients with NSCLC was identified as 10 mg/kg. The safety profile was consistent with the previously defined AE profile.	[Horinouchi, Hidehito; Yamamoto, Noboru; Fujiwara, Yutaka; Sekine, Ikuo; Nokihara, Hiroshi; Kubota, Kaoru; Kanda, Shintaro; Yagishita, Shigehiro; Wakui, Hiroshi; Kitazono, Satoru; Mizugaki, Hidenori; Tamura, Tomohide] Natl Canc Ctr, Dept Thorac Oncol, Chuo Ku, Tokyo 1040045, Japan; [Tokudome, Takuto] Bristol Myers KK, Clin Res, R&D, Shinjyuku Ku, Tokyo 1631328, Japan	Horinouchi, H (reprint author), Natl Canc Ctr, Dept Thorac Oncol, Chuo Ku, Tsukiji 5-1-1, Tokyo 1040045, Japan.	hhorinou@ncc.go.jp			Bristol-Myers K.K.; Bristol-Myers Squibb	We would like to thank the patients and investigators who participated in study CA184-113. This study was funded by Bristol-Myers K.K. The authors wish to acknowledge Jennifer DiNieri and Karin McGlynn of StemScientific, an Ashfield Company, part of UDG Healthcare plc, funded by Bristol-Myers Squibb, for providing writing and editorial support.	King PD, 2001, ONCOLOGIST, V6, P162, DOI 10.1634/theoncologist.6-2-162; Wolchok JD, 2009, CLIN CANCER RES, V15, P7412, DOI 10.1158/1078-0432.CCR-09-1624; Hanaizi Z, 2012, EUR J CANCER, V48, P237, DOI 10.1016/j.ejca.2011.09.018; Weber JS, 2008, J CLIN ONCOL, V26, P5950, DOI 10.1200/JCO.2008.16.1927; [Anonymous], 2006, COMM TERM CRIT ADV E; Brennan FR, 2010, MABS-AUSTIN, V2, P233; Brahmer JR, 2013, CANCER IMMUNOL RES, V1, P85, DOI 10.1158/2326-6066.CIR-13-0078; Hoos A, 2010, SEMIN ONCOL, V37, P533, DOI 10.1053/j.seminoncol.2010.09.015; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Wolchok JD, 2013, ANN NY ACAD SCI, V1291, P1, DOI 10.1111/nyas.12180; Lynch TJ, 2012, J CLIN ONCOL, V30, P2046, DOI 10.1200/JCO.2011.38.4032; Chemocare.com, 2015, HYP HIGH BLOOD LIP L; Clinicaltrials.gov, 2011, RAND MULT DOUBL BLIN; Feng Y, 2013, CLIN CANCER RES, V19, P3977, DOI 10.1158/1078-0432.CCR-12-3243; Hoos A, 2012, ANN ONCOL, V23, P47, DOI 10.1093/annonc/mds263; Loprinzi CL, 2012, CANCERCARE CONNECT B; National Comprehensive Cancer Network, 2014, CLIN PRACT GUID ONC; Pazdur R, 2013, FDA APPROVAL IPILIMU; Squibb Bristol-Myers, 2011, YERVOY IPILIMUMAB RI; Weber Jeffrey, 2013, Cancer Immun, V13, P7	20	2	2	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0167-6997	1573-0646		INVEST NEW DRUG	Invest. New Drugs	AUG	2015	33	4					881	889		10.1007/s10637-015-0243-5		9	Oncology; Pharmacology & Pharmacy	Oncology; Pharmacology & Pharmacy	CM1TH	WOS:000357462700010		
J	Nakayama, N; Sato, A; Tanaka, S; Shimada, K; Konishi, K; Sasaki, E; Hibi, K; Ichikawa, H; Kikuchi, Y; Sakuyama, T; Sekikawa, T; Hayashi, K; Nishina, H				Nakayama, Norisuke; Sato, Atsushi; Tanaka, Soichi; Shimada, Ken; Konishi, Kazuo; Sasaki, Eisaku; Hibi, Kenji; Ichikawa, Hiroko; Kikuchi, Yoshinori; Sakuyama, Toshikazu; Sekikawa, Takashi; Hayashi, Kazuhiko; Nishina, Haruhiro		Tokyo Cooperative Oncology Grp	A phase II study of bevacizumab with modified OPTIMOX1 as first-line therapy for metastatic colorectal cancer: the TCOG-GI 0802 study	INVESTIGATIONAL NEW DRUGS			English	Article						Bevacizumab; mOPTIMOX1; Colorectal cancer	DOUBLE-BLIND; OXALIPLATIN; FLUOROURACIL; LEUCOVORIN; TRIAL; GERCOR	Background Although bevacizumab plus FOLFOX is a standard treatment for metastatic colorectal cancer, oxaliplatin must be withdrawn in many patients because of cumulative neurotoxicity. We postulated that a reduced dose of oxaliplatin and modified treatment schedule would prolong the time to treatment failure and evaluated bevacizumab combined with a modified OPTIMOX1 regimen (mOPTIMOX1, oxaliplatin dose: 85 mg/m(2)). Methods Eligible patients had a histologically confirmed diagnosis of metastatic colorectal cancer and a performance status of 0-1. Patients were excluded if they had grade 1 or higher peripheral sensory neuropathy or had previously received chemotherapy for metastatic colorectal cancer. Patients received bevacizumab plus mFOLFOX6 every 2 weeks for 6 cycles, followed by 12 cycles of a simplified biweekly regimen of leucovorin and fluorouracil (sLV5FU2) plus bevacizumab. Oxaliplatin was then reintroduced, and bevacizumab plus mFOLFOX6 was continued until progressive disease. Results The median duration of disease control was 11.7 months (95 % confidence interval [CI], 9.7-13.5 months). The median overall survival was 23.1 months (95 % CI, 18.8-27.9 months). The overall response rate according to both the RECIST and WHO criteria was 51.3 %. The most common grade 3 or 4 toxicities were neutropaenia (32.5 %), hypertension (17.5 %), leukocytopaenia, sensory neuropathy, and diarrhoea (10.0 %). There were no treatment-related deaths. Conclusions Bevacizumab plus mFOLFOX6 was well tolerated, and patients could continue chemotherapy for longer than with conventional FOLFOX regimens. This regimen might be an effective treatment option for patients with metastatic colorectal cancer.	[Nakayama, Norisuke] Kanagawa Canc Ctr Hosp, Dept Gastroenterol, Asahi Ku, Yokohama, Kanagawa 2418515, Japan; [Sato, Atsushi] Hirosaki Univ, Dept Med Oncol, Grad Sch Med, Hirosaki, Aomori 0368562, Japan; [Tanaka, Soichi] Matsuda Hosp, Unit Coloproctol, Hamamatsu, Shizuoka 4328061, Japan; [Shimada, Ken] Showa Univ, Dept Internal Med, Northern Yokohama Hosp, Yokohama, Kanagawa 2248503, Japan; [Konishi, Kazuo] Showa Univ, Div Gastroenterol, Dept Med, Sch Med, Tokyo 1428666, Japan; [Sasaki, Eisaku] Tokyo Metropolitan Canc & Infect Dis Ctr Komagome, Dept Chemotherapy, Tokyo 1138677, Japan; [Hibi, Kenji] Showa Univ, Dept Surg, Fujigaoka Hosp, Yokohama, Kanagawa 2278501, Japan; [Ichikawa, Hiroko] Tokyo Rinkai Hosp, Div Gastroenterol, Tokyo 1340086, Japan; [Kikuchi, Yoshinori] Toho Univ, Dept Clin Oncol, Grad Sch Med, Tokyo 1438541, Japan; [Sakuyama, Toshikazu] Jikei Univ, Div Clin Oncol Hematol, Dept Internal Med, Sch Med, Tokyo 1058471, Japan; [Sekikawa, Takashi] Showa Univ, Dept Internal Med, Toyosu Hosp, Tokyo 1358577, Japan; [Hayashi, Kazuhiko] Tokyo Womens Med Univ Hosp, Dept Chemotherapy & Palliat Care, Tokyo 1628666, Japan; [Nishina, Haruhiro] Koto Hosp, Div Surg, Tokyo 1360072, Japan	Nakayama, N (reprint author), Kanagawa Canc Ctr Hosp, Dept Gastroenterol, Asahi Ku, 2-3-2 Nakao, Yokohama, Kanagawa 2418515, Japan.	norisuke@kcch.jp					de Gramont A, 2000, J CLIN ONCOL, V18, P2938; Tournigand C, 2004, J CLIN ONCOL, V22, P229, DOI 10.1200/JCO.2004.05.113; Schmoll HJ, 2012, J CLIN ONCOL, V30, P3588, DOI 10.1200/JCO.2012.42.5355; Loprinzi CL, 2014, J CLIN ONCOL, V32, P997, DOI 10.1200/JCO.2013.52.0536; Chibaudel B, 2009, J CLIN ONCOL, V27, P5727, DOI 10.1200/JCO.2009.23.4344; Saltz L, 2012, CLIN COLORECTAL CANC, V11, P101, DOI [10.1016/j.clcc.2011.05.006, 10.1016/clcc.2011.05.006]; Saltz LB, 2008, J CLIN ONCOL, V26, P2013, DOI 10.1200/JCO.2007.14.9930; Tournigand C, 2006, J CLIN ONCOL, V24, P394, DOI 10.1200/JCO.2005.03.0106; Hochster HS, 2008, J CLIN ONCOL, V26, P3523, DOI 10.1200/JCO.2007.15.4138; deGramont A, 1997, J CLIN ONCOL, V15, P808; de Gramont A, 2007, J CLIN ONCOL, V25, P3224, DOI 10.1200/JCO.2006.10.4380; Goldberg RM, 2004, J CLIN ONCOL, V22, P23, DOI 10.1200/JCO.2004.09.046; Cassidy J, 2008, J CLIN ONCOL, V26, P2006, DOI 10.1200/JCO.2007.14.9898	13	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0167-6997	1573-0646		INVEST NEW DRUG	Invest. New Drugs	AUG	2015	33	4					954	962		10.1007/s10637-015-0239-1		9	Oncology; Pharmacology & Pharmacy	Oncology; Pharmacology & Pharmacy	CM1TH	WOS:000357462700018		
J	Nozaki, H; Suda, S				Nozaki, Hiroshi; Suda, Sho			Weighing matrices and spherical codes	JOURNAL OF ALGEBRAIC COMBINATORICS			English	Article						Weighing matrices; Mutually unbiased weighing matrices; Root system; Kerdock codes over Z(4)	GOETHALS; KERDOCK	Mutually unbiased weighing matrices (MUWM) are closely related to an antipodal spherical code with 4 angles. In this paper, we clarify the relation between MUWM and the spherical codes and determine the maximum size of a set of MUWM with weight 4 for any order. Moreover, we define mutually quasi-unbiased weighing matrices (MQUWM) as a natural generalization of MUWM from the viewpoint of spherical codes. We determine the maximum size of a set of MQUWM for the parameters and . This includes an affirmative answer to the problem of Best, Kharaghani, and Ramp.	[Nozaki, Hiroshi; Suda, Sho] Aichi Univ Educ, Dept Math Educ, Kariya, Aichi 4488542, Japan	Suda, S (reprint author), Aichi Univ Educ, Dept Math Educ, 1 Hirosawa,Igaya Cho, Kariya, Aichi 4488542, Japan.	hnozaki@auecc.aichi-edu.ac.jp; suda@auecc.aichi-edu.ac.jp			JSPS KAKENHI [25800011]	We would like to thank the two anonymous refrees for their valuable comments for the first version of this paper. The first author was supported by JSPS KAKENHI Grant Number 25800011.	HAMMONS AR, 1994, IEEE T INFORM THEORY, V40, P301, DOI 10.1109/18.312154; Best D, 2015, DESIGN CODE CRYPTOGR, V76, P237, DOI 10.1007/s10623-014-9944-6; Best D, 2013, DISCRETE MATH, V313, P855, DOI 10.1016/j.disc.2012.12.022; Bonnecaze A, 1997, IEEE T INFORM THEORY, V43, P1218, DOI 10.1109/18.605585; Boykin P.O., ARXIVQUANTPH0502024V; CALDERBANK AR, 1995, LINEAR ALGEBRA APPL, V226, P647, DOI 10.1016/0024-3795(95)00239-N; Chan H.C., 1986, ARS COMBINATORIA, V21-A, P299; Delsarte P., 1973, PHILIPS RES REP S, V10; Delsarte P., 1977, GEOMETRIAE DEDICATA, V6, P363, DOI 10.1007/BF03187604; Ebeling W., 2013, ADV LECT MATH; Harada M., 2012, J COMB DES, V20, P45; Harary F., 1969, GRAPH THEORY; Holzmann WH, 2010, CONTEMP MATH, V531, P243; Huffman W.C., 2003, FUNDAMENTALS ERROR C; MacWilliams F. J., 1977, THEORY ERROR CORRECT; Ohmori H., 1998, Designs, Codes and Cryptography, V15, DOI 10.1023/A:1008321209012; OHMORI H, 1993, DISCRETE MATH, V116, P55, DOI 10.1016/0012-365X(93)90394-9	17	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0925-9899	1572-9192		J ALGEBR COMB	J. Algebr. Comb.	AUG	2015	42	1					283	291		10.1007/s10801-015-0581-6		9	Mathematics	Mathematics	CL9HO	WOS:000357288400011		
J	Mori, R				Mori, Ryohei			Capacity recovery of aluminium-air battery by refilling salty water with cell structure modification	JOURNAL OF APPLIED ELECTROCHEMISTRY			English	Article						Aluminium-air battery; Rechargeable battery; Salty water battery; Electricity generation	MOLECULAR-DYNAMICS; LITHIUM INSERTION; SECONDARY BATTERY; NACL SOLUTIONS; ION BATTERIES; AQUEOUS NACL; CARBON; ANODE; CORROSION; GRAPHITE	By modifying the aluminium-air battery structure with placing layers of activated carbon between an aqueous NaCl electrolyte and both an aluminium anode and an air cathode, capacity recovery was observed. When the NaCl aqueous electrolyte was refilled after electrolyte evaporation, a repeatable cell capacity was obtained. It was suggested that repeatable cell capacity was obtained because by products deposited on carbon internal layer, instead of depositing on the electrodes directly. One also deducted that the large discharge current with the large cell capacity was obtained by synergetic effect of the capacitor (large electric current) and the aluminium-air battery (large cell capacity). The results suggested that aluminium-associated ions as well as sodium-associated ions may participate in the relevant electrochemical reactions.	Fuji Pigment Co Ltd, Kawanishi, Hyogo 6660015, Japan	Mori, R (reprint author), Fuji Pigment Co Ltd, 2-23-2 Obana, Kawanishi, Hyogo 6660015, Japan.	moriryohei@fuji-pigment.co.jp					Abedin S. Z. E., 2004, Journal of Applied Electrochemistry, V34, DOI 10.1023/B:JACH.0000015611.65219.64; Mori R, 2013, RSC ADV, V3, P11547, DOI 10.1039/c3ra42211a; Kalluri RK, 2011, J PHYS CHEM C, V115, P13786, DOI 10.1021/jp203086x; Ma JL, 2014, J POWER SOURCES, V253, P419, DOI 10.1016/j.jpowsour.2013.12.053; Mukherjee A, 1996, J POWER SOURCES, V58, P183, DOI 10.1016/S0378-7753(96)02388-9; DAHN JR, 1995, SCIENCE, V270, P590, DOI 10.1126/science.270.5236.590; Tachikawa H, 2006, J PHYS CHEM B, V110, P20445, DOI 10.1021/jp0616031; Nakadaira M, 1997, J MATER RES, V12, P1367, DOI 10.1557/JMR.1997.0186; Liu YH, 1996, CARBON, V34, P193, DOI 10.1016/0008-6223(96)00177-7; Ein-Eli Y, 2003, J POWER SOURCES, V114, P330, DOI 10.1016/S0378-7753(02)00598-0; Kobayashi Y, 1997, CHEM MATER, V9, P1649, DOI 10.1021/cm970004b; Fujita M, 1996, J PHYS SOC JPN, V65, P1920, DOI 10.1143/JPSJ.65.1920; Li QF, 2002, J POWER SOURCES, V110, P1, DOI 10.1016/S0378-7753(01)01014-X; Yoshioka H, 2014, J EUR CERAM SOC, V34, P373, DOI 10.1016/j.jeurceramsoc.2013.08.041; Wang GX, 2009, CARBON, V47, P2049, DOI 10.1016/j.carbon.2009.03.053; Paramasivam M, 2001, J APPL ELECTROCHEM, V31, P115, DOI 10.1023/A:1004194832336; Frackowiak E, 2001, CARBON, V39, P937, DOI 10.1016/S0008-6223(00)00183-4; Qu QT, 2008, ELECTROCHEM COMMUN, V10, P1652, DOI 10.1016/j.elecom.2008.08.020; Kalluri RK, 2013, J PHYS CHEM C, V117, P13609, DOI 10.1021/jp4002127; Licht S, 2000, J ELECTROCHEM SOC, V147, P496, DOI 10.1149/1.1393223; Mori R, 2014, RSC ADV, V4, P30346, DOI 10.1039/c4ra02165g; Gallant BM, 2013, ENERG ENVIRON SCI, V6, P2518, DOI 10.1039/c3ee40998h; MACDONALD DD, 1990, J APPL ELECTROCHEM, V20, P405, DOI 10.1007/BF01076049; Hibino T, 2013, J MATER CHEM A, V1, P14844, DOI 10.1039/c3ta12707a; Doche ML, 1997, J POWER SOURCES, V65, P197, DOI 10.1016/S0378-7753(97)02473-7; Park YU, 2013, J AM CHEM SOC, V135, P13870, DOI 10.1021/ja406016j; Su CJ, 2013, ELECTROCHEM COMMUN, V34, P170, DOI 10.1016/j.elecom.2013.05.040; Tarascon JM, 2001, NATURE, V414, P359, DOI 10.1038/35104644; Maayta AK, 2004, CORROS SCI, V46, P1129, DOI 10.1016/j.corsci.2003.09.009; Egan DR, 2013, J POWER SOURCES, V236, P293, DOI 10.1016/j.jpowsour.2013.01.141; Marquez A, 1998, J ELECTROCHEM SOC, V145, P3328; Cheekatia L, 2011, MAT CHALL ALTERN REN, V224, P117; Krishnan M, 1997, CORROS SCI, V17, P893; Manke I, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2742283; Mori R, 2015, J ELECTROCHEM SOC, V162, pA188; Mori R, 2014, RSC ADV, V4, P1982, DOI 10.1039/c3ra44659j; Mori R, 2011, J MATER SCI, V46, P1341, DOI 10.1007/s10853-010-4925-2; Orikasa Yuki, 2014, Sci Rep, V4, P5622, DOI 10.1038/srep05622; PATNAIK RSM, 1994, J POWER SOURCES, V50, P331, DOI 10.1016/0378-7753(94)01909-6; RUDD EJ, 1994, J POWER SOURCES, V47, P329, DOI 10.1016/0378-7753(94)87012-8; Shao H. B., 2002, MATER CHEM PHYS, V77, P305; Wang X, 2014, SCI REP, V3, P1401; Wen Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5033	43	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0021-891X	1572-8838		J APPL ELECTROCHEM	J. Appl. Electrochem.	AUG	2015	45	8					821	829		10.1007/s10800-015-0834-z		9	Electrochemistry	Electrochemistry	CM4PV	WOS:000357667800002		
J	Iwai, H; Fukushima, M; Motomura, T; Kato, T; Kosugi, C				Iwai, Hisanori; Fukushima, Masami; Motomura, Taizo; Kato, Toshiaki; Kosugi, Chika			Effect of iron complexes with seawater extractable organic matter on oogenesis in gametophytes of a brown macroalga (Saccharina japonica)	JOURNAL OF APPLIED PHYCOLOGY			English	Article						Seawater extractable organic matter; Bioavailability; Iron complexes; Brown macroalgae; Gametogenesis; Restoration	HUMIC SUBSTANCES; SEA-URCHINS; KELP; PHYTOPLANKTON; TRANSPORT; KINETICS; SOUTHERN; GROWTH; BIOAVAILABILITY; REPRODUCTION	The phenomenon of macroalgae depletion is a serious worldwide problem in terms of the destruction of eco-systems and reducing carbon fixation capacity in coastal areas. A lack of dissolved Fe is thought to be one of reasons for this phenomenon, and attempts have beenmade to develop Fe fertilization techniques. This study reports on the bioavailability of Fe species that are complexed with seawater extractable organic matter (SWEOM) derived from a compost and various chelators on oogenesis in a brown macroalga (Saccharina japonica). Oogenesis is induced by Fe uptake. Oogenesis assays indicate that Fe uptake can be explained by a ligand exchange reaction, suggesting that dissolved Fe in the form of a labile complex species could be used as a fertilizer. Fifty to eighty percent of gametophytes induced oogenesis in the presence of 0.16-0.27 mu M Fe species complexed with SWEOM. However, no oogenesis was observed in the presence of 1 mu M Fe species complexed with N,N'-bis(2-hydroxybenzyl) ethylenediamine-N,N'-diacetic acid, an inert Fe-containing complex. These results show that SWEOM can serve as a chelator for Fe fertilization. Moreover, the concentration of SWEOM extracted from a bark compost was more than ten times higher than the corresponding values obtained from dredged soil and peat, suggesting this type of compost represents a suitable source of SWEOM. These findings extend our current knowledge of the use of Fe fertilization for the restoration of seaweed beds.	[Iwai, Hisanori] Osaka Prefecture Univ, Grad Sch Engn, Dept Marine Syst Engn, Sakai, Osaka 5998531, Japan; [Fukushima, Masami] Hokkaido Univ, Grad Sch Engn, Div Sustainable Resource Engn, Sapporo, Hokkaido 0608628, Japan; [Motomura, Taizo] Hokkaido Univ, Field Sci Ctr Northern Biosphere, Muroran Marine Stn, Muroran, Hokkaido 0510013, Japan; [Kato, Toshiaki; Kosugi, Chika] Nippon Steel & Sumitomo Met Corp, R&D Labs, Futtsu 2938511, Japan	Iwai, H (reprint author), Osaka Prefecture Univ, Grad Sch Engn, Dept Marine Syst Engn, Sakai, Osaka 5998531, Japan.	h-iwai@marine.osakafu-u.ac.jp	Fukushima, Masami/D-6150-2012				ANDERSON MA, 1982, LIMNOL OCEANOGR, V27, P789; Chen M, 2001, LIMNOL OCEANOGR, V46, P1956; Chung IK, 2011, J APPL PHYCOL, V23, P877, DOI 10.1007/s10811-010-9604-9; Bartsch I, 2008, EUR J PHYCOL, V43, P1, DOI 10.1080/09670260701711376; Iwai H, 2012, ANAL SCI, V28, P819; Fujita Daisuke, 2010, Bulletin of Fisheries Research Agency, P33; GAO K, 1994, J APPL PHYCOL, V6, P45, DOI 10.1007/BF02185904; Iwai H, 2013, ANAL SCI, V29, P723; Hirose K, 2007, APPL GEOCHEM, V22, P1636, DOI 10.1016/j.apgeochem.2007.03.042; Iwai H, 2013, J ANAL APPL PYROL, V99, P9, DOI 10.1016/j.jaap.2012.11.012; Aristilde L, 2010, ENVIRON SCI TECHNOL, V46, P5438; Bottger LH, 2012, J EXP BOT, V63, P5763, DOI 10.1093/jxb/ers225; CHAPMAN ARO, 1981, MAR BIOL, V62, P307, DOI 10.1007/BF00397697; Chen M, 2008, AQUAT BIOL, V3, P155, DOI 10.3354/ab00064; Gobler CJ, 2002, MAR CHEM, V77, P71, DOI 10.1016/S0304-4203(01)00076-7; Hassler CS, 2006, ENVIRON SCI TECHNOL, V40, P2544, DOI 10.1021/es051795i; Hassler C.S., 2009, BIOGEOSCI DISCUSS, V6, P1677; HUDSON RJM, 1990, LIMNOL OCEANOGR, V35, P1002; Kawachi M, 2005, ALGAL CULTURING TECH, P65, DOI 10.1016/B978-012088426-1/50006-8; KUMA K, 1993, WATER RES, V27, P651, DOI 10.1016/0043-1354(93)90175-H; Lobban CS, 2000, SEAWEED ECOLOGY PHYS; LUNING K, 1978, MAR BIOL, V45, P297, DOI 10.1007/BF00391816; LUNING K, 1981, BRIT PHYCOL J, V16, P379; Macrellis MM, 2001, MAR CHEM, V76, P175; MANN KH, 1977, HELGOLAND WISS MEER, V30, P455, DOI 10.1007/BF02207854; MATSUNAGA K, 1994, J APPL PHYCOL, V6, P397, DOI 10.1007/BF02182156; Matsunaga K, 1999, J EXP MAR BIOL ECOL, V241, P193, DOI 10.1016/S0022-0981(99)00077-5; Millar A. J. K., 2003, P313; Morel FMM, 2008, LIMNOL OCEANOGR, V53, P400, DOI 10.4319/lo.2008.53.1.0400; MOTOMURA T, 1981, B JPN SOC SCI FISH, V47, P1535; Motomura T, 1984, JAP J PHYCOL, V32, P209; Naito K, 2008, PHYCOL RES, V56, P58, DOI 10.1111/j.1440-1835.2008.00485.x; Okuda K, 2008, KUROSHIO SCI, V2, P15; Pettit G, 1999, SC DATABASE; Provasoli L, 1963, P 4 INT SEAW S, P9; Rico JM, 1997, EUR J PHYCOL, V32, P267; SCHNEIDER R, 1981, FEMS MICROBIOL LETT, V11, P115; Sunda WG, 2001, BIOGEOCHEMISTRY IRON, P41; SUZUKI Y, 1994, FISHERIES SCI, V60, P373; TEGNER MJ, 1991, MAR ECOL PROG SER, V77, P49, DOI 10.3354/meps077049; Tipping E., 2002, CATION BINDING HUMIC; Yamamoto M, 2010, J CHEM ENG JPN, V43, P627	42	1	1	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0921-8971	1573-5176		J APPL PHYCOL	J. Appl. Phycol.	AUG	2015	27	4					1583	1591		10.1007/s10811-014-0479-z		9	Biotechnology & Applied Microbiology; Marine & Freshwater Biology	Biotechnology & Applied Microbiology; Marine & Freshwater Biology	CM1NZ	WOS:000357448900021		
J	Hung, LD; Hirayama, M; Ly, BM; Hori, K				Le Dinh Hung; Hirayama, Makoto; Bui Minh Ly; Hori, Kanji			Purification, primary structure, and biological activity of the high-mannose N-glycan-specific lectin from cultivated Eucheuma denticulatum	JOURNAL OF APPLIED PHYCOLOGY			English	Article						cDNA cloning; Eucheuma denticulatum; Rhodophyta; Lectin; Carbohydrate-binding specificity; High-mannose type N-glycan; Antibacterial activity; Marine vibrios; Primary structure	ANTI-HIV ACTIVITY; MARINE RED ALGA; CARBOHYDRATE-BINDING; CYANOVIRIN-N; OSCILLATORIA-AGARDHII; CULTURED CYANOBACTERIUM; INACTIVATING PROTEIN; ENTRY INHIBITOR; POTENT; GRIFFITHSIN	Three isolectins from cultivated Eucheuma denticulatum were isolated. They were commonly monomeric proteins of about 28 kDa with a range of averaged molecular weights from 27,834 to 27,868 Da among the isolectins and shared almost the same 20 N-terminal amino acid sequences. Complementary DNA (cDNA) cloning based on the rapid amplification cDNA ends (RACE) methods elucidated the full-length sequence of EDA-2 which encodes 269 amino acids, including initiating methionine, with four tandemly repeated domains of about 67 amino acids. The primary structure of EDA-2 is highly similar to those of the high-mannose N-glycan specific lectins including Oscillatoria agardhii (OAA) and Burkholderia oklahomensis EO147 (BOA) from cyanobacteria, Myxococcus xanthus (MBHA) and Pseudomonas fluorescens Pf0-1 (PFL) from bacteria, and ESA-2 from a macro red alga. The hemagglutination activities were commonly inhibited by the glycoproteins bearing high-mannose N-glycans, but not by monosaccharides examined, including mannose. In a direct binding experiment with pyridylaminated oligosaccharides, an isolectin EDA-2 exclusively bound to high-mannose type N-glycans, but not to other glycans that include complex types and a core pentasaccharide of N-glycans, indicating that it recognized the branched oligomannoside moiety. Its binding activity was subtly different among the oligomannoside structures examined, showing that the lectin has preference affinity for high-mannose type N-glycans with an exposed (alpha 1-3) mannose residue in the D2 arm. Interestingly, EDAs, the mixture of three isolectins inhibited the growth of shrimp pathogenic bacterium, Vibrio alginolyticus, although it did not affect the growth of V. parahaemolyticus and V. harveyi. Growth inhibition of V. alginolyticus with EDAs was not observed in the presence of yeast mannan bearing high-mannose N-glycans, suggesting that EDAs caused the activity through binding to the target receptor(s) on the surface of V. alginolyticus. These results indicate that cultivated carrageenophyte E. denticulatum is a good source of a lectin(s) that may be useful as a carbohydrate probe and an antibacterial reagent.	[Le Dinh Hung; Hirayama, Makoto; Hori, Kanji] Hiroshima Univ, Grad Sch Biosphere Sci, Higashi, Hiroshima 7398528, Japan; [Le Dinh Hung; Bui Minh Ly] Vietnam Acad Sci & Technol, Nhatrang Inst Technol Res & Applicat, Nhatrang City, Khanhhoa Provin, Vietnam	Hung, LD (reprint author), Vietnam Acad Sci & Technol, Nhatrang Inst Technol Res & Applicat, 2A Hungvuong St, Nhatrang City, Khanhhoa Provin, Vietnam.	ledinhhungims@yahoo.co.uk; hirayama@hiroshima-u.ac.jp; kanhori@hiroshima-u.ac.jp			JSPS-RONPAKU Program-Japan; Vietnam National Foundation for Science and Technology Development (NAFOSTED) [106.05 2011.35]; Japan Society of the Promotion of Science;  [VAST.HTQT.JAPAN.03/2012-2013]	This research was supported by JSPS-RONPAKU Program-Japan, Vietnam National Foundation for Science and Technology Development (NAFOSTED) under grant number 106.05 2011.35, and VAST.HTQT.JAPAN.03/2012-2013, in addition to Grant-in-Aid for Scientific Research (B) from Japan Society of the Promotion of Science.	Sato Y, 2007, J BIOL CHEM, V282, P11021, DOI 10.1074/jbc.M701252200; Bokesch HR, 2003, BIOCHEMISTRY-US, V42, P2578, DOI 10.1021/bi0205698; Sato Y, 2011, BIOCHEM BIOPH RES CO, V405, P291, DOI 10.1016/j.bbrc.2011.01.031; Moulaei T, 2010, STRUCTURE, V18, P1104, DOI 10.1016/j.str.2010.05.016; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Zorrilla I, 2003, J FISH DIS, V26, P103, DOI 10.1046/j.1365-2761.2003.00437.x; Charungchitrak S, 2011, FOOD CHEM, V126, P1025, DOI 10.1016/j.foodchem.2010.11.114; Helle F, 2006, J BIOL CHEM, V281, P25177, DOI 10.1074/jbc.M602431200; O'Keefe BR, 2010, J VIROL, V84, P2511, DOI 10.1128/JVI.02322-09; Liao WR, 2003, J IND MICROBIOL BIOT, V30, P433, DOI 10.1007/s10295-003-0068-7; Hori K, 2007, GLYCOBIOLOGY, V17, P479, DOI 10.1093/glycob/cwm007; Boyd MR, 1997, ANTIMICROB AGENTS CH, V41, P1521; Sato Y, 2011, J BIOL CHEM, V286, P19446, DOI 10.1074/jbc.M110.216655; Koharudin LMI, 2012, J BIOL CHEM, V287, P33796, DOI 10.1074/jbc.M112.388579; Whitley MJ, 2013, FEBS J, V280, P2056, DOI 10.1111/febs.12229; Hung LD, 2011, PHYTOCHEMISTRY, V72, P855, DOI 10.1016/j.phytochem.2011.03.009; SLIFKIN M, 1990, CLIN MICROBIOL REV, V3, P197; Kawakubo A, 1999, J APPL PHYCOL, V11, P149, DOI 10.1023/A:1008062127564; ROMEO JM, 1986, P NATL ACAD SCI USA, V83, P6332, DOI 10.1073/pnas.83.17.6332; Suzuki T, 2012, GLYCOBIOLOGY, V22, P616, DOI 10.1093/glycob/cwr187; Mori T, 2005, J BIOL CHEM, V280, P9345, DOI 10.1074/jbc.M411122200; Ask EI, 2002, AQUACULTURE, V206, P257, DOI 10.1016/S0044-8486(01)00724-4; Sato T, 2009, FISHERIES SCI, V75, P743, DOI 10.1007/s12562-009-0074-4; Botos I, 2002, J BIOL CHEM, V277, P34336, DOI 10.1074/jbc.M205909200; Santi-Gadelha T, 2006, BIOCHEM BIOPH RES CO, V350, P1050, DOI 10.1016/j.bbrc.2006.09.149; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Barrientos LG, 2003, ANTIVIR RES, V58, P47, DOI 10.1016/S0166-3542(02)00183-3; Riera AS, 2003, BIOCELL, V27, P37; Bachhawat K, 2001, J BIOL CHEM, V276, P5541, DOI 10.1074/jbc.M009533200; Balzarini Jan, 2007, Antiviral Chemistry & Chemotherapy, V18, P1; Balzarini J, 2006, ANTIVIR RES, V71, P237, DOI 10.1016/j.antiviral.2006.02.004; Botos I, 2005, PROG BIOPHYS MOL BIO, V88, P233, DOI 10.1016/j.pbiomolbio.2004.05.001; Dam TK, 1998, J BIOL CHEM, V273, P5528, DOI 10.1074/jbc.273.10.5528; FAO, 2013, FAO MARD TECHN WORKS; HORI K, 1986, B JPN SOC SCI FISH, V52, P323; HORI K, 1988, PHYTOCHEMISTRY, V27, P2063; HORI K, 1986, BIOCHIM BIOPHYS ACTA, V873, P228, DOI 10.1016/0167-4838(86)90049-X; Hung LD, 2009, J APPL PHYCOL, V21, P89; Hung L.D., 2009, FISHERIES SCI, V75, P723; Kawakubo AL, 1997, J APPL PHYCOL, V9, P331, DOI 10.1023/A:1007915006334; Marhual NP, 2010, J AQUACULTURE TROP, V25, P25; Nakamura S, 2005, FEBS J, V272, P2784, DOI 10.1111/j.1742-4658.2005.04698.x; Sato Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045922; Sharon N., 2003, LECTINS; Tracy HH, 2007, APPL ENVIRON MICROB, V73, P7703; Williams DC, 2005, J BIOL CHEM, V280, P29269, DOI 10.1074/jbc.M504642200; Ziolkowska NE, 2006, ACTA BIOCHIM POL, V53, P617	48	2	2	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0921-8971	1573-5176		J APPL PHYCOL	J. Appl. Phycol.	AUG	2015	27	4					1657	1669		10.1007/s10811-014-0441-0		13	Biotechnology & Applied Microbiology; Marine & Freshwater Biology	Biotechnology & Applied Microbiology; Marine & Freshwater Biology	CM1NZ	WOS:000357448900028		
J	Bast, F; Kubota, S; Okuda, K				Bast, Felix; Kubota, Satoshi; Okuda, Kazuo			Phylogeographic assessment of panmictic Monostroma species from Kuroshio Coast, Japan, reveals sympatric speciation	JOURNAL OF APPLIED PHYCOLOGY			English	Article						Biological species; DNA barcoding; Kuroshio; Morphometry; nrDNA 18S; nrDNA ITS1; Phylogeny; Phylogeography; Sympatric speciation	RIBOSOMAL-RNA; PHYLOGENETIC INFERENCE; MAXIMUM-LIKELIHOOD; DNA-SEQUENCES; CHLOROPHYTA; ALGAE; ULTRASTRUCTURE; ENTEROMORPHA; CHLOROPLAST; ULVOPHYCEAE	The marine algae genus Monostroma (Thuret) consists of some of the common intertidal green seaweeds in the world. However, reports on its interbreeding potential between geographical radiations or its phylogeography are nonexistent. Here, we show that warmwater Monostroma in SW Japan, previously thought to be composed of two morphological species, viz., Monostroma latissimum and Monostroma nitidum, is indeed a single biological species, as revealed by mating tests. Using morphometry and DNA barcoding by primary and secondary structure analyses of highly variable first internal transcribed spacer (nrDNA ITS1) and more evolutionarily conserved gene encoding small subunit ribosome (nrDNA 18S), we conclude that isolates of Monostroma latissimum-nitidum complex represent an emergence of sympatric speciation. Our molecular phylogenetic analyses suggest that this alga originated in Ise Bay and was deliberately introduced elsewhere in Japan for cultivation purposes. Our phylogenetic analyses also suggest that the character state of the ability to interbreed is more evolutionarily conserved than either ontological or morphological differences in this alga. This is the first report of such an extensive intraspecific sequence divergence in any of the panmictic eukaryotes.	[Bast, Felix; Kubota, Satoshi; Okuda, Kazuo] Kochi Univ, Grad Sch Kuroshio Sci, Kochi 7808520, Japan	Bast, F (reprint author), Cent Univ Punjab, Ctr Biosci, Mansa Rd, Bathinda 151001, India.	felix.bast@gmail.com			MEXT, Japanese Government	This study was supported in part by Monbukagakusho Ph.D. fellowship from MEXT, Japanese Government, nominated by Ministry of Human Resources Development, Government of India, awarded to FB. FB also thank Japan Railways for contributing sampling expeditions undertaken in this report via discounted tickets (Seishun Jyuhachi Kippu). The following people kindly assisted us during the acquisition of samples: Masafumi Iima, Mine Ichiro, Miyuki Maegawa, Norishige Yotsukura, Ryuta Terada, Christine A Maggs, and Frederic Mineur. MP Ajaikumar contributed his time and expertise in reading this manuscript that led to some improvisations.	ANDERSEN RA, 1992, BIODIVERS CONSERV, V1, P267, DOI 10.1007/BF00693765; KOOISTRA WHCF, 1992, J PHYCOL, V28, P660, DOI 10.1111/j.0022-3646.1992.00660.x; Gruber AR, 2008, NUCLEIC ACIDS RES, V36, pW70, DOI 10.1093/nar/gkn188; Blomster J, 1998, J PHYCOL, V34, P319, DOI 10.1046/j.1529-8817.1998.340319.x; HILLIS DM, 1991, Q REV BIOL, V66, P411, DOI 10.1086/417338; O'kelly CJ, 2004, J PHYCOL, V40, P209, DOI 10.1046/j.1529-8817.2004.03104.x; Alvarez I, 2003, MOL PHYLOGENET EVOL, V29, P417, DOI 10.1016/S1055-7903(03)00208-2; TURNER DH, 1988, ANNU REV BIOPHYS BIO, V17, P167; Hayden HS, 2002, J PHYCOL, V38, P1200, DOI 10.1046/j.1529-8817.2002.01167.x; YANG ZB, 1994, J MOL EVOL, V39, P105; Hayden HS, 2003, EUR J PHYCOL, V38, P277, DOI 10.1080/1364253031000136321; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Coyer JA, 2001, J PHYCOL, V37, P574, DOI 10.1046/j.1529-8817.2001.037001574.x; Hughey JR, 2001, J PHYCOL, V37, P1091, DOI 10.1046/j.1529-8817.2001.01048.x; WHEELER WC, 1990, CLADISTICS, V6, P363, DOI 10.1111/j.1096-0031.1990.tb00550.x; Arasaki S, 1949, NIPPON SUISAN GAKK, V15, P137; Bast F, 2009, HYDROBIOLOGIA, V630, P161, DOI 10.1007/s10750-009-9789-6; Bast F, 2009, AQUAT BOT, V91, P213, DOI 10.1016/j.aquabot.2009.06.006; BLIDING C, 1968, BOT NOTISER, V121, P535; Carter N, 1926, ANN BOT-LONDON, V40, P665; Coleman AW, 1997, J MOL EVOL, V45, P168, DOI 10.1007/PL00006217; COLEMAN AW, 1994, J PHYCOL, V30, P80, DOI 10.1111/j.0022-3646.1994.00080.x; Doyle J. L. ., 1987, PHYTOCHEMISTRY B, V19, P11; Edger PP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101341; Felsenstein J, 1985, EVOLUTION, V39, P137; GAYRAL P, 1964, CR HEBD ACAD SCI, V258, P2149; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; HORI T, 1973, J PHYCOL, V9, P190, DOI 10.1111/j.0022-3646.1973.00190.x; Kawashima Y, 2013, FISHERIES SCI, V79, P521, DOI 10.1007/s12562-013-0610-0; KIDA W, 1990, MAR BEHAV PHYSIOL, V16, P109; Kunieda H, 1934, P IMP ACAD TOKYO, V10, P103; Marks JC, 1996, J PHYCOL, V32, P1035, DOI 10.1111/j.0022-3646.1996.01035.x; Nagura K, 1921, REP AICHI PREF EXP S, V24, P1; PAPENFUSS GEORGE F., 1960, JOUR LINNEAN SOC LONDON BOT, V56, P303; Reiche K, 2007, ALGORITHM MOL BIOL, V2, DOI 10.1186/1748-7188-2-6; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Su Q, 2002, THESIS NE FORESTRY U; THOMPSON AJ, 1994, J MOL BIOL, V236, P455, DOI 10.1006/jmbi.1994.1157; Thuret G, 1854, MEMOIRES SOC SCI NAT, V2, P17; Van de Peer Y, 2000, NUCLEIC ACIDS RES, V28, P175, DOI 10.1093/nar/28.1.175; VANNUES RW, 1994, NUCLEIC ACIDS RES, V22, P912, DOI 10.1093/nar/22.6.912; van Oppen MJH, 1995, THESIS RIJKSUNIVERSI; VANTUSSENBROEK BI, 1989, PHYCOLOGIA, V28, P520, DOI 10.2216/i0031-8884-28-4-520.1; White TJ, 1990, PCR PROTOCOLS GUIDE, V18, P315, DOI DOI 10.1016/B978-0-12-372180-8.50042-1; Wittrock VB, 1866, THESIS UPPSALA U SWE; YANG ZH, 1994, J MOL EVOL, V39, P306, DOI 10.1007/BF00160154; Yendo K, 1917, BOT MAG, V31, P183; Yoshida T, 1998, MARINE ALGAE JAPAN	48	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0921-8971	1573-5176		J APPL PHYCOL	J. Appl. Phycol.	AUG	2015	27	4					1725	1735		10.1007/s10811-014-0452-x		11	Biotechnology & Applied Microbiology; Marine & Freshwater Biology	Biotechnology & Applied Microbiology; Marine & Freshwater Biology	CM1NZ	WOS:000357448900035		
J	Itahashi, M; Abe, H; Tanaka, T; Mizukami, S; Kikuchihara, Y; Yoshida, T; Shibutani, M				Itahashi, Megu; Abe, Hajime; Tanaka, Takeshi; Mizukami, Sayaka; Kikuchihara, Yoh; Yoshida, Toshinori; Shibutani, Makoto			Maternal exposure to 3,3 '-iminodipropionitrile targets late-stage differentiation of hippocampal granule cell lineages to affect brain-derived neurotrophic factor signaling and interneuron subpopulations in rat offspring	JOURNAL OF APPLIED TOXICOLOGY			English	Article						3,3 '-iminodipropionitrile; hippocampal dentate gyrus; brain-derived neurotrophic factor; gamma-aminobutyric acid-ergic interneuron; neuritogenesis; phosphorylated neurofilament, heavy polypeptide	DENTATE GYRUS; DEVELOPMENTAL EXPOSURE; NEUROFILAMENT PROTEINS; SYNAPTIC PLASTICITY; AXONAL-TRANSPORT; PROGENITOR CELLS; GENE-EXPRESSION; DOWN-REGULATION; CA1 AREA; NEUROGENESIS	3,3'-Iminodipropionitrile (IDPN) causes neurofilament (NF)-filled swellings in the proximal segments of many large-caliber myelinated axons. This study investigated the effect of maternal exposure to IDPN on hippocampal neurogenesis in rat offspring using pregnant rats supplemented with 0 (controls), 67 or 200 ppm IDPN in drinking water from gestational day 6 to day 21 after delivery. On postnatal day (PND) 21, female offspring subjected to analysis had decreased parvalbumin(+), reelin(+) and phospho-TrkB(+) interneurons in the dentate hilus at 200 ppm and increased granule cell populations expressing immediate-early gene products, Arc or c-Fos, at >= 67 ppm. mRNA expression in the dentate gyrus examined at 200 ppm decreased with brain-derived neurotrophic factor (Bdnf) and very low density lipoprotein receptor. Immunoreactivity for phosphorylated NF heavy polypeptide decreased in the molecular layer of the dentate gyrus and the stratum radiatum of the cornu ammonis (CA) 3, portions showing axonal projections from mossy cells and pyramidal neurons, at 200 ppm on PND 21, whereas immunoreactivity for synaptophysin was unchanged in the dentate gyrus. Observed changes all disappeared on PND 77. There were no fluctuations in the numbers of apoptotic cells, proliferating cells and subpopulations of granule cell lineage in the subgranular zone on PND 21 and PND 77. Thus, maternal IDPN exposure may reversibly affect late-stage differentiation of granule cell lineages involving neuronal plasticity as evident by immediate-early gene responses to cause BDNF downregulation resulting in a reduction in parvalbumin(+) or reelin(+) interneurons and suppression of axonal plasticity in the mossy cells and CA3 pyramidal neurons. Copyright (C) 2014 John Wiley & Sons, Ltd.	[Itahashi, Megu; Abe, Hajime; Tanaka, Takeshi; Mizukami, Sayaka; Kikuchihara, Yoh; Yoshida, Toshinori; Shibutani, Makoto] Tokyo Univ Agr & Technol, Lab Vet Pathol, Fuchu, Tokyo 1838509, Japan; [Itahashi, Megu; Abe, Hajime; Tanaka, Takeshi; Mizukami, Sayaka] Gifu Univ, United Grad Sch Vet Sci, Pathogenet Vet Sci, Gifu, Gifu 5011193, Japan	Shibutani, M (reprint author), Tokyo Univ Agr & Technol, Lab Vet Pathol, 3-5-8 Saiwai Cho, Fuchu, Tokyo 1838509, Japan.	mshibuta@cc.tuat.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan	The authors thank Mrs Shigeko Suzuki for her technical assistance in preparing the histological specimens. This work was supported by a Grant-in-Aid for Scientific Research (B) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. All the authors confirm that they have no conflicts of interest that could have inappropriately influenced the outcomes of the present study.	Akane H, 2013, TOXICOL SCI, V134, P140, DOI 10.1093/toxsci/kft092; ALTAR CA, 1994, EXP NEUROL, V130, P31, DOI 10.1006/exnr.1994.1182; Benson DL, 1996, J NEUROCYTOL, V25, P181, DOI 10.1007/BF02284795; Akane H, 2014, TOXICOL APPL PHARM, V279, P150, DOI 10.1016/j.taap.2014.05.017; Qin LN, 2011, BEHAV BRAIN RES, V217, P142, DOI 10.1016/j.bbr.2010.10.018; GRIFFIN JW, 1978, SCIENCE, V202, P633, DOI 10.1126/science.81524; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Seoane A, 1999, BRAIN RES, V833, P258, DOI 10.1016/S0006-8993(99)01552-8; Buhl EH, 1996, HIPPOCAMPUS, V6, P294; DArcangelo G, 1997, J NEUROSCI, V17, P23; WIEDENMANN B, 1985, CELL, V41, P1017, DOI 10.1016/S0092-8674(85)80082-9; Kempermann G, 2004, TRENDS NEUROSCI, V27, P447, DOI 10.1016/j.tins.2004.05.013; Waterhouse EG, 2012, J NEUROSCI, V32, P14318, DOI 10.1523/JNEUROSCI.0709-12.2012; Toni N, 2008, NAT NEUROSCI, V11, P901, DOI 10.1038/nn.2156; Sibbe M, 2009, J NEUROSCI, V29, P8578, DOI 10.1523/JNEUROSCI.0958-09.2009; Huang ZJ, 1999, CELL, V98, P739, DOI 10.1016/S0092-8674(00)81509-3; Hodge RD, 2008, J NEUROSCI, V28, P3707, DOI 10.1523/JNEUROSCI.4280-07.2008; Pawluski JL, 2009, FRONT NEUROENDOCRIN, V30, P343, DOI 10.1016/j.yfrne.2009.03.007; Wang LY, 2013, TOXICOL SCI, V136, P154, DOI 10.1093/toxsci/kft183; Llorens J, 1997, NEUROTOXICOL TERATOL, V19, P117, DOI 10.1016/S0892-0362(96)00216-4; Drake CT, 1999, J NEUROSCI, V19, P8009; Jungenitz T, 2014, CEREB CORTEX, V24, P1845, DOI 10.1093/cercor/bht035; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Jiao YY, 2011, P NATL ACAD SCI USA, V108, P12131, DOI 10.1073/pnas.1105296108; Danzer SC, 2004, J NEUROSCI, V24, P11346, DOI 10.1523/JNEUROSCI.3846-04.2004; Gong C, 2007, J NEUROSCI, V27, P1803, DOI 10.1523/JNEUROSCI.3111-06.2007; Berghuis P, 2004, EUR J NEUROSCI, V20, P1290, DOI 10.1111/j.1460-9568.2004.03561.x; PERUMAL AS, 1991, BRAIN RES BULL, V26, P653, DOI 10.1016/0361-9230(91)90111-V; Guzowski JF, 2002, HIPPOCAMPUS, V12, P86, DOI 10.1002/hipo.10010; Tozuka Y, 2005, NEURON, V47, P803, DOI 10.1016/j.neuron.2005.08.023; Shiraki A, 2012, ARCH TOXICOL, V86, P1559, DOI 10.1007/s00204-012-0846-y; Seoane A, 2003, ACTA NEUROPATHOL, V106, P458, DOI 10.1007/s00401-003-0744-8; LAURBERG S, 1981, BRAIN RES, V212, P287, DOI 10.1016/0006-8993(81)90463-7; Zhao CS, 2008, EPILEPSIA, V49, P3, DOI 10.1111/j.1528-1167.2008.01632.x; McDonald HY, 2005, NEUROSCI LETT, V385, P70, DOI 10.1016/j.neulet.2005.05.022; Akane H, 2013, J TOXICOL SCI, V38, P431; CHEN S, 1992, BRAIN RES, V577, P169, DOI 10.1016/0006-8993(92)90553-L; CLARK AW, 1980, J NEUROPATH EXP NEUR, V39, P42, DOI 10.1097/00005072-198001000-00004; CROFTON KM, 1994, HEARING RES, V80, P129, DOI 10.1016/0378-5955(94)90104-X; Do HT, 2013, J BIOL CHEM, V288, P29613, DOI 10.1074/jbc.M113.500967; Garcia M.L., 2012, J AMINO ACIDS, V2012, DOI DOI 10.1155/2012/382107; GIANUTSOS G, 1985, NEUROTOXICOLOGY, V6, P159; GOLDEY ES, 1993, HEARING RES, V69, P221, DOI 10.1016/0378-5955(93)90111-D; GRIFFIN JW, 1985, NEUROTOXICOLOGY, V6, P43; Halasy K, 1996, HIPPOCAMPUS, V6, P306, DOI 10.1002/(SICI)1098-1063(1996)6:3<306::AID-HIPO8>3.0.CO;2-K; Itahashi M, 2014, TOXICOL LETT, V226, P285, DOI 10.1016/j.toxlet.2014.02.018; Kadar E, 2013, GENES BRAIN BEHAV, V12, P771, DOI 10.1111/gbb.12065; LANGLAIS PJ, 1975, J NEUROSCI RES, V1, P419, DOI 10.1002/jnr.490010510; LLORENS J, 1994, HEARING RES, V76, P78, DOI 10.1016/0378-5955(94)90090-6; Ogawa B, 2012, ARCH TOXICOL, V86, P779, DOI 10.1007/s00204-012-0801-y; Reines A, 2004, NEUROSCIENCE, V129, P529, DOI 10.1016/j.neuroscience.2004.08.026; Saegusa Y, 2010, REPROD TOXICOL, V29, P407, DOI 10.1016/j.reprotox.2010.03.006; Ylagan LR, 1997, MODERN PATHOL, V10, P1239; Zmarowski A, 2012, REPROD TOXICOL, V34, P192, DOI 10.1016/j.reprotox.2012.05.091	54	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0260-437X	1099-1263		J APPL TOXICOL	J. Appl. Toxicol.	AUG	2015	35	8					884	894		10.1002/jat.3086		11	Toxicology	Toxicology	CM6QR	WOS:000357814200002		
J	Takahashi, H; Wrasse, CM; Otsuka, Y; Ivo, A; Gomes, V; Paulino, I; Medeiros, AF; Denardini, CM; Sant'Anna, N; Shiokawa, K				Takahashi, H.; Wrasse, C. M.; Otsuka, Y.; Ivo, A.; Gomes, V.; Paulino, I.; Medeiros, A. F.; Denardini, C. M.; Sant'Anna, N.; Shiokawa, K.			Plasma bubble monitoring by TEC map and 630 nm airglow image	JOURNAL OF ATMOSPHERIC AND SOLAR-TERRESTRIAL PHYSICS			English	Article						Plasma bubbles; TEC mapping; Optical imaging; Solar terminator	TRAVELING IONOSPHERIC DISTURBANCES; SPREADFEX CAMPAIGN; EQUATORIAL; GPS; BRAZIL; IRREGULARITIES; NETWORK	Equatorial ionosphere plasma bubbles over the South American continent were successfully observed by mapping the total electron content (TECMAP) using data provided by ground-based GNSS receiver networks. The TECMAP could cover almost all of the continent within 4000 km distance in longitude and latitude, monitoring TEC variability continuously with a time resolution of 10 min. Simultaneous observations of OI 630 nm all-sky image at Cachoeira Paulista (22.7 degrees S, 45.0 degrees W) and Cariri (7.4 degrees S, 36.5 degrees W) were used to compare the bubble structures. The spatial resolution of the TECMAP varied from 50 km to 1000 km, depending on the density of the observation sites. On the other hand, optical imaging has a spatial resolution better than 15 km, depicting the fine structure of the bubbles but covering a limited area (similar to 1600 km diameter). TECMAP has an advantage in its spatial coverage and the continuous monitoring (day and night) form. The initial phase of plasma depletion in the post-sunset equatorial ionization anomaly (PS-EIA) trough region, followed by development of plasma bubbles in the crest region, could be monitored in a progressive way over the magnetic equator. In December 2013 to January 2014, periodically spaced bubble structures were frequently observed. The longitudinal spacing between the bubbles was around 600-800 km depending on the day. The periodic form of plasma bubbles may suggest a seeding process related to the solar terminator passage in the ionosphere. (C) 2015 Elsevier Ltd. All rights reserved.	[Takahashi, H.; Wrasse, C. M.; Ivo, A.; Gomes, V.; Denardini, C. M.; Sant'Anna, N.] Inst Nacl Pesquisas Espadais, EMBRACE, Sao Jose Dos Campos, SP, Brazil; [Otsuka, Y.; Shiokawa, K.] Nagoya Univ, STEL, Nagoya, Aichi 4648601, Japan; [Paulino, I.; Medeiros, A. F.] Univ Fed Campina Grande, Campina Grande, PB, Brazil	Takahashi, H (reprint author), Inst Nacl Pesquisas Espadais, EMBRACE, Sao Jose Dos Campos, SP, Brazil.	hisao.takahashi@inpe.br	De Nardin, Clezio/C-4103-2012	De Nardin, Clezio/0000-0002-3624-2461	CNPq [30.5321/2010-2]	The GPS ground-based receiver data were collected from the different GNSS networks in South America: RBMC of IBGE, RAMSAC from Argentina and IGS and LISN of Boston University. We are grateful to these network sites for providing the data continuously. Without their data, it would not have been possible to generate such a TECMAP. The present work was partially supported by CNPq under the Project 30.5321/2010-2.	Huang CS, 2013, J GEOPHYS RES-SPACE, V118, P3602, DOI 10.1002/jgra.50338; Burke WJ, 2004, J GEOPHYS RES-SPACE, V109, DOI 10.1029/2004JA010583; Makela JJ, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL043968; Saito A, 2001, GEOPHYS RES LETT, V28, P689, DOI 10.1029/2000GL011884; Carter BA, 2013, J GEOPHYS RES-SPACE, V118, P892, DOI 10.1002/jgra.50089; Abdu MA, 2009, ANN GEOPHYS-GERMANY, V27, P2607; Otsuka Y, 2002, EARTH PLANETS SPACE, V54, P63; Thampi SV, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL039887; Ogawa T, 2005, EARTH PLANETS SPACE, V57, P385; Tsunoda RT, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL049173; Otsuka Y, 2013, ANN GEOPHYS-GERMANY, V31, P163, DOI 10.5194/angeo-31-163-2013; Rishbeth H, 2000, ANN GEOPHYS-ATM HYDR, V18, P730, DOI 10.1007/s00585-000-0730-6; Retterer JM, 2014, ANN GEOPHYS-GERMANY, V32, P485, DOI 10.5194/angeo-32-485-2014; Takahashi H, 2014, ADV SPACE RES, V54, P385, DOI 10.1016/j.asr.2014.01.032; Takahashi H, 2009, ANN GEOPHYS-GERMANY, V27, P1477; Sobral JHA, 2002, J ATMOS SOL-TERR PHY, V64, P1517, DOI 10.1016/S1364-6826(02)00089-5; Makela JJ, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017106; Liu HX, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL038165; Dao E, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL047046; Haase JS, 2011, ADV SPACE RES, V47, P1758, DOI 10.1016/j.asr.2010.09.025; Kelley MC, 2009, INT GEOPHYS SER, V96, P1; Nishioka M, 2008, J GEOPHYS RES-SPACE, V113, DOI 10.1029/2007JA012605; Ram ST, 2014, J GEOPHYS RES-SPACE, V119, P2288, DOI 10.1002/2013JA019712; Valladares CE, 2004, ANN GEOPHYS-GERMANY, V22, P3155	24	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	1364-6826	1879-1824		J ATMOS SOL-TERR PHY	J. Atmos. Sol.-Terr. Phys.	AUG	2015	130						151	158		10.1016/j.jastp.2015.06.003		8	Geochemistry & Geophysics; Meteorology & Atmospheric Sciences	Geochemistry & Geophysics; Meteorology & Atmospheric Sciences	CM5UH	WOS:000357754000015		
J	Matsumoto, G; Ueda, T; Sugita, Y; Kubo, K; Mizoguchi, M; Kotani, E; Oda, N; Kawamata, S; Segami, N; Mori, H				Matsumoto, Goichi; Ueda, Takayo; Sugita, Yoshihiko; Kubo, Katsutoshi; Mizoguchi, Megumi; Kotani, Eiji; Oda, Naoki; Kawamata, Shin; Segami, Natsuki; Mori, Hajime			Polyhedral microcrystals encapsulating bone morphogenetic protein 2 improve healing in the alveolar ridge	JOURNAL OF BIOMATERIALS APPLICATIONS			English	Article						BMP-2; polyhedra; alveolar ridge; bone regeneration; atelocollagen sponge	SPINAL-FUSION; COLLAGEN SPONGE; RABBIT MODEL; REGENERATION; RHBMP-2; SAFETY; DELIVERY; SURGERY; IMPLANTS; EFFICACY	Atelocollagen sponges incorporating polyhedra encapsulating bone morphogenetic protein 2 (BMP-2) were implanted into lateral bone defects in the mandible. Half of the bone defects on the left side were treated with atelocollagen sponges containing 1.8x10(7) BMP-2 polyhedra, and half were treated with sponges containing 3.6x10(6) BMP-2 polyhedra. As controls, we treated the right-side bone defects in each animal with an atelocollagen sponge containing 5 mu g of recombinant human BMP-2 (rhBMP-2) or 1.8x10(7) empty polyhedral. After a healing period of six months, whole mandibles were removed for micro-computed tomography (CT) and histological analyses. Micro-CT images showed that more bone had formed at all experimental sites than at control sites. However, the density of the new bone was not significantly higher at sites with an atelocollagen sponge containing BMP-2 polyhedra than at sites with an atelocollagen sponge containing rhBMP-2 or empty polyhedra. Histological examination confirmed that the BMP-2 polyhedra almost entirely replaced the atelocollagen sponges and connected the original bone with the regenerated bone. These results show that the BMP-2 delivery system facilitates the regeneration of new bone in the mandibular alveolar bone ridge and has an advance in the technology of bone regeneration for implant site development.	[Matsumoto, Goichi] Kanagawa Dent Univ, Yokohama Clin Educ Ctr, Div Oral Surg, Kanagawa Ku, Yokohama, Kanagawa 2210835, Japan; [Ueda, Takayo; Mizoguchi, Megumi; Kotani, Eiji; Oda, Naoki; Mori, Hajime] Kyoto Inst Technol, Insect Biomed Res Ctr, Sakyo Ku, Kyoto 606, Japan; [Sugita, Yoshihiko; Kubo, Katsutoshi] Aichi Gakuin Univ, Sch Dent, Dept Oral Pathol, Chikusa Ku, Nagoya, Aichi 464, Japan; [Matsumoto, Goichi; Segami, Natsuki] Kanazawa Med Univ, Dept Oral & Maxillofacial Surg, Uchinada, Ishikawa 92002, Japan; [Kawamata, Shin] Fdn Biomed Res & Innovat, Basic Res Grp Regenerat Med, Kobe, Hyogo, Japan	Matsumoto, G (reprint author), Kanagawa Dent Univ, Yokohama Clin Educ Ctr, Div Oral Surg, Kanagawa Ku, 3-31-6 Tsuruya Cho, Yokohama, Kanagawa 2210835, Japan.	gmatsu@kanazawa-med.ac.jp			A-STEP exploratory research from JST [AS232Z00847F]; JSPS [90237131]	This work was supported in part by A-STEP exploratory research AS232Z00847F from JST and Grants-in-Aid for Scientific Research (C) 90237131 from JSPS.	Fiedler J, 2002, J CELL BIOCHEM, V87, P305, DOI 10.1002/jcb.10309; Shields LBE, 2006, SPINE, V31, P542, DOI 10.1097/01.brs.0000201424.27509.72; Bishop GB, 2007, INT ORTHOP, V31, P721, DOI 10.1007/s00264-007-0424-8; Seeherman H, 2005, CYTOKINE GROWTH F R, V16, P329, DOI 10.1016/j.cytogfr.2005.05.001; Vaccaro AR, 2008, SPINE J, V8, P457, DOI 10.1016/j.spinee.2007.03.012; Geiger M, 2003, ADV DRUG DELIVER REV, V55, P1613, DOI 10.1016/j.addr.2003.08.010; Benglis D, 2008, NEUROSURGERY, V62, P423, DOI 10.1227/01.neu.0000326030.24220.d8; Carragee EJ, 2011, SPINE J, V11, P471, DOI 10.1016/j.spinee.2011.04.023; REDDI AH, 1994, J CELL BIOCHEM, V56, P192, DOI 10.1002/jcb.240560213; Yang XBB, 2004, TISSUE ENG, V10, P1037, DOI 10.1089/ten.2004.10.1037; Cahill KS, 2009, JAMA-J AM MED ASSOC, V302, P58, DOI 10.1001/jama.2009.956; Coulibaly F, 2007, NATURE, V446, P97, DOI 10.1038/nature05628; Petite H, 2000, NAT BIOTECHNOL, V18, P959, DOI 10.1038/79449; La WG, 2010, ARTIF ORGANS, V34, P1150, DOI 10.1111/j.1525-1594.2009.00988.x; Reddi AH, 1997, NAT MED, V3, P837, DOI 10.1038/nm0897-837; Schmitt JM, 1999, J ORTHOPAED RES, V17, P269, DOI 10.1002/jor.1100170217; Triplett RG, 2009, J ORAL MAXIL SURG, V67, P1947, DOI 10.1016/j.joms.2009.04.085; Cochran DI, 2000, J PERIODONTOL, V71, P1241, DOI 10.1902/jop.2000.71.8.1241; Burkus JK, 2002, J SPINAL DISORD TECH, V15, P337; Helm GA, 1997, J NEUROSURG, V86, P93, DOI 10.3171/jns.1997.86.1.0093; Govender S, 2002, J BONE JOINT SURG AM, V84A, P2123; Boraiah S, 2009, CLIN ORTHOP RELAT R, V467, P3257, DOI 10.1007/s11999-009-1039-8; ROHRMANN GF, 1986, J GEN VIROL, V67, P1499, DOI 10.1099/0022-1317-67-8-1499; Argintar E, 2010, INJURY, V42, P730; Choi Y, 2011, CLIN ORAL IMPLAN RES, V23, P682; Hsu WK, 2008, SPINE J, V8, P419; Jeppsson C, 1999, ACTA ORTHOP SCAND, V70, P77, DOI 10.3109/17453679909000963; Koo KH, 2012, ARTIF ORGANS, V36, P629, DOI 10.1111/j.1525-1594.2012.01444.x; Lee J, 2012, CLINICAL ORAL IMPLAN, V24, P497, DOI DOI 10.1111/J.1600-0501.2011.02419.X; Matsumoto G, 2012, SCI REP-UK, V2, DOI 10.1038/srep00935; Matsushima K, 2010, TISSUE ENG PT A, V16, P3329, DOI 10.1089/ten.TEA.2009.0739; Meikle MC, 2007, SURG-J R COLL SURG E, V5, P232; Mont MA, 2004, J BONE JOINT SURG AM, V86A, P41; Paramore CG, 1999, NEUROSURGERY, V44, P1151, DOI 10.1097/00006123-199905000-00134; Singh K, 2007, SPINE J, V7, P326, DOI 10.1016/j.spinee.2006.06.397; Zabka AG, 2001, J ORTHOPAED RES, V19, P318, DOI 10.1016/S0736-0266(00)90003-2	36	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0885-3282	1530-8022		J BIOMATER APPL	J. Biomater. Appl.	AUG	2015	30	2					193	200		10.1177/0885328215575763		8	Engineering, Biomedical; Materials Science, Biomaterials	Engineering; Materials Science	CM5PH	WOS:000357740000006		
J	Zhang, YQ; Zhang, SY; Thabane, L; Furukawa, TA; Johnston, BC; Guyatt, GH				Zhang, Yuqing; Zhang, Shiyuan; Thabane, Lehana; Furukawa, Toshi A.; Johnston, Bradley C.; Guyatt, Gordon H.			Although not consistently superior, the absolute approach to framing the minimally important difference has advantages over the relative approach	JOURNAL OF CLINICAL EPIDEMIOLOGY			English	Article						Minimal important different; Health-related quality of life; Patient-reported outcomes; MID; MCID; HRQOL; PRO; Global rating of change; Anchor-based method	QUALITY-OF-LIFE; RANDOMIZED CONTROLLED-TRIAL; HEALTH-STATUS; DISEASE; METAANALYSIS; RESPONSES; EVALUATE	Objectives: Using studies that established minimal important difference (MID) using anchor-based methods, we set out to address the relative merits of absolute and relative changes in establishing an instrument's MlD. Study Design and Setting: In seven data sets, we calculated correlations between global change ratings and absolute and relative score changes and conducted meta-analyses. We considered that the measure with the higher correlation represented the more valid approach. Results: The meta-analyses showed no significant difference between pooled correlations of absolute and relative difference on health-related quality of life instrument with global transition scores of symptoms, emotional function, physical function, and cognitive function. In four of five domains, there was at least one study in which the absolute was significantly superior to the relative; in one of these four, one study showed statistically significant superior performance of the relative. In an analysis restricted to patients with low baseline scores for the domain of cognitive function, the relative approach showed higher correlation with global rating than did the absolute approach. Conclusion: Although we found no consistent superiority of either approach to establishing the MID, when differences existed they usually favored the absolute, which also has advantages of simplicity and ease of pooling across studies. Researchers may consider the absolute as a default but also compare both methods on an instrument by instrument basis.(C) 2015 Elsevier Inc. All rights reserved.	[Zhang, Yuqing; Zhang, Shiyuan; Thabane, Lehana; Guyatt, Gordon H.] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON L8S 4K1, Canada; [Furukawa, Toshi A.] Kyoto Univ, Grad Sch Med, Sch Publ Hlth, Dept Hlth Promot & Human Behav,Sakyo Ku, Kyoto 6068501, Japan; [Furukawa, Toshi A.] Kyoto Univ, Grad Sch Med, Sch Publ Hlth, Dept Clin Epidemiol,Sakyo Ku, Kyoto 6068501, Japan; [Johnston, Bradley C.] Univ Toronto, Hosp Sick Children, Dept Anaesthesia & Pain Med, Toronto, ON M5G 1X8, Canada; [Johnston, Bradley C.] Univ Toronto, Dalla Lana Sch Publ Hlth, Inst Hlth Policy Management & Evaluat, Toronto, ON M5T 3M6, Canada; [Johnston, Bradley C.] Hosp Sick Children, Res Inst, Child Hlth Evaluat Sci, Toronto, ON M5G 1X8, Canada; [Guyatt, Gordon H.] McMaster Univ, Dept Med, Hamilton, ON L8S 4K1, Canada	Guyatt, GH (reprint author), McMaster Univ, Dept Clin Epidemiol & Biostat, 1280 Main St West, Hamilton, ON L8S 4K1, Canada.	guyatt@mcmaster.ca					JAESCHKE R, 1989, CONTROL CLIN TRIALS, V10, P407, DOI 10.1016/0197-2456(89)90005-6; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; GUYATT GH, 1993, ANN INTERN MED, V118, P622; GOLDSTEIN RS, 1994, LANCET, V344, P1394, DOI 10.1016/S0140-6736(94)90568-1; Cepeda MS, 2003, PAIN, V105, P151, DOI 10.1016/S0304-3959(03)00176-3; JUNIPER EF, 1994, J CLIN EPIDEMIOL, V47, P81, DOI 10.1016/0895-4356(94)90036-1; Cook DJ, 1997, OSTEOPOROSIS INT, V7, P478; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Guyatt GH, 2002, J CLIN EPIDEMIOL, V55, P900, DOI 10.1016/S0895-4356(02)00435-3; GUYATT GH, 1985, J CHRON DIS, V38, P1003, DOI 10.1016/0021-9681(85)90098-0; Redelmeier DA, 1996, J CLIN EPIDEMIOL, V49, P1215, DOI 10.1016/S0895-4356(96)00206-5; LYDICK E, 1993, QUAL LIFE RES, V2, P221, DOI 10.1007/BF00435226; Blalock (JR) HM, 1979, SOCIAL STAT; Cook D, 2001, AM J RESP CRIT CARE, V163, P85; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Guyatt G, 2008, USERS GUIDES MED LIT; Jaeschke R, 1996, J GEN INTERN MED, V11, P744, DOI 10.1007/BF02598988; Little R. J. A., 2002, STAT ANAL MISSING DA; McKnight P. E., 2007, MISSING DATA GENTLE; Schunemann H, 2002, CHEST, V122, P1701, DOI 10.1378/chest.122.5.1701; Schünemann Holger J, 2005, COPD, V2, P81, DOI 10.1081/COPD-200050651; Schunemann HJ, 2004, MED CARE, V42, P1132; Talley NJ, 2001, AM J GASTROENTEROL, V96, P1998, DOI 10.1016/S0002-9270(01)02495-9	23	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0895-4356	1878-5921		J CLIN EPIDEMIOL	J. Clin. Epidemiol.	AUG	2015	68	8					888	894		10.1016/j.jclinepi.2015.02.017		7	Health Care Sciences & Services; Public, Environmental & Occupational Health	Health Care Sciences & Services; Public, Environmental & Occupational Health	CM3ZJ	WOS:000357623700007		
J	Fosdick, R; Fried, E				Fosdick, Roger; Fried, Eliot			Translation of Michael Sadowsky's Paper "An Elementary Proof for the Existence of a Developable MOBIUS Band and the Attribution of the Geometric Problem to a Variational Problem (vol 119, pg 3, 2015)	JOURNAL OF ELASTICITY			English	Correction									[Fosdick, Roger] Univ Minnesota, Dept Aerosp Engn & Mech, Minneapolis, MN 55455 USA; [Fried, Eliot] Okinawa Inst Sci & Technol, Math Soft Matter Unit, Onna, Okinawa 9040495, Japan	Fosdick, R (reprint author), Univ Minnesota, Dept Aerosp Engn & Mech, Minneapolis, MN 55455 USA.	fosdick@aem.umn.edu; eliot.fried@oist.jp					Hinz DF, 2015, J ELASTICITY, V119, P3, DOI 10.1007/s10659-014-9490-5	1	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0374-3535	1573-2681		J ELASTICITY	J. Elast.	AUG	2015	120	2					277	277				1	Engineering, Multidisciplinary; Materials Science, Multidisciplinary; Mechanics	Engineering; Materials Science; Mechanics	CM4QW	WOS:000357670800008		
J	Fosdick, R; Fried, E				Fosdick, Roger; Fried, Eliot			Uber ein abwickelbaresMobiusband (vol 119, pg 23, 2015)	JOURNAL OF ELASTICITY			English	Correction									[Fosdick, Roger] Univ Minnesota, Dept Aerosp Engn & Mech, Minneapolis, MN 55455 USA; [Fried, Eliot] Okinawa Inst Sci & Technol, Math Soft Matter Unit, Onna, Okinawa 9040495, Japan	Fosdick, R (reprint author), Univ Minnesota, Dept Aerosp Engn & Mech, Minneapolis, MN 55455 USA.	fosdick@aem.umn.edu; eliot.fried@oist.jp					Todres RE, 2015, J ELASTICITY, V119, P23, DOI 10.1007/s10659-014-9489-y	1	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0374-3535	1573-2681		J ELASTICITY	J. Elast.	AUG	2015	120	2					277	277				1	Engineering, Multidisciplinary; Materials Science, Multidisciplinary; Mechanics	Engineering; Materials Science; Mechanics	CM4QW	WOS:000357670800006		
J	Fosdick, R; Fried, E				Fosdick, Roger; Fried, Eliot			Translation of Michael Sadowsky's Paper "The Differential Equations of the MOBIUS Band" (vol 119, pg 19, 2015)	JOURNAL OF ELASTICITY			English	Correction									[Fosdick, Roger] Univ Minnesota, Dept Aerosp Engn & Mech, Minneapolis, MN 55455 USA; [Fried, Eliot] Okinawa Inst Sci & Technol, Math Soft Matter Unit, Onna, Okinawa 9040495, Japan	Fosdick, R (reprint author), Univ Minnesota, Dept Aerosp Engn & Mech, Minneapolis, MN 55455 USA.	fosdick@aem.umn.edu; eliot.fried@oist.jp					FOSDICK R, 2015, J ELASTICITY, V119, P19, DOI DOI 10.1007/S10659-014-9491-4	1	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0374-3535	1573-2681		J ELASTICITY	J. Elast.	AUG	2015	120	2					277	277				1	Engineering, Multidisciplinary; Materials Science, Multidisciplinary; Mechanics	Engineering; Materials Science; Mechanics	CM4QW	WOS:000357670800007		
J	Ishikawa, T; Vladimirov, VA				Ishikawa, Takuji; Vladimirov, V. A.			A Stepping Microrobot Controlled by Flow Oscillations	JOURNAL OF FLUIDS ENGINEERING-TRANSACTIONS OF THE ASME			English	Article							LOW-REYNOLDS-NUMBER; SWIMMER	A self-locomotive microrobot can be a key technology for medical applications, manufacturing, or micro total analysis systems (mu TAS). Although previous studies have mostly used magnetic, electric, chemical, or optical forces to control microrobots, we utilized flow oscillations. The results showed that the locomotion of the microrobot was stepwise near a wall when the oscillations were applied both horizontally and vertically. The most efficient microrobot was capable of propelling itself about 2 x 10(-3) times its radius during one oscillation period. These results illustrate that the proposed stepping microrobot has great potential for future applications.	[Ishikawa, Takuji] Tohoku Univ, Dept Bioengn & Robot, Sendai, Miyagi 9808579, Japan; [Vladimirov, V. A.] Univ York, Dept Math, York YO10 5DD, N Yorkshire, England	Ishikawa, T (reprint author), Tohoku Univ, Dept Bioengn & Robot, Sendai, Miyagi 9808579, Japan.	ishikawa@pfsl.mech.tohoku.ac.jp			NEXT program; JSPS	This work was supported by the NEXT program and Grant-in-Aids from JSPS.	Peyer KE, 2013, NANOSCALE, V5, P1259, DOI 10.1039/c2nr32554c; Chang ST, 2007, NAT MATER, V6, P235, DOI 10.1038/nmat1843; Thutupalli S, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/7/073021; Jiang HR, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.038302; Golestanian R, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.036308; Romanczuk P, 2012, EUR PHYS J-SPEC TOP, V202, P1, DOI 10.1140/epjst/e2012-01529-y; Sitti M, 2009, NATURE, V458, P1121, DOI 10.1038/4581121a; Wang W, 2013, J AM CHEM SOC, V135, P10557, DOI 10.1021/ja405135f; BLAKE JR, 1974, J ENG MATH, V8, P23, DOI 10.1007/BF02353701; Ishikawa T, 2006, J FLUID MECH, V568, P119, DOI 10.1017/S0022112006002631; Lauga E, 2011, SOFT MATTER, V7, P3060, DOI 10.1039/c0sm00953a; Tam D, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.068105; Burton LJ, 2010, PHYS FLUIDS, V22, DOI 10.1063/1.3481785; Dreyfus R, 2005, NATURE, V437, P862, DOI 10.1038/nature04090; YOUNGREN GK, 1975, J FLUID MECH, V69, P377, DOI 10.1017/S0022112075001486; Najafi A, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.062901; Becker LE, 2003, J FLUID MECH, V490, P15, DOI 10.1017/S0022112003005184; PURCELL EM, 1977, AM J PHYS, V45, P3, DOI 10.1119/1.10903; Snezhko A, 2011, NAT MATER, V10, P698, DOI [10.1038/nmat3083, 10.1038/NMAT3083]; Cheang UK, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3518982; Leoni M, 2009, SOFT MATTER, V5, P472, DOI 10.1039/b812393d; Loget G, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1550; Pozrikidis C., 1992, BOUNDARY INTEGRAL SI; Vladimirov V., 2013, J FLUID MECH, V716, P1; Vladimirov V. A., 2013, J FLUID MECH, V717, P1; Yizhar O., 2012, PHYS REV LETT, V108	26	0	0	ASME	NEW YORK	TWO PARK AVE, NEW YORK, NY 10016-5990 USA	0098-2202	1528-901X		J FLUID ENG-T ASME	J. Fluids Eng.-Trans. ASME	AUG	2015	137	8							084501	10.1115/1.4029840		3	Engineering, Mechanical	Engineering	CM3SH	WOS:000357603700010		
J	Hosokawa-Muto, J; Fujinami, Y; Mizuno, N				Hosokawa-Muto, Junji; Fujinami, Yoshihito; Mizuno, Natsuko			Evaluation of the Universal Viral Transport system for long-term storage of virus specimens for microbial forensics	JOURNAL OF FORENSIC AND LEGAL MEDICINE			English	Article						Virus; Transport medium; Storage; Quantitative PCR; Sampling; Microbial forensics	WASHINGTON; RECOVERY; OUTBREAK; DC	Forensic microbial specimens, including bacteria and viruses, are collected at biocrime and bioterrorism scenes. Although it is preferable that the pathogens in these samples are alive and kept in a steady state, the samples may be stored for prolonged periods before analysis. Therefore, it is important to understand the effects of storage conditions on the pathogens contained within such samples. To evaluate the capacity to preserve viable virus and the viral genome, influenza virus was added to the transport medium of the Universal Viral Transport system and stored for over 3 months at various temperatures, after which virus titrations and quantitative analysis of the influenza hemagglutinin gene were performed. Although viable viruses became undetectable 29 days after the medium was stored at room temperature, viruses in the medium stored at 4 degrees C were viable even after 99 days. A quantitative PCR analysis indicated that the hemagglutinin gene was maintained for 99 days at both 4 degrees C and room temperature. Therefore, long-term storage at 4 degrees C has little effect on viable virus and viral genes, so the Universal Viral Transport system can be useful for microbial forensics. This study provides important information for the handling of forensic virus specimens. (C) 2015 Elsevier Ltd and Faculty of Forensic and Legal Medicine. All rights reserved.	[Hosokawa-Muto, Junji; Fujinami, Yoshihito; Mizuno, Natsuko] Natl Res Inst Police Sci, Dept Forens Sci 1, Biol Sect 5, Kashiwa, Chiba 2770882, Japan	Hosokawa-Muto, J (reprint author), Natl Res Inst Police Sci, Dept Forens Sci 1, Biol Sect 5, 6-3-1 Kashiwanoha, Kashiwa, Chiba 2770882, Japan.	junji@nrips.go.jp					Metzker ML, 2002, P NATL ACAD SCI USA, V99, P14292, DOI 10.1073/pnas.222522599; Scaduto DI, 2010, P NATL ACAD SCI USA, V107, P21242, DOI 10.1073/pnas.1015673107; Budowle B, 2005, INT J LEGAL MED, V119, P317, DOI 10.1007/s00414-005-0535-y; Nolte KB, 2010, AM J FOREN MED PATH, V31, P308, DOI 10.1097/PAF.0b013e3181c187b5; Torok TJ, 1997, JAMA-J AM MED ASSOC, V278, P389, DOI 10.1001/jama.278.5.389; Barr KL, 2013, J CLIN VIROL, V56, P57, DOI 10.1016/j.jcv.2012.09.005; BISHAI FR, 1974, CAN J MICROBIOL, V20, P75; Budowle B, 2006, APPL ENVIRON MICROB, V72, P6431, DOI 10.1128/AEM.01165-06; Centers for Disease Control and Prevention, 2001, MMWR-MORBID MORTAL W, V50, P909; Daum LT, 2002, EMERG INFECT DIS, V8, P408; Dewan PK, 2002, EMERG INFECT DIS, V8, P1066; Dunn JJ, 2003, DIAGN MICR INFEC DIS, V45, P191, DOI 10.1016/S0732-8893(02)00541-2; Fernandez-Rodriguez A, 2015, EUR J CLIN MICROBIOL, V34, P1045, DOI 10.1007/s10096-015-2317-x; Forman MS, 2011, MANUAL CLIN MICROBIO, V2, P1276; Hsu VP, 2002, EMERG INFECT DIS, V8, P1039; JENSEN C, 1994, DIAGN MICR INFEC DIS, V19, P137, DOI 10.1016/0732-8893(94)90055-8; JOHNSON FB, 1990, CLIN MICROBIOL REV, V3, P120; Karber G., 1931, ARCH EXP PATHOL PH, V162, P480; Kramer A, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-130; Landry ML, 2011, MANUAL CLIN MICROBIO, V2, P1297; Ohuchi Y, 2008, CLIN VIROL, V36, P61; Takemura T, 2012, EVID-BASED COMPL ALT, DOI 10.1155/2012/946867; Urushisaki T, 2011, EVID-BASED COMPL ALT, P1, DOI 10.1155/2011/254914	23	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1752-928X	1532-2009		J FORENSIC LEG MED	J. Forensic Leg. Med.	AUG	2015	34						29	33		10.1016/j.jflm.2015.04.019		5	Medicine, Legal	Legal Medicine	CM5QL	WOS:000357743300006		
J	Seki, T; Abe, K; Nakamura, K; Egawa, Y; Miki, R; Juni, K; Seki, T				Seki, Tomohiro; Abe, Keigo; Nakamura, Kiminobu; Egawa, Yuya; Miki, Ryotaro; Juni, Kazuhiko; Seki, Toshinobu			Sugar-responsive pseudopolyrotaxanes and their application in sugar-induced release of PEGylated insulin	JOURNAL OF INCLUSION PHENOMENA AND MACROCYCLIC CHEMISTRY			English	Article						Cyclodextrin; Pseudopolyrotaxane; Phenylboronic acid; Insulin; Polypseudorotaxane; Intelligent material	BORONIC ACID; PROTEIN PEGYLATION; PHENYLBORONIC ACID; DRUG-DELIVERY; GENE DELIVERY; SLOW-RELEASE; CYCLODEXTRINS; SENSORS; SYSTEM; POLYPSEUDOROTAXANES	We have designed a pseudopolyrotaxane (PPRX), known as a molecular necklace, consisting of phenylboronic acid-modified gamma-cyclodextrin (PBA-gamma-CyD) and naphthalene-modified polyethylene glycol (Naph-PEG) for developing sugar-responsive insulin delivery systems. Interestingly, structural analyses show that the Naph-PEG/PBA-gamma-CyD PPRX obtained by our method was single stranded, whereas ordinary PPRXs using parent gamma-CyD were double stranded. The Naph-PEG/PBA-gamma-CyD PPRX was poorly water soluble at pH 7.4; however, sugar addition induced disintegration of the PPRX, and the components were dissolved, suggesting that the PBA moiety acts as a sugar sensor. We also have developed a PPRX consisting of Naph-PEG-appended insulin (Naph-PEG-Ins) and PBA-gamma-CyD and have confirmed that the release rate of Naph-PEG-Ins was accelerated following sugar addition. Graphical abstract	[Seki, Tomohiro; Abe, Keigo; Nakamura, Kiminobu; Egawa, Yuya; Miki, Ryotaro; Juni, Kazuhiko; Seki, Toshinobu] Josai Univ, Fac Pharmaceut Sci, Sakado, Saitama 3500295, Japan	Egawa, Y (reprint author), Josai Univ, Fac Pharmaceut Sci, Sakado, Saitama 3500295, Japan.	yegawa@josai.ac.jp			JSPS KAKENHI [25860027]	This work was supported by JSPS KAKENHI Grant Number 25860027.	Abu Hashim II, 2010, INT J PHARMACEUT, V392, P83, DOI 10.1016/j.ijpharm.2010.03.026; American Diabetes Association, 2014, DIABETES CARE S1, V37, pS14, DOI [DOI 10.2337/DC14-S014, 10.2337/dc14-S014]; Ooya T, 2006, J AM CHEM SOC, V128, P3852, DOI 10.1021/ja055868+; Egawa Y, 2011, MAT SCI ENG C-MATER, V31, P1257, DOI 10.1016/j.msec.2011.05.007; Matsumoto A, 2004, BIOMACROMOLECULES, V5, P1038, DOI 10.1021/bm0345413; Muijsers RBR, 2001, DRUGS, V61, P2289, DOI 10.2165/00003495-200161150-00014; Higashi T, 2009, INT J PHARMACEUT, V374, P26, DOI 10.1016/j.ijpharm.2009.02.017; Harada A, 2009, CHEM SOC REV, V38, P875, DOI 10.1039/b705458k; Qiu Y, 2001, ADV DRUG DELIVER REV, V53, P321, DOI 10.1016/S0169-409X(01)00203-4; Higashi T, 2008, BIOMATERIALS, V29, P3866, DOI 10.1016/j.biomaterials.2008.06.019; Li J, 2008, ADV DRUG DELIVER REV, V60, P1000, DOI 10.1016/j.addr.2008.02.011; HARADA A, 1994, NATURE, V370, P126, DOI 10.1038/370126a0; Meng FH, 2009, BIOMACROMOLECULES, V10, P197, DOI 10.1021/bm801127d; Roberts MJ, 2002, ADV DRUG DELIVER REV, V54, P459, DOI 10.1016/S0169-409X(02)00022-4; Li JJ, 2011, APPL MICROBIOL BIOT, V90, P427, DOI 10.1007/s00253-010-3037-x; Veronese FM, 2001, BIOMATERIALS, V22, P405, DOI 10.1016/S0142-9612(00)00193-9; Kim H, 2012, J AM CHEM SOC, V134, P4030, DOI 10.1021/ja211728x; Yan J, 2005, MED RES REV, V25, P490, DOI 10.1002/med.20038; Fang H, 2004, J FLUORESC, V14, P481, DOI 10.1023/B:JOFL.0000039336.51399.3b; Seo JH, 2013, J AM CHEM SOC, V135, P5513, DOI 10.1021/ja400817q; Sato K, 2012, ANAL SCI, V28, P929; Fossey JS, 2012, CHEM REC, V12, P464, DOI 10.1002/tcr.201200006; HARADA A, 1992, NATURE, V356, P325, DOI 10.1038/356325a0; James TD, 1996, ANGEW CHEM INT EDIT, V35, P1910, DOI 10.1002/anie.199619101; Park C, 2007, ANGEW CHEM INT EDIT, V46, P1455, DOI 10.1002/anie.200603404; Liu P, 2010, J PHYS CHEM LETT, V1, P1776, DOI 10.1021/jz100414j; Fujisaki Y, 2006, DRUG DEV IND PHARM, V32, P207, DOI 10.1080/03639040500466155; Egawa Y, 2014, MATERIALS, V7, P1201, DOI 10.3390/ma7021201; Harada A, 2001, ACCOUNTS CHEM RES, V34, P456, DOI 10.1021/ar000174l; Harada A, 2003, J POLYM SCI POL CHEM, V41, P3519, DOI 10.1002/pola.10831; Higashi T, 2007, BIOORG MED CHEM LETT, V17, P1871, DOI 10.1016/j.bmcl.2007.01.029; Higashi T, 2009, CHEM PHARM BULL, V57, P541; Hoeg-Jensen T, 2005, J AM CHEM SOC, V127, P6158, DOI 10.1021/ja051038k; JAMES TD, 1995, J AM CHEM SOC, V117, P8982, DOI 10.1021/ja00140a013; JUNI K, 1986, Journal of Controlled Release, V4, P25; Nakamura K, 2013, CHEM PHARM BULL, V61, P1188; Ohya Y, 2009, BIOMACROMOLECULES, V10, P2261, DOI 10.1021/bm900440v; OKADA H, 1995, CRIT REV THER DRUG, V12, P1; Ozawa R., 2007, J INCL PHENOM MACRO, V60, P253, DOI DOI 10.1007/S10847-007-9373-5; SEKI T, 1991, J CONTROL RELEASE, V17, P41, DOI 10.1016/0168-3659(91)90129-2; Yamauchi A, 2006, CHEM COMMUN, P4312, DOI 10.1039/b606342j	41	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0923-0750	1573-1111		J INCL PHENOM MACRO	J. Incl. Phenom. Macrocycl. Chem.	AUG	2015	82	3-4					417	424		10.1007/s10847-015-0504-0		8	Chemistry, Multidisciplinary	Chemistry	CM3HJ	WOS:000357572400012		
J	Saito, S				Saito, Shinichi			Synthesis of interlocked compounds utilizing the catalytic activity of macrocyclic phenanthroline-Cu complexes	JOURNAL OF INCLUSION PHENOMENA AND MACROCYCLIC CHEMISTRY			English	Article						Rotaxane; Rotacatenane; Catenane; [3]Rotaxane; Phenanthroline; Glaser coupling	TEMPLATE-DIRECTED SYNTHESIS; YIELDING ROTAXANE SYNTHESIS; MOLECULAR MACHINES; BLOCKING GROUP; CATENANES; RING; KNOTS; PSEUDOROTAXANES; CYCLODEXTRINS; ARCHITECTURES	A new method for the synthesis of interlocked compounds utilizing the catalytic activity of macrocyclic phenanthroline-Cu complexes was developed. The macrocyclic phenanthroline-Cu complexes were found to be good catalysts for several coupling reactions, and this catalytic activity was subsequently utilized for the synthesis of [2]rotaxanes and [2]catenanes. By combining the catalytic threading approach with the well-known metal-template method, several rotacatenanes were synthesized. In addition, one-pot synthesis of [3]rotaxanes was achieved in good yield by performing the threading reaction twice in a one-ring component.	Tokyo Univ Sci, Fac Sci, Dept Chem, Shinjuku Ku, Tokyo 1628601, Japan	Saito, S (reprint author), Tokyo Univ Sci, Fac Sci, Dept Chem, Shinjuku Ku, Tokyo 1628601, Japan.	ssaito@rs.kagu.tus.ac.jp			JSPS KAKENHI [26410125, 21655017]; Yamada Science Foundation; UBE Foundation	The author thanks the Organizing Committee of Host-Guest and Supramolecular Chemistry Society, Japan for giving him the HGCS Japan Award of Excellence 2014 and the opportunity to write this review. The author acknowledges Dr. Ryu Yamasaki, Dr. Yuichiro Mutoh, and all collaborators for their significant contribution. The author thanks Dr. Takeshi Kasama (Tokyo Medical and Dental University) for performing MALDI-TOF MS analysis. This work was supported by JSPS KAKENHI Grant Number 26410125 and 21655017, Yamada Science Foundation, and the UBE Foundation.	Amabilino DB, 1999, EUR J ORG CHEM, P1295; Anderson S, 1997, ANGEW CHEM INT EDIT, V36, P1310, DOI 10.1002/anie.199713101; Crowley JD, 2009, CHEM SOC REV, V38, P1530, DOI 10.1039/b804243h; Forgan RS, 2011, CHEM REV, V111, P5434, DOI 10.1021/cr200034u; Cheng HM, 2011, J AM CHEM SOC, V133, P12298, DOI 10.1021/ja205167e; Hancock LM, 2009, CHEM-EUR J, V15, P42, DOI 10.1002/chem.200802029; Santandrea J, 2014, ORG LETT, V16, P3892, DOI 10.1021/ol501898b; Barin G, 2011, CHEM-EUR J, V17, P213, DOI 10.1002/chem.201002152; Ugajin K, 2013, ORG LETT, V15, P2684, DOI 10.1021/ol400992p; Yamashita Y, 2015, CHEM-EUR J, V21, P2139, DOI 10.1002/chem.201405090; Amabilino DB, 1995, CHEM REV, V95, P2725, DOI 10.1021/cr00040a005; Saito S, 2006, ORG LETT, V8, P5133, DOI 10.1021/ol062247s; Klotz EJF, 2006, J AM CHEM SOC, V128, P15374, DOI 10.1021/ja0665139; HAY AS, 1962, J ORG CHEM, V27, P3320, DOI 10.1021/jo01056a511; Sato Y, 2009, ANGEW CHEM INT EDIT, V48, P504, DOI 10.1002/anie.200804864; Saito S, 2013, J ORG CHEM, V78, P3553, DOI 10.1021/jo302800t; Beves JE, 2011, ANGEW CHEM INT EDIT, V50, P9260, DOI 10.1002/anie.201007963; Nakashima N, 1998, J INCLUS PHENOM MOL, V32, P363, DOI 10.1023/A:1008084015958; Terao J, 2009, J AM CHEM SOC, V131, P18046, DOI 10.1021/ja908783f; Raymo FM, 1999, CHEM REV, V99, P1643, DOI 10.1021/cr970081q; Hiratani K, 2002, TETRAHEDRON LETT, V43, P5747, DOI 10.1016/S0040-4039(02)01201-7; Monnier F, 2008, ORG LETT, V10, P3203, DOI 10.1021/ol801025u; Johnston AG, 1996, J AM CHEM SOC, V118, P10662, DOI 10.1021/ja962046r; Nepogodiev SA, 1998, CHEM REV, V98, P1959, DOI 10.1021/cr970049w; Megiatto JD, 2011, ORG LETT, V13, P1808, DOI 10.1021/ol200304d; Tian H, 2006, CHEM SOC REV, V35, P361, DOI 10.1039/b512178g; Ashton PR, 1998, J AM CHEM SOC, V120, P2297, DOI 10.1021/ja9731276; Strutt NL, 2011, J AM CHEM SOC, V133, P5668, DOI 10.1021/ja111418j; Neal EA, 2014, CHEM COMMUN, V50, P5128, DOI 10.1039/c3cc47842d; Hayashi R, 2014, CHEM COMMUN, V50, P204, DOI 10.1039/c3cc47425a; Bates CG, 2002, ORG LETT, V4, P2803, DOI 10.1021/ol0264105; Niu ZB, 2009, CHEM REV, V109, P6024, DOI 10.1021/cr900002h; HARADA A, 1992, NATURE, V356, P325, DOI 10.1038/356325a0; Weisbach N, 2012, CHEM COMMUN, V48, P7562, DOI 10.1039/c2cc33321j; Aucagne V, 2006, J AM CHEM SOC, V128, P2186, DOI 10.1021/ja056903f; Movsisyan LD, 2014, J AM CHEM SOC, V136, P17996, DOI 10.1021/ja510663z; Bates CG, 2004, ORG LETT, V6, P1441, DOI 10.1021/ol049706e; Hubner GM, 1999, ANGEW CHEM INT EDIT, V38, P383; ASHTON PR, 1991, TETRAHEDRON LETT, V32, P6235, DOI 10.1016/0040-4039(91)80797-A; CHAMBRON JC, 1992, J CHEM SOC CHEM COMM, P1131, DOI 10.1039/c39920001131; Davidson GJE, 2001, J CHEM SOC DALTON, P3135, DOI 10.1039/b107257a; DIETRICHBUCHECKER CO, 1983, TETRAHEDRON LETT, V24, P5095, DOI 10.1016/S0040-4039(00)94050-4; Furusho Y, 2004, TETRAHEDRON LETT, V45, P9593, DOI 10.1016/j.tetlet.2004.10.152; HARRISON IT, 1967, J AM CHEM SOC, V89, P5723, DOI 10.1021/ja00998a052; Hirose K, 2007, ORG LETT, V9, P2969, DOI 10.1021/ol070999w; Hunter CA, 2001, ANGEW CHEM INT EDIT, V40, P2678, DOI 10.1002/1521-3773(20010716)40:14<2678::AID-ANIE2678>3.3.CO;2-L; Iwamoto H, 2010, CHEM LETT, V39, P24, DOI 10.1246/cl.2010.24; Jager R, 1997, ANGEW CHEM INT EDIT, V36, P930, DOI 10.1002/anie.199709301; Kawai H., 2006, ANGEW CHEM, V118, P4387, DOI 10.1002/ange.200600750; Loeb SJ, 2000, CHEM COMMUN, P845, DOI 10.1039/b001018i; Movsisyan LD, 2012, ORG LETT, V14, P3424, DOI [10.1021/ol301392t, 10.1021/ol3013921]; OGINO H, 1981, J AM CHEM SOC, V103, P1303, DOI 10.1021/ja00395a091; Ogoshi T, 2012, J AM CHEM SOC, V134, P20322, DOI 10.1021/ja310757p; Prikhod'ko AI, 2008, J AM CHEM SOC, V130, P448, DOI 10.1021/ja078216p; Saito S, 2006, J ORG CHEM, V71, P7477, DOI 10.1021/jo060829h; SAUVAGE JP, 1990, ACCOUNTS CHEM RES, V23, P319, DOI 10.1021/ar00178a001; Sauvage JP, 1998, ACCOUNTS CHEM RES, V31, P611, DOI 10.1021/ar960263r; SCHILL G, 1969, LIEBIGS ANN CHEM, V721, P53; Siemsen P, 2000, ANGEW CHEM INT EDIT, V39, P2632, DOI [10.1002/1521-3773(20000804)39:152632:AID-ANIE26323.0. CO, DOI 10.1002/1521-3773(20000804)39:15<2632::AID-ANIE2632>3.0.CO;2-F]; Takata T, 1999, CHEM LETT, P223; Tokunaga Y, 2009, J ORG CHEM, V74, P2374, DOI 10.1021/jo8025143; Vogtle F., 1995, LIEBIGS ANN, V1995, P739, DOI 10.1002/jlac.1995199505109; WENZ G, 1992, ANGEW CHEM INT EDIT, V31, P197, DOI 10.1002/anie.199201971; WU C, 1991, CHEM MATER, V3, P569, DOI 10.1021/cm00016a002; Yerin A, 2008, PURE APPL CHEM, V80, P2041, DOI 10.1351/pac200880092041; Yu G, 2012, CHEM-ASIAN J, V7, P207, DOI 10.1002/asia.201100617	66	2	2	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0923-0750	1573-1111		J INCL PHENOM MACRO	J. Incl. Phenom. Macrocycl. Chem.	AUG	2015	82	3-4					437	451		10.1007/s10847-015-0511-1		15	Chemistry, Multidisciplinary	Chemistry	CM3HJ	WOS:000357572400014		
J	Nakamura, H; Kawahito, Y; Nishimoto, K; Katayama, S				Nakamura, Hiroshi; Kawahito, Yousuke; Nishimoto, Koji; Katayama, Seiji			Elucidation of melt flows and spatter formation mechanisms during high power laser welding of pure titanium	JOURNAL OF LASER APPLICATIONS			English	Article						laser welding; melt flow; titanium; spatter; keyhole; plume; X-ray transmission in-situ observation	MOLTEN POOL; FIBER LASER; PENETRATION	This study was undertaken to clarify the relationship among the laser-induced plume ejected from the keyhole, the melt flows in the molten pool, and the formation mechanisms of spatters ejected from the molten pool during 10 kW laser welding of a pure titanium plate. High-speed video camera observation results showed that laser-induced plumes occurred at intervals of about 0.5 ms, and that the maximum plume ejection velocity reached 250 m/s. Three-dimensional X-ray transmission in-situ observation of the weld molten pool with tungsten carbide tracers revealed that the melt flowed mainly along the bottom of the molten pool from the keyhole tip to the rear part and then from the rear to the front near the surface of the molten pool at high speeds, while the melt in front of a keyhole flowed upward along the keyhole wall at a velocity of less than 0.6 m/s and then was accelerated to 2.1 m/s at the height of about 2 mm above the keyhole inlet. One-way upward melt flows were continuously piled up at the tip of the elongated melt, resulting in spattering as droplets from the molten pool due to the strong ejection of laser-induced plumes. Spatters were formed from part of a molten metal elongated around the keyhole inlet, and approximately 20 ms was required to form spatters. About 80% of spatters were generated from melts of the front or sides of the keyhole at the speeds of less than 50 mm/s. When the welding speed increased from 50-100 mm/s to 300 mm/s, the ratio and the size of spatters occurring from the rear part of a keyhole increased from 20% to 80% and became smaller than 1 mm. (C) 2015 Laser Institute of America.	[Nakamura, Hiroshi] Charmant Inc, Sabae, Fukui 916088, Japan; [Kawahito, Yousuke; Katayama, Seiji] Osaka Univ, Joining & Welding Res Inst JWRI, Ibaraki, Osaka 5670047, Japan; [Nishimoto, Koji] Anan Coll, Natl Inst Technol, Anan, Tokushima 7740017, Japan	Nakamura, H (reprint author), Charmant Inc, 6-8 Kawasari, Sabae, Fukui 916088, Japan.	h.nakamura@charmant.co.jp			KAKENHI [25289240]	This work was partly supported by KAKENHI 25289240. The authors would like to thank Masami Mizutani, Technical Officer of JWRI, Osaka University, for discussion.	Zhang MJ, 2013, APPL SURF SCI, V280, P868, DOI 10.1016/j.apsusc.2013.05.081; Li SC, 2014, APPL SURF SCI, V303, P481, DOI 10.1016/j.apsusc.2014.03.030; Kawahito Y, 2009, SCI TECHNOL WELD JOI, V14, P288, DOI 10.1179/136217108X372531; Matsunawa A, 1998, J LASER APPL, V10, P247; Schweier M, 2013, PHYSCS PROC, V41, P20, DOI 10.1016/j.phpro.2013.03.047; Heider A, 2013, PHYSCS PROC, V41, P112, DOI 10.1016/j.phpro.2013.03.058; Kamimuki K, 2002, J LASER APPL, V14, P136, DOI 10.2351/1.1493766; Kaplan AFH, 2011, J LASER APPL, V23, DOI 10.2351/1.3597830; Katayama S, 2001, J LASER APPL, V13, P187	9	0	0	AMER INST PHYSICS	MELVILLE	1305 WALT WHITMAN RD, STE 300, MELVILLE, NY 11747-4501 USA	1042-346X	1938-1387		J LASER APPL	J. Laser Appl.	AUG	2015	27	3							032012	10.2351/1.4922383		10	Materials Science, Multidisciplinary; Optics; Physics, Applied	Materials Science; Optics; Physics	CM4YK	WOS:000357692400012		
J	Roques, L; Hosono, Y; Bonnefon, O; Boivin, T				Roques, L.; Hosono, Y.; Bonnefon, O.; Boivin, T.			The effect of competition on the neutral intraspecific diversity of invasive species	JOURNAL OF MATHEMATICAL BIOLOGY			English	Article						Lotka-Volterra; Competition; Genetic diversity; Pulled and pushed waves; Nonlinear speed	NONLINEAR DIFFUSION EQUATIONS; LONG-DISTANCE DISPERSAL; GENETIC-VARIATION; TRAVELING-WAVES; POPULATION-GENETICS; LINEAR DETERMINACY; RANGE EXPANSION; COLONIZATION; EVOLUTION; SYSTEMS	This paper deals with the effect of interspecific competition on the dynamics of neutral genetic diversity in a range-expanding population. The spread of an invasive species in an environment already hosting a resident competitor is described by a traveling wave solution with minimal speed, , of a diffusive Lotka-Volterra competition model. The description of the dynamics of neutral genetic fractions in this wave is based on a decomposition of the wave into several components, as proposed by Roques et al. (Proc Natl Acad Sci USA 109(23):8828-8833, 2012). Our analytical results reveal that the wave can be either the pulled type, corresponding to strong erosion of the diversity, or the pushed type, corresponding to maintenance of the initial diversity. The pulled/pushed nature of the wave depends on the linear or nonlinear nature of the speed . Our results show that, for sufficiently strong competition, the speed is nonlinear, and therefore all of the genetic diversity in the invasive population is maintained. Conversely, in the absence of competition, or when competition is mild, the speed is linear, which means that only the furthest forward fraction in the initial invasive population eventually remains in the colonization front. Our numerical results also show that the sufficient conditions of Lewis et al. (J Math Biol 45(3):219-233, 2002) and Huang (J Dyn Differ Equ 22(2):285-297, 2010) for the linearity of the speed can still be improved, and they show that nonlinear speeds occur across a wide region of the parameter space, providing a counterpoint to recent analytical results suggesting that nonlinear speeds only occur in certain limiting cases.	[Roques, L.; Bonnefon, O.] INRA, UR Biostat & Proc Spatiaux 546, F-84914 Avignon, France; [Hosono, Y.] Kyoto Sangyo Univ, Dept Math, Kyoto 6038555, Japan; [Boivin, T.] INRA, UR Ecol Forets Mediterraneennes 629, F-84914 Avignon, France	Roques, L (reprint author), INRA, UR Biostat & Proc Spatiaux 546, F-84914 Avignon, France.	lionel.roques@avignon.inra.fr			European Research Council under the European Union [321186-ReaDi]; French Agence Nationale pour la Recherche [ANR-10-INTB-1705-04-MACBI]; JSPS KAKENHI Grant [22540156]; ReaDiLab (CNRS) [LIA 197]	The research leading to these results has received funding from the European Research Council under the European Union's Seventh Framework Programme (FP/2007-2013) / ERC Grant Agreement N. 321186-ReaDi-Reaction-Diffusion Equations, Propagation and Modelling, and from the French Agence Nationale pour la Recherche, within the ANR-10-INTB-1705-04-MACBI project. The second author was supported by JSPS KAKENHI Grant Number 22540156 and the ReaDiLab (LIA 197, CNRS).	Bridle JR, 2007, TRENDS ECOL EVOL, V22, P140, DOI 10.1016/j.tree.2006.11.002; Pluess AR, 2011, MOL ECOL, V20, P473, DOI 10.1111/j.1365-294X.2010.04972.x; Hecht F, 2012, J NUMER MATH, V20, P251, DOI 10.1515/jnum-2012-0013; Lewis MA, 2002, J MATH BIOL, V45, P219, DOI 10.1007/s002850200144; Guo JS, 2012, DISCRETE CONT DYN-B, V17, P2713, DOI 10.3934/dcdsb.2012.17.2713; Vlad MO, 2004, P NATL ACAD SCI USA, V101, P10249, DOI 10.1073/pnas.0403419101; Wilson JRU, 2009, TRENDS ECOL EVOL, V24, P136, DOI 10.1016/j.tree.2008.10.007; Li BT, 2005, MATH BIOSCI, V196, P82, DOI 10.1016/j.mbs.2005.03.008; Garnier J, 2012, J MATH PURE APPL, V98, P428, DOI 10.1016/j.matpur.2012.02.005; Ibrahim KM, 1996, HEREDITY, V77, P282; ARONSON DG, 1978, ADV MATH, V30, P33, DOI 10.1016/0001-8708(78)90130-5; Holzer M, 2012, NONLINEARITY, V25, P2151, DOI 10.1088/0951-7715/25/7/2151; HADELER KP, 1975, J MATH BIOL, V2, P251, DOI 10.1007/BF00277154; STOKES AN, 1976, MATH BIOSCI, V31, P307, DOI 10.1016/0025-5564(76)90087-0; Sexton JP, 2009, ANNU REV ECOL EVOL S, V40, P415, DOI 10.1146/annurev.ecolsys.110308.120317; Excoffier L, 2008, TRENDS ECOL EVOL, V23, P347, DOI 10.1016/j.tree.2008.04.004; Gaston KJ, 2009, P ROY SOC B-BIOL SCI, V276, P1391, DOI 10.1098/rspb.2009.0100; Eckert CG, 2008, MOL ECOL, V17, P1170, DOI 10.1111/j.1365-294X.2007.03659.x; Huang WZ, 2010, J DYN DIFFER EQU, V22, P285, DOI 10.1007/s10884-010-9159-0; FIFE PC, 1977, ARCH RATION MECH AN, V65, P335; Burton OJ, 2010, ECOL LETT, V13, P1210, DOI 10.1111/j.1461-0248.2010.01505.x; Roques L, 2012, P NATL ACAD SCI USA, V109, P8828, DOI 10.1073/pnas.1201695109; KANON Y, 1995, SIAM J MATH ANAL, V26, P340, DOI 10.1137/S0036141093244556; Austerlitz F, 2000, GENETICS, V154, P1309; Morita Y, 2009, SIAM J MATH ANAL, V40, P2217, DOI 10.1137/080723715; Excoffier L, 2009, ANNU REV ECOL EVOL S, V40, P481, DOI 10.1146/annurev.ecolsys.39.110707.173414; Hosono Y, 1998, B MATH BIOL, V60, P435, DOI 10.1006/bulm.1997.0008; Weinberger HF, 2002, J MATH BIOL, V45, P183, DOI 10.1007/s002850200145; Agashe D, 2011, EVOLUTION, V65, P2481, DOI 10.1111/j.1558-5646.2011.01307.x; Hosono Y, 2003, DISCRETE CONT DYN-B, V3, P79; Guo JS, 2011, J DYN DIFFER EQU, V23, P353, DOI 10.1007/s10884-011-9214-5; Austerlitz F, 2003, HEREDITY, V90, P282, DOI 10.1038/sj.hdy.6800243; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Shea K, 2002, TRENDS ECOL EVOL, V17, P170, DOI 10.1016/S0169-5347(02)02495-3; Dlugosch KM, 2008, MOL ECOL, V17, P431, DOI 10.1111/j.1365-294X.2007.03538.x; Aronson D G, 1975, LECT NOTES MATH, V446, P5; Bonnefon O, 2014, DISC CONT D IN PRESS; Bonnefon O, 2013, MATH MODEL NAT PHENO, V8, P44; Crooks ECM, 2003, ADV DIFF EQ, V8, P279; Facon B, 2011, CURR BIOL, V21, P424, DOI 10.1016/j.cub.2011.01.068; Fayard J, 2009, J EVOLUTION BIOL, V22, P2171, DOI 10.1111/j.1420-9101.2009.01832.x; Garnier J, 2014, PREPRINT; Hallatschek O, 2008, THEOR POPUL BIOL, V73, P158, DOI 10.1016/j.tpb.2007.08.008; HENRY D., 1981, GEOMETRIC THEORY SEM; Huang WZ, 2011, J DIFFER EQUATIONS, V251, P1549, DOI 10.1016/j.jde.2011.05.012; Kan-on Y., 1996, JAPAN J IND APPL MAT, V13, P343; Kolmogorov A N, 1937, B MGU A, V1, P1; MOLLISON D, 1977, J ROY STAT SOC B MET, V39, P283; Murray J. D., 2002, INTERDISCIPLINARY AP, V17; OKUBO A, 1989, PROC R SOC SER B-BIO, V238, P113, DOI 10.1098/rspb.1989.0070; Roques Alain, 2009, V3, P63; Uchiyama K, 1978, J MATH KYOTO U, V18, P453; Yukio KO, 1997, NONLINEAR ANAL-THEOR, V28, P145, DOI 10.1016/0362-546X(95)00142-I	53	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0303-6812	1432-1416		J MATH BIOL	J. Math. Biol.	AUG	2015	71	2					465	489		10.1007/s00285-014-0825-4		25	Biology; Mathematical & Computational Biology	Life Sciences & Biomedicine - Other Topics; Mathematical & Computational Biology	CM4RI	WOS:000357672000007		
J	Kagotani, M; Ueda, H				Kagotani, Masanori; Ueda, Hiroyuki			Influence of Installation Tension on Transmission Error Due to Resonance in a Synchronous Belt	JOURNAL OF MECHANICAL DESIGN			English	Article							APPLIED INITIAL TENSION; TIMING BELT; THEORETICAL-ANALYSIS; DRIVES; NOISE; STATE; IDLER	In synchronous belt drives, a transmission error is generated due to resonance of the belt spanning the driving and driven pulleys when the transverse natural frequency of the belt approaches the meshing frequency of the belt and the pulley teeth. The behavior of this transmission error has been assumed to be dependent on the installation tension. In the present study, the influence of the installation tension on the transmission error in a synchronous belt drive under no transmitted load was experimentally investigated for the case in which first mode vibration due to resonance was induced in both the upper and lower spans. In addition, an analysis of the transmission error based on the experimental results was carried out. A method for reducing the error was also investigated. The transmission error contains two components: one with a period equal to the pitch of the pulley, and the other with a period of half the pulley pitch. Good agreement was found between the calculation and experimental results, thus confirming the validity of the analysis method. For a fixed pulley speed, the transmission error was largest when the installation tension was applied at a position where the displacement of the upper span was equal to that of the lower span. It was found that the transmission error could be reduced by pushing an idler lightly against the center of the span of the belt that was undergoing the largest displacement.	[Kagotani, Masanori; Ueda, Hiroyuki] Osaka Sangyo Univ, Dept Mech Engn Transportat, Daito, Osaka 5748530, Japan	Kagotani, M (reprint author), Osaka Sangyo Univ, Dept Mech Engn Transportat, 3-1-1 Nakagaito, Daito, Osaka 5748530, Japan.	kagotani@tm.osaka-sandai.ac.jp; ueda@tm.osaka-sandai.ac.jp					Aher V, 2011, 2011280140 SAE; KAGOTANI M, 1983, B JSME, V26, P1238; KAGOTANI M, 1981, B JSME, V24, P723; [Anonymous], 2001, ASME, DOI DOI 10.1115/1.1326916; KAGOTANI M, 1983, B JSME, V26, P132; [Anonymous], 2000, J MECH DESIGN; [Anonymous], 1993, J MECH DESIGN; Hosek M., 2009, IMECE200910111 ASME, P17; KAGOTANI M, 1984, B JSME, V27, P1780; Kagotani M., 2009, J MECH DESIGN, V131; Kagotani M., 2000, T JSME C, V66, P951; KAGOTANI M, 2004, ASME, V126, P881, DOI DOI 10.1115/1.1765118; Kagotani M., 1989, T JPN SOC MECH ENG-C, V55, P2831; KOYAMA T, 1990, J MECH DESIGN, V112, P419, DOI DOI 10.1115/1.2912624; Kubo A, 1971, B JSME, V14, P991; MAKITA K, 2003, ASME, V125, P404, DOI DOI 10.1115/1.1564072; MAKITA K, 2004, J MECH DESIGN, V126, P148; Monternot C., 1996, ASME P 1996 INT POW, V88, P297; Scurtu P, 2009, 2009011198 SAE; Takano K, 1998, T JPN SOC MECH ENG, V64, P421; Ueda H, 2010, J MECH DESIGN, V132; Ueda H, 2012, J MECH DESIGN, V134; WATANABE K, 1990, J MECH DESIGN, V112, P424; Zhang W, 2004, T JPN SOC MECH ENG-C, V70, P1244	24	0	0	ASME	NEW YORK	TWO PARK AVE, NEW YORK, NY 10016-5990 USA	1050-0472			J MECH DESIGN	J. Mech. Des.	AUG	2015	137	8							083301	10.1115/1.4030204		9	Engineering, Mechanical	Engineering	CM0BC	WOS:000357342200009		
J	Weller, OM; Wallis, SR; Aoya, M; Nagaya, T				Weller, O. M.; Wallis, S. R.; Aoya, M.; Nagaya, T.			Phase equilibria modelling of blueschist and eclogite from the Sanbagawa metamorphic belt of southwest Japan reveals along-strike consistency in tectonothermal architecture	JOURNAL OF METAMORPHIC GEOLOGY			English	Article						blueschist; eclogite facies; phase equilibria modelling; ridge approach; Sanbagawa metamorphic belt	FACIES METAMORPHISM; CENTRAL SHIKOKU; SW JAPAN; MIXING PROPERTIES; BESSHI DISTRICT; PELITIC SCHISTS; LU-HF; CONSTRAINTS; EVOLUTION; PATH	The Sanbagawa metamorphic belt of southwest Japan is one of the type localities of subduction-related high-P metamorphism. However, variable pressure-temperature (P-T) paths and metabasic assemblages have been reported for eclogite units in the region, leading to uncertainty about the subduction zone paleo-thermal structure and associated tectonometamorphic conditions. To analyse this variation, phase equilibria modelling was applied to the three main high-P metabasic rock types documented in the region - glaucophane eclogite, barroisite eclogite and garnet blueschist - with modelling performed over a range of P, T, bulk rock H2O and bulk rock ferric iron conditions using thermocalc. All samples are calculated to share a common steep prograde P-T path to similar peak conditions of approximate to 16-20kbar and 560-610 degrees C. The results establish that regional assemblage variation is systematic, with the alternation in peak amphibole phase due to peak conditions overlapping the glaucophane-barroisite solvus, and bulk composition effects stabilizing blueschist v. eclogite facies assemblages at similar P-T conditions. Furthermore, the results reveal that a steep prograde P-T path is common to all eclogite units in the Sanbagawa belt, indicating that metamorphic conditions were consistent along strike. All localities are compatible with predictions made by a ridge approach model, which attributes eclogite facies metamorphism and exhumation of the Sanbagawa belt to the approach of a spreading ridge.	[Weller, O. M.; Wallis, S. R.; Nagaya, T.] Nagoya Univ, Grad Sch Environm Studies, Dept Earth & Planetary Sci, Nagoya, Aichi 4648601, Japan; [Aoya, M.] Univ Tokushima, Inst Socioarts & Sci, Tokushima 7708502, Japan	Weller, OM (reprint author), Geol Survey Canada, 601 Booth St, Ottawa, ON K1A 0E8, Canada.	oweller@nrcan.gc.ca			Japan Society for the Promotion of Science (JSPS)	O. Weller was funded by a short-term Postdoctoral Fellowship from the Japan Society for the Promotion of Science (JSPS). Members of the petrology group at Nagoya University, S. Endo (AIST), R. Palin (Mainz) and J. Diener (UCT) are thanked for stimulating discussion, and D. Waters (Oxford) and D. Tinkham (Laurentian) are thanked for providing the methodology to produce the pixel map shown in Fig. 6d. Thorough and constructive comments from M. St-Onge (GSC), C. Wei (Peking) and P. Pitra (Rennes) are gratefully acknowledged.	Angiboust S., 2011, J METAMORPH GEOL, V30, P37, DOI [10.1111/j.1525-1314.2011.00951.x, DOI 10.1111/J.1525-1314.2011.00951.X]; Stipp M, 2002, J STRUCT GEOL, V24, P1861, DOI 10.1016/S0191-8141(02)00035-4; Aoya M, 2001, J PETROL, V42, P1225, DOI 10.1093/petrology/42.7.1225; Tian ZL, 2014, J METAMORPH GEOL, V32, P743, DOI 10.1111/jmg.12089; Hattori K, 2010, ISL ARC, V19, P192, DOI 10.1111/j.1440-1738.2009.00696.x; Enami M, 2004, J METAMORPH GEOL, V22, P1, DOI 10.1111/j.1525-1314.2003.00492.x; Endo S, 2009, J METAMORPH GEOL, V27, P371, DOI 10.1111/j.1525-1314.2009.00821.x; Holland T, 2003, CONTRIB MINERAL PETR, V145, P492, DOI 10.1007/s00410-003-0464-z; Wallis SR, 2009, J METAMORPH GEOL, V27, P93, DOI 10.1111/j.1525-1314.2008.00806.x; Guiraud M, 2001, J METAMORPH GEOL, V19, P445, DOI 10.1046/j.0263-4929.2001.00320.x; Holland T, 1998, EUR J MINERAL, V10, P395; Yang YT, 2013, EARTH-SCI REV, V126, P96, DOI 10.1016/j.earscirev.2013.07.010; Coggon R, 2002, J METAMORPH GEOL, V20, P683, DOI 10.1046/j.1525-1314.2002.00395.x; Whitney DL, 2010, AM MINERAL, V95, P185, DOI 10.2138/am.2010.3371; White RW, 2007, J METAMORPH GEOL, V25, P511, DOI 10.1111/j.1525-1314.2007.00711.x; Okamoto K, 2004, TERRA NOVA, V16, P81, DOI 10.1111/j.1365-3121.2004.00531.x; ISOZAKI Y, 1990, J METAMORPH GEOL, V8, P401, DOI 10.1111/j.1525-1314.1990.tb00627.x; BENCE AE, 1968, J GEOL, V76, P382; de Capitani C, 2010, AM MINERAL, V95, P1006, DOI 10.2138/am.2010.3354; Powell R, 2008, J METAMORPH GEOL, V26, P155, DOI 10.1111/j.1525-1314.2007.00756.x; Holland TJB, 1998, J METAMORPH GEOL, V16, P309, DOI 10.1111/j.1525-1314.1998.00140.x; Endo S, 2012, LITHOS, V146, P183, DOI 10.1016/j.lithos.2012.05.010; Maruyama S, 1997, ISL ARC, V6, P121, DOI 10.1111/j.1440-1738.1997.tb00043.x; Okamoto A, 2005, J METAMORPH GEOL, V23, P335, DOI 10.1111/j.1525-1314.2005.00580.x; Tsuchiya S, 2013, J MINER PETROL SCI, V108, P166, DOI 10.2465/jmps121022b; St-Onge MR, 2013, J METAMORPH GEOL, V31, P469, DOI 10.1111/jmg.12030; Diener JFA, 2012, J METAMORPH GEOL, V30, P131, DOI 10.1111/j.1525-1314.2011.00959.x; Aoya M, 2003, GEOLOGY, V31, P1045, DOI 10.1130/G19927.1; Mahar EM, 1997, J METAMORPH GEOL, V15, P223, DOI 10.1111/j.1525-1314.1997.00011.x; White RW, 2000, J METAMORPH GEOL, V18, P497; TAKASU A, 1994, LITHOS, V33, P119, DOI 10.1016/0024-4937(94)90057-4; Kouketsu Y, 2010, J MINER PETROL SCI, V105, P9, DOI 10.2465/jmps.090217; Aoya M, 2006, LITHOS, V89, P107, DOI 10.1016/j.lithos.2005.10.001; Banno S., 1989, GEOLOGICAL SOC SPECI, V43, P519, DOI 10.1144/GSL.SP.1989.043.01.50; Charvet J., 2013, J ASIAN EARTH SCI, V72, P81; Desmons J., 2007, SYSTEMATIC NOMENCLAT; Endo S, 2013, J MINER PETROL SCI, V108, P189, DOI 10.2465/jmps.121125; Endo S, 2013, J METAMORPH GEOL, V31, P647, DOI 10.1111/jmg.12038; Goto A., 1996, RIGAKU J, V13, P20; Holland T, 2009, J INTELL DISABIL RES, V53, P1, DOI 10.1111/j.1365-2788.2008.01145.x; KARABINOS P, 1984, AM J SCI, V284, P1008; Kato T, 2005, GEOSTAND GEOANAL RES, V29, P83, DOI 10.1111/j.1751-908X.2005.tb00657.x; Knittel U, 2014, J ASIAN EARTH SCI, V96, P148, DOI 10.1016/j.jseaes.2014.09.001; Ko ZW, 2005, LITHOS, V81, P79, DOI 10.1016/j.lithos.2004.09.018; Kouketsu Y, 2014, ISL ARC, V23, P263, DOI 10.1111/iar.12075; Matsumoto M, 2003, J METAMORPH GEOL, V21, P363; MIYASHIRO A, 1961, J PETROL, V2, P277; Passchier C.W., 2005, MICROTECTONICS; Takasu A, 1989, GEOL SOC LOND SPEC P, V43, P533, DOI 10.1144/GSL.SP.1989.043.01.51; TAKASU A, 1984, J PETROL, V25, P619; Takasu A., 2012, 2012 ANN M JAP ASS M; Ubukawa T, 2007, ISL ARC, V16, P553, DOI 10.1111/j.1440-1738.2007.00582.x; Uehara S. -I., 2005, TECTONICS, V24, P1, DOI DOI 10.1029/2004TC001715; Wallis S, 2000, J METAMORPH GEOL, V18, P653, DOI 10.1046/j.1525-1314.2000.00285.x; Wallis S. R., 1992, ISL ARC, V1, P176, DOI 10.1111/j.1440-1738.1992.tb00068.x; Wei CJ, 2014, ISL ARC, V23, P254, DOI 10.1111/iar.12087; Weller OM, 2015, J METAMORPH GEOL, V33, P91, DOI 10.1111/jmg.12112; Woodsworth GJ, 1977, CAN MINERAL, V15, P230	58	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0263-4929	1525-1314		J METAMORPH GEOL	J. Metamorph. Geol.	AUG	2015	33	6					579	596		10.1111/jmg.12134		18	Geology	Geology	CM2CL	WOS:000357487300002		
J	Shirai, Y; Watanabe, M; Sakagami, H; Suzuki, T				Shirai, Yoshinori; Watanabe, Masahiko; Sakagami, Hiroyuki; Suzuki, Tatsuo			Novel splice variants in the 5 ' UTR of Gtf2i expressed in the rat brain: alternative 5 ' UTRs and differential expression in the neuronal dendrites	JOURNAL OF NEUROCHEMISTRY			English	Article						5 ' UTR; alternative splicing; dendrite; synaptic plasticity; Gtf2i; mRNA	WILLIAMS-BEUREN-SYNDROME; TFII-I; MESSENGER-RNA; LOCAL TRANSLATION; GENE-EXPRESSION; REGION; IDENTIFICATION; TRANSCRIPTION; MECHANISMS; SEQUENCES	General transcription factor II-I (Gtf2i) is a transcription factor and one of the genes implicated in Willams-Beuren syndrome, an autism spectrum disorder. In this study, we investigated splice variants of the Gtf2i gene in both the 5'untranslated region (5'UTR) and the coding region. To search for novel 5'UTRs of Gtf2i, we utilized the cap analysis gene expression database of the mouse. We identified seven novel Gtf2i transcripts with alternatively spliced 5'UTRs in the rat brain. We also identified four novel splice variants in the coding sequence of Gtf2i. Furthermore, we identified a selective usage of certain types of 5'UTR by coding variants. In situ hybridization demonstrated a differential pattern of expression of Gtf2i mRNAs with alternatively spliced 5'UTRs among neuronal cells, and the localization of one of the variants in neuronal dendrites in the rat brain. Immunohistochemistry also demonstrated a distribution of Gtf2i-immunoreactivity in the dendrites. These results suggest multiple pathways of expression of Gtf2i gene in the brain. The expression patterns may be under the control of alternative promoters coupled to the alternative splicing in the coding region. Differential localization of mRNA to neuronal dendrites suggests spatiotemporal-specific translation at the post-synaptic sites that is involved in transfer of synaptic activity to expression of specific sets of genes in the nucleus.	[Shirai, Yoshinori; Suzuki, Tatsuo] Shinshu Univ, Grad Sch Med, Inst Pathogenesis & Dis Prevent, Dept Neuroplast, Matsumoto, Nagano 3908621, Japan; [Watanabe, Masahiko] Hokkaido Univ, Grad Sch Med, Dept Anat, Sapporo, Hokkaido, Japan; [Sakagami, Hiroyuki] Kitasato Univ, Sch Med, Dept Anat, Sagamihara, Kanagawa 228, Japan; [Suzuki, Tatsuo] Shinshu Univ, Dept Biol Sci Intractable Neurol Dis, Inst Biomed Sci, Interdisciplinary Cluster Cutting Edge Res, Matsumoto, Nagano 3908621, Japan	Suzuki, T (reprint author), Shinshu Univ, Grad Sch Med, Inst Pathogenesis & Dis Prevent, Dept Neuroplast, 3-1-1 Asahi, Matsumoto, Nagano 3908621, Japan.	suzukit@shinshu-u.ac.jp			JSPS KAKENHI [23650189, 15K06771]; Comprehensive Brain Science Network (CBSN)	This work was supported by JSPS KAKENHI Grant Number 23650189 and 15K06771. This work was supported by Comprehensive Brain Science Network (CBSN). Pacific Edit reviewed the manuscript prior to submission. The authors have no conflicts of interest to declare.	Doyle M, 2011, EMBO J, V30, P3540, DOI 10.1038/emboj.2011.278; Merla G, 2010, HUM GENET, V128, P3, DOI 10.1007/s00439-010-0827-2; Roy AL, 2012, GENE, V492, P32, DOI 10.1016/j.gene.2011.10.030; Schaeffer C, 2001, EMBO J, V20, P4803, DOI 10.1093/emboj/20.17.4803; Cheriyath V, 2002, J BIOL CHEM, V277, P22798, DOI 10.1074/jbc.M202956200; Bramham CR, 2007, NAT REV NEUROSCI, V8, P776, DOI 10.1038/nrn2150; Meyer-Lindenberg A, 2006, NAT REV NEUROSCI, V7, P380, DOI 10.1038/nrn1906; Jung H, 2014, CELL, V157, P26, DOI 10.1016/j.cell.2014.03.005; Rubenstein JLR, 2003, GENES BRAIN BEHAV, V2, P255, DOI 10.1046/j.1601-183X.2003.00037.x; Sakurai T, 2011, AUTISM RES, V4, P28, DOI 10.1002/aur.169; Dai L, 2009, AM J MED GENET A, V149A, P302, DOI 10.1002/ajmg.a.32652; Holt CE, 2013, NEURON, V80, P648, DOI 10.1016/j.neuron.2013.10.036; Hakre S, 2006, MOL CELL, V24, P301, DOI 10.1016/j.molcel.2006.09.005; Darnell JC, 2001, CELL, V107, P489, DOI 10.1016/S0092-8674(01)00566-9; Tian QB, 1999, MOL BRAIN RES, V72, P147, DOI 10.1016/S0169-328X(99)00214-4; Bugaut A, 2012, NUCLEIC ACIDS RES, V40, P4727, DOI 10.1093/nar/gks068; Rechsteiner M, 1996, TRENDS BIOCHEM SCI, V21, P267, DOI 10.1016/S0968-0004(96)10031-1; Somerville MJ, 2005, NEW ENGL J MED, V353, P1694, DOI 10.1056/NEJMoa051962; Greer PL, 2008, NEURON, V59, P846, DOI 10.1016/j.neuron.2008.09.002; Hinsley TA, 2004, PROTEIN SCI, V13, P2588, DOI 10.1110/ps.04747604; Dani VS, 2005, P NATL ACAD SCI USA, V102, P12560, DOI 10.1073/pnas.0506071102; Sanders SJ, 2011, NEURON, V70, P863, DOI 10.1016/j.neuron.2011.05.002; Subramanian M, 2011, EMBO REP, V12, P697, DOI 10.1038/embor.2011.76; Shiraki T, 2003, P NATL ACAD SCI USA, V100, P15776, DOI 10.1073/pnas.2136655100; Caraveo G, 2006, SCIENCE, V314, P122, DOI 10.1126/science.1127815; Cheriyath V, 2001, J BIOL CHEM, V276, P8377, DOI 10.1074/jbc.M008411200; Cheriyath V, 2000, J BIOL CHEM, V275, P26300, DOI 10.1074/jbc.M002980200; Chimge NO, 2008, P NATL ACAD SCI USA, V105, P9006, DOI 10.1073/pnas.0803051105; Enkhmandakh B, 2004, GENE EXPR PATTERNS, V4, P25, DOI 10.1016/S1567-133X(03)00155-8; Kikin O, 2008, NUCLEIC ACIDS RES, V36, pD141, DOI 10.1093/nar/gkm982; Makeyev AV, 2009, GENE, V433, P16, DOI 10.1016/j.gene.2008.11.027; Novina CD, 1999, MOL CELL BIOL, V19, P5014; Poitras L, 2010, DEVELOPMENT, V137, P3089, DOI 10.1242/dev.051052; Shirai Y, 2004, J NEUROCYTOL, V33, P297, DOI 10.1023/B:NEUR.0000044191.83858.f7; Suzuki T, 2007, NEUROSCI RES, V57, P61, DOI 10.1016/j.neures.2006.09.009; Suzuki T, 2011, NEUROMETHODS, V57, P47, DOI 10.1007/978-1-61779-111-6_4; Tapia-Paez I, 2008, FASEB J, V22, P3001, DOI 10.1096/fj.07-104455	37	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3042	1471-4159		J NEUROCHEM	J. Neurochem.	AUG	2015	134	3					578	589		10.1111/jnc.13136		12	Biochemistry & Molecular Biology; Neurosciences	Biochemistry & Molecular Biology; Neurosciences & Neurology	CM5JS	WOS:000357724700016		
J	Takeda, T; Imoto, Y; Nagasawa, H; Muroya, M; Shiina, M				Takeda, Takashi; Imoto, Yoko; Nagasawa, Hiroyo; Muroya, Miyuki; Shiina, Masami			Premenstrual Syndrome and Premenstrual Dysphoric Disorder in Japanese Collegiate Athletes	JOURNAL OF PEDIATRIC AND ADOLESCENT GYNECOLOGY			English	Article						PMS; PMDD; Collegiate athlete; Athletic performance	HIGH-SCHOOL-STUDENTS; MENSTRUAL-CYCLE; PERFORMANCE; SYMPTOMS; PREVALENCE; DIAGNOSIS; TRIAD; WOMEN	Study Objective: To determine the prevalence and impact of premenstrual syndrome (PMS) and premenstrual dysphoric disorder (PMDD) in Japanese collegiate athletes, with a focus on their disruption of athletic performance. Design: Cross-sectional study. Setting: A university in Osaka, the largest city in western Japan. Participants: 232 female collegiate athletes. Main Outcome Measures: Premenstrual symptoms and social activities. Results: The prevalence of each premenstrual symptom was high. The prevalence of moderate to severe PMS and PMDD was 8.6% and 2.9%, respectively, the same as in general high school students. The athletic performance of 44.3% of athletes was found to suffer in a game or in practice. "Elite athletes" (OR 8.63,95% CI: 1.22-120.0), "Difficulty concentrating" (OR 3.15, 95% CI: 1.05-10.6), and "Fatigue or lack of energy" (OR 5.92, 95% CI: 1.32-34.5) increased the risk of poor athletic performance. Conclusions: This study showed that premenstrual symptoms affect not only the daily activities but also the athletic performance of collegiate athletes.	[Takeda, Takashi; Imoto, Yoko; Nagasawa, Hiroyo; Muroya, Miyuki; Shiina, Masami] Kinki Univ, Sch Med, Div Womens Hlth, Res Inst Tradit Asian Med, Sayama, Osaka 5898511, Japan; [Shiina, Masami] Kinki Univ, Sch Med, Dept Obstet & Gynecol, Sayama, Osaka 5898511, Japan	Takeda, T (reprint author), Kinki Univ, Sch Med, Div Womens Hlth, Res Inst Tradit Asian Med, 377-2 Ohno Higashi, Sayama, Osaka 5898511, Japan.	take@med.kindai.ac.jp					Takeda T, 2006, ARCH WOMEN MENT HLTH, V9, P209, DOI 10.1007/s00737-006-0137-9; Patel DR, 2010, J PEDIATR ADOL GYNEC, V23, P325, DOI 10.1016/j.jpag.2010.04.004; Dimmock PW, 2000, LANCET, V356, P1131, DOI 10.1016/S0140-6736(00)02754-9; Javed A, 2013, MAYO CLIN PROC, V88, P996, DOI 10.1016/j.mayocp.2013.07.001; Yonkers KA, 2008, LANCET, V371, P1200, DOI 10.1016/S0140-6736(08)60527-9; Sadler C, 2010, J WOMENS HEALTH, V19, P391, DOI 10.1089/jwh.2008.1210; [Anonymous], 1994, DIAGN STAT MAN MENT, V4th, P771; Kitamura M, 2012, ARCH WOMEN MENT HLTH, V15, P131, DOI 10.1007/s00737-012-0266-2; Angst J, 2001, ACTA PSYCHIAT SCAND, V104, P110, DOI 10.1034/j.1600-0447.2001.00412.x; Heim C, 2000, JAMA-J AM MED ASSOC, V284, P592, DOI 10.1001/jama.284.5.592; Daley A, 2009, J WOMENS HEALTH, V18, P895, DOI 10.1089/jwh.2008.1098; Grady-Weliky TA, 2003, NEW ENGL J MED, V348, P433, DOI 10.1056/NEJMcp012067; Constantini Naama W, 2005, Clin Sports Med, V24, pe51, DOI 10.1016/j.csm.2005.01.003; ESTON RG, 1984, SPORTS MED, V1, P431, DOI 10.2165/00007256-198401060-00003; Glick ID, 2005, CLIN SPORT MED, V24, P771, DOI 10.1016/j.csm.2005.03.007; Kishali NF, 2006, INT J NEUROSCI, V116, P1549, DOI 10.1080/00207450600675217; Nattiv Aurelia, 2007, Med Sci Sports Exerc, V39, P1867; Otis CL, 1997, MED SCI SPORT EXER, V29, pR1, DOI 10.1097/00005768-199705000-00037; Reardon CL, 2010, SPORTS MED, V40, P961, DOI 10.2165/11536580-000000000-00000; Segebladh B, 2009, AM J OBSTET GYNECOL, V201, p139e1; Steiner M, 2003, Arch Womens Ment Health, V6, P203, DOI 10.1007/s00737-003-0018-4; Takeda T, 2010, ARCH WOMEN MENT HLTH, V13, P535, DOI 10.1007/s00737-010-0181-3; Vishnupriya R, 2011, J Obstet Gynaecol India, V61, P675, DOI 10.1007/s13224-011-0117-5	23	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1083-3188	1873-4332		J PEDIATR ADOL GYNEC	J. Pediatr Adolesc. Gynecol.	AUG	2015	28	4					215	218		10.1016/j.jpag.2014.07.006		4	Obstetrics & Gynecology; Pediatrics	Obstetrics & Gynecology; Pediatrics	CM5VB	WOS:000357756000003		
J	Matsuda, S; Fujita, T; Kajiya, M; Kashiwai, K; Takeda, K; Shiba, H; Kurihara, H				Matsuda, S.; Fujita, T.; Kajiya, M.; Kashiwai, K.; Takeda, K.; Shiba, H.; Kurihara, H.			Brain-derived neurotrophic factor prevents the endothelial barrier dysfunction induced by interleukin-1 beta and tumor necrosis factor-alpha	JOURNAL OF PERIODONTAL RESEARCH			English	Article						brain-derived neurotrophic factor; endothelial cell permeability; inflammatory cytokine; periodontal tissue regeneration	NERVE GROWTH-FACTOR; PERIODONTAL TISSUE REGENERATION; VE-CADHERIN; CELL PERMEABILITY; FACTOR RECEPTOR; MONOLAYER PERMEABILITY; GENE-TRANSFER; IN-VITRO; KAPPA-B; EXPRESSION	Background and ObjectiveBrain-derived neurotrophic factor (BDNF) promotes the regeneration of periodontal tissue. Although a local inflammatory step is required to initiate the subsequent process of tissue regeneration, excessive inflammation may inhibit or delay tissue regeneration. Therefore, the regulation of inflammation is essential for periodontal tissue regeneration. In the present study, we examined the influence of BDNF on the human microvascular endothelial cell (HMVEC) barrier dysfunction induced by interleukin (IL)-1 or tumor necrosis factor (TNF)- to determine the effects of BDNF on the regulation of local inflammation in periodontal tissue regeneration. Material and MethodsEndothelial permeability was analyzed using a Dextran transport assay with transwell plates. The expression of vascular endothelial (VE)-cadherin was assessed by immunoblotting and immunofluorescence microscopy. ResultsBDNF (25ng/mL) inhibited increase induced in endothelial permeability by IL-1 and TNF-. IL-1 and TNF- decreased VE-cadherin protein levels, while BDNF recovered the reduction in HMVECs. BDNF protected the increase induced in endothelial permeability by IL-1 and TNF- through TrkB. The single addition of BDNF into the culture increased the expression of VE-cadherin in HMVECs. ConclusionBDNF played an important role in inhibiting endothelial barrier dysfunction, which suggests that it may assist in enhancing periodontal tissue regeneration.	[Matsuda, S.; Fujita, T.; Kajiya, M.; Kashiwai, K.; Takeda, K.; Shiba, H.; Kurihara, H.] Hiroshima Univ, Inst Biomed & Hlth Sci, Div Appl Life Sci, Dept Periodontal Med, Hiroshima 7348553, Japan	Matsuda, S (reprint author), Hiroshima Univ, Inst Biomed & Hlth Sci, Div Appl Life Sci, Dept Periodontal Med,Minami Ku, 1-2-3 Kasumi, Hiroshima 7348553, Japan.	matsudas@hiroshima-u.ac.jp			Japan Society for the Promotion of Science, Japan [2139055700, 247923300A]	This study was supported in part by a Grant-in-Aid for Scientific Research (B) (2139055700) and a Grant-in-Aid for Encouragement of Young Scientists (B) (247923300A) from the Japan Society for the Promotion of Science, Japan.	Aveleira CA, 2010, DIABETES, V59, P2872, DOI 10.2337/db09-1606; Friedl J, 2002, BLOOD, V100, P1334; LAMPUGNANI MG, 1992, J CELL BIOL, V118, P1511, DOI 10.1083/jcb.118.6.1511; Takeda K, 2005, TISSUE ENG, V11, P1618, DOI 10.1089/ten.2005.11.1618; Yan XZ, 2010, J PERIODONTOL, V81, P1289, DOI 10.1902/jop.2010.090655; Puhlmann M, 2005, J TRANSL MED, V3, DOI 10.1186/1479-5876-3-37; Ma TY, 2004, AM J PHYSIOL-GASTR L, V286, pG367, DOI 10.1152/ajpgi.00173.2003; Goertz O, 2011, BURNS, V37, P656, DOI 10.1016/j.burns.2011.01.004; Kerschensteiner M, 1999, J EXP MED, V189, P865, DOI 10.1084/jem.189.5.865; Zhang GX, 2005, APPL ENVIRON MICROB, V71, P3213, DOI 10.1128/AEM.71.6.3213-3227.2005; Bibel M, 2000, GENE DEV, V14, P2919, DOI 10.1101/gad.841400; FURUKAWA Y, 1984, J BIOL CHEM, V259, P1259; Petrache I, 2003, AM J RESP CELL MOL, V28, P574, DOI 10.1165/rcmb.2002-0075OC; JOHNSON JE, 1986, J NEUROSCI, V6, P3031; Lacey DC, 2009, OSTEOARTHR CARTILAGE, V17, P735, DOI 10.1016/j.joca.2008.11.011; Lee K, 2011, J R SOC INTERFACE, V8, P153, DOI 10.1098/rsif.2010.0223; Hempstead BL, 2002, CURR OPIN NEUROBIOL, V12, P260, DOI 10.1016/S0959-4388(02)00321-5; Ratanavaraporn J, 2012, BIOMATERIALS, V33, P304, DOI 10.1016/j.biomaterials.2011.09.050; Asaumi K, 2000, BONE, V26, P625, DOI 10.1016/S8756-3282(00)00281-7; Kajiya M, 2009, J CELL PHYSIOL, V221, P696, DOI 10.1002/jcp.21909; MACGROGAN D, 1992, J NEUROCHEM, V59, P1381, DOI 10.1111/j.1471-4159.1992.tb08451.x; MEMBERG SP, 1995, MOL CELL NEUROSCI, V6, P323, DOI 10.1006/mcne.1995.1025; OTTEN U, 1989, P NATL ACAD SCI USA, V86, P10059, DOI 10.1073/pnas.86.24.10059; Niessen CM, 2007, J INVEST DERMATOL, V127, P2525, DOI 10.1038/sj.jid.5700865; Patapoutian A, 2001, CURR OPIN NEUROBIOL, V11, P272, DOI 10.1016/S0959-4388(00)00208-7; Cooper PR, 2010, J DENT, V38, P687, DOI 10.1016/j.jdent.2010.05.016; Bitto A, 2008, CLIN SCI, V114, P707, DOI 10.1042/CS20070250; Fainaru O, 2008, FASEB J, V22, P3728, DOI 10.1096/fj.08-110494; Nakahashi T, 2000, FEBS LETT, V470, P113, DOI 10.1016/S0014-5793(00)01302-8; RADEKE MJ, 1987, NATURE, V325, P593, DOI 10.1038/325593a0; Yamashiro T, 2001, BONE, V28, P404, DOI 10.1016/S8756-3282(01)00405-7; Carmeliet P, 1999, CELL, V98, P147, DOI 10.1016/S0092-8674(00)81010-7; Kermani P, 2007, TRENDS CARDIOVAS MED, V17, P140, DOI 10.1016/j.tcm.2007.03.002; Donovan MJ, 2000, DEVELOPMENT, V127, P4531; Nosrat CA, 1997, CELL TISSUE RES, V290, P569, DOI 10.1007/s004410050962; BARBACID M, 1994, J NEUROBIOL, V25, P1386, DOI 10.1002/neu.480251107; Feng D, 2000, MICROVASC RES, V59, P24, DOI 10.1006/mvre.1999.2207; Gavard J, 2006, NAT CELL BIOL, V8, P1223, DOI 10.1038/ncb1486; Argaw AT, 2006, J IMMUNOL, V177, P5574; Wu G, 2010, BIOMATERIALS, V31, P7485, DOI 10.1016/j.biomaterials.2010.06.037; Yuan XC, 2011, J PINEAL RES, V51, P220, DOI 10.1111/j.1600-079X.2011.00882.x; BARKER PA, 1992, MOL CELL BIOCHEM, V110, P1, DOI 10.1007/BF02385000; EBENDAL T, 1992, J NEUROSCI RES, V32, P461, DOI 10.1002/jnr.490320402; Friedl J, 2003, INT J ONCOL, V23, P611; Fujita T, 2012, J PERIODONTAL RES, V47, P55, DOI 10.1111/j.1600-0765.2011.01404.x; Kajiya M, 2014, INT IMMUNOPHARMACOL, V19, P245, DOI 10.1016/j.intimp.2014.01.028; Kajiya M, 2008, J BIOL CHEM, V283, P16259, DOI 10.1074/jbc.M800668200; Kato M, 1997, J CLIN ANESTH, V9, P293, DOI 10.1016/S0952-8180(97)00006-8; Kolluru G. K., 2012, INT J VASC MED, V2012, DOI DOI 10.1155/2012/918267; Kurihara H, 2003, J PERIODONTOL, V74, P76, DOI 10.1902/jop.2003.74.1.76; Li YZ, 2010, ACTA PHARMACOL SIN, V31, P1389, DOI 10.1038/aps.2010.165; Matsuda S, 2012, J CELL PHYSIOL, V227, P2123, DOI 10.1002/jcp.22942; Mizuno N, 2008, J PERIODONTOL, V79, P2182, DOI 10.1902/jop.2008.070402 ; MORRIS RE, 1993, ANN NY ACAD SCI, V685, P68, DOI 10.1111/j.1749-6632.1993.tb35853.x; MORRIS RE, 1992, SEMIN NEPHROL, V12, P304; NAKANISHI T, 1994, BIOCHEM BIOPH RES CO, V198, P891, DOI 10.1006/bbrc.1994.1127; Norman MU, 2005, BRIT J PHARMACOL, V144, P265, DOI 10.1038/sj.bjp.0706081; Nwariaku FE, 2004, BLOOD, V104, P3214, DOI 10.1182/blood-2004-05-1868; Shivanna M, 2010, MOL VIS, V16, P1781; Takahashi J, 2002, J SPINAL DISORD TECH, V15, P294, DOI 10.1097/01.BSD.0000027740.19919.66; Takeda K, 2011, TISSUE ENG PT A, V17, P955, DOI [10.1089/ten.TEA.2010.0070, 10.1089/ten.tea.2010.0070]; Vestweber D, 2010, CURR OPIN HEMATOL, V17, P230, DOI 10.1097/MOH.0b013e328338664b	62	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3484	1600-0765		J PERIODONTAL RES	J. Periodont. Res.	AUG	2015	50	4					444	451		10.1111/jre.12226		8	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CM4ZY	WOS:000357696900003		
J	Murata, H; Hattori, T; Maeda, H; Takashiba, S; Takigawa, M; Kido, J; Nagata, T				Murata, H.; Hattori, T.; Maeda, H.; Takashiba, S.; Takigawa, M.; Kido, J.; Nagata, T.			Identification of transactivation-responsive DNA-binding protein 43 (TARDBP43; TDP-43) as a novel factor for TNF-alpha expression upon lipopolysaccharide stimulation in human monocytes	JOURNAL OF PERIODONTAL RESEARCH			English	Article						lipopolysaccharide; monocyte; TDP-43; tumor necrosis factor alpha	TUMOR-NECROSIS-FACTOR; AMYOTROPHIC-LATERAL-SCLEROSIS; FACTOR-KAPPA-B; FRONTOTEMPORAL LOBAR DEGENERATION; PARKINSONISM-DEMENTIA COMPLEX; GENE-EXPRESSION; 3'-UNTRANSLATED REGION; PERIODONTAL-DISEASE; TISSUE DESTRUCTION; TRANSCRIPTION	Background and ObjectiveTumor necrosis factor alpha (TNF-) is a major cytokine implicated in various inflammatory diseases. The nature of the nuclear factors associated with human TNF- gene regulation is not well elucidated. We previously identified a novel region located from -550 to -487 in human TNF- promoter that did not contain the reported binding sites for nuclear factor kappa B (NF-B) but showed lipopolysaccharide (LPS)-induced transcriptional activity. The purpose of this study is to identify novel factors that bind to the promoter region and regulate TNF- expression. Material and MethodsTo identify DNA-binding proteins that bound to the target region of TNF- promoter, a cDNA library from LPS-stimulated human monocytic cell line THP-1 was screened using a yeast one-hybrid system. Cellular localizations of the DNA-binding protein in the cells were examined by subcellular immunocytochemistry. Nuclear amounts of the protein in LPS-stimulated THP-1 cells were identified by western blot analysis. Expression of mRNA of the protein in the cells was quantified by real-time polymerase chain reaction. Electrophoretic mobility shift assays were performed to confirm the DNA-binding profile. Overexpression of the protein and knockdown of the gene were also performed to investigate the role for TNF- expression. ResultsSeveral candidates were identified from the cDNA library and transactivation-responsive DNA-binding protein 43 (TARDBP43; TDP-43) was focused on. Western blot analysis revealed that nuclear TDP-43 protein was increased in the LPS-stimulated THP-1 cells. Expression of TDP-43 mRNA was already enhanced before TNF- induction by LPS. Electrophoretic mobility shift assay analysis showed that nuclear extracts obtained by overexpressing FLAG-tagged TDP-43 bound to the -550 to -487 TNF- promoter fragments. Overexpression of TDP-43 in THP-1 cells resulted in an increase of TNF- expression. Knockdown of TDP-43 in THP-1 cells downregulated TNF- expression. ConclusionWe identified TDP-43 as one of the novel TNF- factors and found that it bound to the LPS-responsive element in the TNF- promoter to increase TNF- expression.	[Murata, H.; Kido, J.; Nagata, T.] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Periodontol & Endodontol, Tokushima 7708504, Japan; [Hattori, T.; Takigawa, M.] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Biochem & Mol Dent, Okayama, Japan; [Maeda, H.; Takashiba, S.] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Pathophysiol Periodontal Sci, Okayama, Japan	Nagata, T (reprint author), Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Periodontol & Endodontol, 3-18-15 Kuramoto, Tokushima 7708504, Japan.	nagata@dent.tokushima-u.ac.jp			Japan Society for the Promotion of Science [12470471, 14571982, 17791555, 24792332]	This study was supported by Grants-in-Aid (12470471, 14571982, 17791555, 24792332) for Scientific Research from the Japan Society for the Promotion of Science. The authors report no conflicts of interest in this study.	Liu HT, 2000, J IMMUNOL, V164, P4277; Hashimoto S, 2000, BLOOD, V96, P2206; Uranishi H, 2001, J BIOL CHEM, V276, P13395, DOI 10.1074/jbc.M011176200; Ling SC, 2010, P NATL ACAD SCI USA, V107, P13318, DOI 10.1073/pnas.1008227107; Geser F, 2008, ACTA NEUROPATHOL, V115, P133, DOI 10.1007/s00401-007-0257-y; LEITMAN DC, 1991, J BIOL CHEM, V266, P9343; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Lee JY, 2001, INFECT IMMUN, V69, P2847, DOI 10.1128/IAI.69.5.2847-2852.2001; Hasegawa M, 2007, BRAIN, V130, P1386, DOI 10.1093/brain/awm065; Zughaier SM, 2005, INFECT IMMUN, V73, P2940, DOI 10.1128/IAI.73.5.2940-2950.2005; MULLER JM, 1993, IMMUNOBIOLOGY, V187, P233; Kwong LK, 2007, ACTA NEUROPATHOL, V114, P63, DOI 10.1007/s00401-007-0226-5; Ozenci V, 2000, CLIN EXP IMMUNOL, V120, P147, DOI 10.1046/j.1365-2249.2000.01175.x; Targan SR, 1997, NEW ENGL J MED, V337, P1029, DOI 10.1056/NEJM199710093371502; Frodge BD, 2008, J PERIODONTOL, V79, P1913, DOI 10.1902/jop.2008.080070 ; Amador-Ortiz C, 2007, ANN NEUROL, V61, P435, DOI 10.1002/ana.21154; Ayala YM, 2008, J CELL SCI, V121, P3778, DOI 10.1242/jcs.038950; Wang IF, 2008, J NEUROCHEM, V105, P797, DOI 10.1111/j.1471-4159.2007.05190.x; Borst SE, 2004, ENDOCRINE, V23, P177, DOI 10.1385/ENDO:23:2-3:177; Swarup V, 2011, J EXP MED, V208, P2429, DOI 10.1084/jem.20111313; BRENNAN FM, 1992, BRIT J RHEUMATOL, V31, P293; Hattori T, 2006, J BIOL CHEM, V281, P14417, DOI 10.1074/jbc.M511330200; Myokai F, 1999, P NATL ACAD SCI USA, V96, P4518, DOI 10.1073/pnas.96.8.4518; Garlet GP, 2010, J DENT RES, V89, P1349, DOI 10.1177/0022034510376402; Cekici A, 2014, PERIODONTOL 2000, V64, P57, DOI 10.1111/prd.12002; Takashiba S, 1999, INFECT IMMUN, V67, P5573; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Ince PG, 2011, ACTA NEUROPATHOL, V122, P657, DOI 10.1007/s00401-011-0913-0; Reynolds JJ, 1997, PERIODONTOL 2000, V14, P144, DOI 10.1111/j.1600-0757.1997.tb00195.x; Buratti E, 2010, RNA BIOL, V7, P420; Kadokura A, 2009, NEUROPATHOLOGY, V29, P566, DOI 10.1111/j.1440-1789.2009.01017.x; Dumitru CD, 2000, CELL, V103, P1071, DOI 10.1016/S0092-8674(00)00210-5; Nakajima T, 2010, J PERIODONTAL RES, V45, P116, DOI 10.1111/j.1600-0765.2009.01209.x; Arsene M, 2011, EUR CYTOKINE NETW, V22, P88; Bretz WA, 2005, J AM GERIATR SOC, V53, P1532, DOI 10.1111/j.1532-5415.2005.53468.x; GALLAY P, 1993, J IMMUNOL, V150, P5086; Garlet GP, 2007, CLIN EXP IMMUNOL, V147, P128, DOI 10.1111/j.1365-2249.2006.03260.x; Guanglin C, 2012, J NEUROINFLAMM, V9, P235; Lalmansingh AS, 2011, J BIOL CHEM, V286, P10970, DOI 10.1074/jbc.M110.166587; Melissa KM, 2008, J NEUROINFLAMM, V5, P45; Murayama H, 2010, NATURE, V465, P223; NEDOSPASOV SA, 1986, COLD SPRING HARB SYM, V51, P611; NEDWIN GE, 1985, NUCLEIC ACIDS RES, V13, P6361, DOI 10.1093/nar/13.17.6361; Osman F, 1999, GENE DEV, V13, P3280, DOI 10.1101/gad.13.24.3280; Ou S.-H. Ignatius, 1995, Journal of Virology, V69, P3584; Paludan SR, 2001, J IMMUNOL, V167, P2202; Posch PE, 2003, GENES IMMUN, V4, P547, DOI 10.1038/sj.gene.6364023; Shi L, 2002, AM J PHYSIOL-CELL PH, V282, P1205; Suzuki T, 2000, BLOOD, V96, P2584; TAKASHIBA S, 1993, GENE, V131, P307, DOI 10.1016/0378-1119(93)90314-S; TAKASHIBA S, 1995, INFECT IMMUN, V63, P1529; Wedel A, 1996, CYTOKINE, V8, P335, DOI 10.1006/cyto.1996.0046	52	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3484	1600-0765		J PERIODONTAL RES	J. Periodont. Res.	AUG	2015	50	4					452	460		10.1111/jre.12227		9	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CM4ZY	WOS:000357696900004		
J	Ichikawa, Y; Watahiki, J; Nampo, T; Nose, K; Yamamoto, G; Irie, T; Mishima, K; Maki, K				Ichikawa, Y.; Watahiki, J.; Nampo, T.; Nose, K.; Yamamoto, G.; Irie, T.; Mishima, K.; Maki, K.			Differences in the developmental origins of the periosteum may influence bone healing	JOURNAL OF PERIODONTAL RESEARCH			English	Article						animal model; periodontal ligament; periodontal healing; regeneration; stem cells	MARROW STROMAL CELLS; CREST STEM-CELLS; NEURAL CREST; SKELETAL DEVELOPMENT; LAMINA PROPRIA; SELF-RENEWAL; GROWTH; IDENTIFICATION; MULTIPOTENCY; REGENERATION	Background and ObjectiveThe jaw bone, unlike most other bones, is derived from neural crest stem cells, so we hypothesized that it may have different characteristics to bones from other parts of the body, especially in the nature of its periosteum. The periosteum exhibits osteogenic potential and has received considerable attention as a grafting material for the repair of bone and joint defects. Material and MethodsGene expression profiles of jaw bone and periosteum were evaluated by DNA microarray and real-time polymerase chain reaction. Furthermore, we perforated an area 2mm in diameter on mouse frontal and parietal bones. Bone regeneration of these calvarial defects was evaluated using microcomputed tomography and histological analysis. ResultsThe DNA microarray data revealed close homology between the gene expression profiles within the ilium and femur. The gene expression of Wnt-1, SOX10, nestin, and musashi-1 were significantly higher in the jaw bone than in other locations. Microcomputed tomography and histological analysis revealed that the jaw bone had superior bone regenerative abilities than other bones. ConclusionJaw bone periosteum exhibits a unique gene expression profile that is associated with neural crest cells and has a positive influence on bone regeneration when used as a graft material to repair bone defects. A full investigation of the biological and mechanical properties of jaw bone as an alternative graft material for jaw reconstructive surgery is recommended.	[Ichikawa, Y.; Watahiki, J.; Nampo, T.; Nose, K.; Maki, K.] Showa Univ, Sch Dent, Dept Orthodont, Ohta Ku, Tokyo 1458515, Japan; [Yamamoto, G.; Irie, T.; Mishima, K.] Showa Univ, Sch Dent, Dept Oral Pathol & Diag, Shinagawa Ku, Tokyo 1458515, Japan	Watahiki, J (reprint author), Showa Univ, Sch Dent, Dept Orthodont, Ohta Ku, 2-1-1 Kitasenzoku, Tokyo 1458515, Japan.	junwata2000@ybb.ne.jp			High-Tech Research Center Project for Private Universities; Special Subsidies in Subsidies for Ordinary Expenses of Private Schools from the Promotion and Mutual Aid Corporation for Private Schools of Japan	This study was supported by the High-Tech Research Center Project for Private Universities and in part by the Special Subsidies in Subsidies for Ordinary Expenses of Private Schools from the Promotion and Mutual Aid Corporation for Private Schools of Japan. Equipment was provided by the Animal Research Committee of Showa University. The authors report no conflicts of interest related to this study.	Aghaloo TL, 2010, J DENT RES, V89, P1293, DOI 10.1177/0022034510378427; Marynka-Kalmani K, 2010, STEM CELLS, V28, P984, DOI 10.1002/stem.425; Toma JG, 2001, NAT CELL BIOL, V3, P778, DOI 10.1038/ncb0901-778; Akintoye SO, 2006, BONE, V38, P758, DOI 10.1016/j.bone.2005.10.027; Kjaer I, 1998, CRIT REV ORAL BIOL M, V9, P224; Valentini P, 2000, INT J PERIODONT REST, V20, P245; Orwoll ES, 2003, J BONE MINER RES, V18, P949, DOI 10.1359/jbmr.2003.18.6.949; Abzhanov A, 2007, DEVELOPMENT, V134, P3133, DOI 10.1242/dev.002709; Wong CE, 2006, J CELL BIOL, V175, P1005, DOI 10.1083/jcb.200606062; Liu JAJ, 2013, P NATL ACAD SCI USA, V110, P2882, DOI 10.1073/pnas.1211747110; ERLEBACHER A, 1995, CELL, V80, P371, DOI 10.1016/0092-8674(95)90487-5; Davies LC, 2010, STEM CELLS DEV, V19, P819, DOI 10.1089/scd.2009.0089; Karsenty G, 2002, DEV CELL, V2, P389, DOI 10.1016/S1534-5807(02)00157-0; Nagoshi N, 2008, CELL STEM CELL, V2, P392, DOI 10.1016/j.stem.2008.03.005; Chung IH, 2009, STEM CELLS, V27, P866, DOI 10.1002/stem.2; Colnot C, 2009, J BONE MINER RES, V24, P274, DOI [10.1359/jbmr.081003, 10.1359/JBMR.081003]; Sakata Y, 2006, J CRANIO MAXILL SURG, V34, P461, DOI 10.1016/j.jcms.2006.07.861; Horiuchi K, 1999, J BONE MINER RES, V14, P1239, DOI 10.1359/jbmr.1999.14.7.1239; Morrison SJ, 1999, CELL, V96, P737, DOI 10.1016/S0092-8674(00)80583-8; OSUMIYAMASHITA N, 1994, DEV BIOL, V164, P409, DOI 10.1006/dbio.1994.1211; Kawaguchi A, 2001, MOL CELL NEUROSCI, V17, P259, DOI 10.1006/mcne.2000.0925; De Bari C, 2006, ARTHRITIS RHEUM, V54, P1209, DOI 10.1002/art.21753; Yoshida T, 2008, MECH DEVELOP, V125, P797, DOI 10.1016/j.mod.2008.06.007; Kelsh RN, 2006, BIOESSAYS, V28, P788, DOI 10.1002/bies.20445; Duverger O, 2013, J CELL PHYSIOL, V228, P654, DOI 10.1002/jcp.24175; Widera D, 2009, STEM CELLS, V27, P1899, DOI 10.1002/stem.104; Sakakibara S, 1996, DEV BIOL, V176, P230, DOI 10.1006/dbio.1996.0130; KUSIAK JF, 1985, PLAST RECONSTR SURG, V76, P510, DOI 10.1097/00006534-198510000-00003; Artzi Z, 2005, J CLIN PERIODONTOL, V32, P193, DOI 10.1111/j.1600-051X.2005.00656.x; BHASKAR SN, 1971, ORAL SURG ORAL MED O, V31, P282, DOI 10.1016/0030-4220(71)90086-7; Brian AP, 1993, DEVELOPMENT, V119, P247; Chan AA, 2013, PLOS ONE, V8, P1; Donos N, 2005, CLIN ORAL IMPLAN RES, V16, P133, DOI 10.1111/j.1600-0501.2004.01104.x; Emily JA, 2009, TISSUE ENG, V15, P2637; Evans AL, 2005, HUM MOL GENET, V14, P3347, DOI 10.1093/hmg/ddi365; Fan W, 2008, BONE, V42, P81, DOI 10.1016/j.bone.2007.08.048; Igarashi A, 2007, TISSUE ENG, V13, P2405, DOI 10.1089/ten.2006.0340; Kikuchi M, 2011, GENES CELLS, V16, P273, DOI 10.1111/j.1365-2443.2011.01485.x; Matthew R, 2004, BONE, V35, P1003; Mizuno H, 2006, TISSUE ENG, V12, P1227, DOI 10.1089/ten.2006.12.1227; Nampo T, 2010, J PERIODONTOL, V81, P1264, DOI 10.1902/jop.2010.100016; Neirinckx V, 2014, STEM CELLS, V32, P829, DOI 10.1002/stem.1579; Ozaki A, 2000, J Orthop Sci, V5, P64, DOI 10.1007/s007760050010; Quarto N, 2009, J BONE MINER RES, V25, P1680; Takehiro M, 2005, J BONE MINER RES, V20, P399; THILANDER B, 1995, ACTA ODONTOL SCAND, V53, P144, DOI 10.3109/00016359509005964; TOPAZIAN RG, 1971, J ORAL SURG, V29, P792; Ueno T, 2003, ACTA HISTOCHEM CYTOC, V36, P61; Utvag SE, 1996, J ORTHOP TRAUMA, V10, P279, DOI 10.1097/00005131-199605000-00009; Watahiki J, 2008, BONE, V42, P1053, DOI 10.1016/j.bone.2007.09.048	50	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3484	1600-0765		J PERIODONTAL RES	J. Periodont. Res.	AUG	2015	50	4					468	478		10.1111/jre.12229		11	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CM4ZY	WOS:000357696900006		
J	Fujita, T; Yoshimoto, T; Matsuda, S; Kajiya, M; Kittaka, M; Imai, H; Iwata, T; Uchida, Y; Shiba, H; Kurihara, H				Fujita, T.; Yoshimoto, T.; Matsuda, S.; Kajiya, M.; Kittaka, M.; Imai, H.; Iwata, T.; Uchida, Y.; Shiba, H.; Kurihara, H.			Interleukin-8 induces DNA synthesis, migration and down-regulation of cleaved caspase-3 in cultured human gingival epithelial cells	JOURNAL OF PERIODONTAL RESEARCH			English	Article						caspase-3; DNA synthesis; gingival epithelial cells; interleukin-8; migration	REGENERATING JUNCTIONAL EPITHELIUM; ACTINOBACILLUS-ACTINOMYCETEMCOMITANS; ADULT PERIODONTITIS; IRSOGLADINE MALEATE; INDUCED APOPTOSIS; CXC-CHEMOKINES; EXPRESSION; RECEPTOR; IL-8; CHEMOTAXIS	Background and ObjectiveMigration of the junctional epithelium occurs in association with the formation of a periodontal pocket. Although the migration of junctional epithelium is known to be related to the proliferation and migration of gingival junctional epithelial cells, the mechanism has not been clarified. In patients with periodontitis, the levels of interleukin-8 (IL-8) in both gingival tissue and gingival crevicular fluid are dramatically increased. IL-8 has broad bioactive functions. In this study, we examined the role of IL-8 in DNA synthesis, migration and protection against apoptosis in cultured human gingival epithelial cells (HGEC). Material and MethodsDNA synthesis was estimated by measuring the incorporation of bromodeoxyuridine. The migration of gingival epithelial cells was assessed in a wound-healing assay. The expression of integrin beta-1 was analyzed using immunofluorescence confocal microscopy and western blotting. Cleaved caspase-3 was detected using western blotting and a Caspase-Glo assay kit. ResultsIL-8 increased the synthesis of DNA in HGEC, and the maximal effect was seen at 25 or 50ng/mL of IL-8. In addition, 50ng/mL of IL-8 induced cell migration, and a neutralizing antibody of integrin beta-1 inhibited the migration. IL-8 also activated expression of integrin beta-1. Furthermore, IL-8 reduced the Aggregatibacter actinomycetemcomitans-induced increase in caspase-3 expression in HGEC. ConclusionIL-8 may facilitate the migration of gingival junctional epithelium by enhancing DNA synthesis, migration and preventing apoptosis of gingival epithelial cells.	[Fujita, T.; Yoshimoto, T.; Matsuda, S.; Kajiya, M.; Kittaka, M.; Imai, H.; Iwata, T.; Uchida, Y.; Shiba, H.; Kurihara, H.] Hiroshima Univ, Inst Biomed & Hlth Sci, Div Appl Life Sci, Dept Periodontal Med, Hiroshima 7348553, Japan	Fujita, T (reprint author), Hiroshima Univ, Inst Biomed & Hlth Sci, Div Appl Life Sci, Dept Periodontal Med,Minami Ku, 1-2-3 Kasumi, Hiroshima 7348553, Japan.	tfuji@hiroshima-u.ac.jp			Japan Society for the Promotion of Science, Japan [24593123]	This study was supported in part by a grant-in-aid for scientific research (C) (No.24593123) from the Japan Society for the Promotion of Science, Japan. There is no conflict of interest in the present study for any of the authors.	Abdollahi T, 2003, CANCER RES, V63, P4521; Abdollahi T, 2005, APOPTOSIS, V10, P1383, DOI 10.1007/s10495-005-2139-x; Sturm A, 2005, CYTOKINE, V29, P42, DOI 10.1016/j.cyto.2004.09.007; Lee CY, 2011, J CELL BIOCHEM, V112, P2549, DOI 10.1002/jcb.23179; WANG JM, 1990, BIOCHEM BIOPH RES CO, V169, P165, DOI 10.1016/0006-291X(90)91449-3; Bosshardt DD, 2005, J DENT RES, V84, P9; Youngs SJ, 1997, INT J CANCER, V71, P257, DOI 10.1002/(SICI)1097-0215(19970410)71:2<257::AID-IJC22>3.0.CO;2-D; Romagnani P, 2004, TRENDS IMMUNOL, V25, P201, DOI 10.1016/j.it.2004.02.006; Silva TA, 2007, J DENT RES, V86, P306; Berezow AB, 2011, PERIODONTOL 2000, V55, P36, DOI 10.1111/j.1600-0757.2010.00350.x; Rennekampff HO, 2000, J SURG RES, V93, P41, DOI 10.1006/jsre.2000.5892; Gillitzer R, 2001, J LEUKOCYTE BIOL, V69, P513; Ekuni D, 2005, J PERIODONTOL, V76, P43, DOI 10.1902/jop.2005.76.1.43; Gamonal J, 2001, J PERIODONTAL RES, V36, P194, DOI 10.1034/j.1600-0765.2001.360309.x; Kinumatsu T, 2009, J PERIODONTAL RES, V44, P13, DOI 10.1111/j.1600-0765.2007.01036.x; Xie KP, 2001, CYTOKINE GROWTH F R, V12, P375, DOI 10.1016/S1359-6101(01)00016-8; TSAI CC, 1995, J PERIODONTOL, V66, P852; Larjava H, 2011, J DENT RES, V90, P1367, DOI 10.1177/0022034511402207; Aumailley M, 2003, MATRIX BIOL, V22, P49, DOI 10.1016/S0945-053X(03)00013-1; Dickinson BC, 2011, MOL ORAL MICROBIOL, V26, P210, DOI 10.1111/j.2041-1014.2011.00609.x; Darveau RP, 2010, NAT REV MICROBIOL, V8, P481, DOI 10.1038/nrmicro2337; Reiland J, 1999, PROSTATE, V41, P78; Garlet GP, 2003, J PERIODONTAL RES, V38, P210, DOI 10.1034/j.1600-0765.2003.02012.x; Sfakianakis A, 2002, J PERIODONTAL RES, V37, P154, DOI 10.1034/j.1600-0765.2002.00024.x; BRAGA AM, 1980, J PERIODONTOL, V51, P386; Ekuni D, 2006, J PERIODONTAL RES, V41, P340, DOI 10.1111/j.1600-0765.2006.00881.x; FRANK R, 1972, J PERIODONTOL, V43, P597; Fujita T, 2010, BIOCHEM PHARMACOL, V79, P1496, DOI 10.1016/j.bcp.2010.01.017; Fujita T, 2006, CYTOKINE, V34, P271, DOI 10.1016/j.cyto.2006.06.002; Fujita T, 2012, J PERIODONTAL RES, V47, P55, DOI 10.1111/j.1600-0765.2011.01404.x; GYULAI R, 1994, CLIN EXP DERMATOL, V19, P309, DOI 10.1111/j.1365-2230.1994.tb01201.x; Hillmann G, 1990, Dtsch Zahnarztl Z, V45, P264; INNES P B, 1970, Journal of Periodontal Research, V5, P196, DOI 10.1111/j.1600-0765.1970.tb00717.x; Ishikawa H, 2005, J PERIODONTAL RES, V40, P354, DOI 10.1111/j.1600-0765.2005.00815.x; Kang J, 2012, INFECT IMMUN, V80, P2247, DOI 10.1128/IAI.06371-11; LISTGARTEN MAX A., 1967, J PERIODONTAL RES, V2, P46; LISTGART.MA, 1973, J PERIODONTAL RES, V8, P143, DOI 10.1111/j.1600-0765.1973.tb01752.x; Marsh P.D., 2006, INT J DENT HYG S1, V4, P50; Marsh P D, 2006, Int J Dent Hyg, V4 Suppl 1, P3, DOI 10.1111/j.1601-5037.2006.00195.x; Masaoka T, 2009, J PERIODONTAL RES, V44, P489, DOI 10.1111/j.1600-0765.2008.01142.x; MICHEL G, 1992, FEBS LETT, V305, P241, DOI 10.1016/0014-5793(92)80677-9; Miyauchi M, 2004, HISTOCHEM CELL BIOL, V121, P291, DOI 10.1007/s00418-004-0636-6; Schroeder HE, 1997, PERIODONTOL 2000, V13, P91, DOI 10.1111/j.1600-0757.1997.tb00097.x; Stathopoulou PG, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-107; Sugisawa M, 2010, J PERIODONTAL RES, V45, P284, DOI 10.1111/j.1600-0765.2009.01231.x; TAKATA T, 1988, J PERIODONTOL, V59, P215; TensCate AR, 1996, ORAL DIS, V2, P55; TONETTI MS, 1994, INFECT IMMUN, V62, P4005; TUSCHIL A, 1992, J INVEST DERMATOL, V99, P294, DOI 10.1111/1523-1747.ep12616634; Uchida Y, 2001, CYTOKINE, V14, P152, DOI 10.1006/cyto.2001.0863	50	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3484	1600-0765		J PERIODONTAL RES	J. Periodont. Res.	AUG	2015	50	4					479	485		10.1111/jre.12230		7	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CM4ZY	WOS:000357696900007		
J	Savitri, IJ; Ouhara, K; Fujita, T; Kajiya, M; Miyagawa, T; Kittaka, M; Yamakawa, M; Shiba, H; Kurihara, H				Savitri, I. J.; Ouhara, K.; Fujita, T.; Kajiya, M.; Miyagawa, T.; Kittaka, M.; Yamakawa, M.; Shiba, H.; Kurihara, H.			Irsogladine maleate inhibits Porphyromonas gingivalis-mediated expression of toll-like receptor 2 and interleukin-8 in human gingival epithelial cells	JOURNAL OF PERIODONTAL RESEARCH			English	Article						human gingival epithelial cell; irsogladine maleate; Porphyromonas gingivalis; toll-like receptor 2	JUNCTIONAL INTERCELLULAR COMMUNICATION; NOD-LIKE RECEPTORS; SIGNALING PATHWAYS; LIPOPOLYSACCHARIDE; FIMBRIAE; GENES; IL-8; ACTINOMYCETEMCOMITANS; STIMULATION; SUPPRESSION	Background and ObjectivePeriodontitis is an infectious disease caused by an interaction between the host and periodontopathogenic bacteria. Regulating the immune response in human gingival epithelial cells (HGEC) may contribute to the prevention of periodontitis. Irsogladine maleate (IM) has previously been shown to regulate inflammation and the cell-cell junctional barrier in HGEC. In addition to these functions, control of bacterial recognition is important for preventing inflammation in periodontal tissue. Innate immunity in gingival epithelium is the first line of defense and plays a crucial role against bacterial challenge. Therefore, the effect of IM on regulating toll-like receptor 2 (TLR2), which is part of the innate immunity, was determined in this study. Material and MethodsOBA-9, an immortalized human gingival epithelial cell line, and primary cultured HGEC were used in this study. Real-time PCR and western blotting were performed in OBA-9 or HGEC stimulated with whole cells of Porphyromonas gingivalis or with lipopolysaccharide (LPS) derived from P. gingivalis (PgLPS) in the presence or absence of IM to determine expression of TLR2 mRNA and production of TLR2 protein. Small interfering RNA (siRNA) against TLR2 was transfected into OBA-9 to clarify the association between the induction of TLR2 and interleukin-8 (IL-8) production. ResultsThe addition of IM into P. gingivalis or PgLPS-induced OBA-9 suppressed IL-8 production (p<0.01). The addition of IM also abolished the induction of TLR2 by P. gingivalis or PgLPS in OBA-9 and primary cultured HGEC (p<0.01). The suppressive effect of IM on the induction of TLR2 was also confirmed by immunohistostaining. Stimulation with peptidoglycan, a specific ligand for TLR2, suppressed the expression of toll-like receptor 4 (TLR4) mRNA in the presence of IM (p<0.01). However, LPS derived from Escherichia coli, a ligand for TLR4, did not induce the expression of TLR2 mRNA. The PgLPS-induced expression of TLR4 mRNA was abolished by IM. Knockdown of TLR2 by siRNA transfection resulted in a weaker response of induction of IL8 mRNA in P. gingivalis or PgLPS-stimulated OBA-9. ConclusionThese results suggest that IM suppresses the induction of IL-8 production by regulating increased levels of TLR2.	[Savitri, I. J.; Ouhara, K.; Fujita, T.; Kajiya, M.; Miyagawa, T.; Kittaka, M.; Yamakawa, M.; Shiba, H.; Kurihara, H.] Hiroshima Univ, Dept Periodontal Med, Inst Biomed & Hlth Sci, Div Appl Life Sci, Hiroshima, Japan	Ouhara, K (reprint author), Hiroshima Univ, Dept Periodontal Med, Inst Biomed & Hlth Sci, Div Appl Life Sci, Hiroshima, Japan.	kouhara@hiroshima-u.ac.jp			Japan Society for the Promotion of Science [22792085]	We would like to thank to Professor Shinya Murakami (Osaka University) for kindly providing OBA-9 cells. This research was supported by a Grant-in-Aid for the Encouragement of Young Scientists (B) (22792085) from the Japan Society for the Promotion of Science. We would like to thank Mr Tomoya Matsumoto (Keyence) for his helpful advice and technical support.	Abe N, 2004, BIOL CHEM, V385, P1041, DOI 10.1515/BC.2004.135; Sahingur SE, 2010, MOL ORAL MICROBIOL, V25, P123, DOI 10.1111/j.2041-1014.2009.00551.x; Meka A, 2010, MOL ORAL MICROBIOL, V25, P61, DOI 10.1111/j.2041-1014.2009.00555.x; Kanneganti TD, 2007, IMMUNITY, V27, P549, DOI 10.1016/j.immuni.2007.10.002; Kadowaki T, 2000, J BIOCHEM-TOKYO, V128, P153; Amano A, 2004, J PERIODONTAL RES, V39, P136, DOI 10.1111/j.1600-0765.2004.00719.x; Hajishengallis G, 2006, CELL MICROBIOL, V8, P1557, DOI 10.1111/j.1462-5822.2006.00730.x; Davey M, 2008, J IMMUNOL, V180, P2187; Seibert SA, 2010, IMMUNOL LETT, V127, P126, DOI 10.1016/j.imlet.2009.10.008; Wara-aswapati N, 2013, J PERIODONTOL, V84, P1010, DOI 10.1902/jop.2012.120362; Kocgozlu L, 2009, J DENT RES, V88, P741, DOI 10.1177/0022034509341166; Lu Q, 2009, INNATE IMMUN, V15, P325, DOI 10.1177/1753425909104899; Fukata M, 2009, SEMIN IMMUNOL, V21, P242, DOI 10.1016/j.smim.2009.06.005; Kusumoto Y, 2004, J PERIODONTOL, V75, P370, DOI 10.1902/jop.2004.75.3.370; Chen T, 2004, J BACTERIOL, V186, P5473, DOI 10.1128/JB.186.16.5473-5479.2004; Barksby HE, 2009, CLIN EXP IMMUNOL, V156, P479, DOI 10.1111/j.1365-2249.2009.03920.x; Ogawa T, 2007, FRONT BIOSCI, V12, P3795, DOI 10.2741/2353; Darveau RP, 2004, INFECT IMMUN, V72, P5041, DOI 10.1128/IAI.72.9.5041-5051.2004; Dasu Mohan R, 2014, World J Diabetes, V5, P219, DOI 10.4239/wjd.v5.i2.219; Ding PH, 2013, INNATE IMMUN-LONDON, V19, P66, DOI 10.1177/1753425912450348; Fujita T, 2006, CYTOKINE, V34, P271, DOI 10.1016/j.cyto.2006.06.002; Fujita T, 2008, J PERIODONTAL RES, V43, P96, DOI 10.1111/j.1600-0765.2007.01000.x; Fujita T, 2012, J PERIODONTAL RES, V47, P55, DOI 10.1111/j.1600-0765.2011.01404.x; Fujita T, 2010, J PERIODONTAL RES, V45, P579, DOI 10.1111/j.1600-0765.2009.01258.x; Herath TDK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058496; Kaufmann A, 2005, J BIOL CHEM, V280, P32459, DOI 10.1074/jbc.M505301200; Kudo C, 2012, J DENT RES, V91, P1190, DOI 10.1177/0022034512461796; Liu JR, 2014, INFLAMMATION, V37, P522, DOI 10.1007/s10753-013-9766-0; Lugade Amit A, 2011, Front Immunol, V2, P10, DOI 10.3389/fimmu.2011.00010; Marchesan JT, 2012, MOL ORAL MICROBIOL, V27, P483, DOI 10.1111/omi.12001; Miyagawa T, 2013, INT IMMUNOPHARMACOL, V15, P340, DOI 10.1016/j.intimp.2012.12.011; Puliti M, 2009, INFECT IMMUN, V77, P1524, DOI 10.1128/IAI.00965-08; Shiba H, 2009, J ENDODONT, V35, P373, DOI 10.1016/j.joen.2008.11.028; Socransky SS, 1994, COMPEND S, V685, P688; Socransky SS, 1994, COMPEND S, V685, pS714; Tietze K, 2006, J PERIODONTAL RES, V41, P447, DOI 10.1111/j.1600-0765.2006.00890.x; Uchida Y, 2005, BIOCHEM BIOPH RES CO, V333, P502, DOI 10.1016/j.bbrc.2005.05.147; Wang DQ, 2006, J CLIN PERIODONTOL, V33, P632, DOI 10.1111/j.1600-051X.2006.00963.x; Yao J, 2007, BRIT J PHARMACOL, V151, P457, DOI 10.1038/sj.bjp.0707255	39	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3484	1600-0765		J PERIODONTAL RES	J. Periodont. Res.	AUG	2015	50	4					486	493		10.1111/jre.12231		8	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CM4ZY	WOS:000357696900008		
J	Mizutani, S; Ekuni, D; Tomofuji, T; Yamane, M; Azuma, T; Iwasaki, Y; Morita, M				Mizutani, S.; Ekuni, D.; Tomofuji, T.; Yamane, M.; Azuma, T.; Iwasaki, Y.; Morita, M.			Gingival condition and tooth-brushing behavior after alcohol consumption	JOURNAL OF PERIODONTAL RESEARCH			English	Article						alcohol; cross-sectional studies; epidemiology; gingival condition; tooth-brushing; young adult	JAPANESE UNIVERSITY-STUDENTS; PERIODONTAL-DISEASE; ALDH2 GENOTYPES; ORAL-HEALTH; DRINKING; INDEX; ASSOCIATION; SYMPTOMS	Background and ObjectiveVarious studies have reported the relationship between alcohol consumption and gingival condition. However, they focus on the direct effects of alcohol consumption or alcohol sensitivity on gingival condition, and it is unclear how oral health behaviors relate these relationships. The aims of this study were to assess the inter-relationships between gingival condition, tooth-brushing behavior after drinking alcohol and alcohol sensitivity in university students who drink more than once per week on average. Material and MethodsA total of 808 students (541 males, 267 females) that habitually consume alcohol were analyzed. The disease activity of gingival condition was assessed as the percentage of bleeding on probing (%BOP). Additional information regarding alcohol sensitivity and oral health behaviors, including tooth-brushing behavior after drinking, were also collected. ResultsThirteen percent of the current participants reported neglecting tooth-brushing after drinking, and their alcohol consumption was higher than those who did not neglect tooth-brushing. Logistic regression analysis showed that high %BOP (%BOP 20) was associated with male (OR=1.53; 95% CI, 1.01-2.33), neglect of tooth-brushing after drinking (OR=2.60; 95% CI, 1.20-5.61) and debris index (OR=8.38; 95% CI, 4.24-16.60) in participants with low alcohol sensitivity. In participants with high alcohol sensitivity, high %BOP was associated with debris index (OR=7.60; 95% CI, 3.12-18.51), but not with any oral health behaviors. ConclusionsThe study revealed that alcohol consumption was indirectly related to gingival disease activity through the neglect of tooth-brushing after drinking alcohol in university students with low alcohol sensitivity.	[Mizutani, S.; Ekuni, D.; Tomofuji, T.; Yamane, M.; Azuma, T.; Morita, M.] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Prevent Dent, Okayama 7008558, Japan; [Tomofuji, T.] Okayama Univ, Sch Dent, Adv Res Ctr Oral & Craniofacial Sci, Okayama 7008558, Japan; [Iwasaki, Y.] Okayama Univ, Hlth Serv Ctr, Okayama 7008558, Japan	Mizutani, S (reprint author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Prevent Dent, Kita Ku, 2-5-1 Shikata Cho, Okayama 7008558, Japan.	pbme8eie@s.okayama-u.ac.jp					Ekuni D, 2008, J PERIODONTAL RES, V43, P417, DOI 10.1111/j.1600-0765.2007.01063.x; Tamaki N, 2008, J PERIODONTOL, V79, P2136, DOI 10.1902/jop.2008.080082 ; Cheng SH, 2012, PSYCHIAT RES, V197, P270, DOI 10.1016/j.psychres.2011.08.011; Wechsler H, 2000, J AM COLL HEALTH, V48, P199; Nishida N, 2010, J DENT RES, V89, P138, DOI 10.1177/0022034509356045; AINAMO J, 1982, INT DENT J, V32, P281; Pitiphat W, 2003, J DENT RES, V82, P509; Pihlstrom BL, 2005, LANCET, V366, P1809, DOI 10.1016/S0140-6736(05)67728-8; Mizutani S, 2012, J CLIN PERIODONTOL, V39, P844, DOI 10.1111/j.1600-051X.2012.01919.x; Jansson L, 2008, J CLIN PERIODONTOL, V35, P379, DOI 10.1111/j.1600-051X.2008.01210.x; Tezal M, 2004, J CLIN PERIODONTOL, V31, P484, DOI 10.1111/j.1600-051X.2004.00503.x; Tezal M, 2001, J PERIODONTOL, V72, P183, DOI 10.1902/jop.2001.72.2.183; Armitage GC, 1996, J PERIODONTOL, V67, P57; Asakage T, 2007, CARCINOGENESIS, V28, P865, DOI 10.1093/carcin/bgl206; Bergström Jan, 2004, Odontology, V92, P1, DOI 10.1007/s10266-004-0043-4; Furuta M, 2011, J PERIODONTOL, V82, P558, DOI 10.1902/jop.2010.100444; GREENE JC, 1964, J AM DENT ASSOC, V68, P7; GREENSTEIN G, 1984, J PERIODONTOL, V55, P684; Harada S, 2001, Nihon Arukoru Yakubutsu Igakkai Zasshi, V36, P85; Khocht A, 2009, J SUBST ABUSE TREAT, V37, P214, DOI 10.1016/j.jsat.2008.11.009; Kojima A, 2013, BMC ORAL HEALTH, V13, DOI 10.1186/1472-6831-13-62; Mizutani S, 2014, J PERIODONTAL RES, V50, P74; Modéer T, 2000, Dent Clin North Am, V44, P633; Takeshita T, 1998, ALCOHOL CLIN EXP RES, V22, P1409, DOI 10.1111/j.1530-0277.1998.tb03928.x; Takeshita T, 1999, ALCOHOL CLIN EXP RES, V23, P1065, DOI 10.1097/00000374-199906000-00015	25	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3484	1600-0765		J PERIODONTAL RES	J. Periodont. Res.	AUG	2015	50	4					494	499		10.1111/jre.12233		6	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CM4ZY	WOS:000357696900009		
J	Yamada, H; Nakajima, T; Domon, H; Honda, T; Yamazaki, K				Yamada, H.; Nakajima, T.; Domon, H.; Honda, T.; Yamazaki, K.			Endoplasmic reticulum stress response and bone loss in experimental periodontitis in mice	JOURNAL OF PERIODONTAL RESEARCH			English	Article						endoplasmic reticulum stress; osteoclast; periodontitis; Porphyromonas gingivalis	NF-KAPPA-B; UNFOLDED PROTEIN RESPONSE; MOUSE MODEL; ER STRESS; DISEASE; OSTEOCLASTOGENESIS; ACTIVATION; EXPRESSION; INFLAMMATION; PATHWAY	Background and ObjectiveEndoplasmic reticulum (ER) stress is the cell response that activates the unfolded protein response (UPR) pathway in a variety of conditions, such as inflammation and bone metabolism. The UPR may be associated with the pathogenesis of periodontal disease because the disease is inflammatory in nature, and alveolar bone resorption is a characteristic feature of the disease. However, the relationship between ER stress and alveolar bone resorption observed in periodontal disease remains elusive. Material and MethodsC57BL/6 mice were orally administered Porphyromonas gingivalis, a representative periodontopathic bacterium, in the presence or absence of a chemical chaperone, 4-phenylbutyrate (4-PBA). The gene expression of UPR-related molecules and cytokines in gingival tissues were analyzed using real-time polymerase chain reaction, and alveolar bone resorption and osteoclast numbers were evaluated histologically. The in vitro effect of 4-PBA on the differentiation of mouse bone marrow cells induced by receptor activator of nuclear factor-B ligand in the presence of macrophage colony-stimulating factor was analyzed. ResultsThe gene expression levels of UPR-related molecules and proinflammatory cytokines and alveolar bone resorption were significantly increased in P.gingivalis-administered mice. UPR-related gene expression and alveolar bone resorption were significantly suppressed by the administration of 4-PBA. However, no effect of 4-PBA was observed for proinflammatory cytokine expression in gingival tissues. Osteoclastic differentiation of bone marrow cells was also suppressed by 4-PBA with a concomitant reduction in the gene expression of cathepsin K and tartrate-resistant alkaline phosphatase genes. ConclusionER stress induced by oral administration of P.gingivalis is involved in alveolar bone resorption independent of inflammatory cytokines in mice.	[Yamada, H.; Nakajima, T.; Domon, H.; Honda, T.; Yamazaki, K.] Niigata Univ, Grad Sch Med & Dent Sci, Lab Periodontol & Immunol, Div Oral Sci Hlth Promot, Niigata 9518514, Japan; [Yamada, H.; Domon, H.; Honda, T.] Niigata Univ, Grad Sch Med & Dent Sci, Div Periodontol, Niigata 9518514, Japan; [Nakajima, T.] Niigata Univ, Grad Sch Med & Dent Sci, Div Dent Educ Res Dev, Niigata 9518514, Japan	Yamazaki, K (reprint author), Niigata Univ, Grad Sch Med & Dent Sci, Lab Periodontol & Immunol, Div Oral Sci Hlth Promot,Chu O Ku, 5274 Gakkocho 2 Ban Cho, Niigata 9518514, Japan.	kaz@dent.niigata-u.ac.jp			JSPS KAKENHI [23390476, 23659974, 26463131]	This work was supported by JSPS KAKENHI grant nos 23390476, 23659974, and 26463131. The authors declare no conflicts of interests.	Zhang KZ, 2008, NATURE, V454, P455, DOI 10.1038/nature07203; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Sulniute R, 2011, AM J PATHOL, V179, P819, DOI 10.1016/j.ajpath.2011.05.003; Kang HL, 2002, P NATL ACAD SCI USA, V99, P838, DOI 10.1073/pnas.022631999; BAKER PJ, 1994, ARCH ORAL BIOL, V39, P1035, DOI 10.1016/0003-9969(94)90055-8; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Wang KK, 2011, J MOL CELL BIOL, V3, P360, DOI 10.1093/jmcb/mjr021; Hotamisligil GS, 2008, NAT REV IMMUNOL, V8, P923, DOI 10.1038/nri2449; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Hu P, 2006, MOL CELL BIOL, V26, P3071, DOI 10.1128/MCB.26.8.3071-3084.2006; Darnay BG, 1999, J BIOL CHEM, V274, P7724, DOI 10.1074/jbc.274.12.7724; Boyce BF, 2013, J BONE MINER RES, V28, P711, DOI 10.1002/jbmr.1885; Saito T, 2007, PERIODONTOL 2000, V43, P254, DOI 10.1111/j.1600-0757.2006.00186.x; Zode GS, 2011, J CLIN INVEST, V121, P3542, DOI 10.1172/JCI58183; Lalla E, 2011, NAT REV ENDOCRINOL, V7, P738, DOI 10.1038/nrendo.2011.106; Henriksen K, 2007, OSTEOPOROSIS INT, V18, P681, DOI 10.1007/s00198-006-0286-8; Bernales S, 2006, ANNU REV CELL DEV BI, V22, P487, DOI 10.1146/annurev.cellbio.21.122303.120200; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Baker PJ, 1999, INFECT IMMUN, V67, P2804; Arimatsu K, 2014, SCI REP-UK, V4, DOI 10.1038/srep04828; Blasco-Baque V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048220; Bonapace G, 2004, P NATL ACAD SCI USA, V101, P12300, DOI 10.1073/pnas.0404764101; Domon H, 2009, CLIN CHIM ACTA, V401, P134, DOI 10.1016/j.cca.2008.12.007; Ha J, 2010, J IMMUNOL, V184, P4717, DOI 10.4049/jimmunol.0902444; Hamamura K, 2013, J BONE MINER METAB, V31, P618, DOI 10.1007/s00774-013-0450-0; Maekawa T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020240; Merquiol E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024660; Nakajima T, 2009, ODONTOLOGY, V97, P84, DOI 10.1007/s10266-009-0104-9; Tohmonda T, 2013, J BIOL CHEM, V288, P1691, DOI 10.1074/jbc.C112.424606	30	0	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3484	1600-0765		J PERIODONTAL RES	J. Periodont. Res.	AUG	2015	50	4					500	508		10.1111/jre.12232		9	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CM4ZY	WOS:000357696900010		
J	Huang, CS; Xiao, F; Arbogast, T				Huang, Chieh-Sen; Xiao, Feng; Arbogast, Todd			Fifth Order Multi-moment WENO Schemes for Hyperbolic Conservation Laws	JOURNAL OF SCIENTIFIC COMPUTING			English	Article						Multi-moment; MM-WENO scheme; Hyperbolic conservation law; Finite volume; Finite difference	ESSENTIALLY NONOSCILLATORY SCHEMES; FINITE-VOLUME METHOD; INCOMPRESSIBLE FLOWS; UNIFIED FORMULATION; EQUATIONS	A general approach is given to extend WENO reconstructions to a class of numerical schemes that use different types of moments (i.e., multi-moments) simultaneously as the computational variables, such as point values and grid cell averages. The key is to re-map the multi-moment values to single moment values (e.g., cell average or point values), which can then be used to invoke known, standard reconstruction coefficients and smoothness indicators for single moment WENO reconstructions. The WENO reconstructions in turn provide the numerical approximations for the flux functions and other required quantities. One major advantage of using multi-moments for WENO reconstructions is its compactness. We present two new multi-moment WENO (MM-WENO) schemes of fifth order that use reconstructions supported over only three grid cells, as opposed to the usual five. This is similar to the Hermite WENO schemes of Qiu and Shu (J Comput Phys 193:115-135, 2003), which can also be derived using our general approach. Numerical tests demonstrate that the new schemes achieve their designed fifth order accuracy and eliminate spurious oscillations effectively. The numerical solutions to all benchmark tests are of good quality and comparable to the classic, single moment WENO scheme of the same order of accuracy. The basic idea presented in this paper is universal, which makes the WENO reconstruction an easy-to-follow method for developing a wide variety of additional multi-moment numerical schemes.	[Huang, Chieh-Sen] Natl Sun Yat Sen Univ, Dept Appl Math, Kaohsiung 804, Taiwan; [Huang, Chieh-Sen] Natl Sun Yat Sen Univ, Natl Ctr Theoret Sci, Kaohsiung 804, Taiwan; [Xiao, Feng] Tokyo Inst Technol, Midori Ku, Yokohama, Kanagawa 2268502, Japan; [Arbogast, Todd] Univ Texas Austin, Inst Computat Engn & Sci, Austin, TX 78712 USA	Huang, CS (reprint author), Natl Sun Yat Sen Univ, Dept Appl Math, Kaohsiung 804, Taiwan.	huangcs@math.nsysu.edu.tw; xiao@es.tiech.ac.jp; arbogast@ices.utexas.edu			Taiwan National Science Council [NSC 102-2115-M-110-010-MY3]; JSPS KAKENHI [24560187]; Center for Frontiers of Subsurface Energy Security, an Energy Frontier Research Center - US Department of Energy [DE-SC0001114]; US National Science Foundation [DMS-0835745]	Authors supported in part for the first under Taiwan National Science Council Grant NSC 102-2115-M-110-010-MY3; the second by JSPS KAKENHI (24560187); and the third as part of the Center for Frontiers of Subsurface Energy Security, an Energy Frontier Research Center funded by the US Department of Energy under Award Number DE-SC0001114, and by the US National Science Foundation Grant DMS-0835745.	Xiao F, 2001, J COMPUT PHYS, V170, P498, DOI 10.1006/jcph.2001.6746; Chen CG, 2008, J COMPUT PHYS, V227, P5019, DOI 10.1016/j.jcp.2008.01.033; Yabe T, 2001, J COMPUT PHYS, V169, P556, DOI 10.1006/jcph.2000.6625; LIU XD, 1994, J COMPUT PHYS, V115, P200, DOI 10.1006/jcph.1994.1187; Xiao F, 2005, COMPUT STRUCT, V83, P409, DOI 10.1016/j.compstruc.2004.06.005; Ii S, 2009, J COMPUT PHYS, V228, P3669, DOI 10.1016/j.jcp.2009.02.009; Henrick AK, 2005, J COMPUT PHYS, V207, P542, DOI 10.1016/j.jcp.2005.01.023; Castro M, 2011, J COMPUT PHYS, V230, P1766, DOI 10.1016/j.jcp.2010.11.028; Xiao F, 1996, COMPUT PHYS COMMUN, V93, P1, DOI 10.1016/0010-4655(95)00124-7; Xiao F, 2006, J COMPUT PHYS, V213, P31, DOI 10.1016/j.jcp.2005.08.002; SHU CW, 1989, J COMPUT PHYS, V83, P32, DOI 10.1016/0021-9991(89)90222-2; HARTEN A, 1987, J COMPUT PHYS, V71, P231, DOI 10.1016/0021-9991(87)90031-3; Ii S, 2007, J COMPUT PHYS, V222, P849, DOI 10.1016/j.jcp.2006.08.015; Akoh R, 2010, J COMPUT PHYS, V229, P4567, DOI 10.1016/j.jcp.2010.02.023; Huang CS, 2012, J COMPUT PHYS, V231, P4028, DOI 10.1016/j.jcp.2012.01.030; Huang C.-S., EULERIAN LAGRA UNPUB; Huang CS, 2014, J COMPUT PHYS, V262, P291, DOI 10.1016/j.jcp.2013.12.056; Jiang J.-S., 1996, J COMPUT PHYS, V126, P202; Jiang J.-S., 2000, SIAM J SCI COMPUT, V21, P2126; Qiu J., 2003, J COMPUT PHYS, V193, P115; Shu C.-W., ICASE199765; Xiao F, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD001532; Xiao F, 2004, J COMPUT PHYS, V195, P629, DOI 10.1016/j.jcp.2003.10.014	23	1	1	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0885-7474	1573-7691		J SCI COMPUT	J. Sci. Comput.	AUG	2015	64	2					477	507		10.1007/s10915-014-9940-z		31	Mathematics, Applied	Mathematics	CM0BQ	WOS:000357343600008		
J	Takata, S				Takata, Shigeru			A Toy-Model Study of the Grazing Collisions in the Kinetic Theory	JOURNAL OF STATISTICAL PHYSICS			English	Article						Lorentz gas; Grazing collisions; Kinetic theory; Boltzmann equation	NUMERICAL-ANALYSIS; EQUATION	As a toy model study for the grazing collision effect in the Boltzmann equation, a spatially homogeneous problem for the two-dimensional Lorentz gas from the initial data with a jump discontinuity is investigated. The collision kernel of our model has the same angular singularity as the Boltzmann collision kernel. Thanks to the simplicity of the model, the jump propagation and its regularization are clearly seen, depending on whether the collision cross-section is finite or infinite. Three types of behavior are observed: a jump propagation, a jump propagation accompanied with a divergent derivative, and no jump propagation. For the model with a critical parameter, the switching from the second type to the last is observed.	[Takata, Shigeru] Kyoto Univ, Dept Aeronaut & Astronaut, Nishikyo Ku, Kyoto 6158540, Japan; [Takata, Shigeru] Kyoto Univ, Adv Res Inst Fluid Sci & Engn, Nishikyo Ku, Kyoto 6158540, Japan	Takata, S (reprint author), Kyoto Univ, Dept Aeronaut & Astronaut, Nishikyo Ku, Kyoto 6158540, Japan.	takata.shigeru.4a@kyoto-u.ac.jp	Takata, Shigeru/G-2933-2011	Takata, Shigeru/0000-0001-6787-6777			ABRAMOWITZ M., 1972, HDB MATH FUNCTIONS; Alexandre R, 2010, ARCH RATION MECH AN, V198, P39, DOI 10.1007/s00205-010-0290-1; SUGIMOTO H, 1992, PHYS FLUIDS A-FLUID, V4, P419, DOI 10.1063/1.858313; DESVILLETTES L, 1995, COMMUN MATH PHYS, V168, P417, DOI 10.1007/BF02101556; Bird G. A., 1994, MOL GAS DYNAMICS DIR; Cercignani C, 1998, BOLTZMANN EQUATIONS; Desvillettes L., 1999, STOCH PROC APPL, V84, P15; Folland G, 1992, FOURIER ANAL ITS APP; Le Bellac M., 2004, EQUILIBRIUM NONEQUIL; Lucquin-Desreux B., 2003, TRANSPORT THEOR STAT, V32, P293; Moriguchi S., 1960, IWANAMI SUGAKU KOUSI; Pareschi L., 2003, NUMER MATH, V93, P523; Sone Y., 2007, MOL GAS DYNAMICS; Sone Y., 1992, Transport Theory and Statistical Physics, V21, DOI 10.1080/00411459208203796; Sone Y., 1990, ADIABATIC WAVES LIQU, P293; Takata S., 2008, NAGARE J JPN SOC FLU, V27, P387; TAKATA S, 1993, PHYS FLUIDS A-FLUID, V5, P716, DOI 10.1063/1.858655; Villani C., 2002, HDB MATH FLUID DYNAM, V1	18	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0022-4715	1572-9613		J STAT PHYS	J. Stat. Phys.	AUG	2015	160	3					770	792		10.1007/s10955-015-1259-0		23	Physics, Mathematical	Physics	CM0BS	WOS:000357343800013		
J	Koizumi, H; Tachiki, M				Koizumi, Hiroyasu; Tachiki, Masashi			Instability of the BCS Type Pairing in Magnetic Field Due to the Rashba Spin-Orbit Interaction and Supercurrent Generation by Spin-Twisting Itinerant Motion of Electrons in BCS Superconductors	JOURNAL OF SUPERCONDUCTIVITY AND NOVEL MAGNETISM			English	Article						Spin-twisting itinerant motion; Supercurrent generation; BCS superconductors	FLOW-THROUGH; DERIVATION	In a uniform magnetic field, the BCS type pairing is taken over by the pairing of spin-twisting itinerant motion states due to the Rashba spin-orbit interaction. It gives rise to stable eddy currents forced to flow by the single-valued requirement of the wave function. They are stabilized by the energy gap of the electron pairing and protected by topological winding numbers of the wave function for the spin-twisting itinerant motion. The supercurrent is generated by a collection of such eddy currents.	[Koizumi, Hiroyasu] Univ Tsukuba, Div Mat Sci, Tsukuba, Ibaraki 3058573, Japan; [Tachiki, Masashi] Tohoku Univ, Dept Phys, Sendai, Miyagi 9808578, Japan	Koizumi, H (reprint author), Univ Tsukuba, Div Mat Sci, Tsukuba, Ibaraki 3058573, Japan.	koizumi@ims.tsukuba.ac.jp					ABRIKOSOV AA, 1957, SOV PHYS JETP-USSR, V5, P1174; Anderson P W, 1984, BASIC NOTIONS CONDEN; JOSEPHSON BD, 1962, PHYS LETT, V1, P251, DOI 10.1016/0031-9163(62)91369-0; Koizumi H, 2014, J SUPERCOND NOV MAGN, V27, P121, DOI 10.1007/s10948-013-2277-2; WALDRAM JR, 1976, REP PROG PHYS, V39, P751, DOI 10.1088/0034-4885/39/8/002; EMERY VJ, 1995, NATURE, V374, P434, DOI 10.1038/374434a0; NAMBU Y, 1960, PHYS REV, V117, P648, DOI 10.1103/PhysRev.117.648; RASHBA EI, 1960, SOV PHYS-SOL STATE, V2, P1109; SHAPIRO S, 1963, PHYS REV LETT, V11, P80, DOI 10.1103/PhysRevLett.11.80; WICK GC, 1970, PHYS REV D, V1, P3267, DOI 10.1103/PhysRevD.1.3267; Koizumi H, 2014, J SUPERCOND NOV MAGN, V27, P2435, DOI 10.1007/s10948-014-2626-9; Hidekata R, 2011, J SUPERCOND NOV MAGN, V24, P2253, DOI 10.1007/s10948-011-1194-5; BARDEEN J, 1957, PHYS REV, V108, P1175, DOI 10.1103/PhysRev.108.1175; BEDNORZ JG, 1986, Z PHYS B CON MAT, V64, P189, DOI 10.1007/BF01303701; ANDERSON PW, 1958, PHYS REV, V112, P1900, DOI 10.1103/PhysRev.112.1900; de Gennes P. G., 1966, SUPERCONDUCTIVITY ME; Feynman R., 1965, LECT PHYS, V3; FISKE MD, 1964, REV MOD PHYS, V36, P221, DOI 10.1103/RevModPhys.36.221; Giavever I., 1965, PHYS REV LETT, V14, P904; Ginzburg V.L., 1950, EKSP TEOR FIZ, V20, P1064; GORKOV LP, 1959, SOV PHYS JETP-USSR, V9, P1364; Kittel C., 1986, INTRO SOLID STATE PH; Koizumi H., 2015, UNPUB; Koizumi H, 2011, J SUPERCOND NOV MAGN, V24, P1997, DOI 10.1007/s10948-011-1159-8; Koizumi H, 2015, J SUPERCOND NOV MAGN, V28, P61, DOI 10.1007/s10948-014-2877-5; Leggett A. J., 2006, QUANTUM LIQUIDS BOSE; Onnes H.K., 1911, LEIDEN COMM B, V119b; Onnes H.K., 1911, LEIDEN COMM B, V122b; PEIERLS R, 1992, CONTEMP PHYS, V33, P221, DOI 10.1080/00107519208223971; Rickayzen G., 1965, THEORY SUPERCONDUCTI; Tinkham M., 1996, INTRO SUPERCONDUCTIV; Yanson I.K., 1965, SOV PHYS JETP, V48, P976	32	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1557-1939	1557-1947		J SUPERCOND NOV MAGN	J. Supercond. Nov. Magn	AUG	2015	28	8					2267	2273		10.1007/s10948-015-3034-5		7	Physics, Applied; Physics, Condensed Matter	Physics	CM1SM	WOS:000357460600007		
J	Igami, M; Nagaoka, S; Walsh, JP				Igami, Masatsura; Nagaoka, Sadao; Walsh, John P.			Contribution of postdoctoral fellows to fast-moving and competitive scientific research	JOURNAL OF TECHNOLOGY TRANSFER			English	Article						Science; Priority; Competition; Postdoctoral fellows	REFERENCE NETWORKS; CELLS	This study explores the prevalence of postdoctoral fellows in fast-moving and competitive scientific research. We use the results of a new and original large-scale survey of scientists in Japan and the United States for the analyses. Descriptive statistics show that, in both Japan and the United States: (1) the mean citation time lag was shorter by about 2 years in the highly cited papers (top 1 %) compared to other normal papers; and (2) the perceived degree of competitive threat was also higher for the projects producing the highly cited papers compared to those for normal papers. We also found that the likelihood of participation of postdoctoral fellows is significantly higher in research with shorter mean time lag and higher competitive threat (while that of students is not), controlling for author size, suggesting that postdoctoral fellows are especially prevalent in research efforts in fast-moving and competitive scientific research.	[Igami, Masatsura] Natl Inst Sci & Technol Policy, Chiyoda Ku, Tokyo 1000013, Japan; [Nagaoka, Sadao] Hitotsubashi Univ, Inst Innovat Res, Kunitachi, Tokyo 1868603, Japan; [Walsh, John P.] Georgia Inst Technol, Sch Publ Policy, Atlanta, GA 30332 USA	Igami, M (reprint author), Natl Inst Sci & Technol Policy, Chiyoda Ku, 3-2-2 Kasumigaseki, Tokyo 1000013, Japan.	igami@nistep.go.jp		IGAMI, Masatsura/0000-0003-4653-3032	Japan's Ministry of Education, Culture, Sports, Science and Technology; JSPS KAKENHI [21243020]; US National Science Foundation [OISE-1019038]	This research represents collaboration between the Institute of Innovation Research (IIR) of Hitotsubashi University and the National Institute of Science and Technology Policy (NISTEP), as part of the "Industry-university-government joint research on the innovation process'' project, with support from Special Funds for Education and Research from Japan's Ministry of Education, Culture, Sports, Science and Technology. This work was also supported by JSPS KAKENHI 21243020, and by the US National Science Foundation (OISE-1019038). The Georgia Institute of Technology implemented the survey in the United States, in collaboration with IIR and NISTEP. Paula Stephan contributed significantly to the design of our survey. We have benefitted significantly from the participants of the conference on "The Organisation, Economics and Policy of Scientific Research,'' in February 2011 (Torino); the EUSPRI Conference on "Path-breaking Innovation: Understanding, Managing and Providing Support for Continuous Radical Change in Science and Innovation,'' in June 2012 (Milan); and the 17th International Conference on Science and Technology Indicators, in September 2012 (Montreal).	Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1172482; PRICE DJD, 1965, SCIENCE, V149, P510; HAGSTROM WO, 1974, AM SOCIOL REV, V39, P1, DOI 10.2307/2094272; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; WU MK, 1987, PHYS REV LETT, V58, P908, DOI 10.1103/PhysRevLett.58.908; Adams JD, 2005, RES POLICY, V34, P259, DOI 10.1016/j.respol.2005.01.014; Baldi S, 1997, SOC STUD SCI, V27, P669, DOI 10.1177/030631297027004004; Bednorz G., 1986, Z PHYS B, V64, P189; Black G. C., 2010, AM U GLOBAL MARKET, P129; Empirica GmbH, 2005, POSTD LIF SCI; Franzoni C., 2012, NBER WORKING PAPER S; Hall B.H., 2004, 10901 NBER; Hargens LL, 2000, AM SOCIOL REV, V65, P846, DOI 10.2307/2657516; Igami M., 2007, OECD SCI TECHNOLOGY; Kamerlingh Onnes H., 1911, DISAPPEARANCE RESIST, p122b; Lariviere V, 2012, SCIENTOMETRICS, V90, P463, DOI 10.1007/s11192-011-0495-6; Merton RK, 1973, SOCIOLOGY SCI THEORE; OECD, 2009, PAT STAT MAN; Stephan Paula, 2012, EC SHAPES SCI; Wuchty S., 2007, SCIENCE, V316, P1030	21	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0892-9912	1573-7047		J TECHNOL TRANSFER	J. Technol. Transf.	AUG	2015	40	4					723	741		10.1007/s10961-014-9366-7		19	Engineering, Industrial; Management	Engineering; Business & Economics	CM2EG	WOS:000357492000008		
J	Yuen, K; Miura, T; Sakai, I; Kiyosue, A; Yamashita, M				Yuen, Keiji; Miura, Tetsuya; Sakai, Iori; Kiyosue, Akiko; Yamashita, Masuo			Intraoperative Fluorescence Imaging for Detection of Sentinel Lymph Nodes and Lymphatic Vessels during Open Prostatectomy using Indocyanine Green	JOURNAL OF UROLOGY			English	Article						prostatic neoplasms; sentinel lymph node biopsy; indocyanine green; optical imaging	RADICAL PROSTATECTOMY; PELVIC LYMPHADENECTOMY; CANCER; SURGERY; IMPACT; EXTENT	Purpose: We investigated the feasibility and validity of intraoperative fluorescence imaging using indocyanine green for the detection of sentinel lymph nodes and lymphatic vessels during open prostatectomy. Materials and Methods: Indocyanine green was injected into the prostate under transrectal ultrasound guidance just before surgery. Intraoperative fluorescence imaging was performed using a near-infrared camera system in 66 consecutive patients with clinically localized prostate cancer after a 10-patient pilot test to optimize indocyanine green dosing, observation timing and injection method. Lymphatic vessels were visualized and followed to identify the sentinel lymph nodes. Confirmatory pelvic lymph node dissection including all fluorescent nodes and open radical prostatectomy were performed in all patients. Results: Lymphatic vessels were successfully visualized in 65 patients (98%) and sentinel lymph nodes in 64 patients (97%). Sentinel lymph nodes were located in the obturator fossa, internal and external iliac regions, and rarely in the common iliac and presacral regions. A median of 4 sentinel lymph nodes per patient was detected. Three lymphatic pathways, the paravesical, internal and lateral routes, were identified. Pathological examination revealed metastases to 9 sentinel lymph nodes in 6 patients (9%). All pathologically positive lymph nodes were detected as sentinel lymph nodes using this imaging. No adverse reactions due to the use of indocyanine green were observed. Conclusions: Intraoperative fluorescence imaging using indocyanine green during open prostatectomy enables the detection of lymphatic vessels and sentinel lymph nodes with high sensitivity. This novel method is technically feasible, safe and easy to apply with minimal additional operative time.	[Yuen, Keiji; Miura, Tetsuya; Sakai, Iori; Kiyosue, Akiko; Yamashita, Masuo] Shinko Hosp, Dept Urol, Kobe, Hyogo, Japan	Yuen, K (reprint author), Shinko Hosp, Kobe, Hyogo, Japan.						Polom K, 2011, CANCER-AM CANCER SOC, V117, P4812, DOI 10.1002/cncr.26087; Heidenreich A, 2002, J UROLOGY, V167, P1681, DOI 10.1016/S0022-5347(05)65177-4; Mattei A, 2008, EUR UROL, V53, P118, DOI 10.1016/j.eururo-2007.07.035; Buckle T, 2012, J NUCL MED, V53, P1026, DOI 10.2967/jnumed.111.098517; Wagner M, 2008, J UROLOGY, V179, P408, DOI 10.1016/j.juro.2007.09.027; Hovels AM, 2008, CLIN RADIOL, V63, P387, DOI 10.1016/j.crad.2007.05.022; Manny TB, 2014, EUR UROL, V65, P1162, DOI 10.1016/j.eururo.2013.11.017; Allaf ME, 2004, J UROLOGY, V172, P1840, DOI 10.1097/01.ju.0000140912.45821.1d; RAGHAVAIAH NV, 1979, J UROLOGY, V121, P178; Wawroschek F, 1999, EUR UROL, V36, P595, DOI 10.1159/000020054; Holl G, 2009, EUR J NUCL MED MOL I, V36, P1377, DOI 10.1007/s00259-009-1157-2; van der Poel HG, 2011, EUR UROL, V60, P826, DOI 10.1016/j.eururo.2011.03.024; Seiler R, 2014, J UROLOGY, V191, P1280, DOI 10.1016/j.juro.2013.11.029; Schaafsma BE, 2011, J SURG ONCOL, V104, P323, DOI 10.1002/jso.21943; Joslyn SA, 2006, UROLOGY, V68, P121, DOI 10.1016/j.urology.2006.01.055; BENSON RC, 1978, PHYS MED BIOL, V23, P159, DOI 10.1088/0031-9155/23/1/017; D'Amico AV, 1998, JAMA-J AM MED ASSOC, V280, P969, DOI 10.1001/jama.280.11.969; Jeschke S, 2012, UROLOGY, V80, P5; KleinJan GH, 2014, EUR UROL, V66, P991, DOI 10.1016/j.eururo.2014.07.014; Weckermann Dorothea, 2007, J Urol, V177, P916, DOI 10.1016/j.juro.2006.10.074	20	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0022-5347	1527-3792		J UROLOGY	J. Urol.	AUG	2015	194	2					371	377		10.1016/j.juro.2015.01.008		7	Urology & Nephrology	Urology & Nephrology	CM5QA	WOS:000357742000027		
J	Umegaki, H; Ikezoe, T; Nakamura, M; Nishishita, S; Kobayashi, T; Fujita, K; Tanaka, H; Ichihashi, N				Umegaki, Hiroki; Ikezoe, Tome; Nakamura, Masatoshi; Nishishita, Satoru; Kobayashi, Takuya; Fujita, Kosuke; Tanaka, Hiroki; Ichihashi, Noriaki			Acute effects of static stretching on the hamstrings using shear elastic modulus determined by ultrasound shear wave elastography: Differences in flexibility between hamstring muscle components	MANUAL THERAPY			English	Article						Hamstrings; Stretching; Shear wave elastography	GASTROCNEMIUS-MUSCLE; TENDON UNIT; PASSIVE STIFFNESS; SOCCER PLAYERS; ELITE SOCCER; WARM-UP; IN-VIVO; PREVENTION; INJURIES; HARDNESS	Background: Static stretching (SS) with hip flexion and knee extension is often used to stretch the hamstrings. However, it is unclear whether there are the differences in the acute effect of this SS maneuver on flexibility between each component of the hamstrings, namely the semitendinosus (ST), semimembranosus (SM), and biceps femoris (BF) muscles. Objectives: The aims of this study were to investigate the acute effects of SS on the flexibility of the individual muscle components of the hamstrings, and to examine the difference in the acute effect of SS between these components using shear elastic modulus as the index of muscle flexibility. Method: Twenty healthy men (age, 23.4 +/- 2.3years) volunteered for this study. The shear elastic modulus of the ST, SM and BF muscles were measured using ultrasound shear wave elastography before (PRE) and immediately after (POST) 5 min of SS. Measurements of shear elastic modulus were taken with the knee at 900 (slack position) and 450 (extension position) of flexion. Results: In all muscles, the shear elastic modulus at both knee angles decreased significantly after SS. The percentage change in the shear elastic modulus from PRE to POST in the muscles at 450 of knee flexion was greatest in the SM. Conclusions: These results suggest that SS with hip flexion and knee extension has acute effects on increasing flexibility of the hamstring muscle components, especially the SM muscle. (C) 2015 Published by Elsevier Ltd.	[Umegaki, Hiroki; Ikezoe, Tome; Nakamura, Masatoshi; Nishishita, Satoru; Kobayashi, Takuya; Fujita, Kosuke; Tanaka, Hiroki; Ichihashi, Noriaki] Kyoto Univ, Grad Sch Med, Human Hlth Sci, Kyoto 6068507, Japan; [Nakamura, Masatoshi] Doshisha Univ, Fac Hlth & Sports Sci, Kyoto 602, Japan	Umegaki, H (reprint author), Kyoto Univ, Grad Sch Med, Human Hlth Sci, Sakyo Ku, 53 Shogoin Kawahara Cho, Kyoto 6068507, Japan.	umegaki.hiroki.86x@st.kyoto-u.ac.jp					Arnason A, 2008, SCAND J MED SCI SPOR, V18, P40, DOI 10.1111/j.1600-0838.2006.00634.x; Witvrouw E, 2003, AM J SPORT MED, V31, P41; Akagi R, 2013, MED SCI SPORT EXER, V45, P1348, DOI 10.1249/MSS.0b013e3182850e17; Maisetti O, 2012, J BIOMECH, V45, P978, DOI 10.1016/j.jbiomech.2012.01.009; de Weijer VC, 2003, J ORTHOP SPORT PHYS, V33, P727; Chernak LA, 2013, PHYSIOL MEAS, V34, P713, DOI 10.1088/0967-3334/34/6/713; Nakamura M, 2014, ULTRASOUND MED BIOL, V40, P1991, DOI 10.1016/j.ultrasmedbio.2014.03.024; McHugh MP, 2010, SCAND J MED SCI SPOR, V20, P169, DOI 10.1111/j.1600-0838.2009.01058.x; Koulouris G, 2007, AM J SPORT MED, V35, P1500, DOI 10.1177/0363546507301258; Morse CI, 2008, J PHYSIOL-LONDON, V586, P97, DOI 10.1113/jphysiol.2007.140434; Magnusson SP, 1998, INT J SPORTS MED, V19, P310, DOI 10.1055/s-2007-971923; Nakamura M, 2011, J ORTHOP RES, V29, P1759, DOI 10.1002/jor.21445; Bradley PS, 2007, J STRENGTH COND RES, V21, P1155, DOI 10.1519/R-20416.1; VANMECHELEN W, 1993, AM J SPORT MED, V21, P711, DOI 10.1177/036354659302100513; Verrall GM, 2003, AM J SPORT MED, V31, P969; Koo TK, 2013, J BIOMECH, V46, P2053, DOI 10.1016/j.jbiomech.2013.05.016; Magnusson SP, 1996, AM J SPORT MED, V24, P622, DOI 10.1177/036354659602400510; Magnusson SP, 2000, MED SCI SPORT EXER, V32, P1160, DOI 10.1097/00005768-200006000-00020; Matsuo S, 2013, J STRENGTH COND RES, V27, P3367, DOI 10.1519/JSC.0b013e318290c26f; Taniguchi K, 2015, SCAND J MED SCI SPOR, V25, P32, DOI 10.1111/sms.12146; Umegaki H, 2015, MANUAL THER, V20, P134, DOI 10.1016/j.math.2014.07.016	21	1	1	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	1356-689X	1532-2769		MANUAL THER	Man. Ther.	AUG	2015	20	4					610	613		10.1016/j.math.2015.02.006		4	Rehabilitation	Rehabilitation	CM0EV	WOS:000357352100015		
J	Huang, JY; Xu, J; Xia, Z; Liu, LQ; Zhang, YB; Li, J; Lan, GD; Qi, YK; Kamon, M; Sun, XM; Li, Y				Huang, Junyi; Xu, Jun; Xia, Zhen; Liu, Liqiang; Zhang, Yinbo; Li, Jing; Lan, Guangdong; Qi, Yuekun; Kamon, Masashi; Sun, Xiaoming; Li, Yan			Identification of influential parameters through sensitivity analysis of the TOUGH plus Hydrate model using LH-OAT sampling	MARINE AND PETROLEUM GEOLOGY			English	Article						Gas hydrate; TOUGH plus Hydrate (T plus H) model; Parameter sensitivity analysis; Segmentation; Parameter ranking	COMPLEX ECOLOGICAL MODELS; GLOBAL SENSITIVITY; UNCERTAINTY ANALYSIS; POROUS-MEDIA; HEAT-FLOW; HYDRAULIC CONDUCTIVITY; ACCRETIONARY PRISM; ENERGY RESOURCE; FLUID EXPULSION; WASTE-DISPOSAL	The over-parameterisation, as a common issue in numerical models, may be unavoidable in the TOUGH + Hydrate (T + H) model. Therefore, a global sensitivity analysis of the influence of main or uneasily-measured 26 input parameters on five model outputs, i.e. cumulative gas production, gas production rate, hydrate saturation, gas saturation and aqueous saturation, under depressurization and brine-inhibitor injection was performed using the LH-OAT sampling method. The 26 parameters were classified as 'Very important', 'Important', 'Slightly important', and 'Unimportant' by analyzing their sensitivity indices at different sampling times and sampling positions in the modeling area, using the TSPAC segmentation package. The sensitivity of an input parameter to a model output was dependent on sampling time, sampling position and the identity of the model output in question. Cumulative gas production and gas production rate were governed by four permeability-related parameters (parameter n and residual aqueous saturation (in the relative permeability-saturation model), permeability reduction exponent and critical mobile phase saturation) and four inhibitor-related parameters (inhibitor density, the specific enthalpy of the dissolution of the inhibitor in water, reference inhibitor mole fraction in the aqueous phase and inhibitor-induced reference temperature depression). Hydrate saturation was governed by two hydrate dissociation-related parameters (temperature-dependent hydrate specific heat and hydrate density) and two parameters related to the flow of released fluids in the pore network (permeability and pore structure expansion). Gas saturation was governed by several types of input parameters: six parameters related to the flow of pore gas (parameter n and residual aqueous saturation (in the relative permeability-saturation model), critical mobile phase saturation, intrinsic permeability, permeability reduction exponent and pore compressibility), three inhibitor-related parameters (the specific enthalpy of the dissolution of the inhibitor in water, reference inhibitor mole fraction in the aqueous phase and inhibitor-induced reference temperature depression) and two hydrate dissociation-related parameters (temperature-dependent hydrate density polynomial and temperature-dependent hydrate specific heat polynomial). Finally, aqueous saturation was governed by five permeability-related parameters (parameter A and residual aqueous saturation (in the saturation-capillary pressure function model), pore expansion, grain specific heat and the tortuosity factor model). Overall, the most influential parameter for all five model outputs was the parameter n in the relative permeability-saturation function model. (C) 2015 Elsevier Ltd. All rights reserved.	[Huang, Junyi; Li, Jing; Sun, Xiaoming; Li, Yan] Sun Yat Sen Univ, Sch Marine Sci, Guangdong Prov Key Lab Marine Resources & Coastal, Key Lab Aquat Prod Safety,Minist Educ, Guangzhou 510275, Guangdong, Peoples R China; [Xu, Jun] Hohai Univ, Sch Earth Sci & Engn, Nanjing 210098, Jiangsu, Peoples R China; [Xia, Zhen; Liu, Liqiang] Guangzhou Marine Geol Survey, Guangzhou 510760, Guangdong, Peoples R China; [Zhang, Yinbo] Minist Environm Protect, South China Inst Environm Sci, Guangzhou 510655, Guangdong, Peoples R China; [Lan, Guangdong] Sun Yat Sen Univ, Sch Environm Sci & Engn, Guangzhou 510275, Guangdong, Peoples R China; [Qi, Yuekun] Chongqing Environm Protect Engn Design Inst Co Lt, Chongqing 401100, Peoples R China; [Kamon, Masashi] Takamatsu Natl Coll Technol, Takamatsu, Kagawa 7618058, Japan	Sun, XM (reprint author), Sun Yat Sen Univ, Sch Marine Sci, Guangdong Prov Key Lab Marine Resources & Coastal, Key Lab Aquat Prod Safety,Minist Educ, 135 Xingang RD, Guangzhou 510275, Guangdong, Peoples R China.	eessxm@mail.sysu.edu.cn; eesly@mail.sysu.edu.cn			Gas Hydrate Prospecting Assessment and Trial Mining Project [GZH201100311]; Gas Hydrate Resource Exploration and Mining Project [GZH201100305-06-06]; Chinese National Science Foundation [41072182, 91128101]; Guangdong Science-Technology Planning Project [2012A030700008]; Chinese National Undergraduate Innovative Training Program [201302016]; Guangdong Provincial Marine and Fishery Special Foundation of Science and Technology Dissemination Project [B201300A04]	This work was supported by the Gas Hydrate Prospecting Assessment and Trial Mining Project (Grant No. GZH201100311), the Gas Hydrate Resource Exploration and Mining Project (Grant No. GZH201100305-06-06), the Chinese National Science Foundation (Grant No. 41072182; 91128101), the Guangdong Science-Technology Planning Project (Grant No. 2012A030700008), the Chinese National Undergraduate Innovative Training Program (Grant. No 201302016), and the Guangdong Provincial Marine and Fishery Special Foundation of Science and Technology Dissemination Project (Grant No. B201300A04).	Wainwright HM, 2014, COMPUT GEOSCI-UK, V65, P84, DOI 10.1016/j.cageo.2013.06.006; van Griensven A, 2006, J HYDROL, V324, P10, DOI 10.1016/j.jhydrol.2005.09.008; Fox GA, 2010, J HYDROL, V384, P164, DOI 10.1016/j.jhydrol.2010.01.020; Cariboni J, 2007, ECOL MODEL, V203, P167, DOI 10.1016/j.ecolmodel.2005.10.045; [Anonymous], 2007, CMG STARS; Ginot V, 2006, ECOL MODEL, V193, P479, DOI 10.1016/j.ecolmodel.2005.08.025; KVENVOLDEN KA, 1993, REV GEOPHYS, V31, P173, DOI 10.1029/93RG00268; Saltelli A, 1999, TECHNOMETRICS, V41, P39, DOI 10.2307/1270993; DAVIS EE, 1990, J GEOPHYS RES-SOLID, V95, P8869, DOI 10.1029/JB095iB06p08869; Ray N, 2006, ECOL MODEL, V195, P172, DOI 10.1016/j.ecolmodel.2005.11.039; Lu YC, 2001, RELIAB ENG SYST SAFE, V72, P275, DOI 10.1016/S0951-8320(01)00020-5; Campolongo F, 2007, ENVIRON MODELL SOFTW, V22, P1509, DOI 10.1016/j.envsoft.2006.10.004; MACDONALD GJ, 1990, ANNU REV ENERGY, V15, P53, DOI 10.1146/annurev.eg.15.110190.000413; MORRIS MD, 1991, TECHNOMETRICS, V33, P161, DOI 10.2307/1269043; Munoz-Carpena R, 2010, J ENVIRON QUAL, V39, P630, DOI 10.2134/jeq2009.0300; MCRAE GJ, 1982, COMPUT CHEM ENG, V6, P15, DOI 10.1016/0098-1354(82)80003-3; Collett TS, 2002, AAPG BULL, V86, P1971; deYoung B, 2004, SCIENCE, V304, P1463, DOI 10.1126/science.1094858; Iwata M, 2000, SOLID STATE IONICS, V132, P297, DOI 10.1016/S0167-2738(00)00645-7; SPEAR RC, 1980, WATER RES, V14, P43, DOI 10.1016/0043-1354(80)90040-8; Helton JC, 2006, RELIAB ENG SYST SAFE, V91, P1175, DOI 10.1016/j.ress.2005.11.017; Makler-Pick V, 2011, ENVIRON MODELL SOFTW, V26, P124, DOI 10.1016/j.envsoft.2010.06.010; Helton JC, 2003, RELIAB ENG SYST SAFE, V81, P23, DOI 10.1016/S0951-8320(03)00058-9; Gan YJ, 2014, ENVIRON MODELL SOFTW, V51, P269, DOI 10.1016/j.envsoft.2013.09.031; Frey HC, 2002, RISK ANAL, V22, P553; Cacuci DG, 2004, NUCL SCI ENG, V147, P204; Marino S, 2008, J THEOR BIOL, V254, P178, DOI 10.1016/j.jtbi.2008.04.011; Beres DL, 2001, ECOL MODEL, V141, P171, DOI 10.1016/S0304-3800(01)00271-X; MUALEM Y, 1976, WATER RESOUR RES, V12, P513, DOI 10.1029/WR012i003p00513; Jiang XX, 2012, ENERGY, V39, P281, DOI 10.1016/j.energy.2012.01.016; Holvoet K, 2005, PHYS CHEM EARTH, V30, P518, DOI 10.1016/j.pce.2005.07.006; Miao ZW, 2011, ENVIRON MODELL SOFTW, V26, P1112, DOI 10.1016/j.envsoft.2011.03.004; Moridis GJ, 2011, J PETROL SCI ENG, V76, P124, DOI 10.1016/j.petrol.2010.12.001; Kleijnen JPC, 1999, RELIAB ENG SYST SAFE, V65, P147, DOI 10.1016/S0951-8320(98)00091-X; Wu YS, 1998, TRANSPORT POROUS MED, V32, P117, DOI 10.1023/A:1006535211684; SALTELLI A, 1995, COMPUT STAT DATA AN, V20, P387, DOI 10.1016/0167-9473(95)92843-M; Winter CL, 2006, J COMPUT PHYS, V217, P166, DOI 10.1016/j.jcp.2006.01.047; Helton JC, 2002, RISK ANAL, V22, P591, DOI 10.1111/0272-4332.00041; Saltelli A, 2005, CHEM REV, V105, P2811, DOI 10.1021/cr040659d; Chu PC, 2007, ECOL MODEL, V206, P369, DOI 10.1016/j.ecolmodel.2007.04.006; Morris DJ, 2014, ECOL MODEL, V273, P251, DOI 10.1016/j.ecolmodel.2013.11.019; VANGENUCHTEN MT, 1980, SOIL SCI SOC AM J, V44, P892; Xu CG, 2008, RELIAB ENG SYST SAFE, V93, P1563, DOI 10.1016/j.ress.2007.06.003; Ascough II J.C., 2005, INT C MOD SIM P SOC, P170; Bai YH, 2013, ENERG CONVERS MANAGE, V67, P138, DOI 10.1016/j.enconman.2012.11.014; Bar Massada A, 2008, ECOL MODEL, V213, P463, DOI 10.1016/j.ecolmodel.2008.01.021; Borgonovo E, 2003, RELIAB ENG SYST SAFE, V79, P175, DOI 10.1016/S0951-8320(02)00228-4; Brugnach M, 2005, ECOL MODEL, V187, P99, DOI 10.1016/j.ecolmodel.2005.01.044; Collett T.S., 1993, 1570 US GEOL SURV, P299; Collett TS, 1997, B CAN PETROL GEOL, V45, P317; COLLETT TS, 1993, AAPG BULL, V77, P793; Cryer SA, 1999, ENVIRON MODELL SOFTW, V14, P613, DOI 10.1016/S1364-8152(99)00003-1; Edmonds B., 1996, SPE35569; ENGLEZOS P, 1993, CAN J CHEM ENG, V71, P322; EPA (U.S. Environmental Protection Agency), 2003, GUID DEV EV IN PRESS; European Commission, 2005, 7913 SEC EUR COMM; Fieberg J, 2005, ECOL MODEL, V187, P259, DOI 10.1016/j.ecolmodel.2005.01.042; Freeze R.A., 1979, GROUNDWATER, P28; Frey H.C, 2004, RECOMMENDED PRACTICE; Hamby M, 1994, ENVIRON MONIT ASSESS, V32, P135; HELTON JC, 1993, RELIAB ENG SYST SAFE, V42, P327, DOI 10.1016/0951-8320(93)90097-I; Helton J.C., 2003, STRUCTURAL DYNAMICS, V6, P4648; Helton JC, 2005, RELIAB ENG SYST SAFE, V89, P305, DOI [10.1016/j.ress.2004.09.006, 10.1016/j.ress.2004.08.006]; HYNDMAN RD, 1993, J GEOPHYS RES-SOL EA, V98, P21865, DOI 10.1029/93JB02391; HYNDMAN RD, 1992, EARTH PLANET SC LETT, V109, P289, DOI 10.1016/0012-821X(92)90093-B; IMAN RL, 1988, RISK ANAL, V8, P71, DOI 10.1111/j.1539-6924.1988.tb01155.x; Iman RL, 2002, RELIAB ENG SYST SAFE, V78, P131, DOI 10.1016/S0951-8320(02)00133-3; Iman RL, 2002, RELIAB ENG SYST SAFE, V78, P147, DOI 10.1016/S0951-8320(02)00134-5; Imhoff PT, 2003, J CONTAM HYDROL, V64, P73, DOI 10.1016/S0169-7722(02)00106-7; Jorgensen S.E., 1994, FUNDAMENTAL ECOLOGIC; Jung YW, 2010, NUTR CYCL AGROECOSYS, V87, P261, DOI 10.1007/s10705-009-9337-9; KATZ DL, 1971, J PETROL TECHNOL, V23, P419; Kaul N, 2000, MAR GEOL, V164, P37, DOI 10.1016/S0025-3227(99)00125-5; Keogh E., 2004, DATA MINING TIME SER, V57, P1, DOI 10.1142/9789812565402_0001; Kumar A, 2010, J PETROL SCI ENG, V70, P109, DOI 10.1016/j.petrol.2009.10.005; Kvenvolden K.A., 1993, FUTURE ENERGY GASES, P279; Kvenvolden K.A., 1993, 1570 USGS, P555; Lee Do-Hun, 2006, [JOURNAL OF KOREA WATER RESOURCES ASSOCITION, 한국수자원학회 논문집], V39, P677; Li G., 2011, CIESC J, V62, P458; Li G, 2010, ACTA CHIM SINICA, V68, P1083; Li Y, 2014, J HYDROL, V519, P271, DOI 10.1016/j.jhydrol.2014.07.019; Makogon Y.F, 1997, HYDRATES NATURAL GAS; Makogon Y.F, 1965, GAZOV PROMST, V5, P14; Mattern JP, 2013, J GEOPHYS RES-OCEANS, V118, P1316, DOI 10.1002/jgrc.20130; McKay MD, 1997, RELIAB ENG SYST SAFE, V57, P267, DOI 10.1016/S0951-8320(97)00039-2; McKay M.D, 1988, SENSITIVITY UNCERTAI, P145; Milkov AV, 2003, MAR PETROL GEOL, V20, P111, DOI 10.1016/S0264-8172(03)00024-2; Mishra S, 2009, J HYDROINFORM, V11, P282, DOI 10.2166/hydro.2009.048; Mishra S, 2003, RELIAB ENG SYST SAFE, V79, P123, DOI 10.1016/S0951-8320(02)00222-3; Moore L.M., 1999, P 1999 WINT SIM C, P486; Moridis G.J., 2005, LBNL58950; Moridis G.J., 2005, DEAC0376SF00098 DEP; Moridis GJ, 2008, TOUGH HYDRATE V1 0 U; Moridis G.J., 2007, STRATEGIES GAS PRODU; Moridis G.J, 2010, EVALUATION DEPOSITE; Munoz-Carpena R, 2007, T ASABE, V50, P1719; Pan F, 2011, J HYDROL, V397, P238, DOI 10.1016/j.jhydrol.2010.11.045; Pruess K., 1983, LBL15227; Ravalico JK, 2005, MODSIM 2005: INTERNATIONAL CONGRESS ON MODELLING AND SIMULATION: ADVANCES AND APPLICATIONS FOR MANAGEMENT AND DECISION MAKING, P2533; Reagan M., 2009, OFFSH TECHN C HOUST; Saltelli A., 2000, PROBABILITY STAT SER; Saltelli A., 2008, GLOBAL SENSITIVITY A; SCLOVE SL, 1983, INFORM SCIENCES, V29, P7, DOI 10.1016/0020-0255(83)90007-5; Sloan E. D., 1998, CLATHRATE HYDRATE NA; Sloan E.D., 1990, CLATHRATE HYDRATE NA; Sobol IM, 2001, MATH COMPUT SIMULAT, V55, P271, DOI 10.1016/S0378-4754(00)00270-6; THORNTON KW, 1979, SIMULATION, V32, P155, DOI 10.1177/003754977903200503; Uusitalo L, 2015, ENVIRON MODELL SOFTW, V63, P24, DOI 10.1016/j.envsoft.2014.09.017; Vandenberghe V, 2001, WATER SCI TECHNOL, V43, P295; Vanrolleghem PA, 2015, J HYDROL, V522, P339, DOI 10.1016/j.jhydrol.2014.12.056; Waples D.W., 2004, NAT RESOUR RES, V13.2, P97, DOI DOI 10.1023/B:NARR.0000032647.41046.E7; White M.D., 2006, PNNL15782UC2010; Wilder J.W., 2008, P 6 INT C GAS HYDR I; [吴能友 WU Nengyou], 2007, [天然气工业, Natural Gas Industry], V27, P1; Xu JH, 2012, EARTH SCI INFORM, V5, P167, DOI 10.1007/s12145-012-0105-z	115	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0264-8172	1873-4073		MAR PETROL GEOL	Mar. Pet. Geol.	AUG	2015	65						141	156		10.1016/j.marpetgeo.2015.04.009		16	Geosciences, Multidisciplinary	Geology	CL8MV	WOS:000357229700009		
J	Yasugi, M; Sugahara, Y; Hoshi, H; Kondo, K; Talukdar, PK; Sarker, MR; Yamamoto, S; Kamata, Y; Miyake, M				Yasugi, Mayo; Sugahara, Yuki; Hoshi, Hidenobu; Kondo, Kaori; Talukdar, Prabhat K.; Sarker, Mahfuzur R.; Yamamoto, Shigeki; Kamata, Yoichi; Miyake, Masami			In vitro cytotoxicity induced by Clostridium perfringens isolate carrying a chromosomal cpe gene is exclusively dependent on sporulation and enterotoxin production	MICROBIAL PATHOGENESIS			English	Article						Clostridium perfringens; Food poisoning; Caco-2 cells; Enterotoxin; Cytotoxicity	QUORUM-SENSING SYSTEM; TOXIN PRODUCTION; ALPHA-TOXIN; FLUID ACCUMULATION; ESCHERICHIA-COLI; LOOP MODEL; EXPRESSION; STRAINS; DISEASE; IDENTIFICATION	Clostridium perfringens type A is a common source of food poisoning (FP) and non-food-borne (NFB) gastrointestinal diseases in humans. In the intestinal tract, the vegetative cells sporulate and produce a major pathogenic factor, C perfringens enterotoxin (CPE). Most type A FP isolates carry a chromosomal cpe gene, whereas NFB type A isolates typically carry a plasmid-encoded cpe. In vitro, the purified CPE protein binds to a receptor and forms pores, exerting a cytotoxic activity in epithelial cells. However, it remains unclear if CPE is indispensable for C perfringens cytotoxicity. In this study, we examined the cytotoxicity of cpe-harboring C perfringens isolates co-cultured with human intestinal epithelial Caco-2 cells. The FP strains showed severe cytotoxicity during sporulation and CPE production, but not during vegetative cell growth. While Caco-2 cells were intact during co-culturing with cpe-null mutant derivative of strain SM101 (a FP strain carrying a chromosomal cpe gene), the wild-type level cytotoxicity was observed with cpe-complemented strain. In contrast, both wild-type and cpe-null mutant derivative of the NFB strain F4969 induced Caco-2 cell death during both vegetative and sporulation growth. Collectively, the Caco-2 cell cytotoxicity caused by C perfringens strain SM101 is considered to be exclusively dependent on CPE production, whereas some additional toxins should be involved in F4969-mediated in vitro cytotoxicity. (C) 2015 Elsevier Ltd. All rights reserved.	[Yasugi, Mayo; Sugahara, Yuki; Hoshi, Hidenobu; Kondo, Kaori; Miyake, Masami] Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Izumisano, Osaka 5988531, Japan; [Talukdar, Prabhat K.; Sarker, Mahfuzur R.] Oregon State Univ, Dept Biomed Sci, Corvallis, OR 97331 USA; [Talukdar, Prabhat K.; Sarker, Mahfuzur R.] Oregon State Univ, Dept Microbiol, Corvallis, OR 97331 USA; [Yamamoto, Shigeki] Tokai Univ, Sch Marine Sci & Technol, Shimizu, Shizuoka 4248610, Japan; [Kamata, Yoichi] Iwate Univ, Dept Agr, Morioka, Iwate 0208550, Japan	Yasugi, M (reprint author), Osaka Prefecture Univ, Grad Sch Life & Environm Sci, 1-58 Rinku Ourai Kita, Izumisano, Osaka 5988531, Japan.	shishimaru@vet.osakafu-u.ac.jp			JSPS KAKENHI [25860467]; Takeda Science Foundation; Ministry of Health, Labor and Welfare of Japan [201327009A]; Department of Defense Multidisciplinary University Research Initiative (MURI) through the U.S. Army Research Laboratory; U.S. Army Research Office [W911NF-09-1-0286]	We thank Dr. Tohru Shimizu and Dr. Kaori Ohtani (Kanazawa University) for providing the bacterial strains; Dr. Chie Monma (Tokyo Metropolitan Institute for Public Health) for providing the bacterial strains and helpful advice; Dr. Yasuhiko Horiguchi (Osaka University) for providing the rabbit anti-CPE antibody and purified CPE protein; Dr. Masahiro Nagahama (Tokushima Bunri University) for providing the rabbit anti-alpha-toxin antibody; and Dr. Koji Hosomi (Osaka Prefecture University) for technical assistance. This work was supported in part by JSPS KAKENHI (grant number 25860467) to M.Y., a grant from the Takeda Science Foundation to M.Y., a Health Sciences Research Grant from the Ministry of Health, Labor and Welfare of Japan 201327009A to Y.K. and M.M., a Department of Defense Multidisciplinary University Research Initiative (MURI) award through the U.S. Army Research Laboratory, and the U.S. Army Research Office under contract number W911NF-09-1-0286 to M.R.S.	Akaeda H, 1987, Nihon Saikingaku Zasshi, V42, P575; Allaart JG, 2014, VET MICROBIOL, V171, P132, DOI 10.1016/j.vetmic.2014.03.020; Scallan E, 2011, EMERG INFECT DIS, V17, P7, DOI 10.3201/eid1701.091101p1; Rohde KH, 2007, CELL HOST MICROBE, V2, P352, DOI 10.1016/j.chom.2007.09.006; Chen Y, 2005, APPL ENVIRON MICROB, V71, P7542, DOI 10.1128/AEM.71.11.7542-7547.2005; Li JH, 2013, MICROBIOL MOL BIOL R, V77, P208, DOI 10.1128/MMBR.00062-12; Brynestad S, 2002, INT J FOOD MICROBIOL, V74, P195, DOI 10.1016/S0168-1605(01)00680-8; Vidal JE, 2009, CELL MICROBIOL, V11, P1306, DOI 10.1111/j.1462-5822.2009.01332.x; [Anonymous], 2011, J INFECT CHEMOTHE S1, V17, P135; Okumura K, 2008, J BACTERIOL, V190, P7719, DOI 10.1128/JB.01573-07; Takahashi A, 2005, J CONTROL RELEASE, V108, P56, DOI 10.1016/j.jconrel.2005.07.008; Miyamoto K, 2012, MICROBES ENVIRON, V27, P343, DOI 10.1264/jsme2.ME12002; Obana N, 2013, J BACTERIOL, V195, P2937, DOI 10.1128/JB.00148-13; Uzal FA, 2014, FUTURE MICROBIOL, V9, P361, DOI 10.2217/fmb.13.168; Varga J, 2004, J BACTERIOL, V186, P5221, DOI 10.1128/JB.186.16.5221-5229.2004; McClane BA, 2001, TOXICON, V39, P1781, DOI 10.1016/S0041-0101(01)00164-7; Chen JM, 2012, INFECT IMMUN, V80, P3008, DOI 10.1128/IAI.00438-12; Sayeed S, 2008, MOL MICROBIOL, V67, P15, DOI 10.1111/j.1365-2958.2007.06007.x; O'Brien DK, 2004, INFECT IMMUN, V72, P5204, DOI 10.1128/IAI.72.9.5204-5215.2004; Gormley FJ, 2011, EPIDEMIOL INFECT, V139, P688, DOI 10.1017/S0950268810001858; Antunes A, 2012, NUCLEIC ACIDS RES, V40, P10701, DOI 10.1093/nar/gks864; Bullifent HL, 1996, ANAEROBE, V2, P365, DOI 10.1006/anae.1996.0046; Caserta JA, 2011, INFECT IMMUN, V79, P3020, DOI 10.1128/IAI.01342-10; Chen Jianming, 2014, Gut Microbes, V5, P96, DOI 10.4161/gmic.26419; Czeczulin JR, 1996, INFECT IMMUN, V64, P3301; Deguchi A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005598; De Jong AEI, 2002, J FOOD PROTECT, V65, P1457; DUNCAN CL, 1968, APPL MICROBIOL, V16, P82; Miyakawa MEF, 2005, INFECT IMMUN, V73, P8407, DOI 10.1128/IAI.73.12.8407-8410.2005; Flores-Diaz M, 2003, TOXICON, V42, P979, DOI 10.1016/j.toxicon.2003.11.013; Heredia N L, 1991, FEMS Microbiol Lett, V68, P15; Homolka S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000988; Katayama S, 2013, ANAEROBE, V23, P62, DOI 10.1016/j.anaerobe.2013.06.007; Kimura J, 2010, J BIOL CHEM, V285, P401, DOI 10.1074/jbc.M109.051417; Kitadokoro K, 2011, J BIOL CHEM, V286, P19549, DOI 10.1074/jbc.M111.228478; LABBE RG, 1975, APPL MICROBIOL, V29, P345; Li JH, 2010, INFECT IMMUN, V78, P4286, DOI 10.1128/IAI.00528-10; Ma M., 2011, MBIO, V2; MCDONEL JL, 1980, PHARMACOL THERAPEUT, V10, P617, DOI 10.1016/0163-7258(80)90031-5; Mitchell LA, 2010, TOXINS, V2, P1595, DOI 10.3390/toxins2071595; Mittal R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091885; Miyake M, 2005, BIOCHEM BIOPH RES CO, V337, P922, DOI 10.1016/j.bbrc.2005.09.130; Nakashima R, 2013, VET IMMUNOL IMMUNOP, V152, P78, DOI 10.1016/j.vetimm.2012.09.026; Ohtani K, 1997, FEMS MICROBIOL LETT, V146, P155, DOI 10.1016/S0378-1097(96)00472-7; Ohtani K., 2014, RES MICROBIOL; Rochat T, 2013, FEMS MICROBIOL LETT, V344, P104, DOI 10.1111/1574-6968.12162; Sarker MR, 1999, MOL MICROBIOL, V33, P946, DOI 10.1046/j.1365-2958.1999.01534.x; SHERMAN S, 1994, J DIARRHOEAL DIS RES, V12, P200; Shrestha A., 2013, MBIO, V4; SKJELKVALE R, 1977, J APPL BACTERIOL, V43, P281, DOI 10.1111/j.1365-2672.1977.tb00752.x; Veshnyakova A, 2010, TOXINS, V2, P1336, DOI 10.3390/toxins2061336; Vidal JE, 2012, MOL MICROBIOL, V83, P179, DOI 10.1111/j.1365-2958.2011.07925.x; Wu SB, 2011, APPL ENVIRON MICROB, V77, P1135, DOI 10.1128/AEM.01803-10; YAMAMOTO K, 1979, APPL ENVIRON MICROB, V37, P181; Zhao YL, 1998, J BACTERIOL, V180, P136	55	0	0	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	0882-4010			MICROB PATHOGENESIS	Microb. Pathog.	AUG	2015	85						1	10		10.1016/j.micpath.2015.04.003		10	Immunology; Microbiology	Immunology; Microbiology	CM5CF	WOS:000357703700001		
J	Toth, M; Haggkvist, J; Stepanov, V; Takano, A; Nakao, R; Amini, N; Miura, S; Kimura, H; Taniguchi, T; Gulyas, B; Halldin, C				Toth, Miklos; Haggkvist, Jenny; Stepanov, Vladimir; Takano, Akihiro; Nakao, Ryuji; Amini, Nahid; Miura, Shotaro; Kimura, Haruhide; Taniguchi, Takahiko; Gulyas, Balazs; Halldin, Christer			Molecular Imaging of PDE10A Knockout Mice with a Novel PET Radiotracer: [C-11]T-773	MOLECULAR IMAGING AND BIOLOGY			English	Article						Carbon-11; [C-11]T-773; Positron emission tomography (PET); PDE10A; CNS; Brain imaging; Mouse	IN-VIVO EVALUATION; PHOSPHODIESTERASE 10A; PRECLINICAL EVALUATION; PERFORMANCE EVALUATION; BRAIN; RADIOLIGAND; INHIBITORS; TRACER	[C-11]T-773 is a new radioligand for positron emission tomography (PET) targeting the phosphodiesterase 10A enzyme (PDE10A). PDE10A is highly expressed in the striatum by medium spiny neurons, and it has been demonstrated to be involved in the regulation of striatal signaling through the reduction of medium spiny neuronal sensitivity towards glutamatergic excitation. PDE10A is associated with Parkinson's disease and different neuropsychiatric disorders such as Huntington's disease, obsessive-compulsive disorders (OCD) and schizophrenia. Studies have indicated that the inhibition of PDE10A may represent a novel therapeutic approach to the treatment of the aforementioned diseases characterized by the reduced activity of medium spiny neurons. An appropriate PET radioligand for PDE10A would help to facilitate drug development and drug evaluation. We have evaluated the [C-11]T-773 ligand in PDE10A knockout mice (heterozygous [HET] and homozygous [HOM]) as well as in normal control animals (WILD) with PET. The regional percent standardized uptake values (%SUV; mean +/- SD) in the striatum were 48.2 +/- 1.0 (HOM), 63.6 +/- 5.3 (HET) and 85.1 +/- 6.3 (WILD). Between each animal group the striatal %SUV values were significantly different (p < 0.0001). The striatal BPND values (mean +/- SD) were 0.0 +/- 0.0 (HOM), 0.14 +/- 0.07 (HET) and 0.56 +/- 0.15 (WILD). The BPND values were significantly lower in homozygous and heterozygous animals compared to wild type (p < 0.0001). The novel PDE10A radioligand [C-11]T-773 shows increased signals with higher levels of PDE10A and acceptable binding in the striatum in control animals compared to knockout mice.	[Toth, Miklos; Haggkvist, Jenny; Stepanov, Vladimir; Takano, Akihiro; Nakao, Ryuji; Amini, Nahid; Miura, Shotaro; Gulyas, Balazs; Halldin, Christer] Karolinska Inst, Ctr Psychiat Res, Dept Clin Neurosci, SE-17176 Stockholm, Sweden; [Miura, Shotaro; Kimura, Haruhide; Taniguchi, Takahiko] TAKEDA Pharmaceut Co Ltd, Div Pharmaceut Res, CNS Drug Discovery Unit, Fujisawa, Kanagawa, Japan; [Gulyas, Balazs; Halldin, Christer] Nanyang Technol Univ, NTU Imperial Coll, Lee Kong Chian Sch Med, Singapore 639798, Singapore	Toth, M (reprint author), Karolinska Inst, Ctr Psychiat Res, Dept Clin Neurosci, SE-17176 Stockholm, Sweden.	miklos.toth@ki.se			Takeda Pharmaceutical Company Limited; COST Action [TD1007]	This work was sponsored by the Takeda Pharmaceutical Company Limited. The authors express their gratitude to members of the Karolinska PET group for their contribution to the experiments. Special thanks to Bjorn Wolbert, Kalman Nagy and Sara Lundqvist for their participation in the PET imaging. The research leading to these results has received funding from the COST Action TD1007 ("Bimodal PET-MRI molecular imaging technologies and applications for in vivo monitoring of disease and biological processes").	Tu Z, 2010, NUCL MED BIOL, V37, P509, DOI 10.1016/j.nucmedbio.2009.12.012; Seeger TF, 2003, BRAIN RES, V985, P113, DOI 10.1016/S0006-8993(03)02754-9; Schmidt CJ, 2008, J PHARMACOL EXP THER, V325, P681, DOI 10.1124/jpet.107.132910; Van Laere K, 2013, J NUCL MED, V54, P1285, DOI 10.2967/jnumed.112.118679; Barret O, 2014, J NUCL MED, V55, P1297, DOI 10.2967/jnumed.113.122895; Harada A, 2015, NUCL MED BIOL, V42, P146, DOI 10.1016/j.nucmedbio.2014.09.005; Fan JD, 2014, BIOORGAN MED CHEM, V22, P2648, DOI 10.1016/j.bmc.2014.03.028; Siuciak JA, 2006, NEUROPHARMACOLOGY, V51, P374, DOI 10.1016/j.neuropharm.2006.01.012; Celen S, 2010, J NUCL MED, V51, P1584, DOI 10.2967/jnumed.110.077040; Siuciak JA, 2006, NEUROPHARMACOLOGY, V51, P386, DOI 10.1016/j.neuropharm.2006.04.013; Plisson C, 2011, NUCL MED BIOL, V38, P875, DOI 10.1016/j.nucmedbio.2011.02.005; Szanda I, 2011, J NUCL MED, V52, P1741, DOI 10.2967/jnumed.111.088260; Nagy K, 2013, J NUCL MED, V54, P1825, DOI 10.2967/jnumed.112.119065; Celen S, 2013, NEUROIMAGE, V82, P13, DOI 10.1016/j.neuroimage.2013.04.123; Lammertsma AA, 1996, NEUROIMAGE, V4, P153, DOI 10.1006/nimg.1996.0066; Barret O, 2012, J NUCL MED S1, V53; Chappie T, 2009, CURR OPIN DRUG DISC, V12, P458; Stepanov V, 2013, J LABELLED COMP RADI, V56, pS1	18	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1536-1632	1860-2002		MOL IMAGING BIOL	Mol. Imaging. Biol.	AUG	2015	17	4					445	449		10.1007/s11307-015-0822-z		5	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CM2IV	WOS:000357504300002		
J	Song, T; Wang, X				Song, Tao; Wang, Xun			Homogenous Spiking Neural P Systems with Inhibitory Synapses	NEURAL PROCESSING LETTERS			English	Article						Membrane computing; P system; Spiking neural P system; Anti-spike; Turing completeness	NEURONS; RECOGNIZERS; INDUCTION; RULES	Spiking neural P systems with inhibitory synapses (ISN P systems, for short) are a class of discrete neural-like computing models, which are inspired by the way of biological neurons storing and processing information and communication by means of excited and inhibitory impulses. In this work, we prove that ISN P systems can compute and accept any set of Turing computable numbers by using one type of neurons, thus can achieve Turing universality. Such systems are called homogenous ISN P systems. The results give a positive answer to an open problem left in (Pan and Pun, Int J Comput Commun 4(3):273-282, 2009) that "whether the number of types of neurons in universal SN P systems can be decreased by using inhibitory synapses". The obtained result is optimal in the sense of having minimal number of types of neurons in Turing universal SN P systems.	[Song, Tao] Huazhong Univ Sci & Technol, Sch Automat, Wuhan 430074, Hubei, Peoples R China; [Wang, Xun] Univ Tsukuba, Grad Sch Syst & Informat Engn, Tsukuba, Ibaraki 3050006, Japan	Wang, X (reprint author), Univ Tsukuba, Grad Sch Syst & Informat Engn, Tsukuba, Ibaraki 3050006, Japan.	wangxun0830@hotmail.com			National Natural Science Foundation of China [61033003, 91130034, 61100145, 61202011, 61272071]; Ph.D. Programs Foundation of Ministry of Education of China [20100142110072, 2012014213 008]; Natural Science Foundation of Hubei Province [2011CDA027]	This work was supported by National Natural Science Foundation of China (61033003, 91130034, 61100145, 61202011 and 61272071), Ph.D. Programs Foundation of Ministry of Education of China (20100142110072 and 2012014213 008), and Natural Science Foundation of Hubei Province (2011CDA027).	Paun G, 2000, J COMPUT SYST SCI, V61, P108, DOI 10.1006/jcss.1999.1693; SIEGELMANN HT, 1995, J COMPUT SYST SCI, V50, P132, DOI 10.1006/jcss.1995.1013; Ionescu M, 2006, FUND INFORM, V71, P279; Paun A, 2007, BIOSYSTEMS, V90, P48, DOI 10.1016/j.biosystems.2006.06.006; Zeng XX, 2009, FUND INFORM, V97, P275, DOI 10.3233/FI-2009-200; Cavaliere M, 2009, THEOR COMPUT SCI, V410, P2352, DOI 10.1016/j.tcs.2009.02.031; Song T, 2013, INFORM SCIENCES, V219, P197, DOI 10.1016/j.ins.2012.07.023; Zhang GX, 2012, NAT COMPUT, V11, P701, DOI 10.1007/s11047-012-9320-2; Xiao JH, 2012, CHINESE SCI BULL, V57, P698, DOI 10.1007/s11434-011-4928-7; Pan LQ, 2009, INT J COMPUT COMMUN, V4, P273; Freund R, 2005, THEOR COMPUT SCI, V330, P101, DOI 10.1016/j.tcs.2004.09.013; Pan LQ, 2010, LECT NOTES COMPUT SC, V5957, P436; Zhang GX, 2013, APPL SOFT COMPUT, V13, P1528, DOI 10.1016/j.asoc.2012.05.032; Song T, 2012, IEEE T NANOBIOSCI, V11, P352, DOI 10.1109/TNB.2012.2208122; Song T, 2014, THEOR COMPUT SCI, V529, P82, DOI 10.1016/j.tcs.2014.01.001; Pan LQ, 2010, THEOR COMPUT SCI, V411, P906, DOI 10.1016/j.tcs.2009.11.010; Pan LQ, 2011, IEEE T NANOBIOSCI, V10, P99, DOI 10.1109/TNB.2011.2160281; Maass W, 1997, NEURAL NETWORKS, V10, P1659, DOI 10.1016/S0893-6080(97)00011-7; Ishdorj TO, 2010, THEOR COMPUT SCI, V411, P2345, DOI 10.1016/j.tcs.2010.01.019; Chen HM, 2007, FUND INFORM, V75, P141; Zhang Xingyi, 2008, Natural Computing, V7, P535, DOI 10.1007/s11047-008-9079-7; Pan LQ, 2011, SCI CHINA INFORM SCI, V54, P1596, DOI 10.1007/s11432-011-4303-y; Ghosh DS, 2009, INT J NEURAL SYST, V19, P295; Giles CL, 1992, P 1992 IEE SIGN PROC, P13; Hyoetyniemi H, 1996, P STEP 96 GEN NETS S, P13; Ionescu M, 2007, P 8 WORKSH MEMBR COM, P383; Maass W, 1999, INFORM COMPUT, V153, P26, DOI 10.1006/inco.1999.2806; Macias-Ramos LF, 2013, LECT NOTES COMPUTER, V7762, P228; Minsky M., 1967, COMPUTATION FINITE I; Moore C, 1998, THEOR COMPUT SCI, V201, P99, DOI 10.1016/S0304-3975(97)00028-5; Natschlager T, 2002, THEOR COMPUT SCI, V287, P251, DOI 10.1016/S0304-3975(02)00099-3; Nishida T., 2004, P BRAINST WORKSH UNC, P185; Nishida TY, 2006, MEMBRANE ALGORITHMS; Pan L, 2012, NEURAL COMPUT, V24, P1; Paun G., 2002, MEMBRANE COMPUTING I; Paun G., 2007, J UNIVERS COMPUT SCI, V13, P1707; Paun G., 2010, OXFORD HDB MEMBRANE; POLLACK JB, 1991, MACH LEARN, V7, P227, DOI 10.1007/BF00114845; Rozenberg Grzegorz, 2011, HDB NATURAL COMPUTIN; Salomaa A., 1997, HDB FORMAL LANGUAGES; Song T, 2014, NEURAL COMPUT APPL, V24, P1833, DOI 10.1007/s00521-013-1397-8; Wang KT, 2011, CHEM ENG J, V167, P228, DOI 10.1016/j.cej.2010.12.036; Zhao JH, 2011, IND ENG CHEM RES, V50, P1691, DOI 10.1021/ie101002n	43	2	2	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1370-4621	1573-773X		NEURAL PROCESS LETT	Neural Process. Lett.	AUG	2015	42	1			SI		199	214		10.1007/s11063-014-9352-y		16	Computer Science, Artificial Intelligence	Computer Science	CM5KL	WOS:000357726600012		
J	Iwata, S; Ito, M; Nakata, T; Noguchi, Y; Okuno, T; Ohkawara, B; Masuda, A; Goto, T; Adachi, M; Osaka, H; Nonaka, R; Arikawa-Hirasawa, E; Ohno, K				Iwata, Satoshi; Ito, Mikako; Nakata, Tomohiko; Noguchi, Yoichiro; Okuno, Tatsuya; Ohkawara, Bisei; Masuda, Akio; Goto, Tomohide; Adachi, Masanori; Osaka, Hitoshi; Nonaka, Risa; Arikawa-Hirasawa, Eri; Ohno, Kinji			A missense mutation in domain III in HSPG2 in Schwartz-Jampel syndrome compromises secretion of perlecan into the extracellular space	NEUROMUSCULAR DISORDERS			English	Article						Schwartz-Jampel syndrome; Perlecan; Whole genome resequencing analysis	PERIPHERAL-NERVE HYPEREXCITABILITY; NEUROMUSCULAR-JUNCTION; BASEMENT-MEMBRANES; MOUSE MODEL; ACETYLCHOLINESTERASE; PROTEIN; CHONDRODYSPLASIA; CARTILAGE; MYOPATHY; REVEALS	Schwartz-Jampel syndrome (SJS) type 1 is characterized by short stature, myotonia, and chondrodysplasia, and is caused by partial loss-of-function mutations in HSPG2 encoding perlecan. Six missense mutations have been reported in SJS to date and only one has been characterized using a recombinant protein. We report an 11-year-old Japanese boy with SJS, who shows "rigid" walking with less flexion of knees/ankles and protruded mouth. His intelligence is normal. We identified by whole genome resequencing a heterozygous missense p.Leu1088Pro in domain III-2 and a heterozygous nonsense p.G1n3061Ter in domain IV of perlecan. Expression studies revealed that p.Leu1088Pro markedly reduces the cellular expression of domain III-2 and almost nullifies its secretion into the culture medium. As five of the seven missense mutations in SJS affect domain III of perlecan, domain III is likely to be essential for secretion of perlecan into the extracellular space. (C) 2015 Elsevier B.A. All rights reserved.	[Iwata, Satoshi; Ito, Mikako; Nakata, Tomohiko; Noguchi, Yoichiro; Okuno, Tatsuya; Ohkawara, Bisei; Masuda, Akio; Ohno, Kinji] Nagoya Univ, Grad Sch Med, Div Neurogenet, Ctr Neurol Dis & Canc, Nagoya, Aichi 4668550, Japan; [Goto, Tomohide; Osaka, Hitoshi] Kanagawa Childrens Med Ctr, Dept Neurol, Yokohama, Kanagawa, Japan; [Adachi, Masanori] Kanagawa Childrens Med Ctr, Dept Endocrinol & Metab, Yokohama, Kanagawa, Japan; [Osaka, Hitoshi] Jichi Med Sch, Dept Pediat, Shimotsuke, Tochigi, Japan; [Nonaka, Risa; Arikawa-Hirasawa, Eri] Juntendo Univ, Grad Sch Med, Res Inst Dis Old Age, Tokyo, Japan	Ohno, K (reprint author), Nagoya Univ, Grad Sch Med, Div Neurogenet, Showa Ku, 65 Tsurumai, Nagoya, Aichi 4668550, Japan.	ohnok@med.nagoya-u.ac.jp	Masuda, Akio/H-6323-2012		MEXT of Japan; MHLW of Japan	This study was supported by Grants-in-Aid from the MEXT and MHLW of Japan.	Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Whitelock JM, 2005, CHEM REV, V105, P2745, DOI 10.1021/cr010213m; Nicole S, 2000, NAT GENET, V26, P480; Arikawa-Hirasawa E, 2001, NAT GENET, V27, P431, DOI 10.1038/86941; Bell CJ, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001756; Arikawa-Hirasawa E, 1999, NAT GENET, V23, P354; Costell M, 1999, J CELL BIOL, V147, P1109, DOI 10.1083/jcb.147.5.1109; Arikawa-Hirasawa E, 2002, NAT NEUROSCI, V5, P119, DOI 10.1038/nn801; Peng HB, 1999, J CELL BIOL, V145, P911, DOI 10.1083/jcb.145.4.911; Vorechovsky I, 2010, HUM GENET, V127, P135, DOI 10.1007/s00439-009-0752-4; Stum M, 2006, HUM MUTAT, V27, P1082, DOI 10.1002/humu.20388; Whitelock JM, 2008, BIOCHEMISTRY-US, V47, P11174, DOI 10.1021/bi8013938; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Echaniz-Laguna A, 2009, MUSCLE NERVE, V40, P55, DOI 10.1002/mus.21253; Smith SML, 2007, ARCH BIOCHEM BIOPHYS, V468, P244, DOI 10.1016/j.abb.2007.10.006; Sher I, 2006, J BIOL CHEM, V281, P5178, DOI 10.1074/jbc.M509500200; Rodgers KD, 2007, HUM MOL GENET, V16, P515, DOI 10.1093/hmg/ddl484; Arikawa-Hirasawa E, 2002, AM J HUM GENET, V70, P1368, DOI 10.1086/340390; Bangratz M, 2012, AM J PATHOL, V180, P2040, DOI [10.1016/j.ajpath.2012.01.035, 10.1016/j.ajpatb.2012.01.035]; Bauche S, 2013, NEUROMUSCULAR DISORD, V23, P998, DOI 10.1016/j.nmd.2013.07.005; Ghiselli G, 2001, BIOCHEM J, V359, P153, DOI 10.1042/0264-6021:3590153; Ito M, 2012, MOL THER, V20, P1384, DOI 10.1038/mt.2012.34; Rieubland C, 2010, EUR J MED GENET, V53, P294, DOI 10.1016/j.ejmg.2010.06.005; SCHWARTZ O, 1962, ARCH OPHTHALMOL-CHIC, V68, P52; Stum M, 2008, HUM MOL GENET, V17, P3166, DOI 10.1093/hmg/ddn213	25	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0960-8966	1873-2364		NEUROMUSCULAR DISORD	Neuromusc. Disord.	AUG	2015	25	8					667	671		10.1016/j.nmd.2015.05.002		5	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CM5YP	WOS:000357765200010		
J	Asaoka, N; Nagayasu, K; Nishitani, N; Yamashiro, M; Shirakawa, H; Nakagawa, T; Kaneko, S				Asaoka, Nozomi; Nagayasu, Kazuki; Nishitani, Naoya; Yamashiro, Mayumi; Shirakawa, Hisashi; Nakagawa, Takayuki; Kaneko, Shuji			Olanzapine augments the effect of selective serotonin reuptake inhibitors by suppressing GABAergic inhibition via antagonism of 5-HT6 receptors in the dorsal raphe nucleus	NEUROPHARMACOLOGY			English	Article						Olanzapine; Selective serotonin reuptake inhibitor; Serotonergic neurons; 5-HT6 receptor; GABAergic neurons; Depression	TREATMENT-RESISTANT DEPRESSION; MEDIAL PREFRONTAL CORTEX; CENTRAL-NERVOUS-SYSTEM; IN-VIVO MICRODIALYSIS; SLICE CULTURES; OLANZAPINE/FLUOXETINE COMBINATION; SUSTAINED EXPOSURE; DOPAMINE RELEASE; MAJOR DEPRESSION; MESSENGER-RNAS	The combination of the selective serotonin reuptake inhibitors (SSRIs) and atypical antipsychotic drugs shows better therapeutic efficacy than SSRI monotherapy in the treatment of depression. However, the underlying mechanisms responsible for the augmenting effects of olanzapine are not fully understood. Here, we report that olanzapine enhances the SSRI-induced increase in extracellular serotonin (5-HT) levels and antidepressant-like effects by inhibiting GABAergic neurons through 5-HT6 receptor antagonism in the dorsal raphe nucleus (DRN). In organotypic raphe slice cultures, treatment with olanzapine (1-100 mu M) enhanced the increase in extracellular 5-HT levels in the presence of fluoxetine (10 mu M) or citalopram (1 mu M). The enhancing effect of olanzapine was not further augmented by the GABA(A) receptor antagonist bicuculline. Electrophysiological analysis revealed that olanzapine (50 mu M) decreased the firing frequency of GABAergic neurons in acute DRN slices. Among many serotonergic agents, the 5-HT6 receptor antagonist SB399885 (1-100 mu M) mimicked the effects of olanzapine by enhancing the SSRI-induced increase in extracellular 5-HT levels, which was not further augmented by bicuculline or olanzapine. SB399885 (50 mu M) also decreased the firing frequency of GABAergic neurons in the DRN. In addition, an intraperitoneal administration of SB399885 (10 mg/kg) to mice significantly enhanced the antidepressant-like effect of a subeffective dose of citalopram (3 mg/kg) in the tail-suspension test. These results suggest that olanzapine decreases local inhibitory GABAergic tone in the DRN through antagonism of 5-HT6 receptors, thereby increasing the activity of at least part of serotonergic neurons, which may contribute to the augmentation of the efficacy of SSRIs. (C) 2015 Elsevier Ltd. All rights reserved.	[Asaoka, Nozomi; Nagayasu, Kazuki; Nishitani, Naoya; Yamashiro, Mayumi; Shirakawa, Hisashi; Nakagawa, Takayuki; Kaneko, Shuji] Kyoto Univ, Dept Mol Pharmacol, Grad Sch Pharmaceut Sci, Kyoto, Japan; [Nagayasu, Kazuki] Osaka Univ, Grad Sch Pharmaceut Sci, Drug Innovat Ctr, Osaka, Japan; [Nagayasu, Kazuki] Osaka Univ, Grad Sch Pharmaceut Sci, Lab Mol Neuropharmacol, Osaka, Japan; [Nakagawa, Takayuki] Kyoto Univ Hosp, Dept Clin Pharmacol & Therapeut, Kyoto 6068507, Japan	Nakagawa, T (reprint author), Kyoto Univ Hosp, Dept Clin Pharmacol & Therapeut, Sakyo Ku, 54 Shogoin Kawahara Cho, Kyoto 6068507, Japan.	tknakaga@kuhp.kyoto-u.ac.p			Ministry of Education, Culture, Sport, Science and Technology of Japan [26120714]; Japanese Society for the Promotion of Science [24390016, 26293019]	We thank Prof. Momiyama (Jikei University School of Medicine) for expert assistance in raphe slice electrophysiology. This work was supported in part by Grants-in-Aid for Scientific Research (KAKENHI) from the Ministry of Education, Culture, Sport, Science and Technology of Japan (a Grant-in-Aid for Scientific Research in the Innovative Area "Prediction and Decision Making" to S.K. [26120714]), and from the Japanese Society for the Promotion of Science (Grants-in-Aid for Scientific Research (B) to S.K. [24390016] and T.N. [26293019]).	Amargos-Bosch M, 2007, J NEUROCHEM, V102, P550, DOI 10.1111/j.1471-4159.2007.04532.x; ANDERSSON JL, 1995, N-S ARCH PHARMACOL, V352, P374; Tye KM, 2013, NATURE, V493, P537, DOI 10.1038/nature11740; McIntyre A, 2007, DEPRESS ANXIETY, V24, P487, DOI 10.1002/da.20275; Hammack SE, 2012, NEUROPHARMACOLOGY, V62, P565, DOI 10.1016/j.neuropharm.2011.02.024; Nishitani N, 2014, INT J NEUROPSYCHOPH, V17, P1321, DOI 10.1017/S1461145714000649; Marek GJ, 2005, NEUROPSYCHOPHARMACOL, V30, P2205, DOI 10.1038/sj.npp.1300762; AGHAJANIAN GK, 1977, BRAIN RES, V122, P229, DOI 10.1016/0006-8993(77)90291-8; Schechter LE, 2008, NEUROPSYCHOPHARMACOL, V33, P1323, DOI 10.1038/sj.npp.1301503; Wesolowska A, 2007, NEUROPHARMACOLOGY, V52, P1274, DOI 10.1016/j.neuropharm.2007.01.007; Zhang W, 2000, NEUROPSYCHOPHARMACOL, V23, P250, DOI 10.1016/S0893-133X(00)00119-6; Bosker FJ, 2001, J NEUROCHEM, V76, P1645, DOI 10.1046/j.1471-4159.2001.00194.x; Bymaster FP, 1999, SCHIZOPHR RES, V37, P107, DOI 10.1016/S0920-9964(98)00146-7; Roberts JC, 2002, BRAIN RES, V934, P49, DOI 10.1016/S0006-8993(02)02360-0; Hirano K, 2009, LIFE SCI, V84, P558, DOI 10.1016/j.lfs.2009.01.019; Challis C, 2013, J NEUROSCI, V33, P13978, DOI 10.1523/JNEUROSCI.2383-13.2013; Michelsen KA, 2008, PROG BRAIN RES, V172, P233, DOI 10.1016/S0079-6123(08)00912-6; Whale R, 2010, J PSYCHOPHARMACOL, V24, P513, DOI 10.1177/0269881108097714; King MV, 2004, NEUROPHARMACOLOGY, V47, P195, DOI 10.1016/j.neuropharm.2004.03.012; Bymaster FP, 2001, EUR J PHARMACOL, V430, P341, DOI 10.1016/S0014-2999(01)01399-1; Gerard C, 1996, SYNAPSE, V23, P164, DOI 10.1002/(SICI)1098-2396(199607)23:3<164::AID-SYN5>3.3.CO;2-C; Martin-Ruiz R, 2001, J NEUROSCI, V21, P9856; Svenningsson P, 2007, J NEUROSCI, V27, P4201, DOI 10.1523/JNEUROSCI.3110-06.2007; Woolley ML, 2001, NEUROPHARMACOLOGY, V41, P210, DOI 10.1016/S0028-3908(01)00056-9; Nelson JC, 2009, AM J PSYCHIAT, V166, P980, DOI 10.1176/appi.ajp.2009.09030312; Belmaker RH, 2008, NEW ENGL J MED, V358, P55, DOI 10.1056/NEJMra073096; Nagayasu K, 2013, INT J NEUROPSYCHOPH, V16, P2295, DOI 10.1017/S1461145713000771; Gerard C, 1997, BRAIN RES, V746, P207, DOI 10.1016/S0006-8993(96)01224-3; Tohen M, 2003, ARCH GEN PSYCHIAT, V60, P1079, DOI 10.1001/archpsyc.60.11.1079; Corya SA, 2006, DEPRESS ANXIETY, V23, P364, DOI 10.1002/da.20130; Bang SJ, 2012, J COMP NEUROL, V520, P4157, DOI 10.1002/cne.23146; Bergner CL, 2010, METHODS MOL BIOL, V602, P267, DOI 10.1007/978-1-60761-058-8_16; Bernotas RC, 2009, BIOORGAN MED CHEM, V17, P5153, DOI 10.1016/j.bmc.2009.05.055; Boothman LJ, 2006, NEUROPHARMACOLOGY, V50, P726, DOI 10.1016/j.neuropharm.2005.11.020; Carvalho AF, 2014, PSYCHOTHER PSYCHOSOM, V83, P70, DOI 10.1159/000357500; Corradetti R, 2005, J PHARMACOL EXP THER, V315, P109, DOI 10.1124/jpet.105.087809; Dube S, 2007, BIPOLAR DISORD, V9, P618, DOI 10.1111/j.1399-5618.2007.00491.x; Gartside SE, 2007, EUR J NEUROSCI, V25, P3001, DOI 10.1111/j.1460-9568.2007.05577.x; Higuchi M, 2008, J NEUROCHEM, V106, P2410, DOI 10.1111/j.1471-4159.2008.05583.x; Kaminska K, 2013, PHARMACOL REP, V65, P1144; Khan A, 2011, J PSYCHIATR RES, V45, P1489, DOI 10.1016/j.jpsychires.2011.06.016; Koch S, 2004, NEUROPHARMACOLOGY, V46, P232, DOI 10.1016/j.neuropharm.2003.09.001; Liu RJ, 2000, BRAIN RES, V873, P34, DOI 10.1016/S0006-8993(00)02468-9; Marek GJ, 2003, NEUROPSYCHOPHARMACOL, V28, P402, DOI 10.1038/sj.npp.1300057; Miller BH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014458; Mitsumori T, 2011, EUR J NEUROSCI, V34, P594, DOI 10.1111/j.1460-9568.2011.07774.x; Nagayasu K, 2010, BRIT J PHARMACOL, V161, P1527, DOI 10.1111/j.1476-5381.2010.00978.x; Nagayasu K, 2010, J PHARMACOL SCI, V113, P197, DOI 10.1254/jphs.10075SC; POMPEIANO M, 1994, MOL BRAIN RES, V23, P163, DOI 10.1016/0169-328X(94)90223-2; Schreiber R, 2007, EUR NEUROPSYCHOPHARM, V17, P277, DOI 10.1016/j.euroneuro.2006.06.009; SEE RE, 1991, NEUROPHARMACOLOGY, V30, P1269, DOI 10.1016/0028-3908(91)90022-4; Shikanai H, 2012, J NEUROSCI, V32, P14415, DOI 10.1523/JNEUROSCI.5929-11.2012; Theisen FM, 2007, PHARMACOGENOMICS J, V7, P275, DOI 10.1038/sj.tpj.6500418; Wegener G, 2000, BRAIN RES, V871, P338, DOI 10.1016/S0006-8993(00)02461-6; WRIGHT DE, 1995, J COMP NEUROL, V351, P357, DOI 10.1002/cne.903510304	55	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0028-3908	1873-7064		NEUROPHARMACOLOGY	Neuropharmacology	AUG	2015	95						261	268		10.1016/j.neuropharm.2015.03.032		8	Neurosciences; Pharmacology & Pharmacy	Neurosciences & Neurology; Pharmacology & Pharmacy	CM0DR	WOS:000357349100025		
J	Shimizu, T; Tanaka, K; Shimizu, S; Higashi, Y; Yawata, T; Nakamura, K; Taniuchi, K; Ueba, T; Yuri, K; Saito, M				Shimizu, Takahiro; Tanaka, Kenjiro; Shimizu, Shogo; Higashi, Youichirou; Yawata, Toshio; Nakamura, Kumiko; Taniuchi, Keisuke; Ueba, Tetsuya; Yuri, Kazunari; Saito, Motoaki			Possible inhibitory role of endogenous 2-arachidonoylglycerol as an endocannabinoid in (+/-)-epibatidine-induced activation of central adrenomedullary outflow in the rat	NEUROPHARMACOLOGY			English	Article						(+/-)-Epibatidine; Brain; Endocannabinoid; 2-Arachidonoylglycerol; Cannabinoid CB1 receptor; Central adrenomedullary outflow	NICOTINIC ACETYLCHOLINE-RECEPTORS; HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; BRAIN PHOSPHOLIPASE-C; DIACYLGLYCEROL LIPASE; CANNABINOID RECEPTOR; SPINAL-CORD; ADRENAL-MEDULLA; SYNAPTIC-TRANSMISSION; CB1 RECEPTOR; RELEASE	We previously reported that intracerebroventricularly (i.c.v.) administered (+/-)-epibatidine (1, 5 or 10 nmol/animal), a nicotinic acetylcholine receptor agonist, dose-dependently induced secretion of noradrenaline and adrenaline (catecholamines) from the rat adrenal medulla by brain diacylglycerol lipase- (DGL), monoacylglycerol lipase- (MGL) and cyclooxygenase-mediated mechanisms. Diacylglycerol is hydrolyzed by DGL into 2-arachidonoylglycerol (2-AG), which is further hydrolyzed by MGL to arachidonic acid (AA), a cyclooxygenase substrate. These findings. suggest that brain 2-AG-derived AA is involved in the (+/-)-epibatidine-induced response. This AA precursor 2-AG is also a major brain endocannabinoid, which inhibits synaptic transmission through presynaptic cannabinoid CB1 receptors. Released 2-AG into the synaptic cleft is rapidly inactivated by cellular uptake. Here, we examined a role of brain 2-AG as an endocannabinoid in the (+/-)-epibatidine-induced activation of central adrenomedullary outflow using anesthetized male Wistar rats. In central presence of AM251 (CB1 antagonist) (90 and 180 nmol/animal, i.c.v.), (+/-)-epibatidine elevated plasma catecholamines even at an ineffective dose (1 nmol/animal, i.c.v.). Central pretreatment with ACEA (CB1 agonist) (0.7 and 1.4 mu mol/animal, i.c.v.), 2-AG ether (stable 2-AG analog for MGL) (0.5 and 1.0 gmol/animal, i.c.v.) or AM404 (endocannabinoid uptake inhibitor) (80 and 250 nmol/animal, i.c.v.) significantly reduced an effective dose of (+/-)-epibatidine- (5 nmol/animal, i.c.v.) induced elevation of plasma catecholamines, and AM251 (90 and 180 nmol/animal, i.c.v.) centrally abolished the reduction induced by 2-AG ether (1.0 mu mol/animal, i.c.v.) or AM404 (250 nmol/animal, i.c.v.). Immunohistochemical studies demonstrated that (+/-)-epibatidine (10 nmol/animal, i.c.v.) activated DGL alpha-positive spinally projecting neurons in the hypothalamic para-ventricular nucleus, a control center of central adrenomedullary system. These results suggest a possibility that a brain endocannabinoid, probably 2-AG, plays an inhibitory role in (+/-)-epibatidine-induced activation of central adrenomedullary outflow through brain CB1 receptors in the rat. (C) 2015 Elsevier Ltd. All rights reserved.	[Shimizu, Takahiro; Shimizu, Shogo; Higashi, Youichirou; Nakamura, Kumiko; Saito, Motoaki] Kochi Univ, Kochi Med Sch, Dept Pharmacol, Nankoku, Kochi 7838505, Japan; [Tanaka, Kenjiro; Yuri, Kazunari] Kochi Univ, Kochi Med Sch, Dept Neurobiol & Anat, Nankoku, Kochi 7838505, Japan; [Yawata, Toshio; Ueba, Tetsuya] Kochi Univ, Kochi Med Sch, Dept Neurosurg, Nankoku, Kochi 7838505, Japan; [Taniuchi, Keisuke] Kochi Univ, Kochi Med Sch, Dept Gastroenterol & Hepatol, Nankoku, Kochi 7838505, Japan	Shimizu, T (reprint author), Kochi Univ, Kochi Med Sch, Dept Pharmacol, Nankoku, Kochi 7838505, Japan.	shimizu@kochi-u.ac.jp			Smoking Research Foundation in Japan; Japan Society for the Promotion of Science [26460909, 23790744, 23790745, 25670354]; Japan Health Foundation; Discretionary Grant of the President of the Kochi University	This work was supported in part by a grant from The Smoking Research Foundation in Japan, a Grant-in-Aid for Scientific Research (C) (No. 26460909 to T.S.), a Grant-in-Aid for Young Scientists (B) (No. 23790744 to T.S. and No. 23790745 to K.T.) and Grant-in-Aid for Challenging Exploratory Research (No. 25670354 to K.T.) from the Japan Society for the Promotion of Science, a grant from The Japan Health Foundation, and a Discretionary Grant of the President of the Kochi University.	Tanaka K, 2014, BRIT J PHARMACOL, V171, P202, DOI 10.1111/bph.12471; Kirkham TC, 2002, BRIT J PHARMACOL, V136, P550, DOI 10.1038/sj.bjp.0704767; Steffens M, 2005, BIOCHEM PHARMACOL, V69, P169, DOI 10.1016/j.bcp.2004.08.033; Breivogel CS, 2009, INT REV PSYCHIATR, V21, P113, DOI 10.1080/09540260902782760; Yoshino H, 2011, J PHYSIOL-LONDON, V589, P4857, DOI 10.1113/jphysiol.2011.212225; Hanus L, 2001, P NATL ACAD SCI USA, V98, P3662, DOI 10.1073/pnas.061029898; Virdis A, 2010, CURR PHARM DESIGN, V16, P2518; Shafton AD, 1998, BRAIN RES, V801, P239, DOI 10.1016/S0006-8993(98)00587-3; Howlett AC, 2002, PHARMACOL REV, V54, P161, DOI 10.1124/pr.54.2.161; Sugiura T, 2006, PROG LIPID RES, V45, P405, DOI 10.1016/j.plipres.2006.03.003; Di S, 2005, J PHYSIOL-LONDON, V569, P751, DOI 10.1113/jphysiol.2005.097477; Pyner S, 2000, NEUROSCIENCE, V100, P549, DOI 10.1016/S0306-4522(00)00283-9; Bisogno T, 2008, J NEUROENDOCRINOL, V20, P1, DOI 10.1111/j.1365-2826.2008.01676.x; Pyner S, 2009, J CHEM NEUROANAT, V38, P197, DOI 10.1016/j.jchemneu.2009.03.005; Katona I, 2012, ANNU REV NEUROSCI, V35, P529, DOI 10.1146/annurev-neuro-062111-150420; Bisogno T, 2003, J CELL BIOL, V163, P463, DOI 10.1083/jcb.200305129; Gauthier KM, 2005, AM J PHYSIOL-HEART C, V288, pH1344, DOI 10.1152/ajpheart.00537.2004; Beltramo M, 1997, SCIENCE, V277, P1094, DOI 10.1126/science.277.5329.1094; SUGIURA T, 1995, BIOCHEM BIOPH RES CO, V215, P89, DOI 10.1006/bbrc.1995.2437; Gao Y, 2010, J NEUROSCI, V30, P2017, DOI 10.1523/JNEUROSCI.5693-09.2010; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; SAWCHENKO PE, 1982, J COMP NEUROL, V205, P260, DOI 10.1002/cne.902050306; DEVANE WA, 1992, SCIENCE, V258, P1946, DOI 10.1126/science.1470919; Hering D, 2010, BLOOD PRESSURE, V19, P152, DOI 10.3109/08037051.2010.484150; Di Marzo V, 2006, TRENDS PHARMACOL SCI, V27, P134, DOI 10.1016/j.tips.2006.01.010; TSENG CJ, 1993, J PHARMACOL EXP THER, V265, P1511; Long JZ, 2009, NAT CHEM BIOL, V5, P37, DOI 10.1038/nchembio.129; Bisogno T, 2001, EUR J BIOCHEM, V268, P1982, DOI 10.1046/j.1432-1327.2001.02072.x; JANSEN ASP, 1995, SCIENCE, V270, P644, DOI 10.1126/science.270.5236.644; Heifets BD, 2009, ANNU REV PHYSIOL, V71, P283, DOI 10.1146/annurev.physiol.010908.163149; Soria-Gomez E, 2014, NEUROSCIENCE, V263, P46, DOI 10.1016/j.neuroscience.2014.01.005; ANTON AH, 1962, J PHARMACOL EXP THER, V138, P360; Burke JE, 2009, J LIPID RES, V50, pS237, DOI 10.1194/jlr.R800033-JLR200; Hillard CJ, 1999, J PHARMACOL EXP THER, V289, P1427; Guindon J, 2009, CNS NEUROL DISORD-DR, V8, P403; Tanimura A, 2010, NEURON, V65, P320, DOI 10.1016/j.neuron.2010.01.021; Nomura DK, 2011, SCIENCE, V334, P809, DOI 10.1126/science.1209200; Balogh G, 2010, BBA-MOL CELL BIOL L, V1801, P1036, DOI 10.1016/j.bbalip.2010.04.011; Brozoski DT, 2005, BRAIN RES, V1059, P197, DOI 10.1016/j.brainres.2005.08.030; Buccafusco J.J., 1993, BRAIN RES B, V32, P681; de Lago E, 2005, BIOCHEM PHARMACOL, V70, P446, DOI 10.1016/j.bcp.2005.05.011; Giuffrida A, 2001, J PHARMACOL EXP THER, V298, P7; IKUSHIMA S, 1982, J PHARMACOL EXP THER, V222, P463; KIRITSYROY JA, 1990, NEUROPHARMACOLOGY, V29, P579, DOI 10.1016/0028-3908(90)90071-X; Laine K, 2002, INVEST OPHTH VIS SCI, V43, P3216; Lan RX, 1999, J MED CHEM, V42, P769, DOI 10.1021/jm980363y; Lembeck F, 1999, N-S ARCH PHARMACOL, V359, P378, DOI 10.1007/PL00005364; Ohno-Shosaku T, 2014, CURR OPIN NEUROBIOL, V29, P1, DOI 10.1016/j.conb.2014.03.017; Paxinos G., 2005, RAT BRAIN STEREOTAXI; PYNER S, 1994, J COMP NEUROL, V342, P15, DOI 10.1002/cne.903420103; Shimizu T, 2008, EUR J PHARMACOL, V582, P62, DOI 10.1016/j.ejphar.2007.12.020; Shimizu T, 2009, EUR J PHARMACOL, V606, P77, DOI 10.1016/j.ejphar.2009.01.032; Shimizu T, 2012, EUR J PHARMACOL, V691, P93, DOI 10.1016/j.ejphar.2012.07.017; Shimizu T, 2011, EUR J PHARMACOL, V654, P241, DOI 10.1016/j.ejphar.2010.12.034; Shimizu T, 2013, J PHARMACOL SCI, V121, P157, DOI 10.1254/jphs.12208FP; Shimizu T, 2011, EUR J PHARMACOL, V658, P123, DOI 10.1016/j.ejphar.2011.02.023; Shimizu T, 2004, EUR J PHARMACOL, V499, P99, DOI 10.1016/j.ejphar.2004.07.087; Shimizu T, 2010, EUR J PHARMACOL, V641, P54, DOI 10.1016/j.ejphar.2010.05.007; Tanaka K, 2014, LIFE SCI, V100, P85, DOI 10.1016/j.lfs.2014.01.079; Tang X, 2006, AM J PHYSIOL-HEART C, V290, pH37, DOI 10.1152/ajpheart.00491.2005; Yates ML, 2009, MOL PHARMACOL, V76, P11, DOI 10.1124/mol.109.055251; Yokotani K, 2000, EUR J PHARMACOL, V402, P223, DOI 10.1016/S0014-2999(00)00533-1; Yokotani K, 2000, EUR J PHARMACOL, V398, P341, DOI 10.1016/S0014-2999(00)00276-4; Yokotani K, 2002, EUR J PHARMACOL, V446, P83, DOI 10.1016/S0014-2999(02)01819-8	64	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0028-3908	1873-7064		NEUROPHARMACOLOGY	Neuropharmacology	AUG	2015	95						278	289		10.1016/j.neuropharm.2015.03.034		12	Neurosciences; Pharmacology & Pharmacy	Neurosciences & Neurology; Pharmacology & Pharmacy	CM0DR	WOS:000357349100027		
J	Hirayama, M; Ogata, M; Kawamata, T; Ishibashi, H				Hirayama, Michiko; Ogata, Masanori; Kawamata, Tomoyuki; Ishibashi, Hitoshi			Muscarinic receptor-mediated excitation of rat intracardiac ganglion neurons	NEUROPHARMACOLOGY			English	Article						Muscarinic receptors; Parasympathetic ganglion; Action potential firing; Perforated patch-clamp recording; Nonselective cationic channels	INOSITOL 1,4,5-TRISPHOSPHATE RECEPTORS; PARASYMPATHETIC CARDIAC GANGLIA; GUINEA-PIG; TRP CHANNELS; POTASSIUM CURRENTS; CALCIUM-CHANNELS; CATION CHANNELS; SMOOTH-MUSCLE; ACETYLCHOLINE; ACTIVATION	Modulation of the membrane excitability of rat parasympathetic intracardiac ganglion neurons by muscarinic receptors was studied using an amphotericin B-perforated patch-clamp recording configuration. Activation of muscarinic receptors by oxotremorine-M (OxoM) depolarized the membrane, accompanied by repetitive action potentials. OxoM evoked inward currents under voltage-clamp conditions at a holding potential of -60 mV. Removal of extracellular Ca2+ markedly increased the OxoM-induced current (I-OxoM). The inward I-OxoM in the absence of extracellular Ca2+ was fully inhibited by removal of extracellular Na+, indicating the involvement of non-selective cation channels. The I-OxoM was inhibited by organic cation channel antagonists including SKF-96365 and ML-204. The I-OxoM was antagonized by muscarinic receptor antagonists with the following potency: 4-DAMP > pirenzepine = darifenacin > methoctramine. Muscarinic toxin 7 (MT-7), a highly selective inhibitor for M-1 receptor, produced partial inhibition of the I-OxoM. In the presence of MT-7, concentration -inhibition curve of the M3-preferring antagonist darifenacin was shifted to the left. These results suggest the contribution of M-1 and M-3 receptors to the OxoM response. The I-OxoM was inhibited by U-73122, a phospholipase C inhibitor. The membrane-permeable IP3 receptor blocker xestospongin C also inhibited the I-OxoM Furthermore, pretreatment with thapsigargin and BAPTA-AM inhibited the I-OxoM, while KN-62, a blocker of Ca2+/calmodulin-dependent protein kinase II, had no effect. These results suggest that the activation mechanism involves a PLC pathway, release of Ca2+ from intracellular Ca2+ stores and calmodulin. The cation channels activated by muscarinic receptors may play an important role in neuronal membrane depolarization in rat intracardiac ganglion neurons. (C) 2015 Elsevier Ltd. All rights reserved.	[Hirayama, Michiko; Ogata, Masanori; Ishibashi, Hitoshi] Kitasato Univ, Dept Physiol, Sch Allied Hlth Sci, Sagamihara, Kanagawa 2520373, Japan; [Hirayama, Michiko; Kawamata, Tomoyuki] Wakayama Med Univ, Dept Anesthesiol, Wakayama 6410012, Japan	Ishibashi, H (reprint author), Kitasato Univ, Dept Physiol, Sch Allied Hlth Sci, Sagamihara, Kanagawa 2520373, Japan.	isibasih@kitasato-u.ac.jp			JSPS KAKENHI [24590739]; Kitasato University School of Allied Health Sciences [2013-1029, 2014-1019]	This study was supported by JSPS KAKENHI (24590739). This study was also supported by grants from the Kitasato University School of Allied Health Sciences (Research Project No. 2013-1029 and 2014-1019).	ALLEN TGJ, 1990, J PHYSIOL-LONDON, V422, P463; Obukhov AG, 2005, J NEUROSCI, V25, P1234, DOI 10.1523/JNEUROSCI.4451-04.2005; Xu SZ, 2008, NATURE, V451, P69, DOI 10.1038/nature06414; Gafni J, 1997, NEURON, V19, P723, DOI 10.1016/S0896-6273(00)80384-0; BROWN DA, 1980, NATURE, V283, P673, DOI 10.1038/283673a0; MURASE K, 1989, NEUROSCI LETT, V103, P56, DOI 10.1016/0304-3940(89)90485-0; Caulfield MP, 1998, PHARMACOL REV, V50, P279; Shen MJ, 2014, CIRC RES, V114, P1004, DOI 10.1161/CIRCRESAHA.113.302549; Zhu MX, 2005, PFLUG ARCH EUR J PHY, V451, P105, DOI 10.1007/s00424-005-1427-1; Evans RJ, 1996, J PHYSIOL-LONDON, V497, P413; Kadamur G, 2013, ANNU REV PHYSIOL, V75, P127, DOI 10.1146/annurev-physiol-030212-183750; Miller M, 2011, J BIOL CHEM, V286, P33436, DOI 10.1074/jbc.M111.274167; Servent D, 2009, J NEUROCHEM, V109, P1193, DOI 10.1111/j.1471-4159.2009.06092.x; KATZ B, 1965, PROC R SOC SER B-BIO, V161, P483, DOI 10.1098/rspb.1965.0016; Chin D, 2000, TRENDS CELL BIOL, V10, P322, DOI 10.1016/S0962-8924(00)01800-6; AKAIKE N, 1994, JPN J PHYSIOL, V44, P433, DOI 10.2170/jjphysiol.44.433; RUDY B, 1988, NEUROSCIENCE, V25, P729, DOI 10.1016/0306-4522(88)90033-4; ALMERS W, 1984, J PHYSIOL-LONDON, V353, P585; Owsianik G, 2006, ANNU REV PHYSIOL, V68, P685, DOI 10.1146/annurev.physiol.68.040204.101406; Zhang ZM, 2001, P NATL ACAD SCI USA, V98, P3168, DOI 10.1073/pnas.051632698; DeHaven W, 2004, J BIOL CHEM, V279, P40609, DOI 10.1074/jbc.M404743200; Arora RC, 2003, ANAT REC PART A, V271A, P249, DOI 10.1002/ar.a.10030; ADAMS PR, 1982, J PHYSIOL-LONDON, V332, P223; Tang J, 2001, J BIOL CHEM, V276, P21303, DOI 10.1074/jbc.M102316200; BONNER TI, 1989, TRENDS NEUROSCI, V12, P148, DOI 10.1016/0166-2236(89)90054-4; Batulevicius D, 2003, ANN ANAT, V185, P449, DOI 10.1016/S0940-9602(03)80105-X; Beker F, 2003, J NEUROPHYSIOL, V90, P1956, DOI 10.1152/jn.01079.2002; BIRDSALL NJM, 1983, BRIT J PHARMACOL, V78, P257; Bymaster Frank P., 2002, Current Drug Targets - CNS and Neurological Disorders, V1, P163, DOI 10.2174/1568007024606249; Calupca MA, 2000, J COMP NEUROL, V426, P493; CAULFIELD MP, 1993, PHARMACOL THERAPEUT, V58, P319, DOI 10.1016/0163-7258(93)90027-B; CONSTANTI A, 1981, NEUROSCI LETT, V24, P289, DOI 10.1016/0304-3940(81)90173-7; Cuevas J, 2000, J NEUROPHYSIOL, V84, P1961; Cuevas J, 1997, J NEUROPHYSIOL, V78, P1903; Dallanoce C, 1999, BIOORGAN MED CHEM, V7, P1539, DOI 10.1016/S0968-0896(99)00107-8; FIEBER LA, 1991, J PHYSIOL-LONDON, V434, P215; HASSALL CJS, 1993, NEUROSCIENCE, V56, P1041, DOI 10.1016/0306-4522(93)90149-A; Heldman E, 1996, EUR J PHARMACOL, V297, P283, DOI 10.1016/0014-2999(95)00745-8; Helliwell RM, 1996, J PHYSIOL-LONDON, V492, P75; HOOVER DB, 1994, CIRC RES, V75, P813; Ishibashi H, 2003, J PHYSIOL-LONDON, V548, P111, DOI 10.1113/jphysiol.2002.033100; Ishibashi H., 2012, SPRINGER PROTOCOLS H, P71; Kanemoto Y, 2002, BRIT J PHARMACOL, V135, P1403, DOI 10.1038/sj.bjp.0704610; KONOPKA LM, 1992, CAN J PHYSIOL PHARM, V70, pS32; LEE MW, 1994, AM J PHYSIOL, V267, pC659; Leung YM, 1999, JPN J PHARMACOL, V81, P253, DOI 10.1254/jjp.81.253; MEANS AR, 1991, PHARMACOL THERAPEUT, V50, P255, DOI 10.1016/0163-7258(91)90017-G; Merriam LA, 2004, REGUL PEPTIDES, V123, P123, DOI 10.1016/j.regpep.2004.04.019; Mitchelson FJ, 2012, PHARMACOL THERAPEUT, V135, P216, DOI 10.1016/j.pharmthera.2012.05.008; Murai Y, 1998, BRIT J PHARMACOL, V123, P1441, DOI 10.1038/sj.bjp.0701753; PARDINI BJ, 1987, J AUTONOM NERV SYST, V20, P91, DOI 10.1016/0165-1838(87)90106-8; PARSONS RL, 1987, J NEUROSCI, V7, P837; Plant TD, 2003, CELL CALCIUM, V33, P441, DOI 10.1016/S0143-4160(03)00055-1; RINK TJ, 1990, FEBS LETT, V268, P381, DOI 10.1016/0014-5793(90)81290-5; Sorensen SD, 1998, MOL PHARMACOL, V53, P827; Tsuboi M, 2000, AM J PHYSIOL-HEART C, V279, pH1201; XIMOY SX, 1995, J PHYSIOL-LONDON, V486, P15; XIMOY SX, 1993, J AUTONOM NERV SYST, V42, P201, DOI 10.1016/0165-1838(93)90365-2; XU ZJ, 1992, J PHYSIOL-LONDON, V456, P405; Zhang LL, 2001, AM J PHYSIOL-REG I, V281, pR1792; Zhang LL, 2005, J PHARMACOL SCI, V99, P228, DOI 10.1254/jphs.FP0050437	61	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0028-3908	1873-7064		NEUROPHARMACOLOGY	Neuropharmacology	AUG	2015	95						395	404		10.1016/j.neuropharm.2015.04.014		10	Neurosciences; Pharmacology & Pharmacy	Neurosciences & Neurology; Pharmacology & Pharmacy	CM0DR	WOS:000357349100039		
J	Irie, T; Kikura-Hanajiri, R; Usami, M; Uchiyama, N; Goda, Y; Sekino, Y				Irie, Tomohiko; Kikura-Hanajiri, Ruri; Usami, Makoto; Uchiyama, Nahoko; Goda, Yukihiro; Sekino, Yuko			MAM-2201, a synthetic cannabinoid drug of abuse, suppresses the synaptic input to cerebellar Purkinje cells via activation of presynaptic CB1 receptors	NEUROPHARMACOLOGY			English	Article						Synthetic cannabinoids; MAM-2201; Cannabinoid receptor type 1; Purkinje cell; Cerebellum; Neurotransmitter release	LONG-TERM DEPRESSION; ENDOGENOUS CANNABINOIDS; METABOTROPIC GLUTAMATE; RETROGRADE INHIBITION; COCHLEAR NUCLEUS; HERBAL BLENDS; RAT; TRANSMISSION; SYNAPSES; CURRENTS	Herbal products containing synthetic cannabinoids-initially sold as legal alternatives to marijuana have become major drugs of abuse. Among the synthetic cannabinoids, [1-(5-fluoropentyl)-1H-indol-3-yl](4-methyl-1-naphthalenyl)-methanone (MAM-2201) has been recently detected in herbal products and has psychoactive and intoxicating effects in humans, suggesting that MAM-2201 alters brain function. Nevertheless, the pharmacological actions of MAM-2201 on cannabinoid receptor type 1 (CB1R) and neuronal functions have not been elucidated. We found that MAM-2201 acted as an agonist of human CB1Rs expressed in AtT-20 cells. In whole-cell patch-clamp recordings made from Purkinje cells (PCs) in slice preparations of the mouse cerebellum, we also found that MAM-2201 inhibited glutamate release at parallel fiber-PC synapses via activation of presynaptic CB1Rs. MAM-2201 inhibited neurotransmitter release with an inhibitory concentration 50% of 0.36 mu M. MAM-2201 caused greater inhibition of neurotransmitter release than Delta(9)-tetrahydrocannabinol within the range of 0.1-30 mu M and JWH-018, one of the most popular and potent synthetic cannabinoids detected in the herbal products, within the range of 0.03-3 mu M. MAM-2201 caused a concentration-dependent suppression of GABA release onto PCs. Furthermore, MAM-2201 induced suppression of glutamate release at climbing fiber-PC synapses, leading to reduced dendritic Ca2+ transients in PCs. These results suggest that MAM-2201 is likely to suppress neurotransmitter release at CB1R-expressing synapses in humans. The reduction of neurotransmitter release from CB1R-containing synapses could contribute to some of the symptoms of synthetic cannabinoid intoxication including impairments in cerebellum-dependent motor coordination and motor learning. (C) 2015 Elsevier Ltd. All rights reserved.	[Irie, Tomohiko; Usami, Makoto; Sekino, Yuko] Natl Inst Hlth Sci, Div Pharmacol, Tokyo 1588501, Japan; [Kikura-Hanajiri, Ruri] Natl Inst Hlth Sci, Div Pharmacognosy Phytochem & Narcot, Tokyo 1588501, Japan; [Uchiyama, Nahoko; Goda, Yukihiro] Natl Inst Hlth Sci, Div Drugs, Tokyo 1588501, Japan	Irie, T (reprint author), Natl Inst Hlth Sci, Div Pharmacol, Setagaya Ku, 1-18-1 Kamiyoga, Tokyo 1588501, Japan.	irie@nihs.go.jp; yukos@nihs.go.jp			Health Labour Sciences Research Grants	This work was supported by Health Labour Sciences Research Grants. We thank Dr. Nobutake Hosoi (Gunma University) for technical advice on intracellular Ca<SUP>2+</SUP> imaging.	Maejima T, 2001, NEURON, V31, P463, DOI 10.1016/S0896-6273(01)00375-0; Atwood BK, 2010, BRIT J PHARMACOL, V160, P585, DOI 10.1111/j.1476-5381.2009.00582.x; Musshoff F, 2014, INT J LEGAL MED, V128, P59, DOI 10.1007/s00414-013-0864-1; Showalter VM, 1996, J PHARMACOL EXP THER, V278, P989; Hashimoto K, 2013, CELL MOL LIFE SCI, V70, P4667, DOI 10.1007/s00018-013-1405-2; Kreitzer AC, 2001, NEURON, V29, P717, DOI 10.1016/S0896-6273(01)00246-X; Uchiyama N, 2013, FORENSIC SCI INT, V227, P21, DOI 10.1016/j.forsciint.2012.08.047; Safo PK, 2005, NEURON, V48, P647, DOI 10.1016/j.neuron.2005.09.020; Huestis MA, 2001, ARCH GEN PSYCHIAT, V58, P322, DOI 10.1001/archpsyc.58.4.322; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547; Szabo B, 2004, J PHARMACOL EXP THER, V310, P915, DOI 10.1124/jpet.104.066670; DeSanty KP, 2001, PHARMACOL BIOCHEM BE, V69, P251, DOI 10.1016/S0091-3057(01)00539-1; Navakkode S, 2014, NEUROPHARMACOLOGY, V79, P525, DOI 10.1016/j.neuropharm.2013.11.018; Gardner EL, 2005, PHARMACOL BIOCHEM BE, V81, P263, DOI 10.1016/j.pbb.2005.01.032; Derungs A, 2013, FORENSIC TOXICOL, V31, P164, DOI 10.1007/s11419-012-0166-1; McKay BE, 2005, J PHYSIOL-LONDON, V567, P829, DOI 10.1113/jphysiol.2005.089383; Kano M, 2009, PHYSIOL REV, V89, P309, DOI 10.1152/physrev.00019.2008; Wilson RI, 2002, SCIENCE, V296, P678, DOI 10.1126/science.1063545; Seely KA, 2012, PROG NEURO-PSYCHOPH, V39, P234, DOI 10.1016/j.pnpbp.2012.04.017; Kakegawa W, 2008, J NEUROSCI, V28, P1460, DOI 10.1523/JNEUROSCI.2553-07.2008; KONNERTH A, 1992, P NATL ACAD SCI USA, V89, P7051, DOI 10.1073/pnas.89.15.7051; Kawamura Y, 2006, J NEUROSCI, V26, P2991, DOI 10.1523/JNEUROSCI.4872-05.2006; Xu-Friedman MA, 1999, BIOPHYS J, V76, P2029; MACKIE K, 1995, J NEUROSCI, V15, P6552; Auwarter V, 2009, J MASS SPECTROM, V44, P832, DOI 10.1002/jms.1558; Shuvaev AN, 2011, J NEUROSCI, V31, P14324, DOI 10.1523/JNEUROSCI.5530-10.2011; Khaliq ZM, 2005, J NEUROSCI, V25, P454, DOI 10.1523/JNEUROSCI.3045-04.2005; Irie T, 2008, BIOCHEM BIOPH RES CO, V367, P503, DOI 10.1016/j.bbrc.2008.01.001; Taura F, 2007, CHEM BIODIVERS, V4, P1649, DOI 10.1002/cbdv.200790145; Diana MA, 2002, J NEUROSCI, V22, P200; Patel S, 2001, J PHARMACOL EXP THER, V297, P629; Saito T, 2013, FORENSIC TOXICOL, V31, P333, DOI 10.1007/s11419-013-0190-9; Voogd J, 1998, TRENDS COGN SCI, V2, P307, DOI 10.1016/S1364-6613(98)01210-8; Vardakou I, 2010, TOXICOL LETT, V197, P157, DOI 10.1016/j.toxlet.2010.06.002; Mackie K, 2008, MOL CELL ENDOCRINOL, V286, pS60, DOI 10.1016/j.mce.2008.01.022; Mittmann W, 2005, J PHYSIOL-LONDON, V563, P369, DOI 10.1113/jphysiol.2004.075028; Ito M, 2001, PHYSIOL REV, V81, P1143; Hampson RE, 2000, J NEUROSCI, V20, P8932; Brown SP, 2004, J NEUROSCI, V24, P5623, DOI 10.1523/JNEUROSCI.0918-04.2004; Bruno A, 2014, SCI REP-UK, V4, DOI 10.1038/srep03757; Carey MR, 2009, NEURON, V62, P112, DOI 10.1016/j.neuron.2009.02.022; DOUSMANIS AG, 1992, PFLUG ARCH EUR J PHY, V422, P98, DOI 10.1007/BF00370408; Felder CC, 1998, J PHARMACOL EXP THER, V284, P291; Frontali M, 2001, BRAIN RES BULL, V56, P227, DOI 10.1016/S0361-9230(01)00574-3; HAGIWARA S, 1976, J GEN PHYSIOL, V67, P621, DOI 10.1085/jgp.67.6.621; Irie T, 2014, J PHYSIOL-LONDON, V592, P229, DOI 10.1113/jphysiol.2013.264309; Irie T, 2006, J NEUROPHYSIOL, V96, P2633, DOI 10.1152/jn.00396.2006; Kayakabe Mikiko, 2013, Front Cell Neurosci, V7, P286, DOI 10.3389/fncel.2013.00286; Kikura-Hanajiri R., 2013, DRUG TEST ANAL; KORN H, 1991, TRENDS NEUROSCI, V14, P439, DOI 10.1016/0166-2236(91)90042-S; KUBO Y, 1993, NATURE, V364, P802, DOI 10.1038/364802a0; Kushmerick C, 2004, J NEUROSCI, V24, P5955, DOI 10.1523/JNEUROSCI.0768-04.2004; Levenes C, 1998, J PHYSIOL-LONDON, V510, P867, DOI 10.1111/j.1469-7793.1998.867bj.x; Llinas R. R., 2004, SYNAPTIC ORG BRAIN, P271, DOI 10.1093/acprof:oso/9780195159561.003.0007; Lonati D., 2014, ANN EMERG MED; Luk T, 2004, BRIT J PHARMACOL, V142, P495, DOI 10.1038/sj.bjp.0705792; Monory Krisztina, 2007, PLoS Biol, V5, pe269, DOI 10.1371/journal.pbio.0050269; Moosmann B, 2012, FORENSIC SCI INT, V220, pE17, DOI 10.1016/j.forsciint.2011.12.010; Porras-Garcia ME, 2013, FRONT NEUROANAT, V7, DOI 10.3389/fnana.2013.00004; Regehr WG, 2009, NEURON, V63, P154, DOI 10.1016/j.neuron.2009.06.021; Safo PK, 2006, CEREBELLUM, V5, P134, DOI 10.1080/14734220600791477; Shen MX, 1999, MOL PHARMACOL, V55, P8; Takahashi KA, 2000, J NEUROPHYSIOL, V83, P1167; Vincent P, 1996, J PHYSIOL-LONDON, V494, P183; Yuzaki M., 2012, NEURAL NETW; Zheng N, 2010, CEREBELLUM, V9, P56, DOI 10.1007/s12311-009-0140-6	66	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0028-3908	1873-7064		NEUROPHARMACOLOGY	Neuropharmacology	AUG	2015	95						479	491		10.1016/j.neuropharm.2015.02.025		13	Neurosciences; Pharmacology & Pharmacy	Neurosciences & Neurology; Pharmacology & Pharmacy	CM0DR	WOS:000357349100048		
J	Shimomura, H; Ito, M; Nishiyama, A; Tanizawa, T; Takeshima, Y; Nishimaru, H; Arata, A				Shimomura, Hideki; Ito, Mari; Nishiyama, Ayae; Tanizawa, Takakuni; Takeshima, Yasuhiro; Nishimaru, Hiroshi; Arata, Akiko			Glycine plays a crucial role as a co-agonist of NMDA receptors in the neuronal circuit generating body movements in rat fetuses	NEUROSCIENCE RESEARCH			English	Article						Strychnine; NMDA receptor glycine binding site; Fetal movement; Brainstem-spinal cord preparation	RESPIRATORY RHYTHM GENERATION; EMBRYONIC SPINAL-CORD; IN-VITRO; BRAIN-STEM; FETAL-RAT; SYNAPTIC INHIBITION; LOCOMOTOR CIRCUITS; NEONATAL-RAT; NEWBORN RAT; HYPEREKPLEXIA	Neuronal circuits generating fetal movements in mammals are localized in the brainstem and the spinal cord. It has been shown that glycine plays an important role through the strychnine-sensitive glycine receptors in these circuits. However, the role of glycine as the NMDA receptor co-agonist in fetal period is not fully understood. In this study, we examined the contribution of glycine to the perinatal rat spinal circuit generating forelimb movements utilizing isolated brainstem-cervical-spinal-cord preparations. In late embryonic-days-preparations, spontaneous motor bursts related to forelimb movements (forelimb-movement-related bursts; FMRBs) and respiration-related activity were observed. In neonatal preparations, spontaneous FMRBs were not observed but periodic motor bursts resembling the FMRBs could be induced after bath application of strychnine (strychnine-induced motor bursts; SIMBs). Both FMRBs and SIMBs were blocked by either the NMDA receptor antagonist APV or the antagonists of the glycine binding site of NMDA receptors [5,7-dichlorokynurenic acid (DCKA) or L-689560]. Furthermore, these motor bursts were facilitated by the glycine uptake blocker sarcosine. This effect of sarcosine was blocked by DCKA. The findings indicate that glycine plays a crucial role as a NMDA receptor co-agonist in generating spontaneous fetal motor activity before functioning as a classical inhibitory neurotransmitter in suppressing the fetal neuronal circuits. (C) 2015 Elsevier Ireland Ltd and the Japan Neuroscience Society. All rights reserved.	[Shimomura, Hideki; Ito, Mari; Nishiyama, Ayae; Arata, Akiko] Hyogo Coll Med, Dept Physiol, Div Physiome, Nishinomiya, Hyogo, Japan; [Shimomura, Hideki; Tanizawa, Takakuni; Takeshima, Yasuhiro] Hyogo Coll Med, Dept Pediat, Nishinomiya, Hyogo, Japan; [Nishimaru, Hiroshi] Univ Tsukuba, Fac Med, Div Biomed Sci, Tsukuba, Ibaraki 305, Japan	Arata, A (reprint author), Hyogo Coll Med, Dept Physiol, Div Physiome, Nishinomiya, Hyogo, Japan.	Hiroshi.Nishimaru@md.tsukuba.ac.jp; akoarata@hyo-med.ac.jp			Hyogo College of Medicine	We would like to express thanks to Yuko Hesaka, Masatoshi Yoshikane and Ayako Yotsumoto for their help to collect data for our research. (They participated in our research as a program for medical student research courses of Hyogo College of Medicine.) This work was supported by Grant-in-Aid for Researchers, Hyogo College of Medicine, 2013.	Dehorter N, 2012, EUR J NEUROSCI, V35, P1846, DOI 10.1111/j.1460-9568.2012.08152.x; GREER JJ, 1992, J NEUROPHYSIOL, V67, P996; Vinay L, 2000, BRAIN RES BULL, V53, P635, DOI 10.1016/S0361-9230(00)00397-X; JOHNSON JW, 1987, NATURE, V325, P529, DOI 10.1038/325529a0; Nakayama K, 1999, J NEUROPHYSIOL, V81, P2592; Thomas RH, 2013, BRAIN, V136, P3085, DOI 10.1093/brain/awt207; Brockhaus J, 1998, EUR J NEUROSCI, V10, P3823, DOI 10.1046/j.1460-9568.1998.00396.x; Ren J, 2003, J NEUROPHYSIOL, V89, P1187, DOI 10.1152/jn.00539.2002; Branchereau P, 2002, J NEUROSCI, V22, P2598; Chung SK, 2010, J NEUROSCI, V30, P9612, DOI 10.1523/JNEUROSCI.1763-10.2010; DIPASQUALE E, 1992, EXP BRAIN RES, V89, P459; Hanson MG, 2004, NEURON, V43, P687, DOI 10.1016/j.neuron.2004.08.018; Arata A, 1998, EXP BRAIN RES, V119, P399, DOI 10.1007/s002210050355; Gomeza J, 2003, NEURON, V40, P785, DOI 10.1016/S0896-6273(03)00672-X; Myers CP, 2005, NEURON, V46, P37, DOI 10.1016/j.neuron.2005.02.022; Bertrand S, 1999, NEUROSCIENCE, V94, P1199, DOI 10.1016/S0306-4522(99)00301-2; Delpy A, 2008, J PHYSIOL-LONDON, V586, P1059, DOI 10.1113/jphysiol.2007.146993; Fujii M, 2006, BRAIN RES, V1090, P45, DOI 10.1016/j.brainres.2006.02.028; Fujii M, 2007, NEUROSCIENCE, V146, P1044, DOI 10.1016/j.neuroscience.2007.02.050; GIACOIA GP, 1994, ARCH PEDIAT ADOL MED, V148, P540; Issberner JP, 2007, EUR J NEUROSCI, V26, P2556, DOI 10.1111/j.1460-9568.2007.05892.x; KUDO N, 1987, NEUROSCI LETT, V75, P43, DOI 10.1016/0304-3940(87)90072-3; KUDO N, 1993, NEUROSCI RES, V16, P131, DOI 10.1016/0168-0102(93)90080-A; Lim R, 2004, J NEUROPHYSIOL, V92, P2530, DOI 10.1152/jn.01123.2003; Nakayama K, 2002, J NEUROSCI, V22, P10388; Nakayama K, 2001, NEUROSCI LETT, V307, P1, DOI 10.1016/S0304-3940(01)01913-9; NARAYANA.CH, 1971, BEHAVIOUR, V40, P100, DOI 10.1163/156853971X00357; Nishimaru H, 2009, ACTA PHYSIOL, V197, P83, DOI 10.1111/j.1748-1716.2009.02020.x; Nishimaru H, 1996, J PHYSIOL-LONDON, V497, P131; Onimaru H, 2002, NEUROSCI RES, V42, P209, DOI 10.1016/S0168-0102(01)00322-4; Ozaki S, 1996, DEV BRAIN RES, V97, P118, DOI 10.1016/S0165-3806(96)00139-3; Schaefer N, 2013, BRIT J PHARMACOL, V170, P933, DOI 10.1111/bph.12335; Shao XM, 1997, J NEUROPHYSIOL, V77, P1853; SUZUE T, 1984, J PHYSIOL-LONDON, V354, P173; SUZUE T, 1994, NEUROSCI RES, V21, P173, DOI 10.1016/0168-0102(94)90160-0; TIMORTRITSCH I, 1976, AM J OBSTET GYNECOL, V126, P70	36	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0168-0102	1872-8111		NEUROSCI RES	Neurosci. Res.	AUG	2015	97						13	19		10.1016/j.neures.2015.03.004		7	Neurosciences	Neurosciences & Neurology	CM5VG	WOS:000357756500003		
J	Kase, D; Uta, D; Ishihara, H; Imoto, K				Kase, Daisuke; Uta, Daisuke; Ishihara, Hiromi; Imoto, Keiji			Inhibitory synaptic transmission from the substantia nigra pars reticulata to the ventral medial thalamus in mice	NEUROSCIENCE RESEARCH			English	Article						Ventral medial nucleus; Substantia nigra pars reticulata; GABA; NEURON simulator; beta-Band activity	BASAL GANGLIA; TOPOGRAPHICAL ORGANIZATION; DOPAMINERGIC-NEURONS; SUBTHALAMIC NUCLEUS; ABSENCE SEIZURES; MOTOR THALAMUS; RAT; PATHWAY; PROJECTIONS; MOVEMENTS	The cortico-basal ganglia-thalamic loop circuit is involved in variety of motor, association and limbic functions. The basal ganglia receive neural information from various areas of the cerebral cortex and transfer them back to the frontal and motor cortex via the ventral medial (VM), and the anterior-ventral lateral thalamic complex. The projection from the basal ganglia to the thalamus is GABAergic, and, therefore, the output from the basal ganglia cannot directly evoke excitation in the thalamic nuclei. The mechanism underlying the information transfer via the inhibitory projection remains unclear. To address this issue, we recorded electrophysiological properties of nigro-thalamic synapses from the VM neuron. We developed a nigro-thalamic slice preparation, in which the projection from the substantia nigra pars reticulata (SNr) to VM nucleus is stored, to enable the selective activation of the projection from the SNr. We characterized synaptic properties and membrane properties of the VM neuron, and developed a VM neuron model to simulate the impacts of SNr inputs on VM neuron activity. Neural simulation suggested that the inhibitory projection from SNr can control neural activity in two ways: a disinhibition from the spontaneous nigral inhibition and a beta-band synchronization evoked by combination of excitation and inhibition of SNr activity. (C) 2015 Elsevier Ireland Ltd and the Japan Neuroscience Society. All rights reserved.	[Kase, Daisuke; Uta, Daisuke; Ishihara, Hiromi; Imoto, Keiji] Natl Inst Physiol Sci, Dept Informat Physiol, Okazaki, Aichi 444, Japan; [Kase, Daisuke] Univ Bordeaux Segalen, UMR 5293, Inst Malad Neurodegenerat, F-33076 Bordeaux, France; [Uta, Daisuke] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Appl Pharmacol, Toyama, Toyama 930, Japan; [Imoto, Keiji] Grad Univ Adv Studies, Sch Life Sci, SOKENDAI, Dept Physiol Sci, Okazaki, Aichi, Japan	Kase, D (reprint author), Univ Bordeaux Segalen, CNRS UMR 5293, Inst Malad Neurodegenerat, 146 Rue Leo Saignat, F-33076 Bordeaux, France.	daisuke.kase@u-bordeaux.fr					ALEXANDER GE, 1990, PROG BRAIN RES, V85, P119; Gillies A, 2004, MED ENG PHYS, V26, P723, DOI 10.1016/j.medengphy.2004.06.003; Middleton FA, 2000, BRAIN RES REV, V31, P236, DOI 10.1016/S0165-0173(99)00040-5; Yamaguchi T, 2013, EUR J NEUROSCI, V38, P3602, DOI 10.1111/ejn.12359; JOEL D, 1994, NEUROSCIENCE, V63, P363, DOI 10.1016/0306-4522(94)90536-3; UEKI A, 1983, EXP BRAIN RES, V49, P116; Brittain JS, 2014, NEUROIMAGE, V85, P637, DOI 10.1016/j.neuroimage.2013.05.084; Powell KL, 2009, J NEUROSCI, V29, P371, DOI 10.1523/JNEUROSCI.5295-08.2009; Paz JT, 2007, J NEUROSCI, V27, P929, DOI 10.1523/JNEUROSCI.4677-06.2007; Nakamura KC, 2014, CEREB CORTEX, V24, P81, DOI 10.1093/cercor/bhs287; BECKSTEAD RM, 1979, BRAIN RES, V175, P191, DOI 10.1016/0006-8993(79)91001-1; Kha HT, 2001, J COMP NEUROL, V440, P20, DOI 10.1002/cne.1367; Lanciego JL, 1998, HISTOCHEM CELL BIOL, V110, P509, DOI 10.1007/s004180050312; Hemond P, 2008, HIPPOCAMPUS, V18, P411, DOI 10.1002/hipo.20404; Bodor AL, 2008, J NEUROSCI, V28, P3090, DOI 10.1523/JNEUROSCI.5266-07.2008; Sano H, 2013, J NEUROSCI, V33, P7583, DOI 10.1523/JNEUROSCI.4932-12.2013; Antal M, 2014, J NEUROSCI, V34, P8032, DOI 10.1523/JNEUROSCI.0236-14.2014; CHEVALIER G, 1982, EXP BRAIN RES, V48, P369; Cebrian C, 2005, J COMP NEUROL, V492, P349, DOI 10.1002/cne.20741; Gulley JM, 2002, NEUROSCIENCE, V111, P337, DOI 10.1016/S0306-4522(02)00018-0; REDGRAVE P, 1992, NEUROSCIENCE, V50, P571, DOI 10.1016/0306-4522(92)90448-B; Kolomiets BP, 2003, NEUROSCIENCE, V117, P931, DOI 10.1016/S0306-4522(02)00824-2; Sakai ST, 1998, J COMP NEUROL, V391, P506, DOI 10.1002/(SICI)1096-9861(19980222)391:4<506::AID-CNE7>3.0.CO;2-4; Basso MA, 2005, EUR J NEUROSCI, V22, P448, DOI 10.1111/j.1460-9568.2005.04215.x; Brazhnik E, 2008, J NEUROSCI, V28, P10386, DOI 10.1523/JNEUROSCI.2387-08.2008; Chang JY, 2006, EXP BRAIN RES, V172, P193, DOI 10.1007/s00221-005-0312-7; DEUTCH AY, 1986, NEUROSCI LETT, V71, P257, DOI 10.1016/0304-3940(86)90630-0; DICHIARA G, 1979, BRAIN RES, V176, P273, DOI 10.1016/0006-8993(79)90983-1; FUJIMOTO K, 1992, NEUROSCI LETT, V142, P105, DOI 10.1016/0304-3940(92)90630-P; Graybiel AM, 2005, CURR OPIN NEUROBIOL, V15, P638, DOI 10.1016/j.conb.2005.10.006; GROENEWEGEN HJ, 1990, PROG BRAIN RES, V85, P95; GROFOVA I, 1982, J COMP NEUROL, V208, P352, DOI 10.1002/cne.902080406; Haber S.N., 2008, BRAIN RES B, V78, P69; Hines M.L., 2006, NEURON BOOK; JIMENEZCASTELLANOS J, 1985, J COMP NEUROL, V236, P297, DOI 10.1002/cne.902360303; Jones EG, 2007, THALAMUS; Kase D, 2012, J NEUROPHYSIOL, V107, P393, DOI 10.1152/jn.00937.2010; Kuramoto E., 2010, EUR J NEUROSCI, V33, P95; Kuramoto E, 2015, CEREB CORTEX, V25, P221, DOI 10.1093/cercor/bht216; Nambu Atsushi, 2014, Front Syst Neurosci, V8, P74, DOI 10.3389/fnsys.2014.00074; OERTEL WH, 1982, BRAIN RES BULL, V9, P463, DOI 10.1016/0361-9230(82)90155-1; Paxinos G, 2008, MOUSE BRAIN STEREOTA; SMITH Y, 1987, J COMP NEUROL, V259, P50, DOI 10.1002/cne.902590105; Wichmann T, 2004, J NEUROPHYSIOL, V91, P815, DOI 10.1152/jn.01180.2002	44	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0168-0102	1872-8111		NEUROSCI RES	Neurosci. Res.	AUG	2015	97						26	35		10.1016/j.neures.2015.03.007		10	Neurosciences	Neurosciences & Neurology	CM5VG	WOS:000357756500005		
J	Matsuda, T; Kubo, A; Taguchi, T; Mizumura, K				Matsuda, Teru; Kubo, Asako; Taguchi, Toru; Mizumura, Kazue			ATP decreases mechanical sensitivity of muscle thin-fiber afferents in rats	NEUROSCIENCE RESEARCH			English	Article						ATP; C-fiber; Muscle nociceptors; Rats; Mechanical response	EXERCISE PRESSOR REFLEX; IN-VITRO; SKELETAL-MUSCLE; SENSORY RECEPTORS; PAIN; NOCICEPTORS; CONTRACTION; SENSITIZATION; HYPERALGESIA; STIMULATION	ATP is an energy rich substance contained in cells in the order of mM. It is released when cells are damaged and when muscle is compressed or contracted. Subcutaneous injection of ATP induces pain-related behavior and hyperalgesia to mechanical and heat stimulation in rats. However, the effects of ATP in muscle have not been fully studied. In the present study we examined the effects of ATP on muscle C-fiber afferent activities using single fiber recordings, and on nociceptive behavior. Muscle C-fiber activities were recorded in vitro using extensor digitorum longus muscle-common peroneal nerve preparations excised from rats deeply anesthetized with pentobarbital. ATP (100 mu M and 1 mM, but not 1 mu M) superfused for 5 min before the mechanical stimulation suppressed the mechanical responses of muscle thin fibers irrespective of whether they excited the fiber. This suppressive effect was reversed by P2X receptor antagonists PPADS (100 mu M) and suramin (300 mu M). We also found that subcutaneous injection of ATP (10 mM) induced nociceptive behavior, whereas intramuscular injection had no effect. These findings showed that effects of ATP on muscle afferents differ from those on cutaneous afferents. (C) 2015 Elsevier Ireland Ltd and the Japan Neuroscience Society. All rights reserved.	[Matsuda, Teru; Kubo, Asako; Taguchi, Toru; Mizumura, Kazue] Nagoya Univ, Environm Med Res Inst, Dept Neurosci 2, Nagoya, Aichi 464, Japan; [Matsuda, Teru; Kubo, Asako; Mizumura, Kazue] Chubu Univ, Coll Life & Hlth Sci, Dept Phys Therapy, Kasugai, Aichi 4878501, Japan	Mizumura, K (reprint author), Chubu Univ, Coll Life & Hlth Sci, Dept Phys Therapy, Matumocho Cho, Kasugai, Aichi 4878501, Japan.	mizu@isc.chubu.ac.jp			JSPS (KAKENHI) [20390063]	This work was supported in part by JSPS (KAKENHI No. 20390063).	Page AJ, 2000, J PHYSIOL-LONDON, V523, P403, DOI 10.1111/j.1469-7793.2000.00403.x; Takahashi K, 2005, SOMATOSENS MOT RES, V22, P299, DOI 10.1080/08990220500420475; Wu G, 2004, EUR J PHARMACOL, V504, P45, DOI 10.1016/j.ejphar.2004.09.056; Reitz M, 2009, CEPHALALGIA, V29, P58, DOI 10.1111/j.1468-2982.2008.01700.x; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; Kobayashi K, 2013, ANAT SCI INT, V88, P10, DOI 10.1007/s12565-012-0163-9; Hilliges M, 2002, PAIN, V98, P59, DOI 10.1016/S0304-3959(01)00469-9; KUMAZAWA T, 1977, J PHYSIOL-LONDON, V273, P179; Yajima H, 2005, NEUROSCI RES, V51, P405, DOI 10.1016/j.neures.2004.12.008; Li JH, 2003, J APPL PHYSIOL, V95, P577, DOI 10.1152/japplphysiol.00185.2003; Shinoda M, 2008, PAIN, V134, P148, DOI 10.1016/j.pain.2007.04.006; Hanna RL, 2003, J APPL PHYSIOL, V94, P1437, DOI 10.1152/japplphysiol.01011.2002; Clifford PS, 2004, J APPL PHYSIOL, V97, P393, DOI 10.1152/japplphysiol.00179.2004; Reinohl J, 2003, NEUROSCI LETT, V338, P25, DOI 10.1016/S0304-3940(02)01360-5; REEH PW, 1986, NEUROSCI LETT, V66, P141, DOI 10.1016/0304-3940(86)90180-1; TAIWO YO, 1989, BRAIN RES, V487, P148, DOI 10.1016/0006-8993(89)90950-5; Taguchi T, 2005, J NEUROPHYSIOL, V94, P2822, DOI 10.1152/jn.00470.2005; Noma N, 2013, J DENT RES, V92, P456, DOI 10.1177/0022034513483770; Kindig AE, 2007, AM J PHYSIOL-HEART C, V293, pH2995, DOI 10.1152/ajpheart.00743.2007; Mork H, 2003, EUR J PAIN, V7, P145, DOI 10.1016/S1090-3801(02)00096-4; Cook SP, 2002, PAIN, V95, P41, DOI 10.1016/S0304-3959(01)00372-4; Burnstock G, 2007, CELL MOL LIFE SCI, V64, P1471, DOI 10.1007/s00018-007-6497-0; Collo G, 1996, J NEUROSCI, V16, P2495; Hamilton SG, 2000, BRAIN, V123, P1238, DOI 10.1093/brain/123.6.1238; Matsuda T, 2010, NEUROSCI RES, V68, pE164, DOI 10.1016/j.neures.2010.07.2298; Santos DA, 2003, NEUROSCI LETT, V338, P225, DOI 10.1016/S0304-3940(02)01419-2; Taguchi T, 2008, NEUROSCI LETT, V434, P277, DOI 10.1016/j.neulet.2008.01.068; Tsuda M, 2000, J NEUROSCI, V20	28	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0168-0102	1872-8111		NEUROSCI RES	Neurosci. Res.	AUG	2015	97						36	44		10.1016/j.neures.2015.04.001		9	Neurosciences	Neurosciences & Neurology	CM5VG	WOS:000357756500006		
J	Miyamoto, R; Otsuguro, K; Yamaguchi, S; Ito, S				Miyamoto, Ryo; Otsuguro, Ken-ichi; Yamaguchi, Soichiro; Ito, Shigeo			Neuronal regulation of expression of hydrogen sulfide-producing enzyme cystathionine beta-synthase in rat spinal cord astrocytes	NEUROSCIENCE RESEARCH			English	Article						Astrocyte; Cystathionine beta-synthase; Homocysteine; Hydrogen sulfide; Neuron	NEURODEGENERATIVE DISORDERS; HOMOCYSTEINE METABOLISM; PLASMA HOMOCYSTEINE; ALZHEIMERS-DISEASE; INJURY; SULFURTRANSFERASE; ACTIVATION; BRAIN; CNS	Cystathionine beta-synthase (CBS), expressed in astrocytes, generates a gaseous neuromodulator, hydrogen sulfide (H2S) in the central nervous system (CNS). However, little is known about the regulatory mechanisms of astrocytic CBS expression and activity. This study evaluated the influence of neurons on astrocytic CBS expression by employing multiple culture systems. Substantial CBS expression was observed in the intact neonatal rat spinal cord, while CBS content was markedly reduced in an astrocyte-enriched culture prepared from the neonatal spinal cord. Immunofluorescence analysis confirmed the localization of spinal cord CBS in astrocytes, but not in neurons. Although CBS expression was weak in the embryonic rat spinal cord, enzyme levels were time-dependently increased in a neuron/astrocyte mixed culture originating from embryonic spinal cord. The reduced CBS expression in isolated neonatal astrocytes was restored by co-culture with embryonic neurons. Together with the observed CBS expression levels, H2S production was relatively low in astrocytes cultured alone, but was considerably higher in astrocytes cultured with neurons. These results indicate that neurons are essential for maintaining the expression and H2S-producing activity of astrocytic CBS in the rat spinal cord. (C) 2015 Elsevier Ireland Ltd and the Japan Neuroscience Society. All rights reserved.	[Miyamoto, Ryo; Otsuguro, Ken-ichi; Yamaguchi, Soichiro; Ito, Shigeo] Hokkaido Univ, Grad Sch Vet Med, Pharmacol Lab, Sapporo, Hokkaido 0600818, Japan	Otsuguro, K (reprint author), Hokkaido Univ, Grad Sch Vet Med, Pharmacol Lab, Kita 18,Nishi 9, Sapporo, Hokkaido 0600818, Japan.	Otsuguro@vetmed.hokudai.ac.jp	Otsuguro, Ken-ichi/A-4840-2012		JSPS [26450440];  [24-2358]	We would like to thank Dr. Osamu Ichii and Rie Hasebe (Hokkaido University) for their technical advice for immunofluorescence analysis of the spinal cord and the culture of cells derived from embryonic rat spinal cord, respectively. This work was supported by a Grant-in-Aid for JSPS (Japan Society for the Promotion of Science) Fellows (No. 24-2358 to R.M.) and a Grant-in-Aid for Scientific Research from JSPS (No. 26450440 to K.O.).	Whiteman M, 2004, J NEUROCHEM, V90, P765, DOI 10.1111/j.1471-4159.2004.02617.x; Valentino F, 2010, EUR J NEUROL, V17, P84, DOI 10.1111/j.1468-1331.2009.02752.x; Enokido Y, 2005, FASEB J, V19, P1854, DOI 10.1096/fj.05-3724fje; Fellin T, 2004, J PHYSIOL-LONDON, V559, P3, DOI 10.1113/jphysiol.2004.063214; Kimura Y, 2004, FASEB J, V18, P1165, DOI 10.1096/fj.04-1815fje; Kimura H, 2014, NITRIC OXIDE-BIOL CH, V41, P4, DOI 10.1016/j.niox.2014.01.002; Zhao KX, 2014, EMBO REP, V15, P792, DOI 10.1002/embr.201338213; REGLAND B, 1995, J NEURAL TRANSM-GEN, V100, P165, DOI 10.1007/BF01271539; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; Qian XM, 2000, NEURON, V28, P69, DOI 10.1016/S0896-6273(00)00086-6; Mattson MP, 2003, TRENDS NEUROSCI, V26, P137, DOI 10.1016/S0166-2236(03)00032-8; Xuan AG, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-202; Agulhon C, 2008, NEURON, V59, P932, DOI 10.1016/j.neuron.2008.09.004; Seshadri S, 2002, NEW ENGL J MED, V346, P476, DOI 10.1056/NEJMoa011613; Kida K, 2011, ANTIOXID REDOX SIGN, V15, P343, DOI 10.1089/ars.2010.3671; Oyinbo CA, 2011, ACTA NEUROBIOL EXP, V71, P281; Lee M, 2009, NEUROBIOL AGING, V30, P1523, DOI 10.1016/j.neurobiolaging.2009.06.001; Mattson MP, 2000, NAT REV MOL CELL BIO, V1, P120, DOI 10.1038/35040009; Schlag BD, 1998, MOL PHARMACOL, V53, P355; MUDD SH, 1964, SCIENCE, V143, P1443, DOI 10.1126/science.143.3613.1443; Shibuya N, 2009, ANTIOXID REDOX SIGN, V11, P703, DOI 10.1089/ARS.2008.2253; Swanson RA, 1997, J NEUROSCI, V17, P932; Beard Jr R.S., 2011, AM J PHYSIOL-HEART C, V300, P13; Campolo M, 2013, FASEB J, V27, P4489, DOI 10.1096/fj.13-234716; Garg SK, 2011, ANTIOXID REDOX SIGN, V14, P2385, DOI 10.1089/ars.2010.3681; GIAMBANCO I, 1991, FEBS LETT, V290, P131, DOI 10.1016/0014-5793(91)81242-Z; HATTEN ME, 1985, J CELL BIOL, V100, P384, DOI 10.1083/jcb.100.2.384; Koulakoff A, 2008, GLIA, V56, P1299, DOI 10.1002/glia.20698; Lee MY, 2006, SPINAL CORD, V44, P474, DOI 10.1038/sj.sc.3101873; Miyamoto R, 2014, J NEUROCHEM, V130, P29, DOI 10.1111/jnc.12698; Rouach N, 2000, J CELL BIOL, V149, P1513, DOI 10.1083/jcb.149.7.1513; SKOVBY F, 1984, J BIOL CHEM, V259, P588	32	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0168-0102	1872-8111		NEUROSCI RES	Neurosci. Res.	AUG	2015	97						52	59		10.1016/j.neures.2015.03.003		8	Neurosciences	Neurosciences & Neurology	CM5VG	WOS:000357756500008		
J	Ichihashi, R; Tateno, M				Ichihashi, Ryuji; Tateno, Masaki			Biomass allocation and long-term growth patterns of temperate lianas in comparison with trees	NEW PHYTOLOGIST			English	Article						allometry; cool-temperate forest; deciduous liana; deciduous tree; extension growth; stem turnover; strategy; woody vine	BARRO-COLORADO-ISLAND; CURRENT-YEAR SHOOTS; TROPICAL FOREST; STEM DIAMETER; RAIN-FOREST; ABUNDANCE; JAPAN; DIFFERENTIATION; MORTALITY; CANOPY	The host-dependent support habit of lianas is generally interpreted as a strategy designed to reduce resource investment in mechanical tissues; this allows preferential allocation to leaf and stem extension, thereby enhancing productivity and competitive abilities. However, this hypothesis has not been rigorously tested. We examined the aboveground allometries regarding biomass allocation (leaf mass and current-year stem mass (approximated as biomass allocated to extension growth) vs total aboveground mass) and long-term apparent growth patterns (height and aboveground mass vs age, i.e. numbers of growth rings) for nine deciduous liana species in Japan. Lianas had, on average, three- and five-fold greater leaf and current-year stem mass, respectively, than trees for a given aboveground mass, whereas the time course to reach the forest canopy was comparable and biomass accumulation during that period was only one-tenth that of co-occurring canopy trees. The balance between the lengths of yearly stem extension and existing older stems indicated that lianas lost c. 75% of stem length during growth to the canopy, which is probably a consequence of the host-dependent growth. Our observations suggest that, although lianas rely on hosts mechanically, allowing for short-term vigorous growth, this habit requires a large cost and could limit plant growth over protracted periods.	[Ichihashi, Ryuji; Tateno, Masaki] Univ Tokyo, Nikko Bot Garden, Nikko, Tochigi 3211435, Japan	Ichihashi, R (reprint author), Kagawa Univ, Fac Agr, Miki, Kagawa 7610795, Japan.	ichihashiryuji184@gmail.com			Japan Society for the Promotion of Science (JSPS) [25450205]	We thank Hisae Nagashima and Noriyuki Osada for valuable comments on the manuscript, Yasuhiro Utsumi for instructions related to microscopy, and Masae Ishihara for information on literature related to tree allometry. R.I. is truly grateful to Mrs Eiko Ito for all her support during his life in Nikko. This study was partly supported by the Japan Society for the Promotion of Science (JSPS) (25450205, Kiyoshi Umeki and Yoshiyuki Miyazawa).	Allen BP, 2005, FOREST ECOL MANAG, V218, P259, DOI 10.1016/j.foreco.2005.08.021; Yorke SR, 2013, BIOTROPICA, V45, P317, DOI 10.1111/btp.12015; Schnitzer SA, 2002, TRENDS ECOL EVOL, V17, P223, DOI 10.1016/S0169-5347(02)02491-6; Schnitzer SA, 2005, AM NAT, V166, P262, DOI 10.1086/431250; PUTZ FE, 1984, ECOLOGY, V65, P1713, DOI 10.2307/1937767; van der Heijden GM, 2013, BIOTROPICA, V45, P682, DOI 10.1111/btp.12060; NIKLAS KJ, 1994, AM J BOT, V81, P1416, DOI 10.2307/2445314; Wyka TP, 2013, ANN BOT-LONDON, V112, P1667, DOI 10.1093/aob/mct236; PUTZ FE, 1983, BIOTROPICA, V15, P185, DOI 10.2307/2387827; Ohtsuka T, 2005, AGR FOREST METEOROL, V134, P27, DOI 10.1016/j.agrformet.2005.11.005; Schnitzer SA, 2011, ECOL LETT, V14, P397, DOI 10.1111/j.1461-0248.2011.01590.x; REICH PB, 1991, OECOLOGIA, V86, P16, DOI 10.1007/BF00317383; Selaya NG, 2008, FUNCT ECOL, V22, P30, DOI 10.1111/j.1365-2435.2007.01350.x; Duran SM, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0301; Campanello PI, 2012, FOREST ECOL MANAG, V284, P213, DOI 10.1016/j.foreco.2012.07.043; Darwin C, 1865, J LINN SOC LOND, V9, P1; FRENCH JC, 1977, AM J BOT, V64, P292, DOI 10.2307/2441973; GARTNER BL, 1991, AM J BOT, V78, P1345, DOI 10.2307/2445273; Gentry A.H., 1991, BIOL VINES, P3; Gerwing JJ, 2006, FOREST ECOL MANAG, V221, P83, DOI 10.1016/j.foreco.2005.09.008; Gianoli E, 2004, P ROY SOC B-BIOL SCI, V271, P2011, DOI 10.1098/rspb.2004.2827; Hegarty E. E., 1991, BIOL VINES, P313; HEGARTY EE, 1991, J TROP ECOL, V7, P201; Henriksson J, 2001, OECOLOGIA, V126, P482, DOI 10.1007/s004420000547; Ichihashi R, 2011, J ECOL, V99, P1071, DOI 10.1111/j.1365-2745.2011.01808.x; Ichihashi R, 2010, PLANT ECOL, V211, P181, DOI 10.1007/s11258-010-9783-0; Ichihashi R, 2009, ECOL RES, V24, P393, DOI 10.1007/s11284-008-0512-2; Ikushima I, 1964, REPORT SCI RES MOUNT, P106; INAGAKI A, 1989, Journal of UOEH, V11, P247; KATAGIRI S, 1984, B FACULTY AGR, V18, P53; Komiyama A., 2002, Journal of the Japanese Forestry Society, V84, P130; Kurzel BP, 2006, BIOTROPICA, V38, P262, DOI 10.1111/j.1744-7429.2006.00135.x; Kusumoto B, 2008, J FOREST RES-JPN, V13, P35, DOI 10.1007/s10310-007-0046-4; Ladwig LM, 2009, FOREST ECOL MANAG, V259, P195, DOI 10.1016/j.foreco.2009.10.012; MONSI M., 1970, Prediction and measurement of photosynthetic productivity. Proceedings of the IBP/PP Technical Meeting, Tfebon, [Czechoslovakia], 14-21 September, 1969., P115; Nabe-Nielsen J, 2001, J TROP ECOL, V17, P1, DOI 10.1017/S0266467401001018; Ogino K., 1977, JIBP SYNTHESIS, V16, P172; Phillips OL, 2005, ECOLOGY, V86, P1250, DOI 10.1890/04-1446; PUTZ FE, 1990, BIOTROPICA, V22, P103, DOI 10.2307/2388725; Putz FE, 1991, BIOL VINES, P73; Sakai A, 1999, J FOREST RES, V4, P183, DOI 10.1007/BF02762245; Sassa T., 1982, JAPANESE J FOREST EN, V24, P29; Satake Y, 1989, WILD FLOWERS JAPAN W; Schnitzer SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052114; Segawa K, 1970, ANN REP TOHOKU BR FO, V11, P188; Tadaki Y., 1995, B NAGOYA U FOR, V14, P1; Takahashi K., 1999, Research Bulletin of the Hokkaido University Forests, V56, P70; Takenaka A, 2000, TREE PHYSIOL, V20, P987; Tang Y, 2012, CHINESE SCI BULL, V57, P307, DOI 10.1007/s11434-011-4690-x; Umeki K, 2006, TREE PHYSIOL, V26, P623; Whitmore TC, 1998, INTRO TROPICAL RAIN; Yagi T, 2000, J PLANT RES, V113, P171, DOI 10.1007/PL00013928	52	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0028-646X	1469-8137		NEW PHYTOL	New Phytol.	AUG	2015	207	3					604	612		10.1111/nph.13391		9	Plant Sciences	Plant Sciences	CM6TZ	WOS:000357824400015		
J	Urakubo, T				Urakubo, Takateru			Feedback stabilization of a nonholonomic system with potential fields: application to a two-wheeled mobile robot among obstacles	NONLINEAR DYNAMICS			English	Article						Nonholonomic system; Feedback control; Lyapunov stability; Potential field method	EXPONENTIAL STABILIZATION; CHAINED SYSTEMS; MOTION CONTROL; NAVIGATION; AVOIDANCE; MANIPULATORS; SPACE	In this paper, a feedback controller for a nonholonomic system with three states and two inputs is derived using an artificial potential function that has no local minima, and the stability of equilibria of the system is analyzed. Although the system with the controller has an infinite number of equilibria due to the nonholonomic constraint, those equilibria except the critical points of the potential function are unstable because of a skew-symmetric component of the controller. When the potential function has critical points of saddle type, the saddles may be stable equilibria in addition to the stable equilibrium at the minimum of the function. The controller is applied to a two-wheeled mobile robot among obstacles and modified by using a time-varying potential function in order to avoid convergence to the saddles. As a result, with the controller, the mobile robot converges to a desired position and orientation without collision with obstacles.	Kobe Univ, Dept Syst Sci, Nada Ku, Kobe, Hyogo 6578501, Japan	Urakubo, T (reprint author), Kobe Univ, Dept Syst Sci, Nada Ku, 1-1 Rokkodai Cho, Kobe, Hyogo 6578501, Japan.	t.urakubo@silver.kobe-u.ac.jp					LAUMOND JP, 1994, IEEE T ROBOTIC AUTOM, V10, P577, DOI 10.1109/70.326564; Ge SS, 2000, IEEE T ROBOTIC AUTOM, V16, P615, DOI 10.1109/70.880813; Lamiraux F, 1999, IEEE T ROBOTIC AUTOM, V15, P640, DOI 10.1109/70.781968; MCloskey RT, 1997, IEEE T AUTOMAT CONTR, V42, P614, DOI 10.1109/9.580865; Yang SX, 2003, IEEE T NEURAL NETWOR, V14, P1541, DOI 10.1109/TNN.2003.820618; RIMON E, 1992, IEEE T ROBOTIC AUTOM, V8, P501, DOI 10.1109/70.163777; Huang WH, 2006, ROBOT AUTON SYST, V54, P288, DOI 10.1016/j.robot.2005.11.004; KOLMANOVSKY I, 1995, IEEE CONTR SYST MAG, V15, P20, DOI 10.1109/37.476384; Tanner HG, 2003, IEEE T ROBOTIC AUTOM, V19, P53, DOI 10.1109/TRA.2002.807549; Patel S, 2002, 2002 IEEE INTERNATIONAL CONFERENCE ON ROBOTICS AND AUTOMATION, VOLS I-IV, PROCEEDINGS, P3081; Astolfi A, 1999, J DYN SYST-T ASME, V121, P121, DOI 10.1115/1.2802429; Lamiraux F, 2004, IEEE T ROBOTIC AUTOM, V20, P967, DOI 10.1109/TRO.2004.829459; Brockett R. W., 1983, PROGR MATH, V27, P181; Divelbiss AW, 1997, IEEE T ROBOTIC AUTOM, V13, P443, DOI 10.1109/70.585905; GULDNER J, 1995, IEEE T ROBOTIC AUTOM, V11, P247, DOI 10.1109/70.370505; Jacobs P., 1993, NONHOLONOMIC MOTION, P271; Kallem V, 2011, IEEE T ROBOT, V27, P1152, DOI 10.1109/TRO.2011.2161159; Karydis K, 2012, 2012 IEEE INTERNATIONAL CONFERENCE ON ROBOTICS AND AUTOMATION (ICRA), P3206, DOI 10.1109/ICRA.2012.6225202; KHATIB O, 1986, INT J ROBOT RES, V5, P90, DOI 10.1177/027836498600500106; Khennouf H., 1996, P IFAC 13 WORLD C SA, p2b; KIM JO, 1992, IEEE T ROBOTIC AUTOM, V8, P338, DOI 10.1109/70.143352; LaValle SM, 2001, INT J ROBOT RES, V20, P378, DOI 10.1177/02783640122067453; LaValle SM, 2001, INT J ROBOT RES, V20, P729, DOI 10.1177/02783640122067633; Neimark J. I., 1972, DYNAMICS NONHOLONOMI; Papadopoulos E, 2002, INT J ROBOT RES, V21, P367; Que Z., 2004, IEEE T ROBOT, V20, P978; Ramirez G, 2001, ROBOTICA, V19, P543; Rigatos GG, 2001, IEE P-CONTR THEOR AP, V148, P169, DOI 10.1049/ip-cta:20010199; RIMON E, 1991, T AM MATH SOC, V327, P71, DOI 10.2307/2001835; SAMSON C, 1995, IEEE T AUTOMAT CONTR, V40, P64, DOI 10.1109/9.362899; Sekhavat S, 1998, IEEE T ROBOTIC AUTOM, V14, P671, DOI 10.1109/70.720344; Tanner H. G., 2001, Proceedings 2001 IEEE/RSJ International Conference on Intelligent Robots and Systems. Expanding the Societal Role of Robotics in the the Next Millennium (Cat. No.01CH37180), DOI 10.1109/IROS.2001.977149; Tayebi A, 2001, NONLINEAR DYNAM, V24, P167, DOI 10.1023/A:1008318423148; Tsuchiya K, 2002, J GUID CONTROL DYNAM, V25, P285, DOI 10.2514/2.4880; Urakubo T., 2004, P IEEE RSJ 2004 IROS, P2428; Urakubo T, 2001, ADV ROBOTICS, V15, P711, DOI 10.1163/15685530152744581; Valbuena L, 2012, J INTELL ROBOT SYST, V68, P307, DOI 10.1007/s10846-012-9685-6; Weir MK, 2010, IEEE INT CONF ROBOT, P3221, DOI 10.1109/ROBOT.2010.5509519; Xiang X., 2010, P IEEE RSJ INT C INT, P6064; Zhu HP, 2002, MECH RES COMMUN, V29, P307, DOI 10.1016/S0093-6413(02)00268-9	40	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0924-090X	1573-269X		NONLINEAR DYNAM	Nonlinear Dyn.	AUG	2015	81	3					1475	1487		10.1007/s11071-015-2082-5		13	Engineering, Mechanical; Mechanics	Engineering; Mechanics	CM4VP	WOS:000357683500032		
J	Funatsu, S; Kondoh, T; Kawase, T; Ikeda, H; Nagasawa, M; Denbow, DM; Furuse, M				Funatsu, Shoichiro; Kondoh, Takashi; Kawase, Takahiro; Ikeda, Hiromi; Nagasawa, Mao; Denbow, D. Michael; Furuse, Mitsuhiro			Long-term consumption of dried bonito dashi (a traditional Japanese fish stock) reduces anxiety and modifies central amino acid levels in rats	NUTRITIONAL NEUROSCIENCE			English	Article						Dried bonito dashi; Anxiety; Depression; Emotion; Brain amino acid; Hippocampus; Functional food; Rats	OXIDATIVE STRESS MARKER; PERIPHERAL-BLOOD FLOW; BROTH; METABOLISM; HUMANS; BRAIN; FATIGUE; HIPPOCAMPUS; DOPAMINE; SKIPJACK	Dried bonito dashi, a traditional Japanese fish stock, enhances palatability of various dishes because of its specific flavor. Daily intake of dashi has also been shown to improve mood status such as tension-anxiety in humans. This study aimed at investigating beneficial effects of dashi ingestion on anxiety/depression-like behaviors and changes in amino acid levels in the brain and plasma in rats. Male Wistar rats were given either dried bonito dashi or water for long-term (29 days; Experiment 1) or single oral administration (Experiment 2). Anxiety and depression-like behaviors were tested using the open field and forced swimming tests, respectively. Concentrations of amino acids were measured in the hippocampus, hypothalamus, cerebellum, and jugular vein. During the long-term (29 days) consumption, rats given 2% dashi frequently entered the center zone and spent more time compared with the water controls in the open field test. However, the dashi was ineffective on depression-like behavior. In the hippocampus, concentrations of hydroxyproline, anserine, and valine were increased by dashi while those of asparagine and phenylalanine were decreased. In the hypothalamus, the methionine concentration was decreased. In a single oral administration experiment, the dashi (1%, 2% or 10%) showed no effects on behaviors. Significance was observed only in the concentrations of alpha-aminoadipic acid, cystathionine, and ornithine in the hippocampus. Dried bonito dashi is a functional food having anxiolytic-like effects. Daily ingestion of the dashi, even at lower concentrations found in the cuisine, reduces anxiety and alters amino acid levels in the brain.	[Funatsu, Shoichiro; Kawase, Takahiro; Ikeda, Hiromi; Nagasawa, Mao; Furuse, Mitsuhiro] Kyushu Univ, Lab Regulat Metab & Behav, Fac Agr, Fukuoka 8128581, Japan; [Kondoh, Takashi] Kyoto Univ, Grad Sch Agr, AJINOMOTO Integrat Res Adv Dieting, Kyoto, Japan; [Denbow, D. Michael] Virginia Tech, Dept Anim & Poultry Sci, Blacksburg, VA USA	Furuse, M (reprint author), Kyushu Univ, Lab Regulat Metab & Behav, Fac Agr, Fukuoka 8128581, Japan.	furuse@brs.kyushu-u.ac.jp			Japan Society for the Promotion of Science [23248046]	Part of this work was supported by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (No. 23248046).	Domorakova I, 2009, CELL MOL NEUROBIOL, V29, P837, DOI 10.1007/s10571-009-9365-7; Matsumoto H, 2005, EUR J APPL PHYSIOL, V94, P36, DOI 10.1007/s00421-004-1279-y; Chen FH, 2013, SYNAPSE, V67, P127, DOI 10.1002/syn.21622; Steinberg EE, 2013, BRAIN RES, V1511, P46, DOI 10.1016/j.brainres.2012.09.036; PACAK K, 1995, FRONT NEUROENDOCRIN, V16, P89, DOI 10.1006/frne.1995.1004; Wu GY, 2011, AMINO ACIDS, V40, P1053, DOI 10.1007/s00726-010-0715-z; Manto M, 2012, CEREBELLUM, V11, P457, DOI 10.1007/s12311-011-0331-9; Fernandes CG, 2010, CELL MOL NEUROBIOL, V30, P317, DOI 10.1007/s10571-009-9455-6; THIERRY AM, 1976, NATURE, V263, P242, DOI 10.1038/263242a0; Chao HX, 2012, ENDOCRINOLOGY, V153, P166, DOI 10.1210/en.2011-1312; Cohen A, 2009, PSYCHOPHARMACOLOGY, V204, P541, DOI 10.1007/s00213-009-1486-7; Deshpande G, 2007, J NEUROSURG ANESTH, V19, P243, DOI 10.1097/ANA.0b013e31811ecdf6; FUKE S, 1989, J JPN SOC FOOD SCI, V36, P67; Honda M, 2006, J JPN SOC FOOD SCI, V53, P443; Honda M, 2006, JPN J VIS SCI, V27, P95; Hu TJ, 2009, INT J BIOL MACROMOL, V45, P279, DOI 10.1016/j.ijbiomac.2009.06.011; INOUE T, 1993, PHARMACOL BIOCHEM BE, V44, P371, DOI 10.1016/0091-3057(93)90476-A; Kawaguchi H., 2005, JPN J TASTE SMELL RE, V12, P123; Kobayashi H, 2005, REP RES COMM ESSEN A, V172, P10; Kubomura D, 2010, SHOKUHINKOGYO, V53, P60; Kuroda M, 2008, BIOMED RES-TOKYO, V29, P175, DOI 10.2220/biomedres.29.175; Kuroda M, 2007, PHYSIOL BEHAV, V92, P957, DOI 10.1016/j.physbeh.2007.07.002; Lee Keou Won, 2011, J Prev Med Public Health, V44, P9, DOI 10.3961/jpmph.2011.44.1.9; Murakami H., 2004, KAGAKU KOGYO, V57, P522; Murakami T, 2009, EUR J PHARMACOL, V602, P73, DOI 10.1016/j.ejphar.2008.10.049; Nagasawa M, 2012, ANIM SCI J, V83, P493, DOI 10.1111/j.1740-0929.2011.00987.x; Nozawa Y, 2007, J HEALTH SCI, V53, P339, DOI 10.1248/jhs.53.339; Nozawa Y, 2007, J HEALTH SCI, V53, P543, DOI 10.1248/jhs.53.543; Nozawa Y, 2009, BIOL PHARM BULL, V32, P468; Nozawa Y, 2008, PHYSIOL BEHAV, V93, P267, DOI 10.1016/j.physbeh.2007.08.021; Sanchez Lopez CL, 2010, ACTA PHYSL HUNG, V97, P224; Strata P., 2011, PHYSIOL REV, V60, P39; Takahashi Y, 2009, DASHI UMAMI HEART JA; Takenami E, 2003, J JPN COLL ANGIOL, V43, P331; Tomonaga S, 2007, NUTR NEUROSCI, V10, P181, DOI 10.1080/10284150701587338; Umeki Y, 2008, J CLIN BIOCHEM NUTR, V43, P175, DOI 10.3164/jcbn.2008061; Undarmaa J, 2013, J PHYSL SOC JAPAN, V75, P188; Yamada K, 2006, J NUTR FOOD, V9, P53; YOKOGOSHI H, 1986, METABOLISM, V35, P837, DOI 10.1016/0026-0495(86)90225-8	39	0	0	MANEY PUBLISHING	LEEDS	STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND	1028-415X	1476-8305		NUTR NEUROSCI	Nutr. Neurosci.	AUG	2015	18	6					256	264		10.1179/1476830514Y.0000000124		9	Neurosciences; Nutrition & Dietetics	Neurosciences & Neurology; Nutrition & Dietetics	CM5NU	WOS:000357735800003		
J	Fujioka, K; Sugiyama, A; Fujimoto, Y; Kawanaka, J; Miyanaga, N				Fujioka, Kana; Sugiyama, Akira; Fujimoto, Yasushi; Kawanaka, Junji; Miyanaga, Noriaki			Ion diffusion at the bonding interface of undoped YAG/Yb:YAG composite ceramics	OPTICAL MATERIALS			English	Article						Ion diffusion; Yttrium aluminum garnet; Ceramic; Composite; Grain boundary	YTTRIUM-ALUMINUM-GARNET; GRAIN-BOUNDARY DIFFUSION; YVO4 LASER CRYSTALS; TRANSPARENT CERAMICS; YAG CERAMICS; STABILIZED ZIRCONIA; ROOM-TEMPERATURE; CATION DIFFUSION; SILICON-WAFERS; MECHANISMS	Cation diffusion across a boundary between ytterbium (Yb)-doped and undoped yttrium aluminum garnet (YAG) ceramics was examined by electron microprobe analysis (EPMA). Polished Yb:YAG and undoped YAG ceramics were bonded by surface treatment with argon fast atom beam, and then heat-treated at 1400 or 1600 degrees C for 50 h or at 1400 degrees C for 10 h under vacuum. We obtained EPMA mapping images of the bonded samples that clearly showed the bulk and grain-boundary diffusion of Y and Yb ions. The number density profiles showed that the total diffusion distances of Yb and Y ions were almost equal and approximately 2 and 15 pm at 1400 and 1600 degrees C, respectively, and the dependence of diffusion distance on heating time was weak. The diffusion curves were well modeled by Harrison type B kinetics including bulk and grain-boundary diffusion. In addition, it was found that Si ions added to the samples as a sintering aid might be segregated at the grain boundary by heat treatment, and diffused only along grain boundaries. (C) 2015 Elsevier B.V. All rights reserved.	[Fujioka, Kana; Fujimoto, Yasushi; Kawanaka, Junji; Miyanaga, Noriaki] Osaka Univ, Inst Laser Engn, Suita, Osaka 5650871, Japan; [Sugiyama, Akira] Japan Atom Energy Agcy, Kansai Photon Sci Inst, Kizugawa, Kyoto 6190215, Japan	Fujioka, K (reprint author), Osaka Univ, Inst Laser Engn, 2-6 Yamada Oka, Suita, Osaka 5650871, Japan.	fujioka-kana@ile.osaka-u.ac.jp	Kawanaka, Junji/P-8065-2015	Kawanaka, Junji/0000-0001-5655-7981			Qin GS, 2004, SOLID STATE COMMUN, V132, P103, DOI 10.1016/j.ssc.2004.07.018; Sugiyama A, 2005, CERAM INT, V31, P1085, DOI 10.1016/j.ceramint.2004.11.009; Cherniak DJ, 1998, PHYS CHEM MINER, V26, P156, DOI 10.1007/s002690050172; Sakaguchi I, 1996, J AM CERAM SOC, V79, P1627, DOI 10.1111/j.1151-2916.1996.tb08774.x; Ikesue A, 2006, J AM CERAM SOC, V89, P1936, DOI 10.1111/j.1551-2916.2006.01043.x; Boulesteix R, 2013, J AM CERAM SOC, V96, P1724, DOI 10.1111/jace.12315; Sato Y, 2007, IEEE J SEL TOP QUANT, V13, P838, DOI 10.1109/JSTQE.2007.896564; HARRISON LG, 1961, T FARADAY SOC, V57, P1191, DOI 10.1039/tf9615701191; Yagi H, 2005, LASER PHYS, V15, P1338; Stevenson AJ, 2011, J AM CERAM SOC, V94, P1380, DOI 10.1111/j.1551-2916.2010.04260.x; Li J, 2008, INT J APPL CERAM TEC, V5, P360, DOI 10.1111/j.1744-7402.2008.02244.x; Jimenez-Melendo M, 2001, J AM CERAM SOC, V84, P2356; STENGL R, 1989, JPN J APPL PHYS 1, V28, P1735, DOI 10.1143/JJAP.28.1735; Haneda H, 2001, J CERAM SOC JPN, V109, P114, DOI 10.2109/jcersj.109.1266_114; Takagi H, 1996, APPL PHYS LETT, V68, P2222, DOI 10.1063/1.115865; Boulesteix R, 2009, J EUR CERAM SOC, V29, P2517, DOI 10.1016/j.jeurceramsoc.2009.03.003; Crank J., 1975, MATH DIFFUSION; Denis T, 2010, APPL OPTICS, V49, P811, DOI 10.1364/AO.49.000811; Hollingsworth JP, 2011, OPT MATER, V33, P592, DOI 10.1016/j.optmat.2010.10.048; Hollingsworth JP, 2009, J PHYS D APPL PHYS, V42, DOI 10.1088/0022-3727/42/5/052001; Kaur I., 1995, FUNDAMENTALS GRAIN I; Kawanaka J, 2010, LASER PHYS, V20, P1079, DOI 10.1134/S1054660X10090252; Kowalski K, 2000, J EUR CERAM SOC, V20, P951, DOI 10.1016/S0955-2219(99)00212-5; LECLAIRE AD, 1963, BRIT J APPL PHYS, V14, P351; LEVING HS, 1960, J APPL PHYS, V31, P595, DOI 10.1063/1.1735634; Mehrer Helmut, 2007, SPRINGER SERIES SOLI, V155; Smith JB, 2006, J AM CERAM SOC, V89, P582, DOI 10.1111/j.1551-2916.2005.00712.x; Sugiyama A, 2002, P SOC PHOTO-OPT INS, V4944, P361; Takagi H, 1999, APPL PHYS LETT, V74, P2387, DOI 10.1063/1.123860; Taylor MA, 2004, SOLID STATE IONICS, V173, P51, DOI 10.1016/j.ssi.2004.07.051; Yagi H, 2006, JPN J APPL PHYS 1, V45, P133, DOI [10.1143/JJAP.45.133, 10.1143/JJAP.45.L207]	31	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0925-3467	1873-1252		OPT MATER	Opt. Mater.	AUG	2015	46						542	547		10.1016/j.optmat.2015.05.023		6	Materials Science, Multidisciplinary; Optics	Materials Science; Optics	CM0EH	WOS:000357350700088		
J	Senthil, K; Kalainathan, S; Hamada, F; Yamada, M; Aravindan, PG				Senthil, K.; Kalainathan, S.; Hamada, F.; Yamada, M.; Aravindan, P. G.			Synthesis, growth, structural and HOMO and LUMO, MEP analysis of a new stilbazolium derivative crystal: A enhanced third-order NLO properties with a high laser-induced damage threshold for NLO applications	OPTICAL MATERIALS			English	Article						Crystal growth; Optical materials; Optical properties; Dielectric properties; Z-scan technique	NONLINEAR-OPTICAL PROPERTIES; SINGLE-CRYSTALS; Z-SCAN; DAST CRYSTALS; TOSYLATE; MICROHARDNESS; GENERATION; MORPHOLOGY; 2ND-ORDER; ACID	A new organic third-order nonlinear optical crystal from stilbazolium family 2-[2-(4-methoxy-phenyl) vinyl]-1-methyl-pyridinium tetrafluoroborate (4MSTB) has been synthesized and grown by slow, evaporation method for the first time. The grown crystal structure was confirmed by single crystal X-ray diffraction analysis, and it is revealed that the grown crystal crystallized in a triclinic crystal system with centrosymmetric space group PT. The HOMO and LUMO energies were calculated for the grown crystal explains charge transfer takes place within the molecule and confirms the suitability of the title crystal for NLO applications. The presence of various vibration modes of expected functional groups was identified by FT-IR analysis. The transmittance ability of the grown crystal was also analyzed by using UV-Vis-NIR spectral studies and shows that the crystal has no absorption of light in the entire Vis-NIR region. The thermal stability of the title crystal has been investigated by TGA/DTA studies and revealed that the material was thermally stable up to the melting point, 193 degrees C. The hardness number, Meyer index, yield strength, and elastic stiffness constant has been estimated for the grown 4MSTB crystal using Vickers microhardness tester. Photoluminescence excitation studies showed green emission radiation occurred at 517 nm. The dielectric properties of the grown crystal have been analyzed as a function of temperature over a wide range of frequency (50 Hz-5 MHz) by using LCR meter. The result of ac electrical conductivity of 4MSTB was found to be 5.25 x 10(-5) (Omega m)(-1). The laser damage threshold (LDT) energy for the grown crystal has been measured by using a Q-switched Nd:YAG laser as a source in single-shot mode (1064 nm, 10 Hz, 420 mJ). The result of LDT indicates that grown title crystal has excellent resistance to laser radiation than those of known some inorganic NLO materials. The chemical etching studies were carried out to assess the perfection of the grown crystals. Its third-order nonlinear optical properties were investigated by Z-scan technique and proved that the 4MSTB crystal possesses two-photon absorptions (TPA) and the self-defocusing effect. The second-order molecular hyperpolarizability (gamma) value at 632.8 nm is calculated to be 3.555 x 10(-34) esu. The photoconductivity study of 4MSTB reveals that the negative phetoconducting nature. The obtained all the results in the present work are making a 4MSTB promising candidate for the possible applications in optical switches, optical power limiter, and non-linear optical applications. (C) 2015 Elsevier B.V. All rights reserved.	[Senthil, K.; Kalainathan, S.] VIT Univ, Sch Adv Sci, Ctr Crystal Growth, Vellore 632014, Tamil Nadu, India; [Aravindan, P. G.] VIT Univ, Sch Adv Sci, Crystal Growth & Crystallog Div, Vellore 632014, Tamil Nadu, India; [Hamada, F.] Akita Univ, Grad Sch Engn & Resource Sci, Dept Appl Chem, Akita 0108502, Japan; [Yamada, M.] Akita Univ, Grad Sch Engn & Resource Sci, CGES, Akita 0108502, Japan	Kalainathan, S (reprint author), VIT Univ, Sch Adv Sci, Ctr Crystal Growth, Vellore 632014, Tamil Nadu, India.				Defence Research and Development Organisation (DRDO), Government of India	The authors are expressing their thanks to Defence Research and Development Organisation (DRDO), Government of India, for financial assistance. The authors also thanks to VIT University management for their constant support and providing excellent research facilities towards the research work.	Adachi H, 2004, JPN J APPL PHYS 2, V43, pL1121, DOI 10.1143/JJAP.43.L1121; WOOSTER WA, 1953, REP PROG PHYS, V16, P62, DOI 10.1088/0034-4885/16/1/302; Geis W, 2004, APPL PHYS LETT, V84, P3729, DOI 10.1063/1.1723697; Wang JX, 2004, SOLID STATE COMMUN, V131, P435, DOI 10.1016/j.ssc.2004.06.009; Kumari L, 2010, CRYST RES TECHNOL, V45, P311, DOI 10.1002/crat.200900600; SHEIKBAHAE M, 1989, OPT LETT, V14, P955, DOI 10.1364/OL.14.000955; Ruiz B, 2006, J MATER CHEM, V16, P2839, DOI 10.1039/b603049a; LONG NJ, 1995, ANGEW CHEM INT EDIT, V34, P21, DOI 10.1002/anie.199500211; Senthil K, 2014, RSC ADV, V4, P56112, DOI 10.1039/c4ra09112d; Geskin VM, 2003, J AM CHEM SOC, V125, P15651, DOI 10.1021/ja035862p; REDDY RR, 1995, J PHYS CHEM SOLIDS, V56, P825, DOI 10.1016/0022-3697(94)00268-1; Mukerji S, 1999, J CRYST GROWTH, V204, P341, DOI 10.1016/S0022-0248(99)00137-2; SHEIKBAHAE M, 1990, IEEE J QUANTUM ELECT, V26, P760, DOI 10.1109/3.53394; Hrobarik P, 2010, J PHYS CHEM C, V114, P22289, DOI 10.1021/jp.108623d; RAVINDRA NM, 1981, INFRARED PHYS, V21, P369, DOI 10.1016/0020-0891(81)90045-2; Pabitha G, 2013, OPT LASER TECHNOL, V50, P150, DOI 10.1016/j.optlastec.2013.03.004; Girisun TCS, 2011, MATER CHEM PHYS, V129, P9, DOI 10.1016/j.matchemphys.2011.04.013; Girisun TCS, 2011, CURR APPL PHYS, V11, P838, DOI 10.1016/j.cap.2010.12.004; Kwon SJ, 2010, CRYST GROWTH DES, V10, P1552, DOI 10.1021/cg900882h; Balachandran V, 2012, SPECTROCHIM ACTA A, V97, P1101, DOI 10.1016/j.saa.2012.07.112; Chapple PB, 1997, J NONLINEAR OPT PHYS, V6, P251, DOI 10.1142/S0218863597000204; RAO KV, 1965, J APPL PHYS, V36, P2031, DOI 10.1063/1.1714397; Yang Z, 2005, ADV FUNCT MATER, V15, P1072, DOI 10.1002/adfm.20050036; Boaz BM, 2009, INDIAN J PHYS, V83, P1647; TAUC J, 1966, PHYS STATUS SOLIDI, V15, P627, DOI 10.1002/pssb.19660150224; da Silva MAFM, 2013, OPT MATER, V35, P543, DOI 10.1016/j.optmat.2012.10.008; Kumar MK, 2014, OPTIK, V125, P751, DOI 10.1016/j.ijleo.2013.07.040; Audebert P, 2003, CHEM PHYS LETT, V367, P62, DOI 10.1016/S0009-2614(02)01575-0; [Anonymous], 2011, SPART 10 VERS 1 10 9; Vijay RJ, 2010, J CRYST GROWTH, V312, P420, DOI 10.1016/j.jcrysgro.2009.10.067; Schneider A, 2004, APPL PHYS LETT, V84, P2229, DOI 10.1063/1.1688986; RONDA CR, 1995, J ALLOY COMPD, V225, P534, DOI 10.1016/0925-8388(94)07065-2; BALAREW C, 1984, J SOLID STATE CHEM, V55, P1, DOI 10.1016/0022-4596(84)90240-8; Zhou YS, 1999, POLYHEDRON, V18, P1419, DOI 10.1016/S0277-5387(98)00448-3; BREDAS JL, 1994, CHEM REV, V94, P243, DOI 10.1021/cr00025a008; Balarew C., 1984, J SOLID STATE CHEM, V155, P1; Barsoukov E, 2005, IMPEDANCE SPECTROSCOPY: THEORY, EXPERIMENT, AND APPLICATIONS, 2ND EDITION, pXII; Breitzer JG, 1999, J PHYS CHEM A, V103, P6930, DOI 10.1021/jp990137f; Bube R. H., 1960, PHOTOCONDUCTIVITY SO; Bube R. H, 1981, PHOTOCONDUCTIVITY SO; CLYMER B, 1985, OPT ENG, V24, P74, DOI 10.1117/12.7973428; Dongol M., 2002, Egyptian Journal of Solids, V25; El-Fadl A. A., 2007, CRYST RES TECHNOL, V42, P364; Farrugia LJ, 1997, J APPL CRYSTALLOGR, V30, P565, DOI DOI 10.1107/S0021889897003117; Gokce H, 2013, LETT ORG CHEM, V10, P395; Hales JM, 2006, J AM CHEM SOC, V128, P11362, DOI 10.1021/ja063535m; Hanneman M., 1941, METALL MANCHU, V23, P135; Jackson J. D., 1978, CLASSICAL ELECTRODYN, P321; Jagannathan K, 2009, SPECTROCHIM ACTA A, V73, P79, DOI 10.1016/j.saa.2009.01.025; Joshi V.N., 1990, PHOTOCONDUCTIVITY; Kalaiselvi P, 2013, OPTIK, V124, P6978, DOI 10.1016/j.ijleo.2013.05.183; Kaminsky W, 2007, J APPL CRYSTALLOGR, V40, P382, DOI 10.1107/S0021889807003986; Hays C., 1973, Metallography, V6, DOI 10.1016/0026-0800(73)90053-0; KITAZAWA M, 1994, APPL PHYS LETT, V64, P2477, DOI 10.1063/1.111602; Kumar M. Krishna, 2014, OPT MATER, V34, P988; Kumar VK, 2014, SPECTROCHIM ACTA A, V125, P201, DOI 10.1016/j.saa.2013.12.070; Marder S.R., 1991, MAT NONLINEAR OPTICS; Mohammad SF, 2013, INT J ELECTROCHEM SC, V8, P6145; Nagapandiselvi P, 2014, RSC ADV, V4, P22350, DOI 10.1039/c4ra02393e; Onitsch E.M., 1947, MIKROSKOPIE, V2, P131; Pan F, 1999, APPL PHYS LETT, V74, P492, DOI 10.1063/1.123956; Pandey V., 2005, CHALCOGENIDE LETT, V2, P39; PECAUT J, 1993, ACTA CRYSTALLOGR B, V49, P535, DOI 10.1107/S0108768192011431; Phillips J. C., 1973, BONDS BUNDS SEMICOND; Ragavan C. M., 2009, J CRYST GROWTH, V311, P346; Rai RN, 2011, J CRYST GROWTH, V321, P72, DOI 10.1016/j.jcrysgro.2011.02.019; Ramya C. S., 2008, J NONCRYST SOLIDS, V345, P1494; Robert R, 2010, PHYSICA B, V405, P20, DOI 10.1016/j.physb.2009.08.015; Sakai J. I., 1992, PHASE CONJUGATE OPTI; Sangwal K, 2002, J OPTOELECTRON ADV M, V4, P875; Sati DC, 2006, TURK J PHYS, V30, P519; Senthil K, 2013, Acta Crystallogr Sect E Struct Rep Online, V69, po1848, DOI 10.1107/S1600536813031929; Sheldrick G.M., 1997, SHELX97; Shen Y. R., 1984, PRINCIPLES NONLINEAR; Shettigar S, 2007, SYNTHETIC MET, V157, P142, DOI 10.1016/j.synthmet.2007.01.003; Silambarasan A, 2015, J CRYST GROWTH, V420, P11, DOI 10.1016/j.jcrysgro.2015.03.033; Sowmya NS, 2015, SPECTROCHIM ACTA A, V145, P333, DOI 10.1016/j.saa.2015.03.004; Sudharsan R., 1985, MAT SCI LETT, V4, P830; Tan YW, 2000, J SOLID STATE CHEM, V150, P178, DOI 10.1006/jssc.1999.8574; Tauc J., 1974, AMORPHOUS LIQUID SEM; Ushasree PM, 1998, B ELECTROCHEM, V14, P407; Vesta C, 2009, J CRYST GROWTH, V311, P1516, DOI 10.1016/j.jcrysgro.2008.10.115; Vijayan N, 2006, CRYST GROWTH DES, V6, P1542, DOI 10.1021/cg060002g; Wang WS, 1999, J CRYST GROWTH, V198, P578, DOI 10.1016/S0022-0248(98)01041-0; Zhao LY, 2007, SPECTROCHIM ACTA A, V67, P1120, DOI 10.1016/j.saa.2006.09.033; ZHAO W, 1993, APPL PHYS LETT, V63, P1613, DOI 10.1063/1.110712; Zhou J, 2001, OPT COMMUN, V191, P427, DOI 10.1016/S0030-4018(01)01144-0; Zyss J, 1994, MOL NONLINEAR OPTICS	88	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0925-3467	1873-1252		OPT MATER	Opt. Mater.	AUG	2015	46						565	577		10.1016/j.optmat.2015.05.029		13	Materials Science, Multidisciplinary; Optics	Materials Science; Optics	CM0EH	WOS:000357350700092		
J	Abad, MD; Parker, S; Frazer, D; de Figueiredo, MR; Lupinacci, A; Kikuchi, K; Hosemann, P				Abad, M. D.; Parker, S.; Frazer, D.; de Figueiredo, M. Rebelo; Lupinacci, A.; Kikuchi, K.; Hosemann, P.			Evaluation of the Mechanical Properties of Naturally Grown Multilayered Oxides Formed on HCM12A Using Small Scale Mechanical Testing	OXIDATION OF METALS			English	Article						Oxide coatings; Raman; Nanoindentation; Micro-cantilever; Fracture toughness	BI EUTECTIC ALLOY; LEAD-BISMUTH; HIGH-TEMPERATURE; STAINLESS-STEEL; SUPERCRITICAL WATER; OXIDATION MECHANISM; FRACTURE-TOUGHNESS; FE-9CR-1MO STEEL; MAGNETITE FE3O4; LIQUID-METAL	The microstructure and mechanical integrity of protective multilayered oxide films grown in liquid metal on F/M steel HCM12A was investigated utilizing Raman spectroscopy, nanoindentation and micro-cantilever testing methods. The Raman spectra showed a Fe3O4 outer layer and a Cr-rich spinel structure inner layer. The nanoindentation results showed a higher hardness value for the inner layer than for the outer layer. In addition, the hardness of the diffusion layer in between the inner layer and the bulk steel was measured. Quantitative fracture properties were obtained of the steel/oxide interface and within the oxide layers utilizing micro-cantilever testing. Furthermore the strength and elastic properties of the multilayered oxide film were measured and it was found that the porous structure in the inner Fe-Cr oxide limits the integrity of the steel/oxide interface.	[Abad, M. D.; Parker, S.; Frazer, D.; de Figueiredo, M. Rebelo; Lupinacci, A.; Hosemann, P.] Univ Calif Berkeley, Dept Nucl Engn, Berkeley, CA 94720 USA; [Kikuchi, K.] Ibaraki Univ, Frontier Res Ctr Appl Nucl Sci, Mito, Ibaraki, Japan	Parker, S (reprint author), Univ Calif Berkeley, Dept Nucl Engn, Berkeley, CA 94720 USA.	scottparker@berkeley.edu	Abad, Manuel David/N-7333-2014	Abad, Manuel David/0000-0002-5935-5709	NRC faculty development grant [NRC-38-09-948]; Department of Energy [DE-EE0005941]; nuclear energy university program (NEUP)	The Authors thank the NRC faculty development grant NRC-38-09-948 for providing funding for this work. This material is based upon work supported by the Department of Energy under Award Number DE-EE0005941 as well as the nuclear energy university program (NEUP). The authors would also like to thank Biomolecular Nanotechnology Center (BNC) at UC Berkeley for the use for the SEM/FIB facilities.	Chamritski I, 2005, J PHYS CHEM B, V109, P4965, DOI 10.1021/jp048748h; Bischoff J, 2012, J NUCL MATER, V430, P171, DOI 10.1016/j.jnucmat.2012.06.017; Bischoff J, 2012, J NUCL MATER, V424, P261, DOI 10.1016/j.jnucmat.2012.03.009; Tan L, 2007, J NUCL MATER, V371, P161, DOI 10.1016/j.jnucmat.2007.05.001; Kikuchi K, 2014, J NUCL MATER, V450, P237, DOI 10.1016/j.jnucmat.2013.09.011; Boyce BL, 2004, ACTA MATER, V52, P1609, DOI 10.1016/j.actamat.2003.12.032; Shebanova ON, 2003, J RAMAN SPECTROSC, V34, P845, DOI 10.1002/jrs 1056; Zhang JS, 2007, CORROS SCI, V49, P4154, DOI 10.1016/j.corsci.2007.05.012; Frazer D, 2014, ENRGY PROCED, V49, P627, DOI 10.1016/j.egypro.2014.03.068; Yamaki E, 2011, CORROS SCI, V53, P3075, DOI 10.1016/j.corsci.2011.05.031; Di Maio D, 2005, J MATER RES, V20, P299, DOI 10.1557/JMR.2005.0048; Armstrong DEJ, 2012, THIN SOLID FILMS, V520, P4369, DOI 10.1016/j.tsf.2012.02.059; Kim J, 2014, J NUCL MATER, V449, P181, DOI 10.1016/j.jnucmat.2014.03.038; ROBERTSON J, 1990, MATER SCI TECH SER, V6, P81; Hosemann P, 2008, J NUCL MATER, V375, P323, DOI 10.1016/j.jnucmat.2007.12.005; Hosemann P, 2008, J NUCL MATER, V377, P201, DOI 10.1016/j.jnucmat.2008.02.073; Martin FJ, 2004, J NUCL MATER, V335, P194, DOI 10.1016/j.jnucmat.2004.07.017; Zhao X, 2008, SCRIPTA MATER, V59, P39, DOI 10.1016/j.scriptamat.2008.02.022; Ampornrat P, 2007, J NUCL MATER, V371, P1, DOI 10.1016/j.jnucmat.2007.05.023; Zhao YX, 2012, CORROS SCI, V65, P163, DOI 10.1016/j.corsci.2012.08.016; MCCARTY KF, 1989, J SOLID STATE CHEM, V79, P19, DOI 10.1016/0022-4596(89)90245-4; Armstrong DEJ, 2009, SCRIPTA MATER, V61, P741, DOI 10.1016/j.scriptamat.2009.06.017; Martinelli L, 2008, CORROS SCI, V50, P2523, DOI 10.1016/j.corsci.2008.06.050; Martinelli L, 2008, CORROS SCI, V50, P2537, DOI 10.1016/j.corsci.2008.06.051; Gasparov LV, 2000, PHYS REV B, V62, P7939, DOI 10.1103/PhysRevB.62.7939; Elder KR, 2011, PHILOS MAG, V91, P151, DOI 10.1080/14786435.2010.506427; Mougin J, 2001, J RAMAN SPECTROSC, V32, P739, DOI 10.1002/jrs.734; Armitt J., 1978, 686 EPRI FP; Armstrong D.E.J., 2011, PFMC FEMAS C P; Brissonneau L, 2011, J NUCL MATER, V415, P348, DOI 10.1016/j.jnucmat.2011.04.040; Chicot D, 2011, MATER CHEM PHYS, V129, P862, DOI 10.1016/j.matchemphys.2011.05.056; Forsberg C., 2005, PROGR NUCL ENERGY, V47; Frazer D., 2015, COMPOSITES, V70; Harrison P. L., 1967, CORROSION SCI, V7; Hilson G., 2006, MAT SCI FORUM, V524-525; Hosemann P, 2013, CORROS SCI, V66, P196, DOI 10.1016/j.corsci.2012.09.019; Hosemann P, 2012, J NUCL MATER, V421, P140, DOI 10.1016/j.jnucmat.2011.11.042; Hosterman B.D., 2011, THESIS U NEVADA LAS; Jauffres D., 2011, PROCEDIA ENG, V10; Jubb AM, 2010, ACS APPL MATER INTER, V2, P2804, DOI 10.1021/am1004943; Kapsalis C., EUROCORR STOCKH 11; Kikuchi K, 2012, J NUCL MATER, V431, P120, DOI 10.1016/j.jnucmat.2011.11.020; Lenaz D, 2013, PHYS CHEM MINER, V40, P491, DOI 10.1007/s00269-013-0586-4; Martinell L., 2008, CORROSION SCI, V50; Miyazawa T, 2005, J NUCL SCI TECHNOL, V42, P233, DOI 10.3327/jnst.42.233; Mizuno T, 2004, NUCL TECHNOL, V146, P155; Mueller M. G., 2015, ACTA MAT, V86; Muller G, 2000, J NUCL MATER, V278, P85, DOI 10.1016/S0022-3115(99)00211-1; NAGL M, 1993, J PHYS IV, V3, P933, DOI 10.1051/jp4:1993996; OLIVER WC, 1992, J MATER RES, V7, P1564, DOI 10.1557/JMR.1992.1564; Proy M, 2014, J MATER ENG PERFORM, V23, P2847, DOI 10.1007/s11665-014-1073-x; Schmitt G, 2008, MATER CORROS, V59, P181, DOI 10.1002/maco.200804153; Schmitt G., 2010, SHREIRS CORROSION, V2, P954; Schmitt G., 2007, POWER PLANT CHEM, V9; Schroer C, 2012, CORROS SCI, V61, P63, DOI 10.1016/j.corsci.2012.04.022; Schutze M., 2010, OXIDATION METALS, V73; Shankar V., 2012, CORROSION SCI, V63; Tsisar V., 2014, J NUCL MAT, V454; Yamaki E, 2010, J NUCL MATER, V398, P153, DOI 10.1016/j.jnucmat.2009.10.026; Yang Y, 2009, EXP MECH, V49, P731, DOI 10.1007/s11340-008-9180-y; Yogi A., 2013, J ADV CERAMICS, V2; Zhang J, 2010, J NUCL MATER, V404, P82, DOI 10.1016/j.jnucmat.2010.05.024; Zhang JS, 2008, J NUCL MATER, V373, P351, DOI 10.1016/j.jnucmat.2007.06.019; Zhang JS, 2005, J NUCL MATER, V342, P1, DOI 10.1016/j.jnucmat.2005.03.003; Zhang JS, 2003, NUCL TECHNOL, V144, P379	65	0	0	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0030-770X	1573-4889		OXID MET	Oxid. Met.	AUG	2015	84	1-2					211	231		10.1007/s11085-015-9551-6		21	Metallurgy & Metallurgical Engineering	Metallurgy & Metallurgical Engineering	CM0BW	WOS:000357344200013		
J	Nakayama, R; Mihara, T; Miyamoto, Y; Ka, K				Nakayama, Rika; Mihara, Takahiro; Miyamoto, Yoshihisa; Ka, Koui			The association of hypotension with the insertion of an abdominal retractor during lower abdominal surgery in pediatric patients: a retrospective observational study	PEDIATRIC ANESTHESIA			English	Article						child; infant; adverse events; hypotension; logistic regression	PORT	BackgroundThe Alexis((R)) wound retractor is composed of an inner- and outer-ring, with the inner-ring placed inside the abdominal cavity. This placement can constrict the internal organs and large vessels, especially in children, which can lead to hypotension. Our study aimed to investigate the relation between the incidence of hypotension and insertion of the wound retractor during lower abdominal surgery in pediatric patients. MethodsWe retrospectively examined 161 pediatric patients (<4years old), who underwent lower abdominal surgery, regardless of abdominal retractor type. Hypotension was defined as a decrease in systolic blood pressure of >15% from baseline. We used logistic regression to predict hypotension using the following nine parameters: age, height, weight, American Society of Anesthesiologists physical status (ASA-PS), sex, laterality of the operation (unilateral or bilateral), presence or absence of caudal block, wound length, and type of retractor (retractors with or without an inner-ring). ResultsLogistic multivariate regression analysis revealed that a retractor with an inner-ring use (odds ratio 3.28, 95% CI 1.41-7.63, P=0.006) and younger age (odds ratio 1.07 per month, 95% CI 1.02-1.12, P=0.010) were independent risk factors associated with hypotension following lower abdominal surgery in this age group. ConclusionsPatient age and use of a wound retractor with an inner-ring are independent risk factors associated with hypotension during insertion of the abdominal retractor in lower abdominal surgery.	[Nakayama, Rika; Mihara, Takahiro; Miyamoto, Yoshihisa; Ka, Koui] Kanagawa Childrens Med Ctr, Dept Anesthesia, Yokohama, Kanagawa, Japan	Mihara, T (reprint author), 2-138-4 Mutsukawa,Minami Ku, Yokohama, Kanagawa 2328555, Japan.	miharaxxxtotoro@yahoo.co.jp					Akaike H, 1976, MATH SCI, V14, P5; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Nafiu OO, 2009, PEDIATR ANESTH, V19, P1048, DOI 10.1111/j.1460-9592.2009.03140.x; Tai HC, 2010, SURG ENDOSC, V24, P705, DOI 10.1007/s00464-009-0620-2; Chung SD, 2011, SURG ENDOSC, V25, P3579, DOI 10.1007/s00464-011-1761-7; Nafiu OO, 2009, PEDIATR ANESTH, V19, P232, DOI 10.1111/j.1460-9592.2008.02871.x; Edwards JP, 2012, ANN SURG, V256, P53, DOI 10.1097/SLA.0b013e3182570372; Hirokawa F, 2011, HEPATO-GASTROENTEROL, V58, P153; Ibrahim F, 2011, SOC SCI MED, V6, P277, DOI 10.3923/sscience.2011.277.282; Kanamori Y, 2006, SURG TODAY, V36, P98, DOI 10.1007/s00595-005-3092-6; Kim HJ, 2010, SURG ENDOSC, V24, P2765, DOI 10.1007/s00464-010-1043-9; Lee SW, 2011, J ENDOUROL, V25, P257, DOI 10.1089/end.2010.0445; Nakayama R, 2014, INT J CLIN ANESTHESI, V2, P1031; Nishimura A, 2011, SURG ENDOSC, V25, P3459, DOI 10.1007/s00464-011-1716-z; Tajiri T, 2008, PEDIATR SURG INT, V24, P1123, DOI 10.1007/s00383-008-2230-9; Tsunezuka Y, 2006, EUR J CARDIO-THORAC, V29, P110, DOI 10.1016/j.ejcts.2005.10.027	16	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1155-5645	1460-9592		PEDIATR ANESTH	Pediatr. Anesth.	AUG	2015	25	8					824	828		10.1111/pan.12656		5	Anesthesiology; Pediatrics	Anesthesiology; Pediatrics	CM5LY	WOS:000357730600010		
J	Fujii, M; Tachibana, K; Takeuchi, M; Nishio, J; Kinouchi, K				Fujii, Masashi; Tachibana, Kazuya; Takeuchi, Muneyuki; Nishio, Juntaro; Kinouchi, Keiko			Perioperative management of 19 infants undergoing glossopexy (tongue-lip adhesion) procedure: a retrospective study	PEDIATRIC ANESTHESIA			English	Article						newborn; infant; anomalies; airway; difficult airway; congenital anomalies and syndromes	ROBIN-SEQUENCE; CHILDREN	BackgroundGlossopexy (tongue-lip adhesion) is a procedure in which the tongue is anchored to the lower lip and mandible to relieve the upper airway obstruction mainly in infants with Pierre Robin sequence. Infants suffering from severe upper airway obstruction and feeding difficulties due to glossoptosis are the candidates for this procedure and are predicted to demonstrate difficult airway and difficult intubation. MethodsWe retrospectively examined the perioperative management of 19 infants undergoing glossopexy procedure at our institution from 1992 to 2010. ResultsOut of 19 patients, Pierre Robin sequence was diagnosed in 17, Treacher Collins syndrome in 1, and Stickler syndrome in 1. In all of them, inhalation anesthesia was induced with a nasopharyngeal tube in place. Nine patients underwent fiberoptic intubation. After surgery, 12 patients were extubated in the operating room and 11 of them required a nasopharyngeal tube to keep the airway open. Seven patients left the operating room with the trachea intubated. Two patients received tracheostomy at the age of 2months. Seventeen patients underwent release of tongue-lip adhesion coincidentally with the palate repair at 7-14months of age. For this surgery, no one required fiberoptic intubation. ConclusionsThe airway of these patients should be managed carefully not only before but also after the operation. A nasopharyngeal tube was effective in maintaining the upper airway patency during anesthesia induction and before and after operation.	[Fujii, Masashi; Tachibana, Kazuya; Takeuchi, Muneyuki; Kinouchi, Keiko] Osaka Med Ctr, Dept Anesthesia & Intens Care, Izumi, Japan; [Fujii, Masashi; Tachibana, Kazuya; Takeuchi, Muneyuki; Nishio, Juntaro; Kinouchi, Keiko] Res Inst Maternal & Child Hlth, Izumi, Japan; [Nishio, Juntaro] Osaka Med Ctr, Dept Oral & Maxillofacial Surg, Izumi, Japan	Kinouchi, K (reprint author), Osaka Med Ctr, Hosp, Dept Anesthesia & Intens Care, Izumi, Japan.	kinouchi@mch.pref.osaka.jp					Kirschner RE, 2003, CLEFT PALATE-CRAN J, V40, P13, DOI 10.1597/1545-1569(2003)040<0013:SAMIPR>2.0.CO;2; Rogers GF, 2011, PLAST RECONSTR SURG, V128, P243, DOI 10.1097/PRS.0b013e318217420d; Flores RL, 2014, PLAST RECONSTR SURG, V133, P1433, DOI 10.1097/PRS.0000000000000225; KINOUCHI K, 1992, ANESTHESIOLOGY, V77, P1105, DOI 10.1097/00000542-199212000-00010; Evans KN, 2011, PEDIATRICS, V127, P936, DOI 10.1542/peds.2010-2615; ARGAMASO RV, 1992, CLEFT PALATE-CRAN J, V29, P232, DOI 10.1597/1545-1569(1992)029<0232:GFUAOI>2.3.CO;2; Gangopadhyay Noopur, 2012, Semin Plast Surg, V26, P76, DOI 10.1055/s-0032-1320065; Kitamura S, 1999, PAEDIATR ANAESTH, V9, P119, DOI 10.1046/j.1460-9592.1999.9220294.x; KNILL RL, 1993, CAN J ANAESTH, V40, P279; SADEWITZ VL, 1992, CLEFT PALATE-CRAN J, V29, P246, DOI 10.1597/1545-1569(1992)029<0246:RSCITL>2.3.CO;2; SINGER L, 1992, CLEFT PALATE-CRAN J, V29, P220, DOI 10.1597/1545-1569(1992)029<0220:PMORS>2.3.CO;2	11	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1155-5645	1460-9592		PEDIATR ANESTH	Pediatr. Anesth.	AUG	2015	25	8					829	833		10.1111/pan.12675		5	Anesthesiology; Pediatrics	Anesthesiology; Pediatrics	CM5LY	WOS:000357730600011		
J	Ito, N; Ito, K; Ikebuchi, Y; Toyoda, Y; Takada, T; Hisaka, A; Oka, A; Suzuki, H				Ito, Naoki; Ito, Kousei; Ikebuchi, Yuki; Toyoda, Yu; Takada, Tappei; Hisaka, Akihiro; Oka, Akira; Suzuki, Hiroshi			Prediction of Drug Transfer into Milk Considering Breast Cancer Resistance Protein (BCRP)-Mediated Transport	PHARMACEUTICAL RESEARCH			English	Article						breast cancer resistance protein; drugtransport; lactation; mammary epithelium; milk	MAMMARY-GLAND; ACTIVE-TRANSPORT; P-GLYCOPROTEIN; IN-VITRO; PHYSICOCHEMICAL CHARACTERISTICS; BILIARY-EXCRETION; ABC TRANSPORTERS; RAT MILK; EXPRESSION; BCRP/ABCG2	Purpose Drug transfer into milk is of concern due to the unnecessary exposure of infants to drugs. Proposed prediction methods for such transfer assume only passive drug diffusion across the mammary epithelium. This study reorganized data from the literature to assess the contribution of carrier-mediated transport to drug transfer into milk, and to improve the predictability thereof. Methods Milk-to-plasma drug concentration ratios (M/Ps) in humans were exhaustively collected from the literature and converted into observed unbound concentration ratios (M/P-unbound,P- obs). The ratios were also predicted based on passive diffusion across the mammary epithelium (M/P-unbound,P- pred). An in vitro transport assay was performed for selected drugs in breast cancer resistance protein (BCRP)-expressing cell monolayers. Results M/P-unbound,P- obs and M/P-unbound,P- pred values were compared for 166 drugs. M/(Punbound, obs) values were 1.5 times or more higher than M/(Punbound, pred) values for as many as 13 out of 16 known BCRP substrates, reconfirming BCRP as the predominant transporter contributing to secretory transfer of drugs into milk. Predictability of M/P values for selected BCRP substrates and non-substrates was improved by considering in vitro-evaluated BCRP-mediated transport relative to passive diffusion alone. Conclusions The current analysis improved the predictability of drug transfer into milk, particularly for BCRP substrates, based on an exhaustive data overhaul followed by focused in vitro transport experimentation.	[Ito, Naoki; Oka, Akira] Univ Tokyo, Tokyo Univ Hosp, Dept Pediat, Fac Med,Bunkyo Ku, Tokyo 1138655, Japan; [Ito, Kousei] Chiba Univ, Grad Sch Pharmaceut Sci, Lab Biopharmaceut, Chuo Ku, Chiba 2608675, Japan; [Ikebuchi, Yuki; Toyoda, Yu; Takada, Tappei; Suzuki, Hiroshi] Univ Tokyo, Dept Pharm, Tokyo Univ Hosp, Fac Med,Bunkyo Ku, Tokyo 1138655, Japan; [Hisaka, Akihiro] Chiba Univ, Grad Sch Pharmaceut Sci, Lab Geriatr Pharmacol & Therapeut, Chuo Ku, Chiba 2638675, Japan	Ito, K (reprint author), Chiba Univ, Grad Sch Pharmaceut Sci, Lab Biopharmaceut, Chuo Ku, Inohana 1-8-1, Chiba 2608675, Japan.	itokousei@chiba-u.jp			Japan Research Foundation for Clinical Pharmacology; Ministry of Education, Science and Culture of Japan [22136015]	This work was supported by a research scholarship from the Japan Research Foundation for Clinical Pharmacology, and a Grant-in-Aid for Scientific Research on Innovative Areas HD-Physiology from the Ministry of Education, Science and Culture of Japan (Grant No. 22136015).	Agatonovic-Kustrin S, 2002, J PHARMACEUT BIOMED, V29, P103, DOI 10.1016/S0731-7085(02)00037-7; ANDERSON PO, 1991, CLIN PHARMACY, V10, P594; Kondo C, 2004, PHARM RES, V21, P1895, DOI 10.1023/B:PHAM.0000045245.21637.d4; Jones G, 2003, LANCET, V362, P65, DOI 10.1016/S0140-6736(03)13811-1; Merino G, 2006, DRUG METAB DISPOS, V34, P690, DOI 10.1124/dmd.105.008219; Wang X, 2003, MOL PHARMACOL, V63, P65, DOI 10.1124/mol.63.1.65; Marki-Zay J, 2013, CLIN EXP RHEUMATOL, V31, P779; van Herwaarden AE, 2006, TRENDS PHARMACOL SCI, V27, P10, DOI 10.1016/j.tips.2005.11.007; Pan GY, 2007, DRUG METAB DISPOS, V35, P1165, DOI 10.1124/dmd.106.014274; Flacking R, 2007, SOC SCI MED, V64, P2405, DOI 10.1016/j.socscimed.2007.03.008; Hasegawa M, 2007, J AM SOC NEPHROL, V18, P37, DOI 10.1681/ASN.2005090966; Pavek P, 2005, J PHARMACOL EXP THER, V312, P144, DOI 10.1124/jpet.104.073916; Jonker JW, 2005, NAT MED, V11, P127, DOI 10.1038/nm1186; Groneberg DA, 2002, AM J PHYSIOL-ENDOC M, V282, pE1172, DOI 10.1152/ajpendo.00381.2001; Lilienblum W, 2008, ARCH TOXICOL, V82, P211, DOI 10.1007/s00204-008-0279-9; Lagas JS, 2010, MOL CANCER THER, V9, P319, DOI 10.1158/1535-7163.MCT-09-0663; Gunness P, 2011, CAN J PHYSIOL PHARM, V89, P675, DOI 10.1139/Y11-045; Alcorn J, 2002, J PHARMACOL EXP THER, V303, P487, DOI 10.1124/jpet.102.038315; Gilchrist SE, 2010, FUND CLIN PHARMACOL, V24, P205, DOI 10.1111/j.1472-8206.2009.00760.x; Kramer MS, 2010, EARLY HUM DEV, V86, P729, DOI 10.1016/j.earlhumdev.2010.08.005; Kodaira H, 2011, J PHARMACOL EXP THER, V339, P935, DOI 10.1124/jpet.111.180398; Ando T, 2007, DRUG METAB DISPOS, V35, P1873, DOI 10.1124/dmd.107.014969; Merino G, 2005, MOL PHARMACOL, V67, P1758, DOI 10.1124/mol.104.010439; Zhao CY, 2006, PHARM RES, V23, P41, DOI 10.1007/s11095-005-8716-4; Kato Y, 2008, DRUG METAB DISPOS, V36, P1088, DOI 10.1124/dmd.107.019125; ATKINSON HC, 1990, CLIN PHARMACOKINET, V18, P151; ATKINSON HC, 1988, J PHARM SCI, V77, P796, DOI 10.1002/jps.2600770916; Barrera B, 2012, ANTIMICROB AGENTS CH, V56, P3535, DOI 10.1128/AAC.06345-11; Beery E, 2012, DRUG METAB PHARMACOK, V27, P349, DOI 10.2133/dmpk.DMPK-11-NT-068; BEGG EJ, 1992, BRIT J CLIN PHARMACO, V33, P501; DOSTAL LA, 1990, TOXICOL APPL PHARM, V102, P430, DOI 10.1016/0041-008X(90)90039-W; Farke C, 2008, J DAIRY RES, V75, P406, DOI 10.1017/S002202990800335X; Fleishaker JC, 2003, ADV DRUG DELIVER REV, V55, P643, DOI 10.1016/S0169-409X(03)00032-2; FLEISHAKER JC, 1987, J PHARM SCI, V76, P189, DOI 10.1002/jps.2600760302; Gerk PM, 2001, J PHARMACOL EXP THER, V296, P175; Gerk PM, 2001, PHARMACOTHERAPY, V21, P669, DOI 10.1592/phco.21.7.669.34574; Hale TW, 2008, MEDICATIONS MOTHERS, V13th; Hemauer SJ, 2010, BIOCHEM PHARMACOL, V80, P1076, DOI 10.1016/j.bcp.2010.06.025; Ito N, 2014, J PHARM SCI IN PRESS; Ito N, 2013, PHARM RES-DORDR, V30, P2410, DOI 10.1007/s11095-013-1085-5; Ito S, 2003, ADV DRUG DELIVER REV, V55, P653, DOI 10.1016/S0169-409X(03)00031-0; Katritzky AR, 2005, BIOORGAN MED CHEM, V13, P1623, DOI 10.1016/j.bmc.2004.12.015; Kim HS, 2007, BRIT J CLIN PHARMACO, V64, P645, DOI 10.1111/j.1365-2125.2007.02944.x; Koshimichi H, 2011, DRUG METAB DISPOS, V39, P2370, DOI 10.1124/dmd.111.040972; LAU RJ, 1987, OBSTET GYNECOL, V69, P468; MATHESON I, 1985, BRIT MED J, V290, P1588; MCNAMARA PJ, 1992, J PHARMACOL EXP THER, V261, P918; MESKIN MS, 1985, J CLIN HOSP PHARM, V10, P269, DOI 10.1111/j.1365-2710.1985.tb00924.x; MILLER ME, 1982, J PEDIATR-US, V101, P789, DOI 10.1016/S0022-3476(82)80323-5; Nakanishi H, 2013, EUR J PHARMACOL, V710, P20, DOI 10.1016/j.ejphar.2013.03.049; Noguchi Kohji, 2014, Pharmgenomics Pers Med, V7, P53, DOI 10.2147/PGPM.S38295; NOTARIANNI LJ, 1995, BRIT J CLIN PHARMACO, V40, P333; OO CY, 1995, CLIN PHARMACOL THER, V58, P548, DOI 10.1016/0009-9236(95)90175-2; RASMUSSEN F, 1959, ACTA PHARMACOL TOX, V16, P194; WERTHMAN.MW, 1972, J PEDIATR-US, V81, P781, DOI 10.1016/S0022-3476(72)80102-1	55	0	0	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0724-8741	1573-904X		PHARM RES-DORDR	Pharm. Res.	AUG	2015	32	8					2527	2537		10.1007/s11095-015-1641-2		11	Chemistry, Multidisciplinary; Pharmacology & Pharmacy	Chemistry; Pharmacology & Pharmacy	CL9FM	WOS:000357281500004		
J	Shingaki, T; Hume, WE; Takashima, T; Katayama, Y; Okauchi, T; Hayashinaka, E; Wada, Y; Cui, YL; Kusuhara, H; Sugiyama, Y; Watanabe, Y				Shingaki, Tomotaka; Hume, W. Ewan; Takashima, Tadayuki; Katayama, Yumiko; Okauchi, Takashi; Hayashinaka, Emi; Wada, Yasuhiro; Cui, Yilong; Kusuhara, Hiroyuki; Sugiyama, Yuichi; Watanabe, Yasuyoshi			Quantitative Evaluation of mMate1 Function Based on Minimally Invasive Measurement of Tissue Concentration Using PET with [C-11] Metformin in Mouse	PHARMACEUTICAL RESEARCH			English	Article						Drug-drug interactions (DDIs); Metformin; Multidrug and toxin extrusion proteins (Mates); Organic cation transporters (Octs); Positron emission tomography (PET)	TOXIN EXTRUSION 1; INTERNATIONAL TRANSPORTER CONSORTIUM; POSITRON-EMISSION-TOMOGRAPHY; ORGANIC CATION TRANSPORTER-1; HEPATOBILIARY TRANSPORT; GENETIC-VARIATION; HUMAN MULTIDRUG; HEPATIC-UPTAKE; IN-VIVO; MATE1	Purpose To evaluate the function of multidrug and toxin extrusion proteins (MATEs) using C-11-labeled metformin ([C-11] metformin) by positron emission tomography (PET). Methods PET was performed by intravenous bolus injection of [C-11] metformin. Pyrimethamine at 0.5 and 5 mg/kg was intravenously administered to mice 30 min prior to the scan. Integration plot analysis was conducted for calculating liver (CLuptake, liver), kidney (CLuptake, kidney) tissue uptake, intrinsic biliary (CLint, bile) and urinary (CLint, urine) excretion clearances of [C-11] metformin. Results Visualization by PET showed that pyrimethamine increased concentrations of [C-11] metformin in the liver and kidneys, and decreased the concentrations in the urinary bladder without changing the blood profiles. Pyrimethamine had no effect on the CLuptake, liver and CLuptake, kidney, which were similar to the blood-flow rate. CLint, bile with regard to the liver concentration was unable to be determined, but administration of 0.5 and 5 mg/kg of pyrimethamine increased the liver-to-blood ratio to 1.6 and 2.3-fold, respectively, indicating that pyrimethamine inhibited the efflux of [C-11] metformin from the liver. CLint, urine with regard to the corticomedullary region concentrations was decreased 37 and 68% of the control by administration of 0.5 and 5 mg/kg of pyrimethamine, respectively (P<0.05). Conclusions Tissue concentration based investigations using [C-11] metformin by PET enables the functional analysis of MATEs in the liver and kidneys.	[Shingaki, Tomotaka; Hume, W. Ewan; Katayama, Yumiko; Okauchi, Takashi; Hayashinaka, Emi; Wada, Yasuhiro; Cui, Yilong; Watanabe, Yasuyoshi] RIKEN, Ctr Life Sci Technol, Chuo Ku, Kobe, Hyogo 6500047, Japan; [Takashima, Tadayuki] RIKEN, Ctr Mol Imaging Sci, Ctr Life Sci Technol, Chuo Ku, Kobe, Hyogo 6500047, Japan; [Kusuhara, Hiroyuki] Univ Tokyo, Grad Sch Pharmaceut Sci, Lab Mol Pharmacokinet, Bunkyo Ku, Tokyo 1130033, Japan; [Sugiyama, Yuichi] RIKEN, Innovat Ctr, Sugiyama Lab, Yokohama Bio Ind Ctr,Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan	Watanabe, Y (reprint author), RIKEN, Ctr Life Sci Technol, Chuo Ku, 6-7-3 Minatojima Minamimachi, Kobe, Hyogo 6500047, Japan.	yywata@riken.jp			New Energy and Industrial Technology Development Organization; JSPS KAKENHI [24229002]	We thank Mr. Masahiro Kurahashi of Sumitomo Heavy Industry Accelerator Service Ltd. for operation of the cyclotron. This study was partly carried out as the Research Project for the "Establishment of Evolutional Drug Development with the Use of Microdose Clinical Trial" sponsored by the New Energy and Industrial Technology Development Organization. Part of this work was also supported by JSPS KAKENHI Grant number 24229002.	Tanihara Y, 2007, BIOCHEM PHARMACOL, V74, P359, DOI 10.1016/j.bcp.2007.04.010; Masuda S, 2006, J AM SOC NEPHROL, V17, P2127, DOI 10.1681/ASN.2006030205; Hillgren KM, 2013, CLIN PHARMACOL THER, V94, P52, DOI 10.1038/clpt.2013.74; Watanabe T, 2010, J PHARMACOKINET PHAR, V37, P575, DOI 10.1007/s10928-010-9176-y; Tsuda M, 2009, J PHARMACOL EXP THER, V329, P185, DOI 10.1124/jpet.108.147918; Stocker SL, 2013, CLIN PHARMACOL THER, V93, P186, DOI 10.1038/clpt.2012.210; Terada T, 2008, BIOCHEM PHARMACOL, V75, P1689, DOI 10.1016/j.bcp.2007.12.008; Takashima T, 2011, J NUCL MED, V52, P950, DOI 10.2967/jnumed.110.083949; Moriyama Y, 2008, XENOBIOTICA, V38, P1107, DOI 10.1080/00498250701883753 ; Otsuka M, 2005, P NATL ACAD SCI USA, V102, P17923, DOI 10.1073/pnas.0506483102; Christensen MMH, 2013, PHARMACOGENET GENOM, V23, P526, DOI 10.1097/FPC.0b013e328364a57d; Wang ZJ, 2008, PHARMACOGENET GENOM, V18, P637, DOI 10.1097/FPC.0b013e328302cd41; Wang DS, 2002, J PHARMACOL EXP THER, V302, P510, DOI 10.1124/jpct.102.034140; Kusuhara H, 2011, CLIN PHARMACOL THER, V89, P837, DOI 10.1038/clpt.2011.36; Ito S, 2010, J PHARMACOL EXP THER, V333, P341, DOI 10.1124/jpet.109.163642; Becker MSL, 2009, DIABETES, V58, P745, DOI 10.2337/db08-1028; Kusuhara H, 2013, CLIN PHARMACOL THER, V94, P33, DOI 10.1038/clpt.2013.85; Nakamura T, 2010, BIOCHEM PHARMACOL, V80, P1762, DOI 10.1016/j.bcp.2010.08.019; Yonezawa A, 2011, BRIT J PHARMACOL, V164, P1817, DOI 10.1111/j.1476-5381.2011.01394.x; Ito S, 2012, J PHARMACOL EXP THER, V340, P393, DOI 10.1124/jpet.111.184986; Shu Y, 2008, CLIN PHARMACOL THER, V83, P273, DOI 10.1038/sj.clpt.6100275; Shingaki T, 2013, J PHARMACOL EXP THER, V347, P193, DOI 10.1124/jpet.113.206425; Tsuda M, 2009, MOL PHARMACOL, V75, P1280, DOI 10.1124/mol.109.056242; Grun B, 2013, BRIT J CLIN PHARMACO, V76, P787, DOI 10.1111/bcp.12079; DAVIES B, 1993, PHARMACEUT RES, V10, P1093, DOI 10.1023/A:1018943613122; Hume WE, 2013, BIOORGAN MED CHEM, V21, P7584, DOI 10.1016/j.bmc.2013.10.041; Ijuin R, 2012, BIOORGAN MED CHEM, V20, P3703, DOI 10.1016/j.bmc.2012.04.051; SOMOGYI A, 1987, BRIT J CLIN PHARMACO, V23, P545; Takashima T, 2010, J PHARMACOL EXP THER, V335, P314, DOI 10.1124/jpet.110.170092; Takashima T, 2013, J NUCL MED, V54, P267, DOI 10.2967/jnumed.112.110254; Takashima T, 2012, J NUCL MED, V53, P741, DOI 10.2967/jnumed.111.098681; Takashima T, 2011, MOL PHARMACEUT, V8, P1789, DOI 10.1021/mp200160t; Umehara KI, 2007, XENOBIOTICA, V37, P818, DOI 10.1080/00498250701546012; Zamek-Gliszczynski MJ, 2012, CLIN PHARMACOL THER, V92, P553, DOI 10.1038/clpt.2012.126	34	1	1	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0724-8741	1573-904X		PHARM RES-DORDR	Pharm. Res.	AUG	2015	32	8					2538	2547		10.1007/s11095-015-1642-1		10	Chemistry, Multidisciplinary; Pharmacology & Pharmacy	Chemistry; Pharmacology & Pharmacy	CL9FM	WOS:000357281500005		
J	Imada, C; Takahashi, T; Kuramoto, M; Masuda, K; Ogawara, K; Sato, A; Wataya, Y; Kim, HS; Higaki, K				Imada, Chikako; Takahashi, Takuma; Kuramoto, Makoto; Masuda, Kazufumi; Ogawara, Ken-ichi; Sato, Akira; Wataya, Yusuke; Kim, Hye-Sook; Higaki, Kazutaka			Improvement of Oral Bioavailability of N-251, a Novel Antimalarial Drug, by Increasing Lymphatic Transport with Long-Chain Fatty Acid-Based Self-Nanoemulsifying Drug Delivery System	PHARMACEUTICAL RESEARCH			English	Article						antimalarial drug; bioavailability; hepatic first-pass elimination; long-chain fatty acid; lymphatic transport; medium-chain fatty acid; self-nanoemulsifying drug delivery system (SNEDDS)	LIPOPHILIC DRUGS; ABSORPTION; HALOFANTRINE; ARTEMISININ; DISSOLUTION; SMEDDS; FORMULATION; COMPOUND; VEHICLES; MALARIA	Purpose The objective of this study was to improve the absorption behavior of N-251, a novel antimalarial drug, by preparing an appropriate self-nanoemulsifying drug delivery system (SNEDDS). Methods Two different types of SNEDDS formulations, medium-chain fatty acid-based SNEDDS (MC-SNEDDS) and long-chain fatty acid-based SNEDDS (LC-SNEDDS), were prepared based on pseudo-ternary phase diagram, and examined for their in vivo oral absorption behavior in rats. Results Oral dosing of MC-SNEDDS formulations significantly improved the bioavailability (BA) of N-251 compared with N-251 powders. However, its high hepatic extraction limited the BA of N-251 to only 0.49 for MC-SNEDDS B, the best formulation of MC-SNEDDS. LC-SNEDDS formulations, especially LC-SNEDDS F provided the highest BA, 0.65, and successfully attenuated the inter-individual difference in the absorption behavior. Furthermore, it was confirmed that lymphatic transport of N-251 for LC-SNEDDS F was significantly increased up to around 3.19 times larger than that for MC-SNEDDS B. Simulation study suggested that 20 to 39% of N-251 uptaken by the small intestine would be delivered to lymphatic system after oral administration of LC-SNEDDS F. Conclusions SNEDDS formulations significantly improved the absorption behavior of N-251 and long-chain fatty acid-based lipid further improved it by avoiding the hepatic first-pass elimination.	[Imada, Chikako; Takahashi, Takuma; Kuramoto, Makoto; Ogawara, Ken-ichi; Higaki, Kazutaka] Okayama Univ, Dept Pharmaceut, Fac Pharmaceut Sci, Kita Ku, Okayama 7008530, Japan; [Masuda, Kazufumi] Shujitsu Univ, Dept Phys Chem, Grad Sch Clin Pharm, Naka Ku, Okayama 7038516, Japan; [Sato, Akira; Wataya, Yusuke; Kim, Hye-Sook] Okayama Univ, Dept Drug Informat, Fac Pharmaceut Sci, Kita Ku, Okayama 7008530, Japan	Higaki, K (reprint author), Okayama Univ, Dept Pharmaceut, Fac Pharmaceut Sci, Kita Ku, 1-1-1 Tsushima Naka, Okayama 7008530, Japan.	higaki@pharm.okayama-u.ac.jp			National Institute of Biomedical Innovation (NIBIO) [04-09, 09-21]; Ministry of Education, Culture, Sports, Science and Technologies, Japan [25305008, 22590099]	This study was partially supported by the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO) (Project No. 04-09 and 09-21, PI; Y.W.), Grant-in-Aid for Scientific Research (B) (25305008, H.-S.K.), and Grant-in-Aid for Scientific Research (C) (22590099, H.-S.K.) from the Ministry of Education, Culture, Sports, Science and Technologies, Japan.	Caliph SM, 2013, J PHARM SCI-US, V102, P2395, DOI 10.1002/jps.23597; Gursoy RN, 2004, BIOMED PHARMACOTHER, V58, P173, DOI 10.1016/j.biopha.2004.02.001; Trevaskis NL, 2010, PHARM RES-DORDR, V27, P1949, DOI 10.1007/s11095-010-0199-2; Porter CJH, 2008, ADV DRUG DELIVER REV, V60, P673, DOI 10.1016/j.addr.2007.10.014; Choi YK, 2012, INT J PHARMACEUT, V434, P264, DOI 10.1016/j.ijpharm.2012.05.039; CHARMAN WNA, 1986, INT J PHARM, V34, P175, DOI 10.1016/0378-5173(86)90027-X; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Kang BK, 2004, INT J PHARM, V274, P65, DOI 10.1016/j.ijpharm.2003.12.028; Trevaskis NL, 2008, ADV DRUG DELIVER REV, V60, P702, DOI 10.1016/j.addr.2007.09.007; SHAH NH, 1994, INT J PHARM, V106, P15, DOI 10.1016/0378-5173(94)90271-2; White NJ, 2008, SCIENCE, V320, P330, DOI 10.1126/science.1155165; Caliph SM, 2000, J PHARM SCI, V89, P1073, DOI 10.1002/1520-6017(200008)89:8<1073::AID-JPS12>3.0.CO;2-V; McConville C, 2013, EUR J PHARM BIOPHARM, V83, P322, DOI 10.1016/j.ejpb.2012.10.007; CONSTANTINIDES PP, 1995, PHARMACEUT RES, V12, P1561, DOI 10.1023/A:1016268311867; Khoo SM, 2003, PHARMACEUT RES, V20, P1460, DOI 10.1023/A:1025718513246; CHARMAN SA, 1992, PHARMACEUT RES, V9, P87, DOI 10.1023/A:1018987928936; DECKELBAUM RJ, 1990, BIOCHEMISTRY-US, V29, P1136, DOI 10.1021/bi00457a006; Pouton CW, 2000, EUR J PHARM SCI, V11, pS93, DOI 10.1016/S0928-0987(00)00167-6; Serajuddin ATM, 1999, J PHARM SCI, V88, P1058, DOI 10.1021/js980403l; Anton N, 2011, PHARM RES-DORDR, V28, P978, DOI 10.1007/s11095-010-0309-1; Dressman JB, 2000, EUR J PHARM SCI S, V11, P573; Fujioka Y, 2008, INT J PHARM, V352, P36, DOI 10.1016/j.ijpharm.2007.10.008; Gibson L, 2007, ORAL LIPID BASED FOR, P33; Grove M, 2007, ORAL LIPID BASED FOR, P107; Higaki Kazutaka, 2010, Yakuzaigaku, V70, P32; Higaki K, 2003, XENOBIOTICA, V33, P1097, DOI 10.1080/00498250310001615771; Holm R, 2003, EUR J PHARM SCI, V20, P91, DOI 10.1016/S0928-0987(03)00174-X; HOLMBERG I, 1990, BIOPHARM DRUG DISPOS, V11, P807, DOI 10.1002/bdd.2510110908; Johnson LR, 1997, GASTROINTESTINAL PHY, P113; Kuentz M., 2012, DRUG DISCOV TODAY TE, V9, pe71; Kvetina J, 1961, PHARMACOLOGY, V2, P65; Milovic M, 2012, INT J PHARMACEUT, V436, P58, DOI 10.1016/j.ijpharm.2012.06.032; Nankervis R, 1996, INT J PHARM, V130, P57, DOI 10.1016/0378-5173(95)04265-2; Noedl H, 2008, NEW ENGL J MED, V359, P2619, DOI 10.1056/NEJMc0805011; Sato A, 2011, PARASITOL INT, V60, P270, DOI 10.1016/j.parint.2011.04.001; Sato A, 2011, PARASITOL INT, V60, P488, DOI 10.1016/j.parint.2011.08.017; Veld PAV, 1987, J LIPID RES, V28, P810	37	0	0	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0724-8741	1573-904X		PHARM RES-DORDR	Pharm. Res.	AUG	2015	32	8					2595	2608		10.1007/s11095-015-1646-x		14	Chemistry, Multidisciplinary; Pharmacology & Pharmacy	Chemistry; Pharmacology & Pharmacy	CL9FM	WOS:000357281500009		
J	Provin, C; Nicolas, A; Gregoire, S; Fujii, T				Provin, Christophe; Nicolas, Alexandre; Gregoire, Sebastien; Fujii, Teruo			A Microfluidic Diffusion Cell for Fast and Easy Percutaneous Absorption Assays	PHARMACEUTICAL RESEARCH			English	Article						membrane; online monitoring; permeability coefficient; stratum corneum; time lag	RECONSTRUCTED HUMAN EPIDERMIS; DIFFERENT BODY SITES; HAIRLESS MOUSE SKIN; STRATUM-CORNEUM; FAST PREDICTION; IN-VIVO; PERMEABILITY; MODEL; PENETRATION; ACID	Purpose Percutaneous absorption assays of molecules for pharmaceutical and cosmetology purposes are important to determine the bioavailability of new compounds, once topically applied. The current method of choice is to measure the rate of diffusion through excised human skin using a diffusion cell. This method however entails significant drawbacks such as scarce availability and poor reproducibility of the sample, low sampling rate, and tedious assay setup. Methods The objective of the present work is to propose an alternative method that overcomes these issues by integrating an experimental model of the skin (artificial stratum corneum) and online optical sensors into a microfluidic device. Results The measurement of the diffusion profile followed by the calculation of the permeability coefficients and time lag were performed on seven different molecules and obtained data positively fit with those available from literature on human skin penetration. The coating of the lipid mixture to generate the artificial stratum corneum also proved robust and reproducible. The results show that the proposed device is able to give fast, real-time, accurate, and reproducible data in a user-friendly manner, and can be produced at a large scale. Conclusion These assets should help both the cosmetics and pharmaceutics fields where the skin is the target or a pathway of a formulated compound, by allowing more candidate molecules or formulations to be assessed during the various stages of their development.	[Provin, Christophe; Fujii, Teruo] Univ Tokyo, LIMMS CNRS IIS UMI 2820, Inst Ind Sci, Meguro Ku, Tokyo 1538505, Japan; [Nicolas, Alexandre] Nihon LOreal KK, KSP R&D, Takatsu Ku, Kawasaki, Kanagawa 2130012, Japan; [Gregoire, Sebastien] LOreal Res & Innovat, F-93601 Aulnay Ss Bois, France	Provin, C (reprint author), Nikon & Essilor Int Joint Res Ctr Co Ltd, KSP R&D, Takatsu Ku, Build C10F-1032 3-2-1, Kawasaki, Kanagawa 2130012, Japan.	cprovin@iis.u-tokyo.ac.jp; tfujii@iis.u-tokyo.ac.jp			Nihon L'Oreal K.K.	This collaborative work has been initiated in the frame of LIMMS/CNRS-IIS (UMI 2820), an international joint research laboratory between CNRS, France and IIS, University of Tokyo, Japan, and was supported by a grant from Nihon L'Oreal K.K. A patent application about the presented device (PCT/FR2013/051080) has been filed on May 16, 2013, with the authors listed as inventors. The authors would like to thank Dr. Haruyuki Kinoshita (IIS, The University of Tokyo) for measuring the lipid thickness and his help with the fabrication of devices, and Dr. Momoko Kumemura (LIMMS/IIS, The University of Tokyo) for her help with the fabrication of devices.	Kimura H, 2008, LAB CHIP, V8, P741, DOI 10.1039/b717091b; van de Sandt JJM, 2004, REGUL TOXICOL PHARM, V39, P271, DOI 10.1016/j.yrtph.2004.02.004; ROBERTS MS, 1977, J PHARM PHARMACOL, V29, P677; Ohno K, 2008, ELECTROPHORESIS, V29, P4443, DOI 10.1002/elps.200800121; Robertson K, 2010, ACTA DERM-VENEREOL, V90, P368, DOI 10.2340/00015555-0875; Pirot F, 1997, P NATL ACAD SCI USA, V94, P1562, DOI 10.1073/pnas.94.4.1562; WILLIAMS AC, 1991, PHARMACEUT RES, V8, P17, DOI 10.1023/A:1015813803205; Sunkara V, 2011, LAB CHIP, V11, P962, DOI [10.1039/c0lc00272k, 10.1039/c01c00272k]; Anissimov YG, 2013, ADV DRUG DELIVER REV, V65, P169, DOI 10.1016/j.addr.2012.04.009; Laurent A, 2007, VACCINE, V25, P6423, DOI 10.1016/j.vaccine.2007.05.046; Chilcott RP, 2005, J PHARM SCI-US, V94, P632, DOI 10.1002/jps.20229; POTTS RO, 1992, PHARMACEUT RES, V9, P663, DOI 10.1023/A:1015810312465; SOUTHWELL D, 1984, INT J PHARM, V18, P299, DOI 10.1016/0378-5173(84)90145-5; Ottaviani G, 2006, J MED CHEM, V49, P3948, DOI 10.1021/jm060230+; MORIMOTO Y, 1992, J PHARM PHARMACOL, V44, P634; Sinko B, 2012, EUR J PHARM SCI, V45, P698, DOI 10.1016/j.ejps.2012.01.011; Toepke MW, 2006, LAB CHIP, V6, P1484, DOI 10.1039/b612140c; Dias M, 1999, INT J PHARM, V182, P41, DOI 10.1016/S0378-5173(99)00067-8; Whitesides GM, 2006, NATURE, V442, P368, DOI 10.1038/nature05058; Sandby-Moller J, 2003, ACTA DERM-VENEREOL, V83, P410, DOI 10.1080/00015550310015419; ROUGIER A, 1983, J INVEST DERMATOL, V81, P275, DOI 10.1111/1523-1747.ep12518298; Faller B, 2008, CURR DRUG METAB, V9, P886, DOI 10.2174/138920008786485227; Xia YN, 1998, ANGEW CHEM INT EDIT, V37, P550, DOI 10.1002/(SICI)1521-3773(19980316)37:5<550::AID-ANIE550>3.0.CO;2-G; Netzlaff F, 2007, EUR J PHARM BIOPHARM, V66, P127, DOI 10.1016/j.ejpb.2006.08.012; Bhatia SN, 2014, NAT BIOTECHNOL, V32, P760, DOI 10.1038/nbt.2989; BOND JR, 1988, J INVEST DERMATOL, V90, P486, DOI 10.1111/1523-1747.ep12460958; de Jager M, 2006, PHARM RES, V23, P951, DOI 10.1007/s11095-006-9909-1; de Jager MW, 2005, J LIPID RES, V46, P2649, DOI 10.1194/jlr.M500221-JLR200; ELIAS PM, 1979, J INVEST DERMATOL, V73, P339, DOI 10.1111/1523-1747.ep12550377; Flynn G. L., 1990, PRINCIPLES ROUTE ROU, P93; FLYNN GL, 1988, DRUG DEVELOP RES, V13, P169, DOI 10.1002/ddr.430130209; FRISCH HL, 1957, J PHYS CHEM-US, V61, P93, DOI 10.1021/j150547a018; Garrigues-Mazert A, 2011, 8 WORLD C ALT AN US; GOLDSMITH LA, 1990, ARCH DERMATOL, V126, P301, DOI 10.1001/archderm.126.3.301; Groen D, 2008, BBA-BIOMEMBRANES, V1778, P2421, DOI 10.1016/j.bbamem.2008.06.015; Hou LL, 2013, LAB CHIP, V13, P1868, DOI 10.1039/c3lc41231h; Kessner D, 2008, EUR BIOPHYS J BIOPHY, V37, P989, DOI 10.1007/s00249-008-0328-6; Michelet JF, 2012, EXP DERMATOL, V21, P398, DOI 10.1111/j.1600-0625.2012.01480.x; Moss GP, 2012, CURR OPIN COLLOID IN, V17, P166, DOI 10.1016/j.cocis.2012.01.002; RIGG PC, 1990, J INVEST DERMATOL, V94, P235, DOI 10.1111/1523-1747.ep12874561; Schaefer H, 1996, SKIN BARRIER PRINCIP, P310; Schafer-Korting M, 2008, ATLA-ALTERN LAB ANIM, V36, P161; Scheuplein KJ, 1983, BIOCH PHYSL SKIN, V11, P1255; Scheuplein RJ, 2011, COMPREHENSIVE PHYSL, P299; Schreiber S, 2005, TOXICOL IN VITRO, V19, P813, DOI 10.1016/j.tiv.2005.04.004; Talreja P., 2001, AAPS PHARMSCI, V3, P48, DOI 10.1208/ps030213	46	0	0	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0724-8741	1573-904X		PHARM RES-DORDR	Pharm. Res.	AUG	2015	32	8					2704	2712		10.1007/s11095-015-1654-x		9	Chemistry, Multidisciplinary; Pharmacology & Pharmacy	Chemistry; Pharmacology & Pharmacy	CL9FM	WOS:000357281500017		
J	Terada, T; Noda, S; Inui, K				Terada, Tomohiro; Noda, Satoshi; Inui, Ken-ichi			Management of dose variability and side effects for individualized cancer pharmacotherapy with tyrosine kinase inhibitors	PHARMACOLOGY & THERAPEUTICS			English	Review						Tyrosine kinase inhibitors; Drug transporter; Drug interaction; Therapeutic drug monitoring; Skin disorders	RENAL-CELL CARCINOMA; REFRACTORY SOLID TUMORS; P-GLYCOPROTEIN ABCB1; ADVANCED HEPATOCELLULAR-CARCINOMA; RESISTANCE PROTEIN BCRP/ABCG2; SUNITINIB-INDUCED TOXICITY; ENDOTHELIAL GROWTH-FACTOR; DRUG-DRUG INTERACTIONS; LUNG-CANCER; PHASE-I	Molecular-targeted therapies with tyrosine kinase inhibitors (TKIs) have provided a major breakthrough in cancer treatment. These agents are given orally and demonstrated to be substrates for drug transporters. In clinical settings, TKIs are mainly used at a fixed dose, but wide interpatient variability has been observed in their pharmacokinetics and/or pharmacodynamics. Genetic polymorphisms of ABC transporters, drug-drug interaction and adherence are among the factors causing such variation. To overcome these problems, therapeutic drug monitoring has been applied in clinical practice for patient care. Skin disorders are frequently observed as adverse drug reactions when using TKIs, and are commonly managed by symptomatic therapy based on clinical experience. Recent studies have provided some insights into the molecular mechanisms underlying skin disorders induced by TKIs. This review article summarizes the accumulated clinical and basic pharmacological evidence of TKIs, focusing on erlotinib, sorafenib and sunitinib. (C) 2015 The Authors. Published by Elsevier Inc.	[Terada, Tomohiro; Noda, Satoshi] Shiga Univ Med Sci Hosp, Dept Pharm, Otsu, Shiga 5202192, Japan; [Inui, Ken-ichi] Kyoto Pharmaceut Univ, Yamashina Ku, Kyoto, Kyoto 6078414, Japan	Terada, T (reprint author), Shiga Univ Med Sci Hosp, Dept Pharm, Otsu, Shiga 5202192, Japan.	teradat@belle.shiga-med.ac.jp			Japanese Ministry of Education, Culture, Sports, Science and Technology	Work in the authors' laboratory is supported by Grant-in-Aid for Scientific Research from the Japanese Ministry of Education, Culture, Sports, Science and Technology.	Mascia F, 2003, AM J PATHOL, V163, P303, DOI 10.1016/S0002-9440(10)63654-1; Bezjak A, 2006, J CLIN ONCOL, V24, P3831, DOI 10.1200/JCO.2006.05.8073; Lathia C, 2006, CANCER CHEMOTH PHARM, V57, P685, DOI 10.1007/s00280-005-0068-6; Garcia-Donas J, 2011, LANCET ONCOL, V12, P1143, DOI 10.1016/S1470-2045(11)70266-2; van Leeuwen RWF, 2014, LANCET ONCOL, V15, pE315, DOI 10.1016/S1470-2045(13)70579-5; Adams VR, 2007, CLIN THER, V29, P1338, DOI 10.1016/j.clinthera.2007.07.022; Noda S, 2013, CANCER CHEMOTH PHARM, V72, P269, DOI 10.1007/s00280-013-2187-9; Zhang L, 2014, CLIN PHARMACOL THER, V96, P266, DOI 10.1038/clpt.2014.87; Minami H, 2008, CANCER SCI, V99, P1492, DOI 10.1111/j.1349-7006.2008.00837.x; Thomas F, 2009, EUR J CANCER, V45, P2316, DOI 10.1016/j.ejca.2009.05.007; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Noens L, 2009, BLOOD, V113, P5401, DOI 10.1182/blood-2008-12-196543; Yang F, 2010, MOL CANCER THER, V9, P953, DOI 10.1158/1535-7163.MCT-09-0947; Sparreboom A, 2004, CLIN PHARMACOL THER, V76, P38, DOI 10.1016/j.clpt.2004.03.003; Kunimatsu S, 2013, DRUG METAB DISPOS, V41, P1592, DOI 10.1124/dmd.112.050286; Kodaira H, 2010, J PHARMACOL EXP THER, V333, P788, DOI 10.1124/jpet.109.162321; Tang SC, 2013, J PHARMACOL EXP THER, V346, P486, DOI 10.1124/jpet.113.205583; Clark JW, 2005, CLIN CANCER RES, V11, P5472, DOI 10.1158/1078-0432.CCR-04-2658; Fukudo M, 2013, CLIN PHARMACOKINET, V52, P593, DOI 10.1007/s40262-013-0058-5; Josephs DH, 2013, THER DRUG MONIT, V35, P562, DOI 10.1097/FTD.0b013e318292b931; Giacomini KM, 2013, CLIN PHARMACOL THER, V94, P23, DOI 10.1038/clpt.2013.12; Gomo C, 2011, INVEST NEW DRUG, V29, P1511, DOI 10.1007/s10637-010-9514-3; Swift B, 2013, DRUG METAB DISPOS, V41, P1179, DOI 10.1124/dmd.112.048181; Togashi Y, 2010, J THORAC ONCOL, V5, P601, DOI 10.1097/JTO.0b013e3181d32287; Rakhit A, 2008, EUR J CLIN PHARMACOL, V64, P31, DOI 10.1007/s00228-007-0396-z; Herraez E, 2013, HEPATOLOGY, V58, P1065, DOI 10.1002/hep.26425; Li J, 2007, CLIN CANCER RES, V13, P3731, DOI 10.1158/1078-0432.CCR-07-0088; Bello CL, 2006, ANTI-CANCER DRUG, V17, P353, DOI 10.1097/00001813-200603000-00015; Johnson JR, 2005, CLIN CANCER RES, V11, P6414, DOI 10.1158/1078-CCR-05-0790; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Lagas JS, 2010, MOL CANCER THER, V9, P319, DOI 10.1158/1535-7163.MCT-09-0663; Houk BE, 2009, CLIN CANCER RES, V15, P2497, DOI 10.1158/1078-0432.CCR-08-1893; Gnoth MJ, 2010, DRUG METAB DISPOS, V38, P1341, DOI 10.1124/dmd.110.032052; White-Koning M, 2011, CLIN CANCER RES, V17, P4862, DOI 10.1158/1078-0432.CCR-10-3278; Uemura H, 2010, JPN J CLIN ONCOL, V40, P194, DOI 10.1093/jjco/hyp146; Park SJ, 2012, LUNG CANCER, V77, P556, DOI 10.1016/j.lungcan.2012.05.092; Faivre S, 2006, J CLIN ONCOL, V24, P25, DOI 10.1200/JCO.2005.02.2194; van der Veldt AAM, 2011, CLIN CANCER RES, V17, P620, DOI 10.1158/1078-0432.CCR-10-1828; Oostendorp RL, 2009, INVEST NEW DRUG, V27, P31, DOI 10.1007/s10637-008-9138-z; van Erp NP, 2009, J CLIN ONCOL, V27, P4406, DOI 10.1200/JCO.2008.21.7679; Cheng AL, 2009, LANCET ONCOL, V10, P25, DOI 10.1016/S1470-2045(08)70285-7; Hamilton M, 2006, CLIN CANCER RES, V12, P2166, DOI 10.1158/1078-0432.CCR-05-2235; Yamamoto N, 2011, MOL PHARMACOL, V80, P466, DOI 10.1124/mol.110.070862; Hidalgo M, 2001, J CLIN ONCOL, V19, P3267; Boudou-Rouquette P, 2012, ONCOLOGIST, V17, P1204, DOI 10.1634/theoncologist.2011-0439; Hu SY, 2009, CLIN CANCER RES, V15, P6062, DOI 10.1158/1078-0432.CCR-09-0048; Duran I, 2007, CLIN CANCER RES, V13, P4849, DOI 10.1158/1078-0432.CCR-07-0382; Shepherd FA, 2005, NEW ENGL J MED, V353, P123, DOI 10.1056/NEJMoa050753; Mendel DB, 2003, CLIN CANCER RES, V9, P327; Gore ME, 2009, LANCET ONCOL, V10, P757, DOI 10.1016/S1470-2045(09)70162-7; Mir O, 2011, NEW ENGL J MED, V365, P379, DOI 10.1056/NEJMc1105083; Houk BE, 2010, CANCER CHEMOTH PHARM, V66, P357, DOI 10.1007/s00280-009-1170-y; Yamasaki Y, 2008, CLIN PHARMACOL THER, V84, P95, DOI 10.1038/sj.clpt.6100459; Lu JF, 2006, CLIN PHARMACOL THER, V80, P136, DOI 10.1016/j.clpt.2006.04.007; Woodworth CD, 2005, MOL CANCER THER, V4, P650, DOI 10.1158/1535-7163.MCT-04-0238; Keating GM, 2009, DRUGS, V69, P223, DOI 10.2165/00003495-200969020-00006; Hamada A, 2012, PHARMACOGENOMICS, V13, P615, DOI [10.2217/pgs.11.176, 10.2217/PGS.11.176]; Ling J, 2008, ANTI-CANCER DRUG, V19, P209, DOI 10.1097/CAD.0b013e3282f2d8e4; Gao B, 2012, J CLIN ONCOL, V30, P4017, DOI 10.1200/JCO.2012.43.5362; Togashi Y, 2012, CANCER CHEMOTH PHARM, V70, P399, DOI 10.1007/s00280-012-1929-4; Motzer RJ, 2007, NEW ENGL J MED, V356, P115, DOI 10.1056/NEJMoa065044; Zimmerman EI, 2013, CLIN CANCER RES, V19, P1458, DOI 10.1158/1078-0432.CCR-12-3306; Hong MH, 2009, CANCER RES TREAT, V41, P67, DOI 10.4143/crt.2009.41.2.67; Akaza H, 2007, JPN J CLIN ONCOL, V37, P755, DOI 10.1093/jjco/hym095; Polli JW, 2009, DRUG METAB DISPOS, V37, P439, DOI 10.1124/dmd.108.024646; Rudin CM, 2008, J CLIN ONCOL, V26, P1119, DOI 10.1200/JCO.2007.13.1128; Zhang W, 2006, CLIN CHIM ACTA, V373, P99, DOI 10.1016/j.cca.2006.05.010; Furukawa T, 2009, PHARM RES-DORD, V26, P469, DOI 10.1007/s11095-008-9752-7; Yu HX, 2014, CLIN PHARMACOKINET, V53, P305, DOI 10.1007/s40262-014-0137-2; Mizuno T, 2010, ANN ONCOL, V21, P1382, DOI 10.1093/annonc/mdq150; Li J, 2007, CANCER BIOL THER, V6, P432; Britten CD, 2008, CANCER CHEMOTH PHARM, V61, P515, DOI 10.1007/s00280-007-0498-4; Budha NR, 2012, CLIN PHARMACOL THER, V92, P203, DOI 10.1038/clpt.2012.73; Liu L, 2006, CANCER RES, V66, P11851, DOI 10.1158/0008-5472.CAN-06-1377; Agarwal S, 2010, J PHARMACOL EXP THER, V334, P147, DOI 10.1124/jpet.110.167601; Diekstra MHM, 2014, CLIN PHARMACOL THER, V96, P81, DOI 10.1038/clpt.2014.47; Quadros MRD, 2004, CANCER RES, V64, P3934, DOI 10.1158/0008-5472.CAN-04-0214; Kane RC, 2006, CLIN CANCER RES, V12, P7271, DOI 10.1158/1078-0432.CCR-06-1249; Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308; Marchetti S, 2008, MOL CANCER THER, V7, P2280, DOI 10.1158/1535-7163.MCT-07-2250; Ling J, 2006, DRUG METAB DISPOS, V34, P420, DOI 10.1124/dmd.105.007765; Yoo C, 2010, JPN J CLIN ONCOL, V40, P980, DOI 10.1093/jjco/hyq073; Vandyke K, 2010, BLOOD, V115, P766, DOI 10.1182/blood-2009-08-237404; Baker SD, 2002, J NATL CANCER I, V94, P1883; Boudou-Rouquette P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042875; Chan A, 2014, SUPPORT CARE CANCER, V22, P1441, DOI 10.1007/s00520-014-2229-9; de Wit D, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-575; Duong Silvia, 2011, J Oncol Pharm Pract, V17, P448, DOI 10.1177/1078155210381794; Elmeliegy MA, 2011, CLIN CANCER RES, V17, P89, DOI 10.1158/1078-0432.CCR-10-1934; Fujita K, 2014, LUNG CANCER, V86, P113, DOI 10.1016/j.lungcan.2014.07.021; Fukudo M, 2014, CLIN PHARMACOKINET, V53, P185, DOI 10.1007/s40262-013-0108-z; Glavinas Hristos, 2004, Current Drug Delivery, V1, P27, DOI 10.2174/1567201043480036; Hidalgo M, 2003, SEMIN ONCOL, V30, P25, DOI 10.1016/S0093-7754(03)00186-6; Homecker M., 2012, INVEST NEW DRUGS, V30, P1991; Jain L, 2011, BRIT J CLIN PHARMACO, V72, P294, DOI 10.1111/j.1365-2125.2011.03963.x; Kim DH, 2011, ANN DERMATOL, V23, P119, DOI 10.5021/ad.2011.23.1.119; Kim HR, 2013, CANCER CHEMOTH PHARM, V72, P825, DOI 10.1007/s00280-013-2258-y; Kliimpen H. J., 2011, CANC TREAT REV, V37, P251; Lankheet NAG, 2014, BRIT J CANCER, V110, P2441, DOI 10.1038/bjc.2014.194; Mann D, 2010, J CLIN ONCOL, V28, P2381; Mizuno T, 2012, DRUG METAB PHARMACOK, V27, P631, DOI 10.2133/dmpk.DMPK-12-RG-026; Mizuno T, 2014, THER DRUG MONIT, V36, P310, DOI 10.1097/FTD.0000000000000025; Noda Satoshi, 2012, Case Rep Oncol, V5, P627, DOI 10.1159/000345694; Noda S., 2015, CLIN GENITO IN PRESS; Relling MV, 2000, LANCET, V356, P285, DOI 10.1016/S0140-6736(00)02503-4; Richly H, 2006, ANN ONCOL, V17, P866, DOI 10.1093/annonc/mdl017; Shinsako K, 2010, INT J CLIN ONCOL, V15, P512, DOI 10.1007/s10147-010-0070-9; Siegelin MD, 2010, NEUROSCI LETT, V478, P165, DOI 10.1016/j.neulet.2010.05.009; Strumberg D, 2007, ONCOLOGIST, V12, P426, DOI 10.1634/theoncologist.12-4-426; Tang SC, 2012, J PHARMACOL EXP THER, V341, P164, DOI 10.1124/jpet.111.186908; Togashi Y., 2010, J THORAC ONCOL, p[7, 950]; van Erp NP, 2011, CANCER CHEMOTH PHARM, V67, P695, DOI 10.1007/s00280-010-1367-0; Yamamoto K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102110	113	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0163-7258			PHARMACOL THERAPEUT	Pharmacol. Ther.	AUG	2015	152						125	134		10.1016/j.pharmthera.2015.05.009		10	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CM5US	WOS:000357755100011		
J	Takeda, T; Nakano, Y; Takahashi, M; Konno, N; Sakamoto, Y; Arashida, R; Marukawa, Y; Yoshida, E; Ishikawa, T; Suzuki, K				Takeda, Takumi; Nakano, Yuki; Takahashi, Machiko; Konno, Naotake; Sakamoto, Yuichi; Arashida, Ryo; Marukawa, Yuka; Yoshida, Eriko; Ishikawa, Takahiro; Suzuki, Kengo			Identification and enzymatic characterization of an endo-1,3-beta-glucanase from Euglena gracilis	PHYTOCHEMISTRY			English	Article						Euglena; Euglenaceae; Endo-1,3-beta-glucanase; Paramylon; Hydrolysis; Transglycosylation; Glycoside hydrolase family 17	SEQUENCE-BASED CLASSIFICATION; GLYCOSIDE HYDROLASE; DEGRADATION; WALLS; PURIFICATION; TRANSFERASE; PROTEINS; GLUCANS; CLONING; ORYZAE	Euglena produces paramylon as a storage polysaccharide, and is thought to require beta-1,3-glucan degrading enzymes to release and utilize the accumulated carbohydrate. To investigate beta-1,3-glucan degradation in Euglena, endo-1,3-beta-glucanases were partially purified from Euglena gracilis by hydrophobic, gel filtration and anion-exchange chromatography. Tryptic digests and mass-spectrometric analysis identified three proteins in the purified fraction as a member of glycoside hydrolase family (GH) 17 and two members of GH81. These genes were cloned from an Euglena cDNA pool by PCR. EgCel17A fused with a histidine-tag at the carboxy terminus was heterologously produced by Aspergillus oryzae and purified by immobilized metal affinity chromatography. Purified EgCel17A had a molecular weight of about 40 kDa by SDS-PAGE, which was identical to that deduced from its amino acid sequence. The enzyme showed hydrolytic activity towards beta-1,3-glucans such as laminarin and paramylon. Maximum activity of laminarin degradation by EgCel17A was attained at pH 4.0-5.5 and 60 degrees C after 1 h incubation or 50 degrees C after 20 h incubation. The enzyme had a K-m of 0.21 mg/ml and a V-max, of 40.5 units/mg protein for laminarin degradation at pH 5.0 and 50 degrees C. Furthermore, EgCel17A catalyzed a transglycosylation reaction by which reaction products with a higher molecular weight than the supplied substrates were initially generated; however, ultimately the substrates were degraded into glucose, laminaribiose and laminaritriose. EgCel17A effectively produced soluble beta-1,3-glucans from alkaline-treated Euglena freeze-dried powder containing paramylon. Thus, EgCel17 is the first functional endo-1,3-beta-glucanase to be identified from E. gracilis. (C) 2015 Elsevier Ltd. All rights reserved.	[Takeda, Takumi; Nakano, Yuki; Takahashi, Machiko; Konno, Naotake; Sakamoto, Yuichi] Lwate Biotechnol Res Ctr, Kitakami, Iwate 0240003, Japan; [Arashida, Ryo; Marukawa, Yuka; Yoshida, Eriko; Suzuki, Kengo] Euglena Co Ltd, Bunkyo Ku, Tokyo 1120004, Japan; [Ishikawa, Takahiro] Shimane Univ, Fac Life & Environm Sci, Matsue, Shimane 6908504, Japan	Takeda, T (reprint author), Lwate Biotechnol Res Ctr, 22-174-4 Narita, Kitakami, Iwate 0240003, Japan.	takumitakeda27@gmail.com			Iwate Prefecture	This work was supported by Iwate Prefecture.	Kawamura Y, 2003, PLANT J, V36, P141, DOI 10.1046/j.1365-313X.2003.01864.x; Takahashi M, 2013, J BIOL CHEM, V288, P13821, DOI 10.1074/jbc.M112.448902; Shi PJ, 2011, ENZYME MICROB TECH, V49, P277, DOI 10.1016/j.enzmictec.2011.06.003; FRY SC, 1992, BIOCHEM J, V282, P821; BARRAS DR, 1969, BIOCHIM BIOPHYS ACTA, V191, P329, DOI 10.1016/0005-2744(69)90252-6; Michel G, 2010, NEW PHYTOL, V188, P67, DOI 10.1111/j.1469-8137.2010.03345.x; NISHITANI K, 1992, J BIOL CHEM, V267, P21058; Yano A, 2009, MICROBIOL RES, V164, P642, DOI 10.1016/j.micres.2008.12.001; Henrissat B, 1996, BIOCHEM J, V316, P695; Gupta R, 2012, APPL BIOCHEM BIOTECH, V168, P1681, DOI 10.1007/s12010-012-9889-z; de Groot PWJ, 2003, YEAST, V20, P781, DOI 10.1002/yea.1007; GOMI K, 1987, AGR BIOL CHEM TOKYO, V51, P2549; BARRAS DR, 1969, BIOCHIM BIOPHYS ACTA, V191, P342, DOI 10.1016/0005-2744(69)90253-8; Ducret A, 2002, BIOTECHNOL BIOENG, V77, P752, DOI 10.1002/bit.10156; Hong ZL, 2001, PLANT CELL, V13, P755, DOI 10.1105/tpc.13.4.755; Bhatia Y, 2002, CRIT REV BIOTECHNOL, V22, P375, DOI 10.1080/07388550290789568; Chen Xiong-Yan, 2009, Plant Signal Behav, V4, P489; Cheng R, 2013, BMC BIOTECHNOL, V13, DOI 10.1186/1472-6750-13-105; CLINE K, 1981, PLANT PHYSIOL, V68, P207, DOI 10.1104/pp.68.1.207; Hartland RP, 1996, J BIOL CHEM, V271, P26843; Henrissat B, 1997, CURR OPIN STRUC BIOL, V7, P637, DOI 10.1016/S0959-440X(97)80072-3; HENRISSAT B, 1991, BIOCHEM J, V280, P309; Johnston SL, 2013, PLANTA, V237, P173, DOI 10.1007/s00425-012-1766-z; KOREN LE, 1967, J PROTOZOOL, VS 14, P17; MCCORMICK S, 1993, PLANT CELL, V5, P1265, DOI 10.1105/tpc.5.10.1265; Miller M., 1972, ANAL BIOCHEM, V47, P273; Nakajima M, 2012, APPL ENVIRON MICROB, V78, P5682, DOI 10.1128/AEM.00483-12; Peumans J.W., 2000, EUR J BIOCHEM, V267, P1188; RUEL K, 1991, APPL ENVIRON MICROB, V57, P374; SIETSMA JH, 1981, J GEN MICROBIOL, V125, P209; SUMIDA S, 1987, PLANT CELL PHYSIOL, V28, P1587; Takahashi M, 2011, APPL MICROBIOL BIOT, V91, P1073, DOI 10.1007/s00253-011-3340-1; van Bueren AL, 2005, J BIOL CHEM, V280, P530, DOI 10.1074/jbc.M410113200	33	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0031-9422			PHYTOCHEMISTRY	Phytochemistry	AUG	2015	116						21	27		10.1016/j.phytochem.2015.05.010		7	Biochemistry & Molecular Biology; Plant Sciences	Biochemistry & Molecular Biology; Plant Sciences	CM1JW	WOS:000357438200002		
J	Yamamoto, Y; Ohshika, J; Takahashi, T; Ishizaki, K; Kohchi, T; Matusuura, H; Takahashi, K				Yamamoto, Yusuke; Ohshika, Jun; Takahashi, Tomohiro; Ishizaki, Kimitsune; Kohchi, Takayuki; Matusuura, Hideyuki; Takahashi, Kosaku			Functional analysis of allene oxide cyclase, MpAOC, in the liverwort Marchantia polymorpha	PHYTOCHEMISTRY			English	Article						Allene oxide cyclase; Marchantia polymorpha; Marchantiaceae; Octadecanoid pathway; 12-Oxo-phytodienoic acid; Stress response	AGROBACTERIUM-MEDIATED TRANSFORMATION; PHYSCOMITRELLA-PATENS; 12-OXO-PHYTODIENOIC ACID; ARABIDOPSIS-THALIANA; NICOTIANA-TABACUM; JASMONIC ACID; PLANTS; SYNTHASE; GENES; LAND	12-Oxo-phytodienoic acid (OPDA) is an intermediate in jasmonic acid (JA) biosynthesis. OPDA exerts JA-dependent and JA-independent biological effects; therefore, it is considered a signaling molecule in flowering plants. OPDA is induced by bacterial infection and wounding and inhibits growth in the moss Physcomitrella patens. The functions of OPDA and allene oxide cyclase (AOC) in the liverwort Marchantia polymorpha were explored, which represents the most basal lineage of extant land plants. The analysis of OPDA showed that it is present in M. polymorpha and is increased by wounding. OPDA has been suggested to be involved in the response to environmental stresses. Moreover, OPDA showed growth inhibitory activity in M. polymorpha. Nonetheless JA in M. polymorpha was not found in this study. AOC synthesizes OPDA from an unstable allene oxide. A database search of the M. polymorpha genome identified only a putative gene encoding allene oxide cyclase (MpAOC). Recombinant MpAOC showed AOC activity similar to that in flowering plants. MpAOC was localized to chloroplasts, as in flowering plants. Expression of MpAOC was induced by wounding and OPDA treatment, and positive feedback regulation of OPDA was demonstrated in M. polymorpha. Overexpression of MpAOC increased the endogenous OPDA level and suppressed growth in M. polymorpha. These results indicate the role of OPDA as a signaling molecule regulating growth and the response to wounding in the liverwort M. polymorpha. (C) 2015 Elsevier Ltd. All rights reserved.	[Yamamoto, Yusuke; Ohshika, Jun; Takahashi, Tomohiro; Matusuura, Hideyuki; Takahashi, Kosaku] Hokkaido Univ, Res Fac Agr, Sapporo, Hokkaido 0608589, Japan; [Ishizaki, Kimitsune] Kobe Univ, Grad Sch Sci, Kobe, Hyogo 6578501, Japan; [Kohchi, Takayuki] Kyoto Univ, Grad Sch Biostudies, Kyoto 6068502, Japan	Takahashi, K (reprint author), Hokkaido Univ, Res Fac Agr, Kita Ku, Rita 9,Nishi 9, Sapporo, Hokkaido 0608589, Japan.	kosaku@chem.agr.hokudai.ac.jp		Ishizaki, Kimitsune/0000-0003-0504-8196			Agrawal GK, 2003, PLANT SCI, V164, P979, DOI 10.1016/S0168-9452(03)00082-7; Kubota A, 2013, BIOSCI BIOTECH BIOCH, V77, P167, DOI 10.1271/bbb.120700; Prigge MJ, 2010, CURR BIOL, V20, P1907, DOI 10.1016/j.cub.2010.08.050; Bottcher C, 2009, FEBS J, V276, P4693, DOI 10.1111/j.1742-4658.2009.07195.x; Neumann P, 2012, PLANT PHYSIOL, V160, P1251, DOI 10.1104/pp.112.205138; De Leon IP, 2012, MOL PLANT PATHOL, V13, P960, DOI 10.1111/j.1364-3703.2012.00806.x; Qiu YL, 2006, P NATL ACAD SCI USA, V103, P15511, DOI 10.1073/pnas.0603335103; Goetz S, 2012, PLANT PHYSIOL, V158, P1715, DOI 10.1104/pp.111.192658; Tougane K, 2010, PLANT PHYSIOL, V152, P1529, DOI 10.1104/pp.110.153387; Schaller A, 2009, PHYTOCHEMISTRY, V70, P1532, DOI 10.1016/j.phytochem.2009.07.032; Ishizaki K, 2008, PLANT CELL PHYSIOL, V49, P1084, DOI 10.1093/pcp/pcn085; Laudert D, 2000, PLANTA, V211, P163, DOI 10.1007/s004250000316; Mosblech A, 2009, PLANT PHYSIOL BIOCH, V47, P511, DOI 10.1016/j.plaphy.2008.12.011; Bowman JL, 2007, CELL, V129, P229, DOI 10.1016/j.cell.2007.04.004; Oliver JP, 2009, PLANTA, V230, P569, DOI 10.1007/s00425-009-0969-4; Rensing SA, 2008, SCIENCE, V319, P64, DOI 10.1126/science.1150646; Fonseca S, 2009, NAT CHEM BIOL, V5, P344, DOI 10.1038/nchembio.161; Chiyoda S, 2008, PLANT CELL REP, V27, P1467, DOI 10.1007/s00299-008-0570-5; Wasternack C, 2013, ANN BOT-LONDON, V111, P1021, DOI 10.1093/aob/mct067; Stenzel I, 2003, PLANT MOL BIOL, V51, P895, DOI 10.1023/A:1023049319723; Schaller F, 2008, FEBS J, V275, P2428, DOI 10.1111/j.1742-4658.2008.06388.x; Stumpe M, 2010, NEW PHYTOL, V188, P740, DOI 10.1111/j.1469-8137.2010.03406.x; Sato C, 2009, BIOSCI BIOTECH BIOCH, V73, P1962, DOI 10.1271/bbb.90119; Ishizaki K, 2012, J PLANT RES, V125, P643, DOI 10.1007/s10265-012-0477-7; Bandara PKGSS, 2009, BIOSCI BIOTECH BIOCH, V73, P2356, DOI 10.1271/bbb.90457; Takezawa D, 2011, J PLANT RES, V124, P437, DOI 10.1007/s10265-011-0410-5; Taki N, 2005, PLANT PHYSIOL, V139, P1268, DOI 10.1104/pp.105.067058; Hashimoto H., 2011, PLANT GROWTH REGUL, V65, P239; Ishizaki K, 2013, SCI REP-UK, V3, DOI 10.1038/srep01532; Kajiwara A, 2012, BIOSCI BIOTECH BIOCH, V76, P2325, DOI 10.1271/bbb.120506; Laudert D, 1997, ANAL BIOCHEM, V246, P211, DOI 10.1006/abio.1997.2012; Scholz J, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-228; Toshima E, 2014, BIOSCI BIOTECH BIOCH, V78, P946, DOI 10.1080/09168451.2014.912112; von Schwartzenberg K, 2007, PLANT PHYSIOL, V145, P786, DOI 10.1104/pp.107.103176	34	4	4	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0031-9422			PHYTOCHEMISTRY	Phytochemistry	AUG	2015	116						48	56		10.1016/j.phytochem.2015.03.008		9	Biochemistry & Molecular Biology; Plant Sciences	Biochemistry & Molecular Biology; Plant Sciences	CM1JW	WOS:000357438200005		
J	Miyauchi, R; Takatsu, T; Suzuki, T; Ono, Y; Shiba, Y				Miyauchi, Ryuki; Takatsu, Toshio; Suzuki, Tetsuya; Ono, Yasunori; Shiba, Yoichiro			Biosynthesis of nectrisine in Thelonectria discophora SANK 18292	PHYTOCHEMISTRY			English	Article						Thelonectria discophora; Nectriaceae; Biosynthesis; Nectrisine; Iminosugar; Aminoalcohol	ESCHERICHIA-COLI RIBOKINASE; STEREOSELECTIVE-SYNTHESIS; STREPTOMYCES-SUBRUTILUS; THERAPEUTIC AGENTS; RADICAMINE-B; AMINO-ACIDS; 1-DEOXYNOJIRIMYCIN; IMMUNOMODULATOR; IDENTIFICATION; 7-FLUORO-4-NITROBENZO-2-OXA-1,3-DIAZOLE	Nectrisine, an iminosugar with a heterocyclic nitrogen-containing 5-membered ring, acts as a glycosidase inhibitor. Thelonectria discophora SANK 18292, a fungus, was identified as a nectrisine producer from its microbial library in our screening for nectrisine producing microorganisms. Biosynthesis of nectrisine produced by the fungus was studied using stable isotope tracer techniques. Incorporation of C-13-labeled D-ribose and D-xylose into nectrisine was confirmed by mass spectrometry and C-13 NMR spectroscopy, which suggested that these were its precursors. Chromatographic separation of the hot water extract from the culture broth afforded not only nectrisine, but also substantial amounts of 4-amino-4-deoxyarabinitol. Incubation of the latter with the crude enzyme of the fungus at room temp. caused an increase in levels of nectrisine together with a decrease in amounts of the administered potential precursor suggesting that it is a biosynthetic intermediate. From these results, a biosynthetic pathway to nectrisine is proposed via D-xylulose 5-phosphate and 4-amino-4-deoxyarabinitol by the pentose phosphate pathway. (C) 2015 Elsevier Ltd. All rights reserved.	[Miyauchi, Ryuki] Daiichi Sankyo Co Ltd, R&D Div, New Modal Res Labs, Shinagawa Ku, Tokyo 1408710, Japan; [Takatsu, Toshio] Daiichi Sankyo RD Novare Co Ltd, Ctr Pharmaceut & Biomed Anal, Edogawa Ku, Tokyo 1348630, Japan; [Suzuki, Tetsuya] Daiichi Sankyo Co Ltd, Pharmaceut Technol Div, Analyt & Qual Evaluat Res Labs, Shinagawa Ku, Tokyo 1408710, Japan; [Ono, Yasunori] Daiichi Sankyo RD Novare Co Ltd, Drug Discovery & Biomed Technol Unit, Discovery Sci & Technol Dept, Edogawa Ku, Tokyo 1348630, Japan; [Shiba, Yoichiro] Daiichi Sankyo Co Ltd, Pharmaceut Technol Div, CM&C Planning Dept, Hiratsuka, Kanagawa 2540014, Japan	Miyauchi, R (reprint author), Daiichi Sankyo Co Ltd, R&D Div, New Modal Res Labs, Shinagawa Ku, 1-2-58 Hiromachi, Tokyo 1408710, Japan.	miyauchi.ryuki.d4@daiichisankyo.co.jp					Butters TD, 2000, CHEM REV, V100, P4683, DOI 10.1021/cr990292q; IMAI K, 1981, ANAL CHIM ACTA, V130, P377, DOI 10.1016/S0003-2670(01)93016-8; Kimura T, 2004, J AGR FOOD CHEM, V52, P1415, DOI 10.1021/jf0306901; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; Nash RJ, 2011, FUTURE MED CHEM, V3, P1513, DOI [10.4155/fmc.11.117, 10.4155/FMC.11.117]; Flack HD, 2000, J APPL CRYSTALLOGR, V33, P1143, DOI 10.1107/S0021889800007184; WITTEVEEN CFB, 1989, J GEN MICROBIOL, V135, P2163; Brayford D, 2004, MYCOLOGIA, V96, P572, DOI 10.2307/3762176; Chaverri P, 2011, STUD MYCOL, P57, DOI 10.3114/sim.2011.68.03; Tsujii E, 1996, BIOCHEM BIOPH RES CO, V220, P459, DOI 10.1006/bbrc.1996.0427; Asano N, 2003, GLYCOBIOLOGY, V13, p93R, DOI 10.1093/glycob/cwg090; Clark LF, 2011, CHEMBIOCHEM, V12, P2147, DOI 10.1002/cbic.201100347; Compain P., 2007, IMINOSUGARS SYNTHESI; HARDICK DJ, 1993, TETRAHEDRON, V49, P6707, DOI 10.1016/S0040-4020(01)81840-8; HARDICK DJ, 1992, TETRAHEDRON, V48, P6285, DOI 10.1016/S0040-4020(01)88220-X; HARDICK DJ, 1991, J CHEM SOC CHEM COMM, P729, DOI 10.1039/c39910000729; Horne Graeme, 2011, Drug Discov Today, V16, P107, DOI 10.1016/j.drudis.2010.08.017; Hulme AN, 2003, TETRAHEDRON LETT, V44, P7649, DOI 10.1016/j.tetlet.2003.08.030; Kang KD, 2011, J MICROBIOL, V49, P431, DOI 10.1007/s12275-011-1238-3; KAYAKIRI H, 1988, TETRAHEDRON LETT, V29, P1725, DOI 10.1016/S0040-4039(00)82028-6; KAYAKIRI H, 1991, CHEM PHARM BULL, V39, P2807; Merino P, 2008, EUR J ORG CHEM, P2929, DOI 10.1002/ejoc.200800098; Nangia-Makker P, 2002, TRENDS MOL MED, V8, P187, DOI 10.1016/S1471-4914(02)02295-5; Ribes C, 2008, J ORG CHEM, V73, P7779, DOI 10.1021/jo8012989; Seiboth B, 2011, APPL MICROBIOL BIOT, V89, P1665, DOI 10.1007/s00253-010-3071-8; Shibano M, 2004, PHYTOCHEMISTRY, V65, P2661, DOI 10.1016/j.phytochem.2004.08.013; SHIBATA T, 1988, J ANTIBIOT, V41, P296; Sigrell JA, 1998, STRUCTURE, V6, P183, DOI 10.1016/S0969-2126(98)00020-3; Sigrell JA, 1997, PROTEIN SCI, V6, P2474; Sui-Hui C., 1990, TETRAHEDRON LETT, V31, P2229, DOI 10.1016/0040-4039(90)80192-O; Tozzi MG, 2006, FEBS J, V273, P1089, DOI 10.1111/j.1742-4658.2006.05155.x; WATANABE Y, 1981, ANAL BIOCHEM, V116, P471, DOI 10.1016/0003-2697(81)90390-0; White TJ, 1990, PCR PROTOCOLS GUIDE, P315, DOI DOI 10.1139/B07-071	34	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0031-9422			PHYTOCHEMISTRY	Phytochemistry	AUG	2015	116						87	93		10.1016/j.phytochem.2015.03.011		7	Biochemistry & Molecular Biology; Plant Sciences	Biochemistry & Molecular Biology; Plant Sciences	CM1JW	WOS:000357438200009		
J	Morikawa, T; Ninomiya, K; Takamori, Y; Nishida, E; Yasue, M; Hayakawa, T; Muraoka, O; Li, XZ; Nakamura, S; Yoshikawa, M; Matsuda, H				Morikawa, Toshio; Ninomiya, Kiyofumi; Takamori, Yasunobu; Nishida, Eriko; Yasue, Misato; Hayakawa, Takao; Muraoka, Osamu; Li, Xuezheng; Nakamura, Seikou; Yoshikawa, Masayuki; Matsuda, Hisashi			Oleanane-type triterpene saponins with collagen synthesis-promoting activity from the flowers of Bellis perennis	PHYTOCHEMISTRY			English	Article						Daisy; Bellis perennis; Asteraceae; Collagen synthesis promoting activity; Perennisoside; Oleanane-type triterpene saponin	MEDICINAL FOODSTUFFS; GOTU KOLA; OLIGOGLYCOSIDES; BISDESMOSIDES	The methanol extract from Bellis perennis (Asteraceae) flowers was found to promote collagen synthesis in normal human dermal fibroblasts (NHDFs). Seven oleanane-type triterpene saponins, perennisosides XIII-XIX, and two known saponins, bellissaponins BS5 and BS9, were isolated from the methanol extract. The structures were determined based on chemical and physicochemical data, and confirmed using previously isolated related compounds as references. Among the isolates, including 19 previously reported saponins, perennisosides XVIII, I, II, VII, IX, and XI, asterbatanoside D, bernardioside B-2, and bellissaponins BS5 and BS9 significantly promoted collagen synthesis at 3-30 mu M without cytotoxicity. (C) 2015 Elsevier Ltd. All rights reserved.	[Morikawa, Toshio; Ninomiya, Kiyofumi; Takamori, Yasunobu; Nishida, Eriko; Yasue, Misato; Hayakawa, Takao; Muraoka, Osamu; Yoshikawa, Masayuki] Kinki Univ, Pharmaceut Res & Technol Inst, Higashiosaka, Osaka 5778502, Japan; [Morikawa, Toshio; Ninomiya, Kiyofumi; Muraoka, Osamu] Kinki Univ, Antiaging Ctr, Higashiosaka, Osaka 5778502, Japan; [Li, Xuezheng; Nakamura, Seikou; Yoshikawa, Masayuki; Matsuda, Hisashi] Kyoto Pharmaceut Univ, Yamashina Ku, Kyoto 6078412, Japan	Morikawa, T (reprint author), Kinki Univ, Pharmaceut Res & Technol Inst, 3-4-1 Kowakae, Higashiosaka, Osaka 5778502, Japan.	morikawa@kindai.ac.jp; matsuda@mb.kyoto-phu.ac.jp			MEXT-Supported Program	This work was supported by MEXT-Supported Program for the Strategic Research Foundation at Private Universities, 2014-2018.	Morikawa T, 2008, J NAT PROD, V71, P828, DOI 10.1021/np8000333; Karakas FP, 2014, PHARM BIOL, V52, P951, DOI 10.3109/13880209.2013.874461; BONTE F, 1994, PLANTA MED, V60, P133, DOI 10.1055/s-2006-959434; Koya-Miyata S, 2004, BIOSCI BIOTECH BIOCH, V68, P767, DOI 10.1271/bbb.68.767; BURK MJ, 1995, J AM CHEM SOC, V117, P4423, DOI 10.1021/ja00120a035; Glensk M., 2001, SCI PHARM, V69, P69; Gruenwald J., 2007, PDR HERBAL MED, P896; KASAI R, 1988, PHYTOCHEMISTRY, V27, P1439, DOI 10.1016/0031-9422(88)80212-7; Lee J, 2007, J ETHNOPHARMACOL, V109, P29, DOI 10.1016/j.jep.2006.06.008; Liu M, 2008, PLANTA MED, V74, P809, DOI 10.1055/s-2008-1074533; Matsuda H, 2001, HETEROCYCLES, V55, P1499; Matsuda H, 2001, CHEM PHARM BULL, V49, P1368, DOI 10.1248/cpb.49.1368; MEIGEL WN, 1977, ARCH DERMATOL RES, V259, P1, DOI 10.1007/BF00562732; Morikawa T, 2010, HELV CHIM ACTA, V93, P573, DOI 10.1002/hlca.200900258; Morikawa T, 2011, CHEM PHARM BULL, V59, P889, DOI 10.1248/cpb.59.889; Schopke T, 1996, J NAT PROD, V59, P939, DOI 10.1021/np960400t; Wray V., 1992, PHYTOCHEMSITRY, V31, P2555; Yoshikawa M, 2008, CHEM PHARM BULL, V56, P559, DOI 10.1248/cpb.56.559	18	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0031-9422			PHYTOCHEMISTRY	Phytochemistry	AUG	2015	116						203	212		10.1016/j.phytochem.2015.05.011		10	Biochemistry & Molecular Biology; Plant Sciences	Biochemistry & Molecular Biology; Plant Sciences	CM1JW	WOS:000357438200022		
J	Kurimoto, S; Pu, JX; Sun, HD; Takaishi, Y; Kashiwada, Y				Kurimoto, Shin-ichiro; Pu, Jian-Xin; Sun, Han-Dong; Takaishi, Yoshihisa; Kashiwada, Yoshiki			Acylated neo-clerodanes and 19-nor-neo-clerodanes from the aerial parts of Scutellaria coleifolia (Lamiaceae)	PHYTOCHEMISTRY			English	Article						Scutellaria coleifolia; Lamiaceae; Diterpenoid; Neo-clerodane	NEPALESE CRUDE DRUGS; NEOCLERODANE INSECT ANTIFEEDANTS; DITERPENOID CONSTITUENTS; ALPINA; POLYODON; LEAVES; WALL	Scutefolides A(1) and A(2), two acylated neo-clerodanes with a 19,18-gamma-lactone, scutefolides B-1, B-2 and C, three 19-nor-neo-clerodanes, together with scutefolides D, E-1, E-2 and F, four neo-clerodanes, were isolated from the EtOAc-soluble fraction of the aerial parts of Scutellaria coleifolia. Their structures were established on the basis of spectroscopic analysis. The absolute configurations of four of these compounds were elucidated by the CD exciton chirality method. Cytotoxic activities of scutefolides D-F against four cancer cell lines (KB, A549, HeLa, and MCF7) were also evaluated, but they were inactive. (C) 2015 Elsevier Ltd. All rights reserved.	[Kurimoto, Shin-ichiro; Takaishi, Yoshihisa; Kashiwada, Yoshiki] Univ Tokushima, Grad Sch Pharmaceut Sci, Tokushima 7708505, Japan; [Pu, Jian-Xin; Sun, Han-Dong] Chinese Acad Sci, Kunming Inst Bot, State Key Lab Phytochem & Plant Resources West Ch, Kunming 650201, Peoples R China	Kashiwada, Y (reprint author), Univ Tokushima, Grad Sch Pharmaceut Sci, 1-78 Shomachi, Tokushima 7708505, Japan.	kasiwada@tokushima-u.ac.jp					Shang XF, 2010, J ETHNOPHARMACOL, V128, P279, DOI 10.1016/j.jep.2010.01.006; Lee H, 2011, HELV CHIM ACTA, V94, P643; BOZOV PI, 1993, PHYTOCHEMISTRY, V34, P453, DOI 10.1016/0031-9422(93)80029-R; Calis I, 1996, J NAT PROD, V59, P457, DOI 10.1021/np9602426; Wu YB, 2012, CHEM REV, V112, P5967, DOI 10.1021/cr200058f; Bruno M, 2000, J NAT PROD, V63, P1032, DOI 10.1021/np990624m; COLE MD, 1990, PHYTOCHEMISTRY, V29, P1793, DOI 10.1016/0031-9422(90)85018-B; de la Torre MC, 1997, J NAT PROD, V60, P1229, DOI 10.1021/np970213a; DELATORRE MC, 1995, PHYTOCHEMISTRY, V38, P181, DOI 10.1016/0031-9422(94)00617-3; Esquivel B, 2001, J NAT PROD, V64, P778, DOI 10.1021/np000588n; Hussein AA, 1996, PHYTOCHEMISTRY, V43, P835, DOI 10.1016/0031-9422(96)00380-9; Kizu H, 1998, CHEM PHARM BULL, V46, P988; Kizu H, 1997, CHEM PHARM BULL, V45, P152; Kurimoto S., 2015, CHEM BIODIV IN PRESS; Malakov PY, 1996, PHYTOCHEMISTRY, V43, P173, DOI 10.1016/0031-9422(96)00273-7; MIYAICHI Y, 1994, YAKUGAKU ZASSHI, V114, P264; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Munoz DM, 1997, PHYTOCHEMISTRY, V44, P593, DOI 10.1016/S0031-9422(96)00608-5; Nguyen VH, 2009, EUR J ORG CHEM, P5810, DOI 10.1002/ejoc.200900431; Ohno A, 1997, CHEM PHARM BULL, V45, P1097; Ohno A, 1996, CHEM PHARM BULL, V44, P1540; PFEFFER PE, 1979, J AM CHEM SOC, V101, P1265, DOI 10.1021/ja00499a036; Raccuglia RA, 2010, PHYTOCHEMISTRY, V71, P2087, DOI 10.1016/j.phytochem.2010.08.021; Rodriguez B, 1997, J NAT PROD, V60, P348, DOI 10.1021/np960714g; Wang TieShan, 2012, Journal of Medicinal Plants Research, V6, P4259	25	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0031-9422			PHYTOCHEMISTRY	Phytochemistry	AUG	2015	116						298	304		10.1016/j.phytochem.2015.05.012		7	Biochemistry & Molecular Biology; Plant Sciences	Biochemistry & Molecular Biology; Plant Sciences	CM1JW	WOS:000357438200033		
J	Mitsui, T; Ishihara, R; Hayashi, K; Matsuura, N; Akashi, H; Nozaki, H				Mitsui, Taichi; Ishihara, Risa; Hayashi, Ken-ichiro; Matsuura, Nobuyasu; Akashi, Haruo; Nozaki, Hiroshi			Cassane-type diterpenoids from Caesalpinia echinata (Leguminosae) and their NF-kappa B signaling inhibition activities	PHYTOCHEMISTRY			English	Article						Caesalpinia echinata; Caesalpiniaceae; Cassane diterpene; Echinalide; Nuclear factor kappa B	SESQUITERPENE LACTONES; MINAX; FURANODITERPENES; CRISTA; SEEDS	Fourteen cassane-type diterpenoids, echinalides H-U, were isolated from the stem of Caesalpinia echinata Lam. (Leguminosae). The structures of the echinalides were elucidated by spectroscopic investigation, including 2D NMR spectroscopic analysis. The structures of echinalide H and echinalide T were further confirmed by single-crystal X-ray diffraction. The absolute configurations of echinalides H, I, J and K were determined by CD spectroscopy. Additionally, the absolute configurations of echinalide L and M were determined by chemical conversion from echinalide H. These compounds were evaluated for inhibitory activity against nuclear factor kappa B (NF-kappa B). Echinalide M showed the most potent inhibitory activity (47 +/- 11% at 5 mu M) toward NF-kappa B-responsive gene expression. (C) 2015 Elsevier Ltd. All rights reserved.	[Mitsui, Taichi; Ishihara, Risa; Hayashi, Ken-ichiro; Nozaki, Hiroshi] Okayama Univ Sci, Fac Sci, Dept Biol Chem, Kita Ku, Okayama, Okayama 7000005, Japan; [Matsuura, Nobuyasu] Okayama Univ Sci, Dept Life Sci, Fac Sci, Kita Ku, Okayama, Okayama 7000005, Japan; [Akashi, Haruo] Okayama Univ Sci, Res Inst Nat Sci, Kita Ku, Okayama, Okayama 7000005, Japan	Nozaki, H (reprint author), Okayama Univ Sci, Fac Sci, Dept Biol Chem, Kita Ku, 1-1 Ridai Cho, Okayama, Okayama 7000005, Japan.	nozaki@dbc.ous.ac.jp		Hayashi, Ken-ichiro/0000-0002-9812-2801			Dickson RA, 2007, PHYTOCHEMISTRY, V68, P1436, DOI 10.1016/j.phytochem.2007.03.008; Jiang RW, 2001, J NAT PROD, V64, P1266, DOI 10.1021/np010174+; Zheng Y, 2013, J NAT PROD, V76, P2210, DOI 10.1021/np400545v; Kalauni SK, 2006, BIOL PHARM BULL, V29, P1050, DOI 10.1248/bpb.29.1050; Ochieng CO, 2012, FITOTERAPIA, V83, P74, DOI 10.1016/j.fitote.2011.09.015; Mitsui T, 2014, CHEM PHARM BULL, V62, P267, DOI 10.1248/cpb.c13-00812; Matsuno Y, 2008, BIOORG MED CHEM LETT, V18, P3774, DOI 10.1016/j.bmcl.2008.05.035; Cota BB, 2011, FITOTERAPIA, V82, P969, DOI 10.1016/j.fitote.2011.05.014; Maurya R, 2012, FITOTERAPIA, V83, P272, DOI 10.1016/j.fitote.2011.12.007; Ma GX, 2012, PLANTA MED, V78, P1363, DOI 10.1055/s-0032-1314976; Zanin JLB, 2012, MOLECULES, V17, P7887, DOI 10.3390/molecules17077887; Bork PM, 1997, FEBS LETT, V402, P85, DOI 10.1016/S0014-5793(96)01502-5; Kinoshita T, 2005, CHEM PHARM BULL, V53, P717, DOI 10.1248/cpb.53.717; Lyss G, 1998, J BIOL CHEM, V273, P33508, DOI 10.1074/jbc.273.50.33508; Wu L, 2014, CHEM PHARM BULL, V62, P729; Garcia-Pineres AJ, 2001, J BIOL CHEM, V276, P39713, DOI 10.1074/jbc.M101985200; Jiang RW, 2001, J CHEM SOC PERK T 1, P2920, DOI 10.1039/b107473n; Kuroda C, 2004, B CHEM SOC JPN, V77, P1737, DOI 10.1246/bcsj.77.1737; Ma GX, 2012, CHEM PHARM BULL, V60, P759, DOI 10.1248/cpb.60.759; Mitsui T, 2013, CHEM PHARM BULL, V61, P816	20	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0031-9422			PHYTOCHEMISTRY	Phytochemistry	AUG	2015	116						349	358		10.1016/j.phytochem.2015.03.012		10	Biochemistry & Molecular Biology; Plant Sciences	Biochemistry & Molecular Biology; Plant Sciences	CM1JW	WOS:000357438200039		
J	Santoro, E; Mazzeo, G; Petrovic, AG; Cimmino, A; Koshoubu, J; Evidente, A; Berova, N; Superchi, S				Santoro, Ernesto; Mazzeo, Giuseppe; Petrovic, Ana G.; Cimmino, Alessio; Koshoubu, Jun; Evidente, Antonio; Berova, Nina; Superchi, Stefano			Absolute configurations of phytotoxins seiricardine A and inuloxin A obtained by chiroptical studies	PHYTOCHEMISTRY			English	Article						Phytopathogenic fungi; Phytotoxins; Absolute configuration; Optical rotation; Electronic Circular Dichroism; Vibrational Circular Dichroism	VIBRATIONAL CIRCULAR-DICHROISM; EXCITON CHIRALITY METHOD; BIOLOGICAL-ACTIVITY; ANTICANCER ACTIVITY; FUNGAL PHYTOTOXINS; SOLVATION MODELS; PLANT-DISEASES; INULA-VISCOSA; A-D; SPECTRA	The absolute configuration (AC) of the plant phytotoxin inuloxin A, produced by Inula viscosa, and of the fungal phytotoxin seiricardine A, obtained from Seiridium fungi, pathogen for cypress, has been determined by experimental measurements and theoretical simulations of chiroptical properties of three related methods, namely, Optical Rotatory Dispersion (ORD), Electronic Circular Dichroism (ECD), and Vibrational Circular Dichroism (VCD). Computational prediction by Density Functional Theory (DFT) of VCD spectra and by Time-dependent DFT (TDDFT) of ORD and ECD spectra allowed to assign (7R,8R,10S) AC to naturally occurring (+)-inuloxin A. In the case of compound (-)-seiricardine A, which lacks useful for the analysis UV-Vis absorption, and thus provides a hardly detectable ECD spectrum and quite low ORD values, an introduction of a suitable chromophore by chemical derivatization was performed. The corresponding derivative, 2-O-p-bromobenzoate ester, gave rise to an intense ECD spectrum and higher ORD and VCD values. The comparison of computed spectra with the experimental ones allowed to assign (1S,2R,3aS,4S,5R,7aS) AC to (-)-2-O-p-bromobenzoate ester of seiricardine A and then to (-)-seiricardine A. This study further supports a recent trend of concerted application of more than a single chiroptical technique toward an unambiguous assignment of AC of flexible and complex natural products. Moreover, the use of chemical derivatization, with insertion of suitable chromophoric moieties has allowed to treat also UV-Vis transparent molecules by ECD and ORD spectroscopies. (C) 2015 Elsevier Ltd. All rights reserved.	[Santoro, Ernesto; Superchi, Stefano] Univ Basilicata, Dipartimento Sci, I-85100 Potenza, Italy; [Mazzeo, Giuseppe] Univ Brescia, Dipartimento Med Mol & Traslaz, I-25123 Brescia, Italy; [Petrovic, Ana G.] New York Inst Technol, Dept Life Sci, New York, NY 10023 USA; [Cimmino, Alessio; Evidente, Antonio] Univ Naples Federico II, Dipartimento Sci Chim, I-80126 Naples, Italy; [Koshoubu, Jun] JASCO Corp, Hachioji, Tokyo 1928537, Japan; [Berova, Nina] Columbia Univ, Dept Chem, New York, NY 10027 USA	Evidente, A (reprint author), Univ Naples Federico II, Dipartimento Sci Chim, Complesso Univ Monte S Angelo,Via Cintia 4, I-80126 Naples, Italy.	evidente@unina.it; ndb1@columbia.edu; stefano.superchi@unibas.it	Cimmino, Alessio/I-2121-2012; Superchi, Stefano/I-9270-2012; 	Cimmino, Alessio/0000-0002-1551-4237; Superchi, Stefano/0000-0002-7265-1625; Evidente, Antonio/0000-0001-9110-1656			Poopari MR, 2013, PHYS CHEM CHEM PHYS, V15, P1655, DOI 10.1039/c2cp42722b; Superchi S, 2006, J AM CHEM SOC, V128, P6893, DOI 10.1021/ja058552a; Bruhn T, 2013, CHIRALITY, V25, P243, DOI 10.1002/chir.22138; Wang GW, 2014, EXPERT OPIN INV DRUG, V23, P317, DOI 10.1517/13543784.2014.868882; Evidente A, 2011, CHIRALITY, V23, P674, DOI 10.1002/chir.20966; Polavarapu PL, 2014, CHIRALITY, V26, P539, DOI 10.1002/chir.22316; Graniti A, 1998, ANNU REV PHYTOPATHOL, V36, P91, DOI 10.1146/annurev.phyto.36.1.91; Asai T, 2013, ORG LETT, V15, P4320, DOI 10.1021/ol401741z; Komori K, 2014, ORG LETT, V16, P1386, DOI 10.1021/ol500148g; Stephens PJ, 2004, J AM CHEM SOC, V126, P7514, DOI 10.1021/ja049185q; Poopari MR, 2012, CHEMPHYSCHEM, V13, P2310, DOI 10.1002/cphc.201200152; Tomasi J, 2005, CHEM REV, V105, P2999, DOI 10.1021/cr9904009; Polavarapu PL, 2011, J PHYS CHEM A, V115, P5665, DOI 10.1021/jp202501y; Evidente A, 2013, CHIRALITY, V25, P59, DOI 10.1002/chir.22124; Gobi S, 2011, PHYS CHEM CHEM PHYS, V13, P16130, DOI 10.1039/c1cp21645g; Brenna E, 2003, TETRAHEDRON-ASYMMETR, V14, P1, DOI 10.1016/S0957-4166(02)00713-9; Tartaglia S, 2008, J ORG CHEM, V73, P4865, DOI 10.1021/jo800516f; Mazzeo G, 2013, J NAT PROD, V76, P588, DOI 10.1021/np300770s; Andolfi A, 2013, PHYTOCHEMISTRY, V86, P112, DOI 10.1016/j.phytochem.2012.10.003; Taniguchi T, 2012, J AM CHEM SOC, V134, P3695, DOI 10.1021/ja3001584; Evidente A, 2014, NAT PROD REP, V31, P617, DOI 10.1039/c3np70078j; Evidente A, 2010, AGR ISSUES POLICIES, P177; Polavarapu PL, 2008, CHIRALITY, V20, P664, DOI 10.1002/chir.20475; Superchi S, 2001, ANGEW CHEM INT EDIT, V40, P451, DOI 10.1002/1521-3773(20010119)40:2<451::AID-ANIE451>3.3.CO;2-U; Balde ES, 2010, J NAT PROD, V73, P969, DOI 10.1021/np900731p; Cimmino A, 2013, CHEM BIODIVERS, V10, P1239, DOI 10.1002/cbdv.201200358; Covington CL, 2013, J PHYS CHEM A, V117, P3377, DOI 10.1021/jp401079s; Autschbach J., 2009, CHIRALITY, V21, P116; Autschbach J., 2012, COMPREHENSIVE CHIROP, V1, P593; Avolio F, 2014, J ANTIBIOT, V67, P597, DOI 10.1038/ja.2014.47; Baillie T.A., 1997, IMPACT STEREOCHEMIST, P21; Bajsa J, 2007, BIOL PHARM BULL, V30, P1740, DOI 10.1248/bpb.30.1740; BALLIO A, 1991, PHYTOCHEMISTRY, V30, P131, DOI 10.1016/0031-9422(91)84113-7; Berova N., 2010, COMPREHENSIVE NATURA, V9, P91; Collins A.N., 1992, CHIRALITY IND, VII; Debie E., 2010, COMP VOA; Evidente A, 2001, BIOACTIVE COMPOUNDS FROM NATURAL SOURCES: ISOLATION CHARACTERISATION AND BIOLOGICAL PROPERTIES, P473; Frisch M. J., 2009, GAUSSIAN 09 REVISION; Holmstedt B., 1990, CHIRALITY BIOL ACTIV; Hongen T, 2014, MACROMOLECULES, V47, P5313, DOI 10.1021/ma501020s; Miyamoto J., 1998, CHIRALITY AGROCHEMIC; Moscowitz A., 1965, MODERN QUANTUM CHE 3, P31; Nicu VP, 2008, J PHYS CHEM A, V112, P6978, DOI [10.1021/jp710201q, 10.1021/jp71020lq]; Polavarapu P.L., 2012, COMPREHENSIVE CHIROP, V2, P387; Schrodinger LLC, MACR SOFTW; Superchi S, 2004, J ORG CHEM, V69, P1685, DOI 10.1021/jo035803u; Superchi S., 2012, COMPREHENSIVE CHIROP, V2, P421; Wang W, 2004, PHYTOPATHOLOGY, V94, P1042, DOI 10.1094/PHYTO.2004.94.10.1042; Zermane N., 2011, 11 WORLD C PAR PLANT, P82	49	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0031-9422			PHYTOCHEMISTRY	Phytochemistry	AUG	2015	116						359	366		10.1016/j.phytochem.2015.03.001		8	Biochemistry & Molecular Biology; Plant Sciences	Biochemistry & Molecular Biology; Plant Sciences	CM1JW	WOS:000357438200040		
J	Goto, S; Sasakura-Shimoda, F; Suetsugu, M; Selvaraj, MG; Hayashi, N; Yamazaki, M; Ishitani, M; Shimono, M; Sugano, S; Matsushita, A; Tanabata, T; Takatsuji, H				Goto, Shingo; Sasakura-Shimoda, Fuyuko; Suetsugu, Mai; Selvaraj, Michael Gomez; Hayashi, Nagao; Yamazaki, Muneo; Ishitani, Manabu; Shimono, Masaki; Sugano, Shoji; Matsushita, Akane; Tanabata, Takanari; Takatsuji, Hiroshi			Development of disease-resistant rice by optimized expression of WRKY45	PLANT BIOTECHNOLOGY JOURNAL			English	Article						Oryza sativa; transcription factor; trade-off; salicylic acid; Magnaporthe oryzae; Xanthomonas oryzae	SYSTEMIC ACQUIRED-RESISTANCE; ACID SIGNALING PATHWAY; ORYZA-SATIVA L.; SALICYLIC-ACID; GENE-EXPRESSION; ARABIDOPSIS-THALIANA; DROUGHT TOLERANCE; STRESS TOLERANCE; FUNCTIONAL-ANALYSIS; MAGNAPORTHE-GRISEA	The rice transcription factor WRKY45 plays a central role in the salicylic acid signalling pathway and mediates chemical-induced resistance to multiple pathogens, including Magnaporthe oryzae and Xanthomonas oryzae pv. oryzae. Previously, we reported that rice transformants overexpressing WRKY45 driven by the maize ubiquitin promoter were strongly resistant to both pathogens; however, their growth and yield were negatively affected because of the trade-off between the two conflicting traits. Also, some unknown environmental factor(s) exacerbated this problem. Here, we report the development of transgenic rice lines resistant to both pathogens and with agronomic traits almost comparable to those of wild-type rice. This was achieved by optimizing the promoter driving WRKY45 expression. We isolated 16 constitutive promoters from rice genomic DNA and tested their ability to drive WRKY45 expression. Comparisons among different transformant lines showed that, overall, the strength of WRKY45 expression was positively correlated with disease resistance and negatively correlated with agronomic traits. We conducted field trials to evaluate the growth of transgenic and control lines. The agronomic traits of two lines expressing WRKY45 driven by the OsUbi7 promoter (P-OsUbi7 lines) were nearly comparable to those of untransformed rice, and both lines were pathogen resistant. Interestingly, excessive WRKY45 expression rendered rice plants sensitive to low temperature and salinity, and stress sensitivity was correlated with the induction of defence genes by these stresses. These negative effects were barely observed in the P-OsUbi7 lines. Moreover, their patterns of defence gene expression were similar to those in plants primed by chemical defence inducers.	[Goto, Shingo; Sasakura-Shimoda, Fuyuko; Suetsugu, Mai; Hayashi, Nagao; Yamazaki, Muneo; Shimono, Masaki; Sugano, Shoji; Matsushita, Akane; Takatsuji, Hiroshi] Natl Inst Agrobiol Sci, Dis Resistant Crops Res Unit, Tsukuba, Ibaraki 3058602, Japan; [Suetsugu, Mai; Takatsuji, Hiroshi] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki, Japan; [Selvaraj, Michael Gomez; Ishitani, Manabu] Ctr Int Agr Trop, Cali, Colombia; [Tanabata, Takanari] Natl Inst Agrobiol Sci, Agrogen Res Ctr, Tsukuba, Ibaraki, Japan	Takatsuji, H (reprint author), Natl Inst Agrobiol Sci, Dis Resistant Crops Res Unit, 2-1-2 Kannondai, Tsukuba, Ibaraki 3058602, Japan.	takatsuh@affrc.go.jp			Japanese Ministry of Agriculture, Forestry and Fisheries [GMA0001, GMO1006]	This work was supported by grants from the Japanese Ministry of Agriculture, Forestry and Fisheries (Genomics for Agricultural Innovation, GMA0001 and Genomics-based Technology for Agricultural Improvement, GMO1006). We thank Dr. Nagamura and Ms. Motoyama for their technical support in the microarray analysis and to Dr. Hirokazu Ochiai for providing Xoo isolates. We thank Ms. Lucia Chavez and Mr. Cesar Zuluaga, CIAT, for their technical support in phenotyping. There is no conflict of interest.	Akagi A, 2014, PLANT MOL BIOL, V86, P171, DOI 10.1007/s11103-014-0221-x; Walters D, 2007, PHYSIOL MOL PLANT P, V71, P3, DOI 10.1016/j.pmpp.2007.09.008; Cao H, 1998, P NATL ACAD SCI USA, V95, P6531, DOI 10.1073/pnas.95.11.6531; Sato Y, 2011, NUCLEIC ACIDS RES, V39, pD1141, DOI 10.1093/nar/gkq1085; Delteil A, 2010, RICE, V3, P56, DOI 10.1007/s12284-009-9035-x; Heil M, 2002, TRENDS PLANT SCI, V7, P61, DOI 10.1016/S1360-1385(01)02186-0; Chern MS, 2001, PLANT J, V27, P101, DOI 10.1046/j.1365-313x.2001.01070.x; Inoue H, 2013, P NATL ACAD SCI USA, V110, P9577, DOI 10.1073/pnas.1222155110; Glazebrook J, 2005, ANNU REV PHYTOPATHOL, V43, P205, DOI 10.1146/annurev.phyto.43.040204.135923; Gnanamanickam SS, 1999, CURR SCI INDIA, V77, P1435; Chern M, 2005, MOL PLANT MICROBE IN, V18, P511, DOI 10.1094/MPMI-18.0511; Xiang Y, 2008, PLANT PHYSIOL, V148, P1938, DOI 10.1104/pp.108.128199; Loake G, 2007, CURR OPIN PLANT BIOL, V10, P466, DOI 10.1016/j.pbi.2007.08.008; Shimono M, 2007, PLANT CELL, V19, P2064, DOI 10.1105/tpc.106.046250; Cao H, 1997, CELL, V88, P57, DOI 10.1016/S0092-8674(00)81858-9; WILMINK A, 1995, PLANT MOL BIOL, V28, P949, DOI 10.1007/BF00042079; Sugano S, 2010, PLANT MOL BIOL, V74, P549, DOI 10.1007/s11103-010-9695-3; Spoel SH, 2009, CELL, V137, P860, DOI 10.1016/j.cell.2009.03.038; Kohler A, 2002, PLANT PHYSIOL, V128, P1046, DOI 10.1104/pp.010744; Conrath U, 2001, EUR J PLANT PATHOL, V107, P113, DOI 10.1023/A:1008768516313; Matsushita A, 2013, PLANT J, V73, P302, DOI 10.1111/tpj.12035; Durrant WE, 2004, ANNU REV PHYTOPATHOL, V42, P185, DOI 10.1146/annurev.phyto.42.040803.140421; Jiang CJ, 2010, MOL PLANT MICROBE IN, V23, P791, DOI 10.1094/MPMI-23-6-0791; Tao Z, 2011, J EXP BOT, V62, P4863, DOI 10.1093/jxb/err144; Zhang QF, 2007, P NATL ACAD SCI USA, V104, P16402, DOI 10.1073/pnas.0708013104; Iwai T, 2007, PLANT CELL PHYSIOL, V48, P915, DOI 10.1093/pcp/pcm062; Sticher L, 1997, ANNU REV PHYTOPATHOL, V35, P235, DOI 10.1146/annurev.phyto.35.1.235; Peng XX, 2012, PLANTA, V236, P1485, DOI 10.1007/s00425-012-1698-7; Lawton KA, 1996, PLANT J, V10, P71, DOI 10.1046/j.1365-313X.1996.10010071.x; BONMAN JM, 1992, ANNU REV PHYTOPATHOL, V30, P507, DOI 10.1146/annurev.py.30.090192.002451; Xiong LZ, 2003, PLANT CELL, V15, P745, DOI 10.1105/tpc.008714; Qiu DY, 2007, MOL PLANT MICROBE IN, V20, P492, DOI 10.1094/MPMI-20-5-0492; Walters DR, 2005, PHYSIOL MOL PLANT P, V66, P40, DOI 10.1016/j.pmpp.2005.04.002; Shimura K, 2007, J BIOL CHEM, V282, P34013, DOI 10.1074/jbc.M703344200; Friedrich L, 1996, PLANT J, V10, P61, DOI 10.1046/j.1365-313X.1996.10010061.x; Yuan YX, 2007, PLANT BIOTECHNOL J, V5, P313, DOI 10.1111/j.1467-7652.2007.00243.x; Heidel AJ, 2004, GENETICS, V168, P2197, DOI 10.1534/genetics.104.032193; Tao Z, 2009, PLANT PHYSIOL, V151, P936, DOI 10.1104/pp.109.145623; De Vleesschauwer D, 2010, PLANT PHYSIOL, V152, P2036, DOI 10.1104/pp.109.152702; Schultheiss H, 2003, PLANT J, V36, P589, DOI 10.1046/j.1365-313X.2003.01905.x; SILVERMAN P, 1995, PLANT PHYSIOL, V108, P633; Shen HS, 2012, PLANT MOL BIOL, V80, P241, DOI 10.1007/s11103-012-9941-y; Takatsuji H, 2010, JARQ-JPN AGR RES Q, V44, P217; Dubouzet JG, 2003, PLANT J, V33, P751, DOI 10.1046/j.1365-313X.2003.01661.x; Schubert D, 2004, PLANT CELL, V16, P2561, DOI 10.1105/tpc.104.024547; Xiao J, 2013, PLANT PHYSIOL, V163, P1868, DOI 10.1104/pp.113.226019; Conrath U, 2006, MOL PLANT MICROBE IN, V19, P1062, DOI 10.1094/MPMI-19-1062; Sato Y, 2013, NUCLEIC ACIDS RES, V41, pD1206, DOI 10.1093/nar/gks1125; Qiu DY, 2008, MOL PLANT, V1, P538, DOI 10.1093/mp/ssn012; Matyssek R, 2005, PLANT BIOLOGY, V7, P560, DOI 10.1055/s-2005-872981; Wang HH, 2007, PLANT MOL BIOL, V65, P799, DOI 10.1007/s11103-007-9244-x; Lu G, 2009, PLANTA, V229, P605, DOI 10.1007/s00425-008-0857-3; Gorlach J, 1996, PLANT CELL, V8, P629; Shimono M, 2012, MOL PLANT PATHOL, V13, P83, DOI 10.1111/j.1364-3703.2011.00732.x; Katz VA, 1998, PLANT PHYSIOL, V117, P1333, DOI 10.1104/pp.117.4.1333; Yokotani N, 2013, J EXP BOT, V64, P5085, DOI 10.1093/jxb/ert298; Hu HH, 2006, P NATL ACAD SCI USA, V103, P12987, DOI 10.1073/pnas.0604882103; Maleck K, 1999, TRENDS PLANT SCI, V4, P215, DOI 10.1016/S1360-1385(99)01415-6; De Vleesschauwer D, 2013, TRENDS PLANT SCI, V18, P555, DOI 10.1016/j.tplants.2013.07.002; Hayashi N., 2005, MAFF MICROORGANISM G, P1; Heidel AJ, 2006, GENETICS, V173, P1621, DOI 10.1534/genetics.106.059022; IWATA M, 1980, Annals of the Phytopathological Society of Japan, V46, P297; Jiang CJ, 2013, MOL PLANT MICROBE IN, V26, P287, DOI 10.1094/MPMI-06-12-0152-R; Nagaya S, 2005, PLANT CELL PHYSIOL, V46, P438, DOI 10.1093/pcp/pci039; Nakayama A, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-150; Ochiai H, 2000, PHYTOPATHOLOGY, V90, P415, DOI 10.1094/PHYTO.2000.90.4.415; OMIRULLEH S, 1993, PLANT MOL BIOL, V21, P415, DOI 10.1007/BF00028800; Ou S. H., 1987, RICE DIS; Perales L, 2008, J PLANT PHYSIOL, V165, P159, DOI 10.1016/j.jplph.2006.12.012; Qiu DY, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-74; Takatsuji H, 2014, PHYTOHORMONES WINDOW, P323, DOI DOI 10.1007/978-1-4939-0491-4; Ueno Y, 2013, PLANT SIGNAL BEHAV, V8, DOI DOI 10.4161/PSB.24510; Wang JL, 2000, PLANT SCI, V156, P201, DOI 10.1016/S0168-9452(00)00255-7; Wang MB, 2000, PLANT MOL BIOL, V43, P67, DOI 10.1023/A:1006490331303; Xu J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067413	75	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1467-7644	1467-7652		PLANT BIOTECHNOL J	Plant Biotechnol. J.	AUG	2015	13	6					753	765		10.1111/pbi.12303		13	Biotechnology & Applied Microbiology; Plant Sciences	Biotechnology & Applied Microbiology; Plant Sciences	CM3TI	WOS:000357606800003		
J	Tsuji, Y; Vanholme, R; Tobimatsu, Y; Ishikawa, Y; Foster, CE; Kamimura, N; Hishiyama, S; Hashimoto, S; Shino, A; Hara, H; Sato-Izawa, K; Oyarce, P; Goeminne, G; Morreel, K; Kikuchi, J; Takano, T; Fukuda, M; Katayama, Y; Boerjan, W; Ralph, J; Masai, E; Kajita, S				Tsuji, Yukiko; Vanholme, Ruben; Tobimatsu, Yuki; Ishikawa, Yasuyuki; Foster, Clifton E.; Kamimura, Naofumi; Hishiyama, Shojiro; Hashimoto, Saki; Shino, Amiu; Hara, Hirofumi; Sato-Izawa, Kanna; Oyarce, Paula; Goeminne, Geert; Morreel, Kris; Kikuchi, Jun; Takano, Toshiyuki; Fukuda, Masao; Katayama, Yoshihiro; Boerjan, Wout; Ralph, John; Masai, Eiji; Kajita, Shinya			Introduction of chemically labile substructures into Arabidopsis lignin through the use of LigD, the C-dehydrogenase from Sphingobium sp strain SYK-6	PLANT BIOTECHNOLOGY JOURNAL			English	Article						Arabidopsis thaliana; C-dehydrogenase; lignin biosynthesis; NMR; Sphingobium sp; SYK-6	BETA-ARYL ETHER; CINNAMYL ALCOHOL-DEHYDROGENASE; CELL-WALL; FERULATE 5-HYDROXYLASE; TRACHEARY ELEMENTS; DOWN-REGULATION; CARBONYL GROUPS; COA REDUCTASE; PINUS-RADIATA; POPLAR XYLEM	Bacteria-derived enzymes that can modify specific lignin substructures are potential targets to engineer plants for better biomass processability. The Gram-negative bacterium Sphingobium sp. SYK-6 possesses a C-dehydrogenase (LigD) enzyme that has been shown to oxidize the -hydroxy functionalities in -O-4-linked dimers into -keto analogues that are more chemically labile. Here, we show that recombinant LigD can oxidize an even wider range of -O-4-linked dimers and oligomers, including the genuine dilignols, guaiacylglycerol--coniferyl alcohol ether and syringylglycerol--sinapyl alcohol ether. We explored the possibility of using LigD for biosynthetically engineering lignin by expressing the codon-optimized ligD gene in Arabidopsis thaliana. The ligD cDNA, with or without a signal peptide for apoplast targeting, has been successfully expressed, and LigD activity could be detected in the extracts of the transgenic plants. UPLC-MS/MS-based metabolite profiling indicated that levels of oxidized guaiacyl (G) -O-4-coupled dilignols and analogues were significantly elevated in the LigD transgenic plants regardless of the signal peptide attachment to LigD. In parallel, 2D NMR analysis revealed a 2.1-to 2.8-fold increased level of G-type -keto--O-4 linkages in cellulolytic enzyme lignins isolated from the stem cell walls of the LigD transgenic plants, indicating that the transformation was capable of altering lignin structure in the desired manner.	[Tsuji, Yukiko; Ishikawa, Yasuyuki; Hashimoto, Saki; Sato-Izawa, Kanna; Kajita, Shinya] Tokyo Univ Agr & Technol, Grad Sch Bioapplicat & Syst Engn, Tokyo, Japan; [Vanholme, Ruben; Oyarce, Paula; Goeminne, Geert; Morreel, Kris; Boerjan, Wout] Univ Ghent, Dept Plant Biotechnol & Bioinformat, B-9000 Ghent, Belgium; [Vanholme, Ruben; Oyarce, Paula; Goeminne, Geert; Morreel, Kris; Boerjan, Wout] VIB, Dept Plant Syst Biol, Ghent, Belgium; [Tobimatsu, Yuki; Ralph, John] Univ Wisconsin, Dept Biochem, Madison, WI 53705 USA; [Tobimatsu, Yuki; Foster, Clifton E.; Ralph, John] US DOE, Wisconsin Energy Inst, Great Lakes Bioenergy Res Ctr, Madison, WI USA; [Foster, Clifton E.] Michigan State Univ, E Lansing, MI 48824 USA; [Kamimura, Naofumi; Fukuda, Masao; Masai, Eiji] Nagaoka Univ Technol, Dept Bioengn, Niigata, Japan; [Hishiyama, Shojiro] Forestry & Forest Prod Res Inst, Ibaraki, Japan; [Shino, Amiu; Kikuchi, Jun] RIKEN, Ctr Sustainable Resource Sci, Yokohama, Kanagawa, Japan; [Hara, Hirofumi] Univ Teknol Malaysia, Malaysia Japan Int Inst Technol, Kuala Lumpur, Malaysia; [Takano, Toshiyuki] Kyoto Univ, Grad Sch Agr, Kyoto, Japan; [Katayama, Yoshihiro] Nihon Univ, Coll Bioresource Sci, Fujisawa, Kanagawa, Japan	Kajita, S (reprint author), Tokyo Univ Agr & Technol, Grad Sch Bioapplicat & Syst Engn, Tokyo, Japan.	kajita@cc.tuat.ac.jp	Kajita, Shinya/F-9246-2013; Kikuchi, Jun/M-5512-2015	Kikuchi, Jun/0000-0002-6809-394X	Japan Science and Technology Agency (Advanced Low Carbon Technology Research and Development Program); New Energy and Industrial Technology Development Organization of Japan (Development of Preparatory Basic Bioenergy Technology); European Commission [270089]; Ghent University for the Synapt Q-Tof [AUGE/014]; Ghent University [01MRB510W]; US Department of Energy (DOE) Great Lakes Bioenergy Research Center (DOE Office of Science BER) [DE-FC02-07ER64494]; National Commission for Scientific and Technological Research (of Chile); Research Foundation-Flanders (FWO)	This work was supported in part by the Japan Science and Technology Agency (Advanced Low Carbon Technology Research and Development Program), the New Energy and Industrial Technology Development Organization of Japan (Development of Preparatory Basic Bioenergy Technology), the European Commission's Directorate-General for Research within the 7th Framework Program (FP7/2007-2013) under the grant agreement NO 270089 (MULTIBIOPRO), the Hercules program of Ghent University for the Synapt Q-Tof (grant no. AUGE/014), the 'Bijzondere Onderzoeksfonds-Zware Apparatuur' of Ghent University for the FT-ICR-MS instrument (174PZA05) and the Multidisciplinary Research Partnership 'Biotechnology for a Sustainable Economy' (01MRB510W) of Ghent University. YT, CEF and JR acknowledge funding from the US Department of Energy (DOE) Great Lakes Bioenergy Research Center (DOE Office of Science BER DE-FC02-07ER64494). PO is indebted to the National Commission for Scientific and Technological Research (of Chile) for a predoctoral fellowship, and RV is indebted to the Research Foundation-Flanders (FWO) for a postdoctoral fellowship. The authors also thank Takahito Mizukami for his assistance with preparation of LigD substrates.	Li X, 2008, PLANT J, V54, P569, DOI 10.1111/j.1365-313X.2008.03457.x; Zhao Q, 2011, TRENDS PLANT SCI, V16, P227, DOI 10.1016/j.tplants.2010.12.005; Eudes A, 2012, PLANT BIOTECHNOL J, V10, P609, DOI 10.1111/j.1467-7652.2012.00692.x; Chen F, 2007, NAT BIOTECHNOL, V25, P759, DOI 10.1038/nbt1316; Wagner A, 2011, PLANT J, V67, P119, DOI 10.1111/j.1365-313X.2011.04580.x; Zhou R, 2010, P NATL ACAD SCI USA, V107, P17803, DOI 10.1073/pnas.1012900107; Bonawitz ND, 2014, NATURE, V509, P376, DOI 10.1038/nature13084; Morreel K, 2004, PLANT PHYSIOL, V136, P3537, DOI 10.1104/pp.104.049304; Pilate G, 2002, NAT BIOTECHNOL, V20, P607, DOI 10.1038/nbt0602-607; Demura T, 2010, CURR OPIN PLANT BIOL, V13, P299, DOI 10.1016/j.pbi.2010.03.002; Vanholme R, 2010, PLANT PHYSIOL, V153, P895, DOI 10.1104/pp.110.155119; Lu FC, 1998, J AGR FOOD CHEM, V46, P547, DOI 10.1021/jf970676m; Lu FC, 2008, ORG BIOMOL CHEM, V6, P3681, DOI 10.1039/b809464k; Masai E, 2007, BIOSCI BIOTECH BIOCH, V71, P1, DOI 10.1271/bbb.60437; Ralph J, 2010, PHYTOCHEM REV, V9, P65, DOI 10.1007/s11101-009-9141-9; Voelker SL, 2011, PLANT CELL ENVIRON, V34, P655, DOI 10.1111/j.1365-3040.2010.02270.x; Stewart JJ, 2009, PLANT PHYSIOL, V150, P621, DOI 10.1104/pp.109.137059; Lu FC, 2003, PLANT J, V35, P535, DOI 10.1046/j.1365-313X.2003.01817.x; Hatfield RD, 1999, J AGR FOOD CHEM, V47, P628, DOI 10.1021/jf9808776; Rahimi A, 2014, NATURE, V515, P249, DOI 10.1038/nature13867; Zhang KW, 2012, PLANT CELL, V24, P3135, DOI 10.1105/tpc.112.101287; Gall DL, 2014, J BIOL CHEM, V289, P8656, DOI 10.1074/jbc.M113.536250; Weng JK, 2010, PLANT J, V64, P898, DOI 10.1111/j.1365-313X.2010.04391.x; Pesquet E, 2013, PLANT CELL, V25, P1314, DOI 10.1105/tpc.113.110593; Ammalahti E, 1998, J AGR FOOD CHEM, V46, P5113, DOI 10.1021/jf980249o; Chen F, 2012, P NATL ACAD SCI USA, V109, P1772, DOI 10.1073/pnas.1120992109; Sonoki T, 2002, J WOOD SCI, V48, P429, DOI 10.1007/BF00770705; Leple JC, 2007, PLANT CELL, V19, P3669, DOI 10.1105/tpc.107.054148; Sato Y, 2009, APPL ENVIRON MICROB, V75, P5195, DOI 10.1128/AEM.00880-09; Boerjan W, 2003, ANNU REV PLANT BIOL, V54, P519, DOI 10.1146/annurev.arplant.54.031902.134938; Greiner S, 1998, PLANT PHYSIOL, V116, P733, DOI 10.1104/pp.116.2.733; Wilkerson CG, 2014, SCIENCE, V344, P90, DOI 10.1126/science.1250161; Vanholme R, 2012, PLANT CELL, V24, P3506, DOI 10.1105/tpc.112.102574; Van Acker R, 2014, P NATL ACAD SCI USA, V111, P845, DOI 10.1073/pnas.1321673111; Morreel K, 2014, PLANT CELL, V26, P929, DOI 10.1105/tpc.113.122242; Shiraishi T, 2013, ELECTROCHIM ACTA, V106, P440, DOI 10.1016/j.electacta.2013.05.112; GIERER J, 1979, SVEN PAPPERSTIDN, V82, P71; Tobimatsu Y, 2013, PLANT CELL, V25, P2587, DOI 10.1105/tpc.113.113142; Rahimi A, 2013, J AM CHEM SOC, V135, P6415, DOI 10.1021/ja401793n; BENJAMINI Y, 1995, J ROY STAT SOC B MET, V57, P289; Fu CX, 2011, P NATL ACAD SCI USA, V108, P3803, DOI 10.1073/pnas.1100310108; Mansfield SD, 2012, NAT PROTOC, V7, P1579, DOI 10.1038/nprot.2012.064; Vanholme R, 2010, PLANT J, V64, P885, DOI 10.1111/j.1365-313X.2010.04353.x; Bonawitz ND, 2010, ANNU REV GENET, V44, P337, DOI 10.1146/annurev-genet-102209-163508; Morreel K, 2010, ANAL CHEM, V82, P8095, DOI 10.1021/ac100968g; Matsuda F, 2010, PLANT PHYSIOL, V152, P566, DOI 10.1104/pp.109.148031; Vanholme R, 2013, SCIENCE, V341, P1103, DOI 10.1126/science.1241602; MASAI E, 1993, BIOSCI BIOTECH BIOCH, V57, P1655; Marita JM, 1999, P NATL ACAD SCI USA, V96, P12328, DOI 10.1073/pnas.96.22.12328; Katahira R, 2006, J WOOD SCI, V52, P255, DOI 10.1007/s10086-005-0756-1; Reiter J, 2013, GREEN CHEM, V15, P1373, DOI 10.1039/c3gc40295a; Kamimura N, 2010, APPL ENVIRON MICROB, V76, P8093, DOI 10.1128/AEM.01863-10; Smith RA, 2013, PLANT CELL, V25, P3988, DOI 10.1105/tpc.113.117176; Baucher M, 2003, CRIT REV BIOCHEM MOL, V38, P305, DOI 10.1080/10409230390242443; Imai A, 2007, J AGR FOOD CHEM, V55, P9043, DOI 10.1021/jf071147d; Criss DL, 1998, HOLZFORSCHUNG, V52, P57, DOI 10.1515/hfsg.1998.52.1.57; DelsRio J. C., 2007, J AGR FOOD CHEM, V55, P5461; GIERER J, 1980, SVEN PAPPERSTIDN, V83, P75; GIERER J, 1982, HOLZFORSCHUNG, V36, P123, DOI 10.1515/hfsg.1982.36.3.123; Grabber JH, 2008, BIOMACROMOLECULES, V9, P2510, DOI 10.1021/bm800528f; Kajita S, 2002, J SCI FOOD AGR, V82, P1216, DOI 10.1002/jsfa.1168; Lanot A, 2006, PLANT J, V48, P286, DOI 10.1111/j.1365-313X.2006.02872.x; Lapierre C, 2000, J AGR FOOD CHEM, V48, P2326, DOI 10.1021/jf991398p; Li X, 2010, BIOTECHNOL BIOFUELS, V3, DOI 10.1186/1754-6834-3-27; Niculaes C, 2014, PLANT CELL, V26, P3775, DOI 10.1105/tpc.114.125260; O'Connell A, 2002, TRANSGENIC RES, V11, P495, DOI 10.1023/A:1020362705497; Otter T, 1997, PLANT CELL PHYSIOL, V38, P595; Ralph John, 2004, Phytochemistry Reviews, V3, P29, DOI 10.1023/B:PHYT.0000047809.65444.a4; Ralph John, 2004, Phytochemistry Reviews, V3, P79, DOI 10.1023/B:PHYT.0000047811.13837.fb; SHINKLE JR, 1992, PLANT PHYSIOL, V98, P1336, DOI 10.1104/pp.98.4.1336; SMITH DCC, 1955, J CHEM SOC, P2347, DOI 10.1039/jr9550002347; Tanahashi M., 1976, WOOD RES, V61, P44; Tobimatsu Y, 2012, CHEMSUSCHEM, V5, P676, DOI 10.1002/cssc.201100573; Wagner A, 2013, PLANT MOL BIOL, V81, P105, DOI 10.1007/s11103-012-9985-z; Wang Y., 2013, FRONT PLANT SCI, V9, P220; Yang F, 2013, PLANT BIOTECHNOL J, V11, P325, DOI 10.1111/pbi.12016	76	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1467-7644	1467-7652		PLANT BIOTECHNOL J	Plant Biotechnol. J.	AUG	2015	13	6					821	832		10.1111/pbi.12316		12	Biotechnology & Applied Microbiology; Plant Sciences	Biotechnology & Applied Microbiology; Plant Sciences	CM3TI	WOS:000357606800009		
J	Yamada, Y; Koibuchi, M; Miyamoto, K; Ueda, J; Uheda, E				Yamada, Yoshiya; Koibuchi, Mizuki; Miyamoto, Kensuke; Ueda, Junichi; Uheda, Eiji			Breakdown of middle lamella pectin by (OH)-O-. during rapid abscission in Azolla	PLANT CELL AND ENVIRONMENT			English	Article						Impatiens; abscission zone cells; cell separation	CELL-SEPARATION PROCESSES; HYDROXYL RADICALS; ELONGATION GROWTH; IN-VITRO; HYDROGEN-PEROXIDE; ORGAN ABSCISSION; EXTENSION GROWTH; LEAF ABSCISSION; ROOTS; PLANTS	Azolla, a small water fern, abscises its roots and branches within 30min upon treatment with various stresses. This study was conducted to test whether, in the rapid abscission that occurs in Azolla, breakdown of wall components of abscission zone cells by (OH)-O-. is involved. Experimentally generated (OH)-O-. caused the rapid separation of abscission zone cells from detached roots and the rapid shedding of roots from whole plants. Electron microscopic observations revealed that (OH)-O-. rapidly and selectively dissolved a well-developed middle lamella between abscission zone cells and resultantly caused rapid cell separation and shedding. Treatment of abscission zones of Impatiens leaf petiole with (OH)-O-. also accelerated the separation of abscission zone cells. However, compared with that of Azolla roots, accelerative effects in Impatiens were weak. A large amount of (OH)-O-. was cytochemically detected in abscission zone cells both of Azolla roots and of Impatiens leaf petioles. These results suggest that (OH)-O-. is involved in the cell separation process not only in the rapid abscission in Azolla but also in the abscission of Impatiens. However, for rapid abscission to occur, a well-developed middle lamella, a unique structure, which is sensitive to the attack of (OH)-O-., might be needed. Azolla, a small water fern, abscises its roots and branches within 30 min upon treatment with various stresses. This study was conducted to test whether, in the rapid abscission that occurs in Azolla, the breakdown of wall components of abscission zone cells by (OH)-O-. is involved. Furthermore, the effects of (OH)-O-. on the cell separation of abscission zone cells of Impatiens leaf petioles were also examined and compared with those of Azolla. The results suggest that (OH)-O-. is involved in the cell separation process not only in the rapid abscission in Azolla but also in the abscission of Impatiens.	[Yamada, Yoshiya; Koibuchi, Mizuki; Ueda, Junichi; Uheda, Eiji] Osaka Prefecture Univ, Grad Sch Sci, Dept Biol Sci, Sakai, Osaka 5998570, Japan; [Miyamoto, Kensuke] Osaka Prefecture Univ, Fac Liberal Arts & Sci, Sakai, Osaka 5998531, Japan	Uheda, E (reprint author), Osaka Prefecture Univ, Grad Sch Sci, Dept Biol Sci, Sakai, Osaka 5998570, Japan.	uheda@b.s.osakafu-u.ac.jp					Addicott FT., 1982, ABSCISSION; Liszkay A, 2003, PLANTA, V217, P658, DOI 10.1007/s00425-003-1028-1; Fry SC, 1998, BIOCHEM J, V332, P507; Chen SX, 1999, EUR J BIOCHEM, V260, P726, DOI 10.1046/j.1432-1327.1999.00199.x; Bleecker AB, 1997, PLANT CELL, V9, P1169, DOI 10.1105/tpc.9.7.1169; Bar-Dror T, 2011, PLANT CELL, V23, P4146, DOI 10.1105/tpc.111.092494; Muller K, 2009, PLANT PHYSIOL, V150, P1855, DOI 10.1104/pp.109.139204; Cummins I, 2004, PLANT J, V39, P894, DOI 10.1111/j.1365-313X.2004.02174.x; SEXTON R, 1982, ANNU REV PLANT PHYS, V33, P133, DOI 10.1146/annurev.pp.33.060182.001025; Patterson SE, 2001, PLANT PHYSIOL, V126, P494, DOI 10.1104/pp.126.2.494; Schopfer P, 2001, PLANT J, V28, P679, DOI 10.1046/j.1365-313x.2001.01187.x; Liszkay A, 2004, PLANT PHYSIOL, V136, P3114, DOI 10.1104/pp.104.044784; Taylor JE, 2001, NEW PHYTOL, V151, P323, DOI 10.1046/j.0028-646x.2001.00194.x; Schopfer P, 2001, PLANT PHYSIOL, V125, P1591, DOI 10.1104/pp.125.4.1591; Setsukinai K, 2003, J BIOL CHEM, V278, P3170, DOI 10.1074/jbc.M209264200; Roberts JA, 2002, ANNU REV PLANT BIOL, V53, P131, DOI 10.1146/annurev.arplant.53.092701.180236; Roberts JA, 2000, ANN BOT-LONDON, V86, P223, DOI 10.1006/anbo.2000.1203; Binder B. M., 2009, Stewart Postharvest Review, V5, P1, DOI 10.2212/spr.2009.1.1; Bowling AJ, 2011, AM J BOT, V98, P619, DOI 10.3732/ajb.1000268; Cohen MF, 2014, PLANT SCI, V217, P120, DOI 10.1016/j.plantsci.2013.12.008; Dumville JC, 2003, PLANTA, V217, P951, DOI 10.1007/s00425-003-1061-0; Fry SC, 2001, BIOCHEM J, V357, P729, DOI 10.1042/0264-6021:3570729; Fukuda K, 2013, J PLANT PHYSIOL, V170, P18, DOI 10.1016/j.jplph.2012.08.008; Gurung S., 2012, J AMINO ACIDS, V2012, P1; Gutteridge J. M. C., 1999, FREE RADICALS BIOL M; Haslam R, 2001, PESTIC BIOCHEM PHYS, V71, P178, DOI 10.1006/pest.2001.2575; Leslie Michelle E., 2007, V25, P106; Maejima K, 2002, ENVIRON EXP BOT, V47, P143, DOI 10.1016/S0098-8472(01)00120-4; Nakano T, 2013, PLANT BIOTECHNOL-NAR, V30, P209, DOI 10.5511/plantbiotechnology.13.0318a; Sakamoto M, 2008, PLANT J, V56, P13, DOI 10.1111/j.1365-313X.2008.03577.x; Schopfer P, 2002, PLANTA, V214, P821, DOI 10.1007/s00425-001-0699-8; Uheda E, 2000, PLANT CELL PHYSIOL, V41, P1365, DOI 10.1093/pcp/pcd071; UHEDA E, 1994, PLANT CELL PHYSIOL, V35, P37; UHEDA E, 1995, INT J PLANT SCI, V156, P756, DOI 10.1086/297299; Uheda E, 1999, AQUAT BOT, V64, P87, DOI 10.1016/S0304-3770(99)00002-9; UHEDA E, 1994, J EXP BOT, V45, P1451, DOI 10.1093/jxb/45.10.1451	36	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0140-7791	1365-3040		PLANT CELL ENVIRON	Plant Cell Environ.	AUG	2015	38	8					1555	1564		10.1111/pce.12505		10	Plant Sciences	Plant Sciences	CM3UB	WOS:000357609100011		
J	Fuji, S; Zen, S; Sato, I; Kishi, H; Furuya, H; Okuda, M				Fuji, S.; Zen, S.; Sato, I.; Kishi, H.; Furuya, H.; Okuda, M.			Population dynamics of iris yellow spot virus in onion fields and lisianthus greenhouses in Japan	PLANT PATHOLOGY			English	Article						Eustoma; genotype; iris yellow spot virus; nucleocapsid protein; onion; population structure	TABACI THYSANOPTERA THRIPIDAE; DISEASE; WILT; PATTERNS; GEORGIA; TOMATO; PEPPER; CROPS	Iris yellow spot virus (IYSV, genus Tospovirus) mainly occurs on onion and lisianthus plants (Eustoma grandiflorum) in Japan. The virus is genetically diverse and is classified based on its nucleocapsid protein sequence into two genotypes, IYSVNL (NL) and IYSVBR (BR), first isolated in the Netherlands and Brazil, respectively. Both genotypes are present in Japan, and they are sometimes found in the same field. Furthermore, the two genotypes are occasionally detected in a single necrotic lesion of an infected plant (designated as a mosaic' genotype). In this study, the population structures of these two genotypes and their dynamics in onion fields and lisianthus greenhouses from 2004 to 2006 were analysed using reverse transcription-PCR-restriction length polymorphism analysis (RT-PCR-RFLP). In onion fields the two genotypes were detected in all three years, and the BR genotype predominated within a year. On the other hand, both genotypes were detected at the first outbreak each year in almost all lisianthus greenhouses; however, the BR genotype was more widespread than the NL genotype. These results suggest that the incidence of IYSV disease in lisianthus during each year was triggered by the invasion of viruliferous Thrips tabaci that have acquired one or both genotypes from nearby onion fields. Although the BR genotype predominated in the last stages of cultivation, IYSV disease might be expanded by monocyclic patterns but may occasionally spread secondarily in lisianthus greenhouses.	[Fuji, S.; Sato, I.; Kishi, H.; Furuya, H.] Akita Prefectural Univ, Fac Bioresource Sci, Akita, Japan; [Zen, S.] Saga Prefectural Agr Support Ctr, Saga, Japan; [Okuda, M.] Natl Agr & Food Res Org, Agr Res Ctr, Ibaraki, Japan	Fuji, S (reprint author), Akita Prefectural Univ, Fac Bioresource Sci, Akita, Japan.	sfuji@akita-pu.ac.jp					Pozzer L, 1999, PLANT DIS, V83, P345, DOI 10.1094/PDIS.1999.83.4.345; Srinivasan R, 2012, J ECON ENTOMOL, V105, P40, DOI 10.1603/EC11094; Hsu CL, 2010, ENVIRON ENTOMOL, V39, P266, DOI 10.1603/EN09165; Smith TN, 2006, AUSTRALAS PLANT PATH, V35, P359, DOI 10.1071/AP06031; Gent DH, 2006, PLANT DIS, V90, P1468, DOI 10.1094/PD-90-1468; Jones RAC, 2004, VIRUS RES, V100, P5, DOI 10.1016/j.viruses.2003.12.011; Arli-Sokmen M, 2013, PHYTOPARASITICA, V41, P159, DOI 10.1007/s12600-012-0275-8; CAMANN MA, 1995, PHYTOPATHOLOGY, V85, P879, DOI 10.1094/Phyto-85-879; Cortes I, 1998, PHYTOPATHOLOGY, V88, P1276, DOI 10.1094/PHYTO.1998.88.12.1276; Coutts BA, 2004, ANN APPL BIOL, V145, P231, DOI 10.1111/j.1744-7348.2004.tb00379.x; Doi M., 2003, Japanese Journal of Phytopathology, V69, P181; Gitaitis RD, 1998, PLANT DIS, V82, P752, DOI 10.1094/PDIS.1998.82.7.752; Krauthausen HJ, 2012, EUR J PLANT PATHOL, V134, P345, DOI 10.1007/s10658-012-9993-5; Kritzman A, 2000, PLANT DIS, V84, P1185, DOI 10.1094/PDIS.2000.84.11.1185; Nischwitz C, 2012, PLANT DIS, V96, P1165, DOI 10.1094/PDIS-09-11-0747-RE; Okuda M., 2005, Japanese Journal of Phytopathology, V71, P119; Zen S., 2005, Japanese Journal of Phytopathology, V71, P123; Zen S, 2012, THESIS AKITA PREFECT; Zen S, 2008, J PLANT PATHOL, V90, P511	19	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0032-0862	1365-3059		PLANT PATHOL	Plant Pathol.	AUG	2015	64	4					808	816		10.1111/ppa.12334		9	Agronomy; Plant Sciences	Agriculture; Plant Sciences	CM1XN	WOS:000357474000008		
J	Momonoi, K; Mori, M; Matsuura, K; Moriwaki, J; Morikawa, T				Momonoi, K.; Mori, M.; Matsuura, K.; Moriwaki, J.; Morikawa, T.			Quantification of Mirafiori lettuce big-vein virus and its vector, Olpidium virulentus, from soil using real-time PCR	PLANT PATHOLOGY			English	Article						Mirafiori lettuce big-vein virus; Olpidium virulentus; real-time PCR	SPONGOSPORA-SUBTERRANEA; ASSAY; TRANSMISSION; BRASSICAE; DIAGNOSIS; DISEASE; TUBERS	Big vein disease of lettuce (Lactuca sativa) is an economically important disease transmitted through soil by Olpidium virulentus, and has occurred in most production areas worldwide. The disease is assumed to be caused by Mirafiori lettuce big-vein virus (MiLBVV). To understand the dynamics of the virus and its vector, MiLBVV and O.virulentus were directly detected in soil. DNA and RNA were extracted from 5g soil using a bead beating method, followed by purification using adsorption to a column. Detection and quantification were performed using real-time PCR and a TaqMan probe that was prepared based on the CP region of MiLBVV and the rDNA-ITS region of O.virulentus, respectively. Furthermore, using a visual assessment of the incidence rate of big vein disease on lettuce in agricultural fields, the C-t values of MiLBVV and O.virulentus from soil were also determined using real-time PCR. The results showed that MiLBVV concentrations in the soil were high in the field, as also determined by a visual assessment of the incidence rate of big vein disease on lettuce. However, the amount of O.virulentus in soil was not directly correlated with the incidence of MiLBVV. From these results, it is suggested that the risk of lettuce crops developing big vein disease can be estimated using an index of the amount of MiLBVV in the soil.	[Momonoi, K.; Moriwaki, J.] Forestry & Fisheries Res Ctr, Inst Hort Res, Toyama Prefectural Agr, Tonami, Toyama 9391327, Japan; [Mori, M.] Kagawa Prefecture Agr Expt Stn, Ayauta, Kagawa 7612306, Japan; [Matsuura, K.] Hyogo Prefectural Technol Ctr Agr Forestry & Fish, Kasai, Hyogo 6790198, Japan; [Morikawa, T.] Toyama Prefectural Agr, Forestry & Fisheries Res Ctr, Agr Res Inst, Toyama, Toyama 9398153, Japan	Momonoi, K (reprint author), Forestry & Fisheries Res Ctr, Inst Hort Res, Toyama Prefectural Agr, Tonami, Toyama 9391327, Japan.	kazumi.momonoi@pref.toyama.lg.jp			Science and Technology Research Promotion Programme for the Ministry of Agriculture, Forestry and Fisheries (Japan)	The authors thank Drs S. Tsuda and K. Nomiyama of the National Agricultural Research Center for providing the O. bornovanus isolates and O. brassicae isolate, respectively. This work was supported by the Science and Technology Research Promotion Programme for the Ministry of Agriculture, Forestry and Fisheries (Japan).	Bell KS, 1999, EUR J PLANT PATHOL, V105, P905, DOI 10.1023/A:1008782309333; TOMLINSON JA, 1986, ANN APPL BIOL, V108, P71, DOI 10.1111/j.1744-7348.1986.tb01967.x; Lot H, 2002, PHYTOPATHOLOGY, V92, P288, DOI 10.1094/PHYTO.2002.92.3.288; Wang Y, 2012, MICROBES ENVIRON, V27, P111, DOI 10.1264/jsme2.ME11304; Ashizawa T, 2010, EUR J PLANT PATHOL, V128, P221, DOI 10.1007/s10658-010-9647-4; Singh M, 2013, AM J POTATO RES, V90, P43, DOI 10.1007/s12230-012-9274-z; Brierley JL, 2009, APPL SOIL ECOL, V41, P234, DOI 10.1016/j.apsoil.2008.11.004; Campbell RN, 1996, ANNU REV PHYTOPATHOL, V34, P87, DOI 10.1146/annurev.phyto.34.1.87; Herrera-Vasquez JA, 2009, MYCOL RES, V113, P602, DOI 10.1016/j.mycres.2009.01.007; IWAKI M, 1978, Annals of the Phytopathological Society of Japan, V44, P578; Iwamoto Y, 2010, PLANT PROT, V64, P229; Kawabe M, 2014, P KANSAI PLANT PROTE, V56, P7; Maccarone LD, 2010, PLANT DIS, V94, P563, DOI 10.1094/PDIS-94-5-0563; Morikawa T., 2004, Soil Microorganisms, V58, P43; Mumford RA, 2000, PHYTOPATHOLOGY, V90, P448, DOI 10.1094/PHYTO.2000.90.5.448; Navarro JA, 2004, PHYTOPATHOLOGY, V94, P470, DOI 10.1094/PHYTO.2004.94.5.470; Navarro JA, 2005, ARCH VIROL, V150, P681, DOI 10.1007/s00705-004-0456-y; Sasaya T, 2008, PHYTOPATHOLOGY, V98, P464, DOI 10.1094/PHYTO-98-4-0464; Sasaya Takahide, 2006, Journal of General Plant Pathology, V72, P20, DOI 10.1007/s10327-005-0239-7; van de Graaf P, 2003, EUR J PLANT PATHOL, V109, P589, DOI 10.1023/A:1024764432164; Wang Y, 2008, BIOSCI BIOTECH BIOCH, V72, P694, DOI 10.1271/bbb.70493; Ward LI, 2004, PLANT PATHOL, V53, P485, DOI 10.1111/j.1365-3059.2004.01017	22	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0032-0862	1365-3059		PLANT PATHOL	Plant Pathol.	AUG	2015	64	4					825	830		10.1111/ppa.12333		6	Agronomy; Plant Sciences	Agriculture; Plant Sciences	CM1XN	WOS:000357474000010		
J	Goto, N; Jetten, J; Karasawa, M; Hornsey, MJ				Goto, Nobuhiko; Jetten, Jolanda; Karasawa, Minoru; Hornsey, Matthew J.			The Sins of Their Fathers: When Current Generations Are Held to Account for the Transgressions of Previous Generations	POLITICAL PSYCHOLOGY			English	Article						intergenerational guilt; cultural continuity; intergroup; guilt expressions	IDENTIFICATION; RESPONSIBILITY; FORGIVENESS; EXPRESSIONS; GUILT	When are current generations held accountable for transgressions committed by previous generations? In two studies, we test the prediction that current generations will only be assigned guilt for past atrocities when victim group members perceive high levels of cultural continuity between historical perpetrators and the current generation within the perpetrator group. Japanese participants were presented with information describing the current generation of Americans as either similar or dissimilar in personality to the Americans who were implicated in dropping the atomic bomb on Japan during World War II. The results of both studies revealed that victim group members assigned more guilt to current Americans when they perceived high (compared to low) outgroup continuity, and they did so relatively independently of the transgressor group's guilt expressions.	[Goto, Nobuhiko; Karasawa, Minoru] Nagoya Univ, Nagoya, Aichi 4648601, Japan; [Jetten, Jolanda; Hornsey, Matthew J.] Univ Queensland, Brisbane, Qld 4072, Australia	Goto, N (reprint author), Nagoya Univ, Dept Psychol, Grad Sch Environm Studies, Chikusa Ku, B4-1 780 Furo Cho, Nagoya, Aichi 4648601, Japan.	nobutgal@hotmail.com	Jetten, Jolanda/H-3285-2014	Jetten, Jolanda/0000-0002-7588-5355	Japan Society for the Promotion of Science	The present research was supported by a Bilateral Joint Projects/Seminars Program from the Japan Society for the Promotion of Science granted to the third author. Correspondence concerning this article should be sent to Nobuhiko Goto, Department of Psychology, Graduate School of Environmental Studies, Nagoya University, B4-1 (780) Furo-cho, Chikusa-ku, Nagoya, 464-8601 Japan. E-mail: nobutgal@hotmail.com	Wohl MJA, 2011, SOC ISS POLICY REV, V5, P70, DOI 10.1111/j.1751-2409.2011.01026.x; Wohl MJA, 2005, J PERS SOC PSYCHOL, V88, P288, DOI 10.1037/0022-3514.88.2.288; Sani F, 2007, EUR J SOC PSYCHOL, V37, P1118, DOI 10.1002/ejsp.430; Halperin E, 2011, SCIENCE, V333, P1767, DOI 10.1126/science.1202925; Nadler A, 2006, PERS SOC PSYCHOL B, V32, P459, DOI 10.1177/0146167205276431; Wohl MJA, 2012, J PERS SOC PSYCHOL, V102, P306, DOI 10.1037/a0024838; Giner-Sorolla R, 2008, J EXP SOC PSYCHOL, V44, P519, DOI 10.1016/j.jesp.2007.08.003; Zebel S, 2007, GROUP PROCESS INTERG, V10, P71, DOI 10.1177/1368430207071342; Tropp LR, 2001, PERS SOC PSYCHOL B, V27, P585, DOI 10.1177/0146167201275007; Branscombe Nyla R., 2004, COLLECTIVE GUILT INT, P16; Exline JJ, 2000, FORGIVENESS, P133; Hornsey MJ, 2013, EUR REV SOC PSYCHOL, V24, P1, DOI 10.1080/10463283.2013.822206; Licata L, 2012, GROUP PROCESS INTERG, V15, P179, DOI 10.1177/1368430211414445	13	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0162-895X	1467-9221		POLIT PSYCHOL	Polit. Psychol.	AUG	2015	36	4					479	487		10.1111/pops.12172		9	Political Science; Psychology, Social	Government & Law; Psychology	CM2NW	WOS:000357518900008		
J	Saisho, Y; Tanaka, C; Tanaka, K; Roberts, R; Abe, T; Tanaka, M; Meguro, S; Irie, J; Kawai, T; Itoh, H				Saisho, Yoshifumi; Tanaka, Chihiro; Tanaka, Kumiko; Roberts, Rachel; Abe, Takayuki; Tanaka, Masami; Meguro, Shu; Irie, Junichiro; Kawai, Toshihide; Itoh, Hiroshi			Relationships among different glycemic variability indices obtained by continuous glucose monitoring	PRIMARY CARE DIABETES			English	Article						Glycemic variability; Diabetes mellitus; Continuous glucose monitoring; Standard deviation	CARDIOVASCULAR-DISEASE; BLOOD-GLUCOSE; HYPOGLYCEMIA; RISK; TOLERANCE; VETERANS; OUTCOMES	The aim of this study was to assess the relationships among indices of glycemic variability obtained by continuous glucose monitoring (CGM). CGM was performed in 88 patients with diabetes (20 type 1 and 68 type 2 diabetes, age 59 +/- 15 years) admitted to our hospital (Keio University Hospital, Tokyo, Japan) between 2010 and 2012. Mean glucose, glucose standard deviation (SDglu) and other glycemic indices such as index of glycemic control (ICG), J-index, mean of daily differences (MODD), continuous overlapping net glycemic action 1 (CONGA1), mean amplitude of glycemic excursions (MAGE) and M value were calculated from CGM data, and the correlations among these indices were assessed. There were strong correlations between SDglu and the indices MAGE, CONGA1, MODD and M value (all r > 0.8, P < 0.05). On the other hand, mean glucose was strongly correlated with J index and M value (both r > 0.8, P < 0.05). SDglu and other glycemic variability indices were more strongly correlated with hypoglycemia than was mean glucose, and the combination of mean glucose and SDglu was useful for predicting hypoglycemia in patients with diabetes. In this study, we demonstrated the characteristics of various glycemic variability indices in relation to mean glucose and SDglu. This information will help physicians to understand the characteristics of various glycemic variability indices and to select an appropriate index for their purpose. Our results also underpin the importance of glycemic variability in relation to risk of hypoglycemia in patients with diabetes. (C) 2014 Primary Care Diabetes Europe. Published by Elsevier Ltd. All rights reserved.	[Saisho, Yoshifumi; Tanaka, Chihiro; Tanaka, Kumiko; Tanaka, Masami; Meguro, Shu; Irie, Junichiro; Kawai, Toshihide; Itoh, Hiroshi] Keio Univ, Dept Internal Med, Sch Med, Tokyo 1608582, Japan; [Roberts, Rachel; Abe, Takayuki] Keio Univ, Clin Res Ctr, Sch Med, Tokyo 1608582, Japan	Saisho, Y (reprint author), Keio Univ, Dept Internal Med, Sch Med, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	ysaisho@z5.keio.jp					Patel A, 2008, NEW ENGL J MED, V358, P2560; Duckworth W, 2009, NEW ENGL J MED, V360, P129, DOI 10.1056/NEJMoa0808431; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Frier BM, 2011, DIABETES CARE, V34, pS132, DOI [10.2337/dc11-s220, 10.2337/dc11.-s220]; Tominaga M, 1999, DIABETES CARE, V22, P920, DOI 10.2337/diacare.22.6.920; Rodbard D, 2009, DIABETES TECHNOL THE, V11, P551, DOI 10.1089/dia.2009.0015; Desouza CV, 2010, DIABETES CARE, V33, P1389, DOI 10.2337/dc09-2082; SERVICE FJ, 1980, DIABETES CARE, V3, P58, DOI 10.2337/diacare.3.1.58; SERVICE FJ, 1970, DIABETES, V19, P644; Seaquist ER, 2013, DIABETES CARE, V36, P1384, DOI 10.2337/dc12-2480; Monnier L, 2011, DIABETES TECHNOL THE, V13, P813, DOI 10.1089/dia.2011.0049; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545; Committee on the Standardization of Diabetes Mellitus-Related Laboratory Testing of Japan Diabetes Society, 2012, DIABETOL INT, V3, P8; Japan Diabetes Society, 2010, GUID TREATM DIAB; Kilpatrick ES, 2007, DIABETOLOGIA, V50, P2553, DOI 10.1007/s00125-007-0820-z; Lipska KJ, 2013, DIABETES CARE, V36, P3535, DOI 10.2337/dc13-0610; McDonnell C M, 2005, Diabetes Technol Ther, V7, P253, DOI 10.1089/dia.2005.7.253; Monnier Louis, 2008, J Diabetes Sci Technol, V2, P1094; Murata GH, 2004, ARCH INTERN MED, V164, P1445, DOI 10.1001/archinte.164.13.1445; Rodbard David, 2012, J Diabetes Sci Technol, V6, P712; Rodbard D, 2009, DIABETES TECHNOL THE, V11, pS55, DOI 10.1089/dia.2008.0132; SCHLICHT.J, 1965, ACTA MED SCAND, V177, P95; Nathan DM, 2005, NEW ENGL J MED, V353, P2643; Tanaka C., 2014, DIABETOL INT, V5, P36, DOI DOI 10.1007/S13340-013-0129-8; Borch-Johnsen K, 2001, ARCH INTERN MED, V161, P397; WOJCICKI JM, 1995, HORM METAB RES, V27, P41, DOI 10.1055/s-2007-979906	26	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1751-9918	1878-0210		PRIM CARE DIABETES	Prim. Care Diabetes	AUG	2015	9	4					290	296		10.1016/j.pcd.2014.10.001		7	Endocrinology & Metabolism; Primary Health Care	Endocrinology & Metabolism; General & Internal Medicine	CM5VK	WOS:000357756900008		
J	Hirano, A; Ohara, T; Takahashi, A; Aoki, M; Fuyuno, Y; Ashikawa, K; Morihara, T; Takeda, M; Kamino, K; Oshima, E; Okahisa, Y; Shibata, N; Arai, H; Akatsu, H; Ikeda, M; Iwata, N; Ninomiya, T; Monji, A; Kitazono, T; Kiyohara, Y; Kubo, M; Kanba, S				Hirano, Atsushi; Ohara, Tomoyuki; Takahashi, Atsushi; Aoki, Masayuki; Fuyuno, Yuta; Ashikawa, Kyota; Morihara, Takashi; Takeda, Masatoshi; Kamino, Kouzin; Oshima, Etsuko; Okahisa, Yuko; Shibata, Nobuto; Arai, Heii; Akatsu, Hiroyasu; Ikeda, Masashi; Iwata, Nakao; Ninomiya, Toshiharu; Monji, Akira; Kitazono, Takanari; Kiyohara, Yutaka; Kubo, Michiaki; Kanba, Shigenobu			A genome-wide association study of late-onset Alzheimer's disease in a Japanese population	PSYCHIATRIC GENETICS			English	Article						CNTNAP2; genome-wide association study; Japanese; late-onset Alzheimer's disease	NEUREXIN SUPERFAMILY; IDENTIFIES VARIANTS; MISSENSE MUTATIONS; COMMON VARIANTS; GENE; CNTNAP2; AUTISM; CONTACTIN-ASSOCIATED-PROTEIN-LIKE-2; PREVALENCE; DISORDERS	ObjectiveAlthough a number of genome-wide association studies (GWASs) of late-onset Alzheimer's disease (LOAD) have been carried out, there have been little GWAS data on East Asian populations.DesignTo discover the novel susceptibility loci of LOAD, we carried out a GWAS using 816 LOAD cases and 7992 controls with a replication analysis using an independent panel of 1011 LOAD cases and 7212 controls in a Japanese population. In addition, we carried out a stratified analysis by APOE-epsilon 4 status to eliminate the established effect of APOE region.ResultsOur data indicated that 18p11.32 (rs1992269, P=9.77x10(-7)), CNTNAP2 (rs802571, P=1.26x10(-6)), and 12q24.23 (rs11613092, P=6.85x10(-6)) were suggestive loci for susceptibility to LOAD.ConclusionWe identified three suggestive loci for susceptibility to LOAD in a Japanese population. Among these, rs802571, located at intron 1 of CNTNAP2, was considered to be a plausible candidate locus from a functional perspective.	[Hirano, Atsushi; Ohara, Tomoyuki; Takahashi, Atsushi; Aoki, Masayuki; Fuyuno, Yuta; Ashikawa, Kyota; Kubo, Michiaki] RIKEN Yokohama Inst, Ctr Integrat Med Sci, Lab Genotyping Dev, Yokohama, Kanagawa 2300045, Japan; [Hirano, Atsushi; Fuyuno, Yuta; Kitazono, Takanari] Kyushu Univ, Grad Sch Med Sci, Dept Med & Clin Sci, Fukuoka 812, Japan; [Ohara, Tomoyuki; Kanba, Shigenobu] Kyushu Univ, Grad Sch Med Sci, Dept Neuropsychiat, Fukuoka 812, Japan; [Ohara, Tomoyuki; Ninomiya, Toshiharu; Kiyohara, Yutaka] Kyushu Univ, Grad Sch Med Sci, Dept Environm Med, Fukuoka 812, Japan; [Morihara, Takashi; Takeda, Masatoshi] Osaka Univ, Grad Sch Med, Dept Psychiat, Osaka, Japan; [Kamino, Kouzin] Natl Hosp Org Yamato Mental Med Ctr, Nara, Japan; [Oshima, Etsuko; Okahisa, Yuko] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Neuropsychiat, Okayama 7008530, Japan; [Shibata, Nobuto; Arai, Heii] Juntendo Univ, Sch Med, Dept Psychiat, Tokyo 113, Japan; [Akatsu, Hiroyasu] Fukushimura Hosp, Choju Med Inst, Fukushima, Japan; [Ikeda, Masashi; Iwata, Nakao] Fujita Hlth Univ, Sch Med, Dept Psychiat, Toyoake, Aichi, Japan; [Monji, Akira] Saga Univ, Fac Med, Dept Psychiat, Saga 840, Japan	Hirano, A (reprint author), RIKEN Yokohama Inst, Ctr Integrat Med Sci, Lab Genotyping Dev, 1-7-22 Suehiro Cho, Yokohama, Kanagawa 2300045, Japan.	atsuhira@intmed2.med.kyushu-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan; Ministry of Health, Labour and Welfare of Japan [H20-Chouju-004]	This study was supported in part by the Ministry of Education, Culture, Sports, Science and Technology of Japan, and a Health and Labour Sciences Research Grant of the Ministry of Health, Labour and Welfare of Japan (Comprehensive Research on Aging and Health: H20-Chouju-004). For collecting clinical samples, we thank K. Sasaki, A. Ohashi, N. Oribe, and member of the Department of Neuropsychiatry (Kyushu University Hospital); M. Takita (Takita Memory Mental Clinic); S. Maki (Maki Hospital); M. Saito (Yahata Kosei Hospital); N. Ikko (Yukuhashi Kinen Hospital); R. Nakagawa and S. Yoshimoto (Ureshino Onsen Hospital); K. Serikawa (Monowasure Mental Clinic); T. Toyonaga (Iizuka Kinen Hospital); M. Hayashi (Asakura Kinen Hospital); N. Fujikawa (Fujikawa Medicare Clinic); A. Notomi (Imazu Red Cross Hospital); Y. Sumita (Sumita Hospital); M. Sakurai (Shinmoji Hospital); N. Ohara (Minamigaoka Hospital); K. Nishimaru (Yoshizuka Hayashi Hospital); S. Hisano (Kanenokuma Hospital); M. Ito (Nogata Nakamura Hospital); Y. Hasuo (Wakasugi Hospital); F. Hattori (Nagao Hospital); I. Fujii (Shineikai Hospital); Y. Tanizaki (Kotake Town Hospital). We also thank the staff of Laboratory for Genotyping Development, Center for Integrative Medical Sciences, RIKEN, for their contribution to the completion of our study.	Naj AC, 2011, NAT GENET, V43, P436, DOI 10.1038/ng.801; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Alarcon M, 2008, AM J HUM GENET, V82, P150, DOI 10.1016/j.ajhg.2007.09.005; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; Poliak S, 1999, NEURON, V24, P1037, DOI 10.1016/S0896-6273(00)81049-1; Seshadri S, 2010, JAMA-J AM MED ASSOC, V303, P1832, DOI 10.1001/jama.2010.574; Logue MW, 2011, ARCH NEUROL-CHICAGO, V68, P1569, DOI 10.1001/archneurol.2011.646; Gatz M, 2006, ARCH GEN PSYCHIAT, V63, P168, DOI 10.1001/archpsyc.63.2.168; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; Liu JZ, 2010, AM J HUM GENET, V87, P139, DOI 10.1016/j.ajhg.2010.06.009; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Vernes SC, 2008, NEW ENGL J MED, V359, P2337, DOI 10.1056/NEJMoa0802828; Sekita A, 2010, ACTA PSYCHIAT SCAND, V122, P319, DOI 10.1111/j.1600-0447.2010.01587.x; Strauss KA, 2006, NEW ENGL J MED, V354, P1370, DOI 10.1056/NEJMoa052773; Lobo A, 2000, NEUROLOGY, V54, pS4; Verkerk AJMH, 2003, GENOMICS, V82, P1, DOI 10.1016/S0888-7543(03)00097-1; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ohnishi Y, 2001, J HUM GENET, V46, P471, DOI 10.1007/s100380170047; Ballard C, 2011, LANCET, V377, P1019, DOI 10.1016/S0140-6736(10)61349-9; Arking DE, 2008, AM J HUM GENET, V82, P160, DOI 10.1016/j.ajhg.2007.09.015; Lambert JC, 2009, NAT GENET, V41, P1094, DOI 10.1038/ng.439; Lambert JC, 2013, NAT GENET, V45, P1452, DOI 10.1038/ng.2802; Bakkaloglu B, 2008, AM J HUM GENET, V82, P165, DOI 10.1016/j.ajhg.2007.09.017; Yamaguchi-Kabata Y, 2008, AM J HUM GENET, V83, P445, DOI 10.1016/j.ajhg.2008.08.019; Hollingworth P, 2011, NAT GENET, V43, P429, DOI 10.1038/ng.803; ROGAEV EI, 1995, NATURE, V376, P775, DOI 10.1038/376775a0; Belbin O, 2007, HUM MOL GENET, V16, P2199, DOI 10.1093/hmg/ddm171; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Friedman JI, 2008, MOL PSYCHIATR, V13, P261, DOI 10.1038/sj.mp.4002049; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; MCKHANN G, 1984, NEUROLOGY, V34, P939; Miyashita A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058618; Nakamura Yusuke, 2007, Clin Adv Hematol Oncol, V5, P696; Ohara T, 2012, PSYCHIAT GENET, V22, P290, DOI 10.1097/YPG.0b013e3283586215; Pericak-Vance MA, 2009, LANCET NEUROL, V8, P977, DOI 10.1016/S1474-4422(09)70277-7; van Abel D, 2012, J ALZHEIMERS DIS, V31, P793, DOI 10.3233/JAD-2012-120472	36	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0955-8829	1473-5873		PSYCHIAT GENET	Psychiatr. Genet.	AUG	2015	25	4					139	146		10.1097/YPG.0000000000000090		8	Genetics & Heredity; Neurosciences	Genetics & Heredity; Neurosciences & Neurology	CL9RD	WOS:000357314900001		
J	Nakamura, H; Suzuki, S; Kajikawa, Y; Osawa, M				Nakamura, Hiroko; Suzuki, Shinji; Kajikawa, Yuya; Osawa, Masataka			The effect of patent family information in patent citation network analysis: a comparative case study in the drivetrain domain	SCIENTOMETRICS			English	Article						Citation analysis; Bibliometrics; Patent; Patent family	INDICATORS; BIBLIOMETRICS; STATISTICS; INNOVATION	Previous researchers of citation analysis often analyze patent data of a single authority because of the availability of the data and the simplicity of analysis. Patent analysis, on the other hand, is used not only for filing and litigation, but also for technology trend analysis. However, global technology trends cannot be understood only with the analysis of patent data issued by a single authority. In this paper, we propose the use of patents from multiple authorities and discuss the effect of bundling patent family information. We investigate the effect of patent families with cases from automobile drivetrain technology. Based on the results, we conclude that the use of multiple authorities' patent data bundled with the patent family information can significantly improve the coverage and practicability of patent citation analysis.	[Nakamura, Hiroko; Suzuki, Shinji] Univ Tokyo, CAIR, Bunkyo Ku, Tokyo 1138654, Japan; [Kajikawa, Yuya] Tokyo Inst Technol, Grad Sch Innovat Management, Tokyo 152, Japan; [Osawa, Masataka] Toyota Cent R&D Lab, Nagakute, Aichi, Japan	Nakamura, H (reprint author), Univ Tokyo, CAIR, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138654, Japan.	techhn@mail.ecc.u-tokyo.ac.jp					Alberts D, 2011, INFORM RETRIEVAL SER, V29, P3, DOI 10.1007/978-3-642-19231-9_1; Alcacer A., 2006, REV ECON STAT, V88, P774; Lai KK, 2005, INFORM PROCESS MANAG, V41, P313, DOI 10.1016/j.ipm.2003.11.004; NARIN F, 1994, SCIENTOMETRICS, V30, P147, DOI 10.1007/BF02017219; Meyer M, 2000, SCIENTOMETRICS, V49, P93, DOI 10.1023/A:1005613325648; Meyer M, 2002, SCIENTOMETRICS, V54, P193, DOI 10.1023/A:1016057727209; Nicolaisen J, 2007, ANNU REV INFORM SCI, V41, P609, DOI 10.1002/aris.2007.1440410120; Cronin B, 2001, J INFORM SCI, V27, P1; PAVITT K, 1985, SCIENTOMETRICS, V7, P77, DOI 10.1007/BF02020142; Kajikawa Y, 2008, TECHNOL FORECAST SOC, V75, P771, DOI 10.1016/j.techfore.2007.05.005; Leydesdorff L, 2014, SCIENTOMETRICS, V98, P1583, DOI 10.1007/s11192-012-0923-2; Lee C, 2013, TECHNOL ANAL STRATEG, V25, P487, DOI 10.1080/09537325.2013.785513; Charkrabarti A. K., 1991, IEEE T ENG MANAGE, V38, P78; Clark KL, 2012, WIRES DATA MIN KNOWL, V2, P427, DOI 10.1002/widm.1066; Erdi P., 2012, SCIENTOMETRICS, V95, P225; GRILICHES Z, 1990, J ECON LIT, V28, P1661; Leydesdorff L, 2008, J AM SOC INF SCI TEC, V59, P1582, DOI 10.1002/asi.20814; Lloyd M, 2013, AMBERBLOG; Nakamura H, 2011, SCIENTOMETRICS, V87, P221, DOI 10.1007/s11192-011-0341-x; Newman MEJ, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.026113; Simmons E. S., 2009, WORLD PATENT INFORM, V31, P11, DOI 10.1016/j.wpi.2008.08.005; Su FP, 2011, TECHNOL FORECAST SOC, V78, P319, DOI 10.1016/j.techfore.2010.10.011; Su FP, 2009, J AM SOC INF SCI TEC, V60, P2353, DOI 10.1002/asi.21169; Trippe T., 2013, DATA MINING LESSONS	24	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0138-9130	1588-2861		SCIENTOMETRICS	Scientometrics	AUG	2015	104	2					437	452		10.1007/s11192-015-1626-2		16	Computer Science, Interdisciplinary Applications; Information Science & Library Science	Computer Science; Information Science & Library Science	CM4YO	WOS:000357693000003		
J	Kokusho, T; Mimori, Y				Kokusho, T.; Mimori, Y.			Liquefaction potential evaluations by energy-based method and stress-based method for various ground motions	SOIL DYNAMICS AND EARTHQUAKE ENGINEERING			English	Article						Liquefaction potential evaluation; Energy-based method; Case history; Stress-based method; Seismic wave energy	DISSIPATION; SANDS	An energy-based liquefaction potential evaluation method (EBM) previously developed was applied to a uniform sand model shaken by seismic motions recorded at different sites during different magnitude earthquakes. It was also applied to actual liquefaction case histories in Urayasu city during the 2011 M9.0 Tohoku earthquake and in Tanno-cho during the 2003 M8.0 Tokachi-oki earthquake. In all these evaluations, the results were compared with those by the currently used stress-based method (SBM) under exactly the same seismic and geotechnical conditions. It was found that EBM yields similar results with SBM for several ground motions of recent earthquakes but has easier applicability without considering associated parameters. In Urayasu city, the two methods yielded nearly consistent results by using an appropriate coefficient in SBM for the M9.0 earthquake, though both overestimated the actual liquefaction performance, probably because effects of plasticity and aging on in situ liquefaction strength were not taken into account. In Tanno-cho, EBM could evaluate actual liquefaction performance due to a small-acceleration motion during a far-field large magnitude earthquake while SBM could not. (C) 2015 Elsevier Ltd. All rights reserved.	[Kokusho, T.; Mimori, Y.] Chuo Univ, Dept Civil & Environm Engn, Tokyo 112, Japan	Kokusho, T (reprint author), 46-5-1504 Senju Asahicho,Adachi Ku, Tokyo 1200026, Japan.	koktak@ad.email.ne.jp					FIGUEROA JL, 1994, J GEOTECH ENG-ASCE, V120, P1554, DOI 10.1061/(ASCE)0733-9410(1994)120:9(1554); Kayen RE, 1997, J GEOTECH GEOENVIRON, V123, P1162, DOI 10.1061/(ASCE)1090-0241(1997)123:12(1162); Arias A., 1970, SEISMIC DESIGN NUCL, P438; DAVIS RO, 1982, EARTHQUAKE ENG STRUC, V10, P59; Hardin B. O., 1972, J SOIL MECHANICS F D, V98, P667; Idriss IM, 2008, MNO12 EARTHQ ENG RES, P31; Inada T, 1960, J JPN GEOTECH SOC, V8, P13; Jafarian Y, 2012, SOIL DYN EARTHQ ENG, V35, P13, DOI 10.1016/j.soildyn.2011.11.006; Japan Road Association, 2002, LIQ POT EV METH DES, P65; Kokusho T, 2013, CAN GEOTECH J, V50, P1; Kokusho T, 1998, P 33 NAT GEOT ANN C; Kokusho T., 2014, FUNDAMENTALS EARTHQU; Kokusho T, 2002, J GEOTECH GEOENVIRON, V128, P309, DOI 10.1061/(ASCE)1090-0241(2002)128:4(609); Schnabel P.B., 1972, 7212 EERC U CAL; TIMOSHENKO S., 1951, THEORY ELASTICITY; Tokimatsu K., 1983, SOILS FOUND, V23, P56; Towhata I, 1985, SOILS FOUND, V25, P73, DOI DOI 10.3208/SANDF1972.25.3_; Tsukamoto Y, 2009, EARTHQUAKE GEOTECHNICAL CASE HISTORIES FOR PERFORMANCE-BASED DESIGN, P109; Yanagisawa E Sugano T, 1994, P INT C SMFE SPEC VO, P155	19	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0267-7261	1879-341X		SOIL DYN EARTHQ ENG	Soil Dyn. Earthq. Eng.	AUG	2015	75						130	146		10.1016/j.soildyn.2015.04.002		17	Engineering, Geological; Geosciences, Multidisciplinary	Engineering; Geology	CM0EL	WOS:000357351100013		
J	Matsubara, Y; Morisaki, K; Matsuda, D; Aoyagi, Y; Tanaka, S; Okadome, J; Fukunaga, R; Matsumoto, T; Maehara, Y				Matsubara, Yutaka; Morisaki, Koichi; Matsuda, Daisuke; Aoyagi, Yukihiko; Tanaka, Shinichi; Okadome, Jun; Fukunaga, Ryota; Matsumoto, Takuya; Maehara, Yoshihiko			Thoracic endovascular aortic repair and coil embolization of the pulmonary artery for primary racemose hemangioma of the bronchial artery with a bronchial-pulmonary artery fistula	VASCULAR			English	Article						TEVAR; coil embolization; racemose hemangioma; pulmonary artery; bronchial artery; fistula	HEMOPTYSIS; MANAGEMENT; ANEURYSMS; LUNG	A 69-year-old male visited a doctor with dyspnea. A bronchial-pulmonary artery fistula, which is called racemose hemangioma, and dilated pulmonary artery were detected by a computed tomography (CT) scan. The bronchial-pulmonary artery fistula can cause lethal hemoptysis, therefore, we performed thoracic endovascular aortic repair (TEVAR) to seal the bronchial artery and coil embolization of the pulmonary artery. Postoperative CT showed the thrombosed racemose hemangioma of the bronchial artery. TEVAR and coil embolization of the pulmonary artery is considered to be a useful treatment option for a racemose hemangioma.	[Matsubara, Yutaka; Morisaki, Koichi; Matsuda, Daisuke; Aoyagi, Yukihiko; Tanaka, Shinichi; Okadome, Jun; Fukunaga, Ryota; Matsumoto, Takuya; Maehara, Yoshihiko] Kyushu Univ, Dept Surg & Sci, Grad Sch Med Sci, Fukuoka 8128582, Japan	Matsubara, Y (reprint author), Kyushu Univ, Dept Surg & Sci, Grad Sch Med Sci, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	y_matsu@surg2.med.kyushu-u.ac.jp					Abdoulhossein D, 2006, INT J THORAC CARDIOV, V22, P141, DOI 10.1007/s12055-006-0023-0; POUWELS HMM, 1992, EUR RESPIR J, V5, P1288; [Anonymous], 1976, ROFO-FORTSCHR RONTG; Osaki S, 2000, RESPIRATION, V67, P412, DOI 10.1159/000029540; REMY J, 1977, RADIOLOGY, V122, P33; CREMASCHI P, 1993, ANGIOLOGY, V44, P295, DOI 10.1177/000331979304400405; BARTTER T, 1988, ARCH INTERN MED, V148, P471, DOI 10.1001/archinte.148.2.471; MONCHIK J, 1974, ANN THORAC SURG, V17, P496; Aoshima H, 2006, J JPN RESP ENDOSC, V28, P365; CAIN H, 1980, KLIN WOCHENSCHR, V58, P347, DOI 10.1007/BF01477277; Herve P, 2006, J APPL PHYSIOL, V100, P1101, DOI 10.1152/japplphysiol.01554.2005; ISHIHARA T, 1974, CHEST, V66, P633, DOI 10.1378/chest.66.6.633; Ishikawa Y, 2001, KIKANSHI GAKU JPN, V23, P69; Iwasaki M, 2001, INTERNAL MED, V40, P650, DOI 10.2169/internalmedicine.40.650; Kase M, 2000, NIHON KOKYUUKIGEKA G, V14, P637; Kobayashi Hiromi, 2007, Nihon Kokyuki Gakkai Zasshi, V45, P627; Mitsushima H, 2001, Nihon Kokyuki Gakkai Zasshi, V39, P135; Narato Ritsuko, 2006, Nihon Kokyuki Gakkai Zasshi, V44, P641; Okubo K, 1992, KIKANSHI GAKU JPN, V14, P537; PILLAI R, 1982, THORAX, V37, P386, DOI 10.1136/thx.37.5.386; Rajiv P, 2010, DISCLOSURE VASC, V18, P37; STOLL JF, 1988, CARDIOVASC INTER RAD, V11, P263, DOI 10.1007/BF02577032; UFLACKER R, 1985, RADIOLOGY, V157, P637; UNGARO R, 1976, J THORAC CARDIOV SUR, V71, P566; WHOLEY MH, 1976, JAMA-J AM MED ASSOC, V236, P2501, DOI 10.1001/jama.236.22.2501	25	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1708-5381	1708-539X		VASCULAR	Vascular	AUG	2015	23	4					436	439		10.1177/1708538114551196		4	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CM2NV	WOS:000357518700016		
J	Nomura, Y; Shimono, Y; Tominaga, T				Nomura, Y.; Shimono, Y.; Tominaga, T.			Development of chloroplast DNA markers in Japanese Imperata cylindrica	WEED RESEARCH			English	Article						climate ecotypes; cogongrass; global warming; heterosis; hybridisation	BRASSICACEAE; INVASION	Imperata cylindrica (cogongrass) is one of the most invasive grass weeds found worldwide. In Japan, this grass grows as three climate types: cool temperate (CT), common (CM) and subtropical (ST). An early flowering (E) type has been also reported. Among them, the CM type is large and most invasive. Recent global warming may cause the extension of distribution of the CM type to northern parts of Japan and may allow hybrids to form between the CM and CT or E types. The hybrids sometimes show heterosis and this leads to new weed problems. Distinguishing between the hybrids and parents on a morphological basis is difficult. We investigated polymorphisms of eight cpDNAs to enable distinction between the ecotypes and the hybrids. Fourteen haplotypes were detected in 33 Japanese clones, based on variations in eight cpDNA regions. Based on three substitutions in the psbA-matK spacer, the ORF170 intron1, the trnL(UAA) intron-trnF(GAA) spacer and indels in the trnL(UAA) intron-trnF(GAA) spacer, the haplotypes were clustered into three phylogenetic groups: I, IIa and IIb, which corresponded with the CM and ST, E and CT types, respectively. The polymorphism in the cpDNA therefore enables us to distinguish among the ecotypes and is useful for prediction of the range expansion of the CM type.	[Nomura, Y.; Shimono, Y.; Tominaga, T.] Kyoto Univ, Grad Sch Agr, Sakyo Ku, Kyoto 6068502, Japan	Tominaga, T (reprint author), Kyoto Univ, Grad Sch Agr, Sakyo Ku, Kitashirakawa Oiwake Cho, Kyoto 6068502, Japan.	tominaga@kais.kyoto-u.ac.jp			ESPEC Foundation for Global Environment Research and Technology	This work was partly supported by ESPEC Foundation for Global Environment Research and Technology to TT. No conflict of interests have been declared.	MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Gaskin JF, 2005, MOL ECOL, V14, P2331, DOI 10.1111/j.1365-294X.2005.02589.x; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Barnaud A, 2013, BIOL INVASIONS, V15, P2455, DOI 10.1007/s10530-013-0465-4; Bleeker W, 2003, MOL ECOL, V12, P1831, DOI 10.1046/j.1365-294X.2003.01854.x; Holm LG, 1977, WORLDS WORST WEEDS D, P62; Maeda J, 2009, CONSERV GENET RESOUR, V1, P127, DOI 10.1007/s12686-009-9031-x; Matumura M, 1980, RES B FAC AGR GIFU U, V43, P233; Mizuguti Aki, 2004, Grassland Science, V50, P9; Muranishi S, 2013, TREE GENET GENOMES, V9, P1005, DOI 10.1007/s11295-013-0612-1; TABERLET P, 1991, PLANT MOL BIOL, V17, P1105, DOI 10.1007/BF00037152; Tominaga T, 1989, J JAPANESE SOC GRASS, V35, P164; Tominaga T., 2007, Journal of Weed Science and Technology, V52, P17, DOI 10.3719/weed.52.17; Yasuda K., 2006, Journal of Weed Science and Technology, V51, P146, DOI 10.3719/weed.51.146	14	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0043-1737	1365-3180		WEED RES	Weed Res.	AUG	2015	55	4					329	333		10.1111/wre.12149		5	Agronomy; Plant Sciences	Agriculture; Plant Sciences	CM3QB	WOS:000357596800001		
J	Fernandez, N; Ferro, Y; Kato, D				Fernandez, N.; Ferro, Y.; Kato, D.			Hydrogen diffusion and vacancies formation in tungsten: Density Functional Theory calculations and statistical models	ACTA MATERIALIA			English	Article						DFT; Tungsten; Hydrogen; Vacancies; Nuclear material	HIGH-STRENGTH STEELS; DEUTERIUM RETENTION; SUPERABUNDANT VACANCIES; THERMAL-DESORPTION; POINT-DEFECTS; TEMPERATURE; IRRADIATION; PARAMETERS; DEPENDENCE; ALLOYS	The interaction of hydrogen with tungsten is investigated by means of the Density Functional Theory (DFT) and statistical methods based on the transition-state theory and thermodynamics. This model yields temperature-dependent data that can help understanding macro-scale experimental results. Within this model, the concentrations of trapped hydrogen atoms at thermodynamic equilibrium are established. Taking into account the configurational entropy, hydrogen is shown to induce vacancy formation below 1000 K. Based on this model, TDS spectra are simulated with a basic kinetic model to provide some better insight into the desorption process of hydrogen. Finally, revised mechanisms for hydrogen diffusion in tungsten are proposed; we conclude that the discrepancy existing between the experimental diffusion coefficient measured by Frauenfelder (1969) and the one calculated by DFT would be reconciled provided one uses two different diffusion regimes that would depend on temperature and vacancies concentration. (C) 2015 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.	[Fernandez, N.; Ferro, Y.] Aix Marseille Univ, CNRS, PIIM UMR 7345, F-13397 Marseille, France; [Kato, D.] Natl Inst Nat Sci, Natl Inst Fus Sci, Toki, Gifu 5095292, Japan; [Kato, D.] Grad Univ Adv Studies SOKENDAI, Toki, Gifu 5095292, Japan	Ferro, Y (reprint author), Aix Marseille Univ, CNRS, PIIM UMR 7345, F-13397 Marseille, France.	yves.ferro@univ-amu.fr			European Communities; Joint Usage/Research Program on Zero-Emission Energy Research (Institute of Advanced Energy, Kyoto University) [ZE26A-8]; NIFS/NINS under the project of Formation of International Scientific Base and Network	The authors of this work were granted access to the HPC resources of IDRIS under the allocation i2012096614 made by GENCI (Grand Equipement National de Calcul Intensif). This work, supported by the European Communities under the partnering contract with EURATOM-CEA, and with the French Research Federation for fusion studies FR-FMC, was carried out within the framework of the European Fusion Development Agreement. The views and opinions expressed herein do not necessarily reflect those of the European Commission. This work is partially supported by Joint Usage/Research Program on Zero-Emission Energy Research (Institute of Advanced Energy, Kyoto University, ZE26A-8), and NIFS/NINS under the project of Formation of International Scientific Base and Network.	Nagumo M, 2001, METALL MATER TRANS A, V32, P339, DOI 10.1007/s11661-001-0265-9; Henkelman G, 1999, J CHEM PHYS, V111, P7010, DOI 10.1063/1.480097; Ogorodnikova OV, 2008, J APPL PHYS, V103, DOI 10.1063/1.2828139; You YW, 2013, AIP ADV, V3, DOI 10.1063/1.4789547; Becquart CS, 2009, J NUCL MATER, V385, P223, DOI 10.1016/j.jnucmat.2008.11.027; Derlet PM, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.054107; Serra E, 1998, J NUCL MATER, V255, P105, DOI 10.1016/S0022-3115(98)00038-5; Roszell JP, 2012, J NUCL MATER, V429, P48, DOI 10.1016/j.jnucmat.2012.05.018; BLOCHL PE, 1994, PHYS REV B, V50, P17953, DOI 10.1103/PhysRevB.50.17953; Quastel AD, 2006, J NUCL MATER, V359, P8, DOI 10.1016/j.jnucmat.2006.07.012; Causey RA, 2002, J NUCL MATER, V300, P91, DOI 10.1016/S0022-3115(01)00732-2; Weinan E, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.052301; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; Satta A, 1998, PHYS REV B, V57, P11184, DOI 10.1103/PhysRevB.57.11184; HIRTH JP, 1980, METALL TRANS A, V11, P861, DOI 10.1007/BF02654700; FUKAI Y, 1994, PHYS REV LETT, V73, P1640, DOI 10.1103/PhysRevLett.73.1640; Becquart CS, 2009, J NUCL MATER, V386-88, P109, DOI 10.1016/j.jnucmat.2008.12.085; Nazarov R, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.224104; Becquart CS, 2007, NUCL INSTRUM METH B, V255, P23, DOI 10.1016/j.nimb.2006.11.006; Kanai Y, 2004, J CHEM PHYS, V121, P3359, DOI 10.1063/1.1773159; Ohsawa K, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.184117; Heinola K, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.094102; Fukai Y, 2003, J ALLOY COMPD, V356, P263, DOI 10.1016/S0925-8388(02)01269-0; Muzyk M, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.104115; Bukonte L, 2014, J APPL PHYS, V115, DOI 10.1063/1.4869497; Haasz AA, 1998, J NUCL MATER, V258, P889, DOI 10.1016/S0022-3115(98)00072-5; Ventelon L, 2012, J NUCL MATER, V425, P16, DOI 10.1016/j.jnucmat.2011.08.024; RASCH KD, 1980, PHILOS MAG A, V41, P91; Ohsawa K, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.094102; Eliaz N, 2002, ENG FAIL ANAL, V9, P167, DOI 10.1016/S1350-6307(01)00009-7; Hayward E, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.174103; Ahlgren T, 2012, J NUCL MATER, V427, P152, DOI 10.1016/j.jnucmat.2012.04.031; Lu GH, 2014, NUCL FUSION, V54, DOI 10.1088/0029-5515/54/8/086001; Liu YL, 2009, J NUCL MATER, V390-91, P1032, DOI 10.1016/j.jnucmat.2009.01.277; Johnson DF, 2010, J MATER RES, V25, P315, DOI 10.1557/JMR.2010.0036; Poon M, 2008, J NUCL MATER, V374, P390, DOI 10.1016/j.jnucmat.2007.09.028; Liu YL, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.172103; Ogorodnikova OV, 2003, J NUCL MATER, V313, P469, DOI 10.1016/S0022-3115(02)01375-2; Sun L, 2013, J NUCL MATER, V434, P395, DOI 10.1016/j.jnucmat.2012.12.008; Tanabe T, 2014, PHYS SCRIPTA, VT159, DOI 10.1088/0031-8949/2014/T159/014044; Baroni S, 2001, REV MOD PHYS, V73, P515, DOI 10.1103/RevModPhys.73.515; Ogorodnikova OV, 2009, PHYS SCRIPTA, VT138, DOI 10.1088/0031-8949/2009/T138/014053; VANDERBILT D, 1990, PHYS REV B, V41, P7892, DOI 10.1103/PhysRevB.41.7892; Liu YL, 2011, J ALLOY COMPD, V509, P8277, DOI 10.1016/j.jallcom.2011.03.117; You YW, 2013, J NUCL MATER, V433, P167, DOI 10.1016/j.jnucmat.2012.09.025; Giannozzi P, 2009, J PHYS-CONDENS MAT, V21, DOI 10.1088/0953-8984/21/39/395502; Heinola K, 2010, J APPL PHYS, V107, DOI 10.1063/1.3386515; Enomoto N, 2009, J NUCL MATER, V385, P606, DOI 10.1016/j.jnucmat.2009.01.298; Pitts RA, 2009, PHYS SCRIPTA, VT138, DOI 10.1088/0031-8949/2009/T138/014001; Shu WM, 2007, NUCL FUSION, V47, P201, DOI 10.1088/0029-5515/47/3/006; Benamati G, 2000, J NUCL MATER, V283, P1033, DOI 10.1016/S0022-3115(00)00202-6; DESHPANDE VT, 1962, CURR SCI INDIA, V31, P497; Elliot S., 1998, PHYS CHEM SOLIDS; FRAUENFE.R, 1969, J VAC SCI TECHNOL, V6, P388, DOI 10.1116/1.1492699; Fukai Y, 1997, J JPN I MET, V61, P663; FUKAI Y, 1993, JPN J APPL PHYS 2, V32, pL1256; Gumbsch P, 1998, SCIENCE, V282, P1293, DOI 10.1126/science.282.5392.1293; HATCHER RD, 1979, PHYS REV B, V19, P5083, DOI 10.1103/PhysRevB.19.5083; Kato D, 2011, J NUCL MATER, V417, P1115, DOI 10.1016/j.jnucmat.2010.12.211; Kato D., 2009, J PLASMA FUSION RES, V8, P404; Lassner E., 1999, TUNGSTEN PROPERTIES; Liu YN, 2013, AIP ADV, V3, DOI 10.1063/1.4849775; Mattsson AE, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.155101; Middleburgh SC, 2014, J NUCL MATER, V448, P270, DOI 10.1016/j.jnucmat.2014.02.014; Mundy J.N., 1987, PHILOS MAG A, V56, P861; MUNDY JN, 1982, PHILOS MAG A, V46, P345; Poon M, 2003, J NUCL MATER, V313, P199, DOI 10.1016/S0022-3115(02)01445-9; Reith M., 2013, J NUCL MATER, V442, pS173; Schmid K, 2014, J APPL PHYS, V116, DOI 10.1063/1.4896580; Zakharov A.P., 1975, ACAD SCI UKRAINIAN S, V9, P149	70	5	5	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	1359-6454	1873-2453		ACTA MATER	Acta Mater.	AUG 1	2015	94						307	318		10.1016/j.actamat.2015.04.052		12	Materials Science, Multidisciplinary; Metallurgy & Metallurgical Engineering	Materials Science; Metallurgy & Metallurgical Engineering	CL7HQ	WOS:000357143500028		
J	Yamauchi, E; Suzuki, Y; So, KH; Suzuki, K; Katoh, K; Roh, SG				Yamauchi, Eri; Suzuki, Yutaka; So, Kyoung-Ha; Suzuki, Kei-ichi; Katoh, Kazuo; Roh, Sang-Gun			Single Nucleotide Polymorphism in the Coding Region of Bovine Chemerin Gene and Their Associations with Carcass Traits in Japanese Black Cattle	ASIAN-AUSTRALASIAN JOURNAL OF ANIMAL SCIENCES			English	Article						Japanese Black Cattle; Chemerin; Single Nucleotide Polymorphism; Carcass Trait	FATTY-ACID-COMPOSITION; METABOLIC SYNDROME; BEEF-CATTLE; ADIPOKINE; ADIPOGENESIS; DESATURASE; GROWTH; EXPRESSION; RARRES2; ANALOG	Chemerin, highly expressed in adipose and liver tissues, regulates glucose and lipid metabolism and immunity in these tissues in ruminants and mice. Our previous reports showed that chemerin is involved in adipogenesis and lipid metabolism in adipose tissue as an adipokine. The aim of the present study was to identify single nucleotide polymorphisms (SNPs) in the coding region of the chemerin gene and to analyze their effects on carcass traits and intramuscular fatty acid compositions in Japanese Black cattle. The SNPs in the bovine chemerin gene were detected in 232 Japanese Black steers (n = 161) and heifers (n = 71) using DNA sequencing. The results revealed five novel silent mutations: NM_001046020: c.12A>G (4aa), c.165G<A (55aa), c.276C>T (92aa), c.321 A>G (107aa), and c.396C>T (132aa). There was no association between 4 of the SNPs (c.12A>G [4aa], c.165G<A [55aa], c.321 A>G [107aa], and c.396C>T) and carcass traits or intramuscular fatty acid compositions. Regarding the remaining SNP, c.276C>T, we found that cattle with genotype CC had a higher beef marbling score than that of cattle with genotype CT, whereas cattle with genotype CT had a higher body condition score (p<0.10). Further, cattle with genotype CC had significantly higher C18:0 content in their intramuscular fat tissue than that of cattle with genotype CT (p<0.05). On the other hand, cattle with genotype CT had significantly higher C14:0 and C16:0 content in their intramuscular fat tissue (p<0.05). Moreover, the number of individuals carrying the minor allele of c.276C>T SNP is small. It is suggested that the c.276C>T SNP of the chemerin gene has potential in cattle breeding using modern methods, such as marker assisted selection. So, further functional and physiological research elucidating the impact of the chemerin gene on bovine lipid metabolism including fatty acid synthesis will help in understanding these results.	[Yamauchi, Eri; Suzuki, Yutaka; So, Kyoung-Ha; Suzuki, Kei-ichi; Katoh, Kazuo; Roh, Sang-Gun] Tohoku Univ, Grad Sch Agr Sci, Physiol Anim Lab, Sendai, Miyagi 9818555, Japan	Roh, SG (reprint author), Tohoku Univ, Grad Sch Agr Sci, Physiol Anim Lab, Sendai, Miyagi 9818555, Japan.	sanggun_roh@bios.tohoku.ac.p			JSPS	This study was partly supported by a grant-in-aid from JSPS.	Sell H, 2009, DIABETES, V58, P2731, DOI 10.2337/db09-0277; HIGGINS DG, 1988, GENE, V73, P237, DOI 10.1016/0378-1119(88)90330-7; Roh SG, 2007, BIOCHEM BIOPH RES CO, V362, P1013, DOI 10.1016/j.bbrc.2007.08.104; Song SH, 2010, DOMEST ANIM ENDOCRIN, V39, P97, DOI 10.1016/j.domaniend.2010.02.007; Roh SG, 2006, ANIM SCI J, V77, P472, DOI 10.1111/j.1740-0929.2006.00374.x; Yokota S, 2012, ANIM GENET, V43, P790, DOI 10.1111/j.1365-2052.2012.02331.x; Cartegni L, 2002, NAT REV GENET, V3, P285, DOI 10.1038/nrg775; Yang HS, 2012, CYTOKINE, V60, P646, DOI 10.1016/j.cyto.2012.07.033; Goralski KB, 2007, J BIOL CHEM, V282, P28175, DOI 10.1074/jbc.M700793200; Suzuki Y, 2012, ASIAN AUSTRAL J ANIM, V25, P1316, DOI 10.5713/ajas.2012.12083; Suzuki Y, 2012, ANIM SCI J, V83, P263, DOI 10.1111/j.1740-0929.2011.01002.x; Tian WQ, 2011, GENET MOL RES, V10, P2833, DOI 10.4238/2011.November.17.1; Matsuhashi T, 2011, J ANIM SCI, V89, P12, DOI 10.2527/jas.2010-3121; Bozaoglu K, 2007, ENDOCRINOLOGY, V148, P4687, DOI 10.1210/en.2007-0175; Taniguchi M, 2004, MAMM GENOME, V15, P142, DOI 10.1007/s00335-003-2286-8; Abe T, 2009, BIOCHEM GENET, V47, P397, DOI 10.1007/s10528-009-9235-5; Sell H, 2010, J CLIN ENDOCR METAB, V95, P2892, DOI 10.1210/jc.2009-2374; Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308; Ardiyanti A, 2012, ASIAN AUSTRAL J ANIM, V25, P1055, DOI 10.5713/ajas.2012.12029; Ardiyanti A, 2009, DOMEST ANIM ENDOCRIN, V37, P243, DOI 10.1016/j.domaniend.2009.07.002; Hashemi M, 2012, GENE, V510, P113, DOI 10.1016/j.gene.2012.08.048; Lindholm-Perry Amanda K., 2012, Frontiers in Genetics, V3, P39, DOI 10.3389/fgene.2012.00039; Mussig K, 2009, METABOLISM, V58, P519, DOI 10.1016/j.metabol.2008.11.011; Smith SB, 2006, ANIM SCI J, V77, P478, DOI 10.1111/j.1740-0929.2006.00375.x; Yang A, 1999, MEAT SCI, V51, P1, DOI 10.1016/S0309-1740(98)00065-5	25	0	0	ASIAN-AUSTRALASIAN ASSOC ANIMAL PRODUCTION SOC	SEOUL	ROOM 708 SAMMO SPOREX, 1638-32, SEOWON-DONG, GWANAK-GU, SEOUL 151-730, SOUTH KOREA	1011-2367	1976-5517		ASIAN AUSTRAL J ANIM	Asian Australas. J. Anim. Sci.	AUG	2015	28	8					1084	1089		10.5713/ajas.14.0560		6	Agriculture, Dairy & Animal Science	Agriculture	CL7IL	WOS:000357145600004		
J	Kashimura, T; Takemura, A				Kashimura, Takuya; Takemura, Akimichi			Standard imsets for undirected and chain graphical models	BERNOULLI			English	Article						conditional independence; decomposable graph; maximal prime subgraph; triangulation	CONDITIONAL-INDEPENDENCE	We derive standard imsets for undirected graphical models and chain graphical models. Standard imsets for undirected graphical models are described in terms of minimal triangulations for maximal prime subgraphs of the undirected graphs. For describing standard imsets for chain graphical models, we first define a triangulation of a chain graph. We then use the triangulation to generalize our results for the undirected graphs to chain graphs.	[Kashimura, Takuya; Takemura, Akimichi] Univ Tokyo, Dept Math Informat, Grad Sch Informat Sci & Technol, Bunkyo Ku, Tokyo 1138656, Japan; [Takemura, Akimichi] JST, CREST, Chiyoda Ku, Tokyo 1020075, Japan	Kashimura, T (reprint author), Univ Tokyo, Dept Math Informat, Grad Sch Informat Sci & Technol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.	takemura@stat.t.u-tokyo.ac.jp					Andersson SA, 1997, SCAND J STAT, V24, P81; LAURITZEN SL, 1990, NETWORKS, V20, P491, DOI 10.1002/net.3230200503; Hara H, 2010, COMMUN STAT-THEOR M, V39, P1643, DOI 10.1080/03610920802238662; LEIMER HG, 1993, DISCRETE MATH, V113, P99, DOI 10.1016/0012-365X(93)90510-Z; GEIGER D, 1993, ANN STAT, V21, P2001, DOI 10.1214/aos/1176349407; Studeny M, 1998, ANN STAT, V26, P1434; Heggernes P, 2006, DISCRETE MATH, V306, P297, DOI 10.1016/j.disc.2005.12.003; Bouckaert R, 2010, J MACH LEARN RES, V11, P3453; FRYDENBERG M, 1990, SCAND J STAT, V17, P333; Hemmecke R, 2008, COMB PROBAB COMPUT, V17, P239, DOI 10.1017/S0963548307008838; Hemmecke R., 2010, PREPRINT; Lauritzen S. L., 1996, OXFORD STAT SCI SERI, V17; OHTSUKI T, 1976, J MATH ANAL APPL, V54, P622, DOI 10.1016/0022-247X(76)90182-7; Pearl J., 1988, MORGAN KAUFMANN SERI; Studeny M., 1994, International Journal of General Systems, V23; Studeny M., 1994, INT J GEN SYST, V23, P201; Studeny M, 2009, INT J APPROX REASON, V50, P385, DOI 10.1016/j.ijar.2008.09.001; Studeny M., 2001, HSSS WORKSH STOCH SY; Studeny M, 2010, INT J APPROX REASON, V51, P573, DOI 10.1016/j.ijar.2010.01.014; Studeny M., 2005, PROBABILISTIC CONDIT; Studeny M, 2009, KYBERNETIKA, V45, P208; Studeny M., 1994, INT J GEN SYST, V23, P323; VERMA T, 1990, MACH INTELL PATT REC, V9, P69; Vomlel J, 2007, STUD FUZZ SOFT COMP, V213, P55	24	0	0	INT STATISTICAL INST	VOORBURG	428 PRINSES BEATRIXLAAN, 2270 AZ VOORBURG, NETHERLANDS	1350-7265	1573-9759		BERNOULLI	Bernoulli	AUG	2015	21	3					1467	1493		10.3150/14-BEJ611		27	Statistics & Probability	Mathematics	CL5IM	WOS:000356993100008		
J	Oka, S; Hirai, J; Yasukawa, T; Nakahara, Y; Inoue, YH				Oka, Saori; Hirai, Jun; Yasukawa, Takashi; Nakahara, Yasuyuki; Inoue, Yoshihiro H.			A correlation of reactive oxygen species accumulation by depletion of superoxide dismutases with age-dependent impairment in the nervous system and muscles of Drosophila adults	BIOGERONTOLOGY			English	Article						Oxidative stress; Drosophila; Aging; SOD1; SOD2	EXACERBATES CEREBRAL INFARCTION; LIFE-SPAN; OXIDATIVE STRESS; GENE-EXPRESSION; NULL MUTATION; GAL4 SYSTEM; COPPER-ZINC; MELANOGASTER; OVEREXPRESSION; CATALASE	The theory that accumulation of reactive oxygen species (ROS) in internal organs is a major promoter of aging has been considered negatively. However, it is still controversial whether overexpression of superoxide dismutases (SODs), which remove ROS, extends the lifespan in Drosophila adults. We examined whether ROS accumulation by depletion of Cu/Zn-SOD (SOD1) or Mn-SOD (SOD2) influenced age-related impairment of the nervous system and muscles in Drosophila. We confirmed the efficient depletion of Sod1 and Sod2 through RNAi and ROS accumulation by monitoring of ROS-inducible gene expression. Both RNAi flies displayed accelerated impairment of locomotor activity with age and shortened lifespan. Similarly, adults with nervous system-specific depletion of Sod1 or Sod2 also showed reduced lifespan. We then found an accelerated loss of dopaminergic neurons in the flies with suppressed SOD expression. A half-dose reduction of three pro-apoptotic genes resulted in a significant suppression of the neuronal loss, suggesting that apoptosis was involved in the neuronal loss caused by SOD silencing. In addition, depletion of Sod1 or Sod2 in musculature is also associated with enhancement of age-related locomotion impairment. In indirect flight muscles from SOD-depleted adults, abnormal protein aggregates containing poly-ubiquitin accumulated at an early adult stage and continued to increase as the flies aged. Most of these protein aggregates were observed between myofibril layers. Moreover, immuno-electron microscopy indicated that the aggregates were predominantly localized in damaged mitochondria. These findings suggest that muscular and neuronal ROS accumulation may have a significant effect on age-dependent impairment of the Drosophila adults.	[Oka, Saori; Hirai, Jun; Yasukawa, Takashi; Nakahara, Yasuyuki; Inoue, Yoshihiro H.] Kyoto Inst Technol, Insect Biomed Res Ctr, Sakyo Ku, Kyoto 6060962, Japan	Inoue, YH (reprint author), Kyoto Inst Technol, Insect Biomed Res Ctr, Sakyo Ku, Kyoto 6060962, Japan.	yhinoue@kit.ac.jp			 [22241052]	We acknowledge D. Bohmann (Rochester university) and Bloomington Stock Center for providing the fly stocks. This study was partially supported by Grant-in-Aid for Scientific Research A (22241052).	Zhang Y, 2000, NEUROBIOL DIS, V7, P240, DOI 10.1006/nbdi.2000.0319; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Halliwell B, 1996, ANNU REV NUTR, V16, P33, DOI 10.1146/annurev.nutr.16.1.33; Jang YC, 2009, J GERONTOL A-BIOL, V64, P1114, DOI 10.1093/gerona/glp100; Agrawal L, 2010, BRAIN RES, V1306, P116, DOI 10.1016/j.brainres.2009.09.113; Kops GJPL, 2002, NATURE, V419, P316, DOI 10.1038/nature01036; Kim GW, 2002, STROKE, V33, P809, DOI 10.1161/hs0302.103745; Landis GN, 2005, MECH AGEING DEV, V126, P365, DOI 10.1016/j.mad.2004.08.012; PHILLIPS JP, 1989, P NATL ACAD SCI USA, V86, P2761, DOI 10.1073/pnas.86.8.2761; Cooke MS, 2003, FASEB J, V17, P1195, DOI 10.1096/fj.02-0752rev; Murakami K, 1998, J NEUROSCI, V18, P205; SETO NOL, 1990, P NATL ACAD SCI USA, V87, P4270, DOI 10.1073/pnas.87.11.4270; Parkes TL, 1998, NAT GENET, V19, P171, DOI 10.1038/534; Rahman MM, 2013, AGING CELL, V12, P554, DOI 10.1111/acel.12078; Phelps CB, 1998, METHODS, V14, P367, DOI 10.1006/meth.1998.0592; Sun JT, 2002, GENETICS, V161, P661; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Lapointe J, 2010, CELL MOL LIFE SCI, V67, P1, DOI 10.1007/s00018-009-0138-8; Zelko IN, 2002, FREE RADICAL BIO MED, V33, P337, DOI 10.1016/S0891-5849(02)00905-X; ORR WC, 1994, SCIENCE, V263, P1128, DOI 10.1126/science.8108730; Ferguson M, 2005, BIOCHEM J, V390, P501, DOI 10.1042/BJ20042130; HARMAN D, 1972, J AM GERIATR SOC, V20, P145; BAYNES JW, 1991, DIABETES, V40, P405, DOI 10.2337/diabetes.40.4.405; Fujimura M, 1999, J NEUROSCI, V19, P3414; Sykiotis GP, 2008, DEV CELL, V14, P76, DOI 10.1016/j.devcel.2007.12.002; Botella JA, 2009, NEUROMOL MED, V11, P268, DOI 10.1007/s12017-009-8098-6; Sun JT, 1999, MOL CELL BIOL, V19, P216; Speakman JR, 2011, BIOESSAYS, V33, P255, DOI 10.1002/bies.201000132; HARMAN D, 1956, J GERONTOL, V11, P298; Duffy JB, 2002, GENESIS, V34, P1, DOI 10.1002/gene.1015; Demontis F, 2010, CELL, V143, P813, DOI 10.1016/j.cell.2010.10.007; Gems D, 2009, CELL CYCLE, V8, P1681, DOI 10.4161/cc.8.11.8595; Perez VI, 2009, BBA-GEN SUBJECTS, V1790, P1005, DOI 10.1016/j.bbagen.2009.06.003; Duttaroy A, 2003, GENETICS, V165, P2295; Miller MS, 2008, BIOPHYS J, V95, P2391, DOI [10.1529/biophysj.108.130005, 10.1529/hiophysj.108.130005]; Cui H., 2012, J SIGNAL TRANSDUCT, V2012, P13, DOI DOI 10.1155/2012/646354; Das N, 2001, BIOCHEM J, V360, P209, DOI 10.1042/0264-6021:3600209; Godenschwege T, 2009, GENETICS, V183, P175, DOI 10.1534/genetics.109.103515; Gutteridge J. M. C., 1999, FREE RADICALS BIOL M; Jung I, 2011, FEBS LETT, V585, P1973, DOI 10.1016/j.febslet.2011.05.033; Martin I, 2009, FREE RADICAL BIO MED, V47, P803, DOI 10.1016/j.freeradbiomed.2009.06.021; Martinez VG, 2007, DEV NEUROBIOL, V67, P778, DOI 10.1002/dneu.20388; Mockett RJ, 2003, FREE RADICAL BIO MED, V34, P207, DOI 10.1016/S0891-5849(02)01190-5; Mockett RJ, 2010, FREE RADICAL BIO MED, V49, P2028, DOI 10.1016/j.freeradbiomed.2010.09.029; Orr WC, 2003, J BIOL CHEM, V278, P26418, DOI 10.1074/jbc.M303095200; Paul A, 2007, MECH AGEING DEV, V128, P706, DOI 10.1016/j.mad.2007.10.013; Tan Y, 2011, DEVELOPMENT, V138, P2197, DOI 10.1242/dev.058826; Ueyama M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011557; Van Raamsdonk JM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000361	49	2	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1389-5729	1573-6768		BIOGERONTOLOGY	Biogerontology	AUG	2015	16	4					485	501		10.1007/s10522-015-9570-3		17	Geriatrics & Gerontology	Geriatrics & Gerontology	CL6YG	WOS:000357114600009		
J	Fukushima, T; Taniguchi, E; Yamada, H; Kato, K; Shimizu, A; Nishiguchi, Y; Onozato, M; Ichiba, H; Azuma, Y				Fukushima, Takeshi; Taniguchi, Erina; Yamada, Hiroshi; Kato, Kiyomasa; Shimizu, Ayako; Nishiguchi, Yoshikazu; Onozato, Mayu; Ichiba, Hideaki; Azuma, Yutaro			Anti-proliferative effect of Fe(III) complexed with 1-(2-hydroxy-3-methoxybenzaldehyde)-4-aminosalicylhydrazone in HepG2 cells	BIOMETALS			English	Article						1-(2-Hydroxy-3-methoxybenzaldehyde)-4-aminosalicylhydrazone; Metal complex; Anti-proliferation; Fe(III); HepG2 cells	FLUORESCENT CHELATING LIGAND; PLATINUM(II) COMPLEXES; IRON CHELATORS; CANCER-CELLS; GALLIUM ION; ZINC-ION; APOPTOSIS; ACID; CYTOTOXICITY; ANTITUMOR	We previously developed a chelating ligand, 1-(2-hydroxy-3-methoxybenzaldehyde)-4-aminosalicylhydrazone (HMB-ASH), which can chelate Fe(III) to form a complex. The HMB-ASH-Fe(III) complex exhibits a dose-dependent anti-proliferative effect in HepG2 cells, whereas the ligand, HMB-ASH, and Fe(III) alone had no considerable effect. The HMB-ASH-Fe(III) complex was composed of Fe(III):HMB-ASH (1:2), as determined by high-performance liquid chromatography with high-resolution mass spectrometry. The IC50 value was approximately 20 mu M, which was comparable to those of the anti-cancer drugs oxaliplatin (OXP) and etoposide (ETP) under the same conditions. Similar to OXP and ETP, HMB-ASH-Fe(III) induced apoptosis in HepG2 cells, as revealed by terminal deoxynucleotidyl transferase fluorescein-12-dUTP nick end labeling assay.	[Fukushima, Takeshi; Taniguchi, Erina; Yamada, Hiroshi; Kato, Kiyomasa; Shimizu, Ayako; Onozato, Mayu; Ichiba, Hideaki] Toho Univ, Fac Pharmaceut Sci, Dept Analyt Chem, Funabashi, Chiba 2748510, Japan; [Nishiguchi, Yoshikazu] Toho Univ, Fac Pharmaceut Sci, Dept Pharmaceut Practice, Funabashi, Chiba 2748510, Japan; [Azuma, Yutaro] Toho Univ, Dept Med Biochem, Fac Pharmaceut Sci, Funabashi, Chiba 2748510, Japan	Fukushima, T (reprint author), Toho Univ, Fac Pharmaceut Sci, Dept Analyt Chem, 2-2-1 Miyama, Funabashi, Chiba 2748510, Japan.	t-fukushima@phar.toho-u.ac.jp					Alexandrova RI, 2012, CENT EUR J CHEM, V10, P1464, DOI 10.2478/s11532-012-0071-9; Huang KB, 2013, EUR J MED CHEM, V63, P76, DOI 10.1016/j.ejmech.2013.01.055; Hsu CW, 2013, BIOMETALS, V26, P1, DOI 10.1007/s10534-012-9589-8; Chen Y, 2013, BIOCHIMIE, V95, P2050, DOI 10.1016/j.biochi.2013.07.016; Kovacevic Z, 2011, CURR TOP MED CHEM, V11, P483, DOI 10.2174/156802611794785190; Farag AM, 2013, MED CHEM RES, V22, P4727, DOI 10.1007/s00044-013-0482-y; Yu Y, 2012, CURR MED CHEM, V19, P2689; Nath M, 2014, INORG CHIM ACTA, V423, P70, DOI 10.1016/j.ica.2014.02.034; Genc ZK, 2014, MED CHEM RES, V23, P2476, DOI 10.1007/s00044-013-0826-7; Dyakova L, 2014, BIOTECHNOL BIOTEC EQ, V28, P543, DOI 10.1080/13102818.2014.927973; Hou MH, 2005, NUCLEIC ACIDS RES, V33, P1352, DOI 10.1093/nar/gki276; Kimura J, 2009, ANAL CHIM ACTA, V635, P207, DOI 10.1016/j.aca.2009.01.008; Kimura J, 2009, J LUMIN, V129, P1362, DOI 10.1016/j.jlumin.2009.07.005; Mahmudov KT, 2014, J ORGANOMET CHEM, V760, P67, DOI 10.1016/j.jorganchem.2013.12.019; Roy P, 2007, INORG CHEM, V46, P6405, DOI 10.1021/ic700420w; Rubino S, 2014, INORG CHIM ACTA, V418, P112, DOI 10.1016/j.ica.2014.03.028; Tan J, 2009, BIOORGAN MED CHEM, V17, P614, DOI 10.1016/j.bmc.2008.11.063; Thati B, 2007, EUR J PHARMACOL, V569, P16, DOI 10.1016/j.ejphar.2007.04.064; Yamada H, 2012, SPECTROCHIM ACTA A, V90, P72, DOI 10.1016/j.saa.2012.01.014; Yamada H, 2010, CHEM PHARM BULL, V58, P875	20	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0966-0844	1572-8773		BIOMETALS	Biometals	AUG	2015	28	4					669	677		10.1007/s10534-015-9852-x		9	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CL3UY	WOS:000356877600006		
J	Okada, A; Yoshikawa, Y; Watanabe, K; Orino, K				Okada, Akiko; Yoshikawa, Yasunaga; Watanabe, Kiyotaka; Orino, Koichi			Analysis of the binding of bovine and human fibrinogen to ferritin: evidence that fibrinogen is a common ferritin-binding protein in mammals	BIOMETALS			English	Article						Ferritin-binding protein; Fibrinogen; Hemin; Protoporphyrin; Zinc	OXIDATIVE MODIFICATION; PROTOPORPHYRIN-IX; CARBON-MONOXIDE; HORSE PLASMA; HEME; IRON; ANTIOXIDANT; MONOCYTES; KININOGEN; ARTERIAL	Both human and horse fibrinogen are heme-binding proteins, and horse fibrinogen also exhibits heme-mediated ferritin binding. This study found that bovine and human fibrinogen are heme-mediated ferritin-binding proteins and demonstrated direct binding of bovine ferritin to protoporphyrin (PPIX) and its derivatives or to Zn ions. Binding of bovine and human fibrinogen to bovine spleen ferritin coated on microtiter plate wells was detected using an anti-human fibrinogen antibody, and this binding was inhibited in a dose-dependent manner by hemin (iron-PPIX) and also inhibited by Zn-PPIX. PPIX showed less of an inhibitory effect on the binding of bovine and human fibrinogen to bovine ferritin. The inhibitory effect of Sn-PPIX was similar to that of PPIX, but with respect to human fibrinogen, PPIX did not inhibit the binding of human fibrinogen to ferritin. Bovine fibrinogen immobilized on CNBr-activated Sepharose 4B beads showed affinity for hemin, Sn-PPIX, Zn-PPIX, and iron-free PPIX in the order Sn-PPIX < iron-free PPIX < hemin < Zn-PPIX. The fibrinogen beads also directly bound to zinc ions. These results suggest that bovine fibrinogen is a heme- and zinc-binding protein and that binding of circulating mammalian fibrinogen to ferritin is heme mediated.	[Okada, Akiko; Yoshikawa, Yasunaga; Watanabe, Kiyotaka; Orino, Koichi] Kitasato Univ, Sch Vet Med, Vet Biochem Lab, Aomori 0348628, Japan	Orino, K (reprint author), Kitasato Univ, Sch Vet Med, Vet Biochem Lab, Aomori 0348628, Japan.	orino@vmas.kitasato-u.ac.jp					ALTIERI DC, 1986, J CLIN INVEST, V78, P968, DOI 10.1172/JCI112687; Nowak P, 2007, THROMB RES, V121, P163, DOI 10.1016/j.thromres.2007.03.017; Orino K, 2008, VET J, V178, P191, DOI 10.1016/j.tvjl.2007.07.006; Mosesson MW, 2001, ANN NY ACAD SCI, V936, P11; Riedel T, 2011, BLOOD, V117, P1700, DOI 10.1182/blood-2010-08-300301; Mosesson MW, 2005, J THROMB HAEMOST, V3, P1894, DOI 10.1111/j.1538-7836.2005.01365.x; Watt RK, 2011, BIOMETALS, V24, P489, DOI 10.1007/s10534-011-9415-8; SHACTER E, 1995, FREE RADICAL BIO MED, V18, P815, DOI 10.1016/0891-5849(95)93872-4; Undas A, 2014, THROMB HAEMOSTASIS, V112, P32, DOI 10.1160/TH14-01-0032; SHACTER E, 1994, FREE RADICAL BIO MED, V17, P429, DOI 10.1016/0891-5849(94)90169-4; SMITH EB, 1990, ARTERIOSCLEROSIS, V10, P263; Sassa S, 2006, J CLIN BIOCHEM NUTR, V38, P138, DOI 10.3164/jcbn.38.138; Ryu JK, 2009, J THROMB HAEMOST, V7, P151, DOI 10.1111/j.1538-7836.2009.03438.x; DRUMMOND GS, 1981, P NATL ACAD SCI-BIOL, V78, P6466, DOI 10.1073/pnas.78.10.6466; Barrera V, 2011, BLOOD, V117, P5674, DOI 10.1182/blood-2010-10-312413; Crichton RR, 1997, BIOCHEMISTRY-US, V36, P15049, DOI 10.1021/bi9709147; DANG CV, 1989, AM J MED, V87, P567; GUSTAFSON EJ, 1989, J CELL BIOL, V109, P377, DOI 10.1083/jcb.109.1.377; Han J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023800; Kammath S, 2003, Q J MED, V96, P711; Kaplan IV, 2001, ATHEROSCLEROSIS, V158, P455, DOI 10.1016/S0021-9150(01)00452-X; Labbe RF, 1999, CLIN CHEM, V45, P2060; Lishko VK, 2004, J BIOL CHEM, V279, P44897, DOI 10.1074/jbc.M408012200; Mark G, 1988, ARCH BIOCHEM BIOPHYS, V266, P285; MASSOVER WH, 1994, ANN NY ACAD SCI, V737, P468, DOI 10.1111/j.1749-6632.1994.tb44342.x; MORIKAWA K, 1994, BLOOD, V83, P737; Nakai M, 2011, J VET MED SCI, V73, P313, DOI 10.1292/jvms.10-0375; Nielsen VG, 2011, BLOOD COAGUL FIBRIN, V22, P443, DOI 10.1097/MBC.0b013e328345c069; Olinescu RM, 2001, J NUTR BIOCHEM, V12, P162, DOI 10.1016/S0955-2863(00)00147-9; ORINO K, 1993, J VET MED SCI, V55, P785; Orino K, 2013, BIOMETALS, V26, P789, DOI 10.1007/s10534-013-9657-8; SANTAMBROGIO P, 1989, BRIT J HAEMATOL, V71, P281, DOI 10.1111/j.1365-2141.1989.tb04268.x; Sassa S, 2004, ANTIOXID REDOX SIGN, V6, P819, DOI 10.1089/ars.2004.6.819; Seki T, 2008, BIOMETALS, V21, P61, DOI 10.1007/s10534-007-9093-8; STEIN TP, 1978, AM J PHYSIOL, V234, pE504; Takahashi K, 2013, ACTA VET SCAND, V55, DOI 10.1186/1751-0147-55-70; Torti SV, 1998, J BIOL CHEM, V273, P13630, DOI 10.1074/jbc.273.22.13630; Undas A, 2011, ARTERIOSCL THROM VAS, V31, pE88, DOI 10.1161/ATVBAHA.111.230631; Yildiz H, 2005, B VET I PULAWY, V49, P209	39	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0966-0844	1572-8773		BIOMETALS	Biometals	AUG	2015	28	4					679	685		10.1007/s10534-015-9853-9		7	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CL3UY	WOS:000356877600007		
J	Murakami, K; Yoshino, M				Murakami, Keiko; Yoshino, Masataka			Effect of fructose 1,6-bisphosphate on the iron redox state relating to the generation of reactive oxygen species	BIOMETALS			English	Article						Fructose 1,6-bisphosphate; Superoxide radical; Aconitase inactivation; Ferrous ion; Crabtree effect	MITOCHONDRIAL OUTER-MEMBRANE; EHRLICH ASCITES TUMOR; OXIDATIVE STRESS; ESCHERICHIA-COLI; PYRUVATE-KINASE; HEPATOMA-CELLS; ACONITASE; YEAST; PHOSPHOFRUCTOKINASE; INACTIVATION	Role of fructose 1,6-bisphosphate-mediated iron oxidation in the generation of reactive oxygen species was analyzed. Aconitase the most sensitive enzyme to oxidative stress was inactivated potently by fructose 1,6-bisphosphate in the presence of ferrous ion, and further by ADP and PEP to a lesser extent. The inactivation requires cyanide, suggesting that the superoxide radical is responsible for the inactivation. Addition of ascorbic acid and dithiothreitol prevented aconitase from the inactivation. Fructose 1,6-bisphosphate, ADP and PEP stimulated the oxidation of ferrous ion causing one-electron reduction of oxygen molecule. Superoxide radical formed with iron oxidation participates in the oxidative inactivation of aconitase and the citric acid cycle, resulting in the induction of the Crabtree effect, that is, high glucose-mediated inhibition of oxidative metabolism in mitochondria.	[Murakami, Keiko; Yoshino, Masataka] Aichi Med Univ, Dept Biochem, Sch Med, Nagakute, Aichi 4801195, Japan	Yoshino, M (reprint author), Aichi Med Univ, Dept Biochem, Sch Med, Nagakute, Aichi 4801195, Japan.	yoshino@aichi-med-u.ac.jp					GARDNER PR, 1992, J BIOL CHEM, V267, P8757; Gaetke LM, 2003, TOXICOLOGY, V189, P147, DOI 10.1016/S0300-483X(03)00159-8; Vasquez-Vivar J, 2000, J BIOL CHEM, V275, P14064, DOI 10.1074/jbc.275.19.14064; FRIDOVICH I, 1995, ANNU REV BIOCHEM, V64, P97, DOI 10.1146/annurev.bi.64.070195.000525; Diaz-Ruiz R, 2008, J BIOL CHEM, V283, P26948, DOI 10.1074/jbc.M800408200; Gardner PR, 2002, METHOD ENZYMOL, V349, P9; HALLIWELL B, 1990, METHOD ENZYMOL, V186, P1; Murakami K, 1997, BIOCHEM MOL BIOL INT, V41, P481; Pierre JL, 1999, BIOMETALS, V12, P195, DOI 10.1023/A:1009252919854; Valko M, 2005, CURR MED CHEM, V12, P1161, DOI 10.2174/0929867053764635; VANURK H, 1990, APPL ENVIRON MICROB, V56, P281; Bajic A, 2011, CARBOHYD RES, V346, P416, DOI 10.1016/j.carres.2010.12.008; CHAPMAN C, 1969, BIOCHEM J, V111, P609; Crabtree HG, 1929, BIOCHEM J, V22, P1289; EVTODIENKO YV, 1994, CELL CALCIUM, V15, P439, DOI 10.1016/0143-4160(94)90108-2; GATT S, 1959, J BIOL CHEM, V234, P1015; LEE AC, 1994, J BIOL CHEM, V269, P30974; MURAKAMI K, 1980, ANAL BIOCHEM, V105, P407, DOI 10.1016/0003-2697(80)90479-0; Murakami K, 2006, ARCH MICROBIOL, V186, P385, DOI 10.1007/s00203-006-0153-1; Murakami K, 2006, BIOMETALS, V19, P429, DOI 10.1007/s10534-005-4528-6; Rodriguez-Enriquez S, 2001, EUR J BIOCHEM, V268, P2512, DOI 10.1046/j.1432-1327.2001.02140.x; SALAS ML, 1965, BIOCHEM BIOPH RES CO, V19, P371, DOI 10.1016/0006-291X(65)90471-7; TORNHEIM K, 1980, J THEOR BIOL, V85, P199, DOI 10.1016/0022-5193(80)90018-1; Wojtczak L, 1999, EUR J BIOCHEM, V263, P495, DOI 10.1046/j.1432-1327.1999.00522.x; Yoshino M, 1998, ANAL BIOCHEM, V257, P40, DOI 10.1006/abio.1997.2522; YOSHINO M, 1985, J BIOL CHEM, V260, P4729; ZIZI M, 1994, J BIOL CHEM, V269, P1614	27	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0966-0844	1572-8773		BIOMETALS	Biometals	AUG	2015	28	4					687	691		10.1007/s10534-015-9856-6		5	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CL3UY	WOS:000356877600008		
J	Yashima, Y; Okamoto, K; Sakai, E; Iwatake, M; Fukuma, Y; Nishishita, K; Tsukuba, T				Yashima, Yuka; Okamoto, Kuniaki; Sakai, Eiko; Iwatake, Mayumi; Fukuma, Yutaka; Nishishita, Kazuhisa; Tsukuba, Takayuki			Cobalt protoporphyrin represses osteoclastogenesis through blocking multiple signaling pathways	BIOMETALS			English	Article						Osteoclasts; Cobalt protoporphyrin; Hemeoxigenase-1; RANKL	NF-KAPPA-B; HEME OXYGENASE-1 INDUCTION; DENDRITIC CELL MATURATION; BONE-RESORPTION; UP-REGULATION; RANKL; ACTIVATION; DIFFERENTIATION; APOPTOSIS; RECEPTOR	Cobalt protoporphyrin (CoPP) is a metallo-protoporphyrin that works as a powerful inducer of heme oxigenase-1 (HO-1) in various tissues and cells. Our recent studies have demonstrated that induction of HO-1 by several reagents inhibited differentiation and activation of osteoclasts (OCLs), which are multinucleated bone resorbing cells. However, the effects of CoPP on osteoclastogenesis remain to be elucidated. In this study, we report that CoPP inhibits receptor activator of nuclear factor kappa B ligand (RANKL)-induced OCL formation in a dose dependent manner. Importantly, CoPP had little cytotoxicity, but rather enhanced cell proliferation of OCLs. CoPP suppressed the protein levels of nuclear factor of activated T cells cytoplasmic-1 (NFATc1) as well as those of OCLs markers such as Src and cathepsin K, which are transcriptionally regulated by NFATc1 in mature OCLs. Western blot analyses also showed that CoPP abolished RANKL-stimulated phosphorylation of several major signaling pathways such as I kappa B, Akt, ERK, JNK and p38 MAPKs in OCL precursor cells. Thus, our results show that CoPP represses osteoclastogenesis through blocking multiple signaling pathways.	[Yashima, Yuka; Okamoto, Kuniaki; Sakai, Eiko; Iwatake, Mayumi; Fukuma, Yutaka; Nishishita, Kazuhisa; Tsukuba, Takayuki] Nagasaki Univ, Div Dent Pharmacol, Grad Sch Biomed Sci, Nagasaki 8528588, Japan	Tsukuba, T (reprint author), Nagasaki Univ, Div Dent Pharmacol, Grad Sch Biomed Sci, 1-7-1 Sakamoto, Nagasaki 8528588, Japan.	tsuta@nagasaki-u.ac.jp			 [25293383];  [15H05298];  [30264055]	This work was supported in part by Grants-in-Aid for Scientific Research (B) Grant Number 25293383, 15H05298, and for Exploratory Research Grant Number 30264055. (T.T).	Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Chauveau C, 2005, BLOOD, V106, P1694, DOI 10.1182/blood-2005-02-0494; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; Cai CX, 2012, J BIOL CHEM, V287, P33720, DOI 10.1074/jbc.M112.385542; Amersi F, 1999, J CLIN INVEST, V104, P1631, DOI 10.1172/JCI7903; Hotokezaka H, 2002, J BIOL CHEM, V277, P47366, DOI 10.1074/jbc.M208284200; Ha H, 2004, EXP CELL RES, V301, P119, DOI 10.1016/j.yexer.2004.07.035; Clerigues V, 2012, CLIN SCI, V122, P239, DOI 10.1042/CS20100519; Darnay BG, 1999, J BIOL CHEM, V274, P7724, DOI 10.1074/jbc.274.12.7724; Busserolles J, 2006, INT J BIOCHEM CELL B, V38, P1510, DOI 10.1016/j.biocel.2006.03.013; Kim MS, 2010, J BIOL CHEM, V285, P6913, DOI 10.1074/jbc.M109.051557; Delaisse JM, 2003, MICROSC RES TECHNIQ, V61, P504, DOI 10.1002/jemt.10374; Guillen MI, 2008, J PATHOL, V214, P515, DOI 10.1002/path.2313; Matsumoto M, 2000, J BIOL CHEM, V275, P31155, DOI 10.1074/jbc.M001229200; Lee NK, 2005, BLOOD, V106, P852, DOI 10.1182/blood-2004-09-3662; Lee WY, 2014, TOXICOL APPL PHARM, V274, P55, DOI 10.1016/j.taap.2013.10.027; Sakai E, 2013, J PHARMACOL SCI, V121, P288, DOI 10.1254/jphs.12243FP; Zwerina J, 2005, FASEB J, V19, P2011, DOI 10.1096/fj.05-4278fje; Nicolai A, 2009, HYPERTENSION, V53, P508, DOI 10.1161/HYPERTENSIONAHA.108.124701; Kamiya T, 1998, J BIOCHEM-TOKYO, V123, P752; Zhang YH, 2001, J BIOL CHEM, V276, P563; Sakai E, 2012, J CELL BIOCHEM, V113, P486, DOI 10.1002/jcb.23372; Elmarakby AA, 2012, AM J PHYSIOL-RENAL, V302, pF791, DOI 10.1152/ajprenal.00472.2011; Fumimoto R, 2012, J PHARMACOL SCI, V118, P479, DOI 10.1254/jphs.11212FP; Hu JP, 2008, EUR J PHARMACOL, V580, P70, DOI 10.1016/j.ejphar.2007.11.013; Kim SJ, 2012, LIFE SCI, V90, P169, DOI 10.1016/j.lfs.2011.10.003; Lin HY, 2009, CHEM-BIOL INTERACT, V180, P202, DOI 10.1016/j.cbi.2009.01.004; Mashreghi MF, 2008, J IMMUNOL, V180, P7919; Shan Y, 2000, ARCH BIOCHEM BIOPHYS, V380, P219, DOI 10.1006/abbi.2000.1921; Song JD, 2011, INT J MOL MED, V28, P841, DOI 10.3892/ijmm.2011.736	30	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0966-0844	1572-8773		BIOMETALS	Biometals	AUG	2015	28	4					725	732		10.1007/s10534-015-9861-9		8	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CL3UY	WOS:000356877600012		
J	Shimizu, T				Shimizu, Takanori			Effect of Coordinate Rotation Systems on Calculated Fluxes over a Forest in Complex Terrain: A Comprehensive Comparison	BOUNDARY-LAYER METEOROLOGY			English	Article						Complex terrain; Coordinate system; Heat and mass fluxes; Offset error	EDDY-CORRELATION SYSTEMS; SONIC ANEMOMETERS; ENERGY IMBALANCE; QUALITY-CONTROL; PART 1; COVARIANCE; PATH; APPLICABILITY; CO2; EVAPOTRANSPIRATION	Seven coordinate rotation systems were compared to determine a suitable system for a forest in complex terrain, using eddy-covariance data for a period of 40 days. The traditional double rotation was set as the standard of comparison with six other fixed coordinate systems, whose coefficients were carefully determined based on wind component data for a two-year period. Differences in total heat fluxes and daytime fluxes calculated from all systems were small, except those from the sector-wise planar fit, which linearly and systematically underestimated the fluxes by about 5 %. The nighttime flux was also underestimated by the sector-wise planar fit, but there was significant scatter in the plots, and the mean difference was 7 %. The standard deviations of the wind components and scalars normalized by the friction velocity and the dynamic parameters were calculated for each system, and the errors from the relationships obtained previously from flat and homogenous terrain were examined. The nighttime normalized standard deviation for scalars agreed better with the relationships after applying the sector-wise planar fit than those calculated by the other systems, although no remarkable difference was found in the daytime data. Therefore, the sector-wise planar fit was not the first choice for our site during daytime based on the energy imbalance, which was mainly caused by underestimating daytime heat fluxes. Double rotation or one of the four systems without the roll rotation process might be superior at our site. However, the offset error in the vertical wind component of the sonic anemometer induced errors of several percent in the fluxes in these systems, which was equivalent to the underestimation using the sector-wise planar fit. Meanwhile, the sector-wise planar fit system might still be the best system for calculating nighttime flux, considering the tendency of the nighttime normalized standard deviations.	Forestry & Forest Prod Res Inst, Dept Soil & Water Conservat, Tsukuba, Ibaraki 3058687, Japan	Shimizu, T (reprint author), Forestry & Forest Prod Res Inst, Dept Soil & Water Conservat, 1 Matsunosato, Tsukuba, Ibaraki 3058687, Japan.	simizuta@affrc.go.jp					Inagaki A, 2006, J METEOROL SOC JPN, V84, P187, DOI 10.2151/jmsj.84.187; Gockede M, 2008, BIOGEOSCIENCES, V5, P433; Finnigan JJ, 2004, BOUND-LAY METEOROL, V113, P1, DOI 10.1023/B:BOUN.0000037348.64252.45; WEBB EK, 1980, Q J ROY METEOR SOC, V106, P85, DOI 10.1002/qj.49710644707; Ibrom A, 2007, TELLUS B, V59, P937, DOI 10.1111/j.1600-0889.2007.00311.x; Turnipseed AA, 2003, AGR FOREST METEOROL, V119, P1, DOI 10.1016/S0168-1923(03)00136-9; Mildenberger K, 2009, AGR FOREST METEOROL, V149, P1730, DOI 10.1016/j.agrformet.2009.06.004; Wilczak JM, 2001, BOUND-LAY METEOROL, V99, P127, DOI 10.1023/A:1018966204465; Foken T, 2008, ECOL APPL, V18, P1351, DOI 10.1890/06-0922.1; Finnigan JJ, 2003, BOUND-LAY METEOROL, V107, P1, DOI 10.1023/A:1021554900225; Foken T, 2004, ATMOS OCEAN SCI LIB, V29, P181; Ibrom A, 2007, AGR FOREST METEOROL, V147, P140, DOI 10.1016/j.agrformet.2007.07.007; Nakai T, 2006, AGR FOREST METEOROL, V136, P19, DOI 10.1016/j.agrformet.2006.01.006; Yuan RM, 2011, METEOROL ATMOS PHYS, V110, P123, DOI 10.1007/s00703-010-0113-9; Lee XH, 2004, ATMOS OCEAN SCI LIB, V29, P33; Leuning R, 2012, AGR FOREST METEOROL, V156, P65, DOI 10.1016/j.agrformet.2011.12.002; Aubinet M, 2000, ADV ECOL RES, V30, P113; Foken T, 2006, ATMOS CHEM PHYS, V6, P4395; Foken T, 2008, MICROMETEOROLOGY; ISO, 2002, 16622 ISO; Kaimal J. C., 1994, ATMOSPHERIC BOUNDARY; Kaimal JC, 1988, LECT NOTES; Kosugi Y, 2007, J HYDROL, V337, P269, DOI 10.1016/j.jhydrol.2007.01.039; Lee X, 1998, AGR FOR METEOROL, V91, P29; Li M, 2013, ATMOS MEAS TECH, V6, P221, DOI 10.5194/amt-6-221-2013; Massman W, 2004, ATMOS OCEAN SCI LIB, V29, P133; MCMILLEN RT, 1988, BOUND-LAY METEOROL, V43, P231, DOI 10.1007/BF00128405; MOORE CJ, 1986, BOUND-LAY METEOROL, V37, P17, DOI 10.1007/BF00122754; Ono Keisuke, 2008, Journal of Agricultural Meteorology, V64, P121, DOI 10.2480/agrmet.64.3.5; Paw U. K. T., 2000, BOUND-LAY METEOROL, V97, P487, DOI [10.1023/a:1002786702909, DOI 10.1023/A:1002786702909]; Rebmann C., 2012, EDDY COVARIANCE PRAC, P59, DOI [DOI 10.1007/978-94-007-2351-1_3, DOI 10.1007/978-94-007-2351-1]; Shimizu T, 1999, BOUND-LAY METEOROL, V93, P227, DOI 10.1023/A:1002053313130; Shimizu T, 2007, BOUND-LAY METEOROL, V122, P417, DOI 10.1007/s10546-006-9115-z; Shimizu T, 2015, J HYDROL, V522, P250, DOI 10.1016/j.jhydrol.2014.12.021; Siebicke L, 2012, THEOR APPL CLIMATOL, V109, P109, DOI 10.1007/s00704-011-0552-3; Su HB, 2004, BOUND-LAY METEOROL, V110, P213, DOI 10.1023/A:1026099523505; Sun JL, 2007, BOUND-LAY METEOROL, V124, P143, DOI 10.1007/s10546-007-9186-5; Thomas C, 2002, 15TH SYMPOSIUM ON BOUNDARY LAYERS AND TURBULENCE, P129; Vickers D, 2006, AGR FOREST METEOROL, V138, P93, DOI 10.1016/j.agrformet.2006.04.001; Wieser A, 2001, J ATMOS OCEAN TECH, V18, P1585, DOI 10.1175/1520-0426(2001)018<1585:TIOTSD>2.0.CO;2; Yuan R, 2007, KOREAN J AGR FOR MET, V9, P100	41	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0006-8314	1573-1472		BOUND-LAY METEOROL	Bound.-Layer Meteor.	AUG	2015	156	2					277	301		10.1007/s10546-015-0027-7		25	Meteorology & Atmospheric Sciences	Meteorology & Atmospheric Sciences	CL9HE	WOS:000357287200006		
J	Hasegawa, S; Matsushige, T; Kajimoto, M; Inoue, H; Momonaka, H; Oka, M; Ohga, S; Ichiyama, T				Hasegawa, Shunji; Matsushige, Takeshi; Kajimoto, Madoka; Inoue, Hirofumi; Momonaka, Hiroshi; Oka, Momoko; Ohga, Shouchi; Ichiyama, Takashi		Japanese Soc Pediat Immunemediated	A nationwide survey of opsoclonus-myoclonus syndrome in Japanese children	BRAIN & DEVELOPMENT			English	Article						Opsoclonus-myoclonus syndrome (OMS); Incidence; Japan; Survey	ATAXIA SYNDROME; NEUROBLASTOMA; RITUXIMAB	Background: Opsoclonus-myoclonus syndrome (OMS) is a rare neurological disease characterized by opsoclonus, myoclonus, ataxia, and behavioral changes. The aim of our study was to investigate the epidemiological characteristics of OMS in Japan and to clarify the association between therapy and prognosis. Methods: We retrospectively collected the data from 626 Japanese medical institutions from 2005 to 2010, and analyzed the clinical features of pediatric patients with OMS based on the data. Results: In this survey, there were 23 patients.(10 males and 13 females). The median ages at the disease onset and the time of study were 16.5 months (range: 11-152 months) and 54 months (range: 24-160 months), respectively. The principal symptoms were opsoclonus (23 patients, 100%), myoclonus (21 patients, 91.3%), and ataxia (23 patients, 100%). The related factors were neuroblastoma (10, 43.5%), infection (9, 39.1%), and immunization (2, 8.7%). The treatments for OMS were included intravenous immunoglobulin (17, 73.9%), methylprednisolone pulse (13, 56.5%), oral prednisolone (12 patients, 52.2%), and chemotherapy and/or operation for the underlying tumors (6, 26.1%), and rituximab (2, 8.7%). Complete remissions were obtained in 35.3%, 23.1%, 33.3%, 66.7%, and 100% of these treatments, respectively. At the latest follow-up period, 8 (34.8%) and 17 patients (73.9%) showed neurological sequelae of motor and intellectual functions, respectively. Patients whose treatment was started more than 30 weeks after the disease onset suffered from the severest neurological sequelae (OMS severity 4) more frequently than those less than 30 weeks (p = 0.022). Conclusion: The annual incidence of OMS was estimated to be 0.27-0.40 cases per million in Japanese children. More than 70% of OMS patients had neurological sequelae, especially intellectual function. Early effective treatments within 30 weeks after the onset may be required to prevent the serious neurological outcome. (C) 2014 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved.	[Hasegawa, Shunji; Matsushige, Takeshi; Kajimoto, Madoka; Inoue, Hirofumi; Momonaka, Hiroshi; Oka, Momoko; Ohga, Shouchi; Ichiyama, Takashi] Yamaguchi Univ, Dept Pediat, Grad Sch Med, Ube, Yamaguchi 7558505, Japan; [Ichiyama, Takashi] Tsudumigaura Handicapped Childrens Hosp, Dept Pediat, Tokyo, Japan	Hasegawa, S (reprint author), Yamaguchi Univ, Dept Pediat, Grad Sch Med, Ube, Yamaguchi 7558505, Japan.	shunji@yamaguchi-u.ac.jp					Alavi S, 2012, CASE REP ONCOL MED, V2012; Sinha S, 2014, INDIAN J PEDIATR, V81, P218, DOI 10.1007/s12098-013-1042-7; Klein A, 2007, EUR J PEDIATR, V166, P359, DOI 10.1007/s00431-006-0247-4; Fuhlhuber V, 2009, J NEUROIMMUNOL, V210, P87, DOI 10.1016/j.jneuroim.2009.03.006; Gorman MP, 2010, CURR OPIN PEDIATR, V22, P745, DOI 10.1097/MOP.0b013e32833fde3f; Dalakas MC, 2008, NEUROLOGY, V70, P2252, DOI 10.1212/01.wnl.0000313840.27060.bf; Pranzatelli MR, 2011, CYTOKINE, V53, P384, DOI 10.1016/j.cyto.2010.12.004; Pang KK, 2010, EUR J PAEDIATR NEURO, V14, P156, DOI 10.1016/j.ejpn.2009.03.002; Raffaghello L, 2009, EUR J PAEDIATR NEURO, V13, P219, DOI 10.1016/j.ejpn.2008.04.012; Battaglia T, 2012, EUR J PAEDIATR NEURO, V16, P192, DOI 10.1016/j.ejpn.2011.05.013; Brunklaus A, 2011, PEDIATRICS, V128, pE388, DOI 10.1542/peds.2010-3114; Desai J, 2012, J CHILD NEUROL, V27, P1482, DOI 10.1177/0883073812450318; KINSBOURNE M, 1962, J NEUROL NEUROSUR PS, V25, P271, DOI 10.1136/jnnp.25.3.271; Krug P, 2010, EUR J PAEDIATR NEURO, V14, P400, DOI 10.1016/j.ejpn.2009.12.005; Leen WG, 2008, PEDIATR NEUROL, V39, P213, DOI 10.1016/j.pediatrneurol.2008.05.015; Matthay KK, 2005, CANCER LETT, V228, P275, DOI 10.1016/j.canlet.2005.01.051; Pranzatelli MR, 2004, MOVEMENT DISORD, V19, P770, DOI 10.1002/mds.20125; Sahu Jitendra Kumar, 2011, Pract Neurol, V11, P160, DOI 10.1136/practneurol-2011-000017; Singhi P, 2014, J CHILD NEUROL, V29, P58, DOI 10.1177/0883073812471433; Tate Elizabeth D, 2005, J Pediatr Oncol Nurs, V22, P8, DOI 10.1177/1043454204272560	20	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0387-7604	1872-7131		BRAIN DEV-JPN	Brain Dev.	AUG	2015	37	7					656	660		10.1016/j.braindev.2014.10.010		5	Clinical Neurology	Neurosciences & Neurology	CL8SB	WOS:000357243300002		
J	Takarada, T; Nishida, A; Takeuchi, A; Lee, T; Takeshima, Y; Matsuo, M				Takarada, Toru; Nishida, Atsushi; Takeuchi, Atsuko; Lee, Tomoko; Takeshima, Yasuhiro; Matsuo, Masafumi			Resveratrol enhances splicing of insulin receptor exon 11 in myotonic dystrophy type 1 fibroblasts	BRAIN & DEVELOPMENT			English	Article						Resveratrol; Insulin receptor; Splicing; Myotonic dystrophy 1	RNA; BINDING; CELLS; IDENTIFICATION; INCLUSION; ISOFORM; TARGETS; PROTEIN; DESIGN; GENE	Introduction: Myotonic dystrophy type 1 (DM1) is characterized by splicing abnormalities caused by CUG expansion of the DMPK gene transcript. Splicing of exon 11 of the insulin receptor (IR) gene is deregulated to suppress exon 11 inclusion into mRNA in DM1. Consequently, the exon 11-deleted IR isoform that is less sensitive to insulin is predominantly produced, leading to glucose intolerance in DM1. Upregulation of exon 11 retaining full-length IR mRNA is a potential way to recover insulin sensitivity in DM1. Methods: We examined candidate chemicals for their ability to enhance inclusion of exon 11 of the IR gene in cultured cells by reverse transcription-PCR amplification of a fragment extending from exons 10 to 12 of IR mRNA. Results: We revealed that resveratrol (RES) enhanced the percentage of exon 11-containing IR mRNA among the total IR mRNA in HeLa cells. The RES-mediated enhancement of exon 11 inclusion was cell-specific and highest in fibroblasts. We tested RES on four fibroblast samples from three generations of one DM1 family. In each sample, RES treatment significantly upregulated the percentage of exon 11-containing IR mRNA to levels higher than that of the control, irrespective of the length of the sample's CTG repeat expansion. Discussion: A natural compound, RES, was shown for the first time to upregulate the full-length IR mRNA in fibroblasts from DM1 cases. Our results provide the justification of RES as a leading compound to improve glucose tolerance in DM1. (C) 2014 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved.	[Takarada, Toru; Nishida, Atsushi; Matsuo, Masafumi] Kobegakuin Univ, Fac Rehabil, Dept Rehabil Med, Nishi Ku, Kobe, Hyogo 6512180, Japan; [Takarada, Toru; Takeuchi, Atsuko] Kobe Pharmaceut Univ, Higashinada Ku, Kobe, Hyogo 6588558, Japan; [Lee, Tomoko; Takeshima, Yasuhiro] Hyogo Coll Med, Dept Pediat, Nishinomiya, Hyogo 6638131, Japan	Matsuo, M (reprint author), Kobegakuin Univ, Fac Rehabil, Dept Rehabil Med, Nishi Ku, 518 Arise, Kobe, Hyogo 6512180, Japan.	mmatsuo@reha.kobegakuin.ac.jp			Japan Society for the Promotion of Science; Ministry of Health, Labour and Welfare, Japan	This work was supported by a Grant-in-Aid for Scientific Research (B) and a Grant-in-Aid for Exploratory Research from the Japan Society for the Promotion of Science, a Health and Labour Sciences Research Grant for Research on Psychiatric and Neurological Diseases and Mental Health, and a research Grant for Nervous and Mental Disorders from the Ministry of Health, Labour and Welfare, Japan.	Baur JA, 2006, NAT REV DRUG DISCOV, V5, P493, DOI 10.1038/nrd2060; Warf MB, 2009, P NATL ACAD SCI USA, V106, P18551, DOI 10.1073/pnas.0903234106; Savkur RS, 2001, NAT GENET, V29, P40, DOI 10.1038/ng704; Magana JJ, 2011, J NEUROSCI RES, V89, P275, DOI 10.1002/jnr.22551; Fubini SL, 2001, J ORTHOPAED RES, V19, P688, DOI 10.1016/S0736-0266(00)00060-7; Osborne RJ, 2006, HUM MOL GENET, V15, pR162, DOI 10.1093/hmg/ddl181; Timmers S, 2011, CELL METAB, V14, P612, DOI 10.1016/j.cmet.2011.10.002; Sen S, 2009, MOL CELL BIOL, V29, P871, DOI 10.1128/MCB.01709-08; Parkesh R, 2012, J AM CHEM SOC, V134, P4731, DOI 10.1021/ja210088v; Dasgupta B, 2007, P NATL ACAD SCI USA, V104, P7217, DOI 10.1073/pnas.0610068104; Frasca F, 1999, MOL CELL BIOL, V19, P3278; Udd B, 2012, LANCET NEUROL, V11, P891, DOI 10.1016/S1474-4422(12)70204-1; Munch C, 2008, NEUROCHEM RES, V33, P1005, DOI 10.1007/s11064-007-9540-5; Baur JA, 2012, NAT REV DRUG DISCOV, V11, P443, DOI 10.1038/nrd3738; Hims MM, 2007, J MOL MED-JMM, V85, P149, DOI 10.1007/s00109-006-0137-2; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Baur JA, 2010, BBA-PROTEINS PROTEOM, V1804, P1626, DOI 10.1016/j.bbapap.2009.10.025; Philips AV, 1998, SCIENCE, V280, P737, DOI 10.1126/science.280.5364.737; Pushechnikov A, 2009, J AM CHEM SOC, V131, P9767, DOI 10.1021/ja9020149; Patel R, 2013, J BIOL CHEM, V288, P26834, DOI 10.1074/jbc.M113.482638; Brown VA, 2010, CANCER RES, V70, P9003, DOI 10.1158/0008-5472.CAN-10-2364; Dardis A, 2014, NUCLEIC ACIDS RES, V42, P1291, DOI 10.1093/nar/gkt987; Day JW, 2005, NEUROMUSCULAR DISORD, V15, P5, DOI 10.1016/j.nmd.2004.09.012; Echeverria GV, 2014, NUCLEIC ACIDS RES, V42, P1893, DOI 10.1093/nar/gkt1020; Gao ZH, 2013, HUM GENE THER, V24, P499, DOI 10.1089/hum.2012.212; Leiro JM, 2010, MOL IMMUNOL, V47, P1114, DOI 10.1016/j.molimm.2009.10.030; Mahadevan MS, 2012, CURR OPIN NEUROL, V25, P609, DOI 10.1097/WCO.0b013e328357b0d9; Markus MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028926; Nilsen Timothy W, 2013, Cold Spring Harb Protoc, V2013, P584, DOI 10.1101/pdb.prot075184; Nishida A, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1306; Perez-Carro R, 2014, CLIN GENET, V86, P167, DOI 10.1111/cge.12243; Sciacca L, 2003, ENDOCRINOLOGY, V144, P2650, DOI 10.1210/en.2002-0136; Sen S, 2010, J BIOL CHEM, V285, P25426, DOI 10.1074/jbc.M109.095224; Talukdar I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027869; Vang O, 2013, ANN NY ACAD SCI, V1290, P1, DOI 10.1111/nyas.12173; Vang O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019881	36	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0387-7604	1872-7131		BRAIN DEV-JPN	Brain Dev.	AUG	2015	37	7					661	668		10.1016/j.braindev.2014.11.001		8	Clinical Neurology	Neurosciences & Neurology	CL8SB	WOS:000357243300003		
J	Harahap, NIF; Takeuchi, A; Yusoff, S; Tominaga, K; Okinaga, T; Kitai, Y; Takarada, T; Kubo, Y; Saito, K; Sa'adah, N; Nurputra, DK; Nishimura, N; Saito, T; Nishio, H				Harahap, Nur Imma Fatimah; Takeuchi, Atsuko; Yusoff, Surini; Tominaga, Koji; Okinaga, Takeshi; Kitai, Yukihiro; Takarada, Toru; Kubo, Yuji; Saito, Kayoko; Sa'adah, Nihayatus; Nurputra, Dian Kesumapramudya; Nishimura, Noriyuki; Saito, Toshio; Nishio, Hisahide			Trinucleotide insertion in the SMN2 promoter may not be related to the clinical phenotype of SMA	BRAIN & DEVELOPMENT			English	Article						Spinal muscular atrophy; SMN1; SMN2; Promoter; Polymorphism	SPINAL MUSCULAR-ATROPHY; SINGLE NUCLEOTIDE; COPY NUMBER; GENE; SEVERITY; CELLS; EXPRESSION; MUTATIONS; PCR	Background: More than 90% of spinal muscular atrophy (SMA) patients show homozygous deletion of SMN1 (survival motor neuron 1). They retain SMN2, a highly homologous gene to SMN1, which may partially compensate for deletion of SMN1. Although the promoter sequences of these two genes are almost identical, a GCC insertion polymorphism has been identified at c.-320_-321 in the SMN1 promoter. We have also found this insertion polymorphism in an SMN2 promoter in an SMA patient (Patient A) who has SMA type 2/3. Purpose: The aims of this study were to determine the frequency of the GCC insertion polymorphism in SMA patients, and to evaluate its effect on SMN transcription efficiency. Patients and methods: Fifty-one SMA patients, including Patient A, were involved in this study. SMN2 transcript levels in white blood cells were measured by real-time polymerase chain reaction. Screening of the GCC insertion polymorphism was performed using denaturing high-pressure liquid chromatography. The transcription efficiency of the promoter with the insertion mutation was evaluated using a reporter-gene assay. Results: All SMA patients in this study were homozygous for SMN1 deletion. Patient A retained two copies of SMN2, and showed only a small amount of SMN2 transcript in white blood cells. We detected a GCC insertion polymorphism at c.-320_-321 only in Patient A, and not in 50 other SMA patients. The polymorphism had a slight but significant negative effect on transcription efficiency. Discussion and conclusion: Patient A was judged to be an exceptional case of SMA, because the GCC insertion polymorphism rarely exists in SMN1-deleted SMA patients. The GCC insertion polymorphism did not enhance the transcriptional efficiency of SMN2. Thus, this GCC insertion polymorphism in the SMN2 promoter may not be associated with the milder phenotype of the patient. Patient A suggests that there are other unknown factors modifying the clinical phenotype of SMA. (C) 2014 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved.	[Harahap, Nur Imma Fatimah; Yusoff, Surini; Sa'adah, Nihayatus; Nurputra, Dian Kesumapramudya; Nishimura, Noriyuki; Nishio, Hisahide] Kobe Univ, Grad Sch Med, Dept Community Med & Social Healthcare Sci, Kobe, Hyogo 6500017, Japan; [Takeuchi, Atsuko; Takarada, Toru] Kobe Pharmaceut Univ, Kobe, Hyogo 6588558, Japan; [Yusoff, Surini] Univ Sains Malaysia, Dept Pediat, Kelantan 16150, Malaysia; [Tominaga, Koji] Osaka Univ, Dept Pediat, Grad Sch Med, Osaka 5650871, Japan; [Okinaga, Takeshi] Bell Land Gen Hosp, Dept Pediat, Sakai, Osaka 5998247, Japan; [Kitai, Yukihiro] Morinomiya Hosp, Dept Pediat Neurol, Osaka 5360023, Japan; [Kubo, Yuji; Saito, Kayoko] Tokyo Womens Med Univ, Inst Med Genet, Tokyo, Japan; [Nishimura, Noriyuki; Nishio, Hisahide] Kobe Univ, Grad Sch Med, Dept Pediat, Kobe, Hyogo 6500871, Japan; [Saito, Toshio] Natl Hosp Org Toneyama Natl Hosp, Div Child Neurol, Dept Neurol, Toyonaka, Osaka, Japan	Nishio, H (reprint author), Kobe Univ, Grad Sch Med, Dept Community Med & Social Healthcare Sci, Chuo Ku, 7-5-1 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	nishio@med.kobe-u.ac.jp		Yusoff, Surini/0000-0003-1274-0930	Ministry of Education, Science, Sports and Culture of Japan [22591127]; Research Committee of Spinal Muscular Atrophy (SMA), the Ministry of Health, Labour and Welfare of Japan	This work was supported by a Grant-in-Aid from the Ministry of Education, Science, Sports and Culture of Japan (project number 22591127) and a Grant-in-Aid from the Research Committee of Spinal Muscular Atrophy (SMA), the Ministry of Health, Labour and Welfare of Japan.	Harada Y, 2002, J NEUROL, V249, P1211, DOI 10.1007/s00415-002-0811-4; Oprea GE, 2008, SCIENCE, V320, P524, DOI [10.1126/science.1155085, 10.1126/science.1155085\]; Lefebvre S, 1997, NAT GENET, V16, P265, DOI 10.1038/ng0797-265; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; Nurputra DK, 2013, ANN HUM GENET, V77, P435, DOI 10.1111/ahg.12031; Monani UR, 1999, HUM MOL GENET, V8, P1177, DOI 10.1093/hmg/8.7.1177; Feldkotter M, 2002, AM J HUM GENET, V70, P358, DOI 10.1086/338627; Lorson CL, 1999, P NATL ACAD SCI USA, V96, P6307, DOI 10.1073/pnas.96.11.6307; Sutomo R, 2002, AM J MED GENET, V113, P225, DOI 10.1002/ajmg.10744; Kolb SJ, 2011, ARCH NEUROL-CHICAGO, V68, P979, DOI 10.1001/archneurol.2011.74; Riessland M, 2006, HUM GENET, V120, P101, DOI 10.1007/s00439-006-0186-1; Swoboda KJ, 2005, ANN NEUROL, V57, P704, DOI 10.1002/ana.20473; Tran VK, 2008, PEDIATR INT, V50, P346, DOI 10.1111/j.1442-200X.2008.02590.x; Prior TW, 2009, AM J HUM GENET, V85, P408, DOI 10.1016/j.ajhg.2009.08.002; VANDERSTEEGE G, 1995, LANCET, V345, P985, DOI 10.1016/S0140-6736(95)90732-7; Lorson CL, 1998, NAT GENET, V19, P63, DOI 10.1038/ng0598-63; Boda B, 2004, EUR J HUM GENET, V12, P729, DOI 10.1038/sj.ejhg.5201217; DUBOWITZ V, 1995, NEUROMUSCULAR DISORD, V5, P3; Echaniz-Laguna A, 1999, AM J HUM GENET, V64, P1365, DOI 10.1086/302372; Harahap ISK, 2012, BRAIN DEV-JPN, V34, P213, DOI 10.1016/j.braindev.2011.04.010; Monani UR, 1999, BBA-GENE STRUCT EXPR, V1445, P330, DOI 10.1016/S0167-4781(99)00060-3; Sun Y, 2005, HUM MUTAT, V25, P64, DOI 10.1002/humu.20111; Vezain M, 2010, HUM MUTAT, V31, pE1110, DOI 10.1002/humu.21173; Wirth Brunhilde, 2006, Semin Pediatr Neurol, V13, P121, DOI 10.1016/j.spen.2006.06.008; Wu G, 1998, J NEUROCYTOL, V27, P1, DOI 10.1023/A:1006910001869; Yamamoto T, 2014, BRAIN DEV-JPN, V36, P914, DOI 10.1016/j.braindev.2013.11.009; Zerres K, 1999, Neuromuscul Disord, V9, P272, DOI 10.1016/S0960-8966(99)00016-4	27	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0387-7604	1872-7131		BRAIN DEV-JPN	Brain Dev.	AUG	2015	37	7					669	676		10.1016/j.braindev.2014.10.006		8	Clinical Neurology	Neurosciences & Neurology	CL8SB	WOS:000357243300004		
J	Okumura, A; Ozaki, M; Niida, Y				Okumura, Akiko; Ozaki, Mamoru; Niida, Yo			Development of a practical NF1 genetic testing method through the pilot analysis of five Japanese families with neurofibromatosis type 1	BRAIN & DEVELOPMENT			English	Article						Neurofibromatosis type 1; NF1; Genetic testing; Enzyme mismatch cleavage; CEL nuclease; DNA microarray	ENZYME MISMATCH CLEAVAGE; LOW-COPY REPEATS; COMMON DELETION; SOTOS-SYNDROME; MICRODELETIONS; MUTATIONS; SPECTRUM	Objective: Mutation analysis of NF1, the responsible gene for neurofibromatosis type 1 (NF1), is still difficult due to its large size, lack of mutational hotspots, the presence of many pseudogenes, and its wide spectrum of mutations. To develop a simple and inexpensive NF1 genetic testing for clinical use, we analyzed five Japanese families with NF1 as a pilot study. Methods: Our original method, CEL endonuclease mediated heteroduplex incision with polyacrylamide gel electrophoresis and silver staining (CHIPS) was optimized for NF1 mutation screening, and reverse transcription polymerase chain reaction (RT-PCR) was performed to determine the effect of transcription. Also, we employed DNA microarray analysis to evaluate the break points of the large deletion. Results: A new nonsense mutation, p.G1n209*, was detected in family 1 and the splicing donor site mutation, c.2850+1G>T, was detected in family 2 In family 3, c.4402A>G was detected in exon 34 and the p.Ser1468Gly missense mutation was predicted. However mRNA analysis revealed that this substitution created an aberrant splicing acceptor site, thereby causing the p.Phe1457* nonsense mutation. In the other two families, type-1 and unique NF1 microdeletions were detected by DNA microarray analysis. Conclusions: Our results show that the combination of CHIPS and RT-PCR effectively screen and characterize NF1 point mutations, and both DNA and RNA level analysis are required to understand the nature of the NF1 mutation. Our results also suggest the possibility of a higher incidence and unique profile of NF1 large deletions in the Japanese population as compared to previous studies performed in Europe. (C) 2014 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved.	[Okumura, Akiko] Kanazawa Univ, Grad Sch Med Sci, Dept Pediat, Kanazawa, Ishikawa 9201192, Japan; [Ozaki, Mamoru; Niida, Yo] Kanazawa Med Univ, Med Res Inst, Div Genom Med, Dept Adv Med, Uchinada, Ishikawa 9200293, Japan; [Ozaki, Mamoru; Niida, Yo] Kanazawa Med Univ Hosp, Ctr Med Genet, Kanazawa, Ishikawa, Japan	Niida, Y (reprint author), Kanazawa Med Univ, Med Res Inst, Div Genom Med, Dept Adv Med, 1-1 Daigaku, Uchinada, Ishikawa 9200293, Japan.	niida@kanazawa-med.ac.jp			JSPS KAKENHI grant [22591122]	This work was supported by JSPS KAKENHI grant (No. 22591122).	Kurotaki N, 2003, HUM MUTAT, V22, P378, DOI 10.1002/humu.10270; Balla B, 2014, J MOL NEUROSCI, V53, P204, DOI 10.1007/s12031-014-0286-7; WALLACE MR, 1990, SCIENCE, V249, P181, DOI 10.1126/science.2134734; Ji YT, 2007, ELECTROPHORESIS, V28, P1173, DOI 10.1002/elps.200600557; Hirbe AC, 2014, LANCET NEUROL, V13, P834, DOI 10.1016/S1474-4422(14)70063-8; Tsuji T, 2008, ELECTROPHORESIS, V29, P1473, DOI 10.1002/elps.200700729; Lopez-Correa C, 2001, HUM MOL GENET, V10, P1387, DOI 10.1093/hmg/10.13.1387; Brinckmann A, 2007, ELECTROPHORESIS, V28, P4295, DOI 10.1002/elps.200700118; Sharif S, 2011, J MED GENET, V48, P256, DOI 10.1136/jmg.2010.081760; Upadhyaya M, 1997, HUM GENET, V99, P88; LAHIRI DK, 1993, BIOCHEM GENET, V31, P321, DOI 10.1007/BF00553174; Osborn MJ, 1999, HUM GENET, V105, P327, DOI 10.1007/s004390051109; Ko JM, 2013, PEDIATR NEUROL, V48, P447, DOI 10.1016/j.pediatrneurol.2013.02.004; Kluwe L, 2004, HUM MUTAT, V23, P111, DOI 10.1002/humu.10299; Franz DN, 2012, CURR NEUROL NEUROSCI, V12, P294, DOI 10.1007/s11910-012-0269-4; Kurotaki N, 2005, HUM MOL GENET, V14, P535, DOI 10.1093/hmg/ddi050; Cappione AJ, 1997, AM J HUM GENET, V60, P305; Fahsold R, 2000, AM J HUM GENET, V66, P790, DOI 10.1086/302809; Taschner PEM, 2011, HUM MUTAT, V32, P507, DOI 10.1002/humu.21427; Guttmann DH, 1997, JAMA-J AM MED ASSOC, V278, P51; Hua C, 2014, PEDIATRICS, V133, pE1792, DOI 10.1542/peds.2013-1224; Jones K. L., 2013, SMITHS RECOGNIZABLE; [Anonymous], 1988, ARCH NEUROL-CHICAGO, V45, P575, DOI 10.1097/00005537-199606000-00007; Niida Y, 2014, CLIN GENET; Niida Y, 2012, MOL GENET METAB, V107, P580, DOI 10.1016/j.ymgme.2012.09.008; Pasmant E, 2010, HUM MUTAT, V31, pE1506, DOI 10.1002/humu.21271; Stenson PD, 2012, CURR PROTOC BIOINFOR, DOI DOI 10.1002/0471250953.BI0113S39; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Yohay Kaleb H, 2006, Semin Pediatr Neurol, V13, P21, DOI 10.1016/j.spen.2006.01.007; Yoshida Y, 2008, NIPPON HIFUKA GAKKAI, V118, P1657	30	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0387-7604	1872-7131		BRAIN DEV-JPN	Brain Dev.	AUG	2015	37	7					677	689		10.1016/j.braindev.2014.11.002		13	Clinical Neurology	Neurosciences & Neurology	CL8SB	WOS:000357243300005		
J	Furushima, W; Kaga, M; Nakamura, M; Gunji, A; Inagaki, M				Furushima, Wakana; Kaga, Makiko; Nakamura, Masako; Gunji, Atsuko; Inagaki, Masumi			Auditory agnosia as a clinical symptom of childhood adrenoleukodystrophy	BRAIN & DEVELOPMENT			English	Article						Adrenoleukodystrophy (ALD); Auditory agnosia; Speech discrimination	X-LINKED ADRENOLEUKODYSTROPHY; HEMATOPOIETIC-CELL TRANSPLANTATION; LESIONS; AGE	Objective: To investigate detailed auditory features in patients with auditory impairment as the first clinical symptoms of childhood adrenoleukodystrophy (CSALD). Subjects and methods: Three patients who had hearing difficulty as the first clinical signs and/or symptoms of ALD. Precise examination of the clinical characteristics of hearing and auditory function was performed, including assessments of pure tone audiometry, verbal sound discrimination, otoacoustic emission (OAE), and auditory brainstem response (ABR), as well as an environmental sound discrimination test, a sound lateralization test, and a dichotic listening test (DLT). The auditory pathway was evaluated by MRI in each patient. Results: Poor response to calling was detected in all patients. Two patients were not aware of their hearing difficulty, and had been diagnosed with normal hearing by otolaryngologists at first. Pure-tone audiometry disclosed normal hearing in all patients. All patients showed a normal wave V ABR threshold. Three patients showed obvious difficulty in discriminating verbal sounds, environmental sounds, and sound lateralization and strong left-ear suppression in a dichotic listening test. However, once they discriminated verbal sounds, they correctly understood the meaning. Two patients showed elongation of the I-V and III-V interwave intervals in ABR, but one showed no abnormality. MRIs of these three patients revealed signal changes in auditory radiation including in other subcortical areas. Conclusion: The hearing features of these subjects were diagnosed as auditory agnosia and not aphasia. It should be emphasized that when patients are suspected to have hearing impairment but have no abnormalities in pure tone audiometry and/or ABR, this should not be diagnosed immediately as psychogenic response or pathomimesis, but auditory agnosia must also be considered. (C) 2014 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved.	[Furushima, Wakana; Kaga, Makiko; Nakamura, Masako; Gunji, Atsuko; Inagaki, Masumi] Natl Ctr Neurol & Psychiat, Dept Dev Disorders, NIMH, Kodaira, Tokyo 1878553, Japan; [Furushima, Wakana] Tokyo Med & Dent Univ, Dept Pediat, Tokyo, Japan; [Kaga, Makiko] Tokyo Metropolitan Tobu Med Ctr Children Adults D, Dept Child Neurol, Tokyo, Japan; [Nakamura, Masako] Int Hlth & Welf Univ, Mita Hosp, Dept Otorhinolaryngol, Tokyo, Japan	Kaga, M (reprint author), Tokyo Metropolitan Med Ctr East Children Adults D, Koto Ku, 3-3-25 Shinsuna, Tokyo 1360075, Japan.	kaga@ncnp.go.jp			Research Committee for Adrenoleukodystrophy Project of Research on Measures for Intractable Diseases from the Ministry of Health, Labor and Welfare, Japan; Research Committee for Ataxic Diseases Project of Research on Measures for Intractable Diseases from the Ministry of Health, Labor and Welfare, Japan; Research Committee for Lysosomal Disorders in Childhood Project of Research on Measures for Intractable Diseases from the Ministry of Health, Labor and Welfare, Japan	This study was supported in part by a grant from the Research Committee for Adrenoleukodystrophy (research representative; Shoji Tsuji), the Research Committee for Ataxic Diseases (research representative; Nishizawa Y.) and the Research Committee for Lysosomal Disorders in Childhood (research representative; Etoh Y.) of the Projects of Research on Measures for Intractable Diseases from the Ministry of Health, Labor and Welfare, Japan.	Peters C, 2004, BLOOD, V104, P881, DOI 10.1182/blood-2003-10-3402; Cartier N, 2009, SCIENCE, V326, P818, DOI 10.1126/science.1171242; Shapiro E, 2000, LANCET, V356, P713, DOI 10.1016/S0140-6736(00)02629-5; SUGISHITA M, 1995, BRAIN, V118, P417, DOI 10.1093/brain/118.2.417; Moser HW, 2000, NEUROPEDIATRICS, V31, P227, DOI 10.1055/s-2000-9236; MOSSER J, 1993, NATURE, V361, P726, DOI 10.1038/361726a0; Bamiou Doris-Eva, 2004, J Am Acad Audiol, V15, P152, DOI 10.3766/jaaa.15.2.5; Chiba S, 1996, SHITSUGOSHO KENKYU T, V16, P302; Hatori Takayuki, 2004, No To Hattatsu, V36, P232; Inagaki M, 1996, KENSA TO GIJUTSU TOK, V24, P729; KAGA K, 1980, ARCH OTO-RHINO-LARYN, V228, P17, DOI 10.1007/BF00455890; Kaga K, 1997, ACTA OTO-LARYNGOL, P77; Kaga Kimitaka, 2004, Cochlear Implants Int, V5 Suppl 1, P90, DOI 10.1002/cii.182; Kaga M, 2000, J CHILD NEUROL, V15, P626, DOI 10.1177/088307380001500911; KAGA M, 1992, Acta Paediatrica Japonica, V34, P134; Kaga M, 1999, J CHILD NEUROL, V14, P118, DOI 10.1177/088307389901400210; Kaga M, 2002, BRAIN DEV-JPN, V24, P197, DOI 10.1016/S0387-7604(02)00027-X; Kon K, 2000, BRAIN DEV-JPN, V22, P41, DOI 10.1016/S0387-7604(99)00114-X; Mahmood A, 2007, LANCET NEUROL, V6, P687, DOI 10.1016/S1474-4422(07)70177-1; Moser H, 2001, METABOLIC MOL BASES, VII, P3257; Ohta F, 1981, NO TO CHOUKAKUSHOUGA; Shirane Seiko, 2004, No To Hattatsu, V36, P311; Spreen O., 1977, NEUROSENSORY CTR COM; Suzuki Y, 2005, BRAIN DEV-JPN, V27, P353, DOI 10.1016/j.braindev.2004.09.008; Tanaka K, 1989, NIHON SHONIKA GAKKAI, V93, P950; Tanaka Y, 2002, CORTEX, V38, P69, DOI 10.1016/S0010-9452(08)70639-7; YAMADA K, 1991, Audiology Japan, V34, P238; Yamada K, 1996, HEARING RES, V101, P173, DOI 10.1016/S0378-5955(96)00144-X	28	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0387-7604	1872-7131		BRAIN DEV-JPN	Brain Dev.	AUG	2015	37	7					690	697		10.1016/j.braindev.2014.10.011		8	Clinical Neurology	Neurosciences & Neurology	CL8SB	WOS:000357243300006		
J	Vatanavicharn, N; Yamada, K; Aoyama, Y; Fukao, T; Densupsoontorn, N; Jirapinyo, P; Sathienkijkanchai, A; Yamaguchi, S; Wasant, P				Vatanavicharn, Nithiwat; Yamada, Kenji; Aoyama, Yuka; Fukao, Toshiyuki; Densupsoontorn, Narumon; Jirapinyo, Pipop; Sathienkijkanchai, Achara; Yamaguchi, Seiji; Wasant, Pornswan			Carnitine-acylcarnitine translocase deficiency: Two neonatal cases with common splicing mutation and in vitro bezafibrate response	BRAIN & DEVELOPMENT			English	Article						CACT deficiency; SLC25A20 mutation; IVP assay; Bezafibrate	ACID OXIDATION DISORDERS; CACT DEFICIENCY; FIBROBLASTS; PATIENT; GENE; IDENTIFICATION; DIAGNOSIS; SPECTRUM; THERAPY; DEFECT	Background. Mitochondrial fatty acid oxidation (FAO) disorders are among the causes of acute encephalopathy- or myopathy-like illness. Carnitine acylcarnitine translocase (CACT) deficiency is a rare FAO disorder, which represent an energy production insufficiency during prolonged fasting, febrile illness, or increased muscular activity. CACT deficiency is caused by mutations of the SLC25A20 gene. Most patients developed severe metabolic decompensation in the neonatal period and died in infancy despite aggressive treatment. Patients and methods: We herein report the clinical findings of two unrelated cases of CACT deficiency with mutation confirmation, and in vitro bezafibrate responses using in vitro probe acylcarnitine (IVP) assay. Patients 1 and 2 are products of nonconsanguineous parents. Both patients developed cardiac arrest at day 3 of life but survived the initial events. Their blood chemistry revealed hypoglycemia and metabolic acidosis. The acylcarnitine profiles in both patients demonstrated increased long-chain acylcarnitines, suggesting CACT or carnitine palmitoyltransferase-2 (CPT2) deficiency. Results: The mutation analysis identified homozygous IVS2-10T>G in the SLC25A20 gene in both patients, confirming the diagnosis of CACT deficiency. The IVP assay revealed increased C16, C16:1, but decreased C2 with improvement by bezafibrate in the cultured fibroblasts. The short-term clinical trial of bezafibrate in Patient 1 did not show clinical improvement, and died after starting the trial for 6 months. Conclusion: This splicing mutation has been identified in other Asian populations indicating a possible founder effect. IVP assay of cultured fibroblasts could determine a response to bezafibrate treatment. A long-term clinical trial of more enrolled patients is required for evaluation of this therapy. (C) 2014 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved.	[Vatanavicharn, Nithiwat; Sathienkijkanchai, Achara; Wasant, Pornswan] Mahidol Univ, Siriraj Hosp, Fac Med, Div Med Genet,Dept Pediat, Bangkok 10700, Thailand; [Yamada, Kenji; Yamaguchi, Seiji] Shimane Univ, Sch Med, Dept Pediat, Izumo, Shimane, Japan; [Aoyama, Yuka] Gifu Univ, United Grad Sch Drug Discovery & Med Informat Sci, Med Informat Sci Div, Gifu, Japan; [Fukao, Toshiyuki] Gifu Univ, Grad Sch Med, Dept Pediat, Gifu, Japan; [Densupsoontorn, Narumon; Jirapinyo, Pipop] Mahidol Univ, Siriraj Hosp, Fac Med, Div Nutr,Dept Pediat, Bangkok 10700, Thailand	Vatanavicharn, N (reprint author), Siriraj Hosp, Dept Pediat, Fac Med, Div Med Genet, 9th Floor Chaofamahachakri Bldg,2 Prannok Rd, Bangkok 10700, Thailand.	nithiwat_v@hotmail.com			Siriraj Chalermprakiat Fund	We would like to thank the patients and their families for their participation in this study. N.V. is a recipient of the Siriraj Chalermprakiat Fund.	Saudubray JM, 1999, J INHERIT METAB DIS, V22, P488; Okun JG, 2002, BBA-MOL CELL BIOL L, V1584, P91, DOI 10.1016/S1388-1981(02)00296-2; Bonnefont JP, 2009, NEW ENGL J MED, V360, P838, DOI 10.1056/NEJMc0806334; Djouadi F, 2005, HUM MOL GENET, V14, P2695, DOI 10.1093/hmg/ddi303; Huizing M, 1997, AM J HUM GENET, V61, P1239, DOI 10.1086/301628; Yamaguchi S, 2012, MOL GENET METAB, V107, P87, DOI 10.1016/j.ymgme.2012.07.004; Costa C, 2003, MOL GENET METAB, V78, P68, DOI 10.1016/S1096-7192(02)00205-6; Distelmaier F, 2007, PEDIATR NEPHROL, V22, P2119, DOI 10.1007/s00467-007-0536-9; El-Beshlawy A, 2007, ANN HEMATOL, V86, P31, DOI 10.1007/s00277-006-0181-6; Fukushima T, 2013, J HUM GENET, V58, P788, DOI 10.1038/jhg.2013.103; Gobin-Limballe S, 2007, AM J HUM GENET, V81, P1133, DOI 10.1086/522375; Hui JN, 2014, PATHOLOGY, V46, P375, DOI 10.1097/PAT.0000000000000140; Iacobazzi V, 1998, BIOCHEM BIOPH RES CO, V252, P770, DOI 10.1006/bbrc.1998.9738; Iacobazzi V, 2004, HUM MUTAT, V24, P312, DOI 10.1002/humu.20085; Lee Robert S. Y., 2007, Hong Kong Medical Journal, V13, P66; Li H, 2010, BRAIN DEV-JPN, V32, P362, DOI 10.1016/j.braindev.2009.06.001; MONK JP, 1987, DRUGS, V33, P539, DOI 10.2165/00003495-198733060-00002; Ogawa A, 2000, J HUM GENET, V45, P52, DOI 10.1007/s100380050010; Pierre G, 2007, J INHERIT METAB DIS, V30, P815, DOI 10.1007/s10545-007-0518-x; Rubio-Gozalbo M. E., 2004, Molecular Aspects of Medicine, V25, P521, DOI 10.1016/j.mam.2004.06.007; Rubio-Gozalbo ME, 2003, ACTA PAEDIATR, V92, P501; Sekoguchi E, 2003, J BIOL CHEM, V278, P38796, DOI 10.1074/jbc.M306372200; STANLEY CA, 1992, NEW ENGL J MED, V327, P19, DOI 10.1056/NEJM199207023270104; Wang GL, 2011, MOL GENET METAB, V103, P349, DOI 10.1016/j.ymgme.2011.05.001	24	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0387-7604	1872-7131		BRAIN DEV-JPN	Brain Dev.	AUG	2015	37	7					698	703		10.1016/j.braindev.2014.10.005		6	Clinical Neurology	Neurosciences & Neurology	CL8SB	WOS:000357243300007		
J	Mimaki, M; Shiihara, T; Watanabe, M; Hirakata, K; Sakazume, S; Ishiguro, A; Shimojima, K; Yamamoto, T; Oka, A; Mizuguchi, M				Mimaki, Masakazu; Shiihara, Takashi; Watanabe, Mio; Hirakata, Kyoko; Sakazume, Satoru; Ishiguro, Akio; Shimojima, Keiko; Yamamoto, Toshiyuki; Oka, Akira; Mizuguchi, Masashi			Holoprosencephaly with cerebellar vermis hypoplasia in 13q deletion syndrome: Critical region for cerebellar dysgenesis within 13q32.2q34	BRAIN & DEVELOPMENT			English	Article						Chromosome 13; Distal 13q deletion; Cerebellar vermis hypoplasia	DANDY-WALKER MALFORMATION; ZIC2; CHROMOSOME-13; MUTATIONS; PHENOTYPE; DISEASE; GENE	We describe two unrelated patients with terminal deletions in the long arm of chromosome 13 showing brain malformation consisting of holoprosencephaly and cerebellar vermis hypoplasia. Array comparative genomic hybridization analysis revealed a pure terminal deletion of 13q31.3q34 in one patient and a mosaic ring chromosome with 13q32.2q34 deletion in the other. Mutations in ZIC2, located within region 13q32, cause holoprosencephaly, whereas the 13q32.2q32.3 region is associated with cerebellar vermis hypoplasia (Dandy-Walker syndrome). The rare concurrence of these major brain malformations in our patients provides further evidence that 13q32.2q32.3 deletion, harboring ZIC2 and ZIC5, leads to cerebellar dysgenesis. (C) 2014 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved.	[Mimaki, Masakazu; Ishiguro, Akio; Oka, Akira; Mizuguchi, Masashi] Univ Tokyo, Grad Sch Med, Dept Pediat, Tokyo 1138655, Japan; [Shiihara, Takashi; Watanabe, Mio] Gunma Childrens Med Ctr, Dept Neurol, Gunma, Japan; [Hirakata, Kyoko] Gunma Childrens Med Ctr, Dept Ophthalmol, Gunma, Japan; [Sakazume, Satoru] Dokkyo Med Univ, Koshigaya Hosp, Clin Genet Ctr, Dokkyo, Japan; [Shimojima, Keiko; Yamamoto, Toshiyuki] Tokyo Womens Med Univ, Inst Integrated Med Sci, Tokyo, Japan; [Mizuguchi, Masashi] Univ Tokyo, Grad Sch Med, Dev Med Sci, Tokyo 1138655, Japan	Mimaki, M (reprint author), Univ Tokyo, Grad Sch Med, Dept Pediat, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	mimaki-tky@umin.ac.jp		Shiihara, Takashi/0000-0002-0852-7451	Program for Promoting the Establishment of Strategic Research Centers, Special Coordination Funds for Promoting Science and Technology, Ministry of Education, Culture, Sports, Science and Technology (Japan)	We thank Dr. W.B. Dobyns for providing valuable insight on our patient 2. This work is supported by the Program for Promoting the Establishment of Strategic Research Centers, Special Coordination Funds for Promoting Science and Technology, Ministry of Education, Culture, Sports, Science and Technology (Japan).	Alanay Y, 2005, AM J MED GENET A, V136A, P265, DOI 10.1002/ajmg.a.30808; Quelin C, 2009, EUR J MED GENET, V52, P41, DOI 10.1016/j.ejmg.2008.10.002; BROWN S, 1995, AM J HUM GENET, V57, P859; Grinberg I, 2005, CLIN GENET, V67, P290, DOI 10.1111/j.1399-0004.2005.00418.x; Brown SA, 1998, NAT GENET, V20, P180, DOI 10.1038/2484; Ballarati L, 2007, J MED GENET, V44, DOI 10.1136/jmg.2006.043059; Chabchoub E, 2012, CLIN GENET, V81, P584, DOI 10.1111/j.1399-0004.2011.01684.x; Inoue T, 2004, DEV BIOL, V270, P146, DOI 10.1016/j.ydbio.2004.02.017; Kirchhoff M, 2009, AM J MED GENET A, V149A, P894, DOI 10.1002/ajmg.a.32814; Mademont-Soler I, 2010, AM J MED GENET A, V152A, P2308, DOI 10.1002/ajmg.a.33550; Marcorelles P, 2002, PEDIATR DEVEL PATHOL, V5, P170, DOI 10.1007/s10024-001-0200-5; McCormack WM, 2002, AM J MED GENET, V112, P384, DOI 10.1002/ajmg.10659; Roessler E, 2009, HUM MUTAT, V30, pE541, DOI 10.1002/humu.20982; Shimojima K, 2009, BRAIN DEV-JPN, V31, P629, DOI 10.1016/j.braindev.2008.08.013	14	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0387-7604	1872-7131		BRAIN DEV-JPN	Brain Dev.	AUG	2015	37	7					714	718		10.1016/j.braindev.2014.10.009		5	Clinical Neurology	Neurosciences & Neurology	CL8SB	WOS:000357243300009		
J	Montassir, H; Maegaki, Y; Murayama, K; Yamazaki, T; Kohda, M; Ohtake, A; Iwasa, H; Yatsuka, Y; Okazaki, Y; Sugiura, C; Nagata, I; Toyoshima, M; Saito, Y; Itoh, M; Nishino, I; Ohno, K				Montassir, Hesham; Maegaki, Yoshihiro; Murayama, Kei; Yamazaki, Taro; Kohda, Masakazu; Ohtake, Akira; Iwasa, Hiroyasu; Yatsuka, Yukiko; Okazaki, Yasushi; Sugiura, Chitose; Nagata, Ikuo; Toyoshima, Mitsuo; Saito, Yoshiaki; Itoh, Masayuki; Nishino, Ichizo; Ohno, Kousaku			Myocerebrohepatopathy spectrum disorder due to POLG mutations: A clinicopathological report	BRAIN & DEVELOPMENT			English	Article						Alpers syndrome; Mitochondrial DNA depletion; Myocerebrohepatopathy spectrum disorder; POLG	MITOCHONDRIAL-DNA DEPLETION; POLYMERASE-GAMMA; ALPERS-SYNDROME; HEPATOCEREBRAL SYNDROMES; MOLECULAR DIAGNOSIS; DEFICIENCY; CHILDHOOD; ENCEPHALOPATHY	We report on the clinical, neuropathological, and genetic findings of a Japanese case with myocerebrohepatopathy spectrum (MCHS) disorder due to polymerase gamma (POLG) mutations. A girl manifested poor sucking and failure to thrive since 4 months of age and had frequent vomiting and developmental regression at 5 months of age. She showed significant hypotonia and hepatomegaly. Laboratory tests showed hepatocellular dysfunction and elevated protein and lactate levels in the cerebrospinal fluid. Her liver function and neurologic condition exacerbated, and she died at 8 months of age. At autopsy, fatty degeneration and fibrosis were observed in the liver. Neuropathological examination revealed white matter-predominant spongy changes with Alzheimer type II glia and loss of myelin. Enzyme activities of the respiratory chain complex I, III, and IV relative to citrate synthase in the muscle were normal in the biopsied muscle tissue, but they were reduced in the liver to 0%, 10%, and 14% of normal values, respectively. In the liver, the copy number of mitochondrial DNA compared to nuclear DNA was reduced to 3.3% of normal values as evaluated by quantitative polymerase chain reaction. Genetic analysis revealed compound heterozygous mutations for POLG (I1185T/A957V). This case represents the differential involvement of multiple organs and phenotype-specific distribution of brain lesions in mitochondrial DNA depletion disorders. (C) 2014 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved.	[Montassir, Hesham; Maegaki, Yoshihiro; Sugiura, Chitose; Saito, Yoshiaki; Ohno, Kousaku] Tottori Univ, Div Child Neurol, Fac Med, Yonago, Tottori 6838504, Japan; [Montassir, Hesham] Cairo Univ, Fac Med, Dept Family Med, Cairo, Egypt; [Murayama, Kei] Chiba Childrens Hosp, Dept Metab, Chiba, Japan; [Yamazaki, Taro; Ohtake, Akira] Saitama Med Univ, Sch Med, Dept Pediat, Saitama, Japan; [Kohda, Masakazu; Iwasa, Hiroyasu; Okazaki, Yasushi] Saitama Med Univ, Res Ctr Genom Med, Div Translat Res, Hidaka, Japan; [Yatsuka, Yukiko; Okazaki, Yasushi] Saitama Med Univ, Div Funct Genom & Syst Med, Res Ctr Genom Med, Hidaka, Japan; [Nagata, Ikuo] Tottori Univ, Div Pediat & Perinatol, Fac Med, Yonago, Tottori 6838504, Japan; [Toyoshima, Mitsuo] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Pediat, Kagoshima 890, Japan; [Itoh, Masayuki] Natl Ctr Neurol & Psychiat, Dept Mental Retardat & Birth Defect Res, Tokyo, Japan; [Nishino, Ichizo] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Neuromuscular Res, Tokyo, Japan	Maegaki, Y (reprint author), Tottori Univ, Div Child Neurol, Fac Med, 36-1 Nishi Cho, Yonago, Tottori 6838504, Japan.	maegaki@med.tottori-u.ac.jp			Research Program of Innovative Cell Biology by Innovative Technology (Cell Innovation); Promotion and Mutual Aid Corporation for Private Schools of Japan from MEXT; Ministry of Health, Labour and Welfare of Japan; Kawano Masanori Memorial Public Interest Incorporated Foundation for Promotion of Pediatrics	This study was supported in part by a grant from the Research Program of Innovative Cell Biology by Innovative Technology (Cell Innovation), a Grant-in-Aid for the Development of New Technology from The Promotion and Mutual Aid Corporation for Private Schools of Japan from MEXT (to Y. Okazaki), Grants-in-Aid for the Research on Intractable Diseases (Mitochondrial Disease) from the Ministry of Health, Labour and Welfare of Japan to A. Ohtake. Dr Murayama was supported by the Kawano Masanori Memorial Public Interest Incorporated Foundation for Promotion of Pediatrics.	Ferrari G, 2005, BRAIN, V128, P723, DOI 10.1093/brain/awh410; Pagnamenta AT, 2006, HUM REPROD, V21, P2467, DOI 10.1093/humrep/del076; Kirby DM, 1999, NEUROLOGY, V52, P1255; Tang S, 2011, J MED GENET, V48, P669, DOI 10.1136/jmedgenet-2011-100222; Bao XH, 2008, BRAIN DEV-JPN, V30, P295, DOI 10.1016/j.braindev.2007.08.009; Nguyen KV, 2006, J HEPATOL, V45, P108, DOI 10.1016/j.jhep.2005.12.026; Kaji S, 2009, MOL GENET METAB, V97, P292, DOI 10.1016/j.ymgme.2009.04.014; MORAES CT, 1991, AM J HUM GENET, V48, P492; Cohen BH, 2010, METHODS, V51, P364, DOI 10.1016/j.ymeth.2010.05.008; Sarzi E, 2007, J PEDIATR-US, V150, P531, DOI 10.1016/j.jpeds.2007.01.044; Boustany R, 2006, PEDIAT NEUROLOGY PRI, P1326; Cheldi A, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-8; de Vries MC, 2007, EUR J PEDIATR, V166, P229, DOI 10.1007/s00431-006-0234-9; Gonzalez-Vioque E, 2006, ARCH NEUROL-CHICAGO, V63, P107, DOI 10.1001/archneur.63.1.107; Kollberg G, 2006, J NEUROPATH EXP NEUR, V65, P758; Kurt B, 2010, ARCH NEUROL-CHICAGO, V67, P239, DOI 10.1001/archneurol.2009.332; Martikainen MH, 2010, BMJ CASE REPORTS, DOI [10.1336/bcr.01.2010.2604, DOI 10.1336/BCR.01.2010.2604]; Scalais E, 2012, EUR J PAEDIATR NEURO, V16, P542, DOI 10.1016/j.ejpn.2012.01.013; Wong L-J, 2008, HUM MUTAT, V29, P150; Yamazaki T, 2014, PEDIATR INT, V56, P180, DOI 10.1111/ped.12249	20	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0387-7604	1872-7131		BRAIN DEV-JPN	Brain Dev.	AUG	2015	37	7					719	724		10.1016/j.braindev.2014.10.013		6	Clinical Neurology	Neurosciences & Neurology	CL8SB	WOS:000357243300010		
J	Magara, S; Kawashima, H; Kobayashi, Y; Akasaka, N; Yamazaki, S; Tohyama, J				Magara, Shin-ichi; Kawashima, Hideshi; Kobayashi, Yu; Akasaka, Noriyuki; Yamazaki, Sawako; Tohyama, Jun			Rub epilepsy in an infant with Turner syndrome	BRAIN & DEVELOPMENT			English	Article						Turner syndrome; Focal clonic seizures; Rub epilepsy; Focal cortical dysplasia	MOSAICISM; PATIENT	We report a case of infantile refractory epilepsy associated with Turner syndrome (TS), showing very frequent, focal clonic seizures of the left upper extremity. Characteristically, in addition to spontaneous fits, her seizure was inducible by rubbing her left hand and forearm for a few seconds. Accordingly, she was diagnosed with a rare form of reflex epilepsy, "rub epilepsy". Neuroradiological investigation indicated the existence of cortical abnormalities, such as focal cortical dysplasia of the right parietal lobe. Patients with TS are reported to have neuroanatomical abnormalities, especially of the parietal lobe. Thus, our case may imply a causal relationship between potential cortical hyperexcitability of the parietal lobe and epilepsy in TS. This is the first reported infantile case of rub epilepsy, and more generally, reflex epilepsy associated with TS. (C) 2014 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved.	[Magara, Shin-ichi; Kawashima, Hideshi; Kobayashi, Yu; Akasaka, Noriyuki; Tohyama, Jun] Nishi Niigata Chuo Natl Hosp, Dept Child Neurol, Niigata 9502085, Japan; [Yamazaki, Sawako] Niigata City Gen Hosp, Dept Pediat, Niigata, Japan	Magara, S (reprint author), Nishi Niigata Chuo Natl Hosp, Dept Child Neurol, Nishi Ku, 1-14-1 Masago, Niigata 9502085, Japan.	magara@masa.go.jp					Cutter WJ, 2006, BIOL PSYCHIAT, V59, P273, DOI 10.1016/j.biopsych.2005.06.026; Kanemoto K, 2001, J NEUROL NEUROSUR PS, V70, P541, DOI 10.1136/jnnp.70.4.541; Barkovich AJ, 2012, PEDIAT NEUROIMAGING, P367; Hsieh CY, 2011, NEUROL SCI, V32, P297, DOI 10.1007/s10072-010-0383-5; Knickmeyer RC, 2011, J NEURODEV DISORD, V3, P293, DOI 10.1007/s11689-011-9089-0; Palmini A, 2010, EPILEPSIA, V51, P23, DOI 10.1111/j.1528-1167.2009.02437.x; Striano S, 2005, CLIN NEUROL NEUROSUR, V108, P56, DOI 10.1016/j.clineuro.2004.11.012; Terao Y, 1996, DEV MED CHILD NEUROL, V38, P455; Tombini M, 2003, J NEUROL SCI, V213, P83, DOI 10.1016/S0022-510X(03)00148-5; TSUBOI T, 1985, ACTA NEUROL SCAND, V72, P590	10	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0387-7604	1872-7131		BRAIN DEV-JPN	Brain Dev.	AUG	2015	37	7					725	728		10.1016/j.braindev.2014.11.004		4	Clinical Neurology	Neurosciences & Neurology	CL8SB	WOS:000357243300011		
J	Shimakawa, S; Nomura, S; Ogino, M; Fukui, M; Kashiwagi, M; Tanabe, T; Tamai, H				Shimakawa, Shuichi; Nomura, Shohei; Ogino, Motoko; Fukui, Miho; Kashiwagi, Mitsuru; Tanabe, Takuya; Tamai, Hiroshi			ACTH therapy on intractable epilepsy in Hemiconvulsion-Hemiplegia-Epilepsy syndrome	BRAIN & DEVELOPMENT			English	Article						Hemiconvulsion-Hemiplegia-Epilepsy syndrome; Adrenocorticotropic hormone therapy; Lamotrigine; Treatment	SEIZURES; SPASMS	Introduction: In the chronic phase of Hemiconvulsion-Hemiplegia-Epilepsy (HHE) syndrome, developing epilepsy may be intractable. Herein, we report a case where adrenocorticotropic hormone (ACTH) ceased an intractable habitual partial seizure in a patient with HHE syndrome. Case report: A developmentally normal one-year-old girl presented with left focal motor status epilepticus in the clinical course of rotavirus infection. She was diagnosed with HH syndrome. At 4 months after status epilepticus, she developed partial seizures that occurred daily, and which resulted in a stooped posture, head rotation to the right, and contraction of both upper limbs predominantly in the left arm. At this time, she was diagnosed with idiopathic HHE syndrome. Her seizures were not reduced by sodium valproate, clonazepam, clobazam, zonisamide, phenytoin, phenobarbital, topiramate, lamotrigine, or liposteroid. At the age of 7, ACTH therapy was performed. On the 10th day of ACTH therapy, the habitual seizure was ceased. However, partial seizures characterized by left arm contraction then developed. Treatment with 350 mg/day lamotrigine prevented this emerging seizure. She has been free of both seizure types for more than one year, with no serious adverse effects of ACTH therapy. Conclusion: We suggest that ACTH therapy may be useful for patients with HHE, although further studies are required. (C) 2014 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved.	[Shimakawa, Shuichi; Nomura, Shohei; Ogino, Motoko; Fukui, Miho; Tamai, Hiroshi] Osaka Med Coll, Dept Pediat, Takatsuki, Osaka 5698686, Japan; [Kashiwagi, Mitsuru] Hirakata Municipal Hosp, Dept Pediat, Hirakata, Osaka, Japan; [Tanabe, Takuya] Tanabe Childrens Clin, Dept Pediat Neurol, Hirakata, Osaka, Japan	Shimakawa, S (reprint author), Osaka Med Coll, Dept Pediat, 2-7 Daigaku Machi, Takatsuki, Osaka 5698686, Japan.	ZVQ10523@nifty.com					Nabbout R, 2011, LANCET NEUROL, V10, P99, DOI 10.1016/S1474-4422(10)70214-3; Verhelst H, 2005, SEIZURE-EUR J EPILEP, V14, P412, DOI 10.1016/j.seizure.2005.07.002; Okumura A, 2006, SEIZURE-EUR J EPILEP, V15, P469, DOI 10.1016/j.seizure.2006.05.010; Nabbout R, 2013, EPILEPSIA, V54, P54, DOI 10.1111/epi.12278; Tenney JR, 2012, NEUROLOGY, V79, pE1, DOI 10.1212/WNL.0b013e31825dce5f; Nabbout R, 2012, EPILEPSIA, V53, P58, DOI 10.1111/j.1528-1167.2012.03614.x; Kim DW, 2008, NEUROLOGY, V70, P2116, DOI 10.1212/01.wnl.0000289192.50924.93; Fukui M, 2014, SEIZURE-EUR J EPILEP, V23, P521, DOI 10.1016/j.seizure.2014.03.013; Fukui M, 2014, BRAIN DEV-JPN, V36, P80, DOI 10.1016/j.braindev.2013.01.001; Gayatri NA, 2007, COCHRANE DB SYST REV, V1	10	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0387-7604	1872-7131		BRAIN DEV-JPN	Brain Dev.	AUG	2015	37	7					733	737		10.1016/j.braindev.2014.11.003		5	Clinical Neurology	Neurosciences & Neurology	CL8SB	WOS:000357243300013		
J	Takao-Kawabata, R; Isogai, Y; Takakura, A; Shimazu, Y; Sugimoto, E; Nakazono, O; Ikegaki, I; Kuriyama, H; Tanaka, S; Oda, H; Ishizuya, T				Takao-Kawabata, Ryoko; Isogai, Yukihiro; Takakura, Aya; Shimazu, Yukari; Sugimoto, Emika; Nakazono, Osamu; Ikegaki, Ichiro; Kuriyama, Hiroshi; Tanaka, Shinya; Oda, Hiromi; Ishizuya, Toshinori			Three-Times-Weekly Administration of Teriparatide Improves Vertebral and Peripheral Bone Density, Microarchitecture, and Mechanical Properties Without Accelerating Bone Resorption in Ovariectomized Rats	CALCIFIED TISSUE INTERNATIONAL			English	Article						Teriparatide; Three-times-weekly; Bone metabolism; Mechanical strength; Micro-computed tomography	PARATHYROID-HORMONE 1-34; POSTMENOPAUSAL WOMEN; CORTICAL BONE; FEMORAL-NECK; BIOMECHANICAL PROPERTIES; PRIMARY OSTEOPOROSIS; MINERAL DENSITY; TRABECULAR BONE; ESTROGEN; HISTOMORPHOMETRY	Daily and weekly administration of teriparatide (PTH1-34) reduces the risk of osteoporotic bone fractures. However, their effects on markers of bone formation and bone resorption differ. These results indicate that the dosing frequency of teriparatide may affect bone metabolism and bone structure, with different effects on bone strength. In the present study, to evaluate the dose-related effects of a low administration frequency of teriparatide on bone status, we investigated the effects of three-times-weekly administration of teriparatide (1.1, 5.6, or 28.2 A mu g/kg) for 12 months on bone parameters, including bone metabolism markers, bone mineral density (BMD), micro-computed tomography, and bone strength, using 6-month-old ovariectomized (OVX) rats. Three-times-weekly administration of teriparatide dose-dependently increased the BMD of the lumbar vertebra and femur in OVX rats, and increased serum osteocalcin (a marker of bone formation), but not type I collagen C-telopeptide (a marker of bone resorption). The trabecular number and thickness increased in the vertebrae and femur, as in prior reports of daily teriparatide administration in OVX rats. Cortical thickness increased only toward the endocortical side of the femur, unlike with daily administration. Bone strength of the vertebrae and proximal and shaft of the femur was correlated with the changes in BMD and bone structure. These results demonstrate the effects of low frequency, intermittent administration of teriparatide on the biomechanical, and microstructural properties of bone in OVX rats.	[Takao-Kawabata, Ryoko; Isogai, Yukihiro; Takakura, Aya; Shimazu, Yukari; Sugimoto, Emika; Nakazono, Osamu; Ikegaki, Ichiro; Kuriyama, Hiroshi; Ishizuya, Toshinori] Asahi Kasei Pharma Corp, Pharmacol Lab, Pharmaceut Res Ctr, Shizuoka 4102321, Japan; [Takao-Kawabata, Ryoko; Tanaka, Shinya; Oda, Hiromi] Saitama Med Univ, Dept Orthopaed Surg, Moroyama, Saitama 3500495, Japan	Takao-Kawabata, R (reprint author), Asahi Kasei Pharma Corp, Pharmacol Lab, Pharmaceut Res Ctr, 632-1 Mifuku, Shizuoka 4102321, Japan.	takao.rb@om.asahi-kasei.co.jp			Asahi Kasei Pharma Corporation	This study was funded by Asahi Kasei Pharma Corporation. The authors wish to thank Dr. Kenichi Kasahara and Ms. Rika Ohishi for advice regarding statistical analyses; Mr. Atsushi Watanabe, V.M.D., for performing pathological examinations; and Nicholas D. Smith, PhD, for providing editorial support.	Greenspan SL, 2007, ANN INTERN MED, V146, P326; Frolik CA, 2003, BONE, V33, P372, DOI 10.1016/S8756-3282(03)00202-3; Neer RM, 2001, NEW ENGL J MED, V344, P1434, DOI 10.1056/NEJM200105103441904; Prestwood KM, 2000, J CLIN ENDOCR METAB, V85, P2197, DOI 10.1210/jc.85.6.2197; Chavassieux PM, 1997, J CLIN INVEST, V100, P1475, DOI 10.1172/JCI119668; Nakamura T, 2012, J CLIN ENDOCR METAB, V97, P3097, DOI 10.1210/jc.2011-3479; Fox J, 2006, CALCIFIED TISSUE INT, V79, P262, DOI 10.1007/s00223-006-0108-1; Ito M, 2014, OSTEOPOROSIS INT, V25, P1163, DOI 10.1007/s00198-013-2596-y; MOSEKILDE L, 1993, BONE, V14, P1, DOI 10.1016/8756-3282(93)90248-9; WRONSKI TJ, 1994, BONE, V15, P51, DOI 10.1016/8756-3282(94)90891-5; CARTER DR, 1977, J BONE JOINT SURG AM, V59, P954; Sato M, 2002, J PHARMACOL EXP THER, V302, P304, DOI 10.1124/jpet.302.1.304; Li CY, 2003, CALCIFIED TISSUE INT, V72, P42, DOI 10.1007/s00223-001-1086-y; Milz S, 2005, ADV ANAT EMBRYOL CEL, V178, P1; WILLIAMS DA, 1971, BIOMETRICS, V27, P103, DOI 10.2307/2528930; Dobnig H, 1997, ENDOCRINOLOGY, V138, P4607, DOI 10.1210/en.138.11.4607; Dobnig H, 2005, J CLIN ENDOCR METAB, V90, P3970, DOI 10.1210/jc.2003-1703; HAHN M, 1992, BONE, V13, P327, DOI 10.1016/8756-3282(92)90078-B; HORI M, 1988, BONE MINER, V3, P193; Laib A, 2001, OSTEOPOROSIS INT, V12, P936, DOI 10.1007/s001980170022; Ma YF, 1995, BONE, V17, P549, DOI 10.1016/8756-3282(95)00387-8; Miki T, 2004, J BONE MINER METAB, V22, P569, DOI 10.1007/s00774-004-0525-z; MOLSTER AO, 1986, CLIN ORTHOP RELAT R, P278; Sato M, 1997, ENDOCRINOLOGY, V138, P4330, DOI 10.1210/en.138.10.4330; SOGAARD CH, 1994, ENDOCRINOLOGY, V134, P650, DOI 10.1210/en.134.2.650; Ste-Marie LG, 2004, CALCIFIED TISSUE INT, V75, P469, DOI 10.1007/s00223-004-0039-7; Tanaka S, 2004, J BONE MINER RES, V19, P1813, DOI 10.1359/JBMR.040808; TSURUKAMI H, 1994, CALCIFIED TISSUE INT, V54, P142, DOI 10.1007/BF00296065; World Health Organization, 2003, WHO TECHN REP SER, V921, P2003; Zhang L, 1998, TOHOKU J EXP MED, V186, P131, DOI 10.1620/tjem.186.131; Zienkiewicz OC, 1996, FINITE ELEMENT METHO	31	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0171-967X	1432-0827		CALCIFIED TISSUE INT	Calcif. Tissue Int.	AUG	2015	97	2					156	168		10.1007/s00223-015-9998-0		13	Endocrinology & Metabolism	Endocrinology & Metabolism	CM1SI	WOS:000357460200007		
J	Isaka, Y; Sato, T				Isaka, Y.; Sato, T.			Was species diversification in Tenthredinoidea (Hymenoptera: Symphyta) related to the origin and diversification of angiosperms?	CANADIAN ENTOMOLOGIST			English	Article							MORPHOLOGICAL EVIDENCE; SAWFLIES HYMENOPTERA; SENSITIVITY-ANALYSIS; BASAL LINEAGES; PHYLOGENY; INSECTA; EVOLUTION; CLASSIFICATION; SUPERTREE; INSIGHTS	The paraphyletic grouping "Symphyta" (8353 described species) represents the basal lineages of the insect order Hymenoptera. The most species-rich superfamily in Symphyta is Tenthredinoidea (7390 species), with six extant families. Most of tenthredinoids species are phytophagous at the larval stage, and the species using angiosperms as a host are more numerous (6265 species) than those using gymnosperms (140 species) or pteridophytes (985 species). In this study, we investigated whether diversification of Tenthredinoidea could be attributed to their use of angiosperms as hosts by examining host plant usage by lineage. We performed molecular phylogenetic and divergence time estimation analyses using molecular data (similar to 2 kilobase sequence in five DNA regions) and conducted a diversification analysis. Our results suggest that Tenthredinoidea (excluding Blasticotomidae) had used angiosperms since its origin; the phylogeny of Tenthredinoidea showed a significant shift in diversification at two nodes, and those nodes overlap with the periods of origin and diversification of angiosperms.	[Isaka, Y.] Shinshu Univ, Dept Mt & Environm Sci, Interdisciplinary Grad Sch Sci & Technol, Matsumoto, Nagano 3908621, Japan; [Sato, T.] Shinshu Univ, Dept Biol, Fac Sci, Matsumoto, Nagano 3908621, Japan	Isaka, Y (reprint author), Shinshu Univ, Dept Mt & Environm Sci, Interdisciplinary Grad Sch Sci & Technol, Matsumoto, Nagano 3908621, Japan.	u1isaka19810327@gmail.com					Heraty J, 2011, MOL PHYLOGENET EVOL, V60, P73, DOI 10.1016/j.ympev.2011.04.003; Schneider H, 2004, NATURE, V428, P553, DOI 10.1038/nature02361; Quek SP, 2004, EVOLUTION, V58, P554, DOI 10.1554/03-361; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Farrell BD, 1998, SCIENCE, V281, P555, DOI 10.1126/science.281.5376.555; Gernhard T, 2008, J THEOR BIOL, V253, P769, DOI 10.1016/j.jtbi.2008.04.005; Sharkey MJ, 2007, ZOOTAXA, P521; Smith SA, 2010, P NATL ACAD SCI USA, V107, P5897, DOI 10.1073/pnas.1001225107; Vilhelmsen L, 2001, ZOOL J LINN SOC-LOND, V131, P393, DOI 10.1006/zjls.2000.0255; Ronquist F, 2012, SYST BIOL, V61, P973, DOI 10.1093/sysbio/sys058; Sunnucks P, 1996, MOL BIOL EVOL, V13, P510; Janz N, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-4; Schulmeister S, 2003, BIOL J LINN SOC, V79, P245, DOI 10.1046/j.1095-8312.2003.00233.x; Davis RB, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-109; Bell CD, 2010, AM J BOT, V97, P1296, DOI 10.3732/ajb.0900346; Boeve JL, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-198; Nyman T, 2006, EVOLUTION, V60, P1622, DOI 10.1554/05-674.1; Clarke JT, 2011, NEW PHYTOL, V192, P266, DOI 10.1111/j.1469-8137.2011.03794.x; Davies TJ, 2004, P NATL ACAD SCI USA, V101, P1904, DOI 10.1073/pnas.0308127100; Rasnitsyn AP, 2004, PALAEONTOLOGY, V47, P1507, DOI 10.1111/j.0031-0239.2004.00416.x; Taeger A, 2010, ZOOTAXA, P1; NEE S, 1994, PHILOS T ROY SOC B, V344, P305, DOI 10.1098/rstb.1994.0068; Shcherbakov D. E., 2006, Russian Entomological Journal, V15, P67; Futuyma DJ, 2009, P NATL ACAD SCI USA, V106, P18054, DOI 10.1073/pnas.0904106106; SANDERSON MJ, 1994, SCIENCE, V264, P1590, DOI 10.1126/science.264.5165.1590; Hunt T, 2007, SCIENCE, V318, P1913, DOI 10.1126/science.1146954; FARRIS JS, 1976, SYST ZOOL, V25, P196, DOI 10.2307/2412748; Tanabe AS, 2007, MOL ECOL NOTES, V7, P962, DOI 10.1111/j.1471-8286.2007.01807.x; Leppanen SA, 2012, MOL PHYLOGENET EVOL, V64, P331, DOI 10.1016/j.ympev.2012.04.005; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Schulmeister S, 2003, BIOL J LINN SOC, V79, P209, DOI 10.1046/j.1095-8312.2003.00232.x; CRANE PR, 1995, NATURE, V374, P27, DOI 10.1038/374027a0; Badenes-Perez FR, 2007, BIOL CONTROL, V43, P95, DOI 10.1016/j.biocontrol.2007.05.01; Benson R. B., 1963, ANN MAGAZINE NATU 13, V58, P631; Blank SM, 2012, ECATSYM ELECT WORLD; Christopher J. E., 2013, GYMNOSPERM DATABASE; Costa JT, 2001, ANN ENTOMOL SOC AM, V94, P480, DOI 10.1603/0013-8746(2001)094[0480:GFATFB]2.0.CO;2; Davis RB, 2009, J EVOLUTION BIOL, V22, P1750, DOI 10.1111/j.1420-9101.2009.01789.x; Drummond A. J., 2009, TRACER V1 5; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Friss E. M., 2006, PALAEOECOLOGY, V232, P251, DOI [10.1016/j.palaeo.2005.07.006, DOI 10.1016/J.PALAEO.2005.07.006]; Goulet H, 1993, HYMENOPTERA WORLD ID; Grimaldi David, 2005, pi; Isaka Y, 2014, ENTOMOL SCI, V17, P435, DOI 10.1111/ens.12080; Maddison W. P., 2011, MESQUITE MODULAR SYS; Malm T., 2014, CLADISTICS, DOI [10.1111/cla.12069.26074662, DOI 10.1111/CLA.12069.26074662]; Mayhew PJ, 2002, P ROY SOC B-BIOL SCI, V269, P969, DOI 10.1098/rspb.2002.1957; Naito T., 2004, SPECIES DIVERSITY SA; Rasnitsyn A. P., 2010, ENTOMOL REV, V90, P263, DOI 10.1134/S0013873810030012; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Schmidt Stefan, 2006, Contributions of the American Entomological Institute, V34, P1; Schulmeister S, 2002, CLADISTICS, V18, P455, DOI 10.1016/S0748-3007(02)00100-7; Sharkey MJ, 2012, CLADISTICS, V28, P80, DOI 10.1111/j.1096-0031.2011.00366.x; Taeger A., 2011, ECATSYM V 3 10; Vilhelmsen Lars, 2006, P31; Wiegmann BM, 2002, ZOOL SCR, V31, P67, DOI 10.1046/j.0300-3256.2001.00091.x; Yoshida H., 2006, SYMPHYTA HYMENOPTERA; Zhang J., 1985, GEOL SHANDONG, V1, P23	58	1	1	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0008-347X	1918-3240		CAN ENTOMOL	Can. Entomol.	AUG	2015	147	4					443	458		10.4039/tce.2014.60		16	Entomology	Entomology	CM3UR	WOS:000357610800010		
J	Nishiokada, A; Miyoshi, M; Fujiwara, M; Aoyama-Ishikawa, M; Maeshige, N; Takahashi, M; Hamada, Y; Usami, Y; Honda, M; Arita, M; Usami, M				Nishiokada, Aya; Miyoshi, Makoto; Fujiwara, Mayu; Aoyama-Ishikawa, Michiko; Maeshige, Noriaki; Takahashi, Michiko; Hamada, Yasuhiro; Usami, Yu; Honda, Mie; Arita, Makoto; Usami, Makoto			Changes of hepatic lipid mediators associated with intake of high-fat diet for 12 weeks in endotoxemic rats using LC-ESI-MS/MS	CLINICAL NUTRITION			English	Article						Lipid mediator; Lipidomics; High-fat diet; Lard; Sepsis; Lipopolysaccharide	INFLAMMATORY RESPONSE; OBESITY; LIVER; MICE; ACTIVATION; ACID; PATHOPHYSIOLOGY; RESOLUTION; MORTALITY; TISSUE	Background & aims: It has recently been reported that anti-inflammatory lipid mediators are increased in the late phase of acute inflammation, whereas proinflammatory lipid mediators are regulated at the initiation of inflammation. The purpose of this study was to evaluate changes of hepatic lipid mediators due to high-fat diet (HFD) feeding in endotoxemic rats. Methods: Male Wistar rats were fed either HFD or control diet for 12 weeks, and were then killed 0, 1.5, and 6 h after lipopolysaccharide (LPS) injection. Analyses included lipidomics assessment of mediators using liquid chromatography-electrospray ionization/multi-stage mass spectrometry; measuring expression of hepatic polyunsaturated fatty acid (PUFA)-oxidizing enzyme, tumor necrosis factor (TNF)-alpha, interleukin (IL)-6, and inducible nitric oxide synthase mRNA levels; blood biochemical tests; and liver histology. Results: HFD feeding worsened liver injury, increased expression of TNF-alpha and IL-6 mRNA, and increased oxidative stress after LPS injection. PUFA-oxidizing enzymes were higher in HFD-fed rats after LPS injection. The proinflammatory prostaglandin (PG)E-2 and thromboxane B-2 were increased 1.5 h after LPS injection, and had decreased by 6 h in HFD-fed rats. In contrast, potent pro-resolving resolvins derived from eicosapentaenoic acid and docosahexaenoic acid were not detected, but anti-inflammatory epoxyeicosatrienoic acids, lipoxin A(4), and 15-deoxy-PGJ(2) were increased after LPS injection in HFD-fed rats. Conclusions: HFD feeding for 12 weeks enhanced proinflammatory lipid mediators 1.5 h after LPS injection suggesting relation to liver injury. (C) 2014 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.	[Nishiokada, Aya; Miyoshi, Makoto; Fujiwara, Mayu; Aoyama-Ishikawa, Michiko; Maeshige, Noriaki; Usami, Makoto] Kobe Univ, Grad Sch Hlth Sci, Div Nutr & Metab, Kobe, Hyogo 6540142, Japan; [Takahashi, Michiko; Usami, Makoto] Kobe Univ, Sch Med, Kobe Univ Hosp, Dept Nutr, Kobe, Hyogo 650, Japan; [Hamada, Yasuhiro] Tokushima Grad Sch, Inst Hlth Biosci, Dept Therapeut Nutr, Tokushima, Japan; [Usami, Yu] Osaka Univ, Dent Hosp, Clin Lab, Osaka, Japan; [Honda, Mie; Arita, Makoto] Univ Tokyo, Grad Sch Pharmaceut Sci, Tokyo, Japan	Usami, M (reprint author), Kobe Univ, Grad Sch Hlth Sci, Div Nutr & Metab, Dept Biophys,Suma Ku, 7-10-2 Tomogaoka, Kobe, Hyogo 6540142, Japan.	musa@kobe-u.ac.jp			JSPS [25450450]	This work was partially supported by JSPS KAKENHI (Grant-in-aid for Scientific Research), Grant Number 25450450.	Arita M, 2012, J BIOCHEM, V152, P313, DOI 10.1093/jb/mvs092; Kaplan JM, 2005, SHOCK, V24, P59, DOI 10.1097/01.shk.0000167108.88376.f2; Misra A, 2008, J CLIN ENDOCR METAB, V93, pS9, DOI 10.1210/jc.2008-1595; Miyoshi M, 2011, CLIN NUTR, V30, P252, DOI 10.1016/j.clnu.2010.09.012; Kure I, 2010, J PHARMACOL EXP THER, V332, P541, DOI 10.1124/jpet.109.159046; Ishida T, 2010, INFLAMM BOWEL DIS, V16, P87, DOI 10.1002/ibd.21029; Sakai S, 2013, J SURG RES, V185, P353, DOI 10.1016/j.jss.2013.06.002; White PJ, 2010, DIABETES, V59, P3066, DOI 10.2337/db10-0054; Hinson RM, 1996, P NATL ACAD SCI USA, V93, P4885, DOI 10.1073/pnas.93.10.4885; Gilroy DW, 1999, NAT MED, V5, P698, DOI 10.1038/9550; Akinnusi ME, 2008, CRIT CARE MED, V36, P151, DOI 10.1097/01.CCM.0000297885.60037.6E; Abbott SK, 2012, BBA-BIOMEMBRANES, V1818, P1309, DOI 10.1016/j.bbamem.2012.01.011; Esposito E, 2009, J NUTR, V139, P905, DOI 10.3945/jn.108.101808; Hariri N, 2010, NUTR RES REV, V23, P270, DOI 10.1017/S0954422410000168; Currais A, 2014, AGING CELL, V13, P379, DOI 10.1111/acel.12185; Xu ZJ, 2010, DIGEST DIS SCI, V55, P931, DOI 10.1007/s10620-009-0815-3; Bannenberg G, 2010, BBA-MOL CELL BIOL L, V1801, P1260, DOI 10.1016/j.bbalip.2010.08.002; Anwar-mohamed A, 2010, PHARMACOL RES, V61, P410, DOI 10.1016/j.phrs.2009.12.015; Woods SC, 2003, J NUTR, V133, P1081; Harrold JA, 2000, J NEUROCHEM, V74, P1224; Bitto A, 2012, CRIT CARE, V16, DOI 10.1186/1364-8535-16-R32; Bulger EM, 2000, CRIT CARE MED, V28, pN27, DOI 10.1097/00003246-200004001-00004; Guyton K, 2003, SHOCK, V20, P56, DOI 10.1097/01.shk.0000070903.21762.f8; Ito S, 2008, SHOCK, V30, P87, DOI 10.1097/SHK.0b013e31815d06a1; Kawada N, 1988, Nihon Shokakibyo Gakkai Zasshi, V85, P2193; KAWADA N, 1990, PROSTAG LEUKOTR ESS, V40, P149, DOI 10.1016/0952-3278(90)90158-H; Lee SO, 2002, NUTR CANCER, V44, P71, DOI 10.1207/S15327914NC441_10; Rivera Chantal A., 2010, BMC Physiology, V10, P20, DOI 10.1186/1472-6793-10-20; Sacerdoti D, 2003, PROSTAG OTH LIPID M, V72, P51, DOI 10.1016/S1098-8823(03)00077-7; Theken KN, 2011, DRUG METAB DISPOS, V39, P22, DOI 10.1124/dmd.110.035287	30	1	1	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0261-5614	1532-1983		CLIN NUTR	Clin. Nutr.	AUG	2015	34	4					685	693		10.1016/j.clnu.2014.07.013		9	Nutrition & Dietetics	Nutrition & Dietetics	CL8RN	WOS:000357241900019		
J	Shamoto, H; Wakabayashi, H; Maeda, K				Shamoto, Hiroshi; Wakabayashi, Hidetaka; Maeda, Keisuke			Changes in body composition in heart failure patients after a resistance exercise program and branched chain amino acid supplementation - Letter to Editor	CLINICAL NUTRITION			English	Letter						Resistance training; Protein intake; Rehabilitation nutrition	PROTEIN-INTAKE		[Shamoto, Hiroshi] Minamisoma Municipal Gen Hosp, Dept Neurosurg, Haramachi Ward, Fukushima 9750033, Japan; [Wakabayashi, Hidetaka] Yokohama City Univ, Med Ctr, Dept Rehabil Med, Minami Ward, Yokohama, Kanagawa 2320024, Japan; [Maeda, Keisuke] Tamana Reg Hlth Med Ctr, Dept Internal Med, Tamana City, Kumamoto 8650005, Japan	Shamoto, H (reprint author), Minamisoma Municipal Gen Hosp, Dept Neurosurg, Haramachi Ward, 2-54-6 Takami Chou, Fukushima 9750033, Japan.	shahonvs17@gmail.com; noventurenoglory@gmail.com; maeda4work@tng.bbiq.jp		Maeda, Keisuke/0000-0001-7132-7818; Wakabayashi, HIdetaka/0000-0002-0364-0818			Esmarck B, 2001, J PHYSIOL-LONDON, V535, P301, DOI 10.1111/j.1469-7793.2001.00301.x; Deutz NEP, 2014, CLIN NUTR, V33, P929, DOI 10.1016/j.clnu.2014.04.007; Pineda-Juarez J.A., 2015, CLIN NUTR; Rondanelli M, 2015, BIOMED RES INT; Wakabayashi H, 2014, J CACHEXIA SARCOPENI, V5, P269, DOI 10.1007/s13539-014-0162-x	5	0	0	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0261-5614	1532-1983		CLIN NUTR	Clin. Nutr.	AUG	2015	34	4					779	780		10.1016/j.clnu.2015.04.007		2	Nutrition & Dietetics	Nutrition & Dietetics	CL8RN	WOS:000357241900033		
J	Sato, M; Katayama, Y				Sato, Mari; Katayama, Yoshio			Osteocytes and Homeostasis of Remote Organs	CURRENT OSTEOPOROSIS REPORTS			English	Article						Hematopoietic stem cell; Niche; Osteocyte; Thymus; Fat metabolism	HEMATOPOIETIC STEM-CELLS; BONE-MARROW NICHE; STEM/PROGENITOR CELLS; ENDOSTEAL NICHE; RECEPTOR; OSTEOBLASTS; SPACEFLIGHT; METABOLISM	The study of bones has attracted researchers from many medical fields. To understand bone-organ interactions, hematologists were challenged to investigate bone marrow (BM), the core of bone where hematopoiesis takes place. Through studies of the hematopoietic stem cells niche, hematologists contributed to the discovery of unexpected functions of bone-forming osteoblasts and bone-buried osteocytes. In particular, the recent findings about osteocytes, as the regulatory system of lympho-hematopoiesis and fat metabolism, highlighted the central role of skeletal tissue in inter-organ communication. The cross-cutting consideration including hematology and many other fields will expand the bone research.	[Sato, Mari] Hokkaido Univ, Grad Sch Dent Med, Dept Oral Biochem & Mol Biol, Kita Ku, Sapporo, Hokkaido 0608586, Japan; [Katayama, Yoshio] Kobe Univ, Grad Sch Med, Dept Med, Hematol, Kobe, Hyogo 657, Japan	Sato, M (reprint author), Hokkaido Univ, Grad Sch Dent Med, Dept Oral Biochem & Mol Biol, Kita Ku, Kita13 Nishi7, Sapporo, Hokkaido 0608586, Japan.	satomari@den.hokudai.ac.jp					Passweg JR, 2012, BONE MARROW TRANSPL, V47, P906, DOI 10.1038/bmt.2012.66; Xie YC, 2009, NATURE, V457, P97, DOI 10.1038/nature07639; Ferron M, 2010, CELL, V142, P296, DOI 10.1016/j.cell.2010.06.003; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Bonewald LF, 2011, J BONE MINER RES, V26, P229, DOI 10.1002/jbmr.320; Adams GB, 2006, NATURE, V439, P599, DOI 10.1038/nature04247; Katayama Y, 2006, CELL, V124, P407, DOI 10.1016/j.cell.2005.10.041; Kode A, 2014, NATURE, V506, P240, DOI 10.1038/nature12883; Yamazaki S, 2011, CELL, V147, P1146, DOI 10.1016/j.cell.2011.09.053; Grassinger J, 2010, BLOOD, V116, P3185, DOI 10.1182/blood-2009-12-260703; Fulzele K, 2010, CELL, V142, P309, DOI 10.1016/j.cell.2010.06.002; Fulzele K, 2013, BLOOD, V121, P930, DOI 10.1182/blood-2012-06-437160; Calvi LM, 2012, BLOOD, V119, P2489, DOI 10.1182/blood-2011-06-360933; Sugiyama T, 2006, IMMUNITY, V25, P977, DOI 10.1016/j.immuni.2006.10.016; Ding L, 2012, NATURE, V481, P457, DOI 10.1038/nature10783; Belavy DL, 2011, OSTEOPOROSIS INT, V22, P1581, DOI 10.1007/s00198-010-1371-6; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Klein-Nulend J, 2013, BONE, V54, P182, DOI 10.1016/j.bone.2012.10.013; Raaijmakers MHGP, 2010, NATURE, V464, P852, DOI 10.1038/nature08851; Nakamura Y, 2010, BLOOD, V116, P1422, DOI 10.1182/blood-2009-08-239194; Asada N, 2013, CELL STEM CELL, V12, P737, DOI 10.1016/j.stem.2013.05.001; Tatsumi S, 2007, CELL METAB, V5, P464, DOI 10.1016/j.cmet.2007.05.001; Lo Celso C, 2009, NATURE, V457, P92, DOI 10.1038/nature07434; Visnjic D, 2004, BLOOD, V103, P3258, DOI 10.1182/blood-2003-11-4011; Crucian B, 2009, J LEUKOCYTE BIOL, V86, P1017, DOI 10.1189/jlb.0709500; Lang T, 2004, J BONE MINER RES, V19, P1006, DOI 10.1359/JBMR.040307; Oury F, 2011, CELL, V144, P796, DOI 10.1016/j.cell.2011.02.004; Gueguinou N, 2009, J LEUKOCYTE BIOL, V86, P1027, DOI 10.1189/jlb.0309167; Kawamori Y, 2010, BLOOD, V116, P5528, DOI 10.1182/blood-2010-04-279216; Sato M, 2013, CELL METAB, V18, P749, DOI 10.1016/j.cmet.2013.09.014; Tu X, 2015, P NATL ACAD SCI US	33	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA		1544-2241		CURR OSTEOPOROS REP	Curr. Osteoporos. Rep.	AUG	2015	13	4					193	197		10.1007/s11914-015-0269-9		5	Endocrinology & Metabolism	Endocrinology & Metabolism	CL7CI	WOS:000357127300001		
J	Mizuhashi, F; Koide, K; Takahashi, M				Mizuhashi, Fumi; Koide, Kaoru; Takahashi, Mutsumi			Thickness and fit of mouthguards adjusted by notching thermoplastic sheets under different heating conditions	DENTAL TRAUMATOLOGY			English	Article						Mouthguard; Thickness; Fit; Notching; Heating condition	HOLDING CONDITIONS	This study examines the thickness and fit of mouthguards by notching thermoplastic copolymer ethylene vinyl acetate (EVA) sheets and then heating them to various degrees. The material used was a 3.8-mm-thick sports mouthguard. Notches with a length of 90 and 80mm were cut into an EVA sheet 20mm from the anterior and posterior margins and 15mm from the right and left margins, respectively, and the sheet was compared with the original. The sheets were formed using a vacuum former when the sheets were heated until they hung 1.5, 2.0, 2.5, and 3.0cm from the baseline. We measured the thickness and fit of the mouthguard at the central incisor and first molar. Differences in thickness and fit according to the measurement parts, sheet type, and heating conditions were analyzed by three-way anova. The measurement parts and sheet type significantly differed (P<0.01), and the notched sheet maintained the required thickness. Fit differed among the measurement parts and by heating conditions (P<0.01), but was not affected by the notching. The mouthguard fit was optimal when the sheets were heated to a hanging distance of 3.0cm. These results suggest that the thickness and fit of the EVA sheet could be maintained by notching and heating the sheet to a hanging distance of 3.0cm. These findings could be useful for fabricating appropriate mouthguards.	[Mizuhashi, Fumi; Koide, Kaoru; Takahashi, Mutsumi] Nippon Dent Univ, Sch Life Dent Niigata, Dept Removable Prosthodont, Niigata 9518580, Japan	Mizuhashi, F (reprint author), Nippon Dent Univ, Sch Life Dent Niigata, Dept Removable Prosthodont, Chuo Ku, 1-8 Hamaura Cho, Niigata 9518580, Japan.	fumichan@ngt.ndu.ac.jp					ADA Council on Access Prevention and Interprofessional Relations ADA Council on Scientific Affairs, 2006, J AM DENT ASS, V137, P1712; Westerman B, 2002, DENT TRAUMATOL, V18, P24, DOI 10.1034/j.1600-9657.2002.180103.x; Tran D, 2001, DENT TRAUMATOL, V17, P260, DOI 10.1034/j.1600-9657.2001.170604.x; Choy M M, 1998, Hawaii Dent J, V29, P28; DELSROSSI G, 2008, DENT TRAUMTOL, V24, P197; Gould TE, 2009, DENT MATER, V25, P1593, DOI 10.1016/j.dental.2009.08.003; Hoffmann J, 1999, ENDOD DENT TRAUMATOL, V15, P157; Labella CR, 2002, MED SCI SPORT EXER, V34, P41, DOI 10.1097/00005768-200201000-00007; Low Danny, 2002, Ann R Australas Coll Dent Surg, V16, P153; Maeda Masahiko, 2008, Nihon Hotetsu Shika Gakkai Zasshi, V52, P211, DOI 10.2186/jjps.52.211; Mizuhashi F, 2012, DENT TRAUMATOL, V28, P291, DOI 10.1111/j.1600-9657.2011.01091.x; Mizuhashi F, 2014, DENT TRAUMATOL, V30, P140, DOI 10.1111/edt.12043; Mizuhashi F, 2012, ANN JPN PROSTHODONT, V4, P1; Padilla R, 1996, J Calif Dent Assoc, V24, P30; Patrick DG, 2005, BRIT J SPORT MED, V39, P278, DOI 10.1136/bjsm.2004.012658; Santos FP, 2007, J CONT DENT PRACT, V8, P89; Spinas E, 2007, Eur J Paediatr Dent, V8, P193; Takahashi F, 2003, J SPORTS DENT, V6, P30; Takahashi F, 2004, J SPORTS DENT, V7, P12; Takeuchi M, 2006, COMPLETE APPL THERMO; Waked EJ, 2005, QUINTESSENCE INT, V36, P462; Yonehata Y, 2003, J PROSTHET DENT, V89, P23, DOI 10.1067/mpr.2003.62	22	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1600-4469	1600-9657		DENT TRAUMATOL	Dent. Traumatol.	AUG	2015	31	4					288	293		10.1111/edt.12143		6	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CM1HT	WOS:000357432600005		
J	Takahashi, M; Koide, K; Mizuhashi, F; Sato, T				Takahashi, Mutsumi; Koide, Kaoru; Mizuhashi, Fumi; Sato, Toshihide			Investigation of vacuum forming techniques for reduction of loss in mouthguard thickness: part 2effects of sheet grooving and thermal shrinkage	DENTAL TRAUMATOLOGY			English	Article						mouthguard; thermoforming; thickness; thermal shrinkage; sheet form		The aim of this study was to investigate vacuum forming techniques for reduction of loss in mouthguard thickness effects of sheet grooving and thermal shrinkage of extruded sheets on molded mouthguard thickness. Mouthguards were fabricated with ethylene vinyl acetate (EVA) sheets (4.0mm thick) using a vacuum forming machine. Sheet form was a convexing v-shaped groove toward the back, 10-40mm from the anterior end. The sheets were placed in the forming machine with the sheet extrusion direction either vertical or parallel to the model's centerline of right and left. Molding was performed by crimping the sheet using suction when the most descending portion of the sheet sagged downwards from the clamp, 15mm below the basal surface. Postmolding thickness was determined using a measuring device. Measurement points were the incisal portion (incisal edge and labial surface) and molar portion (cusp and buccal surface). Differences in molded mouthguard thickness with the sheet orientation of extruded EVA sheets were analyzed by student's t-test. The sheet in parallel axis orientation with the model's centerline yielded higher thickness than vertical orientation at the labial surface and the buccal surface. The present results suggested that addition of a groove to the sheet in conjunction with placement of the sheet with its axis of orientation parallel the centerline of the working model can effectively reduce thickness loss in the molded mouthguard with the equipment and materials used in this study.	[Takahashi, Mutsumi; Koide, Kaoru; Mizuhashi, Fumi; Sato, Toshihide] Nippon Dent Univ, Sch Life Dent, Dept Removable Prosthodont, Niigata, Niigata 9518580, Japan	Takahashi, M (reprint author), Nippon Dent Univ, Sch Life Dent, Dept Removable Prosthodont, Chuo Ku, 1-8 Hamaura Cho, Niigata, Niigata 9518580, Japan.	mutsumit@ngt.ndu.ac.jp					Westerman B, 2002, DENT TRAUMATOL, V18, P24, DOI 10.1034/j.1600-9657.2002.180103.x; Takahashi M, 2013, J PROSTHODONT RES, V57, P169, DOI 10.1016/j.jpor.2013.01.004; Bemelmanns P, 2001, INT J SPORTS MED, V22, P149, DOI 10.1055/s-2001-11342; DORNEY B, 1994, PHILLIP J, V9, P311; Geary JL, 2008, DENT TRAUMATOL, V24, P350, DOI 10.1111/j.1600-9657.2007.00550.x; Maeda Masahiko, 2008, Nihon Hotetsu Shika Gakkai Zasshi, V52, P211, DOI 10.2186/jjps.52.211; Mizuhashi F, 2012, DENT TRAUMATOL, V28, P291, DOI 10.1111/j.1600-9657.2011.01091.x; Nakajima K, 2008, DENT TRAUMATOL, V24, P50, DOI 10.1111/j.1600-9657.2006.00398.x; Padilla R, 1996, J Calif Dent Assoc, V24, P30; Padilla R R, 1999, J Calif Dent Assoc, V27, P200; Takahashi F, 2008, J SPORTS DENT, V11, P64; Takahashi F, 2004, J SPORTS DENT, V7, P12; Takahashi M, 2013, J PROSTHODONT RES, V57, P179, DOI 10.1016/j.jpor.2013.04.002; Takahashi M, 2010, ANN JPN PROTHODONT S, V2, P61; Takahashi M, 2012, ANN JPN PROTHODONT S, V4, P286; Takeuchi M, 2006, EFFECTIVELY THERMOFO, p[24, 54]; Westerman B, 1995, AUST DENT J, V40, P389	17	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1600-4469	1600-9657		DENT TRAUMATOL	Dent. Traumatol.	AUG	2015	31	4					314	317		10.1111/edt.12162		4	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CM1HT	WOS:000357432600009		
J	Mauerhofer, V; Kim, RE; Stevens, C				Mauerhofer, Volker; Kim, Rakhyun E.; Stevens, Casey			When implementation works: A comparison of Ramsar Convention implementation in different continents	ENVIRONMENTAL SCIENCE & POLICY			English	Article						Implementation; International law; Global environmental politics; Multilevel governance; Ramsar Convention on Wetlands; Biodiversity conservation; Local public participation; Regional integration; Funding	MULTILATERAL ENVIRONMENTAL AGREEMENTS; INTERNATIONAL-LAW; BIOLOGICAL DIVERSITY; GOVERNANCE; MEXICO; CONSERVATION; KNOWLEDGE; WETLANDS; SCIENCE; COMPLEX	What are the processes that shape implementation of multilateral environmental agreements (MEAs) in multilevel governance? In an attempt to address this question, we move from a top-down view of implementation as compliance with international rules to viewing it as a dynamic process shaped by action at various levels. The Ramsar Convention on Wetlands offers an important context to understand the mechanisms that shape multilevel implementation outcomes. We examine Ramsar Convention implementation in Austria, Mexico, and the Republic of Korea in order to identify relevant processes that define multilevel implementation. These cases represent three different types of government, and shed light on the ways in which international law is implemented by respective governments. The Austrian case, a federal government, illustrates the ways in which subnational authorities (the provinces) are influenced by binding regional institutions (EU-rules) to create a more robust context for protection in terms of designation of Ramsar sites. The Mexican case, a semi-federal government, shows how spurred involvement by local NGOs, states, and scientists can result in significant expansion, of efforts. The Korean case, a unitary government, demonstrates the ways in which aligning institutional interests (in this case local governments with national ministries) can lead to strong implementation. Analysis of these cases provides two robust findings and one deserving additional study. First, overlapping governance efforts where activity has ties with multiple regional and international biodiversity efforts tend to see cumulative implementation. Second, institutional and organizational complexity can provide opportunities for local actors to drive the implementation agenda through a mix of processes of coordination and contentious politics. A third, more tentative finding, is that multilevel funding sources can ease implementation. (C) 2015 Elsevier Ltd. All rights reserved.	[Mauerhofer, Volker] Univ Vienna, Dept Bot & Biodivers Res, Fac Life Sci, A-1030 Vienna, Austria; [Mauerhofer, Volker; Stevens, Casey] United Nations Univ Inst Adv Study Sustainabil UN, Tokyo, Japan; [Mauerhofer, Volker] Minist Agr Forestry & Fisheries, PRIMAFF Policy Res Inst, Tokyo, Japan; [Kim, Rakhyun E.] Griffith Univ, Griffith Law Sch, Nathan, Qld 4111, Australia; [Stevens, Casey] Providence Coll, Providence, RI USA	Mauerhofer, V (reprint author), Univ Vienna, Dept Bot & Biodivers Res, Fac Life Sci, Rennweg 14, A-1030 Vienna, Austria.	volker.mauerhofer@univie.ac.at			Japan Society for the Promotion of Science (JSPS)	The authors thank two anonymous reviewers of the journal for their very helpful comments. The second author thanks Dr. Nial Moores, the director of Birds Korea, for his comments on the country part related to Korea and the third author acknowledges the generous post-doctoral fellowship provided by the Japan Society for the Promotion of Science (JSPS) during his stay at UNU-IAS. The usual disclaimer applies.	Andrews J.M., 2006, LANDSCAPE URBAN PLAN, V74, P191; Folke C, 2006, GLOBAL ENVIRON CHANG, V16, P253, DOI 10.1016/j.gloenvcha.2006.04.002; Newig J, 2014, ROUTLEDGE HANDBOOK OF GLOBAL ENVIRONMENTAL POLITICS, P439; Haas PM, 2011, POLIT SCI ENVIRON, P125; Raustiala K, 2004, INT ORGAN, V58, P277, DOI 10.1017/S0020818304582036; Farrier D, 2000, J ENVIRON LAW, V12, P21, DOI 10.1093/jel/12.1.21; Fung A, 2006, PUBLIC ADMIN REV, V66, P66, DOI 10.1111/j.1540-6210.2006.00667.x; Normile D, 2010, SCIENCE, V327, P1568, DOI 10.1126/science.327.5973.1568; Young OR, 2011, P NATL ACAD SCI USA, V108, P19853, DOI 10.1073/pnas.1111690108; Koetz T, 2008, ENVIRON SCI POLICY, V11, P505, DOI 10.1016/j.envsci.2008.05.001; Chasek P, 2011, LAND DEGRAD DEV, V22, P272, DOI 10.1002/ldr.1096; Oberthur S, 2009, INT ENVIRON AGREEM-P, V9, P371, DOI 10.1007/s10784-009-9109-7; Mastenbroek E, 2005, J EUR PUBLIC POLICY, V12, P1103, DOI 10.1080/13501760500270869; Neumayer E, 2002, J PEACE RES, V39, P139, DOI 10.1177/0022343302039002001; Stoll-Kleemann S, 2010, BASIC APPL ECOL, V11, P377, DOI 10.1016/j.baae.2010.06.004; Rockstrom J, 2009, NATURE, V461, P472, DOI 10.1038/461472a; Berman PS, 2005, COLUMBIA J TRANS LAW, V43, P485; Bowman Michael, 2002, YB INT COOPERATION E, V10, P61; Cardesa-Salzmann A, 2012, J ENVIRON LAW, V24, P103, DOI 10.1093/jel/eqr022; Cashman L., 2006, JEEPL, V5, P385; Castro G., 2002, RAMSAR CONVENTION ME; Comision Nacional para el Conocimiento y Uso de la Biodiversidad, 2013, BIOD MEX; Courtney L, 2001, COLORADO J INT ENV L, P129; Dugan P., 1990, WETLAND CONSERVATION; Dugan P.J., 2005, PHILIPS GUIDE WETLAN; E.E.C, 1992, OFFICIAL J EUROPEAN, V206, P7; EEC, 1979, OFF J L, V20, P7; European Union, 2013, OFF J L, V347, P185; Fuentes-George K.D, 2011, THESIS U MASSACHUSET; Fuller T, 2007, BIOL CONSERV, V134, P593, DOI 10.1016/j.biocon.2006.08.028; Gagnon-Legare A, 2014, J ENVIRON DEV, V23, P220, DOI 10.1177/1070496514525404; Hill M., 2003, PUBLIC MANAGEMENT RE, V5, P471, DOI DOI 10.1080/1471903032000178545; Hupe P. L., 2014, PUBLIC POLICY ADM, V29, P164, DOI DOI 10.1177/0952076713518339; Kellow A, 2012, INT ENVIRON AGREEM-P, V12, P327, DOI 10.1007/s10784-012-9172-3; Kellow A, 2006, AUST J INT AFF, V60, P287, DOI 10.1080/10357710600696183; Kim R.E, 2011, COLUMBIA J ASIAN LAW, V24, P437; Kim R.E, 2008, GOVERNANCE SUSTAINAB, P1; Ko YK, 2011, ENVIRONMENT, V53, P3, DOI 10.1080/00139157.2011.570640; Luken R, 2006, ECOL ECON, V56, P241, DOI 10.1016/j.ecolecon.2004.04.013; MARVEL MK, 1982, ADMIN SOC, V14, P15, DOI 10.1177/009539978201400102; Matthews G. V. T., 1993, RAMSAR CONVENTION WE; Mauerhofer V, 2010, BIODIVERS CONSERV, V19, P601, DOI 10.1007/s10531-009-9737-9; Mauerhofer V, 2011, LAND USE POLICY, V28, P877, DOI 10.1016/j.landusepol.2011.03.004; Mauerhofer V, 2014, ROUTLEDGE HANDBOOK OF GLOBAL ENVIRONMENTAL POLITICS, P481; Mauerhofer V., PUBLIC PART IN PRESS; Mauerhofer Volker, 2008, P1; Mayaux P, 2005, PHILOS T ROY SOC B, V360, P373, DOI 10.1098/rstb.2004.1590; Morzaria-Luna HN, 2014, WETL ECOL MANAG, V22, P267, DOI 10.1007/s11273-013-9328-0; NAVID D, 1989, NAT RESOUR J, V29, P1001; Newig J., 2009, Environmental Policy and Governance, V19, P197, DOI 10.1002/eet.509; NICHOLS JD, 1995, ANNU REV ECOL SYST, V26, P177, DOI 10.1146/annurev.es.26.110195.001141; North American Waterfowl Management Plan Committee, 2012, N AM WAT MAN PLAN 20; North D.C., 1990, I I CHANGE EC PERFOR; O'Connor A., 2003, TIMES NEW YORK  0723; Oberthiir S., 2011, MANAGING I COMPLEXIT; Parker C., 2012, LITTLE BIODIVERSITY; Perez-Arteaga A, 2002, BIOL CONSERV, V107, P47, DOI 10.1016/S0006-3207(02)00043-5; Perez-Arteaga A, 2005, ANIM CONSERV, V8, P41, DOI 10.1017/S1367943004001817; Peterson M.J., 1997, GLOBAL GOVERNANCE DR, P115; Ramsar Secretary General, 2012, 11 M C PART CONV WET; Republic of Korea, 1999, 7 M C CONTR PART CON; Republic of Korea, 2012, 11 M C CONTR P UNPUB; Selee A, 2011, DECENTRALIZATION, DEMOCRATIZATION, AND INFORMAL POWER IN MEXICO, P1; Skjaerseth JB, 2006, GLOBAL ENVIRON POLIT, V6, P104, DOI 10.1162/glep.2006.6.3.104; Steffen W, 2015, SCIENCE, V347, P736, DOI 10.1126/science.1259855; Suncheon City Council, 2014, M GOV ADM LOC AUT CO; UNdata, 2011, UN DEM YB; VanDeveer S. D., 2001, GLOBAL ENVIRON POLIT, V1, P18, DOI 10.1162/152638001750336569; Vega X., 2002, WATERBIRDS WORLD GLO; WILS WPJ, 1994, J ENVIRON LAW, V6, P219, DOI 10.1093/jel/6.2.219; Zhao JM, 2003, CHINA QUART, P708	71	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1462-9011	1873-6416		ENVIRON SCI POLICY	Environ. Sci. Policy	AUG	2015	51						95	105		10.1016/j.envsci.2015.03.016		11	Environmental Sciences	Environmental Sciences & Ecology	CL7JB	WOS:000357147200009		
J	Takumi, K; Fukukura, Y; Higashi, M; Ideue, J; Umanodan, T; Hakamada, H; Kanetsuki, I; Yoshiura, T				Takumi, Koji; Fukukura, Yoshihiko; Higashi, Michiyo; Ideue, Junnichi; Umanodan, Tomokazu; Hakamada, Hiroto; Kanetsuki, Ichiro; Yoshiura, Takashi			Pancreatic neuroendocrine tumors: Correlation between the contrast-enhanced computed tomography features and the pathological tumor grade	EUROPEAN JOURNAL OF RADIOLOGY			English	Article						Neoplasma; Neuroendocrine tumor; Pancreas; CT	ISLET-CELL TUMORS; ENDOCRINE TUMORS; MICROVASCULAR DENSITY; PROGNOSTIC-FACTORS; HELICAL CT; CLASSIFICATION; MALIGNANCY; SURVIVAL; BEHAVIOR; PROPOSAL	Objective: To determine whether CT features can predict the pathological tumor grades of pancreatic neuroendocrine tumors (PanNETs) according to the recent WHO classification. Materials and methods: In all, 28 patients with histologically confirmed PanNETs underwent preoperative contrast CT examinations. Thirteen tumors were classified as G1 and 15 as G2. Two radiologists independently evaluated the CT features (tumor delineation, peripancreatic vascular involvement, upstream pancreatic duct dilatation, N (regional lymph node metastasis) and M (distant metastasis) grades, tumor homogeneity, cystic or necrotic change, and tumor conspicuity). The tumor sizes and Hounsfield unit values of all PanNETs during each phase on CT were measured by one radiologist. We compared the CT features between pathological tumor grades using Fisher's exact test for nominal scales and Mann-Whitney U test for ordinal scales or continuous variables. Additionally, we evaluated the performances of the CT findings and their combinations to diagnose G2 tumors. Results: G2 tumors showed significantly larger in tumor size than G1 tumors (p = 0.029). All 4 tumors with hepatic metastases were G2. Non-hyperattenuation compared with pancreatic parenchyma during portal venous phase (PVP) was significantly associated with G2 (p = 0.016). The accuracy for G2 diagnosis of tumor size (>= 20 mm), M grade (M1), and tumor conspicuity (non-hyperattenuation during PVP) were 71%, 61%, and 71%, respectively, while the accuracy of their combination was 82%. Conclusion: Contrast-enhanced CT features (tumor size, M grade, and tumor conspicuity during PVP) can predict the pathological tumor grades of PanNETs. (C) 2015 Elsevier Ireland Ltd. All rights reserved.	[Takumi, Koji; Fukukura, Yoshihiko; Ideue, Junnichi; Umanodan, Tomokazu; Hakamada, Hiroto; Yoshiura, Takashi] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Radiol, Kagoshima 8908544, Japan; [Higashi, Michiyo] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Human Pathol, Kagoshima 8908544, Japan; [Kanetsuki, Ichiro] Koseiren Hosp, Dept Radiol, Kagoshima 8900061, Japan	Takumi, K (reprint author), Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Radiol, 8-35-1 Sakuragaoka, Kagoshima 8908544, Japan.	takumi@m2.kufm.kagoshima-u.ac.jp					Pape UF, 2008, CANCER-AM CANCER SOC, V113, P256, DOI 10.1002/cncr.23549; Jann H, 2011, CANCER-AM CANCER SOC, V117, P3332, DOI 10.1002/cncr.25855; Couvelard A, 2005, BRIT J CANCER, V92, P94, DOI 10.1038/sj.bjc.6602245; Rodallec M, 2006, PANCREATOLOGY, V6, P77, DOI 10.1159/000090026; Horton KM, 2006, RADIOGRAPHICS, V26, P453, DOI 10.1148/rg.262055056; Gallotti A, 2013, AM J ROENTGENOL, V200, P355, DOI 10.2214/AJR.11.8037; Tatsumoto S, 2013, ABDOM IMAGING, V38, P358, DOI 10.1007/s00261-012-9953-8; Piani C, 2008, ENDOCR-RELAT CANCER, V15, P175, DOI 10.1677/ERC-07-0126; Manfredi R, 2013, EUR RADIOL, V23, P3029, DOI 10.1007/s00330-013-2929-4; Bergers G, 2003, NAT REV CANCER, V3, P401, DOI 10.1038/nrc1093; Halfdanarson TR, 2008, ANN ONCOL, V19, P1727, DOI 10.1093/annonc/mdn351; Marion-Audibert AM, 2003, GASTROENTEROLOGY, V125, P1094, DOI 10.1053/S0016-5085(03)01198-3; Bettini R, 2011, SURGERY, V150, P75, DOI 10.1016/j.surg.2011.02.022; Lewis RB, 2010, RADIOGRAPHICS, V30, P1445, DOI 10.1148/rg.306105523; Ichikawa T, 2000, RADIOLOGY, V216, P163; BUETOW PC, 1995, AM J ROENTGENOL, V165, P1175; Rindi G, 2006, VIRCHOWS ARCH, V449, P395, DOI 10.1007/s00428-006-0250-1; Kawamoto S, 2013, AM J ROENTGENOL, V200, pW283, DOI 10.2214/AJR.12.8941; Rha SE, 2007, EUR J RADIOL, V62, P371, DOI 10.1016/j.ejrad.2007.02.036; d'Assignies G, 2009, RADIOLOGY, V250, P407, DOI 10.1148/radiol.2501080291; Cho MY, 2013, KOREAN J PATHOL, V47, P227, DOI 10.4132/KoreanJPathol.2013.47.3.227; Fidler JL, 2003, AM J ROENTGENOL, V181, P775; Klimstra DS, 2010, WHO CLASSIFICATION T, P322; Luo YJ, 2014, EUR RADIOL, V24, P2945, DOI 10.1007/s00330-014-3317-4; Ohike N, 2005, ENDOCR PATHOL, V16, P33, DOI 10.1385/EP:16:1:033; Singhi AD, 2012, AM J SURG PATHOL, V36, P1666, DOI 10.1097/PAS.0b013e31826a0048; Solcia E, 2000, WHO INT HISTOLOGICAL, V2nd	27	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0720-048X	1872-7727		EUR J RADIOL	Eur. J. Radiol.	AUG	2015	84	8					1436	1443		10.1016/j.ejrad.2015.05.005		8	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CM1XP	WOS:000357474200004		
J	Nakamura, M; Kido, T; Kido, T; Tanabe, Y; Matsuda, T; Nishiyama, Y; Miyagawa, M; Mochizuki, T				Nakamura, Masashi; Kido, Tomoyuki; Kido, Teruhito; Tanabe, Yuki; Matsuda, Takuya; Nishiyama, Yoshiko; Miyagawa, Masao; Mochizuki, Teruhito			Quantitative circumferential strain analysis using adenosine triphosphate-stress/rest 3-T tagged magnetic resonance to evaluate regional contractile dysfunction in ischemic heart disease	EUROPEAN JOURNAL OF RADIOLOGY			English	Article						Magnetic resonance imaging; Myocardial ischemia; Myocardial infarction; Tagged MR; Circumferential strain	CORONARY-ARTERY-DISEASE; 3 TESLA; MYOCARDIAL-INFARCTION; MRI; VIABILITY; RESERVE	Purpose: We evaluated whether a quantitative circumferential strain (CS) analysis using adenosine triphosphate (ATP)-stress/rest 3-T tagged magnetic resonance (MR) imaging can depict myocardial ischemia as contractile dysfunction during stress in patients with suspected coronary artery disease (CAD). We evaluated whether it can differentiate between non-ischemia, myocardial ischemia, and infarction. We assessed its diagnostic performance in comparison with ATP-stress myocardial perfusion MR and late gadolinium enhancement (LGE)-MR imaging. Methods: In 38 patients suspected of having CAD, myocardial segments were categorized as non-ischemic (n = 485), ischemic (n = 74), or infarcted (n = 49) from the results of perfusion MR and LGE-MR. The peak negative CS value, peak circumferential systolic strain rate (CSR), and time-to-peak CS were measured in 16 segments. Results: A cutoff value of -12.0% for CS at rest allowed differentiation between infarcted and other segments with a sensitivity of 79%, specificity of 76%, accuracy of 76%, and an area under the curve (AUC) of 0.81. Additionally, a cutoff value of 477.3 ms for time-to-peak CS at rest allowed differentiation between infarcted and other segments with a sensitivity of 61%, specificity of 91%, accuracy of 88%, and an AUC of 0.75. The differences in CS values between ATP-stress and rest conditions ( A CS) in non-ischemic segments (median [first quartile, third quartile] -1.7 [-3.2, -0.1] %) were smaller than in segments with ischemia (+1.1 [+0.3, +2.3] %, p < 0.001). A cutoff value of +0.3% for the Delta CS value could differentiate segments with ischemia from non-ischemic segments with a sensitivity of 75%, a specificity of 82%, an accuracy of 82%, and an AUC of 0.86. Conclusions: Circumferential strain analysis using tagged MR can quantitatively assess contractile dysfunction in ischemic and infarcted myocardium. (C) 2015 Elsevier Ireland Ltd. All rights reserved.	[Nakamura, Masashi; Kido, Teruhito; Tanabe, Yuki; Matsuda, Takuya; Nishiyama, Yoshiko; Miyagawa, Masao; Mochizuki, Teruhito] Ehime Univ, Grad Sch Med, Dept Radiol, Toon City, Ehime 7910295, Japan; [Kido, Tomoyuki] Saiseikai Matsuyama Hosp, Dept Radiol, Matsuyama, Ehime 7910295, Japan	Nakamura, M (reprint author), Ehime Univ, Grad Sch Med, Dept Radiol, Toon City, Ehime 7910295, Japan.	m.nakamura1230@gmail.com					Azevedo CF, 2004, EUR HEART J, V25, P1419, DOI 10.1016/j.ehj.2004.06.024; Schwitter J, 2008, EUR HEART J, V29, P480, DOI 10.1093/eurheartj/ehm617; Shan K, 2004, CIRCULATION, V109, P1328, DOI 10.1161/01.CIR.0000120294.67948.E3; Kim RJ, 1999, CIRCULATION, V100, P1992; Berry C, 2007, EUR HEART J, V28, P278, DOI 10.1093/eurheartj/ehl446; Yu CM, 2002, CIRCULATION, V105, P1195, DOI 10.1161/hc1002.105185; Skulstad H, 2002, CIRCULATION, V106, P718, DOI 10.1161/01.CIR.0000024102.55150.B6; ZERHOUNI EA, 1988, RADIOLOGY, V169, P59; Croisille P, 1999, CIRCULATION, V99, P284; Denney TS, 2003, MAGNET RESON MED, V49, P743, DOI 10.1002/mrm.10434; Druz RS, 2004, J NUCL CARDIOL, V11, P534, DOI 10.1016/j.nuclcard.2004.05.009; Ebersberger U, 2013, EUR HEART J-CARD IMG, V14, P1174, DOI 10.1093/ehjci/jet074; Greenwood JP, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-62; Kido T, 2013, CIRC J, V77, P1235, DOI 10.1253/circj.CJ-12-1106; Korosoglou G, 2010, JACC-CARDIOVASC IMAG, V3, P361, DOI 10.1016/j.jcmg.2009.11.015; Kramer CM, 2000, J AM COLL CARDIOL, V36, P1835, DOI 10.1016/S0735-1097(00)00945-1; Le Y, 2010, MAGN RESON MED, V64, P787, DOI 10.1002/mrm.22461; Ran H, 2012, ECHOCARDIOGR-J CARD, V29, P688, DOI 10.1111/j.1540-8175.2012.01690.x; Thomas D, 2008, J CARDIOVASC MAGN R, V10, DOI 10.1186/1532-429X-10-59; Toumanidis ST, 2013, HELL J CARDIOL, V54, P264; Valeti VU, 2006, J MAGN RESON IMAGING, V23, P477, DOI 10.1002/jmri.20527; Wai B, 2013, EUR J RADIOL, V82, P337; Walcher T, 2013, INT J CARDIOVAS IMAG, V29, P355, DOI 10.1007/s10554-012-0099-0	23	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0720-048X	1872-7727		EUR J RADIOL	Eur. J. Radiol.	AUG	2015	84	8					1493	1501		10.1016/j.ejrad.2015.04.025		9	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CM1XP	WOS:000357474200012		
J	Mori, H; Isobe, S; Sakai, S; Yamada, T; Watanabe, N; Miura, M; Uchida, Y; Kanashiro, M; Ichimiya, S; Okumura, T; Murohara, T				Mori, Hiroaki; Isobe, Satoshi; Sakai, Shinichi; Yamada, Takashi; Watanabe, Naoki; Miura, Manabu; Uchida, Yasuhiro; Kanashiro, Masaaki; Ichimiya, Satoshi; Okumura, Takahiro; Murohara, Toyoaki			Microvascular obstruction on delayed enhancement cardiac magnetic resonance imaging after acute myocardial infarction, compared with myocardial Tl-201 and I-123-BMIPP dual SPECT findings	EUROPEAN JOURNAL OF RADIOLOGY			English	Article						Microvascular obstruction; Magnetic resonance imaging; Tl-201 and in I-BMIPP dual SPECT; Acute myocardial infarction	LEFT-VENTRICULAR FUNCTION; FATTY-ACID-METABOLISM; PROGNOSTIC-SIGNIFICANCE; CORONARY ANGIOPLASTY; CONTRAST ENHANCEMENT; BLOOD-FLOW; NO-REFLOW; RECOVERY; IMAGES; IODINE-123-BMIPP	Background: The hypo-enhanced regions within the hyper-enhanced infarct areas detected by cardiac magnetic resonance (CMR) imaging reflect microvascular obstruction (MO) after acute myocardial infarction (AMI). The combined myocardial thallium-201 (Tl-201)/iodine-123-15-(p-iodophenyl)-3-(R,S)-methylpentadecanoic acid (I-123-BMIPP) dual single-photon emission computed tomography (SPECT) is a useful tool for detecting myocardial reversibility after AMI. We evaluated whether MO could be an early predictor of irreversible myocardial damage in comparison with Tl-201 and I-123-BMIPP dual SPECT findings in AMI patients. Methods: Sixty-two patients with initial AMI who successfully underwent coronary revascularization were enrolled. MO was defined by CMR imaging. Patients were divided into 2 groups as follows: MO group (n = 32) and non-MO group (n = 30). Scintigraphic defect scores were calculated using a 17-segment model with a 5-point scoring system. The mismatch score (MMS) was calculated as follows: the total sum of (Sigma) I-123-BMIPP defect score minus Sigma Tl-201 defect score. The percentage mismatch score (%MMS) was calculated as follows: MMS/(Sigma I-123-BMIPP score) x 100 (%). Results: The percentage infarct size (%IS) was significantly greater in the MO group than in the nonMO group (32.2 +/- 13.8% vs. 18.3 +/- 12.1%, p < 0.001). The %MMS significantly correlated with the %IS and the percentage MO (r= -0.26, p = 0.03; r = -0.45, p < 0.001, respectively). The %MMS was significantly greater in the non-MO group than in the MO group (45.4 +/- 42.4% vs. 13.3 +/- 28.0%, p = 0.001), and was an independent predictor for MO (OR 0.97, 95%CI 0.94-0.99, p = 0.02). Conclusions: Our results reconfirm that, in comparison with myocardial dual scintigraphy, MO is an important structural abnormality. CMR imaging is useful for the early detection of irreversible myocardial damage after AMI. (C) 2015 Elsevier Ireland Ltd. All rights reserved.	[Mori, Hiroaki; Isobe, Satoshi; Yamada, Takashi; Okumura, Takahiro; Murohara, Toyoaki] Nagoya Univ, Grad Sch Med, Dept Cardiol, Nagoya, Aichi 4668560, Japan; [Mori, Hiroaki; Sakai, Shinichi; Watanabe, Naoki; Miura, Manabu] Kainan Hosp, Dept Cardiol, Yatomi, Japan; [Uchida, Yasuhiro; Kanashiro, Masaaki; Ichimiya, Satoshi] Yokkaichi Municipal Hosp, Dept Cardiol, Yokaichi, Japan	Isobe, S (reprint author), Nagoya Univ, Grad Sch Med, Dept Cardiol, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668560, Japan.	sisobe@med.nagoya-u.ac.jp	Murohara, Toyoaki/M-4958-2014				Hombach V, 2005, EUR HEART J, V26, P549, DOI 10.1093/eurheartj/ehi147; Kim RJ, 1996, CIRCULATION, V94, P3318; LIMA JAC, 1995, CIRCULATION, V92, P1117; Wu KC, 1998, J AM COLL CARDIOL, V32, P1756, DOI 10.1016/S0735-1097(98)00429-X; Gerber BL, 2000, CIRCULATION, V101, P2734; JUDD RM, 1995, CIRCULATION, V92, P1902; Bolognese L, 2004, CIRCULATION, V109, P1121, DOI 10.1161/01.CIR.0000118496.44135.A7; Shimonagata T, 1998, AM J CARDIOL, V82, P559, DOI 10.1016/S0002-9149(98)00399-3; Iwakura K, 2001, J AM COLL CARDIOL, V38, P472, DOI 10.1016/S0735-1097(01)01405-X; Nijveldt R, 2009, RADIOLOGY, V250, P363, DOI 10.1148/radiol.2502080739; Beltrame JF, 2012, CIRC J, V76, P818, DOI 10.1253/circj.CJ-12-0205; Amado LC, 2004, J AM COLL CARDIOL, V44, P2383, DOI 10.1016/j.jacc.2004.09.020; RAGOSTA M, 1994, CIRCULATION, V89, P2562; Wu KC, 1998, CIRCULATION, V97, P765; Chikamori T, 2007, J NUCL CARDIOL, V14, P111, DOI 10.1016/j.nuclcard.2006.11.007; DEGEETER F, 1994, EUR J NUCL MED, V21, P283; DUDCZAK R, 1986, EUR J NUCL MED, V12, pS45; Hashimoto A, 1995, J Cardiol, V26, P59; Ishii H, 2005, CIRCULATION, V112, P1284, DOI 10.1161/CIRCULATIONAHA.104.530329; Ito T, 1996, EUR J NUCL MED, V23, P917, DOI 10.1007/BF01084365; Iwakura K, 1996, CIRCULATION, V94, P1269; Kidambi A, 2013, J CARDIOVASC MAGN R, V15, DOI 10.1186/1532-429X-15-58; Kropp J, 1993, ANN NUCL MED, V7, P93; MATSUNARI I, 1994, J NUCL MED, V35, P1279; Nakata T, 2000, NUCL MED COMMUN, V21, P897, DOI 10.1097/00006231-200010000-00003; Nakata T, 1998, J NUCL MED, V39, P1492; Naruse H, 1998, J NUCL CARDIOL, V5, P275, DOI 10.1016/S1071-3581(98)90129-5; Raff GL, 2006, RADIOLOGY, V240, P529, DOI 10.1148/radiol.2402050369; TAMAKI N, 1992, J NUCL MED, V33, P659	29	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0720-048X	1872-7727		EUR J RADIOL	Eur. J. Radiol.	AUG	2015	84	8					1516	1524		10.1016/j.ejrad.2015.05.002		9	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CM1XP	WOS:000357474200015		
J	Fukuhara, T; Aikata, H; Hyogo, H; Honda, Y; Morio, K; Morio, R; Hatooka, M; Kobayashi, T; Naeshiro, N; Kawaoka, T; Tsuge, M; Hiramatsu, A; Imamura, M; Kawakami, Y; Chayama, K				Fukuhara, Takayuki; Aikata, Hiroshi; Hyogo, Hideyuki; Honda, Yohji; Morio, Kei; Morio, Reona; Hatooka, Masahiro; Kobayashi, Tomoki; Naeshiro, Noriaki; Kawaoka, Tomokazu; Tsuge, Masataka; Hiramatsu, Akira; Imamura, Michio; Kawakami, Yoshiiku; Chayama, Kazuaki			Efficacy of radiofrequency ablation for initial recurrent hepatocellular carcinoma after curative treatment: Comparison with primary cases	EUROPEAN JOURNAL OF RADIOLOGY			English	Article						Hepatocellular carcinoma; Radiofrequency ablation; Recurrence; Prognostic factor	REPEATED LIVER RESECTION; PROGNOSTIC-FACTORS; INTRAHEPATIC RECURRENCE; REPEAT HEPATECTOMY; HEPATIC RESECTION; CIRRHOSIS; SURVIVAL; CT; EXPERIENCE; MANAGEMENT	Objective: To determine the efficacy of radiofrequency ablation (RFA) for initial recurrence of small hepatocellular carcinoma (HCC; <= 3 nodules, each nodule <= 3 cm in diameter) after curative treatment and identify prognostic factors affecting therapeutic outcome, we compared clinical and outcome factors between patients with primary HCC and those with initial recurrent HCC who underwent RFA. Methods: In this retrospective cohort study, 211 HCC patients who underwent RFA were enrolled and comprised two groups: primary group (n = 139) and initial recurrent group (n = 72). We compared local tumor progression, overall survival (OS), disease-free survival (DFS), and RFA safety between the groups. Results: Median follow-up was 53 months. Local tumor progression rate was 5.8% in the primary group and 4.2% in the recurrent group. OS rates at 5 years and 10 years were 63.2% and 25.5% in the primary group and 54.5% and 33.4% in the recurrent group, respectively. Corresponding DFS rates were 30.7% and 14.6% and 19.2% and 11.0%. DFS was significantly shorter in the recurrent group (hazard ratio [HR] = 1.81; 95% confidence interval [CI], 1.27-2.57; P=0.001). In the recurrent group, time from primary HCC development to recurrence was a determinant of OS (<= 2 years; HR = 3.42; 95% CI, 1.52-7.72; P = 0.003). Conclusion: Although local tumor control and OS were similar between the groups, the recurrent group had shorter DFS than the primary group. Time from primary HCC development to recurrence was a prognostic factor for recurrence of HCC. (C) 2015 Elsevier Ireland Ltd. All rights reserved.	[Fukuhara, Takayuki; Aikata, Hiroshi; Hyogo, Hideyuki; Honda, Yohji; Morio, Kei; Morio, Reona; Hatooka, Masahiro; Kobayashi, Tomoki; Naeshiro, Noriaki; Kawaoka, Tomokazu; Tsuge, Masataka; Hiramatsu, Akira; Imamura, Michio; Kawakami, Yoshiiku; Chayama, Kazuaki] Hiroshima Univ Hosp, Dept Gastroenterol & Metab, Minami Ku, Hiroshima 7348551, Japan	Aikata, H (reprint author), Hiroshima Univ Hosp, Dept Gastroenterol & Metab, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348551, Japan.	aikata@hiroshima-u.ac.jp					Wu CC, 2009, BRIT J SURG, V96, P1049, DOI 10.1002/bjs.6690; Goldberg SN, 2005, RADIOLOGY, V235, P728, DOI 10.1148/radiol.2353042205; Hayashi M, 2002, RADIOLOGY, V225, P143, DOI 10.1148/radiol.2251011298; Lee DH, 2014, CARDIOVASC INTER RAD, V37, P705, DOI 10.1007/s00270-013-0708-x; Tateishi R, 2005, CANCER, V103, P1201, DOI 10.1002/cncr.20892; Kudo M, 2011, DIGEST DIS, V29, P339, DOI 10.1159/000327577; Bruix J, 2005, HEPATOLOGY, V42, P1208, DOI 10.1002/hep20933; Balsells J, 1996, BRIT J SURG, V83, P758, DOI 10.1002/bjs.1800830610; Choi D, 2007, ANN SURG ONCOL, V14, P2319, DOI 10.1245/s10434-006-9220-8; Neeleman N, 1996, BRIT J SURG, V83, P893, DOI 10.1002/bjs.1800830705; Fujimori M, 2013, J VASC INTERV RADIOL, V24, P655, DOI 10.1016/j.jvir.2012.12.009; Poon RTP, 1999, ANN SURG, V229, P216, DOI 10.1097/00000658-199902000-00009; Shimada M, 1996, GASTROENTEROLOGY, V111, P720, DOI 10.1053/gast.1996.v111.pm8780578; Shiina S, 2012, AM J GASTROENTEROL, V107, P569, DOI 10.1038/ajg.2011.425; Lencioni R, 2005, RADIOLOGY, V234, P961, DOI 10.1148/radiol.2343040350; Livraghi T, 2008, HEPATOLOGY, V47, P82, DOI 10.1002/hep.21933; Minagawa M, 2003, ANN SURG, V238, P703, DOI 10.1097/01.sla.0000094549.11754.e6; Hanazaki K, 2000, J AM COLL SURGEONS, V191, P381, DOI 10.1016/S1072-7515(00)00700-6; Chan ACY, 2012, WORLD J SURG, V36, P151, DOI 10.1007/s00268-011-1323-0; Faber W, 2011, J GASTROEN HEPATOL, V26, P1189, DOI 10.1111/j.1440-1746.2011.06721.x; Imamura H, 2003, J HEPATOL, V38, P200, DOI 10.1016/S0168-8278(02)00360-4; Itamoto T, 2007, SURGERY, V141, P589, DOI 10.1016/j.surg.2006.12.014; Lim JH, 2002, AM J ROENTGENOL, V179, P67; Sakon M, 2000, ARCH SURG-CHICAGO, V135, P1456, DOI 10.1001/archsurg.135.12.1456; Spreafico C, 1997, RADIOLOGY, V203, P457; Waki K, 2010, J GASTROEN HEPATOL, V5, P597	26	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0720-048X	1872-7727		EUR J RADIOL	Eur. J. Radiol.	AUG	2015	84	8					1540	1545		10.1016/j.ejrad.2015.04.020		6	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CM1XP	WOS:000357474200017		
J	Okada, M; Masuda, Y; Nakashima, Y; Nomura, T; Nakao, S; Suga, K; Kido, S; Matsunaga, N				Okada, Munemasa; Masuda, Yu; Nakashima, Yoshiteru; Nomura, Takafumi; Nakao, Sei; Suga, Kazuyoshi; Kido, Shoji; Matsunaga, Naofumi			Factors affecting the lung perfused blood volume in patients with intrapulmonary clots after anti-coagulation therapy	EUROPEAN JOURNAL OF RADIOLOGY			English	Article						Pulmonary embolism; Intrapulmonary clot burden; Computed tomography (CT); Dual energy CT; Anti-coagulation therapy	ACUTE PULMONARY-EMBOLISM; DUAL-ENERGY CT; RIGHT-VENTRICULAR ENLARGEMENT; CHEST COMPUTED-TOMOGRAPHY; FOLLOW-UP; HELICAL CT; QUANTIFICATION; ANGIOGRAPHY; RESOLUTION; SCINTIGRAPHY	Objective: Factors affecting the improvement in the lung perfused blood volume (LPBV) were evaluated based on the presence of intrapulmonary clots (IPCs) after anti-coagulation therapy using 64-slice dual-energy CT. Materials and methods: 96 patients exhibiting venous thromboembolism underwent initial and repeated LPBV examinations between December 2008 and July 2014. Fifteen patients were excluded due to pulmonary comorbidities, and a total of 81 patients were included in this study. Acute pulmonary embolism( PE) was diagnosed in 46 of the patients (56.7%). LPBV images were three-dimensionally reconstructed with two threshold ranges: 1-120 HU (V-120) and 1-5 HU (V-5), and the relative value of V-5 per V-120 expressed as % V-5. These values were subsequently compared with indicators of the severity of PE, such as the D-dimer level, heart rate and CT measurements. This study was approved by the local ethics committee. Results: In patients with IPCs, the D-dimer, V-5 and % V-5 values were significantly larger (p <= 0.01) in the initial LPBV, although these differences disappeared in subsequent LPBV after treatment. The right ventricular (RV) diameter, RV/left ventricular (RV/LV) diameter ratio and % V-5 values were also significantly reduced, whereas the V-5 value did not significantly decrease (p = 0.07), but V-120 value significantly increased (p < 0.001) after treatment. However, in patients with IPCs the change rate in % V-5[(subsequent-initial)/initial % V-5] showed a better correlation with that in V-5 (r = 0.94, p < 0.001) rate than that in V-120 (r = 0.19, p = 0.19) after treatment. Conclusions: Increased whole lung perfusion (V-120) and a decreased low perfusion volume (V-5) affect the improvement in the % V-5 values after treatment. (C) 2015 Elsevier Ireland Ltd. All rights reserved.	[Okada, Munemasa; Nomura, Takafumi; Nakao, Sei; Matsunaga, Naofumi] Yamaguchi Univ, Grad Sch Med, Dept Radiol, Ube, Yamaguchi 7558505, Japan; [Masuda, Yu] Yamaguchi Univ, Fac Med & Hlth Sci, Dept Med, Grade Year Med Doctor Program 4 6, Ube, Yamaguchi 7558505, Japan; [Nakashima, Yoshiteru] Yamaguchi Grand Med Ctr, Dept Radiol, Hofu, Yamaguchi 7478511, Japan; [Suga, Kazuyoshi] St Hills Hosp, Dept Radiol, Ube, Yamaguchi 7550155, Japan; [Kido, Shoji] Yamaguchi Univ, Appl Med Engn Sci Grad Sch Med, Comp Aided Diag & Biomed Imaging Res Biomed Engn, Ube, Yamaguchi 7558611, Japan	Okada, M (reprint author), Yamaguchi Univ, Grad Sch Med, Dept Radiol, 1-1-1 Minamikogushi, Ube, Yamaguchi 7558505, Japan.	radokada@yamaguchi-u.ac.jp					Horlander KR, 2003, ARCH INTERN MED, V163, P1711, DOI 10.1001/archinte.163.14.1711; van der Meer RW, 2005, RADIOLOGY, V235, P798, DOI 10.1148/radiol.2353040893; Okada M, 2013, ACTA RADIOL, V54, P628, DOI 10.1177/0284185113479053; Ribeiro A, 1999, CIRCULATION, V99, P1325; Johnson TRC, 2007, EUR RADIOL, V17, P1510, DOI 10.1007/s00330-006-0517-6; Nagayama H, 2013, CLIN IMAG, V37, P493, DOI 10.1016/j.clinimag.2012.08.007; Aghayev A, 2013, AM J ROENTGENOL, V200, P791, DOI 10.2214/AJR.12.8624; Quiroz R, 2004, CIRCULATION, V109, P2401, DOI 10.1161/01.CIR.0000129302.90476.BC; Meneveau N, 2013, EUR HEART J, V34, P693, DOI 10.1093/eurheartj/ehs365; Becattini C, 2012, J THROMB THROMBOLYS, V33, P48, DOI 10.1007/s11239-011-0648-8; Nijkeuter M, 2006, CHEST, V129, P192, DOI 10.1378/chest.129.1.192; Meneveau N, 2003, EUR HEART J, V24, P1447, DOI 10.1016/S0195-668X(03)00307-5; Stein PD, 2006, NEW ENGL J MED, V354, P2317, DOI 10.1056/NEJMoa052367; Thieme SF, 2008, EUR J RADIOL, V68, P369, DOI 10.1016/j.ejrad.2008.07.031; Schoepf UJ, 2004, CIRCULATION, V110, P3276, DOI 10.1161/01.CIR.0000147612.59751.4C; Begic A, 2011, NUCL MED COMMUN, V32, P508, DOI 10.1097/MNM.0b013e328344dfd5; Collomb D, 2003, EUR RADIOL, V13, P1508, DOI 10.1007/s00330-002-1804-5; Ghaye B, 2006, RADIOLOGY, V239, P884, DOI 10.1148/radiol.2392050075; GURNEY JW, 1993, RADIOLOGY, V188, P618; Kang MJ, 2010, AM J ROENTGENOL, V195, pW325, DOI 10.2214/AJR.09.3241; Okada M, 2013, CLIN RADIOL, V68, pE669, DOI 10.1016/j.crad.2013.07.018; Okada M, 2015, EUR J RADIOL, V84, P172, DOI [10.1016/j.ejrad.2014.09.009, 10.1016/j.cjrad.2014.09.009]; Sakamoto A, 2014, AM J ROENTGENOL, V203, P287, DOI 10.2214/AJR.13.11586; Stein PD, 2010, AM J ROENTGENOL, V194, P1263, DOI 10.2214/AJR.09.3410; Sueyoshi E, 2011, EUR J RADIOL, V80, pE505, DOI 10.1016/j.ejrad.2010.10.011	25	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0720-048X	1872-7727		EUR J RADIOL	Eur. J. Radiol.	AUG	2015	84	8					1614	1620		10.1016/j.ejrad.2015.05.018		7	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CM1XP	WOS:000357474200028		
J	Gotoh, T; Moriya, D; Nachman, G				Gotoh, Tetsuo; Moriya, Daisuke; Nachman, Gosta			Development and reproduction of five Tetranychus species (Acari: Tetranychidae): Do they all have the potential to become major pests?	EXPERIMENTAL AND APPLIED ACAROLOGY			English	Article						Tetranychus ludeni; T. phaselus; T. piercei; T. truncatus; T. urticae; Thermal threshold; Intrinsic rate of natural increase	2-SPOTTED SPIDER-MITE; JAPANESE PEAR ORCHARDS; POPULATION-DYNAMICS; URTICAE ACARI; LIFE-TABLES; TEMPERATURE; PARAMETERS; PERFORMANCE; PREDATORS; INSECTS	The objective of this study was to investigate whether four spider mite species, Tetranychus ludeni, T. phaselus, T. piercei and T. truncatus, currently with insignificant economic impact, have the potential to achieve the same status as T. urticae, which until now has been considered as the most serious tetranychid pest species in orchards and greenhouses. We investigated the effect of temperature on development, survival and oviposition at 11 constant temperatures ranging from 15 to 40 A degrees C at intervals of 2.5 A degrees C and estimated demographic parameters, such as the intrinsic rate of natural increase (r (m)), for these five species at five constant temperatures. Developmental time from egg to adult (female and male) decreased with increasing temperature from 15 to 32.5 A degrees C in all five species, but increased slightly at 35 A degrees C or higher, especially in T. ludeni and T. urticae. Using linear and non-linear developmental rate models, the lower thermal thresholds for egg-to-adult (female and male) and egg-to-egg development were found to range from 9.8 to 11.7 and from 9.8 to 11.4 A degrees C, respectively. The intrinsic optimal temperature (T (I broken vertical bar)) ranged from 18.0 to 27.4 A degrees C for egg-to-female adult and from 23.9 to 27.2 A degrees C for egg-to-egg development. The oviposition period and adult longevity were strongly affected by temperature. The r (m)-values increased with increasing temperature from 15 to 30 or 35 A degrees C in all five species. The highest r (m)-values at each temperature were 0.114 day(-1) at 15 A degrees C for T. ludeni, 0.199 day(-1) at 20 A degrees C for T. urticae, 0.314 day(-1) at 25 A degrees C for T. ludeni, 0.451 day(-1) at 30 A degrees C for T. ludeni and 0.433 day(-1) at 35 A degrees C for T. truncatus. The total fecundity, net reproductive rate (R (0)) and r (m) of T. ludeni were higher than those of T. urticae at all temperatures. T. piercei and T. truncatus showed higher r (m)-values at 30 and 35 A degrees C than T. urticae. The results indicate that the former three species are better adapted to hot weather than T. urticae and have a high potential to become serious pests.	[Gotoh, Tetsuo; Moriya, Daisuke] Ibaraki Univ, Lab Appl Entomol & Zool, Fac Agr, Ami, Ibaraki 3000393, Japan; [Nachman, Gosta] Univ Copenhagen, Dept Biol, Sect Ecol & Evolut, DK-2100 Copenhagen O, Denmark	Gotoh, T (reprint author), Ibaraki Univ, Lab Appl Entomol & Zool, Fac Agr, Ami, Ibaraki 3000393, Japan.	gotoh@mx.ibaraki.ac.jp; gnachman@bio.ku.dk					Takafuji A, 2000, EXP APPL ACAROL, V24, P317, DOI 10.1023/A:1006453209154; Ferrero M, 2007, EXP APPL ACAROL, V41, P45, DOI 10.1007/s10493-007-9053-6; Kiritani K, 2013, APPL ENTOMOL ZOOL, V48, P97, DOI 10.1007/s13355-012-0158-y; Bounfour M, 2001, ANN ENTOMOL SOC AM, V94, P400, DOI 10.1603/0013-8746(2001)094[0400:EOTODA]2.0.CO;2; Gotoh T, 2003, APPL ENTOMOL ZOOL, V38, P7, DOI 10.1303/aez.2003.7; SAITO Y, 1979, APPL ENTOMOL ZOOL, V14, P83; Bonato O, 1999, EXP APPL ACAROL, V23, P11, DOI 10.1023/A:1006144610009; Riahi E, 2013, J AGR SCI TECH-IRAN, V15, P661; Estay SA, 2014, OIKOS, V123, P131, DOI 10.1111/j.1600-0706.2013.00607.x; Khanamani M, 2013, INT J ACAROL, V39, P638, DOI 10.1080/01647954.2013.861867; TRICHILO PJ, 1993, EXP APPL ACAROL, V17, P291, DOI 10.1007/BF02337279; Riahi Elham, 2011, Acarologia (Paris), V51, P473, DOI 10.1051/acarologia/20112029; WYATT IJ, 1977, J APPL ECOL, V14, P757, DOI 10.2307/2402807; BIRCH LC, 1948, J ANIM ECOL, V17, P15, DOI 10.2307/1605; Ikemoto T, 2000, ENVIRON ENTOMOL, V29, P671; Chao S. R. S., 1974, Journal of Taiwan Agricultural Research, V23, P126; Chen CY, 2013, B ENTOMOL RES, V103, P406, DOI 10.1017/S0007485312000867; Davies J, 2009, EXP APPL ACAROL, V47, P133, DOI 10.1007/s10493-008-9198-y; [范丽清 Fan Liqing], 2003, [植物保护, Plant Protection], V29, P32; Fujibayashi Y, 1992, ANN REPT PLANT PROT, V43, P152; Goka K, 1999, EXP APPL ACAROL, V23, P419, DOI 10.1023/A:1006184605889; Gotoh T, 2004, APPL ENTOMOL ZOOL, V39, P675, DOI 10.1303/aez.2004.675; Gotoh T, 1997, APPL ENTOMOL ZOOL, V32, P207; Gotoh T, 2010, EXP APPL ACAROL, V52, P239, DOI 10.1007/s10493-010-9362-z; Ikemoto T, 2013, INSECT SCI, V20, P420, DOI 10.1111/j.1744-7917.2012.01525.x; Ikemoto T, 2008, J MED ENTOMOL, V45, P963, DOI 10.1603/0022-2585(2008)45[963:TMDNMH]2.0.CO;2; Ikemoto T, 2005, ENVIRON ENTOMOL, V34, P1377; Kishimoto H, 2002, APPL ENTOMOL ZOOL, V37, P603, DOI 10.1303/aez.2002.603; KONDO A, 1985, RES POPUL ECOL, V27, P145, DOI 10.1007/BF02515487; Lawo JP, 2011, J APPL ENTOMOL, V135, P715, DOI 10.1111/j.1439-0418.2011.01608.x; Manly BFJ, 1990, STAGE STRUCTURED POP, P187; McCullagh P., 1989, MONOGRAPHS STAT APPL, V37; Migeon A., 2006, SPIDER MITES WEB COM; Mizukoshi T, 2003, ANN REPT PLANT PROT, V55, P232; Nakagaki S, 1980, B IBARAKI FRUIT TREE, V8, P37; Okazaki K, 2000, AGR TECH, V59, P409; Pang Bao-ping, 2004, Acta Entomologica Sinica, V47, P55; Sabelis M.W., 1985, P265; Sabelis MW, 1981, BIOL CONTROL 2 SPO 1, V910; Sabelis M.W., 1991, P23; Sakunwarin Suthida, 2003, Systematic and Applied Acarology, V8, P13; SAS, 2006, SAS ENT GUID 4 1; Scranton K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072980; Shi PJ, 2011, ENVIRON ENTOMOL, V40, P462, DOI 10.1603/EN10265; SNELL TW, 1978, OECOLOGIA, V32, P119, DOI 10.1007/BF00344696; TAKAFUJI A, 1984, RES POPUL ECOL, V26, P113, DOI 10.1007/BF02515511; Takafuji Akio, 1996, Journal of the Acarological Society of Japan, V5, P75; TAKAFUJI A, 1980, RES POPUL ECOL, V21, P197, DOI 10.1007/BF02513621; Uchida M, 1982, SPEC B TOTTORI FRUIT, V2, P1; Ullah MS, 2011, EXP APPL ACAROL, V54, P1, DOI 10.1007/s10493-010-9420-6; VANDEVRI.M, 1972, HILGARDIA, V41, P343; Wrensch D.L., 1985, P165	52	1	1	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0168-8162	1572-9702		EXP APPL ACAROL	Exp. Appl. Acarol.	AUG	2015	66	4					453	479		10.1007/s10493-015-9919-y		27	Entomology	Entomology	CL3WE	WOS:000356881500001		
J	Chamnanchanunt, S; Kuroki, C; Desakorn, V; Enomoto, M; Thanachartwet, V; Sahassananda, D; Sattabongkot, J; Jenwithisuk, R; Fucharoen, S; Svasti, S; Umemura, T				Chamnanchanunt, Supat; Kuroki, Chieri; Desakorn, Varunee; Enomoto, Mari; Thanachartwet, Vipa; Sahassananda, Duangjai; Sattabongkot, Jetsumon; Jenwithisuk, Rachaneeporn; Fucharoen, Suthat; Svasti, Saovaros; Umemura, Tsukuru			Downregulation of plasma miR-451 and miR-16 in Plasmodium vivax infection	EXPERIMENTAL PARASITOLOGY			English	Article						Plasma miRNAs; Malaria; Biomarker; miR-451; miR-16; Plasmodium vivax	CIRCULATING MICRORNAS; MALARIA; SERUM; EXPRESSION; BIOMARKERS; PARASITE; DISEASES; CANCER; HUMANS; HOST	Malaria is a common parasitic disease in tropical countries, causing one to two million deaths every year. To establish the new biomarker, we analyzed plasma miRNAs obtained from 19 malaria patients and 19 normal subjects, using reverse transcription-based quantitative polymerase chain reaction (RT-qPCR). The average levels of plasma miR-451 and miR-16 were significantly lower in malaria patients, (8.9-fold; p < 0.001 and 10.4-fold; p = 0.01, respectively). The levels of other abundant miRNAs in plasma (miR-223, miR-226-3p) did not change significantly in malaria patients. Our data suggest that plasma miR-451 and miR-16 are relevant biomarkers for malaria infection. (C) 2015 Elsevier Inc. All rights reserved.	[Chamnanchanunt, Supat; Desakorn, Varunee; Thanachartwet, Vipa] Mahidol Univ, Fac Trop Med, Dept Clin Trop Med, Bangkok 10400, Thailand; [Kuroki, Chieri; Enomoto, Mari; Umemura, Tsukuru] Kyushu Univ, Grad Sch Hlth Sci, Dept Med Technol, Fukuoka 812, Japan; [Sahassananda, Duangjai] Mahidol Univ, Fac Trop Med, Informat Technol Unit, Bangkok 10400, Thailand; [Sattabongkot, Jetsumon; Jenwithisuk, Rachaneeporn] Mahidol Univ, Fac Trop Med, Mahidol Vivax Res Unit, Bangkok 10400, Thailand; [Fucharoen, Suthat; Svasti, Saovaros] Mahidol Univ, Inst Mol Biosci, Thalassemia Res Ctr, Nakhon Pathom 73170, Thailand; [Umemura, Tsukuru] Int Univ Hlth & Welf, Dept Med Technol & Sci, Fukuoka, Japan	Umemura, T (reprint author), Kyushu Univ, Grad Sch Hlth Sci, Dept Med Technol, Fukuoka 812, Japan.	umemura@med.kyushu-u.ac.jp			Vaccine Trial center; Faculty of Tropical Medicine, Institute of Molecular Biosciences (Mahidol University); Takeda Science Foundation; Japan Society for the Promotion of Science (JSPS) [21659240]; Thailand Research Fund (TRF), Research Chair Grant, National Science and Technology Development Agency, Thailand (NSTDA)	This study was supported by Vaccine Trial center, the Faculty of Tropical Medicine, Institute of Molecular Biosciences (Mahidol University), the Takeda Science Foundation, the Japan Society for the Promotion of Science (JSPS) (21659240), and Thailand Research Fund (TRF), Research Chair Grant, National Science and Technology Development Agency, Thailand (NSTDA).	El-Assaad F, 2011, INFECT IMMUN, V79, P2379, DOI 10.1128/IAI.01136-10; Amexo M, 2004, LANCET, V364, P1896, DOI 10.1016/S0140-6736(04)17446-1; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Buffet PA, 2011, BLOOD, V117, P381, DOI 10.1182/blood-2010-04-202911; Xiang MQ, 2014, BIOCHEM BIOPH RES CO, V454, P210, DOI 10.1016/j.bbrc.2014.10.064; Redova M, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-55; White NJ, 2014, LANCET, V383, P723, DOI 10.1016/S0140-6736(13)60024-0; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Beg MA, 2002, AM J TROP MED HYG, V67, P230; Murray CK, 2008, CLIN MICROBIOL REV, V21, P97, DOI 10.1128/CMR.00035-07; Zhu Z, 2014, VIRUSES-BASEL, V6, P1525, DOI 10.3390/v6041525; Masaki S, 2007, BIOCHEM BIOPH RES CO, V364, P509, DOI 10.1016/j.bbrc.2007.10.077; LaMonte G, 2012, CELL HOST MICROBE, V12, P187, DOI 10.1016/j.chom.2012.06.007; Reid G, 2011, CRIT REV ONCOL HEMAT, V80, P193, DOI 10.1016/j.critrevonc.2010.11.004; Rathjen T, 2006, FEBS LETT, V580, P5185, DOI 10.1016/j.febslet.2006.08.063; Xu L, 2013, J CELL PHYSIOL, V228, P1713, DOI 10.1002/jcp.24344; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Baltimore D, 2008, NAT IMMUNOL, V9, P839, DOI 10.1038/ni.f.209; Chen SY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002360; Genton B, 2008, PLOS MED, V5, P881, DOI 10.1371/journal.pmed.0050127; He X, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-272; Kirschner MB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024145; McGready R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040244; Ohrt C, 2002, J INFECT DIS, V186, P540, DOI 10.1086/341938; Pritchard CC, 2011, CANC PREV RES, V5, P492; Sagaki P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071503; Saunderson SC, 2014, BLOOD, V123, P208, DOI 10.1182/blood-2013-03-489732; Schantz-Dunn Julianna, 2009, Rev Obstet Gynecol, V2, P186; Togawa N., 2012, BR J NUTR, V109, P383; Umemura T, 2009, BLOOD, V114, P1550; Vasilescu C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007405	31	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4894	1090-2449		EXP PARASITOL	Exp. Parasitol.	AUG	2015	155						19	25		10.1016/j.exppara.2015.04.013		7	Parasitology	Parasitology	CM0IB	WOS:000357360500004		
J	Baba, M; Sato, M; Kitoh, K; Takashima, Y				Baba, Minami; Sato, Masanao; Kitoh, Katsuya; Takashima, Yasuhiro			The distribution pattern of alpha 2,3-and alpha 2,6-linked sialic acids affects host cell preference in Toxoplasma gondii	EXPERIMENTAL PARASITOLOGY			English	Article						Cell adhesion; alpha 2,3-linkage; alpha 2,6-linkage; Sialic acid; Toxoplasma gondii	INFLUENZA-A VIRUSES; MOLECULAR-BASIS; RECOGNITION; INFECTION; PROTEIN; PARASITES; INVASION	Tachyzoites of Toxoplasma gondii, an obligate intracellular parasite, actively invade almost all types of nucleated cells. However, T. gondii tachyzoites preferentially infect particular types of animal tissue cells. The mechanism underlying the host cell preference of T. gondii is not yet known. In this study, we found that enzymatic removal of alpha 2,3- but not alpha 2,6-linked sialic acids on the surface of Vero cells decreased T. gondii tachyzoite adhesion or invasion to the treated cells. Although Chinese hamster ovary (CHO) cells express only alpha 2,3-linked sialic acid, a genetically modified CHO cell line constructed by transfection with the alpha 2,6-sialiltransferase gene contains subpopulations with a variety of expression patterns of alpha 2,3- and alpha 2,6-linked sialic acids. When T gondii tachyzoites were added to the modified CHO cells, the tachyzoites preferentially attached to cells belonging to a subpopulation of cells that highly expressed alpha 2,3-linked sialic acids. Additionally, multiple regression analysis performed to analyse the relationship between the amount of alpha 2,3-linked/alpha 2,6-linked sialic acids and parasite-expressed fluorescence intensity suggested that more tachyzoites adhered to individual alpha 2,3-linked sialic acid rich-cells than to alpha 2,3-linked sialic acid-poor/null cells. The results of confocal laser microscopy confirmed this finding. These results indicate that the host cell preference of T. gondii was, at least partially, affected by the distribution pattern of alpha 2,3-, but almost never alpha 2,6-linked sialic acids on host cells. (C) 2015 Elsevier Inc. All rights reserved.	[Baba, Minami; Kitoh, Katsuya; Takashima, Yasuhiro] Gifu Univ, Dept Vet Parasitol, Gifu 5011193, Japan; [Sato, Masanao] Okazaki Inst Integrat Biosci, Natl Inst Basic Biol, Okazaki, Aichi 4448787, Japan	Takashima, Y (reprint author), Gifu Univ, Dept Vet Parasitol, 1-1 Yanagido, Gifu 5011193, Japan.	atakashi@gifu-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology [15H04592]	This work was partially supported by the Ministry of Education, Culture, Sports, Science, and Technology, Grants-in-Aid for Scientific Research (B), 15H04592. We would like to thank Dr. Hiromu Takematsu who kindly provide ST6 cell.	Ito T, 1998, J VIROL, V72, P7367; Garnett JA, 2009, PROTEIN SCI, V18, P1935, DOI 10.1002/pro.204; Huynh MH, 2003, EMBO J, V22, P2082, DOI 10.1093/emboj/cdg217; Delputte PL, 2004, J VIROL, V78, P8094, DOI 10.1128/JVI.78.15.8094-8101.2004; Friedrich N, 2010, J BIOL CHEM, V285, P2064, DOI 10.1074/jbc.M109.060988; Naito Y, 2007, MOL CELL BIOL, V27, P3008, DOI 10.1128/MCB.02047-06; Cowper B, 2012, MOL BIOCHEM PARASIT, V186, P1, DOI 10.1016/j.molbiopara.2012.08.007; Monteiro VG, 1998, FEMS MICROBIOL LETT, V164, P323, DOI 10.1111/j.1574-6968.1998.tb13105.x; Hahne F, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-106; Carruthers VB, 2000, INFECT IMMUN, V68, P4005, DOI 10.1128/IAI.68.7.4005-4011.2000; Blumenschein TMA, 2007, EMBO J, V26, P2808, DOI 10.1038/sj.emboj.7601704; Abbasi M, 2003, J INFECT DIS, V188, P608, DOI 10.1086/377132; Cerede O, 2005, J EXP MED, V201, P453, DOI 10.1080/jem.20041672; Ito T, 2000, MICROBIOL IMMUNOL, V44, P423; Robbins JR, 2012, INFECT IMMUN, V80, P418, DOI 10.1128/IAI.05899-11; Traving C, 1998, CELL MOL LIFE SCI, V54, P1330, DOI 10.1007/s000180050258; LEE EU, 1989, J BIOL CHEM, V264, P13848; Eckhardt M, 1998, J BIOL CHEM, V273, P20189, DOI 10.1074/jbc.273.32.20189; Reiss M, 2001, J CELL BIOL, V152, P563, DOI 10.1083/jcb.152.3.563; Carruthers Vern B., 1999, Parasitology International, V48, P1; Channon JY, 2000, INFECT IMMUN, V68, P4822, DOI 10.1128/IAI.68.8.4822-4826.2000; NELSON J, 1993, VIRUS RES, V29, P155; HOYER LL, 1991, J BIOCHEM-TOKYO, V110, P462; Nishikawa Y, 2008, PARASITOL INT, V57, P219, DOI 10.1016/j.parint.2007.10.004; RDC Team, 2013, R LANG ENV STAT COMP; Sheiner L., 2010, MOL MICROBIOL; UCHIDA Y, 1979, J BIOCHEM-TOKYO, V86, P1573; Varki NM, 2011, ANNU REV PATHOL-MECH, V6, P365, DOI 10.1146/annurev-pathol-011110-130315; Yang XY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110026	29	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4894	1090-2449		EXP PARASITOL	Exp. Parasitol.	AUG	2015	155						74	81		10.1016/j.exppara.2015.05.005		8	Parasitology	Parasitology	CM0IB	WOS:000357360500012		
J	Wang, BS; Cao, JP; Zhao, XY; Bian, Y; Song, C; Zhao, YP; Fan, X; Wei, XY; Takarada, T				Wang, Ben-Shui; Cao, Jing-Pei; Zhao, Xiao-Yan; Bian, Yue; Song, Chong; Zhao, Yun-Peng; Fan, Xing; Wei, Xian-Yong; Takarada, Takayuki			Preparation of nickel-loaded on lignite char for catalytic gasification of biomass	FUEL PROCESSING TECHNOLOGY			English	Article						Corncob; Catalytic reforming; Nickel loaded on lignite char; Tar decomposition; Nickel crystallite size	FLUIDIZED-BED; BROWN-COAL; PYROLYSIS CHARACTERISTICS; GAS-PRODUCTION; TAR; DECOMPOSITION; CARBON; WASTE; STEAM; AIR	A novel catalyst was prepared by loading nickel on Shenli lignite char via ion-exchange. The results show that the nickel crystallite size (NCS) and specific surface area (SSA) of the catalyst significantly depended on solution pH and carbonization temperature. The catalyst prepared in pH 11 at 650 degrees C reached the maximum SSA of 236.3 m(2)/g and the nickel particles dispersed quite well in the catalyst with a NCS of 5.6 nm. The catalyst was used for corncob volatiles reforming in a two-stage fixed-bed reactor to study the effects of temperature, steam, and space velocity on gas yields and carbon distributions. It effectively improved tar decomposition at 650 degrees C under inert atmosphere and produced a tar-free syngas in a yield of 43.9 mmol/g, which is higher than that over a commercial Ni/Al2O3. The increase of the NCS during catalytic reforming above 650 degrees C leads to the catalyst deactivation for tar decomposition. The study revealed the possibility of using Ni/char as a potential catalyst for low-temperature gasification of biomass. (C) 2014 Elsevier B.V. All rights reserved.	[Wang, Ben-Shui; Cao, Jing-Pei; Zhao, Xiao-Yan; Bian, Yue; Song, Chong; Zhao, Yun-Peng; Fan, Xing; Wei, Xian-Yong] China Univ Min & Technol, Key Lab Coal Proc & Efficient Utilizat, Minist Educ, Xuzhou 221008, Jiangsu, Peoples R China; [Takarada, Takayuki] Gunma Univ, Div Environm Engn Sci, Kiryu, Gumma 3768515, Japan	Cao, JP (reprint author), China Univ Min & Technol, Key Lab Coal Proc & Efficient Utilizat, Minist Educ, Xuzhou 221008, Jiangsu, Peoples R China.	beyondcao@hotmail.com; zhaoxiaoyan@cumt.edu.cn	Fan, Xing/I-1863-2013; Cao, Jing-Pei/K-9006-2015; Zhongtan, Huaxue/L-7668-2015	Fan, Xing/0000-0001-5530-5563; Cao, Jing-Pei/0000-0002-1544-7441; 	National Natural Science Foundation of China [21206189, 21306224, 21206188]; Fundamental Research Funds for the Central Universities (China University of Mining and Technology) [2012QNA15, 2012QNA18]; Science and Technology Project of Xuzhou [XM13B106]; Natural Science Foundation of China for Innovative Research Group [51221462]; Strategic Chinese-Japanese Joint Research Program [2013DFG60060]; Priority Academic Program Development of Jiangsu Higher Education Institutions	This work was subsidized by the National Natural Science Foundation of China (Grants 21206189, 21306224, and 21206188), the Fundamental Research Funds for the Central Universities (China University of Mining and Technology, Grants 2012QNA15 and 2012QNA18), the Science and Technology Project of Xuzhou (XM13B106), the fund from the Natural Science Foundation of China for Innovative Research Group (Grant 51221462), the Strategic Chinese-Japanese Joint Research Program (Grant 2013DFG60060), and the Priority Academic Program Development of Jiangsu Higher Education Institutions.	Brunauer S, 1940, J AM CHEM SOC, V62, P1723, DOI 10.1021/ja01864a025; Vamvuka D, 2003, FUEL, V82, P1949, DOI 10.1016/S0016-2361(03)00153-4; Song QS, 2002, J POWER SOURCES, V112, P428, DOI 10.1016/S0378-7753(02)00396-8; Devi L, 2003, BIOMASS BIOENERG, V24, P125, DOI 10.1016/S0961-9534(02)00102-2; Sharma A, 2006, FUEL, V85, P2396, DOI 10.1016/j.fuel.2006.04.007; Xiao B, 2001, POLYM DEGRAD STABIL, V74, P307, DOI 10.1016/S0141-3910(01)00163-X; Guldogan Y, 2002, ENERG SOURCE, V24, P753, DOI 10.1080/00908310290086671; Nordgreen T, 2006, FUEL, V85, P689, DOI 10.1016/j.fuel.2005.08.026; Xiao XB, 2013, FUEL, V103, P135, DOI 10.1016/j.fuel.2011.06.077; Uddin MA, 2008, FUEL, V87, P451, DOI 10.1016/j.fuel.2007.06.021; vandenBroek R, 1996, BIOMASS BIOENERG, V11, P271, DOI 10.1016/0961-9534(96)00033-5; Min ZH, 2011, FUEL, V90, P2545, DOI 10.1016/j.fuel.2011.03.027; Cao JP, 2014, FUEL PROCESS TECHNOL, V123, P34, DOI 10.1016/j.fuproc.2014.01.042; Sunny V, 2010, CARBON, V48, P1643, DOI 10.1016/j.carbon.2010.01.006; Cao Y, 2006, FUEL PROCESS TECHNOL, V87, P343, DOI 10.1016/j.fuproc.2005.10.003; Kumabe K, 2007, FUEL, V86, P684, DOI 10.1016/j.fuel.2006.08.026; Sutton D, 2001, FUEL PROCESS TECHNOL, V73, P155, DOI 10.1016/S0378-3820(01)00208-9; Xu CB, 2010, FUEL, V89, P1784, DOI 10.1016/j.fuel.2010.02.014; Kumar A, 2008, BIOMASS BIOENERG, V32, P460, DOI 10.1016/j.biombioe.2007.11.004; Mansaray KG, 1999, BIOMASS BIOENERG, V17, P19, DOI 10.1016/S0961-9534(99)00022-7; Cao JP, 2014, INT J HYDROGEN ENERG, V39, P9193, DOI 10.1016/j.ijhydene.2014.03.222; Li CZ, 2007, FUEL, V86, P1664, DOI 10.1016/j.fuel.2007.01.008; Li LY, 2010, FUEL PROCESS TECHNOL, V91, P889, DOI 10.1016/j.fuproc.2009.08.003; Corella J, 1998, IND ENG CHEM RES, V37, P4617, DOI 10.1021/ie980254h; Garcia L, 1999, ENERG FUEL, V13, P851, DOI 10.1021/ef980250p; Arauzo J, 1997, IND ENG CHEM RES, V36, P67, DOI 10.1021/ie950271w; Bangala DN, 1997, IND ENG CHEM RES, V36, P4184, DOI 10.1021/ie960785a; Cao JP, 2011, BIORESOURCE TECHNOL, V102, P2009, DOI 10.1016/j.biortech.2010.09.057; Cao JP, 2014, ENERG FUEL, V28, P2041, DOI 10.1021/ef5001216; Delagado J., 1997, IND ENG CHEM RES, V36, P1535; Elbeyli IY, 2006, J THERM ANAL CALORIM, V83, P721, DOI 10.1007/s10973-005-9995-z; loannidou O., 2009, RENEW SUST ENERG REV, V13, P750; Murakami K, 1996, FUEL PROCESS TECHNOL, V46, P183, DOI 10.1016/0378-3820(95)00056-9; SCHAFER HNS, 1970, FUEL, V49, P197, DOI 10.1016/0016-2361(70)90040-2; Shopova N, 1997, J THERM ANAL, V48, P309, DOI 10.1007/BF01979274; Suzuki K, 2005, CHEM LETT, V34, P870, DOI 10.1246/cl.2005.870; TOMITA A, 1985, FUEL, V64, P795, DOI 10.1016/0016-2361(85)90012-2	37	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0378-3820	1873-7188		FUEL PROCESS TECHNOL	Fuel Process. Technol.	AUG	2015	136				SI		17	24		10.1016/j.fuproc.2014.07.024		8	Chemistry, Applied; Energy & Fuels; Engineering, Chemical	Chemistry; Energy & Fuels; Engineering	CM3AE	WOS:000357552700003		
J	Ishihara, A; Imai, T; Hashimoto, T; Nasu, H				Ishihara, Atsushi; Imai, Tatsuya; Hashimoto, Tadanori; Nasu, Hiroyuki			Hydrothermal gasification of phenol water on novel carbon-supported Ni catalysts prepared by the sol-gel method using tartaric acid and alminum tri-sec-butoxide	FUEL PROCESSING TECHNOLOGY			English	Article						Hydrothermal gasification; Phenol water; Carbon-supported Ni catalysts; Tartaric acid; Alminum tri-sec-butoxide	PRESSURE AQUEOUS ENVIRONMENTS; SUPERCRITICAL WATER; HYDROGEN-PRODUCTION; BIOMASS GASIFICATION; WASTE-WATER; GAS SHIFT; GLUCOSE; NICKEL; MODEL; PYROLYSIS	The purpose of this study is to prepare novel carbon-supported Ni (Ni/C/Al2O3) catalysts by the sol-gel method and to perform the hydrothermal gasification of phenol water as a model of wastewater. Catalysts were prepared by the combination of aluminum tri-sec-butoxide (ASB) and tartaric acid as an organic template and the addition of active metal, nickel nitrate hexahydrate at the preparation of catalysts. After calcination under the nitrogen atmosphere, the larger amounts of active metal species were built at the carbon skeletal in the catalysts. Introduction of tartaric acid dispersed metal Ni with high loading on carbon derived from ammonium tartrate. Hydrothermal gasification was performed under the following conditions: 350 degrees C, pressure of 20 MPa, phenol water of 2-20 g/L, and LHSV of 48 h(-1).16N63C21A catalyst, which represents 16 wt.% Ni, 63% carbon in tartalic acid, and 21% Al2O3 at the preparation of the catalyst, showed the highest activity and the highest carbon balance between feed and products within 8 h among all the Ni catalysts. The activity of each catalyst increased with the elapse of time and the phenol conversion reached 100 % under the condition and phenol concentration of 2 g/L. No deactivtion was observed. (C) 2014 Elsevier B.V. All rights reserved.	[Ishihara, Atsushi; Imai, Tatsuya; Hashimoto, Tadanori; Nasu, Hiroyuki] Mie Univ, Grad Sch Engn, Div Chem Mat, Tsu, Mie 5148507, Japan	Ishihara, A (reprint author), Mie Univ, Grad Sch Engn, Div Chem Mat, 1577 Kurima Machiya Cho, Tsu, Mie 5148507, Japan.	ishihara@chem.mie-u.ac.jp	Ishihara, Atsushi/N-9481-2015; HASHIMOTO, Tadanori/J-3909-2013	Ishihara, Atsushi/0000-0002-6390-8898; HASHIMOTO, Tadanori/0000-0003-2887-7536	Tanikawa Fund Promotion of Thermal Technology	A part of this work was supported by the Tanikawa Fund Promotion of Thermal Technology.	Miyazawa T, 2006, CATAL TODAY, V115, P254, DOI 10.1016/j.cattod.2006.02.055; Sharma A, 2006, FUEL, V85, P179, DOI 10.1016/j.fuel.2005.04.035; Xu DH, 2011, IND ENG CHEM RES, V50, P4301, DOI 10.1021/ie1016255; Elliott DC, 1999, IND ENG CHEM RES, V38, P879, DOI 10.1021/ie980525o; Liu XG, 2001, FUEL PROCESS TECHNOL, V69, P1, DOI 10.1016/S0378-3820(00)00113-2; Schmieder H, 2000, J SUPERCRIT FLUID, V17, P145, DOI 10.1016/S0896-8446(99)00051-0; Lu YJ, 2010, INT J HYDROGEN ENERG, V35, P7161, DOI 10.1016/j.ijhydene.2009.12.047; Yu JL, 2001, APPL CATAL B-ENVIRON, V31, P123, DOI 10.1016/S0926-3373(00)00273-3; Lu YJ, 2013, FUEL, V103, P193, DOI 10.1016/j.fuel.2012.04.038; Azadi P, 2009, FUEL PROCESS TECHNOL, V90, P145, DOI 10.1016/j.fuproc.2008.08.009; Jacobs G, 2005, J CATAL, V229, P499, DOI 10.1016/j.jcat.2004.11.031; Li S, 2011, INT J HYDROGEN ENERG, V36, P14391, DOI 10.1016/j.ijhydene.2011.07.144; Pairojpiriyakul T, 2013, INT J HYDROGEN ENERG, V38, P4368, DOI 10.1016/j.ijhydene.2013.01.169; Haryanto A, 2007, CATAL TODAY, V129, P269, DOI 10.1016/j.cattod.2006.09.039; Kruse A, 2009, J SUPERCRIT FLUID, V47, P391, DOI 10.1016/j.supflu.2008.10.009; Ishihara A, 2005, FUEL, V84, P1462, DOI 10.1016/j.fuel.2005.03.006; Dileo GJ, 2007, ENERG FUEL, V21, P2340, DOI 10.1021/ef070056f; May A, 2010, CHEM ENG J, V160, P751, DOI 10.1016/j.cej.2010.04.005; Yan B, 2009, J SUPERCRIT FLUID, V50, P155, DOI 10.1016/j.supflu.2009.04.015; Sato T, 2011, BIOMASS BIOENERG, V35, P1245, DOI 10.1016/j.biombioe.2010.12.015; Azadi P, 2012, APPL CATAL B-ENVIRON, V117, P330, DOI 10.1016/j.apcatb.2012.01.035; Zhang LH, 2011, INT J HYDROGEN ENERG, V36, P9591, DOI 10.1016/j.ijhydene.2011.05.077; Zhang LH, 2011, BIORESOURCE TECHNOL, V102, P8279, DOI 10.1016/j.biortech.2011.06.051; Byrd AJ, 2010, APPL CATAL A-GEN, V381, P177, DOI 10.1016/j.apcata.2010.04.006; ELLIOTT DC, 1993, IND ENG CHEM RES, V32, P1542, DOI 10.1021/ie00020a002; Ishihara A., 2013, J JAPAN I ENERGY, V92, P687; Kabe T., 2004, COAL COAL RELATED CO, P250; Takenaka S, 2008, APPL CATAL A-GEN, V351, P189, DOI 10.1016/j.apcata.2008.09.017	28	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0378-3820	1873-7188		FUEL PROCESS TECHNOL	Fuel Process. Technol.	AUG	2015	136				SI		34	40		10.1016/j.fuproc.2014.07.040		7	Chemistry, Applied; Energy & Fuels; Engineering, Chemical	Chemistry; Energy & Fuels; Engineering	CM3AE	WOS:000357552700005		
J	Li, CM; Fujimoto, K				Li, Congming; Fujimoto, Kaoru			Efficient conversion of carbon dioxide to non-methane light hydrocarbons - Two stage process with intercooler	FUEL PROCESSING TECHNOLOGY			English	Article						LPG synthesis; Two-stage process; CO2	METHANOL SYNTHESIS CATALYST; SELECTIVE SYNTHESIS; SYNTHESIS GAS; HYBRID CATALYSTS; COMPOSITE CATALYSTS; LPG; HYDROGENATION; ZEOLITE; CO2	Liquefied petroleum gas (LPG) synthesis from CO2 hydrogenation was carried out in a new technical route consisting of two packed tubular reactors in series with an inter-stage water removal. In this way, CO2 was transformed to DME-rich products in the first stage over the Cu-Zn-Zr-Al/Pd-beta catalyst and then to hydrocarbons in the second stage over the Pd-beta catalyst. CO2 conversion and LPG selectivity were mainly dominated by the first and second stages, respectively. The obtained results disclosed that the reaction performance of the two-stage process with intercooler was significantly superior to the single-stage process and its analog without intercooler for either yield or selectivity of the target product. The tests were conducted at 260-300 degrees C, 2.0-3.3 MPa, with a H-2/CO2 mole ratio of 3-5. It is noted that the hybrid catalyst gave conversion as high as 85% with high hydrocarbon selectivity by using the designed reaction system. (C) 2014 Published by Elsevier B.V.	[Li, Congming; Fujimoto, Kaoru] Japan Gas Synth Co LTD, Minato Ku, Tokyo 1058527, Japan	Fujimoto, K (reprint author), Japan Gas Synth Co LTD, Minato Ku, 5-20 Kaigan 1 Chome, Tokyo 1058527, Japan.	fujimoto@env.kitakyu-u.ac.jp			New Energy and Industrial Technology Development Organization (NEDO)	This work was supported by the New Energy and Industrial Technology Development Organization (NEDO).	Wang W, 2011, CHEM SOC REV, V40, P3703, DOI 10.1039/c1cs15008a; Dorner RW, 2010, ENERG ENVIRON SCI, V3, P884, DOI 10.1039/c001514h; Yu KMK, 2008, CHEMSUSCHEM, V1, P893, DOI 10.1002/cssc.200800169; Li C, 2014, APPL CATAL A-GEN, V469, P306, DOI 10.1016/j.apcata.2013.10.010; Li CM, 2014, APPL CATAL A-GEN, V475, P155, DOI 10.1016/j.apcata.2014.01.025; He MY, 2013, ANGEW CHEM INT EDIT, V52, P9620, DOI 10.1002/anie.201209384; Natesakhawat S, 2012, ACS CATAL, V2, P1667, DOI 10.1021/cs300008g; Song CS, 2006, CATAL TODAY, V115, P2, DOI 10.1016/j.cattod.2006.02.029; Asami K, 2004, STUD SURF SCI CATAL, V147, P427; Ceviz MA, 2006, RENEW ENERG, V31, P1950, DOI 10.1016/j.renene.2005.09.016; FUJIMOTO K, 1987, APPL CATAL, V31, P13, DOI 10.1016/S0166-9834(00)80663-6; FUJIWARA M, 1995, APPL CATAL A-GEN, V121, P113, DOI 10.1016/0926-860X(95)85014-7; Ge QJ, 2007, J MOL CATAL A-CHEM, V278, P215, DOI 10.1016/j.molcata.2007.09.008; INUI T, 1993, APPL CATAL A-GEN, V94, P31, DOI 10.1016/0926-860X(93)80043-P; JEON JK, 1995, APPL CATAL A-GEN, V124, P91, DOI 10.1016/0926-860X(94)00258-4; Jin YJ, 2004, FUEL PROCESS TECHNOL, V85, P1151, DOI 10.1016/j.fuproc.2003.11.039; Li CM, 2014, ENERG FUEL, V28, P1331, DOI 10.1021/ef402393j; LIU G, 1984, J CATAL, V90, P139, DOI 10.1016/0021-9517(84)90094-0; Liu M. A., 2007, ENERGY CONVERSION MA, V48, P395; Ma XG, 2012, J NAT GAS CHEM, V21, P615, DOI 10.1016/S1003-9953(11)60415-5; Ma XG, 2013, FUEL PROCESS TECHNOL, V109, P1, DOI 10.1016/j.fuproc.2013.01.002; Olah G. A., 2006, OIL GAS METHANOL EC; Qe Q. J., 2008, CATAL COMMUN, V9, P256; Zhang QW, 2004, FUEL PROCESS TECHNOL, V85, P1139, DOI 10.1016/j.fuproc.2003.10.016	24	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0378-3820	1873-7188		FUEL PROCESS TECHNOL	Fuel Process. Technol.	AUG	2015	136				SI		50	55		10.1016/j.fuproc.2014.09.012		6	Chemistry, Applied; Energy & Fuels; Engineering, Chemical	Chemistry; Energy & Fuels; Engineering	CM3AE	WOS:000357552700007		
J	Yoshino, A; Yamato, R; Sato, K; Takarada, T				Yoshino, Atsushi; Yamato, Ryosuke; Sato, Kazuyoshi; Takarada, Takayuki			Cu recovery from industrial wastewater using brown coal	FUEL PROCESSING TECHNOLOGY			English	Article						Copper recovery; Brown coal; Wastewater; Low temperature combustion; Catalyst	FLUIDIZED-BED; GASIFICATION; BIOMASS	The etching process by copper chloride is widely used in printed wiring board manufacturing. Brown coal has an ion exchange ability because it has carboxy groups and hydroxyl groups in it. Using this ability of brown coal, the copper recovery from the waste etching solution by low energy consumption method is studied. Copper ion in the waste solution can be loaded on Loy Yang brown coal around 8.5 wt.% by adding ammonium hydroxide, adjusting pH to 9-11.5 and stirring the solution at room temperature. Cu-loaded brown coal can be burnt at extremely low temperature; 160-180 degrees C, and 0.5-1.0 mu m copper oxide particles are formed as the residue. In order to commercialize the copper recovery system, since Cu-loading amount and low temperature combustion of Cu-loaded brown coal are key factors of this process cost, Cu-loading conditions and the reaction kinetics of low temperature combustion of Cu-loaded brown coal by TG analysis are studied. By the kinetic analysis using TG data, activation energy of initial combustion is affected by Cu-loading amount. When Cu-loading is 8.6 wt.%, it is estimated that the activadon energy is reduced to 56% of that of the raw coal. (C) 2014 Elsevier B.V. All rights reserved.	[Yoshino, Atsushi; Yamato, Ryosuke; Sato, Kazuyoshi; Takarada, Takayuki] Gunma Univ, Dept Chem & Environm Engn, Kiryu, Gumma 3768515, Japan	Yoshino, A (reprint author), Gunma Univ, Dept Chem & Environm Engn, 1-5-1 Tenjin Cho, Kiryu, Gumma 3768515, Japan.	a-yoshino@hitachi-chem.co.jp					Meesuk S, 2012, J ANAL APPL PYROL, V94, P238, DOI 10.1016/j.jaap.2011.12.011; Xiao XB, 2011, BIORESOURCE TECHNOL, V102, P1975, DOI 10.1016/j.biortech.2010.09.016; Meesuk S, 2011, ENERG FUEL, V25, P4113, DOI 10.1021/ef200867q; Cao JP, 2013, FUEL, V104, P1, DOI 10.1016/j.fuel.2010.08.015; Li LY, 2010, FUEL PROCESS TECHNOL, V91, P889, DOI 10.1016/j.fuproc.2009.08.003; Cao JP, 2011, BIORESOURCE TECHNOL, V102, P2009, DOI 10.1016/j.biortech.2010.09.057; Coats A. V., 1999, J THERMOCHIMICA ACTA, V340/341, P53; Le D. D., 2009, J CHEM ENG JAPAN, V57, P4251; Le DD, 2010, J CHEM ENG JPN, V43, P443; Meesuk S, 2011, ENERG FUEL, V25, P5438, DOI 10.1021/ef201266b; Murakami M., 2009, J MMIJ, V125, P38; NISHIYAMA Y, 1994, KAGAKU KOGAKU RONBUN, V20, P793; Semenov NN, 1959, SOME PROBLEMS CHEM K, V2; Yoshino A., 2014, J JAPAN I ENERGY, V93, P542	14	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0378-3820	1873-7188		FUEL PROCESS TECHNOL	Fuel Process. Technol.	AUG	2015	136				SI		64	67		10.1016/j.fuproc.2014.09.029		4	Chemistry, Applied; Energy & Fuels; Engineering, Chemical	Chemistry; Energy & Fuels; Engineering	CM3AE	WOS:000357552700009		
J	Xing, C; Sun, J; Yang, GH; Shen, WZ; Tan, L; Zhu, PF; Wei, QH; Li, J; Kyodo, M; Yang, RQ; Yoneyama, Y; Tsubaki, N				Xing, Chuang; Sun, Jian; Yang, Guohui; Shen, Wenzhong; Tan, Li; Zhu, Pengfei; Wei, Qinhong; Li, Jie; Kyodo, Masahiro; Yang, Ruiqin; Yoneyama, Yoshiharu; Tsubaki, Noritatsu			Tunable isoparaffin and olefin synthesis in Fischer-Tropsch synthesis achieved by composite catalyst	FUEL PROCESSING TECHNOLOGY			English	Article						Hierarchical; HZSM-5; Mesopore; Fischer-Tropsch synthesis; Isoparaffin	MESOPOROUS ZSM-5; SINGLE-CRYSTALS; SYNTHESIS GAS; ZEOLITE; CARBON; SELECTIVITY; TEMPLATES; SYNGAS	Hierarchical HZSM-5 zeolite with combined micropores and mesopores was synthesized by one-step approach with TPAOH and F127 as dual templates. The physical and acidic properties of the hierarchical HZSM-5 zeolite were characterized by XRD, N-2 adsorption-desorption isotherm, SEM, TEM, and NH3-TPD techniques. The hierarchical HZSM-5 zeolite exhibited a significantly higher mesopore surface area and larger mesopore volume than that of the conventional HZSM-5. The prepared hierarchical HZSM-5 and conventional HZSM-5 zeolite supported cobalt catalysts were evaluated via Fischer-Tropsch synthesis (FTS) reaction to tune product selectivity. Compared with the conventional catalyst, the CO conversion of FTS reaction on the present catalyst increased significantly. Meanwhile, the C5+ selectivity and isoparaffin selectivity also increased. The C5-11 hydrocarbons with a lot of isoparaffin and olefin had become the main FTS products due to the optimized hydrocracking and isomerization afforded by the hierarchical pore structure, different from the conventional FTS hydrocarbons which were mainly composed of normal paraffin. (C) 2014 Elsevier B.V. All rights reserved.	[Xing, Chuang; Sun, Jian; Yang, Guohui; Tan, Li; Zhu, Pengfei; Wei, Qinhong; Li, Jie; Kyodo, Masahiro; Yoneyama, Yoshiharu; Tsubaki, Noritatsu] Toyama Univ, Grad Sch Engn, Dept Appl Chem, Toyama 9308555, Japan; [Xing, Chuang; Yang, Ruiqin] Zhejiang Univ Sci & Technol, Zhejiang Prov Key Lab Chem & Bio Proc Technol Far, Hangzhou 310023, Zhejiang, Peoples R China; [Shen, Wenzhong] Chinese Acad Sci, Inst Coal Chem, State Key Lab Coal Convers, Taiyuan 030001, Peoples R China	Tsubaki, N (reprint author), Toyama Univ, Grad Sch Engn, Dept Appl Chem, Gofuku 3190, Toyama 9308555, Japan.	tsubaki@eng.u-toyama.ac.jp					Cheng K, 2012, ACS CATAL, V2, P441, DOI 10.1021/cs200670j; Zhou JA, 2011, ACS CATAL, V1, P287, DOI 10.1021/cs1000976; Li XH, 2003, CATAL TODAY, V84, P59, DOI 10.1016/S0920-5861(03)00301-8; Lee J, 2013, FUEL PROCESS TECHNOL, V108, P25, DOI 10.1016/j.fuproc.2012.03.005; Chen LH, 2012, J MATER CHEM, V22, P17381, DOI 10.1039/c2jm31957h; Zhu H, 2008, CHEM MATER, V20, P1134, DOI 10.1021/cm071385o; Li YP, 2010, FUEL PROCESS TECHNOL, V91, P388, DOI 10.1016/j.fuproc.2009.07.002; Yoneyama Y, 2005, CATAL TODAY, V104, P37, DOI 10.1016/j.cattod.2005.03.031; Liu H, 2012, FUEL PROCESS TECHNOL, V96, P195, DOI 10.1016/j.fuproc.2011.12.034; Schmidt I, 2001, CHEM MATER, V13, P4416, DOI 10.1021/cm011206h; Rownaghi AA, 2012, MICROPOR MESOPOR MAT, V151, P26, DOI 10.1016/j.micromeso.2011.11.020; Xu L, 2008, CATAL COMMUN, V9, P1272, DOI 10.1016/j.catcom.2007.11.018; Zhao LA, 2011, FUEL PROCESS TECHNOL, V92, P414, DOI 10.1016/j.fuproc.2010.10.003; Cho HS, 2012, MICROPOR MESOPOR MAT, V151, P107, DOI 10.1016/j.micromeso.2011.11.007; Li CL, 2009, MICROPOR MESOPOR MAT, V117, P104, DOI 10.1016/j.micromeso.2008.06.017; Janssen AH, 2003, MICROPOR MESOPOR MAT, V65, P59, DOI 10.1016/j.micromeso.2003.07.003; Chum HL, 2001, FUEL PROCESS TECHNOL, V71, P187, DOI 10.1016/S0378-3820(01)00146-1; Huang X, 2011, APPL CATAL A-GEN, V408, P38, DOI 10.1016/j.apcata.2011.09.004; Bao J, 2008, ANGEW CHEM INT EDIT, V47, P353, DOI 10.1002/anie.200703335; Sun J, 2013, J MATER CHEM A, V1, P5670, DOI 10.1039/c3ta10627f; Sun J., 2013, ACS CATAL, V4, P1; Tao Y, 2005, J PHYS CHEM B, V109, P194, DOI 10.1021/jp0464167	22	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0378-3820	1873-7188		FUEL PROCESS TECHNOL	Fuel Process. Technol.	AUG	2015	136				SI		68	72		10.1016/j.fuproc.2014.10.001		5	Chemistry, Applied; Energy & Fuels; Engineering, Chemical	Chemistry; Energy & Fuels; Engineering	CM3AE	WOS:000357552700010		
J	Uemura, K; Appari, S; Kudo, S; Hayashi, J; Einaga, H; Norinaga, K				Uemura, Kazuhiro; Appari, Srinivas; Kudo, Shinji; Hayashi, Jun-ichiro; Einaga, Hisahiro; Norinaga, Koyo			In-situ reforming of the volatiles from fast pyrolysis of ligno-cellulosic biomass over zeolite catalysts for aromatic compound production	FUEL PROCESSING TECHNOLOGY			English	Article						Catalytic reforming; Reaction mechanism; Nascent volatiles from ligno-cellulosic biomass; Arenes; Zeolite catalysts	VAPOR-PHASE CRACKING; CHAR INTERACTIONS; CELLULOSE; FUELS; GASIFICATION; CONVERSION; GASOLINE; OIL	Characteristics of in-situ catalytic reforming of the products derived from fast pyrolysis of biomass were studied with an originally designed analytical pyrolysis technique. The volatile products derived from ligno-cellulosic biomass as well as cellulose, xylan, and lignin were converted using a two-stage tubular reactor at 550 degrees C over various zeolite catalysts with different acidities and pore structures. HZSM-5 exhibited the best performance for converting the cedar derived volatiles to arenes, which mainly composed of benzene, toluene, and naphthalene with a selectivity of 26% on carbon basis. The HZSM-5 had a little effect in increasing the yields of the arenes for xylan and lignin, while it had a significant effect for cellulose, showing that more than 30% of carbon in cellulose was converted into arenes. A reaction pathway analysis for reforming of volatiles suggested that alkyne and diene such as acetylene, propyne, and cyclopentadiene are the important precursors of the major aromatic hydrocarbon products such as benzene, toluene, and naphthalene. The formations of those intermediates were also confirmed experimentally in an early stage of the in-situ reforming. (C) 2014 Elsevier B.V. All rights reserved.	[Uemura, Kazuhiro; Hayashi, Jun-ichiro; Norinaga, Koyo] Kyushu Univ, Interdisciplinary Grad Sch Engn Sci, Kasuga, Fukuoka 8168580, Japan; [Appari, Srinivas; Kudo, Shinji; Hayashi, Jun-ichiro; Norinaga, Koyo] Kyushu Univ, Inst Mat Chem & Engn, Kasuga, Fukuoka 8168580, Japan; [Hayashi, Jun-ichiro] Kyushu Univ, Res & Educ Ctr Carbon Resources, Kasuga, Fukuoka 8168580, Japan; [Einaga, Hisahiro] Kyushu Univ, Fac Engn Sci, Dept Energy & Mat Sci, Kasuga, Fukuoka 8168580, Japan	Norinaga, K (reprint author), Kyushu Univ, Inst Mat Chem & Engn, Kasuga, Fukuoka 8168580, Japan.	norinaga@cm.kyuhsu-u.ac.jp	Hisahiro, Einaga/I-5440-2015; Norinaga, Koyo/A-2597-2010	Hisahiro, Einaga/0000-0002-4819-9755; 	Ministry of Education, Science, Sports and Culture [23686112, 24651080]; MOST-JST, Strategic International Collaborative Research Program, SICORP	Part of this research was funded by the Ministry of Education, Science, Sports and Culture Grant-in-Aid for Young Scientists (No. 23686112) and for Challenging Exploratory Research (No. 24651080), and the MOST-JST, Strategic International Collaborative Research Program, SICORP.	Carlson TR, 2008, CHEMSUSCHEM, V1, P397, DOI 10.1002/cssc.200800018; Norinaga K, 2013, FUEL, V103, P141, DOI 10.1016/j.fuel.2011.07.045; Bridgwater AV, 2000, RENEW SUST ENERG REV, V4, P1, DOI 10.1016/S1364-0321(99)00007-6; Goyal HB, 2008, RENEW SUST ENERG REV, V12, P504, DOI 10.1016/j.rser.2006.07.014; Thring RW, 2000, FUEL PROCESS TECHNOL, V62, P17, DOI 10.1016/S0378-3820(99)00061-2; Li CZ, 2013, FUEL, V112, P609, DOI 10.1016/j.fuel.2013.01.031; Mohan D, 2006, ENERG FUEL, V20, P848, DOI 10.1021/ef0502397; Chiaramonti D, 2007, RENEW SUST ENERG REV, V11, P1056, DOI 10.1016/j.rser.2005.07.008; Carlson TR, 2011, ENERG ENVIRON SCI, V4, P145, DOI 10.1039/c0ee00341g; Shin EJ, 2001, FUEL, V80, P1697, DOI 10.1016/S0016-2361(01)00056-4; Gani A, 2007, RENEW ENERG, V32, P649, DOI 10.1016/j.renene.2006.02.017; Czernik S, 2004, ENERG FUEL, V18, P590, DOI 10.1021/ef034067u; Huber GW, 2006, CHEM REV, V106, P4044, DOI 10.1021/cr068360d; Song Y, 2014, FUEL, V122, P60, DOI 10.1016/j.fuel.2014.01.002; Adam J, 2006, MICROPOR MESOPOR MAT, V96, P93, DOI 10.1016/j.micromeso.2006.06.021; Carlson TR, 2009, TOP CATAL, V52, P241, DOI 10.1007/s11244-008-9160-6; Nokkosmaki MI, 2000, J ANAL APPL PYROL, V55, P119, DOI 10.1016/S0165-2370(99)00071-6; Horne P.A., 1996, FUEL, V75, P1043; Norinaga K, 2014, BIOMASS BIOENERG, V69, P144, DOI 10.1016/j.biombioe.2014.07.008; Sternberg J. C., 1962, GAS CHROMATOGRAPHY	20	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0378-3820	1873-7188		FUEL PROCESS TECHNOL	Fuel Process. Technol.	AUG	2015	136				SI		73	78		10.1016/j.fuproc.2014.10.002		6	Chemistry, Applied; Energy & Fuels; Engineering, Chemical	Chemistry; Energy & Fuels; Engineering	CM3AE	WOS:000357552700011		
J	Liu, YP; Kansha, Y; Ishizuka, M; Fu, Q; Tsutsumi, A				Liu, Yuping; Kansha, Yasuki; Ishizuka, Masanori; Fu, Qian; Tsutsumi, Atsushi			Experimental and simulation investigations on self-heat recuperative fluidized bed dryer for biomass drying with superheated steam	FUEL PROCESSING TECHNOLOGY			English	Article						Drying; Self-heat recuperation technology; Steam; Heat pairing	WOOD CHIPS; ENERGY; PARTICLES	An exergy recuperative module was developed and applied to biomass drying. The proposed drying process has an energy consumption 1/20 that of a conventional heat recovery drying system. Experimental work was conducted to confirm the details of the self-heat recuperation technology concept. A high drying rate and a stable heat exchange were found through the experimental drying results. Furthermore, the heat pairing was confirmed in the drying system for the first time. (C) 2014 Published by Elsevier B.V.	[Liu, Yuping; Kansha, Yasuki; Ishizuka, Masanori; Fu, Qian; Tsutsumi, Atsushi] Univ Tokyo, Collaborat Res Ctr Energy Engn, Inst Ind Sci, Meguro Ku, Tokyo 1538505, Japan	Tsutsumi, A (reprint author), Univ Tokyo, Collaborat Res Ctr Energy Engn, Inst Ind Sci, Meguro Ku, 4-6-1 Komaba, Tokyo 1538505, Japan.	a-tsu2mi@iis.u-tokyo.ac.jp	Tsutsumi, Atsushi/K-8988-2012	Tsutsumi, Atsushi/0000-0001-9679-4383	Japanese-Canadian (JST-NSERC) Research Cooperative Program as part of the FY Strategic International Research Cooperative Program	The authors are grateful for financial support provided by the Japanese-Canadian (JST-NSERC) Research Cooperative Program as part of the FY 2012 Strategic International Research Cooperative Program.	Kaliyan N, 2009, BIOMASS BIOENERG, V33, P337, DOI 10.1016/j.biombioe.2008.08.005; Wang L, 2008, BIOMASS BIOENERG, V32, P573, DOI 10.1016/j.biombioe.2007.12.007; McKendry P, 2002, BIORESOURCE TECHNOL, V83, P47, DOI 10.1016/S0960-8524(01)00119-5; LINNHOFF B, 1983, CHEM ENG SCI, V38, P745, DOI 10.1016/0009-2509(83)80185-7; Kemp IC, 2005, DRY TECHNOL, V23, P2089, DOI 10.1080/07373930500210572; Song GH, 2011, IND ENG CHEM RES, V50, P9758, DOI 10.1021/ie200534n; Liu YP, 2014, FUEL PROCESS TECHNOL, V117, P66, DOI 10.1016/j.fuproc.2013.02.007; Moreno R, 2006, BIOSYST ENG, V94, P47, DOI 10.1016/j.biosystemseng.2006.01.011; Kansha Y, 2009, IND ENG CHEM RES, V48, P7682, DOI 10.1021/ie9007419; Cui HP, 2007, CHEM ENG SCI, V62, P45, DOI 10.1016/j.ces.2006.08.006; BILBAO R, 1987, POWDER TECHNOL, V52, P1, DOI 10.1016/0032-5910(87)80001-3; Clarke KL, 2005, CHEM ENG SCI, V60, P6909, DOI 10.1016/j.ces.2005.06.004; Djaeni M, 2007, DRY TECHNOL, V25, P1053, DOI 10.1080/07373930701396535; Fitzpatrick J. J., 1995, Food and Bioproducts Processing, V73, P3; Fyhr C, 1996, AICHE J, V42, P2491, DOI 10.1002/aic.690420909; Fyhr C, 1997, DRY TECHNOL, V15, P1775, DOI 10.1080/07373939708917326; Krokida M., 2009, HDB IND DRYING; Kunii D., 1991, FLUIDIZATION ENG; Maciejewska A., COFIRING BIOMASS COA	19	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0378-3820	1873-7188		FUEL PROCESS TECHNOL	Fuel Process. Technol.	AUG	2015	136				SI		79	86		10.1016/j.fuproc.2014.10.005		8	Chemistry, Applied; Energy & Fuels; Engineering, Chemical	Chemistry; Energy & Fuels; Engineering	CM3AE	WOS:000357552700012		
J	Yoshiie, R; Hikosaka, N; Nunome, Y; Ueki, Y; Naruse, I				Yoshiie, Ryo; Hikosaka, Naoki; Nunome, Yoko; Ueki, Yasuaki; Naruse, Ichiro			Effects of flue gas re-circulation and nitrogen contents in coal on NOX emissions under oxy-fuel coal combustion	FUEL PROCESSING TECHNOLOGY			English	Article						Oxy-fuel coal combustion; Flue gas recirculation; NO and N2O; Nitrogen content in coal	CHAR; GASIFICATION; CO2	Oxy-fuel coal combustion has drawn attention as a useful technique to achieve carbon dioxide capture and storage (CCS). It is the technique that enriches CO2 in exhaust gas by flue gas recirculation with additional pure O-2, which makes it easy to capture and liquidize CO2 downstream. However, in the oxy-fuel combustion system, various impurities in the flue gas are brought back to the combustion zone with recirculated flue gas, and more have accumulated in a boiler compared with the air combustion system. NOX formations, in particular, can be affected by nitrogen contents in the raw coal and recirculated multiple NOX compounds, such as NO and N2O. Then, in this study, we experimentally estimated the effects of NO and N2O recirculation by a drop tube furnace equipment simulating oxy-fuel atmosphere for three coal samples with different nitrogen contents. As a result, contributions of recirculated NOX to NOX emissions were found to be very small in oxy-fuel coal combustion. Instead, nitrogen conversion ratios to NO and N2O were governed by the ratio of char-N to fuel-N. (C) 2014 Elsevier B.V. All rights reserved.	[Yoshiie, Ryo; Hikosaka, Naoki] Nagoya Univ, Dept Mech Sci & Engn, Chikusa Ku, Nagoya, Aichi 4648603, Japan; [Nunome, Yoko; Ueki, Yasuaki; Naruse, Ichiro] Nagoya Univ, EcoTopia Sci Inst, Chikusa Ku, Nagoya, Aichi 4648603, Japan	Yoshiie, R (reprint author), Nagoya Univ, Dept Mech Sci & Engn, Chikusa Ku, Nagoya, Aichi 4648603, Japan.	ryoshiie@mech.nagoya-u.ac.jp					Roy B, 2013, FUEL, V114, P135, DOI 10.1016/j.fuel.2012.09.080; Maffei T, 2013, COMBUST FLAME, V160, P2559, DOI 10.1016/j.combustflame.2013.06.002; Geier M, 2013, P COMBUST INST, V34, P2411, DOI 10.1016/j.proci.2012.07.009; Gonzalo-Tirado C, 2013, COMBUST FLAME, V160, P411, DOI 10.1016/j.combustflame.2012.10.020; Czakiert T, 2010, FUEL PROCESS TECHNOL, V91, P1617, DOI 10.1016/j.fuproc.2010.06.010; Wall T, 2013, FUEL, V108, P85, DOI 10.1016/j.fuel.2011.03.037; Ndibe C, 2013, FUEL, V107, P749, DOI 10.1016/j.fuel.2013.01.055; Wen C, 2013, P COMBUST INST, V34, P2383, DOI 10.1016/j.proci.2012.07.080; Hecht ES, 2012, COMBUST FLAME, V159, P3437, DOI 10.1016/j.combustflame.2012.06.009; Yoshiie R, 2011, ENERG FUEL, V25, P2481, DOI 10.1021/ef200277q; Armesto L, 2003, FUEL, V82, P1845, DOI 10.1016/S0016-2361(03)00169-8; Duan LB, 2011, FUEL PROCESS TECHNOL, V92, P379, DOI 10.1016/j.fuproc.2010.09.031; Brix J, 2013, FUEL, V106, P72, DOI 10.1016/j.fuel.2013.01.017; Feng B, 1996, ENERG FUEL, V10, P203, DOI 10.1021/ef9500898	14	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0378-3820	1873-7188		FUEL PROCESS TECHNOL	Fuel Process. Technol.	AUG	2015	136				SI		106	111		10.1016/j.fuproc.2014.10.036		6	Chemistry, Applied; Energy & Fuels; Engineering, Chemical	Chemistry; Energy & Fuels; Engineering	CM3AE	WOS:000357552700015		
J	Matsumoto, H; Neba, Y; Asahara, H				Matsumoto, Hirokazu; Neba, Yasuhiko; Asahara, Hiroyuki			Variable-Form Carrier-Based PWM for Boost-Voltage Motor Driver With a Charge-Pump Circuit	IEEE TRANSACTIONS ON INDUSTRIAL ELECTRONICS			English	Article						Charge pump (CP); motor driver; pulsewidth modulation (PWM); zero-sequence signal (ZSS)	SUPERCAPACITOR; SYSTEM	A boost-voltage motor driver with a charge pump (CP) circuit has higher efficiency than the conventional boost-voltage motor driver with a chopper circuit. This paper presents a variable-form carrier-based (VFCB) pulsewidth modulation (PWM) technique for the driver with the CP circuit. This technique has two triangular carriers and a variable-form carrier that is dependent on the voltage command signals. The technique is compared with the space vector modulation (SVM) technique in terms of the number of switching cycles, harmonics in the output voltage, linear modulation range, input power to the CP capacitor, processing time, and efficiency. The VFCB PWM technique is confirmed to operate the driver with the CP circuit at the same performance level as the SVM technique, with shortened processing time.	[Matsumoto, Hirokazu; Neba, Yasuhiko; Asahara, Hiroyuki] Fukuoka Univ, Dept Elect Engn, Fukuoka 8190395, Japan	Matsumoto, H (reprint author), Fukuoka Univ, Dept Elect Engn, Fukuoka 8190395, Japan.	matsumoto@fukuoka-u.ac.jp; neba@fukuoka-u.ac.jp; asahara@fukuoka-u.ac.jp			JSPS KAKENHI [26820104]	Manuscript received July 16, 2014; revised November 3, 2014 and December 18, 2014; accepted January 20, 2015. Date of publication February 16, 2015; date of current version June 26, 2015. This work was supported by JSPS KAKENHI under Grant 26820104.	Amjadi Z, 2010, IEEE T IND ELECTRON, V57, P926, DOI 10.1109/TIE.2009.2032196; Dixon J, 2010, IEEE T IND ELECTRON, V57, P943, DOI 10.1109/TIE.2009.2027920; Allegre AL, 2010, IEEE T IND ELECTRON, V57, P4001, DOI 10.1109/TIE.2010.2044124; Hava AM, 1998, IEEE T IND APPL, V34, P1059, DOI 10.1109/28.720446; Attaianese C, 2012, IEEE T VEH TECHNOL, V61, P1961, DOI 10.1109/TVT.2012.2191987; Blasko V, 1997, IEEE T IND APPL, V33, P756, DOI 10.1109/28.585866; Broeck H.W., 1988, IEEE T IND APPL, V24, P142; Cao J., 2012, IEEE T POWER ELECTR, V27, P122; Grbovic PJ, 2011, IEEE T IND ELECTRON, V58, P925, DOI 10.1109/TIE.2010.2048838; Khaligh A., 2010, IEEE T VEH TECHNOL, V58, P2806; KOLAR JW, 1991, IEEE T IND APPL, V27, P1063, DOI 10.1109/28.108456; Matsumoto H, 2014, IEEE T IND ELECTRON, V61, P3178, DOI 10.1109/TIE.2013.2278956; Matsumoto H., 2014, IEEJ T IND APPL, V134, P229; Matsumoto H, 2010, IEEE T POWER ELECTR, V25, P2276, DOI 10.1109/TPEL.2010.2046912; PFAFF G, 1984, IEEE T IND APPL, V20, P814, DOI 10.1109/TIA.1984.4504491; Schonung A., 1964, Brown Boveri Review, V51	16	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0278-0046	1557-9948		IEEE T IND ELECTRON	IEEE Trans. Ind. Electron.	AUG	2015	62	8					4728	4738		10.1109/TIE.2015.2404304		11	Automation & Control Systems; Engineering, Electrical & Electronic; Instruments & Instrumentation	Automation & Control Systems; Engineering; Instruments & Instrumentation	CL9BG	WOS:000357268300007		
J	Lu, ZG; Sekiyama, K; Aoyama, T; Hasegawa, Y; Kobayashi, T; Fukuda, T				Lu, Zhiguo; Sekiyama, Kosuke; Aoyama, Tadayoshi; Hasegawa, Yasuhisa; Kobayashi, Taisuke; Fukuda, Toshio			Energetically Efficient Ladder Descent Motion With Internal Stress and Body Motion Optimized for a Multilocomotion Robot	IEEE TRANSACTIONS ON INDUSTRIAL ELECTRONICS			English	Article						Closed chain; energy efficiency; internal stress; multilocomotion robot (MLR)	HARNESS ASSEMBLY SYSTEMS; HUMANOID ROBOT; ELECTRIC CONNECTORS; FORCE DISTRIBUTION; FAULT-DETECTION; GENERATION; MODEL; FORMULATION	Energy efficiency of locomotion is a significant issue for autonomous mobile robots. This paper focuses on the pace gait ladder descent motion that has a closed kinematic chain formed by the robot links and the environment. To reduce the energy cost in the closed kinematic chain, we propose an optimal control strategy by optimizing the internal stress and motion trajectories in parametric form. As the main contributions of this paper, three types of energetically efficient ladder descent motions are generated with different motion-mode assumptions. Critical factors, including cycle time, horizontal distance between the robot and the vertical ladder, and value of internal stress, are analyzed theoretically. Simulation and experimental results indicate that the proposed control strategy is effective for planning an energetically efficient ladder descent motion.	[Lu, Zhiguo] Northeastern Univ, Dept Mech Engn & Automat, Shenyang 110819, Peoples R China; [Sekiyama, Kosuke; Hasegawa, Yasuhisa; Kobayashi, Taisuke; Fukuda, Toshio] Nagoya Univ, Dept Micronano Syst Engn, Nagoya, Aichi 4648603, Japan; [Aoyama, Tadayoshi] Hiroshima Univ, Dept Syst Cybernet, Higashihiroshima 7398527, Japan	Lu, ZG (reprint author), Northeastern Univ, Dept Mech Engn & Automat, Shenyang 110819, Peoples R China.	zglu@me.neu.edu.cn; sekiyama@mein.nagoya-u.ac.jp; aoyama@robotics.hiroshima-u.ac.jp; hasegawa@mein.nagoya-u.ac.jp; kobayashi@robo.mein.nagoya-u.ac.jp; fukuda@mein.nagoya-u.ac.jp			Fundamental Research Funds for the Central Universities [N140304008]; Research Fund for the Doctoral Program of Higher Education of China [20130042120027]; University Innovation Team of Liaoning Province [LT2014006]	Manuscript received May 17, 2014; revised September 3, 2014 and October 11, 2014; accepted November 20, 2014. Date of publication January 30, 2015; date of current version June 26, 2015. This work was supported in part by the Fundamental Research Funds for the Central Universities (N140304008), in part by the Research Fund for the Doctoral Program of Higher Education of China (20130042120027), and in part by the University Innovation Team of Liaoning Province (LT2014006).	KUMAR VR, 1988, IEEE T ROBOTIC AUTOM, V4, P657, DOI 10.1109/56.9303; Ugurlu B, 2010, IEEE T IND ELECTRON, V57, P1701, DOI 10.1109/TIE.2009.2032439; Erbatur K, 2009, IEEE T IND ELECTRON, V56, P835, DOI 10.1109/TIE.2008.2005150; Saab L, 2013, IEEE T ROBOT, V29, P346, DOI 10.1109/TRO.2012.2234351; Harada K, 2006, IEEE T ROBOT, V22, P568, DOI 10.1109/TRO.2006.870649; Shimmyo S, 2013, IEEE T IND ELECTRON, V60, P5137, DOI 10.1109/TIE.2012.2221111; Yu XX, 2014, IEEE T IND ELECTRON, V61, P1053, DOI 10.1109/TIE.2013.2266080; Righetti L, 2011, IEEE INT CONF ROBOT, P1085, DOI 10.1109/ICRA.2011.5980156; KERR J, 1986, INT J ROBOT RES, V4, P3, DOI 10.1177/027836498600400401; Fu CL, 2008, IEEE T IND ELECTRON, V55, P2111, DOI 10.1109/TIE.2008.921205; Hyon SH, 2007, IEEE T ROBOT, V23, P884, DOI 10.1109/TRO.2007.904896; Sato T, 2011, IEEE T IND ELECTRON, V58, P376, DOI 10.1109/TIE.2010.2052535; Sentis L, 2010, IEEE T ROBOT, V26, P483, DOI 10.1109/TRO.2010.2043757; Collins S, 2005, SCIENCE, V307, P1082, DOI 10.1126/science.1107799; Craig J., 2004, INTRO ROBOTICS MECH; Escande A, 2009, 2009 IEEE-RSJ INTERNATIONAL CONFERENCE ON INTELLIGENT ROBOTS AND SYSTEMS, P435, DOI 10.1109/IROS.2009.5354371; Huang J, 2008, IEEE-ASME T MECH, V13, P86, DOI 10.1109/TMECH.2007.915063; Huang JA, 2010, IEEE T CONTR SYST T, V18, P1207, DOI 10.1109/TCST.2009.2034735; Hung MH, 2000, IEEE T SYST MAN CY B, V30, P529, DOI 10.1109/3477.865170; KHATIB O, 1987, IEEE T ROBOTIC AUTOM, V3, P43; Lengagne S., 2010, P IEEE RAS INT C HUM, P14; Lu ZG, 2012, IEEE INT C INT ROBOT, P2216; Norton RL, 1999, DESIGN MACHINERY INT; Ohashi E, 2007, IEEE T IND ELECTRON, V54, P1632, DOI 10.1109/TIE.2007.894728; Pchelkin S., 2011, P IEEE RSJ INT C INT, P5094; Raibert M. H., 1981, T ASME, V102, P126; Wakita K, 2013, IEEE-ASME T MECH, V18, P285, DOI 10.1109/TMECH.2011.2169980; Xu Y., 1988, Proceedings of the 1988 IEEE International Conference on Robotics and Automation (Cat. No.88CH2555-1), DOI 10.1109/ROBOT.1988.12220	28	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0278-0046	1557-9948		IEEE T IND ELECTRON	IEEE Trans. Ind. Electron.	AUG	2015	62	8					4972	4984		10.1109/TIE.2015.2396872		13	Automation & Control Systems; Engineering, Electrical & Electronic; Instruments & Instrumentation	Automation & Control Systems; Engineering; Instruments & Instrumentation	CL9BG	WOS:000357268300031		
J	Sanguanpak, S; Chiemchaisri, C; Chiemchaisri, W; Yamamoto, K				Sanguanpak, Samunya; Chiemchaisri, Chart; Chiemchaisri, Wilai; Yamamoto, Kazuo			Influence of operating pH on biodegradation performance and fouling propensity in membrane bioreactors for landfill leachate treatment	INTERNATIONAL BIODETERIORATION & BIODEGRADATION			English	Article						Landfill leachate; MBR; Biodegradability; Membrane fouling; Mixed liquor pH	DISSOLVED ORGANIC-MATTER; WASTE-WATER TREATMENT; EXTRACELLULAR POLYMERIC SUBSTANCES; PARTIALLY-STABILIZED LEACHATE; ACTIVATED-SLUDGE; COMMUNITY STRUCTURES; SYSTEM; EPS; DOM	This research has investigated the effects of varying mixed liquor pH (i.e. 5.5, 6.5, 7.5, 8.5) on the landfill leachate biodegradability and fouling behavior in two submerged membrane bioreactors (MBR) for a 150-day period. In the experiments, variations in organic removal and dissolved organic matters (DOM) transformation, microbial community and mixed liquor properties as well as the fouling behavior were monitored and systematically analyzed. The findings indicated that the organic removal in both MBRs was insignificantly different for the entire experimental pH range and that the pH levels influenced the DOM transformation. In the analysis of microbial community, PCR-DGGE revealed considerable structural changes, pointing to an effect of pH on the dynamic shift in bacterial species. In addition, clone library analysis showed that Proteobacteria was the dominant phylum in the MBRs and that the dominant bacterial community belonged to the classes Betaproteobacteria and Gammaproteobacteria, both of which were more abundant at pH 8.5 than at pH 5.5. The experiment also showed that the mixed liquor properties were affected by the pH variations. The extracellular polymeric substance (EPS) formation in the mixed liquor at pH 5.5 significantly contributed to membrane fouling while hindering the inorganic and humic substances fouling. Nevertheless, the organic fouling under the low pH condition could be effectively removed by membrane chemical cleaning. It is expected that the experimental results could be applied to enhance the biodegradability and mitigate the fouling in the MBR process. (C) 2015 Elsevier Ltd. All rights reserved.	[Sanguanpak, Samunya; Chiemchaisri, Chart; Chiemchaisri, Wilai] Kasetsart Univ, Fac Engn, Dept Environm Engn, Bangkok 10900, Thailand; [Yamamoto, Kazuo] Univ Tokyo, Ctr Environm Sci, Tokyo 113, Japan	Chiemchaisri, C (reprint author), Kasetsart Univ, Fac Engn, Dept Environm Engn, Bangkok 10900, Thailand.	samunys@mtec.or.th; fengccc@ku.ac.th; fengwlc@ku.ac.th; yamamoto@esc.u-tokyo.ac.jp			Kasetsart University Research and Development Institute (KURDI) [PT(D) 141.56]	This research is part of the Research and Development for Water Reuse Technology in Tropical Regions (WaterIntro) project of the Japan International Cooperation Agency (JICA) and the Japan Science and Technology Agency (JST). The authors would also like to extend deep gratitude to the Kasetsart University Research and Development Institute (KURDI) (Grant Number PT(D) 141.56) for financial support.	Amonette J. E., 2004, PREPR PAP AM CHEM SO, V49, P366; Le-Clech P, 2006, J MEMBRANE SCI, V284, P17, DOI 10.1016/j.memsci.2006.08.019; Meng FG, 2006, SEP PURIF TECHNOL, V51, P95, DOI 10.1016/j.seppur.2006.01.002; Ahmed FN, 2012, DESALINATION, V287, P41, DOI 10.1016/j.desal.2011.12.012; Cosenza A, 2013, BIORESOURCE TECHNOL, V147, P184, DOI 10.1016/j.biortech.2013.08.026; Nanda D, 2010, J MEMBRANE SCI, V349, P411, DOI 10.1016/j.memsci.2009.12.004; Gao WJJ, 2010, PROCESS BIOCHEM, V45, P1279, DOI 10.1016/j.procbio.2010.04.018; Comstock SEH, 2010, CHEMOSPHERE, V81, P976, DOI 10.1016/j.chemosphere.2010.07.030; Mnif S, 2012, INT BIODETER BIODEGR, V73, P50, DOI 10.1016/j.ibiod.2012.04.014; Kang KH, 2002, WATER RES, V36, P4023, DOI 10.1016/S0043-1354(02)00114-8; Huang YT, 2012, INT BIODETER BIODEGR, V66, P47, DOI 10.1016/j.ibiod.2011.09.009; Tadkaew N, 2011, WATER RES, V45, P2439, DOI 10.1016/j.watres.2011.01.023; Sweity A, 2011, J MEMBRANE SCI, V378, P186, DOI 10.1016/j.memsci.2011.04.056; Li XY, 2007, WATER RES, V41, P1022, DOI 10.1016/j.watres.2006.06.037; Gao DW, 2014, BIORESOURCE TECHNOL, V154, P87, DOI 10.1016/j.biortech.2013.11.051; He PJ, 2006, WATER RES, V40, P1465, DOI 10.1016/j.watres.2006.01.048; Zhang Y, 2014, BIORESOURCE TECHNOL, V152, P7, DOI 10.1016/j.biortech.2013.10.096; Lu F, 2009, CHEMOSPHERE, V74, P575, DOI 10.1016/j.chemosphere.2008.09.060; Meng FG, 2009, WATER RES, V43, P1489, DOI 10.1016/j.watres.2008.12.044; SHANNON CE, 1948, AT&T TECH J, V27, P623; Boonnorat J, 2014, BIORESOURCE TECHNOL, V165, P50, DOI 10.1016/j.biortech.2014.04.024; Hu M, 2012, BIORESOURCE TECHNOL, V117, P72, DOI 10.1016/j.biortech.2012.04.061; Miura Y, 2007, WATER RES, V41, P627, DOI 10.1016/j.watres.2006.11.005; APHA, 2005, STANDARD METHODS EXA; Baldwin DD, 2001, WATER QUAL RES J CAN, V36, P519; Chiemchaisri C, 2011, WATER SCI TECHNOL, V64, P1064, DOI 10.2166/wst.2011.534; Huo SL, 2009, WATER ENVIRON J, V23, P15, DOI 10.1111/j.1747-6593.2007.00104.x; Ittisupornrat S, 2014, APPL MICROBIOL BIOT, V98, P9107, DOI 10.1007/s00253-014-5914-1; Molina-Munoz M, 2009, SCI TOTAL ENVIRON, V407, P3994, DOI 10.1016/j.scitotenv.2009.03.024; Ollis D.F., 1986, BIOCH ENG FUNDAMENTA; Sanguanpak S, 2013, WATER SCI TECHNOL, V68, P1091, DOI 10.2166/wst.2013.350; Wu JL, 2010, SEP SCI TECHNOL, V45, P890, DOI 10.1080/01496391003666924; Zhao J, 2013, INT BIODETER BIODEGR, V85, P631, DOI 10.1016/j.ibiod.2013.05.012	33	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0964-8305	1879-0208		INT BIODETER BIODEGR	Int. Biodeterior. Biodegrad.	AUG	2015	102				SI		64	72		10.1016/j.ibiod.2015.03.024		9	Biotechnology & Applied Microbiology; Environmental Sciences	Biotechnology & Applied Microbiology; Environmental Sciences & Ecology	CM0EF	WOS:000357350500010		
J	Ratanatamskul, C; Wattanayommanaporn, O; Yamamoto, K				Ratanatamskul, C.; Wattanayommanaporn, O.; Yamamoto, K.			An on-site prototype two-stage anaerobic digester for co-digestion of food waste and sewage sludge for biogas production from high-rise building	INTERNATIONAL BIODETERIORATION & BIODEGRADATION			English	Article						On-site prototype two-stage anaerobic digester; Co-digestion process; Mixing ratio of FW/WS; Hydraulic retention time; On-site biogas production	MUNICIPAL SOLID-WASTES; ORGANIC FRACTION; MILL; PERFORMANCE; MANURE	Up to now, there has been less results from on-site pilot-scale anaerobic co-digestion system, especially for high-rise building application. The objective of this study was to develop an on-site prototype two-stage anaerobic digester for co-digestion of food waste and sewage sludge from high-rise building for biogas production. The optimal mixing ratio of food waste to sewage sludge, obtained from laboratory-scale, was found to be 7:1. Then, the prototype two-stage anaerobic digester was further designed and constructed. The results showed that COD and total volatile solid (TVS) reduction could be achieved up to 89 and 74%, respectively with the applied hydraulic retention time (HRT) of 24 days. The methane content of biogas was 64 percent. Up to now, the biogas from on-site production has been utilized for cooking at Chulalongkorn University as a model case study for high-rise building application. (C) 2015 Elsevier Ltd. All rights reserved.	[Ratanatamskul, C.] Chulalongkorn Univ, Dept Environm Engn, Bangkok 10330, Thailand; [Wattanayommanaporn, O.] Chulalongkorn Univ, Interdept Environm Sci, Bangkok 10330, Thailand; [Yamamoto, K.] Univ Tokyo, Dept Urban Engn, Tokyo 113, Japan	Ratanatamskul, C (reprint author), Chulalongkorn Univ, Dept Environm Engn, Bangkok 10330, Thailand.	dr_chawalit@yahoo.com			Japan International Cooperation Agency (JICA)	This research work was financially supported by Japan International Cooperation Agency (JICA) (JICA) under Research and Development of Water Reuse Technology in Tropical Region (WaterInTro) Project.	Angelidaki I, 2005, WATER SCI TECHNOL, V52, P189; Angelidaki I, 2002, WATER SCI TECHNOL, V45, P213; Ratanatamskul C, 2014, INT BIODETER BIODEGR, V95, P176, DOI 10.1016/j.ibiod.2014.06.010; Mata-Alvarez J, 2000, BIORESOURCE TECHNOL, V74, P3, DOI 10.1016/S0960-8524(00)00023-7; Marques IP, 2001, DESALINATION, V137, P233, DOI 10.1016/S0011-9164(01)00224-7; Dinsdale RM, 2000, BIORESOURCE TECHNOL, V72, P159, DOI 10.1016/S0960-8524(99)00105-4; Sosnowski P, 2003, ADV ENVIRON RES, V7, P609, DOI 10.1016/S1093-0191(02)00049-7; Bouallagui H, 2004, BIOCHEM ENG J, V21, P193, DOI 10.1016/j.bej.2004.05.001; Stroot PG, 2001, WATER RES, V35, P1804, DOI 10.1016/S0043-1354(00)00439-5; Demirel B, 2008, BIOMASS BIOENERG, V32, P203, DOI 10.1016/j.biombioe.2007.09.011; APHA-AWWA-WPCF (American Public Health Association American Water Works Association Water Environment Federation), 2005, STANDARD METHODS EXA; Bujoczek G, 2002, ENVIRON TECHNOL, V23, P227, DOI 10.1080/09593332508618423; Callaghan F., 2000, BIOMASS BIOENERG, V27, P71; Converti A, 1999, BIOPROCESS ENG, V21, P371, DOI 10.1007/s004490050689; Digman B, 2008, ENVIRON PROG, V27, P524, DOI 10.1002/ep.10312; European Council, 2002, OFF J EUR COMMUN, V11, P27; Poggi-Varaldo HM, 1999, WATER SCI TECHNOL, V40, P179, DOI 10.1016/S0273-1223(99)00716-7; Pollution Control Department, 2012, THAIL STAT POLL REP; Tchobanoglous G., 1993, INTEGRATED SOLID WAS, P69	19	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0964-8305	1879-0208		INT BIODETER BIODEGR	Int. Biodeterior. Biodegrad.	AUG	2015	102				SI		143	148		10.1016/j.ibiod.2015.03.019		6	Biotechnology & Applied Microbiology; Environmental Sciences	Biotechnology & Applied Microbiology; Environmental Sciences & Ecology	CM0EF	WOS:000357350500021		
J	Aono, J; Ikeda, S; Katsumata, Y; Higashi, H; Ohshima, K; Ishibashi, K; Matsuoka, H; Watanabe, K; Hamada, M				Aono, Jun; Ikeda, Shuntaro; Katsumata, Yuriko; Higashi, Haruhiko; Ohshima, Kousei; Ishibashi, Ken; Matsuoka, Hiroshi; Watanabe, Kouki; Hamada, Mareomi			Correlation between plaque vulnerability of aorta and coronary artery: an evaluation of plaque activity by direct visualization with angioscopy	INTERNATIONAL JOURNAL OF CARDIOVASCULAR IMAGING			English	Article						Atherosclerosis; Angioscopy; Thoracic aorta; Coronary artery; Atherosclerotic plaque	C-REACTIVE PROTEIN; PULSE-WAVE VELOCITY; INTIMA-MEDIA THICKNESS; THORACIC AORTA; FOLLOW-UP; ATHEROSCLEROTIC DISEASE; ISCHEMIC-STROKE; STIFFNESS; LESIONS; INFLAMMATION	This study investigated the relationship between the degree of atherosclerotic changes in the descending thoracic aorta (TA) and the coronary artery using angioscopy. Twenty-five consecutive patients undergoing angioscopy of the TA and coronary angiography were enrolled in this study. Participants were divided into three groups according to the angioscopic grading of the TA: white plaque group (W-group), yellow plaque group (Y-group) and intensive yellow, ruptured plaque with ulceration and/or thrombus group (RP-group). The maximum plaque grade, plaque score, number of yellow plaques, frequency of yellow-plaque grades by coronary angioscopy, and SYNTAX score by coronary angiography were evaluated. Brachial-artery pulse wave velocity and high-sensitivity C-reactive protein level tended to be higher in the RP-group than in the other groups, although the differences were not statistically significant. The SYNTAX score was significantly higher in the RP-group than in the W-group (W-group 4.0 +/- A 3.6 vs. RP-group 17.5 +/- A 10.0, P = 0.045). In addition, the angioscopic maximum plaque grade, plaque score, and number of yellow plaques in the RP-group were significantly higher than in the W-group (maximum plaque grade W-group 0.8 +/- A 0.4 vs. RP-group 1.8 +/- A 0.8, P = 0.026; plaque score W-group 1.0 +/- A 1.2 vs. RP-group 4.0 +/- A 1.4, P = 0.014; and number of yellow plaques W-group 1.0 +/- A 1.2 vs. RP-group 2.5 +/- A 0.5, P = 0.023). The yellow-plaque grade in the coronary artery was correlated significantly with the plaque grading of TA (P = 0.043). Our study suggests that the angioscopic progression of aortic atherosclerosis is closely associated with vulnerability to and the extent of coronary stenosis, indicating that vulnerability toward atherosclerotic plaque development occurs simultaneously in the coronary tree and systemic arteries.	[Aono, Jun; Higashi, Haruhiko] Kitaishikai Hosp, Div Cardiol, Ozu, Ehime, Japan; [Aono, Jun] Univ Kentucky, Saha Cardiovasc Res Ctr, Lexington, KY USA; [Ikeda, Shuntaro; Hamada, Mareomi] Uwajima City Hosp, Div Cardiol, Uwajima, Ehime 7988510, Japan; [Katsumata, Yuriko] Univ Kentucky, Dept Biostat, Lexington, KY USA; [Ohshima, Kousei] Prefectural Niihama Hosp, Div Cardiol, Niihama, Ehime, Japan; [Ishibashi, Ken] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Cardiovasc Med, Hiroshima, Japan; [Matsuoka, Hiroshi] Prefectural Imabari Hosp, Div Cardiol, Imabari, Ehime, Japan; [Watanabe, Kouki] Saiseikai Matsuyama Hosp, Div Cardiol, Matsuyama, Ehime, Japan	Ikeda, S (reprint author), Uwajima City Hosp, Div Cardiol, 1-1 Gotenmachi, Uwajima, Ehime 7988510, Japan.	ikeda.shuntaro@gmail.com					Andrie RP, 2009, ATHEROSCLEROSIS, V202, P135, DOI 10.1016/j.atherosclerosis.2008.03.028; Cohen A, 1997, CIRCULATION, V96, P3838; Ueda Y, 2003, HERZ, V28, P501, DOI 10.1007/s00059-003-2486-8; Kubo T, 2008, JACC-CARDIOVASC INTE, V1, P74, DOI 10.1016/j.jcin.2007.11.001; Khoury Z, 1997, AM J CARDIOL, V80, P1429, DOI 10.1016/S0002-9149(97)00701-7; Takasu J, 2009, ATHEROSCLEROSIS, V204, P440, DOI 10.1016/j.atherosclerosis.2008.09.041; Rohani M, 2005, ATHEROSCLEROSIS, V179, P311, DOI 10.1016/j.atherosclerosis.2004.10.012; Nagano M, 2005, ATHEROSCLEROSIS, V180, P189, DOI 10.1016/j.atherosclerosis.2004.11.019; Capodanno D, 2009, CIRC-CARDIOVASC INTE, V2, P302, DOI 10.1161/CIRCINTERVENTIONS.108.847137; Libby P, 2004, AM J MED, V116, P9, DOI 10.1016/j.amjmed.2004.02.006; Laurent S, 2001, HYPERTENSION, V37, P1236; Tunick PA, 2000, J AM COLL CARDIOL, V35, P545, DOI 10.1016/S0735-1097(99)00604-X; Lind L, 2003, ATHEROSCLEROSIS, V169, P203, DOI 10.1016/S0021-9150(03)00012-1; Liu CS, 2011, J ATHEROSCLER THROMB, V18, P652; Takano M, 2005, J AM COLL CARDIOL, V45, P652, DOI 10.1016/j.jacc.2004.09.077; Ashida K, 2007, J CARDIOVASC MAGN R, V9, P855, DOI 10.1080/10976640701693584; Bae JH, 2003, CLIN CARDIOL, V26, P574, DOI 10.1002/clc.4960261206; Cruickshank K, 2002, CIRCULATION, V106, P2085, DOI 10.1161/01.CIR.0000033824.02722.F7; Cwynar M, 2006, ACTA CARDIOL, V61, P421, DOI 10.1243/AC.61.4.2017303; Gu XY, 2011, AM J CARDIOL, V107, P175, DOI 10.1016/j.amjcard.2010.09.003; Hirayama A, 2000, J Cardiol, V35 Suppl 1, P57; Komorovsky Roman, 2005, Vasc Health Risk Manag, V1, P131, DOI 10.2147/vhrm.1.2.131.64077; Mizuno Kyoichi, 2011, Cardiovasc Interv Ther, V26, P89, DOI 10.1007/s12928-011-0055-2; Momiyama Y, 2010, J ATHEROSCLER THROMB, V17, P460; Nakhai-Pour HR, 2007, J HUM HYPERTENS, V21, P949, DOI 10.1038/sj.jhh.1002255; Shin JY, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-30; Sianos Georgios, 2005, EuroIntervention, V1, P219; SOLBERG LA, 1983, ARTERIOSCLEROSIS, V3, P187; Steffens S, 2004, HERZ, V29, P741, DOI 10.1007/s00059-004-2634-9; Amarenco P, 1996, NEW ENGL J MED, V334, P1216; TOBLER HG, 1988, J THORAC CARDIOV SUR, V96, P304; Uchida Y, 2012, WORLD J CARDIOVASC S, V2, P114; Ueda Y, 1996, J AM COLL CARDIOL, V27, P606, DOI 10.1016/0735-1097(95)00534-X; Ueda Y, 2001, J AM COLL CARDIOL, V38, P1916, DOI 10.1016/S0735-1097(01)01673-4; Wang ZY, 2010, INT HEART J, V51, P383, DOI 10.1536/ihj.51.383	35	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1569-5794	1573-0743		INT J CARDIOVAS IMAG	Int. J. Cardiovasc. Imaging	AUG	2015	31	6					1107	1114		10.1007/s10554-015-0669-z		8	Cardiac & Cardiovascular Systems; Radiology, Nuclear Medicine & Medical Imaging	Cardiovascular System & Cardiology; Radiology, Nuclear Medicine & Medical Imaging	CL7BS	WOS:000357125600002		
J	Koyama, K; Yoneyama, K; Mitarai, T; Kuwata, S; Kongoji, K; Harada, T; Akashi, YJ				Koyama, Kohei; Yoneyama, Kihei; Mitarai, Takanobu; Kuwata, Shingo; Kongoji, Ken; Harada, Tomoo; Akashi, Yoshihiro J.			Evaluation of the influence of cardiac motion on the accuracy and reproducibility of longitudinal measurements and the corresponding image quality in optical frequency domain imaging: an ex vivo investigation of the optimal pullback speed	INTERNATIONAL JOURNAL OF CARDIOVASCULAR IMAGING			English	Article						Interstudy variability; Reproducibility; Fourier domain optical coherence tomography; Intravascular ultrasound; Longitudinal measurement; Three-dimensional reconstruction	EXPERT CONSENSUS DOCUMENT; INTRAVASCULAR ULTRASOUND; 3-DIMENSIONAL RECONSTRUCTION; ACQUISITION; DIMENSIONS; STANDARDS; LUMEN	Longitudinal measurement using intravascular ultrasound is limited because the motorized pullback device assumes no cardiac motion. A newly developed intracoronary imaging modality, optical frequency domain imaging (OFDI), has higher resolution and an increased auto-pullback speed with presumably lesser susceptibility to cardiac motion artifacts during pullback for longitudinal measurement; however, it has not been fully investigated. We aimed to clarify the influence of cardiac motion on the accuracy and reproducibility of longitudinal measurements obtained using OFDI and to determine the optimal pullback speed. This ex vivo study included 31 stents deployed in the mid left anterior descending artery under phantom heartbeat and coronary flow simulation. Longitudinal stent lengths were measured twice using OFDI at three pullback speeds. Differences in stent lengths between OFDI and microscopy and between two repetitive pullbacks were assessed to determine accuracy and reproducibility. Furthermore, three-dimensional (3D) reconstruction was used for evaluating image quality. With regard to differences in stent length between OFDI and microscopy, the intraclass correlation coefficient values were 0.985, 0.994, and 0.995 at 10, 20, and 40 mm/s, respectively. With regard to reproducibility, the values were 0.995, 0.996, and 0.996 at 10, 20, and 40 mm/s, respectively. 3D reconstruction showed a superior image quality at 10 and 20 mm/s compared with that at 40 mm/s. OFDI demonstrated high accuracy and reproducibility for longitudinal stent measurements. Moreover, its accuracy and reproducibility were remarkable at a higher pullback speed. A 20-mm/s pullback speed may be optimal for clinical and research purposes.	[Koyama, Kohei; Yoneyama, Kihei; Mitarai, Takanobu; Kuwata, Shingo; Kongoji, Ken; Harada, Tomoo; Akashi, Yoshihiro J.] St Marianna Univ, Sch Med, Dept Internal Med, Div Cardiol,Miyamae Ku, Kawasaki, Kanagawa 2168511, Japan	Koyama, K (reprint author), St Marianna Univ, Sch Med, Dept Internal Med, Div Cardiol,Miyamae Ku, 2-16-1 Sugao, Kawasaki, Kanagawa 2168511, Japan.	kkouhei21@gmail.com	Akashi, Yoshihiro/E-5227-2011	Akashi, Yoshihiro/0000-0001-7670-7326	TERUMO Corporation	We would like to thank TERUMO Corporation for their support.	Witzenbichler B, 2014, CIRCULATION, V129, P463, DOI 10.1161/CIRCULATIONAHA.113.003942; Mintz GS, 2001, J AM COLL CARDIOL, V37, P1478, DOI 10.1016/S0735-1097(01)01175-5; Arbab-Zadeh A, 1999, AM HEART J, V138, P865, DOI 10.1016/S0002-8703(99)70011-6; Gutierrez-Chico JL, 2012, INT J CARDIOVAS IMAG, V28, P467, DOI 10.1007/s10554-011-9829-y; Okamura T, 2012, EUROINTERVENTION, V7, P1216, DOI 10.4244/EIJV7I10A194; Stone GW, 2011, NEW ENGL J MED, V364, P226, DOI 10.1056/NEJMoa1002358; vonBirgelen C, 1997, CIRCULATION, V96, P2944; Mintz GS, 2011, EUROINTERVENTION, V6, P1123, DOI 10.4244/EIJV6I9A195; BLAND JM, 1986, LANCET, V1, P307; Okumura T, 2010, EUROINTERVENTION, V6, P371; vonBirgelen C, 1997, J AM COLL CARDIOL, V30, P436, DOI 10.1016/S0735-1097(97)00154-X	11	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1569-5794	1573-0743		INT J CARDIOVAS IMAG	Int. J. Cardiovasc. Imaging	AUG	2015	31	6					1115	1123		10.1007/s10554-015-0676-0		9	Cardiac & Cardiovascular Systems; Radiology, Nuclear Medicine & Medical Imaging	Cardiovascular System & Cardiology; Radiology, Nuclear Medicine & Medical Imaging	CL7BS	WOS:000357125600003		
J	Yamane, Y; Takahashi, K; Hamada, K; Morikawa, K; Bahagia, SN; Diawati, L; Cakravastia, A				Yamane, Yasuo; Takahashi, Katsuhiko; Hamada, Kunihiro; Morikawa, Katsumi; Bahagia, Senator Nur; Diawati, Lucia; Cakravastia, Andi			Developing a plant system prediction model for technology transfer	INTERNATIONAL JOURNAL OF PRODUCTION ECONOMICS			English	Article						Plant capacity; Technology level; Management of technology; Learning curve	LEARNING-CURVE MODEL; DEVELOPING-COUNTRIES; FIRM PERFORMANCE; RAMP-UP; PRODUCTIVITY; KNOWLEDGE; IMPROVEMENT; QUALITY; GROWTH; INVESTMENT	Technology transfer (TT) is the process of transferring skills, knowledge, technologies, methods of manufacturing, and facilities. Successful TT demands an integrated approach in order to plan, implement, evaluate and improve the transfer process comprehensively. For quantifying the technology level, various models have been developed and applied, however the total performance of a plant has not been quantified by the model. It is necessary to develop a mechanism of integrating the quantified technology level of each process into the total performance of the plant. This paper develops a plant system prediction model. In the model, a V-process model is utilized for defining the whole procedure for analyzing the plant system, and the technology level quantification model developed by Yamane, Y., Takahashi, K., Hamada, K., Morikawa, K., Nur Bahagia, S., Diawati, L., Cakravastia, A., 2011. Quantifying the technology level of production system for technology transfer. Ind. Eng. Manag. Syst., 10(2), 97-103 is utilized for quantifying the technology level of each process. Also, to integrate the quantified technology level into that of the plant system, some functions are formulated. A case study in a manufacturing industry shows the effectiveness of the developed model. (C) 2015 Elsevier B.V. All rights reserved.	[Yamane, Yasuo; Takahashi, Katsuhiko; Hamada, Kunihiro; Morikawa, Katsumi] Hiroshima Univ, Fac Engn, Higashihiroshima 7398527, Japan; [Bahagia, Senator Nur; Diawati, Lucia; Cakravastia, Andi] Bandung Inst Technol, Fac Ind Technol, Bandung 40132, Indonesia	Takahashi, K (reprint author), Hiroshima Univ, Fac Engn, 1-4-1 Kagamiyama, Higashihiroshima 7398527, Japan.	takahasi@hiroshima-u.ac.jp			Japan Society for the Promotion of Science; Nishikawa Rubbers Co. Ltd.	The work in this paper was partially supported by the Japan Society for the Promotion of Science with a Grant-in-Aid for Joint Research in 2009-2011 and Nishikawa Rubbers Co. Ltd.	de Lima EP, 2013, INT J PROD ECON, V146, P524, DOI 10.1016/j.ijpe.2012.05.007; Jaber MY, 2002, INT J PROD ECON, V76, P229, DOI 10.1016/S0925-5273(01)00169-4; Jaber MY, 2010, INT J PROD ECON, V127, P27, DOI 10.1016/j.ijpe.2010.04.010; Plaza M, 2008, INT J PROD ECON, V115, P72, DOI 10.1016/j.ijpe.2008.05.005; Jaber MY, 2009, INT J PROD ECON, V118, P19, DOI 10.1016/j.ijpe.2008.08.006; BADIRU AB, 1992, IEEE T ENG MANAGE, V39, P176, DOI 10.1109/17.141275; Terwiesch C, 2001, INT J PROD ECON, V70, P1, DOI 10.1016/S0925-5273(00)00045-1; Lapre MA, 2001, MANAGE SCI, V47, P1311, DOI 10.1287/mnsc.47.10.1311.10264; Lapre MA, 2000, MANAGE SCI, V46, P597, DOI 10.1287/mnsc.46.5.597.12049; Plaza M, 2010, EUR J OPER RES, V200, P518, DOI 10.1016/j.ejor.2009.01.010; Ngwenyama O, 2007, INT J PROD ECON, V105, P524, DOI 10.1016/j.ijpe.2006.02.013; Glock CH, 2012, INT J PROD RES, V50, P5707, DOI 10.1080/00207543.2011.616549; Jaber MY, 2008, EUR J OPER RES, V189, P93, DOI 10.1016/j.ejor.2007.05.024; Li G, 1998, EUR J OPER RES, V105, P143, DOI 10.1016/S0377-2217(97)00033-7; VIGIL DP, 1994, INT J PROD ECON, V34, P187, DOI 10.1016/0925-5273(94)90035-3; Jaber MY, 2010, INT J PROD ECON, V124, P32, DOI 10.1016/j.ijpe.2009.09.004; Mukherjee AS, 1998, MANAGE SCI, V44, pS35, DOI 10.1287/mnsc.44.11.S35; Jaber MY, 2004, INT J PROD ECON, V92, P281, DOI 10.1016/j.ijpe.2003.10.019; Jaber MY, 2004, EUR J OPER RES, V159, P663, DOI [10.1016/S0377-2217(03)00436-3, 10.1016/s0377-2217(03)00436-3]; Anderson EG, 2001, EUR J OPER RES, V134, P508, DOI 10.1016/S0377-2217(00)00273-3; Wang YM, 2009, INT J PROD RES, V47, P6663, DOI 10.1080/00207540802314845; Andrade MC, 1999, INT J PROD ECON, V62, P175, DOI 10.1016/S0925-5273(97)00136-9; Armbruster D, 2007, EUR J OPER RES, V176, P264, DOI 10.1016/j.ejor.2005.06.052; Bivin DG, 2003, INT J PROD ECON, V81-2, P141, DOI 10.1016/S0925-5273(02)00347-X; Carr G. W., 1946, AVIATION, V45, P76; Corbett CJ, 1999, SLOAN MANAGE REV, V40, P71; Gavronski I, 2012, INT J PROD ECON, V140, P183, DOI 10.1016/j.ijpe.2012.01.037; Genius M, 2012, EUR J OPER RES, V220, P844, DOI 10.1016/j.ejor.2012.02.023; GUNASEKARAN A, 1994, INT J PROD ECON, V36, P169, DOI 10.1016/0925-5273(94)90022-1; Hannula M, 2002, INT J PROD ECON, V78, P57, DOI 10.1016/S0925-5273(00)00186-9; Henderson SC, 2004, INT J PROD RES, V42, P1933, DOI 10.1080/00207540310001645138; Hsu CI, 2009, INT J PROD ECON, V118, P486, DOI 10.1016/j.ijpe.2008.09.015; Jaber MY, 2003, INT J PROD ECON, V83, P95, DOI 10.1016/S0925-5273(02)00322-5; Kahen G, 1995, INT J COMPUT APPL T, V8, P325; Karsak EE, 2008, INT J PROD RES, V46, P6933, DOI 10.1080/00207540701419364; Khan M, 2011, IND INNOV SER, P211; KIM DH, 1993, SLOAN MANAGE REV, V35, P37; Lapre MA, 2003, CALIF MANAGE REV, V46, P53; Li XH, 2001, INT J PROD RES, V39, P2895, DOI 10.1080/00207540110052544; Lieven L., 2005, INT J PROD ECON, V95, P265; Mefford RN, 1998, INT J PROD ECON, V56-7, P433, DOI 10.1016/S0925-5273(98)00085-1; Oral M, 1999, EUR J OPER RES, V118, P271, DOI 10.1016/S0377-2217(99)00025-9; Ould M.A., 1990, STRATEGIES SOFTWARE; Sage A. P., 2000, INTRO SYSTEMS ENG; Tarakci H, 2009, EUR J OPER RES, V192, P138, DOI 10.1016/j.ejor.2007.09.016; Usubamatov R, 2013, INT J ADV MANUF TECH, V66, P59, DOI 10.1007/s00170-012-4305-y; Vinodh S, 2011, INT J PROD RES, V49, P431, DOI 10.1080/00207540903471494; Wright T. P., 1936, J AERONAUT SCI, V3, P122; Yamane Yasuo, 2011, Industrial Engineeering & Management Systems An International Journal, V10, P97; Zelenyuk V, 2006, EUR J OPER RES, V174, P1076, DOI 10.1016/j.ejor.2005.02.061	50	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0925-5273	1873-7579		INT J PROD ECON	Int. J. Prod. Econ.	AUG	2015	166				SI		119	128		10.1016/j.ijpe.2015.05.014		10	Engineering, Industrial; Engineering, Manufacturing; Operations Research & Management Science	Engineering; Operations Research & Management Science	CL8QF	WOS:000357238500011		
J	Igarashi, T; Ono, M; Fujimoto, C; Suzuki, H; Takahashi, H				Igarashi, Tsutomu; Ono, Masafumi; Fujimoto, Chiaki; Suzuki, Hisaharu; Takahashi, Hiroshi			The conjunctival sensitivity in soft contact lens wearers	INTERNATIONAL OPHTHALMOLOGY			English	Article							TFOS INTERNATIONAL WORKSHOP; VIVO CONFOCAL MICROSCOPY; CORNEAL SENSITIVITY; OCULAR SURFACE; LONG-TERM; DISCOMFORT REPORT; SUBCOMMITTEE	We determined the influence of soft contact lenses (SCLs) on conjunctival sensitivity. A total of 26 volunteers (11 males, 15 females; mean age 28.3 +/- A 4.6 years; range 22-39 years) without dry eye were enrolled in the study. Subjects with a low corneal touch threshold, atopic keratoconjunctivitis, or vernal keratoconjunctivitis were excluded. In 26 participants, 12 were disposable SCL wearers. Touch thresholds were determined using a Cochet-Bonnet esthesiometer with a 0-60 mm nylon monofilament in 5 mm increments. The length (mm) was converted to tension (g/mm(2)). Mean touch sense thresholds in the SCL wearers (n = 12) and non-wearers (n = 14) were 10.7 +/- A 2.57 and 24.6 +/- A 7.3 g/mm(2) in the whole conjunctiva, and 9.07 +/- A 3.02 and 19.2 +/- A 7.8 g/mm(2) in the upper palpebral conjunctiva, respectively. Significant differences were observed in all locations (p < 0.01). The enhanced conjunctival sensitivity associated with SCL use may contribute to the dry eye-like symptoms in SCL users who do not have dry eye.	[Igarashi, Tsutomu; Ono, Masafumi; Fujimoto, Chiaki; Suzuki, Hisaharu; Takahashi, Hiroshi] Nippon Med Sch, Dept Ophthalmol, Bunkyo Ku, Tokyo 1138602, Japan	Igarashi, T (reprint author), Nippon Med Sch, Dept Ophthalmol, Bunkyo Ku, 1-1-5 Sendagi, Tokyo 1138602, Japan.	tutomu@nms.ac.jp			MEXT (Ministry of Education, Culture, Sports, Science and Technology, Japan) [23792014]	This work was supported in part by a Grant-in-Aid for Young Scientists (B) (23792014) from MEXT (Ministry of Education, Culture, Sports, Science and Technology, Japan).	Stapleton F, 2013, INVEST OPHTH VIS SCI, V54, P71, DOI 10.1167/iovs.13-13226; Efron N, 2013, INVEST OPHTH VIS SCI, V54, P98, DOI 10.1167/iovs.13-13187; Murphy PJ, 2001, CORNEA, V20, P264, DOI 10.1097/00003226-200104000-00006; Macri A, 2000, ARCH OPHTHALMOL-CHIC, V118, P1632; Efron N, 2010, CORNEA, V29, P43, DOI 10.1097/ICO.0b013e3181acf82a; Villani E, 2014, CURR EYE RES, V39, P213, DOI 10.3109/02713683.2013.842592; Epstein Arthur B, 2006, Eye Contact Lens, V32, P128, DOI 10.1097/01.icl.0000178850.55802.1c; Golebiowski B, 2012, INVEST OPHTH VIS SCI, V53, P1177, DOI 10.1167/iovs.11-8416; Hu Y, 2007, ALLERGY, V62, P917, DOI 10.1111/j.1398-9995.2007.01414.x; Key James E, 2007, Eye Contact Lens, V33, P343, DOI 10.1097/ICL.0b013e318157c230; MCGOWAN DP, 1994, ACTA OPHTHALMOL, V72, P57; MILLODOT M, 1978, ARCH OPHTHALMOL-CHIC, V96, P1225; MILLODOT M, 1974, BRIT J OPHTHALMOL, V58, P752, DOI 10.1136/bjo.58.8.752; MILLODOT M, 1979, AM J OPTOM PHYS OPT, V56, P628; NORN MS, 1973, ACTA OPHTHALMOL, V51, P58; Sanaty M, 1998, OPHTHALMOLOGICA, V212, P328, DOI 10.1159/000027317; Shimazaki J., 2007, J EYE, V24, P181; Stapleton F, 2004, BRIT J OPHTHALMOL, V88, P1547, DOI 10.1136/bjo.2004.044024; Takamura Etsuko, 2011, Allergology International, V60, P191, DOI 10.2332/allergolint.11-RAI-0335; VELASCO MJ, 1994, ACTA OPHTHALMOL, V72, P53; Villani E, 2011, INVEST OPHTH VIS SCI, V52, P5215, DOI 10.1167/iovs.11-7427	21	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0165-5701	1573-2630		INT OPHTHALMOL	Int. Ophthalmol.	AUG	2015	35	4					569	573		10.1007/s10792-014-9985-x		5	Ophthalmology	Ophthalmology	CL9HI	WOS:000357287700017		
J	Miyama, A; Mimura, T; Noma, H; Goto, M; Kamei, Y; Kondo, A; Saito, Y; Okuma, H; Matsubara, M				Miyama, Anri; Mimura, Tatsuya; Noma, Hidetaka; Goto, Mari; Kamei, Yuko; Kondo, Aki; Saito, Yusuke; Okuma, Hiroko; Matsubara, Masao			Specific IgG for cat allergens in patients with allergic conjunctivitis	INTERNATIONAL OPHTHALMOLOGY			English	Article							TOTAL TEAR IGE; IMMUNOGLOBULIN-E; SERUM IGE; OCULAR ALLERGY; SENSITIZATION; EXPOSURE; IMMUNOCHROMATOGRAPHY; REACTIVITY; ANTIBODIES; RESPONSES	Immunoglobulin G (IgG) antibodies are involved in type II and type III hypersensitivity. We evaluated the relation between perennial allergic conjunctivitis and serum levels of specific IgG for cat allergens. A prospective study was conducted in patients with seasonal allergic conjunctivitis (seasonal group, n = 10), patients with perennial allergic conjunctivitis (perennial group, n = 10), and healthy control subjects (control group, n = 10). Serum levels of specific IgE and IgG for cat allergens and total tear IgE were measured, and a skin prick test was also performed. In addition, a severity score associated with allergic conjunctivitis was calculated (0-30). The positive rates and scores of for total tear IgE, serum cat-specific IgE, and serum cat-specific IgG were all higher in the seasonal and perennial groups than in the control group (all p < 0.05). Serum cat-specific IgG levels were higher in the perennial group than in the seasonal group (p = 0.0156), but there was no significant difference in the grade of cat-specific IgE between the two groups (p = 0.3008). On multivariate analysis, the mean wheal diameter for cat allergen was associated with the serum level of cat-specific IgG (not IgE) in all patients [odds ratio (OR) = 31.979, p < 0.0001]. Multivariate analysis revealed that the total objective score was strongly associated with serum cat-specific IgG (OR = 23.015, p < 0.0001). These findings suggest that specific IgG antibodies may be involved in perennial allergic symptoms caused by indoor allergens such as cat allergens.	[Miyama, Anri; Mimura, Tatsuya; Goto, Mari; Kamei, Yuko; Kondo, Aki; Saito, Yusuke; Okuma, Hiroko; Matsubara, Masao] Tokyo Womens Med Univ, Dept Ophthalmol, Med Ctr East, Arakawa Ku, Tokyo 1168567, Japan; [Noma, Hidetaka] Tokyo Med Univ, Hachioji Med Ctr, Dept Ophthalmol, Tokyo 1608402, Japan	Mimura, T (reprint author), Tokyo Womens Med Univ, Dept Ophthalmol, Med Ctr East, Arakawa Ku, 2-1-10 Nishiogu, Tokyo 1168567, Japan.	mimurat-tky@umin.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan; Health Labour Sciences Research Grant from The Ministry of Health Labour and Welfare of Japan	This work was supported in part by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan and Health Labour Sciences Research Grant from The Ministry of Health Labour and Welfare of Japan.	Aburuz S., 2011, Eastern Mediterranean Health Journal, V17, P604; Almqvist C, 1999, J ALLERGY CLIN IMMUN, V103, P1012, DOI 10.1016/S0091-6749(99)70172-7; Leonardi A, 2012, ALLERGY, V67, P1327, DOI 10.1111/all.12009; Zuo XL, 2007, CLIN EXP ALLERGY, V37, P823, DOI 10.1111/j.1365-2222.2007.02727.x; Almqvist C, 2003, CLIN EXP ALLERGY, V33, P1190, DOI 10.1046/j.1365-2222.2003.01764.x; Custovic A, 2011, J ALLERGY CLIN IMMUN, V127, P1480, DOI 10.1016/j.jaci.2011.03.014; Mimura T, 2013, CURR EYE RES, V38, P917, DOI 10.3109/02713683.2013.794248; Uchio E, 2008, GRAEF ARCH CLIN EXP, V246, P291, DOI 10.1007/s00417-007-0697-z; Inada Noriko, 2009, Allergology International, V58, P585, DOI 10.2332/allergolint.09-OA-0101; CUSTOVIC A, 1994, CLIN EXP ALLERGY, V24, P1164; Mimura T, 2012, CURR EYE RES, V37, P864, DOI 10.3109/02713683.2012.689069; Svanes C, 2003, J ALLERGY CLIN IMMUN, V112, P289, DOI 10.1067/mai.2003.1596; Gould HJ, 2003, ANNU REV IMMUNOL, V21, P579, DOI 10.1146/annurev.immunol.21.120601.141103; Ben Ezra D, 1994, OCUL IMMUNOL INFLA S, V2, P17; Bethlehem S, 2012, VET IMMUNOL IMMUNOP, V145, P582, DOI 10.1016/j.vetimm.2012.01.003; Bollinger ME, 1996, J ALLERGY CLIN IMMUN, V97, P907, DOI 10.1016/S0091-6749(96)80064-9; DAmato G, 1997, J ALLERGY CLIN IMMUN, V99, P577, DOI 10.1016/S0091-6749(97)70088-5; ENBERG RN, 1993, ANN ALLERGY, V70, P471; Fernandez C, 2007, CLIN EXP ALLERGY, V37, P391, DOI 10.1111/j.1365-2222.2007.02659.x; Heissenhuber A, 2003, ALLERGY, V58, P154, DOI 10.1034/j.1398-9995.2003.00037.x; Hodsdon W, 2010, NATURAL MED J, V2, P8; Japanese Ocular Allergology Study Group, 2006, NIPPON GANKA GAKKAI, V110, P103; Liccardi G, 2003, INT ARCH ALLERGY IMM, V132, P1, DOI 10.1159/000073259; Liccardi G, 2005, RESP MED, V99, P535, DOI 10.1016/j.rmed.2004.09.018; Mimura FT, 2010, J INVEST ALLERG CLIN, V20, P627; Mimura T, 2011, INT ARCH ALLERGY IMM, V156, P381, DOI 10.1159/000323908; Mimura T, 2004, OCUL IMMUNOL INFLAMM, V12, P45, DOI 10.1076/ocii.12.1.45.28067; Mimura T, 2013, CORNEA, V32, P14, DOI 10.1097/ICO.0b013e318253214b; Mimura T, 2011, INT ARCH ALLERGY IMM, V154, P349, DOI 10.1159/000321828; Mimura T, J INVESTIG IN PRESS; Mimura T, 2011, CORNEA, V30, P790, DOI 10.1097/ICO.0b013e3182000feb; Mimura T, 2005, EYE, V19, P995, DOI 10.1038/sj.eye.6701701; Mimura T, 2010, J ASTHMA, V47, P1153, DOI 10.3109/02770903.2010.527025; Monzon S, 2009, J ALLERGY CAIRO, V2009, P1, DOI DOI 10.1155/2009/518903; Ohashi Y, 2010, J OCUL PHARMACOL TH, V26, P165, DOI 10.1089/jop.2009.0087; Partti-Pellinen K, 2000, ALLERGY, V55, P65, DOI 10.1034/j.1398-9995.2000.00226.x; Patchett K, 1997, J ALLERGY CLIN IMMUN, V100, P755, DOI 10.1016/S0091-6749(97)70269-0; Ritz BR, 2002, ALLERGY, V57, P357, DOI 10.1034/j.1398-9995.2002.1s3404.x; Suen RM, 2003, CLIN RELEVANCE IGG F, P1; Sverremark-Ekstrom E, 2012, PEDIAT ALLERG IMM-UK, V23, P224, DOI 10.1111/j.1399-3038.2012.01290.x; Volpi N, 2009, J IMMUNOASS IMMUNOCH, V30, P51, DOI 10.1080/15321810802571903; Warm K, 2013, ALLERGY ASTHMA CL IM, V9, DOI 10.1186/1710-1492-9-20; Yuen Anthony P. W., 2007, Hong Kong Medical Journal, V13, P131; Zimmer A, 2011, VET IMMUNOL IMMUNOP, V144, P442, DOI 10.1016/j.vetimm.2011.09.001	44	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0165-5701	1573-2630		INT OPHTHALMOL	Int. Ophthalmol.	AUG	2015	35	4					575	586		10.1007/s10792-014-9987-8		12	Ophthalmology	Ophthalmology	CL9HI	WOS:000357287700018		
J	Ohashi, A; Elsayed, AA; Yasuma, T; Iijima, T; Nakamura, S				Ohashi, Akiko; Elsayed, Ahmed Ali; Yasuma, Tetsushi; Iijima, Takahiko; Nakamura, Shigeo			Conjunctival mucoepithelial hyperplasia of the elderly	INTERNATIONAL OPHTHALMOLOGY			English	Article							GOBLET-CELL HYPERPLASIA; SQUAMOUS METAPLASIA; EPITHELIUM	The ocular surface is exposed to many chronic inflammatory stimuli, and goblet cell hyperplasia of the conjunctiva occurs in many situations. We report two cases of epithelial goblet cell hyperplasia with nonspecific chronic inflammation which occurred on the internal canthus of elderly people. These cases shared the same clinicopathological features that mimicked neoplastic lesion macroscopically, but are composed of nonspecific inflammatory changes pathologically. Immunostaining of the tissue showed few IgG4+ plasma cells, and no neoplastic changes were observed. Both cases arose in elderly patients over the age of 80 years. Pathogenesis and clinical significance of the lesion is unclear, but it might be age related. Recognition of this diagnosis might help us avoid overdiagnosis of malignancy and to reach the correct diagnosis.	[Ohashi, Akiko; Elsayed, Ahmed Ali; Nakamura, Shigeo] Nagoya Univ, Grad Sch Med, Dept Pathol, Showa Ku, Nagoya, Aichi 4668550, Japan; [Yasuma, Tetsushi] Yasuma Eye Clin, Nagoya, Aichi, Japan; [Iijima, Takahiko] Takamori Eye Clin, Nagano, Japan	Ohashi, A (reprint author), Nagoya Univ, Grad Sch Med, Dept Pathol, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.	akikooha@yahoo.co.jp	OHASHI, Akiko/E-4412-2015				ABDELKHALEK LMR, 1978, BRIT J OPHTHALMOL, V62, P792, DOI 10.1136/bjo.62.11.792; De Paiva CS, 2007, INVEST OPHTH VIS SCI, V48, P2553, DOI 10.1167/iovs.07-0069; Murube J, 2003, EUR J OPHTHALMOL, V13, P246; Novaes P, 2007, ENVIRON HEALTH PERSP, V115, P1753, DOI 10.1289/ehp.10363; ROAT MI, 1993, AM J OPHTHALMOL, V116, P456; Doughty MJ, 2012, OCUL SURF, V10, P149, DOI 10.1016/j.jtos.2012.05.001; Fletcher Christopher DM, 2013, DIAGNOSTIC HISTOPATH, V4, P2093; Geneva II, 2013, JAMA OPHTHALMOL, V131, P249, DOI 10.1001/jamaophthalmol.2013.578; Ito T, 1991, SOSHIKIGAKU, V6th, P319; Levy J, 2009, EYE, V23, P1004, DOI 10.1038/eye.2008.316; Margo CE, 2001, OPHTHALMOLOGY, V108, P135, DOI 10.1016/S0161-6420(00)00501-7; Okisaka S, 1992, GANBYOURI ATLAS ATLA, P9; Rosai J, 2011, ROSAI ACKERMANS SURG, V10th, P2483; WHALEY K, 1972, Age and Ageing, V1, P197, DOI 10.1093/ageing/1.4.197; Zhu WQ, 2010, BRIT J OPHTHALMOL, V94, P1448, DOI 10.1136/bjo.2008.155820	15	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0165-5701	1573-2630		INT OPHTHALMOL	Int. Ophthalmol.	AUG	2015	35	4					611	614		10.1007/s10792-015-0083-5		4	Ophthalmology	Ophthalmology	CL9HI	WOS:000357287700024		
J	Mao, WW; Aoyama, S; Goto, S; Towhata, I				Mao, Wuwei; Aoyama, Shogo; Goto, Shigeru; Towhata, Ikuo			Acoustic emission characteristics of subsoil subjected to vertical pile loading in sand	JOURNAL OF APPLIED GEOPHYSICS			English	Article						Acoustic emission; Pile; Sand; Subsoil; Yielding	BEARING CAPACITY; DRIVEN PILES; SOILS; INSTALLATION; DISPLACEMENT; SHEARING; DESIGN; SYSTEM	The response of the subsoil subjected to pile loading is crucial to clarify the bearing mechanism of pile foundations. This study presents a novel acoustic emission (AE) method to monitor the subsoil behavior in a model pile testing system. The AE testing aims to capture the "micro-noises" released from sand grain dislocation and crushing around the pile shaft during penetration. The correlations between the pile settlement and the AE characteristics including count, amplitude and energy are revealed and discussed, highlighting that the ground density and the shear zone formed during pile penetration mainly affect the AE behavior. The results also suggest that the yielding of ground can be determined based on the development of the AE activity. The technique shows promise as an in-situ methodology for monitoring of subsoil behavior during the process of pile loading. (C) 2015 Elsevier B.V. All rights reserved.	[Mao, Wuwei; Aoyama, Shogo; Goto, Shigeru; Towhata, Ikuo] Univ Tokyo, Dept Civil Engn, Tokyo 1138656, Japan	Mao, WW (reprint author), Univ Tokyo, Dept Civil Engn, Tokyo 1138656, Japan.	maowuwei@geot.t.u-tokyo.ac.jp			Japanese Ministry of Education, Culture, Sports, Science & Technology (MEXT) [123113]	The financial assistance provided by Japanese Ministry of Education, Culture, Sports, Science & Technology (MEXT, Grant No. 123113) for PhD studies of the first author is gratefully acknowledged. The authors are grateful to the advice and expertise provided by Professor Junichi Koseki, Professor Reiko Kuwano and Associate Professor Taro Uchimura of the University of Tokyo. We also thank Dr. Sadao Yabuuchi, President of Japan Pile Corporation for his invaluable support.	Yang ZX, 2010, GEOTECHNIQUE, V60, P469, DOI 10.1680/geot.2010.60.6.469; Dagois-Bohy S, 2010, ULTRASONICS, V50, P127, DOI 10.1016/j.ultras.2009.09.027; Jardine RJ, 2013, GEOTECHNIQUE, V63, P1, DOI 10.1680/geot.9.P.137; [Anonymous], 1992, ASM HDB, V17, P593; RANDOLPH MF, 1994, GEOTECHNIQUE, V44, P427; Dixon N, 2003, P I CIVIL ENG-GEOTEC, V156, P83; Randolph MF, 2003, GEOTECHNIQUE, V53, P847, DOI 10.1680/geot.53.10.847.37518; White DJ, 2004, GEOTECHNIQUE, V54, P375, DOI 10.1680/geot.2004.54.6.375; Ohtsu M, 2001, CONSTR BUILD MATER, V15, P217, DOI 10.1016/S0950-0618(00)00071-4; Zhang LY, 2012, CAN GEOTECH J, V49, P394, DOI 10.1139/T2012-005; Jomdecha C, 2007, NDT&E INT, V40, P584, DOI 10.1016/j.ndteint.2007.05.003; Michlmayr G, 2014, GRANUL MATTER, V16, P627, DOI 10.1007/s10035-014-0516-2; Burlon S, 2014, GEOTECHNIQUE, V64, P513, DOI 10.1680/geot.13.P.061; Ekisar T., 2012, GEOTEXT GEOMEMBR, V32, P44; Foray P, 1998, CAN GEOTECH J, V35, P374, DOI 10.1139/cgj-35-2-374; Hung MH, 2009, J GEOTECH GEOENVIRON, V135, P566, DOI 10.1061/(ASCE)1090-0241(2009)135:4(566); Koemer R.M., 1974, J ACOUST SOC AM, V56, P1924, DOI 10.1121/1.1903538; Koerner R.M., 1981, ASTM STP, V750, P93; Kurlenya MV, 1997, J MIN SCI+, V33, P88, DOI 10.1007/BF02765435; Kuwajima K, 2009, J GEOTECH GEOENVIRON, V135, P901, DOI 10.1061/(ASCE)GT.1943-5606.0000057; Labuz JF, 2001, CONSTR BUILD MATER, V15, P225, DOI 10.1016/S0950-0618(00)00072-6; LORD AE, 1975, J ACOUST SOC AM, V57, P516, DOI 10.1121/1.2033173; Lu ZQ, 2012, SOIL SCI SOC AM J, V76, P853, DOI 10.2136/sssaj2011.0308; Mao WW, 2015, APPL ACOUST, V94, P39, DOI 10.1016/j.apacoust.2015.02.007; Poulos H. G., 1980, PILE FDN ANAL DESIGN; SWINDLEH.W, 1973, NON-DESTRUCT TEST, V6, P152, DOI 10.1016/0029-1021(73)90017-0; Takano T, 2013, J APPL GEOPHYS, V94, P1, DOI 10.1016/j.jappgeo.2013.03.016; Tanimoto K, 1986, SOILS FOUND, V26, P69; Yang ZX, 2014, J GEOTECH GEOENVIRON, V140, DOI 10.1061/(ASCE)GT.1943-5606.0001022; Yasufuku N, 1995, GEOTECHNIQUE, V45, P663; Zhang C, 2014, GEOTECH LETT, V4, P11, DOI 10.1680/geolett.13.00075	31	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0926-9851	1879-1859		J APPL GEOPHYS	J. Appl. Geophys.	AUG	2015	119						119	127		10.1016/j.jappgeo.2015.05.017		9	Geosciences, Multidisciplinary; Mining & Mineral Processing	Geology; Mining & Mineral Processing	CL8LN	WOS:000357226300012		
J	Tomizawa, M; Shinozaki, F; Motoyoshi, Y; Sugiyama, T; Yamamoto, S; Ishige, N				Tomizawa, Minoru; Shinozaki, Fuminobu; Motoyoshi, Yasufumi; Sugiyama, Takao; Yamamoto, Shigenori; Ishige, Naoki			An Optimal Medium Supplementation Regimen for Initiation of Hepatocyte Differentiation in Human Induced Pluripotent Stem Cells	JOURNAL OF CELLULAR BIOCHEMISTRY			English	Article						apoptosis inhibitor; oncostatin M; real-time quantitative PCR	ONCOSTATIN-M; AMINO-ACID; GROWTH; FIBROBLASTS; INDUCTION; ARGININE; PYRUVATE; LIVER	Human induced pluripotent stem (hiPS) cells are an ideal source for hepatocytes. Glucose and arginine are necessary for cells to survive. Hepatocytes have galactokinase (GALK), which metabolizes galactose for gluconeogenesis, and ornithine transcarbamylase (OTC), which converts ornithine to arginine in the urea cycle. Hepatocyte selection medium (HSM) lacks both glucose and arginine, but contains galactose and ornithine. Although human primary hepatocytes survive in HSM, all the hiPS cells die in 3 days. The aim of this study was to modify HSM so as to initiate hepatocyte differentiation in hiPS cells within 2 days. Hepatocyte differentiation initiating medium (HDI) was prepared by adding oncostatin M (10ng/ml), hepatocyte functional proliferation inducer (10nM), 2,2'-methylenebis (1,3-cyclohexanedione) (M50054) (100g/ml), 1x non-essential amino acid, 1x sodium pyruvate, nicotinamide (1.2mg/ml), L-proline (30ng/ml), and L-glutamine (0.3mg/ml) to HSM. HiPS cells (201B7 cells) were cultured in HDI for 2 days. RNA was isolated, used as template for cDNA, and subjected to real-time quantitative polymerase chain reaction. Alpha-fetoprotein, -glutamyl transpeptidase, and delta-like 1 were upregulated. Expression of albumin was not observed. Expression of transcription factors specific to hepatocytes was upregulated. The expression of GALK2, OTC, and CYP3A4 were increased. In conclusion, differentiation of 201B7 cells to hepatoblast-like cells was initiated in HDI. Limitations were small number of cells were obtained, and the cells with HDI were not mature hepatocytes. J. Cell. Biochem. 116: 1479-1489, 2015. (c) 2015 Wiley Periodicals, Inc.	[Tomizawa, Minoru] Shimoshizu Hosp, Dept Gastroenterol, Natl Hosp Org, Yotsukaido City, Chiba 2840003, Japan; [Shinozaki, Fuminobu] Shimoshizu Hosp, Dept Radiol, Natl Hosp Org, Yotsukaido City, Chiba 2840003, Japan; [Motoyoshi, Yasufumi] Shimoshizu Hosp, Dept Neurol, Natl Hosp Org, Yotsukaido City, Chiba 2840003, Japan; [Sugiyama, Takao] Shimoshizu Hosp, Dept Rheumatol, Natl Hosp Org, Yotsukaido City, Chiba 2840003, Japan; [Yamamoto, Shigenori] Shimoshizu Hosp, Dept Pediat, Natl Hosp Org, Yotsukaido City, Chiba 2840003, Japan; [Ishige, Naoki] Shimoshizu Hosp, Dept Neurosurg, Natl Hosp Org, Yotsukaido City, Chiba 2840003, Japan	Tomizawa, M (reprint author), Shimoshizu Hosp, Dept Gastroenterol, Natl Hosp Org, 934-5 Shikawatashi, Yotsukaido City, Chiba 2840003, Japan.	nihminor-cib@umin.ac.jp					AI YJ, 1995, GENOME RES, V5, P53, DOI 10.1101/gr.5.1.53; Inamura M, 2011, MOL THER, V19, P400, DOI 10.1038/mt.2010.241; Wheatley DN, 2000, CELL PHYSIOL BIOCHEM, V10, P37, DOI 10.1159/000016333; Takebe T, 2013, NATURE, V499, P481, DOI 10.1038/nature12271; Shan J, 2013, NAT CHEM BIOL, V9, P514, DOI 10.1038/nchembio.1270; Strom SC, 1999, SEMIN LIVER DIS, V19, P39, DOI 10.1055/s-2007-1007096; Abe K, 1996, EXP CELL RES, V229, P27, DOI 10.1006/excr.1996.0340; Tanaka M, 2009, MECH DEVELOP, V126, P665, DOI 10.1016/j.mod.2009.06.939; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Ogawa K, 2004, GENES CELLS, V9, P471, DOI 10.1111/j.1365-9597.2004.00736.x; NAKAMURA T, 1984, BIOCHEM BIOPH RES CO, V122, P884, DOI 10.1016/0006-291X(84)91173-2; Sugawara K, 2012, J GASTROENTEROL, V47, P849, DOI 10.1007/s00535-012-0624-x; Si-Tayeb K, 2010, HEPATOLOGY, V51, P297, DOI 10.1002/hep.23354; Caffarel MM, 2014, J PATHOL, V232, P386, DOI 10.1002/path.4305; Kamiya A, 2002, HEPATOLOGY, V35, P1351, DOI 10.1053/jhep.2002.33331; Tomizawa M, 1998, BIOCHEM BIOPH RES CO, V249, P1, DOI 10.1006/bbrc.1998.8999; Fabrega E, 2013, INT J HEPATOL, V2013, DOI DOI 10.1155/2013/928960]; Fisher RA, 2004, CELL TRANSPLANT, V13, P677, DOI 10.3727/000000004783983576; LEFFERT HL, 1972, J CELL BIOL, V52, P559, DOI 10.1083/jcb.52.3.559; MATSUMOTO K, 1994, NEUROL RES, V16, P460; MITAKA T, 1991, HEPATOLOGY, V13, P21, DOI 10.1016/0270-9139(91)90211-D; Ohira RH, 2005, BIOCHEM BIOPH RES CO, V331, P239, DOI 10.1016/j.bbrc.2005.03.143; Tateno C, 2010, J HISTOCHEM CYTOCHEM, V58, P61, DOI 10.1369/jhc.2009.954560; Tomizawa M, 2013, BIOMED REP, V1, P18, DOI DOI 10.3892/BR.2012.2; Tomizawa M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071897; Tomizawa M, 2014, BIOMED REP, V2, P799; Tomizawa M, 2008, CELL TISSUE RES, V333, P17, DOI 10.1007/s00441-008-0618-4; Tsuda T, 2001, EUR J PHARMACOL, V433, P37, DOI 10.1016/S0014-2999(01)01489-3	29	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0730-2312	1097-4644		J CELL BIOCHEM	J. Cell. Biochem.	AUG	2015	116	8					1479	1489		10.1002/jcb.25139		11	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	CK8YI	WOS:000356525800001		
J	Asai, M; McAleer, M				Asai, Manabu; McAleer, Michael			Leverage and feedback effects on multifactor Wishart stochastic volatility for option pricing	JOURNAL OF ECONOMETRICS			English	Article						Multivariate stochastic volatility; Wishart process; Leverage effects; Feedback effects; Multifactor model; Option pricing	ASYMPTOTIC FILTERING THEORY; ARCH MODELS; MICROSTRUCTURE NOISE; CURRENCY OPTIONS; ASSET RETURNS; MATRIX; HETEROSKEDASTICITY; DIFFUSIONS; VARIANCE	The paper proposes a general asymmetric multifactor Wishart stochastic volatility (AMWSV) diffusion process which accommodates leverage, feedback effects and multifactor for the covariance process. The paper gives the closed-form solution for the conditional and unconditional Laplace transform of the AMWSV models. The paper also suggests estimating the AMWSV model by the generalized method of moments using information not only of stock prices but also of realized volatilities and co-volatilities. The empirical results for the bivariate AMWSV model is preferred among several nested models. (C) 2015 Elsevier B.V. All rights reserved.	[Asai, Manabu] Soka Univ, Fac Econ, Hachioji, Tokyo 1928577, Japan; [McAleer, Michael] Natl Tsing Hua Univ, Dept Quantitat Finance, Hsinchu, Taiwan; [McAleer, Michael] Erasmus Univ, Erasmus Sch Econ, Inst Econometr, Rotterdam, Netherlands; [McAleer, Michael] Tinbergen Inst, Tinbergen, Netherlands; [McAleer, Michael] Univ Complutense Madrid, Dept Quantitat Econ, E-28040 Madrid, Spain	Asai, M (reprint author), Soka Univ, Fac Econ, 1-236 Tangi Cho, Hachioji, Tokyo 1928577, Japan.	m-asai@soka.ac.jp			Japan Ministry of Education, Culture, Sports, Science and Technology; Japan Society for the Promotion of Science; Australian Academy of Science; Australian Research Council and National Science Council, Taiwan	The authors are most grateful to Yoshi Baba, Christian Hafner, Karen Lewis and two anonymous reviewers for very helpful comments and suggestions. The first author acknowledges the financial support of the Japan Ministry of Education, Culture, Sports, Science and Technology, Japan Society for the Promotion of Science, and Australian Academy of Science. The second author is most grateful for the financial support of the Australian Research Council and National Science Council, Taiwan.	Muhle-Karbe J, 2012, SIAM J FINANC MATH, V3, P66, DOI 10.1137/100803687; Nelson DB, 1996, J ECONOMETRICS, V71, P1, DOI 10.1016/0304-4076(94)01679-8; Chiu TYM, 1996, J AM STAT ASSOC, V91, P198, DOI 10.2307/2291396; Koopman SJ, 2002, J APPL ECONOM, V17, P667, DOI 10.1002/jae.652; Chernov M, 2003, J ECONOMETRICS, V116, P225, DOI 10.1016/S0304-4076(03)00108-8; McAleer M, 2005, ECONOMET THEOR, V21, P232, DOI 10.1017/S0266466605050140; Voev V, 2007, J FINANC ECONOMET, V5, P68, DOI 10.1093/jjfinec/nbl011; NEWEY WK, 1987, ECONOMETRICA, V55, P703, DOI 10.2307/1913610; NELSON DB, 1994, ECONOMETRICA, V62, P1, DOI 10.2307/2951474; Gourieroux C, 2006, ECONOMET REV, V25, P177, DOI 10.1080/07474930600713234; Tao MJ, 2011, J AM STAT ASSOC, V106, P1025, DOI 10.1198/jasa.2011.tm10276; Gourieroux C, 2010, J BUS ECON STAT, V28, P438, DOI 10.1198/jbes.2009.08105; Malliavin P, 2002, FINANC STOCH, V6, P49, DOI 10.1007/s780-002-8400-6; MELINO A, 1990, J ECONOMETRICS, V45, P239, DOI 10.1016/0304-4076(90)90100-8; HESTON SL, 1993, REV FINANC STUD, V6, P327, DOI 10.1093/rfs/6.2.327; Zhang L, 2011, J ECONOMETRICS, V160, P33, DOI 10.1016/j.jeconom.2010.03.012; Wang YZ, 2010, ANN STAT, V38, P943, DOI 10.1214/09-AOS730; Drost FC, 1996, J ECONOMETRICS, V74, P31, DOI 10.1016/0304-4076(95)01750-X; Harvey AC, 1996, J BUS ECON STAT, V14, P429, DOI 10.2307/1392251; Griffin JE, 2011, J ECONOMETRICS, V160, P58, DOI 10.1016/j.jeconom.2010.03.015; Chib S., 2009, HDB FINANCIAL TIME S, P365, DOI 10.1007/978-3-540-71297-8_16; CHRISTIE AA, 1982, J FINANC ECON, V10, P407, DOI 10.1016/0304-405X(82)90018-6; COX JC, 1985, ECONOMETRICA, V53, P385, DOI 10.2307/1911242; Duan J., 1995, MATH FINANC, V5, P13, DOI 10.1111/j.1467-9965.1995.tb00099.x; Duffie D, 2000, ECONOMETRICA, V68, P1343, DOI 10.1111/1468-0262.00164; Eberlein E., 2010, APPL MATH FINANCE, V17, P211; Engle R., 1987, ECONOMETRICA, V5, P391, DOI DOI 10.2307/1913242; Engle R.F., 1999, COINTEGRATION CAUSAL, P475; Fonseca J., 2008, QUANTITATIVE FINANCE, V8, P591; Fornari A., 1997, J APPL ECONOMET, V12, P49; Gallant AR, 1999, REV ECON STAT, V81, P617, DOI 10.1162/003465399558481; Ghysels E., 1996, HDB STAT STAT METHOD, V14; Glosten L., 1992, J FINANC, V46, P1779; HANSEN LP, 1982, ECONOMETRICA, V50, P1029, DOI 10.2307/1912775; NELSON DB, 1990, J ECONOMETRICS, V45, P7, DOI 10.1016/0304-4076(90)90092-8; NELSON DB, 1991, ECONOMETRICA, V59, P347, DOI 10.2307/2938260; SCOTT LO, 1987, J FINANC QUANT ANAL, V22, P419, DOI 10.2307/2330793; Shoji I, 1998, BIOMETRIKA, V85, P240, DOI 10.1093/biomet/85.1.240; Silvennoinen A., 2009, HDB FINANCIAL TIME S, P201, DOI 10.1007/978-3-540-71297-8_9; HULL J, 1987, J FINANC, V42, P281	40	1	1	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0304-4076	1872-6895		J ECONOMETRICS	J. Econom.	AUG	2015	187	2					436	446		10.1016/j.jeconom.2015.02.029		11	Economics; Mathematics, Interdisciplinary Applications; Social Sciences, Mathematical Methods	Business & Economics; Mathematics; Mathematical Methods In Social Sciences	CM0DJ	WOS:000357348300004		
J	Hong, JS; Wagata, H; Ohashi, N; Katsumata, K; Okada, K; Matsushita, N				Hong, Jeong Soo; Wagata, Hajime; Ohashi, Naoki; Katsumata, Ken-ichi; Okada, Kiyoshi; Matsushita, Nobuhiro			Transparent ZnO Films Deposited by Aqueous Solution Process Under Various pH Conditions	JOURNAL OF ELECTRONIC MATERIALS			English	Article						ZnO; solution; pH; spin-spray	CHEMICAL BATH DEPOSITION; THIN-FILMS; SPRAY-PYROLYSIS; PHYSICAL-PROPERTIES; OPTICAL-CONSTANTS; LIGHT-SCATTERING; GLASS SUBSTRATE; ENVELOPE METHOD; SOLAR-CELLS; FABRICATION	ZnO films were deposited using a spin-spray method with the source solution containing zinc nitrate and an oxidizing solution containing trisodium citrate onto glass substrates under various pH conditions. A ZnO film with a columnar structure was obtained at pH higher than 7.0, while no ZnO film was formed at a mixed solution pH of 6.7. The transparent and conductive ZnO film obtained from a mixed solution with pH 10.7 exhibited the lowest resistivity of 9.9 x 10(-3) Omega cm with a high transmittance above 90%.	[Hong, Jeong Soo; Katsumata, Ken-ichi; Okada, Kiyoshi; Matsushita, Nobuhiro] Tokyo Inst Technol, Mat & Struct Lab, Tokyo 152, Japan; [Wagata, Hajime] Shinshu Univ, Dept Environm Sci & Technol, Matsumoto, Nagano 390, Japan; [Ohashi, Naoki] Natl Inst Mat Sci, Tsukuba, Ibaraki, Japan	Matsushita, N (reprint author), Tokyo Inst Technol, Mat & Struct Lab, Tokyo 152, Japan.	matsushita.n.ab@m.titech.ac.jp					Agouram S, 2007, APPL PHYS A-MATER, V88, P83, DOI 10.1007/S00339-007-3970-4; Amin G, 2011, J NANOMATER, DOI 10.1155/2011/269692; Zheng YZ, 2010, CHEM MATER, V22, P928, DOI 10.1021/cm901780z; SERNELIUS BE, 1988, PHYS REV B, V37, P10244, DOI 10.1103/PhysRevB.37.10244; Caglar M, 2006, J OPTOELECTRON ADV M, V8, P1410; Ilican S, 2008, J OPTOELECTRON ADV M, V10, P2578; Wagata H, 2012, J MATER CHEM, V22, P20706, DOI 10.1039/c2jm33584k; Ivanova T, 2010, MATER LETT, V64, P1147, DOI 10.1016/j.matlet.2010.02.033; Wang HH, 2006, J CRYST GROWTH, V291, P187, DOI 10.1016/j.jcrysgro.2006.02.043; Liu YL, 2013, J NANOMATER, DOI 10.1155/2013/196521; Hong JS, 2011, MOL CRYST LIQ CRYST, V538, P103, DOI 10.1080/15421406.2011.563666; Krc J, 2003, THIN SOLID FILMS, V426, P296, DOI 10.1016/S0040-6090(03)00006-3; Rao TP, 2010, PHYSICA B, V405, P2226, DOI 10.1016/j.physb.2010.02.016; Ashour A, 2006, APPL SURF SCI, V252, P7844, DOI 10.1016/j.apsusc.2005.09.048; Qamar M, 2009, DESALINATION, V249, P535, DOI 10.1016/j.desal.2009.01.022; Ilican S, 2007, MATER SCI-POLAND, V25, P709; Li SZ, 2007, MATER LETT, V61, P30, DOI 10.1016/j.matlet.2006.03.145; Timoshevskii V, 2008, J APPL PHYS, V103, DOI 10.1063/1.2937188; Rao TP, 2009, APPL SURF SCI, V255, P7212, DOI 10.1016/j.apsusc.2009.03.065; Prepelita P, 2010, APPL SURF SCI, V256, P1807, DOI 10.1016/j.apsusc.2009.10.011; Zaier A, 2009, MAT SCI SEMICON PROC, V12, P207, DOI 10.1016/j.mssp.2009.12.002; Ashida A, 2008, THIN SOLID FILMS, V517, P1461, DOI 10.1016/j.tsf.2008.09.006; Baruah S, 2009, SCI TECHNOL ADV MAT, V10, DOI 10.1088/1468-6996/10/1/013001; DAVIS EA, 1970, PHILOS MAG, V22, P903, DOI 10.1080/14786437008221061; Dodd AC, 2006, J NANOPART RES, V8, P43, DOI 10.1007/s11051-005-5131-z; Hong J, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.110108; Lehraki N, 2012, CURR APPL PHYS, V12, P1283, DOI 10.1016/j.cap.2012.03.012; Postels B, 2008, APPL PHYS A-MATER, V91, P595, DOI 10.1007/s00339-008-4487-1; Saeed T, 1995, THIN SOLID FILMS, V271, P35, DOI 10.1016/0040-6090(95)06826-0; Tauc J., 1974, AMORPHOUS LIQUID SEM; Tena-Zaera R, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.3040054; Wagata H, 2010, CRYST GROWTH DES, V10, P4968, DOI 10.1021/cg1010693; Wagata H, 2010, CRYST GROWTH DES, V10, P3502, DOI 10.1021/cg100386c	33	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0361-5235	1543-186X		J ELECTRON MATER	J. Electron. Mater.	AUG	2015	44	8					2657	2662		10.1007/s11664-015-3670-3		6	Engineering, Electrical & Electronic; Materials Science, Multidisciplinary; Physics, Applied	Engineering; Materials Science; Physics	CL5YL	WOS:000357041400015		
J	Funahashi, R; Matsumura, Y; Barbier, T; Takeuchi, T; Suzuki, RO; Katsuyama, S; Yamamoto, A; Takazawa, H; Combe, E				Funahashi, Ryoji; Matsumura, Yoko; Barbier, Tristan; Takeuchi, Tomonari; Suzuki, Ryosuke O.; Katsuyama, Shigeru; Yamamoto, Atsushi; Takazawa, Hiroyuki; Combe, Emmanuel			Durability of Silicide-Based Thermoelectric Modules at High Temperatures in Air	JOURNAL OF ELECTRONIC MATERIALS			English	Article						Thermoelectric generation; silicide; durability; module	LEGS	Thermoelectric modules consisting of n-type Mn2.7Cr0.3Si4Al2 and p-type MnSi1.75 legs have been fabricated by use of composite pastes of Ag with Pt or Pd. For the module prepared by Ni-B plating and with Ag paste, the specific power density reached 370 mW/cm(2) at a heat-source temperature of 873 K. Ni-B plating 5 mu m thick on the surfaces of the silicide legs reduced both the internal resistance and degradation of the power generated by silicide modules at temperatures up to 873 K in air. This is because of oxidation of Al diffusing into the n-type legs and reaching the Ag electrodes on both the hot and cold sides. Ni-B plating can suppress Al diffusion into n-type legs. However, cracking was observed parallel to the contact surface in the middle of the Ni-B plating layer on the p-type legs. It was also found that incorporating Pt or Pd into the Ag paste effectively suppressed degradation of the contact resistance between the silicide legs and the Ag electrodes.	[Funahashi, Ryoji; Matsumura, Yoko; Barbier, Tristan; Takeuchi, Tomonari; Combe, Emmanuel] Natl Inst Adv Ind Sci & Technol, Res Inst Ubiquitous Energy Devices, Ikeda, Osaka 5638577, Japan; [Suzuki, Ryosuke O.] Hokkaido Univ, Div Mat Sci, Fac Engn, Kita Ku, Sapporo, Hokkaido 0608628, Japan; [Katsuyama, Shigeru] Osaka Univ, Grad Sch Engn, Div Mat & Mfg Sci, Suita, Osaka 5650871, Japan; [Yamamoto, Atsushi; Takazawa, Hiroyuki] Natl Inst Adv Ind Sci & Technol, Energy Technol Res Inst, Tsukuba, Ibaraki 3058568, Japan	Funahashi, R (reprint author), Natl Inst Adv Ind Sci & Technol, Res Inst Ubiquitous Energy Devices, Ikeda, Osaka 5638577, Japan.	funahashi-r@aist.go.jp	Funahashi, Ryoji/G-3039-2014	Funahashi, Ryoji/0000-0002-1004-0204			Aoyama I, 2005, JPN J APPL PHYS 1, V44, P4275, DOI 10.1143/JJAP.44.4275; Funahashi R, 2006, J APPL PHYS, V99, DOI 10.1063/1.2180449; Battiston S, 2012, THIN SOLID FILMS, V526, P150, DOI 10.1016/j.tsf.2012.10.114; BOSSELET F, 1993, MAT SCI ENG A-STRUCT, V167, P147, DOI 10.1016/0921-5093(93)90348-I; Fujimura T, 1999, J MATER SCI, V34, P235, DOI 10.1023/A:1004428816391; Funahashi R., 2012, MATER RES SOC S P, V1490, P103; Funahashi R, 2012, J APPL PHYS, V112, DOI 10.1063/1.4755793; Kittl JA, 2008, MATER SCI ENG B-ADV, V154, P144, DOI 10.1016/j.mseb.2008.09.033; Nemoto T, 2013, J ELECTRON MATER, V42, P2192, DOI 10.1007/s11664-013-2569-0; Nemoto T, 2012, J ELECTRON MATER, V41, P1312, DOI 10.1007/s11664-012-1963-3; Urata S, 2007, INT J APPL CERAM TEC, V4, P535	11	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0361-5235	1543-186X		J ELECTRON MATER	J. Electron. Mater.	AUG	2015	44	8					2946	2952		10.1007/s11664-015-3784-7		7	Engineering, Electrical & Electronic; Materials Science, Multidisciplinary; Physics, Applied	Engineering; Materials Science; Physics	CL5YL	WOS:000357041400053		
J	Miwa, S; Kiryu, I; Yuasa, K; Ito, T; Kaneko, T				Miwa, S.; Kiryu, I.; Yuasa, K.; Ito, T.; Kaneko, T.			Pathogenesis of acute and chronic diseases caused by cyprinid herpesvirus-3	JOURNAL OF FISH DISEASES			English	Article						CyHV-3; histopathology; in situ hybridization; koi herpesvirus; osmolality; pathogenesis	SALMON SALMO-SALAR; KOI HERPESVIRUS; COMMON CARP; NECROSIS VIRUS; KHV; INFECTION; JAPAN; DNA; MORPHOGENESIS; ENCEPHALITIS	The pathogenesis of cyprinid herpesvirus-3 (CyHV-3) was studied using different lineages of carp/koi. After exposure to the virus, infected cells were first found in the skin by histopathology and by in situ hybridization. The epidermis of the skin was most severely damaged and often sloughed off in the fish sampled on days 5 through 8, and the fish that were highly sensitive to the virus died within 8 or 10days after infection. Serum osmolality of the infected fish, particularly just before death, was significantly lower, suggesting that the osmotic shock consequent on the damage to the skin was the direct cause of the acute deaths. On the other hand, clinical and histopathological observations indicate that the carp of a less sensitive lineage most probably died of viral encephalitis around 3weeks after infection. For these fish, the largest number of infected cells was found in the central nervous system (CNS) sampled on day 12. A substantial amount of viral genome was found in the CNS of carp surviving more than 1year after the infection. Thus, the CNS is probably a major target for CyHV-3, and the virus can persistently infect the CNS, presumably establishing latency.	[Miwa, S.; Kiryu, I.; Yuasa, K.] Fisheries Res Agcy, Natl Res Inst Aquaculture, Minamiise, Mie, Japan; [Ito, T.] Fisheries Res Agcy, Natl Res Inst Aquaculture, Inland Stn, Tamaki, Mie, Japan; [Kaneko, T.] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Aquat Biosci, Tokyo, Japan	Miwa, S (reprint author), Natl Res Inst Aquaculture, Nakatsuhamaura 422-1, Minamiise, Mie 5160193, Japan.	miwasat@affrc.go.jp			Ministry of Agriculture, Forestry and Fisheries, Japan	CCB cells were kindly provided by Dr. O. Haenen of CIDC-Lelystad, the Netherlands, with permission of Dr Neukirch. This study was supported by the Ministry of Agriculture, Forestry and Fisheries, Japan.	Adamek M, 2013, VET MICROBIOL, V162, P456, DOI 10.1016/j.vetmic.2012.10.033; Hedrick RP, 2000, J AQUAT ANIM HEALTH, V12, P44, DOI 10.1577/1548-8667(2000)012<0044:AHAWMM>2.0.CO;2; Miwa S, 2011, J FISH DIS, V34, P901, DOI 10.1111/j.1365-2761.2011.01312.x; Sano M, 2004, FISH PATHOL, V39, P165; Pikarsky E, 2004, J VIROL, V78, P9544, DOI 10.1128/JVI.78.17.9544-9551.2004; Cheng L, 2011, J FISH DIS, V34, P547, DOI 10.1111/j.1365-2761.2011.01266.x; Yuasa K, 2005, FISH PATHOL, V40, P37; Davison AJ, 2009, ARCH VIROL, V154, P171, DOI 10.1007/s00705-008-0278-4; Mabuchi K, 2008, MOL ECOL, V17, P796, DOI 10.1111/j.1365-294X.2007.03626.x; Miyazaki T, 2008, DIS AQUAT ORGAN, V80, P1, DOI 10.3354/dao01929; Costes B, 2009, J VIROL, V83, P2819, DOI 10.1128/JVI.02305-08; Neukirch M, 1999, BULL EUR ASSN FISH P, V19, P221; BROCKLEBANK JR, 1995, CAN VET J, V36, P631; Eide KE, 2011, J VIROL, V85, P4954, DOI 10.1128/JVI.01384-10; Frasca S, 1998, DIS AQUAT ORGAN, V32, P211, DOI 10.3354/dao032211; Gilad O, 2004, DIS AQUAT ORGAN, V60, P179, DOI 10.3354/dao060179; Gilad O, 2002, DIS AQUAT ORGAN, V48, P101, DOI 10.3354/dao048101; Gray WL, 2002, J FISH DIS, V25, P171, DOI 10.1046/j.1365-2761.2002.00355.x; Gray WL, 1999, J GEN VIROL, V80, P1817; Hibiya T., 1982, ATLAS FISH HISTOLOGY, P74; King A.M.Q., 2011, VIRUS TAXONOMY; Mabuchi K, 2005, J FISH BIOL, V66, P1516, DOI 10.1111/j.0022-1112.2005.00676.x; Michel B, 2010, EMERG INFECT DIS, V16, P1835, DOI 10.3201/eid1612.100593; Miwa S, 2007, J FISH DIS, V30, P715, DOI 10.1111/j.1365-2761.2007.00850.x; Perelberg A, 2003, ISR J AQUACULT-BAMID, V55, P5; Sunarto A., 2005, DIS ASIAN AQUACULTUR, P125; Tang KFJ, 2000, AQUACULTURE, V190, P203, DOI 10.1016/S0044-8486(00)00407-5; Yuasa K, 2012, FISH PATHOL, V47, P97	28	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0140-7775	1365-2761		J FISH DIS	J. Fish Dis.	AUG	2015	38	8					695	712		10.1111/jfd.12282		18	Fisheries; Marine & Freshwater Biology; Veterinary Sciences	Fisheries; Marine & Freshwater Biology; Veterinary Sciences	CL9LZ	WOS:000357301500002		
J	Shibata, A; Nakagawa, K; Tsuduki, T; Miyazawa, T				Shibata, Akira; Nakagawa, Kiyotaka; Tsuduki, Tsuyoshi; Miyazawa, Teruo			delta-Tocotrienol treatment is more effective against hypoxic tumor cells than normoxic cells: potential implications for cancer therapy	JOURNAL OF NUTRITIONAL BIOCHEMISTRY			English	Article						Angiogenesis; Tocotrienol; Tocopherol; Normoxia; Hypoxia	COLORECTAL ADENOCARCINOMA CELLS; HUMAN GASTRIC-CANCER; GAMMA-TOCOTRIENOL; RICH FRACTION; SIGNALING PATHWAY; INDUCED APOPTOSIS; GENE-EXPRESSION; MOUSE MODEL; SUPPRESSION; CYCLE	Tocotrienols, unsaturated forms of vitamin E, inhibit the proliferation of a variety of cancer cells and suppress angiogenesis. However, the mechanisms underlying those effects on cancer cell growth remain unclear especially under hypoxic conditions. In this study, we demonstrated that delta-tocotrienol (delta-T3) could be used as a novel anticancer agent against human colorectal adenocarcinoma (DLD-1) cells under both normoxic and hypoxic conditions. delta-T3 inhibited the growth of DID-1 cells in a dose-dependent fashion by inducing cell cycle arrest and apoptosis. This effect was more potent under hypoxic than normoxic conditions. The anticancer effect of delta-T3 was achieved by its upregulation of cyclin-dependent kinase inhibitors (p21 and p27), the activation of caspases and the suppression of phospholylation of protein kinase B (Akt) at Thr(308) and Ser(473). In in vivo studies, oral administration of rice bran tocotrienol (RBT3, mainly gamma-T3) (10 mg/mouse/day) significantly inhibited tumor growth in nude mice. in tumor analyses, RBT3 activated p21, p27, caspase-3 and caspase-9 and decreased Akt phosphorylation. Furthermore, immunostaining revealed that RBT3 decreased the number of cells positive for CD31/platelet endothelial cell adhesion molecule-1 in microvessels in the tumor. Taken together, these data suggest that tocotrienols are potent antitumor agents capable of inducing apoptosis and inhibiting angiogenesis under both hypoxic and normoxic conditions. Tocotrienols could have significant therapeutic potential in the clinical treatment of tumors. (C) 2015 Elsevier Inc. All rights reserved.	[Shibata, Akira; Nakagawa, Kiyotaka; Miyazawa, Teruo] Tohoku Univ, Grad Sch Agr Sci, Food & Biodynam Chem Lab, Sendai, Miyagi 9818555, Japan; [Tsuduki, Tsuyoshi] Tohoku Univ, Grad Sch Agr Sci, Lab Food & Biomol Sci, Sendai, Miyagi 9818555, Japan	Nakagawa, K (reprint author), Tohoku Univ, Grad Sch Agr Sci, Food & Biodynam Chem Lab, Aoba Ku, 1-1 Tsutsumidori Amamiyamachi, Sendai, Miyagi 9818555, Japan.	nkgw@m.tohoku.ac.jp					Agarwal MK, 2004, CELL CYCLE, V3, P205; Ananthula S, 2014, BIOMED RES INT, DOI 10.1155/2014/285752; Schwartz GK, 2005, J CLIN ONCOL, V23, P9408, DOI 10.1200/JCO.2005.01.5594; Kannappan R, 2010, MOL CANCER THER, V9, P2196, DOI 10.1158/1535-7163.MCT-10-0277; Iqbal J, 2003, EUR J CANCER PREV, V12, P447, DOI 10.1097/00008469-200312000-00002; Bi S, 2010, TOXICOLOGY, V274, P27, DOI 10.1016/j.tox.2010.05.002; Eitsuka T, 2006, BIOCHEM BIOPH RES CO, V348, P170, DOI 10.1016/j.bbrc.2006.07.029; Shibata A, 2009, J AGR FOOD CHEM, V57, P8696, DOI 10.1021/jf9012899; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Shibata A, 2008, BIOCHEM PHARMACOL, V76, P330, DOI 10.1016/j.bcp.2008.05.017; Samant GV, 2006, CELL PROLIFERAT, V39, P563, DOI 10.1111/j.1365-2184.2006.00412.x; Sun WG, 2008, BRIT J NUTR, V99, P1247, DOI 10.1017/S0007114507879128; Ananthula S, 2014, ANTICANCER RES, V34, P2715; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Melillo G, 2007, CANCER METAST REV, V26, P341, DOI 10.1007/s10555-007-9059-x; Shibata A, 2008, J NUTR, V138, P2136, DOI 10.3945/jn.108.093237; Ji XM, 2012, INT J CANCER, V131, P2668, DOI 10.1002/ijc.27549; Sakai M, 2006, J NUTR BIOCHEM, V17, P672, DOI 10.1016/j.jnutbio.2005.11.001; Ishiyama M, 1996, BIOL PHARM BULL, V19, P1518; Manu KA, 2012, CLIN CANCER RES, V18, P2220, DOI 10.1158/1078-0432.CCR-11-2470; Weng-Yew W, 2009, NUTR CANCER, V61, P367, DOI 10.1080/01635580802582736; Brown JM, 2004, NAT REV CANCER, V4, P437, DOI 10.1038/nrc1367; Miyazawa T, 2009, J NUTR BIOCHEM, V20, P79, DOI 10.1016/j.jnutbio.2008.09.003; Newaz MA, 1999, CLIN EXP HYPERTENS, V21, P1297; Denko NC, 2003, ONCOGENE, V22, P5907, DOI 10.1038/sj.onc.1206703; Hanze J, 2003, BIOCHEM BIOPH RES CO, V312, P571, DOI 10.1016/j.bbrc.2003.10.153; Ahn KS, 2007, J BIOL CHEM, V282, P809, DOI 10.1074/jbc.M610028200; Pugh CW, 2003, NAT MED, V9, P677, DOI 10.1038/nm0603-677; Borriello A, 2011, EXPERT OPIN THER TAR, V15, P677, DOI 10.1517/14728222.2011.561318; Semenza GL, 2013, J CLIN INVEST, V123, P3664, DOI 10.1172/JCI67230; Kannappan R, 2010, J BIOL CHEM, V285, P33520, DOI 10.1074/jbc.M110.158378; Srivastava JK, 2006, BIOCHEM BIOPH RES CO, V346, P447, DOI 10.1016/j.bbrc.2006.05.147; Baliarsingh S, 2005, ATHEROSCLEROSIS, V182, P367, DOI 10.1016/j.atherosclerosis.2005.02.020; Gao DM, 2009, CELL DIV, V4, DOI 10.1186/1747-1028-4-11; Gillett CE, 1998, J CLIN PATHOL-MOL PA, V51, P310; Hiura Y, 2009, J NUTR BIOCHEM, V20, P607, DOI 10.1016/j.jnutbio.2008.06.004; Hodul PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052526; Kashiwagi K, 2008, BIOCHEM BIOPH RES CO, V365, P875, DOI 10.1016/j.bbrc.2007.11.085; Kawakami Y, 2007, BIOSCI BIOTECH BIOCH, V71, P464, DOI 10.1271/bbb.60524; Khanna S, 2010, J NEUROCHEM, V112, P1249, DOI 10.1111/j.1471-4159.2009.06550.x; Ling MT, 2012, CARCINOGENESIS, V33, P233, DOI 10.1093/carcin/bgr261; Mahalingam D, 2011, EUR J CLIN NUTR, V65, P63, DOI 10.1038/ejcn.2010.184; Nesaretnam K, 2004, LIPIDS, V39, P459, DOI 10.1007/s11745-004-1251-1; NGAH WZW, 1991, AM J CLIN NUTR, V53, pS1076; Siveen KS, 2014, ONCOTARGET, V5, P1897; Strese S, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-331; Zhang JS, 2011, TOXICOLOGY, V285, P8, DOI 10.1016/j.tox.2011.03.011	47	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0955-2863	1873-4847		J NUTR BIOCHEM	J. Nutr. Biochem.	AUG	2015	26	8					832	840		10.1016/j.jnutbio.2015.02.011		9	Biochemistry & Molecular Biology; Nutrition & Dietetics	Biochemistry & Molecular Biology; Nutrition & Dietetics	CL4EZ	WOS:000356906700005		
J	Matsukawa, T; Inaguma, T; Han, J; Villareal, MO; Isoda, H				Matsukawa, Toshiya; Inaguma, Tetsuya; Han, Junkyu; Villareal, Myra O.; Isoda, Hiroko			Cyanidin-3-glucoside derived from black soybeans ameliorate type 2 diabetes through the induction of differentiation of preadipocytes into smaller and insulin-sensitive adipocytes	JOURNAL OF NUTRITIONAL BIOCHEMISTRY			English	Article						Type 2 diabetes; Insulin sensitivity; Black soybean seed coat; Cyanidin-3-glucoside; Adipocyte differentiation	ACTIVATED RECEPTOR-GAMMA; GLYCINE-MAX L.; PPAR-GAMMA; 3T3-L1 CELLS; ADIPOSE-TISSUE; ENHANCES DIFFERENTIATION; GLUCOSE-UPTAKE; C/EBP-ALPHA; SEED COATS; RESISTANCE	Black soybean is a health food has been reported to have antidiabetes effect. The onset of diabetes is closely associated with adipocyte differentiation, and at present, the effect of black soybean on adipocyte differentiation is unknown. Here, we investigated the antidiabetes effect of black soybean, and its anthocyanin cyanidin-3-glucoside (Cy3G), on adipocyte differentiation. Orally administered black soybean seed coat extract (BSSCE) reduced the body and white adipose tissue (WAT) weight of db/db mice accompanied by a decrease in the size of adipocytes in WAT. Furthermore, 3T3-L1 cells treated with BSSCE and Cy3G were observed to differentiate into smaller adipocytes which correlated with increased PPAR gamma and C/EBP alpha gene expressions, increased adiponectin secretion, decreased tumor necrosis factor-alpha secretion, activation of insulin signalling and increased glucose uptake. C2C12 myotubes cultured with conditioned medium, obtained from 3T3-L1 adipocyte cultures treated with Cy3G, also showed significantly increased expression of PGC-1 alpha, SIRT1 and UCP-3 genes. Here we report that BSSCE, as well as its active compound Cy3G, has antidiabetes effects on db/db mice by promoting adipocyte differentiation. This notion is supported by BSSCE and Cy3G inducing the differentiation of 3T3-L1 preadipocytes into smaller, insulin-sensitive adipocytes, and it induced the activation of skeletal muscle metabolism. This is the first report on the modulation effect of Cy3G on adipocyte differentiation. (C) 2015 Elsevier Inc. All rights reserved.	[Matsukawa, Toshiya; Inaguma, Tetsuya] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan; [Han, Junkyu; Villareal, Myra O.; Isoda, Hiroko] Univ Tsukuba, Fac Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan; [Han, Junkyu; Villareal, Myra O.; Isoda, Hiroko] Univ Tsukuba, Alliance Res North Africa ARENA, Tsukuba, Ibaraki 3058572, Japan	Isoda, H (reprint author), Univ Tsukuba, Alliance Res North Africa ARENA, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058572, Japan.	isoda.hiroko.ga@u.tsukuba.ac.jp					Felgines C, 2009, MOL NUTR FOOD RES, V53, P1098, DOI 10.1002/mnfr.200800323; Houseknecht KL, 2002, DOMEST ANIM ENDOCRIN, V22, P1, DOI 10.1016/S0739-7240(01)00117-5; Ali AT, 2013, EUR J CELL BIOL, V92, P229, DOI 10.1016/j.ejcb.2013.06.001; Rangwala SM, 2004, TRENDS PHARMACOL SCI, V25, P331, DOI 10.1016/j.tips.2004.03.012; Lafontan M, 2014, DIABETES METAB, V40, P16, DOI 10.1016/j.diabet.2013.08.002; Saltiel AR, 1996, DIABETES, V45, P1661, DOI 10.2337/diabetes.45.12.1661; Rosen ED, 2002, GENE DEV, V16, P22, DOI 10.1101/gad.948702; Kopelman PG, 2000, NATURE, V404, P635; Yamauchi T, 2001, J BIOL CHEM, V276, P41245, DOI 10.1074/jbc.M103241200; Guo L, 2006, PHARMACOL THERAPEUT, V111, P145, DOI 10.1016/j.pharmthera.2005.10.009; HUMMEL KP, 1966, SCIENCE, V153, P1127, DOI 10.1126/science.153.3740.1127; Paz K, 1997, J BIOL CHEM, V272, P29911, DOI 10.1074/jbc.272.47.29911; Kim JM, 2008, J AGR FOOD CHEM, V56, P8427, DOI 10.1021/jf801342p; Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984; GREEN H, 1975, CELL, V5, P19, DOI 10.1016/0092-8674(75)90087-2; Saito T, 2007, BIOCHEM BIOPH RES CO, V357, P371, DOI 10.1016/j.bbrc.2007.03.169; Kadowaki T, 2005, ENDOCR REV, V26, P439, DOI 10.1210/er.2005-0005; Kelley DE, 2002, DIABETES, V51, P2944, DOI 10.2337/diabetes.51.10.2944; Choung MG, 2001, J AGR FOOD CHEM, V49, P5848, DOI 10.1021/jf010550w; Wu ZD, 1999, MOL CELL, V3, P151, DOI 10.1016/S1097-2765(00)80306-8; Arner P, 2003, TRENDS ENDOCRIN MET, V14, P137, DOI 10.1016/S1043-2760(03)00024-9; Huang SH, 2007, CELL METAB, V5, P237, DOI 10.1016/j.cmet.2007.03.006; SALANS LB, 1968, J CLIN INVEST, V47, P153, DOI 10.1172/JCI105705; Tsuda T, 2005, BBA-MOL CELL BIOL L, V1733, P137, DOI 10.1016/j.bbalip.2004.12.014; Suwa M, 2003, J APPL PHYSIOL, V95, P960, DOI 10.1152/japplphysiol.00349.2003; Nawrocki AR, 2005, DRUG DISCOV TODAY, V10, P1219, DOI 10.1016/S1359-6446(05)03569-5; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Lee JH, 2009, FOOD CHEM, V112, P226, DOI 10.1016/j.foodchem.2008.05.056; Kurimoto Y, 2013, J AGR FOOD CHEM, V61, P5558, DOI 10.1021/jf401190y; Tartaglia LA, 1997, J BIOL CHEM, V272, P6093; Gil-Campos M, 2004, CLIN NUTR, V23, P963, DOI 10.1016/j.clnu.2004.04.010; Farmer SR, 2006, CELL METAB, V4, P263, DOI 10.1016/j.cmet.2006.07.001; Kanamoto Y, 2011, J AGR FOOD CHEM, V59, P8985, DOI 10.1021/jf201471p; Guo HH, 2012, FOOD CHEM TOXICOL, V50, P3040, DOI 10.1016/j.fct.2012.06.015; Saito T, 2008, BIOCHEM BIOPH RES CO, V372, P835, DOI 10.1016/j.bbrc.2008.05.146; Capurso C, 2012, VASC PHARMACOL, V57, P91, DOI 10.1016/j.vph.2012.05.003; Iwabu M, 2010, NATURE, V464, P1313, DOI 10.1038/nature08991; Leiherer A, 2013, VASC PHARMACOL, V58, P3, DOI 10.1016/j.vph.2012.09.002; Gregoire FM, 2001, EXP BIOL MED, V226, P997; Badshah H, 2013, NEUROPEPTIDES, V47, P347, DOI 10.1016/j.npep.2013.06.001; Choi SS, 2009, LIFE SCI, V84, P908, DOI 10.1016/j.lfs.2009.04.001; Gonzalez-Castejon M, 2011, PHARMACOL RES, V64, P438, DOI 10.1016/j.phrs.2011.07.004; Guo HH, 2012, J NUTR BIOCHEM, V23, P349, DOI 10.1016/j.jnutbio.2010.12.013; Hassan M, 2007, BIOCHEM BIOPH RES CO, V361, P208, DOI 10.1016/j.bbrc.2007.07.021; Karnieli E, 2008, AM J PHYSIOL-ENDOC M, V295, P38; Mineo H, 2007, CELL BIOL INT, V31, P703, DOI 10.1016/j.cellbi.2007.01.002; Park SY, 2008, ATHEROSCLEROSIS, V201, P258, DOI 10.1016/j.atherosclerosis.2008.02.006; Saito T, 2009, BIOCHEM BIOPH RES CO, V380, P281, DOI 10.1016/j.bbrc.2009.01.058; Sasaki Rie, 2007, Biochem Pharmacol, V74, P1619, DOI 10.1016/j.bcp.2007.08.008; Slavin M, 2013, FOOD CHEM, V141, P1166, DOI 10.1016/j.foodchem.2013.04.039; Smith SA, 2003, BIOCHIMIE, V85, P1219, DOI 10.1016/j.biochi.2003.10.010; Zou CH, 2008, J NUTR BIOCHEM, V19, P277, DOI 10.1016/j.jnutbio.2007.06.006	52	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0955-2863	1873-4847		J NUTR BIOCHEM	J. Nutr. Biochem.	AUG	2015	26	8					860	867		10.1016/j.jnutbio.2015.03.006		8	Biochemistry & Molecular Biology; Nutrition & Dietetics	Biochemistry & Molecular Biology; Nutrition & Dietetics	CL4EZ	WOS:000356906700008		
J	Shi, HT; Wang, X; Tan, DX; Reiter, RJ; Chan, ZL				Shi, Haitao; Wang, Xin; Tan, Dun-Xian; Reiter, Russel J.; Chan, Zhulong			Comparative physiological and proteomic analyses reveal the actions of melatonin in the reduction of oxidative stress in Bermuda grass (Cynodon dactylon (L). Pers.)	JOURNAL OF PINEAL RESEARCH			English	Article						Bermuda grass; iTRAQ (isobaric tags for relative and absolute quantitation); melatonin; oxidative stress; proteomic; reactive oxygen species	LEAF SENESCENCE; GLUTATHIONE-PEROXIDASE; EXOGENOUS APPLICATION; MALUS-HUPEHENSIS; TOMATO PLANTS; EDIBLE PLANTS; ANTIOXIDANT; DROUGHT; ARABIDOPSIS; MECHANISMS	The fact of melatonin as an important antioxidant in animals led plant researchers to speculate that melatonin also acts in the similar manner in plants. Although melatonin has significant effects on alleviating stress-triggered reactive oxygen species (ROS), the involvement of melatonin in direct oxidative stress and the underlying physiological and molecular mechanisms remain unclear in plants. In this study, we found that exogenous melatonin significantly alleviated hydrogen peroxide (H2O2)-modulated plant growth, cell damage, and ROS accumulation in Bermuda grass. Additionally, 76 proteins significantly influenced by melatonin during mock or H2O2 treatment were identified by gel-free proteomics using iTRAQ (isobaric tags for relative and absolute quantitation). Metabolic pathway analysis showed that several pathways were markedly enhanced by melatonin and H2O2 treatments, including polyamine metabolism, ribosome pathway, major carbohydrate metabolism, photosynthesis, redox, and amino acid metabolism. Taken together, this study provides more comprehensive insights into the physiological and molecular mechanisms of melatonin in Bermuda grass responses to direct oxidative stress. This may relate to the activation of antioxidants, modulation of metabolic pathways, and extensive proteome reprograming.	[Shi, Haitao] Hainan Univ, Coll Agr, Hainan Key Lab Sustainable Utilizat Trop Bioresou, Haikou, Peoples R China; [Shi, Haitao; Chan, Zhulong] Chinese Acad Sci, Wuhan Bot Garden, Key Lab Plant Germplasm Enhancement & Specialty A, Wuhan 430074, Peoples R China; [Wang, Xin] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki, Japan; [Wang, Xin] Natl Agr & Food Res Org, Natl Inst Crop Sci, Tsukuba, Ibaraki, Japan; [Tan, Dun-Xian; Reiter, Russel J.] Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA	Chan, ZL (reprint author), Chinese Acad Sci, Wuhan Bot Garden, Key Lab Plant Germplasm Enhancement & Specialty A, Wuhan 430074, Peoples R China.	zhulongch@wbgcas.cn			'the Hundred Talents Program' of Chinese Academy of Sciences [54Y154761O01076, 29Y329631O0263]; Knowledge Innovative Key Program of Chinese Academy of Sciences [55Y455446O0544]; Hainan University [kyqd1531]	We thank PTM (Protein Post-translational Modification) Biolabs InC (www.ptm-biolab.com.cn) for the help in iTRAQ analysis. This research was supported by 'the Hundred Talents Program' of Chinese Academy of Sciences (No. 54Y154761O01076 and 29Y329631O0263) to Zhulong Chan, the Knowledge Innovative Key Program of Chinese Academy of Sciences (No. 55Y455446O0544) and the startup funding of Hainan University (kyqd1531) to Haitao Shi.	Shi HT, 2014, PLANT PHYSIOL BIOCH, V82, P218, DOI 10.1016/j.plaphy.2014.06.006; Tan DX, 2012, J EXP BOT, V63, P577, DOI 10.1093/jxb/err256; Cardinali DP, 2012, J PINEAL RES, V52, P365, DOI 10.1111/j.1600-079X.2011.00962.x; Manchester LC, 2000, LIFE SCI, V67, P3023, DOI 10.1016/S0024-3205(00)00896-1; Arnao MB, 2001, PHYTOCHEM ANALYSIS, V12, P138, DOI 10.1002/pca.571; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Pablos MI, 1998, NEUROCHEM INT, V32, P69, DOI 10.1016/S0197-0186(97)00043-0; Burkhardt S, 2001, J AGR FOOD CHEM, V49, P4898, DOI 10.1021/jf010321+; Wang P, 2013, J PINEAL RES, V54, P292, DOI 10.1111/jpi.12017; Zhang N, 2014, J PINEAL RES, V56, P39, DOI 10.1111/jpi.12095; Okazaki M, 2010, J PINEAL RES, V49, P239, DOI 10.1111/j.1600-079X.2010.00788.x; Wang L, 2014, J PINEAL RES, V56, P134, DOI 10.1111/jpi.12105; Hernandez-Ruiz J, 2008, J AGR FOOD CHEM, V56, P10567, DOI 10.1021/jf8022063; Cano A, 2006, J PLANT RES, V119, P321, DOI 10.1007/s10265-006-0275-1; Pape C, 2006, J PINEAL RES, V41, P157, DOI 10.1111/j.1600-079X.2006.00348.x; Arnao MB, 2009, J PINEAL RES, V46, P295, DOI 10.1111/j.1600-079X.2008.00660.x; Rodriguez C, 2004, J PINEAL RES, V36, P1, DOI 10.1046/j.1600-079X.2003.00092.x; Shi HT, 2013, J PROTEOME RES, V12, P4951, DOI 10.1021/pr400479k; Arnao MB, 2013, FOOD CHEM, V138, P1212, DOI 10.1016/j.foodchem.2012.10.077; Hardeland R, 2005, ENDOCRINE, V27, P119, DOI 10.1385/ENDO:27:2:119; Ramakrishna A, 2012, J PINEAL RES, V52, P470, DOI 10.1111/j.1600-079X.2011.00964.x; Reiter RJ, 2009, CRIT REV BIOCHEM MOL, V44, P175, DOI 10.1080/10409230903044914; Mittler R, 2004, TRENDS PLANT SCI, V9, P490, DOI 10.1016/j.tplants.2004.08.009; Murch SJ, 2009, J PINEAL RES, V47, P277, DOI 10.1111/j.1600-079X.2009.00711.x; BARLOWWALDEN LR, 1995, NEUROCHEM INT, V26, P497, DOI 10.1016/0197-0186(94)00154-M; Zhao Y, 2013, J PINEAL RES, V55, P79, DOI 10.1111/jpi.12044; Calvo JR, 2013, J PINEAL RES, V55, P103, DOI 10.1111/jpi.12075; Wang P, 2012, J PINEAL RES, V53, P11, DOI 10.1111/j.1600-079X.2011.00966.x; Tan DX, 2003, J PINEAL RES, V34, P249; Miller G, 2010, PLANT CELL ENVIRON, V33, P453, DOI 10.1111/j.1365-3040.2009.02041.x; Wang P, 2013, J PINEAL RES, V55, P424, DOI 10.1111/jpi.12091; Shi HT, 2013, PLANT PHYSIOL BIOCH, V71, P226, DOI 10.1016/j.plaphy.2013.07.021; DUBBELS R, 1995, J PINEAL RES, V18, P28, DOI 10.1111/j.1600-079X.1995.tb00136.x; Galano A, 2013, J PINEAL RES, V54, P245, DOI 10.1111/jpi.12010; Arnao Marino B, 2006, Plant Signal Behav, V1, P89, DOI 10.4161/psb.1.3.2640; Arnao MB, 2014, TRENDS PLANT SCI, V19, P789, DOI 10.1016/j.tplants.2014.07.006; Carroll AJ, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00032; desHoon M. J. L., 2004, BIOINFORMATICS OXFOR, V20, P1453; HATTORI A, 1995, BIOCHEM MOL BIOL INT, V35, P627; Kolar J, 2005, J PINEAL RES, V39, P333, DOI 10.1111/j.1600-079X.2005.00276.x; Li M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099970; Mittler R., 2011, TRENDS PLANT SCI, V16, P1360; Paredes SD, 2009, J EXP BOT, V60, P67; Provart N, 2003, CURR COMPUT MOL BIOL, V2003, P271; Reiter RJ, 2014, PHYSIOLOGY, V29, P325, DOI 10.1152/physiol.00011.2014; Shi HT, 2014, J PINEAL RES, V57, P185, DOI 10.1111/jpi.12155; Shi HT, 2015, J PINEAL RES, V58, P26, DOI 10.1111/jpi.12188; Shi HT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053422; Shi HT, 2014, J INTEGR PLANT BIOL, V56, P1064, DOI 10.1111/jipb.12167; Shi HT, 2015, J EXP BOT, V66, P681, DOI 10.1093/jxb/eru373; Shi HT, 2015, J PINEAL RES, V58, P335, DOI 10.1111/jpi.12219; Tan D-X, 1993, ENDOCR J, V1, P57; Wang P, 2014, J PINEAL RES, V57, P291, DOI 10.1111/jpi.12169; Weeda S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093462; Zhang HM, 2014, J PINEAL RES, V57, P131, DOI 10.1111/jpi.12162; Zhang N, 2014, J EXP BOT, V66, P647	56	6	6	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0742-3098	1600-079X		J PINEAL RES	J. Pineal Res.	AUG	2015	59	1					120	131		10.1111/jpi.12246		12	Endocrinology & Metabolism; Neurosciences; Physiology	Endocrinology & Metabolism; Neurosciences & Neurology; Physiology	CM0NQ	WOS:000357375400011		
J	Miyao, T				Miyao, Tadahiro			Upper Bounds on the Charge Susceptibility of Many-Electron Systems Coupled to the Quantized Radiation Field	LETTERS IN MATHEMATICAL PHYSICS			English	Article						Hubbard model; quantized radiation field; Euclidean-Bose field; charge susceptibility	HUBBARD-MODEL; TRANSITION METALS; FERROMAGNETISM; BAND; NARROW; PHASE; SPACE	We extend the Kubo-Kishi theorem concerning the charge susceptibility of the Hubbard model in the following way: (i) The electron-photon interaction is taken into account. (ii) Not only on-site but also general Coulomb repulsions are considered.	Hokkaido Univ, Dept Math, Sapporo, Hokkaido 0600810, Japan	Miyao, T (reprint author), Hokkaido Univ, Dept Math, Sapporo, Hokkaido 0600810, Japan.	miyao@math.sci.hokudai.ac.jp			KAKENHI [20554421]	I would like to thank Prof. Arai for helpful comments. I would be grateful to the anonymous referee for useful suggestions. This work was supported by KAKENHI(20554421).	NAGAOKA Y, 1966, PHYS REV, V147, P392, DOI 10.1103/PhysRev.147.392; KANAMORI J, 1963, PROG THEOR PHYS, V30, P275, DOI 10.1143/PTP.30.275; GUTZWILLER MC, 1963, PHYS REV LETT, V10, P159, DOI 10.1103/PhysRevLett.10.159; Giuliani A, 2012, ANN PHYS-NEW YORK, V327, P461, DOI 10.1016/j.aop.2011.10.007; LIEB EH, 1989, PHYS REV LETT, V62, P1201, DOI 10.1103/PhysRevLett.62.1201; DYSON FJ, 1978, J STAT PHYS, V18, P335, DOI 10.1007/BF01106729; LIEB EH, 1994, PHYS REV LETT, V73, P2158, DOI 10.1103/PhysRevLett.73.2158; ARAI A, 1989, J FUNCT ANAL, V82, P330, DOI 10.1016/0022-1236(89)90075-X; Arai A, 1996, J FUNCT ANAL, V136, P510, DOI 10.1006/jfan.1996.0036; Dollard J.D., 1979, ENCY MATH ITS APPL, V10; Giuliani A, 2012, COMMUN MATH PHYS, V311, P317, DOI 10.1007/s00220-012-1444-9; GROSS L, 1977, J FUNCT ANAL, V25, P162, DOI 10.1016/0022-1236(77)90039-8; HOEGHKRO.R, 1974, COMMUN MATH PHYS, V38, P195, DOI 10.1007/BF01651542; HUBBARD J, 1963, PROC R SOC LON SER-A, V276, P238, DOI 10.1098/rspa.1963.0204; KUBO K, 1990, PHYS REV B, V41, P4866, DOI 10.1103/PhysRevB.41.4866; Lorinczi J., 2011, DEGRUYTER STUDIES MA, V34; Miyao T, 2012, J STAT PHYS, V149, P519, DOI 10.1007/s10955-012-0598-3; Miyao T., ARXIV14025202; Simon B, 2005, MATH SURVEYS MONOGRA, V120; Tasaki H, 1998, PROG THEOR PHYS, V99, P489, DOI 10.1143/PTP.99.489	20	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0377-9017	1573-0530		LETT MATH PHYS	Lett. Math. Phys.	AUG	2015	105	8					1119	1133		10.1007/s11005-015-0775-9		15	Physics, Mathematical	Physics	CM1TX	WOS:000357464400004		
J	Motegi, K				Motegi, Kohei			Nonstandard Representations of Type C Affine Hecke Algebra from K-Operators	LETTERS IN MATHEMATICAL PHYSICS			English	Article						affine Hecke algebra; Yang-Baxter equation; reflection equation; quantum integrable models	INTEGRABLE QUANTUM-SYSTEMS; YANG-BAXTER EQUATION; R-MATRIX; REFLECTION EQUATION; SPIN CHAIN; XYZ-SPIN; MODEL	We construct nonstandard finite-dimensional representations of type C affine Hecke algebra from the viewpoint of quantum integrable models. There exists two classes of nonstandard solutions to the Yang-Baxter equation called the Cremmer-Gervais and Jordanian R-matrices. These R-matrices also satisfy the Hecke-relation, thus can be used to construct nonstandard finite-dimensional representations of type A affine Hecke algebra. We construct the corresponding nonstandard representations for type C affine Hecke algebra by explicitly constructing solutions to the reflection equation under the Hecke relation. We achieve this by taking the finite-dimensional representations and deBaxterizing the K-operators acting on the infinite-dimensional function space, taking advantage of the fact that the Cremmer-Gervais and Jordanian R-matrices can be obtained from the R-operator.	Okayama Inst Quantum Phys, Okayama 7000015, Japan	Motegi, K (reprint author), Okayama Inst Quantum Phys, Kyoyama 1-9-1, Okayama 7000015, Japan.	motegi@gokutan.c.u-tokyo.ac.jp			 [24540393];  [25800223]	This work was partially supported by grants-in-aid for Scientific Research (C) No. 24540393 and for Young Scientists (B) No. 25800223.	Sahi S, 1999, ANN MATH, V150, P267, DOI 10.2307/121102; BELAVIN AA, 1981, NUCL PHYS B, V180, P189, DOI 10.1016/0550-3213(81)90414-4; JIMBO M, 1985, LETT MATH PHYS, V10, P63, DOI 10.1007/BF00704588; Antonov A, 1997, NUCL PHYS B, V503, P747, DOI 10.1016/S0550-3213(97)00520-8; KULISH PP, 1991, J PHYS A-MATH GEN, V24, pL435, DOI 10.1088/0305-4470/24/8/009; CREMMER E, 1990, COMMUN MATH PHYS, V134, P619, DOI 10.1007/BF02098449; Bethe H, 1931, Z PHYS, V71, P205, DOI 10.1007/BF01341708; Baxter R. J., 1982, EXACTLY SOLVED MODEL; BAXTER RJ, 1972, ANN PHYS-NEW YORK, V70, P193, DOI 10.1016/0003-4916(72)90335-1; Cherednik I., 2005, DOUBLE AFFINE HECKE; DEVEGA HJ, 1994, J PHYS A-MATH GEN, V27, P6129, DOI 10.1088/0305-4470/27/18/021; Drinfeld V.G., 1985, SOV MATH DOKL, V32, P254; Endelman R, 2004, LETT MATH PHYS, V68, P151, DOI 10.1023/B:MATH.0000045551.15442.52; Endelman R, 2000, LETT MATH PHYS, V52, P225, DOI 10.1023/A:1007693603336; Faddeev L.D., 1979, THEOR MATH PHYS, V40, P194; FELDER G, 1994, LETT MATH PHYS, V32, P167, DOI 10.1007/BF00739425; Gerstenhaber M, 1997, LETT MATH PHYS, V40, P337, DOI 10.1023/A:1007363911649; Hikami K, 1996, J PHYS A-MATH GEN, V29, P2135, DOI 10.1088/0305-4470/29/9/025; Hikami K., 1997, J PHYS A, V30, P4341; INAMI T, 1994, J PHYS A-MATH GEN, V27, pL913, DOI 10.1088/0305-4470/27/24/002; Jimbo M, 1995, ALGEBRAIC ANAL SOLVA; Johnson G, 2010, LETT MATH PHYS, V94, P115, DOI 10.1007/s11005-010-0421-5; Korepin V. E., 1993, QUANTUM INVERSE SCAT; Kulish PP, 2006, LETT MATH PHYS, V75, P151, DOI 10.1007/s11005-005-0043-5; Levin A, 2014, J HIGH ENERGY PHYS, DOI 10.1007/JHEP07(2014)012; Macdonald I.G., 2003, AFFINE HECKE ALGEBRA; Motegi K, 2010, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2010/04/P04005; Nepomechie RI, 2002, LETT MATH PHYS, V62, P83, DOI 10.1023/A:1021666606803; Noumi M., 1995, SURIKAISEKIKENKYUSHO, V919, P44; SHIBUKAWA Y, 1992, LETT MATH PHYS, V25, P239, DOI 10.1007/BF00406551; SKLYANIN EK, 1988, J PHYS A-MATH GEN, V21, P2375, DOI 10.1088/0305-4470/21/10/015; Yamada Y, 2002, PHYS LETT A, V298, P350, DOI 10.1016/S0375-9601(02)00573-X	32	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0377-9017	1573-0530		LETT MATH PHYS	Lett. Math. Phys.	AUG	2015	105	8					1165	1192		10.1007/s11005-015-0772-z		28	Physics, Mathematical	Physics	CM1TX	WOS:000357464400006		
J	Tsukamoto, H				Tsukamoto, Hideaki			Impact compressive behavior of deep-drawn cups consisting of aluminum/duralumin multi-layered graded structures	MATERIALS SCIENCE AND ENGINEERING B-ADVANCED FUNCTIONAL SOLID-STATE MATERIALS			English	Article						Crash box; Multi-layered structure; Functionally Graded Materials (FGMs); Deep drawing; Impact compressive behavior	THIN-WALLED STRUCTURES; ENERGY-ABSORPTION; ALUMINUM TUBES; BOX STRUCTURES; CRASH BOXES; FOAM; COMPOSITE; DESIGN; OPTIMIZATION	This study aims to investigate impact compressive behavior of deep-drawn cups consisting of aluminum (A1050)/duralumin (A2017) multi-layered structures, which are fabricated by hot rolling. Such multilayered structures are possibly used for a new type of crash boxes in automobiles to effectively absorb impact energy. The effect of heat treatments on micro-Vickers hardness gradients at the interfaces between layers in 2 and 6-layered aluminum/duralumin structures have been investigated. Impact compressive behavior of deep-drawn cups consisting of such aluminum/duralumin multi-layered graded structures has been studied in terms of energy absorption, maximum force and maximum displacement with examination based on micro-Vickers hardness results. Deep-drawn cups consisting of 6-layerd clad structures with gradient properties exhibited superior impact compressive characteristics to be effective in application to vehicle crash absorbers. (C) 2015 Elsevier B.V. All rights reserved.	Nagoya Inst Technol, Grad Sch Engn, Showa Ku, Nagoya, Aichi 4668555, Japan	Tsukamoto, H (reprint author), Nagoya Inst Technol, Grad Sch Engn, Showa Ku, Gokiso Cho, Nagoya, Aichi 4668555, Japan.	tsukamoto.hideaki@nitech.ac.jp					Abramowicz W., 1986, INT J IMPACT ENG, V4, P243, DOI 10.1016/0734-743X(86)90017-5; Alexander J. M, 1960, J MECH APPL MATH, V13, P10; Alvandi-Tabrizi Y, 2014, P MAT SCI, V4, P377; Lau STW, 2012, COMPOS STRUCT, V94, P803, DOI 10.1016/j.compstruct.2011.09.013; Toksoy AK, 2010, THIN WALL STRUCT, V48, P482, DOI 10.1016/j.tws.2010.02.002; Sun GY, 2010, MAT SCI ENG A-STRUCT, V527, P1911, DOI 10.1016/j.msea.2009.11.022; Santosa S, 1998, COMPUT STRUCT, V68, P343, DOI 10.1016/S0045-7949(98)00067-4; Lee JE, 2007, J MATER PROCESS TECH, V187, P546, DOI 10.1016/j.jmatprotec.2006.11.021; Jin ZH, 2004, SURF COAT TECH, V179, P210, DOI 10.1016/S0257-8972(03)00803-X; Zarei H, 2008, COMPOS STRUCT, V85, P245, DOI 10.1016/j.compstruct.2007.10.028; Langseth M, 1996, INT J IMPACT ENG, V18, P949, DOI 10.1016/S0734-743X(96)00025-5; Yin HF, 2014, MATER DESIGN, V55, P747, DOI 10.1016/j.matdes.2013.10.054; Zarei HR, 2008, THIN WALL STRUCT, V46, P214, DOI 10.1016/j.tws.2007.07.016; Obradovic J, 2012, COMPOS STRUCT, V94, P423, DOI 10.1016/j.compstruct.2011.08.005; Aktay L, 2006, MATER DESIGN, V27, P556, DOI 10.1016/j.matdes.2004.12.019; WIERZBICKI T, 1983, J APPL MECH-T ASME, V50, P727; De Giorgi M, 2010, COMPUT STRUCT, V88, P25, DOI 10.1016/j.compstruc.2009.06.005; Cho JU, 2012, MAT SCI ENG A-STRUCT, V539, P250, DOI 10.1016/j.msea.2012.01.091; Ghasemnejad H, 2009, COMPOS STRUCT, V88, P253, DOI 10.1016/j.compstruct.2008.04.006; Han MS, 2013, INT J AUTO TECH-KOR, V14, P61, DOI 10.1007/s12239-013-0008-0; Ince F, 2011, PROCEDIA ENGINEER, V10, P1736, DOI 10.1016/j.proeng.2011.04.289; Kim HC, 2014, COMPOS STRUCT, V112, P1, DOI 10.1016/j.compstruct.2014.01.042; THORNTON PH, 1988, INT J IMPACT ENG, V7, P167, DOI 10.1016/0734-743X(88)90024-3; Tseng HC, 2011, INT J ADV MANUF TECH, V54, P93, DOI 10.1007/s00170-010-2911-0; Tsukamoto H, 2010, MAT SCI ENG A-STRUCT, V527, P3217, DOI 10.1016/j.msea.2010.01.087; Tsukamoto H, 2003, COMPOS PART B-ENG, V34, P561, DOI 10.1016/S1359-8368(02)00037-9	26	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0921-5107	1873-4944		MATER SCI ENG B-ADV	Mater. Sci. Eng. B-Adv. Funct. Solid-State Mater.	AUG	2015	198						25	34		10.1016/j.mseb.2015.04.002		10	Materials Science, Multidisciplinary; Physics, Condensed Matter	Materials Science; Physics	CM0FV	WOS:000357354700005		
J	Irie, S; Sanuki, R; Muranishi, Y; Kato, K; Chaya, T; Furukawaa, T				Irie, Shoichi; Sanuki, Rikako; Muranishi, Yuki; Kato, Kimiko; Chaya, Taro; Furukawaa, Takahisa			Rax Homeoprotein Regulates Photoreceptor Cell Maturation and Survival in Association with Crx in the Postnatal Mouse Retina	MOLECULAR AND CELLULAR BIOLOGY			English	Article							VERTEBRATE EYE DEVELOPMENT; HOMEOBOX GENE; CGMP-PHOSPHODIESTERASE; FATE DETERMINATION; CONE PHOTORECEPTOR; ALPHA-SUBUNIT; EXPRESSION; MICE; TRANSCRIPTION; NRL	The Rax homeobox gene plays essential roles in multiple processes of vertebrate retina development. Many vertebrate species possess Rax and Rax2 genes, and different functions have been suggested. In contrast, mice contain a single Rax gene, and its functional roles in late retinal development are still unclear. To clarify mouse Rax function in postnatal photoreceptor development and maintenance, we generated conditional knockout mice in which Rax in maturing or mature photoreceptor cells was inactivated by tamoxifen treatment (Rax iCKO mice). When Rax was inactivated in postnatal Rax iCKO mice, developing photoreceptor cells showed a significant decrease in the level of the expression of rod and cone photoreceptor genes and mature adult photoreceptors exhibited a specific decrease in cone cell numbers. In luciferase assays, we found that Rax and Crx cooperatively transactivate Rhodopsin and cone opsin promoters and that an optimum Rax expression level to transactivate photoreceptor gene expression exists. Furthermore, Rax and Crx colocalized in maturing photoreceptor cells, and their coimmunoprecipitation was observed in cultured cells. Taken together, these results suggest that Rax plays essential roles in the maturation of both cones and rods and in the survival of cones by regulating photoreceptor gene expression with Crx in the postnatal mouse retina.	[Irie, Shoichi; Sanuki, Rikako; Muranishi, Yuki; Kato, Kimiko; Chaya, Taro; Furukawaa, Takahisa] Osaka Univ, Inst Prot Res, Lab Mol & Dev Biol, Suita, Osaka 565, Japan; [Irie, Shoichi; Sanuki, Rikako; Muranishi, Yuki; Kato, Kimiko; Chaya, Taro; Furukawaa, Takahisa] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Suita, Osaka, Japan; [Irie, Shoichi] Kyoto Univ, Grad Sch Med, Kyoto, Japan	Furukawaa, T (reprint author), Osaka Univ, Inst Prot Res, Lab Mol & Dev Biol, Suita, Osaka 565, Japan.	takahisa.furukawa@protein.osaka-u.ac.jp			Japan Science and Technology Agency (JST); Ministry of Education, Culture, Sports, Science and Technology of Japan; Novartis Research Foundation; Takeda Science Foundation; Kato Memorial Foundation; Uehara Memorial Foundation; Inamori Foundation	This work was supported by the Japan Science and Technology Agency (JST), Core Research for Evolutional Science and Technology (CREST), Grants-in-Aid for Scientific Research on Priority Areas, a Grant-in-Aid for Scientific Research (B), a Grant in Aid for Young Scientists (B), Specially Designated Research Promotion and Scientific Research on Innovative Areas from the Ministry of Education, Culture, Sports, Science and Technology of Japan, the Novartis Research Foundation, the Takeda Science Foundation, the Kato Memorial Foundation, the Uehara Memorial Foundation, and the Inamori Foundation.	Andreazzoli M, 1999, DEVELOPMENT, V126, P2451; Mathers PH, 1997, NATURE, V387, P603, DOI 10.1038/42475; Katoh K, 2010, J NEUROSCI, V30, P6515, DOI 10.1523/JNEUROSCI.0771-10.2010; Szel A, 1996, MICROSC RES TECHNIQ, V35, P445; Livesey FJ, 2001, NAT REV NEUROSCI, V2, P109, DOI 10.1038/35053522; Rojas-Munoz A, 2005, DEV BIOL, V288, P348, DOI 10.1016/j.ydbio.2005.08.046; Furukawa T, 2000, NEURON, V26, P383, DOI 10.1016/S0896-6273(00)81171-X; Sherry DM, 2003, J COMP NEUROL, V465, P480, DOI 10.1002/cne.10838; Furukawa T, 1997, P NATL ACAD SCI USA, V94, P3088, DOI 10.1073/pnas.94.7.3088; Sato S, 2008, NAT NEUROSCI, V11, P923, DOI 10.1038/nn.2160; Chuang JC, 2001, DEV BIOL, V231, P13, DOI 10.1006/dbio.2000.0125; Chen SM, 1997, NEURON, V19, P1017, DOI 10.1016/S0896-6273(00)80394-3; ROBSON JG, 1995, VISUAL NEUROSCI, V12, P837; Chen CMA, 2002, DEVELOPMENT, V129, P5363, DOI 10.1242/dev.00114; Tsang SH, 1996, SCIENCE, V272, P1026, DOI 10.1126/science.272.5264.1026; Calvert PD, 2000, P NATL ACAD SCI USA, V97, P13913, DOI 10.1073/pnas.250478897; Bailey TJ, 2004, INT J DEV BIOL, V48, P761, DOI 10.1387/ijdb.041878tb; Sanuki R, 2011, NAT NEUROSCI, V14, P1125, DOI 10.1038/nn.2897; Cheng H, 2004, HUM MOL GENET, V13, P1563, DOI 10.1093/hmg/ddh173; Muranishi Y, 2012, DEV GROWTH DIFFER, V54, P341, DOI 10.1111/j.1440-169X.2012.01337.x; Muranishi Y, 2011, J NEUROSCI, V31, P16792, DOI 10.1523/JNEUROSCI.3109-11.2011; Cayouette M, 2006, TRENDS NEUROSCI, V29, P563, DOI 10.1016/j.tins.2006.08.003; Wang QL, 2004, HUM MOL GENET, V13, P1025, DOI 10.1093/hmg/ddh117; Rapaport DH, 2004, J COMP NEUROL, V474, P304, DOI 10.1002/cne.20134; Marquardt T, 2002, TRENDS NEUROSCI, V25, P32, DOI 10.1016/S0166-2236(00)02028-2; Chang B, 2009, P NATL ACAD SCI USA, V106, P19581, DOI 10.1073/pnas.0907720106; Terada K, 2006, DEV BIOL, V291, P398, DOI 10.1016/j.ydbio.2005.12.029; Furukawa T, 1999, NAT GENET, V23, P466, DOI 10.1038/70591; Voronina VA, 2004, HUM MOL GENET, V13, P315, DOI 10.1093/hmg/ddh025; CARTERDAWSON LD, 1979, J COMP NEUROL, V188, P245, DOI 10.1002/cne.901880204; Applebury ML, 2000, NEURON, V27, P513, DOI 10.1016/S0896-6273(00)00062-3; Lem J, 1999, P NATL ACAD SCI USA, V96, P736, DOI 10.1073/pnas.96.2.736; Nelson SM, 2009, DEV BIOL, V328, P24, DOI 10.1016/j.ydbio.2008.12.040; Trifunovic D, 2010, J COMP NEUROL, V518, P3604, DOI 10.1002/cne.22416; Cepko CL, 1996, P NATL ACAD SCI USA, V93, P589, DOI 10.1073/pnas.93.2.589; Hsiau THC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000643; Kimura A, 2000, J BIOL CHEM, V275, P1152, DOI 10.1074/jbc.275.2.1152; Lerner LE, 2001, J BIOL CHEM, V276, P34999, DOI 10.1074/jbc.M103301200; Morrow EM, 1998, TRENDS CELL BIOL, V8, P353, DOI 10.1016/S0962-8924(98)01341-5; Pan Y, 2010, DEV BIOL, V339, P494, DOI 10.1016/j.ydbio.2009.12.032; Pan Y, 2006, INVEST OPHTH VIS SCI, V47, P4245, DOI 10.1167/iovs.06-0167; Pittler SJ, 2004, J BIOL CHEM, V279, P19800, DOI 10.1074/jbc.M401864200; Rehemtulla A, 1996, P NATL ACAD SCI USA, V93, P191, DOI 10.1073/pnas.93.1.191; Reks SE, 2014, BMC MOL BIOL, V15, DOI 10.1186/1471-2199-15-4; Sanuki R, 2010, FEBS LETT, V584, P753, DOI 10.1016/j.febslet.2009.12.030; Schulte JE, 2014, MOL BIOL EVOL, V31, P2297, DOI 10.1093/molbev/msu172; Terada K, 2010, DEV BIOL, V347, P180, DOI 10.1016/j.ydbio.2010.08.023	47	0	0	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0270-7306	1098-5549		MOL CELL BIOL	Mol. Cell. Biol.	AUG	2015	35	15					2583	2596		10.1128/MCB.00048-15		14	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	CM1RZ	WOS:000357459300002		
J	Tojo, Y; Sekine, H; Hirano, I; Pan, XQ; Souma, T; Tsujita, T; Kawaguchi, S; Takeda, N; Takeda, K; Fong, GH; Dan, T; Ichinose, M; Miyata, T; Yamamoto, M; Suzuki, N				Tojo, Yutaka; Sekine, Hiroki; Hirano, Ikuo; Pan, Xiaoqing; Souma, Tomokazu; Tsujita, Tadayuki; Kawaguchi, Shin-ichi; Takeda, Norihiko; Takeda, Kotaro; Fong, Guo-Hua; Dan, Takashi; Ichinose, Masakazu; Miyata, Toshio; Yamamoto, Masayuki; Suzuki, Norio			Hypoxia Signaling Cascade for Erythropoietin Production in Hepatocytes	MOLECULAR AND CELLULAR BIOLOGY			English	Article							HYDROXYLASE DOMAIN PROTEIN-2; LINDAU TUMOR-SUPPRESSOR; INDUCIBLE-FACTOR; GENE-EXPRESSION; ERYTHROID PROGENITORS; PROLYL HYDROXYLATION; RESPONSIVE ELEMENT; LIPID-METABOLISM; CANCER-CELLS; MICE LACKING	Erythropoietin (Epo) is produced in the kidney and liver in a hypoxia-inducible manner via the activation of hypoxia-inducible transcription factors (HIFs) to maintain oxygen homeostasis. Accelerating Epo production in hepatocytes is one plausible therapeutic strategy for treating anemia caused by kidney diseases. To elucidate the regulatory mechanisms of hepatic Epo production, we analyzed mouse lines harboring liver-specific deletions of genes encoding HIF-prolyl-hydroxylase isoforms (PHD1, PHD2, and PHD3) that mediate the inactivation of HIF1 alpha and HIF2 alpha under normal oxygen conditions. The loss of all PHD isoforms results in both polycythemia, which is caused by Epo overproduction, and fatty livers. We found that deleting any combination of two PHD isoforms induces polycythemia without steatosis complications, whereas the deletion of a single isoform induces no apparent phenotype. Polycythemia is prevented by the loss of either HIF2 alpha or the hepatocyte-specific Epo gene enhancer (EpoHE). Chromatin analyses show that the histones around EpoHE dissociate from the nucleosome structure after HIF2 alpha activation. HIF2 alpha also induces the expression of HIF3 alpha, which is involved in the attenuation of Epo production. These results demonstrate that the total amount of PHD activity is more important than the specific function of each isoform for hepatic Epo expression regulated by a PHD-HIF2 alpha-EpoHE cascade in vivo.	[Tojo, Yutaka; Sekine, Hiroki; Pan, Xiaoqing; Suzuki, Norio] Tohoku Univ, Div Interdisciplinary Med Sci, Sendai, Miyagi 980, Japan; [Tojo, Yutaka; Sekine, Hiroki; Hirano, Ikuo; Pan, Xiaoqing; Souma, Tomokazu; Tsujita, Tadayuki; Yamamoto, Masayuki] Tohoku Univ, Dept Med Biochem, Sendai, Miyagi 980, Japan; [Tojo, Yutaka; Ichinose, Masakazu] Tohoku Univ, Dept Resp Med, Sendai, Miyagi 980, Japan; [Kawaguchi, Shin-ichi; Dan, Takashi; Miyata, Toshio] Tohoku Univ, Div Mol Med & Therapy, Sendai, Miyagi 980, Japan; [Takeda, Norihiko] Univ Tokyo, Dept Cardiovasc Med, Grad Sch Med, Tokyo, Japan; [Takeda, Kotaro; Fong, Guo-Hua] Univ Connecticut, Ctr Hlth, Dept Cell Biol, Ctr Vasc Biol, Farmington, CT USA	Suzuki, N (reprint author), Tohoku Univ, Div Interdisciplinary Med Sci, Sendai, Miyagi 980, Japan.	sunorio@med.tohoku.ac.jp	Miyata, Toshio/A-4872-2010; Kawaguchi, Shin-ichi/D-1182-2012		MEXT/JSPS KAKENHI [26111002, 24249015, 26116702, 25670157]; Inamori Foundation; Takeda Science Foundation; MEXT, Japan	This work was supported in part by grants-in-aid from MEXT/JSPS KAKENHI (grants 26111002 and 24249015 to M.Y. and 26116702 and 25670157 to N.S.), the Inamori Foundation (N.S.), the Takeda Science Foundation (N.S.), and the Platform for Drug Discovery, Informatics, and Structural Life Science from MEXT, Japan (T.T., T.M., M.Y., and N.S.).	Albiero E, 2012, HAEMATOL-HEMATOL J, V97, P123, DOI 10.3324/haematol.2010.039545; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Qu AJ, 2011, HEPATOLOGY, V54, P472, DOI 10.1002/hep.24400; Ohtsuji M, 2008, J BIOL CHEM, V283, P33554, DOI 10.1074/jbc.M804597200; Rankin EB, 2007, J CLIN INVEST, V117, P1068, DOI 10.1172/JCI30117; Fielder PJ, 1996, BLOOD, V87, P2154; Takeda K, 2008, BLOOD, V111, P3229, DOI 10.1182/blood-2007-09-114561; Souma T, 2013, J AM SOC NEPHROL, V24, P1599, DOI 10.1681/ASN.2013010030; Postic C, 1999, J BIOL CHEM, V274, P305, DOI 10.1074/jbc.274.1.305; Minamishima YA, 2009, MOL CELL BIOL, V29, P5729, DOI 10.1128/MCB.00331-09; Asada N, 2011, J CLIN INVEST, V121, P3981, DOI 10.1172/JCI57301; Percy MJ, 2006, P NATL ACAD SCI USA, V103, P654, DOI 10.1073/pnas.0508423103; Warnecke C, 2004, FASEB J, V18, P1462, DOI 10.1096/fj.04-1640fje; Lendahl U, 2009, NAT REV GENET, V10, P821, DOI 10.1038/nrg2665; Obara N, 2008, BLOOD, V111, P5223, DOI 10.1182/blood-2007-10-115857; Scheuermann TH, 2013, NAT CHEM BIOL, V9, P271, DOI [10.1038/nchembio.1185, 10.1038/NCHEMBIO.1185]; Liu QD, 2012, J CLIN INVEST, V122, P4635, DOI 10.1172/JCI63924; Bernhardt WM, 2010, J AM SOC NEPHROL, V21, P2151, DOI 10.1681/ASN.2010010116; Pasanen A, 2010, INT J BIOCHEM CELL B, V42, P1189, DOI 10.1016/j.biocel.2010.04.008; Ebert BL, 1999, BLOOD, V94, P1864; Makino Y, 2001, NATURE, V414, P550, DOI 10.1038/35107085; Kallio PJ, 1999, J BIOL CHEM, V274, P6519, DOI 10.1074/jbc.274.10.6519; Rankin EB, 2009, MOL CELL BIOL, V29, P4527, DOI 10.1128/MCB.00200-09; Miyata T, 2013, KIDNEY INT, V84, P693, DOI 10.1038/ki.2013.74; Suzuki N, 2011, MOL CELL BIOL, V31, P3896, DOI 10.1128/MCB.05463-11; Tanaka T, 2009, BIOCHEM J, V424, P143, DOI 10.1042/BJ20090120; Takeda K, 2006, MOL CELL BIOL, V26, P8336, DOI 10.1128/MCB.00425-06; Babitt JL, 2012, J AM SOC NEPHROL, V23, P1631, DOI 10.1681/ASN.2011111078; Metzen E, 2005, BIOCHEM J, V387, P711, DOI 10.1042/BJ20041736; Pescador N, 2005, BIOCHEM J, V390, P189, DOI 10.1042/BJ20042121; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Befani C, 2013, INT J BIOCHEM CELL B, V45, P2359, DOI 10.1016/j.biocel.2013.07.025; Haase VH, 2001, P NATL ACAD SCI USA, V98, P1583, DOI 10.1073/pnas.98.4.1583; Gross AW, 2006, J BIOL CHEM, V281, P2024, DOI 10.1074/jbc.M510493200; Makino Y, 2002, J BIOL CHEM, V277, P32405, DOI 10.1074/jbc.C200328200; Lee K, 2009, P NATL ACAD SCI USA, V106, P17910, DOI 10.1073/pnas.0909353106; MILLEDGE JS, 1985, J APPL PHYSIOL, V59, P360; Vachal P, 2012, J MED CHEM, V55, P2945, DOI 10.1021/jm201542d; GREENSPAN P, 1985, J CELL BIOL, V100, P965, DOI 10.1083/jcb.100.3.965; Wang F, 2004, J BIOL CHEM, V279, P46733, DOI 10.1074/jbc.M409002200; Chen P, 2013, GENE DEV, V27, P2109, DOI 10.1101/gad.222174.113; Minamishima YA, 2010, SCIENCE, V329, P407, DOI 10.1126/science.1192811; Zhang J, 2009, CELL DEATH DIFFER, V16, P939, DOI 10.1038/cdd.2009.16; Ivan M, 2002, P NATL ACAD SCI USA, V99, P13459, DOI 10.1073/pnas.192342099; Gruber M, 2007, P NATL ACAD SCI USA, V104, P2301, DOI 10.1073/pnas.0608382104; SEMENZA GL, 1991, P NATL ACAD SCI USA, V88, P8725, DOI 10.1073/pnas.88.19.8725; Makino Y, 2007, J BIOL CHEM, V282, P14073, DOI 10.1074/jbc.M700732200; WU H, 1995, CELL, V83, P59, DOI 10.1016/0092-8674(95)90234-1; Maynard MA, 2003, J BIOL CHEM, V278, P11032, DOI 10.1074/jbc.M208681200; Franke K, 2013, BLOOD, V122, P1122, DOI 10.1182/blood-2013-01-478065; Duan LJ, 2014, AM J PATHOL, V184, P1240, DOI 10.1016/j.ajpath.2013.12.014; GOLDBERG MA, 1987, P NATL ACAD SCI USA, V84, P7972, DOI 10.1073/pnas.84.22.7972; GUIDET B, 1987, CHEST, V92, P867, DOI 10.1378/chest.92.5.867; Haase HV, 2013, BLOOD REV, V27, P47; Ladroue C, 2012, HAEMATOL-HEMATOL J, V97, P9, DOI 10.3324/haematol.2011.044644; Pan XQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025839; Pappalardi MB, 2011, BIOCHEM J, V436, P363, DOI 10.1042/BJ20101201; Park SK, 2007, INT J ONCOL, V30, P341; Percy MJ, 2012, AM J HEMATOL, V87, P439, DOI 10.1002/ajh.23123; Perrotta S, 2013, HAEMATOLOGICA, V98, P1624, DOI 10.3324/haematol.2013.088369; Querbes W, 2012, BLOOD, V120, P1916, DOI 10.1182/blood-2012-04-423715; Rahtu-Korpela L, 2014, DIABETES, V63, P3324, DOI 10.2337/db14-0472; SAKISAKA S, 1993, HEPATOLOGY, V18, P1357, DOI 10.1016/0270-9139(93)90224-B; Semenza G L, 2011, Cold Spring Harb Symp Quant Biol, V76, P347, DOI 10.1101/sqb.2011.76.010678; Sena JA, 2013, MOL CELL BIOL, V33, P3849, DOI 10.1128/MCB.00731-13; Suzuki N, 2003, BLOOD, V102, P3575, DOI 10.1182/blood-2003-04-1154; Suzuki N, 2007, METHOD ENZYMOL, V435, P157, DOI 10.1016/S0076-6879(07)35009-X; Yamashita T, 2008, MOL CELL BIOL, V28, P1285, DOI 10.1128/MCB.01332-07; Yamazaki S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2950; Zhang JZ, 1998, ARCH BIOCHEM BIOPHYS, V356, P86, DOI 10.1006/abbi.1998.0760	70	0	0	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0270-7306	1098-5549		MOL CELL BIOL	Mol. Cell. Biol.	AUG	2015	35	15					2658	2672		10.1128/MCB.00161-15		15	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	CM1RZ	WOS:000357459300007		
J	Morooka, S; Hoshina, M; Kii, I; Okabe, T; Kojima, H; Inoue, N; Okuno, Y; Denawa, M; Yoshida, S; Fukuhara, J; Ninomiya, K; Ikura, T; Furuya, T; Nagano, T; Noda, K; Ishida, S; Hosoya, T; Ito, N; Yoshimura, N; Hagiwara, M				Morooka, Satoshi; Hoshina, Mitsuteru; Kii, Isao; Okabe, Takayoshi; Kojima, Hirotatsu; Inoue, Naoko; Okuno, Yukiko; Denawa, Masatsugu; Yoshida, Suguru; Fukuhara, Junichi; Ninomiya, Kensuke; Ikura, Teikichi; Furuya, Toshio; Nagano, Tetsuo; Noda, Kousuke; Ishida, Susumu; Hosoya, Takamitsu; Ito, Nobutoshi; Yoshimura, Nagahisa; Hagiwara, Masatoshi			Identification of a Dual Inhibitor of SRPK1 and CK2 That Attenuates Pathological Angiogenesis of Macular Degeneration in Mice	MOLECULAR PHARMACOLOGY			English	Article							PROTEIN-KINASE CK2; EXPERIMENTAL CHOROIDAL NEOVASCULARIZATION; VEGF-SIGNALING GENES; CELL-SURVIVAL; RETINAL NEOVASCULARIZATION; ENDOTHELIAL-CELLS; CASEIN KINASE-2; MAP KINASE; CANCER; PHOSPHORYLATION	Excessive angiogenesis contributes to numerous diseases, including cancer and blinding retinopathy. Antibodies against vascular endothelial growth factor (VEGF) have been approved and are widely used in clinical treatment. Our previous studies using SRPIN340, a small molecule inhibitor of SRPK1 (serine-arginine protein kinase 1), demonstrated that SRPK1 is a potential target for the development of antiangiogenic drugs. In this study, we solved the structure of SRPK1 bound to SRPIN340 by X-ray crystallography. Using pharmacophore docking models followed by in vitro kinase assays, we screened a large-scale chemical library, and thus identified a new inhibitor of SRPK1. This inhibitor, SRPIN803, prevented VEGF production more effectively than SRPIN340 owing to the dual inhibition of SRPK1 and CK2 (casein kinase 2). In a mouse model of age-related macular degeneration, topical administration of eye ointment containing SRPIN803 significantly inhibited choroidal neovascularization, suggesting a clinical potential of SRPIN803 as a topical ointment for ocular neovascularization. Thus SRPIN803 merits further investigation as a novel inhibitor of VEGF.	[Morooka, Satoshi; Yoshimura, Nagahisa] Kyoto Univ, Grad Sch Med, Dept Ophthalmol & Visual Sci, Kyoto 6068501, Japan; [Morooka, Satoshi; Kii, Isao; Ninomiya, Kensuke; Hagiwara, Masatoshi] Kyoto Univ, Grad Sch Med, Dept Anat & Dev Biol, Kyoto 6068501, Japan; [Okuno, Yukiko; Denawa, Masatsugu] Kyoto Univ, Grad Sch Med, Med Res Support Ctr, Kyoto 6068501, Japan; [Hoshina, Mitsuteru; Ikura, Teikichi; Ito, Nobutoshi] Tokyo Med & Dent Univ, Med Res Inst, Struct Biol Lab, Tokyo, Japan; [Yoshida, Suguru; Hosoya, Takamitsu] Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Lab Chem Biosci, Tokyo, Japan; [Okabe, Takayoshi; Kojima, Hirotatsu; Nagano, Tetsuo] Univ Tokyo, Open Innovat Ctr Drug Discovery, Tokyo, Japan; [Inoue, Naoko; Furuya, Toshio] PharmaDesign Inc, Tokyo, Japan; [Fukuhara, Junichi; Noda, Kousuke; Ishida, Susumu] Hokkaido Univ, Grad Sch Med, Dept Ophthalmol, Sapporo, Hokkaido, Japan	Hagiwara, M (reprint author), Kyoto Univ, Grad Sch Med, Dept Anat & Dev Biol, Sakyo Ku, Yoshida Konoe Cho, Kyoto 6068501, Japan.	hagiwara.masatoshi.8c@kyoto-u.ac.jp	Ikura, Teikichi/N-1490-2015	Ikura, Teikichi/0000-0003-2377-5434			Martin D, 2009, J BIOL CHEM, V284, P6038, DOI 10.1074/jbc.C800207200; Litchfield DW, 2003, BIOCHEM J, V369, P1, DOI 10.1042/BJ20021469; Dong ZY, 2013, MOL VIS, V19, P536; Feng DL, 2012, ANGIOGENESIS, V15, P243, DOI 10.1007/s10456-012-9256-2; Fukuda R, 2002, J BIOL CHEM, V277, P38205, DOI 10.1074/jbc.M203781200; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Ljubimov AV, 2004, INVEST OPHTH VIS SCI, V45, P4583, DOI 10.1167/iovs.04-0686; Wolf A, 2011, J EXP MED, V208, P313, DOI 10.1084/jem.20101470; Shima C, 2008, ACTA OPHTHALMOL, V86, P372, DOI 10.1111/j.1600-0420.2007.01067.x; Baell JB, 2010, J MED CHEM, V53, P2719, DOI 10.1021/jm901137j; Ngo JCK, 2005, MOL CELL, V20, P77, DOI 10.1016/j.molcel.2005.08.025; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Dulak J, 2008, CIRCULATION, V117, P231, DOI 10.1161/CIRCULATIONAHA.107.698316; Nowak DG, 2010, J BIOL CHEM, V285, P5532, DOI 10.1074/jbc.M109.074930; Schaal S, 2008, OPHTHALMOLOGY, V115, P2199, DOI 10.1016/j.ophtha.2008.07.007; Mottet D, 2005, INT J CANCER, V117, P764, DOI 10.1002/ijc.21268; Grossniklaus HE, 2002, MOL VIS, V8, P119; Amin EM, 2011, CANCER CELL, V20, P768, DOI 10.1016/j.ccr.2011.10.016; Gammons MV, 2014, BRIT J CANCER, V111, P477, DOI 10.1038/bjc.2014.342; Fitzgerald CE, 2003, NAT STRUCT BIOL, V10, P764, DOI 10.1038/nsb949; Maharaj ASR, 2007, MICROVASC RES, V74, P100, DOI 10.1016/j.mvr.2007.03.004; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Heier JS, 2012, OPHTHALMOLOGY, V119, P2537, DOI 10.1016/j.ophtha.2012.09.006; Ogawa Y, 2012, PHARMACOL THERAPEUT, V134, P298, DOI 10.1016/j.pharmthera.2012.02.001; Rosenfeld PJ, 2006, NEW ENGL J MED, V355, P1419, DOI 10.1056/NEJMoa054481; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; KLEIN R, 1995, INVEST OPHTH VIS SCI, V36, P182; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Daub H, 2002, J VIROL, V76, P8124, DOI 10.1128/JVI.76.16.8124-8137.2002; Meggio F, 2003, FASEB J, V17, P349, DOI 10.1096/fj.02-0473rev; FERRIS FL, 1984, ARCH OPHTHALMOL-CHIC, V102, P1640; Sakurai E, 2003, INVEST OPHTH VIS SCI, V44, P3578, DOI 10.1167/iovs.03-0097; Aguilar E, 2008, METHOD ENZYMOL, V444, P115, DOI 10.1016/S0076-6879(08)02806-1; Gragoudas ES, 2004, NEW ENGL J MED, V351, P2805, DOI 10.1056/NEJMoa042760; Salcedo R, 2000, BLOOD, V96, P34; De Moliner E, 2003, J BIOL CHEM, V278, P1831, DOI 10.1074/jbc.M209367200; Espinosa-Heidmann DG, 2003, INVEST OPHTH VIS SCI, V44, P3586, DOI 10.1167/iovs.03-0038; Fukuhara T, 2006, P NATL ACAD SCI USA, V103, P11329, DOI 10.1073/pnas.0604616103; Gammons MVR, 2013, INVEST OPHTH VIS SCI, V54, P5797, DOI 10.1167/iovs.13-11634; HATHAWAY GM, 1982, CURR TOP CELL REGUL, V21, P101; Hu SI, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002466; Kramerov AA, 2008, MOL CELL BIOCHEM, V316, P177, DOI 10.1007/s11010-008-9831-4; Martin DF, 2012, OPHTHALMOLOGY, V119, DOI 10.1016/j.ophtha.2012.03.053; MEISNER H, 1989, BIOCHEMISTRY-US, V28, P4072, DOI 10.1021/bi00435a066; Mylonis I, 2003, BIOCHEM BIOPH RES CO, V301, P650, DOI 10.1016/S0006-291X(02)03055-3; Ngo JCK, 2007, STRUCTURE, V15, P123, DOI 10.1016/j.str.2006.11.011; Nikolakaki E, 2008, BBA-GEN SUBJECTS, V1780, P214, DOI 10.1016/j.bbagen.2007.10.014; Nishida A, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1306; Nolen B, 2003, BIOCHEMISTRY-US, V42, P9575, DOI 10.1021/bi0344331; Noy P, 2012, LEUKEMIA RES, V36, P1434, DOI 10.1016/j.leukres.2012.07.013; Noy P, 2012, NUCLEIC ACIDS RES, V40, P9008, DOI 10.1093/nar/gks687; Okabe K, 2014, CELL, V159, P584, DOI 10.1016/j.cell.2014.09.025; Olsten MEK, 2004, BIOCHEM CELL BIOL, V82, P681, DOI 10.1139/O04-116; PINNA LA, 1990, BIOCHIM BIOPHYS ACTA, V1054, P267, DOI 10.1016/0167-4889(90)90098-X; Pollreisz A, 2013, EXP EYE RES, V116, P177, DOI 10.1016/j.exer.2013.08.021; Seddon Johanna M., 2004, International Ophthalmology Clinics, V44, P17, DOI 10.1097/00004397-200404440-00004; Tatar O, 2008, ARCH OPHTHALMOL-CHIC, V126, P782, DOI 10.1001/archopht.126.6.782; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Unger GM, 2004, CURR CANCER DRUG TAR, V4, P77, DOI 10.2174/1568009043481687; Ventrice P, 2013, J PHARM PHARMACOT S1, V1, pS38; Wang PP, 2014, MOL CELL, V54, P378, DOI 10.1016/j.molcel.2014.03.007; Xu J, 2008, J CELL MOL MED, V12, P2395, DOI 10.1111/j.1582-4934.2008.00266.x; Xue YF, 2013, CHEMMEDCHEM, V8, P1846, DOI 10.1002/cmdc.201300274	64	0	0	AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3995 USA	0026-895X	1521-0111		MOL PHARMACOL	Mol. Pharmacol.	AUG	2015	88	2					316	325		10.1124/mol.114.097345		10	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CL6QR	WOS:000357092600011		
J	Tang, RQ; Gao, LJ; Kawatani, M; Chen, JZ; Cao, XL; Osada, H; Xiang, L; Qi, JH				Tang, Ruiqi; Gao, Lijuan; Kawatani, Makoto; Chen, Jianzhong; Cao, Xueli; Osada, Hiroyuki; Xiang, Lan; Qi, Jianhua			Neuritogenic Activity of Tetradecyl 2,3-Dihydroxybenzoate Is Mediated through the Insulin-Like Growth Factor 1 Receptor/Phosphatidylinositol 3 Kinase/Mitogen-Activated Protein Kinase Signaling Pathway	MOLECULAR PHARMACOLOGY			English	Article							STARFISH LINCKIA-LAEVIGATA; NEURITE OUTGROWTH; PC12 CELLS; NEURONAL DIFFERENTIATION; PHOSPHATIDYLINOSITOL 3-KINASE; NEUROTROPHIN RECEPTORS; SYMPATHETIC NEURONS; STEROID GLYCOSIDES; CYCLIC-AMP; SURVIVAL	Tetradecyl 2,3-dihydroxybenzoate (ABG-001) is a lead compound derived from neuritogenic gentisides. In the present study, we investigated the mechanism by which ABG-001 induces neurite outgrowth in a rat adrenal pheochromocytoma cell line (PC12). Inhibitors of insulin-like growth factor 1 (IGF-1) receptor, phosphatidylinositol 3-kinase (PI3K), and extracellular signal-regulated kinase (ERK) 1/2 significantly decreased ABG-001-induced neurite outgrowth. Western blot analysis revealed that ABG-001 significantly induced phosphorylation of IGF-1 receptor, protein kinase B (Akt), ERK, and cAMP responsive element-binding protein (CREB). These effects were markedly reduced by addition of the corresponding inhibitors. We also found that ABG-001-induced neurite outgrowth was reduced by protein kinase C inhibitor as well as small-interfering RNA against the IGF-1 receptor. Furthermore, like ABG-001, IGF-1 also induced neurite outgrowth of PC12 cells, and low-dose nerve growth factor augmented the observed effects of ABG-001 on neurite outgrowth. These results suggest that ABG-001 targets the IGF-1 receptor and activates PI3K, mitogen-activated protein kinase, and their downstream signaling cascades to induce neurite outgrowth.	[Tang, Ruiqi; Gao, Lijuan; Chen, Jianzhong; Cao, Xueli; Xiang, Lan; Qi, Jianhua] Zhejiang Univ, Coll Pharmaceut Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Kawatani, Makoto; Osada, Hiroyuki] RIKEN, Adv Sci Inst, Chem Biol Core Facil, Saitama, Japan	Qi, JH (reprint author), Coll Pharmaceut Sci, Inst Med Chem, Yu Hang Tang Rd 866, Hangzhou 310058, Zhejiang, Peoples R China.	lxiang@zju.edu.cn; qijianhua@zju.edu.cn					Annenkov A, 2009, MOL NEUROBIOL, V40, P195, DOI 10.1007/s12035-009-8081-0; TAPLEY P, 1992, ONCOGENE, V7, P371; Chao MV, 2003, NAT REV NEUROSCI, V4, P299, DOI 10.1038/nrn1078; Sabbagh MN, 2009, AM J GERIATR PHARMAC, V7, P167, DOI 10.1016/j.amjopharm.2009.06.003; Alessi DR, 1997, FEBS LETT, V402, P121, DOI 10.1016/S0014-5793(96)01510-4; TRAVERSE S, 1992, BIOCHEM J, V288, P351; Cui QL, 2007, J NEUROCHEM, V100, P1480, DOI 10.1111/j.1471-4159.2006.04329.x; Qi JH, 2004, BIOORGAN MED CHEM, V12, P4259, DOI 10.1016/j.bmc.2004.04.049; Gao LJ, 2010, BIOORGAN MED CHEM, V18, P2131, DOI 10.1016/j.bmc.2010.02.004; McAllister AK, 2001, CELL MOL LIFE SCI, V58, P1054, DOI 10.1007/PL00000920; Pierchala BA, 2004, J BIOL CHEM, V279, P27986, DOI 10.1074/jbc.M312237200; Qi JH, 2000, TETRAHEDRON, V56, P5835, DOI 10.1016/S0040-4020(00)00548-2; Bibollet-Bahena O, 2009, J NEUROCHEM, V109, P1440, DOI 10.1111/j.1471-4159.2009.06071.x; Kusunoki T, 2008, NEUROSCI LETT, V431, P256, DOI 10.1016/j.neulet.2007.11.058; Chitnis MM, 2008, CLIN CANCER RES, V14, P6364, DOI 10.1158/1078-0432.CCR-07-4879; Yang TT, 2009, J PHARMACOL EXP THER, V331, P244, DOI 10.1124/jpet.109.155176; Rubinfeld H, 2005, MOL BIOTECHNOL, V31, P151, DOI 10.1385/MB:31:2:151; Macready AL, 2009, GENES NUTR, V4, P227, DOI 10.1007/s12263-009-0135-4; Vaudry D, 2002, SCIENCE, V296, P1648, DOI 10.1126/science.1071552; Dawbarn D, 2003, NEUROPATH APPL NEURO, V29, P211, DOI 10.1046/j.1365-2990.2003.00487.x; Gao LJ, 2010, BIOORGAN MED CHEM, V18, P6995, DOI 10.1016/j.bmc.2010.08.020; Qi JH, 2002, BIOORGAN MED CHEM, V10, P1961, DOI 10.1016/S0968-0896(02)00006-8; Crowder RJ, 1998, J NEUROSCI, V18, P2933; Kolkova K, 2000, J NEUROSCI, V20, P2238; Chen APJ, 2010, TETRAHEDRON, V66, P6842, DOI 10.1016/j.tet.2010.06.056; Clement CM, 2009, NEUROSCI LETT, V459, P157, DOI 10.1016/j.neulet.2009.05.010; Gelderblom M, 2004, INT J DEV NEUROSCI, V22, P559, DOI 10.1016/j.ijdevneu.2004.07.014; Hansen TVO, 2000, J NEUROCHEM, V75, P1870, DOI 10.1046/j.1471-4159.2000.0751870.x; Jeon CY, 2010, SYNAPSE, V64, P765, DOI 10.1002/syn.20789; Jeon CY, 2010, J CELL PHYSIOL, V224, P786, DOI 10.1002/jcp.22184; Kaplan DR, 1997, CURR OPIN CELL BIOL, V9, P213, DOI 10.1016/S0955-0674(97)80065-8; Li P, 2003, DEV BRAIN RES, V145, P177, DOI 10.1016/S0165-3806(03)00239-6; Linder S, 2007, CANCER RES, V67, P2899, DOI 10.1158/0008-5472.CAN-06-0635; Luo Y, 2011, CHEMMEDCHEM, V6, P1986, DOI 10.1002/cmdc.201100348; Pandya CD, 2014, CELL COMMUN SIGNAL, V12, DOI 10.1186/s12964-014-0047-9; Tang TH, 1977, DICT TRADITIONAL CHI, P627; Wen B, 2001, BRIT J CANCER, V85, P2017, DOI 10.1054/bjoc.2001.2171; Weng MS, 2011, J AGR FOOD CHEM, V59, P1031, DOI 10.1021/jf104263s; Yamazaki M, 2001, BIOL PHARM BULL, V24, P1434, DOI 10.1248/bpb.24.1434	39	0	0	AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3995 USA	0026-895X	1521-0111		MOL PHARMACOL	Mol. Pharmacol.	AUG	2015	88	2					326	334		10.1124/mol.115.097758		9	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CL6QR	WOS:000357092600012		
J	Ogura, R; Tsukamoto, Y; Natsumeda, M; Isogawa, M; Aoki, H; Kobayashi, T; Yoshida, S; Okamoto, K; Takahashi, H; Fujii, Y; Kakita, A				Ogura, Ryosuke; Tsukamoto, Yoshihiro; Natsumeda, Manabu; Isogawa, Mizuho; Aoki, Hiroshi; Kobayashi, Tsutomu; Yoshida, Seiichi; Okamoto, Kouichiro; Takahashi, Hitoshi; Fujii, Yukihiko; Kakita, Akiyoshi			Immunohistochemical profiles of IDH1, MGMT and P53: Practical significance for prognostication of patients with diffuse gliomas	NEUROPATHOLOGY			English	Article						glioma; IDH1; immunohistochemistry; MGMT; p53	O-6-METHYLGUANINE-DNA METHYLTRANSFERASE MGMT; PROMOTER METHYLATION; CPG ISLAND; GLIOBLASTOMA-MULTIFORME; ULCERATIVE-COLITIS; PROTEIN EXPRESSION; MALIGNANT GLIOMAS; GENE-EXPRESSION; GRADE GLIOMAS; MUTATIONS	Genetic and epigenetic status, including mutations of isocitrate dehydrogenase (IDH) and TP53 and methylation of O-6-methylguanine-DNA methyltransferase (MGMT), are associated with the development of various types of glioma and are useful for prognostication. Here, using routinely available histology sections from 312 patients with diffuse gliomas, we performed immunohistochemistry using antibodies specific for IDH1 mutation, MGMT methylation status, and aberrant p53 expression to evaluate the possible prognostic significance of these features. With regard to overall survival (OS), univariate analysis indicated that an IDH1-positive profile in patients with glioblastoma (GBM), anaplastic astrocytoma (AA), anaplastic oligoastrocytoma and oligodendroglioma, or a MGMT-negative profile in patients with GBM and AA were significantly associated with a favorable outcome. Multivariate analysis revealed that both profiles were independent factors influencing prognosis. The OS of patients with IDH1-positive/MGMT-negative profiles was significantly longer than that of patients with negative/negative and negative/positive profiles. A p53 profile was not an independent prognostic factor. However, for GBM/AA patients with IDH1-negative/MGMT-negative profiles, p53 overexpression was significantly associated with an unfavorable outcome. Thus, the immunohistochemical profiles of IDH1 and MGMT are of considerable significance in gliomas, and a combination of IDH1, MGMT and p53 profiles may be useful for prognostication of GBM/AA.	[Natsumeda, Manabu; Isogawa, Mizuho; Aoki, Hiroshi; Kobayashi, Tsutomu; Yoshida, Seiichi; Okamoto, Kouichiro; Fujii, Yukihiko] Niigata Univ, Brain Res Inst, Dept Neurosurg, Niigata 9518585, Japan; [Ogura, Ryosuke; Tsukamoto, Yoshihiro; Takahashi, Hitoshi; Kakita, Akiyoshi] Niigata Univ, Brain Res Inst, Dept Pathol, Niigata 9518585, Japan	Kakita, A (reprint author), Niigata Univ, Brain Res Inst, Dept Pathol, Chuo Ku, 1-757 Asahimachi, Niigata 9518585, Japan.	kakita@bri.niigata-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology, Japan [25250008]; Ministry of Health, Labor and Welfare, Japan [24-7]	We thank Professor Kouhei Akazawa, Department of Medical Informatics, University of Niigata, for statistical analysis. This work was supported by a Grant-in-Aid for Scientific Research (no. 25250008) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan, and a grant (24-7) for Nervous and Mental Disorders from the Ministry of Health, Labor and Welfare, Japan.	Sanson M, 2009, J CLIN ONCOL, V27, P4150, DOI 10.1200/JCO.2009.21.9832; Preusser M, 2008, BRAIN PATHOL, V18, P520, DOI 10.1111/j.1750-3639.2008.00153.x; Issa JPJ, 2001, CANCER RES, V61, P3573; Cooks T, 2013, CANCER CELL, V23, P634, DOI 10.1016/j.ccr.2013.03.022; Arita H, 2013, ACTA NEUROPATHOL, V126, P267, DOI 10.1007/s00401-013-1141-6; Bleeker FE, 2009, HUM MUTAT, V30, P7, DOI 10.1002/humu.20937; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; Cao VT, 2009, NEUROSURGERY, V65, P866, DOI 10.1227/01.NEU.0000357325.90347.A1; Peraud A, 2002, CLIN CANCER RES, V8, P1117; Dubbink HJ, 2009, NEUROLOGY, V73, P1792, DOI 10.1212/WNL.0b013e3181c34ace; Xu W, 2011, CANCER CELL, V19, P17, DOI 10.1016/j.ccr.2010.12.014; Weller M, 2012, NEURO-ONCOLOGY, V14, P100, DOI 10.1093/neuonc/nos206; Capper D, 2008, ACTA NEUROPATHOL, V115, P249, DOI 10.1007/s00401-007-0310-x; Loussouarn D, 2012, INT J ONCOL, V40, P2058, DOI 10.3892/ijo.2012.1404; Everhard S, 2009, NEURO-ONCOLOGY, V11, P348, DOI 10.1215/15228517-2009-001; Ichimura K, 2009, NEURO-ONCOLOGY, V11, P341, DOI 10.1215/15228517-2009-025; Reifenberger J, 1996, J NEUROPATH EXP NEUR, V55, P822, DOI 10.1097/00005072-199607000-00007; Mellai M, 2011, J NEURO-ONCOL, V105, P345, DOI 10.1007/s11060-011-0596-3; Momota H, 2010, BRAIN TUMOR PATHOL, V27, P95, DOI 10.1007/s10014-010-0272-x; Sonoda Y, 2009, CANCER SCI, V100, P1996, DOI 10.1111/j.1349-7006.2009.01270.x; Gupta R, 2011, J CLIN PATHOL, V64, P835, DOI 10.1136/jclinpath-2011-200227; Agarwal S, 2013, NEURO-ONCOLOGY, V15, P718, DOI 10.1093/neuonc/not015; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Capper D, 2010, BRAIN PATHOL, V20, P245, DOI 10.1111/j.1750-3639.2009.00352.x; Wick W, 2009, J CLIN ONCOL, V27, P5874, DOI 10.1200/JCO.2009.23.6497; Pardo FS, 2004, BRIT J CANCER, V91, P1678, DOI 10.1038/sj.bjc.6602161; Nobusawa S, 2010, BRAIN PATHOL, V20, P936, DOI 10.1111/j.1750-3639.2010.00395.x; Quillien V, 2012, CANCER-AM CANCER SOC, V118, P4201, DOI 10.1002/cncr.27392; Ogura R, 2013, NEUROPATHOLOGY, V33, P436, DOI 10.1111/neup.12005; Zhang CZ, 2013, NEURO-ONCOLOGY, V15, P1114, DOI 10.1093/neuonc/not087; Weller M, 2009, J CLIN ONCOL, V27, P5743, DOI 10.1200/JCO.2009.23.0805; Hsieh CJ, 1998, CANCER RES, V58, P3942; Rodriguez FJ, 2010, AM J SURG PATHOL, V34, P147, DOI 10.1097/PAS.0b013e3181c75238; Weller M, 2010, NAT REV NEUROL, V6, P39, DOI 10.1038/nrneurol.2009.197; Houillier C, 2010, NEUROLOGY, V75, P1560, DOI 10.1212/WNL.0b013e3181f96282; Parkinson JF, 2008, J NEURO-ONCOL, V87, P71, DOI 10.1007/s11060-007-9486-0; van den Bent MJ, 2010, CLIN CANCER RES, V16, P1597, DOI 10.1158/1078-0432.CCR-09-2902; Nakagawachi T, 2003, ONCOGENE, V22, P8835, DOI 10.1038/sj.onc.1207183; Zhao W, 2005, J BIOCHEM, V137, P431, DOI 10.1093/jb/mvi048; Ramakrishnan V, 2011, CANCER BIOMARK, V10, P185, DOI 10.3233/CBM-2012-0245; Hegi ME, 2005, NEW ENGL J MED, V352, P997, DOI 10.1056/NEJMoa043331; Lalezari S, 2013, NEURO-ONCOLOGY, V15, P370, DOI 10.1093/neuonc/nos308; Turcan S, 2012, NATURE, V483, P479, DOI 10.1038/nature10866; Kitange GJ, 2012, CLIN CANCER RES, V18, P4070, DOI 10.1158/1078-0432.CCR-12-0560; Arita H, 2015, BRAIN TUMOR PATHOL, V32, P22, DOI 10.1007/s10014-014-0186-0; Cancer Genome Atlas Research Network, 2008, NATURE, V455, P1061, DOI DOI 10.1038/NATURE07385; Chen WW, 2013, MOL THER-NUCL ACIDS, V2, DOI 10.1038/mtna.2013.28; Felsberg J, 2010, ACTA NEUROPATHOL, V119, P501, DOI 10.1007/s00401-010-0647-4; Figarella-Branger D, 2011, REV NEUROL-FRANCE, V167, P683, DOI 10.1016/j.neurol.2011.07.006; Figarella-Branger D, 2012, J NEURO-ONCOL, V110, P205, DOI 10.1007/s11060-012-0953-x; Horbinski C, 2009, J NEUROPATHOL EXP NE, V268, P1597; Kreth S, 2013, ACTA NEUROPATHOL, V125, P671, DOI 10.1007/s00401-013-1081-1; Kuo LT, 2009, PLOS ONE, V24; Louis DN, 2007, WHO CLASSIFICATION T; Molenaar RJ, 2014, NEURO-ONCOLOGY, DOI [10.1093/neuonc/nou005, DOI 10.1093/NEU0NC/N0U005]; Nakasu S, 2004, J NEURO-ONCOL, V70, P333, DOI 10.1007/s11060-004-9170-6; Sasai K, 2008, AM J SURG PATHOL, V32, P1220, DOI 10.1097/PAS.0b013e318164c3f0; Spiegl-Kreinecker S, 2010, NEURO-ONCOLOGY, V12, P28, DOI 10.1093/neuonc/nop003; Takami H, 2015, BRAIN PATHOL, V25, P256, DOI 10.1111/bpa.12173	59	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0919-6544	1440-1789		NEUROPATHOLOGY	Neuropathology	AUG	2015	35	4					324	335		10.1111/neup.12196		12	Clinical Neurology; Neurosciences; Pathology	Neurosciences & Neurology; Pathology	CL9YR	WOS:000357335600003		
J	Kondo, R; Sugita, Y; Arakawa, K; Nakashima, S; Umeno, Y; Todoroki, K; Yoshida, T; Takase, Y; Kage, M; Oshima, K; Yano, H				Kondo, Reiichiro; Sugita, Yasuo; Arakawa, Kenji; Nakashima, Shinji; Umeno, Yumi; Todoroki, Keita; Yoshida, Tomoko; Takase, Yorihiko; Kage, Masayoshi; Oshima, Koichi; Yano, Hirohisa			Neurogenic pulmonary edema following Cryptococcal meningoencephalitis associated with HIV infection	NEUROPATHOLOGY			English	Article						autopsy; cryptococcus; HIV; meningitis; pulmonary edema	MENINGITIS; HEMORRHAGE; AIDS	Neurogenic pulmonary edema (NPE) is a clinical syndrome characterized by the acute onset of pulmonary edema following a significant central nervous system insult. Only a few cases of NPE after Cryptococcal meningitis have been reported. We report a case of NPE following Cryptococcal meningoencephalitis. A 40-year-old man with no medical history was hospitalized for disturbance of consciousness. Blood glucose level was 124mg/dL. Non-contrast head computed tomography showed no abnormalities. Lumbar puncture revealed a pressure of over 300mm H2O and cerebrospinal fluid (CSF) confirmed a white blood cell count of 65/mm(3). The CSF glucose level was 0mg/dL. The patient was empirically started on treatment for presumptive bacterial and viral meningitis. Four days after, the patient died in a sudden severe pulmonary edema. Autopsy was performed. We found at autopsy a brain edema with small hemorrhage of the right basal ganglia, severe pulmonary edema and mild cardiomegaly. Histologically, dilated Virchow-Robin spaces, crowded with Cryptococci were observed. In the right basal ganglia, Virchow-Robin spaces were destroyed with hemorrhage and Cryptococci spread to parenchyma of the brain. No inflammatory reaction of the lung was seen. Finally, acute pulmonary edema in this case was diagnosed as NPE following Cryptococcal meningoencephalitis. After autopsy, we found that he was positive for serum antibodies to human immunodeficiency virus.	[Kondo, Reiichiro; Sugita, Yasuo; Nakashima, Shinji; Umeno, Yumi; Todoroki, Keita; Oshima, Koichi; Yano, Hirohisa] Kurume Univ, Sch Med, Dept Pathol, Kurume, Fukuoka 8300011, Japan; [Kondo, Reiichiro; Kage, Masayoshi] Kurume Univ Hosp, Ctr Canc, Fukuoka, Japan; [Kondo, Reiichiro; Yoshida, Tomoko; Takase, Yorihiko; Kage, Masayoshi] Kurume Univ Hosp, Dept Diagnost Pathol, Fukuoka, Japan; [Arakawa, Kenji] Saiseikai Futsukaichi Hosp, Dept Neurol, Fukuoka, Japan	Kondo, R (reprint author), Kurume Univ, Sch Med, Dept Pathol, 67 Asahi Machi, Kurume, Fukuoka 8300011, Japan.	kondou_reiichirou@kurume-u.ac.jp					Visnegarwala F, 1998, CLIN INFECT DIS, V27, P1231, DOI 10.1086/514984; Jarvis JN, 2007, AIDS, V21, P2119; Bahloul M, 2006, AM J CRIT CARE, V15, P462; Lee SC, 1996, HUM PATHOL, V27, P839, DOI 10.1016/S0046-8177(96)90459-1; Klock C, 2009, INT J SURG PATHOL, V17, P444, DOI 10.1177/1066896908320550; ROGERS FB, 1995, J TRAUMA, V39, P860, DOI 10.1097/00005373-199511000-00009; Fontes RBV, 2003, J NEUROSURG ANESTH, V15, P144, DOI 10.1097/00008506-200304000-00013; Muroi C, 2008, J NEUROSURG ANESTH, V20, P188, DOI 10.1097/ANA.0b013e3181778156; Baumann A, 2007, ACTA ANAESTH SCAND, V51, P447, DOI 10.1111/j.1399-6576.2007.01276; Bos HM, 2001, NEUROLOGY, V57, P1560; Chotmongkol V, 1990, J MED ASS THAI, V9, P530; Davison DL, 2012, CRIT CARE, V16, DOI 10.1186/cc11226; D'Souza R, 2001, SCOT MED J, V46, P115; FRANKEL RJ, 1976, POSTGRAD MED J, V52, P529; Krous HF, 2007, PEDIATR DEVEL PATHOL, V10, P463, DOI 10.2350/06-08-0156.1; Makaryus JN, 2009, HEART LUNG CIRC, V18, P155, DOI 10.1016/j.hlc.2007.10.007; Padley JR, 2012, HEART LUNG CIRC, V21, P853, DOI 10.1016/j.hlc.2012.06.003; Pai-Ching T, 2014, NEUROL ASIA, V19, P195; Peter P, 2003, PEDIATR CRIT CARE ME, V4, P377	19	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0919-6544	1440-1789		NEUROPATHOLOGY	Neuropathology	AUG	2015	35	4					343	347		10.1111/neup.12193		5	Clinical Neurology; Neurosciences; Pathology	Neurosciences & Neurology; Pathology	CL9YR	WOS:000357335600005		
J	Kitayama, T; Morita, Y; Nakajima, K; Narumi, K; Saitoh, Y; Matsuda, M; Sataka, M; Tsujimoto, M; Isoda, S; Toulemonde, M; Kimura, K				Kitayama, T.; Morita, Y.; Nakajima, K.; Narumi, K.; Saitoh, Y.; Matsuda, M.; Sataka, M.; Tsujimoto, M.; Isoda, S.; Toulemonde, M.; Kimura, K.			Formation of ion tracks in amorphous silicon nitride films with MeV C-60 ions	NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION B-BEAM INTERACTIONS WITH MATERIALS AND ATOMS			English	Article						Ion track; C-60; Silicon nitride	SI3N4 FILMS; CREATION	Amorphous silicon nitride (a-SiN) films (thickness 5-100 nm) were irradiated with 0.12-5 MeV C-60, 100 MeV Xe, 200 MeV Kr, and 200 and 420 MeV Au ions. Ion tracks were clearly observed using high-angle annular dark field scanning transmission electron microscopy (HAADF-STEM) except for 100 MeV Xe and 200 MeV Kr. The observed HAADF-STEM images showed that the ion tracks consist of a low density core (0.5-2 nm in radius) and a high density shell (several nm in radius). The observed core and shell radii are not simply correlated with the electronic energy loss indicating that the nuclear energy loss plays an important role in the both core and shell formations. The observed track radii were well reproduced by the unified thermal spike model with two thresholds for shell and core formations. (C) 2015 Elsevier B.V. All rights reserved.	[Kitayama, T.; Morita, Y.; Nakajima, K.; Kimura, K.] Kyoto Univ, Dept Micro Engn, Kyoto 6068501, Japan; [Narumi, K.; Saitoh, Y.] Japan Atom Energy Agcy, Takasaki Adv Radiat Res Inst, Takasaki, Gumma 3701292, Japan; [Matsuda, M.; Sataka, M.] Japan Atom Energy Agcy, Nucl Sci Res Inst, Naka, Ibaraki 3191195, Japan; [Tsujimoto, M.; Isoda, S.] Kyoto Univ, Inst Integrated Cell Mat Sci, Kyoto 6068501, Japan; [Toulemonde, M.] Univ Caen Basse Normandie, CNRS, CEA, ENSICAEN,CIMAP,GANIL, F-14070 Caen, France	Kimura, K (reprint author), Kyoto Univ, Dept Micro Engn, Kyoto 6068501, Japan.	kimura@kues.kyoto-u.ac.jp			JSPS KAKENHI Grant [24651114, 26246025]	This work was performed under the shared use program of JAEA facilities. The authors are grateful to the crews of the 400-kV ion implanter and the 3 MV tandem accelerator at JAEA/Takasaki for irradiation of C<INF>60</INF> ions. They are also grateful to the technical staff of the accelerator facilities at JAEA/Tokai for the irradiation of Kr, Xe and Au ions. This work was supported by JSPS KAKENHI Grant (Grant Numbers 24651114 and 26246025).	Toulemonde M, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.054112; Toulemonde M, 2012, NUCL INSTRUM METH B, V277, P28, DOI 10.1016/j.nimb.2011.12.045; Pakarinen OH, 2009, NUCL INSTRUM METH B, V267, P1456, DOI 10.1016/j.nimb.2009.01.071; DUNLOP A, 1993, RADIAT EFF DEFECT S, V126, P123, DOI 10.1080/10420159308219692; Nakajima K, 2014, NUCL INSTRUM METH B, V332, P117, DOI 10.1016/j.nimb.2014.02.042; Nakajima K, 2012, NUCL INSTRUM METH B, V291, P12, DOI 10.1016/j.nimb.2012.09.007; SILK ECH, 1959, PHILOS MAG, V4, P970, DOI 10.1080/14786435908238273; Rotaru C, 2012, NUCL INSTRUM METH B, V272, P9, DOI 10.1016/j.nimb.2011.01.022; Meftah A, 2005, NUCL INSTRUM METH B, V237, P563, DOI 10.1016/j.nimb.2005.02.025; Morita Y, 2013, NUCL INSTRUM METH B, V315, P142, DOI 10.1016/j.nimb.2013.03.043; Toulemonde M, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.054106; Jensen J, 1998, NUCL INSTRUM METH B, V146, P412, DOI 10.1016/S0168-583X(98)00442-X; Trautmann C, 2000, NUCL INSTRUM METH B, V164, P365, DOI 10.1016/S0168-583X(99)01066-6; Kluth P, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.175503; Canut B, 2008, NUCL INSTRUM METH B, V266, P2819, DOI 10.1016/j.nimb.2008.03.125; Dunlop A., 1997, ACAD SCI B, V325, P397; LANG M, 2009, PHYS REV B, V79; Mohanty T, 2003, RADIAT MEAS, V36, P137, DOI 10.1016/S1350-4487(03)00110-0; Nakajima K., UNPUB; Shima K., 1992, DATA NUCL DATA TABLE, V51, P173; Toulemonde M., 2006, MAT FYS MEDD K DAN V, V52, P263; Ziegler J. F., 1985, STOPPING RANGE IONS	22	3	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0168-583X	1872-9584		NUCL INSTRUM METH B	Nucl. Instrum. Methods Phys. Res. Sect. B-Beam Interact. Mater. Atoms	AUG 1	2015	356						22	27		10.1016/j.nimb.2015.04.051		6	Instruments & Instrumentation; Nuclear Science & Technology; Physics, Atomic, Molecular & Chemical; Physics, Nuclear	Instruments & Instrumentation; Nuclear Science & Technology; Physics	CL5HM	WOS:000356990400005		
J	Nakagawa, S; Murakami, T				Nakagawa, Seiko; Murakami, Takeshi			ESR spin trapping of radicals in methanol solution irradiated by heavy ion beams. Dependence on specific energy and LET	NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION B-BEAM INTERACTIONS WITH MATERIALS AND ATOMS			English	Article						ESR; Spin-trapping; Methanol; LET; Specific energy	WATER RADIOLYSIS; LIQUID WATER; OH RADICALS; YIELDS; COPOLYMERIZATION; RESONANCE; MALEIMIDE; STYRENE; VALUES; CARBON	Radicals produced by the heavy ion (He, C, Ne, Si, Ar, and Fe) irradiation of methanol were spin trapped with PBN. Three kinds of radicals, PBN-CH3O, PBN-CH2OH, and PBN-H, were observed similar to those by gamma-irradiation. The relative radical yields, PBN-CH3O/PBN-CH2OH and (PBN-CH3O + PBN-CH2OH)/PBN-H, varied depending on the LET value, the specific energy and mass of ions. (C) 2015 Elsevier B.V. All rights reserved.	[Nakagawa, Seiko] Tokyo Metropolitan Ind Technol Res Inst, Koto Ku, Tokyo 1350064, Japan; [Nakagawa, Seiko] Kanagawa Univ, Facil Sci, Dept Chem, Hiratsuka, Kanagawa 2591293, Japan; [Murakami, Takeshi] Natl Inst Radiol Sci, Res Program Applicat Heavy Ions Med Sci, Res Ctr Charged Particle Therapy, Inage Ku, Chiba 2638555, Japan	Nakagawa, S (reprint author), Tokyo Metropolitan Ind Technol Res Inst, Koto Ku, 2-4-10 Aomi, Tokyo 1350064, Japan.	Nakagawa.Seiko@iri-tokyo.jp			Research Project with Heavy Ions at NIRS-HIMAC	This work was supported by Research Project with Heavy Ions at NIRS-HIMAC.	Yamashita S, 2008, RADIAT PHYS CHEM, V77, P439, DOI [10.1016/j.radphyschem.2007.07.005, 10.1016/j.radphyscheni.2007.07.005]; Meesungnoen J, 2005, J PHYS CHEM A, V109, P6406, DOI 10.1021/jp058037z; Nakagawa S, 2011, RADIAT PHYS CHEM, V80, P1199, DOI 10.1016/j.radphyschem.2011.05.012; APPLEBY A, 1985, RADIAT RES, V104, P263, DOI 10.2307/3576588; Baldacchino G, 2006, NUCL INSTRUM METH B, V245, P288, DOI 10.1016/j.nimb.2005.11.116; Koehler W., 1987, PHYS REV, V35, P4031; LaVerne J.A., 2004, CHARGED PARTICLE PHO, P403; LaVerne JA, 2005, J PHYS CHEM A, V109, P9393, DOI 10.1021/jp0530303; MAO SW, 1974, CHEM PHYS LETT, V24, P505, DOI 10.1016/0009-2614(74)80165-X; MICHALIK J, 1978, J MAGN RESON, V31, P259, DOI 10.1016/0022-2364(78)90188-9; Moritake T, 2003, RADIAT RES, V159, P670, DOI 10.1667/0033-7587(2003)159[0670:ESTOHR]2.0.CO;2; Nakagawa S, 2013, RADIAT PHYS CHEM, V91, P143, DOI 10.1016/j.radphyschem.2013.05.022; SARGENT FP, 1976, J PHYS CHEM-US, V80, P854, DOI 10.1021/j100549a018; SHIOTANI M, 1976, INT J RADIAT PHYS CH, V8, P483, DOI 10.1016/0020-7055(76)90012-7; Spinks JWT, 1990, INTRO RAD CHEM; Taguchi M, 2007, NUCL SCI TECH, V18, P35, DOI 10.1016/S1001-8042(07)60015-3; Taguchi M, 2005, RADIAT RES, V163, P455, DOI 10.1667/RR3330; Yamashita S, 2008, RADIAT PHYS CHEM, V77, P1224, DOI 10.1016/j.radphyschem.2008.05.037; Ziegler JF, 1998, NUCL INSTRUM METH B, V136, P141, DOI 10.1016/S0168-583X(97)00664-2	19	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0168-583X	1872-9584		NUCL INSTRUM METH B	Nucl. Instrum. Methods Phys. Res. Sect. B-Beam Interact. Mater. Atoms	AUG 1	2015	356						108	113		10.1016/j.nimb.2015.04.040		6	Instruments & Instrumentation; Nuclear Science & Technology; Physics, Atomic, Molecular & Chemical; Physics, Nuclear	Instruments & Instrumentation; Nuclear Science & Technology; Physics	CL5HM	WOS:000356990400019		
J	Amemiya, K; Koshikawa, H; Yamaki, T; Maekawa, Y; Shitomi, H; Numata, T; Kinoshita, K; Tanabe, M; Fukuda, D				Amemiya, Kuniaki; Koshikawa, Hiroshi; Yamaki, Tetsuya; Maekawa, Yasunari; Shitomi, Hiroshi; Numata, Takayuki; Kinoshita, Kenichi; Tanabe, Minoru; Fukuda, Daiji			Fabrication of hard-coated optical absorbers with microstructured surfaces using etched ion tracks: Toward broadband ultra-low reflectance	NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION B-BEAM INTERACTIONS WITH MATERIALS AND ATOMS			English	Article						Optical absorber; Low reflectance; Microstructured; Ion tracks; Hard coated	ALIGNED CARBON NANOTUBES; SILICON SOLAR-CELLS; BLACK COATINGS; NICKEL; FILMS; DETECTOR; SPHERE; PULSES; REGION; RF	Broadband low reflectance materials have various applications in the field of optical energy management; however, materials with ultra-low reflectance (below 0.1%) have been considered as mechanically delicate. We have developed a novel hard-surface optical absorber with microstructured, diamond-like carbon coated ion tracks on CR-39 plastic substrate. The spectral reflectance of the first prototype was below 2% for wavelengths ranging from 400 nm to 1400 nm; moreover, the optical absorber had mechanically hard surface and exhibited temporal durability. Choosing the appropriate design of the surface structure and coating layer is likely to reduce the reflectance to the order of 0.1%. This technique yields easy-to-handle broadband ultra-low reflectance absorbers. (C) 2015 Elsevier B.V. All rights reserved.	[Amemiya, Kuniaki; Shitomi, Hiroshi; Numata, Takayuki; Kinoshita, Kenichi; Tanabe, Minoru; Fukuda, Daiji] Natl Inst Adv Ind Sci & Technol, Natl Metrol Inst Japan, Tsukuba, Ibaraki 3058563, Japan; [Koshikawa, Hiroshi; Yamaki, Tetsuya; Maekawa, Yasunari] Japan Atom Energy Agcy, Quantum Beam Sci Ctr, Takasaki, Gunma 3701292, Japan	Amemiya, K (reprint author), Natl Inst Adv Ind Sci & Technol, Natl Metrol Inst Japan, Tsukuba, Ibaraki 3058563, Japan.	k.amemiya@aist.go.jp			KAKENHI from the Japan Society for the Promotion of Science (JSPS), Japan [24760326]; University of Tokyo, Japan; Tsukuba Innovation Arena for Nanotechnology (TIA-nano) of National Institute of Advanced Industrial Science and Technology (AIST), Japan	This work was partially supported by KAKENHI 24760326 [Grant-in-Aid for Young Scientists (B)] from the Japan Society for the Promotion of Science (JSPS), Japan. The ion beam irradiation experiment was performed at Takasaki Ion Accelerators for Advanced Radiation Application (TIARA) of Japan Atomic Energy Agency (JAEA), Takasaki, Japan, which was also supported by the University of Tokyo, Japan.; SEM imaging was performed with support from Tsukuba Innovation Arena for Nanotechnology (TIA-nano) of National Institute of Advanced Industrial Science and Technology (AIST), Japan.	Amemiya K, 2012, APPL OPTICS, V51, P6917, DOI 10.1364/AO.51.006917; Amemiya K., 2011, METROLOGIA, V48; Kang TD, 2007, J KOREAN PHYS SOC, V50, P632; Yang ZP, 2008, NANO LETT, V8, P446, DOI 10.1021/nl072369t; Liu Y, 2014, NANO ENERGY, V3, P127, DOI 10.1016/j.nanoen.2013.11.002; Oskooi AF, 2010, COMPUT PHYS COMMUN, V181, P687, DOI 10.1016/j.cpc.2009.11.008; Oh J, 2012, NAT NANOTECHNOL, V7, P743, DOI [10.1038/nnano.2012.166, 10.1038/NNANO.2012.166]; Ziegler JF, 2010, NUCL INSTRUM METH B, V268, P1818, DOI 10.1016/j.nimb.2010.02.091; Lehman J, 2010, NANO LETT, V10, P3261, DOI 10.1021/nl100582j; Theocharous E, 2006, APPL OPTICS, V45, P1093, DOI 10.1364/AO.45.001093; Rakic AD, 1998, APPL OPTICS, V37, P5271, DOI 10.1364/AO.37.005271; Iyengar VV, 2010, APPL OPTICS, V49, P5983, DOI 10.1364/AO.49.005983; Liu XG, 2014, ENERG ENVIRON SCI, V7, P3223, DOI 10.1039/c4ee01152j; Mizuno K, 2009, P NATL ACAD SCI USA, V106, P6044, DOI 10.1073/pnas.0900155106; Theocharous E, 2011, INFRARED PHYS TECHN, V54, P34, DOI 10.1016/j.infrared.2010.10.004; CARTWRIGHT BG, 1978, NUCL INSTRUM METHODS, V153, P457, DOI 10.1016/0029-554X(78)90989-8; Futaba DN, 2006, NAT MATER, V5, P987, DOI 10.1038/nmat1782; Azoubel S, 2015, SURF COAT TECH, V262, P21, DOI 10.1016/j.surfcoat.2014.11.063; Brown RJC, 2002, J MATER CHEM, V12, P2749, DOI 10.1039/b204483h; Chunnilall CJ, 2012, CARBON, V50, P5348, DOI 10.1016/j.carbon.2012.07.014; De Volder MFL, 2011, J MICROMECH MICROENG, V21, DOI 10.1088/0960-1317/21/4/045033; Duncan RN, 1996, PLAT SURF FINISH, V83, P65; Endo M, 2005, IEEE T INSTRUM MEAS, V54, P688, DOI 10.1109/TIM.2005.843538; Hwang TY, 2012, APPL PHYS A-MATER, V108, P299, DOI 10.1007/s00339-012-6909-3; Kodaira S, 2011, RADIAT MEAS, V46, P1782, DOI 10.1016/j.radmeas.2011.08.015; KODAMA S, 1990, IEEE T INSTRUM MEAS, V39, P230, DOI 10.1109/19.50450; Lehman J, 2003, MEAS SCI TECHNOL, V14, P916, DOI 10.1088/0957-0233/14/7/304; MATTOX DM, 1973, J VAC SCI TECHNOL, V10, P47, DOI 10.1116/1.1318041; Mokuno Y, 2002, SURF COAT TECH, V156, P328, DOI 10.1016/S0257-8972(02)00103-2; MORAVEC TJ, 1982, J VAC SCI TECHNOL, V20, P338, DOI 10.1116/1.571459; Nguyen KN, 2012, MICROSYST TECHNOL, V18, P1807, DOI 10.1007/s00542-012-1486-0; Nishimura Y, 2002, SURF COAT TECH, V156, P50, DOI 10.1016/S0257-8972(02)00111-1; Shimizu Y, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.068004; Shitomi H, 2009, METROLOGIA, V46, pS186, DOI 10.1088/0026-1394/46/4/S10; Shitomi H, 2003, METROLOGIA, V40, pS185, DOI 10.1088/0026-1394/40/1/342; Steglich M, 2014, LASER PHOTONICS REV, V8, pL13, DOI 10.1002/lpor.201300142; Theocharous E, 2014, OPT EXPRESS, V22, P7290, DOI 10.1364/OE.22.007290; Tomlin NA, 2014, CARBON, V74, P329, DOI 10.1016/j.carbon.2014.03.040; Verploegen E, 2011, J APPL PHYS, V109, DOI 10.1063/1.3584759	39	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0168-583X	1872-9584		NUCL INSTRUM METH B	Nucl. Instrum. Methods Phys. Res. Sect. B-Beam Interact. Mater. Atoms	AUG 1	2015	356						154	159		10.1016/j.nimb.2015.05.002		6	Instruments & Instrumentation; Nuclear Science & Technology; Physics, Atomic, Molecular & Chemical; Physics, Nuclear	Instruments & Instrumentation; Nuclear Science & Technology; Physics	CL5HM	WOS:000356990400024		
J	Doi, Y; Kanagawa, M; Maya, Y; Tanaka, A; Oka, S; Nakata, N; Toyama, M; Matsumoto, H; Shirakami, Y				Doi, Yoshihiro; Kanagawa, Masaru; Maya, Yoshifumi; Tanaka, Akihiro; Oka, Shuntaro; Nakata, Norihito; Toyama, Masahito; Matsumoto, Hiroki; Shirakami, Yoshifumi			Evaluation of trans-1-amino-3-F-18-fluorocyclobutanecarboxylic acid accumulation in low-grade glioma in chemically induced rat models: PET and autoradiography compared with morphological images and histopathological findings	NUCLEAR MEDICINE AND BIOLOGY			English	Article						Anti-F-18-FACBC; Positron emission tomography; Magnetic resonance imaging; Blood-Brain barrier; Glioma	POSITRON-EMISSION-TOMOGRAPHY; BRAIN-TUMORS; TRANSPORT MECHANISMS; PROSTATE-CANCER; CELL-DENSITY; C-11-METHIONINE; ANTI-F-18-FACBC; PERMEABILITY; MRI	Introduction: Magnetic resonance imaging (MRI) can have a problem to delineate diffuse gliomas with an intact blood-brain barrier (BBB) especially when a marked peritumoral edema is present. We evaluated the potential of trans-1-amino-3-F-18-fluorocyclobutanecarboxylic acid (anti-F-18-FACBC) positron emission tomography (PET) to delineate the extent of diffuse gliomas by comparing PET findings with autoradiography, in vivo and ex vivo MRI, and histopathology findings. Methods: Dynamic PET was performed in rats with N-ethyl-N-nitrosourea-induced glioma for 60 min after anti-F-18-FACBC injection. Contrast-enhanced MRI was performed before or after PET. The PET images were fused with in vivo and ex vivo MR images, and histopathological images for direct comparisons. Autoradiograms were compared with the results of Evans Blue (EB) extravasation (to assess BBB integrity) and hematoxylin-eosin staining. Results: Histopathological examination, including EB extravasation assessment, and enhanced Ti-weighted MRI identified several diffuse gliomas with slight BBB disruption, similar to low-grade human gliomas. Anti-F-18-FACBC uptake was specific and high in the gliomas, irrespective of BBB integrity. Higher anti-F-18-FACBC uptake corresponded to areas of T2 hyperintensity, independent of gadolinium enhancement. Ex vivo autoradiography also showed high anti-F-18-FACBC accumulation in tumors lacking EB extravasation and a correlation between anti-F-18-FACBC accumulation and tumor cell density, but not EB extravasation. Conclusions: Anti-F-18-FACBC-PET allowed visualization of gliomas irrespective of BBB integrity. The tumor-to-normal uptake ratio of anti-F-18-FACBC generally correlated with the relative cell density. Anti-F-18-FACBC PET combined with MRI shows promise for preoperative glioma delineation. Advances in knowledge: Radiopharmaceuticals that cross the BBB, such as anti-F-18-FACBC, are taken up by low-grade gliomas with equivocal MRI findings due to an intact BBB. Implications for patient care: Surgery is the first-line therapy for low-grade gliomas; therefore, delineation of their extent in the presence of an intact BBB is essential to planning surgery that removes the entire neoplasm, which will positively affect long-term survival. (C) 2015 Elsevier Inc. All rights reserved.	[Doi, Yoshihiro; Kanagawa, Masaru; Maya, Yoshifumi; Tanaka, Akihiro; Oka, Shuntaro; Nakata, Norihito; Toyama, Masahito; Matsumoto, Hiroki; Shirakami, Yoshifumi] Nihon Medi Phys Co Ltd, Res Ctr, Sodegaura, Chiba 2990266, Japan	Doi, Y (reprint author), Nihon Medi Phys Co Ltd, Res Ctr, Kitasode 3-1, Sodegaura, Chiba 2990266, Japan.	yoshihiro_doi@nmp.co.jp					Akhurst T, 2006, J NUCL MED S1, V47, p79P; Rousset OG, 2008, J NUCL MED, V49, P1097, DOI 10.2967/jnumed.107.048330; Pirotte B, 2006, J NEUROSURG, V104, P238, DOI 10.3171/jns.2006.104.2.238; Langen KJ, 2003, NUCL MED BIOL, V30, P501, DOI 10.1016/S0969-8051(03)00023-4; Schuster DM, 2007, J NUCL MED, V48, P56; Shoup TM, 1999, J NUCL MED, V40, P331; Oka S, 2012, NUCL MED BIOL, V39, P109, DOI 10.1016/j.nucmedbio.2011.06.008; Doblas S, 2010, J MAGN RESON IMAGING, V32, P267, DOI 10.1002/jmri.22263; Price SJ, 2011, BRIT J RADIOL, V84, pS159, DOI 10.1259/bjr/26838774; Upadhyay N, 2011, BRIT J RADIOL, V84, pS107, DOI 10.1259/bjr/65711810; Ono M, 2013, BRAIN RES, V1535, P24, DOI 10.1016/j.brainres.2013.08.037; Okudaira H, 2011, J NUCL MED, V52, P822, DOI 10.2967/jnumed.110.086074; Stockhammer F, 2008, J NEURO-ONCOL, V88, P205, DOI 10.1007/s11060-008-9551-3; Van Laere K, 2005, EUR J NUCL MED MOL I, V32, P39, DOI 10.1007/s00259-004-1564-3; Rousset OG, 1998, J NUCL MED, V39, P904; Fuchs BC, 2005, SEMIN CANCER BIOL, V15, P254, DOI 10.1016/j.semcancer.2005.04.005; Kato T, 2008, AM J NEURORADIOL, V29, P1176, DOI 10.3174/ajnr.A1008; Hervey-Jumper SL, 2014, CURR TREAT OPTION NE, V16, DOI 10.1007/s11940-014-0284-7; INOUE T, 1988, ACTA NEUROCHIR, V91, P67, DOI 10.1007/BF01400531; Nye JA, 2007, J NUCL MED, V48, P1017, DOI 10.2967/jnumed.107.040097; Okita Y, 2010, NEUROIMAGE, V49, P2977, DOI 10.1016/j.neuroimage.2009.11.024; Riva M, 2014, CURR OPIN ONCOL, V26, P615, DOI 10.1097/CCO.0000000000000120; Sasajima T, 2013, NUCL MED BIOL, V40, P808, DOI 10.1016/j.nucmedbio.2013.04.007; Sato Y, 2004, J TOXICOL PATHOL, V17, P7, DOI 10.1293/tox.17.7; Skinner JT, 2012, CONTRAST MEDIA MOL I, V7, P494, DOI 10.1002/cmmi.1479; Spaeth N, 2006, EUR J NUCL MED MOL I, V33, P673, DOI 10.1007/s00259-005-0045-7; VAQUERO J, 1992, AM J PATHOL, V141, P1037; YAMADA K, 1981, J NEUROSURG, V55, P922, DOI 10.3171/jns.1981.55.6.0922; Zook BC, 2000, TOXICOL PATHOL, V28, P193, DOI 10.1177/019262330002800124	29	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0969-8051	1872-9614		NUCL MED BIOL	Nucl. Med. Biol.	AUG	2015	42	8					664	672		10.1016/j.nucmedbio.2015.04.008		9	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CM0HN	WOS:000357359100003		
J	Higuchi, Y; Hisamatsu, T				Higuchi, Yohei; Hisamatsu, Tamotsu			CsTFL1, a constitutive local repressor of flowering, modulates floral initiation by antagonising florigen complex activity in chrysanthemum	PLANT SCIENCE			English	Article						Antiflorigen; Chrysanthemum; Florigen; Flowering	LOCUS-T; ARABIDOPSIS-THALIANA; INTEGRATOR FT; HIGH SALINITY; PROTEIN; GENE; ARCHITECTURE; TRANSITION; INDUCTION; HOMOLOG	Chrysanthemums require repeated cycles of short-day (SD) photoperiod for successful anthesis, but their vegetative state is strictly maintained under long-day (LD) or night-break (NB) conditions. We have previously demonstrated that photoperiodic flowering of a wild diploid chrysanthemum (Chrysanthemum seticuspe f. boreale) is controlled by a pair of systemic floral regulators, florigen (CsFTL3) and anti-florigen (CsAFT), produced in the leaves. Here, we report the functional characterisation of a local floral regulator, CsTFL1, a chrysanthemum orthologue of TERMINAL FLOWER 1 gene in Arabidopsis. Constitutive expression of CsTFL1 in C. seticuspe (CsTFL1-ox) resulted in extremely late flowering under SD and prevented up-regulation of floral meristem identity genes in shoot tips and leaves. Bimolecular fluorescence complementation assay showed that both C5TFL1 and CsFTL3 interacted with CsFDL1, a bZIP transcription factor FD homologue, in the nucleus. The transient gene expression assay indicated that C5TFL1 suppresses flowering by directly antagonising the flower inductive activity of the CsFTL3-CsFDL1 complex. Our results suggest that strict maintenance of vegetative state under non-inductive photoperiod is achieved by the coordinated action of both the systemic floral inhibitor and local floral inhibitor C5TFL1, which is constitutively expressed in shoot tips. (C) 2015 Elsevier Ireland Ltd. All rights reserved.	[Higuchi, Yohei; Hisamatsu, Tamotsu] Natl Agr & Food Res Org NARO, NARO Inst Floricultural Sci, Tsukuba, Ibaraki 3058519, Japan	Hisamatsu, T (reprint author), Natl Agr & Food Res Org NARO, NARO Inst Floricultural Sci, 2-1 Fujimoto, Tsukuba, Ibaraki 3058519, Japan.	tamotsu@affrc.go.jp			Ministry of Agriculture, Forestry and Fisheries of Japan	We thank T. Nakagawa for the BiFC vectors and N. Mitsuda for the transient expression vector. We also thank S. Kamei and T. Hashimoto for technical assistance. This work was supported by the grant 'Elucidation of biological mechanisms of photoresponse and development of advanced technologies utilising light' from the Ministry of Agriculture, Forestry and Fisheries of Japan.	Tamaki S, 2007, SCIENCE, V316, P1033, DOI 10.1126/science.1141753; Abe M, 2005, SCIENCE, V309, P1052, DOI 10.1126/science.1115983; Yamaguchi A, 2005, PLANT CELL PHYSIOL, V46, P1175, DOI 10.1093/pcp/pci151; Corbesier L, 2007, SCIENCE, V316, P1030, DOI 10.1126/science.1141752; Hanano S, 2011, PLANT CELL, V23, P3172, DOI 10.1105/tpc.111.088641; Ratcliffe OJ, 1998, DEVELOPMENT, V125, P1609; Lin MK, 2007, PLANT CELL, V19, P1488, DOI 10.1105/tpc.107.051920; Jaeger KE, 2013, PLANT CELL, V25, P820, DOI 10.1105/tpc.113.109355; Lifschitz E, 2006, P NATL ACAD SCI USA, V103, P6398, DOI 10.1073/pnas.0601620103; Kardailsky I, 1999, SCIENCE, V286, P1962, DOI 10.1126/science.286.5446.1962; Preston JC, 2008, PLANT PHYSIOL, V146, P265, DOI 10.1104/pp.107.109561; Mimida N, 2001, GENES CELLS, V6, P327, DOI 10.1046/j.1365-2443.2001.00425.x; Yoo SJ, 2010, PLANT J, V63, P241, DOI 10.1111/j.1365-313X.2010.04234.x; Conti L, 2007, PLANT CELL, V19, P767, DOI 10.1105/tpc.106.049767; Teper-Bamnolker P, 2005, PLANT CELL, V17, P2661, DOI 10.1105/tpc.105.035766; Hino T, 2011, BIOSCI BIOTECH BIOCH, V75, P1848, DOI 10.1271/bbb.110331; Pin PA, 2010, SCIENCE, V330, P1397, DOI 10.1126/science.1197004; Ratcliffe OJ, 1999, DEVELOPMENT, V126, P1109; Kobayashi Y, 1999, SCIENCE, V286, P1960, DOI 10.1126/science.286.5446.1960; Bradley D, 1997, SCIENCE, V275, P80, DOI 10.1126/science.275.5296.80; Chen A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003134; Wigge PA, 2005, SCIENCE, V309, P1056, DOI 10.1126/science.1114358; Higuchi Y, 2013, P NATL ACAD SCI USA, V110, P17137, DOI 10.1073/pnas.1307617110; Higuchi Y, 2012, J PLANT PHYSIOL, V169, P1789, DOI 10.1016/j.jplph.2012.07.003; Huang NC, 2012, PLANT J, V72, P175, DOI 10.1111/j.1365-313X.2012.05076.x; Iwata H, 2012, PLANT J, V69, P116, DOI 10.1111/j.1365-313X.2011.04776.x; Koskela EA, 2012, PLANT PHYSIOL, V159, P1043, DOI 10.1104/pp.112.196659; Li T, 2009, J HORTIC SCI BIOTECH, V84, P447; Nakano Y, 2013, J EXP BOT, V64, P909, DOI 10.1093/jxb/ers370; Oda A, 2012, J EXP BOT, V63, P1461, DOI 10.1093/jxb/err387; Oshima Y, 2011, PLANT BIOTECHNOL-NAR, V28, P201, DOI 10.5511/plantbiotechnology.11.0124a; Randoux M, 2014, NEW PHYTOL, V202, P161, DOI 10.1111/nph.12625; Ryu JY, 2014, MOL PLANT, V7, P377, DOI 10.1093/mp/sst114; Ryu JY, 2011, MOL CELLS, V32, P295, DOI 10.1007/s10059-011-0112-9; Shchennikova AV, 2004, PLANT PHYSIOL, V134, P1632, DOI 10.1104/pp.103.036665; Shimada S, 2009, PLANT J, V58, P668, DOI 10.1111/j.1365-313X.2009.03806.x	36	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0168-9452			PLANT SCI	Plant Sci.	AUG	2015	237						1	7		10.1016/j.plantsci.2015.04.011		7	Biochemistry & Molecular Biology; Plant Sciences	Biochemistry & Molecular Biology; Plant Sciences	CL8LP	WOS:000357226500001		
J	Mizuta, K; Taguchi, S; Sato, S				Mizuta, Katsutoshi; Taguchi, Satoru; Sato, Shinjiro			Soil aggregate formation and stability induced by starch and cellulose	SOIL BIOLOGY & BIOCHEMISTRY			English	Article						Soil structure; Soil respiration; Soil carbon; Modeling; Slaking; Tropical soil	ORGANIC-MATTER; MICROBIAL BIOMASS; BACTERIAL-GROWTH; CARBON; DECOMPOSITION; RESPIRATION; FUNGAL; SEQUESTRATION; PROTECTION; FERTILIZER	Soil aggregate (SA) can be formed and stabilized when soil organic matter (SOM) is decomposed in the soil. However, the relationships between the SA dynamics and SOM with different decomposition rates have not been clarified. Therefore, this study examined the effects of the addition of polysaccharides to soil on SA formation and stability. A Japanese tropical soil was incubated for 99 d at 30 degrees C in a dark environment following the addition of 0.5% (w/w) starch or cellulose. The decomposition rates of the amendments, and SA formation and stability were evaluated by measuring soil respiration rates, and distribution fractions of soil aggregate sizes and mean weight diameter (MWD) of SA, respectively. The cumulative soil respirations with all treatments rapidly increased until Day 12 of the incubation. The initial slope of the cumulative soil respiration in the soil with starch was significantly higher than that in the soil with cellulose. In either soil with starch or cellulose, the fractions of macro-aggregates (>1000 mu m in diameter) significantly increased, respectively, compared with control soil. However, the fractions of meso-aggregates (250-1000 mu m) and nano-aggregate (<20 mu m) in the soil with starch significantly decreased, while those fractions in the soil with cellulose fluctuated until Day 6. The MWDs reached the maximum on Day 6, indicating the SA formation in the soils with starch or cellulose. The increasing rate of the SA formation in the starch-amended soil was greatly higher than that in the cellulose-amended soil. After Day 6, the MWDs in the soils with either polysaccharide decreased with similar trends with no significant differences between treatments, indicating similar stability of the SA in both treatments. This study showed that the different decomposability of the organic amendments might influence the SA formation differently, but not the SA stability. (C) 2015 Elsevier Ltd. All rights reserved.	[Mizuta, Katsutoshi; Taguchi, Satoru; Sato, Shinjiro] Soka Univ, Dept Environm Engn Symbiosis, Tokyo 1928577, Japan	Sato, S (reprint author), Soka Univ, Dept Environm Engn Symbiosis, Tokyo 1928577, Japan.	ssato@soka.ac.jp					ALBERTS EE, 1983, T ASAE, V26, P465; Setia R, 2010, BIOL FERT SOILS, V46, P781, DOI 10.1007/s00374-010-0479-3; Rodeghiero M, 2005, GLOBAL CHANGE BIOL, V11, P1024, DOI 10.1111/j.1365-2486.2005.00963.x; Celik I, 2004, SOIL TILL RES, V78, P59, DOI 10.1016/j.still.2004.02.012; Guggenberger G, 1999, SOIL BIOL BIOCHEM, V31, P407, DOI 10.1016/S0038-0717(98)00143-6; Miltner A, 1998, SOIL BIOL BIOCHEM, V30, P1, DOI 10.1016/S0038-0717(97)00092-8; Aanderud ZT, 2013, SOIL BIOL BIOCHEM, V57, P217, DOI 10.1016/j.soilbio.2012.07.022; Meidute S, 2008, SOIL BIOL BIOCHEM, V40, P2334, DOI 10.1016/j.soilbio.2008.05.011; Rousk J, 2007, FEMS MICROBIOL ECOL, V62, P258, DOI 10.1111/j.1574-6941.2007.00398.x; Wang WJ, 2003, SOIL BIOL BIOCHEM, V35, P273, DOI 10.1016/S0038-0717(02)00274-2; Martens DA, 2000, SOIL BIOL BIOCHEM, V32, P361, DOI 10.1016/S0038-0717(99)00162-5; Chang W, 2013, CHEMOSPHERE, V91, P1620, DOI 10.1016/j.chemosphere.2012.12.058; Moller J, 1999, SOIL BIOL BIOCHEM, V31, P367, DOI 10.1016/S0038-0717(98)00138-2; Abiven S, 2009, SOIL BIOL BIOCHEM, V41, P1, DOI 10.1016/j.soilbio.2008.09.015; Gusewell S, 2009, FUNCT ECOL, V23, P211, DOI 10.1111/j.1365-2435.2008.01478.x; McCarthy JF, 2008, GEOCHIM COSMOCHIM AC, V72, P4725, DOI 10.1016/j.gca.2008.06.015; Plante AF, 2002, SOIL TILL RES, V66, P79, DOI 10.1016/S0167-1987(02)00015-6; Bronick CJ, 2005, GEODERMA, V124, P3, DOI 10.1016/j.geoderma.2004.03.005; Stockmann U, 2013, AGR ECOSYST ENVIRON, V164, P80, DOI 10.1016/j.agee.2012.10.001; EDWARDS AP, 1967, J SOIL SCI, V18, P64; Six J, 2004, SOIL TILL RES, V79, P7, DOI 10.1016/j.still.2004.03.008; Degens B, 1996, SOIL BIOL BIOCHEM, V28, P453, DOI 10.1016/0038-0717(96)00014-4; Chan KY, 1999, SOIL SCI SOC AM J, V63, P1841; Jastrow JD, 1996, SOIL BIOL BIOCHEM, V28, P665, DOI 10.1016/0038-0717(95)00159-X; Craine JM, 2007, ECOLOGY, V88, P2105, DOI 10.1890/06-1847.1; Liu AG, 2005, SOIL SCI SOC AM J, V69, P2041, DOI 10.2136/sssaj2005.0032; Bossuyt H, 2005, SOIL BIOL BIOCHEM, V37, P251, DOI 10.1016/j.soilbio.2004.07.035; Yoo G, 2014, SOIL SCI SOC AM J, V78, P852, DOI 10.2136/sssaj2013.05.0160; FORTUN A, 1989, J SOIL SCI, V40, P293; Blagodatskaya E, 2008, BIOL FERT SOILS, V45, P115, DOI 10.1007/s00374-008-0334-y; Boer Wietse de, 2005, FEMS Microbiol Rev, V29, P795, DOI 10.1016/j.femsre.2004.11.005; BOSWELL J. G., 1941, NEW PHYTOL, V40, P20, DOI 10.1111/j.1469-8137.1941.tb07026.x; Cassel D. K., 1986, AGRONOMY, V9, P901; Gee GW, 1986, AGRONOMY, V9, P383, DOI DOI 10.2136/SSSAB00KSER5.1.2ED.C15; GRIFFITHS E., 1965, Plant and Soil, V23, P17, DOI 10.1007/BF01349115; Harris RF, 1966, ADV AGRON, V18, P107, DOI 10.1016/S0065-2113(08)60649-5; Kiem R, 1997, APPL SOIL ECOL, V5, P221, DOI 10.1016/S0929-1393(96)00132-1; Kolar L, 2007, PLANT SOIL ENVIRON, V53, P24; Loeppert R.H., 1996, METHODS SOIL ANAL 3, P456; Luo Y., 2006, SOIL RESP ENV, P161, DOI 10.1016/B978-012088782-8/50008-5; Martin JP, 1940, SOIL SCI, V50, P29, DOI 10.1097/00010694-194007000-00004; MCCALLA TM, 1945, SOIL SCI, V59, P287, DOI 10.1097/00010694-194504000-00004; MOREL JL, 1987, BIOL FERT SOILS, V5, P13; Nielsen D.R., 1996, METHODS SOIL ANAL 3, P961; Nimmo J.R., 2002, SSSA BOOK SER, V5, P317; NORDGREN A, 1988, SOIL BIOL BIOCHEM, V20, P955, DOI 10.1016/0038-0717(88)90110-1; OADES JM, 1991, AUST J SOIL RES, V29, P815, DOI 10.1071/SR9910815; Schlecht-Pietsch S, 1994, APPL SOIL ECOL, V1, P145, DOI 10.1016/0929-1393(94)90034-5; Sonnleitner R, 2003, APPL SOIL ECOL, V22, P195, DOI 10.1016/S0929-1393(02)00159-2; Stolt MH, 2014, SOIL SCI SOC AM J, V78, P1332, DOI 10.2136/sssaj2014.02.0048n; Tisdall J.M., 1995, STRUCTURE ORGANIC MA, P57; TISDALL J.M., 1982, J SOIL SCI, V33, P141, DOI DOI 10.1111/J.1365-2389.1982.TB01755.X; van Bavel C.H.M., 1949, P SOIL SCI SOC AM, V1949, P20; Wickland KP, 2008, BIOGEOCHEMISTRY, V87, P29, DOI 10.1007/s10533-007-9166-3; Williams PC, 1987, NEAR INFRARED TECHNO, P143; Yoder R.E., 1936, AGRON J, V28, P337, DOI DOI 10.2134/AGRONJ1936.00021962002800050001X	56	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0038-0717			SOIL BIOL BIOCHEM	Soil Biol. Biochem.	AUG	2015	87						90	96		10.1016/j.soilbio.2015.04.011		7	Soil Science	Agriculture	CL8SL	WOS:000357244300010		
J	Nakashima, M; Suzuki, M; Saida, M; Kamei, Y; Hossain, MB; Tokumoto, T				Nakashima, Mikiko; Suzuki, Manami; Saida, Misako; Kamei, Yasuhiro; Hossain, Md. Babul; Tokumoto, Toshinobu			Cell-based assay of nongenomic actions of progestins revealed inhibitory G protein coupling to membrane progestin receptor alpha (mPR alpha)	STEROIDS			English	Article						Membrane progestin receptor; Luciferin; Diethylstilbestrol (DES); Endocrine disruptor; Nongenomic steroid action; Goldfish	BREAST-CANCER CELLS; OOCYTE MATURATION; MEIOTIC MATURATION; RAINBOW-TROUT; SEA-TROUT; INVOLVEMENT; EXPRESSION; FISH; IDENTIFICATION; ZEBRAFISH	Previously, we established cell lines stably producing goldfish membrane progestin receptor a (goldfish mPR alpha) proteins, which mediate steroidal nongenomic actions. In this study, we transfected these cell lines (MDA-MD-231) with cDNAs encoding a recombinant luciferase gene (GloSensor). These cells can be used for monitoring the effects of ligands that bind to mPR by means of luminescence, the intensity of which reflects intracellular cyclic adenosine monophosphate (cAMP) levels. Luminescence intensity of the cells increased significantly when cells were treated with forskolin, strong activator of adenylyl cyclase. Then, we established a strategy to measure changes in luminescence that correlated with the actions of the ligands. The actions of ligands were measurable by the prevention of stimulation caused by forskolin after ligand stimulation. The studies using these cell lines indicated that cAMP concentrations were decreased specifically by the mPR ligands 17 alpha,20 beta-dihydroxy-4-pregnen-3-one, diethylstilbestrol and progesterone. Furthermore, pertussis toxin inhibited the decrease in cAMP levels caused by mPR ligands. These results support evidence from previous results that mPR alpha is coupled to an inhibitory G protein. (C) 2015 Elsevier Inc. All rights reserved.	[Nakashima, Mikiko; Tokumoto, Toshinobu] Natl Univ Corp Shizuoka Univ, Grad Sch Sci, Biol Sci Course, Suruga Ku, Shizuoka 4228529, Japan; [Suzuki, Manami] Natl Univ Corp Shizuoka Univ, Fac Sci, Dept Biol, Suruga Ku, Shizuoka 4228529, Japan; [Saida, Misako; Kamei, Yasuhiro] Natl Inst Basic Biol, Spectrog & Bioimaging Facil, Okazaki, Aichi 4458585, Japan; [Kamei, Yasuhiro] Grad Univ Adv Studies SOKENDAI, Sch Life Sci, Dept Basic Biol, Okazaki, Aichi 4448585, Japan; [Hossain, Md. Babul; Tokumoto, Toshinobu] Natl Univ Corp Shizuoka Univ, Grad Sch Sci & Technol, Integrated Biosci Sect, Suruga Ku, Shizuoka 4228529, Japan	Tokumoto, T (reprint author), Natl Univ Corp Shizuoka Univ, Grad Sch Sci, Biol Sci Course, Suruga Ku, Oya 836, Shizuoka 4228529, Japan.	sbttoku@ipc.shizuoka.ac.jp			JSPS KAKENHI [25440154]; Naito Foundation; Japanese Environmental Agency [ExTEND2005]; SUNBOR Grant from the Suntory Institute for Bioorganic Research; NIBS Cooperative Research Program [13-335]	This work was supported by JSPS KAKENHI Grant Number 25440154 (to TT) and a Grant from The Naito Foundation (to TT), Japanese Environmental Agency (ExTEND2005 FS to TT) and a SUNBOR Grant from the Suntory Institute for Bioorganic Research (to TT). This study was carried out under the NIBS Cooperative Research Program (13-335).	Thomas P, 2004, STEROIDS, V69, P567, DOI 10.1016/j.steroids.2004.05.004; Tubbs C, 2009, ENDOCRINOLOGY, V150, P473, DOI 10.1210/en.2008-0512; Sarramegna V, 2003, CELL MOL LIFE SCI, V60, P1529, DOI 10.1007/s00018-003-3168-7; YOSHIKUNI M, 1994, DEV BIOL, V166, P615, DOI 10.1006/dbio.1994.1341; Dressing GE, 2007, STEROIDS, V72, P111, DOI 10.1016/j.steroids.2006.10.006; Chien CH, 2009, HUM REPROD, V24, P1968, DOI 10.1093/humrep/dep099; Tokumoto M, 2006, GEN COMP ENDOCR, V145, P101, DOI 10.1016/j.ygcen.2005.07.002; Tokumoto T, 2007, ENDOCRINOLOGY, V148, P3459, DOI 10.1210/en.2006-1694; Zhu Y, 2003, P NATL ACAD SCI USA, V100, P2231, DOI 10.1073/pnas.0336132100; Hanna RN, 2009, GEN COMP ENDOCR, V161, P153, DOI 10.1016/j.ygcen.2008.10.006; Hanna R, 2006, J ENDOCRINOL, V190, P247, DOI 10.1677/joe.1.06694; Dressing GE, 2012, HORM CANCER-US, V3, P101, DOI 10.1007/s12672-012-0106-x; Zhu Y, 2003, P NATL ACAD SCI USA, V100, P2237, DOI 10.1073/pnas.0436133100; Dressing GE, 2010, ENDOCRINOLOGY, V151, P5916, DOI 10.1210/en.2010-0165; Ndiaye K, 2012, J REPROD IMMUNOL, V95, P15, DOI 10.1016/j.jri.2012.04.004; Tubbs C, 2010, GEN COMP ENDOCR, V165, P144, DOI 10.1016/j.ygcen.2009.06.017; Thomas P, 2007, ENDOCRINOLOGY, V148, P705, DOI 10.1210/en.2006-0974; Pang YF, 2013, ENDOCRINOLOGY, V154, P283, DOI 10.1210/en.2012-1772; CICIRELLI MF, 1985, DEV BIOL, V108, P254, DOI 10.1016/0012-1606(85)90029-6; FINET B, 1988, GAMETE RES, V19, P241, DOI 10.1002/mrd.1120190304; Pace MC, 2005, DEV BIOL, V285, P70, DOI 10.1016/j.ydbio.2005.06.003; Thomas P, 2009, STEROIDS, V74, P614, DOI 10.1016/j.steroids.2008.10.020; Tokumoto T, 2005, REPROD BIOL ENDOCRIN, V3, DOI 10.1186/1477-7827-3-69; Tokumoto T, 2004, P NATL ACAD SCI USA, V101, P3686, DOI 10.1073/pnas.0400072101; Zuo LA, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2588	25	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0039-128X	1878-5867		STEROIDS	Steroids	AUG	2015	100						21	26		10.1016/j.steroids.2015.04.002		6	Biochemistry & Molecular Biology; Endocrinology & Metabolism	Biochemistry & Molecular Biology; Endocrinology & Metabolism	CL8NB	WOS:000357230300005		
J	Htay, MT; Hashimoto, Y				Myo Than Htay; Hashimoto, Yoshio			Field emission property of ZnO nanowires prepared by ultrasonic spray pyrolysis	SUPERLATTICES AND MICROSTRUCTURES			English	Article						ZnO; Nanowire; Field emission; Oxide semiconductor; Ultrasonic spray pyrolysis	ZINC-OXIDE NANOWIRES; CATALYST-FREE SYNTHESIS; PULSED-LASER DEPOSITION; PHOTOLUMINESCENCE PROPERTIES; THERMAL EVAPORATION; NANONEEDLE ARRAYS; SELECTIVE GROWTH; PATTERNED GROWTH; LOW-TEMPERATURE; NANORODS	The field emission property of cold cathode emitters utilizing the ZnO nanowires with various conditions prepared by ultrasonic spray pyrolysis technique was discussed. It is found that the emission current was enhanced in the emitters having higher aspect ratio as well as smaller sheet resistance. Applying of post-annealing process, utilization of additional Mo back electrode in the cathode, and coating of Moon the ZnO nanowires resulted in the improvement of the emission current and lowering the threshold voltage. A threshold voltage of about 5.5 V/mu m to obtain 1.0 mu A/cm(2) was achieved in the sample prepared at the growth temperatures varying continuously from 250 degrees C to 300 degrees C. (C) 2015 Elsevier Ltd. All rights reserved.	[Myo Than Htay; Hashimoto, Yoshio] Shinshu Univ, Fac Engn, Dept Elect & Elect Engn, Inst Carbon Sci & Technol, Nagano 3808553, Japan	Htay, MT (reprint author), Shinshu Univ, Fac Engn, Dept Elect & Elect Engn, Inst Carbon Sci & Technol, 4-17-1 Wakasato, Nagano 3808553, Japan.	myoth@shinshu-u.ac.jp					Sigircik G, 2015, APPL SURF SCI, V340, P1, DOI 10.1016/j.apsusc.2015.02.166; Zhang YS, 2006, MATER LETT, V60, P522, DOI 10.1016/j.matlet.2005.09.028; Naik KK, 2014, APPL PHYS LETT, V105, DOI 10.1063/1.4903271; Jo SH, 2003, APPL PHYS LETT, V83, P4821, DOI 10.1063/1.1631735; Tian ZRR, 2003, NAT MATER, V2, P821, DOI 10.1038/nmat1014; Nishimura R, 2008, JPN J APPL PHYS, V47, P4799, DOI 10.1143/JJAP.47.4799; Xiao J, 2008, APPL SURF SCI, V254, P5426, DOI 10.1016/j.apsusc.2008.02.066; Lee CJ, 2002, APPL PHYS LETT, V81, P3648, DOI 10.1063/1.1518810; Li SY, 2006, J VAC SCI TECHNOL B, V24, P147, DOI 10.1116/1.2151217; Mosquera E, 2013, MATER LETT, V93, P326, DOI 10.1016/j.matlet.2012.11.119; Li Y, 2000, APPL PHYS LETT, V76, P2011, DOI 10.1063/1.126238; Ham H, 2005, CHEM PHYS LETT, V404, P69, DOI 10.1016/j.cplett.2005.01.084; Huang MH, 2001, ADV MATER, V13, P113, DOI 10.1002/1521-4095(200101)13:2<113::AID-ADMA113>3.0.CO;2-H; Xu CX, 2003, APPL PHYS LETT, V83, P3806, DOI 10.1063/1.1625774; Law JBK, 2008, J CRYST GROWTH, V310, P2485, DOI 10.1016/j.jcrysgro.2008.01.012; Chen J, 2008, SOLID STATE ELECTRON, V52, P294, DOI 10.1016/j.sse.2007.09.010; Guo RQ, 2008, APPL PHYS A-MATER, V93, P843, DOI 10.1007/s00339-008-4791-9; Chang LW, 2011, APPL SURF SCI, V257, P3145, DOI 10.1016/j.apsusc.2010.11.145; Zhu YW, 2003, APPL PHYS LETT, V83, P144, DOI 10.1063/1.1589166; Htay MT, 2009, J CRYST GROWTH, V311, P4499, DOI 10.1016/j.jcrysgro.2009.08.008; Shao H, 2007, MAT SCI SEMICON PROC, V10, P68, DOI 10.1016/j.mssp.2007.05.005; Zhang GH, 2013, MATER LETT, V96, P131, DOI 10.1016/j.matlet.2013.01.028; Park CJ, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2643979; Zhang YJ, 2015, APPL SURF SCI, V340, P120, DOI 10.1016/j.apsusc.2015.02.176; Fan HJ, 2004, SUPERLATTICE MICROST, V36, P95, DOI 10.1016/j.spmi.2004.08.028; Fowler RH, 1928, P R SOC LOND A-CONTA, V119, P173, DOI 10.1098/rspa.1928.0091; Htay MT, 2008, JPN J APPL PHYS, V47, P541, DOI 10.1143/JJAP.47.541; Htay MT, 2009, J MATER SCI-MATER EL, V20, P341, DOI 10.1007/s10854-008-9613-5; Htay MT, 2014, THIN SOLID FILMS, V556, P211, DOI 10.1016/j.tsf.2014.01.077; Htay MT, 2007, JPN J APPL PHYS 1, V46, P440, DOI 10.1143/JJAP.46.440; Liu SC, 2002, J MATER CHEM, V12, P3125, DOI 10.1039/b203871d; McCarthy E, 2011, J APPL PHYS, V110, DOI 10.1063/1.3671402; Nayeri FD, 2014, THIN SOLID FILMS, V571, P154, DOI 10.1016/j.tsf.2014.10.036; Sheini FJ, 2010, THIN SOLID FILMS, V519, P184, DOI 10.1016/j.tsf.2010.07.106; Wang WW, 2007, PHYSICA E, V36, P86, DOI 10.1016/j.physe.2006.08.008; Wu Yiying, 2002, Chemistry, V8, P1260, DOI 10.1002/1521-3765(20020315)8:6<1260::AID-CHEM1260>3.3.CO;2-H; Yang WQ, 2006, J NANOSCI NANOTECHNO, V6, P3780, DOI 10.1166/jnn.2006.623; Zhang ZS, 2009, SOLID STATE ELECTRON, V53, P578, DOI 10.1016/j.sse.2009.03.024; Zhou HL, 2008, J CRYST GROWTH, V310, P3626, DOI 10.1016/j.jcrysgro.2008.04.047	39	0	0	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	0749-6036			SUPERLATTICE MICROST	Superlattices Microstruct.	AUG	2015	84						144	153		10.1016/j.spmi.2015.05.003		10	Physics, Condensed Matter	Physics	CL8MD	WOS:000357227900015		
J	Inayoshi, T; Hirata, K; Watanabe, T; Yamazaki, M				Inayoshi, Tomoko; Hirata, Kentaro; Watanabe, Tatsuya; Yamazaki, Masatoshi			Syntheses and properties of a new series of tetrathiafulvalene derivatives incorporating fused ethyleneoxymethylene and ethylenethiomethylene units, and their charge-transfer complexes	SYNTHETIC METALS			English	Article						Tetrathiafulvalene (TTF) derivatives; Ethyleneoxymethylene (EOM); Ethylenethiomethylene (ETM); Crystal structure; MO; Conductivity	ORGANIC METALS; CRYSTAL-STRUCTURE; ELECTROCHEMICAL PROPERTIES; ELECTRON-DONORS; SULFUR-ATOMS; BEDT-TTF; SALTS; ETHYLENEDIOXYTETRATHIAFULVALENES; TETRASELENAFULVALENES; CONDUCTORS	Nine tetrathiafulvalene (TTF) derivatives incorporating fused ethyleneoxymethylene (EOM) and ethylenethiomethylene (ETM) units were newly synthesized by self-coupling or cross-coupling reactions. Unsymmetrical ETMEDT-TTF (4) was also synthesized by a Wittig-type reaction. Crystal structural analysis of these neutral donors revealed specific intermolecular interactions between donors, and many S...S, O...H, and S...H short contacts. Electrochemical properties of these donors were investigated by cyclic voltammetry under two different measurement conditions. Electronic spectra of neutral donors in chloroform and some cation radicals in methanol and on KBr pellets were measured and discussed. A distribution of the highest occupied molecular orbital (HOMO) around the EOM and ETM moieties of these donors was not found. The introduction of EOM and ETM groups to the TTF skeleton only slightly modulated the HOMO energy. Some charge-transfer (Cl') complexes of these donors with tetracyanoquinodimethane (TCNQ) derivatives were prepared. A needle crystal of the CT complex of EOMMDT-TTF (5) with TCNQ was metallic down to 102 K with a high sigma(RT) value of 169 S cm(-1). TTF derivatives incorporating fused EOM groups were more effective in conductivity than those incorporating fused ETM groups. (C) 2015 Elsevier B.V. All rights reserved.	[Inayoshi, Tomoko; Hirata, Kentaro; Watanabe, Tatsuya; Yamazaki, Masatoshi] Aoyama Gakuin Univ, Coll Sci & Engn, Dept Chem & Biol Sci, Chuo Ku, Sagamihara, Kanagawa 2525258, Japan	Inayoshi, T (reprint author), Aoyama Gakuin Univ, Coll Sci & Engn, Dept Chem & Biol Sci, Chuo Ku, 5-10-1 Fuchinobe, Sagamihara, Kanagawa 2525258, Japan.	inayoshi@chem.aoyama.ac.jp					ROVIRA C, 1994, J ORG CHEM, V59, P3307, DOI 10.1021/jo00091a017; Fourmigue M, 2004, CHEM REV, V104, P5379, DOI 10.1021/cr030645s; Mori T, 1999, B CHEM SOC JPN, V72, P179, DOI 10.1246/bcsj.72.179; Domercq B, 2001, J MATER CHEM, V11, P1570, DOI 10.1039/b100103p; FOX MA, 1994, J ORG CHEM, V59, P6519, DOI 10.1021/jo00101a009; MASON WR, 1968, INORG CHEM, V7, P55, DOI 10.1021/ic50059a011; Ashizawa M, 2003, B CHEM SOC JPN, V76, P2091, DOI 10.1246/bcsj.76.2091; BONDI A, 1964, J PHYS CHEM-US, V68, P441, DOI 10.1021/j100785a001; DRAWERT F, 1960, CHEM BER-RECL, V93, P3056, DOI 10.1002/cber.19600931237; ENGLER EM, 1978, J AM CHEM SOC, V100, P3769, DOI 10.1021/ja00480a019; Fabre J., 2004, TETRATHIAFULVALENE C, P3; FANGHANEL E, 1975, J PRAKT CHEM, V317, P123, DOI 10.1002/prac.19753170114; GARIN J, 1995, ADV HETEROCYCL CHEM, V62, P249, DOI 10.1016/S0065-2725(08)60423-7; GIFFARD M, 1993, J CHEM SOC CHEM COMM, P944, DOI 10.1039/c39930000944; HANSEN TK, 1991, J ORG CHEM, V56, P2720, DOI 10.1021/jo00008a027; HELLBERG J, 1994, J CHEM SOC CHEM COMM, P817, DOI 10.1039/c39940000817; Hudhomme P, 1997, ANGEW CHEM INT EDIT, V36, P878, DOI 10.1002/anie.199708781; Hudhomme P, 2001, CHEM-EUR J, V7, P5070, DOI 10.1002/1521-3765(20011203)7:23<5070::AID-CHEM5070>3.0.CO;2-6; Inayoshi T, 2000, SYNTHETIC MET, V110, P153, DOI 10.1016/S0379-6779(99)00293-3; Iyoda M, 2001, HETEROCYCLES, V54, P833; Jigami T, 2001, J MATER CHEM, V11, P1026, DOI 10.1039/b009700o; KATO R, 1984, CHEM LETT, P993, DOI 10.1246/cl.1984.993; KHODORKOVSKY V, 1989, J MOL ELECTRON, V5, P33; KOTOV AI, 1994, J ORG CHEM, V59, P2626, DOI 10.1021/jo00088a058; LICHTENBERGER DL, 1990, J AM CHEM SOC, V112, P3302, DOI 10.1021/ja00165a007; MAYER R, 1964, CHEM BER-RECL, V97, P1298, DOI 10.1002/cber.19640970513; MORI T, 1984, CHEM LETT, P1335, DOI 10.1246/cl.1984.1335; MORI T, 1990, CHEM LETT, P1279, DOI 10.1246/cl.1990.1279; Murata T, 2013, B CHEM SOC JPN, V86, P927, DOI 10.1246/bcsj.20130043; NARITA M, 1976, SYNTHESIS-STUTTGART, P489, DOI 10.1055/s-1976-24099; NIGREY PJ, 1986, SYNTHETIC MET, V16, P1, DOI 10.1016/0379-6779(86)90149-9; Perez-Benitez A, 1999, SYNTHESIS-STUTTGART, P577; Sakurai N, 1999, CHEM LETT, P1191, DOI 10.1246/cl.1999.1191; Senga T, 1997, MOL CRYST LIQ CRYS A, V296, P97, DOI 10.1080/10587259708032316; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Sugimoto H, 2005, INORG CHEM, V44, P6386, DOI 10.1021/ic050234; Tanaka K, 2000, ADV MATER, V12, P661, DOI 10.1002/(SICI)1521-4095(200005)12:9<661::AID-ADMA661>3.0.CO;2-7; Veldhuizen YSJ, 1998, J CHEM SOC DALTON, P2989, DOI 10.1039/a804034f; Yamada J., 2004, TTF CHEM FUNDAMENTAL	39	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0379-6779			SYNTHETIC MET	Synth. Met.	AUG	2015	206						162	177		10.1016/j.synthmet.2015.05.023		16	Materials Science, Multidisciplinary; Physics, Condensed Matter; Polymer Science	Materials Science; Physics; Polymer Science	CM2YP	WOS:000357548600020		
J	Tang, YY; Imasaka, T; Yamamoto, S; Imasaka, T				Tang, Yuanyuan; Imasaka, Tomoko; Yamamoto, Shigekazu; Imasaka, Totaro			Multiphoton ionization mass spectrometry of nitrated polycyclic aromatic hydrocarbons	TALANTA			English	Article						Nitrated polycyclic aromatic hydrocarbons; Multiphoton ionization; Mass spectrometry; Particulate matter 2.5	NITRO-PAHS; FEMTOSECOND LASER; PARTICULATE MATTER; EXHAUST PARTICLES; AMBIENT AIR; 1-NITROPYRENE; PHOTOCHEMISTRY; CHROMATOGRAPHY; URBAN; PRODUCTS	In order to suppress the fragmentation and improve the sensitivity for determination of nitrated polycyclic aromatic hydrocarbons (NPAHs), the mechanism of multiphoton ionization was studied for the following representative NPAHs, 9-nitroanthracene, 3-nitrofluoranthene, and 1-nitropyrene. The analytes were extracted from the PM2.5 on the sampling filter ultrasonically, and were measured using gas chromatography/multiphoton ionization/time-of-flight mass spectrometry with a femtosecond tunable laser in the range from 267 to 405 nm. As a result, a molecular ion was observed as the major ion and fragmentation was suppressed at wavelengths longer than 345 nm. Furthermore, the detection limit measured at 345 nm was measured to be the subpicogram level. The organic compounds were extracted from a 2.19 mg sample of particulate matter 2.5 (PM2.5), and the extract was subjected to multiphoton ionization mass spectrometry after gas chromatograph separation. The background signals were drastically suppressed at 345 nm, and the target NPAHs, including 9-nitroanthracene and 1-nitropyrene, were detected, and their concentrations were determined to be 5 and 3 pg/m(3), respectively. (C) 2015 Elsevier B.V. All rights reserved.	[Tang, Yuanyuan; Imasaka, Totaro] Kyushu Univ, Grad Sch Engn, Dept Appl Chem, Nishi Ku, Fukuoka 8190395, Japan; [Imasaka, Tomoko] Kyushu Univ, Lab Chem, Grad Sch Design, Minami Ku, Fukuoka 8158540, Japan; [Yamamoto, Shigekazu] Fukuoka Inst Hlth & Environm Sci, Div Air Sci, Fukuoka 8180135, Japan; [Imasaka, Totaro] Ctr Future Chem, Div Optoelect & Photon, Nishi Ku, Fukuoka 8190395, Japan	Tang, YY (reprint author), Kyushu Univ, Grad Sch Engn, Dept Appl Chem, Nishi Ku, 744 Motooka, Fukuoka 8190395, Japan.	tang.yuanyuan.398@s.kyushu-u.ac.jp			Japan Society for the Promotion of Science (JSPS) KAKENHI [23245017, 24510227, 26220806]	This research was supported by a Grant-in-Aid from the Japan Society for the Promotion of Science (JSPS) KAKENHI Grant numbers 23245017, 24510227, and 26220806. The quantum chemical calculations were mainly carried out using the computer facilities at the Research Institute for Information Technology, Kyushu University.	Li A, 2011, ANAL CHIM ACTA, V701, P52, DOI 10.1016/j.aca.2011.06.003; Imasaka T, 2013, ANAL BIOANAL CHEM, V405, P6907, DOI 10.1007/s00216-013-6960-8; Bauernschmitt R, 1996, CHEM PHYS LETT, V256, P454, DOI 10.1016/0009-2614(96)00440-X; Li A, 2010, ANAL SCI, V26, P841; Feilberg A, 2001, ATMOS ENVIRON, V35, P353, DOI 10.1016/S1352-2310(00)00142-4; Wang WT, 2011, ENVIRON SCI TECHNOL, V45, P6887, DOI 10.1021/es201443z; Crimmins BS, 2006, ATMOS ENVIRON, V40, P6764, DOI 10.1016/j.atmosenv.2006.05.078; Zimmermann K, 2013, ENVIRON SCI TECHNOL, V47, P8434, DOI 10.1021/es401789x; NIELSEN T, 1984, ENVIRON SCI TECHNOL, V18, P157, DOI 10.1021/es00121a005; CHAPMAN OL, 1966, J AM CHEM SOC, V88, P5550, DOI 10.1021/ja00975a037; ATKINSON R, 1990, INT J CHEM KINET, V22, P999, DOI 10.1002/kin.550220910; ATKINSON R, 1994, INT J CHEM KINET, V26, P929, DOI 10.1002/kin.550260907; Bamford HA, 2003, ATMOS ENVIRON, V37, P2077, DOI 10.1016/S1352-2310(03)00102-X; Teixeira EC, 2011, ATMOS RES, V101, P631, DOI 10.1016/j.atmosres.2011.04.010; Bezabeh DZ, 1997, J AM SOC MASS SPECTR, V8, P630, DOI 10.1016/S1044-0305(97)00078-0; Matsui T, 2012, ANAL SCI, V28, P445; DUNNING TH, 1989, J CHEM PHYS, V90, P1007, DOI 10.1063/1.456153; Crespo-Hernandez CE, 2008, J PHYS CHEM A, V112, P6313, DOI 10.1021/jp803847q; Arce R, 2008, J PHYS CHEM A, V112, P10294, DOI 10.1021/jp803051x; Barrado-Olmedo AI, 2012, TALANTA, V101, P428, DOI 10.1016/j.talanta.2012.09.053; Dotter RN, 1996, ANAL CHEM, V68, P2319, DOI 10.1021/ac951132r; Durant JL, 1996, MUTAT RES-GENET TOX, V371, P123, DOI 10.1016/S0165-1218(96)90103-2; Kaneyasu N., 2010, J JPN SOC ATMOS ENV, V45, P171; Kawanaka Y, 2007, J CHROMATOGR A, V1163, P312, DOI 10.1016/j.chroma.2007.06.038; Li A, 2011, ANAL CHEM, V83, P60, DOI 10.1021/ac101849w; Matsui T, 2011, ANAL CHIM ACTA, V694, P108, DOI 10.1016/j.aca.2011.03.041; Matsui T, 2014, ANAL SCI, V30, P445; Miller-Schulze JP, 2007, J CHROMATOGR A, V1167, P154, DOI 10.1016/j.chroma.2007.08.026; Mora AK, 2013, J PHOTOCH PHOTOBIO A, V271, P24, DOI 10.1016/j.jphotochem.2013.08.003; Morales-Cueto R., 2007, J PHYS CHEM A, V111, P552; Murakami M, 2008, ENVIRON SCI TECHNOL, V42, P1144, DOI 10.1021/es071904o; Oukebdane K, 2010, TALANTA, V82, P227, DOI 10.1016/j.talanta.2010.04.027; Parks M., SPECTROSCOPIC STUDIE; Shitamichi O, 2012, FRONT ENV SCI ENG, V6, P26, DOI 10.1007/s11783-011-0374-7; Tang N, 2003, ANAL SCI, V19, P249, DOI 10.2116/analsci.19.249; Tasker AD, 2003, INT J MASS SPECTROM, V225, P53, DOI 10.1016/S1387-3806(02)01045-X; Tasker AD, 2001, LASER PART BEAMS, V19, P205, DOI 10.1017/S0263034601192062; Watanabe-Ezoe Y, 2010, ANAL CHEM, V82, P6519, DOI 10.1021/ac1009063; Xu JH, 2001, CHEMOSPHERE, V42, P245; Yamaguchi S, 2009, ANAL CHIM ACTA, V632, P229, DOI 10.1016/j.aca.2008.11.005	40	0	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0039-9140	1873-3573		TALANTA	Talanta	AUG 1	2015	140						109	114		10.1016/j.talanta.2015.03.027		6	Chemistry, Analytical	Chemistry	CL5GI	WOS:000356987400017		
J	Song, S				Song, Sopheak			Cambodian teachers' responses to child-centered instructional policies: A mismatch between beliefs and practices	TEACHING AND TEACHER EDUCATION			English	Article						Child-centered pedagogy; Instructional reform; Implementation research; Classroom environment; Teacher beliefs; Cambodia	EDUCATION; IMPLEMENTATION; INNOVATION; COUNTRIES; PROGRAM; QUALITY; REFORM	Cambodia and her international development partners have been promoting child-centered pedagogy for almost two decades. However, classroom instruction remains predominantly front-oriented and textbook-based. Drawing on questionnaire and interview surveys with primary school teachers in two districts of Cambodia, this study analyzes teachers' beliefs in and classroom implementation of child-centered pedagogy. It has found that teachers fail to adopt this new pedagogy in their classrooms despite their overwhelming support for it. Teachers' failure to act on their beliefs stems from two major reasons: constraining classroom realities and their superficial understanding of the principles underlying child-centered pedagogy. (C) 2015 Elsevier Ltd. All rights reserved.	[Song, Sopheak] Hiroshima Univ, Hiroshima 730, Japan	Song, S (reprint author), A205,8510-1 Hara,Hachihonmatsu Cho, Higashihiroshima 7390151, Japan.	pheakathiroshima@gmail.com					AndersonLevitt KM, 2003, LOCAL MEANINGS, GLOBAL SCHOOLING: ANTHROPOLOGY AND WORLD CULTURE THEORY, P1, DOI 10.1057/9781403980359; Coburn CE, 2006, AM EDUC RES J, V43, P343, DOI 10.3102/00028312043003343; Brodie K, 2002, TEACH TEACH EDUC, V18, P541, DOI 10.1016/S0742-051X(02)00015-X; McCormick A, 2012, COMP EDUC REV, V56, P18, DOI 10.1086/661252; O'Sullivan M, 2004, INT J EDUC DEV, V24, P585, DOI 10.1016/S0738-0593(03)00018-X; Spillane JP, 2002, REV EDUC RES, V72, P387, DOI 10.3102/00346543072003387; Spillane JP, 1999, J CURRICULUM STUD, V31, P143, DOI 10.1080/002202799183205; van den Berg R, 2002, REV EDUC RES, V72, P577, DOI 10.3102/00346543072004577; Sriprakash A, 2010, INT J EDUC DEV, V30, P297, DOI 10.1016/j.ijedudev.2009.11.010; Schweisfurth M, 2011, INT J EDUC DEV, V31, P425, DOI 10.1016/j.ijedudev.2011.03.005; Hill HC, 2001, AM EDUC RES J, V38, P289, DOI 10.3102/00028312038002289; Napier DB, 2003, LOCAL MEANINGS, GLOBAL SCHOOLING: ANTHROPOLOGY AND WORLD CULTURE THEORY, P51; Stipek DJ, 2001, TEACH TEACH EDUC, V17, P213, DOI 10.1016/S0742-051X(00)00052-4; Carnoy M, 2002, COMP EDUC REV, V46, P1, DOI 10.1086/324053; Wang D, 2011, TEACH TEACH EDUC, V27, P157, DOI 10.1016/j.tate.2010.07.012; Graneheim UH, 2004, NURS EDUC TODAY, V24, P105, DOI 10.1016/j.nedt.2003.10.001; GENTNER D, 1993, COGNITIVE PSYCHOL, V25, P524, DOI 10.1006/cogp.1993.1013; WEATHERLEY R, 1977, HARVARD EDUC REV, V47, P171; Anorve R. F., 1999, COMP ED DIALECTIC GL, P1; Asian Development Bank, 1996, CAMB ED SECT STRAT S; Ayres D. M., 2000, ANATOMY CRISIS ED DE; Benveniste L., 2008, TEACHING IN CAMBODIA; Berg B. L., 2001, QUALITATIVE RES METH; Bunroeun N., 1999, TEACHER TRAINING SYS, V78, P1; Chisholm L., 2009, INT HDB COMP ED, P685, DOI 10.1007/978-1-4020-6403-6_44; Coburn CE, 2001, EDUC EVAL POLICY AN, V23, P145, DOI 10.3102/01623737023002145; Cohen D. K., 1990, EDUC EVAL POLICY AN, V12, P331, DOI 10.3102/01623737012003331; Cohen D. K., 1990, EDUC EVAL POLICY AN, V12, P233, DOI 10.3102/01623737012003233; Cohen D.K., 2001, LEARNING POLICY STAT; Courtney J, 2008, INT J EDUC DEV, V28, P546, DOI 10.1016/j.ijedudev.2007.07.002; Courtney J, 2014, COMPARE, V44, P416, DOI 10.1080/03057925.2013.765287; Isikoglu N, 2009, TEACH TEACH EDUC, V25, P350, DOI 10.1016/j.tate.2008.08.004; Kennedy M., 2005, INSIDE TEACHING CLAS; Leatham K., 2006, J MATH TEACHER ED, V9, P91, DOI 10.1007/s10857-006-9006-8; Lipsky Michael, 2010, STREET LEVEL BUREAUC; McLaughlin M. W., 1990, EDUC RES, V19, P11; McLaughlin M.W., 1987, EDUC EVAL POLICY AN, V9, P171, DOI DOI 10.3102/01623737009002171; Meyer JW, 2000, DISCOURSE FORMATION, P111; Meyer JW, 2010, SOCIOL EDUC, V83, P111, DOI 10.1177/0038040710367936; MoEYS, 2007, CHILD FRIENDL SCH PO; MoEYS, 2007, EKS KAOMTR KAR AN KA; MoEYS, 2007, EKS KAMV SAL KOM MET; MoEYS, 2001, SIEVPH KRUU KAEN THN; MoEYS, 1994, REB QUAL ED TRAIN CA; MoEYS, 2007, CHILD FRIENDL SCH CF; MoEYS, 2008, KORL VITH SIS MACHH; MoEYS, 2001, EKS SOMR VAEK DAMR T; MoEYS, 2012, KORL NOYORB SDEIP SI; MoEYS, 1997, TXB TEACH GUID UT MA; O'Sullivan M., 2002, COMPARE, V32, P219, DOI DOI 10.1080/03057920220143192; Ogisu T., 2013, COMP ED B JAPAN COMP, V47, P79; Popov O., 1998, CURRICULUM IN PRESS; Raymond AM, 1997, J RES MATH EDUC, V28, P550, DOI 10.2307/749691; Rogan JM, 2003, INT J SCI EDUC, V25, P1171, DOI 10.1080/09500690210145819; Rogan JM, 2007, J CURRICULUM STUD, V39, P97, DOI 10.1080/00220270500532448; Royal Government of Cambodia, 1993, CONST KINGD CAMB; Schon D. A., 1974, THEORY PRACTICE INCR; Schuh KL, 2004, TEACH TEACH EDUC, V20, P833, DOI 10.1016/j.tate.2004.09.008; Spillane J. P., 2004, STANDARD DEVIATIONS; Stein M. K., 1997, MATH TEACHERS TRANSI; SteinerKhamsi G, 2006, EDUCATIONAL IMPORT: LOCAL ENCOUNTERS WITH GLOBAL FORCES IN MONGOLIA, P1, DOI 10.1057/9781403982971; Strauss A., 1990, BASICS QUALITATIVE R; Teddlie C., 2009, FDN MIXED METHODS RE; UNICEF, 2009, MAN CHILD FRIENDL SC; Van den Akker J., 1994, INT ENCY ED, P1491; Wilkins J. L. M., 2008, J MATH TEACHER ED, V11, P139, DOI DOI 10.1007/S10857-007-9068-2	66	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0742-051X			TEACH TEACH EDUC	Teach. Teach. Educ.	AUG	2015	50						36	45		10.1016/j.tate.2015.04.004		10	Education & Educational Research	Education & Educational Research	CM0DV	WOS:000357349500004		
J	Castro-Jimenez, FJ; Fernandez-Fernandez, MC; Koike, T; Takayama, N				Castro-Jimenez, Francisco-Jesus; Fernandez-Fernandez, Maria-Cruz; Koike, Tatsuya; Takayama, Nobuki			IRREGULAR MODIFIED A-HYPERGEOMETRIC SYSTEMS	TRANSACTIONS OF THE AMERICAN MATHEMATICAL SOCIETY			English	Article							MONOMIAL CURVE; GEVREY SOLUTIONS; D-MODULES; SLOPES; INTEGRALS	A modified A-hypergeometric system is a system of differential equations for the function f(t(w) . x), where f(y) is a solution of an A-hypergeometric system in n variables and w is an n-dimensional integer vector, which is called the weight vector. We study the irregularity of modified systems by adapting to this case the notion of umbrella introduced by M. Schulze and U. Walther. Especially, we study slopes and Gevrey series solutions. We develop some applications of this study. Under some conditions we give Laplace integral representations of divergent series solutions of the modified system and we show that certain Gevrey series solutions of the original A-hypergeometric system along coordinate varieties are Gevrey asymptotic expansions of holomorphic solutions of the A-hypergeometric system.	[Castro-Jimenez, Francisco-Jesus; Fernandez-Fernandez, Maria-Cruz] Univ Seville, Dept Algebra, Seville, Spain; [Koike, Tatsuya; Takayama, Nobuki] Kobe Univ, Dept Math, Kobe, Hyogo 657, Japan	Castro-Jimenez, FJ (reprint author), Univ Seville, Dept Algebra, Seville, Spain.	castro@us.es; mcferfer@us.es; koike@math.kobe-u.ac.jp; takayama@math.kobe-u.ac.jp	Castro-Jimenez, Francisco-Jesus/K-1703-2014	Castro-Jimenez, Francisco-Jesus/0000-0002-7513-3786	FEDER; Junta de Andalucia [FQM5849, FQM333]; Max Planck Institute fur Mathematik (Bonn); JSPS [21740098, S-24224001];  [MTM2010-19336];  [S-13025-JSPS]	The first and second authors were partially supported by MTM2010-19336 and FEDER and Junta de Andalucia FQM5849, FQM333.; The first author was also partially supported by S-13025-JSPS (Japan).; The second author was also partially supported by Max Planck Institute fur Mathematik (Bonn).; The third author was partially supported by JSPS grants-in-aid No. 21740098 and No. S-24224001.	GELFAND IM, 1990, ADV MATH, V84, P255, DOI 10.1016/0001-8708(90)90048-R; Schulze M, 2008, DUKE MATH J, V142, P465, DOI 10.1215/00127094-2008-011; Matusevich LF, 2005, J AM MATH SOC, V18, P919, DOI 10.1090/S0894-0347-05-00488-1; ADOLPHSON A, 1994, DUKE MATH J, V73, P269, DOI 10.1215/S0012-7094-94-07313-4; Assi A, 1996, COMPOS MATH, V104, P107; Balser Werner, 1994, LECT NOTES MATH, V1582; Berkesch C, 2014, MICH MATH J, V63, P101; Berngein I. N., 1971, FUNCTIONAL ANAL ITS, V5, P1, DOI 10.1007/BF01075841; Beukers F., ARXIV11010493V2; Castro-Jimenez FJ, 2003, T AM MATH SOC, V355, P3761, DOI 10.1090/S0002-9947-03-03300-2; Dickenstein A, 2012, REV MAT IBEROAM, V28, P723, DOI 10.4171/RMI/689; Esterov A., 2011, ARXIV11070402; Fernandez-Fernandez MC, 2011, J ALGEBRA, V339, P320, DOI 10.1016/j.jalgebra.2011.02.045; Fernandez-Fernandez MC, 2010, ADV MATH, V224, P1735, DOI 10.1016/j.aim.2010.01.017; Fernandez-Fernandez MC, 2011, T AM MATH SOC, V363, P923; GELFAND IM, 1987, DOKL AKAD NAUK SSSR+, V295, P14; Hartillo-Hermoso MI, 2005, T AM MATH SOC, V357, P4633, DOI 10.1090/S0002-9947-04-03614-1; Hermoso MIH, 2003, REV MAT IBEROAM, V19, P455; Hotta R., 1998, ARXIVMATH9805021; Hrabowski Jan, 1985, J MATH ANAL, V16, P876, DOI [10.1137/0516066, DOI 10.1137/0516066]; GELFAND IM, 1989, FUNCT ANAL APPL+, V23, P94, DOI 10.1007/BF01078777; LAUMON G, 1985, ASTERISQUE, P56; Laurent Y, 1999, ANN SCI ECOLE NORM S, V32, P39, DOI 10.1016/S0012-9593(99)80008-1; LAURENT Y, 1987, ANN SCI ECOLE NORM S, V20, P391; Mebkhout Zoghman, 1990, PROGR MATH, VIII, P83, DOI 10.1007/978-0-8176-4576-2_4; Ohara K, 2009, J PURE APPL ALGEBRA, V213, P1536, DOI 10.1016/j.jpaa.2008.11.018; Saito Mutsumi, 2000, ALGORITHMS COMPUTATI, V6; Schulze Mathias, ARXIVMATH0608668V3MA; Sturmfels B., 1996, U LECT SERIES, V8; Takayama N, 2009, KYUSHU J MATH, V63, P113, DOI 10.2206/kyushujm.63.113	30	0	0	AMER MATHEMATICAL SOC	PROVIDENCE	201 CHARLES ST, PROVIDENCE, RI 02940-2213 USA	0002-9947	1088-6850		T AM MATH SOC	Trans. Am. Math. Soc.	AUG	2015	367	8					5415	5445	PII S0002-9947(2014)06225-9			31	Mathematics	Mathematics	CL5ZZ	WOS:000357046100007		
J	Tsutsui, H; Fujiwara, T; Inoue, D; Ito, R; Matsukawa, K; Funamizu, N				Tsutsui, Hirofumi; Fujiwara, Taku; Inoue, Daisuke; Ito, Ryusei; Matsukawa, Kazutsugu; Funamizu, Naoyuki			Relationship between respiratory quotient, nitrification, and nitrous oxide emissions in a forced aerated composting process	WASTE MANAGEMENT			English	Article						Composting; Respiratory quotient; Nitrification; Nitrous oxide	AMMONIA-OXIDIZING ARCHAEA; BACTERIAL COMMUNITIES; GREENHOUSE-GAS; CATTLE MANURE; CH4 EMISSIONS; PIG MANURE; FLOW-RATE; N2O; NH3; WASTE	We assessed the relationship between respiratory quotient (RQ) and nitrification and nitrous oxide (N2O) emission in forced aerated composting using lab-scale reactors. Relatively high RQ values from degradation of readily degradable organics initially occurred. RQ then stabilized at slightly lower values, then decreased. Continuous emission of N2O was observed during the RQ decrease. Correlation between nitrification and N2O emission shows that the latter was triggered by nitrification. Mass balances demonstrated that the O-2 consumption of nitrification (similar to 24.8 mmol) was slightly higher than that of CO2 emission (similar to 20.0 mmol), indicating that the RQ decrease was caused by the occurrence of nitrification. Results indicate that RQ is a useful index, which not only reflects the bioavailability of organics but also predicts the occurrence of nitrification and N2O emission in forced aerated composting. (C) 2015 Elsevier Ltd. All rights reserved.	[Tsutsui, Hirofumi; Fujiwara, Taku] Kochi Univ, Res & Educ Fac, Nat Sci Cluster, Agr Unit, Nankoku, Kochi, Japan; [Inoue, Daisuke] Kitasato Univ, Sch Allied Hlth Sci, Dept Hlth Sci, Sagamihara, Kanagawa 228, Japan; [Ito, Ryusei; Funamizu, Naoyuki] Hokkaido Univ, Dept Environm Engn, Grad Sch Engn, Kita Ku, Sapporo, Hokkaido, Japan; [Matsukawa, Kazutsugu] Kochi Univ, Life & Environm Med Sci Unit, Multidisciplinary Sci Cluster, Res & Educ Fac, Nankoku, Kochi, Japan; [Tsutsui, Hirofumi; Fujiwara, Taku; Inoue, Daisuke; Ito, Ryusei; Matsukawa, Kazutsugu; Funamizu, Naoyuki] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama, Japan	Tsutsui, H (reprint author), Kochi Univ, Res & Educ Fac, Nat Sci Cluster, Agr Unit, B200 Monobe, Nankoku, Kochi, Japan.	jm-tsutsuih@kochi-u.ac.jp			Core Research for Evolutionary Science and Technology (CREST) of the Japan Science and Technology Agency	This research was financially supported by the Core Research for Evolutionary Science and Technology (CREST) of the Japan Science and Technology Agency. The authors wish to thank Dr. Nowaki Hijikata of Hokkaido University for his assistance with the instrumental analyses.	Lee DH, 1996, APPL ENVIRON MICROB, V62, P3112; Bernal MP, 2009, BIORESOURCE TECHNOL, V100, P5444, DOI 10.1016/j.biortech.2008.11.027; Fukumoto Y, 2006, ENVIRON SCI TECHNOL, V40, P6787, DOI 10.1021/es0611801; Tsutsui H, 2013, BIORESOURCE TECHNOL, V141, P205, DOI 10.1016/j.biortech.2013.02.071; Dilly O, 2003, FEMS MICROBIOL ECOL, V43, P375, DOI 10.1111/j.1574-6941.2003.tb01078.x; Fukumoto Y, 2009, SOIL SCI PLANT NUTR, V55, P428, DOI 10.1111/j.1747-0765.2009.00376.x; Hotta S, 2007, BIORESOURCE TECHNOL, V98, P3412, DOI 10.1016/j.biortech.2006.10.045; Fukumoto Y, 2003, BIORESOURCE TECHNOL, V89, P109, DOI 10.1016/S0960-8524(03)00060-9; Fukumoto Y, 2011, BIORESOURCE TECHNOL, V102, P1468, DOI 10.1016/j.biortech.2010.09.089; Ahn HK, 2011, BIORESOURCE TECHNOL, V102, P2904, DOI 10.1016/j.biortech.2010.10.142; Lasaridi K, 2006, J ENVIRON MANAGE, V80, P58, DOI 10.1016/j.jenvman.2005.08.011; Jarvis A, 2009, J APPL MICROBIOL, V106, P1502, DOI 10.1111/j.1365-2672.2008.04111.x; Gea T, 2004, BIOTECHNOL BIOENG, V88, P520, DOI 10.1002/bit.20281; Fujiwara T, 2012, WATER SCI TECHNOL, V66, P1171, DOI 10.2166/wst.2012.246; Szanto GL, 2007, BIORESOURCE TECHNOL, V98, P2659, DOI 10.1016/j.biortech.2006.09.021; Yamada T, 2013, SYST APPL MICROBIOL, V36, P359, DOI 10.1016/j.syapm.2013.02.001; Komilis D, 2011, BIORESOURCE TECHNOL, V102, P5863, DOI 10.1016/j.biortech.2011.02.021; Yamamoto N, 2010, MICROB ECOL, V60, P807, DOI 10.1007/s00248-010-9714-6; Angnes G, 2013, BIORESOURCE TECHNOL, V140, P368, DOI 10.1016/j.biortech.2013.04.112; Gomez RB, 2006, WASTE MANAGE RES, V24, P37, DOI 10.1177/0734242X06062385; Zavala MAL, 2004, WATER RES, V38, P1327, DOI 10.1016/j.watres.2003.10.028; Francis CA, 2005, P NATL ACAD SCI USA, V102, P14683, DOI 10.1073/pnas.0506625102; Maeda K, 2010, APPL ENVIRON MICROB, V76, P1555, DOI 10.1128/AEM.01394-09; Zhang JC, 2011, BIORESOURCE TECHNOL, V102, P2950, DOI 10.1016/j.biortech.2010.11.089; Rotthauwe JH, 1997, APPL ENVIRON MICROB, V63, P4704; Atkinson CF, 1997, WORLD J MICROB BIOT, V13, P519, DOI 10.1023/A:1018557123868; California Compost Quality Council (CCQC), 2001, TECHNICAL REPORT; Chowdhury MA, 2014, CHEMOSPHERE, V97, P16, DOI 10.1016/j.chemosphere.2013.10.030; Komilis D, 2012, BIORESOURCE TECHNOL, V117, P300, DOI 10.1016/j.biortech.2012.04.095; Komilis D, 2011, J ENVIRON MANAGE, V92, P2241, DOI 10.1016/j.jenvman.2011.04.012; Guo R, 2012, BIORESOURCE TECHNOL, V112, P171, DOI 10.1016/j.biortech.2012.02.099; Solomon S., 2007, CLIMATE CHANGE, P235, DOI DOI 10.1038/NCLIMATE1258; Xie KZ, 2012, BIORESOURCE TECHNOL, V120, P70, DOI 10.1016/j.biortech.2012.06.029; Zeng GM, 2011, BIORESOURCE TECHNOL, V102, P9026, DOI 10.1016/j.biortech.2011.07.076	34	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0956-053X			WASTE MANAGE	Waste Manage.	AUG	2015	42						10	16		10.1016/j.wasman.2015.02.038		7	Engineering, Environmental; Environmental Sciences	Engineering; Environmental Sciences & Ecology	CM0DL	WOS:000357348500003		
J	Pratoomchai, W; Kazama, S; Manandhar, S; Ekkawatpanit, C; Saphaokham, S; Komori, D; Thongduang, J				Pratoomchai, Weerayuth; Kazama, So; Manandhar, Sujata; Ekkawatpanit, Chaiwat; Saphaokham, Somkid; Komori, Daisuke; Thongduang, Jaray			Sharing of people's Perceptions of Past and Future Hydro-Meteorological Changes in the Groundwater Use Area	WATER RESOURCES MANAGEMENT			English	Article						Climate change; Drought; Flooding; People's perceptions; Thailand; Water resources	RIVER-BASIN; RESOURCES	The study revealed local people's perceptions (PP) of the past and future hydro-meteorological changes in a groundwater use area in Thailand. A statistically significant increase at the 95 % confidence level was found in the annual mean surface air temperature, rising over the period from 1955 to 2012. From 1993 to 2012, statistical values and hydrological extreme events showed the highest variability relative to the period from 1955 to 1992, which could be a signal of climate change impacts in the study area. The majority of people (94.7-100.0 %) shared that less available surface water may occur and that this result is driven by climate change. However, a majority of elder generation (a parts per thousand yen41 years old, 55.6-84.2 %) do not realize the potential climate change impacts because their groundwater will alleviate the problems. Incorrect PP on groundwater was confirmed by 81.8-89.5 % of people who shared that climate change will not impact groundwater. Furthermore, past hydrological extreme events should bear in the people's mind; however, the shared PP on the flood and drought events were not correct. Exposure time to flood (approximately 1 week) and drought (approximately 5 months) is one of the potential factor on the misperception. Examining the PP of different generations, people who are a parts per thousand yenaEuro parts per thousand 41 years old shared almost the same PP, and the people who are a parts per thousand currency signaEuro parts per thousand 40 years old showed more awareness of climate change impacts. From an optimistic point of view, the younger generation realized potential climate change impacts; thus, the implementation of future adaptations is expected to have strong cooperation.	[Pratoomchai, Weerayuth; Kazama, So; Manandhar, Sujata; Komori, Daisuke] Tohoku Univ, Grad Sch Engn, Dept Civil Engn, Hydroenvironm Syst Lab,Aoba Ku, Sendai, Miyagi 9808579, Japan; [Ekkawatpanit, Chaiwat] King Mongkuts Univ Technol Thonburi, Dept Civil Engn, Fac Engn, Bangkok 10140, Thailand; [Saphaokham, Somkid; Thongduang, Jaray] Royal Irrigat Dept, Bangkok 10300, Thailand	Pratoomchai, W (reprint author), Tohoku Univ, Grad Sch Engn, Dept Civil Engn, Hydroenvironm Syst Lab,Aoba Ku, 6-6-06 Aramaki Aza Aoba, Sendai, Miyagi 9808579, Japan.	ong@kaigan.civil.tohoku.ac.jp			Integrated Study Project on Hydro-Meteorological Prediction and Adaptation to Climate Change in Thailand (IMPAC-T project); Monbukagakusho scholarship	We sincerely thank the Integrated Study Project on Hydro-Meteorological Prediction and Adaptation to Climate Change in Thailand (IMPAC-T project) and the Monbukagakusho scholarship (for the first author) for supporting this study. Special thanks go to Mr. Pongsak Prasongwanna and Mr. Somchai Tamkuan from the Sukhothai Irrigation and Maintenance Project for helping us conduct the field survey as well as the kind co-operation of all interviewees. In addition, we would like to express our sincere thanks to anonymous reviewers for suggestions and comments improving the paper quality.	Hanasaki N, 2008, HYDROL EARTH SYST SC, V12, P1007; Doll P, 2009, ENVIRON RES LETT, V4, DOI 10.1088/1748-9326/4/3/035006; Jackson CR, 2011, J HYDROL, V399, P12, DOI 10.1016/j.jhydrol.2010.12.028; Jones N, 2011, WATER RESOUR MANAG, V25, P509, DOI 10.1007/s11269-010-9711-z; Hanasaki N, 2013, HYDROL EARTH SYST SC, V17, P2393, DOI 10.5194/hess-17-2393-2013; Department of Disaster Prevention and Mitigation, 2014, NAT DIS SIT THAIL; Department of Water Resources, 2007, STRAT PLAN WAT RES M; Dingman S. L., 2008, PHYS HYDROLOGY; Giupponi C, 2014, WATER RESOUR MANAG, V28, P4795, DOI 10.1007/s11269-014-0776-y; Hanasaki N, 2014, HYDROL RES LETT, V8, P9, DOI DOI 10.3178/HRL.8.9; Helsel DR, 2006, 20055275 US GEOL SUR, P4; Jongjaidee J, 2010, J AGR, V26, P29; Kazama S, 2007, J HYDROL, V340, P233, DOI 10.1016/j.jhydrol.2007.04.017; Komori D., 2012, HYDROL RES LETT, V6, P41, DOI DOI 10.3178/HRL.6.41; Kotsuki S, 2010, P 23 C JAP SOC HYDR, P44; Manandhar S, 2013, CLIMATIC CHANGE, V120, P727, DOI 10.1007/s10584-013-0842-0; Manandhar S, 2012, CLIM RES, V54, P167, DOI 10.3354/cr01108; Manandhar S, 2015, INT J DISAST RISK RE, V11, P47, DOI 10.1016/j.ijdrr.2014.11.002; McKee T. B., 1993, P 8 C APPL CLIM, V17, P179; National Drought Mitigation Center, 2014, PROGR CALC STAND PRE; National Statistical Office, 2014, BAS THAIL STAT; Pratoomchai W, 2014, HYDROL RES LETT, V8, P20; Pratoomchai W, 2015, INT J RIVER BASIN MA, V13, P1; Ramnarong V, 1999, THAI HYDROL ASS J, V1, P1; Royal Irrigation Department, 2008, MON MEAS GROUNDW LEV; Royal Irrigation Department, 2010, SYST IRR PLAN FRAM 6; Thai Meteorological Department, 2014, DROUGHT THAIL; Watanabe S, 2014, HYDROL RES LETT, V8, P33	28	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0920-4741	1573-1650		WATER RESOUR MANAG	Water Resour. Manag.	AUG	2015	29	10					3807	3821		10.1007/s11269-015-1030-y		15	Engineering, Civil; Water Resources	Engineering; Water Resources	CM0CH	WOS:000357345300021		
J	Yamane, H; Konishi, K; Sakamaoto, H; Yamamoto, H; Matsushita, N; Oishi, M; Iguchi, H; Inoue, Y				Yamane, Hideo; Konishi, Kazuo; Sakamaoto, Hiramori; Yamamoto, Hidefumi; Matsushita, Naoki; Oishi, Masahiro; Iguchi, Hiroyoshi; Inoue, Yuichi			Practical 3DCT imaging of the vestibular aqueduct for Meniere's disease	ACTA OTO-LARYNGOLOGICA			English	Article						CT image; CT window; endolymphatic duct and sac; endolymphatic hydrops; membranous labyrinth	ENDOLYMPHATIC SAC; COMPUTERIZED-TOMOGRAPHY; INNER-EAR; DUCT; BONE	Conclusion: Radiographic visualization of the vestibular aqueduct (VA) from a lateral inside view was effective in assessing patients with Meniere's disease (MD). There were no VA shapes specific to MD on radiography, except for an obliterated VA. This technique could yield more accurate images and functional assessment of the VA for MD evaluation in a clinically useful and convenient manner, without requiring morphologic measurement. Objective: To visualize the detailed images of the VA using three-dimensional (3D) computed tomography (CT) and discuss its clinical utility in assessing MD. Subjects and methods: The VAs in 13 healthy subjects and 25 MD patients, who were definitely diagnosed according to criteria described by the Committee on Hearing and Equilibrium of the American Academy of Otolaryngology, Head and Neck Surgery (AAO-HNS), were imaged from the medial and lateral sides using 3DCT and compared to conventional CT images. Results: Examination of the VA from both the lateral outside and inside views on 3DCT yielded more precise images than generated by conventional CT and could be useful to estimate the VA function. The estimated VA function in the MD ears was significantly abnormal compared to the function in healthy ears. An obliterated VA was characteristic of affected MD ears.	[Yamane, Hideo; Konishi, Kazuo; Sakamaoto, Hiramori; Yamamoto, Hidefumi; Matsushita, Naoki; Oishi, Masahiro; Iguchi, Hiroyoshi] Osaka City Univ, Grad Sch Med, Dept Otolaryngol, Osaka 5458585, Japan; [Inoue, Yuichi] Osaka City Gen Hosp, Dept Diagnost Radiol, Osaka, Japan	Yamane, H (reprint author), Osaka City Univ, Grad Sch Med, Dept Otorhinolaryngol, Abeno Ku, 1-4-3 Asahimachi, Osaka 5458585, Japan.	ent-yamane@med.osaka-cu.ac.jp					Sajjadi H, 2008, LANCET, V372, P406, DOI 10.1016/S0140-6736(08)61161-7; Anson BJ, 1981, SURG ANATOMY TEMPORA; ARENBERG IK, 1977, ARCH OTOLARYNGOL, V103, P1; BRETLAU P, 1989, AM J OTOL, V10, P259; Clemis J., 1968, OTOLARYNGOL CLIN N A, V1, P339; KIMURA RS, 1980, ACTA OTO-LARYNGOL, V89, P295, DOI 10.3109/00016488009127141; KRAUS EM, 1979, ARCH OTOLARYNGOL, V105, P91; Krombach GA, 2005, EUR RADIOL, V15, P1505, DOI 10.1007/s00330-005-2750-9; Lundquist PG, 1965, ACTA OTO-LARYNGOL, V291, P1; oigaard Thomsen J, 1975, ARCH OTORHINOLARYNGO, V211, P1; RASKANDERSEN H, 1980, ACTA OTO-LARYNGOL, V89, P283, DOI 10.3109/00016488009127140; RUMBAUGH CL, 1974, RADIOL CLIN N AM, V12, P517; Salt AN, 2004, HEARING RES, V191, P90, DOI 10.1016/j.heares.2003.12.018; STAHLE J, 1974, ACTA OTO-LARYNGOL, V78, P36, DOI 10.3109/00016487409126323; Takeda T, 1997, ACTA OTO-LARYNGOL, V528, P283; VALVASSORI GE, 1984, ANN OTO RHINOL LARYN, V93, P547; Yamane H, 2010, ACTA OTO-LARYNGOL, V130, P233, DOI 10.3109/00016480903096648; Yamane H, 2014, ACTA OTO-LARYNGOL, V134, P1016, DOI 10.3109/00016489.2014.913315; YAZAWA Y, 1994, ACTA OTO-LARYNGOL, P67; YUEN SS, 1972, ARCHIV OTOLARYNGOL, V96, P553	20	0	0	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0001-6489	1651-2251		ACTA OTO-LARYNGOL	Acta Oto-Laryngol.	AUG	2015	135	8					799	806		10.3109/00016489.2015.1034879		8	Otorhinolaryngology	Otorhinolaryngology	CL1AD	WOS:000356673400010		
